PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jensen, V; Rappaport, BA				Jensen, Valerie; Rappaport, Bob A.			The Reality of Drug Shortages - The Case of the Injectable Agent Propofol	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jensen, Valerie] Ctr Drug Evaluat & Res, Drug Shortage Program, FDA, Silver Spring, MD USA; [Rappaport, Bob A.] Ctr Drug Evaluat & Res, Div Anesthesia & Analgesia Prod, FDA, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Jensen, V (corresponding author), Ctr Drug Evaluat & Res, Drug Shortage Program, FDA, Silver Spring, MD USA.							Food and Drug Administration, CURR DRUG SHORT; Hampton T, 2007, JAMA-J AM MED ASSOC, V298, P727, DOI 10.1001/jama.298.7.727; *NAT LIB MED, PROP DRUG LAB; Steinbrook R, 2009, NEW ENGL J MED, V361, P1525, DOI 10.1056/NEJMp0906922; 2008, MMWR MORB MORTAL WKL, V57, P513	5	64	65	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 26	2010	363	9					806	807		10.1056/NEJMp1005849	http://dx.doi.org/10.1056/NEJMp1005849			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642HG	20554977				2022-12-01	WOS:000281196600003
J	Moore, MJ; Wang, QQ; Kennedy, CJ; Silver, PA				Moore, Michael J.; Wang, Qingqing; Kennedy, Caleb J.; Silver, Pamela A.			An Alternative Splicing Network Links Cell-Cycle Control to Apoptosis	CELL			English	Article							PRE-MESSENGER-RNA; PROTEIN; STRATEGY; KINASES	Alternative splicing is a vast source of biological regulation and diversity that is misregulated in cancer and other diseases. To investigate global control of alternative splicing in human cells, we analyzed splicing of mRNAs encoding Bcl2 family apoptosis factors in a genome-wide siRNA screen. The screen identified many regulators of Bcl-x and Mcl1 splicing, notably an extensive network of cell-cycle factors linked to aurora kinase A. Drugs or siRNAs that induce mitotic arrest promote proapoptotic splicing of Bcl-x, Mcl1, and caspase-9 and alter splicing of other apoptotic transcripts. This response precedes mitotic arrest, indicating coordinated upregulation of prodeath splice variants that promotes apoptosis in arrested cells. These shifts correspond to posttranslational turnover of splicing regulator ASF/SF2, which directly binds and regulates these target mRNAs and globally regulates apoptosis. Broadly, our results reveal an alternative splicing network linking cell-cycle control to apoptosis.	[Moore, Michael J.; Wang, Qingqing; Kennedy, Caleb J.; Silver, Pamela A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Silver, Pamela A.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University	Silver, PA (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	pamela_silver@hms.harvard.edu			National Science Foundation; National Institutes of Health [NIHGM057476]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057476] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Junying Yuan and Robin Reed for reagents, Jodene Moore for help with flow cytometry, and Jessica Hurt, Natalie Gilks-Farny, Daniel Ducat, William Senapedis, Faisal Aldaye, Deborah Flusberg, and Ian Swinburne for thoughtful critiques and discussions. RNAi screening capability was provided by the ICCB-Longwood screening facility at Harvard Medical School. We are indebted to ICCB-L staff Caroline Shamu, Sean Johnston, Stewart Rudnicki, Zac Cooper, and David Wrobel. M.J.M. was supported by funding from the National Science Foundation. Work was supported by grant NIHGM057476 to P.A.S. from the National Institutes of Health.	Akgul C, 2004, CELL MOL LIFE SCI, V61, P2189, DOI 10.1007/s00018-004-4001-7; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Chen YIG, 2007, NUCLEIC ACIDS RES, V35, P3928, DOI 10.1093/nar/gkm347; Cloutier P, 2008, J BIOL CHEM, V283, P21315, DOI 10.1074/jbc.M800353200; Dassah M, 2009, GENETICS, V182, P725, DOI 10.1534/genetics.109.103473; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Ditchfield Claire, 2005, Methods Mol Biol, V296, P371; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Garneau D, 2005, J BIOL CHEM, V280, P22641, DOI 10.1074/jbc.M501070200; Hardwick JM, 2009, CELL, V138, P404, DOI 10.1016/j.cell.2009.07.003; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Li XL, 2005, GENE DEV, V19, P2705, DOI 10.1101/gad.1359305; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Massiello A, 2006, FASEB J, V20, P1680, DOI 10.1096/fj.05-5021fje; Massiello A, 2006, J LIPID RES, V47, P892, DOI 10.1194/jlr.C600003-JLR200; Mercatante DR, 2002, J BIOL CHEM, V277, P49374, DOI 10.1074/jbc.M209236200; Moore MJ, 2008, RNA, V14, P197, DOI 10.1261/rna.868008; Orengo JP, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl967; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Paronetto MP, 2007, J CELL BIOL, V176, P929, DOI 10.1083/jcb.200701005; Rines DR, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r44; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Shin CS, 2002, CELL, V111, P407, DOI 10.1016/S0092-8674(02)01038-3; Stoilov P, 2008, P NATL ACAD SCI USA, V105, P11218, DOI 10.1073/pnas.0801661105; Taylor JK, 1999, NAT BIOTECHNOL, V17, P1097, DOI 10.1038/15079; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Zhou A, 2008, MOL CELL BIOL, V28, P5924, DOI 10.1128/MCB.00560-08	40	229	254	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2010	142	4					625	636		10.1016/j.cell.2010.07.019	http://dx.doi.org/10.1016/j.cell.2010.07.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20705336	Green Accepted, Bronze			2022-12-01	WOS:000281115900016
J	Richard, TL				Richard, Tom L.			Challenges in Scaling Up Biofuels Infrastructure	SCIENCE			English	Editorial Material							ENVIRONMENTAL-IMPACT; PIPELINE TRANSPORT; BIOMASS FEEDSTOCKS; SOLID BIOFUELS; CORN STOVER; ENERGY; COST; CERTIFICATION; STRATEGIES; EFFICIENCY	Rapid growth in demand for lignocellulosic bioenergy will require major changes in supply chain infrastructure. Even with densification and preprocessing, transport volumes by mid-century are likely to exceed the combined capacity of current agricultural and energy supply chains, including grain, petroleum, and coal. Efficient supply chains can be achieved through decentralized conversion processes that facilitate local sourcing, satellite preprocessing and densification for long-distance transport, and business models that reward biomass growers both nearby and afar. Integrated systems that are cost-effective and energy-efficient will require new ways of thinking about agriculture, energy infrastructure, and rural economic development. Implementing these integrated systems will require innovation and investment in novel technologies, efficient value chains, and socioeconomic and policy frameworks; all are needed to support an expanded biofuels infrastructure that can meet the challenges of scale.	Penn State Univ, Dept Agr & Biol Engn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Richard, TL (corresponding author), Penn State Univ, Dept Agr & Biol Engn, University Pk, PA 16802 USA.	trichard@psu.edu	Richard, Tom L/H-5058-2012; Langholtz, Matthew/B-9416-2012	Langholtz, Matthew/0000-0002-8153-7154; Richard, Tom/0000-0002-0833-4844				Aden A., 2002, NRELTP51032438; Alakangas E, 2006, BIOMASS BIOENERG, V30, P908, DOI 10.1016/j.biombioe.2006.06.001; Alfonso D, 2009, BIOMASS BIOENERG, V33, P1070, DOI 10.1016/j.biombioe.2009.04.002; [Anonymous], 2010, DOEEIA0484; Berndes G, 2003, BIOMASS BIOENERG, V25, P1, DOI 10.1016/S0961-9534(02)00185-X; Berndes G, 2010, BIOMASS BIOENERG, V34, P227, DOI 10.1016/j.biombioe.2009.07.007; Brown R.C., 2003, BIORENEWABLE RESOURC; Campbell JE, 2008, ENVIRON SCI TECHNOL, V42, P5791, DOI 10.1021/es800052w; Carolan JE, 2007, J AGR FOOD IND ORG, DOI [10.2202/1542-0485.1203, DOI 10.2202/1542-0485.1203]; Eisentraut A., 2010, IEA ENERGY PAPERS; Eriksson L, 2010, BIOMASS BIOENERG, V34, P82, DOI 10.1016/j.biombioe.2009.10.002; Faaij A., 2006, Mitigation and Adaptation Strategies for Global Change, V11, P343, DOI 10.1007/s11027-005-9004-7; Farrell AE, 2006, SCIENCE, V311, P506, DOI 10.1126/science.1121416; Gronalt M, 2007, BIOMASS BIOENERG, V31, P393, DOI 10.1016/j.biombioe.2007.01.007; Hess JR, 2007, BIOFUEL BIOPROD BIOR, V1, P181, DOI 10.1002/bbb.26; Huber GW, 2007, ANGEW CHEM INT EDIT, V46, P7184, DOI 10.1002/anie.200604504; Kaltschmitt M, 2006, BIOMASS BIOENERG, V30, P897, DOI 10.1016/j.biombioe.2006.06.009; Kumar A, 2005, BIORESOURCE TECHNOL, V96, P819, DOI 10.1016/j.biortech.2004.07.007; Kumar A, 2004, APPL BIOCHEM BIOTECH, V113, P27, DOI 10.1385/ABAB:113:1-3:027; Kumar A, 2003, BIOMASS BIOENERG, V24, P445, DOI 10.1016/S0961-9534(02)00149-6; Laser M, 2009, BIOFUEL BIOPROD BIOR, V3, P247, DOI 10.1002/bbb.136; Lenox M.J., 2003, BUS STRATEG ENVIRON, V12, P343, DOI [10.1002/bse.380, DOI 10.1002/BSE.380]; Lewandowski I, 2006, BIOMASS BIOENERG, V30, P83, DOI 10.1016/j.biombioe.2005.11.003; Magelli F, 2009, BIOMASS BIOENERG, V33, P434, DOI 10.1016/j.biombioe.2008.08.016; Mahmudi H, 2006, APPL BIOCHEM BIOTECH, V129, P88, DOI 10.1385/ABAB:129:1:88; Mapemba LD, 2008, BIOMASS BIOENERG, V32, P1016, DOI 10.1016/j.biombioe.2008.02.003; National Academy of Sciences National Academy of Engineering National Research Council, 2009, LIQ TRANSP FUELS COA; Phillips S., 2007, TP51041168 NREL; Ravula PP, 2008, BIORESOURCE TECHNOL, V99, P5710, DOI 10.1016/j.biortech.2007.10.044; Ren HY, 2006, BIOTECHNOL PROGR, V22, P78, DOI 10.1021/bp050174q; Searcy E, 2007, APPL BIOCHEM BIOTECH, V137, P639, DOI 10.1007/s12010-007-9085-8; Shinners KJ, 2010, T ASABE, V53, P359; Singh J, 2010, BIOMASS BIOENERG, V34, P483, DOI 10.1016/j.biombioe.2009.12.012; Smeets EMW, 2007, PROG ENERG COMBUST, V33, P56, DOI 10.1016/j.pecs.2006.08.001; Sokhansanj S, 2004, APPL ENG AGRIC, V20, P495; Sokhansanj S, 2010, BIOMASS BIOENERG, V34, P75, DOI 10.1016/j.biombioe.2009.10.001; Uslu A, 2008, ENERGY, V33, P1206, DOI 10.1016/j.energy.2008.03.007; van Dam J, 2008, BIOMASS BIOENERG, V32, P749, DOI 10.1016/j.biombioe.2008.01.018; [No title captured]; [No title captured]; [No title captured]	41	210	218	2	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					793	796		10.1126/science.1189139	http://dx.doi.org/10.1126/science.1189139			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705852				2022-12-01	WOS:000280809900038
J	Mozaffarian, D; Ludwig, DS				Mozaffarian, Dariush; Ludwig, David S.			Dietary Guidelines in the 21st Century-a Time for Food	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MORTALITY; WOMEN; RISK; FAT		[Mozaffarian, Dariush; Ludwig, David S.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Mozaffarian, Dariush; Ludwig, David S.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Mozaffarian, Dariush; Ludwig, David S.] Harvard Univ, Sch Med, Boston, MA USA; [Mozaffarian, Dariush] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Mozaffarian, Dariush; Ludwig, David S.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Ludwig, David S.] Childrens Hosp, Optimal Weight Life Program, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital	Mozaffarian, D (corresponding author), 665 Huntington Ave,Bldg 2-319, Boston, MA 02115 USA.	dmozaffa@hsph.harvard.edu	Mozaffarian, Dariush/B-2276-2008	Ludwig, David/0000-0003-3307-8544	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER; NIDDK NIH HHS [K24DK082730] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2002, DIET NUTR PREV CHRON; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; HARPER AE, 1987, ANNU REV NUTR, V7, P509, DOI 10.1146/annurev.nu.07.070187.002453; Heidemann C, 2008, CIRCULATION, V118, P230, DOI 10.1161/CIRCULATIONAHA.108.771881; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; National Heart Lung and Blood Institute, WE CAN WAYS ENH CHIL; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Tinker LF, 2008, ARCH INTERN MED, V168, P1500, DOI 10.1001/archinte.168.14.1500; *US DEP HHS, DIET GUID AM; [World Cancer Research Fund American Institute for Cancer Research], 2007, FOOD NUTR PHYS ACT P	10	155	157	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2010	304	6					681	682		10.1001/jama.2010.1116	http://dx.doi.org/10.1001/jama.2010.1116			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637PA	20699461				2022-12-01	WOS:000280829200025
J	Maquat, LE; Tarn, WY; Isken, O				Maquat, Lynne E.; Tarn, Woan-Yuh; Isken, Olaf			The Pioneer Round of Translation: Features and Functions	CELL			English	Article							MESSENGER-RNA DECAY; EXON-JUNCTION COMPLEX; UPF1 PHOSPHORYLATION; ENHANCE TRANSLATION; PROLONGED HYPOXIA; GENE-EXPRESSION; BINDING-PROTEIN; NONSENSE; MECHANISMS; INITIATION	In mammalian cells, newly synthesized mRNAs undergo a pioneer round of translation that is important for mRNA quality control. Following maturation of messenger ribonucleoprotein particles during and after the pioneer round, steady-state cycles of mRNA translation generate most of the cell's proteins. Translation factors, RNA-binding proteins, and targets of signaling pathways that are particular to newly synthesized mRNAs regulate critical functions of the pioneer round.	[Maquat, Lynne E.; Tarn, Woan-Yuh] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Maquat, Lynne E.; Tarn, Woan-Yuh] Univ Rochester, Sch Med & Dent, Ctr RNA Biol, Rochester, NY 14642 USA; [Isken, Olaf] Univ Lubeck, Inst Virol & Cell Biol, D-23562 Lubeck, Germany; [Tarn, Woan-Yuh] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan	University of Rochester; University of Rochester; University of Lubeck; Academia Sinica - Taiwan	Maquat, LE (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA.	lynne_maquat@urmc.rochester.edu; isken@molbio.uni-luebeck.de	Tarn, Woan-Yuh/N-8464-2018	Maquat, Lynne/0000-0002-2789-2075	NIGMS NIH HHS [R01 GM059614-11S1, R37 GM074593, GM074593, R01 GM059614-11, R01 GM074593-27, GM59614, R01 GM059614, R01 GM074593] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074593, R01GM059614] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Boyne JR, 2010, EMBO J, V29, P1851, DOI 10.1038/emboj.2010.77; Cakmakci NG, 2008, MOL CELL BIOL, V28, P1182, DOI 10.1128/MCB.01500-07; Choe J, 2010, EMBO REP, V11, P380, DOI 10.1038/embor.2010.44; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; di Penta A, 2009, J CELL BIOL, V184, P423, DOI 10.1083/jcb.200807033; Dias SMG, 2009, NAT STRUCT MOL BIOL, V16, P930, DOI 10.1038/nsmb.1649; Diem MD, 2007, NAT STRUCT MOL BIOL, V14, P1173, DOI 10.1038/nsmb1321; Gehring NH, 2009, CELL, V137, P536, DOI 10.1016/j.cell.2009.02.042; Giorgi C, 2007, CELL, V130, P179, DOI 10.1016/j.cell.2007.05.028; HATCHET O, 2004, NATURE, V428, P959; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hwang J, 2010, MOL CELL, V39, P396, DOI 10.1016/j.molcel.2010.07.004; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; Isken O, 2008, CELL, V133, P314, DOI 10.1016/j.cell.2008.02.030; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kim KM, 2009, GENE DEV, V23, P2033, DOI 10.1101/gad.1823409; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Lee HC, 2008, BIOCHEM BIOPH RES CO, V369, P1160, DOI 10.1016/j.bbrc.2008.03.017; Lee HC, 2009, BIOCHEM BIOPH RES CO, V384, P334, DOI 10.1016/j.bbrc.2009.04.123; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Marin-Vinader L, 2006, BBA-GENE STRUCT EXPR, V1759, P535, DOI 10.1016/J.bbaexp.2006.10.003; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Morris C, 2007, EMBO REP, V8, P596, DOI 10.1038/sj.embor.7400955; Oh N, 2007, FEBS LETT, V581, P5158, DOI 10.1016/j.febslet.2007.10.002; Oh N, 2007, BIOCHEM BIOPH RES CO, V362, P145, DOI 10.1016/j.bbrc.2007.07.169; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Richardson CJ, 2004, CURR BIOL, V14, P1540, DOI 10.1016/j.cub.2004.08.061; Sato H, 2008, MOL CELL, V29, P255, DOI 10.1016/j.molcel.2007.12.009; Sato H, 2009, GENE DEV, V23, P2537, DOI 10.1101/gad.1817109; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Wilson KF, 2000, BIOL CHEM, V381, P357, DOI 10.1515/BC.2000.048; Zdanowicz A, 2009, MOL CELL, V35, P881, DOI 10.1016/j.molcel.2009.09.009; Zhou CS, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-14	38	158	160	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					368	374		10.1016/j.cell.2010.07.022	http://dx.doi.org/10.1016/j.cell.2010.07.022			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691898	Green Accepted, Bronze			2022-12-01	WOS:000280609100014
J	Ouchi, N; Higuchi, A; Ohashi, K; Oshima, Y; Gokce, N; Shibata, R; Akasaki, Y; Shimono, A; Walsh, K				Ouchi, Noriyuki; Higuchi, Akiko; Ohashi, Koji; Oshima, Yuichi; Gokce, Noyan; Shibata, Rei; Akasaki, Yuichi; Shimono, Akihiko; Walsh, Kenneth			Sfrp5 Is an Anti-Inflammatory Adipokine That Modulates Metabolic Dysfunction in Obesity	SCIENCE			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; SIGNALING PATHWAY; INFLAMMATION; JNK; ADIPOGENESIS; ADIPONECTIN; INHIBITION; MECHANISMS; DISEASE	Adipose tissue secretes proteins referred to as adipokines, many of which promote inflammation and disrupt glucose homeostasis. Here we show that secreted frizzled-related protein 5 (Sfrp5), a protein previously linked to the Wnt signaling pathway, is an anti-inflammatory adipokine whose expression is perturbed inmodels of obesity and type 2 diabetes. Sfrp5-deficient mice fed a high-calorie diet developed severe glucose intolerance and hepatic steatosis, and their adipose tissue showed an accumulation of activated macrophages that was associated with activation of the c-Jun N-terminal kinase signaling pathway. Adenovirus-mediated delivery of Sfrp5 to mouse models of obesity ameliorated glucose intolerance and hepatic steatosis. Thus, in the setting of obesity, Sfrp5 secretion by adipocytes exerts salutary effects on metabolic dysfunction by controlling inflammatory cells within adipose tissue.	[Ouchi, Noriyuki; Higuchi, Akiko; Ohashi, Koji; Oshima, Yuichi; Gokce, Noyan; Akasaki, Yuichi; Walsh, Kenneth] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Gokce, Noyan] Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA; [Shibata, Rei] Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Shimono, Akihiko] Natl Univ Singapore, Ctr Life Sci, Canc Sci Inst Singapore, Singapore 117456, Singapore	Boston University; Boston University; Nagoya University; National University of Singapore	Ouchi, N (corresponding author), Boston Univ, Sch Med, Whitaker Cardiovasc Inst, 715 Albany St,W611, Boston, MA 02118 USA.	nouchi@bu.edu; kxwalsh@bu.edu	OHASHI, Koji/I-7307-2014; OUCHI, Noriyuki/I-7306-2014	Walsh, Kenneth/0000-0001-7580-2276; Gokce, Noyan/0000-0003-2920-3445	National Institutes of Health [AG34972, HL86785, AG15052, HL81587]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086785, P01HL081587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034972, R37AG015052, R01AG015052] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Sono-Romanelli for technical assistance. Funded by National Institutes of Health grants (AG34972, HL86785, AG15052, and HL81587) to K.W.	Apovian CM, 2008, ARTERIOSCL THROM VAS, V28, P1654, DOI 10.1161/ATVBAHA.108.170316; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Li Y, 2008, GENE DEV, V22, P3050, DOI 10.1101/gad.1687308; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Vallerie SN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003151; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008	21	336	376	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					454	457		10.1126/science.1188280	http://dx.doi.org/10.1126/science.1188280			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20558665	Green Accepted			2022-12-01	WOS:000280196500041
J	Dray, N; Tessmar-Raible, K; Le Gouar, M; Vibert, L; Christodoulou, F; Schipany, K; Guillou, A; Zantke, J; Snyman, H; Behague, J; Vervoort, M; Arendt, D; Balavoine, G				Dray, Nicolas; Tessmar-Raible, Kristin; Le Gouar, Martine; Vibert, Laura; Christodoulou, Foteini; Schipany, Katharina; Guillou, Aurelien; Zantke, Juliane; Snyman, Heidi; Behague, Julien; Vervoort, Michel; Arendt, Detlev; Balavoine, Guillaume			Hedgehog Signaling Regulates Segment Formation in the Annelid Platynereis	SCIENCE			English	Article							DROSOPHILA EMBRYONIC EPIDERMIS; EXPRESSION PATTERNS; SPATIAL REGULATION; HOMEOBOX GENES; POLARITY GENE; PROTEIN; WINGLESS; ENCODES	Annelids and arthropods share a similar segmented organization of the body whose evolutionary origin remains unclear. The Hedgehog signaling pathway, prominent in arthropod embryonic segment patterning, has not been shown to have a similar function outside arthropods. We show that the ligand Hedgehog, the receptor Patched, and the transcription factor Gli are all expressed in striped patterns before the morphological appearance of segments in the annelid Platynereis dumerilii. Treatments with small molecules antagonistic to Hedgehog signaling disrupt segment formation. Platynereis Hedgehog is not necessary to establish early segment patterns but is required to maintain them. The molecular similarity of segment patterning functions of the Hedgehog pathway in an annelid and in arthropods supports a common origin of segmentation in protostomes.	[Dray, Nicolas; Le Gouar, Martine; Vibert, Laura; Behague, Julien; Vervoort, Michel; Balavoine, Guillaume] CNRS, Ctr Genet Mol, FRE 3144, F-91189 Gif Sur Yvette, France; [Tessmar-Raible, Kristin; Schipany, Katharina; Zantke, Juliane] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria; [Tessmar-Raible, Kristin; Christodoulou, Foteini; Snyman, Heidi; Arendt, Detlev] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; [Guillou, Aurelien; Behague, Julien; Vervoort, Michel; Balavoine, Guillaume] Univ Paris Diderot, CNRS, Inst Jacques Monod, F-75205 Paris 13, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Balavoine, G (corresponding author), CNRS, Ctr Genet Mol, FRE 3144, Ave Terrasse, F-91189 Gif Sur Yvette, France.	balavoine.guillaume@ijm.univ-paris-diderot.fr	dray, nicolas/B-6854-2009; Vervoort, Michel/S-1448-2019; Tessmar-Raible, Kristin/F-9642-2011; Dray, Nicolas/E-1610-2011	Tessmar-Raible, Kristin/0000-0002-8038-1741; Dray, Nicolas/0000-0002-2632-6004	CNRS, University Paris-Diderot; Agence Nationale de la Recherche (France) [BLAN-0294]; Max F. Perutz Laboratories (MFPL); Austrian Science Fund (FWF) [AY0041321]; French Research Ministry; Fondation pour la recherche medicale (FRM); Boehringer Ingelheim Foundation; Marie Curie Research Training Networks [MRTN-CT-2004-005624]; Austrian Science Fund (FWF) [Y 413] Funding Source: researchfish	CNRS, University Paris-Diderot(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); Max F. Perutz Laboratories (MFPL); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); French Research Ministry(Ministry of Research, France); Fondation pour la recherche medicale (FRM)(Fondation pour la Recherche Medicale); Boehringer Ingelheim Foundation(Boehringer Ingelheim); Marie Curie Research Training Networks(European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We acknowledge the following agencies for funding: the CNRS, University Paris-Diderot and the Agence Nationale de la Recherche (France) (ANR grant BLAN-0294); the Max F. Perutz Laboratories (MFPL) funds and the Austrian Science Fund (FWF) START award (AY0041321), the French Research Ministry and the Fondation pour la recherche medicale (FRM) for fellowships (N.D.); the Boehringer Ingelheim Foundation and the Marie Curie Research Training Networks ZOONET (MRTN-CT-2004-005624) for fellowships (K. T. R.). We also thank the platform ImagoSeine staff for help in confocal imagery. GenBank accession numbers for the gene sequences newly identified in this study are HM179271 to HM179276.	Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen WB, 2001, DEVELOPMENT, V128, P2385; Concordet JP, 1996, DEVELOPMENT, V122, P2835; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; DINARDO S, 1994, CURR OPIN GENET DEV, V4, P529, DOI 10.1016/0959-437X(94)90068-E; Farzana L, 2008, DEV GENES EVOL, V218, P181, DOI 10.1007/s00427-008-0207-2; Hatini V, 2001, TRENDS GENET, V17, P574, DOI 10.1016/S0168-9525(01)02448-9; HIDALGO A, 1990, DEVELOPMENT, V110, P291; Holley SA, 2007, DEV DYNAM, V236, P1422, DOI 10.1002/dvdy.21162; Jagla K, 1997, DEVELOPMENT, V124, P91; Kang DM, 2003, DEVELOPMENT, V130, P1645, DOI 10.1242/dev.00395; Pechmann M, 2009, P NATL ACAD SCI USA, V106, P1468, DOI 10.1073/pnas.0811150106; Prud'homme B, 2003, CURR BIOL, V13, P1876, DOI 10.1016/j.cub.2003.10.006; Sanson B, 2001, EMBO REP, V2, P1083, DOI 10.1093/embo-reports/kve255; Saudemont A, 2008, DEV BIOL, V317, P430, DOI 10.1016/j.ydbio.2008.02.013; Seaver EC, 2006, DEV BIOL, V289, P179, DOI 10.1016/j.ydbio.2005.10.025; Simonnet F, 2004, DEV GENES EVOL, V214, P537, DOI 10.1007/s00427-004-0435-z; Steinmetz PRH, 2007, P NATL ACAD SCI USA, V104, P2727, DOI 10.1073/pnas.0606589104; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0	21	74	76	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					339	342		10.1126/science.1188913	http://dx.doi.org/10.1126/science.1188913			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647470	Green Accepted			2022-12-01	WOS:000279925900047
J	Fischer, N; Konevega, AL; Wintermeyer, W; Rodnina, MV; Stark, H				Fischer, Niels; Konevega, Andrey L.; Wintermeyer, Wolfgang; Rodnina, Marina V.; Stark, Holger			Ribosome dynamics and tRNA movement by time-resolved electron cryomicroscopy	NATURE			English	Article							ELONGATION-FACTOR-G; ESCHERICHIA-COLI RIBOSOMES; MESSENGER-RNA; L1 STALK; INTERMEDIATE STATES; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; SINGLE RIBOSOMES; GTP HYDROLYSIS; HYBRID STATES	The translocation step of protein synthesis entails large-scale rearrangements of the ribosome-transfer RNA (tRNA) complex. Here we have followed tRNA movement through the ribosome during translocation by time-resolved single-particle electron cryomicroscopy (cryo-EM). Unbiased computational sorting of cryo-EM images yielded 50 distinct three-dimensional reconstructions, showing the tRNAs in classical, hybrid and various novel intermediate states that provide trajectories and kinetic information about tRNA movement through the ribosome. The structures indicate how tRNA movement is coupled with global and local conformational changes of the ribosome, in particular of the head and body of the small ribosomal subunit, and show that dynamic interactions between tRNAs and ribosomal residues confine the path of the tRNAs through the ribosome. The temperature dependence of ribosome dynamics reveals a surprisingly flat energy landscape of conformational variations at physiological temperature. The ribosome functions as a Brownian machine that couples spontaneous conformational changes driven by thermal energy to directed movement.	[Fischer, Niels; Stark, Holger] Max Planck Inst Biophys Chem, Elect Cryomicroscopy Grp 3D, D-37077 Gottingen, Germany; [Konevega, Andrey L.; Wintermeyer, Wolfgang; Rodnina, Marina V.] Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany; [Konevega, Andrey L.] Petersburg Nucl Phys Inst, Gatchina 188300, Russia	Max Planck Society; Max Planck Society; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute	Stark, H (corresponding author), Max Planck Inst Biophys Chem, Elect Cryomicroscopy Grp 3D, Fassberg 11, D-37077 Gottingen, Germany.	hstark1@gwdg.de	Fischer, Niels/ABA-5342-2021; Konevega, Andrey L./B-7887-2008; Rodnina, Marina V./AAD-4667-2019	Fischer, Niels/0000-0002-4609-4052; Konevega, Andrey L./0000-0003-0125-7150; Rodnina, Marina V./0000-0003-0105-3879; Wintermeyer, Wolfgang/0000-0001-5119-8481; Holger, Stark/0000-0002-6161-1118	Federal Ministry of Education and Research (BMBF), Germany; European Union; state of Lower-Saxony; Volkswagen Foundation, Hannover, Germany; Boehringer-Ingelheim fellowship; Deutsche Forschungsgemeinschaft	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); state of Lower-Saxony(European Commission); Volkswagen Foundation, Hannover, Germany(Volkswagen); Boehringer-Ingelheim fellowship(Boehringer Ingelheim); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank C. Blau for technical help in preparing Fig. 4. Research in the laboratory of H.S. was supported by grants from the Federal Ministry of Education and Research (BMBF), Germany, the Sixth Framework Programme of the European Union via the Integrated Project 3DRepertoire, by the state of Lower-Saxony and the Volkswagen Foundation, Hannover, Germany. N.F. was supported by a Boehringer-Ingelheim fellowship. M.V.R. and W.W. were supported by grants from the Deutsche Forschungsgemeinschaft.	Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; BELLARE JR, 1988, J ELECTRON MICR TECH, V10, P87, DOI 10.1002/jemt.1060100111; BHAT TN, 1984, J APPL CRYSTALLOGR, V17, P244, DOI 10.1107/S0021889884011456; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; CORDOVA NJ, 1992, P NATL ACAD SCI USA, V89, P339, DOI 10.1073/pnas.89.1.339; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Ermolenko DN, 2007, J MOL BIOL, V370, P530, DOI 10.1016/j.jmb.2007.04.042; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Fei JY, 2009, P NATL ACAD SCI USA, V106, P15702, DOI 10.1073/pnas.0908077106; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Fredrick K, 2003, SCIENCE, V300, P1159, DOI 10.1126/science.1084571; GAVRILOVA LP, 1976, J MOL BIOL, V101, P537, DOI 10.1016/0022-2836(76)90243-6; Jenner L, 2007, EMBO REP, V8, P846, DOI 10.1038/sj.embor.7401044; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; Kim HD, 2007, BIOPHYS J, V93, P3575, DOI 10.1529/biophysj.107.109884; Konevega AL, 2007, NAT STRUCT MOL BIOL, V14, P318, DOI 10.1038/nsmb1221; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Lancaster LE, 2008, MOL MICROBIOL, V69, P390, DOI 10.1111/j.1365-2958.2008.06283.x; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marshall RA, 2008, P NATL ACAD SCI USA, V105, P15364, DOI 10.1073/pnas.0805299105; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Munro JB, 2010, P NATL ACAD SCI USA, V107, P709, DOI 10.1073/pnas.0908597107; Pan DL, 2007, MOL CELL, V25, P519, DOI 10.1016/j.molcel.2007.01.014; PAULSEN H, 1986, BIOCHEMISTRY-US, V25, P2749, DOI 10.1021/bi00358a002; ROBERTSON JM, 1986, J MOL BIOL, V192, P351, DOI 10.1016/0022-2836(86)90370-0; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Sander B, 2005, J STRUCT BIOL, V151, P92, DOI [10.1016/j.jsb.2005.04.004, 10.1016/j.jsb,2005.04.004]; Sander B, 2003, J STRUCT BIOL, V143, P219, DOI 10.1016/j.jsb.2003.08.001; Sander B, 2003, J STRUCT BIOL, V142, P392, DOI 10.1016/S1047-8477(03)00072-8; Savelsbergh A, 2005, EMBO J, V24, P4316, DOI 10.1038/sj.emboj.7600884; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Shoji S, 2006, MOL CELL, V24, P931, DOI 10.1016/j.molcel.2006.11.025; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	44	294	296	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					329	333		10.1038/nature09206	http://dx.doi.org/10.1038/nature09206			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631791				2022-12-01	WOS:000279867100040
J	Kamerow, D				Kamerow, Douglas			Yankee Doodling The case of the sugar sweetened beverage tax	BRITISH MEDICAL JOURNAL			English	Editorial Material												dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957					0	11	11	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 14	2010	341								c3719	10.1136/bmj.c3719	http://dx.doi.org/10.1136/bmj.c3719			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628XC	20630952				2022-12-01	WOS:000280156700006
J	Goodall, J; Pintea, L				Goodall, Jane; Pintea, Lilian			Securing a future for chimpanzees	NATURE			English	Editorial Material									[Goodall, Jane; Pintea, Lilian] Jane Goodall Inst, Arlington, VA 22203 USA		Goodall, J (corresponding author), Jane Goodall Inst, 4245 N Fairfax Dr,Suite 600, Arlington, VA 22203 USA.	lpintea@janegoodall.org							0	2	2	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					180	181		10.1038/466180a	http://dx.doi.org/10.1038/466180a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	621LR	20613821				2022-12-01	WOS:000279580800016
J	Ikawa, T; Hirose, S; Masuda, K; Kakugawa, K; Satoh, R; Shibano-Satoh, A; Kominami, R; Katsura, Y; Kawamoto, H				Ikawa, Tomokatsu; Hirose, Satoshi; Masuda, Kyoko; Kakugawa, Kiyokazu; Satoh, Rumi; Shibano-Satoh, Asako; Kominami, Ryo; Katsura, Yoshimoto; Kawamoto, Hiroshi			An Essential Developmental Checkpoint for Production of the T Cell Lineage	SCIENCE			English	Article							PROGENITORS; COMMITMENT; GENE; EXPRESSION; THYMUS; BCL11B; MICE; PAX5	In early T cell development, progenitors retaining the potential to generate myeloid and natural killer lineages are eventually determined to a specific T cell lineage. The molecular mechanisms that drive this determination step remain unclarified. We show that, when murine hematopoietic progenitors were cultured on immobilized Notch ligand DLL4 protein in the presence of a cocktail of cytokines including interleukin-7, progenitors developing toward T cells were arrested and the arrested cells entered a self-renewal cycle, maintaining non-T lineage potentials. Reduced concentrations of interleukin-7 promoted T cell lineage determination. A similar arrest and self-renewal of progenitors were observed in thymocytes of mice deficient in the transcription factor Bcl11b. Our study thus identifies the earliest checkpoint during T cell development and shows that it is Bcl11b-dependent.	[Ikawa, Tomokatsu; Masuda, Kyoko; Kakugawa, Kiyokazu; Satoh, Rumi; Shibano-Satoh, Asako; Katsura, Yoshimoto; Kawamoto, Hiroshi] RIKEN, Res Ctr Allergy & Immunol, Lab Lymphocyte Dev, Yokohama, Kanagawa 2300045, Japan; [Hirose, Satoshi; Kominami, Ryo] Niigata Univ, Grad Sch Med & Dent Sci, Dept Mol Genet, Niigata 9518510, Japan; [Katsura, Yoshimoto] Nihon Univ, Sch Med, Adv Med Res Ctr, Div Cell Regenerat & Transplantat, Tokyo 1738610, Japan	RIKEN; Niigata University; Nihon University	Kawamoto, H (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Lymphocyte Dev, Yokohama, Kanagawa 2300045, Japan.	kawamoto@rcai.riken.jp	Hirose, Satoshi/CAF-1500-2022	Hirose, Satoshi/0000-0001-7825-501X; Kakugawa, Kiyokazu/0000-0002-2560-5562	Ministry of Education, Science, Sports, and Culture, Japan	Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors are grateful to C. Murre, T. Kadesch, Y. Agata, and S. Yamasaki for providing us with reagents and protocols, and to P. Burrows for critical reading of the manuscript. This work was partially supported by Grant-in-Aid for Young Scientists (A) from the Ministry of Education, Science, Sports, and Culture, Japan.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Fehling HJ, 1997, CURR OPIN IMMUNOL, V9, P263, DOI 10.1016/S0952-7915(97)80146-X; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Ikawa T, 2004, IMMUNITY, V20, P349, DOI 10.1016/S1074-7613(04)00049-4; Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721; Katsura Y, 2001, Int Rev Immunol, V20, P1, DOI 10.3109/08830180109056720; Kawamoto H, 2009, TRENDS IMMUNOL, V30, P193, DOI 10.1016/j.it.2009.03.001; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Lu M, 2002, J IMMUNOL, V169, P3519, DOI 10.4049/jimmunol.169.7.3519; Masuda K, 2007, J IMMUNOL, V179, P3699, DOI 10.4049/jimmunol.179.6.3699; McCormack MP, 2010, SCIENCE, V327, P879, DOI 10.1126/science.1182378; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Przybylski GK, 2005, LEUKEMIA, V19, P201, DOI 10.1038/sj.leu.2403619; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wakabayashi Y, 2003, BIOCHEM BIOPH RES CO, V301, P598, DOI 10.1016/S0006-291X(02)03069-3; Yu Q, 2004, J EXP MED, V200, P797, DOI 10.1084/jem.20032183	21	227	229	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					93	96		10.1126/science.1188995	http://dx.doi.org/10.1126/science.1188995			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595615				2022-12-01	WOS:000279402700040
J	Li, L; Leid, M; Rothenberg, EV				Li, Long; Leid, Mark; Rothenberg, Ellen V.			An Early T Cell Lineage Commitment Checkpoint Dependent on the Transcription Factor Bcl11b	SCIENCE			English	Article							ALPHA-BETA; DENDRITIC CELLS; EXPRESSION; DIFFERENTIATION; SURVIVAL; PATHWAY; GENE; DECISION; GATA-3; NOTCH1	The identities of the regulators that mediate commitment of hematopoietic precursors to the T lymphocyte lineage have been unknown. The last stage of T lineage commitment in vivo involves mechanisms to suppress natural killer cell potential, to suppress myeloid and dendritic cell potential, and to silence the stem cell or progenitor cell regulatory functions that initially provide T cell receptor-independent self-renewal capability. The zinc finger transcription factor Bcl11b is T cell-specific in expression among hematopoietic cell types and is first expressed in precursors immediately before T lineage commitment. We found that Bcl11b is necessary for T lineage commitment in mice and is specifically required both to repress natural killer cell-associated genes and to down-regulate a battery of stem cell or progenitor cell genes at the pivotal stage of commitment.	[Li, Long; Rothenberg, Ellen V.] CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; [Leid, Mark] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA	California Institute of Technology; Oregon State University	Rothenberg, EV (corresponding author), CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA.	evroth@its.caltech.edu		Li, Long/0000-0002-4727-9307; Rothenberg, Ellen/0000-0002-3901-347X	California Institute; NIH [R33 HL089123, RC2 CA148278, R01 GM60852]; Caltech-City of Hope Biomedical Initiative; Louis Garfinkle Memorial Laboratory; Al Sherman Foundation; FOGARTY INTERNATIONAL CENTER [F06TW002367] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [RC2CA148278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL089123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060852] Funding Source: NIH RePORTER	California Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech-City of Hope Biomedical Initiative; Louis Garfinkle Memorial Laboratory; Al Sherman Foundation; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Liu, H. Kawamoto, P. Li, T. Ikawa, D. Scripture-Adams, and members of the Rothenberg lab for sharing unpublished results and helpful discussion; D. Metzger and J.-M. Bornert for help with generation of the floxed Bcl11b mice; H.-Y. Kueh for guidance in data analysis; T. Taghon and F. Costantini for vectors and mice; D. Perez and R. Diamond for flow cytometry support; and R. Butler and S. Washburn for animal care and breeding supervision. Supported by a California Institute for Regenerative Medicine fellowship (L. L.), NIH grants R33 HL089123 and RC2 CA148278 (E. V. R.), NIH grant R01 GM60852 (M. L.), the Caltech-City of Hope Biomedical Initiative, the Louis Garfinkle Memorial Laboratory Fund, the Al Sherman Foundation, and the A. B. Ruddock Professorship.	Albu DI, 2007, J EXP MED, V204, P3003, DOI 10.1084/jem.20070863; Bain G, 1999, J EXP MED, V189, P289, DOI 10.1084/jem.189.2.289; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Ciofani M, 2006, IMMUNOL RES, V34, P117, DOI 10.1385/IR:34:2:117; David-Fung ES, 2009, DEV BIOL, V325, P444, DOI 10.1016/j.ydbio.2008.10.021; Dias S, 2008, CURR OPIN GENET DEV, V18, P441, DOI 10.1016/j.gde.2008.07.015; Dontje W, 2006, BLOOD, V107, P2446, DOI 10.1182/blood-2005-05-2090; Doulatov S, 2009, GENE DEV, V23, P2076, DOI 10.1101/gad.1788109; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Georgescu C, 2008, P NATL ACAD SCI USA, V105, P20100, DOI 10.1073/pnas.0806501105; Golonzhka O, 2009, J INVEST DERMATOL, V129, P1459, DOI 10.1038/jid.2008.392; Herblot S, 2000, NAT IMMUNOL, V1, P138, DOI 10.1038/77819; Inoue J, 2006, J IMMUNOL, V176, P5871, DOI 10.4049/jimmunol.176.10.5871; Kamimura K, 2007, BIOCHEM BIOPH RES CO, V355, P538, DOI 10.1016/j.bbrc.2007.02.003; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; O'Neil J, 2004, CANCER CELL, V5, P587, DOI 10.1016/j.ccr.2004.05.023; Przybylski GK, 2005, LEUKEMIA, V19, P201, DOI 10.1038/sj.leu.2403619; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rothenberg EV, 2007, IMMUNITY, V26, P690, DOI 10.1016/j.immuni.2007.06.005; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Tydell CC, 2007, J IMMUNOL, V179, P421, DOI 10.4049/jimmunol.179.1.421; Vosshenrich CAJ, 2007, J EXP MED, V204, P2569, DOI 10.1084/jem.20071451; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Welner RS, 2007, BLOOD, V109, P4825, DOI 10.1182/blood-2006-08-043810; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Ye M, 2007, CURR OPIN IMMUNOL, V19, P123, DOI 10.1016/j.coi.2007.02.007; Yui MA, 2010, J IMMUNOL, V185, P284, DOI 10.4049/jimmunol.1000679; Zhong Y, 2007, ONCOGENE, V26, P6937, DOI 10.1038/sj.onc.1210494	32	263	267	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					89	93		10.1126/science.1188989	http://dx.doi.org/10.1126/science.1188989			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595614	Green Accepted			2022-12-01	WOS:000279402700039
J	Li, P; Burke, S; Wang, JX; Chen, XF; Ortiz, M; Lee, SC; Lu, D; Campos, L; Goulding, D; Ng, BL; Dougan, G; Huntly, B; Gottgens, B; Jenkins, NA; Copeland, NG; Colucci, F; Liu, PT				Li, Peng; Burke, Shannon; Wang, Juexuan; Chen, Xiongfeng; Ortiz, Mariaestela; Lee, Song-Choon; Lu, Dong; Campos, Lia; Goulding, David; Ng, Bee Ling; Dougan, Gordon; Huntly, Brian; Gottgens, Bertie; Jenkins, Nancy A.; Copeland, Neal G.; Colucci, Francesco; Liu, Pentao			Reprogramming of T Cells to Natural Killer-Like Cells upon Bcl11b Deletion	SCIENCE			English	Article							H-2-DEFICIENT LYMPHOMA VARIANTS; IN-VITRO; NK CELLS; DIFFERENTIATION; RECOGNITION; EXPRESSION; SURVIVAL; PATHWAY; VIVO	T cells develop in the thymus and are critical for adaptive immunity. Natural killer (NK) lymphocytes constitute an essential component of the innate immune system in tumor surveillance, reproduction, and defense against microbes and viruses. Here, we show that the transcription factor Bcl11b was expressed in all T cell compartments and was indispensable for T lineage development. When Bcl11b was deleted, T cells from all developmental stages acquired NK cell properties and concomitantly lost or decreased T cell-associated gene expression. These induced T-to-natural killer (ITNK) cells, which were morphologically and genetically similar to conventional NK cells, killed tumor cells in vitro, and effectively prevented tumor metastasis in vivo. Therefore, ITNKs may represent a new cell source for cell-based therapies.	[Li, Peng; Burke, Shannon; Wang, Juexuan; Ortiz, Mariaestela; Lee, Song-Choon; Lu, Dong; Campos, Lia; Goulding, David; Ng, Bee Ling; Dougan, Gordon; Liu, Pentao] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Burke, Shannon; Colucci, Francesco] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England; [Colucci, Francesco] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England; [Chen, Xiongfeng] NCI, SAIC Frederick, Frederick, MD 21701 USA; [Huntly, Brian; Gottgens, Bertie] Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Jenkins, Nancy A.; Copeland, Neal G.] Inst Mol & Cell Biol, Proteos 138673, Singapore	Wellcome Trust Sanger Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Cambridge; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Liu, PT (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England.	pl2@sanger.ac.uk	Colucci, Francesco/F-2844-2010; Li, Peng/AER-7520-2022; huntly, brian JP/E-6725-2014	Colucci, Francesco/0000-0001-5193-6376; huntly, brian JP/0000-0003-0312-161X; Li, Peng/0000-0003-4530-2400; Gottgens, Berthold/0000-0001-6302-5705	Wellcome Trust; MRC; BBSRC; Medical Research Council [G0501150, G0800784B, G116/187, G0800784] Funding Source: researchfish; National Centre for the Replacement [G0900729/1] Funding Source: researchfish; MRC [G116/187, G0501150, G0800784] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work is supported by the Wellcome Trust to P. Liu, from MRC and BBSRC to F. Colucci, and by MRC to B. Huntly. We thank core facilities at Sanger Institute (RSF and microarray), Babraham Institute and CIMR for technical support. Microarray data have been submitted to GEO (Gene Expression Ominibus). Accession number: GSE21016. A patent application has been filed by the Wellcome Trust for production and application of ITNKs (U. K. patent application No. 0912287. U. S. Provisional Application No. 61/225779), and P. L. and P. L. are listed as authors on this application. A Mouse/Tissue Transfer Agreement is required for the use of PLBD mice.	Albu DI, 2007, J EXP MED, V204, P3003, DOI 10.1084/jem.20070863; Bajoghli B, 2009, CELL, V138, P186, DOI 10.1016/j.cell.2009.04.017; Boos MD, 2008, IMMUNOL RES, V40, P193, DOI 10.1007/s12026-007-8006-9; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Ciofani M, 2007, ANNU REV CELL DEV BI, V23, P463, DOI 10.1146/annurev.cellbio.23.090506.123547; Colucci F, 1999, J IMMUNOL, V162, P2761; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; GORELIK E, 1982, INT J CANCER, V30, P107, DOI 10.1002/ijc.2910300118; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; KAWANO YI, 1986, J IMMUNOL, V136, P4729; Krejci A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000140; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; LJUNGGREN HG, 1985, J EXP MED, V162, P1745, DOI 10.1084/jem.162.6.1745; Miaw SC, 2000, IMMUNITY, V12, P323, DOI 10.1016/S1074-7613(00)80185-5; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rothenberg EV, 2007, NAT IMMUNOL, V8, P441, DOI 10.1038/ni1461; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Topark-Ngarm A, 2006, J BIOL CHEM, V281, P32272, DOI 10.1074/jbc.M602776200; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Tydell CC, 2007, J IMMUNOL, V179, P421, DOI 10.4049/jimmunol.179.1.421; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104	26	234	241	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					85	89		10.1126/science.1188063	http://dx.doi.org/10.1126/science.1188063			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20538915	Green Accepted			2022-12-01	WOS:000279402700038
J	El-Bassel, N; Terlikbaeva, A; Pinkham, S				El-Bassel, Nabila; Terlikbaeva, Assel; Pinkham, Sophie			HIV and women who use drugs: double neglect, double risk	LANCET			English	Editorial Material							INTIMATE PARTNER VIOLENCE; PREVENTION; METHADONE		[El-Bassel, Nabila] Columbia Univ, Sch Social Work, New York, NY 10025 USA; [El-Bassel, Nabila; Terlikbaeva, Assel] Columbia Univ, Global Hlth Res Ctr Cent Asia, Alma Ata, Kazakhstan; [Pinkham, Sophie] AIDS Fdn EW, Kiev, Ukraine	Columbia University	El-Bassel, N (corresponding author), Columbia Univ, Sch Social Work, 622 W 113th St, New York, NY 10025 USA.							Auerbach J, 2009, HEALTH AFFAIR, V28, P1655, DOI 10.1377/hlthaff.28.6.1655; Bryant J, 2010, DRUG ALCOHOL DEPEN, V107, P182, DOI 10.1016/j.drugalcdep.2009.10.007; Carael M, 2009, JAIDS-J ACQ IMM DEF, V52, pS111, DOI 10.1097/QAI.0b013e3181baeec2; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; El-Bassel N, 2005, SOC SCI MED, V61, P171, DOI 10.1016/j.socscimed.2004.11.035; El-Bassel N, 2005, AM J PUBLIC HEALTH, V95, P465, DOI 10.2105/AJPH.2003.023200; *JOINT UN PROGR HI, 2008, 2008 REP GLOB AIDS E; Latkin CA, 2009, SOC SCI MED, V68, P740, DOI 10.1016/j.socscimed.2008.11.019; *OP SOC I, 2009, WOM HARM RED HIV KEY; Pinkham S, 2008, REPROD HEALTH MATTER, V16, P168, DOI 10.1016/S0968-8080(08)31345-7; Wechsberg WM, 2008, SUBST USE MISUSE, V43, P1186, DOI 10.1080/10826080801918247	11	78	82	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2010	376	9738					312	314		10.1016/S0140-6736(10)61026-4	http://dx.doi.org/10.1016/S0140-6736(10)61026-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636FW	20650519				2022-12-01	WOS:000280717900008
J	O'Reilly, J; Jones, MM; Parnham, J; Lovibond, K; Rudolf, M				O'Reilly, John; Jones, Melvyn M.; Parnham, Jill; Lovibond, Kate; Rudolf, Michael		Guideline Dev Grp	Guidelines Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AIR-FLOW OBSTRUCTION; DIAGNOSIS; COPD		[O'Reilly, John] Aintree Univ Hosp NHS Fdn Trust, Liverpool L9 7AL, Merseyside, England; [Jones, Melvyn M.] UCL, Sch Med, Dept Primary Care & Populat Hlth, London N19 5LW, England; [Jones, Melvyn M.] Warden Lodge Surg, Cheshunt EN8 8NW, England; [Parnham, Jill; Lovibond, Kate] Royal Coll Phys London, Natl Clin Guideline Ctr, London NW1 4LE, England; [Rudolf, Michael] Ealing Hosp NHS Trust, Ealing UB1 3HW, England	Aintree University Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School	O'Reilly, J (corresponding author), Aintree Univ Hosp NHS Fdn Trust, Liverpool L9 7AL, Merseyside, England.	john.oreilly@aintree.nhs.uk	Jones, Melvyn/C-2300-2008	Jones, Melvyn/0000-0002-8766-7443; O'Reilly, John/0000-0001-6708-2459; GRUFFYDD-JONES, KEVIN/0000-0002-4651-5961				[Anonymous], 2008, GLOB STRAT DIAGN MAN; British Lung Foundation, 2007, INV LIV CHRON OBSTR; Celli BR, 2003, EUR RESPIR J, V22, P268, DOI 10.1183/09031936.03.00075102; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Cerveri I, 2008, THORAX, V63, P1040, DOI 10.1136/thx.2008.095554; Department of Health, 2010, CONS STRAT SERV COPD; FLETCHER CM, 1959, BMJ-BRIT MED J, V2, P257, DOI 10.1136/bmj.2.5147.257; Hardie JA, 2002, EUR RESPIR J, V20, P1117, DOI 10.1183/09031936.02.00023202; *HC, 2006, CLEAN AIR NAT STUD C; Hnizdo Eva, 2006, COPD, V3, P95, DOI 10.1080/15412550600651552; *NAT I HLTH CLIN E, 2008, PUBL HLTH GUID NAT I, V10; *NAT I HLTH CLIN E, 2007, 123 NAT I HLTH CLIN; *NAT I HLTH CLIN E, 2010, CLIN GUID NAT I HLTH, V101; Perez-Padilla Rogelio, 2007, COPD, V4, P113, DOI 10.1080/15412550701341012; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Shirtcliffe P, 2007, EUR RESPIR J, V30, P232, DOI 10.1183/09031936.00157906; Swanney MP, 2008, THORAX, V63, P1046, DOI 10.1136/thx.2008.098483; 2008, THORAX S7, V63; 2004, THORAX S1, V59	20	55	56	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2010	340								c3134	10.1136/bmj.c3134	http://dx.doi.org/10.1136/bmj.c3134			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618IR	20581031				2022-12-01	WOS:000279346600002
J	Biggs, ML; Mukamal, KJ; Luchsinger, JA; Ix, JH; Carnethon, MR; Newman, AB; de Boer, IH; Strotmeyer, ES; Mozaffarian, D; Siscovick, DS				Biggs, Mary L.; Mukamal, Kenneth J.; Luchsinger, Jose A.; Ix, Joachim H.; Carnethon, Mercedes R.; Newman, Anne B.; de Boer, Ian H.; Strotmeyer, Elsa S.; Mozaffarian, Dariush; Siscovick, David S.			Association Between Adiposity in Midlife and Older Age and Risk of Diabetes in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; FAT DISTRIBUTION; WAIST CIRCUMFERENCE; TISSUE DISTRIBUTION; LIFE-STYLE; WEIGHT CHANGE; VISCERAL FAT; MELLITUS; HEALTH; WOMEN	Context Adiposity is a well-recognized risk factor for type 2 diabetes among young and middle-aged adults, but the relationship between body composition and type 2 diabetes is not well described among older adults. Objective To examine the relationship between adiposity, changes in adiposity, and risk of incident type 2 diabetes in adults 65 years of age and older. Design, Setting, and Participants Prospective cohort study (1989-2007) of 4193 men and women 65 years of age and older in the Cardiovascular Health Study. Measures of adiposity were derived from anthropometry and bioelectrical impedance data at baseline and anthropometry repeated 3 years later. Main Outcome Measure Incident diabetes was ascertained based on use of antidiabetic medication or a fasting glucose level of 126 mg/dL or greater. Results Over median follow-up of 12.4 years (range, 0.9-17.8 years), 339 cases of incident diabetes were ascertained (7.1/1000 person-years). The adjusted hazard ratio (HR) (95% confidence interval [CI]) of type 2 diabetes for participants in the highest quintile of baseline measures compared with those in the lowest was 4.3 (95% CI, 2.9-6.5) for body mass index (BMI [calculated as weight in kilograms divided by height in meters squared]), 3.0 (95% CI, 2.0-4.3) for BMI at 50 years of age, 4.2 (95% CI, 2.8-6.4) for weight, 4.0 (95% CI, 2.6-6.0) for fat mass, 4.2 (95% CI, 2.8-6.2) for waist circumference, 2.4 (95% CI, 1.6-3.5) for waist-hip ratio, and 3.8 (95% CI, 2.6-5.5) for waist-height ratio. However, when stratified by age, participants 75 years of age and older had HRs approximately half as large as those 65 to 74 years of age. Compared with weight-stable participants (+/- 2 kg), those who gained the most weight from 50 years of age to baseline (>= 9 kg), and from baseline to the third follow-up visit (>= 6 kg), had HRs for type 2 diabetes of 2.8 (95% CI, 1.9-4.3) and 2.0 (95% CI, 1.1-3.7), respectively. Participants with a greater than 10-cm increase in waist size from baseline to the third follow-up visit had an HR of type 2 diabetes of 1.7 (95% CI, 1.1-2.8) compared with those who gained or lost 2 cm or less. Conclusion Among older adults, overall and central adiposity, and weight gain during middle age and after the age of 65 years are associated with risk of diabetes. JAMA. 2010; 303(24): 2504-2512	[Biggs, Mary L.] Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, Seattle, WA 98195 USA; [Mukamal, Kenneth J.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; [Mukamal, Kenneth J.] Harvard Univ, Sch Med, Boston, MA USA; [Luchsinger, Jose A.] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Med Ctr, New York, NY USA; [Luchsinger, Jose A.] Columbia Univ, Dept Med, Med Ctr, New York, NY USA; [Ix, Joachim H.] Univ Calif San Diego, Dept Med, Div Nephrol, San Diego, CA 92103 USA; [Ix, Joachim H.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Carnethon, Mercedes R.] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Strotmeyer, Elsa S.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [de Boer, Ian H.] Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98195 USA; [Newman, Anne B.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Mozaffarian, Dariush] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Siscovick, David S.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Siscovick, David S.] Univ Washington, Dept Epidemiolf, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Columbia University; Columbia University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Biggs, ML (corresponding author), Bldg 29,Ste 310,6200 NE 74th St, Seattle, WA 98115 USA.	mlbiggs@u.washington.edu	Newman, Anne B./C-6408-2013; Mukamal, Kenneth/GVR-7978-2022; de Boer, Ian/GYJ-3282-2022; Mozaffarian, Dariush/B-2276-2008	Newman, Anne B./0000-0002-0106-1150; Luchsinger, Jose/0000-0002-5886-3648; Carnethon, Mercedes/0000-0001-7035-0848; Strotmeyer, Elsa/0000-0002-4093-6036	National Heart, Lung, and Blood Institute [N01-HC-85079, N01-HC-85086, N01-HC-35129, N01-HC-15103, N01-HC-55222, N01-HC-75150, N01-HC-45133, U01 HL080295, R01 HL-075366, R01 HL-094555]; National Institute on Aging [R01 AG-023629, R01 AG-15928, R01 AG-20098, AG-027058]; University of Pittsburgh Claude; University of Pittsburgh Claude. D. Pepper Older Americans Independence Center [P30-AG-024827]; National Institute of Neurological Disorders and Stroke; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085086, N01HC085083, N01HC085085, N01HC085080, N01HC035129, N01HC085084, N01HC015103, N01HC085079, N01HC085082, N01HC045133, N01HC055222, N01HC085081, N01HC075150] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025015] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL075366, R01HL094555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020098, R01AG027058, P30AG024827, R01AG023629, R01AG015928] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Pittsburgh Claude; University of Pittsburgh Claude. D. Pepper Older Americans Independence Center; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The research reported in this article was supported by contract numbers N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01-HC-15103, N01-HC-55222, N01-HC-75150, N01-HC-45133, and grant numbers U01 HL080295, R01 HL-075366, and R01 HL-094555 from the National Heart, Lung, and Blood Institute; R01 AG-023629, R01 AG-15928, R01 AG-20098, and AG-027058 from the National Institute on Aging; the University of Pittsburgh Claude. D. Pepper Older Americans Independence Center P30-AG-024827, with additional contribution from the National Institute of Neurological Disorders and Stroke.	[Anonymous], 1995, WHO TECHN REP SER, V854, P1, DOI DOI 10.1002/(sici)1520-6300(1996)8:6<786::aid-ajhb11>3.0.co;2-i; Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; CASSANO PA, 1992, AM J EPIDEMIOL, V136, P1474, DOI 10.1093/oxfordjournals.aje.a116468; *CDCP, 2008, DIAB DAT TRENDS; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Deurenberg P, 1990, Basic Life Sci, V55, P391; Diehr P, 1998, AM J PUBLIC HEALTH, V88, P623, DOI 10.2105/AJPH.88.4.623; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117; Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Goodpaster BH, 2003, DIABETES CARE, V26, P372, DOI 10.2337/diacare.26.2.372; Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560; Harris TB, 2002, AM J EPIDEMIOL, V156, P122, DOI 10.1093/aje/kwf024; Harris TB, 2000, ANN NY ACAD SCI, V904, P462; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Kanaya AM, 2004, DIABETES CARE, V27, P1375, DOI 10.2337/diacare.27.6.1375; Koh-Banerjee P, 2004, AM J EPIDEMIOL, V159, P1150, DOI 10.1093/aje/kwh167; Kuk JL, 2005, AM J CLIN NUTR, V81, P1330; LUNDGREN H, 1989, INT J OBESITY, V13, P413; Mozaffarian D, 2009, ARCH INTERN MED, V169, P798, DOI 10.1001/archinternmed.2009.21; *NAT CHOL ED PROGR, 2002, NIH PUBL; Newman AB, 2005, AM J CLIN NUTR, V82, P872, DOI 10.1093/ajcn/82.4.872; Poehlman ET, 2000, J CLIN ENDOCR METAB, V85, P2463, DOI 10.1210/jc.85.7.2463; PSATY BM, 1992, J CLIN EPIDEMIOL, V45, P683, DOI 10.1016/0895-4356(92)90143-B; RIMM EB, 1995, AM J EPIDEMIOL, V141, P1117, DOI 10.1093/oxfordjournals.aje.a117385; Schulze MB, 2006, DIABETES CARE, V29, P1921, DOI 10.2337/dc06-0895; Snijder MB, 2002, INT J OBESITY, V26, P984, DOI 10.1038/sj.ijo.0801968; Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Stevens J, 2001, OBES RES, V9, P696, DOI 10.1038/oby.2001.94; Storti KL, 2006, OBESITY, V14, P244, DOI 10.1038/oby.2006.31; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Tell G S, 1993, Ann Epidemiol, V3, P358, DOI 10.1016/1047-2797(93)90062-9; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wang ZM, 2007, EUR J CARDIOV PREV R, V14, P172, DOI 10.1097/01.hjr.0000220580.34763.fb; Wedick NM, 2001, AM J EPIDEMIOL, V153, P1199, DOI 10.1093/aje/153.12.1199; Wei M, 1997, OBES RES, V5, P16, DOI 10.1002/j.1550-8528.1997.tb00278.x	41	107	108	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2010	303	24					2504	2512		10.1001/jama.2010.843	http://dx.doi.org/10.1001/jama.2010.843			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	613VM	20571017	Bronze, Green Accepted			2022-12-01	WOS:000279010900028
J	Vijaykrishna, D; Poon, LLM; Zhu, HC; Ma, SK; Li, OTW; Cheung, CL; Smith, GJD; Peiris, JSM; Guan, Y				Vijaykrishna, D.; Poon, L. L. M.; Zhu, H. C.; Ma, S. K.; Li, O. T. W.; Cheung, C. L.; Smith, G. J. D.; Peiris, J. S. M.; Guan, Y.			Reassortment of Pandemic H1N1/2009 Influenza A Virus in Swine	SCIENCE			English	Article									[Vijaykrishna, D.; Poon, L. L. M.; Zhu, H. C.; Ma, S. K.; Li, O. T. W.; Cheung, C. L.; Smith, G. J. D.; Peiris, J. S. M.; Guan, Y.] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Vijaykrishna, D.; Poon, L. L. M.; Zhu, H. C.; Ma, S. K.; Li, O. T. W.; Cheung, C. L.; Smith, G. J. D.; Peiris, J. S. M.; Guan, Y.] Univ Hong Kong, Dept Microbiol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Vijaykrishna, D.; Zhu, H. C.; Smith, G. J. D.; Guan, Y.] Shantou Univ, Coll Med, Int Inst Infect & Immun, Shantou 515031, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; Shantou University	Peiris, JSM (corresponding author), Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	malik@hkucc.hku.hk; yguan@hkucc.hku.hk	Poon, Leo/AAP-6887-2020; Dhanasekaran, Vijaykrishna/D-1011-2010; Cheung, Yiu Man/T-2708-2019; Poon, Leo Lit Man/C-4382-2009; Vijaykrishna, Dhanasekaran/AAG-2077-2020; Zhu, Huachen/A-8252-2017	Dhanasekaran, Vijaykrishna/0000-0003-3293-6279; Poon, Leo Lit Man/0000-0002-9101-7953; Vijaykrishna, Dhanasekaran/0000-0003-3293-6279; Zhu, Huachen/0000-0003-2711-0501; Smith, Gavin JD/0000-0001-5031-468X; Guan, Yi/0000-0001-6057-9243	National Institute of Allergy and Infectious Diseases (NIAID) [HHSN266200700005C]; University Grants Committee of the Hong Kong SAR Government [AoE/M-12/06]	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University Grants Committee of the Hong Kong SAR Government	This work was supported in part by the National Institute of Allergy and Infectious Diseases (NIAID) contract HHSN266200700005C and the Area of Excellence Scheme of the University Grants Committee (grant AoE/M-12/06) of the Hong Kong SAR Government. We acknowledge the Food and Environmental Hygiene Department of Hong Kong for facilitating this study. Authors declare no conflict of interest. Sequence data generated from this study were deposited in GenBank with accession nos. CY061626 to CY061881.	Bastien N, 2010, J INFECT DIS, V201, P1178, DOI 10.1086/651507; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Pasma T, 2010, EMERG INFECT DIS, V16, P706, DOI 10.3201/eid1604.091636; Peiris JSM, 2001, J VIROL, V75, P9679, DOI 10.1128/JVI.75.20.9679-9686.2001; Smith GJD, 2009, P NATL ACAD SCI USA, V106, P11709, DOI 10.1073/pnas.0904991106; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; WHO website, PAND H1N1 2009 UPD 8	7	303	324	0	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1529	1529		10.1126/science.1189132	http://dx.doi.org/10.1126/science.1189132			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558710	Green Accepted			2022-12-01	WOS:000278859200038
J	Sun, YJ; Wu, GK; Liu, BH; Li, P; Zhou, M; Xiao, Z; Tao, HW; Zhang, LI				Sun, Yujiao J.; Wu, Guangying K.; Liu, Bao-hua; Li, Pingyang; Zhou, Mu; Xiao, Zhongju; Tao, Huizhong W.; Zhang, Li I.			Fine-tuning of pre-balanced excitation and inhibition during auditory cortical development	NATURE			English	Article							PRIMARY VISUAL-CORTEX; RECEPTIVE-FIELDS; NEURONS; CIRCUITS; RAT; REPRESENTATION; SELECTIVITY; INPUTS; MAPS	Functional receptive fields of neurons in sensory cortices undergo progressive refinement during development(1-4). Such refinement may be attributed to the pruning of non-optimal excitatory inputs, reshaping of the excitatory tuning profile through modifying the strengths of individual inputs, or strengthening of cortical inhibition. These models have not been directly tested because of the technical difficulties in assaying the spatiotemporal patterns of functional synaptic inputs during development. Here we apply in vivo whole-cell voltage-clamp recordings to the recipient layer 4 neurons in the rat primary auditory cortex (A1) to determine the developmental changes in the frequency-intensity tonal receptive fields (TRFs) of their excitatory and inhibitory inputs. Surprisingly, we observe co-tuned excitation and inhibition immediately after the onset of hearing, suggesting that a tripartite thalamocortical circuit with relatively strong feedforward inhibition is formed independently of auditory experience. The frequency ranges of tone-driven excitatory and inhibitory inputs first expand within a few days of the onset of hearing and then persist into adulthood. The latter phase is accompanied by a sharpening of the excitatory but not inhibitory frequency tuning profile, which results in relatively broader inhibitory tuning in adult A1 neurons. Thus the development of cortical synaptic TRFs after the onset of hearing is marked by a slight breakdown of previously formed excitation-inhibition balance. Our results suggest that functional refinement of cortical TRFs does not require a selective pruning of inputs, but may depend more on a fine adjustment of excitatory input strengths.	[Sun, Yujiao J.; Wu, Guangying K.; Liu, Bao-hua; Li, Pingyang; Zhou, Mu; Tao, Huizhong W.; Zhang, Li I.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Zhang, Li I.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90089 USA; [Tao, Huizhong W.] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA; [Xiao, Zhongju] So Med Univ, Sch Basic Med Sci, Dept Physiol, Guangzhou 510515, Guangdong, Peoples R China	University of Southern California; University of Southern California; University of Southern California; Southern Medical University - China	Zhang, LI (corresponding author), Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA.	htao@usc.edu; liizhang@usc.edu	Wu, Guangying/E-8117-2010; Zhou, Mu/K-8137-2016; Tao, Huizhong W/HDM-9767-2022; Sun, Yujiao/E-5668-2015	Zhou, Mu/0000-0001-5326-4884; Wu, Guangying/0000-0002-7243-5412; Sun, Yujiao Jennifer/0000-0003-2437-2936	US National Institutes of Health/National Institute on Deafness and Other Communication Disorders [R01DC008983, R21DC008588]; Searle Scholar Program; Klingenstein Foundation; David and Lucile Packard Foundation; US National Institutes of Health [EY018718, EY019049]; Karl Kirchgessner Foundation; National Natural Science Foundation of China [30730039, 30970982, 30670665]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY018718, R01EY019049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008983, R21DC008588, R03DC006814] Funding Source: NIH RePORTER	US National Institutes of Health/National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Searle Scholar Program; Klingenstein Foundation(Klingenstein Philanthropies); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Karl Kirchgessner Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank J.R. Chan for suggestions. This work was supported by grants to L.I.Z. from the US National Institutes of Health/National Institute on Deafness and Other Communication Disorders (R01DC008983, R21DC008588), the Searle Scholar Program, the Klingenstein Foundation and the David and Lucile Packard Foundation (Packard Fellowships for Science and Engineering). H. W. T. is supported by the US National Institutes of Health (EY018718 and EY019049) and the Karl Kirchgessner Foundation. Z.X. is supported by the National Natural Science Foundation of China (grant numbers 30730039, 30970982 and 30670665).	Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; BLATCHLEY BJ, 1987, DEV BRAIN RES, V32, P75, DOI 10.1016/0165-3806(87)90140-4; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; Chapman B, 1996, J NEUROSCI, V16, P6443; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; GEALDOR M, 1993, HEARING RES, V69, P236, DOI 10.1016/0378-5955(93)90113-F; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Inan M, 2007, NEUROSCIENTIST, V13, P49, DOI 10.1177/1073858406296257; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; Liu BH, 2007, NAT NEUROSCI, V10, P1594, DOI 10.1038/nn2012; Liu BH, 2010, NAT NEUROSCI, V13, P89, DOI 10.1038/nn.2443; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Oswald AMM, 2006, CURR OPIN NEUROBIOL, V16, P371, DOI 10.1016/j.conb.2006.06.015; Richardson RJ, 2009, J NEUROSCI, V29, P6406, DOI 10.1523/JNEUROSCI.0258-09.2009; Romand R, 1997, PROG NEUROBIOL, V51, P1, DOI 10.1016/S0301-0082(96)00043-3; Smith PH, 2001, J COMP NEUROL, V436, P508, DOI 10.1002/cne.1084; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wu GK, 2008, NEURON, V58, P132, DOI 10.1016/j.neuron.2008.01.035; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zhou Y, 2010, NEURON, V65, P706, DOI 10.1016/j.neuron.2010.02.021	30	134	135	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2010	465	7300					927	U8		10.1038/nature09079	http://dx.doi.org/10.1038/nature09079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559386	Green Accepted			2022-12-01	WOS:000278804500038
J	Joly, CA; Rodrigues, RR; Metzger, JP; Haddad, CFB; Verdade, LM; Oliveira, MC; Bolzani, VS				Joly, Carlos A.; Rodrigues, Ricardo R.; Metzger, Jean Paul; Haddad, Celio F. B.; Verdade, Luciano M.; Oliveira, Mariana C.; Bolzani, Vanderlan S.			Biodiversity Conservation Research, Training, and Policy in Sao Paulo	SCIENCE			English	Editorial Material									[Joly, Carlos A.] Univ Estadual Campinas, Inst Biol, Dept Plant Biol, BR-13083970 Campinas, SP, Brazil; [Rodrigues, Ricardo R.; Verdade, Luciano M.] State Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Biol Sci, Piracicaba, SP, Brazil; [Metzger, Jean Paul] Univ Sao Paulo, Inst Biol Sci, Dept Ecol, Sao Paulo, Brazil; [Haddad, Celio F. B.] Univ Estadual Paulista, Inst Biosci, Dept Zool, Rio Claro, SP, Brazil; [Oliveira, Mariana C.] Univ Sao Paulo, Inst Biosci, Dept Bot, Sao Paulo, Brazil; [Bolzani, Vanderlan S.] Univ Estadual Paulista, Dept Organ Chem, Araraquara, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade Estadual Paulista	Joly, CA (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Plant Biol, BR-13083970 Campinas, SP, Brazil.	cjoly@unicamp.br	de Oliveira, Mariana Cabral/G-2512-2012; JOLY, Carlos A./C-4523-2012; Bolzani, Vanderlan S/C-2111-2012; Haddad, Célio F. B./C-4267-2012; Verdade, Luciano M./H-5549-2012; JOLY, Carlos A/H-7925-2012; Metzger, Jean Paul/C-2514-2012; Rodrigues, Ricardo Ribeiro/D-5557-2012; Bolzani, Vanderlan/C-2111-2012	de Oliveira, Mariana Cabral/0000-0001-8495-2962; JOLY, Carlos A./0000-0002-7945-2805; Bolzani, Vanderlan S/0000-0003-0615-8776; Haddad, Célio F. B./0000-0002-7044-5764; Verdade, Luciano M./0000-0002-1326-0886; Metzger, Jean Paul/0000-0002-0087-5240; Rodrigues, Ricardo Ribeiro/0000-0003-4818-0736; Bolzani, Vanderlan/0000-0001-7019-5825				Durigan G., 2006, Edinburgh Journal of Botany, V63, P119, DOI 10.1017/S0960428606000357; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; RODRIGUES RR, 2008, DIRETRIZES CONSERVAC; Shanley P, 2009, BIOTROPICA, V41, P535, DOI 10.1111/j.1744-7429.2009.00561.x	5	66	71	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1358	1359		10.1126/science.1188639	http://dx.doi.org/10.1126/science.1188639			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608PO	20538935				2022-12-01	WOS:000278598400022
J	Zucker, I; Beery, AK				Zucker, Irving; Beery, Annaliese K.			Males still dominate animal studies	NATURE			English	Editorial Material									[Zucker, Irving] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Zucker, Irving] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Zucker, Irving] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Beery, Annaliese K.] Univ Calif San Francisco, Ctr Hlth & Community, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Zucker, I (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.	irvzuck@berkeley.edu		Beery, Annaliese/0000-0002-1249-9182				BEERY AK, NEUROSCI BI IN PRESS; Gold SM, 2009, J NEUROL SCI, V286, P99, DOI 10.1016/j.jns.2009.05.028; Hughes RN, 2007, BEHAV PHARMACOL, V18, P583, DOI 10.1097/FBP.0b013e3282eff0e8; Mogil JS, 2005, PAIN, V117, P1, DOI 10.1016/j.pain.2005.06.020; Veliskova J, 2007, NEUROSCIENTIST, V13, P77, DOI 10.1177/1073858406295827; Wang CH, 1923, COMP PSYCHOL MONOGR, V6, P1	6	277	279	2	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					690	690		10.1038/465690a	http://dx.doi.org/10.1038/465690a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608AM	20535186	Bronze			2022-12-01	WOS:000278551800020
J	Sharp, ZD; Shearer, CK; McKeegan, KD; Barnes, JD; Wang, YQ				Sharp, Z. D.; Shearer, C. K.; McKeegan, K. D.; Barnes, J. D.; Wang, Y. Q.			The Chlorine Isotope Composition of the Moon and Implications for an Anhydrous Mantle	SCIENCE			English	Article							EARTHS; IMPACT; ORIGIN; WATER	Arguably, the most striking geochemical distinction between Earth and the Moon has been the virtual lack of water (hydrogen) in the latter. This conclusion was recently challenged on the basis of geochemical data from lunar materials that suggest that the Moon's water content might be far higher than previously believed. We measured the chlorine isotope composition of Apollo basalts and glasses and found that the range of isotopic values [from -1 to +24 per mil (parts per thousand) versus standard mean ocean chloride] is 25 times the range for Earth. The huge isotopic spread is explained by volatilization of metal halides during basalt eruption-a process that could only occur if the Moon had hydrogen concentrations lower than those of Earth by a factor of similar to 10(4) to 10(5), implying that the lunar interior is essentially anhydrous.	[Sharp, Z. D.; Shearer, C. K.] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87122 USA; [Shearer, C. K.] Univ New Mexico, Inst Meteorit, Albuquerque, NM 87122 USA; [McKeegan, K. D.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Barnes, J. D.] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA; [Wang, Y. Q.] Los Alamos Natl Lab, Div Mat Sci & Technol, Los Alamos, NM 87545 USA	University of New Mexico; University of New Mexico; University of California System; University of California Los Angeles; University of Texas System; University of Texas Austin; United States Department of Energy (DOE); Los Alamos National Laboratory	Sharp, ZD (corresponding author), Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87122 USA.	zsharp@unm.edu	McKeegan, Kevin D/A-4107-2008; Barnes, Jaime D/B-5454-2011	McKeegan, Kevin D/0000-0002-1827-729X; 	NASA [07-SSO07-0077, NNX08AY786]; NSF; DOE Office of Basic Energy Sciences	NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF)); DOE Office of Basic Energy Sciences(United States Department of Energy (DOE))	Supported by NASA Origins grant 07-SSO07-0077 (Z.D.S.), NASA LASER grant NNX08AY786 (C.K.S.), and a NASA Cosmochemistry grant (K.D.M.). The UCLA ion microprobe facility is partially supported by a grant from the NSF Instrumentation and Facilities Program. We thank lunar curator G. Lofgren and staff of the Johnson Space Center, Houston. P. Burger provided imaging and quantitative elemental analyses of apatite. The Ion Beam Materials Laboratory at Los Alamos is partially supported by DOE Office of Basic Energy Sciences programs.	Abe Y., 2000, ORIGIN EARTH MOON, P413; Albarede F, 2009, NATURE, V461, P1227, DOI 10.1038/nature08477; Barnes JD, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002587; Barnes JD, 2008, GEOLOGY, V36, P883, DOI 10.1130/G25182A.1; Bonifacie M, 2008, SCIENCE, V319, P1518, DOI 10.1126/science.1150988; Cameron AGW, 1997, ICARUS, V126, P126, DOI 10.1006/icar.1996.5642; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; CARLSON RW, 2000, ORIGIN EARTH MOON, P25; CHOU CL, 1975, P LUNAR PLANET SCI C, V2, P1701; COLSON RO, 1992, P LUNAR PLANET SCI, V22, P427; ESAT TM, 1988, GEOCHIM COSMOCHIM AC, V52, P1409, DOI 10.1016/0016-7037(88)90211-6; FEGLEY B, 1991, GEOPHYS RES LETT, V18, P2073, DOI 10.1029/91GL02624; Fegley Jr B., 1993, RESOURCES NEAR EARTH, P367; GREENWOOD JP, 2010, LUNAR PLANET SCI C, V41; HARTMANN WK, 1975, ICARUS, V24, P504, DOI 10.1016/0019-1035(75)90070-6; HUMAYUN M, 1995, GEOCHIM COSMOCHIM AC, V59, P2131, DOI 10.1016/0016-7037(95)00132-8; LIU Y, 2010, LUNAR PLANET SCI C, V41; McCubbin FM, 2010, P NATL ACAD SCI USA, V107, P11223, DOI 10.1073/pnas.1006677107; McDonough W.F., 2003, TREATISE GEOCHEMISTR, P547, DOI DOI 10.1016/B0-08-043751-6/02015-6; McKay D. S., 1993, LUNAR PLANET SCI, V24, P961; Morris R.V., 1978, P LUN PLAN SCI C 9, P2287; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; Raymond SN, 2004, ICARUS, V168, P1, DOI 10.1016/j.icarus.2003.11.019; Richter FM, 2007, GEOCHIM COSMOCHIM AC, V71, P5544, DOI 10.1016/j.gca.2007.09.005; RINGWOOD AE, 1979, ORIGIN EARTH MOON; Saal AE, 2008, NATURE, V454, P192, DOI 10.1038/nature07047; Schauble EA, 2003, GEOCHIM COSMOCHIM AC, V67, P3267, DOI 10.1016/S0016-7037(02)01375-3; Sharp ZD, 2007, NATURE, V446, P1062, DOI 10.1038/nature05748; Sharp ZD, 2010, GEOCHIM COSMOCHIM AC, V74, P264, DOI 10.1016/j.gca.2009.09.032; Shearer CK, 2006, REV MINERAL GEOCHEM, V60, P365, DOI 10.2138/rmg.2006.60.4; Shearer CK, 1999, AM MINERAL, V84, P1469; Wiechert U, 2001, SCIENCE, V294, P345, DOI 10.1126/science.1063037	32	163	169	4	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2010	329	5995					1050	1053		10.1126/science.1192606	http://dx.doi.org/10.1126/science.1192606			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20688980				2022-12-01	WOS:000281253500033
J	Seifert, U; Bialy, LP; Ebstein, F; Bech-Otschir, D; Voigt, A; Schroter, F; Prozorovski, T; Lange, N; Steffen, J; Rieger, M; Kuckelkorn, U; Aktas, O; Kloetzel, PM; Kruger, E				Seifert, Ulrike; Bialy, Lukasz P.; Ebstein, Frederic; Bech-Otschir, Dawadschargal; Voigt, Antje; Schroeter, Friederike; Prozorovski, Timour; Lange, Nicole; Steffen, Janos; Rieger, Melanie; Kuckelkorn, Ulrike; Aktas, Orhan; Kloetzel, Peter-M.; Krueger, Elke			Immunoproteasomes Preserve Protein Homeostasis upon Interferon-Induced Oxidative Stress	CELL			English	Article							NEWLY SYNTHESIZED PROTEINS; CD8(+) T-CELLS; PROTEASOME SYSTEM; GAMMA-INTERFERON; HEAT-SHOCK; INDUCTION; DEGRADATION; UBIQUITIN; IMMUNITY; PATHWAY	Interferon (IFN)-induced immunoproteasomes (i-proteasomes) have been associated with improved processing of major histocompatibility complex (MHC) class I antigens. Here, we show that i-proteasomes function to protect cell viability under conditions of IFN-induced oxidative stress. IFNs trigger the production of reactive oxygen species, which induce protein oxidation and the formation of nascent, oxidant-damaged proteins. We find that the ubiquitylation machinery is concomitantly upregulated in response to IFNs, functioning to target defective ribosomal products (DRiPs) for degradation by i-proteasomes. i-proteasome-deficiency in cells and in murine inflammation models results in the formation of aggresome-like induced structures and increased sensitivity to apoptosis. Efficient clearance of these aggregates by the enhanced proteolytic activity of the i-proteasome is important for the preservation of cell viability upon IFN-induced oxidative stress. Our findings suggest that rather than having a specific role in the production of class I antigens, i-proteasomes increase the peptide supply for antigen presentation as part of a more general role in the maintenance of protein homeostasis.	[Seifert, Ulrike; Bialy, Lukasz P.; Ebstein, Frederic; Bech-Otschir, Dawadschargal; Schroeter, Friederike; Lange, Nicole; Steffen, Janos; Rieger, Melanie; Kuckelkorn, Ulrike; Kloetzel, Peter-M.; Krueger, Elke] Charite, Inst Biochem CC2, D-13347 Berlin, Germany; [Voigt, Antje] Charite, Med Klin Kardiol & Angiol CC13, D-10117 Berlin, Germany; [Prozorovski, Timour; Aktas, Orhan] Univ Dusseldorf, Fac Med, Dept Neurol, D-40225 Dusseldorf, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Heinrich Heine University Dusseldorf	Kloetzel, PM (corresponding author), Charite, Inst Biochem CC2, Oudenarder Str 16, D-13347 Berlin, Germany.	p-m.kloetzel@charite.de; elke.krueger@charite.de	Krueger, Elke/B-1462-2012; Steffen, Janos/AAI-7646-2020; Voigt, Antje/E-4332-2013; Biały, Lukasz/AAW-8500-2021; Aktas, Orhan/B-7623-2009; Bialy, Lukasz P./I-1785-2019; Beling, Antje/AAW-5380-2020	Krueger, Elke/0000-0002-2551-242X; Aktas, Orhan/0000-0002-2020-9210; Bialy, Lukasz P./0000-0001-6931-6431; Beling, Antje/0000-0002-1826-5248; Kuckelkorn, Ulrike/0000-0002-3085-9161	Deutsche Forschungsgemeinschaft [SFB421, SFB740, Transregio 19, Transregio 43, KR1915/4-1, SPP 1365]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	D. Ludwig and E. Burger are acknowledged for their excellent technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft (SFB421, SFB740, Transregio 19, Transregio 43, KR1915/4-1, SPP 1365).	AKI M, 1994, J BIOCHEM, V115, P257, DOI 10.1093/oxfordjournals.jbchem.a124327; Bech-Otschir D, 2009, NAT STRUCT MOL BIOL, V16, P219, DOI 10.1038/nsmb.1547; Bose S, 2001, BIOCHEM J, V353, P291, DOI 10.1042/0264-6021:3530291; Callahan MK, 2006, J IMMUNOL, V177, P8393, DOI 10.4049/jimmunol.177.12.8393; Chen WS, 2001, J EXP MED, V193, P1319, DOI 10.1084/jem.193.11.1319; Chou B, 2008, MICROBES INFECT, V10, P241, DOI 10.1016/j.micinf.2007.11.010; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Deol P, 2007, J IMMUNOL, V178, P7557, DOI 10.4049/jimmunol.178.12.7557; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; Ebstein F, 2009, INT J BIOCHEM CELL B, V41, P1205, DOI 10.1016/j.biocel.2008.10.023; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Heink S, 2005, P NATL ACAD SCI USA, V102, P9241, DOI 10.1073/pnas.0501711102; Ishii K, 2006, MICROBES INFECT, V8, P1045, DOI 10.1016/j.micinf.2005.10.023; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kotamraju S, 2006, FREE RADICAL BIO MED, V40, P1034, DOI 10.1016/j.freeradbiomed.2005.10.052; Kruger E, 2004, REV PHYSIOL BIOCH P, V148, P81, DOI 10.1007/s10254-003-0010-4; Lelouard H, 2004, J CELL BIOL, V164, P667, DOI 10.1083/jcb.200312073; Lelouard H, 2007, J CELL BIOL, V179, P1427, DOI 10.1083/jcb.200707166; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Medicherla B, 2008, J CELL BIOL, V182, P663, DOI 10.1083/jcb.200803022; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nussbaum AK, 2005, J IMMUNOL, V175, P1153, DOI 10.4049/jimmunol.175.2.1153; Pearl-Yafe M, 2003, BIOCHEM PHARMACOL, V65, P833, DOI 10.1016/S0006-2952(02)01620-9; Puttaparthi K, 2005, EXP NEUROL, V196, P441, DOI 10.1016/j.expneurol.2005.08.027; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; SASAKI M, 2008, FREE RADICAL RES, V4, P1; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Sijts AJAM, 2000, J EXP MED, V191, P503, DOI 10.1084/jem.191.3.503; Strehl B, 2008, J BIOL CHEM, V283, P17891, DOI 10.1074/jbc.M710042200; Strehl B, 2006, J IMMUNOL, V177, P6238, DOI 10.4049/jimmunol.177.9.6238; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925; VAN KL, 1994, IMMUNITY, V1, P533; Voigt A, 2010, AMINO ACIDS, V39, P243, DOI 10.1007/s00726-009-0434-5; Watanabe Y, 2003, J CELL BIOCHEM, V89, P244, DOI 10.1002/jcb.10501; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008; Yewdell JW, 2005, IMMUNOL REV, V207, P8; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051; Zheng PZ, 2005, P NATL ACAD SCI USA, V102, P7653, DOI 10.1073/pnas.0502825102	49	394	402	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2010	142	4					613	624		10.1016/j.cell.2010.07.036	http://dx.doi.org/10.1016/j.cell.2010.07.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20723761	Bronze			2022-12-01	WOS:000281115900015
J	Wassersug, RJ; Lieberman, T				Wassersug, Richard J.; Lieberman, Tucker			Personal View Contemporary castration: why the modern day eunuch remains invisible	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANDROGEN-DEPRIVATION THERAPY; CHARACTERIZING MEN		[Wassersug, Richard J.] Dalhousie Univ, Halifax, NS, Canada	Dalhousie University	Wassersug, RJ (corresponding author), La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia.	Richard.Wassersug@dal.ca						Alibhai SMH, 2010, CRIT REV ONCOL HEMAT, V73, P167, DOI 10.1016/j.critrevonc.2009.03.005; Cherner MM, 2009, PSYCHO-ONCOLOGY, V18, P237, DOI 10.1002/pon.1401; Cushman M. A., 2010, INT J MENS HLTH, V9, P3, DOI [10.3149/jmh.0901.3, DOI 10.3149/JMH.0901.3]; DiBlasio CJ, 2008, BJU INT, V102, P39, DOI 10.1111/j.1464-410X.2008.07505.x; Engstrom CA, 2008, AM J MENS HEALTH, V2, P122, DOI 10.1177/1557988306298802; Higano C, 2006, HEMATOL ONCOL CLIN N, V20, P909, DOI 10.1016/j.hoc.2006.03.013; Jim HSL, 2010, SUPPORT CARE CANCER, V18, P21, DOI 10.1007/s00520-009-0625-3; Johnson TW, 2007, J SEX MED, V4, P930, DOI 10.1111/j.1743-6109.2007.00521.x; Mohile SG, 2010, J GERIATR ONCOL, V1, P13, DOI [10.1016/j.jgo.2010.03.001, 10.1016/j.critrevonc.2010.06.009]; Murthy V, 2007, BJU INT, V99, P1380, DOI 10.1111/j.1464-410X.2007.06843.x; Navon L, 2004, SOC SCI MED, V58, P2337, DOI 10.1016/j.socscimed.2003.08.029; Nelson CJ, 2008, CANCER, V113, P1097, DOI 10.1002/cncr.23658; Roberts LF, 2008, J SEX MED, V5, P1669, DOI 10.1111/j.1743-6109.2007.00636.x; Smith Matthew R, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P247, DOI 10.1097/MED.0b013e32814db88c; Smith MR, 2004, UROLOGY, V63, P742, DOI 10.1016/j.urology.2003.10.063; Wassersug R, 2010, ANTHROPOL TODAY, V26, P1, DOI 10.1111/j.1467-8322.2010.00707.x; Wassersug RJ, 2007, PERSPECT BIOL MED, V50, P544, DOI 10.1353/pbm.2007.0058; Wassersug RJ, 2009, J RELIG HEALTH, V48, P381, DOI 10.1007/s10943-008-9231-9	18	7	7	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 18	2010	341								c4509	10.1136/bmj.c4509	http://dx.doi.org/10.1136/bmj.c4509			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	642KT	20719851				2022-12-01	WOS:000281213100009
J	Hotez, PJ; Engels, D; Fenwick, A; Savioli, L				Hotez, Peter J.; Engels, Dirk; Fenwick, Alan; Savioli, Lorenzo			Africa is desperate for praziquantel	LANCET			English	Editorial Material							SCHISTOSOMIASIS; MORBIDITY; INFECTION; IMPACT		[Hotez, Peter J.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA; [Hotez, Peter J.] Sabin Vaccine Inst, Washington, DC 20037 USA; [Engels, Dirk; Savioli, Lorenzo] WHO, Dept Control Neglected Trop Dis, CH-1211 Geneva, Switzerland; [Fenwick, Alan] Univ London Imperial Coll Sci Technol & Med, Schistosomiasis Control Initiat, London, England	George Washington University; World Health Organization; Imperial College London	Hotez, PJ (corresponding author), George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20037 USA.	photez@gwu.edu		Hotez, Peter/0000-0001-8770-1042				Chen MG, 2005, ACTA TROP, V96, P168, DOI 10.1016/j.actatropica.2005.07.011; Fenwick A, 2006, ADV PARASIT, V61, P567, DOI 10.1016/S0065-308X(05)61013-5; Hotez PJ, 2009, CLIN PHARMACOL THER, V85, P659, DOI 10.1038/clpt.2009.16; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000485; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407; Kjetland EF, 2006, AIDS, V20, P593, DOI 10.1097/01.aids.0000210614.45212.0a; Koukounari A, 2007, J INFECT DIS, V196, P659, DOI 10.1086/520515; Koukounari A, 2006, AM J TROP MED HYG, V75, P278, DOI 10.4269/ajtmh.2006.75.278; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Zhang Y, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-27; 2006, HIST PRAZIQUANTEL	12	49	50	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 14	2010	376	9740					496	498		10.1016/S0140-6736(10)60879-3	http://dx.doi.org/10.1016/S0140-6736(10)60879-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643BE	20709217				2022-12-01	WOS:000281266800009
J	Beer, C; Reichstein, M; Tomelleri, E; Ciais, P; Jung, M; Carvalhais, N; Rodenbeck, C; Arain, MA; Baldocchi, D; Bonan, GB; Bondeau, A; Cescatti, A; Lasslop, G; Lindroth, A; Lomas, M; Luyssaert, S; Margolis, H; Oleson, KW; Roupsard, O; Veenendaal, E; Viovy, N; Williams, C; Woodward, FI; Papale, D				Beer, Christian; Reichstein, Markus; Tomelleri, Enrico; Ciais, Philippe; Jung, Martin; Carvalhais, Nuno; Roedenbeck, Christian; Arain, M. Altaf; Baldocchi, Dennis; Bonan, Gordon B.; Bondeau, Alberte; Cescatti, Alessandro; Lasslop, Gitta; Lindroth, Anders; Lomas, Mark; Luyssaert, Sebastiaan; Margolis, Hank; Oleson, Keith W.; Roupsard, Olivier; Veenendaal, Elmar; Viovy, Nicolas; Williams, Christopher; Woodward, F. Ian; Papale, Dario			Terrestrial Gross Carbon Dioxide Uptake: Global Distribution and Covariation with Climate	SCIENCE			English	Article							VEGETATION; BIOSPHERE; CO2; RADIATION; PRODUCTS; FRACTION; SULFIDE; NETWORK; IMPACT; MODEL	Terrestrial gross primary production (GPP) is the largest global CO2 flux driving several ecosystem functions. We provide an observation-based estimate of this flux at 123 +/- 8 petagrams of carbon per year (Pg C year(-1)) using eddy covariance flux data and various diagnostic models. Tropical forests and savannahs account for 60%. GPP over 40% of the vegetated land is associated with precipitation. State-of-the-art process-oriented biosphere models used for climate predictions exhibit a large between-model variation of GPP's latitudinal patterns and show higher spatial correlations between GPP and precipitation, suggesting the existence of missing processes or feedback mechanisms which attenuate the vegetation response to climate. Our estimates of spatially distributed GPP and its covariation with climate can help improve coupled climate-carbon cycle process models.	[Beer, Christian; Reichstein, Markus; Tomelleri, Enrico; Jung, Martin; Carvalhais, Nuno; Lasslop, Gitta] Max Planck Inst Biogeochem, Biogeochem Model Data Integrat Grp, D-07745 Jena, Germany; [Ciais, Philippe; Viovy, Nicolas] CEA CNRS UVSQ, Inst Pierre Simon Laplace, Lab Sci Climat & Environm, Gif Sur Yvette, France; [Carvalhais, Nuno] Univ Nova Lisboa, FCT, Caparica, Portugal; [Arain, M. Altaf] McMaster Univ, McMaster Ctr Climate Change, Hamilton, ON, Canada; [Baldocchi, Dennis] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Baldocchi, Dennis] Univ Calif Berkeley, Berkeley Atmospher Sci Ctr, Berkeley, CA 94720 USA; [Bonan, Gordon B.; Oleson, Keith W.] Natl Ctr Atmospher Res, Boulder, CO 80305 USA; [Bondeau, Alberte] Potsdam Inst Climate Impact Res PIK, D-14473 Potsdam, Germany; [Cescatti, Alessandro] Commiss European Communities, DG Joint Res Ctr, Inst Environm & Sustainabil, Climate Change Unit, Ispra, Italy; [Lindroth, Anders] Lund Univ, Dept Earth & Ecosyst Sci, S-22100 Lund, Sweden; [Lomas, Mark] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Luyssaert, Sebastiaan] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Margolis, Hank] Univ Laval, Ctr Etud Foret, Fac Foresterie Geogr & Geomat, Quebec City, PQ, Canada; [Roupsard, Olivier] Cirad Persyst, UPR80, Fonct & Pilotage Ecosyst Plantat, Montpellier, France; [Roupsard, Olivier] CATIE, Turrialba, Costa Rica; [Veenendaal, Elmar] Wageningen Univ, Nat Conservat & Plant Ecol Grp, Wageningen, Netherlands; [Williams, Christopher] Clark Univ, Grad Sch Geog, Worcester, MA 01610 USA; [Papale, Dario] Univ Tuscia, Dept Forest Enviromm & Resources, Viterbo, Italy	Max Planck Society; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Universidade Nova de Lisboa; McMaster University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; National Center Atmospheric Research (NCAR) - USA; Potsdam Institut fur Klimafolgenforschung; European Commission Joint Research Centre; EC JRC ISPRA Site; Lund University; University of Sheffield; University of Antwerp; Laval University; CIRAD; Wageningen University & Research; Clark University; Tuscia University	Beer, C (corresponding author), Max Planck Inst Biogeochem, Biogeochem Model Data Integrat Grp, D-07745 Jena, Germany.	christian.beer@bgc-jena.mpg.de	Bondeau, Alberte/E-9909-2012; Woodward, Ian F/B-7762-2008; Ciais, Philippe M/A-6840-2011; Roupsard, Olivier/C-1219-2008; Arain, M. Altaf/ABA-9750-2020; Papale, Dario/W-7302-2019; Baldocchi, Dennis/A-1625-2009; Veenendaal, Elmar M/B-4628-2009; Tomelleri, Enrico/N-6147-2014; Lindroth, Anders/N-4697-2014; Luyssaert, Sebastiaan/F-6684-2011; Beer, Christian/D-2296-2013; Viovy, Nicolas/S-2631-2018; Cescatti, Alessandro/ABE-6319-2020; Woodward, Frank Ian/P-4530-2019; Reichstein, Markus/A-7494-2011; Oleson, Keith/A-9328-2008; Tomelleri, Enrico/AAJ-3219-2020	Bondeau, Alberte/0000-0002-8729-5061; Ciais, Philippe M/0000-0001-8560-4943; Roupsard, Olivier/0000-0002-1319-142X; Arain, M. Altaf/0000-0002-1433-5173; Papale, Dario/0000-0001-5170-8648; Baldocchi, Dennis/0000-0003-3496-4919; Tomelleri, Enrico/0000-0001-6546-6459; Lindroth, Anders/0000-0002-7669-784X; Luyssaert, Sebastiaan/0000-0003-1121-1869; Beer, Christian/0000-0002-5377-3344; Viovy, Nicolas/0000-0002-9197-6417; Reichstein, Markus/0000-0001-5736-1112; Oleson, Keith/0000-0002-0057-9900; Williams, Christopher A./0000-0002-5047-0639; Lasslop, Gitta/0000-0001-9939-1459; Carvalhais, Nuno/0000-0003-0465-1436	Department of Energy, Biological and Environmental Research [DE-FG02-04ER63917, DE-FG02-04ER63911]; AfriFlux; AsiaFlux; CarboAfrica; CarboEuropeIP; CarboItaly; CarboMont; ChinaFlux; Fluxnet-Canada; CFCAS; NSERC; BIOCAP; Environment Canada; NRCan; GreenGrass; KoFlux; LBA; NECC; OzFlux; TCOS-Siberia; USCCC; FAO-GTOS-TCO; Integrated Land Ecosystem-Atmosphere Processes Study; MaxPlanck Institute for Biogeochemistry; National Science Foundation; University of Tuscia; Universite Laval; NERC [earth010003] Funding Source: UKRI; Natural Environment Research Council [earth010003] Funding Source: researchfish; Div Atmospheric & Geospace Sciences [0910766] Funding Source: National Science Foundation	Department of Energy, Biological and Environmental Research(United States Department of Energy (DOE)); AfriFlux; AsiaFlux; CarboAfrica; CarboEuropeIP(European Commission); CarboItaly; CarboMont; ChinaFlux; Fluxnet-Canada; CFCAS; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); BIOCAP; Environment Canada(CGIAR); NRCan(Natural Resources Canada); GreenGrass; KoFlux; LBA; NECC; OzFlux; TCOS-Siberia; USCCC; FAO-GTOS-TCO; Integrated Land Ecosystem-Atmosphere Processes Study; MaxPlanck Institute for Biogeochemistry; National Science Foundation(National Science Foundation (NSF)); University of Tuscia; Universite Laval; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work used eddy covariance data acquired by the FLUXNET community and in particular by the following networks: AmeriFlux [U.S. Department of Energy, Biological and Environmental Research, Terrestrial Carbon Program (DEFG02-04ER63917 and DE-FG02-04ER63911)], AfriFlux, AsiaFlux, CarboAfrica, CarboEuropeIP, CarboItaly, CarboMont, ChinaFlux, Fluxnet-Canada (supported by CFCAS, NSERC, BIOCAP, Environment Canada, and NRCan), GreenGrass, KoFlux, LBA, NECC, OzFlux, TCOS-Siberia, and USCCC. We acknowledge the support to the eddy covariance data harmonization provided by CarboEuropeIP, FAO-GTOS-TCO, Integrated Land Ecosystem-Atmosphere Processes Study, MaxPlanck Institute for Biogeochemistry, National Science Foundation, University of Tuscia, Universite Laval and Environment Canada and U.S. Department of Energy and the database development and technical support from Berkeley Water Center, Lawrence Berkeley National Laboratory, Microsoft Research eScience, Oak Ridge National Laboratory, University of California-Berkeley, and University of Virginia. Remotely sensed land cover, fAPAR, and LAI were available through the Joint Research Centre of the European Commission, the National Aeronautics and Space Administration, and the projects GLC2000 and CYCLOPES. Climate data came from the European Centre for Medium-Range Weather Forecasts, the Climate Research Unit of the University of East Anglia, and the GEWEX project GPCP. We thank Mahendra K. Karki at GMAO/NASA for extracting the MOD17 required surface meteorological variables from the GMAO reanalysis dataset and Maosheng Zhao at NTSG of University of Montana for calculating the respective daytime VPD. We further acknowledge support by the European Commission FP7 projects COMBINE and CARBO-Extreme and a grant from the Max-Planck Society establishing the MPRG Biogeochemical Model-Data Integration. C.B., D.P., M.R., P.C., D.B., and S.L. conceived the study. C.B., C.R., D.P., E.T., M.J., M.R., and N.C. contributed diagnostic modeling results. C.B., A.B., G.B.B., M.L., F.I.W., and N.V. contributed process model results. C.B., E.T., and M.R. performed the analysis. C.B. and M.R. wrote the manuscript. All other coauthors contributed with data or substantial input to the manuscript.	Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Baret F, 2007, REMOTE SENS ENVIRON, V110, P275, DOI 10.1016/j.rse.2007.02.018; Beer C, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029006; Beer C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003233; Bondeau A, 2007, GLOBAL CHANGE BIOL, V13, P679, DOI 10.1111/j.1365-2486.2006.01305.x; Campbell JE, 2008, SCIENCE, V322, P1085, DOI 10.1126/science.1164015; Ciais P, 1997, J GEOPHYS RES-ATMOS, V102, P5857, DOI 10.1029/96JD02360; DeLucia EH, 2007, GLOBAL CHANGE BIOL, V13, P1157, DOI 10.1111/j.1365-2486.2007.01365.x; FARQUHAR GD, 1993, NATURE, V363, P439, DOI 10.1038/363439a0; Fekete BM, 2004, J CLIMATE, V17, P294, DOI 10.1175/1520-0442(2004)017<0294:UIPATI>2.0.CO;2; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gerten D, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024247; Gobron N, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006511; Jung M, 2009, BIOGEOSCIENCES, V6, P2001, DOI 10.5194/bg-6-2001-2009; Lieth H., 2012, PRIMARY PRODUCTIVITY, V14, DOI [10.1007/978-3-642-80913-2_12, DOI 10.1007/978-3-642-80913-2_12, 10.1007/978-3-642-80913-2, DOI 10.1007/978-3-642-80913-2]; Litton CM, 2007, GLOBAL CHANGE BIOL, V13, P2089, DOI 10.1111/j.1365-2486.2007.01420.x; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Mercado LM, 2009, NATURE, V458, P1014, DOI 10.1038/nature07949; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; MONTEITH JL, 1972, J APPL ECOL, V9, P747, DOI 10.2307/2401901; Myneni RB, 2002, REMOTE SENS ENVIRON, V83, P214, DOI 10.1016/S0034-4257(02)00074-3; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Papale D, 2003, GLOBAL CHANGE BIOL, V9, P525, DOI 10.1046/j.1365-2486.2003.00609.x; POORTER H, 1990, PLANT PHYSIOL, V94, P621, DOI 10.1104/pp.94.2.621; Prentice IC, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P183; Rodenbeck C, 2003, ATMOS CHEM PHYS, V3, P1919; Running SW, 2000, METHODS IN ECOSYSTEM SCIENCE, P44; Sandoval-Soto L, 2005, BIOGEOSCIENCES, V2, P125, DOI 10.5194/bg-2-125-2005; Saugier B., 2001, TERRESTRIAL GLOBAL P, P401; Schulze E. D., 1970, Flora, Jena, V159, P177; Simmons A, 2007, ECMWF NEWSLETTER; Suntharalingam P, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034332; Whittaker RH, 1975, PRIMARY PRODUCTIVITY, P305, DOI DOI 10.1007/978-3-642-80913-2_15; Wingate L, 2009, P NATL ACAD SCI USA, V106, P22411, DOI 10.1073/pnas.0905210106; Zhao M, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2004JG000004	37	1604	1702	70	1252	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2010	329	5993					834	838		10.1126/science.1184984	http://dx.doi.org/10.1126/science.1184984			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20603496	Green Published			2022-12-01	WOS:000280809900049
J	Ittner, LM; Ke, YD; Delerue, F; Bi, MA; Gladbach, A; van Eersel, J; Wolfing, H; Chieng, BC; Christie, MJ; Napier, IA; Eckert, A; Staufenbiel, M; Hardeman, E; Gotz, J				Ittner, Lars M.; Ke, Yazi D.; Delerue, Fabien; Bi, Mian; Gladbach, Amadeus; van Eersel, Janet; Woelfing, Heidrun; Chieng, Billy C.; Christie, MacDonald J.; Napier, Ian A.; Eckert, Anne; Staufenbiel, Matthias; Hardeman, Edna; Goetz, Juergen			Dendritic Function of Tau Mediates Amyloid-beta Toxicity in Alzheimer's Disease Mouse Models	CELL			English	Article							PAIRED HELICAL FILAMENT; APP23 TRANSGENIC MICE; TYROSINE PHOSPHORYLATION; COGNITIVE IMPAIRMENTS; PROTEIN; FYN; DEFICITS; KINASE; SUBUNIT; NEURODEGENERATION	Alzheimer's disease (AD) is characterized by amyloid-beta (A beta) and tau deposition in brain. It has emerged that A beta toxicity is tau dependent, although mechanistically this link remains unclear. Here, we show that tau, known as axonal protein, has a dendritic function in postsynaptic targeting of the Src kinase Fyn, a substrate of which is the NMDA receptor (NR). Missorting of tau in transgenic mice expressing truncated tau (Delta tau) and absence of tau in tau(-/-) mice both disrupt postsynaptic targeting of Fyn. This uncouples NR-mediated excitotoxicity and hence mitigates A beta toxicity. Delta tau expression and tau deficiency prevent memory deficits and improve survival in A beta-forming APP23 mice, a model of AD. These deficits are also fully rescued with a peptide that uncouples the Fyn-mediated interaction of NR and PSD-95 in vivo. Our findings suggest that this dendritic role of tau confers A beta toxicity at the postsynapse with direct implications for patho-genesis and treatment of AD.	[Ittner, Lars M.; Ke, Yazi D.; Delerue, Fabien; Bi, Mian; Gladbach, Amadeus; van Eersel, Janet; Woelfing, Heidrun; Goetz, Juergen] Univ Sydney, Brain & Mind Res Inst, Alzheimers & Parkinsons Dis Lab, Sydney, NSW 2050, Australia; [Chieng, Billy C.; Christie, MacDonald J.; Napier, Ian A.] Univ Sydney, Brain & Mind Res Inst, Neuropharmacol Lab, Sydney, NSW 2050, Australia; [Eckert, Anne] Univ Basel, Psychiat Univ Clin, Neurobiol Res Lab, CH-4025 Basel, Switzerland; [Staufenbiel, Matthias] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland; [Hardeman, Edna] Univ New S Wales, Neuromuscular & Regenerat Med Unit, Sydney, NSW 2052, Australia	University of Sydney; University of Sydney; University of Basel; Novartis; University of New South Wales Sydney	Ittner, LM (corresponding author), Univ Sydney, Brain & Mind Res Inst, Alzheimers & Parkinsons Dis Lab, Sydney, NSW 2050, Australia.	littner@med.usyd.edu.au; jgoetz@med.usyd.edu.au	Götz, Jürgen/C-2448-2014; van Eersel, Janet/AAZ-4197-2020; Hardeman, Edna C/F-8872-2012; Christie, MacDonald J/F-4724-2013; Ke, Yazi/ABC-3052-2020	Götz, Jürgen/0000-0001-8501-7896; van Eersel, Janet/0000-0002-1354-6171; Christie, MacDonald J/0000-0002-0622-609X; Ke, Yazi/0000-0002-1423-0451; Ittner, Lars/0000-0001-6738-3825; Delerue, Fabien/0000-0001-7944-2108; Chieng, Billy/0000-0003-0222-8001; Eckert, Anne/0000-0002-9341-3669; Bi, Mian/0000-0002-4383-3606; Hardeman, Edna/0000-0003-1649-7712	University of Sydney; National Health and Medical Research Council; Australian Research Council; Deutsche Forschungsgemeinschaft	University of Sydney(University of Sydney); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors thank Yves-Alain Barde for providing tau<SUP>-/-</SUP> mice and him as well as Hanns Mohler and Nikolas Haass for helpful comments. This research was supported by grants from the University of Sydney, National Health and Medical Research Council, Australian Research Council, and Deutsche Forschungsgemeinschaft. J.G. is a Medical Foundation Fellow.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Ashe KH, 2007, NEW ENGL J MED, V357, P933, DOI 10.1056/NEJMcibr073552; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chin J, 2004, J NEUROSCI, V24, P4692, DOI 10.1523/JNEUROSCI.0277-04.2004; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; CROWTHER T, 1989, ANN MED, V21, P127, DOI 10.3109/07853898909149199; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Geschwind DH, 2003, NEURON, V40, P457, DOI 10.1016/S0896-6273(03)00681-0; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Gotz J, 2001, J BIOL CHEM, V276, P529, DOI 10.1074/jbc.M006531200; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Kelly PH, 2003, NEUROBIOL AGING, V24, P365, DOI 10.1016/S0197-4580(02)00098-2; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kojima N, 1998, LEARN MEMORY, V5, P429; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; KSIEZAKREDING H, 1991, NEURON, V6, P717, DOI 10.1016/0896-6273(91)90169-Z; Kuo YM, 2001, MOL MED, V7, P609, DOI 10.1007/BF03401867; Lalonde R, 2005, BEHAV BRAIN RES, V157, P91, DOI 10.1016/j.bbr.2004.06.020; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; Lee G, 1998, J CELL SCI, V111, P3167; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Maas T, 2000, J BIOL CHEM, V275, P15733, DOI 10.1074/jbc.M000389200; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Roskam S, 2010, NEUROSCI BIOBEHAV R, V34, P487, DOI 10.1016/j.neubiorev.2009.10.006; Rong YQ, 2001, J NEUROCHEM, V79, P382, DOI 10.1046/j.1471-4159.2001.00565.x; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 1997, SCIENCE, V275, P630, DOI 10.1126/science.275.5300.630; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Van Dam D, 2003, EUR J NEUROSCI, V17, P388, DOI 10.1046/j.1460-9568.2003.02444.x; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; YAGI T, 1993, NATURE, V366, P742, DOI 10.1038/366742a0; Zhao LX, 2006, NAT NEUROSCI, V9, P234, DOI 10.1038/nn1630	54	1262	1318	3	247	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					387	397		10.1016/j.cell.2010.06.036	http://dx.doi.org/10.1016/j.cell.2010.06.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20655099	Bronze			2022-12-01	WOS:000280609100016
J	Luzzatto, L				Luzzatto, Lucio			The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics	LANCET			English	Editorial Material							UNCOMPLICATED FALCIPARUM-MALARIA; CHLORPROGUANIL-DAPSONE; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; SULFADOXINE-PYRIMETHAMINE; ARTEMETHER-LUMEFANTRINE; RANDOMIZED-TRIAL; AFRICAN CHILDREN; PLUS ARTESUNATE; DEHYDROGENASE; LEPROSY		Ist Toscano Tumori, I-50139 Florence, Italy	ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Luzzatto, L (corresponding author), Ist Toscano Tumori, Via Taddeo Alderotti 26N, I-50139 Florence, Italy.							Alloueche A, 2004, LANCET, V363, P1843, DOI 10.1016/S0140-6736(04)16350-2; [Anonymous], 1967, World Health Organ Tech Rep Ser, V366, P1; BIENZLE U, 1972, LANCET, V1, P107; BRUCECHWATT LJ, 1982, BRIT MED J, V284, P767, DOI 10.1136/bmj.284.6318.767; Bukirwa H, 2004, COCHRANE DB SYST REV, V4; BYRD SR, 1991, LEPROSY REV, V62, P171; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; *DAC LAPD, UPD GSKS MAL TREATM; DEGOWIN RL, 1966, B WORLD HEALTH ORGAN, V35, P165; Fanello CI, 2008, T ROY SOC TROP MED H, V102, P412, DOI 10.1016/j.trstmh.2008.01.013; Fanello CI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004031; Jalloh A, 2004, TROP MED INT HEALTH, V9, P615, DOI 10.1111/j.1365-3156.2004.01237.x; Krattiger A., 2007, EXECUTIVE GUIDE INTE, P11; Kremsner PG, 2004, LANCET, V364, P285, DOI 10.1016/S0140-6736(04)16680-4; Owusu-Agyei S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002530; PONNAMPALAM JT, 1981, TROP GEOGR MED, V33, P401; Premji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006682; PUAVILAI S, 1984, J MED ASSOC THAILAND, V67, P404; Sulo J, 2002, LANCET, V360, P1136, DOI 10.1016/S0140-6736(02)11198-6; Winstanley P, 2001, TROP MED INT HEALTH, V6, P952, DOI 10.1046/j.1365-3156.2001.00751.x; WOODRUFF AW, 1981, BMJ-BRIT MED J, V282, P988; [No title captured]; 2004, REV SAFETY CHLORPROG	24	44	44	3	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2010	376	9742					739	741		10.1016/S0140-6736(10)60396-0	http://dx.doi.org/10.1016/S0140-6736(10)60396-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646YW	20599264				2022-12-01	WOS:000281582900033
J	Sachs, J; Remans, R; Smukler, S; Winowiecki, L; Andelman, SJ; Cassman, KG; Castle, D; DeFries, R; Denning, G; Fanzo, J; Jackson, LE; Leemans, R; Lehmann, J; Milder, JC; Naeem, S; Nziguheba, G; Palm, CA; Pingali, PL; Reganold, JP; Richter, DD; Scherr, SJ; Sircely, J; Sullivan, C; Tomich, TP; Sanchez, PA				Sachs, Jeffrey; Remans, Roseline; Smukler, Sean; Winowiecki, Leigh; Andelman, Sandy J.; Cassman, Kenneth G.; Castle, David; DeFries, Ruth; Denning, Glenn; Fanzo, Jessica; Jackson, Louise E.; Leemans, Rik; Lehmann, Johannes; Milder, Jeffrey C.; Naeem, Shahid; Nziguheba, Generose; Palm, Cheryl A.; Pingali, Prabhu L.; Reganold, John P.; Richter, Daniel D.; Scherr, Sara J.; Sircely, Jason; Sullivan, Clare; Tomich, Thomas P.; Sanchez, Pedro A.			Monitoring the world's agriculture	NATURE			English	Editorial Material							GENETICALLY-ENGINEERED PLANTS; SCIENTISTS ANALYSIS; FOODS		[Sachs, Jeffrey; Remans, Roseline; Smukler, Sean; Winowiecki, Leigh; Nziguheba, Generose; Palm, Cheryl A.; Sullivan, Clare; Sanchez, Pedro A.] Columbia Univ, Earth Inst, New York, NY 10027 USA; [Remans, Roseline] Katholieke Univ Leuven, Louvain, Belgium; [Cassman, Kenneth G.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA; [Castle, David] Univ Ottawa, Fac Arts, Ottawa, ON K1N 6N5, Canada; [Castle, David] Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada; [DeFries, Ruth; Naeem, Shahid; Sircely, Jason] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Denning, Glenn] Columbia Univ, Sch Int & Publ Affairs, New York, NY 10027 USA; [Fanzo, Jessica] Biovers Int, Rome, Italy; [Jackson, Louise E.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Leemans, Rik] Wageningen Univ, Environm Syst Anal Grp, Wageningen, Netherlands; [Lehmann, Johannes] Cornell Univ, Dept Crop & Soil Sci, Ithaca, NY 14853 USA; [Milder, Jeffrey C.; Scherr, Sara J.] EcoAgr Partners, Washington, DC USA; [Pingali, Prabhu L.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Reganold, John P.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Richter, Daniel D.] Duke Univ, Nicholas Sch Environm, Environm Sci & Policy Div, Durham, NC 27706 USA; [Tomich, Thomas P.] Univ Calif Davis, Agr Sustainabil Inst, Davis, CA 95616 USA	Columbia University; KU Leuven; University of Nebraska System; University of Nebraska Lincoln; University of Ottawa; University of Ottawa; Columbia University; Columbia University; Alliance; Bioversity International; University of California System; University of California Davis; Wageningen University & Research; Cornell University; Bill & Melinda Gates Foundation; Washington State University; Duke University; University of California System; University of California Davis	Sachs, J (corresponding author), Columbia Univ, Earth Inst, New York, NY 10027 USA.		Jackson, Louise E/A-3562-2010; Lehmann, Johannes/H-2682-2014; Fanzo, Jessica/HCH-3533-2022; Leemans, Rik/A-1548-2009; Cassman, Kenneth G/C-3646-2019; Richter, D.D./AAN-4583-2021	Lehmann, Johannes/0000-0002-4701-2936; Leemans, Rik/0000-0002-4001-6301; Castle, David/0000-0002-6884-0001; Nziguheba, Generose/0000-0003-4227-2242; Fanzo, Jessica/0000-0002-6760-1359				Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007; Jackson L.E., 2005, AGROBIODIVERSITY NEW; Lemaux PG, 2008, ANNU REV PLANT BIOL, V59, P771, DOI 10.1146/annurev.arplant.58.032806.103840; Lemaux PG, 2009, ANNU REV PLANT BIOL, V60, P511, DOI 10.1146/annurev.arplant.043008.092013; McIntyre BD, 2009, AGR CROSSR GLOB REP; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Sachs JD, 2009, SCIENCE, V325, P1502, DOI 10.1126/science.1175035; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970	10	111	118	2	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 29	2010	466	7306					558	560		10.1038/466558a	http://dx.doi.org/10.1038/466558a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	632HA	20671691				2022-12-01	WOS:000280412100017
J	Horton, R; Das, P				Horton, Richard; Das, Pam			Rescuing people with HIV who use drugs	LANCET			English	Editorial Material									[Horton, Richard; Das, Pam] The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Altice FL, 2010, LANCET, V376, P367, DOI 10.1016/S0140-6736(10)60829-X; Beyrer C, 2010, LANCET, V376, P551, DOI 10.1016/S0140-6736(10)60928-2; Colfax G, 2010, LANCET, V376, P458, DOI 10.1016/S0140-6736(10)60753-2; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; *HUM RIGHTS WATCH, 2009, CAMB STOP FORC PART; Jurgens R, 2010, LANCET, V376, P475, DOI 10.1016/S0140-6736(10)60830-6; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X	9	6	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2010	376	9737					207	208		10.1016/S0140-6736(10)61025-2	http://dx.doi.org/10.1016/S0140-6736(10)61025-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632VM	20650525				2022-12-01	WOS:000280457200004
J	Lassance, JM; Groot, AT; Lienard, MA; Antony, B; Borgwardt, C; Andersson, F; Hedenstrom, E; Heckel, DG; Lofstedt, C				Lassance, Jean-Marc; Groot, Astrid T.; Lienard, Marjorie A.; Antony, Binu; Borgwardt, Christin; Andersson, Fredrik; Hedenstrom, Erik; Heckel, David G.; Lofstedt, Christer			Allelic variation in a fatty-acyl reductase gene causes divergence in moth sex pheromones	NATURE			English	Article							EUROPEAN CORN-BORER; DESATURASE GENE; LEPIDOPTERA; POLYMORPHISM; EVOLUTION; SPECIFICITY; SPECIATION; SOFTWARE; LINKAGE; SYSTEM	Pheromone-based behaviours are crucial in animals from insects to mammals(1,2), and reproductive isolation is often based on pheromone differences(1-4). However, the genetic mechanisms by which pheromone signals change during the evolution of new species are largely unknown(4). In the sexual communication system of moths (Insecta: Lepidoptera), females emit a species-specific pheromone blend that attracts males over long distances(1,2,4). The European corn borer, Ostrinia nubilalis, consists of two sex pheromone races, Z and E, that use different ratios of the cis and trans isomers of acetate pheromone components(5). This subtle difference leads to strong reproductive isolation in the field between the two races(6,7), which could represent a first step in speciation. Female sex pheromone production and male behavioural response are under the control of different major genes(8,9), but the identity of these genes is unknown. Here we show that allelic variation in a fatty-acyl reductase gene essential for pheromone biosynthesis accounts for the phenotypic variation in female pheromone production, leading to race-specific signals. Both the cis and trans isomers of the pheromone precursors are produced by both races, but the precursors are differentially reduced to yield opposite ratios in the final pheromone blend as a result of the substrate specificity of the enzymes encoded by the Z and E alleles. This is the first functional characterization of a gene contributing to intraspecific behavioural reproductive isolation in moths, highlighting the importance of evolutionary diversification in a lepidopteran-specific family of reductases. Accumulation of substitutions in the coding region of a single biosynthetic enzyme can produce pheromone differences resulting in reproductive isolation, with speciation as a potential end result.	[Lassance, Jean-Marc; Lienard, Marjorie A.; Antony, Binu; Lofstedt, Christer] Lund Univ, Dept Biol, S-22362 Lund, Sweden; [Groot, Astrid T.; Borgwardt, Christin; Heckel, David G.] Max Planck Inst Chem Ecol, Dept Entomol, D-07745 Jena, Germany; [Andersson, Fredrik; Hedenstrom, Erik] Mid Sweden Univ, Dept Nat Sci Engn & Math, S-85170 Sundsvall, Sweden	Lund University; Max Planck Society; Mid-Sweden University	Lassance, JM (corresponding author), Lund Univ, Dept Biol, S-22362 Lund, Sweden.	jean-marc.lassance@ekol.lu.se; christer.lofstedt@ekol.lu.se	Heckel, David G/K-2138-2013; Löfstedt, Christer/G-2016-2014; Antony, Binu/M-8562-2015; Lassance, Jean-Marc/AAF-3933-2020; Groot, Astrid/A-8954-2013	Heckel, David G/0000-0001-8991-2150; Löfstedt, Christer/0000-0002-3116-6922; Antony, Binu/0000-0002-6292-620X; Lassance, Jean-Marc/0000-0002-3675-6956; Groot, Astrid/0000-0001-9595-0161; Lienard, Marjorie/0000-0003-3193-3666	Swedish Research Council (VR); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); Max-Planck-Gesellschaft	Swedish Research Council (VR)(Swedish Research Council); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Max-Planck-Gesellschaft(Max Planck Society)	We thank R.G. Harrison for his comments and advice. This research was funded by the Swedish Research Council (VR), the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) and the Max-Planck-Gesellschaft.	Antony B, 2009, INSECT BIOCHEM MOLEC, V39, P90, DOI 10.1016/j.ibmb.2008.10.008; CARDE RT, 1978, SCIENCE, V199, P555, DOI 10.1126/science.199.4328.555; Coyne, 2004, SPECIATION; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; Dallerac R, 2000, P NATL ACAD SCI USA, V97, P9449, DOI 10.1073/pnas.150243997; Dopman EB, 2005, P NATL ACAD SCI USA, V102, P14706, DOI 10.1073/pnas.0502054102; Dopman EB, 2004, GENETICS, V167, P301, DOI 10.1534/genetics.167.1.301; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Greenberg AJ, 2003, SCIENCE, V302, P1754, DOI 10.1126/science.1090432; GUTHRIE W. D., 1965, ANN ENTOMOL SOC AMER, V58, P100, DOI 10.1093/aesa/58.1.100; HANSSON BS, 1987, NATURWISSENSCHAFTEN, V74, P497, DOI 10.1007/BF00447935; HECKEL DG, 1993, ANNU REV ENTOMOL, V38, P381, DOI 10.1146/annurev.en.38.010193.002121; Ishikawa Y, 1999, ENTOMOL EXP APPL, V91, P237, DOI 10.1023/A:1003601407578; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KLUN JA, 1973, SCIENCE, V181, P661, DOI 10.1126/science.181.4100.661; KLUN JA, 1979, ENVIRON ENTOMOL, V8, P423, DOI 10.1093/ee/8.3.423; Knipple DC, 2002, GENETICS, V162, P1737; Kochansky J, 1975, J CHEM ECOL, V1, P225, DOI 10.1007/BF00987871; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lassance JM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-10; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lienard MA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-270; LOFSTEDT C, 1989, GENETICS, V123, P553; Malausa T, 2005, SCIENCE, V308, P258, DOI 10.1126/science.1107577; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; Papanicolaou A, 2008, NUCLEIC ACIDS RES, V36, pD582, DOI 10.1093/nar/gkm853; ROELOFS W, 1987, P NATL ACAD SCI USA, V84, P7585, DOI 10.1073/pnas.84.21.7585; Roelofs WL, 2002, P NATL ACAD SCI USA, V99, P13621, DOI 10.1073/pnas.152445399; Shirangi TR, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000168; Smadja C, 2009, HEREDITY, V102, P77, DOI 10.1038/hdy.2008.55; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang J, 2005, NUCLEIC ACIDS RES, V33, pD399, DOI 10.1093/nar/gki116; WOLF WA, 1987, J CHEM ECOL, V13, P1019, DOI 10.1007/BF01020535; Wyatt TD., 2003, PHEROMONES ANIMAL BE; Wyatt TD, 2009, NATURE, V457, P262, DOI 10.1038/457262a; Xue BY, 2007, P NATL ACAD SCI USA, V104, P4467, DOI 10.1073/pnas.0700422104; Zhu JW, 1996, INSECT BIOCHEM MOLEC, V26, P171, DOI 10.1016/0965-1748(95)00079-8	37	150	159	0	80	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					486	U7		10.1038/nature09058	http://dx.doi.org/10.1038/nature09058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20592730				2022-12-01	WOS:000280141200035
J	Basu, P				Basu, Paroma			Forgotten lessons	NATURE			English	Editorial Material																			0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S14	S15		10.1038/nature09241	http://dx.doi.org/10.1038/nature09241			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631697	Bronze			2022-12-01	WOS:000279867100030
J	Sastre, EA				Sastre, Elizabeth Ann			The Hike	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												elizabeth.a.sastre@vanderbilt.edu							0	0	0	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2010	304	2					134	135		10.1001/jama.2010.882	http://dx.doi.org/10.1001/jama.2010.882			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624IN	20628118				2022-12-01	WOS:000279811000001
J	Houtkooper, RH; Williams, RW; Auwerx, J				Houtkooper, Riekelt H.; Williams, Robert W.; Auwerx, Johan			Metabolic Networks of Longevity	CELL			English	Article							EXTENDS LIFE-SPAN; MITOCHONDRIAL-FUNCTION; INSULIN SENSITIVITY; ENERGY-EXPENDITURE; C-ELEGANS; RESVERATROL; SIRT1; MICE; RESTRICTION; DIET		[Houtkooper, Riekelt H.; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland; [Williams, Robert W.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Williams, Robert W.] Ctr Integrat & Translat Genom, Memphis, TN 38163 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Tennessee System; University of Tennessee Health Science Center	Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland.	johan.auwerx@epfl.ch	Houtkooper, Riekelt H/E-1602-2011; Auwerx, Johan/ABE-9307-2021; Houtkooper, Riekelt/P-5001-2019; Williams, Robert W./H-8789-2016	Houtkooper, Riekelt H/0000-0001-9961-0842; Williams, Robert W./0000-0001-8924-4447; Auwerx, Johan/0000-0002-5065-5393	Netherlands Organization for Scientific Research; NIAAA; NIDA; NIMH; Ecole Polytechnique Federale de Lausanne; NIH [DK59820]; EU [ERC-2008-AdG-23118]; Swiss National Science Foundation (SNF) [31003A-124713]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ecole Polytechnique Federale de Lausanne; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Ed Baetge, Ann Kato, Carles Canto, Penelope Andreux, and Evan G. Williams for helpful suggestions. R.H.H. is supported by a Rubicon fellowship of the Netherlands Organization for Scientific Research. GeneNetwork is supported by grants from the NIAAA, NIDA, and NIMH. The authors are supported by the Ecole Polytechnique Federale de Lausanne, NIH (DK59820), the EU Ideas program (Sirtuins; ERC-2008-AdG-23118), and the Swiss National Science Foundation (SNF 31003A-124713).	Anisimov VN, 2008, CELL CYCLE, V7, P2769, DOI 10.4161/cc.7.17.6625; Argmann C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000752; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; CANTO C, 2010, J CELL METAB, V11, P213; Canto C, 2009, TRENDS ENDOCRIN MET, V20, P325, DOI 10.1016/j.tem.2009.03.008; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Curtsinger JW, 2002, MECH AGEING DEV, V123, P81, DOI 10.1016/S0047-6374(01)00345-1; De Haan G, 1999, FASEB J, V13, P707, DOI 10.1096/fasebj.13.6.707; de Magalhaes JP, 2009, AGING CELL, V8, P65, DOI 10.1111/j.1474-9726.2008.00442.x; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; GELMAN R, 1988, GENETICS, V118, P693; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Heikkinen S, 2009, CELL METAB, V9, P88, DOI 10.1016/j.cmet.2008.11.007; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Libert S, 2007, CELL, V131, P1231, DOI 10.1016/j.cell.2007.12.002; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Rutanen J, 2010, DIABETES, V59, P829, DOI 10.2337/db09-1191; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	39	143	150	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 9	2010	142	1					9	14		10.1016/j.cell.2010.06.029	http://dx.doi.org/10.1016/j.cell.2010.06.029			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603007	Bronze, Green Accepted			2022-12-01	WOS:000279637300005
J	Iheanacho, I				Iheanacho, Ike			Drug Tales and Other Stories Listen up: deafness and personal audio players	BRITISH MEDICAL JOURNAL			English	Editorial Material												iiheanacho@bmjgroup.com							0	0	0	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 7	2010	341								c3539	10.1136/bmj.c3539	http://dx.doi.org/10.1136/bmj.c3539			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	625DL	20610496				2022-12-01	WOS:000279874300011
J	Willeit, P; Willeit, J; Mayr, A; Weger, S; Oberhollenzer, F; Brandstatter, A; Kronenberg, F; Kiechl, S				Willeit, Peter; Willeit, Johann; Mayr, Agnes; Weger, Siegfried; Oberhollenzer, Friedrich; Brandstaetter, Anita; Kronenberg, Florian; Kiechl, Stefan			Telomere Length and Risk of Incident Cancer and Cancer Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENDOTHELIAL GROWTH-FACTOR; HUMAN FIBROBLASTS; DYSFUNCTION; INSTABILITY; EXPRESSION; CARCINOMA; DISEASE; MEN	Context Telomeres are essential to preserve the integrity of the genome. Critically short telomeres lead to replicative cell senescence and chromosomal instability and may thereby increase cancer risk. Objective To determine the association between baseline telomere length and incident cancer and cancer mortality. Design, Setting, and Participants Leukocyte telomere length was measured by quantitative polymerase chain reaction in 787 participants free of cancer at baseline in 1995 from the prospective, population-based Bruneck Study in Italy. Main Outcome Measures Incident cancer and cancer mortality over a follow-up period of 10 years (1995-2005 with a follow-up rate of 100%). Results A total of 92 of 787 participants (11.7%) developed cancer (incidence rate, 13.3 per 1000 person-years). Short telomere length at baseline was associated with incident cancer independently of standard cancer risk factors (multivariable hazard ratio [HR] per 1-SD decrease in loge-transformed telomere length, 1.60; 95% confidence interval [CI], 1.30-1.98; P<.001). Compared with participants in the longest telomere length group, the multivariable HR for incident cancer was 2.15 (95% CI, 1.12-4.14) in the middle length group and 3.11 (95% CI, 1.65-5.84) in the shortest length group (P<.001). Incidence rates were 5.1 (95% CI, 2.9-8.7) per 1000 person-years in the longest telomere length group, 14.2 (95% CI, 10.0-20.1) per 1000 person-years in the middle length group, and 22.5 (95% CI, 16.9-29.9) per 1000 person-years in the shortest length group. The association equally applied to men and women and emerged as robust under a variety of circumstances. Furthermore, short telomere length was associated with cancer mortality (multivariable HR per 1-SD decrease in loge-transformed telomere length, 2.13; 95% CI, 1.58-2.86; P<.001) and individual cancer subtypes with a high fatality rate. Conclusion In this study population, there was a statistically significant inverse relationship between telomere length and both cancer incidence and mortality. JAMA. 2010;304(1):69-75 www.jama.com	[Willeit, Peter; Willeit, Johann; Kiechl, Stefan] Innsbruck Med Univ, Dept Neurol, A-6020 Innsbruck, Austria; [Brandstaetter, Anita; Kronenberg, Florian] Innsbruck Med Univ, Div Genet Epidemiol, Dept Human Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria; [Willeit, Peter] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Mayr, Agnes] Bruneck Hosp, Dept Lab Med, Brunico, Italy; [Weger, Siegfried; Oberhollenzer, Friedrich] Bruneck Hosp, Dept Internal Med, Brunico, Italy	Medical University of Innsbruck; Medical University of Innsbruck; University of Cambridge	Kiechl, S (corresponding author), Innsbruck Med Univ, Dept Neurol, Anichstr 35, A-6020 Innsbruck, Austria.	stefan.kiechl@i-med.ac.at	Willeit, Peter/HCI-7091-2022; Kronenberg, Florian/B-1736-2008	Willeit, Peter/0000-0002-1866-7159; Kronenberg, Florian/0000-0003-2229-1120; , Agnes Mayr/0000-0001-9363-873X; Kloss-Brandstatter, Anita/0000-0002-0873-6704	Dr Johannes and Hertha Tuba Foundation; Competence Centers for Excellent Technologies Center; ONCOTYROL; Integriertes Forschungs- und Therapiezentrum of Innsbruck Medical University; Pustertaler Verein zur Pravention von Herz-und Hirngefaesserkrankungen, Gesundheitsbezirk Bruneck; Assessorat fuer Gesundheit, Province of Bolzano, Italy	Dr Johannes and Hertha Tuba Foundation; Competence Centers for Excellent Technologies Center; ONCOTYROL; Integriertes Forschungs- und Therapiezentrum of Innsbruck Medical University; Pustertaler Verein zur Pravention von Herz-und Hirngefaesserkrankungen, Gesundheitsbezirk Bruneck; Assessorat fuer Gesundheit, Province of Bolzano, Italy	Dr P. Willeit was supported by a scholarship from the Dr Johannes and Hertha Tuba Foundation. Dr Kronenberg was supported by a grant from the Competence Centers for Excellent Technologies Center, ONCOTYROL, and the Integriertes Forschungs- und Therapiezentrum of Innsbruck Medical University. The study was supported by the Pustertaler Verein zur Pravention von Herz-und Hirngefaesserkrankungen, Gesundheitsbezirk Bruneck, and the Assessorat fuer Gesundheit, Province of Bolzano, Italy.	Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Broberg K, 2005, CARCINOGENESIS, V26, P1263, DOI 10.1093/carcin/bgi063; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; DAVIDSON HR, 1988, J MED GENET, V25, P843, DOI 10.1136/jmg.25.12.843; De Vivo I, 2009, CANCER EPIDEM BIOMAR, V18, P1152, DOI 10.1158/1055-9965.EPI-08-0998; Hashimoto Y, 2008, J GASTROINTEST SURG, V12, P17, DOI 10.1007/s11605-007-0383-9; Jang JS, 2008, CANCER SCI, V99, P1385, DOI 10.1111/j.1349-7006.2008.00831.x; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Kiechl S, 2007, CIRCULATION, V116, P385, DOI 10.1161/CIRCULATIONAHA.106.686774; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Lan Q, 2009, CLIN CANCER RES, V15, P7429, DOI 10.1158/1078-0432.CCR-09-0845; Lee IM, 2010, CLIN CHEM LAB MED, V48, P259, DOI 10.1515/CCLM.2010.049; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Mukhopadhyay D, 2004, SEMIN CANCER BIOL, V14, P123, DOI 10.1016/j.semcancer.2003.09.019; Plentz RR, 2004, HEPATOLOGY, V40, P80, DOI 10.1002/hep.20271; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Risques RA, 2007, CANCER EPIDEM BIOMAR, V16, P2649, DOI 10.1158/1055-9965.EPI-07-0624; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Shao L, 2007, J UROLOGY, V178, P1492, DOI 10.1016/j.juro.2007.05.112; Shen J, 2009, INT J CANCER, V124, P1637, DOI 10.1002/ijc.24105; Svenson U, 2008, CANCER RES, V68, P3618, DOI 10.1158/0008-5472.CAN-07-6497; Weng NP, 1997, IMMUNOL REV, V160, P43, DOI 10.1111/j.1600-065X.1997.tb01026.x; Wenning GK, 2005, LANCET NEUROL, V4, P815, DOI 10.1016/S1474-4422(05)70226-X; Wood C, 2005, CELL RES, V15, P947, DOI 10.1038/sj.cr.7290372; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; XU QB, 1993, LANCET, V341, P255, DOI 10.1016/0140-6736(93)92613-X; Zee RYL, 2009, CANCER EPIDEM BIOMAR, V18, P2280, DOI 10.1158/1055-9965.EPI-09-0360	34	358	375	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2010	304	1					69	75		10.1001/jama.2010.897	http://dx.doi.org/10.1001/jama.2010.897			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620SJ	20606151	Bronze			2022-12-01	WOS:000279519600023
J	Jewkes, RK; Dunkle, K; Nduna, M; Shai, N				Jewkes, Rachel K.; Dunkle, Kristin; Nduna, Mzikazi; Shai, Nwabisa			Intimate partner violence, relationship power inequity, and incidence of HIV infection in young women in South Africa: a cohort study	LANCET			English	Article							STEPPING STONES; SEXUAL-BEHAVIOR; AMERICAN WOMEN; RISK; GENDER; RAKAI; TRANSMISSION; HEALTH	Background Cross-sectional studies have shown that intimate partner violence and gender inequity in relationships are associated with increased prevalence of HIV in women. Yet temporal sequence and causality have been questioned, and few HIV prevention programmes address these issues. We assessed whether intimate partner violence and relationship power inequity increase risk of incident HIV infection in South African women. Methods We did a longitudinal analysis of data from a previously published cluster-randomised controlled trial undertaken in the Eastern Cape province of South Africa in 2002-06. 1099 women aged 15-26 years who were HIV negative at baseline and had at least one additional HIV test over 2 years of follow-up were included in the analysis. Gender power equity and intimate partner violence were measured by a sexual relationship power scale and the WHO violence against women instrument, respectively. Incidence rate ratios (IRRs) of HIV acquisition at 2 years were derived from Poisson models, adjusted for study design and herpes simplex virus type 2 infection, and used to calculate population attributable fractions. Findings 128 women acquired HIV during 2076 person-years of follow-up (incidence 6.2 per 100 person-years). 51 of 325 women with low relationship power equity at baseline acquired HIV (8.5 per 100 person-years) compared with 73 of 704 women with medium or high relationship power equity (5.5 per 100 person-years); adjusted multivariable Poisson model IRR 1-51, 95% CI 1.05-2.17, p=0.027. 45 of 253 women who reported more than one episode of intimate partner violence at baseline acquired HIV (9.6 per 100 person-years) compared with 83 of 846 who reported one or no episodes (5.2 per 100 person-years); adjusted multivariable Poisson model IRR 1.51, 1.04-2-21, p=0.032. The population attributable fractions were 13.9% (95% CI 2.0-22-2) for relationship power equity and 11.9% (1.4-19.3) for intimate partner violence. Interpretation Relationship power inequity and intimate partner violence increase risk of incident HIV infection in young South African women. Policy, interventions, and programmes for HIV prevention must address both of these risk factors and allocate appropriate resources.	[Jewkes, Rachel K.; Shai, Nwabisa] MRC, Gender & Hlth Res Unit, ZA-0001 Pretoria, South Africa; [Jewkes, Rachel K.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Nduna, Mzikazi] Univ Witwatersrand, Dept Psychol, Johannesburg, South Africa; [Dunkle, Kristin] Emory Univ, Rollins Sch Publ Hlth, Ctr AIDS Res, Atlanta, GA 30322 USA	University of Witwatersrand; University of Witwatersrand; Emory University; Rollins School Public Health	Jewkes, RK (corresponding author), MRC, Gender & Hlth Res Unit, Private Bag X385, ZA-0001 Pretoria, South Africa.	rjewkes@mrc.ac.za	Dunkle, Kristin/AAU-5488-2020	Dunkle, Kristin/0000-0003-3071-5544; Shai, Nwabisa/0000-0003-4171-9129; Jewkes, Rachel/0000-0002-4330-6267	National Institute of Mental Health [MH 64882-01, MH 64882-04S1A1, 1R03MH085599]; South African Medical Research Council; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064882, R03MH085599] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the National Institute of Mental Health (grant numbers MH 64882-01, MH 64882-04S1A1, and 1R03MH085599) and the South African Medical Research Council. We thank all the members of the Stepping Stones study team and the National Institute for Communicable Diseases for quality control, testing, and storage of specimens; the staff who worked on the project; and members of the community advisory board and data safety and monitoring board. Carl Lombard assisted with data analysis.	Bennet, 2000, AIDS BEHAV, V4, P261, DOI [https://doi.org/10.1023/A:1009568718804, DOI 10.1023/A:1009568718804, 10.1023/A:1009568718804.]; Christofides N, 2010, AIDS CARE, V22, P279, DOI 10.1080/09540120903193617; Coovadia H, 2009, LANCET, V374, P817, DOI 10.1016/S0140-6736(09)60951-X; Decker MR, 2009, JAIDS-J ACQ IMM DEF, V51, P593, DOI 10.1097/QAI.0b013e3181a255d6; Doll R, 2002, PERSPECT BIOL MED, V45, P499, DOI 10.1353/pbm.2002.0067; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; El-Bassel N, 1998, Violence Vict, V13, P377; Garcia-Allan C, 2000, J BIOCHEM MOL TOXIC, V14, P65, DOI 10.1002/(SICI)1099-0461(2000)14:2<65::AID-JBT1>3.0.CO;2-#; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Greenland S, 1998, MODERN EPIDEMIOLOGY; Greig A, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000327435.28538.18; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1461, DOI 10.1093/ije/dyl218; Jewkes R, 2006, TROP MED INT HEALTH, V11, P3, DOI 10.1111/j.1365-3156.2005.01530.x; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Jewkes Rachel, 2009, UNDERSTANDING MENS H; Jewkes RK, 2003, SOC SCI MED, V56, P125, DOI 10.1016/S0277-9536(02)00012-6; Johnson SD, 2003, DRUG ALCOHOL DEPEN, V70, P169, DOI 10.1016/S0376-8716(02)00345-9; Lindsey JC, 1998, STAT MED, V17, P219, DOI 10.1002/(SICI)1097-0258(19980130)17:2<219::AID-SIM735>3.0.CO;2-O; Maman S, 2000, SOC SCI MED, V50, P459, DOI 10.1016/S0277-9536(99)00270-1; Maman S, 2002, AM J PUBLIC HEALTH, V92, P1331, DOI 10.2105/AJPH.92.8.1331; Nascimento, 2007, ENGAGING MEN BOYS TR; Pettifor AE, 2004, EMERG INFECT DIS, V10, P1996, DOI 10.3201/eid1011.040252; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; Pulerwitz J, 2006, PROMOTING MORE GENDE; Shisana O., 2005, S AFRICAN NATL HIV P; SOLORZANO I, 2006, POSITIVE IMPACT HIV; *SYN PROJ, 2003, MEN REPR HLTH PROGR; *UNAIDS, 2005, AIDS EP UPD 2005; *UNAIDS JOINT ACT, 2009, UNAIDS OUTC FRAM 200; VANDERSTRATEN A, 1998, AIDS BEHAV, V2, P61, DOI DOI 10.1023/A:1022311424652; Wang S. K., 2007, RAPE MEN COMMUNITY H; Wawer MJ, 2009, LANCET, V374, P229, DOI 10.1016/S0140-6736(09)60998-3; Wingood GM, 1998, J WOMENS HEALTH, V7, P77, DOI 10.1089/jwh.1998.7.77; Wood K, 1998, SOC SCI MED, V47, P233, DOI 10.1016/S0277-9536(98)00057-4; World Health Organization, 2004, RAP HIV TESTS GUID U; World Health Organization, 2000, WHO MULTICOUNTRY STU; Zablotska IB, 2009, AIDS BEHAV, V13, P225, DOI 10.1007/s10461-007-9333-5	39	832	843	1	93	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 3	2010	376	9734					41	48		10.1016/S0140-6736(10)60548-X	http://dx.doi.org/10.1016/S0140-6736(10)60548-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	624SR	20557928	Bronze			2022-12-01	WOS:000279841600023
J	Hang, CT; Yang, J; Han, P; Cheng, HL; Shang, C; Ashley, E; Zhou, B; Chang, CP				Hang, Calvin T.; Yang, Jin; Han, Pei; Cheng, Hsiu-Ling; Shang, Ching; Ashley, Euan; Zhou, Bin; Chang, Ching-Pin			Chromatin regulation by Brg1 underlies heart muscle development and disease	NATURE			English	Article							MYOSIN HEAVY-CHAIN; GENE-EXPRESSION; DILATED CARDIOMYOPATHY; ISOFORM EXPRESSION; CARDIAC GROWTH; POLY(ADP-RIBOSE); HYPERTROPHY; INHIBITION; VENTRICLE	Cardiac hypertrophy and failure are characterized by transcriptional reprogramming of gene expression. Adult cardiomyocytes in mice primarily express alpha-myosin heavy chain (alpha-MHC, also known as Myh6), whereas embryonic cardiomyocytes express beta-MHC (also known as Myh7). Cardiac stress triggers adult hearts to undergo hypertrophy and a shift from alpha-MHC to fetal beta-MHC expression. Here we show that Brg1, a chromatin-remodelling protein, has a critical role in regulating cardiac growth, differentiation and gene expression. In embryos, Brg1 promotes myocyte proliferation by maintaining Bmp10 and suppressing p57(kip2) expression. It preserves fetal cardiac differentiation by interacting with histone deacetylase (HDAC) and poly (ADP ribose) polymerase (PARP) to repress alpha-MHC and activate beta-MHC. In adults, Brg1 (also known as Smarca4) is turned off in cardiomyocytes. It is reactivated by cardiac stresses and forms a complex with its embryonic partners, HDAC and PARP, to induce a pathological alpha-MHC to beta-MHC shift. Preventing Brg1 re-expression decreases hypertrophy and reverses this MHC switch. BRG1 is activated in certain patients with hypertrophic cardiomyopathy, its level correlating with disease severity and MHC changes. Our studies show that Brg1 maintains cardiomyocytes in an embryonic state, and demonstrate an epigenetic mechanism by which three classes of chromatin-modifying factors-Brg1, HDAC and PARP-cooperate to control developmental and pathological gene expression.	[Hang, Calvin T.; Yang, Jin; Han, Pei; Cheng, Hsiu-Ling; Shang, Ching; Ashley, Euan; Chang, Ching-Pin] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Zhou, Bin] Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; [Zhou, Bin] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA; [Zhou, Bin] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA	Stanford University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Chang, CP (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA.	chingpin@stanford.edu	Yang, Jin/C-5468-2013; Pei, Han/E-8237-2012		NIH; American Heart Association (AHA); Children's Heart Foundation; March of Dimes Foundation; Office of the University of California; California Institute of Regenerative Medicine; Kaiser Foundation; Baxter Foundation; Oak Foundation; Stanford Cardiovascular Institute; Kirschstein-NRSA Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085345] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); Children's Heart Foundation; March of Dimes Foundation(March of Dimes); Office of the University of California; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Kaiser Foundation; Baxter Foundation; Oak Foundation; Stanford Cardiovascular Institute; Kirschstein-NRSA Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank B. Black for providing Mef2c-cre mice; G. R. Crabtree, D. Bernstein, M. Rabinovitch, R. Robbins, V. Christoffels, W. Shou, J. Wysocka and K. Zhao for materials and discussions; B. Wu, A. Sun, J. Lehrer-Graiwer, W. Li, C. Y. Lin and C. J. Lin for technical assistance; M. Zhao, M. Zeini and K. Stankunas for technical advice to H.-L. C., P. H. and C. T. H. C.-P. C. was supported by funds from the NIH, American Heart Association (AHA), Children's Heart Foundation, March of Dimes Foundation, Office of the University of California, California Institute of Regenerative Medicine, Kaiser Foundation, Baxter Foundation, Oak Foundation, Stanford Cardiovascular Institute and W. Younger. C. T. H. was supported by predoctoral training fellowships from the NIH and AHA; H.-L. C. by a visiting scholar fellowship; C. S. by Kirschstein-NRSA Postdoctoral Fellowship; B.Z. by NIH and AHA grants.	Abraham WT, 2002, MOL MED, V8, P750, DOI 10.1007/BF03402039; Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Bartha E, 2009, CARDIOVASC RES, V83, P501, DOI 10.1093/cvr/cvp144; Blaxall BC, 2003, J AM COLL CARDIOL, V41, P1096, DOI 10.1016/S0735-1097(03)00043-3; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Braunwald E., 1997, HEART DIS TXB CARDIO, V5th; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Chang CP, 2003, GENESIS, V36, P7, DOI 10.1002/gene.10186; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Herron TJ, 2002, CIRC RES, V90, P1150, DOI 10.1161/01.RES.0000022879.57270.11; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; James J, 2005, CIRCULATION, V111, P2339, DOI 10.1161/01.CIR.0000164233.09448.B1; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kinugawa K, 2001, CIRC RES, V89, P591, DOI 10.1161/hh1901.096706; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Lowes BD, 2002, NEW ENGL J MED, V346, P1357, DOI 10.1056/NEJMoa012630; Lowes BD, 1997, J CLIN INVEST, V100, P2315, DOI 10.1172/JCI119770; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; MORROW AG, 1961, ANN SURG, V154, P181, DOI 10.1097/00000658-196108000-00003; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Pandya K, 2008, P NATL ACAD SCI USA, V105, P13063, DOI 10.1073/pnas.0805120105; Pillai JB, 2006, AM J PHYSIOL-HEART C, V291, pH1545, DOI 10.1152/ajpheart.01124.2005; Schmitt JP, 2006, P NATL ACAD SCI USA, V103, P14525, DOI 10.1073/pnas.0606383103; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; SumiIchinose C, 1997, MOL CELL BIOL, V17, P5976, DOI 10.1128/MCB.17.10.5976; Szabo G, 2002, CIRC RES, V90, P100, DOI 10.1161/hh0102.102657; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wu BR, 2010, GENESIS, V48, P63, DOI 10.1002/dvg.20573	39	328	346	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					62	U74		10.1038/nature09130	http://dx.doi.org/10.1038/nature09130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596014	Green Accepted			2022-12-01	WOS:000279343800035
J	Petukhova, L; Duvic, M; Hordinsky, M; Norris, D; Price, V; Shimomura, Y; Kim, H; Singh, P; Lee, A; Chen, WV; Meyer, KC; Paus, R; Jahoda, CAB; Amos, CI; Gregersen, PK; Christiano, AM				Petukhova, Lynn; Duvic, Madeleine; Hordinsky, Maria; Norris, David; Price, Vera; Shimomura, Yutaka; Kim, Hyunmi; Singh, Pallavi; Lee, Annette; Chen, Wei V.; Meyer, Katja C.; Paus, Ralf; Jahoda, Colin A. B.; Amos, Christopher I.; Gregersen, Peter K.; Christiano, Angela M.			Genome-wide association study in alopecia areata implicates both innate and adaptive immunity	NATURE			English	Article							AUTOIMMUNE-DISEASE; HAIR FOLLICLE; NKG2D LIGAND; RISK LOCUS; EXPRESSION; CANCER; GENES; CELLS; PEROXIREDOXIN-5; SUSCEPTIBILITY	Alopecia areata (AA) is among the most highly prevalent human autoimmune diseases, leading to disfiguring hair loss due to the collapse of immune privilege of the hair follicle and subsequent autoimmune attack(1,2). The genetic basis of AA is largely unknown. We undertook a genome-wide association study (GWAS) in a sample of 1,054 cases and 3,278 controls and identified 139 single nucleotide polymorphisms that are significantly associated with AA (P <= 5 x 10(-7)). Here we show an association with genomic regions containing several genes controlling the activation and proliferation of regulatory T cells (T-reg cells), cytotoxic T lymphocyte-associated antigen 4 (CTLA4), interleukin (IL)-2/IL-21, IL-2 receptor A (IL-2RA; CD25) and Eos (also known as Ikaros family zinc finger 4; IKZF4), as well as the human leukocyte antigen (HLA) region. We also find association evidence for regions containing genes expressed in the hair follicle itself (PRDX5 and STX17). A region of strong association resides within the ULBP (cytomegalovirus UL16-binding protein) gene cluster on chromosome 6q25.1, encoding activating ligands of the natural killer cell receptor NKG2D that have not previously been implicated in an autoimmune disease. By probing the role of ULBP3 in disease pathogenesis, we also show that its expression in lesional scalp from patients with AA is markedly upregulated in the hair follicle dermal sheath during active disease. This study provides evidence for the involvement of both innate and acquired immunity in the pathogenesis of AA. We have defined the genetic underpinnings of AA, placing it within the context of shared pathways among autoimmune diseases, and implicating a novel disease mechanism, the upregulation of ULBP ligands, in triggering autoimmunity.	[Petukhova, Lynn; Shimomura, Yutaka; Kim, Hyunmi; Singh, Pallavi; Christiano, Angela M.] Columbia Univ, Dept Dermatol, New York, NY 10032 USA; [Duvic, Madeleine] Univ Texas MD Anderson Canc Ctr, Dept Dermatol, Houston, TX 77030 USA; [Hordinsky, Maria] Univ Minnesota, Dept Dermatol, Minneapolis, MN 55455 USA; [Norris, David] Univ Colorado, Dept Dermatol, Denver, CO 80010 USA; [Price, Vera] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94115 USA; [Lee, Annette; Gregersen, Peter K.] N Shore LIJHS, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Chen, Wei V.; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Meyer, Katja C.; Paus, Ralf] Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Paus, Ralf] Univ Manchester, Sch Translat Med, Manchester M13 9PT, Lancs, England; [Jahoda, Colin A. B.] Univ Durham, Dept Biol Sci, Durham DH1 3LE, England; [Christiano, Angela M.] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA	Columbia University; University of Texas System; UTMD Anderson Cancer Center; University of Minnesota System; University of Minnesota Twin Cities; University of Colorado System; University of Colorado Denver; University of California System; University of California San Francisco; Northwell Health; University of Texas System; UTMD Anderson Cancer Center; University of Lubeck; University of Manchester; Durham University; Columbia University	Christiano, AM (corresponding author), Columbia Univ, Dept Dermatol, New York, NY 10032 USA.	amc65@columbia.edu	Paus, Ralf/B-5279-2015	Paus, Ralf/0000-0002-3492-9358; Jahoda, Colin/0000-0002-1762-1220	National Alopecia Areata Foundation (NAAF); DFG Cluster of Excellence, Inflammation at Interfaces; National Institutes of Health [R01AR44422, R01CA133996, P30CA016772, R01AR52579, R01AR56016]; NATIONAL CANCER INSTITUTE [R01CA133996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056016, R01AR044422, R01AR052579] Funding Source: NIH RePORTER	National Alopecia Areata Foundation (NAAF); DFG Cluster of Excellence, Inflammation at Interfaces(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the many patients and their family members who participated in the National Alopecia Areata Registry from which the patient cohort was derived; S. Schwartz, D. A. Greenberg, S. E. Hodge, R. Ottman, K. Kiryluk, J. Lee, J. D. Terwilliger and R. Plenge for discussions about statistical methodology; A. Bowcock, M. Girardi, R. Clark, J. Trowsdale, R. Clynes, S. Ghosh and R. Bernstein for critical insights and perspectives on genetics, hair and immunobiology; C. Higgins, M. Kurban, M. Kiuru, H. Lam and M. Zhang for expert assistance in the laboratory; A. Martinez-Mir, M. Peacocke, A. Zlotogorski, M. Grossman, P. Schneiderman, D. Gordon and J. Ott for their critical input in the early phases of this study. We are grateful to the National Alopecia Areata Foundation (NAAF) for support of funding the initial studies, and to V. Kalabokes and her staff at NAAF for their efforts on our behalf. The patient cohort was collected and maintained by the National Alopecia Areata Registry (N01AR62279) (to M. D.). This work was supported in part by the DFG Cluster of Excellence, Inflammation at Interfaces (to R. P.) and by the National Institutes of Health grants R01AR44422 (to C. I. A. and P. K. G.), R01CA133996 and P30CA016772 (to C. I. A.) and R01AR52579 and R01AR56016 (to A. M. C.).	Akar A, 2002, J DERMATOL SCI, V29, P85, DOI 10.1016/S0923-1811(02)00015-4; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bazzi H, 2006, DIFFERENTIATION, V74, P129, DOI 10.1111/j.1432-0436.2006.00061.x; Borchers MT, 2009, J CLIN INVEST, V119, P636, DOI 10.1172/JCI34462; Caillat-Zucman S, 2006, HUM IMMUNOL, V67, P204, DOI 10.1016/j.humimm.2006.02.013; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; Duvic M, 2003, J INVEST DERM SYMP P, V8, P219, DOI 10.1046/j.1087-0024.2003.00814.x; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Eagle RA, 2009, EUR J IMMUNOL, V39, P3207, DOI 10.1002/eji.200939502; Gerard AC, 2005, THYROID, V15, P205, DOI 10.1089/thy.2005.15.205; Gilhar A, 1999, J INVEST DERM SYMP P, V4, P207, DOI 10.1038/sj.jidsp.5640212; Gilhar A, 2003, CLIN IMMUNOL, V106, P181, DOI 10.1016/S1521-6616(02)00042-6; Gilhar A, 2007, J CLIN INVEST, V117, P2019, DOI 10.1172/JCI31942; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Holley JE, 2007, MULT SCLER, V13, P955, DOI 10.1177/1352458507078064; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Ito T, 2008, J INVEST DERMATOL, V128, P1196, DOI 10.1038/sj.jid.5701183; Ito Taisuke, 2008, V10, P27, DOI 10.1159/000131412; Jackow C, 1998, J AM ACAD DERMATOL, V38, P418, DOI 10.1016/S0190-9622(98)70499-2; JELINEK JE, 1972, B NEW YORK ACAD MED, V48, P1003; Karasawa R, 2005, MICROBIOL IMMUNOL, V49, P57, DOI 10.1111/j.1348-0421.2005.tb03640.x; Martinez-Mir A, 2007, AM J HUM GENET, V80, P316, DOI 10.1086/511442; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McDonagh AJG, 2002, CLIN EXP DERMATOL, V27, P409, DOI 10.1046/j.1365-2230.2002.01077.x; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Monteleone G, 2009, TRENDS PHARMACOL SCI, V30, P441, DOI 10.1016/j.tips.2009.05.006; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Pielberg GR, 2008, NAT GENET, V40, P1004, DOI 10.1038/ng.185; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Radosavljevic M, 2002, GENOMICS, V79, P114, DOI 10.1006/geno.2001.6673; SAFAVI KH, 1995, MAYO CLIN PROC, V70, P628, DOI 10.4065/70.7.628; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Tian C, 2009, MOL MED, V15, P371, DOI 10.2119/molmed.2009.00094; VANDERSTEEN P, 1992, ACTA DERM-VENEREOL, V72, P373; Wang MX, 2002, FEBS LETT, V531, P359, DOI 10.1016/S0014-5793(02)03511-1; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zhang Q, 2005, J HISTOCHEM CYTOCHEM, V53, P1371, DOI 10.1369/jhc.4A6508.2005	39	471	490	3	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					113	U129		10.1038/nature09114	http://dx.doi.org/10.1038/nature09114			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596022	Green Accepted			2022-12-01	WOS:000279343800045
J	Iannacone, M; Moseman, EA; Tonti, E; Bosurgi, L; Junt, T; Henrickson, SE; Whelan, SP; Guidotti, LG; von Andrian, UH				Iannacone, Matteo; Moseman, E. Ashley; Tonti, Elena; Bosurgi, Lidia; Junt, Tobias; Henrickson, Sarah E.; Whelan, Sean P.; Guidotti, Luca G.; von Andrian, Ulrich H.			Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus	NATURE			English	Article							LIPOSOME-MEDIATED DEPLETION; VESICULAR STOMATITIS-VIRUS; IN-VIVO DEPLETION; CD8(+) T-CELLS; LYMPH-NODES; B-CELLS; DENDRITIC CELLS; MICE; ACTIVATION; ANTIGEN	Lymph nodes (LNs) capture microorganisms that breach the body's external barriers and enter draining lymphatics, limiting the systemic spread of pathogens(1). Recent work has shown that CD11b(+)CD169(+) macrophages, which populate the subcapsular sinus (SCS) of LNs, are critical for the clearance of viruses from the lymph and for initiating antiviral humoral immune responses(2-4). Here we show, using vesicular stomatitis virus (VSV), a relative of rabies virus transmitted by insect bites, that SCS macrophages perform a third vital function: they prevent lymph-borne neurotropic viruses from infecting the central nervous system (CNS). On local depletion of LN macrophages, about 60% of mice developed ascending paralysis and died 7-10 days after subcutaneous infection with a small dose of VSV, whereas macrophage-sufficient animals remained asymptomatic and cleared the virus. VSV gained access to the nervous system through peripheral nerves in macrophage-depleted LNs. In contrast, within macrophage-sufficient LNs VSV replicated preferentially in SCS macrophages but not in adjacent nerves. Removal of SCS macrophages did not compromise adaptive immune responses against VSV, but decreased type I interferon (IFN-I) production within infected LNs. VSV-infected macrophages recruited IFN-I-producing plasmacytoid dendritic cells to the SCS and in addition were a major source of IFN-I themselves. Experiments in bone marrow chimaeric mice revealed that IFN-I must act on both haematopoietic and stromal compartments, including the intranodal nerves, to prevent lethal infection with VSV. These results identify SCS macrophages as crucial gatekeepers to the CNS that prevent fatal viral invasion of the nervous system on peripheral infection.	[Iannacone, Matteo; Moseman, E. Ashley; Tonti, Elena; Bosurgi, Lidia; Henrickson, Sarah E.; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Iannacone, Matteo; Moseman, E. Ashley; Tonti, Elena; Bosurgi, Lidia; Henrickson, Sarah E.; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Iannacone, Matteo; Guidotti, Luca G.] Ist Sci San Raffaele, Dept Immunol Infect Dis & Transplantat, I-20132 Milan, Italy; [Junt, Tobias] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland; [Whelan, Sean P.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Novartis; Harvard University; Harvard Medical School	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	Matteo_Iannacone@hms.harvard.edu; uva@hms.harvard.edu	Iannacone, Matteo/I-8507-2018; Guidotti, Luca G. G/I-8542-2018; von Andrian, Ulrich H/A-5775-2008; Junt, Tobias/AAE-4389-2021	Iannacone, Matteo/0000-0002-9370-2671; Guidotti, Luca G. G/0000-0002-0205-2678; Whelan, Sean/0000-0003-1564-8590; Bosurgi, Lidia/0000-0002-8775-4950; Tonti, Elena/0000-0001-5002-7613; Henrickson, Sarah/0000-0001-5569-4132	National Institutes of Health (NIH) [AI069259, AI072252, AI078897, AR42689]; Giovanni Armenise-Harvard Foundation; NIH; NATIONAL CANCER INSTITUTE [P01CA071932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069259, R01AI072252, P01AI078897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giovanni Armenise-Harvard Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Cheng and M. Flynn for technical support; J. Alton for secretarial assistance; D. Cureton for help and advice with VSV preparations; H. Leung for help with image quantification; R. M. Zinkernagel and H. Hengartner for providing tg7 mice; R. Bronson for help with reading neuropathology; S. Cohen for advice on nerve staining; N. van Rooijen for clodronate liposomes; and the members of the von Andrian laboratory for discussion. This work was supported by National Institutes of Health (NIH) grants AI069259, AI072252, AI078897 and AR42689 (to U.H.v.A.), the Giovanni Armenise-Harvard Foundation (to M.I.) and a NIH T32 Training Grant in Hematology (to E.A.M.).	Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Brundler MA, 1996, EUR J IMMUNOL, V26, P2257, DOI 10.1002/eji.1830260943; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; DELEMARRE FGA, 1990, J LEUKOCYTE BIOL, V47, P251, DOI 10.1002/jlb.47.3.251; Detje CN, 2009, J IMMUNOL, V182, P2297, DOI 10.4049/jimmunol.0800596; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Iannacone M, 2005, NAT MED, V11, P1167, DOI 10.1038/nm1317; Iannacone M, 2008, P NATL ACAD SCI USA, V105, P629, DOI 10.1073/pnas.0711200105; Iparraguirre A, 2008, J LEUKOCYTE BIOL, V83, P610, DOI 10.1189/jlb.0807511; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1363; Maloy KJ, 1999, J IMMUNOL, V162, P2867; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; Purtha WE, 2008, J VIROL, V82, P10964, DOI 10.1128/JVI.01646-08; Shao CX, 2007, MICROSURG, V27, P487, DOI 10.1002/micr.20392; Thomsen AR, 1997, INT IMMUNOL, V9, P1757, DOI 10.1093/intimm/9.11.1757; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; WHELAN SPJ, 1995, P NATL ACAD SCI USA, V92, P8388, DOI 10.1073/pnas.92.18.8388	26	236	237	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1079	U143		10.1038/nature09118	http://dx.doi.org/10.1038/nature09118			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577213	Green Accepted			2022-12-01	WOS:000279056900053
J	[Anonymous]				[Anonymous]			Who, how, what and where?	NATURE			English	Editorial Material																			0	5	5	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					S8	S9		10.1038/nature09222	http://dx.doi.org/10.1038/nature09222			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20571555	Bronze			2022-12-01	WOS:000279056900026
J	Winickoff, JP; Gottlieb, M; Mello, MM				Winickoff, Jonathan P.; Gottlieb, Mark; Mello, Michelle M.			Regulation of Smoking in Public Housing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ENVIRONMENTAL TOBACCO-SMOKE; GAS-PHASE ORGANICS; RESTRICTIONS; HOME; HOUSEHOLD; EXPOSURE; CESSATION; INFANTS		[Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Winickoff, Jonathan P.] Massachusetts Gen Hosp Children, Dept Pediat, Boston, MA USA; [Winickoff, Jonathan P.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Gottlieb, Mark] Northeastern Univ, Sch Law, Publ Hlth Advocacy Inst, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Northeastern University	Mello, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	mmello@hsph.harvard.edu	Gottlieb, Mark A./ABI-1826-2020	Gottlieb, Mark A./0000-0001-8679-307X	NCI NIH HHS [R01-CA127127, R01 CA127127, R01 CA127127-03] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA127127] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aligne CA, 1997, ARCH PEDIAT ADOL MED, V151, P648, DOI 10.1001/archpedi.1997.02170440010002; American Society of Heating Refrigerating and Air Conditioning Engineers, 2005, ENV TOB SMOK POS DOC; [Anonymous], 2009, SURG GEN CALL ACT PR; [Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P1199; Blackburn C, 2003, BRIT MED J, V327, P257, DOI 10.1136/bmj.327.7409.257; BUSK C, 2009, CHICAGO SUN TIM 0426, pE1; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1227; COOPER K, 2006, WYOMING TRIBUNE 0508, pA1; *COUNC LARG PUBL H, 2004, PORTR PUBL HOUS RES; *DEP HOUS URB DEV, 2010, CURR STAT; *DEP HOUS URB DEV, 2009, HUDS FISC YEAR FY 20; *DEP HOUS URB DEV, TEN ADD SECT 8 PROJ; *DEP HOUS URB DEV, 2009, NONSM POL PUBL HOUS; *DEP HOUS URB DEV, 2010, MULT TEN CHAR SYST; Ditre JW, 2008, NICOTINE TOB RES, V10, P975, DOI 10.1080/14622200802087549; Epstein JA, 1999, TOB CONTROL, V8, P45, DOI 10.1136/tc.8.1.45; Farkas AJ, 2000, JAMA-J AM MED ASSOC, V284, P717, DOI 10.1001/jama.284.6.717; GARCIA C, 2008, AUGUSTA CHRONIC 0722, pA1; Gilpin E A, 1999, Nicotine Tob Res, V1, P153, DOI 10.1080/14622299050011261; Gilpin EA, 2006, NICOTINE TOB RES, V8, P661, DOI 10.1080/14622200600910801; GRONEWOLD SJ, 2007, COMMUNICATION   0801; Hecht SS, 2006, CANCER EPIDEM BIOMAR, V15, P988, DOI 10.1158/1055-9965.EPI-05-0596; Hennrikus D, 2003, TOB CONTROL, V12, P189, DOI 10.1136/tc.12.2.189; Hill SC, 2008, TOB CONTROL, V17, P32, DOI 10.1136/tc.2007.020990; Institute of Medicine Committee on Secondhand Smoke Exposure and Acute Coronary Effects, 2010, SEC SMOK EXP CARD EF; Jarvie JA, 2008, AM J PUBLIC HEALTH, V98, P2140, DOI 10.2105/AJPH.2007.130856; Johansson AK, 2004, PEDIATRICS, V113, pE291, DOI 10.1542/peds.113.4.e291; KOCH W, 2007, US TODAY        1003, pA3; Kraev TA, 2009, TOB CONTROL, V18, P438, DOI 10.1136/tc.2009.029728; LARSON J, TACOMA WEEKLY; Laws MB, 2002, TOB CONTROL, V11, pII71; Leung GM, 2004, ARCH PEDIAT ADOL MED, V158, P687, DOI 10.1001/archpedi.158.7.687; *LIV SMOK FREE, 2009, REST SMOK DAM AP; Matt GE, 2004, TOB CONTROL, V13, P29, DOI 10.1136/tc.2003.003889; MCDONALD J, 2009, SAN DIEGO UNION 0209, pA1; Mello MM, 2008, NEW ENGL J MED, V359, P192, DOI 10.1056/NEJMhle0801929; *OFF SURG GEN, 2006, HLTH CONS INV TOB SM; Otsuka R, 2001, JAMA-J AM MED ASSOC, V286, P436, DOI 10.1001/jama.286.4.436; Pizacani BA, 2003, PREV MED, V36, P99, DOI 10.1006/pmed.2002.1123; Pizacani BA, 2008, NICOTINE TOB RES, V10, P533, DOI 10.1080/14622200801902003; Proescholdbell R J, 2000, Nicotine Tob Res, V2, P159, DOI 10.1080/713688125; *PUBL HLTH SERV OF, 2007, CHILDR SEC SMOK EXP; SCHNEIDER P, 2009, CAPITAL TIMES   0309; Schoenmarklin S, 2005, ANAL AUTHORITY HOUSI; SCHOENMARKLIN S, 2004, INFILTRATION SECONDH; Siahpush M, 2003, NICOTINE TOB RES, V5, P597, DOI 10.1080/1462220031000118711; Singer BC, 2003, ATMOS ENVIRON, V37, P5551, DOI 10.1016/j.atmosenv.2003.07.015; Singer BC, 2002, ENVIRON SCI TECHNOL, V36, P846, DOI 10.1021/es011058w; *SMOK FREE ENV LAW, 2010, HOUS AUTH COMM WHICH; *SMOK FREE HOUS CO, 2004, MUCH DOES SEC SMOK C; Spengler JD, 1999, ENVIRON HEALTH PERSP, V107, P313, DOI 10.2307/3434423; STRANDE MF, 2007, SMOKE FREE MULTIUNIT; Szabo E, 2006, ADDICT BEHAV, V31, P2298, DOI 10.1016/j.addbeh.2006.02.025; URIE H, 2008, BOULDER DAILY C 0320; Wakefield MA, 2000, BRIT MED J, V321, P333, DOI 10.1136/bmj.321.7257.333; WAKEFIELD MA, 2000, BMJ-BRIT MED J, V31, P623; WALKER SY, 2003, COMMUNICATION   0718; Weschler CJ, 2008, ATMOS ENVIRON, V42, P9018, DOI 10.1016/j.atmosenv.2008.09.052; Whitehead T, 2009, AM J EPIDEMIOL, V169, P1113, DOI 10.1093/aje/kwp021; Winickoff JP, 2009, PEDIATRICS, V123, pE74, DOI 10.1542/peds.2008-2184	60	60	60	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 17	2010	362	24					2319	2325		10.1056/NEJMhle1000941	http://dx.doi.org/10.1056/NEJMhle1000941			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611LJ	20554988	Green Accepted, Bronze			2022-12-01	WOS:000278816300014
J	Bernard, A; Lecuyer, C; Vincent, P; Amiot, R; Bardet, N; Buffetaut, E; Cuny, G; Fourel, F; Martineau, F; Mazin, JM; Prieur, A				Bernard, Aurelien; Lecuyer, Christophe; Vincent, Peggy; Amiot, Romain; Bardet, Nathalie; Buffetaut, Eric; Cuny, Gilles; Fourel, Francois; Martineau, Francois; Mazin, Jean-Michel; Prieur, Abel			Regulation of Body Temperature by Some Mesozoic Marine Reptiles	SCIENCE			English	Article							OXYGEN ISOTOPES; BONE; EVOLUTION; FISH; ENDOTHERMY; PHOSPHATE; METABOLISM; SPEED; WATER	What the body temperature and thermoregulation processes of extinct vertebrates were are central questions for understanding their ecology and evolution. The thermophysiologic status of the great marine reptiles is still unknown, even though some studies have suggested that thermoregulation may have contributed to their exceptional evolutionary success as apex predators of Mesozoic aquatic ecosystems. We tested the thermal status of ichthyosaurs, plesiosaurs, and mosasaurs by comparing the oxygen isotope compositions of their tooth phosphate to those of coexisting fish. Data distribution reveals that these large marine reptiles were able to maintain a constant and high body temperature in oceanic environments ranging from tropical to cold temperate. Their estimated body temperatures, in the range from 35 degrees +/- 2 degrees C to 39 degrees +/- 2 degrees C, suggest high metabolic rates required for predation and fast swimming over large distances offshore.	[Bernard, Aurelien; Lecuyer, Christophe; Amiot, Romain; Fourel, Francois; Martineau, Francois; Mazin, Jean-Michel; Prieur, Abel] Univ Lyon 1, CNRS, UMR 5125, F-69622 Villeurbanne, France; [Lecuyer, Christophe] Inst Univ France, F-75005 Paris, France; [Vincent, Peggy; Bardet, Nathalie] Museum Natl Hist Nat, CNRS, UMR 5143, Dept Hist Terre, F-75231 Paris, France; [Buffetaut, Eric] Ecole Normale Super, Geol Lab, CNRS, UMR 8538, F-75231 Paris, France; [Cuny, Gilles] Univ Copenhagen, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut Universitaire de France; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Universite Paris Cite; University of Copenhagen	Lecuyer, C (corresponding author), Univ Lyon 1, CNRS, UMR 5125, 2 Rue Raphael Dubois, F-69622 Villeurbanne, France.	clecuyer@univ-lyonl.fr	BARDET, Nathalie/N-8670-2019; Cuny, Gilles/F-8949-2017; FOUREL, Francois/G-6734-2015; Lecuyer, Christophe/C-8297-2012; Lecuyer, Christophe/AAO-8154-2021; Bardet, Nathalie/I-3805-2015; Amiot, Romain/C-8132-2012	Cuny, Gilles/0000-0001-7680-1697; Lecuyer, Christophe/0000-0001-9513-2492; Bardet, Nathalie/0000-0001-7881-7107	CNRS; Institut Universitaire de France	CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Universitaire de France	The authors thank M. Sander, B. McNab, and R. Seymour for preliminary discussions of these data during the workshop dedicated to "Sauropod gigantism" that was held in Bonn, Germany, in November 2008. We are also grateful to D. Brinkman and J. Gardner (Royal Tyrrell Museum), S. Etches and J. Clarke, G. Suan, J. Lindgren (Lund University), B. Kear (La Trobe University), and A. Schulp (Maastricht University) for providing samples. L. Simon and G. Escarguel helped us in the statistical treatment of data. This study was funded by both CNRS and the Institut Universitaire de France.	Amiot R, 2007, PALAEOGEOGR PALAEOCL, V243, P412, DOI 10.1016/j.palaeo.2006.08.013; ANDERSON TF, 1994, J GEOL SOC LONDON, V151, P125, DOI 10.1144/gsjgs.151.1.0125; BAKKER RT, 1972, NATURE, V238, P81, DOI 10.1038/238081a0; Barrick RE, 1999, PALAIOS, V14, P186, DOI 10.2307/3515374; Bennett AF, 2000, EVOLUTION, V54, P1768; Benton M.J., 2005, VERTEBRATE PALAEONTO; BLOCK BA, 1993, SCIENCE, V260, P210, DOI 10.1126/science.8469974; Carlson JK, 2004, CRC MAR BIOL SER, P203; DEBUFFRENIL V, 1990, PALEOBIOLOGY, V16, P435, DOI 10.1017/S0094837300010174; HEINRICH B, 1989, AM ZOOL, V29, P1157; HICKMAN CP, 2000, INTEGRATED PRINCIPLE; Kear BP, 2005, CRETACEOUS RES, V26, P769, DOI 10.1016/j.cretres.2005.04.006; KOLODNY Y, 1988, PALAEOGEOGR PALAEOCL, V64, P59, DOI 10.1016/0031-0182(88)90142-3; KOLODNY Y, 1983, EARTH PLANET SC LETT, V64, P398, DOI 10.1016/0012-821X(83)90100-0; Kolodny Y, 1991, GEOCHEM SOC SPEC PUB, V3, P105; Lecuyer C, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000863; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; LUTCAVAGE ME, 1992, CAN J ZOOL, V70, P348, DOI 10.1139/z92-051; MASSARE JA, 1994, MECHANICS AND PHYSIOLOGY OF ANIMAL SWIMMING, P133; MASSARE JA, 1988, PALEOBIOLOGY, V14, P187, DOI 10.1017/S009483730001191X; MORRISON P, 1962, BIOL BULL, V123, P154, DOI 10.2307/1539512; Motani R, 2002, PALEOBIOLOGY, V28, P251, DOI 10.1666/0094-8373(2002)028<0251:SSEOEM>2.0.CO;2; Motani R, 2002, NATURE, V415, P309, DOI 10.1038/415309a; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; SEYMOUR RS, 1976, NATURE, V262, P207, DOI 10.1038/262207a0; Seymour RS, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1051, DOI 10.1086/422766; Seymour RS, 2004, PLANT CELL ENVIRON, V27, P1014, DOI 10.1111/j.1365-3040.2004.01206.x; Sharp ZD, 2000, AM J SCI, V300, P222, DOI 10.2475/ajs.300.3.222; Wadley MR, 2002, GLOBAL PLANET CHANGE, V32, P89, DOI 10.1016/S0921-8181(01)00084-4; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; Wiffen J, 1995, GEOBIOS-LYON, V28, P625, DOI 10.1016/S0016-6995(95)80216-9; Zazzo A, 2004, GEOCHIM COSMOCHIM AC, V68, P1, DOI 10.1016/S0016-7037(03)00278-3	32	100	109	3	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 11	2010	328	5984					1379	1382		10.1126/science.1187443	http://dx.doi.org/10.1126/science.1187443			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20538946				2022-12-01	WOS:000278598400033
J	Panakova, D; Werdich, AA; MacRae, CA				Panakova, Daniela; Werdich, Andreas A.; MacRae, Calum A.			Wnt11 patterns a myocardial electrical gradient through regulation of the L-type Ca2+ channel	NATURE			English	Article							VOLTAGE-SENSITIVE DYES; CARDIAC TISSUE; CELL-CULTURES; CONDUCTION; GASTRULATION; ACTIVATION; MOVEMENTS; DIFFERENTIATION; MORPHOGENESIS; MECHANISMS	Electrical gradients are critical for many biological processes, including the normal function of excitable tissues, left-right patterning, organogenesis and wound healing(1-4). The fundamental mechanisms that regulate the establishment and maintenance of such electrical polarities are poorly understood. Here we identify a gradient of electrical coupling across the developing ventricular myocardium using high-speed optical mapping of transmembrane potentials and calcium concentrations in the zebrafish heart. We excluded a role for differences in cellular excitability, connexin localization, tissue geometry and mechanical inputs, but in contrast we were able to demonstrate that non-canonical Wnt11 signals are required for the genesis of this myocardial electrical gradient. Although the traditional planar cell polarity pathway is not involved, we obtained evidence that Wnt11 acts to set up this gradient of electrical coupling through effects on transmembrane Ca2+ conductance mediated by the L-type calcium channel. These data reveal a previously unrecognized role for Wnt/Ca2+ signalling in establishing an electrical gradient in the plane of the developing cardiac epithelium through modulation of ion-channel function. The regulation of cellular coupling through such mechanisms may be a general property of non-canonical Wnt signals.	[Panakova, Daniela; Werdich, Andreas A.; MacRae, Calum A.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	MacRae, CA (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, 75 Francis St,Thorn 11, Boston, MA 02115 USA.	camacrae@bics.bwh.harvard.edu		Werdich, Andreas/0000-0002-1222-1180; Panakova, Daniela/0000-0002-8739-6225	HFSP; NIH; March of Dimes; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL098938, K08HL068711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM075946] Funding Source: NIH RePORTER	HFSP(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. P. Heisenberg, L. Solnica-Krezel and J. Mably for the gift of reagents. We thank R. Peterson and I. Drummond for comments on the manuscript. D. P. is supported by a fellowship from the HFSP. A. A. W. was supported by an NIH training award to the CVRC at MGH. C. A. M. is supported by the March of Dimes and the NIH.	Adams DS, 2006, DEVELOPMENT, V133, P1657, DOI 10.1242/dev.02341; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Auman HJ, 2007, PLOS BIOL, V5, P604, DOI 10.1371/journal.pbio.0050053; Bayly PV, 1998, IEEE T BIO-MED ENG, V45, P563, DOI 10.1109/10.668746; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Chi NC, 2008, PLOS BIOL, V6, P1006, DOI 10.1371/journal.pbio.0060109; Chung CY, 2007, J CARDIOVASC ELECTR, V18, P1323, DOI 10.1111/j.1540-8167.2007.00959.x; Cohen ED, 2008, DEVELOPMENT, V135, P789, DOI 10.1242/dev.016865; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Eisenberg CA, 1999, DEV DYNAM, V216, P45, DOI 10.1002/(SICI)1097-0177(199909)216:1<45::AID-DVDY7>3.3.CO;2-C; Eloff BC, 2001, CARDIOVASC RES, V51, P681, DOI 10.1016/S0008-6363(01)00341-8; Etard C, 2007, DEV BIOL, V308, P133, DOI 10.1016/j.ydbio.2007.05.014; FAST VG, 1993, CIRC RES, V73, P914, DOI 10.1161/01.RES.73.5.914; FAST VG, 1995, CARDIOVASC RES, V29, P697, DOI 10.1016/0008-6363(96)88643-3; Flaherty MP, 2008, TRENDS CARDIOVAS MED, V18, P260, DOI 10.1016/j.tcm.2008.12.001; Girouard SD, 1996, J CARDIOVASC ELECTR, V7, P1024, DOI 10.1111/j.1540-8167.1996.tb00478.x; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; HOYT RH, 1989, CIRC RES, V64, P563, DOI 10.1161/01.RES.64.3.563; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; LOEW LM, 1992, J MEMBRANE BIOL, V130, P1, DOI 10.1007/bf00233734; Milan DJ, 2006, AM J PHYSIOL-HEART C, V291, pH269, DOI 10.1152/ajpheart.00960.2005; Milan DJ, 2006, DEVELOPMENT, V133, P1125, DOI 10.1242/dev.02279; Mills RW, 2008, AM J PHYSIOL-HEART C, V295, pH1270, DOI 10.1152/ajpheart.00350.2008; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; ROHR S, 1994, BIOPHYS J, V67, P1301, DOI 10.1016/S0006-3495(94)80602-2; Rohr S, 1998, BIOPHYS J, V75, P1062, DOI 10.1016/S0006-3495(98)77596-4; Rottbauer W, 2002, CELL, V111, P661, DOI 10.1016/S0092-8674(02)01112-1; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Thisse C., 2005, ZDBPUB0510251; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; WATANABE T, 1983, CIRC RES, V52, P280, DOI 10.1161/01.RES.52.3.280; Windisch H, 2001, OPTICAL MAPPING OF CARDIAC EXCITATION AND ARRHYTHMIAS, P97; Witzel S, 2006, J CELL BIOL, V175, P791, DOI 10.1083/jcb.200606017; Yao L, 2009, HIPPOCAMPUS, V19, P855, DOI 10.1002/hipo.20569; Yao SH, 2008, FEBS LETT, V582, P2325, DOI 10.1016/j.febslet.2008.05.036; Zhao M, 2006, NATURE, V442, P457, DOI 10.1038/nature04925; Zhou WL, 2007, NAT GENET, V39, P1225, DOI 10.1038/ng2112	42	101	102	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2010	466	7308					874	U109		10.1038/nature09249	http://dx.doi.org/10.1038/nature09249			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20657579	Green Accepted			2022-12-01	WOS:000280766100038
J	Anderson, T				Anderson, Tatum			Pain control The politics of pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OPIOIDS; INDIA					tatumnanderson@gmail.com						Adams Vanessa, 2008, J Pain Palliat Care Pharmacother, V22, P101; CLEARY JF, 2010, EUROPE PALLIAT MED, V24, P109; Fishbain DA, 2008, PAIN MED, V9, P444, DOI 10.1111/j.1526-4637.2007.00370.x; Hojsted J, 2007, EUR J PAIN, V11, P490, DOI 10.1016/j.ejpain.2006.08.004; Human Rights Watch, 2009, ACC PAIN TREATM HUM; *INT NARC CONTR BO, 1961, SINGL CONV NARC DRUG; International Narcotics Control Board, REP INT NARC CONTR B; Rajagopal MR, 2007, J PAIN SYMPTOM MANAG, V33, P615, DOI 10.1016/j.jpainsymman.2007.02.028; Rajagopal MR, 2001, LANCET, V358, P139, DOI 10.1016/S0140-6736(01)05322-3; *UN EC SOC COUNC, 2010, COMM NARC DRUGS; *WHO, NARC PSYCH DRUGS ACH; WHO, ACC CONTR MED PROGR	12	10	10	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2010	341								c3800	10.1136/bmj.c3800	http://dx.doi.org/10.1136/bmj.c3800			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	640DR	20702554				2022-12-01	WOS:000281028900004
J	Streicker, DG; Turmelle, AS; Vonhof, MJ; Kuzmin, IV; McCracken, GF; Rupprecht, CE				Streicker, Daniel G.; Turmelle, Amy S.; Vonhof, Maarten J.; Kuzmin, Ivan V.; McCracken, Gary F.; Rupprecht, Charles E.			Host Phylogeny Constrains Cross-Species Emergence and Establishment of Rabies Virus in Bats	SCIENCE			English	Article							UNITED-STATES; EPIDEMIOLOGY; TRANSMISSION; DYNAMICS	For RNA viruses, rapid viral evolution and the biological similarity of closely related host species have been proposed as key determinants of the occurrence and long-term outcome of cross-species transmission. Using a data set of hundreds of rabies viruses sampled from 23 North American bat species, we present a general framework to quantify per capita rates of cross-species transmission and reconstruct historical patterns of viral establishment in new host species using molecular sequence data. These estimates demonstrate diminishing frequencies of both cross-species transmission and host shifts with increasing phylogenetic distance between bat species. Evolutionary constraints on viral host range indicate that host species barriers may trump the intrinsic mutability of RNA viruses in determining the fate of emerging host-virus interactions.	[Streicker, Daniel G.; Turmelle, Amy S.; Kuzmin, Ivan V.; Rupprecht, Charles E.] Ctr Dis Control & Prevent, Rabies Team, Atlanta, GA 30333 USA; [Streicker, Daniel G.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Turmelle, Amy S.; McCracken, Gary F.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Vonhof, Maarten J.] Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA; [Vonhof, Maarten J.] Western Michigan Univ, Environm Studies Program, Kalamazoo, MI 49008 USA	Centers for Disease Control & Prevention - USA; University System of Georgia; University of Georgia; University of Tennessee System; University of Tennessee Knoxville; Western Michigan University; Western Michigan University	Streicker, DG (corresponding author), Ctr Dis Control & Prevent, Rabies Team, Atlanta, GA 30333 USA.	dstrike@uga.edu	Rupprecht, Charles/AAI-1544-2020	Streicker, Daniel/0000-0001-7475-2705; Gilbert, Amy T./0000-0002-8256-0081; McCracken, Gary/0000-0002-2493-8103	Association of Public Health Laboratories/Centers for Disease Control Emerging Infectious Diseases; NSF; NSF-NIH [0430418]; U.S. Army Engineer Research Development Center-Construction Engineering Research Laboratory; Western Michigan University	Association of Public Health Laboratories/Centers for Disease Control Emerging Infectious Diseases; NSF(National Science Foundation (NSF)); NSF-NIH(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Engineer Research Development Center-Construction Engineering Research Laboratory; Western Michigan University	For helpful discussion and comments, we thank P. Beerli, J. Davies, S. Altizer, A. Park, P. Rohani, J. Allgeier, B. Han, P. Stephens, and three anonymous reviewers. For contributing rabid bats, we thank the Arizona State Public Health Laboratory, the California Department of Public Health, the Georgia Department of Community Health, the Florida Department of Health, the Idaho Department of Health and Welfare, the Indiana State Department of Health, the University of Iowa's University Hygienic Laboratory, the Mississippi State Department of Health, the New Jersey Department of Health and Senior Services, the Tennessee Department of Health, the Texas Department of State Health Services, the Virginia Consolidated Laboratory, and the Washington State Department of Health. For providing museum-vouchered bat tissues, we thank the Angelo State Natural History Collection, the Carnegie Museum of Natural History, the Centro de Investigaciones Biologicas del Noroeste, the Louisiana State University Museum of Natural Science, the Museum of Vertebrate Zoology, the U. S. National Museum of Natural History, the Royal Ontario Museum, and the University of Alaska Museum. The sequences generated in this study can be found at GenBank under accession numbers GU644641 to GU645012 and GU722925 to GU723257 (table S1). This work was supported by Association of Public Health Laboratories/Centers for Disease Control Emerging Infectious Diseases and NSF Graduate Research Fellowships to D. G. S., NSF-NIH Ecology of Infectious Disease grant 0430418 to G. F. M., and funding from the U.S. Army Engineer Research Development Center-Construction Engineering Research Laboratory and Western Michigan University to M.J.V.	Anishchenko M, 2006, P NATL ACAD SCI USA, V103, P4994, DOI 10.1073/pnas.0509961103; BAER GM, 1990, LANCET, V335, P664, DOI 10.1016/0140-6736(90)90454-D; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Blanton JD, 2009, JAVMA-J AM VET MED A, V235, P676, DOI 10.2460/javma.235.6.676; BRASS DA, 1994, RABIES BATS NATURAL, P151; Davies TJ, 2008, P ROY SOC B-BIOL SCI, V275, P1695, DOI 10.1098/rspb.2008.0284; de Vienne DM, 2009, J EVOLUTION BIOL, V22, P2532, DOI 10.1111/j.1420-9101.2009.01878.x; Finke S, 2005, VIRUS RES, V111, P120, DOI 10.1016/j.virusres.2005.04.004; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Hsu VP, 2004, EMERG INFECT DIS, V10, P2082, DOI 10.3201/eid1012.040701; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863; Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Rupprecht CE, 2002, LANCET INFECT DIS, V2, P327, DOI 10.1016/S1473-3099(02)00287-6; Smith JS, 1995, SEMIN VIROL, V6, P387, DOI 10.1016/S1044-5773(05)80016-2; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102	19	303	308	1	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					676	679		10.1126/science.1188836	http://dx.doi.org/10.1126/science.1188836			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689015				2022-12-01	WOS:000280602700037
J	Stolfi, A; Gainous, TB; Young, JJ; Mori, A; Levine, M; Christiaen, L				Stolfi, Alberto; Gainous, T. Blair; Young, John J.; Mori, Alessandro; Levine, Michael; Christiaen, Lionel			Early Chordate Origins of the Vertebrate Second Heart Field	SCIENCE			English	Article							ASCIDIAN CIONA-INTESTINALIS; MUSCLE DEVELOPMENT; MYOCARDIAL-CELLS; GENE-EXPRESSION; SPECIFICATION; MIGRATION; MESODERM; MESP	The vertebrate heart is formed from diverse embryonic territories, including the first and second heart fields. The second heart field (SHF) gives rise to the right ventricle and outflow tract, yet its evolutionary origins are unclear. We found that heart progenitor cells of the simple chordate Ciona intestinalis also generate precursors of the atrial siphon muscles (ASMs). These precursors express Islet and Tbx1/10, evocative of the splanchnic mesoderm that produces the lower jaw muscles and SHF of vertebrates. Evidence is presented that the transcription factor COE is a critical determinant of ASM fate. We propose that the last common ancestor of tunicates and vertebrates possessed multipotent cardiopharyngeal muscle precursors, and that their reallocation might have contributed to the emergence of the SHF.	[Stolfi, Alberto; Gainous, T. Blair; Young, John J.; Mori, Alessandro; Levine, Michael; Christiaen, Lionel] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Genet Genom & Dev, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Christiaen, Lionel] NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA	University of California System; University of California Berkeley; New York University	Levine, M (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Genet Genom & Dev, Ctr Integrat Genom, Berkeley, CA 94720 USA.	mlevine@berkeley.edu; lc121@nyu.edu	Stolfi, Alberto/AAS-8031-2021	Levine, Michael/0000-0001-7629-0081; Gainous, T. Blair/0000-0002-8987-3195; Christiaen, Lionel/0000-0001-5930-5667	NSF [IOB 0445470]; NIH [0745322]; New York University Faculty of Arts and Science; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076542] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York University Faculty of Arts and Science; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank D. Hendrix for computational analysis, A. Cooc for technical assistance, and R. Harland, I. Philipp, and T. J. Park for advice. Supported by NSF grant IOB 0445470 (M.L.), NIH training grant 0745322 (T.B.G.), and a New York University Faculty of Arts and Science start-up package (L.C.).	Abu-Issa R, 2007, ANNU REV CELL DEV BI, V23, P45, DOI 10.1146/annurev.cellbio.23.090506.123331; Beh J, 2007, DEVELOPMENT, V134, P3297, DOI 10.1242/dev.010140; Brade T, 2007, DEV BIOL, V311, P297, DOI 10.1016/j.ydbio.2007.08.004; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Chen JY, 1999, NATURE, V402, P518, DOI 10.1038/990080; Christiaen L, 2008, SCIENCE, V320, P1349, DOI 10.1126/science.1158170; Christiaen L, 2009, DEV BIOL, V328, P552, DOI 10.1016/j.ydbio.2009.01.033; Crozatier M, 1999, DEVELOPMENT, V126, P1495; Davidson B, 2005, DEVELOPMENT, V132, P4811, DOI 10.1242/dev.02051; Davidson B, 2007, SEMIN CELL DEV BIOL, V18, P16, DOI 10.1016/j.semcdb.2006.12.007; Davidson B, 2006, GENE DEV, V20, P2728, DOI 10.1101/gad.1467706; de Pater E, 2009, DEVELOPMENT, V136, P1633, DOI 10.1242/dev.030924; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; GANS C, 1983, SCIENCE, V220, P268, DOI 10.1126/science.220.4594.268; Gessert S, 2009, DEV BIOL, V334, P395, DOI 10.1016/j.ydbio.2009.07.037; Giuliano P, 1998, MECH DEVELOP, V78, P199, DOI 10.1016/S0925-4773(98)00143-9; Hirano T, 1997, DEV BIOL, V192, P199, DOI 10.1006/dbio.1997.8772; Kang J, 2009, DEV BIOL, V334, P513, DOI 10.1016/j.ydbio.2009.06.041; Kokubo N, 2010, EVOL DEV, V12, P34, DOI 10.1111/j.1525-142X.2009.00389.x; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; Nathan E, 2008, DEVELOPMENT, V135, P647, DOI 10.1242/dev.007989; Ogasawara M, 2002, DEV GENES EVOL, V212, P173, DOI 10.1007/s00427-002-0230-7; Okkema PG, 1997, DEVELOPMENT, V124, P3965; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Perez-Pomares JM, 2009, INT J DEV BIOL, V53, P1427, DOI 10.1387/ijdb.072409jp; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Satou Y, 2004, DEVELOPMENT, V131, P2533, DOI 10.1242/dev.01145; Takatori N, 2004, DEV DYNAM, V230, P743, DOI 10.1002/dvdy.20082; Tzahor E, 2009, DEV BIOL, V327, P273, DOI 10.1016/j.ydbio.2008.12.035	29	123	124	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					565	568		10.1126/science.1190181	http://dx.doi.org/10.1126/science.1190181			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671188	Green Accepted			2022-12-01	WOS:000280483500037
J	Busskamp, V; Duebel, J; Balya, D; Fradot, M; Viney, TJ; Siegert, S; Groner, AC; Cabuy, E; Forster, V; Seeliger, M; Biel, M; Humphries, P; Paques, M; Mohand-Said, S; Trono, D; Deisseroth, K; Sahel, JA; Picaud, S; Roska, B				Busskamp, Volker; Duebel, Jens; Balya, David; Fradot, Mathias; Viney, Tim James; Siegert, Sandra; Groner, Anna C.; Cabuy, Erik; Forster, Valerie; Seeliger, Mathias; Biel, Martin; Humphries, Peter; Paques, Michel; Mohand-Said, Saddek; Trono, Didier; Deisseroth, Karl; Sahel, Jose A.; Picaud, Serge; Roska, Botond			Genetic Reactivation of Cone Photoreceptors Restores Visual Responses in Retinitis Pigmentosa	SCIENCE			English	Article							HALORHODOPSIN; CELLS; MODEL; SELECTIVITY; EXPRESSION; SEROTYPES; DIRECTION	Retinitis pigmentosa refers to a diverse group of hereditary diseases that lead to incurable blindness, affecting two million people worldwide. As a common pathology, rod photoreceptors die early, whereas light-insensitive, morphologically altered cone photoreceptors persist longer. It is unknown if these cones are accessible for therapeutic intervention. Here, we show that expression of archaebacterial halorhodopsin in light-insensitive cones can substitute for the native phototransduction cascade and restore light sensitivity in mouse models of retinitis pigmentosa. Resensitized photoreceptors activate all retinal cone pathways, drive sophisticated retinal circuit functions (including directional selectivity), activate cortical circuits, and mediate visually guided behaviors. Using human ex vivo retinas, we show that halorhodopsin can reactivate light-insensitive human photoreceptors. Finally, we identified blind patients with persisting, light-insensitive cones for potential halorhodopsin-based therapy.	[Busskamp, Volker; Duebel, Jens; Balya, David; Viney, Tim James; Siegert, Sandra; Cabuy, Erik; Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland; [Busskamp, Volker; Groner, Anna C.; Trono, Didier] Natl Ctr Competence Res Frontiers, Genet Program, CH-1211 Geneva, Switzerland; [Fradot, Mathias; Forster, Valerie; Paques, Michel; Mohand-Said, Saddek; Sahel, Jose A.; Picaud, Serge] INSERM, UMR S968, Inst Vis, Paris, France; [Fradot, Mathias; Forster, Valerie; Paques, Michel; Mohand-Said, Saddek; Sahel, Jose A.; Picaud, Serge] Univ Paris 06, UMR S968, Inst Vis, F-75012 Paris, France; [Fradot, Mathias; Forster, Valerie; Paques, Michel; Mohand-Said, Saddek; Sahel, Jose A.; Picaud, Serge] CNRS, UMR 7210, F-75012 Paris, France; [Groner, Anna C.; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Seeliger, Mathias] Univ Tubingen, Dept Ophthalmol 2, Inst Ophthalm Res, Div Ocular Neurodegenerat, Tubingen, Germany; [Biel, Martin] Univ Munich, Ctr Integrated Prot Sci Munich, Munich, Germany; [Biel, Martin] Univ Munich, Dept Pharm, Munich, Germany; [Humphries, Peter] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Paques, Michel; Mohand-Said, Saddek; Sahel, Jose A.] Ctr Hosp Natl Ophtalmol Quinze Vingts, INSERM, Ctr Invest Clin 503, Paris, France; [Paques, Michel; Sahel, Jose A.; Picaud, Serge] Fdn Ophtalmol Adolphe de Rothschild, Paris, France; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Friedrich Miescher Institute for Biomedical Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; University of Munich; Trinity College Dublin; CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Stanford University; Stanford University	Roska, B (corresponding author), Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland.	botond.roska@fmi.ch	Picaud, Serge/H-4012-2014; Roska, Botond/AAD-7268-2021; Busskamp, Volker/E-6339-2015; Sahel, Jose-Alain/F-3172-2017; Siegert, Sandra/GWC-4507-2022; Biel, Martin/G-1175-2014	Picaud, Serge/0000-0002-0548-5145; Busskamp, Volker/0000-0001-7517-8944; Sahel, Jose-Alain/0000-0002-4831-1153; Siegert, Sandra/0000-0001-8635-0877; Biel, Martin/0000-0002-9974-3052; Paques, Michel/0000-0002-9102-9196; Viney, Tim/0000-0001-6444-1188; Duebel, Jens/0000-0002-9906-5597	Friedrich Miescher Institute; U.S. Office of Naval Research; Marie Curie Excellence grant; European Union (EU) [HEALTH-F2-223156]; Agence nationale de la recherche; Foundation Fighting Blindness (U.S); Swiss National Science Foundation; Marie Curie Postdoctoral Fellowship; National Centers of Competence in Research Frontiers in Genetics; Science Foundation Ireland	Friedrich Miescher Institute; U.S. Office of Naval Research(Office of Naval Research); Marie Curie Excellence grant(European Commission); European Union (EU)(CGIAREuropean Commission); Agence nationale de la recherche(French National Research Agency (ANR)); Foundation Fighting Blindness (U.S); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Marie Curie Postdoctoral Fellowship(European Commission); National Centers of Competence in Research Frontiers in Genetics; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	We thank B. G. Scherf, S. Djaffer, and H. Kohler for technical assistance and P. Lagali, K. Farrow, A. Matus, and S. Oakeley for their comments on the manuscript. pAAV2.1-Rho-EGFP was provided by A. Auricchio, and J. Nathans provided the pRed2.1lacZ. Post-mortem human retinas were provided by T. Wesseling and E. Pels at the Cornea Bank in Amsterdam (Netherlands). This study was supported by Friedrich Miescher Institute funds; a U.S. Office of Naval Research Naval International Cooperative Opportunities in Science and Technology Program grant; a Marie Curie Excellence grant and a European Union (EU) HEALTH-F2-223156 grant to B. R.; a grant from the EU (RETICIRC) to B. R. and S. P.; grants from the Agence nationale de la recherche (MEDINAS, RETINE) to S. P.; a Center Grant from Foundation Fighting Blindness (U.S.) to S.M.-S. and J. A. S.; grants from the Swiss National Science Foundation and the EU to D. T.; a grant from the EU (TREATRUSH) to J. A. S., S. P., and B. R.; a Marie Curie Postdoctoral Fellowship to D. B.; and a National Centers of Competence in Research Frontiers in Genetics fellowship to V. B. and A. C. G. The Ocular Genetics Unit at Trinity College Dublin is supported by Science Foundation Ireland. The data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus (GEO) and are accessible through GEO Series accession no. GSE22338 (www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE22338).	Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; Allocca M, 2007, J VIROL, V81, P11372, DOI 10.1128/JVI.01327-07; BAMBERG E, 1993, P NATL ACAD SCI USA, V90, P639, DOI 10.1073/pnas.90.2.639; Banin E, 1999, NEURON, V23, P549, DOI 10.1016/S0896-6273(00)80807-7; BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Claes E, 2004, INVEST OPHTH VIS SCI, V45, P2039, DOI 10.1167/iovs.03-0741; Cronin T, 2007, CURR GENE THER, V7, P121, DOI 10.2174/156652307780363143; Degenaar P, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/3/035007; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; FARBER DB, 1994, PROG RETIN EYE RES, V13, P31, DOI 10.1016/1350-9462(94)90004-3; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Lebherz C, 2008, J GENE MED, V10, P375, DOI 10.1002/jgm.1126; Leveillard T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000866; LI ZY, 1995, J NEUROSCI, V15, P5429; Lin B, 2009, EXP EYE RES, V88, P589, DOI 10.1016/j.exer.2008.11.022; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; Seki A, 2007, BIOPHYS J, V92, P2559, DOI 10.1529/biophysj.106.093153; Shintani K, 2009, OPTOMETRY, V80, P384, DOI 10.1016/j.optm.2008.01.026; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; Yang Y, 2009, MOL THER, V17, P787, DOI 10.1038/mt.2009.28; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Zhu XM, 2002, FEBS LETT, V524, P116, DOI 10.1016/S0014-5793(02)03014-4; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	33	432	471	2	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2010	329	5990					413	417		10.1126/science.1190897	http://dx.doi.org/10.1126/science.1190897			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20576849	Green Submitted			2022-12-01	WOS:000280196500030
J	Ozgul, A; Childs, DZ; Oli, MK; Armitage, KB; Blumstein, DT; Olson, LE; Tuljapurkar, S; Coulson, T				Ozgul, Arpat; Childs, Dylan Z.; Oli, Madan K.; Armitage, Kenneth B.; Blumstein, Daniel T.; Olson, Lucretia E.; Tuljapurkar, Shripad; Coulson, Tim			Coupled dynamics of body mass and population growth in response to environmental change	NATURE			English	Article							YELLOW-BELLIED MARMOTS; RECENT CLIMATE-CHANGE; REPRODUCTIVE STRATEGIES; QUANTITATIVE TRAIT; NATURAL-SELECTION; LIFE-HISTORY; DEMOGRAPHY; EVOLUTION; FLAVIVENTRIS; SURVIVAL	Environmental change has altered the phenology, morphological traits and population dynamics of many species(1,2). However, the links underlying these joint responses remain largely unknown owing to a paucity of long-term data and the lack of an appropriate analytical framework(3). Here we investigate the link between phenotypic and demographic responses to environmental change using a new methodology and a long-term (1976-2008) data set from a hibernating mammal (the yellow-bellied marmot) inhabiting a dynamic subalpine habitat. We demonstrate how earlier emergence from hibernation and earlier weaning of young has led to a longer growing season and larger body masses before hibernation. The resulting shift in both the phenotype and the relationship between phenotype and fitness components led to a decline in adult mortality, which in turn triggered an abrupt increase in population size in recent years. Direct and trait-mediated effects of environmental change made comparable contributions to the observed marked increase in population growth. Our results help explain how a shift in phenology can cause simultaneous phenotypic and demographic changes, and highlight the need for a theory integrating ecological and evolutionary dynamics in stochastic environments(4,5).	[Ozgul, Arpat; Coulson, Tim] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England; [Childs, Dylan Z.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Oli, Madan K.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA; [Armitage, Kenneth B.] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; [Blumstein, Daniel T.; Olson, Lucretia E.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Tuljapurkar, Shripad] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Imperial College London; University of Sheffield; State University System of Florida; University of Florida; University of Kansas; University of California System; University of California Los Angeles; Stanford University	Ozgul, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England.	a.ozgul@imperial.ac.uk	Blumstein, Daniel T./B-6199-2012; Coulson, Tim/AAL-8148-2021; Ozgul, Arpat/K-2032-2012; Childs, Dylan/P-7388-2018	Blumstein, Daniel T./0000-0001-5793-9244; Coulson, Tim/0000-0001-9371-9003; Ozgul, Arpat/0000-0001-7477-2642; Tuljapurkar, Shripad/0000-0001-5549-4245; Childs, Dylan/0000-0002-0675-4933; Olson, Lucretia/0000-0002-5703-3351	NERC; Wellcome Trust; NSF; NIH; NIA; NERC [NE/E013015/1, NE/G004390/1, NE/E015921/1] Funding Source: UKRI; Natural Environment Research Council [NE/E015921/1, NE/G004390/1, NE/E013015/1] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the 'marmoteers' who participated in collecting the long-term data, Rocky Mountain Biological Laboratory for providing the field facilities, B. Barr and D. Inouye for providing additional information on climate and plant phenology, and L. M. Chevin, J. A. Hostetler, D. Inouye, N. J. Singh and I. M. Smallegange for comments. This work was funded by NERC, the Wellcome Trust, NSF, NIH and NIA.	ANDERSON DC, 1976, ECOLOGY, V57, P552, DOI 10.2307/1936439; [Anonymous], 2008, R LANG ENV STAT COMP; Armitage K. B., 1996, BIODIVERSITY MARMOTS, P223; ARMITAGE KB, 1990, J COMP PHYSIOL B, V160, P491; ARMITAGE KB, 1976, AM MIDL NAT, V96, P36, DOI 10.2307/2424566; ARMITAGE KB, 1981, OECOLOGIA, V48, P36, DOI 10.1007/BF00346986; Armitage KB, 1998, J MAMMAL, V79, P385, DOI 10.2307/1382969; ARMITAGE KB, 1991, ANNU REV ECOL SYST, V22, P379, DOI 10.1146/annurev.ecolsys.22.1.379; ARMITAGE KB, 1974, ECOLOGY, V55, P1233, DOI 10.2307/1935452; Armitage KB., 2003, WILD MAMMALS N AM BI, P188; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; BROWNIE C, 1993, BIOMETRICS, V49, P1173, DOI 10.2307/2532259; Burnham K.P., 2002, MODEL SELECTION MULT, DOI DOI 10.1007/B97636; Caswell H., 2001, MATRIX POPULATION MO, V2nd; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Childs DZ, 2003, P ROY SOC B-BIOL SCI, V270, P1829, DOI 10.1098/rspb.2003.2399; Coulson T, 2006, EVOL ECOL RES, V8, P1155; Coulson T, 2008, AM NAT, V172, P599, DOI 10.1086/591693; Easterling MR, 2000, ECOLOGY, V81, P694, DOI 10.2307/177370; Ellner SP, 2006, AM NAT, V167, P410, DOI 10.1086/499438; Fisher R., 2005, TEACHING CHILDREN TH; FRASE BA, 1989, ETHOL ECOL EVOL, V1, P353, DOI 10.1080/08927014.1989.9525505; FRASE BA, 1980, MAMMALIAN SPECIES, V135, P1; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Humphries MM, 2004, INTEGR COMP BIOL, V44, P152, DOI 10.1093/icb/44.2.152; Inouye DW, 2000, P NATL ACAD SCI USA, V97, P1630, DOI 10.1073/pnas.97.4.1630; Intergovernmental Panel on Climate Change, 2007, PHYS SCI BAS CONTR W; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; Karl TR, 2003, SCIENCE, V302, P1719, DOI 10.1126/science.1090228; KILGORE DL, 1978, ECOLOGY, V59, P78, DOI 10.2307/1936633; Kingsolver JG, 2001, AM NAT, V157, P245, DOI 10.1086/319193; Laake J., 2022, MARK, P109; LANDE R, 1976, EVOLUTION, V30, P314, DOI [10.2307/2407703, 10.1111/j.1558-5646.1976.tb00911.x]; MELCHER JC, 1989, PHYSIOL ZOOL, V62, P429, DOI 10.1086/physzool.62.2.30156178; Ozgul A, 2009, AM NAT, V173, P517, DOI 10.1086/597225; Ozgul A, 2009, SCIENCE, V325, P464, DOI 10.1126/science.1173668; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pelletier F, 2007, SCIENCE, V315, P1571, DOI 10.1126/science.1139024; Pinheiro JC., 2000, MIXED EFFECTS MODELS, V43, P111; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Reale D, 2003, P ROY SOC B-BIOL SCI, V270, P591, DOI 10.1098/rspb.2002.2224; Saether BE, 2000, SCIENCE, V287, P854, DOI 10.1126/science.287.5454.854; SCHLUTER D, 1988, EVOLUTION, V42, P849, DOI [10.2307/2408904, 10.1111/j.1558-5646.1988.tb02507.x]; Schwartz OA, 1998, J ZOOL, V246, P337, DOI 10.1111/j.1469-7998.1998.tb00163.x; Stenseth NC, 2002, P NATL ACAD SCI USA, V99, P13379, DOI 10.1073/pnas.212519399; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Tuljapurkar S., 1997, STRUCTURED POPULATIO; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wood S., 2006, GEN ADDITIVE MODELS; Woods BC, 2003, J MAMMAL, V84, P903, DOI 10.1644/BRG-106	54	442	446	4	391	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 22	2010	466	7305					482	U5		10.1038/nature09210	http://dx.doi.org/10.1038/nature09210			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20651690	Green Accepted, Green Submitted			2022-12-01	WOS:000280141200034
J	Cooper, CJ; Metch, B; Dragavon, J; Coombs, RW; Baden, LR				Cooper, Cristine J.; Metch, Barbara; Dragavon, Joan; Coombs, Robert W.; Baden, Lindsey R.		NIAID HVTN VISP Task Force	Vaccine-Induced HIV Seropositivity/Reactivity in Noninfected HIV Vaccine Recipients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RECOMBINANT GLYCOPROTEIN-120 VACCINE; PHASE-I TRIAL; CANDIDATE VACCINE; EFFICACY TRIAL; DOUBLE-BLIND; SAFETY; IMMUNOGENICITY; INFECTION; HEALTHY	Context Induction of protective anti-human immunodeficiency virus (HIV) immune responses is the goal of an HIV vaccine. However, this may cause a reactive result in routine HIV testing in the absence of HIV infection. Objective To evaluate the frequency of vaccine-induced seropositivity/reactivity (VISP) in HIV vaccine trial participants. Design, Setting, and Participants Three common US Food and Drug Administration-approved enzyme immunoassay (EIA) HIV antibody kits were used to determine VISP, and a routine diagnostic HIV algorithm was used to evaluate VISP frequency in healthy, HIV-seronegative adults who completed phase 1 (n=25) and phase 2a (n=2) vaccine trials conducted from 2000-2010 in the United States, South America, Thailand, and Africa. Main Outcome Measure Vaccine-induced seropositivity/reactivity, defined as reactive on 1 or more EIA tests and either Western blot-negative or Western blot-indeterminate/atypical positive (profile consistent with vaccine product) and HIV-1-negative by nucleic acid testing. Results Among 2176 participants free of HIV infection who received a vaccine product, 908 (41.7%; 95% confidence interval [CI], 39.6%-43.8%) had VISP, but the occurrence of VISP varied substantially across different HIV vaccine product types: 399 of 460 (86.7%; 95% CI, 83.3%-89.7%) adenovirus 5 product recipients, 295 of 552 (53.4%; 95% CI, 49.2%-57.7%) recipients of poxvirus alone or as a boost, and 35 of 555 (6.3%; 95% CI, 4.4%-8.7%) of DNA-alone product recipients developed VISP. Overall, the highest proportion of VISP (891/2176 tested [40.9%]) occurred with the HIV 1/2 (rDNA) EIA kit compared with the rLAV EIA (150/700 tested [21.4%]), HIV-1 Plus O Microelisa System (193/1309 tested [14.7%]), and HIV 1/2 Peptide and HIV 1/2 Plus O (189/2150 tested [8.8%]) kits. Only 17 of the 908 participants (1.9%) with VISP tested nonreactive using the HIV 1/2 (rDNA) kit. All recipients of a glycoprotein 140 vaccine (n=70) had VISP, with 94.3% testing reactive with all 3 EIA kits tested. Among 901 participants with VISP and a Western blot result, 92 (10.2%) had a positive Western blot result (displaying an atypical pattern consistent with vaccine product), and 592 (65.7%) had an indeterminate result. Only 8 participants with VISP received a vaccine not containing an envelope insert. Conclusions The induction of VISP in HIV vaccine recipients is common, especially with vaccines containing both the HIV-1 envelope and group-specific core antigen gene proteins. Development and detection of VISP appear to be associated with the immunogenicity of the vaccine and the EIA assay used. JAMA. 2010;304(3):275-283 www.jama.com	[Baden, Lindsey R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA; [Cooper, Cristine J.; Metch, Barbara] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA; [Dragavon, Joan; Coombs, Robert W.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Baden, LR (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Infect Dis, PBB-A4,75 Francis St, Boston, MA 02115 USA.	lbaden@partners.org		Allen, Mary/0000-0001-8163-0714	NIAID [U01 AI046747, AI068614, AI46725, AI068618, AI046703, AI068635, AI069412]; University of Washington Center for AIDS Research [AI27757]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, U01AI068614, UM1AI068618, U01AI046703, UM1AI068635, UM1AI068614, U01AI068635, UM1AI069412, U01AI069412, U01AI046747, U01AI046725, U01AI068618] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Washington Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by NIAID grants U01 AI046747, AI068614, AI46725, AI068618, AI046703, AI068635, and AI069412 and by the University of Washington Center for AIDS Research grant AI27757.	Ackers ML, 2003, J INFECT DIS, V187, P879, DOI 10.1086/368169; Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Bartlett JG, 2008, JAMA-J AM MED ASSOC, V300, P945, DOI 10.1001/jama.300.8.945; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Centers for Disease Control (CDC), 1989, MMWR Suppl, V38, P1; Cleghorn F, 2007, JAIDS-J ACQ IMM DEF, V46, P222, DOI 10.1097/QAI.0b013e318149297d; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Goepfert PA, 2005, J INFECT DIS, V192, P1249, DOI 10.1086/432915; Goepfert PA, 2007, VACCINE, V25, P510, DOI 10.1016/j.vaccine.2006.07.050; Gorse GJ, 2008, VACCINE, V26, P215, DOI 10.1016/j.vaccine.2007.10.061; Graham BS, 2006, J INFECT DIS, V194, P1650, DOI 10.1086/509259; Gust DA, 2009, JAIDS-J ACQ IMM DEF, V52, P294, DOI 10.1097/QAI.0b013e3181ab6e93; Jin X, 2009, VACCINE, V27, P7080, DOI 10.1016/j.vaccine.2009.09.060; Khurana S, 2006, JAIDS-J ACQ IMM DEF, V43, P304, DOI 10.1097/01.qai.0000242465.50947.5f; McCormack S, 2008, VACCINE, V26, P3162, DOI 10.1016/j.vaccine.2008.02.072; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Mulligan MJ, 2006, AIDS RES HUM RETROV, V22, P678, DOI 10.1089/aid.2006.22.678; Pialoux G, 2008, VACCINE, V26, P2657, DOI 10.1016/j.vaccine.2007.11.002; Pitisuttithum P, 2003, J INFECT DIS, V188, P219, DOI 10.1086/376506; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Priddy FH, 2008, CLIN INFECT DIS, V46, P1769, DOI 10.1086/587993; Quirk EK, 2008, CLIN INFECT DIS, V47, P1593, DOI 10.1086/593313; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Russell ND, 2007, JAIDS-J ACQ IMM DEF, V44, P203, DOI 10.1097/01.qai.0000248356.48501.ff; SCHWARTZ DH, 1995, CLIN DIAGN LAB IMMUN, V2, P268, DOI 10.1128/CDLI.2.3.268-271.1995; Silbermann B, 2008, AIDS RES HUM RETROV, V24, P1445, DOI 10.1089/aid.2008.0107; SIMONSEN L, 1995, AM J EPIDEMIOL, V141, P1089, DOI 10.1093/oxfordjournals.aje.a117374; Spearman P, 2009, VACCINE, V27, P243, DOI 10.1016/j.vaccine.2008.10.051; *WHO, 2008, GLOB SUMM AIDS EP	30	32	33	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					275	283		10.1001/jama.2010.926	http://dx.doi.org/10.1001/jama.2010.926			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639561	Green Accepted, Bronze			2022-12-01	WOS:000280107500017
J	Savile, CK; Janey, JM; Mundorff, EC; Moore, JC; Tam, S; Jarvis, WR; Colbeck, JC; Krebber, A; Fleitz, FJ; Brands, J; Devine, PN; Huisman, GW; Hughes, GJ				Savile, Christopher K.; Janey, Jacob M.; Mundorff, Emily C.; Moore, Jeffrey C.; Tam, Sarena; Jarvis, William R.; Colbeck, Jeffrey C.; Krebber, Anke; Fleitz, Fred J.; Brands, Jos; Devine, Paul N.; Huisman, Gjalt W.; Hughes, Gregory J.			Biocatalytic Asymmetric Synthesis of Chiral Amines from Ketones Applied to Sitagliptin Manufacture	SCIENCE			English	Article							SUBSTRATE-SPECIFICITY; AMINOTRANSFERASE; TRANSAMINASE; CHEMISTRY; EVOLUTION	Pharmaceutical synthesis can benefit greatly from the selectivity gains associated with enzymatic catalysis. Here, we report an efficient biocatalytic process to replace a recently implemented rhodium-catalyzed asymmetric enamine hydrogenation for the large-scale manufacture of the antidiabetic compound sitagliptin. Starting from an enzyme that had the catalytic machinery to perform the desired chemistry but lacked any activity toward the prositagliptin ketone, we applied a substrate walking, modeling, and mutation approach to create a transaminase with marginal activity for the synthesis of the chiral amine; this variant was then further engineered via directed evolution for practical application in a manufacturing setting. The resultant biocatalysts showed broad applicability toward the synthesis of chiral amines that previously were accessible only via resolution. This work underscores the maturation of biocatalysis to enable efficient, economical, and environmentally benign processes for the manufacture of pharmaceuticals.	[Savile, Christopher K.; Mundorff, Emily C.; Tam, Sarena; Jarvis, William R.; Colbeck, Jeffrey C.; Krebber, Anke; Huisman, Gjalt W.] Codexis Inc, Redwood City, CA 94063 USA; [Janey, Jacob M.; Moore, Jeffrey C.; Fleitz, Fred J.; Brands, Jos; Devine, Paul N.; Hughes, Gregory J.] Merck & Co Inc, Merck Res Labs, Dept Proc Res, Rahway, NJ 07065 USA	Merck & Company	Savile, CK (corresponding author), Codexis Inc, 200 Penobscot Dr, Redwood City, CA 94063 USA.	christopher.savile@codexis.com; jacob_janey@merck.com		Janey, Jacob/0000-0001-7697-1709; Huisman, Gjalt/0000-0003-1955-1120				Chen ZL, 2005, J MOL BIOL, V348, P1273, DOI 10.1016/j.jmb.2005.02.070; Cho BK, 2008, BIOTECHNOL BIOENG, V99, P275, DOI 10.1002/bit.21591; Constable DJC, 2007, GREEN CHEM, V9, P411, DOI 10.1039/b703488c; Crump S. P., 1992, BIOCATALYTIC PRODUCT, P43; Davies IW, 2009, SCIENCE, V325, P701, DOI 10.1126/science.1174501; De Wildeman SMA, 2007, ACCOUNTS CHEM RES, V40, P1260, DOI 10.1021/ar7001073; Eijsink VGH, 2004, J BIOTECHNOL, V113, P105, DOI 10.1016/j.jbiotec.2004.03.026; Fox RJ, 2007, NAT BIOTECHNOL, V25, P338, DOI 10.1038/nbt1286; Hansen KB, 2009, J AM CHEM SOC, V131, P8798, DOI 10.1021/ja902462q; Hohne M, 2008, CHEMBIOCHEM, V9, P363, DOI 10.1002/cbic.200700601; Huisman G.W., 2006, BIOCATALYSIS PHARM B, P717; Huisman GW, 2010, CURR OPIN CHEM BIOL, V14, P122, DOI 10.1016/j.cbpa.2009.12.003; Iwasaki A, 2006, APPL MICROBIOL BIOT, V69, P499, DOI 10.1007/s00253-005-0002-1; Johnson NB, 2007, ACCOUNTS CHEM RES, V40, P1291, DOI 10.1021/ar700114k; Kendall DM, 2009, EUR J INTERN MED, V20, pS329, DOI 10.1016/j.ejim.2009.05.009; Koszeleivski D, 2008, ANGEW CHEM INT EDIT, V47, P9337, DOI 10.1002/anie.200803763; Koszelewski D, 2009, EUR J ORG CHEM, V2009, P2289, DOI 10.1002/ejoc.200801265; Koszelewski D, 2008, ADV SYNTH CATAL, V350, P2761, DOI 10.1002/adsc.200800496; Liao J, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-16; Moore JC, 2007, ACCOUNTS CHEM RES, V40, P1412, DOI 10.1021/ar700167a; Shin JS, 2002, J ORG CHEM, V67, P2848, DOI 10.1021/jo016115i; Stutzman-Engwall K, 2005, METAB ENG, V7, P27, DOI 10.1016/j.ymben.2004.07.003; Truppo MD, 2009, CHEM COMMUN, P2127, DOI 10.1039/b902995h; Truppo MD, 2009, ORG BIOMOL CHEM, V7, P395, DOI 10.1039/b817730a; Williams-Herman Debora, 2008, BMC Endocr Disord, V8, P14, DOI 10.1186/1472-6823-8-14; Zhang JH, 1997, P NATL ACAD SCI USA, V94, P4504, DOI 10.1073/pnas.94.9.4504	26	1059	1117	29	784	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					305	309		10.1126/science.1188934	http://dx.doi.org/10.1126/science.1188934			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	625VW	20558668				2022-12-01	WOS:000279925900036
J	Schmid, MC; Mrowka, SW; Turchi, J; Saunders, RC; Wilke, M; Peters, AJ; Ye, FQ; Leopold, DA				Schmid, Michael C.; Mrowka, Sylwia W.; Turchi, Janita; Saunders, Richard C.; Wilke, Melanie; Peters, Andrew J.; Ye, Frank Q.; Leopold, David A.			Blindsight depends on the lateral geniculate nucleus	NATURE			English	Article							VISUAL RESPONSE PROPERTIES; SUPERIOR COLLICULUS; AREA MT; STRIATE CORTEX; MACAQUE MONKEY; GANGLION-CELLS; AFFERENT BASIS; PROJECTION; NEURONS; ACTIVATION	Injury to the primary visual cortex (V1) leads to the loss of visual experience. Nonetheless, careful testing shows that certain visually guided behaviours can persist even in the absence of visual awareness(1-4). The neural circuits supporting this phenomenon, which is often termed blindsight, remain uncertain(4). Here we demonstrate that the thalamic lateral geniculate nucleus (LGN) has a causal role in V1-independent processing of visual information. By comparing functional magnetic resonance imaging (fMRI) and behavioural measures with and without temporary LGN inactivation, we assessed the contribution of the LGN to visual functions of macaque monkeys (Macaca mulatta) with chronic V1 lesions. Before LGN inactivation, high-contrast stimuli presented to the lesion-affected visual field (scotoma) produced significant V1-independent fMRI activation in the extrastriate cortical areas V2, V3, V4, V5/middle temporal (MT), fundus of the superior temporal sulcus (FST) and lateral intraparietal area (LIP) and the animals correctly located the stimuli in a detection task. However, following reversible inactivation of the LGN in the V1-lesioned hemisphere, fMRI responses and behavioural detection were abolished. These results demonstrate that direct LGN projections to the extrastriate cortex have a critical functional contribution to blindsight. They suggest a viable pathway to mediate fast detection during normal vision.	[Schmid, Michael C.; Mrowka, Sylwia W.; Turchi, Janita; Saunders, Richard C.; Wilke, Melanie; Peters, Andrew J.; Leopold, David A.] NIMH, Neuropsychol Lab, Bethesda, MD 20892 USA; [Ye, Frank Q.; Leopold, David A.] NEI, Neurophysiol Imaging Facil, NIMH, NINDS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); NIH National Institute of Mental Health (NIMH); NIH National Institute of Neurological Disorders & Stroke (NINDS)	Schmid, MC (corresponding author), NIMH, Neuropsychol Lab, 49 Convent Dr, Bethesda, MD 20892 USA.	schmidmicha@gmail.com	Schmid, Michael Christoph/AAH-4835-2020; Schmid, Michael C./G-1867-2010	Schmid, Michael Christoph/0000-0003-1424-130X; Schmid, Michael C./0000-0003-1424-130X; Peters, Andrew/0000-0001-9351-1456; Leopold, David/0000-0002-1345-6360	NIMH; NINDS; NEI; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002838, ZICMH002899, ZIAMH002896] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Maier and D. McMahon for comments on the manuscript; S. Smirnakis, R. Berman, R. Wurtz, B. Richmond, S. Guderian and M. Fukushima for discussions; C. Zhu and H. Merkle for magnetic resonance coil construction; K. Smith, N. Phipps, J. Yu, G. Dold, D. Ide and T. Talbot for technical assistance; D. Sheinberg for developing visual stimulation software; and members of the Brian Wandell laboratory for developing and sharing mrVista software. This work was supported by the Intramural Research Programme of the NIMH, the NINDS, and the NEI.	Baseler HA, 1999, J NEUROSCI, V19, P2619; BENDER DB, 1983, BRAIN RES, V279, P258, DOI 10.1016/0006-8993(83)90188-9; Berman RA, 2010, J NEUROSCI, V30, P6342, DOI 10.1523/JNEUROSCI.6176-09.2010; Brewer AA, 2002, J NEUROSCI, V22, P10416; Bridge H, 2008, BRAIN, V131, P1433, DOI 10.1093/brain/awn063; BULLIER J, 1983, EXP BRAIN RES, V53, P168; CAMPION J, 1983, BEHAV BRAIN SCI, V6, P423, DOI 10.1017/S0140525X00016861; Collins CE, 2003, J NEUROSCI, V23, P2251; Cope DW, 2005, J NEUROSCI, V25, P11553, DOI 10.1523/JNEUROSCI.3362-05.2005; COWEY A, 1989, EXP BRAIN RES, V75, P631, DOI 10.1007/bf00249914; COWEY A, 1989, NEUROSCIENCE, V29, P65, DOI 10.1016/0306-4522(89)90333-3; COWEY A, 1995, NATURE, V373, P247, DOI 10.1038/373247a0; Cowey A, 1997, NEUROPSYCHOLOGIA, V35, P929, DOI 10.1016/S0028-3932(97)00021-3; Cowey A, 2010, EXP BRAIN RES, V200, P3, DOI 10.1007/s00221-009-1914-2; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; DIAMOND IT, 1969, SCIENCE, V164, P251, DOI 10.1126/science.164.3877.251; Goebel R, 2001, VISION RES, V41, P1459, DOI 10.1016/S0042-6989(01)00069-4; HARTING JK, 1991, J COMP NEUROL, V304, P275, DOI 10.1002/cne.903040210; KEATING EG, 1980, BRAIN RES, V187, P271, DOI 10.1016/0006-8993(80)90203-6; Lyon DC, 2010, NEURON, V65, P270, DOI 10.1016/j.neuron.2010.01.003; MAUNSELL JHR, 1990, J NEUROSCI, V10, P3323; McAnany JJ, 2007, VISION RES, V47, P2327, DOI 10.1016/j.visres.2007.05.013; MOHLER CW, 1977, J NEUROPHYSIOL, V40, P74, DOI 10.1152/jn.1977.40.1.74; RODMAN HR, 1989, J NEUROSCI, V9, P2033; RODMAN HR, 1990, J NEUROSCI, V10, P1154; SCHILLER PH, 1990, NATURE, V343, P68, DOI 10.1038/343068a0; Schmid MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005527; Sincich LC, 2004, NAT NEUROSCI, V7, P1123, DOI 10.1038/nn1318; Stepniewska I, 1999, EUR J NEUROSCI, V11, P469, DOI 10.1046/j.1460-9568.1999.00461.x; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709	30	224	227	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					373	377		10.1038/nature09179	http://dx.doi.org/10.1038/nature09179			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20574422	Green Accepted			2022-12-01	WOS:000279867100050
J	Trivedi, B				Trivedi, Bijal			The primate connection	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S5	S5		10.1038/nature09236	http://dx.doi.org/10.1038/nature09236			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631704	Bronze			2022-12-01	WOS:000279867100025
J	Willyard, C				Willyard, Cassandra			Tiny steps towards an HIV vaccine	NATURE			English	Editorial Material							MONKEYS; INFECTION; RESPONSES											Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746	5	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S8	S8		10.1038/nature09238	http://dx.doi.org/10.1038/nature09238			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631706				2022-12-01	WOS:000279867100027
J	Loewer, A; Batchelor, E; Gaglia, G; Lahav, G				Loewer, Alexander; Batchelor, Eric; Gaglia, Giorgio; Lahav, Galit			Basal Dynamics of p53 Reveal Transcriptionally Attenuated Pulses in Cycling Cells	CELL			English	Article							P53-MDM2 FEEDBACK LOOP; DNA-DAMAGE; HISTONE H2AX; ACETYLATION; ATM; PHOSPHATASE; PATHWAY; KINASE; WIP1; PHOSPHORYLATION	The tumor suppressor p53 is activated by stress and leads to cellular outcomes such as apoptosis and cell-cycle arrest. Its activation must be highly sensitive to ensure that cells react appropriately to damage. However, proliferating cells often encounter transient damage during normal growth, where cell-cycle arrest or apoptosis may be unfavorable. How does the p53 pathway achieve the right balance between high sensitivity and tolerance to intrinsic damage? Using quantitative time-lapse microscopy of individual human cells, we found that proliferating cells show spontaneous pulses of p53, which are triggered by an excitable mechanism during cell-cycle phases associated with intrinsic DNA damage. However, in the absence of sustained damage, posttranslational modifications keep p53 inactive, preventing it from inducing p21 expression and cell-cycle arrest. Our approach of quantifying basal dynamics in individual cells can now be used to study how other pathways in human cells achieve sensitivity in noisy environments.	[Loewer, Alexander; Batchelor, Eric; Gaglia, Giorgio; Lahav, Galit] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Lahav, G (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	galit@hms.harvard.edu	Loewer, Alexander/AAL-6943-2021	Loewer, Alexander/0000-0002-8819-3040; Batchelor, Eric/0000-0003-3870-5615	National Institutes of Health [GM083303]; German Research Foundation; Charles A. King Trust; American Cancer Society; P. and E. Taft Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [ZIABC011382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); Charles A. King Trust; American Cancer Society(American Cancer Society); P. and E. Taft Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Hornung and M. Oren for the p21 reporter construct; T. Mitchison for the Lamin A/C antibody and for comments; K. Janes and J. Brugge for MCF10A; B. Vogelstein for HCT p53<SUP>-/-</SUP>; S. Elledge for RPE-hTERT and R. Agami for MCF7+p53shRNA cell lines; O. Gozani and E. Appella for antibodies; Martin Tenniswood for help with obtaining JW1521; J. Alzate and M. DiBona for technical assistance; J. Waters (Nikon Imaging Center at Harvard Medical School) for advice on live-cell imaging; and J. Paulsson, U. Alon, Y. Pilpel, M. Springer, B. Ward, M. Jain, and S. Loewer for comments and discussions. This research was supported by National Institutes of Health grant GM083303. A.L. was supported by fellowships from the German Research Foundation and the Charles A. King Trust. E.B. was supported by the American Cancer Society, P. and E. Taft Postdoctoral Fellowship.	Adams CJ, 2008, EMBO REP, V9, P1222, DOI 10.1038/embor.2008.186; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Dart DA, 2004, J BIOL CHEM, V279, P16433, DOI 10.1074/jbc.M314212200; Demonacos C, 2004, NAT CELL BIOL, V6, P968, DOI 10.1038/ncb1170; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huang LC, 1996, P NATL ACAD SCI USA, V93, P4827, DOI 10.1073/pnas.93.10.4827; Ichijima Y, 2005, BIOCHEM BIOPH RES CO, V336, P807, DOI 10.1016/j.bbrc.2005.08.164; Ivanov GS, 2007, MOL CELL BIOL, V27, P6756, DOI 10.1128/MCB.00460-07; Kaku S, 2001, NUCLEIC ACIDS RES, V29, P1989, DOI 10.1093/nar/29.9.1989; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Li AG, 2007, MOL CELL, V28, P408, DOI 10.1016/j.molcel.2007.09.006; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Roy S, 2005, CELL DEATH DIFFER, V12, P482, DOI 10.1038/sj.cdd.4401581; Roy S, 2007, J BIOL CHEM, V282, P4765, DOI 10.1074/jbc.M609588200; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; SHILOH Y, 1983, CARCINOGENESIS, V4, P1317, DOI 10.1093/carcin/4.10.1317; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Sigal A, 2006, NAT METHODS, V3, P525, DOI 10.1038/NMETH892; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Tanaka T, 2006, CELL CYCLE, V5, P1940, DOI 10.4161/cc.5.17.3191; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Toettcher JE, 2009, P NATL ACAD SCI USA, V106, P785, DOI 10.1073/pnas.0806196106; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vassilev LT, 2006, CELL CYCLE, V5, P2555, DOI 10.4161/cc.5.22.3463; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126	51	178	184	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2010	142	1					89	100		10.1016/j.cell.2010.05.031	http://dx.doi.org/10.1016/j.cell.2010.05.031			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20598361	Green Accepted, Bronze			2022-12-01	WOS:000279637300015
J	Cuello, LG; Jogini, V; Cortes, DM; Perozo, E				Cuello, Luis G.; Jogini, Vishwanath; Cortes, D. Marien; Perozo, Eduardo			Structural mechanism of C-type inactivation in K+ channels	NATURE			English	Article							SHAKER POTASSIUM CHANNELS; SELECTIVITY FILTER; SLOW INACTIVATION; ION CONDUCTION; TETRAETHYLAMMONIUM BLOCKADE; CRYSTAL-STRUCTURE; OPEN STATE; KCSA; PORE; MUTATIONS	Interconversion between conductive and non-conductive forms of the K+ channel selectivity filter underlies a variety of gating events, from flicker transitions (at the microsecond timescale) to C-type inactivation (millisecond to second timescale). Here we report the crystal structure of the Streptomyces lividans K+ channel KcsA in its open-inactivated conformation and investigate the mechanism of C-type inactivation gating at the selectivity filter from channels 'trapped' in a series of partially open conformations. Five conformer classes were identified with openings ranging from 12 angstrom in closed KcsA (C alpha-C alpha distances at Thr 112) to 32 angstrom when fully open. They revealed a remarkable correlation between the degree of gate opening and the conformation and ion occupancy of the selectivity filter. We show that a gradual filter backbone reorientation leads first to a loss of the S2 ion binding site and a subsequent loss of the S3 binding site, presumably abrogating ion conduction. These structures indicate a molecular basis for C-type inactivation in K+ channels.	[Perozo, Eduardo] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Perozo, E (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.	eperozo@uchicago.edu			NIH [R01-GM57846]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057846] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Bezanilla, B. Roux, H. Mchaourab and R. Nakamoto for discussions and comments on the manuscript. K. Locher for comments on the manuscripts. R. Mackinnon provided the Fab-expressing hybridoma cells. We also thank S. Chakrapani, J. Cordero-Morales, J. Santos, S. Uysal, O. Dalmas and the members of the Perozo laboratory for discussions and comments on the manuscript. We are thankful to K. R. Rajashankar, R. Sanishvili and the staff at the NE-CAT 24ID and GM-CA 23ID beamlines at the Advanced Photon Source, Argonne National Laboratory. This work was supported in part by NIH grant R01-GM57846 and by a gift from the Palmer family.	Ader C, 2009, J AM CHEM SOC, V131, P170, DOI 10.1021/ja806306e; Alagem N, 2003, BIOPHYS J, V85, P300, DOI 10.1016/S0006-3495(03)74475-0; Alam A, 2009, NAT STRUCT MOL BIOL, V16, P30, DOI 10.1038/nsmb.1531; Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; Baker KA, 2007, NAT STRUCT MOL BIOL, V14, P1089, DOI 10.1038/nsmb1311; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; BEZANILLA F, 1972, J GEN PHYSIOL, V60, P588, DOI 10.1085/jgp.60.5.588; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chakrapani S, 2007, J GEN PHYSIOL, V130, P465, DOI 10.1085/jgp.200709843; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Cortes DM, 1997, BIOCHEMISTRY-US, V36, P10343, DOI 10.1021/bi971018y; Cuello LG, 2010, FEBS LETT, V584, P1133, DOI 10.1016/j.febslet.2010.02.015; Cuello LG, 2010, FEBS LETT, V584, P1126, DOI 10.1016/j.febslet.2010.02.003; DELCOUR AH, 1989, BIOPHYS J, V56, P631, DOI 10.1016/S0006-3495(89)82710-9; Domene C, 2008, J AM CHEM SOC, V130, P9474, DOI 10.1021/ja801792g; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; Kiss L, 1998, BIOPHYS J, V74, P1840, DOI 10.1016/S0006-3495(98)77894-4; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kurata HT, 2006, PROG BIOPHYS MOL BIO, V92, P185, DOI 10.1016/j.pbiomolbio.2005.10.001; Levy DI, 1996, BIOPHYS J, V70, P798, DOI 10.1016/S0006-3495(96)79619-4; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Liu YS, 2001, NAT STRUCT BIOL, V8, P883, DOI 10.1038/nsb1001-883; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Loots E, 1998, J GEN PHYSIOL, V112, P377, DOI 10.1085/jgp.112.4.377; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; Lu T, 2001, NAT NEUROSCI, V4, P239, DOI 10.1038/85080; Molina A, 1997, J PHYSIOL-LONDON, V499, P361, DOI 10.1113/jphysiol.1997.sp021933; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Noskov SY, 2004, NATURE, V431, P830, DOI 10.1038/nature02943; Ogielska EM, 1999, J GEN PHYSIOL, V113, P347, DOI 10.1085/jgp.113.2.347; Olcese R, 1997, J GEN PHYSIOL, V110, P579, DOI 10.1085/jgp.110.5.579; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panyi G, 2006, J GEN PHYSIOL, V128, P547, DOI 10.1085/jgp.200609644; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Piskorowski RA, 2006, J GEN PHYSIOL, V127, P557, DOI 10.1085/jgp.200509482; Proks P, 2001, J GEN PHYSIOL, V118, P341, DOI 10.1085/jgp.118.4.341; Schlief T, 1996, PFLUG ARCH EUR J PHY, V431, P483, DOI 10.1007/BF02191894; Starkus JG, 1997, J GEN PHYSIOL, V110, P539, DOI 10.1085/jgp.110.5.539; Takeuchi K, 2007, J BIOL CHEM, V282, P15179, DOI 10.1074/jbc.M608264200; Thompson AN, 2008, P NATL ACAD SCI USA, V105, P6900, DOI 10.1073/pnas.0800873105; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	53	352	356	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					203	U73		10.1038/nature09153	http://dx.doi.org/10.1038/nature09153			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613835	Green Accepted			2022-12-01	WOS:000279580800029
J	London, M; Roth, A; Beeren, L; Hausser, M; Latham, PE				London, Michael; Roth, Arnd; Beeren, Lisa; Haeusser, Michael; Latham, Peter E.			Sensitivity to perturbations in vivo implies high noise and suggests rate coding in cortex	NATURE			English	Article							PYRAMIDAL NEURONS; VISUAL-CORTEX; NETWORKS; PRECISION; MODEL; COMPUTATION; DENDRITES; NEOCORTEX; PATTERNS; SYSTEMS	It is well known that neural activity exhibits variability, in the sense that identical sensory stimuli produce different responses(1-3), but it has been difficult to determine what this variability means. Is it noise, or does it carry important information-about, for example, the internal state of the organism? Here we address this issue from the bottom up, by asking whether small perturbations to activity in cortical networks are amplified. Based on in vivo whole-cell patch-clamp recordings in rat barrel cortex, we find that a perturbation consisting of a single extra spike in one neuron produces approximately 28 additional spikes in its postsynaptic targets. We also show, using simultaneous intra-and extracellular recordings, that a single spike in a neuron produces a detectable increase in firing rate in the local network. Theoretical analysis indicates that this amplification leads to intrinsic, stimulus-independent variations in membrane potential of the order of +/- 2.2-4.5 mV-variations that are pure noise, and so carry no information at all. Therefore, for the brain to perform reliable computations, it must either use a rate code, or generate very large, fast depolarizing events, such as those proposed by the theory of synfire chains(4,5). However, in our in vivo recordings, we found that such events were very rare. Our findings are thus consistent with the idea that cortex is likely to use primarily a rate code.	[Latham, Peter E.] UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England; [London, Michael; Roth, Arnd; Beeren, Lisa; Haeusser, Michael] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [London, Michael; Roth, Arnd; Beeren, Lisa; Haeusser, Michael] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Latham, PE (corresponding author), UCL, Gatsby Computat Neurosci Unit, Queen Sq, London WC1N 3AR, England.	pel@gatsby.ucl.ac.uk	London, Michael/B-4175-2010; Hausser, Michael/AAW-6827-2020	London, Michael/0000-0001-5137-1707; Hausser, Michael/0000-0002-2673-8957; Roth, Arnd/0000-0003-0325-4287	Gatsby Charitable Foundation; US National Institute of Mental Health [R01 MH62447]; Wellcome Trust; Engineering and Physical Sciences Research Council; Medical Research Council; MRC [G0500244] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/C010841/1] Funding Source: researchfish; Medical Research Council [G0500244] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062447] Funding Source: NIH RePORTER	Gatsby Charitable Foundation; US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome Trust); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank P. Dayan for discussions, I. van Welie and P. Dayan for comments on the manuscript, and H. Cuntz for comments on the spike detection algorithm. P. E. L. was supported by the Gatsby Charitable Foundation and US National Institute of Mental Health grant R01 MH62447. M. L., A. R., L. B. and M. H. were supported by the Wellcome Trust, the Gatsby Charitable Foundation, the Engineering and Physical Sciences Research Council and the Medical Research Council.	Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Arabzadeh E, 2006, J NEUROSCI, V26, P9216, DOI 10.1523/JNEUROSCI.1491-06.2006; Ariav G, 2003, J NEUROSCI, V23, P7750; Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; Banerjee A, 2008, NEURAL COMPUT, V20, P974, DOI 10.1162/neco.2008.05-06-206; Barbour B, 2007, TRENDS NEUROSCI, V30, P622, DOI 10.1016/j.tins.2007.09.005; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Braitenberg V, 1991, ANATOMY CORTEX; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Hausser M, 1997, J NEUROSCI, V17, P7606; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; Herrmann A, 2001, J COMPUT NEUROSCI, V11, P135, DOI 10.1023/A:1012841516004; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Latham PE, 2000, J NEUROPHYSIOL, V83, P808, DOI 10.1152/jn.2000.83.2.808; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Richardson MJE, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021919; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P132, DOI 10.1152/jn.1987.57.1.132; SMALE S, 1967, B AM MATH SOC, V73, P747, DOI 10.1090/S0002-9904-1967-11798-1; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310	35	268	270	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 1	2010	466	7302					123	U142		10.1038/nature09086	http://dx.doi.org/10.1038/nature09086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596024	Green Accepted			2022-12-01	WOS:000279343800047
J	Patenaude, G				Patenaude, Genevieve			Climate class for business schools	NATURE			English	Editorial Material									Univ Edinburgh, Sch Geosci, Edinburgh EH8 9XP, Midlothian, Scotland	University of Edinburgh	Patenaude, G (corresponding author), Univ Edinburgh, Sch Geosci, Edinburgh EH8 9XP, Midlothian, Scotland.	genevieve.patenaude@ed.ac.uk	Patenaude, Genevieve/F-3115-2010	Patenaude, Genevieve/0000-0001-7552-7470				*ASP I, GREY PINSTR 2009 201, P23114; Boykoff MT, 2004, GLOBAL ENVIRON CHANG, V14, P125, DOI 10.1016/j.gloenvcha.2003.10.001; *EC COM, WHICH MBA 2009 FULL, P23114; Felicelli M., 2008, 2008 ROUTE TOP; Goodall AH, 2008, J MANAGE INQUIRY, V17, P408, DOI 10.1177/1056492607311930; *PRICEWATERHOUSECO, 2009, GLOB 500 REP, P23114; Rogers E. M, 2003, DIFFUSION INNOVATION, V5th; *UNFCCC, GREENH GAS INV DAT 2, P23114	8	11	11	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 1	2010	466	7302					30	30		10.1038/466030a	http://dx.doi.org/10.1038/466030a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	618HW	20595996				2022-12-01	WOS:000279343800020
J	Seligman, HK; Schillinger, D				Seligman, Hilary K.; Schillinger, Dean			Hunger and Socioeconomic Disparities in Chronic Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FOOD INSECURITY		[Seligman, Hilary K.; Schillinger, Dean] Univ Calif San Francisco, Ctr Vulnerable Populat, San Francisco, CA 94143 USA; [Seligman, Hilary K.; Schillinger, Dean] San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA 94110 USA; [Schillinger, Dean] Univ Calif San Francisco, Inst Hlth & Aging, San Francisco, CA 94143 USA; [Schillinger, Dean] Calif Dept Publ Hlth, Calif Diabet Program, Sacramento, CA USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; California Department of Public Health	Seligman, HK (corresponding author), Univ Calif San Francisco, Ctr Vulnerable Populat, San Francisco, CA 94143 USA.							Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Nelson K, 2001, J GEN INTERN MED, V16, P404, DOI 10.1046/j.1525-1497.2001.016006404.x; Nord M., 2009, HOUSEHOLD FOOD SECUR; Seligman HK, 2007, J GEN INTERN MED, V22, P1018, DOI 10.1007/s11606-007-0192-6; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573	5	267	275	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2010	363	1					6	9		10.1056/NEJMp1000072	http://dx.doi.org/10.1056/NEJMp1000072			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	618HR	20592297				2022-12-01	WOS:000279343000003
J	Huh, D; Matthews, BD; Mammoto, A; Montoya-Zavala, M; Hsin, HY; Ingber, DE				Huh, Dongeun; Matthews, Benjamin D.; Mammoto, Akiko; Montoya-Zavala, Martin; Hsin, Hong Yuan; Ingber, Donald E.			Reconstituting Organ-Level Lung Functions on a Chip	SCIENCE			English	Article							HUMAN ENDOTHELIAL-CELLS; IN-VITRO MODEL; SILICA NANOPARTICLES; CULTURE; BARRIER; MECHANISMS; SYSTEMS; TISSUE; TOXICITY; CHANNELS	Here, we describe a biomimetic microsystem that reconstitutes the critical functional alveolar-capillary interface of the human lung. This bioinspired microdevice reproduces complex integrated organ-level responses to bacteria and inflammatory cytokines introduced into the alveolar space. In nanotoxicology studies, this lung mimic revealed that cyclic mechanical strain accentuates toxic and inflammatory responses of the lung to silica nanoparticles. Mechanical strain also enhances epithelial and endothelial uptake of nanoparticulates and stimulates their transport into the underlying microvascular channel. Similar effects of physiological breathing on nanoparticle absorption are observed in whole mouse lung. Mechanically active "organ-on-a-chip" microdevices that reconstitute tissue-tissue interfaces critical to organ function may therefore expand the capabilities of cell culture models and provide low-cost alternatives to animal and clinical studies for drug screening and toxicology applications.	[Huh, Dongeun; Montoya-Zavala, Martin; Ingber, Donald E.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Huh, Dongeun; Matthews, Benjamin D.; Mammoto, Akiko; Montoya-Zavala, Martin; Hsin, Hong Yuan; Ingber, Donald E.] Childrens Hosp, Dept Pathol, Vasc Biol Program, Boston, MA 02115 USA; [Huh, Dongeun; Matthews, Benjamin D.; Mammoto, Akiko; Montoya-Zavala, Martin; Hsin, Hong Yuan; Ingber, Donald E.] Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Huh, Dongeun; Matthews, Benjamin D.; Mammoto, Akiko; Montoya-Zavala, Martin; Hsin, Hong Yuan; Ingber, Donald E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Matthews, Benjamin D.] Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Ingber, Donald E.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University	Ingber, DE (corresponding author), Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA.	don.ingber@wyss.harvard.edu	Huh, Dong Eun/J-5715-2012; Huh, Dongeun/I-4152-2013; Ingber, Donald E/AAC-5894-2019		NIH [R01-ES016665]; American Heart Association [0835618D]; Department of Defense [W81XWH-05-1-0115]; Wyss Institute for Biologically Inspired Engineering at Harvard University; Wyss Technology Development Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016665] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Department of Defense(United States Department of Defense); Wyss Institute for Biologically Inspired Engineering at Harvard University; Wyss Technology Development Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank C. K. Thodeti for his help with ROS assays; G. M. Whitesides and P. Cherukuri for providing carbon nanotubes, gold nanoparticles, and helpful comments; N. Korin for helpful discussions; R. Ruch for providing alveolar epithelial cells; R. Mannix for his imaging assistance; and M. Butte for help with neutrophil isolation. This work was supported by grants from NIH (R01-ES016665), the American Heart Association (0835618D), the Department of Defense (W81XWH-05-1-0115), and the Wyss Institute for Biologically Inspired Engineering at Harvard University; D. H. is a recipient of a Wyss Technology Development Fellowship, and D. E. I. is a recipient of a Department of Defense Breast Cancer Innovator Award. A patent on the device described is pending.	Baudoin R, 2007, BIOTECHNOL PROGR, V23, P1245, DOI 10.1021/bp0603513; Bilek AM, 2003, J APPL PHYSIOL, V94, P770, DOI 10.1152/japplphysiol.00764.2002; Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002; Carraro A, 2008, BIOMED MICRODEVICES, V10, P795, DOI 10.1007/s10544-008-9194-3; Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875; Davila JC, 1998, ANNU REV PHARMACOL, V38, P63, DOI 10.1146/annurev.pharmtox.38.1.63; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Frerking I, 2001, INTENS CARE MED, V27, P1699, DOI 10.1007/s00134-001-1121-5; Harris SG, 2003, BIOTECHNOL BIOPROC E, V8, P246, DOI 10.1007/BF02942273; Hermanns MI, 2009, CELL TISSUE RES, V336, P91, DOI 10.1007/s00441-008-0750-1; Huh D, 2007, P NATL ACAD SCI USA, V104, P18886, DOI 10.1073/pnas.0610868104; IBA T, 1991, MICROVASC RES, V42, P245, DOI 10.1016/0026-2862(91)90059-K; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Jang K, 2008, ANAL BIOANAL CHEM, V390, P825, DOI 10.1007/s00216-007-1752-7; Jang KJ, 2010, LAB CHIP, V10, P36, DOI 10.1039/b907515a; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Kim KJ, 2003, AM J PHYSIOL-LUNG C, V284, pL247, DOI 10.1152/ajplung.00235.2002; Lam MT, 2009, BIOMATERIALS, V30, P1150, DOI 10.1016/j.biomaterials.2008.11.014; Lee PJ, 2007, BIOTECHNOL BIOENG, V97, P1340, DOI 10.1002/bit.21360; Lin WS, 2006, TOXICOL APPL PHARM, V217, P252, DOI 10.1016/j.taap.2006.10.004; Mahler GJ, 2009, BIOTECHNOL BIOENG, V104, P193, DOI 10.1002/bit.22366; Merget R, 2002, ARCH TOXICOL, V75, P625, DOI 10.1007/S002040100266; Meyvantsson I, 2008, ANNU REV ANAL CHEM, V1, P423, DOI 10.1146/annurev.anchem.1.031207.113042; Mills NL, 2009, NAT CLIN PRACT CARD, V6, P36, DOI 10.1038/ncpcardio1399; Napierska D, 2009, SMALL, V5, P846, DOI 10.1002/smll.200800461; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Powers MJ, 2002, BIOTECHNOL BIOENG, V78, P257, DOI 10.1002/bit.10143; Shin M, 2004, BIOMED MICRODEVICES, V6, P269, DOI 10.1023/B:BMMD.0000048559.29932.27; SILL HW, 1995, AM J PHYSIOL-HEART C, V268, pH535, DOI 10.1152/ajpheart.1995.268.2.H535; Sin A, 2004, BIOTECHNOL PROGR, V20, P338, DOI 10.1021/bp034077d; Song JW, 2005, ANAL CHEM, V77, P3993, DOI 10.1021/ac050131o; Takayama S, 2001, ADV MATER, V13, P570, DOI 10.1002/1521-4095(200104)13:8<570::AID-ADMA570>3.0.CO;2-B; Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930; Wagner JG, 2000, PHARMACOL REV, V52, P349; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; WONG D, 1992, J NEUROIMMUNOL, V39, P11, DOI 10.1016/0165-5728(92)90170-P; Zhang C, 2009, LAB CHIP, V9, P3185, DOI 10.1039/b915147h	41	2264	2370	83	1678	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1662	1668		10.1126/science.1188302	http://dx.doi.org/10.1126/science.1188302			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576885	Green Accepted			2022-12-01	WOS:000279107400035
J	Petherick, A				Petherick, Anna			Campaigning for Chagas disease	NATURE			English	Editorial Material																			0	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					S21	S22		10.1038/nature09227	http://dx.doi.org/10.1038/nature09227			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20571551	Bronze			2022-12-01	WOS:000279056900031
J	Mayr, FB; Yende, S; Linde-Zwirble, WT; Peck-Palmer, OM; Barnato, AE; Weissfeld, LA; Angus, DC				Mayr, Florian B.; Yende, Sachin; Linde-Zwirble, Walter T.; Peck-Palmer, Octavia M.; Barnato, Amber E.; Weissfeld, Lisa A.; Angus, Derek C.			Infection Rate and Acute Organ Dysfunction Risk as Explanations for Racial Differences in Severe Sepsis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; EPIDEMIOLOGY; DISEASES; OUTCOMES; ADULTS; CARE	Context Severe sepsis, defined as infection complicated by acute organ dysfunction, occurs more frequently and leads to more deaths in black than in white individuals. The optimal approach to minimize these disparities is unclear. Objective To determine the extent to which higher severe sepsis rates in black than in white patients are due to higher infection rates or to a higher risk of acute organ dysfunction. Design, Setting, and Participants Analysis of infection-related hospitalizations from the 2005 hospital discharge data of 7 US states and infection-related emergency department visits from the 2003-2007 National Hospital Ambulatory Care Survey. Main Outcome Measure Age-and sex-standardized severe sepsis and infection hospitalization rates and the risk of acute organ dysfunction. Results Of 8 661 227 non-childbirth-related discharges, 2 261 857 were associated with an infection, and of these, 381 787 (16.8%) had severe sepsis. Black patients had a 67% higher age-and sex-standardized severe sepsis rate than did white patients (9.4; 95% confidence interval [CI], 9.3-9.5 vs 5.6; 95% CI, 5.6-5.6 per 1000 population; P<.001) and 80% higher standardized mortality (1.8, 95% CI, 1.8-1.9 vs 1.0, 95% CI, 1.0-1.1 per 1000 population; P<.001). The higher severe sepsis rate was explained by both a higher infection rate in black patients (47.3; 95% CI, 47.1-47.4 vs 34.0; 95% CI, 33.9-34.0 per 1000 population; incidence rate ratio, 1.39; P<.001) and a higher risk of developing acute organ dysfunction (age-and sex-adjusted odds ratio [OR], 1.29; 95% CI, 1.27-1.30; P<.001). Differences in infection presented broadly across different sites and etiology of infection and for community-and hospital-acquired infections and occurred despite a lower likelihood of being admitted for infection from the emergency department (adjusted OR, 0.70; 95% CI, 0.64-0.76; P<.001). The higher risk of organ dysfunction persisted but was attenuated after adjusting for age, sex, comorbid conditions, poverty, and hospital effect (OR, 1.14; 95% CI, 1.13-1.16; P<.001). Racial disparities in infection and severe sepsis incidence and mortality rates were largest among younger adults (eg, the proportion of invasive pneumococcal disease occurring in adults <65 years was 73.9% among black patients vs 44.5% among white patients, P<.001). Conclusion Racial differences in severe sepsis are explained by both a higher infection rate and a higher risk of acute organ dysfunction in black than in white individuals. JAMA. 2010; 303(24): 2495-2503	[Yende, Sachin] Univ Pittsburgh, Dept Crit Care Med, CRISMA Lab, Pittsburgh, PA 15261 USA; [Mayr, Florian B.; Yende, Sachin; Linde-Zwirble, Walter T.; Peck-Palmer, Octavia M.; Barnato, Amber E.; Angus, Derek C.] Univ Pittsburgh, Clin Res Invest & Syst Modeling Acute Illness Lab, Pittsburgh, PA 15261 USA; [Peck-Palmer, Octavia M.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [Barnato, Amber E.] Univ Pittsburgh, Ctr Res Hlth Care, Pittsburgh, PA 15261 USA; [Weissfeld, Lisa A.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Linde-Zwirble, Walter T.] ZD Associates, Perkasie, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yende, S (corresponding author), Univ Pittsburgh, Dept Crit Care Med, CRISMA Lab, 642A Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	yendes@upmc.edu	Angus, Derek C/E-9671-2012		National Institutes of Health [T32 HL007820-10, K23GM083215]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM083215] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr Mayr was supported by grant T32 HL007820-10, and Dr Yende was supported by grant K23GM083215 both from the National Institutes of Health.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2000, JAMA-J AM MED ASSOC, V283, P1723, DOI 10.1001/jama.283.13.1723; [Anonymous], NATL HOSP AMBULATORY; BAMATO AE, 2008, AM J RESP CRIT CARE, V177, P279; BRANCATI FL, 1992, JAMA-J AM MED ASSOC, V268, P3079, DOI 10.1001/jama.268.21.3079; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; CARRIERE KC, 1994, AM J EPIDEMIOL, V140, P472, DOI 10.1093/oxfordjournals.aje.a117269; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dowd JB, 2009, SOC SCI MED, V68, P699, DOI 10.1016/j.socscimed.2008.12.010; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Ferwerda B, 2009, P NATL ACAD SCI USA, V106, P10272, DOI 10.1073/pnas.0811273106; Jackson LA, 2008, CLIN INFECT DIS, V47, P1328, DOI 10.1086/592691; JOLLIS JG, 1993, ANN INTERN MED, V119, P844, DOI 10.7326/0003-4819-119-8-199310150-00011; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Laterre PF, 2005, CRIT CARE MED, V33, P952, DOI 10.1097/01.CCM.0000162381.24074.D7; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Liu JH, 2003, ARCH SURG-CHICAGO, V138, P1106, DOI 10.1001/archsurg.138.10.1106; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mayr FB, 2010, CRIT CARE MED, V38, P759, DOI 10.1097/CCM.0b013e3181c8fd58; Morse DL, 2009, ANN INTERN MED, V150, P40, DOI 10.7326/0003-4819-150-1-200901060-00008; Mrus JM, 2005, CRIT CARE, V9, pR623, DOI 10.1186/cc3811; OBRIEN TR, 1989, JAMA-J AM MED ASSOC, V262, P1485, DOI 10.1001/jama.262.11.1485; READE MC, 2009, SEPSIS NONINFECTIOUS; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979; Yang HL, 2008, SINGAP MED J, V49, P441; Zajacova A, 2009, J GERONTOL A-BIOL, V64, P272, DOI 10.1093/gerona/gln012	27	163	175	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2010	303	24					2495	2503		10.1001/jama.2010.851	http://dx.doi.org/10.1001/jama.2010.851			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	613VM	20571016	Bronze, Green Accepted			2022-12-01	WOS:000279010900027
J	Cykert, S; Dilworth-Anderson, P; Monroe, MH; Walker, P; McGuire, FR; Corbie-Smith, G; Edwards, LJ; Bunton, AJ				Cykert, Samuel; Dilworth-Anderson, Peggye; Monroe, Michael H.; Walker, Paul; McGuire, Franklin R.; Corbie-Smith, Giselle; Edwards, Lloyd J.; Bunton, Audrina Jones			Factors Associated With Decisions to Undergo Surgery Among Patients With Newly Diagnosed Early-Stage Lung Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICIAN COMMUNICATION; RACIAL DISPARITIES; SURGICAL RESECTION; AFRICAN-AMERICANS; CARE; SURVIVAL; RACE; PREDICTION; EDUCATION; QUALITY	Context Lung cancer is the leading cause of cancer death in the United States. Surgical resection for stage I or II non-small cell cancer remains the only reliable treatment for cure. Patients who do not undergo surgery have a median survival of less than 1 year. Despite the survival disadvantage, many patients with early-stage disease do not receive surgical care and rates are even lower for black patients. Objectives To identify potentially modifiable factors regarding surgery in patients newly diagnosed with early-stage lung cancer and to explore why blacks undergo surgery less often than whites. Design, Setting, and Patients Prospective cohort study with patients identified by pulmonary, oncology, thoracic surgery, and generalist practices in 5 communities through study referral or computerized tomography review protocol. A total of 437 patients with biopsy-proven or probable early-stage lung cancer were enrolled between December 2005 and December 2008. Before establishment of treatment plans, patients were administered a survey including questions about trust, patient-physician communication, attitudes toward cancer, and functional status. Information about comorbid illnesses was obtained through chart audits. Main Outcome Measure Lung cancer surgery within 4 months of diagnosis. Results A total of 386 patients met full eligibility criteria for lung resection surgery. The median age was 66 years (range, 26-90 years) and 29% of patients were black. The surgical rate was 66% for white patients (n=179/273) compared with 55% for black patients (n=62/113; P=.05). Negative perceptions of patient-physician communication manifested by a 5-point decrement on a 25-point communication scale (odds ratio [OR], 0.42; 95% confidence interval [CI], 0.32-0.74) and negative perception of 1-year prognosis postsurgery (OR, 0.27; 95% CI, 0.14-0.50; absolute risk, 34%) were associated with decisions against surgery. Surgical rates for blacks were particularly low when they had 2 or more comorbid illnesses (13% vs 62% for <2 comorbidities; OR, 0.04 [95% CI, 0.01-0.25]; absolute risk, 49%) and when blacks lacked a regular source of care (42% with no regular care vs 57% with regular care; OR, 0.20 [95% CI, 0.10-0.43]; absolute risk, 15%). Conclusions A decision not to undergo surgery by patients with newly diagnosed lung cancer was independently associated with perceptions of communication and prognosis, older age, multiple comorbidities, and black race. Interventions to optimize surgery should consider these factors. JAMA. 2010; 303(23): 2368-2376	[Cykert, Samuel; Corbie-Smith, Giselle; Edwards, Lloyd J.; Bunton, Audrina Jones] Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA; [Cykert, Samuel; Corbie-Smith, Giselle] Univ N Carolina, Sch Med, Div Gen Internal Med & Clin Epidemiol, Chapel Hill, NC USA; [Dilworth-Anderson, Peggye] Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC USA; [Dilworth-Anderson, Peggye] Univ N Carolina, UNC Inst Aging, Chapel Hill, NC USA; [Edwards, Lloyd J.] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Cykert, Samuel] Greensboro Area Hlth Educ Ctr, Moses Cone Hlth Syst, Internal Med Program, Greensboro, NC USA; [Monroe, Michael H.] Carolinas Med Ctr, Dept Internal Med, Charlotte, NC 28203 USA; [Walker, Paul] E Carolina Univ, Leo Jenkins Canc Ctr, Brody Sch Med, Greenville, NC USA; [McGuire, Franklin R.] Univ S Carolina, Sch Med, Div Pulm & Crit Care Med, Columbia, SC 29208 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Carolinas Medical Center; University of North Carolina; East Carolina University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Cykert, S (corresponding author), Moses Cone Hosp, Internal Med Teaching Program, 1200 N Elm St, Greensboro, NC 27401 USA.	samuel_cykert@med.unc.edu	Edwards, Lloyd/N-2759-2019	Edwards, Lloyd/0000-0002-7788-4575; Corbie, Giselle/0000-0003-0737-6775; Cykert, Samuel/0000-0003-2037-6809	American Cancer Society [RSGPB-05-217-01-CPPB]; NATIONAL CANCER INSTITUTE [R01CA150980] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by the American Cancer Society via grant RSGPB-05-217-01-CPPB.	Bach PB, 1999, NEW ENGL J MED, V341, P1198, DOI 10.1056/NEJM199910143411606; Baile WF, 2005, CURR OPIN ONCOL, V17, P331, DOI 10.1097/01.cco.0000167738.49325.2c; Battafarano RJ, 2002, J THORAC CARDIOV SUR, V123, P280, DOI 10.1067/mtc.2002.119338; Bickell NA, 2008, JNCI-J NATL CANCER I, V100, P1717, DOI 10.1093/jnci/djn387; Clever SL, 2006, MED CARE, V44, P398, DOI 10.1097/01.mlr.0000208117.15531.da; Cykert S, 2003, MED DECIS MAKING, V23, P167, DOI 10.1177/0272989X03251244; Dewan NA, 1997, CHEST, V112, P416, DOI 10.1378/chest.112.2.416; Diggle P., 2002, ANAL LONGITUDINAL DA; EDWARDS FH, 1987, CHEST, V92, P888, DOI 10.1378/chest.92.5.888; Esnaola NF, 2008, ANN THORAC SURG, V86, P220, DOI 10.1016/j.athoracsur.2008.02.072; Farjah F, 2009, ARCH SURG-CHICAGO, V144, P14, DOI 10.1001/archsurg.2008.519; Gordon HS, 2006, CANCER-AM CANCER SOC, V107, P1313, DOI 10.1002/cncr.22122; Green AR, 2007, J GEN INTERN MED, V22, P1231, DOI 10.1007/s11606-007-0258-5; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald HP, 1998, AM J PUBLIC HEALTH, V88, P1681, DOI 10.2105/AJPH.88.11.1681; Jamtvedt G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub2; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Johnson RL, 2004, AM J PUBLIC HEALTH, V94, P2084, DOI 10.2105/AJPH.94.12.2084; King WD, 2004, J GEN INTERN MED, V19, P1146, DOI 10.1111/j.1525-1497.2004.30443.x; Kraetschmer N, 2004, HEALTH EXPECT, V7, P317, DOI 10.1111/j.1369-7625.2004.00296.x; Lathan CS, 2006, J CLIN ONCOL, V24, P413, DOI 10.1200/JCO.2005.02.1758; LIN AY, 1992, JAMA-J AM MED ASSOC, V267, P1661, DOI 10.1001/jama.267.12.1661; McCann J, 2005, CHEST, V128, P3440, DOI 10.1378/chest.128.5.3440; McWilliams JM, 2009, ANN INTERN MED, V150, P505, DOI 10.7326/0003-4819-150-8-200904210-00005; Mulligan CR, 2006, CANCER EPIDEM BIOMAR, V15, P25, DOI 10.1158/1055-9965.EPI-05-0537; National Cancer Institute, SEER CANC STAT REV 1; Osborne RH, 1999, PSYCHOL MED, V29, P1335, DOI 10.1017/S0033291799001142; Paasche-Orlow MK, 2005, AM J RESP CRIT CARE, V172, P980, DOI 10.1164/rccm.200409-1291OC; Safran DG, 1998, MED CARE, V36, P728, DOI 10.1097/00005650-199805000-00012; Salkeld G, 2004, HEALTH EXPECT, V7, P104, DOI 10.1111/j.1369-7625.2004.00257.x; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Strand TE, 2007, THORAX, V62, P991, DOI 10.1136/thx.2007.079145; Torke AM, 2004, ARCH INTERN MED, V164, P525, DOI 10.1001/archinte.164.5.525; VRDOLJAK E, 1994, CHEST, V106, P1797, DOI 10.1378/chest.106.6.1797; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Williams SW, 2008, J PALLIAT MED, V11, P1221, DOI 10.1089/jpm.2008.0057; Wilson FL, 2008, COMPR CHILD ADOLES N, V31, P7, DOI 10.1080/01460860701877142; Yin HS, 2008, ARCH PEDIAT ADOL MED, V162, P814, DOI 10.1001/archpedi.162.9.814; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb	39	180	180	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2010	303	23					2368	2376		10.1001/jama.2010.793	http://dx.doi.org/10.1001/jama.2010.793			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	610TE	20551407	Green Published, Bronze, Green Accepted			2022-12-01	WOS:000278759200026
J	Yakubovskaya, E; Mejia, E; Byrnes, J; Hambardjieva, E; Garcia-Diaz, M				Yakubovskaya, Elena; Mejia, Edison; Byrnes, James; Hambardjieva, Elena; Garcia-Diaz, Miguel			Helix Unwinding and Base Flipping Enable Human MTERF1 to Terminate Mitochondrial Transcription	CELL			English	Article							MAMMALIAN MITOCHONDRIA; MTDNA TRANSCRIPTION; CRYSTAL-STRUCTURE; POINT MUTATION; NUCLEIC-ACIDS; RIBOSOMAL-RNA; DNA; PROTEIN; BIOGENESIS; FAMILY	Defects in mitochondrial gene expression are associated with aging and disease. Mterf proteins have been implicated in modulating transcription, replication and protein synthesis. We have solved the structure of a member of this family, the human mitochondrial transcriptional terminator MTERF1, bound to dsDNA containing the termination sequence. The structure indicates that upon sequence recognition MTERF1 unwinds the DNA molecule, promoting eversion of three nucleotides. Base flipping is critical for stable binding and transcriptional termination. Additional structural and biochemical results provide insight into the DNA binding mechanism and explain how MTERF1 recognizes its target sequence. Finally, we have demonstrated that the mitochondrial pathogenic G3249A and G3244A mutations interfere with key interactions for sequence recognition, eliminating termination. Our results provide insight into the role of mterf proteins and suggest a link between mitochondrial disease and the regulation of mitochondrial transcription.	[Yakubovskaya, Elena; Mejia, Edison; Byrnes, James; Hambardjieva, Elena; Garcia-Diaz, Miguel] SUNY Stony Brook, Dept Pharmacol Sci, BST 7-169, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Garcia-Diaz, M (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, BST 7-169, Stony Brook, NY 11794 USA.	mgd@pharm.stonybrook.edu			Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy; National Center for Research Resources of the National Institutes of Health;  [R00 ES015421]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES015421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007518] Funding Source: NIH RePORTER	Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors wish to thank Drs. Bebenek, Bogenhagen, De los Santos, Demple, Garcia-Segura, and Kunkel for critical reading of the manuscript; and the NSLS Protein Crystallography group. NSLS beamlines 325 and 329 are mainly supported by the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy, and the National Center for Research Resources of the National Institutes of Health. This work was supported by R00 ES015421 to M.G.-D.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066; FORTELLE EDL, 1997, METHODS ENZYMOLOGY, V276; Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; HENDRICKSON WA, 1997, METHODS ENZYMOLOGY, V276; HESS JF, 1991, NATURE, V351, P236, DOI 10.1038/351236a0; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Klinge CM, 2008, J CELL BIOCHEM, V105, P1342, DOI 10.1002/jcb.21936; KRUSE B, 1989, CELL, V58, P391, DOI 10.1016/0092-8674(89)90853-2; Lavery R, 2009, NUCLEIC ACIDS RES, V37, P5917, DOI 10.1093/nar/gkp608; Linder T, 2005, CURR GENET, V48, P265, DOI 10.1007/s00294-005-0022-5; Lu G, 2009, CURR OPIN STRUC BIOL, V19, P110, DOI 10.1016/j.sbi.2008.12.009; Martin M, 2005, CELL, V123, P1227, DOI 10.1016/j.cell.2005.09.040; Metodiev MD, 2009, CELL METAB, V9, P386, DOI 10.1016/j.cmet.2009.03.001; Mimaki M, 2009, MITOCHONDRION, V9, P115, DOI 10.1016/j.mito.2009.01.005; Nam SC, 2005, J BIOCHEM MOL BIOL, V38, P690; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Pellegrini M, 2009, BBA-BIOENERGETICS, V1787, P294, DOI 10.1016/j.bbabio.2009.01.018; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; Roberti M, 2009, BBA-BIOENERGETICS, V1787, P303, DOI 10.1016/j.bbabio.2009.01.013; Roberti M, 2006, BBA-BIOENERGETICS, V1757, P1199, DOI 10.1016/j.bbabio.2006.04.026; Roberts RJ, 1998, ANNU REV BIOCHEM, V67, P181, DOI 10.1146/annurev.biochem.67.1.181; Sasarman F, 2008, HUM MOL GENET, V17, P3697, DOI 10.1093/hmg/ddn265; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Seneca S, 2001, ARCH NEUROL-CHICAGO, V58, P1113, DOI 10.1001/archneur.58.7.1113; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; Sibanda BL, 2010, NATURE, V463, P118, DOI 10.1038/nature08648; Sologub M, 2009, CELL, V139, P934, DOI 10.1016/j.cell.2009.10.031; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wenz T, 2009, CELL METAB, V9, P499, DOI 10.1016/j.cmet.2009.04.010	40	75	79	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					982	993		10.1016/j.cell.2010.05.018	http://dx.doi.org/10.1016/j.cell.2010.05.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550934	Bronze, Green Accepted			2022-12-01	WOS:000278618800013
J	Abdool Karim, Q; AbouZahr, C; Dehne, K; Mangiaterra, V; Moodley, J; Rollins, N; Say, L; Schaffer, N; Rosen, JE; de Zoysa, I				Abdool Karim, Quarraisha; AbouZahr, Carla; Dehne, Karl; Mangiaterra, Viviana; Moodley, Jack; Rollins, Nigel; Say, Lale; Schaffer, Nathan; Rosen, James E.; de Zoysa, Isabelle			HIV and maternal mortality: turning the tide	LANCET			English	Editorial Material							SOUTH-AFRICA; MORBIDITY; MALAWI; WOMEN		[AbouZahr, Carla; Mangiaterra, Viviana; Rollins, Nigel; Say, Lale; Schaffer, Nathan; de Zoysa, Isabelle] WHO, CH-1211 Geneva 27, Switzerland; [Abdool Karim, Quarraisha] Ctr AIDS Programme Res S Africa, Durban, Kwazulu Natal, South Africa; [Dehne, Karl] UNAIDS, Geneva, Switzerland; [Moodley, Jack] Univ KwaZulu Natal, Durban, Kwazulu Natal, South Africa; [Rosen, James E.] Univ KwaZulu Natal, Washington, DC USA	World Health Organization; UNAIDS; University of Kwazulu Natal	de Zoysa, I (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.		Abdool Karim, Quarraisha/GVS-1160-2022; , lalesay/AAG-1912-2021	Abdool Karim, Quarraisha/0000-0002-0985-477X; MANGIATERRA, VIVIANA/0000-0002-8815-0841				Bicego G, 2002, AIDS, V16, P1078, DOI 10.1097/00002030-200205030-00019; Black V, 2009, OBSTET GYNECOL, V114, P292, DOI 10.1097/AOG.0b013e3181af33e6; Chilongozi D, 2008, PEDIATR INFECT DIS J, V27, P808, DOI 10.1097/INF.0b013e31817109a4; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Horton R, 2009, LANCET, V374, P1400, DOI 10.1016/S0140-6736(09)61669-X; Khan M, 2001, AIDS, V15, P1857, DOI 10.1097/00002030-200109280-00016; Le Coeur S, 2005, AIDS, V19, P69, DOI 10.1097/00002030-200501030-00008; Louis J, 2007, OBSTET GYNECOL, V110, P385, DOI 10.1097/01.AOG.0000275263.81272.fc; Mbizvo M T, 2005, Cent Afr J Med, V51, P91; McIntyre J, 2003, BRIT MED BULL, V67, P127, DOI 10.1093/bmb/ldg012; National Committee for Confidential Enquiry into Maternal Deaths, 2008, 4 NAT COMM CONF ENQ; Price JE, 2009, AIDS CARE, V21, P608, DOI 10.1080/09540120802310957; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Sewankambo NK, 2000, AIDS, V14, P2391, DOI 10.1097/00002030-200010200-00021; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1; 2010, LANCET, V375, P865	16	42	44	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 5	2010	375	9730					1948	1949		10.1016/S0140-6736(10)60747-7	http://dx.doi.org/10.1016/S0140-6736(10)60747-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	609WT	20569827	Green Submitted			2022-12-01	WOS:000278689600008
J	Matson, PA; Parton, WJ; Power, AG; Swift, MJ				Matson, PA; Parton, WJ; Power, AG; Swift, MJ			Agricultural intensification and ecosystem properties	SCIENCE			English	Article							SOIL ORGANIC-MATTER; VEGETATIONAL DIVERSITY; NITROGEN; CULTIVATION; MANAGEMENT; DYNAMICS; INSECTS; GROWTH	Expansion and intensification of cultivation are among the predominant global changes of this century. Intensification of agriculture by use of high-yielding crop varieties, fertilization, irrigation, and pesticides has contributed substantially to the tremendous increases in food production over the past 50 years. Land conversion and intensification, however, also alter the biotic interactions and patterns of resource availability in ecosystems and can have serious local, regional, and global environmental consequences. The use of ecologically based management strategies can increase the sustainability of agricultural production while reducing off-site consequences.	COLORADO STATE UNIV, NAT RESOURCE ECOL LAB, FT COLLINS, CO 80523 USA; CORNELL UNIV, ECOL & SYSTEMAT SECT, ITHACA, NY 14853 USA; UNESCO, ROSTA, TROP SOIL BIOL & FERTIL PROGRAMME, NAIROBI, KENYA	Colorado State University; Cornell University	Matson, PA (corresponding author), UNIV CALIF BERKELEY, DEPT ENVIRONM SCI POLICY & MANAGEMENT, ECOSYST SCI DIV, BERKELEY, CA 94720 USA.							ALTIERI MA, 1986, AGR ECOSYST ENVIRON, V16, P29, DOI 10.1016/0167-8809(86)90073-3; ANDOW DA, 1991, ANNU REV ENTOMOL, V36, P561, DOI 10.1146/annurev.en.36.010191.003021; Beare MH, 1997, APPL SOIL ECOL, V6, P87, DOI 10.1016/S0929-1393(96)00150-3; BEARE MH, 1992, ECOL MONOGR, V62, P569, DOI 10.2307/2937317; BECKER B, 1997, ISSUES AGR, V10, P63; BOATMAN N, 1994, FIELD MARGINS INTEGR; BOUDREAU MA, 1993, PLANT PATHOL, V42, P16, DOI 10.1111/j.1365-3059.1993.tb01467.x; BOUDREAU MA, 1992, PHYTOPATHOLOGY, V82, P1051, DOI 10.1094/Phyto-82-1051; BOUDREAU MA, 1994, ECOL APPL, V4, P729, DOI 10.2307/1942003; BURKE IC, 1989, SOIL SCI SOC AM J, V53, P800, DOI 10.2136/sssaj1989.03615995005300030029x; Cassman K. G., 1995, Agricultural sustainability: economic, environmental and statistical considerations., P231; CASSMAN KG, 1995, ADV SOIL SCI, P181; CHAMEIDES WL, 1994, SCIENCE, V264, P74, DOI 10.1126/science.264.5155.74; Cicerone RJ, 1988, GLOBAL BIOGEOCHEM CY, V2, P299, DOI 10.1029/GB002i004p00299; CRITCHLEY BR, 1979, PEDOBIOLOGIA, V19, P425; CRITCHLEY BR, 1989, RES METHODS CEREAL L, P200; CROSSON P, 1995, SCIENCE, V269, P461, DOI 10.1126/science.269.5223.461; DELMAS R, NUTR CYCLING AGROECO; Donigian Jr. A.S., 1994, EPA600R94067; GALLOWAY JN, 1995, GLOBAL BIOGEOCHEM CY, V9, P235, DOI 10.1029/95GB00158; Giller PS, 1996, BIODIVERS CONSERV, V5, P135, DOI 10.1007/BF00055827; GREENBERG R, 1994, AUK, V111, P672; Greenberg Russell, 1996, P59; GRIGG D, 1993, WORLD FOOD PROBLEM 1; Hall SJ, 1996, ANNU REV ENERG ENV, V21, P311, DOI 10.1146/annurev.energy.21.1.311; Howarth RW, 1996, BIOGEOCHEMISTRY, V35, P75, DOI 10.1007/BF02179825; Huber D., 1981, CRC HDB PEST MANAGEM, P357; HUBER DM, 1974, ANNU REV PHYTOPATHOL, V12, P139, DOI 10.1146/annurev.py.12.090174.001035; IZAC AMN, 1994, ECOL ECON, V11, P105, DOI 10.1016/0921-8009(94)90022-1; JENKINSON DS, 1990, PHILOS T R SOC B, V329, P361, DOI DOI 10.1098/rstb.1990.0177; LAVELLE P, 1989, PEDOBIOLOGIA, V33, P283; LAVELLE P, 1994, SOIL RESILIENCE AND SUSTAINABLE LAND USE, P291; LAVELLE P, COMMUNICATION; Lynam J. K., 1989, Agricultural Economics, V3, P381, DOI 10.1016/0169-5150(89)90010-8; Matson PA, 1996, J GEOPHYS RES-ATMOS, V101, P18533, DOI 10.1029/96JD01536; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Metherell AK, 1995, SOIL MANAGEMENT GREE, V6, P259; MEYER WB, 1992, ANNU REV ECOL SYST, V23, P39, DOI 10.1146/annurev.es.23.110192.000351; Nambiar K.K., 1994, SOIL FERTILITY CROP, P234; *NAT RES COUNC, 1993, MAN WAST COAST URB A; Naylor R, 1997, POPUL DEV REV, V23, P41, DOI 10.2307/2137460; Naylor R. L., 1997, Nature's services: societal dependence on natural ecosystems., P151; Naylor RL, 1996, ANNU REV ENERG ENV, V21, P99, DOI 10.1146/annurev.energy.21.1.99; NIXON SW, 1995, OPHELIA, V41, P199, DOI 10.1080/00785236.1995.10422044; PANKHURST CE, 1994, SOIL BIOTA MANAGEMEN; PARTON WJ, 1994, SOIL SCI SOC AM J, V58, P530, DOI 10.2136/sssaj1994.03615995005800020040x; Paul E.A., 1997, SOIL ORGANIC MATTER; PAUSTIAN K, 1992, SOIL SCI SOC AM J, V56, P476, DOI 10.2136/sssaj1992.03615995005600020023x; Paustian K, 1995, SOIL MANAGEMENT GREE, P69; PIMENTEL D, 1982, BIOSCIENCE, V32, P595, DOI 10.2307/1308603; Pimentel D, 1993, WORLD SOIL EROSION C; Postel S., 1997, Nature's services: societal dependence on natural ecosystems., P195; Postel Sandra, 1996, V1996, P40; Postel SL, 1996, SCIENCE, V271, P785, DOI 10.1126/science.271.5250.785; Power A.G., 1990, AGROECOL RES ECOL BA, V78, P47; POWER AG, 1991, ECOLOGY, V72, P232, DOI 10.2307/1938917; Power AG, 1996, ECOL STU AN, V122, P173; Power Alison G., 1996, P91; REISSIG WH, 1986, ILLUSTRATED GUIDE IN; RISCH SJ, 1986, ECOLOGY, V67, P505, DOI 10.2307/1938593; ROBBINS CS, 1992, COMP NEOTROPICAL MIG; Robertson G. Philip, 1993, V55, P95; ROBERTSON GP, AGR ECOLOGY; RUSSELL EP, 1989, ENVIRON ENTOMOL, V18, P590, DOI 10.1093/ee/18.4.590; Scriber J.M., 1984, NITROGEN CROP PRODUC; SWIFT MJ, 1997, APPL SOIL ECOL, V6; SWIFT MJ, 1996, 13 GCTE; SWIFT MJ, 1993, BIODIVERSITY ECOSYST, P29; SWIFT MJ, 1997, ADV AGROECOLOGY; Tian G., 1997, P125; TONHASCA A, 1994, ECOL ENTOMOL, V19, P239, DOI 10.1111/j.1365-2311.1994.tb00415.x; *TROP SOIL BIOL FE, 1997, TSBF REP 1997; *UN FAO, 1993, AGR TOW 2010; VITOUSEK PM, 1993, BIOGEOCHEMISTRY OF GLOBAL CHANGE, P193; VITOUSEK PM, IN PRESS ECOL APPL; Williams EJ, 1992, GLOBAL BIOGEOCHEM CY, V6, P351, DOI 10.1029/92GB02124; Woomer P.L., 1994, BIOL MANAG TROP SOIL; WUNDERLE JM, 1993, CONDOR, V95, P904, DOI 10.2307/1369428	78	1858	2026	42	1222	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 25	1997	277	5325					504	509		10.1126/science.277.5325.504	http://dx.doi.org/10.1126/science.277.5325.504			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM867	20662149	Green Submitted			2022-12-01	WOS:A1997XM86700032
J	Campbell, NRC; Legowski, B; Legetic, B				Campbell, Norm R. C.; Legowski, Barbara; Legetic, Branka			Mobilising the Americas for dietary salt reduction	LANCET			English	Editorial Material							HYPERTENSION; HEALTH		[Campbell, Norm R. C.] Univ Calgary, Libin Cardiovasc Inst, Dept Med, Calgary, AB T2N 4Z6, Canada; [Campbell, Norm R. C.] Univ Calgary, Libin Cardiovasc Inst, Dept Community Hlth Sci, Calgary, AB T2N 4Z6, Canada; [Campbell, Norm R. C.] Univ Calgary, Libin Cardiovasc Inst, Dept Pharmacol & Therapeut, Calgary, AB T2N 4Z6, Canada; [Legowski, Barbara; Legetic, Branka] PAHO Secretariat, Reg Expert Grp Cardiovasc Dis Prevent Dietary Sal, Washington, DC USA; [Legetic, Branka] PAHO, Unit Noncommunicable Dis, Washington, DC USA	Libin Cardiovascular Institute Of Alberta; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; Pan American Health Organization	Campbell, NRC (corresponding author), Univ Calgary, Libin Cardiovasc Inst, Dept Med, Calgary, AB T2N 4Z6, Canada.	ncampbel@ucalgary.ca						Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; *GOV BARB, 2009, SALT RED HIGH CNCD C; *HLTH CAN, ISS SOD; Joffres MR, 2007, CAN J CARDIOL, V23, P437, DOI 10.1016/S0828-282X(07)70780-8; MATTES RD, 1991, J AM COLL NUTR, V10, P383; *MIN HLTH ARG, 2009, MIN HLTH LAUNCH CAMP; *MIN HLTH CHIL, GLOB STRAT OB EGO CH; Mohan S, 2009, CAN MED ASSOC J, V181, P605, DOI 10.1503/cmaj.090361; *PAN AM HLTH ORG, 2009, CARD DIS PREV DIET S; Pereira M, 2009, J HYPERTENS, V27, P963, DOI 10.1097/HJH.0b013e3283282f65; Sanchez RA, 2009, J HYPERTENS, V27, P905, DOI 10.1097/HJH.0b013e32832aa6d2; *SECR HLTH MEX, 2010, NAT NUTR HLTH STRAT; 2010, LANCET, V375, P254	13	19	20	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 5	2011	377	9768					793	795		10.1016/S0140-6736(10)60489-8	http://dx.doi.org/10.1016/S0140-6736(10)60489-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	738GO	20663548				2022-12-01	WOS:000288628500009
J	Medina, PP; Nolde, M; Slack, FJ				Medina, Pedro P.; Nolde, Mona; Slack, Frank J.			OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma	NATURE			English	Article							ONCOGENE ADDICTION; EXPRESSION; CANCER; MICRORNAS; PROGNOSIS; INVASION; MIR-21; MYC	MicroRNAs (miRNAs) belong to a recently discovered class of small RNA molecules that regulate gene expression at the post-transcriptional level. miRNAs have crucial functions in the development and establishment of cell identity, and aberrant metabolism or expression of miRNAs has been linked to human diseases, including cancer(1). Components of the miRNA machinery and miRNAs themselves are involved in many cellular processes that are altered in cancer, such as differentiation, proliferation and apoptosis. Some miRNAs, referred to as oncomiRs(2), show differential expression levels in cancer and are able to affect cellular transformation, carcinogenesis and metastasis, acting either as oncogenes or tumour suppressors. The phenomenon of 'oncogene addiction' reveals that despite the multistep nature of tumorigenesis, targeting of certain single oncogenes can have therapeutic value(3,4), and the possibility of oncomiR addiction has been proposed but never demonstrated(3). MicroRNA-21 (miR-21) is a unique miRNA in that it is overexpressed in most tumour types analysed so far. Despite great interest in miR-21, most of the data implicating it in cancer have been obtained through miRNA profiling and limited in vitro functional assays. To explore the role of miR-21 in cancer in vivo, we used Cre and Tet-off technologies to generate mice conditionally expressing miR-21. Here we show that overexpression of miR-21 leads to a pre-B malignant lymphoid-like phenotype, demonstrating that mir-21 is a genuine oncogene. When miR-21 was inactivated, the tumours regressed completely in a few days, partly as a result of apoptosis. These results demonstrate that tumours can become addicted to oncomiRs and support efforts to treat human cancers through pharmacological inactivation of miRNAs such as miR-21.	[Medina, Pedro P.; Nolde, Mona; Slack, Frank J.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Slack, FJ (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	frank.slack@yale.edu	Vico, Pedro Pablo Medina/D-1688-2013	Vico, Pedro Pablo Medina/0000-0002-7834-7093; Slack, Frank/0000-0001-8263-0409	Hope Funds for Cancer Research; James McDonnell Foundation; Yale Comprehensive Cancer Center	Hope Funds for Cancer Research; James McDonnell Foundation; Yale Comprehensive Cancer Center	We thank X. Liang for help in mouse colony maintenance and genotyping; D. Scavone and T. Nottoli for assistance with generating the transgenic mice; Yale rodent care staff M. Bonk, K. Mclaughlin, J. Graham, D. Clark; C. Zeiss, L. Johnson and G. Terwilliger for help with the necropsy/pathological analysis; and I. Babar, P. Trang and J. Sklar for critical reading of the manuscript. P. P. M. is the recipient of a Postdoctoral Fellowship from Hope Funds for Cancer Research. This work was funded by a grant from the James McDonnell Foundation to F. J. S. and J. B. Weidhaas, and a pilot grant from the Yale Comprehensive Cancer Center.	Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Costinean S, 2009, BLOOD, V114, P1374, DOI 10.1182/blood-2009-05-220814; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fulci V, 2007, BLOOD, V109, P4944, DOI 10.1182/blood-2006-12-062398; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huettner CS, 2000, NAT GENET, V24, P57, DOI 10.1038/71691; Imai Y, 2010, STEM CELLS DEV, V19, P461, DOI 10.1089/scd.2009.0251; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jongen-Lavrencic M, 2008, BLOOD, V111, P5078, DOI 10.1182/blood-2008-01-133355; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Lawrie CH, 2007, INT J CANCER, V121, P1156, DOI 10.1002/ijc.22800; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Mao JH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni146; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Morse HC, 2002, BLOOD, V100, P246, DOI 10.1182/blood.V100.1.246; Navarro A, 2008, BLOOD, V111, P2825, DOI 10.1182/blood-2007-06-096784; PENNYCOOK JL, 1993, J EXP MED, V178, P1007, DOI 10.1084/jem.178.3.1007; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Seike M, 2009, P NATL ACAD SCI USA, V106, P12085, DOI 10.1073/pnas.0905234106; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; YOKOYAMA K, 1987, P NATL ACAD SCI USA, V84, P7363, DOI 10.1073/pnas.84.21.7363; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	30	731	807	2	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2010	467	7311					86	U119		10.1038/nature09284	http://dx.doi.org/10.1038/nature09284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20693987				2022-12-01	WOS:000281461200040
J	Somerville, C; Youngs, H; Taylor, C; Davis, SC; Long, SP				Somerville, Chris; Youngs, Heather; Taylor, Caroline; Davis, Sarah C.; Long, Stephen P.			Feedstocks for Lignocellulosic Biofuels	SCIENCE			English	Editorial Material							ENERGY-CONVERSION; MISCANTHUS; BIOENERGY; GROWTH; CROP; LANDS; YIELD	In 2008, the world produced approximately 87 gigaliters of liquid biofuels, which is roughly equal to the volume of liquid fuel consumed by Germany that year. Essentially, all of this biofuel was produced from crops developed for food production, raising concerns about the net energy and greenhouse gas effects and potential competition between use of land for production of fuels, food, animal feed, fiber, and ecosystem services. The pending implementation of improved technologies to more effectively convert the nonedible parts of plants (lignocellulose) to liquid fuels opens diverse options to use biofuel feedstocks that reach beyond current crops and the land currently used for food and feed. However, there has been relatively little discussion of what types of plants may be useful as bioenergy crops.	[Somerville, Chris; Youngs, Heather; Taylor, Caroline] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Davis, Sarah C.; Long, Stephen P.] Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA	University of California System; University of California Berkeley; University of Illinois System; University of Illinois Urbana-Champaign	Somerville, C (corresponding author), Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA.	crs@berkeley.edu	Long, Stephen P/A-2488-2008; Long, Stephen/AAA-1741-2019; Somerville, Christopher R/A-4048-2009	Long, Stephen P/0000-0002-8501-7164; Long, Stephen/0000-0002-8501-7164; Somerville, Christopher R/0000-0003-4647-0094				BEALE CV, 1995, PLANT CELL ENVIRON, V18, P641, DOI 10.1111/j.1365-3040.1995.tb00565.x; Borland AM, 2009, J EXP BOT, V60, P2879, DOI 10.1093/jxb/erp118; Campbell JE, 2008, ENVIRON SCI TECHNOL, V42, P5791, DOI 10.1021/es800052w; Centro de Gestao e Estudos Estrategicos (CGEE), 2008, SUG CAN BAS BIOETH E; Christian DG, 2008, IND CROP PROD, V28, P320, DOI 10.1016/j.indcrop.2008.02.009; Clifton-Brown JC, 2007, GLOBAL CHANGE BIOL, V13, P2296, DOI 10.1111/j.1365-2486.2007.01438.x; Committee on America's Energy Future, 2009, AM EN FUT; Davis SC, 2010, ECOSYSTEMS, V13, P144, DOI 10.1007/s10021-009-9306-9; Dohleman FG, 2009, PLANT CELL ENVIRON, V32, P1525, DOI 10.1111/j.1365-3040.2009.02017.x; Fortman JL, 2008, TRENDS BIOTECHNOL, V26, P375, DOI 10.1016/j.tibtech.2008.03.008; Goldemberg J, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-6; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.1890/1051-0761(2002)012[0891:FCSITN]2.0.CO;2; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; Lal R, 2005, ENVIRON INT, V31, P575, DOI 10.1016/j.envint.2004.09.005; Long SP, 1992, PRIMARY PRODUCTIVITY; Lynd L, 2006, SCIENCE, V312, P1746; Miguez FE, 2008, AGR FOREST METEOROL, V148, P1280, DOI 10.1016/j.agrformet.2008.03.010; Miguez FE, 2009, GCB BIOENERGY, V1, P282, DOI 10.1111/j.1757-1707.2009.01019.x; Mitchell CP, 1995, BIOMASS BIOENERG, V9, P11, DOI 10.1016/0961-9534(95)00076-3; Nobel PS, 1988, ENV BIOL AGAVES CACT; Purseglove J.W., 1972, TROPICAL CROPS MONOC; Pyter R, 2009, METHODS MOL BIOL, V581, P41, DOI 10.1007/978-1-60761-214-8_3; Sokhansanj S, 2002, BIOMASS BIOENERG, V23, P347, DOI 10.1016/S0961-9534(02)00063-6; UNEP, 2007, GLOB ENV OUTL ENV DE; *UNICA, 2010, SUG PROD BRAZ	25	907	938	11	442	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					790	792		10.1126/science.1189268	http://dx.doi.org/10.1126/science.1189268			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705851				2022-12-01	WOS:000280809900037
J	Ieda, M; Fu, JD; Delgado-Olguin, P; Vedantham, V; Hayashi, Y; Bruneau, BG; Srivastava, D				Ieda, Masaki; Fu, Ji-Dong; Delgado-Olguin, Paul; Vedantham, Vasanth; Hayashi, Yohei; Bruneau, Benoit G.; Srivastava, Deepak			Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors	CELL			English	Article							EMBRYONIC STEM-CELLS; CARDIAC FIBROBLASTS; PROGENITOR CELLS; BETA-CELLS; HEART; TRANSCRIPTION; EXPRESSION; CHROMATIN; TBX5; DIFFERENTIATION	The reprogramming of fibroblasts to induced pluripotent stem cells (iPSCs) raises the possibility that a somatic cell could be reprogrammed to an alternative differentiated fate without first becoming a stem/progenitor cell. A large pool of fibroblasts exists in the postnatal heart, yet no single "master regulator'' of direct cardiac reprogramming has been identified. Here, we report that a combination of three developmental transcription factors (i.e., Gata4, Mef2c, and Tbx5) rapidly and efficiently reprogrammed postnatal cardiac or dermal fibroblasts directly into differentiated cardiomyocyte-like cells. Induced cardiomyocytes expressed cardiac-specific markers, had a global gene expression profile similar to cardiomyocytes, and contracted spontaneously. Fibroblasts transplanted into mouse hearts one day after transduction of the three factors also differentiated into cardiomyocyte-like cells. We believe these findings demonstrate that functional cardiomyocytes can be directly reprogrammed from differentiated somatic cells by defined factors. Reprogramming of endogenous or explanted fibroblasts might provide a source of cardiomyocytes for regenerative approaches.	[Ieda, Masaki; Fu, Ji-Dong; Delgado-Olguin, Paul; Vedantham, Vasanth; Hayashi, Yohei; Bruneau, Benoit G.; Srivastava, Deepak] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Ieda, Masaki; Fu, Ji-Dong; Delgado-Olguin, Paul; Bruneau, Benoit G.; Srivastava, Deepak] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Ieda, Masaki; Fu, Ji-Dong; Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Delgado-Olguin, Paul; Bruneau, Benoit G.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Vedantham, Vasanth] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ieda, M (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Shinjuku Ku, Shinanomachi 35, Tokyo 1608582, Japan.	ieda@cpnet.med.keio.ac.jp; dsrivastava@gladstone.ucsf.edu	Hayashi, Yohei/AAF-6059-2020; Hayashi, Yohei/L-8190-2019; Olguin, Paul Delgado/H-9293-2019; Wilson, Matthew H/K-3193-2013; Fu, Jidong/E-8173-2012	Hayashi, Yohei/0000-0001-5490-7052; Olguin, Paul Delgado/0000-0002-5355-247X; Fu, Jidong/0000-0003-2797-5193; Vedantham, Vasanth/0000-0003-1032-700X; Bruneau, Benoit/0000-0002-0804-7597	Uehara Memorial Foundation; GlaxoSmithKline Cardiovascular Research and Education Foundation; NHLBI/NIH; California Institute for Regenerative Medicine; National Center for Research Resources [RR18928-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL089707, U01HL100406, R01HL080592, K08HL101989, R01HL057181] Funding Source: NIH RePORTER	Uehara Memorial Foundation(Uehara Memorial Foundation); GlaxoSmithKline Cardiovascular Research and Education Foundation; NHLBI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to members of the Srivastava lab, to K. Tomoda for critical discussions and comments on the manuscript, to J. Olgin and C. Ding for electrophysiology assistance, to Z. Yang and K. Worringer for help with lentivirus experiments, to Y. Huang for cell transplantation experiments, to B. Taylor, G. Howard, and S. Ordway for editorial assistance and manuscript preparation, to C. Barker and L. Ta in the Gladstone Genomics core, to C. Miller and J. Fish in the Gladstone Histology core, to A. Holloway in the Gladstone Bioinformatics core, and to S. Elmes in the Laboratory for Cell Analysis in UCSF. We also thank S. Yamanaka for helpful discussions and providing pMXs-DsRed Express plasmid, T. Kitamura for Plat-E cells, J. Robbins for alpha-MHC promoter plasmid, T.M. Jessell for Isl1-Cre mice, and F. Costantini for R26R-EYFP mice. M.I. and Y.H. are supported by a grant from the Uehara Memorial Foundation. V.V. is supported by grants from the GlaxoSmithKline Cardiovascular Research and Education Foundation and the NIH/NHLBI. P.D.-O. was a postdoctoral scholar of the California Institute for Regenerative Medicine. D.S. and B.G.B are supported by grants from NHLBI/NIH and the California Institute for Regenerative Medicine. The J. David Gladstone Institutes received support from a National Center for Research Resources Grant RR18928-01. D.S. is a member of the Scientific Advisory Board of iPierian, Inc., and RegeneRx. B.G.B. is a member of the Scientific Advisory Board of iPierian Inc.	Andersen DC, 2009, STEM CELLS, V27, P1571, DOI 10.1002/stem.72; Baeyens L, 2005, DIABETOLOGIA, V48, P49, DOI 10.1007/s00125-004-1606-1; Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; Davis DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007195; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Ghosh TK, 2009, MOL CELL BIOL, V29, P2205, DOI 10.1128/MCB.01923-08; GULICK J, 1991, J BIOL CHEM, V266, P9180; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hudon-David F, 2007, J MOL CELL CARDIOL, V42, P991, DOI 10.1016/j.yjmcc.2007.02.009; Ieda M, 2007, NAT MED, V13, P604, DOI 10.1038/nm1570; Ivey KN, 2006, J CLIN INVEST, V116, P2863, DOI 10.1172/JCI30349; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Saga Y, 1999, DEVELOPMENT, V126, P3437; Snider P, 2009, CIRC RES, V105, P934, DOI 10.1161/CIRCRESAHA.109.201400; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; van Laake LW, 2008, CIRC RES, V102, P1008, DOI 10.1161/CIRCRESAHA.108.175505; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhao R, 2008, DEV BIOL, V317, P614, DOI 10.1016/j.ydbio.2008.03.013; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	38	1714	1873	2	326	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					375	386		10.1016/j.cell.2010.07.002	http://dx.doi.org/10.1016/j.cell.2010.07.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691899	Bronze, Green Accepted			2022-12-01	WOS:000280609100015
J	Kaya, M; Higuchi, H				Kaya, Motoshi; Higuchi, Hideo			Nonlinear Elasticity and an 8-nm Working Stroke of Single Myosin Molecules in Myofilaments	SCIENCE			English	Article							SKELETAL-MUSCLE; FORCE; ACTIN; SIZE; CONTRACTION; DEPENDENCE; STIFFNESS; DYNAMICS; FIBERS; MOTION	Using optical trapping and fluorescence imaging techniques, we measured the step size and stiffness of single skeletal myosins interacting with actin filaments and arranged on myosin-rod cofilaments that approximate myosin mechanics during muscle contraction. Stiffness is dramatically lower for negatively compared to positively strained myosins, consistent with buckling of myosin's subfragment 2 rod domain. Low stiffness minimizes drag of negatively strained myosins during contraction at loaded conditions. Myosin's elastic portion is stretched during active force generation, reducing apparent step size with increasing load, even though the working stroke is approximately constant at about 8 nanometers. Taking account of the nonlinear nature of myosin elasticity is essential to relate myosin's internal structural changes to physiological force generation and filament sliding.	[Kaya, Motoshi; Higuchi, Hideo] Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Higuchi, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	higuchi@phys.s.u-tokyo.ac.jp			Japan Ministry of Education, Culture, Sports, Science, and Technology; Japan Science and Technology Agency; Japan Society for the Promotion of Science	Japan Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to J. Kerssemakers and M. Dogterom for generously providing their step-finding algorithm, W. Herzog and Y. Goldman for valuable discussion and critical reading of this manuscript, and T. Kambara for comments. This work has been supported by Grants-in-Aid for Scientific Research in Priority Areas from the Japan Ministry of Education, Culture, Sports, Science, and Technology (H. H.), Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency (H. H.), and Young Scientists from the Japan Society for the Promotion of Science (M.K.).	Adamovic I, 2008, BIOPHYS J, V94, P3779, DOI 10.1529/biophysj.107.122028; Barclay CJ, 1996, J PHYSIOL-LONDON, V497, P781, DOI 10.1113/jphysiol.1996.sp021809; Bieling P, 2008, EMBO REP, V9, P1121, DOI 10.1038/embor.2008.169; Capitanio M, 2006, P NATL ACAD SCI USA, V103, P87, DOI 10.1073/pnas.0506830102; FORD LE, 1977, J PHYSIOL-LONDON, V269, P441, DOI 10.1113/jphysiol.1977.sp011911; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; GOLDMAN YE, 1988, J PHYSL, V398, P72; HIGUCHI H, 1995, BIOPHYS J, V69, P1000, DOI 10.1016/S0006-3495(95)79975-1; Hopkins SC, 2002, J MOL BIOL, V318, P1275, DOI 10.1016/S0022-2836(02)00189-4; Howard J, 1996, Proc Natl Acad Sci U S A, V93, P4462; Howard J., 2001, MECH MOTOR PROTEINS; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; HUXLEY AF, 1971, J PHYSIOL, V218, P59; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Lewalle A, 2008, BIOPHYS J, V94, P2160, DOI 10.1529/biophysj.107.119396; Nishiyama M, 2001, NAT CELL BIOL, V3, P425, DOI 10.1038/35070116; Nishizaka T, 2000, BIOPHYS J, V79, P962, DOI 10.1016/S0006-3495(00)76350-8; PATE E, 1993, P NATL ACAD SCI USA, V90, P2451, DOI 10.1073/pnas.90.6.2451; Piazzesi G, 2002, J PHYSIOL-LONDON, V545, P145, DOI 10.1113/jphysiol.2002.028969; Piazzesi G, 2007, CELL, V131, P784, DOI 10.1016/j.cell.2007.09.045; Reconditi M, 2004, NATURE, V428, P578, DOI 10.1038/nature02380; Steffen W, 2003, P NATL ACAD SCI USA, V100, P6434, DOI 10.1073/pnas.1231998100; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Veigel C, 1998, BIOPHYS J, V75, P1424, DOI 10.1016/S0006-3495(98)74061-5; WINKELMANN DA, 1995, BIOPHYS J, V68, P2444, DOI 10.1016/S0006-3495(95)80426-1	26	127	130	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					686	689		10.1126/science.1191484	http://dx.doi.org/10.1126/science.1191484			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689017				2022-12-01	WOS:000280602700040
J	Ohiorhenuan, IE; Mechler, F; Purpura, KP; Schmid, AM; Hu, Q; Victor, JD				Ohiorhenuan, Ifije E.; Mechler, Ferenc; Purpura, Keith P.; Schmid, Anita M.; Hu, Qin; Victor, Jonathan D.			Sparse coding and high-order correlations in fine-scale cortical networks	NATURE			English	Article							PRIMARY VISUAL-CORTEX; NEURONS; CONNECTIVITY; INFORMATION; POPULATION; RESPONSES; RETINA	Connectivity in the cortex is organized at multiple scales(1-5), suggesting that scale-dependent correlated activity is particularly important for understanding the behaviour of sensory cortices and their function in stimulus encoding. We analysed the scale-dependent structure of cortical interactions by using maximum entropy models(6-9) to characterize multiple-tetrode recordings from primary visual cortex of anaesthetized macaque monkeys (Macaca mulatta). We compared the properties of firing patterns among local clusters of neurons (<300 mm apart) with those of neurons separated by larger distances (600-2,500 mu m). Here we report that local firing patterns are distinctive: whereas multi-neuronal firing patterns at larger distances can be predicted by pairwise interactions, patterns within local clusters often show evidence of high-order correlations. Surprisingly, these local correlations are flexible and rapidly reorganized by visual input. Although they modestly reduce the amount of information that a cluster conveys, they also modify the format of this information, creating sparser codes by increasing the periods of total quiescence, and concentrating information into briefer periods of common activity. These results imply a hierarchical organization of neuronal correlations: simple pairwise correlations link neurons over scales of tens to hundreds of minicolumns, but on the scale of a few minicolumns, ensembles of neurons form complex subnetworks whose moment-to-moment effective connectivity is dynamically reorganized by the stimulus.	[Ohiorhenuan, Ifije E.; Mechler, Ferenc; Purpura, Keith P.; Schmid, Anita M.; Hu, Qin; Victor, Jonathan D.] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY 10065 USA	Cornell University	Ohiorhenuan, IE (corresponding author), Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY 10065 USA.	ifo2001@med.cornell.edu	Victor, Jonathan D./D-2931-2009	Victor, Jonathan D./0000-0002-9293-0111	National Institutes of Health [EY19454, GM07739, EY09314]; NATIONAL EYE INSTITUTE [R01EY009314, F31EY019454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Nirenberg for comments on a draft of the manuscript. This work was supported by National Institutes of Health grants EY19454 and GM07739 (to I.E.O.) and EY09314 (to J.D.V.).	AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Cover T. M., 2006, ELEMENTS INFORM THEO, V2nd; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Gawne TJ, 1996, CEREB CORTEX, V6, P482, DOI 10.1093/cercor/6.3.482; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; Kennel MB, 2005, NEURAL COMPUT, V17, P1531, DOI 10.1162/0899766053723050; Meister M, 1996, P NATL ACAD SCI USA, V93, P609, DOI 10.1073/pnas.93.2.609; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Puchalla JL, 2005, NEURON, V46, P493, DOI 10.1016/j.neuron.2005.03.026; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; Samonds JM, 2006, J NEUROPHYSIOL, V95, P2602, DOI 10.1152/jn.01070.2005; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Tang A, 2008, J NEUROSCI, V28, P505, DOI 10.1523/JNEUROSCI.3359-07.2008; Thomson MGA, 2001, NETWORK-COMP NEURAL, V12, P271, DOI 10.1088/0954-898X/12/3/303; Victor JD, 2006, J NEUROPHYSIOL, V95, P379, DOI 10.1152/jn.00498.2005; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; Yu S, 2008, CEREB CORTEX, V18, P2891, DOI 10.1093/cercor/bhn047	30	220	221	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 29	2010	466	7306					617	U4		10.1038/nature09178	http://dx.doi.org/10.1038/nature09178			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20601940	Green Accepted			2022-12-01	WOS:000280412100052
J	Evans, J; Rzhetsky, A				Evans, James; Rzhetsky, Andrey			Machine Science	SCIENCE			English	Editorial Material							HYPOTHESIS GENERATION; KNOWLEDGE; SYSTEMS; NETWORK		[Evans, James; Rzhetsky, Andrey] Univ Chicago, Dept Sociol, Chicago, IL 60637 USA	University of Chicago	Evans, J (corresponding author), Univ Chicago, Dept Sociol, Chicago, IL 60637 USA.	jevans@uchicago.edu	rzhetsky, andrey/B-6118-2012	rzhetsky, andrey/0000-0001-6959-7405	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094267] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010132] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM061372-08, R01 GM061372, R01 GM061372-09] Funding Source: Medline; NIMH NIH HHS [P50 MH094267] Funding Source: Medline; NLM NIH HHS [R01 LM010132, R01 LM010132-02, R01 LM010132-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		BLAKE J, 2009, COMMUNICATION   0205; Bongard J, 2007, P NATL ACAD SCI USA, V104, P9943, DOI 10.1073/pnas.0609476104; Cokol M, 2005, NAT BIOTECHNOL, V23, P1243, DOI 10.1038/nbt1005-1243; Feret J, 2009, P NATL ACAD SCI USA, V106, P6453, DOI 10.1073/pnas.0809908106; Golub TR, 2010, NATURE, V464, P679, DOI 10.1038/464679a; Harris Z., 1989, FORM INFORM SCI ANAL; Harris Zellig, 1982, SUBLANGUAGE STUDIES, P231; HOOD L, 2004, BIOCOMMERCE WEE 0909; Hsiao TL, 2010, NAT CHEM BIOL, V6, P34, DOI [10.1038/NCHEMBIO.266, 10.1038/nchembio.266]; Iossifov I, 2008, GENOME RES, V18, P1150, DOI 10.1101/gr.075622.107; King RD, 2004, NATURE, V427, P247, DOI 10.1038/nature02236; King RD, 2009, SCIENCE, V324, P85, DOI 10.1126/science.1165620; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Liu J, 2009, SCIENCE, V323, P1218, DOI 10.1126/science.1157669; O'Malley MA, 2009, CELL, V138, P611, DOI 10.1016/j.cell.2009.08.008; Perez-Iratxeta C, 2002, NAT GENET, V31, P316, DOI 10.1038/ng895; Ruths DA, 2006, J COMPUT BIOL, V13, P1546, DOI 10.1089/cmb.2006.13.1546; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; SWANSON DR, 1986, PERSPECT BIOL MED, V30, P7; Swanson DR, 1997, ARTIF INTELL, V91, P183, DOI 10.1016/S0004-3702(97)00008-8; SWANSON DR, 1990, B MED LIBR ASSOC, V78, P29; Twain Mark, 1889, CONNECTICUT YANKEE K; Weeber M, 2003, J AM MED INFORM ASSN, V10, P252, DOI 10.1197/jamia.M1158; Wren JD, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-145	24	38	39	3	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					399	400		10.1126/science.1189416	http://dx.doi.org/10.1126/science.1189416			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	629KJ	20651141	Green Accepted			2022-12-01	WOS:000280196500023
J	Hughes, V				Hughes, Virginia			The outlook for a cure	NATURE			English	Editorial Material							COMBINATION THERAPY; HIV-1 INFECTION											Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939	5	5	5	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S11	S13		10.1038/nature09240	http://dx.doi.org/10.1038/nature09240			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631696				2022-12-01	WOS:000279867100029
J	Maxmen, A				Maxmen, Amy			Grassroots initiatives	NATURE			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S20	S20		10.1038/nature09244	http://dx.doi.org/10.1038/nature09244			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631701	Bronze			2022-12-01	WOS:000279867100033
J	Pace, P; Mosedale, G; Hodskinson, MR; Rosado, IV; Sivasubramaniam, M; Patel, KJ				Pace, Paul; Mosedale, Georgina; Hodskinson, Michael R.; Rosado, Ivan V.; Sivasubramaniam, Meera; Patel, Ketan J.			Ku70 Corrupts DNA Repair in the Absence of the Fanconi Anemia Pathway	SCIENCE			English	Article							STRAND BREAK REPAIR; PROTEIN; GENE; PROMOTES; RECOMBINATION; FIDELITY; REVEALS	A conserved DNA repair response is defective in the human genetic illness Fanconi anemia (FA). Mutation of some FA genes impairs homologous recombination and error-prone DNA repair, rendering FA cells sensitive to DNA cross-linking agents. We found a genetic interaction between the FA gene FANCC and the nonhomologous end joining (NHEJ) factor Ku70. Disruption of both FANCC and Ku70 suppresses sensitivity to cross-linking agents, diminishes chromosome breaks, and reverses defective homologous recombination. Ku70 binds directly to free DNA ends, committing them to NHEJ repair. We show that purified FANCD2, a downstream effector of the FA pathway, might antagonize Ku70 activity by modifying such DNA substrates. These results reveal a function for the FA pathway in processing DNA ends, thereby diverting double-strand break repair away from abortive NHEJ and toward homologous recombination.	[Pace, Paul; Hodskinson, Michael R.; Rosado, Ivan V.; Sivasubramaniam, Meera; Patel, Ketan J.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Mosedale, Georgina] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England	MRC Laboratory Molecular Biology; University of Oxford	Patel, KJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	kjp@mrc-lmb.cam.ac.uk	Rosado, Ivan/AAZ-9068-2020; Pace, Paul E/A-3104-2012	Rosado, Ivan/0000-0001-7409-7341; Pace, Paul E/0000-0003-1855-5760	Children's Leukaemia Trust; Leukaemia and Lymphoma Research Fund; FEBS; Medical Research Council [MC_U105178811] Funding Source: researchfish; MRC [MC_U105178811] Funding Source: UKRI	Children's Leukaemia Trust; Leukaemia and Lymphoma Research Fund; FEBS; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Takata for the anti-Ku70 antibody and the Ku70 cDNA expression vector; H. Koyama and S. Takeda for Delta Lig4, Delta Ku70, and Delta DNA-PKcs DT40 cell lines; H. Joenje and J. DeWinter for human FANCC cell lines; and W. Niedzwiedz and J. Sale for help with IgM sequence analysis. Supported by the Children's Leukaemia Trust (G. M.), the Leukaemia and Lymphoma Research Fund (M. R. H.), and a FEBS fellowship (I.V.R.).	Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Escarceller M, 1997, SOMAT CELL MOLEC GEN, V23, P401, DOI 10.1007/BF02673750; Escarceller M, 1998, J MOL BIOL, V279, P375, DOI 10.1006/jmbi.1998.1784; Fukushima T, 2001, J BIOL CHEM, V276, P44413, DOI 10.1074/jbc.M106295200; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Houghtaling S, 2005, HUM MOL GENET, V14, P3027, DOI 10.1093/hmg/ddi334; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Matsushita N, 2005, MOL CELL, V19, P841, DOI 10.1016/j.molcel.2005.08.018; Mazloum N, 2009, MOL CELL, V36, P620, DOI 10.1016/j.molcel.2009.09.033; Mazloum N, 2009, MOL CELL, V33, P160, DOI 10.1016/j.molcel.2008.12.023; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Park WH, 2005, J BIOL CHEM, V280, P23593, DOI 10.1074/jbc.M503730200; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Sale JE, 2001, PHILOS T R SOC B, V356, P21, DOI 10.1098/rstb.2000.0744; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Zhang ZM, 2001, J BIOL CHEM, V276, P38231	18	190	196	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					219	223		10.1126/science.1192277	http://dx.doi.org/10.1126/science.1192277			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20538911				2022-12-01	WOS:000279635200050
J	Mulherin, TC				Mulherin, Timothy C.			Personal View Don't forget the family	BRITISH MEDICAL JOURNAL			English	Editorial Material									Deakin Univ, Melbourne, Vic, Australia	Deakin University	Mulherin, TC (corresponding author), Deakin Univ, Melbourne, Vic, Australia.	tmulherin1@hotmail.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 7	2010	341								c3486	10.1136/bmj.c3486	http://dx.doi.org/10.1136/bmj.c3486			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	625DL	20610495				2022-12-01	WOS:000279874300007
J	Langley, JA; Megonigal, JP				Langley, J. Adam; Megonigal, J. Patrick			Ecosystem response to elevated CO2 levels limited by nitrogen-induced plant species shift	NATURE			English	Article							SOIL NUTRIENT; CLIMATE; COMPETITION; LIMITATION; FEEDBACKS; DIVERSITY	Terrestrial ecosystems gain carbon through photosynthesis and lose it mostly in the form of carbon dioxide (CO2). The extent to which the biosphere can act as a buffer against rising atmospheric CO2 concentration in global climate change projections remains uncertain at the present stage(1-4). Biogeochemical theory predicts that soil nitrogen (N) scarcity may limit natural ecosystem response to elevated CO2 concentration, diminishing the CO2-fertilization effect on terrestrial plant productivity in unmanaged ecosystems(3-7). Recent models have incorporated such carbon-nitrogen interactions and suggest that anthropogenic N sources could help sustain the future CO2-fertilization effect(8,9). However, conclusive demonstration that added N enhances plant productivity in response to CO2-fertilization in natural ecosystems remains elusive. Here we manipulated atmospheric CO2 concentration and soil N availability in a herbaceous brackish wetland where plant community composition is dominated by a C-3 sedge and C-4 grasses, and is capable of responding rapidly to environmental change(10). We found that N addition enhanced the CO2-stimulation of plant productivity in the first year of a multi-year experiment, indicating N-limitation of the CO2 response. But we also found that N addition strongly promotes the encroachment of C-4 plant species that respond less strongly to elevated CO2 concentrations. Overall, we found that the observed shift in the plant community composition ultimately suppresses the CO2-stimulation of plant productivity by the third and fourth years. Although extensive research has shown that global change factors such as elevated CO2 concentrations and N pollution affect plant species differently(11-13), and that they may drive plant community changes(14-17), we demonstrate that plant community shifts can act as a feedback effect that alters the whole ecosystem response to elevated CO2 concentrations. Moreover, we suggest that trade-offs between the abilities of plant taxa to respond positively to different perturbations may constrain natural ecosystem response to global change.	[Langley, J. Adam; Megonigal, J. Patrick] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; [Langley, J. Adam] Villanova Univ, Dept Biol, Villanova, PA 19084 USA	Smithsonian Institution; Smithsonian Environmental Research Center; Villanova University	Langley, JA (corresponding author), Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA.	langleya@si.edu		Megonigal, Patrick/0000-0002-2018-7883	USGS [06ERAG0011]; US Department of Energy [DE-FG02-97ER62458]; US Department of Energy's Office of Science (BER) through the Coastal Center of the National Institute of Climate Change Research at Tulane University; Smithsonian Institution; Direct For Biological Sciences [0950080] Funding Source: National Science Foundation	USGS(United States Geological Survey); US Department of Energy(United States Department of Energy (DOE)); US Department of Energy's Office of Science (BER) through the Coastal Center of the National Institute of Climate Change Research at Tulane University(United States Department of Energy (DOE)); Smithsonian Institution(Smithsonian Institution); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We acknowledge the support of D. Cahoon, our primary US Geological Survey collaborator, who co-developed the experimental design of this study. We thank J. Duls, J. Keller, M. Sigrist, G. Peresta, B. Drake, E. Sage, A. Martin, D. McKinley, N. Mudd and K. White for the construction and maintenance of the field site at the Smithsonian Climate Change Facility. We appreciate comments from S. Chapman, A. Classen, J. Hines, B. Hungate, T. Mozdzer, A. Sutton-Grier and D. Whigham. The field study was supported by the USGS Global Change Research Program (cooperative agreement 06ERAG0011), the US Department of Energy (grant DE-FG02-97ER62458), the US Department of Energy's Office of Science (BER) through the Coastal Center of the National Institute of Climate Change Research at Tulane University, and the Smithsonian Institution.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Chapman SK, 2006, NEW PHYTOL, V169, P27, DOI 10.1111/j.1469-8137.2005.01571.x; Craine J.M., 2009, RESOURCE STRATEGIES; Craine JM, 2003, ECOL LETT, V6, P623, DOI 10.1046/j.1461-0248.2003.00467.x; de Graaff MA, 2006, GLOBAL CHANGE BIOL, V12, P2077, DOI 10.1111/j.1365-2486.2006.01240.x; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Dukes JS, 2005, PLOS BIOL, V3, P1829, DOI 10.1371/journal.pbio.0030319; Erickson JE, 2007, GLOBAL CHANGE BIOL, V13, P202, DOI 10.1111/j.1365-2486.2006.01285.x; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Jablonski LM, 2002, NEW PHYTOL, V156, P9, DOI 10.1046/j.1469-8137.2002.00494.x; Keller JK, 2009, BIOGEOCHEMISTRY, V96, P101, DOI 10.1007/s10533-009-9347-3; Langley JA, 2009, P NATL ACAD SCI USA, V106, P6182, DOI 10.1073/pnas.0807695106; Levine JM, 1998, J ECOL, V86, P285, DOI 10.1046/j.1365-2745.1998.00253.x; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Pennings SC, 2005, OIKOS, V110, P547, DOI 10.1111/j.0030-1299.2005.13792.x; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Reich PB, 2001, NEW PHYTOL, V150, P435, DOI 10.1046/j.1469-8137.2001.00114.x; Reich PB, 2006, ANNU REV ECOL EVOL S, V37, P611, DOI 10.1146/annurev.ecolsys.37.091305.110039; Reich PB, 2009, SCIENCE, V326, P1399, DOI 10.1126/science.1178820; REYNOLDS HL, 1993, AM NAT, V141, P51, DOI 10.1086/285460; Schneider MK, 2004, GLOBAL CHANGE BIOL, V10, P1377, DOI 10.1111/j.1365-2486.2004.00803.x; Smith MD, 2009, ECOLOGY, V90, P3279, DOI 10.1890/08-1815.1; Sokolov AP, 2008, J CLIMATE, V21, P3776, DOI 10.1175/2008JCLI2038.1; Thornton PE, 2009, BIOGEOSCIENCES, V6, P2099, DOI 10.5194/bg-6-2099-2009; TILMAN D, 1988; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Zavaleta ES, 2003, ECOL MONOGR, V73, P585, DOI 10.1890/02-4053	30	174	183	4	274	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					96	99		10.1038/nature09176	http://dx.doi.org/10.1038/nature09176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596018				2022-12-01	WOS:000279343800041
J	Cazalla, D; Yario, T; Steitz, J				Cazalla, Demian; Yario, Therese; Steitz, Joan			Down-Regulation of a Host MicroRNA by a Herpesvirus saimiri Noncoding RNA	SCIENCE			English	Article							SMALL NUCLEAR RNAS; TRANSFORMED T-CELLS; GENES; EXPRESSION; DEGRADATION; MIR-27A	T cells transformed by Herpesvirus saimiri express seven viral U-rich noncoding RNAs of unknown function called HSURs. We noted that conserved sequences in HSURs 1 and 2 constitute potential binding sites for three host-cell microRNAs (miRNAs). Coimmunoprecipitation experiments confirmed that HSURs 1 and 2 interact with the predicted miRNAs in virally transformed T cells. The abundance of one of these miRNAs, miR-27, is dramatically lowered in transformed cells, with consequent effects on the expression of miR-27 target genes. Transient knockdown and ectopic expression of HSUR 1 demonstrate that it directs degradation of mature miR-27 in a sequence-specific and binding-dependent manner. This viral strategy illustrates use of a ncRNA to manipulate host-cell gene expression via the miRNA pathway.	[Cazalla, Demian; Yario, Therese; Steitz, Joan] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, Howard Hughes Med Inst,Boyer Ctr Mol Med, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University	Steitz, J (corresponding author), Yale Univ, Sch Med, Dept Mol Biophys & Biochem, Howard Hughes Med Inst,Boyer Ctr Mol Med, 295 Congress Ave, New Haven, CT 06536 USA.	joan.steitz@yale.edu		Cazalla, Demian/0000-0002-9076-3655	NIH [CA16038]; NATIONAL CANCER INSTITUTE [P01CA016038] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Giraldez for initial bioinformatic searches, R. C. Desrosiers for plasmids and cell lines, R. Jobava for technical assistance, K. Tycowski and K. Riley for critical commentary, and A. Miccinello for editorial assistance. This work was supported by grant CA16038 from the NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. J.S. is an investigator at the Howard Hughes Medical Institute.	Albrecht JC, 2000, J VIROL, V74, P1033, DOI 10.1128/JVI.74.2.1033-1037.2000; Ben-Ami O, 2009, P NATL ACAD SCI USA, V106, P238, DOI 10.1073/pnas.0811466106; BIESINGER B, 1990, VIROLOGY, V176, P505, DOI 10.1016/0042-6822(90)90020-R; Buck AH, 2010, RNA, V16, P307, DOI 10.1261/rna.1819210; CIMINO GD, 1985, ANNU REV BIOCHEM, V54, P1151, DOI 10.1146/annurev.bi.54.070185.005443; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cook HL, 2005, CURR BIOL, V15, P974, DOI 10.1016/j.cub.2005.04.034; Cook HL, 2004, MOL CELL BIOL, V24, P4522, DOI 10.1128/MCB.24.10.4522-4533.2004; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ensser A, 1999, J VIROL, V73, P10551, DOI 10.1128/JVI.73.12.10551-10555.1999; Ensser A, 2005, ADV CANCER RES, V93, P91, DOI 10.1016/S0065-230X(05)93003-0; Fan XHC, 1997, GENE DEV, V11, P2557, DOI 10.1101/gad.11.19.2557; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Ideue T, 2009, RNA, V15, P1578, DOI 10.1261/rna.1657609; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LEE SI, 1988, CELL, V54, P599, DOI 10.1016/S0092-8674(88)80004-7; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; MURTHY SCS, 1989, J VIROL, V63, P3307, DOI 10.1128/JVI.63.8.3307-3314.1989; MYER VE, 1992, P NATL ACAD SCI USA, V89, P1296, DOI 10.1073/pnas.89.4.1296; WASSARMAN DA, 1989, NUCLEIC ACIDS RES, V17, P1258, DOI 10.1093/nar/17.3.1258	24	348	367	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1563	1566		10.1126/science.1187197	http://dx.doi.org/10.1126/science.1187197			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558719	Green Accepted			2022-12-01	WOS:000278859200048
J	Levy, C; Khaled, M; Robinson, KC; Veguilla, RA; Chen, PH; Yokoyama, S; Makino, E; Lu, J; Larue, L; Beermann, F; Chin, L; Bosenberg, M; Song, JS; Fisher, DE				Levy, Carmit; Khaled, Mehdi; Robinson, Kathleen C.; Veguilla, Rosa A.; Chen, Po-Hao; Yokoyama, Satoru; Makino, Eiichi; Lu, Jun; Larue, Lionel; Beermann, Friedrich; Chin, Lynda; Bosenberg, Marcus; Song, Jun. S.; Fisher, David E.			Lineage-Specific Transcriptional Regulation of DICER by MITF in Melanocytes	CELL			English	Article							POSTTRANSCRIPTIONAL REGULATION; MICRORNA BIOGENESIS; BCL-2 DEFICIENCY; MASTER REGULATOR; EXPRESSION; MICROPHTHALMIA; MELANOMA; GENE; SURVIVAL; FAMILY	DICER is a central regulator of microRNA maturation. However, little is known about mechanisms regulating its expression in development or disease. While profiling miRNA expression in differentiating melanocytes, two populations were observed: some upregulated at the pre-miRNA stage, and others upregulated as mature miRNAs (with stable pre-miRNA levels). Conversion of pre-miRNAs to fully processed miRNAs appeared to be dependent upon stimulation of DICER expression-an event found to occur via direct transcriptional targeting of DICER by the melanocyte master transcriptional regulator MITF. MITF binds and activates a conserved regulatory element upstream of DICER's transcriptional start site upon melanocyte differentiation. Targeted KO of DICER is lethal to melanocytes, at least partly via DICER-dependent processing of the pre-miRNA-17 similar to 92 cluster thus targeting BIM, a known proapoptotic regulator of melanocyte survival. These observations highlight a central mechanism underlying lineage-specific miRNA regulation which could exist for other cell types during development.	[Levy, Carmit; Khaled, Mehdi; Robinson, Kathleen C.; Veguilla, Rosa A.; Yokoyama, Satoru; Makino, Eiichi; Fisher, David E.] Harvard Univ, Sch Med, Dept Dermatol, Cutaneous Biol Res Ctr,Mass Gen Hosp, Boston, MA 02115 USA; [Chen, Po-Hao] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Lu, Jun] Broad Inst, Cambridge, MA 02141 USA; [Lu, Jun] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Lu, Jun] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Larue, Lionel] UMR CNRS 146, Inst Curie, F-91405 Orsay, France; [Beermann, Friedrich] Swiss Inst Expt Canc Res, EPFL SV ISREC, CH-1015 Lausanne, Switzerland; [Chin, Lynda] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Bosenberg, Marcus] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Song, Jun. S.] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Harvard University; Dana-Farber Cancer Institute; Yale University; Institute for Advanced Study - USA	Fisher, DE (corresponding author), Harvard Univ, Sch Med, Dept Dermatol, Cutaneous Biol Res Ctr,Mass Gen Hosp, Boston, MA 02115 USA.	dfisher3@partners.org	Yokoyama, Satoru/AAT-3254-2021; Fisher, David/AAH-2878-2019; Larue, Lionel/F-7355-2013; Song, Jun S/E-2526-2016; khaled, mehdi/C-4854-2012; Larue, Lionel/I-6532-2016	Song, Jun S/0000-0002-0422-2175; khaled, mehdi/0000-0002-9880-858X; Yokoyama, Satoru/0000-0001-8336-486X	Martin A. and Helen Chooljian Membership; NIH; Melanoma Research Alliance; Doris Duke Charitable Foundation; Adelson Medical Research Foundation; Israel-US Binational Science Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER	Martin A. and Helen Chooljian Membership; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Adelson Medical Research Foundation; Israel-US Binational Science Foundation(US-Israel Binational Science Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors gratefully acknowledge help from Dr. Rod Bronson with mouse pathology; Dr. Carl Novina for useful discussions; Dr. Ian Jackson for Dct-LacZ transgenic mice; Dr. T. Kunisada for K14-SCF transgenic mice; Dr. Clifford J. Tabin for Dicer Floxed mice; Dr. Ruth Halaban for 501mel melanoma cells; Maja Janas, Ana Hernandez, Dr. Jacob Hanna, and members of the Fisher lab for help with numerous aspects of this work. JSS was supported in part by the Martin A. and Helen Chooljian Membership. D.E.F. gratefully acknowledges grant support from NIH, The Melanoma Research Alliance, The Doris Duke Charitable Foundation, The Adelson Medical Research Foundation, and the Israel-US Binational Science Foundation.	Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Asada S, 2008, AM J PHYSIOL-HEART C, V295, pH2512, DOI 10.1152/ajpheart.00233.2008; Barbato C, 2007, BRAIN RES, V1175, P17, DOI 10.1016/j.brainres.2007.07.088; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Bouillet P, 2001, DEV CELL, V1, P645, DOI 10.1016/S1534-5807(01)00083-1; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cai BB, 2006, J BIOL CHEM, V281, P25215, DOI 10.1074/jbc.M512627200; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cartlidge RA, 2008, PIGM CELL MELANOMA R, V21, P534, DOI 10.1111/j.1755-148X.2008.00491.x; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Davis IJ, 2006, CANCER CELL, V9, P473, DOI 10.1016/j.ccr.2006.04.021; Delmas V, 2003, GENESIS, V36, P73, DOI 10.1002/gene.10197; Du TT, 2007, CELL RES, V17, P661, DOI 10.1038/cr.2007.67; Ewings KE, 2007, CELL CYCLE, V6, P2236, DOI 10.4161/cc.6.18.4728; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Guyonneau L, 2004, MOL CELL BIOL, V24, P3396, DOI 10.1128/MCB.24.8.3396-3403.2004; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Jaskiewicz L, 2008, CURR TOP MICROBIOL, V320, P77; KAMADA S, 1995, CANCER RES, V55, P354; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Kunisada T, 1998, J EXP MED, V187, P1565, DOI 10.1084/jem.187.10.1565; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2008, TRENDS GENET, V24, P448, DOI 10.1016/j.tig.2008.06.004; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Maroney PA, 2006, COLD SPRING HARB SYM, V71, P531, DOI 10.1101/sqb.2006.71.043; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Miller AJ, 2004, CANCER RES, V64, P509, DOI 10.1158/0008-5472.CAN-03-2440; Neilson JR, 2008, CELL, V134, P899, DOI 10.1016/j.cell.2008.09.006; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Osawa M, 2005, DEVELOPMENT, V132, P5589, DOI 10.1242/dev.02161; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Price ER, 1998, J BIOL CHEM, V273, P33042, DOI 10.1074/jbc.273.49.33042; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Schier AF, 2006, COLD SPRING HARB SYM, V71, P195, DOI 10.1101/sqb.2006.71.055; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; STEINGRIMSSON E, 2004, ANNU REV GENET, V365, P411; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu HQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007566; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yamamura K, 1996, CANCER RES, V56, P3546; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zeng Yan, 2006, V342, P49, DOI 10.1385/1-59745-123-1:49; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	79	92	97	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					994	1005		10.1016/j.cell.2010.05.004	http://dx.doi.org/10.1016/j.cell.2010.05.004			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550935	Bronze, Green Accepted			2022-12-01	WOS:000278618800014
J	Baldridge, MT; King, KY; Boles, NC; Weksberg, DC; Goodell, MA				Baldridge, Megan T.; King, Katherine Y.; Boles, Nathan C.; Weksberg, David C.; Goodell, Margaret A.			Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection	NATURE			English	Article							PROGENITOR CELLS; IDENTIFICATION; HOMEOSTASIS; DEFICIENT; ALPHA	Lymphocytes and neutrophils are rapidly depleted by systemic infection(1). Progenitor cells of the haematopoietic system, such as common myeloid progenitors and common lymphoid progenitors, increase the production of immune cells to restore and maintain homeostasis during chronic infection, but the contribution of haematopoietic stem cells (HSCs) to this process is largely unknown(2). Here we show, using an in vivo mouse model of Mycobacterium avium infection, that an increased proportion of long-term repopulating HSCs proliferate during M. avium infection, and that this response requires interferon-gamma (IFN-gamma) but not interferon-alpha (IFN-alpha) signalling. Thus, the haematopoietic response to chronic bacterial infection involves the activation not only of intermediate blood progenitors but of long-term repopulating HSCs as well. IFN-gamma is sufficient to promote long-term repopulating HSC proliferation in vivo; furthermore, HSCs from IFN-gamma-deficient mice have a lower proliferative rate, indicating that baseline IFN-gamma tone regulates HSC activity. These findings implicate IFN-gamma both as a regulator of HSCs during homeostasis and under conditions of infectious stress. Our studies contribute to a deeper understanding of haematological responses in patients with chronic infections such as HIV/AIDS or tuberculosis(3-5).	[Baldridge, Megan T.; Weksberg, David C.; Goodell, Margaret A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [King, Katherine Y.; Goodell, Margaret A.] Baylor Coll Med, Dept Pediat, Infect Dis Sect, Houston, TX 77030 USA; [Boles, Nathan C.; Goodell, Margaret A.] Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Goodell, MA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	goodell@bcm.edu	Baldridge, Megan/T-7274-2019; King, Katherine/AAI-2436-2021	Baldridge, Megan/0000-0002-7030-6131; Goodell, Margaret A./0000-0003-1111-2932; King, Katherine/0000-0002-5093-6005	NIDDK institute of the National Institutes of Health (NIH); Texas Children's Hospital Auxiliary; Simmons Foundation; NHLBI institute of the NIH; NCI institute of the NIH; NIBIB institute of the NIH; NATIONAL CANCER INSTITUTE [P50CA126752] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL081007, T32HL092332, K08HL098898, R01HL096360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK082107, R01DK058192] Funding Source: NIH RePORTER	NIDDK institute of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Children's Hospital Auxiliary; Simmons Foundation; NHLBI institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIBIB institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Feng and A. Sher for providing Mycobacterium avium. We also thank D. Levy and C. Schindler for providing us with Stat1 and Ifnar1 knockout mice. We are grateful to G. Challen for providing information about Ifngr1, to Y. Zheng and S. Wu for technical assistance, and to J. Gilbert for critical reading of the manuscript. M. T. B. is supported by the NIDDK institute of the National Institutes of Health (NIH), and K. Y. K. was supported by the Adeline B. Landa Fellowship of the Texas Children's Hospital Auxiliary and the Simmons Foundation Collaborative Research Fund. This work was supported by the NIDDK, NHLBI, NCI and NIBIB institutes of the NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Appelberg R, 2006, IMMUNOL RES, V35, P179, DOI 10.1385/IR:35:3:179; Camargo FD, 2006, BLOOD, V107, P501, DOI 10.1182/blood-2005-02-0655; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Cheshier SH, 2007, STEM CELLS DEV, V16, P707, DOI 10.1089/scd.2007.0017; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Ezoe S, 2004, CELL CYCLE, V3, P314; Feng CG, 2008, CELL STEM CELL, V2, P83, DOI 10.1016/j.stem.2007.10.007; Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163; Florido M, 2005, INFECT IMMUN, V73, P3577, DOI 10.1128/IAI.73.6.3577-3586.2005; Hawkins CA, 2006, INTERN MED J, V36, P385, DOI 10.1111/j.1445-5994.2006.01076.x; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Klautau Giselle Burlamaqui, 2005, Braz J Infect Dis, V9, P464, DOI 10.1590/S1413-86702005000600004; Marleau AM, 2005, J LEUKOCYTE BIOL, V78, P575, DOI 10.1189/jlb.0105050; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Murray PJ, 1998, BLOOD, V91, P2914, DOI 10.1182/blood.V91.8.2914.2914_2914_2924; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Saunders BM, 2002, IMMUNOL CELL BIOL, V80, P544, DOI 10.1046/j.1440-1711.2002.01121.x; Shahbazian LM, 2004, CRIT CARE MED, V32, P1740, DOI 10.1097/01.CCM.0000132900.84627.90; Singh K J, 2001, J Assoc Physicians India, V49, P790; Singh P, 2008, STEM CELLS, V26, P1009, DOI 10.1634/stemcells.2007-0461; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Sundell I Birgitta, 2006, J Stem Cells, V1, P283; VALENTE G, 1992, EUR J IMMUNOL, V22, P2403, DOI 10.1002/eji.1830220933; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Weksberg DC, 2008, BLOOD, V111, P2444, DOI 10.1182/blood-2007-09-115006; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhang P, 2008, STEM CELLS, V26, P1778, DOI 10.1634/stemcells.2007-1027	32	578	584	3	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					793	U9		10.1038/nature09135	http://dx.doi.org/10.1038/nature09135			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535209	Green Accepted			2022-12-01	WOS:000278551800048
J	Terkelsen, CJ; Sorensen, JT; Maeng, M; Jensen, LO; Tilsted, HH; Trautner, S; Vach, W; Johnsen, SP; Thuesen, L; Lassen, JF				Terkelsen, Christian Juhl; Sorensen, Jacob Thorsted; Maeng, Michael; Jensen, Lisette Okkels; Tilsted, Hans-Henrik; Trautner, Sven; Vach, Werner; Johnsen, Soren Paaske; Thuesen, Leif; Lassen, Jens Flensted			System Delay and Mortality Among Patients With STEMI Treated With Primary Percutaneous Coronary Intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; TO-BALLOON TIME; REPERFUSION THERAPY; PRIMARY ANGIOPLASTY; PRIMARY PCI; ASSOCIATION; SURVIVAL; IMPACT; MATTER; SIZE	Context Timely reperfusion therapy is recommended for patients with ST-segment elevation myocardial infarction (STEMI), and door-to-balloon delay has been proposed as a performance measure in triaging patients for primary percutaneous coronary intervention (PCI). However, focusing on the time from first contact with the health care system to the initiation of reperfusion therapy (system delay) may be more relevant, because it constitutes the total time to reperfusion modifiable by the health care system. No previous studies have focused on the association between system delay and outcome in patients with STEMI treated with primary PCI. Objective To evaluate the associations between system, treatment, patient, and door-to-balloon delays and mortality in patients with STEMI. Design, Setting, and Patients Historical follow-up study based on population-based Danish medical registries of patients with STEMI transported by the emergency medical service and treated with primary PCI from January 1, 2002, to December 31, 2008, at 3 high-volume PCI centers in Western Denmark. Patients (N=6209) underwent primary PCI within 12 hours of symptom onset. The median follow-up time was 3.4 (interquartile range, 1.8-5.2) years. Main Outcome Measures Crude and adjusted hazard ratios of mortality obtained by Cox proportional regression analysis. Results A system delay of 0 through 60 minutes (n=347) corresponded to a long-term mortality rate of 15.4% (n=43); a delay of 61 through 120 minutes (n=2643) to a rate of 23.3% (n=380); a delay of 121 through 180 minutes (n=2092) to a rate of 28.1% (n=378); and a delay of 181 through 360 minutes (n=1127) to a rate of 30.8% (n=275) (P<.001). In multivariable analysis adjusted for other predictors of mortality, system delay was independently associated with mortality (adjusted hazard ratio, 1.10 [95% confidence interval, 1.04-1.16] per 1-hour delay), as was its components, prehospital system delay and door-to-balloon delay. Conclusion System delay was associated with mortality in patients with STEMI treated with primary PCI. JAMA. 2010;304(7):763-771 www.jama.com	[Terkelsen, Christian Juhl; Sorensen, Jacob Thorsted; Maeng, Michael; Thuesen, Leif; Lassen, Jens Flensted] Aarhus Univ Hosp, Dept Cardiol, DK-8200 Aarhus N, Denmark; [Johnsen, Soren Paaske] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8200 Aarhus N, Denmark; [Jensen, Lisette Okkels] Odense Univ Hosp, Dept Cardiol, DK-5000 Odense, Denmark; [Tilsted, Hans-Henrik] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Trautner, Sven] Falck Emergency Med Serv, Copenhagen, Denmark; [Vach, Werner] Univ Med Ctr, Dept Clin Epidemiol, Freiburg, Germany	Aarhus University; Aarhus University; University of Southern Denmark; Odense University Hospital; Aalborg University; Aalborg University Hospital; University of Freiburg	Terkelsen, CJ (corresponding author), Aarhus Univ Hosp, Dept Cardiol, DK-8200 Aarhus N, Denmark.	christian_juhl_terkelsen@hotmail.com	terkelsen, christian/ABD-6294-2021; Maeng, Michael/AAY-2135-2021; Vach, Werner/F-2512-2011; Lassen, Jens Flensted/AAY-2127-2021	Maeng, Michael/0000-0002-4310-6433; Vach, Werner/0000-0003-1865-8399; Lassen, Jens Flensted/0000-0001-7972-9192; terkelsen, christian juhl/0000-0003-0205-9551; Jensen, Lisette Okkels/0000-0002-4838-2429	Helga and Peter Kornings Foundation, Aarhus, Denmark [40-134918]; Central Denmark Region, Aarhus, Denmark [1-45-72-1-08]	Helga and Peter Kornings Foundation, Aarhus, Denmark; Central Denmark Region, Aarhus, Denmark	This study was supported by grants from the Helga and Peter Kornings Foundation, Aarhus, Denmark (J.No. 40-134918) and the Health Research Fund of Central Denmark Region, Aarhus, Denmark (J.No. 1-45-72-1-08).	Allison P.D., 2002, MISSING DATA, DOI 10.4135/9781412985079; Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI 10.1016/j.jacc.2007.10.001; Aquaro GD, 2007, AM J CARDIOL, V100, P28, DOI 10.1016/j.amjcard.2007.02.050; Arntz HR, 1998, EUR HEART J, V19, P1140; Blohm MB, 1996, HEART, V76, P430, DOI 10.1136/hrt.76.5.430; Boersma E, 2006, EUR HEART J, V27, P779, DOI 10.1093/eurheartj/ehi810; Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; Bradley EH, 2009, J AM COLL CARDIOL, V54, P2423, DOI 10.1016/j.jacc.2009.11.003; Brodie BR, 1998, J AM COLL CARDIOL, V32, P1312, DOI 10.1016/S0735-1097(98)00395-7; Brodie BR, 2001, AM J CARDIOL, V88, P1085, DOI 10.1016/S0002-9149(01)02039-2; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hedges JR, 2000, ACAD EMERG MED, V7, P862, DOI 10.1111/j.1553-2712.2000.tb02063.x; Le May MR, 2008, NEW ENGL J MED, V358, P231, DOI 10.1056/NEJMoa073102; LEIZOROVICZ A, 1993, NEW ENGL J MED, V329, P383; LOWEL H, 1991, DEUT MED WOCHENSCHR, V116, P729, DOI 10.1055/s-2008-1063671; McNamara RL, 2006, J AM COLL CARDIOL, V47, P45, DOI 10.1016/j.jacc.2005.04.071; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Morrison LJ, 2000, JAMA-J AM MED ASSOC, V283, P2686, DOI 10.1001/jama.283.20.2686; Nallamothu BK, 2005, CIRCULATION, V111, P761, DOI 10.1161/01.CIR.0000155258.44268.F8; Nallamothu BK, 2007, NEW ENGL J MED, V357, P1631, DOI 10.1056/NEJMra065985; Pedersen CB, 2006, DAN MED BULL, V53, P441; Rathore SS, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1807; Schemper M, 1997, STAT MED, V16, P73; SCHEMPER M, 1990, STAT MED, V9, P777, DOI 10.1002/sim.4780090707; Sorensen H T, 1997, Int J Risk Saf Med, V10, P1, DOI 10.3233/JRS-1997-10101; Terkelsen CJ, 2009, HEART, V95, P362, DOI 10.1136/hrt.2007.139493; Terkelsen CJ, 2008, J AM COLL CARDIOL, V52, P1211, DOI 10.1016/j.jacc.2008.05.061; Terkelsen CJ, 2009, J ELECTROCARDIOL, V42, P64, DOI 10.1016/j.jelectrocard.2008.08.038; Terkelsen CJ, 2005, EUR HEART J, V26, P770, DOI 10.1093/eurheartj/ehi100; VACH W, 1993, BIOMETRIKA, V80, P353, DOI 10.2307/2337205; Zijistra F, 2002, EUR HEART J, V23, P550, DOI 10.1053/euhj.2001.2901	34	442	462	1	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 18	2010	304	7					763	771		10.1001/jama.2010.1139	http://dx.doi.org/10.1001/jama.2010.1139			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639SB	20716739				2022-12-01	WOS:000280993700023
J	Mahecha, MD; Reichstein, M; Carvalhais, N; Lasslop, G; Lange, H; Seneviratne, SI; Vargas, R; Ammann, C; Arain, MA; Cescatti, A; Janssens, IA; Migliavacca, M; Montagnani, L; Richardson, AD				Mahecha, Miguel D.; Reichstein, Markus; Carvalhais, Nuno; Lasslop, Gitta; Lange, Holger; Seneviratne, Sonia I.; Vargas, Rodrigo; Ammann, Christof; Arain, M. Altaf; Cescatti, Alessandro; Janssens, Ivan A.; Migliavacca, Mirco; Montagnani, Leonardo; Richardson, Andrew D.			Global Convergence in the Temperature Sensitivity of Respiration at Ecosystem Level	SCIENCE			English	Article							ORGANIC-MATTER DECOMPOSITION; SOIL RESPIRATION; CARBON; CLIMATE; DEPENDENCE; MODEL; EXCHANGE; ASSIMILATION; INTEGRATION; SEPARATION	The respiratory release of carbon dioxide (CO2) from the land surface is a major flux in the global carbon cycle, antipodal to photosynthetic CO2 uptake. Understanding the sensitivity of respiratory processes to temperature is central for quantifying the climate-carbon cycle feedback. We approximated the sensitivity of terrestrial ecosystem respiration to air temperature (Q(10)) across 60 FLUXNET sites with the use of a methodology that circumvents confounding effects. Contrary to previous findings, our results suggest that Q(10) is independent of mean annual temperature, does not differ among biomes, and is confined to values around 1.4 +/- 0.1. The strong relation between photosynthesis and respiration, by contrast, is highly variable among sites. The results may partly explain a less pronounced climate-carbon cycle feedback than suggested by current carbon cycle climate models.	[Mahecha, Miguel D.; Reichstein, Markus; Carvalhais, Nuno; Lasslop, Gitta] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Mahecha, Miguel D.; Seneviratne, Sonia I.] Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland; [Carvalhais, Nuno] Univ Nova Lisboa, FCT, P-2829516 Caparica, Portugal; [Lange, Holger] Norsk Inst Skog Landskap, N-1431 As, Norway; [Vargas, Rodrigo] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Ammann, Christof] Agroscope ART, Fed Res Stn, CH-8046 Zurich, Switzerland; [Arain, M. Altaf] McMaster Univ, McMaster Ctr Climate Change, Hamilton, ON L8S 4L8, Canada; [Cescatti, Alessandro] European Commiss, Joint Res Ctr, Inst Environm & Sustainabil, I-21027 Ispra, Italy; [Janssens, Ivan A.] Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium; [Migliavacca, Mirco] Univ Milano Bicocca, DISAT, Remote Sensing Environm Dynam Lab, I-20126 Milan, Italy; [Montagnani, Leonardo] Prov Autonoma Bolzano, Serv Forestali Agenzia Ambiente, I-39100 Bolzano, Italy; [Montagnani, Leonardo] Free Univ Bozen Bolzano, Fac Sci & Technol, I-39100 Bolzano, Italy; [Richardson, Andrew D.] Harvard Univ Herbaria, Harvard Univ Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; Universidade Nova de Lisboa; University of California System; University of California Berkeley; Swiss Federal Research Station Agroscope; McMaster University; European Commission Joint Research Centre; EC JRC ISPRA Site; University of Antwerp; University of Milano-Bicocca; Free University of Bozen-Bolzano; Harvard University	Mahecha, MD (corresponding author), Max Planck Inst Biogeochem, D-07745 Jena, Germany.	mmahecha@bgc-jena.mpg.de	Montagnani, Leonardo/F-1837-2016; Janssens, Ivan A/P-1331-2014; Reichstein, Markus/A-7494-2011; Mahecha, Miguel D/F-2443-2010; Arain, M. Altaf/ABA-9750-2020; Migliavacca, mirco/C-1260-2011; Migliavacca, Mirco/J-9986-2019; Richardson, Andrew/F-5691-2011; Seneviratne, Sonia I./G-8761-2011; Cescatti, Alessandro/ABE-6319-2020; Lange, Holger/A-2458-2012; Vargas, Rodrigo/C-4720-2008	Montagnani, Leonardo/0000-0003-2957-9071; Janssens, Ivan A/0000-0002-5705-1787; Reichstein, Markus/0000-0001-5736-1112; Mahecha, Miguel D/0000-0003-3031-613X; Arain, M. Altaf/0000-0002-1433-5173; Migliavacca, Mirco/0000-0003-3546-8407; Richardson, Andrew/0000-0002-0148-6714; Seneviratne, Sonia I./0000-0001-9528-2917; Lange, Holger/0000-0001-7099-8740; Vargas, Rodrigo/0000-0001-6829-5333; Ammann, Christof/0000-0002-0783-5444; Lasslop, Gitta/0000-0001-9939-1459; Carvalhais, Nuno/0000-0003-0465-1436	CarboEuropeIP; FAO-GTOS-TCO; Integrated Land Ecosystem-Atmosphere Processes Study (iLEAPS); Max Planck Institute for Biogeochemistry; NSF; University of Tuscia; U.S. Department of Energy; U.S. Department of Energy, Biological and Environmental Research [DE-FG02-04ER63917]; European Research Council; European Commission [FP7-ENV2008-1-226701]; Max Planck Society	CarboEuropeIP(European Commission); FAO-GTOS-TCO; Integrated Land Ecosystem-Atmosphere Processes Study (iLEAPS); Max Planck Institute for Biogeochemistry; NSF(National Science Foundation (NSF)); University of Tuscia; U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy, Biological and Environmental Research(United States Department of Energy (DOE)); European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work is the outcome of the La Thuile FLUXNET workshop 2007, which would not have been possible without the support provided by CarboEuropeIP, FAO-GTOS-TCO, the Integrated Land Ecosystem-Atmosphere Processes Study (iLEAPS, a core project of IGBP), Max Planck Institute for Biogeochemistry, NSF, University of Tuscia, and U.S. Department of Energy. Moreover, we acknowledge databasing and technical support from the Berkeley Water Center, Lawrence Berkeley National Laboratory, Microsoft Research eScience, Oak Ridge National Laboratory, University of California-Berkeley, and University of Virginia. The following networks provided flux data: AmeriFlux, AsiaFlux, CarboEuropeIP, ChinaFlux, FluxnetCanada, Canadian Carbon Program, LBA, NECC, OzFlux, TCOS-Siberia, and USCCC. AmeriFlux is supported by U.S. Department of Energy, Biological and Environmental Research, Terrestrial Carbon Program grant DE-FG02-04ER63917. This work was also supported by the European Research Council via the ERC-Staring Grant QUASOM, the European Commission project CARBO-Extreme (FP7-ENV2008-1-226701), and a grant by the Max Planck Society establishing the MPRG Biogeochemical Model-Data Integration. We appreciate the collaboration of the FLUXNET synthesis team as documented at (23), and we thank M. Bahn, D. Baldocchi, H.-R. Kunsch, D. Papale, P. Rayner, M. Rodeghiero, and S. Zaehle for very valuable comments. M.D.M., M.R., N.C., and G.L. conceived the study and developed the methodology with substantial input from H.L.M.D.M. performed the analysis and co-wrote the paper with M.R. All other authors gave substantial scientific input during the analysis and/or writing phase.	Agren GI, 2007, SOIL BIOL BIOCHEM, V39, P1794, DOI 10.1016/j.soilbio.2007.02.007; Amthor JS, 2000, ANN BOT-LONDON, V86, P1, DOI 10.1006/anbo.2000.1175; Bahn M, 2010, NEW PHYTOL, V186, P292, DOI 10.1111/j.1469-8137.2010.03237.x; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Frank DC, 2010, NATURE, V463, P527, DOI 10.1038/nature08769; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gu LH, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003164; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Heinemeyer A, 2006, NEW PHYTOL, V171, P159, DOI 10.1111/j.1469-8137.2006.01730.x; Jones CD, 2003, TELLUS B, V55, P642, DOI 10.1034/j.1600-0889.2003.01440.x; Katterer T, 1998, BIOL FERT SOILS, V27, P258, DOI 10.1007/s003740050430; Kirschbaum MUF, 2010, GLOBAL CHANGE BIOL, V16, P2117, DOI 10.1111/j.1365-2486.2009.02093.x; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; KNORR W, 1995, TELLUS B, V47, P471, DOI 10.1034/j.1600-0889.47.issue4.7.x; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Krinner G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002199; KUZYAKOV Z, 2010, GLOBAL CHANGE BIOL, DOI DOI 10.1111/J.1365-2486.2010.02179.X; Lasslop G, 2010, GLOBAL CHANGE BIOL, V16, P187, DOI 10.1111/j.1365-2486.2009.02041.x; Lenton TM, 2003, GLOBAL CHANGE BIOL, V9, P1333, DOI 10.1046/j.1365-2486.2003.00674.x; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Migliavacca M, 2011, GLOBAL CHANGE BIOL, V17, P390, DOI 10.1111/j.1365-2486.2010.02243.x; Moyano FE, 2008, AGR FOREST METEOROL, V148, P135, DOI 10.1016/j.agrformet.2007.09.006; Peng SS, 2009, SOIL BIOL BIOCHEM, V41, P1008, DOI 10.1016/j.soilbio.2008.10.023; Randerson JT, 2009, GLOBAL CHANGE BIOL, V15, P2462, DOI 10.1111/j.1365-2486.2009.01912.x; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1754, DOI 10.1111/j.1365-2486.2005.001010.x; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Reichstein M, 2008, J PLANT NUTR SOIL SC, V171, P344, DOI 10.1002/jpln.200700075; Sampson DA, 2007, GLOBAL CHANGE BIOL, V13, P2008, DOI 10.1111/j.1365-2486.2007.01414.x; Thornton PE, 2002, AGR FOREST METEOROL, V113, P185, DOI 10.1016/S0168-1923(02)00108-9	34	350	366	19	373	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2010	329	5993					838	840		10.1126/science.1189587	http://dx.doi.org/10.1126/science.1189587			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20603495				2022-12-01	WOS:000280809900050
J	Buschmann, S; Warkentin, E; Xie, H; Langer, JD; Ermler, U; Michel, H				Buschmann, Sabine; Warkentin, Eberhard; Xie, Hao; Langer, Julian D.; Ermler, Ulrich; Michel, Hartmut			The Structure of cbb(3) Cytochrome Oxidase Provides Insights into Proton Pumping	SCIENCE			English	Article							C-OXIDASE; ACTIVE-SITE; ENERGY TRANSDUCTION; RESPIRATORY-CHAIN; INPUT CHANNEL; OXYGEN; RESOLUTION; REDUCTASES; IDENTIFICATION; MECHANISM	The heme-copper oxidases (HCOs) accomplish the key event of aerobic respiration; they couple O-2 reduction and transmembrane proton pumping. To gain new insights into the still enigmatic process, we structurally characterized a C-family HCO-essential for the pathogenicity of many bacteria-that differs from the two other HCO families, A and B, that have been structurally analyzed. The x-ray structure of the C-family cbb(3) oxidase from Pseudomonas stutzeri at 3.2 angstrom resolution shows an electron supply system different from families A and B. Like family-B HCOs, C HCOs have only one pathway, which conducts protons via an alternative tyrosine-histidine cross-link. Structural differences around hemes b and b(3) suggest a different redox-driven proton-pumping mechanism and provide clues to explain the higher activity of family-C HCOs at low oxygen concentrations.	[Buschmann, Sabine; Warkentin, Eberhard; Xie, Hao; Langer, Julian D.; Ermler, Ulrich; Michel, Hartmut] Max Planck Inst Biophys, D-60438 Frankfurt, Germany	Max Planck Society	Michel, H (corresponding author), Max Planck Inst Biophys, Max von Laue Str 3, D-60438 Frankfurt, Germany.	hartmut.michel@mpibp-frankfurt.mpg.de		Langer, Julian David/0000-0002-5190-577X; Xie, Hao/0000-0002-2422-2527	Max Planck Society; Deutsche Forschungsgemeinschaft [SFB 472]; Cluster of Excellence Macromolecular Complexes Frankfurt	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence Macromolecular Complexes Frankfurt	This work was supported by the Max Planck Society, the Deutsche Forschungsgemeinschaft (SFB 472), and the Cluster of Excellence Macromolecular Complexes Frankfurt. We thank the staffs of the Swiss Light Source and the European Synchrotron Radiation Facility for assistance. Coordinates and structure factors of cbb<INF>3</INF> oxidase of P. stutzeri have been deposited under the pdb accession code 3MK7, the nucleotide sequences under gene bank accession number HM130676.	Abramson J, 2000, NAT STRUCT BIOL, V7, P910; Arslan E, 2000, FEBS LETT, V470, P7, DOI 10.1016/S0014-5793(00)01277-1; Chang HY, 2009, P NATL ACAD SCI USA, V106, P16169, DOI 10.1073/pnas.0905264106; Ducluzeau AL, 2008, MOL BIOL EVOL, V25, P1158, DOI 10.1093/molbev/msn062; Forte E, 2001, EUR J BIOCHEM, V268, P6486, DOI 10.1046/j.0014-2956.2001.02597.x; Hemp J, 2007, BIOCHEMISTRY-US, V46, P9963, DOI 10.1021/bi700659y; Hemp J, 2006, BIOCHEMISTRY-US, V45, P15405, DOI 10.1021/bi062026u; Hosler JP, 2006, ANNU REV BIOCHEM, V75, P165, DOI 10.1146/annurev.biochem.75.062003.101730; Huang YF, 2008, P NATL ACAD SCI USA, V105, P20257, DOI 10.1073/pnas.0805429106; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Koepke J, 2009, BBA-BIOENERGETICS, V1787, P635, DOI 10.1016/j.bbabio.2009.04.003; Moser CC, 2006, PHILOS T R SOC B, V361, P1295, DOI 10.1098/rstb.2006.1868; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; Ozturk M, 2007, MOL BIOL REP, V34, P165, DOI 10.1007/s11033-006-9031-9; Pereira MM, 2008, BBA-BIOENERGETICS, V1777, P929, DOI 10.1016/j.bbabio.2008.05.441; Peters A, 2008, J BACTERIOL, V190, P5576, DOI 10.1128/JB.00534-08; Pitcher RS, 2004, BBA-BIOENERGETICS, V1655, P388, DOI 10.1016/j.bbabio.2003.09.017; Pitcher RS, 2002, J BIOL CHEM, V277, P31474, DOI 10.1074/jbc.M204103200; Preisig O, 1996, J BACTERIOL, V178, P1532, DOI 10.1128/JB.178.6.1532-1538.1996; Qin L, 2006, P NATL ACAD SCI USA, V103, P16117, DOI 10.1073/pnas.0606149103; Rauhamaki V, 2006, P NATL ACAD SCI USA, V103, P16135, DOI 10.1073/pnas.0606254103; Rauhamaki V, 2009, J BIOL CHEM, V284, P11301, DOI 10.1074/jbc.M808839200; Reimann J, 2007, BBA-BIOENERGETICS, V1767, P362, DOI 10.1016/j.bbabio.2007.03.006; Richter OMH, 2009, BBA-BIOENERGETICS, V1787, P626, DOI 10.1016/j.bbabio.2009.02.020; Sharma V, 2008, BIOCHEMISTRY-US, V47, P4221, DOI 10.1021/bi702088r; Sharma V, 2006, BIOCHEMISTRY-US, V45, P5754, DOI 10.1021/bi060169a; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Urbani A, 2001, FEBS LETT, V508, P29, DOI 10.1016/S0014-5793(01)03006-X; Verkhovsky MI, 1996, NATURE, V380, P268, DOI 10.1038/380268a0; Weingarten RA, 2008, APPL ENVIRON MICROB, V74, P1367, DOI 10.1128/AEM.02261-07; Wikstrom M, 2007, BBA-BIOENERGETICS, V1767, P1200, DOI 10.1016/j.bbabio.2007.06.008; Zumft WG, 2005, J INORG BIOCHEM, V99, P194, DOI 10.1016/j.jinorgbio.2004.09.024	34	191	196	3	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2010	329	5989					327	330		10.1126/science.1187303	http://dx.doi.org/10.1126/science.1187303			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20576851				2022-12-01	WOS:000279925900043
J	Wu, YK; Yang, Y; Ye, S; Jiang, YX				Wu, Yunkun; Yang, Yi; Ye, Sheng; Jiang, Youxing			Structure of the gating ring from the human large-conductance Ca2+-gated K+ channel	NATURE			English	Article							DEPENDENT ACTIVATION; VOLTAGE SENSOR; LIPID-MEMBRANE; BKCA CHANNEL; ION-BINDING; RCK DOMAIN; CA2+; SENSITIVITY; MECHANISM; MG2+	Large-conductance Ca2+-gated K+ (BK) channels are essential for many biological processes such as smooth muscle contraction and neurotransmitter release(1-4). This group of channels can be activated synergistically by both voltage and intracellular Ca2+, with the large carboxy-terminal intracellular portion being responsible for Ca2+ sensing(5-13). Here we present the crystal structure of the entire cytoplasmic region of the human BK channel in a Ca2+-free state. The structure reveals four intracellular subunits, each comprising two tandem RCK domains, assembled into a gating ring similar to that seen in the MthK channel 14 and probably representing its physiological assembly. Three Ca2+ binding sites including the Ca2+ bowl are mapped onto the structure based on mutagenesis data. The Ca2+ bowl, located within the second RCK domain, forms an EF-hand-like motif and is strategically positioned close to the assembly interface between two subunits. The other two Ca2+ (or Mg2+) binding sites, Asp 367 and Glu 374/Glu 399, are located on the first RCK domain. The Asp 367 site has high Ca2+ sensitivity and is positioned in the groove between the amino-and carboxyterminal subdomains of RCK1, whereas the low-affinity Mg2+-binding Glu 374/Glu 399 site is positioned on the upper plateau of the gating ring and close to the membrane. Our structure also contains the linker connecting the transmembrane and intracellular domains, allowing us to dock a voltage-gated K+ channel pore of known structure onto the gating ring with reasonable accuracy and generate a structural model for the full BK channel.	[Wu, Yunkun; Yang, Yi; Jiang, Youxing] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Wu, Yunkun; Jiang, Youxing] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Ye, Sheng] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Zhejiang University	Jiang, YX (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	youxing.jiang@utsouthwestern.edu			Howard Hughes Medical Institute; NIH/NIGMS [RO1 GM071621]; Welch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071621] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Alam and M. Derebe for manuscript preparation; A. Pico for discussion in the early stages of this study; and X. Zhang for help in structure determination. Use of the Advanced Photon Source (APS) was supported by the US Department of Energy, Office of Energy Research. We thank the beamline (23ID and 19ID) staff for assistance in data collection. This work was supported by Howard Hughes Medical Institute and by grants from the NIH/NIGMS (RO1 GM071621) and Welch Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bao L, 2004, J GEN PHYSIOL, V123, P475, DOI 10.1085/jgp.200409052; Bao L, 2002, J GEN PHYSIOL, V120, P173, DOI 10.1085/jgp.20028627; Cronin CN, 2007, PROTEIN SCI, V16, P2023, DOI 10.1110/ps.072931407; Cui J, 2009, CELL MOL LIFE SCI, V66, P852, DOI 10.1007/s00018-008-8609-x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FALKE JJ, 1994, Q REV BIOPHYS, V27, P219, DOI 10.1017/S0033583500003012; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Hou SW, 2008, NAT STRUCT MOL BIOL, V15, P403, DOI 10.1038/nsmb.1398; Hou SW, 2009, PHYSIOLOGY, V24, P26, DOI 10.1152/physiol.00032.2008; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Kaczorowski GJ, 1996, J BIOENERG BIOMEMBR, V28, P255, DOI 10.1007/BF02110699; Kim HJ, 2006, J BIOL CHEM, V281, P38573, DOI 10.1074/jbc.M604769200; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; Lingle CJ, 2002, J GEN PHYSIOL, V120, P261, DOI 10.1085/jgp.20028689; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Xia XM, 2004, J NEUROSCI, V24, P5585, DOI 10.1523/JNEUROSCI.1296-04.2004; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yang HH, 2008, NAT STRUCT MOL BIOL, V15, P1152, DOI 10.1038/nsmb.1507; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Yusifov T, 2008, P NATL ACAD SCI USA, V105, P376, DOI 10.1073/pnas.0705261105; Zeng XH, 2005, J GEN PHYSIOL, V125, P273, DOI 10.1085/jgp.200409239; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797; Zhang X, 2001, J GEN PHYSIOL, V118, P607, DOI 10.1085/jgp.118.5.607	39	151	155	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2010	466	7304					393	U148		10.1038/nature09252	http://dx.doi.org/10.1038/nature09252			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20574420	Green Accepted			2022-12-01	WOS:000279867100054
J	Brenner, DJ; Hricak, H				Brenner, David J.; Hricak, Hedvig			Radiation Exposure From Medical Imaging Time to Regulate?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMPUTED-TOMOGRAPHY; CANCER		[Brenner, David J.] Columbia Univ, Med Ctr, Ctr Radiol Res, New York, NY 10024 USA; [Hricak, Hedvig] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA	Columbia University; Memorial Sloan Kettering Cancer Center	Brenner, DJ (corresponding author), Columbia Univ, Med Ctr, Ctr Radiol Res, 630 W 168th St, New York, NY 10024 USA.	djb3@columbia.edu		Hricak, Hedvig/0000-0003-2240-9694				Amis E Stephen Jr, 2007, J Am Coll Radiol, V4, P272, DOI 10.1016/j.jacr.2007.03.002; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Destouet Judy M, 2005, J Am Coll Radiol, V2, P585; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lehnert BE, 2010, J AM COLL RADIOL, V7, P192, DOI 10.1016/j.jacr.2009.11.010; Mettler FA, 2009, RADIOLOGY, V253, P520, DOI 10.1148/radiol.2532082010; Sistrom CL, 2009, RADIOLOGY, V251, P147, DOI 10.1148/radiol.2511081174; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; U.S. Food and Drug Administration website, WHIT PAP IN RED UNN	10	148	156	2	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2010	304	2					208	209		10.1001/jama.2010.973	http://dx.doi.org/10.1001/jama.2010.973			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624IN	20628137				2022-12-01	WOS:000279811000030
J	O'Hare, AM; Rodriguez, RA; Hailpern, SM; Larson, EB; Tamura, MK				O'Hare, Ann M.; Rodriguez, Rudolph A.; Hailpern, Susan M.; Larson, Eric B.; Tamura, Manjula Kurella			Regional Variation in Health Care Intensity and Treatment Practices for End-stage Renal Disease in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-LIFE CARE; DECISION-MAKING; NATIONAL-SURVEY; UNITED-STATES; DIALYSIS; POPULATION	Context An increasing number of older adults are being treated for end-stage renal disease (ESRD) with long-term dialysis. Objectives To determine how ESRD treatment practices for older adults vary across regions with differing end-of-life intensity of care. Design, Setting, and Participants Retrospective observational study using a national ESRD registry to identify a cohort of 41 420 adults (of white or black race), aged 65 years or older, who started long-term dialysis or received a kidney transplant between June 1, 2005, and May 31, 2006. Regional end-of-life intensity of care was defined using an index from the Dartmouth Atlas of Healthcare. Main Outcome Measures Incidence of treated ESRD (dialysis or transplant), preparedness for ESRD (under the care of a nephrologist, having a fistula [vs graft or catheter] at time of hemodialysis initiation), and end-of-life care practices. Results Among whites, the incidence of ESRD was progressively higher in regions with greater intensity of care and this trend was most pronounced at older ages. Among blacks, a similar relationship was present only at advanced ages (men aged >= 80 years and women aged >= 85 years). Patients living in regions in the highest compared with lowest quintile of end-of-life intensity of care were less likely to be under the care of a nephrologist before the onset of ESRD (62.3% [95% confidence interval {CI}, 61.3%-63.3%] vs 71.1% [95% CI, 69.9%-72.2%], respectively) and less likely to have a fistula (vs graft or catheter) at the time of hemodialysis initiation (11.2% [95% CI, 10.6%-11.8%] vs 16.9% [95% CI, 15.9%-17.8%]). Among patients who died within 2 years of ESRD onset (n=21 190), those living in regions in the highest compared with lowest quintile of end-of-life intensity of care were less likely to have discontinued dialysis before death (22.2% [95% CI, 21.1%-23.4%] vs 44.3% [95% CI, 42.5%-46.1%], respectively), less likely to have received hospice care (20.7% [95% CI, 19.5%-21.9%] vs 33.5% [95% CI, 31.7%-35.4%]), and more likely to have died in the hospital (67.8% [95% CI, 66.5%-69.1%] vs 50.3% [95% CI, 48.5%-52.1%]). These differences persisted in adjusted analyses. Conclusion There are pronounced regional differences in treatment practices for ESRD in older adults that are not explained by differences in patient characteristics. JAMA. 2010; 304(2): 180-186 www.jama.com	[O'Hare, Ann M.; Rodriguez, Rudolph A.] VA Puget Sound Healthcare Syst, Dept Med, Seattle, WA 98108 USA; [O'Hare, Ann M.] VA Puget Sound Healthcare Syst, HSR&D Ctr Excellence, Seattle, WA 98108 USA; [O'Hare, Ann M.; Rodriguez, Rudolph A.; Larson, Eric B.] Univ Washington, Dept Med, Seattle, WA USA; [Larson, Eric B.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Tamura, Manjula Kurella] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; [Tamura, Manjula Kurella] VA Palo Alto Healthcare Syst, Dept Med, Palo Alto, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; Group Health Cooperative; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	O'Hare, AM (corresponding author), VA Puget Sound Healthcare Syst, Dept Med, 111J Nephrol,1660 S Columbian Way, Seattle, WA 98108 USA.	Ann.OHare@va.gov	Tamura, Manjula Kurella/C-8284-2014	Tamura, Manjula Kurella/0000-0001-5227-2479	Beeson Career Development Award [K23AG28980, K23AG028952]; National Institutes of Health; Satellite Research; Amgen; American Society of Nephrology; Association of Subspecialty Professors; University of California, San Francisco; NATIONAL INSTITUTE ON AGING [K23AG028980, K23AG028952] Funding Source: NIH RePORTER	Beeson Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Satellite Research; Amgen(Amgen); American Society of Nephrology; Association of Subspecialty Professors; University of California, San Francisco(University of California System); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr O'Hare reported receiving royalties from UpToDate, an honorarium from the Japanese Society for Foot Care, and a Career Development Award from the Department of Veterans Affairs' Health Services Research and Development Service and serving as the principal investigator on an interagency agreement between the Centers for Disease Control and Prevention and the VA Puget Sound Healthcare System. Dr Hailpern reported being employed by LipoScience (Raleigh, North Carolina) during the time frame that she was working on this study but her work on the project was completed during her free time and was not part of her work for the company. Dr Larson reported receiving research support from the National Institutes of Health, royalties from UpToDate, Springer, and Elsevier, and speaker honoraria from universities and other nonprofit organizations. Dr Kurella Tamura reported receiving research funding from Satellite Research, Amgen, a Junior Development Award in Geriatric Nephrology from the American Society of Nephrology and Association of Subspecialty Professors, and an intramural grant from the University of California, San Francisco. The financial disclosures listed herein for Drs O'Hare and Kurella Tamura are for the last 5 years.; Dr O'Hare is supported by Beeson Career Development Award K23AG28980. Dr Kurella Tamura is supported by Beeson Career Development Award K23AG028952.	Barnato AE, 2007, MED CARE, V45, P386, DOI 10.1097/01.mlr.0000255248.79308.41; Davison SN, 2006, CLIN J AM SOC NEPHRO, V1, P1256, DOI 10.2215/CJN.02040606; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Galla JH, 2000, J AM SOC NEPHROL, V11, P1340, DOI 10.1681/ASN.V1171340; Holley JL, 2003, AM J KIDNEY DIS, V42, P813, DOI 10.1016/S0272-6386(03)00868-0; Kurella M, 2007, ANN INTERN MED, V146, P177, DOI 10.7326/0003-4819-146-3-200702060-00006; Mau LW, 2010, AM J KIDNEY DIS, V55, P549, DOI 10.1053/j.ajkd.2009.11.014; Murray AM, 2006, CLIN J AM SOC NEPHRO, V1, P1248, DOI 10.2215/CJN.00970306; Murtagh FEM, 2007, NEPHROL DIAL TRANSPL, V22, P1955, DOI 10.1093/ndt/gfm153; Prendergast TJ, 1998, AM J RESP CRIT CARE, V158, P1163, DOI 10.1164/ajrccm.158.4.9801108; Sekkarie MA, 1998, AM J KIDNEY DIS, V31, P464, DOI 10.1053/ajkd.1998.v31.pm9506683; Sirovich B, 2008, HEALTH AFFAIR, V27, P813, DOI 10.1377/hlthaff.27.3.813; Teno JM, 2010, JAMA-J AM MED ASSOC, V303, P544, DOI 10.1001/jama.2010.79	13	96	96	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2010	304	2					180	186		10.1001/jama.2010.924	http://dx.doi.org/10.1001/jama.2010.924			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624IN	20628131	Green Accepted, Bronze			2022-12-01	WOS:000279811000024
J	Levison, HF; Duncan, MJ; Brasser, R; Kaufmann, DE				Levison, Harold F.; Duncan, Martin J.; Brasser, Ramon; Kaufmann, David E.			Capture of the Sun's Oort Cloud from Stars in Its Birth Cluster	SCIENCE			English	Article							SOLAR-SYSTEM; ORIGIN; EVOLUTION; OBJECTS; COMETS	Oort cloud comets are currently believed to have formed in the Sun's protoplanetary disk and to have been ejected to large heliocentric orbits by the giant planets. Detailed models of this process fail to reproduce all of the available observational constraints, however. In particular, the Oort cloud appears to be substantially more populous than the models predict. Here we present numerical simulations that show that the Sun captured comets from other stars while it was in its birth cluster. Our results imply that a substantial fraction of the Oort cloud comets, perhaps exceeding 90%, are from the protoplanetary disks of other stars.	[Levison, Harold F.; Kaufmann, David E.] SW Res Inst, Boulder, CO 80302 USA; [Duncan, Martin J.] Queens Univ, Dept Phys, Kingston, ON K7L 3N6, Canada; [Brasser, Ramon] Univ Nice Sophia Antipolis, CNRS, Observ Cote Azur, Dept Cassiope, Nice, France	Queens University - Canada; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur	Levison, HF (corresponding author), SW Res Inst, 1050 Walnut St,Suite 300, Boulder, CO 80302 USA.	hal@boulder.swri.edu	Levison, Harold F/C-6061-2013	Levison, Harold F/0000-0001-5847-8099	NASA's Astrobiology Institute; NASA; Isaac Newton Institute at Cambridge University; Natural Sciences and Engineering Research Council, Canada; Germany's Helmholz Alliance	NASA's Astrobiology Institute; NASA(National Aeronautics & Space Administration (NASA)); Isaac Newton Institute at Cambridge University; Natural Sciences and Engineering Research Council, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Germany's Helmholz Alliance	We thank A. Morbidelli and L. Dones for useful discussions. This work was supported by NASA's Astrobiology Institute through a grant to the Goddard Center for Astrobiology. H. F. L. is grateful to NASA for funding through its Operational Support Services and Outer Planets Research programs. M.J.D. is grateful for the hospitality and financial support of the Isaac Newton Institute at Cambridge University, where some of this work was performed. M.J.D. acknowledges the continuing financial support of the Natural Sciences and Engineering Research Council, Canada. R. B. thanks Germany's Helmholz Alliance for financial support.	Adams FC, 2006, ASTROPHYS J, V641, P504, DOI 10.1086/500393; CLARKE CJ, 1993, MON NOT R ASTRON SOC, V261, P190, DOI 10.1093/mnras/261.1.190; Dones L, 2004, SPACE SCI S, P153; DUNCAN M, 1987, ASTRON J, V94, P1330, DOI 10.1086/114571; Eggers S, 1997, PLANET SPACE SCI, V45, P1099, DOI 10.1016/S0032-0633(97)00065-2; Kaib NA, 2009, SCIENCE, V325, P1234, DOI 10.1126/science.1172676; Kenyon SJ, 2004, NATURE, V432, P598, DOI 10.1038/nature03136; Kouwenhoven MBN, 2010, MON NOT R ASTRON SOC, V404, P1835, DOI 10.1111/j.1365-2966.2010.16399.x; Lada CJ, 2003, ANNU REV ASTRON ASTR, V41, P57, DOI 10.1146/annurev.astro.41.011802.094844; Levison HF, 2010, ASTRON J, V139, P1297, DOI 10.1088/0004-6256/139/4/1297; MALHOTRA R, 1995, ASTRON J, V110, P420, DOI 10.1086/117532; Morbidelli A, 2004, ASTRON J, V128, P2564, DOI 10.1086/424617; Paulech T, 2010, ASTRON ASTROPHYS, V509, DOI 10.1051/0004-6361/200912712; Thommes EW, 1999, NATURE, V402, P635, DOI 10.1038/45185; Tsiganis K, 2005, NATURE, V435, P459, DOI 10.1038/nature03539; WEISSMAN PR, 1996, ASTRONOMICAL SOC PAC, V265, P106; Zheng JQ, 1990, CELEST MECH DYN ASTR, V49, P265, DOI 10.1007/BF00049417	17	122	124	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988					187	190		10.1126/science.1187535	http://dx.doi.org/10.1126/science.1187535			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20538912				2022-12-01	WOS:000279635200040
J	Kimber, J; Copeland, L; Hickman, M; Macleod, J; McKenzie, J; De Angelis, D; Robertson, JR				Kimber, Jo; Copeland, Lorraine; Hickman, Matthew; Macleod, John; McKenzie, James; De Angelis, Daniela; Robertson, James Roy			Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOLLOW-UP; MAINTENANCE TREATMENT; CHANGING PATTERNS; AMSTERDAM COHORT; METHADONE; MORTALITY; RELAPSE; PREVENTION; DEPENDENCE; EPIDEMIC	Objectives To examine survival and long term cessation of injecting in a cohort of drug users and to assess the influence of opiate substitution treatment on these outcomes. Design Prospective open cohort study. Setting A single primary care facility in Edinburgh. Participants 794 patients with a history of injecting drug use presenting between 1980 and 2007; 655 (82%) were followed up by interview or linkage to primary care records and mortality register, or both, and contributed 10 390 person years at risk; 557 (85%) had received opiate substitution treatment. Main outcome measures Duration of injecting: years from first injection to long term cessation, defined as last injection before period of five years of non-injecting; mortality before cessation; overall survival. Results In the entire cohort 277 participants achieved long term cessation of injecting, and 228 died. Half of the survivors had poor health related quality of life. Median duration from first injection to death was 24 years for participants with HIV and 41 years for those without HIV. For each additional year of opiate substitution treatment the hazard of death before long term cessation fell 13% (95% confidence interval 17% to 9%) after adjustment for HIV, sex, calendar period, age at first injection, and history of prison and overdose. Conversely exposure to opiate substitution treatment was inversely related to the chances of achieving long term cessation. Conclusions Opiate substitution treatment in injecting drug users in primary care reduces this risk of mortality, with survival benefits increasing with cumulative exposure to treatment. Treatment does not reduce the overall duration of injecting.	[Kimber, Jo; Hickman, Matthew] Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England; [Kimber, Jo; Macleod, John] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW 2052, Australia; [Copeland, Lorraine; McKenzie, James; Robertson, James Roy] Muirhouse Med Grp, Edinburgh EH4 4P, Midlothian, Scotland; [De Angelis, Daniela] Univ Cambridge, Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 1TN, England; [De Angelis, Daniela] Ctr Infect, Hlth Protect Agcy, London, England; [Robertson, James Roy] Univ Edinburgh, Div Community Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland	University of Bristol; University of New South Wales Sydney; Kirby Institute; MRC Biostatistics Unit; University of Cambridge; Health Protection Agency; University of Edinburgh	Hickman, M (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England.	matthew.hickman@bristol.ac.uk	Hickman, Matthew/Y-2400-2019	Hickman, Matthew/0000-0001-9864-459X; Kimber, Jo/0000-0002-8608-7906; De Angelis, Daniela/0000-0001-6619-6112; Macleod, John/0000-0001-8202-1144	Chief Scientist Office for Scotland [CZH/4/318]; National Institute of Health Research; Australian National Health and Medical Research (NHMRC); Australian Government Department of Health and Ageing; Health Protection Agency; Medical Research Council [U.1052.00.007]; ESRC [ES/G007543/1] Funding Source: UKRI; MRC [MC_U105260556] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [G9815508, MC_U105260556] Funding Source: researchfish; Chief Scientist Office [CZH/4/440] Funding Source: researchfish	Chief Scientist Office for Scotland; National Institute of Health Research(National Institute for Health Research (NIHR)); Australian National Health and Medical Research (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Health Protection Agency; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	The present follow-up study of the Edinburgh Addiction Cohort was supported by the Chief Scientist Office for Scotland (CZH/4/318). At the time they undertook this work JM and MH were supported by career scientist fellowship awards from the National Institute of Health Research. JK is supported by an Australian National Health and Medical Research (NHMRC) postdoctoral training fellowship. The National Centre in HIV Epidemiology and Clinical Research is core-funded by the Australian Government Department of Health and Ageing. LC and JMcK were funded by the chief scientist office grant (CZH/4/318), with the latter being seconded to the study by the community drug problem service, (CDPS), Lothian. DDA is funded by Health Protection Agency and the Medical Research Council (grant No U.1052.00.007).	*ADV COUNC MISS DR, 1982, TREATM REH; Allison P.D., 1982, SOCIOL METHODOL, V13, P61, DOI 10.2307/270718; Babor TF, 2001, PRIMARY CARE; Bargagli AM, 2006, EUR J PUBLIC HEALTH, V16, P198, DOI 10.1093/eurpub/cki168; Berrington A, 2000, J ROY STAT SOC A STA, V163, P127, DOI 10.1111/1467-985X.00162; Blane DB, 1996, SOC SCI MED, V42, P751, DOI 10.1016/0277-9536(95)00340-1; COLLET D, 2003, MODELLING SURVIVAL D; Copeland L, 2004, ARCH INTERN MED, V164, P1214, DOI 10.1001/archinte.164.11.1214; Darke S, 2005, J SUBST ABUSE TREAT, V28, P255, DOI 10.1016/j.jsat.2005.01.006; Davoli M, 2007, ADDICTION, V102, P1954, DOI 10.1111/j.1360-0443.2007.02025.x; Degenhardt L, 2006, SEX TRANSM INFECT, V82, pIII56, DOI 10.1136/sti.2005.019273; Department of Health (England) and the devolved administrations, 2007, DRUG MIS DEP UK GUID; Fugelstad A, 2007, ADDICTION, V102, P406, DOI 10.1111/j.1360-0443.2006.01714.x; Gossop M, 2003, ADDICTION, V98, P291, DOI 10.1046/j.1360-0443.2003.00296.x; Gowing L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004145.pub3; Gowing LR, 2006, J GEN INTERN MED, V21, P193, DOI 10.1111/j.1525-1497.2005.00287.x; HARTSOCK P, 1991, LONGITUDINAL STUDIES; Hosmer DW, 1999, APPL SURVIVAL ANAL R; Hser YI, 2001, ARCH GEN PSYCHIAT, V58, P503, DOI 10.1001/archpsyc.58.5.503; Hubbard RL, 2003, J SUBST ABUSE TREAT, V25, P125, DOI 10.1016/S0740-5472(03)00130-2; Kind P, 1999, 172 CTR HLTH EC; Langendam MW, 2000, ADDICTION, V95, P591, DOI 10.1046/j.1360-0443.2000.95459110.x; Macleod J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-101; McCowan C, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2225; McKeganey N, 2006, ADDICT RES THEORY, V14, P557, DOI 10.1080/16066350601002369; OBrien CP, 1996, LANCET, V347, P237, DOI 10.1016/S0140-6736(96)90409-2; OPPENHEIMER E, 1994, ADDICTION, V89, P1299, DOI 10.1111/j.1360-0443.1994.tb03309.x; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rathod NH, 2005, BRIT J PSYCHIAT, V187, P421, DOI 10.1192/bjp.187.5.421; Robertson JR, 2006, ADDICTION, V101, P1752, DOI 10.1111/j.1360-0443.2006.01603.x; ROBERTSON JR, 1986, BRIT MED J, V292, P527, DOI 10.1136/bmj.292.6519.527; Shah NG, 2006, DRUG ALCOHOL DEPEN, V83, P147, DOI 10.1016/j.drugalcdep.2005.11.007; SKIDMORE CA, 1990, BRIT MED J, V300, P219, DOI 10.1136/bmj.300.6719.219; Sweeting MJ, 2009, STAT METHODS MED RES, V18, P381, DOI 10.1177/0962280208094704; Termorshuizen F, 2005, AM J EPIDEMIOL, V161, P271, DOI 10.1093/aje/kwi035; Termorshuizen F, 2005, DRUG ALCOHOL DEPEN, V79, P231, DOI 10.1016/j.drugalcdep.2005.01.013; VAILLANT GE, 1988, BRIT J ADDICT, V83, P1147; Ward J., 1997, METHADONE MAINTENANC; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	40	140	140	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2010	341								c3172	10.1136/bmj.c3172	http://dx.doi.org/10.1136/bmj.c3172			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	621NW	20595255	Green Submitted, Green Published, hybrid			2022-12-01	WOS:000279586600002
J	Matloff, ET; Brierley, KL				Matloff, Ellen T.; Brierley, Karina L.			The double-helix derailed: the story of the BRCA patent	LANCET			English	Editorial Material							CANCER; GENETICS; PHYSICIANS; KNOWLEDGE; HEALTH; BREAST; RISKS		[Matloff, Ellen T.; Brierley, Karina L.] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA	Yale University	Matloff, ET (corresponding author), Yale Univ, Sch Med, Yale Canc Ctr, 333 Cedar St, New Haven, CT 06510 USA.							*AM CIV LIB UN, 2010, BRCA SUPPL DECL E MA; BRIERLEY KL, CONNECTICUT IN PRESS; Doksum T, 2003, GENET MED, V5, P99, DOI 10.1097/01.GIM.0000055198.63593.32; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Gold ER, 2010, GENET MED, V12, pS39, DOI 10.1097/GIM.0b013e3181d72661; Gollust SE, 2002, JAMA-J AM MED ASSOC, V288, P1762, DOI 10.1001/jama.288.14.1762; Greendale K, 2001, AM J MED GENET, V106, P223, DOI 10.1002/ajmg.10010; Kepler TB, 2010, GENOMICS, V95, P312, DOI 10.1016/j.ygeno.2010.03.003; Kesselheim AS, 2010, NEW ENGL J MED, V362, P1855, DOI 10.1056/NEJMp1004026; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; KORITZ S, 2009, CARLSON CRUVE   0909; Lecrubier A, 2002, EMBO REP, V3, P1120, DOI 10.1093/embo-reports/kvf251; *MYR GEN, ACC EX DALL E; *MYR GEN LAB INC, 2010, MYR FIN ASS PROGR FI; *MYR GEN LAB INC, 2009, MYR GEN ANN REP; RAY T, 2010, PHARMACOGENOMIC 0210; Westphal SP, 2002, NEW SCI, V175, P29; Wideroff L, 2005, J MED GENET, V42, P749, DOI 10.1136/jmg.2004.030296; Williams-Jones B, 2006, NEW GENET SOC, V25, P89, DOI 10.1080/14636770600603527; 2009, PHARMACOGENOMIC 0107	20	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL-AUG	2010	376	9738					314	315		10.1016/S0140-6736(10)61150-6	http://dx.doi.org/10.1016/S0140-6736(10)61150-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636FW	20674708				2022-12-01	WOS:000280717900009
J	Jackson, LP; Kelly, BT; McCoy, AJ; Gaffry, T; James, LC; Collins, BM; Honing, S; Evans, PR; Owen, DJ				Jackson, Lauren P.; Kelly, Bernard T.; McCoy, Airlie J.; Gaffry, Thomas; James, Leo C.; Collins, Brett M.; Hoening, Stefan; Evans, Philip R.; Owen, David J.			A Large-Scale Conformational Change Couples Membrane Recruitment to Cargo Binding in the AP2 Clathrin Adaptor Complex	CELL			English	Article							COATED VESICLES; STRUCTURAL EXPLANATION; SORTING SIGNALS; MEDIATED ENDOCYTOSIS; MOLECULAR-GRAPHICS; PHASE INFORMATION; APPENDAGE DOMAIN; ALPHA-ADAPTIN; PROTEINS; RECOGNITION	The AP2 adaptor complex (alpha, beta 2, sigma 2, and mu 2 sub-units) crosslinks the endocytic clathrin scaffold to PtdIns4,5P(2)-containing membranes and transmembrane protein cargo. In the "locked" cytosolic form, AP2's binding sites for the two endocytic motifs, Yxx Phi on the C-terminal domain of mu 2 (C-mu 2) and [ED]xxxL[LI] on sigma 2, are blocked by parts of beta 2. Using protein crystallography, we show that AP2 undergoes a large conformational change in which C-mu 2 relocates to an orthogonal face of the complex, simultaneously unblocking both cargo-binding sites; the previously unstructured mu 2 linker becomes helical and binds back onto the complex. This structural rearrangement results in AP2's four PtdIns4,5P(2)- and two endocytic motif-binding sites becoming coplanar, facilitating their simultaneous interaction with PtdIns4,5P(2)/cargo-containing membranes. Using a range of biophysical techniques, we show that the endocytic cargo binding of AP2 is driven by its interaction with PtdIns4,5P(2)-containing membranes.	[James, Leo C.; Evans, Philip R.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Jackson, Lauren P.; Kelly, Bernard T.; McCoy, Airlie J.; Owen, David J.] Univ Cambridge, Dept Clin Biochem, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Gaffry, Thomas; Hoening, Stefan] Univ Cologne, Inst Biochem 1, D-50931 Cologne, Germany; [Gaffry, Thomas; Hoening, Stefan] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Collins, Brett M.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	MRC Laboratory Molecular Biology; University of Cambridge; University of Cologne; University of Cologne; University of Queensland	Evans, PR (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	pre@mrc-lmb.cam.ac.uk; djo30@cam.ac.uk	Collins, Brett/J-1563-2014	Collins, Brett/0000-0002-6070-3774; Jackson, Lauren/0000-0002-3705-6126	Wellcome Trust; German Science Foundation [SFB 635, TP3, SFB 670 TP7]; Center for Molecular Medicine Cologne [TP C3]; National Health and Medical Research Council (NHMRC), Australia; MRC [MC_U105181010, MC_U105178845] Funding Source: UKRI; Medical Research Council [MC_U105178845, MC_U105181010] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); German Science Foundation(German Research Foundation (DFG)); Center for Molecular Medicine Cologne; National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank the staff of ID29 at the ESRF, especially Elspeth Gordon, and beamline staff at Diamond Lightsource, especially Katherine McAuley and Dave Hall. We also thank Maria Jose Sanchez Barrena for assistance in data collection, Meredith Roberts-Thompson for assistance with fluorescence anisotropy measurements, and Margaret Robinson for access to the transmembrane protein database. We thank Lesley McKeane for creating part of Figure 3. D.J.O., L.P.J., and B. T. K. are supported by a Wellcome Trust Senior Fellowship to D.J.O.; T. G. and S. H. are supported by the German Science Foundation (SFB 635, TP3, SFB 670 TP7) and the Center for Molecular Medicine Cologne (TP C3); and B. M. C. is supported by a Career Development Award from the National Health and Medical Research Council (NHMRC), Australia.	Abrahams JP, 1997, ACTA CRYSTALLOGR D, V53, P371, DOI 10.1107/S0907444996015272; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Austin C, 2000, J BIOL CHEM, V275, P21862, DOI 10.1074/jbc.M908875199; Baust T, 2006, P NATL ACAD SCI USA, V103, P3159, DOI 10.1073/pnas.0511062103; Boehm M, 2001, EMBO J, V20, P6265, DOI 10.1093/emboj/20.22.6265; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Chaudhuri R, 2009, J VIROL, V83, P2518, DOI 10.1128/JVI.02227-08; CHEN HJ, 1993, J BIOL CHEM, V268, P22338; Cheng YF, 2007, J MOL BIOL, V365, P892, DOI 10.1016/j.jmb.2006.10.036; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Gaidarov I, 1996, J BIOL CHEM, V271, P20922, DOI 10.1074/jbc.271.34.20922; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; HELLER H, 1993, J PHYS CHEM-US, V97, P8343, DOI 10.1021/j100133a034; HEUSER JE, 1988, J CELL BIOL, V107, P877, DOI 10.1083/jcb.107.3.877; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; KEEN JH, 1981, J BIOL CHEM, V256, P2538; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kim SH, 2009, J BIOL CHEM, V284, P32803, DOI 10.1074/jbc.M109.039149; KRISSINEL E, 2005, DETECTION PROTEIN AS; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee I, 2008, J CELL BIOL, V180, P467, DOI 10.1083/jcb.200709037; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li YH, 2001, J BIOL CHEM, V276, P18000, DOI 10.1074/jbc.M101589200; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Motley AM, 2006, MOL BIOL CELL, V17, P5298, DOI 10.1091/mbc.E06-05-0452; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Olusanya O, 2001, CURR BIOL, V11, P896, DOI 10.1016/S0960-9822(01)00240-8; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Paleotti O, 2005, J BIOL CHEM, V280, P21661, DOI 10.1074/jbc.m503099200; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; PEARSE BMF, 1984, EMBO J, V3, P1951, DOI 10.1002/j.1460-2075.1984.tb02075.x; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Rohde G, 2002, J CELL BIOL, V158, P209, DOI 10.1083/jcb.200203103; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Schledzewski K, 1999, J MOL EVOL, V48, P770, DOI 10.1007/PL00006521; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P195, DOI 10.1107/S0907444901019291; Semerdjieva S, 2008, J CELL BIOL, V183, P499, DOI 10.1083/jcb.200806016; Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; VOORHEES P, 1995, EMBO J, V14, P4961, DOI 10.1002/j.1460-2075.1995.tb00179.x	55	232	239	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1220	U213		10.1016/j.cell.2010.05.006	http://dx.doi.org/10.1016/j.cell.2010.05.006			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20603002	Green Published, hybrid			2022-12-01	WOS:000279148100018
J	Johnson, KS; Riser, SC; Karl, DM				Johnson, Kenneth S.; Riser, Stephen C.; Karl, David M.			Nitrate supply from deep to near-surface waters of the North Pacific subtropical gyre	NATURE			English	Article							NITROGEN-FIXATION; OXYGEN; FLUX; STOICHIOMETRY; CHLOROPHYLL; PHOSPHORUS; CYCLE; ZONE	Concentrations of dissolved inorganic carbon (DIC) decrease in the surface mixed layers during spring and summer in most of the oligotrophic ocean. Mass balance calculations require that the missing DIC is converted into particulate carbon by photosynthesis(1-3). This DIC uptake represents one of the largest components of net community production in the world ocean(2,4). However, mixed-layer waters in these regions of the ocean typically contain negligible concentrations of plant nutrients such as nitrate and phosphate(3,5). Combined nutrient supply mechanisms including nitrogen fixation, diffusive transport and vertical entrainment are believed to be insufficient to supply the required nutrients for photosynthesis(6,7). The basin-scale potential for episodic nutrient transport by eddy events is unresolved(8,9). As a result, it is not understood how biologically mediated DIC uptake can be supported in the absence of nutrients. Here we report on high-resolution measurements of nitrate (NO3-) and oxygen (O-2) concentration made over 21 months using a profiling float deployed near the Hawaii Ocean Time-series station in the North Pacific subtropical gyre. Our measurements demonstrate that as O-2 was produced and DIC was consumed over two annual cycles, a corresponding seasonal deficit in dissolved NO3- appeared in water at depths from 100 to 250 m. The deep-water deficit in NO3- was in near-stoichiometric balance with the fixed nitrogen exported to depth. Thus, when the water column from the surface to 250 m is considered as a whole, there is near equivalence between nutrient supply and demand. Short-lived transport events (<10 days) that connect deep stocks of nitrate to nutrient-poor surface waters were clearly present in 12 of the 127 vertical profiles.	[Johnson, Kenneth S.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Riser, Stephen C.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Karl, David M.] Univ Hawaii, Ctr Microbial Oceanog Res & Educ, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA	Monterey Bay Aquarium Research Institute; University of Washington; University of Washington Seattle; University of Hawaii System	Johnson, KS (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.	johnson@mbari.org	Johnson, Kenneth S/F-9742-2011; Karl, David/AFP-3837-2022	Johnson, Kenneth S/0000-0001-5513-5584; Karl, David/0000-0002-6660-6721	David and Lucile Packard Foundation; National Science Foundation; National Oceanic and Atmospheric Administration; US Office of Naval Research; Gordon and Betty Moore Foundation; Center for Microbial Oceanography: Research and Education; Directorate For Geosciences [0824990] Funding Source: National Science Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); US Office of Naval Research(Office of Naval Research); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Center for Microbial Oceanography: Research and Education; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was made possible by the engineering efforts of L. Coletti, H. Jannasch and D. Swift to integrate ISUS with the APEX float. C. Sakamoto performed ISUS sensor calibration. This work was supported by the David and Lucile Packard Foundation, the National Science Foundation, the National Oceanic and Atmospheric Administration and the US Office of Naval Research through the National Oceanographic Partnership Program. Funding was also provided by the Gordon and Betty Moore Foundation and the Center for Microbial Oceanography: Research and Education.	Abell J, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002285; ANDERSON LA, 1995, DEEP-SEA RES PT I, V42, P1675, DOI 10.1016/0967-0637(95)00072-E; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Church MJ, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003418; Emerson S, 1997, NATURE, V389, P951, DOI 10.1038/40111; EMERSON S, 1995, J MAR RES, V53, P499, DOI 10.1357/0022240953213179; Emerson S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003095; Hannides CCS, 2009, DEEP-SEA RES PT I, V56, P73, DOI 10.1016/j.dsr.2008.08.003; Jenkins WJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002085; Johnson KS, 2002, DEEP-SEA RES PT I, V49, P1291, DOI 10.1016/S0967-0637(02)00020-1; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Karl DM, 2008, MAR ECOL PROG SER, V364, P257, DOI 10.3354/meps07547; Karl DM, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P705, DOI 10.1016/B978-0-12-372522-6.00016-5; Karl DM, 2003, GLO CH IGBP, P239; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1529, DOI 10.1016/S0967-0645(00)00152-1; Keeling CD, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002227; Kortzinger A, 2005, J ATMOS OCEAN TECH, V22, P302, DOI 10.1175/JTECH1701.1; Lamborg CH, 2008, DEEP-SEA RES PT II, V55, P1540, DOI 10.1016/j.dsr2.2008.04.011; LEDWELL JR, 1993, NATURE, V364, P701, DOI 10.1038/364701a0; Lee K, 2001, LIMNOL OCEANOGR, V46, P1287, DOI 10.4319/lo.2001.46.6.1287; Letelier RM, 2004, LIMNOL OCEANOGR, V49, P508, DOI 10.4319/lo.2004.49.2.0508; Martin AP, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001841; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; MICHAELS AF, 1994, NATURE, V372, P537, DOI 10.1038/372537a0; Riser SC, 2008, NATURE, V451, P323, DOI 10.1038/nature06441; Sakamoto CM, 2009, LIMNOL OCEANOGR-METH, V7, P132, DOI 10.4319/lom.2009.7.132; Tengberg A, 2006, LIMNOL OCEANOGR-METH, V4, P7, DOI 10.4319/lom.2006.4.7; Villareal TA, 1999, NATURE, V397, P423, DOI 10.1038/17103; Williams RG, 2003, GLO CH IGBP, P19	30	167	171	3	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					1062	1065		10.1038/nature09170	http://dx.doi.org/10.1038/nature09170			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577212				2022-12-01	WOS:000279056900049
J	Langston, RF; Ainge, JA; Couey, JJ; Canto, CB; Bjerknes, TL; Witter, MP; Moser, EI; Moser, MB				Langston, Rosamund F.; Ainge, James A.; Couey, Jonathan J.; Canto, Cathrin B.; Bjerknes, Tale L.; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt			Development of the Spatial Representation System in the Rat	SCIENCE			English	Article							ENTORHINAL CORTEX; PLACE CELLS; GRID CELLS; PATH-INTEGRATION; MAP; MODEL; HIPPOCAMPUS; DIRECTION	In the adult brain, space and orientation are represented by an elaborate hippocampal-parahippocampal circuit consisting of head-direction cells, place cells, and grid cells. We report that a rudimentary map of space is already present when 21/2-week-old rat pups explore an open environment outside the nest for the first time. Head-direction cells in the pre- and parasubiculum have adultlike properties from the beginning. Place and grid cells are also present but evolve more gradually. Grid cells show the slowest development. The gradual refinement of the spatial representation is accompanied by an increase in network synchrony among entorhinal stellate cells. The presence of adultlike directional signals at the onset of navigation raises the possibility that such signals are instrumental in setting up networks for place and grid representation.	[Langston, Rosamund F.; Ainge, James A.; Couey, Jonathan J.; Canto, Cathrin B.; Bjerknes, Tale L.; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, N-7489 Trondheim, Norway; [Langston, Rosamund F.; Ainge, James A.; Couey, Jonathan J.; Canto, Cathrin B.; Bjerknes, Tale L.; Witter, Menno P.; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, Ctr Biol Memory, Med Tech Res Ctr, N-7489 Trondheim, Norway; [Ainge, James A.] Univ St Andrews, Sch Psychol, St Andrews KY16 9JP, Fife, Scotland	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of St Andrews	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, Olav Kyrres Gate 9, N-7489 Trondheim, Norway.	edvard.moser@ntnu.no	Ainge, James A/D-5831-2012; Couey, Jonathan/GXG-6340-2022	Ainge, James A/0000-0002-0007-1533; Bjerknes, Tale Litlere/0000-0001-7518-5132; Couey, Jonathan/0000-0003-2658-692X; Langston, Rosamund/0000-0002-4668-3105	European Commission; Kavli Foundation; Research Council of Norway	European Commission(European CommissionEuropean Commission Joint Research Centre); Kavli Foundation; Research Council of Norway(Research Council of Norway)	We thank R. Skjerpeng for programming; C. N. Boccara for sharing adult pre- and parasubiculum data; and A. M. Amundsgard, K. Haugen, K. Jenssen, H. Waade, and T. Asmul for technical assistance. Supported by Fondation Bettencourt-Schueller, Seventh Framework Programme of the European Commission (SPACEBRAIN), Kavli Foundation, and a Centre of Excellence grant from the Research Council of Norway.	BOCCARA CN, 2008, SOC NEUROSCI ABSTR, V34; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; CABALLEROBLEDA M, 1994, EXP BRAIN RES, V101, P93; Fuhs MC, 2006, J NEUROSCI, V26, P4266, DOI 10.1523/JNEUROSCI.4353-05.2006; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; KANT I., 1995, KRITIK REINEN VERNUN; Martin PD, 2002, HIPPOCAMPUS, V12, P465, DOI 10.1002/hipo.10021; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Rolls ET, 2006, NETWORK-COMP NEURAL, V17, P447, DOI 10.1080/09548980601064846; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; TAUBE JS, 1990, J NEUROSCI, V10, P420	20	389	395	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1576	1580		10.1126/science.1188210	http://dx.doi.org/10.1126/science.1188210			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558721				2022-12-01	WOS:000278859200052
J	Brown, JR; O'Connor, GT				Brown, Jeremiah R.; O'Connor, Gerald T.			Focus on Research: Coronary Heart Disease and Prevention in the United States.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material															AHRQ HHS [K01 HS018443] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K01HS018443] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Centers for Disease Control and Prevention, 2005, MOV ACT PROM HEART H; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; National Center for Health Statistics, 2010, HLTH US 2009 SPEC FE; van Dam RM, 2009, CIRCULATION, V120, P1171, DOI 10.1161/CIRCULATIONAHA.109.891507	4	51	52	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2010	362	23					2150	2153		10.1056/NEJMp1003880	http://dx.doi.org/10.1056/NEJMp1003880			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	608AL	20558365				2022-12-01	WOS:000278551500003
J	Poulsen, H; Khandelia, H; Morth, JP; Bublitz, M; Mouritsen, OG; Egebjerg, J; Nissen, P				Poulsen, Hanne; Khandelia, Himanshu; Morth, J. Preben; Bublitz, Maike; Mouritsen, Ole G.; Egebjerg, Jan; Nissen, Poul			Neurological disease mutations compromise a C-terminal ion pathway in the Na+/K+-ATPase	NATURE			English	Article							SITE-DIRECTED MUTAGENESIS; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; ALPHA-SUBUNIT; AMINO-ACID; NA,K-ATPASE; NA+,K+-ATPASE; PUMP; SUBSTITUTIONS; TRANSPORT	The Na+/K+-ATPase pumps three sodium ions out of and two potassium ions into the cell for each ATP molecule that is split, thereby generating the chemical and electrical gradients across the plasma membrane that are essential in, for example, signalling, secondary transport and volume regulation in animal cells. Crystal structures of the potassium-bound form of the pump revealed an intimate docking of the alpha-subunit carboxy terminus at the transmembrane domain(1,2). Here we show that this element is a key regulator of a previously unrecognized ion pathway. Current models of P-type ATPases operate with a single ion conduit through the pump(3-5), but our data suggest an additional pathway in the Na+/K+-ATPase between the ion-binding sites and the cytoplasm. The C-terminal pathway allows a cytoplasmic proton to enter and stabilize site III when empty in the potassium-bound state, and when potassium is released the proton will also return to the cytoplasm, thus allowing an overall asymmetric stoichiometry of the transported ions. The C terminus controls the gate to the pathway. Its structure is crucial for pump function, as demonstrated by at least eight mutations in the region that cause severe neurological diseases(6,7). This novel model for ion transport by the Na+/K+-ATPase is established by electrophysiological studies of C-terminal mutations in familial hemiplegic migraine 2 (FHM2) and is further substantiated by molecular dynamics simulations. A similar ion regulation is likely to apply to the H+/K+-ATPase and the Ca2+-ATPase.	[Poulsen, Hanne; Morth, J. Preben; Bublitz, Maike; Nissen, Poul] Aarhus Univ, Dept Mol Biol, Danish Natl Res Fdn, PUMPKIN Ctr Membrane Pumps Cells & Dis, DK-8000 Aarhus C, Denmark; [Khandelia, Himanshu; Mouritsen, Ole G.] Univ So Denmark, Dept Chem & Phys, Danish Natl Res Fdn, MEMPHYS Ctr Biomembrane Phys, DK-5230 Odense M, Denmark; [Egebjerg, Jan] H Lundbeck & Co AS, DK-2500 Copenhagen, Denmark	Aarhus University; Danmarks Grundforskningsfond; Danmarks Grundforskningsfond; University of Southern Denmark; Lundbeck Corporation	Poulsen, H (corresponding author), Aarhus Univ, Dept Mol Biol, Danish Natl Res Fdn, PUMPKIN Ctr Membrane Pumps Cells & Dis, DK-8000 Aarhus C, Denmark.	hp@mb.au.dk; pn@mb.au.dk	Morth, Jens Preben/G-4450-2013; Morth, Jens Preben/AAP-7834-2021; Nissen, Poul/D-5774-2014	Morth, Jens Preben/0000-0003-4077-0192; Morth, Jens Preben/0000-0003-4077-0192; Nissen, Poul/0000-0003-0948-6628; Bublitz, Maike/0000-0003-3161-418X; Mouritsen, Ole G./0000-0002-4258-8960; Khandelia, Himanshu/0000-0001-9913-6394	European Molecular Biology Organisation; Carlsberg Foundation; Lundbeck Foundation; Danish Ministry of Science and Innovation; Novo Nordisk Foundation; Lundbeck Foundation [R34-2009-3616] Funding Source: researchfish	European Molecular Biology Organisation; Carlsberg Foundation(Carlsberg Foundation); Lundbeck Foundation(Lundbeckfonden); Danish Ministry of Science and Innovation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden)	We acknowledge the Danish Center for Scientific Computing at the University of Southern Denmark, Odense, for computing resources. We thank D. Gadsby, N. Vedovato and A. Gulyas-Kovacs at the Rockefeller University, New York City, for technical advice and discussion, A. Skov Kristensen and M. H. Poulsen (University of Copenhagen) for supplies of oocytes, and M. J. Clausen, G. Hartvigsen and A. M. Nielsen for assistance with experimental procedures. We are grateful to C. Slayman and F. Ashcroft for discussions on electrogenic transport. H. P. was supported by a short-term travel fellowship from the European Molecular Biology Organisation, J. P. M. was supported by grants from the Carlsberg Foundation and the Lundbeck Foundation, and P. N. was supported by an Elite Researcher grant of the Danish Ministry of Science and Innovation and a Hallas-Moller stipend from the Novo Nordisk Foundation.	Anselm IA, 2009, NEUROLOGY, V73, P400, DOI 10.1212/WNL.0b013e3181b04acd; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Blanco-Arias P, 2009, HUM MOL GENET, V18, P2370, DOI 10.1093/hmg/ddp170; Burnay M, 2003, J BIOL CHEM, V278, P19237, DOI 10.1074/jbc.M300946200; Holmgren M, 2000, NATURE, V403, P898, DOI 10.1038/35002599; Jen JC, 2007, J NEUROL NEUROSUR PS, V78, P523, DOI 10.1136/jnnp.2006.103267; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; JEWELLMOTZ EA, 1993, BIOCHEMISTRY-US, V32, P13523, DOI 10.1021/bi00212a018; Li CM, 2006, J MEMBRANE BIOL, V213, P1, DOI 10.1007/s00232-006-0035-0; Meier S, 2010, J GEN PHYSIOL, V135, P115, DOI 10.1085/jgp.200910301; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Morth JP, 2009, PHILOS T R SOC B, V364, P217, DOI 10.1098/rstb.2008.0201; Ogawa H, 2002, P NATL ACAD SCI USA, V99, P15977, DOI 10.1073/pnas.202622299; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; Riant F, 2005, HUM MUTAT, V26, DOI 10.1002/humu.9361; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; SKOU JC, 1980, BIOCHIM BIOPHYS ACTA, V601, P386, DOI 10.1016/0005-2736(80)90543-X; Takeuchi A, 2008, NATURE, V456, P413, DOI 10.1038/nature07350; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Vasilyev A, 2004, J MEMBRANE BIOL, V198, P65, DOI 10.1007/s00232-004-0660-4; Yamamoto S, 1996, J PHYSIOL-LONDON, V495, P733, DOI 10.1113/jphysiol.1996.sp021629; Yaragatupalli S, 2009, P NATL ACAD SCI USA, V106, P15507, DOI 10.1073/pnas.0903752106; Zanotti-Fregonara P, 2008, J NEUROL SCI, V273, P148, DOI 10.1016/j.jns.2008.06.033	28	97	100	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2010	467	7311					99	102		10.1038/nature09309	http://dx.doi.org/10.1038/nature09309			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645MB	20720542				2022-12-01	WOS:000281461200043
J	Tittensor, DP; Mora, C; Jetz, W; Lotze, HK; Ricard, D; Vanden Berghe, E; Worm, B				Tittensor, Derek P.; Mora, Camilo; Jetz, Walter; Lotze, Heike K.; Ricard, Daniel; Vanden Berghe, Edward; Worm, Boris			Global patterns and predictors of marine biodiversity across taxa	NATURE			English	Article							DIVERSITY; CLIMATE; ENERGY; HOTSPOTS; SCALE; SIZE	Global patterns of species richness and their structuring forces have fascinated biologists since Darwin(1,2) and provide critical context for contemporary studies in ecology, evolution and conservation. Anthropogenic impacts and the need for systematic conservation planning have further motivated the analysis of diversity patterns and processes at regional to global scales(3). Whereas land diversity patterns and their predictors are known for numerous taxa(4,5), our understanding of global marine diversity has been more limited, with recent findings revealing some striking contrasts to widely held terrestrial paradigms(6-8). Here we examine global patterns and predictors of species richness across 13 major species groups ranging from zooplankton to marine mammals. Two major patterns emerged: coastal species showed maximum diversity in the Western Pacific, whereas oceanic groups consistently peaked across broad mid-latitudinal bands in all oceans. Spatial regression analyses revealed sea surface temperature as the only environmental predictor highly related to diversity across all 13 taxa. Habitat availability and historical factors were also important for coastal species, whereas other predictors had less significance. Areas of high species richness were disproportionately concentrated in regions with medium or higher human impacts. Our findings indicate a fundamental role of temperature or kinetic energy in structuring cross-taxon marine biodiversity, and indicate that changes in ocean temperature, in conjunction with other human impacts, may ultimately rearrange the global distribution of life in the ocean.	[Tittensor, Derek P.; Mora, Camilo; Lotze, Heike K.; Ricard, Daniel; Worm, Boris] Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada; [Jetz, Walter] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Vanden Berghe, Edward] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA	Dalhousie University; Yale University; Rutgers State University New Brunswick	Tittensor, DP (corresponding author), Dalhousie Univ, Dept Biol, 1355 Oxford St, Halifax, NS B3H 4J1, Canada.	derekt@mathstat.dal.ca	Ricard, Daniel/G-1814-2014; Jetz, Walter/ABF-1517-2020; Tittensor, Derek P./AAV-1117-2021	Tittensor, Derek P./0000-0002-9550-3123; Lotze, Heike/0000-0001-6258-1304; Worm, Boris/0000-0002-5742-8716; Jetz, Walter/0000-0002-1971-7277	Sloan Foundation; NSF [DBI-0960550, BCS-0648733]	Sloan Foundation(Alfred P. Sloan Foundation); NSF(National Science Foundation (NSF))	We acknowledge contributions and sharing of data from L. Lucifora, V. Garcia, M. Kulbicki and P. Hull. We thank all the sources in Supplementary Tables 1 and 2 for making their data available. We are grateful to all OBIS data providers for making this study possible; see www.iobis.org for a full list. A. Rollo, G. Britten and D. Boyce provided technical help; W. Blanchard offered statistical advice. This paper builds on the efforts of all Census of Marine Life contributors, and long-term support from the Sloan Foundation. W.J. acknowledges support from NSF grants DBI-0960550 and BCS-0648733.	ALLEN AP, 2007, SCALING BIODIVERSITY; [Anonymous], 2001, BEHAV RES METH INS C; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; BIVAND R, 1956, SPDEP SPATIAL DEPEND; Briggs JC, 1974, MARINE ZOOGEOGRAPHY, DOI 10.2307/1442613; Brinton E., 2000, EUPHAUSIIDS WORLD OC; Cairns DK, 2008, MAR ECOL PROG SER, V356, P239, DOI 10.3354/meps07286; CASEY KS, 2010, OCEANOGRAPHY SPACE R, pCH16; CHAO A, 1984, SCAND J STAT, V11, P265; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Clarke A, 2006, P ROY SOC B-BIOL SCI, V273, P2257, DOI 10.1098/rspb.2006.3545; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Darwin C.R., 1877, DIFFERENT FORMS FLOW; Dormann CF, 2007, GLOBAL ECOL BIOGEOGR, V16, P774, DOI 10.1111/j.1466-8238.2007.00344.x; Etnoyer Peter, 2004, Oceanography, V17, P90; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; Floeter SR, 2008, J BIOGEOGR, V35, P22, DOI 10.1111/j.1365-2699.2007.01790.x; Fornwall Mark, 2000, Oceanography, V13, P31; Fraser RH, 1996, AM NAT, V148, P138, DOI 10.1086/285915; Froese R., 2014, FISHBASE; Garcia H. E., 2006, NOAA ATLAS NESDIS, V63; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Green E. E. P., 2003, WORLD ATLAS SEAGRASS; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hillebrand H, 2004, MAR ECOL PROG SER, V273, P251, DOI 10.3354/meps273251; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Jetz W, 2009, P ROY SOC B-BIOL SCI, V276, P269, DOI 10.1098/rspb.2008.1005; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; KULBICKI M, 2007, MACROCOSME MICROCOSM; KULBICKI M, 2004, CHALLENGING COASTS T; Kulbicki M, 2007, CYBIUM, V31, P275; Levitus S, 2001, SCIENCE, V292, P267, DOI 10.1126/science.1058154; LUCIFORA L, PLOS ONE IN PRESS; Lutz MJ, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003706; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mora C, 2005, J BIOGEOGR, V32, P277, DOI 10.1111/j.1365-2699.2004.01155.x; Mora C, 2008, P ROY SOC B-BIOL SCI, V275, P149, DOI 10.1098/rspb.2007.1315; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Oksanen J., 2009, VEGAN COMMUNITY ECOL; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Prell W., 1999, IGBP PAGES WORLD DAT; R Core Development Team, 2009, R LANG ENV STAT COMP; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Ricklefs RE, 2007, AM NAT, V170, pS56, DOI 10.1086/519402; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Robertson D. R., 2002, SHOREFISHES TROPICAL; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Roper CFE, 1984, FAO SPECIES CATALOGU, V3; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rutherford S, 1999, NATURE, V400, P749, DOI 10.1038/23449; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; SMITH EP, 1984, BIOMETRICS, V40, P119, DOI 10.2307/2530750; Spalding MD., 1997, WORLD MANGROVE ATLAS, P178; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Veron J., 2000, CORALS WORLD, V1-3; Webb TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010223; Whitehead H, 2008, ECOL LETT, V11, P1198, DOI 10.1111/j.1461-0248.2008.01234.x; Worm B, 2005, SCIENCE, V309, P1365, DOI 10.1126/science.1113399; Worm B, 2009, CLIMATE CHANGE: OBSERVED IMPACTS ON PLANET EARTH, P263, DOI 10.1016/B978-0-444-53301-2.00014-2	62	854	894	26	772	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 26	2010	466	7310					1098	U107		10.1038/nature09329	http://dx.doi.org/10.1038/nature09329			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20668450				2022-12-01	WOS:000281203600038
J	Cates, W				Cates, Willard, Jr.			After CAPRISA 004: time to re-evaluate the HIV lexicon	LANCET			English	Editorial Material							PREVENT		FHI, Res Triangle Pk, NC 27709 USA		Cates, W (corresponding author), FHI, Res Triangle Pk, NC 27709 USA.	wcates@fhi.org						Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Grant RM, 2008, SCIENCE, V321, P532, DOI 10.1126/science.1160355; *IAVI, 2010, E002 IAVI; *IAVI, 2010, E001 IAVI; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; *VOICE, 2010, MTN003 VOICE	7	24	24	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 14	2010	376	9740					495	496		10.1016/S0140-6736(10)61200-7	http://dx.doi.org/10.1016/S0140-6736(10)61200-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	643BE	20709216				2022-12-01	WOS:000281266800008
J	Tsai, MC; Manor, O; Wan, Y; Mosammaparast, N; Wang, JK; Lan, F; Shi, Y; Segal, E; Chang, HY				Tsai, Miao-Chih; Manor, Ohad; Wan, Yue; Mosammaparast, Nima; Wang, Jordon K.; Lan, Fei; Shi, Yang; Segal, Eran; Chang, Howard Y.			Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes	SCIENCE			English	Article							CHROMATIN-STRUCTURE; GENE-EXPRESSION; X-CHROMOSOME; DEMETHYLATION; PROTEIN; CELLS; STATE; LSD1	Long intergenic noncoding RNAs (lincRNAs) regulate chromatin states and epigenetic inheritance. Here, we show that the lincRNA HOTAIR serves as a scaffold for at least two distinct histone modification complexes. A 5' domain of HOTAIR binds polycomb repressive complex 2 (PRC2), whereas a 3' domain of HOTAIR binds the LSD1/CoREST/REST complex. The ability to tether two distinct complexes enables RNA-mediated assembly of PRC2 and LSD1 and coordinates targeting of PRC2 and LSD1 to chromatin for coupled histone H3 lysine 27 methylation and lysine 4 demethylation. Our results suggest that lincRNAs may serve as scaffolds by providing binding surfaces to assemble select histone modification enzymes, thereby specifying the pattern of histone modifications on target genes.	[Tsai, Miao-Chih; Wan, Yue; Wang, Jordon K.; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Tsai, Miao-Chih; Wan, Yue; Wang, Jordon K.; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Manor, Ohad; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Mosammaparast, Nima; Lan, Fei; Shi, Yang] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA; [Mosammaparast, Nima; Lan, Fei; Shi, Yang] Childrens Hosp Boston, Dept Med, Div New Born Med, Cambridge, MA 02138 USA; [Lan, Fei] Constellat Pharmaceut, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Weizmann Institute of Science; Harvard University; Harvard University; Boston Children's Hospital	Chang, HY (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	howchang@stanford.edu	Segal, Eran/AAF-4855-2019; jia, xu/A-8386-2016	Segal, Eran/0000-0002-6859-1164; Wang, Jordon/0000-0003-1108-2534; Tsai, Miao-Chih/0000-0003-4471-4825	California Institute for Regenerative Medicine [RN1-00529-1]; NIH [R01-HG004361, R01-CA118487]; Susan G. Komen Foundation; Azrieli Foundation; NSF; Agency for Science, Technology, and Research; NATIONAL CANCER INSTITUTE [R01CA118750, R01CA119176, R01CA118487] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Azrieli Foundation; NSF(National Science Foundation (NSF)); Agency for Science, Technology, and Research(Agency for Science Technology & Research (A*STAR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Microarray data are deposited in Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/) under accession number GSE22345. We thank members of the D. Herschlag lab for assistance with RNA footprinting and X. Tan, P. Khavari, and J. Wysocka for critical reading of the manuscript. This work was supported by the California Institute for Regenerative Medicine (RN1-00529-1 to H.Y.C.), NIH (R01-HG004361 to H.Y.C. and E. S and R01-CA118487 to Y.S), the Susan G. Komen Foundation (M.-C. T.), the Azrieli Foundation (O.M.), NSF (J. K. W.), and the Agency for Science, Technology, and Research (Y.W.). E. S. is the incumbent of the Soretta and Henry Shapiro career development chair. Y.S. is co-founder and on the scientific advisory board of Constellation Pharmaceuticals. H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Di Stefano L, 2007, CURR BIOL, V17, P808, DOI 10.1016/j.cub.2007.03.068; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kerppola TK, 2009, TRENDS CELL BIOL, V19, P692, DOI 10.1016/j.tcb.2009.10.001; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mulligan P, 2008, MOL CELL, V32, P718, DOI 10.1016/j.molcel.2008.10.025; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Sharon E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000154; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	24	2418	2610	26	498	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					689	693		10.1126/science.1192002	http://dx.doi.org/10.1126/science.1192002			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20616235	Green Submitted, Green Accepted			2022-12-01	WOS:000280602700041
J	Alperin, M; Hoehler, T				Alperin, Marc; Hoehler, Tori			BIOGEOCHEMISTRY The Ongoing Mystery of Sea-Floor Methane	SCIENCE			English	Editorial Material							ANAEROBIC OXIDATION; BACTERIA; CONSTRAINTS; SEDIMENTS; CONSORTIUM; ARCHAEA		[Alperin, Marc] Univ N Carolina, Chapel Hill, NC 27599 USA; [Hoehler, Tori] NASA, Ames Res Ctr, Exobiol Branch, Moffett Field, CA 94035 USA	University of North Carolina; University of North Carolina Chapel Hill; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Alperin, M (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.	alperin@email.unc.edu; tori.m.hoehler@nasa.gov						Alperin MI, 1988, GLOBAL BIOGEOCHEM CY, V2, P279, DOI 10.1029/GB002i003p00279; Alperin MJ, 2009, AM J SCI, V309, P869, DOI 10.2475/10.2009.01; Alperin MJ, 2009, AM J SCI, V309, P958, DOI 10.2475/10.2009.02; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; House CH, 2009, ENVIRON MICROBIOL, V11, P2207, DOI 10.1111/j.1462-2920.2009.01934.x; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Londry KL, 2008, ORG GEOCHEM, V39, P608, DOI 10.1016/j.orggeochem.2008.03.002; Martens CS, 1999, AM J SCI, V299, P589, DOI 10.2475/ajs.299.7-9.589; Orcutt B, 2008, BIOGEOSCIENCES, V5, P1587, DOI 10.5194/bg-5-1587-2008; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Reeburgh WS, 2007, CHEM REV, V107, P486, DOI 10.1021/cr050362v; REEBURGH WS, 1976, EARTH PLANET SC LETT, V28, P337, DOI 10.1016/0012-821X(76)90195-3; Sommer S, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2004GB002389; ZEHNDER AJB, 1979, J BACTERIOL, V137, P420, DOI 10.1128/JB.137.1.420-432.1979	16	29	33	5	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					288	289		10.1126/science.1189966	http://dx.doi.org/10.1126/science.1189966			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647456				2022-12-01	WOS:000279925900028
J	Maunakea, AK; Nagarajan, RP; Bilenky, M; Ballinger, TJ; D'Souza, C; Fouse, SD; Johnson, BE; Hong, CB; Nielsen, C; Zhao, YJ; Turecki, G; Delaney, A; Varhol, R; Thiessen, N; Shchors, K; Heine, VM; Rowitch, DH; Xing, XY; Fiore, C; Schillebeeckx, M; Jones, SJM; Haussler, D; Marra, MA; Hirst, M; Wang, T; Costello, JF				Maunakea, Alika K.; Nagarajan, Raman P.; Bilenky, Mikhail; Ballinger, Tracy J.; D'Souza, Cletus; Fouse, Shaun D.; Johnson, Brett E.; Hong, Chibo; Nielsen, Cydney; Zhao, Yongjun; Turecki, Gustavo; Delaney, Allen; Varhol, Richard; Thiessen, Nina; Shchors, Ksenya; Heine, Vivi M.; Rowitch, David H.; Xing, Xiaoyun; Fiore, Chris; Schillebeeckx, Maximiliaan; Jones, Steven J. M.; Haussler, David; Marra, Marco A.; Hirst, Martin; Wang, Ting; Costello, Joseph F.			Conserved role of intragenic DNA methylation in regulating alternative promoters	NATURE			English	Article							WIDE; ARCHITECTURE; METHYLOME	Although it is known that the methylation of DNA in 5' promoters suppresses gene expression, the role of DNA methylation in gene bodies is unclear(1-5). In mammals, tissue-and cell type-specific methylation is present in a small percentage of 5' CpG island (CGI) promoters, whereas a far greater proportion occurs across gene bodies, coinciding with highly conserved sequences(5-10). Tissue-specific intragenic methylation might reduce(3), or, paradoxically, enhance transcription elongation efficiency(1,2,4,5). Capped analysis of gene expression (CAGE) experiments also indicate that transcription commonly initiates within and between genes(11-15). To investigate the role of intragenic methylation, we generated a map of DNA methylation from the human brain encompassing 24.7 million of the 28 million CpG sites. From the dense, high-resolution coverage of CpG islands, the majority of methylated CpG islands were shown to be in intragenic and intergenic regions, whereas less than 3% of CpG islands in 59 promoters were methylated. The CpG islands in all three locations overlapped with RNA markers of transcription initiation, and unmethylated CpG islands also overlapped significantly with trimethylation of H3K4, a histone modification enriched at promoters 16. The general and CpG-island-specific patterns of methylation are conserved in mouse tissues. An in-depth investigation of the human SHANK3 locus(17,18) and its mouse homologue demonstrated that this tissue-specific DNA methylation regulates intragenic promoter activity in vitro and in vivo. These methylation-regulated, alternative transcripts are expressed in a tissue-and cell type-specific manner, and are expressed differentially within a single cell type from distinct brain regions. These results support a major role for intragenic methylation in regulating cell context-specific alternative promoters in gene bodies.	[Ballinger, Tracy J.; Haussler, David; Wang, Ting] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Maunakea, Alika K.; Nagarajan, Raman P.; Fouse, Shaun D.; Johnson, Brett E.; Hong, Chibo; Costello, Joseph F.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Neurosurg, Brain Tumor Res Ctr, San Francisco, CA 94158 USA; [Bilenky, Mikhail; D'Souza, Cletus; Nielsen, Cydney; Zhao, Yongjun; Delaney, Allen; Varhol, Richard; Thiessen, Nina; Jones, Steven J. M.; Marra, Marco A.; Hirst, Martin] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Turecki, Gustavo] Douglas Hosp, Res Ctr, McGill Grp Suicide Studies, Verdun, PQ H4H 1R3, Canada; [Shchors, Ksenya] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94158 USA; [Heine, Vivi M.; Rowitch, David H.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Heine, Vivi M.; Rowitch, David H.] Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA 94143 USA; [Heine, Vivi M.; Rowitch, David H.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Xing, Xiaoyun; Fiore, Chris; Schillebeeckx, Maximiliaan; Wang, Ting] Washington Univ, Ctr Genome Sci & Syst Biol, Dept Genet, St Louis, MO 63108 USA; [Haussler, David] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; British Columbia Cancer Agency; McGill University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Washington University (WUSTL); Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Wang, T (corresponding author), Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA.	twang@wustl.edu; jcostello@cc.ucsf.edu	Marra, Marco A/B-5987-2008; Turecki, Gustavo/K-5100-2015; Jones, Steven J/C-3621-2009; Heine, Vivi M/F-1741-2011; Hirst, Martin/B-7684-2016	Marra, Marco A/0000-0001-7146-7175; Jones, Steven J/0000-0003-3394-2208; Heine, Vivi M/0000-0003-4416-3875; Rowitch, David/0000-0002-0079-0060; Turecki, Gustavo/0000-0003-4075-2736	NIH [NRSA-F31, NRSA-F32]; National Brain Tumor Society; Goldhirsh Foundation; British Columbia Cancer Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017154] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Brain Tumor Society; Goldhirsh Foundation; British Columbia Cancer Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank S. Vandenberg for technical assistance and The Pleiades Promoter Project and their funders Genome Canada, Genome British Columbia, GlaxoSmithKline R&D Ltd, BC Mental Health and Addiction Services, Child & Family Research Institute, UBC Institute of Mental Health, and the UBC Office of the Vice President Research. This work was supported in part by an NIH NRSA-F31 fellowship to A. K. M. and an NIH NRSA-F32 fellowship to R.P.N., a grant from the National Brain Tumor Society and Goldhirsh Foundation to J.F.C., and by the British Columbia Cancer Foundation. T.W. was a Helen Hay Whitney Fellow and M.A.M. is a Terry Fox Young Investigator and a Michael Smith Senior Research Scholar.	Appanah R, 2007, PLOS GENET, V3, P241, DOI 10.1371/journal.pgen.0030027; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carninci P, 2006, TRENDS GENET, V22, P501, DOI 10.1016/j.tig.2006.07.003; Ching TT, 2005, NAT GENET, V37, P645, DOI 10.1038/ng1563; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Flanagan James M, 2007, Genome Biol, V8, P307, DOI 10.1186/gb-2007-8-6-307; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; LORINCZ MC, 2004, NATURE STRUCT MOL BI; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Song F, 2005, P NATL ACAD SCI USA, V102, P3336, DOI 10.1073/pnas.0408436102; Valen E, 2009, GENOME RES, V19, P255, DOI 10.1101/gr.084541.108; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003	30	1180	1206	1	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2010	466	7303					253	U131		10.1038/nature09165	http://dx.doi.org/10.1038/nature09165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613842	Green Submitted, Green Accepted			2022-12-01	WOS:000279580800040
J	Crowder, DW; Northfield, TD; Strand, MR; Snyder, WE				Crowder, David W.; Northfield, Tobin D.; Strand, Michael R.; Snyder, William E.			Organic agriculture promotes evenness and natural pest control	NATURE			English	Article							PREDATOR DIVERSITY; CURRENT KNOWLEDGE; BIODIVERSITY; METAANALYSIS; COMMUNITIES; SERVICES; ECOLOGY; CONSEQUENCES; EXPLOITATION; LANDSCAPES	Human activity can degrade ecosystem function by reducing species number (richness)(1-4) and by skewing the relative abundance of species (evenness)(5-7). Conservation efforts often focus on restoring or maintaining species number(8,9), reflecting the well-known impacts of richness on many ecological processes(1-4). In contrast, the ecological effects of disrupted evenness have received far less attention(7), and developing strategies for restoring evenness remains a conceptual challenge(7). In farmlands, agricultural pest-management practices often lead to altered food web structure and communities dominated by a few common species, which together contribute to pest outbreaks(6,7,10,11). Here we show that organic farming methods mitigate this ecological damage by promoting evenness among natural enemies. In field enclosures, very even communities of predator and pathogen biological control agents, typical of organic farms, exerted the strongest pest control and yielded the largest plants. In contrast, pest densities were high and plant biomass was low when enemy evenness was disrupted, as is typical under conventional management. Our results were independent of the numerically dominant predator or pathogen species, and so resulted from evenness itself. Moreover, evenness effects among natural enemy groups were independent and complementary. Our results strengthen the argument that rejuvenation of ecosystem function requires restoration of species evenness, rather than just richness. Organic farming potentially offers a means of returning functional evenness to ecosystems.	[Crowder, David W.; Northfield, Tobin D.; Snyder, William E.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Strand, Michael R.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA	Washington State University; University System of Georgia; University of Georgia	Crowder, DW (corresponding author), Washington State Univ, Dept Entomol, Pullman, WA 99164 USA.	dcrowder@wsu.edu	Northfield, Tobin/I-2323-2013	Northfield, Tobin/0000-0002-0563-485X; Crowder, David/0000-0002-3720-1581; Snyder, William/0000-0002-2747-3102	National Research Initiative of the USDA National Institute of Food and Agriculture	National Research Initiative of the USDA National Institute of Food and Agriculture	J. Owen and M. Thomas provided comments on the manuscript. G. Chang, R. Ramirez and A. Snyder provided survey data from potato fields. This project was supported by the National Research Initiative of the USDA National Institute of Food and Agriculture.	Bengtsson J, 2005, J APPL ECOL, V42, P261, DOI 10.1111/j.1365-2664.2005.01005.x; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Casula P, 2006, ECOL LETT, V9, P995, DOI 10.1111/j.1461-0248.2006.00945.x; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Donnelly A, 2001, NEW PHYTOL, V149, P265, DOI 10.1046/j.1469-8137.2001.00015.x; Finke DL, 2008, SCIENCE, V321, P1488, DOI 10.1126/science.1160854; Finke DL, 2004, NATURE, V429, P407, DOI 10.1038/nature02554; Gitay H, 1996, J ECOL, V84, P121, DOI 10.2307/2261706; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Hole DG, 2005, BIOL CONSERV, V122, P113, DOI 10.1016/j.biocon.2004.07.018; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Koss AM, 2005, ENVIRON ENTOMOL, V34, P87, DOI 10.1603/0046-225X-34.1.87; Kutner M.H., 2005, APPL LINEAR STAT MOD; Landis DA, 2008, P NATL ACAD SCI USA, V105, P20552, DOI 10.1073/pnas.0804951106; Letourneau DK, 2008, FRONT ECOL ENVIRON, V6, P430, DOI 10.1890/070081; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Macfadyen S, 2009, ECOL LETT, V12, P229, DOI 10.1111/j.1461-0248.2008.01279.x; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Ramirez RA, 2009, ECOLOGY, V90, P2832, DOI 10.1890/08-1941.1; Ramirez RA, 2009, BIOL CONTROL, V48, P147, DOI 10.1016/j.biocontrol.2008.10.010; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Schmitz OJ, 2007, ECOLOGY, V88, P2415, DOI 10.1890/06-0937.1; Silvertown J, 1999, NATURE, V400, P61, DOI 10.1038/21877; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wilsey BJ, 2002, ECOL LETT, V5, P676, DOI 10.1046/j.1461-0248.2002.00372.x; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	33	352	376	14	509	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 1	2010	466	7302					109	U123		10.1038/nature09183	http://dx.doi.org/10.1038/nature09183			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596021				2022-12-01	WOS:000279343800044
J	Sonnenburg, ED; Zheng, HJ; Joglekar, P; Higginbottom, SK; Firbank, SJ; Bolam, DN; Sonnenburg, JL				Sonnenburg, Erica D.; Zheng, Hongjun; Joglekar, Payal; Higginbottom, Steven K.; Firbank, Susan J.; Bolam, David N.; Sonnenburg, Justin L.			Specificity of Polysaccharide Use in Intestinal Bacteroides Species Determines Diet-Induced Microbiota Alterations	CELL			English	Article							OUTER-MEMBRANE PROTEINS; HUMAN GUT MICROBIOTA; SYMBIOTIC BACTERIA; IN-VIVO; STARCH; INULIN; OLIGOFRUCTOSE; CATABOLISM; PREDICTION; MODEL	The intestinal microbiota impacts many facets of human health and is associated with human diseases. Diet impacts microbiota composition, yet mechanisms that link dietary changes to microbiota alterations remain ill-defined. Here we elucidate the basis of Bacteroides proliferation in response to fructans, a class of fructose-based dietary polysaccharides. Structural and genetic analysis disclosed a fructose-binding, hybrid two-component signaling sensor that controls the fructan utilization locus in Bacteroides thetaiotaomicron. Gene content of this locus differs among Bacteroides species and dictates the specificity and breadth of utilizable fructans. BT1760, an extracellular beta 2-6 endo-fructanase, distinguishes B. thetaiotaomicron genetically and functionally, and enables the use of the beta 2-6-linked fructan levan. The genetic and functional differences between Bacteroides species are predictive of in vivo competitiveness in the presence of dietary fructans. Gene sequences that distinguish species' metabolic capacity serve as potential biomarkers in microbiomic datasets to enable rational manipulation of the microbiota via diet.	[Zheng, Hongjun; Firbank, Susan J.; Bolam, David N.] Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Sonnenburg, Erica D.; Joglekar, Payal; Higginbottom, Steven K.; Sonnenburg, Justin L.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Newcastle University - UK; Stanford University	Bolam, DN (corresponding author), Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	d.n.bolam@ncl.ac.uk; jsonnenburg@stanford.edu		Bolam, David/0000-0003-0314-3122; higginbottom, steven/0000-0002-4609-6840	National Institutes of Health [DP2-OD006515]; NIDDK [K01-DK077053]; Stanford Digestive Disease Center [PO3-DK56339]; BBSRC [BB/F014163/1]; Biotechnology and Biological Sciences Research Council [BB/F014163/1] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK077053, P30DK056339, R01DK085025] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Stanford Digestive Disease Center; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Karla Kirkegaard and Stanley Falkow for valuable comments and Sara Fisher for editing the manuscript. Inulin and FOS for mouse experiments were a kind gift from Beneo-Orafti. Levan was a kind gift from Montana Polysaccharides. We thank Jeffrey Gordon and members of the Gordon Lab for valuable advice; Carl Morland for excellent technical assistance; and Eric Martens and Andrew Goodman for development of genetic tools used in this paper. Some Bacteroides genomic data were produced by The Genome Center at Washington University School of Medicine in St. Louis (genome.wustl.edu). This work was funded in part by grants from National Institutes of Health through the NIH Director's New Innovator Award Program (DP2-OD006515) the NIDDK (K01-DK077053), the Stanford Digestive Disease Center (PO3-DK56339) and the BBSRC (BB/F014163/1).	[Anonymous], 1994, J RAPID METHOD AUTOM, DOI DOI 10.1111/J.1745-4581.1994.TB00308.X; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bolam DN, 2004, J BIOL CHEM, V279, P22953, DOI 10.1074/jbc.M313317200; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cho KH, 2001, J BACTERIOL, V183, P7224, DOI 10.1128/JB.183.24.7224-7230.2001; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Duncan SH, 2003, APPL ENVIRON MICROB, V69, P1136, DOI 10.1128/AEM.69.2.1136-1142.2003; Dwyer MA, 2004, CURR OPIN STRUC BIOL, V14, P495, DOI 10.1016/j.sbi.2004.07.004; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falke JJ, 2009, STRUCTURE, V17, P1149, DOI 10.1016/j.str.2009.08.005; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Hooper LV, 2009, NAT REV MICROBIOL, V7, P367, DOI 10.1038/nrmicro2114; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kolida S, 2007, EUR J CLIN NUTR, V61, P1189, DOI 10.1038/sj.ejcn.1602636; Koropatkin N, 2009, BIOCHEMISTRY-US, V48, P1532, DOI 10.1021/bi801942a; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; LESLIE AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; LEY R, 2006, NATURE, V444, P1023; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Lozupone CA, 2008, P NATL ACAD SCI USA, V105, P15076, DOI 10.1073/pnas.0807339105; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Menne E, 2000, J NUTR, V130, P1197, DOI 10.1093/jn/130.5.1197; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; ROBERFROID M, 1993, NUTR REV, V51, P137, DOI 10.1111/j.1753-4887.1993.tb03090.x; Rossi M, 2005, APPL ENVIRON MICROB, V71, P6150, DOI 10.1128/AEM.71.10.6150-6158.2005; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000; Sonnenburg ED, 2006, P NATL ACAD SCI USA, V103, P8834, DOI 10.1073/pnas.0603249103; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Van der Meulen R, 2006, APPL ENVIRON MICROB, V72, P1006, DOI 10.1128/AEM.72.2.1006-1012.2006; Westover BP, 2005, BIOINFORMATICS, V21, P880, DOI 10.1093/bioinformatics/bti123; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	43	481	500	9	169	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1241	U256		10.1016/j.cell.2010.05.005	http://dx.doi.org/10.1016/j.cell.2010.05.005			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20603004	Bronze, Green Accepted			2022-12-01	WOS:000279148100020
J	Clayton, J				Clayton, Julie			Chagas disease: pushing through the pipeline	NATURE			English	Editorial Material							TRYPANOSOMA-CRUZI; ERGOSTEROL BIOSYNTHESIS; POSACONAZOLE; AMIODARONE; INFECTION											Benaim G, 2006, J MED CHEM, V49, P892, DOI 10.1021/jm050691f; *CLINICALTRIALS GO, 2005, BENEFIT TRIAL EV US; Doyle PS, 2007, ANTIMICROB AGENTS CH, V51, P3932, DOI 10.1128/AAC.00436-07; *GEORG I INT HLTH, 2007, G FINDER GLOB FUND I; *INT FED PHARM MAN, 2009, HLTH PARTN DEV WORLD; Marin-Neto JA, 2008, AM HEART J, V156, P37, DOI 10.1016/j.ahj.2008.04.001; Munoz J, 2009, CLIN INFECT DIS, V48, P1736, DOI 10.1086/599223; Paniz-Mondolfi AE, 2009, CHEMOTHERAPY, V55, P228, DOI 10.1159/000219436; Pinazo MJ, 2010, AM J TROP MED HYG, V82, P583, DOI 10.4269/ajtmh.2010.09-0620; Romanha AJ, 2010, MEM I OSWALDO CRUZ, V105, P233, DOI 10.1590/S0074-02762010000200022; Silva DT, 2006, INT J ANTIMICROB AG, V27, P530, DOI 10.1016/j.ijantimicag.2005.12.012; Urbina JA, 2009, MEM I OSWALDO CRUZ, V104, P311, DOI 10.1590/S0074-02762009000900041; Yun O, 2009, PLOS NEGLECT TROP D, V3, P1	13	111	112	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					S12	S15		10.1038/nature09224	http://dx.doi.org/10.1038/nature09224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20571548	Bronze			2022-12-01	WOS:000279056900028
J	Corbett, KD; Yip, CK; Ee, LS; Walz, T; Amon, A; Harrison, SC				Corbett, Kevin D.; Yip, Calvin K.; Ee, Ly-Sha; Walz, Thomas; Amon, Angelika; Harrison, Stephen C.			The Monopolin Complex Crosslinks Kinetochore Components to Regulate Chromosome-Microtubule Attachments	CELL			English	Article							PROTEIN-INTERACTION MAP; MEIOSIS-I; SACCHAROMYCES-CEREVISIAE; MOLECULAR ARCHITECTURE; DNA-REPLICATION; SISTER KINETOCHORES; YEAST KINETOCHORE; NDC80 COMPLEX; RIBOSOMAL DNA; CELL-CYCLE	The monopolin complex regulates different types of kinetochore-microtubule attachments in fungi, ensuring sister chromatid co-orientation in Saccharomyces cerevisiae meiosis I and inhibiting merotelic attachment in Schizosaccharomyces pombe mitosis. In addition, the monopolin complex maintains the integrity and silencing of ribosomal DNA ( rDNA) repeats in the nucleolus. We show here that the S. cerevisiae Csm1/Lrs4 monopolin subcomplex has a distinctive V-shaped structure, with two pairs of protein-protein interaction domains positioned similar to 10 nm apart. Csm1 presents a conserved hydrophobic surface patch that binds two kinetochore proteins: Dsn1, a subunit of the outer-kinetochore MIND/Mis12 complex, and Mif2/CENP-C. Csm1 point-mutations that disrupt kinetochore-subunit binding also disrupt sister chromatid co-orientation in S. cerevisiae meiosis I. We further show that the same Csm1 point-mutations affect rDNA silencing, probably by disrupting binding to the rDNA-associated protein Tof2. We propose that Csm1/Lrs4 functions as a molecular clamp, crosslinking kinetochore components to enforce sister chromatid co-orientation in S. cerevisiae meiosis I and to suppress merotelic attachment in S. pombe mitosis, and crosslinking rDNA repeats to aid rDNA silencing.	[Corbett, Kevin D.; Harrison, Stephen C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Yip, Calvin K.; Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Ee, Ly-Sha; Amon, Angelika] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Walz, Thomas; Amon, Angelika; Harrison, Stephen C.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Harrison, SC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 250 Longwood Ave, Boston, MA 02115 USA.	harrison@crystal.harvard.edu		Corbett, Kevin/0000-0001-5854-2388; Yip, Calvin/0000-0003-1779-9501; Amon, Angelika/0000-0001-9837-0314; Walz, Thomas/0000-0003-2606-2835	Helen Hay Whitney Foundation; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062207] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the Advanced Photon Source NE-CAT beamlines for advice and assistance with data collection and interpretation; D. Moazed for the gift of S. cerevisiae strains and valuable advice; M. Sawaya for providing advice and script files for anisotropic scaling; J. Al-Bassam for assistance with electron microscopy; members of the Amon laboratory, especially I. Brito and E. Unal, for advice, assistance with yeast strain construction, and light microscopy; and members of the Harrison laboratory and I. Cheeseman for helpful discussions. K.D.C. acknowledges a postdoctoral fellowship from the Helen Hay Whitney Foundation; C.K.Y. acknowledges a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund for Medical Research; T.W., A.A, and S.C.H. are Investigators in the Howard Hughes Medical Institute.	Brito IL, 2010, GENETICS, V185, P55, DOI 10.1534/genetics.110.115139; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Choi SH, 2009, CURR BIOL, V19, P985, DOI 10.1016/j.cub.2009.05.042; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; DING R, 1993, J CELL BIOL, V120, P141, DOI 10.1083/jcb.120.1.141; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gregan J, 2007, CURR BIOL, V17, P1190, DOI 10.1016/j.cub.2007.06.044; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Huang J, 2006, GENE DEV, V20, P2887, DOI 10.1101/gad.1472706; Joglekar AP, 2008, J CELL BIOL, V181, P587, DOI 10.1083/jcb.200803027; Joglekar AP, 2006, NAT CELL BIOL, V8, P581, DOI 10.1038/ncb1414; Johzuka K, 2009, MOL CELL, V34, P26, DOI 10.1016/j.molcel.2009.02.021; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Katis VL, 2004, CURR BIOL, V14, P2183, DOI 10.1016/j.cub.2004.12.020; Lee B, 2001, CURR OPIN CELL BIOL, V13, P770, DOI 10.1016/S0955-0674(00)00282-9; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Li XX, 2009, NAT CELL BIOL, V11, P1103, DOI 10.1038/ncb1923; LO HC, 1980, MOL BIOL CELL, V19, P4956; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; Matos J, 2008, CELL, V135, P662, DOI 10.1016/j.cell.2008.10.026; McEwen BF, 1997, J CELL BIOL, V137, P1567, DOI 10.1083/jcb.137.7.1567; Mekhail K, 2008, NATURE, V456, P667, DOI 10.1038/nature07460; Monje-Casas F, 2007, CELL, V128, P477, DOI 10.1016/j.cell.2006.12.040; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 1999, MOL CELL BIOL, V19, P3184; Tanaka K, 2009, DEV CELL, V17, P334, DOI 10.1016/j.devcel.2009.08.004; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wei RR, 2006, STRUCTURE, V14, P1003, DOI 10.1016/j.str.2006.04.007; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Winey M, 2005, MOL BIOL CELL, V16, P1178, DOI 10.1091/mbc.E04-09-0765; Wong J, 2007, MOL BIOL CELL, V18, P3800, DOI 10.1091/mbc.E07-06-0536; Wysocka M, 2004, EXP CELL RES, V294, P592, DOI 10.1016/j.yexcr.2003.12.008; Yokobayashi S, 2005, CELL, V123, P803, DOI 10.1016/j.cell.2005.09.013; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	44	89	90	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2010	142	4					556	567		10.1016/j.cell.2010.07.017	http://dx.doi.org/10.1016/j.cell.2010.07.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20723757	Green Submitted, Bronze, Green Accepted			2022-12-01	WOS:000281115900010
J	Daniel, JA; Santos, MA; Wang, ZB; Zang, CZ; Schwab, KR; Jankovic, M; Filsuf, D; Chen, HT; Gazumyan, A; Yamane, A; Cho, YW; Sun, HW; Ge, K; Peng, WQ; Nussenzweig, MC; Casellas, R; Dressler, GR; Zhao, KJ; Nussenzweig, A				Daniel, Jeremy A.; Santos, Margarida Almeida; Wang, Zhibin; Zang, Chongzhi; Schwab, Kristopher R.; Jankovic, Mila; Filsuf, Darius; Chen, Hua-Tang; Gazumyan, Anna; Yamane, Arito; Cho, Young-Wook; Sun, Hong-Wei; Ge, Kai; Peng, Weiqun; Nussenzweig, Michel C.; Casellas, Rafael; Dressler, Gregory R.; Zhao, Keji; Nussenzweig, Andre			PTIP Promotes Chromatin Changes Critical for Immunoglobulin Class Switch Recombination	SCIENCE			English	Article							LYSINE-4 METHYLTRANSFERASE COMPLEX; CYTIDINE DEAMINASE AID; RNA-POLYMERASE-II; BRCT-DOMAIN; HISTONE MODIFICATIONS; CHROMOSOME BREAKS; PROTEIN PTIP; DNA-DAMAGE; TRANSCRIPTION; METHYLATION	Programmed genetic rearrangements in lymphocytes require transcription at antigen receptor genes to promote accessibility for initiating double-strand break (DSB) formation critical for DNA recombination and repair. Here, we showed that activated B cells deficient in the PTIP component of the MLL3 (mixed-lineage leukemia 3)-MLL4 complex display impaired trimethylation of histone 3 at lysine 4 (H3K4me3) and transcription initiation of downstream switch regions at the immunoglobulin heavy-chain (Igh) locus, leading to defective immunoglobulin class switching. We also showed that PTIP accumulation at DSBs contributes to class switch recombination (CSR) and genome stability independently of Igh switch transcription. These results demonstrate that PTIP promotes specific chromatin changes that control the accessibility of the Igh locus to CSR and suggest a nonredundant role for the MLL3-MLL4 complex in altering antibody effector function.	[Daniel, Jeremy A.; Santos, Margarida Almeida; Filsuf, Darius; Chen, Hua-Tang; Nussenzweig, Andre] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Wang, Zhibin; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Zang, Chongzhi; Peng, Weiqun] George Washington Univ, Dept Phys, Washington, DC 20052 USA; [Schwab, Kristopher R.; Dressler, Gregory R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Jankovic, Mila; Gazumyan, Anna; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Jankovic, Mila; Gazumyan, Anna; Nussenzweig, Michel C.] Howard Hughes Med Inst, New York, NY 10065 USA; [Yamane, Arito; Casellas, Rafael] NIAMSD NIAMS, Bethesda, MD 20892 USA; [Cho, Young-Wook; Ge, Kai] NIDDKD, Nucl Receptor Biol Sect, CEB, NIH, Bethesda, MD 20892 USA; [Sun, Hong-Wei] NIAMS, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); George Washington University; University of Michigan System; University of Michigan; Rockefeller University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Nussenzweig, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov	/AAI-2516-2019; Cho, Young-Wook/F-8269-2011; Zang, Chongzhi/D-1445-2011; Ge, Kai/H-2810-2019; Daniel, Jeremy/S-4729-2016; Santos, Margarida/GWR-2285-2022; Nussenzweig, Michel/AAE-7292-2019; Yamane, Arito/A-2959-2013	Zang, Chongzhi/0000-0003-4812-3627; Ge, Kai/0000-0002-7442-5138; Daniel, Jeremy/0000-0002-1981-5571; Schwab, Kristopher/0000-0001-8056-1817; Peng, Weiqun/0000-0001-5521-9091	NIH, National Cancer Institute, and Center for Cancer Research; National Heart, Lung, and Blood Institute; NIH; NATIONAL CANCER INSTITUTE [ZIABC010283, ZIABC010959, ZICBC009255] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006030, ZIAHL006031, ZIAHL005801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIHAR041173, ZIAAR041148, ZICAR041181, ZIAAR041149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075003, ZIADK047055] Funding Source: NIH RePORTER	NIH, National Cancer Institute, and Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Gutierrez-Cruz, V. Sartorelli, M. Kruhlak, K. Cui, and Q. Tang for technical assistance. This work was supported by funding from the Intramural Research Program of the NIH, National Cancer Institute, and Center for Cancer Research to A.N.; the Division of Intramural Research at the National Heart, Lung, and Blood Institute to K.Z.; and an NIH Director's Challenge Award on "Epigenomic regulation of mammalian development and differentiation" to A.N., K.Z., and R.C. M.C.N. is a Howard Hughes Medical Institute investigator. The authors declare no competing financial interests and apologize for not being able to cite all primary references due to space limitations. All sequence data have been deposited in the Gene Expression Omnibus database (accession number GSE20852) at http://ncbi.nlm.nih.gov/geo/.	Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Cho EA, 2003, MOL CELL BIOL, V23, P1666, DOI 10.1128/MCB.23.5.1666-1673.2003; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cho YW, 2009, CELL METAB, V10, P27, DOI 10.1016/j.cmet.2009.05.010; Dudley DD, 2005, ADV IMMUNOL, V86, P43, DOI 10.1016/S0065-2776(04)86002-4; Fang M, 2009, DEVELOPMENT, V136, P1929, DOI 10.1242/dev.026559; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Gong ZH, 2009, J BIOL CHEM, V284, P7284, DOI 10.1074/jbc.M809158200; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Jowsey PA, 2004, J BIOL CHEM, V279, P55562, DOI 10.1074/jbc.M411021200; Kuang FL, 2009, P NATL ACAD SCI USA, V106, P5288, DOI 10.1073/pnas.0901368106; Lechner MS, 2000, NUCLEIC ACIDS RES, V28, P2741, DOI 10.1093/nar/28.14.2741; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li L, 2010, J EXP MED, V207, P983, DOI 10.1084/jem.20092437; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Munoz IM, 2007, NUCLEIC ACIDS RES, V35, P5312, DOI 10.1093/nar/gkm493; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; Rajagopal D, 2009, J EXP MED, V206, P1237, DOI 10.1084/jem.20082514; Ramachandran S, 2010, P NATL ACAD SCI USA, V107, P809, DOI 10.1073/pnas.0913790107; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Santos MA, 2010, J EXP MED, V207, P973, DOI 10.1084/jem.20092308; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Wang LL, 2009, J EXP MED, V206, P1817, DOI 10.1084/jem.20081678; Wang X, 2010, GENES CELLS, V15, P243, DOI 10.1111/j.1365-2443.2009.01379.x; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Wu JX, 2009, J BIOL CHEM, V284, P18078, DOI 10.1074/jbc.M109.002527; Xue KM, 2006, J EXP MED, V203, P2085, DOI 10.1084/jem.20061067	39	104	108	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 20	2010	329	5994					917	923		10.1126/science.1187942	http://dx.doi.org/10.1126/science.1187942			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640WN	20671152	Green Accepted			2022-12-01	WOS:000281084800027
J	Zhou, XL; Wang, JL; Lu, J; Song, YP; Kwak, KS; Jiao, QS; Rosenfeld, R; Chen, Q; Boone, T; Simonet, WS; Lacey, DL; Goldberg, AL; Han, HQ				Zhou, Xiaolan; Wang, Jin Lin; Lu, John; Song, Yanping; Kwak, Keith S.; Jiao, Qingsheng; Rosenfeld, Robert; Chen, Qing; Boone, Thomas; Simonet, W. Scott; Lacey, David L.; Goldberg, Alfred L.; Han, H. Q.			Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival	CELL			English	Article							ACTIVIN-A; SATELLITE CELL; TUMOR PROGRESSION; HEART-FAILURE; MYOSTATIN; ATROPHY; INHIBIN; ACTIVATION; MECHANISMS; EXPRESSION	Muscle wasting and cachexia have long been postulated to be key determinants of cancer-related death, but there has been no direct experimental evidence to substantiate this hypothesis. Here, we show that in several cancer cachexia models, pharmacological blockade of ActRIIB pathway not only prevents further muscle wasting but also completely reverses prior loss of skeletal muscle and cancer-induced cardiac atrophy. This treatment dramatically prolongs survival, even of animals in which tumor growth is not inhibited and fat loss and production of proinflammatory cytokines are not reduced. ActRIIB pathway blockade abolished the activation of the ubiquitin-proteasome system and the induction of atrophy-specific ubiquitin ligases in muscles and also markedly stimulated muscle stem cell growth. These findings establish a crucial link between activation of the ActRIIB pathway and the development of cancer cachexia. Thus ActRIIB antagonism is a promising new approach for treating cancer cachexia, whose inhibition per se prolongs survival.	[Zhou, Xiaolan; Wang, Jin Lin; Lu, John; Song, Yanping; Kwak, Keith S.; Jiao, Qingsheng; Rosenfeld, Robert; Chen, Qing; Boone, Thomas; Simonet, W. Scott; Lacey, David L.; Han, H. Q.] Amgen Res, Dept Metab Disorders, Thousand Oaks, CA 91360 USA; [Zhou, Xiaolan; Wang, Jin Lin; Lu, John; Song, Yanping; Kwak, Keith S.; Jiao, Qingsheng; Rosenfeld, Robert; Chen, Qing; Boone, Thomas; Simonet, W. Scott; Lacey, David L.; Han, H. Q.] Amgen Res, Dept Prot Sci, Thousand Oaks, CA 91360 USA; [Goldberg, Alfred L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Han, HQ (corresponding author), Amgen Res, Dept Metab Disorders, Thousand Oaks, CA 91360 USA.	hqhan@amgen.com			National Institutes of Health (NIA); Muscular Dystrophy Association	National Institutes of Health (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Muscular Dystrophy Association(Muscular Dystrophy Association)	We thank Dr. Martin Matzuk for breeding pairs of inhibin-alpha KO mice. We also thank Amgen Protein Science for reagent support, George Doellgast for PK assay, Keith Kelley for confocal microscopy and Keith Langley for helpful comment.; X.Z., J.L.W., J.L., Y.S., K.S.K., R.R., Q.J., Q.C., T.B., W.S.S., D.L.L. and H.Q.H. are all current or former employees of Amgen Inc. A.L.G. is professor of Harvard Medical School and has a consulting agreement with Amgen. His research is supported by grants from the National Institutes of Health (NIA) and the Muscular Dystrophy Association.	Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Argiles JM, 1999, MED RES REV, V19, P223, DOI 10.1002/(SICI)1098-1128(199905)19:3<223::AID-MED3>3.3.CO;2-E; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Cipriano SC, 2000, ENDOCRINOLOGY, V141, P2319, DOI 10.1210/en.141.7.2319; Coerver KA, 1996, MOL ENDOCRINOL, V10, P534, DOI 10.1210/me.10.5.534; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Costelli P, 2008, EUR J CLIN INVEST, V38, P531, DOI 10.1111/j.1365-2362.2008.01970.x; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Fearon KCH, 2008, EUR J CANCER, V44, P1124, DOI 10.1016/j.ejca.2008.02.033; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Harada K, 1996, J CLIN ENDOCR METAB, V81, P2125, DOI 10.1210/jc.81.6.2125; Heineke J, 2010, CIRCULATION, V121, P419, DOI 10.1161/CIRCULATIONAHA.109.882068; HELLERSTEIN HK, 1950, CIRCULATION, V1, P93, DOI 10.1161/01.CIR.1.1.93; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Kwak KS, 2004, CANCER RES, V64, P8193, DOI 10.1158/0008-5472.CAN-04-2102; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Li QL, 2007, MOL HUM REPROD, V13, P675, DOI 10.1093/molehr/gam055; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; MATZUK MM, 1994, P NATL ACAD SCI USA, V91, P8817, DOI 10.1073/pnas.91.19.8817; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; Mitch WE, 1996, NEW ENGL J MED, V335, P1897, DOI 10.1056/NEJM199612193352507; MOORE R, 1993, DEVELOPMENT, V117, P1409; MORI M, 1991, CANCER RES, V51, P6656; Otani T, 2001, GYNECOL ONCOL, V83, P31, DOI 10.1006/gyno.2001.6350; Petraglia F, 1998, J CLIN ENDOCR METAB, V83, P1194, DOI 10.1210/jc.83.4.1194; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; RODGERS BD, 2009, J PHYSL, V15, P4873; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Seder CW, 2009, NEOPLASIA, V11, P388, DOI 10.1593/neo.81582; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Solomon V, 1998, P NATL ACAD SCI USA, V95, P12602, DOI 10.1073/pnas.95.21.12602; Souza TA, 2008, MOL ENDOCRINOL, V22, P2689, DOI 10.1210/me.2008-0290; Springer J, 2010, CIRCULATION, V121, P354, DOI 10.1161/CIR.0b013e3181d0ba8b; STRASSMANN G, 1992, J CLIN INVEST, V89, P1681, DOI 10.1172/JCI115767; TANAKA M, 1993, CANCER LETT, V72, P65, DOI 10.1016/0304-3835(93)90012-X; Thomas TZ, 1997, J CLIN ENDOCR METAB, V82, P3851, DOI 10.1210/jc.82.11.3851; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Wildi S, 2001, GUT, V49, P409, DOI 10.1136/gut.49.3.409; Yndestad A, 2004, CIRCULATION, V109, P1379, DOI 10.1161/01.CIR.0000120704.97934.41; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	48	637	683	4	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2010	142	4					531	543		10.1016/j.cell.2010.07.011	http://dx.doi.org/10.1016/j.cell.2010.07.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20723755	Bronze			2022-12-01	WOS:000281115900008
J	Kanwal, F; Schnitzler, MS; Bacon, BR; Hoang, TY; Buchanan, PM; Asch, SM				Kanwal, Fasiha; Schnitzler, Mark S.; Bacon, Bruce R.; Hoang, Tuyen; Buchanan, Paula M.; Asch, Steven M.			Quality of Care in Patients With Chronic Hepatitis C Virus Infection A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; B VACCINATION; MISSED OPPORTUNITIES; ANTIVIRAL THERAPY; LIVER-DISEASE; VETERANS; PREDICTORS; RIBAVIRIN; IMPACT; MANAGEMENT	Background: Medicare has proposed quality-of-care indicators for chronic hepatitis C virus (HCV) infection. The extent to which these standards are met in practice is largely unknown. Objective: To evaluate the quality of health care that patients with HCV receive and the factors associated with receipt of quality care. Design: Retrospective cohort study. Setting: Nationwide U. S. health insurance company research database. Participants: 10 385 patients with HCV enrolled in the database between 2003 and 2006. Patients were included if they were eligible for at least 1 quality indicator. Measurements: Quality of HCV care received by patients, as measured by 7 explicit quality indicators included in Medicare's 2009 Physician Quality Reporting Initiative. Results: Proportions of patients meeting quality indicators varied, ranging from 21.5% for vaccination to 79% for the HCV genotype testing indicator. Overall, 18.5% of patients (95% CI, 18% to 19%) received all recommended care. Older age and presence of comorbid conditions were associated with lower quality, whereas elevated liver enzyme levels, cirrhosis, and HIV infection were associated with higher quality. Patients who saw both generalists and specialists received the best care (odds ratio of receiving care for which a patient is eligible: specialists alone, 0.79 [CI, 0.66 to 0.95]; primary care physician alone, 0.44 [CI, 0.40 to 0.48]). Limitations: The study had an observational retrospective design, used a convenience sample, and had no information on patient ethnicity. It may be that the indicators or the reporting of the indicators of HCV care-and not the care itself-is suboptimum. Conclusion: Health care quality, based on Medicare criteria, is suboptimum for HCV. Care that included both specialists and generalists is associated with the best quality. Our results support the development of specialist and primary care collaboration to improve the quality of HCV care.	[Kanwal, Fasiha] John Cochran Vet Affairs Med Ctr, St Louis, MO 63106 USA; St Louis Univ, Sch Med, St Louis, MO 63110 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; RAND Corp, Santa Monica, CA USA	Saint Louis University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; RAND Corporation	Kanwal, F (corresponding author), John Cochran Vet Affairs Med Ctr, 915 N Grand Blvd,111 JC GI, St Louis, MO 63106 USA.	fasiha.kanwal@va.gov; schnitm@slu.edu; pbuchan1@slu.edu			Saint Louis University Liver Center; Veterans Affairs Health Services Research and Development Service [IIR-07-111]	Saint Louis University Liver Center; Veterans Affairs Health Services Research and Development Service(US Department of Veterans Affairs)	Primary Funding Source: Saint Louis University Liver Center.; Grant Support: Dr. Kanwal is supported by Veterans Affairs Health Services Research and Development Service Investigator Initiated Research Award IIR-07-111. This study was supported by an intramural grant from the Saint Louis University Liver Center.	*AM HEART ASS, 2007, HEART DIS STROK STAT; ARMSTRONG GL, 2006, ANN INTERN MED, V705, P1999; Ayanian JZ, 2002, NEW ENGL J MED, V347, P1678, DOI 10.1056/NEJMsa020080; Backus LI, 2007, HEPATOLOGY, V46, P37, DOI 10.1002/hep.21662; Butt AA, 2007, GUT, V56, P385, DOI 10.1136/gut.2006.099150; Centers for Disease Control and Prevention, 1980, NUMB MILL CIV NON PE; Centers for Medicare and Medicaid Services, OV PHYS QUAL REP IN; *COPD INT, COPD STAT; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dominitz JA, 2005, HEPATOLOGY, V41, P88, DOI 10.1002/hep.20502; El-Serag HB, 2002, GASTROENTEROLOGY, V123, P476, DOI 10.1053/gast.2002.34750; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hachem CY, 2008, ALIMENT PHARM THER, V28, P1078, DOI 10.1111/j.1365-2036.2008.03827.x; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hernandez B, 2009, AM J GASTROENTEROL, V104, P1961, DOI 10.1038/ajg.2009.252; Kanwal F, 2007, HEPATOLOGY, V46, P1741, DOI 10.1002/hep.21927; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Kim WR, 2002, HEPATOLOGY, V36, P227, DOI 10.1053/jhep.2002.34734; LANZA LL, 1995, ARCH INTERN MED, V155, P1371, DOI 10.1001/archinte.155.13.1371; Ong JP, 2005, J CLIN GASTROENTEROL, V39, P826, DOI 10.1097/01.mcg.0000177258.95562.43; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Puoti C, 1997, HEPATOLOGY, V26, P1393; Puoti C, 1997, ITAL J GASTROENTEROL, V29, P383; RAFIQ N, 2009, 44 ANN M EUR ASS STU; Rongey CA, 2009, AM J PREV MED, V36, P235, DOI 10.1016/j.amepre.2008.10.013; Rousseau CM, 2008, AM J PUBLIC HEALTH, V98, P846, DOI 10.2105/AJPH.2007.113225; Shim M, 2005, HEPATOLOGY, V42, P688, DOI 10.1002/hep.20830; Shiratori Y, 2005, ANN INTERN MED, V142, P105, DOI 10.7326/0003-4819-142-2-200501180-00009; Vento S, 1998, NEW ENGL J MED, V338, P286, DOI 10.1056/NEJM199801293380503; Volk ML, 2009, HEPATOLOGY, V50, P1750, DOI 10.1002/hep.23220; Weinbaum C., 2006, Morbidity and Mortality Weekly Report, V55, P509; Wong VS, 1996, BRIT MED J, V312, P1336, DOI 10.1136/bmj.312.7042.1336; Yoshida H, 2002, GASTROENTEROLOGY, V123, P483, DOI 10.1053/gast.2002.34785	34	53	53	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 17	2010	153	4					231	239		10.7326/0003-4819-153-4-201008170-00005	http://dx.doi.org/10.7326/0003-4819-153-4-201008170-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639KF	20713791				2022-12-01	WOS:000280973000003
J	Strathdee, SA; Hallett, TB; Bobrova, N; Rhodes, T; Booth, R; Abdool, R; Hankins, CA				Strathdee, Steffanie A.; Hallett, Timothy B.; Bobrova, Natalia; Rhodes, Tim; Booth, Robert; Abdool, Reychad; Hankins, Catherine A.			HIV in people who use drugs 1 HIV and risk environment for injecting drug users: the past, present, and future	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HARM REDUCTION PROGRAMS; HEPATITIS-C; SYRINGE EXCHANGE; SOCIAL EPIDEMIOLOGY; GENDER-DIFFERENCES; HIV/AIDS EPIDEMIC; SAN-FRANCISCO; VACCINE TRIAL; PUBLIC-HEALTH	We systematically reviewed reports about determinants of HIV infection in injecting drug users from 2000 to 2009, classifying findings by type of environmental influence. We then modelled changes in risk environments in regions with severe HIV epidemics associated with injecting drug use. Of 94 studies identified, 25 intentionally examined risk environments. Modelling of HIV epidemics showed substantial heterogeneity in the number of HIV infections that are attributed to injecting drug use and unprotected sex. We estimate that, during 2010-15, HIV prevalence could be reduced by 41% in Odessa (Ukraine), 43% in Karachi (Pakistan), and 30% in Nairobi (Kenya) through a 60% reduction of the unmet need of programmes for opioid substitution, needle exchange, and antiretroviral therapy. Mitigation of patient transition to injecting drugs from non-injecting forms could avert a 98% increase in HIV infections in Karachi; whereas elimination of laws prohibiting opioid substitution with concomitant scale-up could prevent 14% of HIV infections in Nairobi. Optimisation of effectiveness and coverage of interventions is crucial for regions with rapidly growing epidemics. Delineation of environmental risk factors provides a crucial insight into HIV prevention. Evidence-informed, rights-based, combination interventions protecting IDUs' access to HIV prevention and treatment could substantially curtail HIV epidemics.	[Strathdee, Steffanie A.] Univ Calif San Diego, Dept Med, Div Global Publ Hlth, La Jolla, CA 92093 USA; [Hallett, Timothy B.] Univ London Imperial Coll Sci Technol & Med, London, England; [Bobrova, Natalia] UCL, London WC1E 6BT, England; [Rhodes, Tim] Univ London, London Sch Hyg & Trop Med, London WC1E 7HU, England; [Booth, Robert] Univ Colorado Denver, Denver, CO USA; [Hankins, Catherine A.] Joint United Nations Programme HIV AIDS, Geneva, Switzerland	University of California System; University of California San Diego; Imperial College London; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Strathdee, SA (corresponding author), Univ Calif San Diego, Dept Med, Div Global Publ Hlth, La Jolla, CA 92093 USA.	sstrathdee@ucsd.edu	Rhodes, Tim/DNJ-9679-2022; Cuscó, Xavier Garcia/S-7576-2019; Hallett, Timothy/A-2390-2011; Strathdee, Steffanie A/B-9042-2009	Cuscó, Xavier Garcia/0000-0001-7199-6931; Strathdee, Steffanie/0000-0002-7724-691X; Hankins, Catherine/0000-0002-1642-8592; Rhodes, Tim/0000-0003-2400-9838; Hallett, Timothy/0000-0002-9681-0424	US National Institute on Drug Abuse [DA027772-S1]; US Office of AIDS Research; The Wellcome Trust (UK); US NIH [RO1DA17620]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017620, R01DA027772] Funding Source: NIH RePORTER	US National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US Office of AIDS Research; The Wellcome Trust (UK)(Wellcome Trust); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This report was funded by the US National Institute on Drug Abuse grant DA027772-S1, the US Office of AIDS Research, and The Wellcome Trust (UK). RB was supported by a US NIH grant (RO1DA17620). We thank Christy Anderson, Richard Armenta, Annick Borquez, Philippe Bourgois, David Celentano, Jessica Cubeta, Penny Coppernoll-Blach, Anna Dovbah, Faran Emmanuel, Samuel R Friedman, Micah Gell-Redman, Eleanor Gouws, Mauro Guarinieri, Peter Hartsock, Brian Houle, Francisco I Bastos, Natalia Kitsenko, Robert Malow, Bradley Mathers, Lisovska Oksana, Jane Marie Ongo'lo, Samiran Panda, Natalia Rehtina, Diana Rossi, Richard Rothenberg, Tatyana Saliuk, Oleg Semeryk, Ani Shakarishvili, Alexandra Thomas, Emily To, Lucas Wiessing, Daniel Wolfe, and Carl Latkin.	Agha A, 2006, J Pak Med Assoc, V56, pS55; Altaf Arshad, 2007, Harm Reduct J, V4, P7, DOI 10.1186/1477-7517-4-7; [Anonymous], REP GLOB AIDS EP 200; [Anonymous], 2000, ACH BAL NAT OP CONTR; [Anonymous], 2009, RAP ADV ANT THER HIV; Azim T, 2008, SUBST USE MISUSE, V43, P2124, DOI 10.1080/10826080802344583; BALAKIREVA O, 2005, BEHAV MONITORING YOU; BALAKIREVA O, 2006, SITUATIONAL ANAL HIV; BALAKIREVA O, 2007, BEHAV MONITORING INJ; BALAKIREVA O, 2005, BEHAV MONITORING INJ; Barnett T, 2000, SOC SCI MED, V51, P1387, DOI 10.1016/S0277-9536(00)00104-0; Barrio G, 2007, EPIDEMIOL INFECT, V135, P592, DOI 10.1017/S0950268806007266; Beyrer C, 2003, AIDS BEHAV, V7, P153, DOI 10.1023/A:1023946324822; Beyrer C, 2009, AIDS RES HUM RETROV, V25, P853, DOI 10.1089/aid.2008.0206; Blankenship KM, 2006, J URBAN HEALTH, V83, P59, DOI 10.1007/s11524-005-9007-4; BLOWER SM, 1991, PHILOS T R SOC B, V331, P171, DOI 10.1098/rstb.1991.0006; Boileau C, 2005, JAIDS-J ACQ IMM DEF, V39, P489, DOI 10.1097/01.qai.0000153424.56379.61; Bokhari A, 2007, INT J STD AIDS, V18, P486, DOI 10.1258/095646207781147201; Booth RE, 2004, JAIDS-J ACQ IMM DEF, V35, P82, DOI 10.1097/00126334-200401010-00012; BOOTH RE, 2010, 16 C INT AIDS SOC VI; Booth RE, 2006, AIDS, V20, P2217, DOI 10.1097/QAD.0b013e328010e019; Booth RE, 2009, ADDICTION, V104, P1864, DOI 10.1111/j.1360-0443.2009.02660.x; Buavirat A, 2003, BRIT MED J, V326, P308, DOI 10.1136/bmj.326.7384.308; Burris S, 2006, AIDS, V20, P117, DOI 10.1097/01.aids.0000194806.81917.19; BURRIS S, 2009, BLUEPRINT REFORMING; March JC, 2007, ENFERM INFEC MICR CL, V25, P91, DOI 10.1157/13098569; Chitwood DD, 2003, J PSYCHOACTIVE DRUGS, V35, P445, DOI 10.1080/02791072.2003.10400491; Choopanya K, 2002, J ACQ IMMUN DEF SYND, V29, P86, DOI 10.1097/00126334-200201010-00012; de la Fuente L, 2006, J EPIDEMIOL COMMUN H, V60, P537, DOI 10.1136/jech.2005.037333; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Des Jarlais DC, 2007, AIDS, V21, P231, DOI 10.1097/QAD.0b013e3280114a15; Dewing S, 2006, DRUG-EDUC PREV POLIC, V13, P121, DOI 10.1080/09687630500480228; Diaz T, 2001, J WOMEN HEALTH GEN-B, V10, P371, DOI 10.1089/152460901750269698; Doherty MC, 2000, AIDS, V14, P717, DOI 10.1097/00002030-200004140-00011; *EHRN, 2009, YOUNG PEOPL INJ DRUG; Emmanuel F, 2008, INT J DRUG POLICY, V19, pS59, DOI 10.1016/j.drugpo.2007.12.012; Emmanuel F, 2009, JAIDS-J ACQ IMM DEF, V51, P85, DOI 10.1097/QAI.0b013e31819906f3; Estebanez P, 2001, EUR J EPIDEMIOL, V17, P573, DOI 10.1023/A:1014563303831; Estebanez PE, 2000, INT J EPIDEMIOL, V29, P734, DOI 10.1093/ije/29.4.734; Friedman SR, 2006, AIDS, V20, P93, DOI 10.1097/01.aids.0000196176.65551.a3; Friedman SR, 2001, AM J PUBLIC HEALTH, V91, P791, DOI 10.2105/AJPH.91.5.791; Galea S, 2004, EPIDEMIOL REV, V26, P36, DOI 10.1093/epirev/mxh007; GELMON L, 2009, UNAIDS KENYA HIV PRE; Glass TA, 2006, SOC SCI MED, V62, P1650, DOI 10.1016/j.socscimed.2005.08.044; Gouws E, 2006, SEX TRANSM INFECT, V82, pIII51, DOI 10.1136/sti.2006.020164; Grassly N. C., 2003, International Journal of Drug Policy, V14, P25, DOI 10.1016/S0955-3959(02)00224-4; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Hacker MA, 2005, SUBST USE MISUSE, V40, P99, DOI 10.1081/JA-200030511; Hankins C, 2002, J ACQ IMMUN DEF SYND, V30, P514, DOI 10.1097/00126334-200208150-00007; HARDING R, 2007, PAIN RELIEVING DRUGS; Hien NT, 2001, J SUBST ABUSE, V13, P45, DOI 10.1016/S0899-3289(01)00059-1; Hu DJ, 2002, J ACQ IMMUN DEF SYND, V30, P240, DOI [10.1097/01.QAI.0000014770.35851.44, 10.1097/00042560-200206010-00013]; ISRAILOV B, 2008, EPIDEMIOL INFECT DIS, V4, P8; Jarlais DCD, 2007, AIDS, V21, pS109, DOI 10.1097/01.aids.0000304705.79541.34; Jarlais DCD, 2009, AM J PUBLIC HEALTH, V99, pS445, DOI 10.2105/AJPH.2008.159327; Jurgens R, 2010, LANCET, V376, P475, DOI 10.1016/S0140-6736(10)60830-6; KHEIRANDISH P, 2009, J ACQ IMMUN DEF SYND, V53, P273; Khuwaja A. K., 2007, SMJ Singapore Medical Journal, V48, P509; KOSHKINA EA, 2005, NARCOLOGIJA, V5, P16; Kral AH, 2003, AM J EPIDEMIOL, V157, P915, DOI 10.1093/aje/kwg070; Kral AH, 2001, LANCET, V357, P1397, DOI 10.1016/S0140-6736(00)04562-1; Latkin CA, 2003, SOC SCI MED, V56, P465, DOI 10.1016/S0277-9536(02)00047-3; Liu W, 2006, ADDICTION, V101, P1493, DOI 10.1111/j.1360-0443.2006.01557.x; Lopez-Zetina J, 2001, ADDICTION, V96, P589, DOI 10.1080/09652140020031638; Maas B, 2007, HEALTH PLACE, V13, P432, DOI 10.1016/j.healthplace.2006.05.005; Maslow CB, 2002, AM J PUBLIC HEALTH, V92, P382, DOI 10.2105/AJPH.92.3.382; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Mayhew S, 2009, SEX TRANSM INFECT, V85, P31, DOI 10.1136/sti.2008.033670; Mehrabadi A, 2008, WOMEN HEALTH, V48, P235, DOI 10.1080/03630240802463186; Mesquita F, 2001, J ACQ IMMUN DEF SYND, V28, P298, DOI 10.1097/00042560-200111010-00016; Miller CL, 2006, SUBST USE MISUSE, V41, P199, DOI 10.1080/10826080500391795; *MIN HLTH UKR, 2008, NAT REP MON PROGR UN; National AIDS Control Program, 2008, HIV 2 GEN SURV PAK N; Neaigus A, 2008, J URBAN HEALTH, V85, P309, DOI 10.1007/s11524-008-9271-1; Niccolai LM, 2010, AIDS BEHAV, V14, P932, DOI 10.1007/s10461-008-9469-y; O'Connell JM, 2005, JAIDS-J ACQ IMM DEF, V40, P83, DOI 10.1097/01.qai.0000157006.28535.mL; ODEKOGUNDE M, 2003, P 14 INT C RED DRUG; Oelrichs RB, 2000, J VIROL, V74, P1149, DOI 10.1128/JVI.74.3.1149-1157.2000; Ouellet LJ, 2000, J ACQ IMMUN DEF SYND, V25, P443, DOI 10.1097/00126334-200012150-00010; *PAIN POL STUD GRO, 2007, INT NARC CONTR BOARD; Panda S, 2005, JAIDS-J ACQ IMM DEF, V39, P9, DOI 10.1097/01.qai.0000160713.94203.9b; Panda S, 2000, INT J STD AIDS, V11, P468, DOI 10.1258/0956462001916137; Parviz S, 2006, INT J INFECT DIS, V10, P364, DOI 10.1016/j.ijid.2005.07.010; Platt L, 2008, JAIDS-J ACQ IMM DEF, V47, P623, DOI 10.1097/QAI.0b013e318165dbf7; Platt L, 2006, AIDS, V20, P2120, DOI 10.1097/01.aids.0000247586.23696.20; POHORILA NB, 2008, ANAL REPORT BASED 20; Poundstone KE, 2004, EPIDEMIOL REV, V26, P22, DOI 10.1093/epirev/mxh005; Reyes JC, 2005, J URBAN HEALTH, V82, P446, DOI 10.1093/jurban/jti073; Rhodes T, 1999, ADDICTION, V94, P1323, DOI 10.1046/j.1360-0443.1999.94913235.x; Rhodes T, 2006, ADDICTION, V101, P252, DOI 10.1111/j.1360-0443.2006.01317.x; Rhodes T, 2005, SOC SCI MED, V61, P1026, DOI 10.1016/j.socscimed.2004.12.024; Rhodes T, 2002, AIDS, V16, pF25, DOI 10.1097/00002030-200209060-00002; Rhodes T, 2005, BMJ-BRIT MED J, V331, P220, DOI 10.1136/bmj.331.7510.220; Rhodes T, 2009, INT J DRUG POLICY, V20, P193, DOI 10.1016/j.drugpo.2008.10.003; Rondinelli AJ, 2009, DRUG ALCOHOL DEPEN, V104, P167, DOI 10.1016/j.drugalcdep.2009.05.013; Rothenberg R, 2001, J URBAN HEALTH, V78, P419, DOI 10.1093/jurban/78.3.419; Ruan YH, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000304695.54884.4f; Salmon AM, 2009, AUST NZ J PUBL HEAL, V33, P280, DOI 10.1111/j.1753-6405.2009.00389.x; Sanchez JL, 2006, DRUG ALCOHOL DEPEN, V82, pS15, DOI 10.1016/S0376-8716(06)80003-7; Santibanez SS, 2006, J URBAN HEALTH, V83, P86, DOI 10.1007/s11524-005-9009-2; Shafer KP, 2002, JAIDS-J ACQ IMM DEF, V31, P422, DOI 10.1097/00126334-200212010-00009; Spittal PM, 2007, INT J CIRCUMPOL HEAL, V66, P226, DOI 10.3402/ijch.v66i3.18259; Spittal PM, 2003, AIDS CARE, V15, P187, DOI 10.1080/0954012031000068335; Spittal PM, 2002, CAN MED ASSOC J, V166, P894; Stachowiak JA, 2006, DRUG ALCOHOL DEPEN, V82, pS7, DOI 10.1016/S0376-8716(06)80002-5; Stark K, 2006, EPIDEMIOL INFECT, V134, P814, DOI 10.1017/S0950268805005613; Strathdee SA, 2001, ARCH INTERN MED, V161, P1281, DOI 10.1001/archinte.161.10.1281; Strathdee SA, 1997, AIDS, V11, pF59, DOI 10.1097/00002030-199708000-00001; Strathdee SA, 2008, JAIDS-J ACQ IMM DEF, V47, P369, DOI 10.1097/QAI.0b013e318160d5ae; Strathdee SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002690; Suntharasamai P, 2009, ADDICTION, V104, P235, DOI 10.1111/j.1360-0443.2008.02436.x; Tariq Zafar, 2002, International Journal of Drug Policy, V13, P121, DOI 10.1016/S0955-3959(02)00011-7; Tran TMT, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-248; Tuan NA, 2007, B WORLD HEALTH ORGAN, V85, P35, DOI 10.2471/BLT.05.026153; Tyndall MW, 2003, AIDS, V17, P887, DOI 10.1097/00002030-200304110-00014; *UN DRUG CONTR PRO, 2002, PROGR DRUG AB REP PA; *UNODC, 2004, STUD LINK DRUG AB IN; *UNODC, 2009, NAIR OUTR SERV TRUST; Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x; Vanichseni S, 2001, AIDS, V15, P397, DOI 10.1097/00002030-200102160-00013; Vertefeuille J, 2002, J DRUG ISSUES, V32, P1125, DOI 10.1177/002204260203200408; Vickerman P, 2006, SEX TRANSM DIS, V33, pS89, DOI 10.1097/01.olq.0000221335.80508.fa; Vorobjov S, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-3; Welp EAE, 2002, AIDS, V16, P1279, DOI 10.1097/00002030-200206140-00011; *WHO REG OFF EUR, 2006, SEX TRANSM INF HIV A; *WHO UNAIDS UNICEF, 2009, SCAL PRIOR HIV AIDS; Williams ML, 2009, AIDS EDUC PREV, V21, P474, DOI 10.1521/aeap.2009.21.5.474; Wolfe D, 2010, LANCET, V376, P355, DOI 10.1016/S0140-6736(10)60832-X; Wood E, 2007, AM J MED, V120, P172, DOI 10.1016/j.amjmed.2006.02.030; Wood Evan, 2009, BMJ, V338, pb1649, DOI 10.1136/bmj.b1649; *WORLD BANK, 2006, INT HIV AIDS ALL UKR; Wylie JL, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-229; Yin Lu, 2007, Harm Reduct J, V4, P6, DOI 10.1186/1477-7517-4-6; Zamani S, 2005, AIDS, V19, P709, DOI 10.1097/01.aids.0000166094.24069.72; Zamani S, 2006, JAIDS-J ACQ IMM DEF, V42, P342, DOI 10.1097/01.qai.0000219785.81163.67; Zhang L, 2008, TROP MED INT HEALTH, V13, P814, DOI 10.1111/j.1365-3156.2008.02071.x; Zhang YZ, 2007, INT J INFECT DIS, V11, P318, DOI 10.1016/j.ijid.2006.09.001; Zhang Y, 2007, J INFECTION, V54, P285, DOI 10.1016/j.jinf.2006.06.001; 2009, PREVENTION HIV AIDS	140	389	392	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2010	376	9737					268	284		10.1016/S0140-6736(10)60743-X	http://dx.doi.org/10.1016/S0140-6736(10)60743-X			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632VM	20650523	Green Accepted			2022-12-01	WOS:000280457200037
J	Greer, EL; Maures, TJ; Hauswirth, AG; Green, EM; Leeman, DS; Maro, GS; Han, S; Banko, MR; Gozani, O; Brunet, A				Greer, Eric L.; Maures, Travis J.; Hauswirth, Anna G.; Green, Erin M.; Leeman, Dena S.; Maro, Geraldine S.; Han, Shuo; Banko, Max R.; Gozani, Or; Brunet, Anne			Members of the H3K4 trimethylation complex regulate lifespan in a germline-dependent manner in C. elegans	NATURE			English	Article							SYSTEMATIC RNAI SCREEN; SET-DOMAIN PROTEIN; CAENORHABDITIS-ELEGANS; HISTONE H3; GENE-EXPRESSION; LONGEVITY; METHYLATION; METHYLTRANSFERASE; METABOLISM; COMPONENTS	The plasticity of ageing suggests that longevity may be controlled epigenetically by specific alterations in chromatin state. The link between chromatin and ageing has mostly focused on histone deacetylation by the Sir2 family(1,2), but less is known about the role of other histone modifications in longevity. Histone methylation has a crucial role in development and in maintaining stem cell pluripotency in mammals(3). Regulators of histone methylation have been associated with ageing in worms(4-7) and flies(8), but characterization of their role and mechanism of action has been limited. Here we identify the ASH-2 trithorax complex(9), which trimethylates histone H3 at lysine 4 (H3K4), as a regulator of lifespan in Caenorhabditis elegans in a directed RNA interference (RNAi) screen in fertile worms. Deficiencies in members of the ASH-2 complex-ASH-2 itself, WDR-5 and the H3K4 methyltransferase SET-2-extend worm lifespan. Conversely, the H3K4 demethylase RBR-2 is required for normal lifespan, consistent with the idea that an excess of H3K4 trimethylation-a mark associated with active chromatin is detrimental for longevity. Lifespan extension induced by ASH-2 complex deficiency requires the presence of an intact adult germline and the continuous production of mature eggs. ASH-2 and RBR-2 act in the germline, at least in part, to regulate lifespan and to control a set of genes involved in lifespan determination. These results indicate that the longevity of the soma is regulated by an H3K4 methyltransferase/demethylase complex acting in the C. elegans germline.	[Greer, Eric L.; Maures, Travis J.; Hauswirth, Anna G.; Leeman, Dena S.; Han, Shuo; Banko, Max R.; Brunet, Anne] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Greer, Eric L.; Leeman, Dena S.; Gozani, Or; Brunet, Anne] Stanford Univ, Canc Biol Grad Program, Stanford, CA 94305 USA; [Green, Erin M.; Maro, Geraldine S.; Gozani, Or] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Maro, Geraldine S.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Brunet, A (corresponding author), Stanford Univ, Dept Genet, 300 Pasteur Dr, Stanford, CA 94305 USA.	anne.brunet@stanford.edu	Gozani, Or P/I-6157-2013; Green, Erin/J-6098-2019	Gozani, Or/0000-0002-1365-4463; Greer, Eric/0000-0002-7501-7371; Green, Erin/0000-0003-3923-6726; han, shuo/0000-0003-1181-351X	NIH [R01-AG31198, T32-CA009302, ARRA-AG31198, T32-HG000044, F31-AG032837]; NSF; Stanford graduate fellowship; Human Frontier Science Program post-doctoral fellowship; Searle Scholar award; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031198, R56AG031198, F31AG032837] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Stanford graduate fellowship(Stanford University); Human Frontier Science Program post-doctoral fellowship(Human Frontier Science Program); Searle Scholar award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to A. Fire, K. Helin, S. Kim, K. Shen, T. Stiernagle and the Caenorhabditis Genetics Center, M. W. Tan and A. Villeneuve for gifts of strains, reagents and antibodies. We thank S. Kim, G. Seydoux, C. Slightam and K. Shen for advice on worm transgenesis, and S. Kim, A. Morgan and Y. Kobayashi for help with microarray analysis. We thank A. Fire, S. Kim, G. Seydoux, M. W. Tan and J. Wysocka for discussions. We thank members of the Brunet laboratory, M. Kaeberlein, J. Lieberman, J. Sage and J. Wysocka for critical reading of the manuscript. This work was supported by NIH grant R01-AG31198 to A. B.; E. L. G. was supported by NIH training grant T32-CA009302, an NSF graduate fellowship and by NIH ARRA-AG31198. T. J. M. was supported by NIH grant T32-HG000044. D. S. L. and E. M. G. were supported by NIH training grant T32-CA009302. S. H. was supported by a Stanford graduate fellowship. G. S. M. was supported by a Human Frontier Science Program post-doctoral fellowship. M. R. B. was supported by NIH fellowship F31-AG032837. O.G. was supported by a Searle Scholar award.	Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Budovskaya YV, 2008, CELL, V134, P291, DOI 10.1016/j.cell.2008.05.044; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Chen S, 2009, P NATL ACAD SCI USA, V106, P1496, DOI 10.1073/pnas.0802674106; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Haag ES, 2002, CURR BIOL, V12, P2035, DOI 10.1016/S0960-9822(02)01333-7; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Kelly WG, 1997, GENETICS, V146, P227; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Li J, 2008, PLOS BIOL, V6, P1870, DOI 10.1371/journal.pbio.0060233; McColl G, 2008, J BIOL CHEM, V283, P350, DOI 10.1074/jbc.M705028200; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; MERRITT C, 2010, WORMBOOK, DOI DOI 10.1895/W0RMBOOK.1.148.1; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Nottke A, 2009, DEVELOPMENT, V136, P879, DOI 10.1242/dev.020966; Papoulas O, 1998, DEVELOPMENT, V125, P3955; Praitis V, 2001, GENETICS, V157, P1217; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Siebold AP, 2010, P NATL ACAD SCI USA, V107, P169, DOI 10.1073/pnas.0907739107; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simonet T, 2007, DEV BIOL, V312, P367, DOI 10.1016/j.ydbio.2007.09.035; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Xu L, 2001, GENETICS, V159, P1019	42	335	392	0	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					383	U137		10.1038/nature09195	http://dx.doi.org/10.1038/nature09195			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20555324	Green Accepted			2022-12-01	WOS:000279867100052
J	Bai, XY; Kim, J; Yang, ZA; Jurynec, MJ; Akie, TE; Lee, J; LeBlanc, J; Sessa, A; Jiang, H; DiBiase, A; Zhou, Y; Grunwald, DJ; Lin, S; Cantor, AB; Orkin, SH; Zon, LI				Bai, Xiaoying; Kim, Jonghwan; Yang, Zhongan; Jurynec, Michael J.; Akie, Thomas E.; Lee, Joseph; LeBlanc, Jocelyn; Sessa, Anna; Jiang, Hong; DiBiase, Anthony; Zhou, Yi; Grunwald, David J.; Lin, Shuo; Cantor, Alan B.; Orkin, Stuart H.; Zon, Leonard I.			TIF1 gamma Controls Erythroid Cell Fate by Regulating Transcription Elongation	CELL			English	Article							POLYMERASE-II ELONGATION; RNA-POLYMERASE; P-TEFB; PAF1 COMPLEX; GATA-1; GENES; DSIF; IDENTIFICATION; HEMATOPOIESIS; METHYLATION	Recent genome-wide studies have demonstrated that pausing of RNA polymerase II (Pol II) occurred on many vertebrate genes. By genetic studies in the zebrafish tif1 gamma mutant moonshine we found that loss of function of Pol II-associated factors PAF or DSIF rescued erythroid gene transcription in tif1 gamma-deficient animals. Biochemical analysis established physical interactions among TIF1 gamma, the blood-specific SCL transcription complex, and the positive elongation factors p-TEFb and FACT. Chromatin immunoprecipitation assays in human CD34(+) cells supported a TIF1 gamma-dependent recruitment of positive elongation factors to erythroid genes to promote transcription elongation by counteracting Pol II pausing. Our study establishes a mechanism for regulating tissue cell fate and differentiation through transcription elongation.	[Bai, Xiaoying; Kim, Jonghwan; Lee, Joseph; LeBlanc, Jocelyn; Sessa, Anna; DiBiase, Anthony; Zhou, Yi; Orkin, Stuart H.; Zon, Leonard I.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Bai, Xiaoying; Lee, Joseph; LeBlanc, Jocelyn; Sessa, Anna; DiBiase, Anthony; Zhou, Yi; Zon, Leonard I.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Bai, Xiaoying; Kim, Jonghwan; Akie, Thomas E.; Lee, Joseph; LeBlanc, Jocelyn; Sessa, Anna; DiBiase, Anthony; Zhou, Yi; Cantor, Alan B.; Orkin, Stuart H.; Zon, Leonard I.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Div Hematol Oncol,Childrens Hosp Boston, Boston, MA 02115 USA; [Kim, Jonghwan; Orkin, Stuart H.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Yang, Zhongan; Jiang, Hong; Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Jurynec, Michael J.; Grunwald, David J.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of California System; University of California Los Angeles; Utah System of Higher Education; University of Utah	Zon, LI (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu	Jurynec, Michael/AAH-8765-2020; Kim, Jonghwan/AAR-2815-2021	Kim, Jonghwan/0000-0002-9919-9843; Cantor, Alan/0000-0002-5136-028X	National Institutes of Health [5PO1HL32262-28, 5R37 DK55381-010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262, R01HL048801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216, R37DK055381, R01DK053298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. H. Chen, S. Guo, S. Takada, E.H. Bresnick, and S.J. Brandt for providing regents, Y. Huang, A. Chen, and R. Mathieu for technical assistance. We are grateful to Drs. T.V. Bowman, C. Ceol, and R. White for helpful discussion and critical comments. This study was supported by National Institutes of Health grants 5PO1HL32262-28 and 5R37 DK55381-010. X. Bai and J. Kim are Howard Hughes Medical Institute (HHMI) research fellows. L.I. Zon and S.H. Orkin are HHMI investigators. L.I.Z. is a founder and stock holder of Fate, Inc. and a scientific advisor for Stemgent.	Akanuma T, 2007, EMBO REP, V8, P858, DOI 10.1038/sj.embor.7401045; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006918; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Elagib KE, 2008, BLOOD, V112, P4884, DOI 10.1182/blood-2008-03-145722; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Guo S, 2000, NATURE, V408, P366, DOI 10.1038/35042590; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Ivanov D, 2000, MOL CELL BIOL, V20, P2970, DOI 10.1128/MCB.20.9.2970-2983.2000; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Keegan BR, 2002, DEVELOPMENT, V129, P1623; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Krishnan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003621; LeDouarin B, 1996, PHILOS T R SOC B, V351, P569, DOI 10.1098/rstb.1996.0056; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Long QM, 1997, DEVELOPMENT, V124, P4105; Meier N, 2006, DEVELOPMENT, V133, P4913, DOI 10.1242/dev.02656; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Penheiter KL, 2005, MOL CELL, V20, P213, DOI 10.1016/j.molcel.2005.08.023; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Qiu HF, 2006, MOL CELL BIOL, V26, P3135, DOI 10.1128/MCB.26.8.3135-3148.2006; Ransom DG, 2004, PLOS BIOL, V2, P1188, DOI 10.1371/journal.pbio.0020237; Ransom DG, 1996, DEVELOPMENT, V123, P311; Rozenblatt-Rosen O, 2009, P NATL ACAD SCI USA, V106, P755, DOI 10.1073/pnas.0812023106; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; Schuh AH, 2005, MOL CELL BIOL, V25, P10235, DOI 10.1128/MCB.25.23.10235-10250.2005; Sheldon KE, 2005, MOL CELL, V20, P225, DOI 10.1016/j.molcel.2005.08.026; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; Shim EY, 2002, GENE DEV, V16, P2135, DOI 10.1101/gad.999002; SOLNICAKREZEL L, 1994, GENETICS, V136, P1401; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Wada T, 2000, MOL CELL, V5, P1067, DOI 10.1016/S1097-2765(00)80272-5; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Weinstein BM, 1996, DEVELOPMENT, V123, P303; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	51	158	164	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2010	142	1					133	143		10.1016/j.cell.2010.05.028	http://dx.doi.org/10.1016/j.cell.2010.05.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603019	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000279637300019
J	Moiseff, A; Copeland, J				Moiseff, Andrew; Copeland, Jonathan			Firefly Synchrony: A Behavioral Strategy to Minimize Visual Clutter	SCIENCE			English	Article									[Moiseff, Andrew] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; [Copeland, Jonathan] Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA	University of Connecticut; University System of Georgia; Georgia Southern University	Moiseff, A (corresponding author), Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA.	Andrew.Moiseff@UConn.edu			Georgia Southern University Department of Biology; University of Connecticut Research Foundation	Georgia Southern University Department of Biology; University of Connecticut Research Foundation	Support for portions of this study were provided by the Georgia Southern University Department of Biology and the University of Connecticut Research Foundation. We thank L. Faust for assistance in the field, E. Lechowicz for technical support, and W. Chapple for commenting on the manuscript. K. Langdon and the Great Smoky Mountain National Park provided logistical support.	ADAMS G, 1981, FLA ENTOMOL, V64, P66, DOI 10.2307/3494601; BUCK J, 1981, J COMP PHYSIOL, V144, P287, DOI 10.1007/BF00612560; BUCK J, 1988, Q REV BIOL, V63, P265, DOI 10.1086/415929; BUCK J, 1968, SCIENCE, V159, P1319, DOI 10.1126/science.159.3821.1319; Buck JB, 1938, Q REV BIOL, V13, P301, DOI 10.1086/394562; GREENFIELD MD, 1994, ANNU REV ECOL SYST, V25, P97, DOI 10.1146/annurev.es.25.110194.000525; LLOYD JAMES E., 1966, MISC PUBLICATIONS MUS ZOOL UNIV MICH, V130, P1; LLOYD JE, 1989, BIOTROPICA, V21, P373, DOI 10.2307/2388290; Morse E. S., 1916, Science, V43, DOI 10.1126/science.43.1101.169; OTTE D, 1980, AM NAT, V116, P587, DOI 10.1086/283648; Strogatz S., 2004, PHYS TODAY, DOI DOI 10.1063/1.1784276	11	55	55	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					181	181		10.1126/science.1190421	http://dx.doi.org/10.1126/science.1190421			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616271				2022-12-01	WOS:000279635200038
J	Ackerman, JM; Nocera, CC; Bargh, JA				Ackerman, Joshua M.; Nocera, Christopher C.; Bargh, John A.			Incidental Haptic Sensations Influence Social Judgments and Decisions	SCIENCE			English	Article							TOUCH; EMBODIMENT; EMOTION; CHOICE; MIND	Touch is both the first sense to develop and a critical means of information acquisition and environmental manipulation. Physical touch experiences may create an ontological scaffold for the development of intrapersonal and interpersonal conceptual and metaphorical knowledge, as well as a springboard for the application of this knowledge. In six experiments, holding heavy or light clipboards, solving rough or smooth puzzles, and touching hard or soft objects nonconsciously influenced impressions and decisions formed about unrelated people and situations. Among other effects, heavy objects made job candidates appear more important, rough objects made social interactions appear more difficult, and hard objects increased rigidity in negotiations. Basic tactile sensations are thus shown to influence higher social cognitive processing in dimension-specific and metaphor-specific ways.	[Ackerman, Joshua M.] MIT, Alfred P Sloan Sch Management, Cambridge, MA 02142 USA; [Nocera, Christopher C.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Bargh, John A.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Massachusetts Institute of Technology (MIT); Harvard University; Yale University	Ackerman, JM (corresponding author), MIT, Alfred P Sloan Sch Management, 77 Massachusetts Ave,E62, Cambridge, MA 02142 USA.		Ackerman, Joshua/A-9315-2013		Sloan School of Management; National Institute of Mental Health [MH60767]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060767] Funding Source: NIH RePORTER	Sloan School of Management; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Sloan School of Management and by National Institute of Mental Health grant MH60767 to J.B. We thank L. Williams, E. Morsella, the Yale ACME lab, and many research assistants for their feedback and aid.	Anderson ML, 2007, PHILOS PSYCHOL, V20, P143, DOI 10.1080/09515080701197163; Barsalou LW, 2003, LANG COGNITIVE PROC, V18, P513, DOI 10.1080/01690960344000026; Boroditsky L, 2002, PSYCHOL SCI, V13, P185, DOI 10.1111/1467-9280.00434; Clark H.H., 1996, USING LANGUAGE; DeYoung CG, 2002, PERS INDIV DIFFER, V33, P533, DOI 10.1016/S0191-8869(01)00171-4; Gallace A, 2008, CONSCIOUS COGN, V17, P370, DOI 10.1016/j.concog.2007.01.005; Gallace A, 2010, NEUROSCI BIOBEHAV R, V34, P246, DOI 10.1016/j.neubiorev.2008.10.004; GIBSON JJ, 1962, PSYCHOL REV, V69, P477, DOI 10.1037/h0046962; Goldinger SD, 2005, PSYCHOL SCI, V16, P525, DOI 10.1111/j.0956-7976.2005.01569.x; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Jostmann NB, 2009, PSYCHOL SCI, V20, P1169, DOI 10.1111/j.1467-9280.2009.02426.x; Kay AC, 2004, ORGAN BEHAV HUM DEC, V95, P83, DOI 10.1016/j.obhdp.2004.06.003; Kovecses Zoltan, 2005, METAPHOR CULTURE UNI; Krishna A, 2008, J CONSUM RES, V34, P807, DOI 10.1086/523286; Lakoff G., 2003, METAPHORS WE LIVE, DOI DOI 10.7208/CHICAGO/9780226470993.001.0001; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; MANDLER JM, 1992, PSYCHOL REV, V99, P587, DOI 10.1037/0033-295X.99.4.587; Meier BP, 2004, PSYCHOL SCI, V15, P243, DOI 10.1111/j.0956-7976.2004.00659.x; MESSICK DM, 1968, J EXP SOC PSYCHOL, V4, P1, DOI 10.1016/0022-1031(68)90046-2; Mortensen CR, 2010, PSYCHOL SCI, V21, P440, DOI 10.1177/0956797610361706; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Niedenthal PM, 2005, PERS SOC PSYCHOL REV, V9, P184, DOI 10.1207/s15327957pspr0903_1; Peck J, 2003, J CONSUM RES, V30, P430, DOI 10.1086/378619; Schacter DL, 2007, CURR OPIN NEUROBIOL, V17, P171, DOI 10.1016/j.conb.2007.02.001; Van Lange PAM, 1999, J PERS SOC PSYCHOL, V77, P337, DOI 10.1037/0022-3514.77.2.337; Wegner D. M., 1998, HDB SOCIAL PSYCHOL, V1, P446; Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548; Williams LE, 2009, EUR J SOC PSYCHOL, V39, P1257, DOI 10.1002/ejsp.665	28	283	309	3	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1712	1715		10.1126/science.1189993	http://dx.doi.org/10.1126/science.1189993			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	615BY	20576894	Green Accepted			2022-12-01	WOS:000279107400049
J	Huang, CRL; Schneider, AM; Lu, YQ; Niranjan, T; Shen, PL; Robinson, MA; Steranka, JP; Valle, D; Civin, CI; Wang, T; Wheelan, SJ; Ji, HK; Boeke, JD; Burns, KH				Huang, Cheng Ran Lisa; Schneider, Anna M.; Lu, Yunqi; Niranjan, Tejasvi; Shen, Peilin; Robinson, Matoya A.; Steranka, Jared P.; Valle, David; Civin, Curt I.; Wang, Tao; Wheelan, Sarah J.; Ji, Hongkai; Boeke, Jef D.; Burns, Kathleen H.			Mobile Interspersed Repeats Are Major Structural Variants in the Human Genome	CELL			English	Article							RETROTRANSPOSON INSERTION; L1 RETROTRANSPOSITION; LINE-1; GENE; SEQUENCE; ELEMENTS; DATABASE; FAMILY; IMPACT	Characterizing structural variants in the human genome is of great importance, but a genome wide analysis to detect interspersed repeats has not been done. Thus, the degree to which mobile DNAs contribute to genetic diversity, heritable disease, and oncogenesis remains speculative. We perform transposon insertion profiling by microarray (TIP-chip) to map human L1(Ta) retrotransposons (LINE-1 s) genome-wide. This identified numerous novel human L1(Ta) insertional polymorphisms with highly variant allelic frequencies. We also explored TIP-chip's usefulness to identify candidate alleles associated with different phenotypes in clinical cohorts. Our data suggest that the occurrence of new insertions is twice as high as previously estimated, and that these repeats are under-recognized as sources of human genomic and phenotypic diversity. We have just begun to probe the universe of human L1(Ta) polymorphisms, and as TIP-chip is applied to other insertions such as Alu SINEs, it will expand the catalog of genomic variants even further.	[Huang, Cheng Ran Lisa; Lu, Yunqi; Niranjan, Tejasvi; Steranka, Jared P.; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21287 USA; [Huang, Cheng Ran Lisa; Lu, Yunqi; Niranjan, Tejasvi; Robinson, Matoya A.; Steranka, Jared P.; Valle, David; Wang, Tao; Burns, Kathleen H.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21287 USA; [Schneider, Anna M.; Shen, Peilin; Burns, Kathleen H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA; [Civin, Curt I.; Wheelan, Sarah J.; Boeke, Jef D.; Burns, Kathleen H.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21287 USA; [Wheelan, Sarah J.; Ji, Hongkai] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21287 USA.	jboeke@jhmi.edu	Burns, Kathleen/A-3360-2011; Niranjan, Tejasvi/ABD-2892-2020	Boeke, Jef/0000-0001-5322-4946; Niranjan, Tejasvi/0000-0002-6458-2017; Burns, Kathleen/0000-0003-1620-3761	NIH [P01-CA16319, RC1 HG005359, K08-CA134746]; Brain Science Institute at Johns Hopkins University School of Medicine; Goldhirsh Foundation; Burroughs Wellcome Foundation; NATIONAL CANCER INSTITUTE [K08CA134746, P01CA016519] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC1HG005359] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Science Institute at Johns Hopkins University School of Medicine; Goldhirsh Foundation; Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported in part by NIH grant P01-CA16319, RC1 HG005359 and grants from the Brain Science Institute at Johns Hopkins University School of Medicine and the Goldhirsh Foundation (J.D.B.), and NIH grant K08-CA134746 and a Career Award for Medical Scientists from the Burroughs Wellcome Foundation (K. H. B.). We thank Jon Alder, Joe Costello, Lisa Scheifele, Daniel Yuan, Syntyche Walker, Ed Davis, Kate O'Donnell, Lixin Dai, Wengfeng An, and Christina Schrum for helpful discussions and Audrey Hendley, Naera El-Sharkawy, Lisa Scheifele, and Daniel Yuan for technical assistance. We thank Robert B. Weiss and Kevin M. Flanigan for X-linked dilated cardiomyopathy and Becker muscular dystrophy patient samples; Cindy Skinner, Cassandra Obie, and Abby Adamczyk for assistance in providing X-linked intellectual disability genomic DNA samples; and Pei-Lung Chen, Darci Ferrer, Sarah E. Ritter, and Gary Cutting for familial and twin genomic DNA. Finally, we thank Bang Wong at ClearScience and Cheng Lai Victor Huang for assistance with artwork.	Arnold C, 1991, PCR Methods Appl, V1, P39; Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Belancio VP, 2008, GENE, V411, P38, DOI 10.1016/j.gene.2007.12.022; Bennettt EA, 2004, GENETICS, V168, P933, DOI 10.1534/genetics.104.031757; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Boissinot S, 2004, GENOME RES, V14, P1221, DOI 10.1101/gr.2326704; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Chen JC, 2006, HUM MOL GENET, V15, P2146, DOI 10.1093/hmg/ddl138; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Credille KM, 2009, BRIT J DERMATOL, V161, P265, DOI 10.1111/j.1365-2133.2009.09161.x; Flanigan KM, 2009, HUM MUTAT, V30, P1657, DOI 10.1002/humu.21114; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gasior SL, 2006, J MOL BIOL, V357, P1383, DOI 10.1016/j.jmb.2006.01.089; Gasior SL, 2007, GENE, V390, P190, DOI 10.1016/j.gene.2006.08.024; Gresham D, 2008, NAT REV GENET, V9, P291, DOI 10.1038/nrg2335; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Han JS, 2005, BIOESSAYS, V27, P775, DOI 10.1002/bies.20257; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kolomietz E, 2002, GENE CHROMOSOME CANC, V35, P97, DOI 10.1002/gcc.10111; Konkel MK, 2007, GENE, V390, P28, DOI 10.1016/j.gene.2006.07.040; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Martini SR, 2000, DEVELOPMENT, V127, P2663; MIKI Y, 1992, CANCER RES, V52, P643; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morisada N, 2010, PEDIATR NEPHROL, V25, P1343, DOI 10.1007/s00467-010-1445-x; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Myers JS, 2002, AM J HUM GENET, V71, P312, DOI 10.1086/341718; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Rozen S, 2000, Methods Mol Biol, V132, P365; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; Smit A., 2004, REPEATMASKER OPEN 3; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Ustyugova SV, 2006, GENETICA, V128, P261, DOI 10.1007/s10709-005-5967-2; Van de Water N, 1998, THROMB HAEMOSTASIS, V79, P938; van den Hurk JAJM, 2007, HUM MOL GENET, V16, P1587, DOI 10.1093/hmg/ddm108; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang JX, 2006, HUM MUTAT, V27, P323, DOI 10.1002/humu.20307; Wheelan SJ, 2006, P NATL ACAD SCI USA, V103, P17632, DOI 10.1073/pnas.0605450103; Wheelan SJ, 2005, GENOME RES, V15, P1073, DOI 10.1101/gr.3688905; Witherspoon DJ, 2006, HUM HERED, V62, P30, DOI 10.1159/000095851; Xing JC, 2009, GENOME RES, V19, P1516, DOI 10.1101/gr.091827.109; Yajima I, 1999, HUM MOL GENET, V8, P1431, DOI 10.1093/hmg/8.8.1431	54	190	194	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1171	U129		10.1016/j.cell.2010.05.026	http://dx.doi.org/10.1016/j.cell.2010.05.026			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20602999	Green Accepted, Bronze			2022-12-01	WOS:000279148100014
J	Petherick, A				Petherick, Anna			Country by country	NATURE			English	Editorial Material							CHAGAS-DISEASE; OUTBREAK; SCHOOL											Ache Alberto, 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P37, DOI 10.1590/S0036-46652001000100008; Aguilar HM, 2007, MEM I OSWALDO CRUZ, V102, P47, DOI 10.1590/S0074-02762007005000098; de Noya BA, 2010, J INFECT DIS, V201, P1308, DOI 10.1086/651608; Miles MA, 2010, J INFECT DIS, V201, P1282, DOI 10.1086/651609	4	24	24	4	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					S10	S11		10.1038/nature09223	http://dx.doi.org/10.1038/nature09223			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20571547	Bronze			2022-12-01	WOS:000279056900027
J	Hui, E; Bravis, V; Hassanein, M; Hanif, W; Malik, R; Chowdhury, TA; Suliman, M; Devendra, D				Hui, E.; Bravis, V.; Hassanein, M.; Hanif, W.; Malik, R.; Chowdhury, T. A.; Suliman, M.; Devendra, D.			Management of people with diabetes wanting to fast during Ramadan	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INSULIN GLARGINE; TYPE-2; REPAGLINIDE; ACARBOSE; MUSLIMS; SAFETY; LISPRO		[Hui, E.; Bravis, V.; Devendra, D.] Univ London Imperial Coll Sci Technol & Med, Dept Investigat Sci, London, England; [Hanif, W.] Univ Hosp Birmingham, Dept Endocrinol & Diabet, Birmingham, W Midlands, England; [Hassanein, M.] Glan Clwyd Gen Hosp, Dept Diabet, Rhyl, Wales; [Malik, R.] Univ Manchester, Cardiovasc Res Grp, Manchester, Lancs, England; [Chowdhury, T. A.] Barts & London NHS Trust, Dept Diabet, London, England; [Suliman, M.] Royal Preston Hosp, Dept Med, Preston, Lancs, England; [Devendra, D.] NW London NHS Trust & Brent Community Serv, London, England	Imperial College London; University of Birmingham; University of Manchester; Barts Health NHS Trust; Royal Preston Hospital	Devendra, D (corresponding author), Cent Middlesex Hosp, Jeffrey Kelson Diabet Ctr, London NW10 7NS, England.	d.devendra@imperial.ac.uk	Malik, Rayaz/H-9231-2019	Malik, Rayaz/0000-0002-7188-8903	National Institute for Health Research [ACF-2007-21-021] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Al-Arouj M, 2005, DIABETES CARE, V28, P2305, DOI 10.2337/diacare.28.9.2305; [Anonymous], KORAN, V2, P256; Anwar A, 2006, Med J Malaysia, V61, P28; Azar Sami T, 2008, J Med Liban, V56, P46; Bakiner O, 2009, ACTA DIABETOL, V46, P63, DOI 10.1007/s00592-008-0062-7; BELKHADIR J, 1993, BRIT MED J, V307, P292, DOI 10.1136/bmj.307.6899.292; Benaji B, 2006, DIABETES RES CLIN PR, V73, P117, DOI 10.1016/j.diabres.2005.10.028; Beshyah SA, 2009, IBNOSINA J MED BIOME, V1, P58; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Bravis V, 2010, DIABETIC MED, V27, P327, DOI 10.1111/j.1464-5491.2010.02948.x; Cesur M, 2007, DIABETES RES CLIN PR, V75, P141, DOI 10.1016/j.diabres.2006.05.012; Devendra D, 2009, INT J CLIN PRACT, V63, P1446, DOI 10.1111/j.1742-1241.2009.02171.x; HUI E, 2010, INT J CLIN PRAC 0310; Kadiri A, 2001, DIABETES METAB, V27, P482; Mafauzy M, 2002, DIABETES RES CLIN PR, V58, P45, DOI 10.1016/S0168-8227(02)00104-3; Mattoo V, 2003, DIABETES RES CLIN PR, V59, P137, DOI 10.1016/S0168-8227(02)00202-4; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Mojaddidi M, 2006, PRESCRIBER, P38; *MUSL SPIR CAR DIV, RAM HLTH FACTSH 2009; National Institute for Health and Clinical Excellence, 2009, TYP 2 DIAB NEW AG PA; Norris SL, 2009, DIABETIC MED, V26, P837, DOI 10.1111/j.1464-5491.2009.02790.x; Pan C, 2008, DIABETIC MED, V25, P435, DOI 10.1111/j.1464-5491.2008.02391.x; RASHED AH, 1992, BRIT MED J, V304, P521, DOI 10.1136/bmj.304.6826.521; Rohban T, 2005, DIABETES CARE, V28, P421; Rosak C, 2009, CURR DIABETES REV, V5, P157, DOI 10.2174/157339909788920910; Salti I, 2004, DIABETES CARE, V27, P2306, DOI 10.2337/diacare.27.10.2306; Sari R, 2004, ENDOCR RES, V30, P169, DOI 10.1081/ERC-200027375; Senthil Vasan, 2006, International Journal of Diabetes in Developing Countries, V26, P70; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Uysal AR, 1998, DIABETES CARE, V21, P2033, DOI 10.2337/diacare.21.11.2033	30	67	68	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2010	340								c3053	10.1136/bmj.c3053	http://dx.doi.org/10.1136/bmj.c3053			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618IO	20570867				2022-12-01	WOS:000279346300003
J	Guiducci, C; Gong, M; Xu, ZH; Gill, M; Chaussabel, D; Meeker, T; Chan, JH; Wright, T; Punaro, M; Bolland, S; Soumelis, V; Banchereau, J; Coffman, RL; Pascual, V; Barrat, FJ				Guiducci, Cristiana; Gong, Mei; Xu, Zhaohui; Gill, Michelle; Chaussabel, Damien; Meeker, Thea; Chan, Jean H.; Wright, Tracey; Punaro, Marilynn; Bolland, Silvia; Soumelis, Vassili; Banchereau, Jacques; Coffman, Robert L.; Pascual, Virginia; Barrat, Franck J.			TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus	NATURE			English	Article							PLASMACYTOID DENDRITIC CELLS; SYSTEMIC-LUPUS; AUTOIMMUNE-DISEASES; I INTERFERON; ERYTHEMATOSUS; RECEPTOR; BLOOD; GENE; MICE; CORTICOSTEROIDS	Glucocorticoids are widely used to treat patients with autoimmune diseases such as systemic lupus erythematosus (SLE)(1,2). However, regimens used to treat many such conditions cannot maintain disease control in the majority of SLE patients and more aggressive approaches such as high-dose methylprednisolone pulse therapy are used to provide transient reductions in disease activity(3,4). The primary anti-inflammatory mechanism of glucocorticoids is thought to be NF-kappa B inhibition(5). Recognition of self nucleic acids by toll-like receptors TLR7 and TLR9 on B cells and plasmacytoid dendritic cells (PDCs) is an important step in the pathogenesis of SLE(6), promoting anti-nuclear antibodies and the production of type I interferon (IFN), both correlated with the severity of disease(1,7). Following their activation by self-nucleic acid-associated immune complexes, PDCs migrate to the tissues(8,9). We demonstrate, in vitro and in vivo, that stimulation of PDCs through TLR7 and 9 can account for the reduced activity of glucocorticoids to inhibit the IFN pathway in SLE patients and in two lupus-prone mouse strains. The triggering of PDCs through TLR7 and 9 by nucleic acid-containing immune complexes or by synthetic ligands activates the NF-kappa B pathway essential for PDC survival. Glucocorticoids do not affect NF-kappa B activation in PDCs, preventing glucocorticoid induction of PDC death and the consequent reduction of systemic IFN-alpha levels. These findings unveil a new role for self nucleic acid recognition by TLRs and indicate that inhibitors of TLR7 and 9 signalling could prove to be effective corticosteroid-sparing drugs.	[Guiducci, Cristiana; Gong, Mei; Meeker, Thea; Chan, Jean H.; Coffman, Robert L.; Barrat, Franck J.] Dynavax Technol Corp, Berkeley, CA 94710 USA; [Xu, Zhaohui; Gill, Michelle; Chaussabel, Damien; Banchereau, Jacques; Pascual, Virginia] Baylor Inst Immunol Res, Dallas, TX 75204 USA; [Wright, Tracey; Punaro, Marilynn; Pascual, Virginia] Texas Scottish Rite Hosp Children, Dallas, TX 75219 USA; [Wright, Tracey; Punaro, Marilynn] Univ Texas Dallas, SW Med Ctr, Dallas, TX 75235 USA; [Wright, Tracey; Punaro, Marilynn] Childrens Med Ctr, Dallas, TX 75235 USA; [Bolland, Silvia] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Soumelis, Vassili] Inst Curie, Dept Immunol, F-75005 Paris, France	Baylor Scott & White Health; Texas Scottish Rite Hospital for Children; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Barrat, FJ (corresponding author), Dynavax Technol Corp, 2929 7th St,Suite 100, Berkeley, CA 94710 USA.	fbarrat@dynavax.com	Pascual, Virginia/ABD-3099-2020; Chaussabel, Damien/AAX-1909-2020	Chaussabel, Damien/0000-0002-6131-7242; Xu, Zhaohui/0000-0003-0645-1737	NIH [P50-ARO54083-01CORT, U19-AI082715-01]; Alliance for Lupus Research; Mary Kirkland Foundation; SBIR [2R44AI066483-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000912, R44AI066483, U19AI082715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR054083] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; Mary Kirkland Foundation; SBIR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We would like to thank A. O'Garra, G. Trinchieri, J.-L. Casanova and our colleagues at Dynavax Technologies for their critical reading of the manuscript. We thank S. Noonan and H. Lopez (Murigenics) for invaluable assistance with animal work. This work was supported by NIH grants P50-ARO54083-01CORT, U19-AI082715-01, The Alliance for Lupus Research, The Mary Kirkland Foundation (to V. P.) and SBIR grant 2R44AI066483-02 (to R. L. C.).	Agrawal H, 2009, J IMMUNOL, V183, P6021, DOI 10.4049/jimmunol.0803872; ATHENS JW, 1961, J CLIN INVEST, V40, P989, DOI 10.1172/JCI104338; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Barrat FJ, 2008, IMMUNOL REV, V223, P271, DOI 10.1111/j.1600-065X.2008.00630.x; Barrat FJ, 2007, EUR J IMMUNOL, V37, P3582, DOI 10.1002/eji.200737815; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Boor P, 2006, AM J TRANSPLANT, V6, P2332, DOI 10.1111/j.1600-6143.2006.01476.x; Chatham WW, 2001, LUPUS, V10, P140, DOI 10.1191/096120301675075008; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Duramad O, 2005, J IMMUNOL, V174, P5193, DOI 10.4049/jimmunol.174.9.5193; Franchin G, 2006, AUTOIMMUN REV, V5, P111, DOI 10.1016/j.autrev.2005.08.003; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Guiducci C, 2008, J EXP MED, V205, P315, DOI 10.1084/jem.20070763; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Hahn BH, 1998, NEW ENGL J MED, V338, P1359, DOI 10.1056/NEJM199805073381906; Laakko T, 2002, IMMUNOLOGY, V105, P111, DOI 10.1046/j.1365-2567.2002.01346.x; Mathian A, 2005, J IMMUNOL, V174, P2499, DOI 10.4049/jimmunol.174.5.2499; Montague J W, 1995, Curr Top Microbiol Immunol, V200, P51; Parker BJ, 2007, LUPUS, V16, P387, DOI 10.1177/0961203307079502; Rozzo SJ, 2001, IMMUNITY, V15, P435, DOI 10.1016/S1074-7613(01)00196-0; Santiago-Raber ML, 2003, J EXP MED, V197, P777, DOI 10.1084/jem.20021996; Shodell M, 2003, LUPUS, V12, P222, DOI 10.1191/0961203303lu362xx; Strickland I, 2001, J EXP MED, V193, P585, DOI 10.1084/jem.193.5.585; Takauji R, 2002, J LEUKOCYTE BIOL, V72, P1011; Trottier MD, 2008, P NATL ACAD SCI USA, V105, P2028, DOI 10.1073/pnas.0712003105; Tucci M, 2008, ARTHRITIS RHEUM-US, V58, P251, DOI 10.1002/art.23186; Wenzel J, 2008, J INVEST DERMATOL, V128, P2392, DOI 10.1038/jid.2008.96	30	259	275	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 17	2010	465	7300					937	U10		10.1038/nature09102	http://dx.doi.org/10.1038/nature09102			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559388	Green Accepted			2022-12-01	WOS:000278804500040
J	Cowling, BJ; Chan, KH; Fang, VJ; Lau, LLH; So, HC; Fung, ROP; Ma, ESK; Kwong, ASK; Chan, C; Tsui, WWS; Ngai, H; Chu, DWS; Lee, PWY; Chiu, M; Leung, GM; Peiris, JSM				Cowling, Benjamin J.; Chan, Kwok Hung; Fang, Vicky J.; Lau, Lincoln L. H.; So, Hau Chi; Fung, Rita O. P.; Ma, Edward S. K.; Kwong, Alfred S. K.; Chan, Chi-Wai; Tsui, Wendy W. S.; Ngai, Ho-Yin; Chu, Daniel W. S.; Lee, Paco W. Y.; Chiu, Ming-Chee; Leung, Gabriel M.; Peiris, Joseph S. M.			Comparative Epidemiology of Pandemic and Seasonal Influenza A in Households.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OSELTAMIVIR TREATMENT; CLINICAL ILLNESS; TRANSMISSION; VIRUS; INFECTION; DIAGNOSIS; CHILDREN; DURATION; A(H1N1); DISEASE	Background: There are few data on the comparative epidemiology and virology of the pandemic 2009 influenza A (H1N1) virus and cocirculating seasonal influenza A viruses in community settings. Methods: We recruited 348 index patients with acute respiratory illness from 14 outpatient clinics in Hong Kong in July and August 2009. We then prospectively followed household members of 99 patients who tested positive for influenza A virus on rapid diagnostic testing. We collected nasal and throat swabs from all household members at three home visits within 7 days for testing by means of quantitative reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay and viral culture. Using hemagglutination-inhibition and viral-neutralization assays, we tested baseline and convalescent serum samples from a subgroup of patients for antibody responses to the pandemic and seasonal influenza A viruses. Results: Secondary attack rates (as confirmed on RT-PCR assay) among household contacts of index patients were similar for the pandemic influenza virus (8%; 95% confidence interval [CI], 3 to 14) and seasonal influenza viruses (9%; 95% CI, 5 to 15). The patterns of viral shedding and the course of illness among index patients were also similar for the pandemic and seasonal influenza viruses. In a subgroup of patients for whom baseline and convalescent serum samples were available, 36% of household contacts who had serologic evidence of pandemic influenza virus infection did not shed detectable virus or report illness. Conclusions: Pandemic 2009 H1N1 virus has characteristics that are broadly similar to those of seasonal influenza A viruses in terms of rates of viral shedding, clinical illness, and transmissibility in the household setting. N Engl J Med 2010;362:2175-84.	[Cowling, Benjamin J.; Fang, Vicky J.; Lau, Lincoln L. H.; So, Hau Chi; Fung, Rita O. P.; Leung, Gabriel M.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Infect Dis Epidemiol Grp, Pokfulam, Hong Kong, Peoples R China; [Chan, Kwok Hung; Ma, Edward S. K.; Peiris, Joseph S. M.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China; [Kwong, Alfred S. K.; Chan, Chi-Wai; Tsui, Wendy W. S.; Ngai, Ho-Yin; Chu, Daniel W. S.] Govt Hong Kong Special Adm Reg, Hosp Author, Hong Kong, Hong Kong, Peoples R China; [Lee, Paco W. Y.] St Pauls Hosp, Hong Kong, Hong Kong, Peoples R China; [Chiu, Ming-Chee] St Teresas Hosp, Hong Kong, Hong Kong, Peoples R China; [Peiris, Joseph S. M.] HKU Pasteur Res Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Hong Kong St. Paul's Hospital; University of Hong Kong	Cowling, BJ (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Infect Dis Epidemiol Grp, Units 624-7,Core F Cyberport 3, Pokfulam, Hong Kong, Peoples R China.	bcowling@hku.hk	Cowling, Benjamin John/C-4263-2009; Chan, Kwok Hung/ABD-5399-2021; Peiris, Joseph Sriyal Malik/C-4380-2009	Cowling, Benjamin John/0000-0002-6297-7154; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; So, Hau Chi/0000-0003-3119-1527; Lau, Lincoln/0000-0002-7386-4104; Leung, Gabriel/0000-0002-2503-6283	National Institute of Allergy and Infectious Diseases [HHS-N266200700005C, N01-AI-70005]; Hong Kong University Grants Committee [AoE/M-12/06]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Hong Kong University Grants Committee	Supported by grants from the National Institute of Allergy and Infectious Diseases (HHS-N266200700005C and N01-AI-70005) and the Hong Kong University Grants Committee (AoE/M-12/06).	Babcock HM, 2006, INFECT CONT HOSP EP, V27, P266, DOI 10.1086/501539; Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; *CDCP, 2009, GUID BUS EMPL PLAN R; *CDCP, 2009, HOM CAR GUID PHYS DI; *CDCP, 2009, CDC REC AM TIM PERS; Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; Chan MCW, 2010, AM J PATHOL, V176, P1828, DOI 10.2353/ajpath.2010.091087; Chen TH, 2009, COMPUT ELECTR ENG, V35, P41, DOI 10.1016/j.compeleceng.2008.05.003; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Cowling BJ, 2009, EPIDEMIOLOGY, V20, P344, DOI 10.1097/EDE.0b013e31819d1092; Cowling BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002101; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Field CA, 2007, J R STAT SOC B, V69, P369, DOI 10.1111/j.1467-9868.2007.00593.x; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Lambert SB, 2008, PEDIATRICS, V122, pE615, DOI 10.1542/peds.2008-0691; Lau LLH, 2010, J INFECT DIS, V201, P1509, DOI 10.1086/652241; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Li IW, 2010, CHEST, V137, P759, DOI 10.1378/chest.09-3072; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Ng S, 2010, CLIN INFECT DIS, V50, P707, DOI 10.1086/650458; Peiris JSM, 2003, EMERG INFECT DIS, V9, P628; Perez CM, 2010, EMERG INFECT DIS, V16, P156, DOI 10.3201/eid1601.091420; Shao J, 1995, JACKKNIFE BOOTSTRAP, P129; Tabu C., 2009, Morbidity and Mortality Weekly Report, V58, P1143; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Vasoo S, 2009, CLIN INFECT DIS, V49, P1090, DOI 10.1086/644743; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216; Yang Y, 2006, J ROY STAT SOC C-APP, V55, P317, DOI 10.1111/j.1467-9876.2006.00539.x; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	38	266	278	1	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2010	362	23					2175	2184		10.1056/NEJMoa0911530	http://dx.doi.org/10.1056/NEJMoa0911530			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608AL	20558368	Bronze, Green Published, Green Accepted			2022-12-01	WOS:000278551500006
J	Bhaskaran, K; Hajat, S; Haines, A; Herrett, E; Wilkinson, P; Smeeth, L				Bhaskaran, Krishnan; Hajat, Shakoor; Haines, Andy; Herrett, Emily; Wilkinson, Paul; Smeeth, Liam			Short term effects of temperature on risk of myocardial infarction in England and Wales: time series regression analysis of the Myocardial Ischaemia National Audit Project (MINAP) registry	BMJ-BRITISH MEDICAL JOURNAL			English	Article							AIR-POLLUTION; COLD WEATHER; SAO-PAULO; MORTALITY; HEAT; INCREASES; DEATHS; FIBRINOGEN; PLATELET; PRESSURE	Objective To examine the short term relation between ambient temperature and risk of myocardial infarction. Design Daily time series regression analysis. Setting 15 conurbations in England and Wales. Participants 84 010 hospital admissions for myocardial infarction recorded in the Myocardial Ischaemia National Audit Project during 2003-6 (median 57 events a day). Main outcome measures Change in risk of myocardial infarction associated with a 1 degrees C difference in temperature, including effects delayed by up to 28 days. Results Smoothed graphs revealed a broadly linear relation between temperature and myocardial infarction, which was well characterised by log-linear models without a temperature threshold: each 1 degrees C reduction in daily mean temperature was associated with a 2.0% (95% confidence interval 1.1% to 2.9%) cumulative increase in risk of myocardial infarction over the current and following 28 days, the strongest effects being estimated at intermediate lags of 2-7 and 8-14 days: increase per 1 degrees C reduction 0.6% (95% confidence interval 0.2% to 1.1%) and 0.7% (0.3% to 1.1%), respectively. Heat had no detrimental effect. Adults aged 75-84 and those with previous coronary heart disease seemed more vulnerable to the effects of cold than other age groups (P for interaction 0.001 or less in each case), whereas those taking aspirin were less vulnerable (P for interaction 0.007). Conclusions Increases in risk of myocardial infarction at colder ambient temperatures may be one driver of cold related increases in overall mortality, but an increased risk of myocardial infarction at higher temperatures was not detected. The risk of myocardial infarction in vulnerable people might be reduced by the provision of targeted advice or other interventions, triggered by forecasts of lower temperature.	[Bhaskaran, Krishnan; Herrett, Emily; Smeeth, Liam] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1F 7HT, England; [Hajat, Shakoor; Wilkinson, Paul] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Bhaskaran, K (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1F 7HT, England.	krishnan.bhaskaran@lshtm.ac.uk	Smeeth, Liam/X-5862-2018	Smeeth, Liam/0000-0002-9168-6022; Wilkinson, Paul/0000-0001-7456-259X; Haines, Andy/0000-0002-8053-4605; Bhaskaran, Krishnan/0000-0001-5364-8757	British Heart Foundation [FS/04/045]; Garfield Weston Trust; Wellcome Trust [076583/Z/05/Z]	British Heart Foundation(British Heart Foundation); Garfield Weston Trust; Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded through grants from the British Heart Foundation (FS/04/045) and the Garfield Weston Trust. LS is supported by a Wellcome Trust senior research fellowship in clinical science. SH is funded by a Wellcome Trust research career development fellowship (076583/Z/05/Z). The funders had no role in the design or conduct of this review, or in the preparation, review, or approval of the manuscript. All authors carried out this research independently of the funding bodies.	Allender S., 2008, CORONARY HEART DIS S; Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266; Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; Baccini M, 2008, EPIDEMIOLOGY, V19, P711, DOI 10.1097/EDE.0b013e318176bfcd; Bhaskaran K, 2009, HEART, V95, P1760, DOI 10.1136/hrt.2009.175000; Bhaskaran K, 2009, HEART, V95, P1746, DOI 10.1136/hrt.2009.175018; Braga ALF, 2002, ENVIRON HEALTH PERSP, V110, P859, DOI 10.1289/ehp.02110859; Brumback BA, 2000, J AM STAT ASSOC, V95, P16; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Danet S, 1999, CIRCULATION, V100, pE11, DOI 10.1161/01.CIR.100.1.e1; Doherty RM, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-S1-S8; DOMINICI F, 2004, RES REP HLTH EFF I, V3, P27; Donaldson GC, 1997, J EPIDEMIOL COMMUN H, V51, P643, DOI 10.1136/jech.51.6.643; ENQUSELASSIE F, 1993, INT J EPIDEMIOL, V22, P632, DOI 10.1093/ije/22.4.632; Fenn B, 2008, EPIDEMIOLOGY, V19, pS172; Hajat S, 2007, OCCUP ENVIRON MED, V64, P93, DOI 10.1136/oem.2006.029017; Hajat S, 2005, EPIDEMIOLOGY, V16, P613, DOI 10.1097/01.ede.0000164559.41092.2a; Hajat S, 2007, J EPIDEMIOL COMMUN H, V61, P719, DOI 10.1136/jech.2006.053942; HEPPELL R, 1991, BRIT MED J, V302, P469, DOI 10.1136/bmj.302.6774.469-c; KEATINGE WR, 1984, BMJ-BRIT MED J, V289, P1405, DOI 10.1136/bmj.289.6456.1405; McCullagh P, 2019, GEN LINEAR MODELS; McMichael AJ, 2008, INT J EPIDEMIOL, V37, P1121, DOI 10.1093/ije/dyn086; Mercer JB, 1999, THROMB RES, V95, P93, DOI 10.1016/S0049-3848(99)00028-6; Messner Torbjorn, 2002, Int J Circumpolar Health, V61, P201; Morabito M, 2006, ENVIRON RES, V102, P52, DOI 10.1016/j.envres.2005.12.007; NEILD PJ, 1994, CLIN SCI, V86, P43, DOI 10.1042/cs0860043; OPPER C, 1995, PHARMACOL BIOCHEM BE, V51, P217, DOI 10.1016/0091-3057(94)00432-I; Pattenden S, 2003, J EPIDEMIOL COMMUN H, V57, P628, DOI 10.1136/jech.57.8.628; RAVEN PB, 1970, J APPL PHYSIOL, V29, P417, DOI 10.1152/jappl.1970.29.4.417; Rossi G, 1999, ARCH ENVIRON HEALTH, V54, P158, DOI 10.1080/00039899909602254; Ruckerl R, 2007, ENVIRON HEALTH PERSP, V115, P1072, DOI 10.1289/ehp.10021; Sharovsky R, 2004, BRAZ J MED BIOL RES, V37, P1651, DOI 10.1590/S0100-879X2004001100009; *UK MET OFF, COPD HLTH FOR WINT 2; Wang Hongli, 2006, Hiroshima Journal of Medical Sciences, V55, P45	34	130	135	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 10	2010	341								c3823	10.1136/bmj.c3823	http://dx.doi.org/10.1136/bmj.c3823			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	640DQ	20699305	Green Published, Green Accepted, hybrid			2022-12-01	WOS:000281028800002
J	Marcheva, B; Ramsey, KM; Buhr, ED; Kobayashi, Y; Su, H; Ko, CH; Ivanova, G; Omura, C; Mo, S; Vitaterna, MH; Lopez, JP; Philipson, LH; Bradfield, CA; Crosby, SD; JeBailey, L; Wang, XZ; Takahashi, JS; Bass, J				Marcheva, Biliana; Ramsey, Kathryn Moynihan; Buhr, Ethan D.; Kobayashi, Yumiko; Su, Hong; Ko, Caroline H.; Ivanova, Ganka; Omura, Chiaki; Mo, Shelley; Vitaterna, Martha H.; Lopez, James P.; Philipson, Louis H.; Bradfield, Christopher A.; Crosby, Seth D.; JeBailey, Lellean; Wang, Xiaozhong; Takahashi, Joseph S.; Bass, Joseph			Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes	NATURE			English	Article							CIRCADIAN GENE-EXPRESSION; INSULIN-SECRETION; MOUSE; LIVER; MICE; TRANSCRIPTION; CHOLESTEROL; BIOLOGY	The molecular clock maintains energy constancy by producing circadian oscillations of rate-limiting enzymes involved in tissue metabolism across the day and night(1-3). During periods of feeding, pancreatic islets secrete insulin to maintain glucose homeostasis, and although rhythmic control of insulin release is recognized to be dysregulated in humans with diabetes(4), it is not known how the circadian clock may affect this process. Here we show that pancreatic islets possess self-sustained circadian gene and protein oscillations of the transcription factors CLOCK and BMAL1. The phase of oscillation of islet genes involved in growth, glucose metabolism and insulin signalling is delayed in circadian mutant mice, and both Clock(5,6) and Bmal1(7) (also called Arntl) mutants show impaired glucose tolerance, reduced insulin secretion and defects in size and proliferation of pancreatic islets that worsen with age. Clock disruption leads to transcriptome-wide alterations in the expression of islet genes involved in growth, survival and synaptic vesicle assembly. Notably, conditional ablation of the pancreatic clock causes diabetes mellitus due to defective beta-cell function at the very latest stage of stimulus-secretion coupling. These results demonstrate a role for the beta-cell clock in coordinating insulin secretion with the sleep-wake cycle, and reveal that ablation of the pancreatic clock can trigger the onset of diabetes mellitus.	[Marcheva, Biliana; Ramsey, Kathryn Moynihan; Kobayashi, Yumiko; Ivanova, Ganka; Omura, Chiaki; Bass, Joseph] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Marcheva, Biliana; Ramsey, Kathryn Moynihan; Buhr, Ethan D.; Kobayashi, Yumiko; Ko, Caroline H.; Ivanova, Ganka; Omura, Chiaki; Bass, Joseph] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Su, Hong; Wang, Xiaozhong] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Mo, Shelley] Northwestern Univ, Weinberg Coll Arts & Sci, Evanston, IL 60208 USA; [Vitaterna, Martha H.; Bass, Joseph] Northwestern Univ, Ctr Sleep & Circadian Biol, Evanston, IL 60208 USA; [Lopez, James P.; Philipson, Louis H.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Bradfield, Christopher A.] Univ Wisconsin, Sch Med & Publ Hlth, McArdle Lab Canc Res, Madison, WI 53706 USA; [Crosby, Seth D.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA; [JeBailey, Lellean] GeneGo Inc, St Joseph, MI 49085 USA; [Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University; Northwestern University; Northwestern University; University of Chicago; University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Bass, J (corresponding author), Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA.	j-bass@northwestern.edu	Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012	Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878; Buhr, Ethan/0000-0002-9250-6644; Marcheva, Biliana/0000-0001-8697-2625	National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health [R37-ES-005703]; Chicago Biomedical Consortium; Juvenile Diabetes Research Foundation; National Institute of Mental Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES005703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011412] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank F. Turek, R. Allada and G. Bell for discussions and comments on the manuscript. We thank A. Kohsaka, E. Chen, J. Doering and C. Radosevich for their technical support, as well as the Biological Imaging Facility at Northwestern University and the Islet Biology Core of the University of Chicago DRTC. We thank D. Melton for the PdxCre mice. Work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases to K. M. R. and L. H. P.; the National Institutes of Health, Chicago Biomedical Consortium Searle Funds, and Juvenile Diabetes Research Foundation to J. B.; grant R37-ES-005703 from the National Institutes of Health to C. A. B.; and the National Institute of Mental Health to J.S.T.	Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Gao N, 2007, CELL METAB, V6, P267, DOI 10.1016/j.cmet.2007.08.015; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Gu GQ, 2002, DEVELOPMENT, V129, P2447; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kudo T, 2008, AM J PHYSIOL-ENDOC M, V294, pE120, DOI 10.1152/ajpendo.00061.2007; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Noshiro M, 2007, J BIOL RHYTHM, V22, P299, DOI 10.1177/0748730407302461; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; POLONSKY KS, 1988, NEW ENGL J MED, V318, P1231, DOI 10.1056/NEJM198805123181903; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Shih DQ, 2001, DIABETES, V50, P2472, DOI 10.2337/diabetes.50.11.2472; Stoffers DA, 2000, DIABETES, V49, P741, DOI 10.2337/diabetes.49.5.741; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Westgate EJ, 2008, CIRCULATION, V117, P2087, DOI 10.1161/CIRCULATIONAHA.107.739227; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	30	973	1026	6	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2010	466	7306					627	631		10.1038/nature09253	http://dx.doi.org/10.1038/nature09253			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20562852	Green Accepted			2022-12-01	WOS:000280412100054
J	Jin, X; Costa, RM				Jin, Xin; Costa, Rui M.			Start/stop signals emerge in nigrostriatal circuits during sequence learning	NATURE			English	Article							DOPAMINE NEURONS ENCODE; HUNTINGTONS-DISEASE; BASAL GANGLIA; STRIATUM; REPRESENTATION; PATTERN; TIME; POPULATIONS; INITIATION; MOVEMENTS	Learning new action sequences subserves a plethora of different abilities such as escaping a predator, playing the piano, or producing fluent speech. Proper initiation and termination of each action sequence is critical for the organization of behaviour, and is compromised in nigrostriatal disorders like Parkinson's and Huntington's diseases. Using a self-paced operant task in which mice learn to perform a particular sequence of actions to obtain an outcome, we found neural activity in nigrostriatal circuits specifically signalling the initiation or the termination of each action sequence. This start/stop activity emerged during sequence learning, was specific for particular actions, and did not reflect interval timing, movement speed or action value. Furthermore, genetically altering the function of striatal circuits disrupted the development of start/stop activity and selectively impaired sequence learning. These results have important implications for understanding the functional organization of actions and the sequence initiation and termination impairments observed in basal ganglia disorders.	[Jin, Xin; Costa, Rui M.] NIAAA, Lab Integrat Neurosci, NIH, Bethesda, MD 20892 USA; [Costa, Rui M.] Inst Gulbenkian Ciencias, Champalimaud Neurosci Programme, P-2780156 Oeiras, Portugal	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Fundacao Champalimaud; Instituto Gulbenkian de Ciencia	Costa, RM (corresponding author), NIAAA, Lab Integrat Neurosci, NIH, 5625 Fishers Lane, Bethesda, MD 20892 USA.	ruicosta@fchampalimaud.org		Costa, Rui M./0000-0003-0495-8374	NIAAA Division of Intramural Clinical and Biological Research; Institute Gulbenkian de Ciencia; European Research Council [243393]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000416] Funding Source: NIH RePORTER	NIAAA Division of Intramural Clinical and Biological Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Institute Gulbenkian de Ciencia; European Research Council(European Research Council (ERC)European Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank Y. Li for the RGS9-Cre mice, C. Gerfen for the TH-Cre mice, K. Nakazawa for the NMDAR1-loxP mice, F. Tecuapetla and S. Lima for help in the optogenetics experiment, G. Luo for genotyping, and D. Lovinger, G. Cui, C. French, C. Gremel and E. Dias-Ferreira for comments on the manuscript. This research was supported by the NIAAA Division of Intramural Clinical and Biological Research, the Champalimaud Neuroscience Programme at Institute Gulbenkian de Ciencia and European Research Council Grant 243393 to R.M.C.	AGOSTINO R, 1992, BRAIN, V115, P1481, DOI 10.1093/brain/115.5.1481; Aldridge JW, 1998, J NEUROSCI, V18, P2777; Bailey KR, 2006, J NEUROSCI, V26, P1016, DOI 10.1523/JNEUROSCI.3883-05.2006; BENECKE R, 1987, BRAIN, V110, P361, DOI 10.1093/brain/110.2.361; Boyd LA, 2009, NEUROBIOL LEARN MEM, V92, P35, DOI 10.1016/j.nlm.2009.02.009; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; CALABRESI P, 1992, EUR J NEUROSCI, V4, P929, DOI 10.1111/j.1460-9568.1992.tb00119.x; CASTIELLO U, 1993, NEUROPSYCHOLOGIA, V31, P395, DOI 10.1016/0028-3932(93)90162-S; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Fujii N, 2003, SCIENCE, V301, P1246, DOI 10.1126/science.1086872; Gallistel CharlesR., 1980, ORG ACTION NEW SYNTH; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Graybiel AM, 1998, NEUROBIOL LEARN MEM, V70, P119, DOI 10.1006/nlme.1998.3843; GRILLNER S, 1985, ANNU REV NEUROSCI, V8, P233, DOI 10.1146/annurev.ne.08.030185.001313; Hikosaka O, 1998, NEUROBIOL LEARN MEM, V70, P137, DOI 10.1006/nlme.1998.3844; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; Hilario MRF, 2007, FRONT INTEGR NEUROSC, V1, DOI [10.3389/neuro.07.006.2007, 10.3389/neuro.07/006.2007]; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; KERMADI I, 1995, J NEUROPHYSIOL, V74, P911, DOI 10.1152/jn.1995.74.3.911; KIMURA M, 1990, J NEUROPHYSIOL, V63, P1277, DOI 10.1152/jn.1990.63.6.1277; Lashley K. S., 1951, CEREBRAL MECH BEHAV; Lau B, 2008, NEURON, V58, P451, DOI 10.1016/j.neuron.2008.02.021; Lima SQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006099; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; Meck WH, 2008, CURR OPIN NEUROBIOL, V18, P145, DOI 10.1016/j.conb.2008.08.002; Meyer-Luehmann M, 2002, EUR J NEUROSCI, V16, P1599, DOI 10.1046/j.1460-9568.2002.02210.x; Miyachi S, 2002, EXP BRAIN RES, V146, P122, DOI 10.1007/s00221-002-1213-7; Morris G, 2006, NAT NEUROSCI, V9, P1057, DOI 10.1038/nn1743; PHILLIPS JG, 1995, NEUROPSYCHOLOGIA, V33, P365, DOI 10.1016/0028-3932(94)00114-5; Pomata PE, 2008, J NEUROSCI, V28, P13384, DOI 10.1523/JNEUROSCI.4343-08.2008; Redgrave P, 2006, NAT REV NEUROSCI, V7, P967, DOI 10.1038/nrn2022; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Stefanova ED, 2000, MOVEMENT DISORD, V15, P1095, DOI 10.1002/1531-8257(200011)15:6<1095::AID-MDS1006>3.0.CO;2-R; WILLINGHAM DB, 1993, PSYCHOBIOLOGY, V21, P173; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261	40	361	362	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					457	462		10.1038/nature09263	http://dx.doi.org/10.1038/nature09263			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20651684	Green Accepted			2022-12-01	WOS:000280141200028
J	Buscher, AL; Giordano, TP				Buscher, April L.; Giordano, Thomas P.			Gaps in Knowledge in Caring for HIV Survivors Long-term	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES; POPULATION		Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Michael E DeBakey VA Med Ctr, Hlth Serv Res & Dev Ctr Excellence, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine	Giordano, TP (corresponding author), Michael E DeBakey VA Med Ctr 152, Hlth Serv Res & Dev Ctr Excellence, 2002 Holcombe Blvd, Houston, TX 77030 USA.	tpg@bcm.tmc.edu		Giordano, Thomas/0000-0002-9346-5530				Campsmith M. L., 2008, Morbidity and Mortality Weekly Report, V57, P1073; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Handford C. D., 2006, COCHRANE DB SYST REV, V3; Harrison KM, 2010, JAIDS-J ACQ IMM DEF, V53, P124, DOI 10.1097/QAI.0b013e3181b563e7; Justice AC, 2004, AIDS, V18, pS49, DOI 10.1097/00002030-200401001-00008; Kirk JB, 2009, J AM GERIATR SOC, V57, P2129, DOI 10.1111/j.1532-5415.2009.02494.x; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Zwahlen M, 2009, INT J EPIDEMIOL, V38, P1624, DOI 10.1093/ije/dyp306	9	11	11	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					340	341		10.1001/jama.2010.870	http://dx.doi.org/10.1001/jama.2010.870			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628HV	20639568				2022-12-01	WOS:000280107500024
J	Holmes, CB; Coggin, W; Jamieson, D; Mihm, H; Granich, R; Savio, P; Hope, M; Ryan, C; Moloney-Kitts, M; Goosby, EP; Dybul, M				Holmes, Charles B.; Coggin, William; Jamieson, David; Mihm, Heidi; Granich, Reuben; Savio, Phillip; Hope, Michael; Ryan, Caroline; Moloney-Kitts, Michele; Goosby, Eric P.; Dybul, Mark			Use of Generic Antiretroviral Agents and Cost Savings in PEPFAR Treatment Programs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TENOFOVIR	Context One of the biggest hurdles to the rapid scale-up of antiretroviral therapy in the developing world was the price of antiretroviral drugs (ARVs). Modification of an existing US Food and Drug Administration (FDA) process to expedite review and approval of generic ARVs quickly resulted in a large number of FDA-tentatively approved ARVs available for use by the US President's Emergency Plan for AIDS Relief (PEPFAR). Objective To evaluate the uptake of generic ARVs among PEPFAR-supported programs in Guyana, Haiti, Vietnam, and 13 countries in Africa, and changes over time in ARV use and costs. Design, Setting, and Participants An annual survey from 2005 to 2008 of ARVs purchased in 16 countries by PEPFAR implementing and procurement partners (organizations using PEPFAR funding to purchase ARVs). Main Outcome Measures Drug expenditures, ARV types and volumes (assessed per pack, a 1-month supply), proportion of generic procurement across years and countries, and cost savings from generic procurement. Results ARV expenditures increased from $116.8 million (2005) to $202.2 million (2008); and procurement increased from 6.2 million to 22.1 million monthly packs. The proportion spent on generic ARVs increased from 9.17% (95% confidence interval [CI], 9.17%-9.18%) in 2005 to 76.41% (95% CI, 76.41%-76.42%) in 2008 (P<.001), and the proportion of generic packs procured increased from 14.8% (95% CI, 14.79%-14.84%) in 2005 to 89.33% (95% CI, 89.32%-89.34%) in 2008 (P similar to. 001). In 2008, there were 8 PEPFAR programs that procured at least 90.0% of ARV packs in generic form; South Africa had the lowest generic procurement (24.7%; 95% CI, 24.6%-24.8%). Procurement of generic fixed-dose combinations increased from 33.3% (95% CI, 33.24%-33.43%) in 2005 to 42.73% (95% CI, 42.71%-42.75%) in 2008. Estimated yearly savings generated through generic ARV use were $8 108 444 in 2005, $24 940 014 in 2006, $75 645 816 in 2007, and $214 648 982 in 2008, a total estimated savings of $323 343 256. Conclusion Among PEPFAR-supported programs in 16 countries, availability of generic ARVs was associated with increased ARV procurement and substantial estimated cost savings. JAMA. 2010;304(3):313-320 www.jama.com	[Holmes, Charles B.; Coggin, William; Granich, Reuben; Ryan, Caroline; Moloney-Kitts, Michele; Goosby, Eric P.; Dybul, Mark] US Dept State, Off US Global AIDS Coordinator, Washington, DC 20522 USA; [Jamieson, David; Savio, Phillip] Supply Chain Management Syst, Arlington, VA USA; [Mihm, Heidi; Hope, Michael] US Agcy Int Dev, Washington, DC 20523 USA	United States Agency for International Development (USAID)	Holmes, CB (corresponding author), US Dept State, Off US Global AIDS Coordinator, 2100 Penn Ave, Washington, DC 20522 USA.	holmescb@state.gov			US government	US government	This study was funded by the President's Emergency Plan for AIDS Relief (PEPFAR) of the US government.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; [Anonymous], 2009, RAP ADV ANT THER HIV; Bender MA, 2010, CLIN INFECT DIS, V50, P416, DOI 10.1086/649884; Bermudez Jorge, 2010, Open AIDS J, V4, P37, DOI 10.2174/1874613601004020037; El-Khatib Z, 2009, SAMJ S AFR MED J, V99, P412; Ford N, 2008, S AFR J HIV MED, P8; Husain M, 2009, INDIAN J CHEM B, V48, P1174; Martinson N, 2009, JAIDS-J ACQ IMM DEF, V50, P327, DOI 10.1097/QAI.0b013e3181958546; *MIN HLTH ZAMB, ANT THER CHRON HIV I; MSF Campaign for Access to Essential Medicines, UNT WEB ANT PRIC RED; Rosen S, 2008, JAIDS-J ACQ IMM DEF, V48, P334, DOI 10.1097/QAI.0b013e31817ae5ef; *SUPPL CHAIN MAN S, US; US Food and Drug Administration, PRES EM PLAN AIDS RE; *US PRES PLAN AIDS, 2008, REP C US GLOB AIDS C; *US PRES PLAN AIDS, WORLD AIDS DAY 2009; *WHO, WHO HLTH SYST SERV P	16	66	66	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					313	320		10.1001/jama.2010.993	http://dx.doi.org/10.1001/jama.2010.993			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639565	Bronze			2022-12-01	WOS:000280107500021
J	Lamont, T; Dougall, A; Johnson, S; Mathew, D; Scarpello, J; Morris, E				Lamont, Tara; Dougall, Anita; Johnson, Sara; Mathew, Dinah; Scarpello, John; Morris, Edward			Safety Alerts Reducing the risk of retained swabs after vaginal birth: summary of a safety report from the National Patient Safety Agency	BRITISH MEDICAL JOURNAL			English	Editorial Material							INSTRUMENTS		[Lamont, Tara; Dougall, Anita; Johnson, Sara; Mathew, Dinah; Scarpello, John] Natl Patient Safety Agcy, London, England; [Morris, Edward] Norfolk & Norwich Univ Hosp, Norfolk, VA USA		Lamont, T (corresponding author), Natl Patient Safety Agcy, London, England.	tara.lamont@npsa.nhs.uk						*ASS PRE PRACT, 2007, SWAB INSTR NEEDL COU; Egorova NN, 2008, ANN SURG, V247, P13, DOI 10.1097/SLA.0b013e3180f633be; Gawande AA, 2003, NEW ENGL J MED, V348, P229, DOI 10.1056/NEJMsa021721; *I CLIN SYST IMPR, 2009, PREV UN RET FOR OBJ; National Institute for Health and Clinical Excellence, 2007, INTR CAR CAR HLTH WO	5	5	5	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 19	2010	341								c3679	10.1136/bmj.c3679	http://dx.doi.org/10.1136/bmj.c3679			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632GU	20643710				2022-12-01	WOS:000280411500001
J	Kondo, T; Plaza, S; Zanet, J; Benrabah, E; Valenti, P; Hashimoto, Y; Kobayashi, S; Payre, F; Kageyama, Y				Kondo, T.; Plaza, S.; Zanet, J.; Benrabah, E.; Valenti, P.; Hashimoto, Y.; Kobayashi, S.; Payre, F.; Kageyama, Y.			Small Peptides Switch the Transcriptional Activity of Shavenbaby During Drosophila Embryogenesis	SCIENCE			English	Article							POLYCISTRONIC MESSENGER-RNA; OPEN READING FRAMES; EPIDERMIS DIFFERENTIATION; GENOME; IDENTIFICATION; MORPHOGENESIS; EVOLUTION; GENES	A substantial proportion of eukaryotic transcripts are considered to be noncoding RNAs because they contain only short open reading frames (sORFs). Recent findings suggest, however, that some sORFs encode small bioactive peptides. Here, we show that peptides of 11 to 32 amino acids encoded by the polished rice (pri) sORF gene control epidermal differentiation in Drosophila by modifying the transcription factor Shavenbaby (Svb). Pri peptides trigger the amino-terminal truncation of the Svb protein, which converts Svb from a repressor to an activator. Our results demonstrate that during Drosophila embryogenesis, Pri sORF peptides provide a strict temporal control to the transcriptional program of epidermal morphogenesis.	[Plaza, S.; Zanet, J.; Benrabah, E.; Valenti, P.; Payre, F.] Univ Toulouse 3, Univ Toulouse, Ctr Dev Biol, F-31062 Toulouse, France; [Kondo, T.; Hashimoto, Y.; Kobayashi, S.; Kageyama, Y.] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Natl Inst Basic Biol, Okazaki, Aichi 4448787, Japan; [Kondo, T.] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Plaza, S.; Zanet, J.; Benrabah, E.; Valenti, P.; Payre, F.] CBD, CNRS, UMR 5547, F-31062 Toulouse, France; [Kobayashi, S.] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448585, Japan; [Hashimoto, Y.; Kageyama, Y.] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); Nara Institute of Science & Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB); Japan Science & Technology Agency (JST)	Payre, F (corresponding author), Univ Toulouse 3, Univ Toulouse, Ctr Dev Biol, Batiment 4R3,118 Route Narbonne, F-31062 Toulouse, France.	payre@cict.fr; kageyama@nibb.ac.jp	plaza, serge/F-5290-2015	PAYRE, Francois/0000-0002-8144-6711; Kondo, Takefumi/0000-0001-8127-1141	Japan Society for the Promotion of Science; JST; Ministry of Education, Culture, Sports, Science and Technology [20370091]; Agence Nationale de la Recherche; Fondation pour la Recherche Medicale; Association pour la Recherche sur le Cancer [1111]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We thank the Kyoto Drosophila Genetic Resource Center (DGRC); Bloomington Drosophila Stock Center for fly strains; the Indiana DGRC; G. Patterson, J. Lippincott-Schwartz, and C. Hill for plasmids; S. Takada and T. Okubo (NIBB) for technical advice; Y. Latapie and B. Ronsin (CBD) and J. D'Alayer (Institut Pasteur) for excellent technical assistance; and members of the Kobayashi laboratory for helpful comments and discussion. This work was supported by a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science; the JST PRESTO program; the Ministry of Education, Culture, Sports, Science and Technology KAKENHI (20370091); Agence Nationale de la Recherche (Programme Blanc "Netoshape"); Fondation pour la Recherche Medicale (Equipe 2005); and Association pour la Recherche sur le Cancer (1111).	Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; Andrews J, 2000, DEVELOPMENT, V127, P881; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chanut-Delalande H, 2006, PLOS BIOL, V4, P1549, DOI 10.1371/journal.pbio.0040290; Delon I, 2003, MECH DEVELOP, V120, P747, DOI 10.1016/S0925-4773(03)00081-9; Fernandes I, 2010, DEV CELL, V18, P64, DOI 10.1016/j.devcel.2009.11.009; Frith MC, 2006, PLOS GENET, V2, P515, DOI 10.1371/journal.pgen.0020052; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; Hanada K, 2007, GENOME RES, V17, P632, DOI 10.1101/gr.5836207; Hashimoto Y, 2008, DEV GROWTH DIFFER, V50, pS269, DOI 10.1111/j.1440-169X.2008.00994.x; Inagaki S, 2005, GENES CELLS, V10, P1163, DOI 10.1111/j.1365-2443.2005.00910.x; Kastenmayer JP, 2006, GENOME RES, V16, P365, DOI 10.1101/gr.4355406; Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Payre F, 2004, INT J DEV BIOL, V48, P207, DOI 10.1387/ijdb.15272387; Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330; Pueyo JI, 2008, DEV BIOL, V324, P192, DOI 10.1016/j.ydbio.2008.08.025; Savard J, 2006, CELL, V126, P559, DOI 10.1016/j.cell.2006.05.053; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102	21	237	255	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2010	329	5989					336	339		10.1126/science.1188158	http://dx.doi.org/10.1126/science.1188158			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647469				2022-12-01	WOS:000279925900046
J	Padma, TV				Padma, T. V.			Developing solutions	NATURE			English	Editorial Material																			0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S16	S17		10.1038/nature09242	http://dx.doi.org/10.1038/nature09242			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631698				2022-12-01	WOS:000279867100031
J	Willyard, C				Willyard, Cassandra			Joining forces	NATURE			English	Editorial Material							MICROBICIDES											Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Saxena BB, 2009, AIDS, V23, P917, DOI 10.1097/QAD.0b013e32832af57c; Watts C, 2001, AIDS, V15, pS43, DOI 10.1097/00002030-200102001-00064	3	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S9	S10		10.1038/nature09239	http://dx.doi.org/10.1038/nature09239			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631707	Bronze			2022-12-01	WOS:000279867100028
J	Roehr, B				Roehr, Bob			Drug laws in Latin America	BRITISH MEDICAL JOURNAL			English	Editorial Material												BobRoehr@aol.com							0	0	0	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 13	2010	341								c3752	10.1136/bmj.c3752	http://dx.doi.org/10.1136/bmj.c3752			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628XB	20627981				2022-12-01	WOS:000280156600019
J	Pieper, AA; Xie, SH; Capota, E; Estill, SJ; Zhong, JN; Long, JM; Becker, GL; Huntington, P; Goldman, SE; Shen, CH; Capota, M; Britt, JK; Kotti, T; Ure, K; Brat, DJ; Williams, NS; MacMillan, KS; Naidoo, J; Melito, L; Hsieh, J; De Brabander, J; Ready, JM; McKnight, SL				Pieper, Andrew A.; Xie, Shanhai; Capota, Emanuela; Estill, Sandi Jo; Zhong, Jeannie; Long, Jeffrey M.; Becker, Ginger L.; Huntington, Paula; Goldman, Shauna E.; Shen, Ching-Han; Capota, Maria; Britt, Jeremiah K.; Kotti, Tiina; Ure, Kerstin; Brat, Daniel J.; Williams, Noelle S.; MacMillan, Karen S.; Naidoo, Jacinth; Melito, Lisa; Hsieh, Jenny; De Brabander, Jef; Ready, Joseph M.; McKnight, Steven L.			Discovery of a Proneurogenic, Neuroprotective Chemical	CELL			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; ALZHEIMERS-DISEASE; TRANSCRIPTION FACTOR; DENTATE GYRUS; CYTOCHROME-C; CELL-DEATH; NEURONS; BRAIN; NPAS3; MICE	An in vivo screen was performed in search of chemicals capable of enhancing neuron formation in the hippocampus of adult mice. Eight of 1000 small molecules tested enhanced neuron formation in the subgranular zone of the dentate gyrus. Among these was an aminopropyl carbazole, designated P7C3, endowed with favorable pharmacological properties. In vivo studies gave evidence that P7C3 exerts its proneurogenic activity by protecting newborn neurons from apoptosis. Mice missing the gene encoding neuronal PAS domain protein 3 (NPAS3) are devoid of hippocampal neurogenesis and display malformation and electrophysiological dysfunction of the dentate gyrus. Prolonged administration of P7C3 to npas3(-/-) mice corrected these deficits by normalizing levels of apoptosis of newborn hippocampal neurons. Prolonged administration of P7C3 to aged rats also enhanced neurogenesis in the dentate gyrus, impeded neuron death, and preserved cognitive capacity as a function of terminal aging.	[Pieper, Andrew A.; Xie, Shanhai; Estill, Sandi Jo; Long, Jeffrey M.; Shen, Ching-Han; Kotti, Tiina; Williams, Noelle S.; MacMillan, Karen S.; Naidoo, Jacinth; Melito, Lisa; De Brabander, Jef; Ready, Joseph M.; McKnight, Steven L.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Pieper, Andrew A.; Capota, Emanuela; Zhong, Jeannie; Becker, Ginger L.; Huntington, Paula; Goldman, Shauna E.; Capota, Maria; Britt, Jeremiah K.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Ure, Kerstin; Hsieh, Jenny] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Brat, Daniel J.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30332 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Emory University	Pieper, AA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	andrew.pieper@utsouthwestern.edu; steven.mcknight@utsouthwestern.edu	Pieper, Andrew A/R-5552-2016; Britt, Jeremiah/L-9441-2015	Britt, Jeremiah/0000-0003-4010-662X; Pieper, Andrew/0000-0001-6299-6577; Goldman, Shauna/0000-0001-5729-890X	Hartwell Foundation; Staglin Family fund; University of Texas Southwestern Medical Center High Risk/High Impact research fund; National Alliance for Research on Schizophrenia and Depression; Morton H. Meyerson Family Tzedakah Fund; National Institute of Mental Health [NIMH] [RO1, 1RO1MH087986]; National Institutes of Health (NIH); National Institute of General Medical Sciences [5DP1OD000276]; NIH Method to Extend Research [NIMH RO1MH59388]; National Cancer Institute Program [5PO1CA95471]; Simons Foundation Autism Research; NATIONAL CANCER INSTITUTE [P01CA095471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059388, R01MH087986, R37MH059388] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000276] Funding Source: NIH RePORTER	Hartwell Foundation; Staglin Family fund; University of Texas Southwestern Medical Center High Risk/High Impact research fund; National Alliance for Research on Schizophrenia and Depression(NARSAD); Morton H. Meyerson Family Tzedakah Fund; National Institute of Mental Health [NIMH](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH Method to Extend Research; National Cancer Institute Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Simons Foundation Autism Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Wang lab for extensive help in establishing the live-cell imaging assay used to measure mitochondrial membrane permeability; Xiaodong Wang and Sol Snyder for invaluable scientific input; Patrick Harran for helping select the 1000 chemicals chosen for in vivo screening; David Russell and members of the Russell lab for extensive help in electrophysiological recording assays; Christopher Cowan and members of the Cowan laboratory for assistance with primary neuronal cultures; Farah Veerjee, Saira Hussein, Latisha McDaniel, Ruth Starwalt, and Leeju Wu for technical assistance; and Huda Zoghbi, Sol Snyder, Joe Goldstein, Ueli Schibler, Al Gilman, Mike Brown, Richard Axel, and Martin Raff for critical review of the manuscript. We thank Angela Diehl for help with the graphical abstract artwork. This work was supported by grants from The Hartwell Foundation, Staglin Family fund, University of Texas Southwestern Medical Center High Risk/High Impact research fund, National Alliance for Research on Schizophrenia and Depression, and Morton H. Meyerson Family Tzedakah Fund awarded to A.A.P.; a Transformative RO1 grant (National Institute of Mental Health [NIMH] 1RO1MH087986) awarded to A.A.P. and S.L.M.; and a National Institutes of Health (NIH) Pioneer grant (National Institute of General Medical Sciences 5DP1OD000276), an NIH Method to Extend Research in Time grant (NIMH RO1MH59388), a National Cancer Institute Program Project Grant (5PO1CA95471), a Simons Foundation Autism Research Initiative grant from the Simons Foundation, and funds from an anonymous donor provided to S.L.M.	ALTMAN J, 1962, SCIENCE, V135, P1127, DOI 10.1126/science.135.3509.1127; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Bachurin S, 2001, ANN NY ACAD SCI, V939, P425; Bachurin SO, 2003, ANN NY ACAD SCI, V993, P334, DOI 10.1111/j.1749-6632.2003.tb07541.x; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Bombrun A, 2003, J MED CHEM, V46, P4365, DOI 10.1021/jm034107j; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Burns A, 2008, LANCET, V372, P179, DOI 10.1016/S0140-6736(08)61046-6; Distelmaier F, 2008, CYTOM PART A, V73A, P129, DOI 10.1002/cyto.a.20503; Doody RS, 2008, LANCET, V372, P207, DOI 10.1016/S0140-6736(08)61074-0; Driscoll I, 2006, NEUROSCIENCE, V139, P1173, DOI 10.1016/j.neuroscience.2006.01.040; Erbel-Sieler C, 2004, P NATL ACAD SCI USA, V101, P13648, DOI 10.1073/pnas.0405310101; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Kamnasaran D, 2003, J MED GENET, V40, P325, DOI 10.1136/jmg.40.5.325; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kim SE, 2010, EXP GERONTOL, V45, P357, DOI 10.1016/j.exger.2010.02.005; Kuhn HG, 2005, EUR J NEUROSCI, V22, P1907, DOI 10.1111/j.1460-9568.2005.04377.x; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Macintyre G, 2010, SCHIZOPHR RES, V120, P143, DOI 10.1016/j.schres.2010.04.002; Martin DSD, 2002, J BIOL CHEM, V277, P34239, DOI 10.1074/jbc.M205289200; McKnight SL, 2010, US Patent, Patent No. [2010/020681, 2010020681]; Miller G, 2010, SCIENCE, V327, P1309, DOI 10.1126/science.327.5971.1309; O'Brien JT, 2008, LANCET NEUROL, V7, P768, DOI 10.1016/S1474-4422(08)70177-7; PATON JA, 1984, SCIENCE, V225, P1046, DOI 10.1126/science.6474166; Pickard BS, 2009, MOL PSYCHIATR, V14, P874, DOI 10.1038/mp.2008.24; Pickard BS, 2006, ANN MED, V38, P439, DOI 10.1080/07853890600946500; Pickard BS, 2005, AM J MED GENET B, V136B, P26, DOI 10.1002/ajmg.b.30204; Pieper AA, 2005, P NATL ACAD SCI USA, V102, P14052, DOI 10.1073/pnas.0506713102; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; STANFIELD BB, 1988, CEREB CORTEX, V7, P91; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; YANG J, 1997, SCIENCE, V275, P1132	34	266	282	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 9	2010	142	1					39	51		10.1016/j.cell.2010.06.018	http://dx.doi.org/10.1016/j.cell.2010.06.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603013	Bronze, Green Accepted			2022-12-01	WOS:000279637300011
J	Cooper-DeHoff, RM; Gong, Y; Handberg, EM; Bavry, AA; Denardo, SJ; Bakris, GL; Pepine, CJ				Cooper-DeHoff, Rhonda M.; Gong, Yan; Handberg, Eileen M.; Bavry, Anthony A.; Denardo, Scott J.; Bakris, George L.; Pepine, Carl J.			Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VERAPAMIL SR-TRANDOLAPRIL; METAANALYSIS; ASSOCIATION; MANAGEMENT; MORTALITY; INVEST	Context Hypertension guidelines advocate treating systolic blood pressure (BP) to less than 130 mm Hg for patients with diabetes mellitus; however, data are lacking for the growing population who also have coronary artery disease (CAD). Objective To determine the association of systolic BP control achieved and adverse cardiovascular outcomes in a cohort of patients with diabetes and CAD. Design, Setting, and Patients Observational subgroup analysis of 6400 of the 22 576 participants in the International Verapamil SR-Trandolapril Study (INVEST). For this analysis, participants were at least 50 years old and had diabetes and CAD. Participants were recruited between September 1997 and December 2000 from 862 sites in 14 countries and were followed up through March 2003 with an extended follow-up through August 2008 through the National Death Index for US participants. Intervention Patients received first-line treatment of either a calcium antagonist or beta-blocker followed by angiotensin-converting enzyme inhibitor, a diuretic, or both to achieve systolic BP of less than 130 and diastolic BP of less than 85 mm Hg. Patients were categorized as having tight control if they could maintain their systolic BP at less than 130 mm Hg; usual control if it ranged from 130 mm Hg to less than 140 mm Hg; and uncontrolled if it was 140 mm Hg or higher. Main Outcome Measures Adverse cardiovascular outcomes, including the primary outcomes which was the first occurrence of all-cause death, nonfatal myocardial infarction, or nonfatal stroke. Results During 16 893 patient-years of follow-up, 286 patients (12.7%) who maintained tight control, 249 (12.6%) who had usual control, and 431 (19.8%) who had uncontrolled systolic BP experienced a primary outcome event. Patients in the usual-control group had a cardiovascular event rate of 12.6% vs a 19.8% event rate for those in the uncontrolled group (adjusted hazard ratio [HR], 1.46; 95% confidence interval [CI], 1.25-1.71; P<.001). However, little difference existed between those with usual control and those with tight control. Their respective event rates were 12.6% vs 12.7% (adjusted HR, 1.11; 95% CI, 0.93-1.32; P=.24). The all-cause mortality rate was 11.0% in the tight-control group vs 10.2% in the usual-control group (adjusted HR, 1.20; 95% CI, 0.99-1.45; P=.06); however, when extended follow-up was included, risk of all-cause mortality was 22.8% in the tight control vs 21.8% in the usual control group (adjusted HR, 1.15; 95% CI, 1.01-1.32; P=.04). Conclusion Tight control of systolic BP among patients with diabetes and CAD was not associated with improved cardiovascular outcomes compared with usual control.	[Cooper-DeHoff, Rhonda M.; Gong, Yan] Univ Florida, Dept Pharmacotherapy & Translat Res, Coll Pharm, Gainesville, FL 32610 USA; [Cooper-DeHoff, Rhonda M.; Handberg, Eileen M.; Bavry, Anthony A.; Denardo, Scott J.; Pepine, Carl J.] Univ Florida, Coll Med, Div Cardiovasc Med, Gainesville, FL 32610 USA; [Bakris, George L.] Univ Chicago, Pritzker Sch Med, Dept Med, Hypertens Dis Unit,Sec Endocrinol Diabet & Metab, Chicago, IL 60637 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Chicago	Cooper-DeHoff, RM (corresponding author), Univ Florida, Dept Pharmacotherapy & Translat Res, Coll Pharm, 1600 SW Archer Rd,POB 100486, Gainesville, FL 32610 USA.	dehoff@cop.ufl.edu		Handberg, Eileen/0000-0002-7805-9577; Patt, Mitchell/0000-0001-9696-4477	Abbott Laboratories; National Heart, Lung, and Blood Institute (NHLBI); Fujisawa; Pfizer; GlaxoSmithKline; Vascular Biology Working Group (AstraZeneca, Sanofi Aventis, Schering-Plough, Daiichi Sankyo Lilly, AtCor Medical, XOMA); Juvenile Diabetes Research Foundation; Forest Laboratories; CVRx; Merck; Novartis; Boehringer-Ingelheim; Takeda; Walgreens; Bristol Meyer Squibb/Sanofi; Gilead; Forest Labs; Fibrogen; Spherix; Johnson Johnson; Daiichi Sankyo; Bioheart Inc; AstraZeneca; AtCor Medical Inc; Daiichi Sankyo Inc; Eli Lilly; Pfizer Inc; Sanofi-Aventis; Schering-Plough; University of Florida; National Institutes of Health [K23HL086558, UOIGM074492]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL086558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074492] Funding Source: NIH RePORTER	Abbott Laboratories(Abbott Laboratories); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Fujisawa; Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline); Vascular Biology Working Group (AstraZeneca, Sanofi Aventis, Schering-Plough, Daiichi Sankyo Lilly, AtCor Medical, XOMA)(Sanofi-AventisMerck & CompanySchering Plough CorporationAstraZeneca); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Forest Laboratories; CVRx; Merck(Merck & Company); Novartis(Novartis); Boehringer-Ingelheim(Boehringer Ingelheim); Takeda(Takeda Pharmaceutical Company Ltd); Walgreens; Bristol Meyer Squibb/Sanofi; Gilead(Gilead Sciences); Forest Labs; Fibrogen; Spherix; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Daiichi Sankyo(Daiichi Sankyo Company Limited); Bioheart Inc; AstraZeneca(AstraZeneca); AtCor Medical Inc; Daiichi Sankyo Inc(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly); Pfizer Inc(Pfizer); Sanofi-Aventis(Sanofi-Aventis); Schering-Plough(Merck & CompanySchering Plough Corporation); University of Florida(University of Florida); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr Cooper-DeHoff reported receiving research funding from Abbott Laboratories during the conduct of INVEST. Dr Handberg reported receiving grant support from National Heart, Lung, and Blood Institute (NHLBI), Abbott Laboratories, Fujisawa, Pfizer, GlaxoSmithKline, and educational grants from the Vascular Biology Working Group (AstraZeneca, Sanofi Aventis, Schering-Plough, Daiichi Sankyo Lilly, AtCor Medical, XOMA. Dr Bakris reported receiving grant and research support from the Juvenile Diabetes Research Foundation, GlaxoSmithKline, Forest Laboratories, and CVRx; reported also serving as a consultant for GlaxoSmithKline, Merck, Novartis, Boehringer-Ingelheim, Takeda, Abbott Laboratories, Walgreens, Bristol Meyer Squibb/Sanofi, Gilead, Forest Labs and CVRx, Fibrogen, Spherix, Johnson & Johnson, Daiichi Sankyo, and Mitsubishi. Dr Pepine reported receiving research grants from the NHLBI, Abbott Laboratories, Baxter, Pfizer, GlaxoSmithKline, and Bioheart Inc; serving as consultant for Abbott Laboratories, Forest Laboratories, Novartis/Cleveland Clinic, NicOx, Angloblast, Sanofi-Aventis, NHLBI, NIH, Medtelligence, and SLACK Inc; receiving unrestricted educational grants from AstraZeneca, AtCor Medical Inc, Daiichi Sankyo Inc, Eli Lilly, Pfizer Inc, Sanofi-Aventis, and Schering-Plough. Drs Gong, Bavry, and Denardo reported that they have no financial disclosures.; INVEST was funded by a grant from Abbott Laboratories and the University of Florida Opportunity Fund. The present research is supported in part by grants K23HL086558 and UOIGM074492 from the National Institutes of Health (Dr Cooper-DeHoff).	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; *AM DIAB ASS, 2002, DIABETES CARE S1, V25, pS85, DOI DOI 10.2337/DIACARE.25.2007.S85; Amer Diabet Assoc, 2002, DIABETES CARE, V25, P213; Amer Diabet Assoc, 2002, DIABETES CARE, V25, P199; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; [Anonymous], 1984, ARCH INTERN MED, V144, P1045; Bakris GL, 2004, HYPERTENSION, V44, P637, DOI 10.1161/01.HYP.0000143851.23721.26; Bavry AA, 2010, HYPERTENSION, V55, P48, DOI 10.1161/HYPERTENSIONAHA.109.142240; Berl T, 2005, J AM SOC NEPHROL, V16, P2170, DOI 10.1681/ASN.2004090763; Boutitie F, 2002, ANN INTERN MED, V136, P438, DOI 10.7326/0003-4819-136-6-200203190-00007; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Denardo SJ, 2009, HYPERTENSION, V53, P624, DOI 10.1161/HYPERTENSIONAHA.108.111542; Estacio RO, 2000, DIABETES CARE, V23, pB54; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; Joint National Committee on Detection Evaluation and Treatment of High Blood Pressure, 1993, ARCH INTERN MED, V153, P154, DOI DOI 10.1001/archinte.1993.00410020010002; Kalaitzidis R, 2009, J CLIN HYPERTENS, V11, P345, DOI 10.1111/j.1751-7176.2009.00143.x; Khosla N, 2009, MED CLIN N AM, V93, P697, DOI 10.1016/j.mcna.2009.02.001; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; Pepine CJ, 1998, J AM COLL CARDIOL, V32, P1228, DOI 10.1016/S0735-1097(98)00423-9; Pepine CJ, 2003, JAMA-J AM MED ASSOC, V290, P2805, DOI 10.1001/jama.290.21.2805; Rosendorff C, 2007, CIRCULATION, V115, P2761, DOI 10.1161/CIRCULATIONAHA.107.183885; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Verdecchia P, 2009, LANCET, V374, P525, DOI 10.1016/S0140-6736(09)61340-4	27	475	503	0	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2010	304	1					61	68		10.1001/jama.2010.884	http://dx.doi.org/10.1001/jama.2010.884			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620SJ	20606150	Green Accepted, Bronze			2022-12-01	WOS:000279519600022
J	Lamont, T; Coates, T; Mathew, D; Scarpello, J; Slater, A				Lamont, Tara; Coates, Tracy; Mathew, Dinah; Scarpello, John; Slater, Andrew			Safety Alerts Checking for pregnancy before surgery: summary of a safety report from the National Patient Safety Agency	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lamont, Tara; Coates, Tracy; Mathew, Dinah; Scarpello, John] Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England; [Slater, Andrew] E Sussex Hosp Trust, Eastbourne BN21 2UD, England		Lamont, T (corresponding author), Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England.	tara.lamont@npsa.nhs.uk						*DEP HLTH, 2004, BEST PRACT GUID DOCT; Kahn RL, 2008, ANESTH ANALG, V106, P1127, DOI 10.1213/ane.0b013e31816788df; National Collaborating Centre for Acute Care, 2003, PREOP TESTS US ROUT; Royal College of Obstetricians and Gynaecologists, 2008, OBT VAL CONS; The National Patient Safety Agency, 2009, WHO SURG SAF CHECKL; Twersky RS, 1996, ANESTH ANALG, V83, P438, DOI 10.1097/00000539-199608000-00059; WALL BF, 2009, 9 RCE HLTH PROT AG; Wilcox AJ, 2001, JAMA-J AM MED ASSOC, V286, P1759, DOI 10.1001/jama.286.14.1759	8	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 6	2010	341								c3402	10.1136/bmj.c3402	http://dx.doi.org/10.1136/bmj.c3402			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625DK	20605880				2022-12-01	WOS:000279874200004
J	Cadwell, K; Patel, KK; Maloney, NS; Liu, TC; Ng, ACY; Storer, CE; Head, RD; Xavier, R; Stappenbeck, TS; Virgin, HW				Cadwell, Ken; Patel, Khushbu K.; Maloney, Nicole S.; Liu, Ta-Chiang; Ng, Aylwin C. Y.; Storer, Chad E.; Head, Richard D.; Xavier, Ramnik; Stappenbeck, Thaddeus S.; Virgin, Herbert W.			Virus-Plus-Susceptibility Gene Interaction Determines Crohn's Disease Gene Atg16L1 Phenotypes in Intestine	CELL			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; MURINE NOROVIRUS; MURINE-NOROVIRUS-1 INFECTION; MONOCLONAL-ANTIBODIES; INFLUENZA-VIRUS; CELIAC-DISEASE; MOUSE MODEL; IN-VITRO; KEY ROLE	It is unclear why disease occurs in only a small proportion of persons carrying common risk alleles of disease susceptibility genes. Here we demonstrate that an interaction between a specific virus infection and a mutation in the Crohn's disease susceptibility gene Atg16L1 induces intestinal pathologies in mice. This virus-plus-susceptibility gene interaction generated abnormalities in granule packaging and unique patterns of gene expression in Paneth cells. Further, the response to injury induced by the toxic substance dextran sodium sulfate was fundamentally altered to include pathologies resembling aspects of Crohn's disease. These pathologies triggered by virus-plus-susceptibility gene interaction were dependent on TNF alpha and IFN gamma and were prevented by treatment with broad spectrum antibiotics. Thus, we provide a specific example of how a virus-plus-susceptibility gene interaction can, in combination with additional environmental factors and commensal bacteria, determine the phenotype of hosts carrying common risk alleles for inflammatory disease.	[Cadwell, Ken; Patel, Khushbu K.; Maloney, Nicole S.; Liu, Ta-Chiang; Stappenbeck, Thaddeus S.; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Virgin, Herbert W.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Ng, Aylwin C. Y.; Xavier, Ramnik] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Ng, Aylwin C. Y.; Xavier, Ramnik] Harvard Univ, Ctr Computat & Integrat Biol, Sch Med, Boston, MA 02114 USA; [Ng, Aylwin C. Y.; Xavier, Ramnik] MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Ng, Aylwin C. Y.; Xavier, Ramnik] Harvard Univ, Cambridge, MA 02142 USA; [Storer, Chad E.; Head, Richard D.] Pfizer Global Res & Dev, Inflammat & Immunol Res Unit, St Louis, MO 63017 USA; [Virgin, Herbert W.] Midwest Reg Ctr Excellence Biodefense & Emerging, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Pfizer	Stappenbeck, TS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	stappenb@wustl.edu; virgin@wustl.edu	Ng, Aylwin/AAQ-6478-2020; Storer, Chad/GZM-2678-2022	Storer, Chad/0000-0002-0139-0819; Virgin, Herbert/0000-0001-8580-7628; Liu, Ta-Chiang/0000-0002-2800-9360; Cadwell, Ken/0000-0002-5860-0661	Project 5 [U54 AI057160]; Broad Foundation [R01 AI084887]; Damon Runyon Cancer Research Foundation [DRG-1972-08]; NIH [T32-AI007172]; Pew Foundation; Washington University Digestive Diseases Research Core Center [DK52574]; Crohn's and Colitis Foundation of America [DK83756, DK086502, DK043351]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084887, T32AI007172, U54AI057160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK086502, P30DK040561, P30DK043351, R01DK083756, P30DK052574] Funding Source: NIH RePORTER	Project 5; Broad Foundation; Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Foundation; Washington University Digestive Diseases Research Core Center; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grant U54 AI057160 Project 5 and the Broad Foundation (K. C., N.M., and H. W. V.), R01 AI084887 (T. S. S. and H. W. V.), the Lallage Feazel Wall Fellowship DRG-1972-08 from the Damon Runyon Cancer Research Foundation (K. C.), training grant NIH T32-AI007172 (N.M.), the Pew Foundation (K. K. P. and T. S. S.), Washington University Digestive Diseases Research Core Center DK52574, Pfizer biomedical agreement with Washington University, fellowship award from the Crohn's and Colitis Foundation of America (A.C.Y.N), and grants DK83756, DK086502, and DK043351 (R.J.X.). Washington University holds U. S. patents 7,041,444 B2, 7,264,923, and US 7,455,972 related to growth and detection of MNV. Washington University and H. W. V. receive income based on licenses for MNV technology.	AGUS SG, 1973, ANN INTERN MED, V79, P18, DOI 10.7326/0003-4819-79-1-18; Alberto L, 2006, GASTROENTEROLOGY, V130, P1588, DOI 10.1053/j.gastro.2006.02.004; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Ammann CG, 2009, J VIROL, V83, P13037, DOI 10.1128/JVI.01445-09; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Brem-Exner BG, 2008, J IMMUNOL, V180, P335, DOI 10.4049/jimmunol.180.1.335; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2009, AUTOPHAGY, V5, P250, DOI 10.4161/auto.5.2.7560; Chachu KA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000236; Chand N, 2006, J CLIN GASTROENTEROL, V40, P3, DOI 10.1097/01.mcg.0000190644.01661.2b; Day DW, 2003, MORSON DAWSONS GASTR; DOLIN R, 1975, AM J MED, V59, P761, DOI 10.1016/0002-9343(75)90461-1; Doom CM, 2009, VIROLOGY, V392, P153, DOI 10.1016/j.virol.2009.05.035; DYRBERG T, 1988, J CLIN INVEST, V81, P928, DOI 10.1172/JCI113405; FAIS S, 1991, GUT, V32, P403, DOI 10.1136/gut.32.4.403; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Goto K, 2009, EXP ANIM TOKYO, V58, P135, DOI 10.1538/expanim.58.135; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Gradel KO, 2009, GASTROENTEROLOGY, V137, P495, DOI 10.1053/j.gastro.2009.04.001; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hensley SE, 2009, J VIROL, V83, P7357, DOI 10.1128/JVI.00623-09; Hsu CC, 2005, CLIN DIAGN LAB IMMUN, V12, P1145, DOI 10.1128/CDLI.12.10.1145-1151.2005; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Ju JS, 2009, AUTOPHAGY, V5, P511, DOI 10.4161/auto.5.4.7761; Kang SS, 2008, PLOS MED, V5, P424, DOI 10.1371/journal.pmed.0050041; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Lencioni KC, 2008, COMPARATIVE MED, V58, P522; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; Mastroianni JR, 2009, J BIOL CHEM, V284, P27848, DOI 10.1074/jbc.M109.050773; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Mumphrey SM, 2007, J VIROL, V81, P3251, DOI 10.1128/JVI.02096-06; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; OLDSTONE MBA, 1988, SCIENCE, V239, P500, DOI 10.1126/science.3277269; Ouellette AJ, 2006, CURR TOP MICROBIOL, V306, P1; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Piguet PF, 1999, LAB INVEST, V79, P495; Porter CK, 2008, GASTROENTEROLOGY, V135, P781, DOI 10.1053/j.gastro.2008.05.081; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Pritchett-Corning KR, 2009, LAB ANIM-UK, V43, P165, DOI 10.1258/la.2008.008009; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; ROBERTS ME, 2009, SURG PATHOLOGY GI TR; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sartor RB, 1997, RES IMMUNOL, V148, P567, DOI 10.1016/S0923-2494(98)80151-X; Scholtens D, 2004, J MULTIVARIATE ANAL, V90, P19, DOI 10.1016/j.jmva.2004.02.004; SCHREIBER RD, 1985, J IMMUNOL, V134, P1609; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; SHEEHAN KCF, 1989, J IMMUNOL, V142, P3884; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stappenbeck TS, 2003, P NATL ACAD SCI USA, V100, P1004, DOI 10.1073/pnas.242735899; Suk K, 2001, J IMMUNOL, V166, P4481, DOI 10.4049/jimmunol.166.7.4481; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; TONIETTI G, 1970, J EXP MED, V132, P89, DOI 10.1084/jem.132.1.89; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Weersma RK, 2008, AM J GASTROENTEROL, V103, P621, DOI 10.1111/j.1572-0241.2007.01660.x; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	71	665	673	0	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1135	U64		10.1016/j.cell.2010.05.009	http://dx.doi.org/10.1016/j.cell.2010.05.009			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20602997	Green Accepted, Bronze			2022-12-01	WOS:000279148100011
J	Guang, SH; Bochner, AF; Burkhart, KB; Burton, N; Pavelec, DM; Kennedy, S				Guang, Shouhong; Bochner, Aaron F.; Burkhart, Kirk B.; Burton, Nick; Pavelec, Derek M.; Kennedy, Scott			Small regulatory RNAs inhibit RNA polymerase II during the elongation phase of transcription	NATURE			English	Article							PRE-MESSENGER-RNA; CAENORHABDITIS-ELEGANS; C-ELEGANS; GENETIC INTERFERENCE; MEDIATED PATHWAYS; REVEALS; NUCLEUS; TARGET; LIN-15	Eukaryotic cells express a wide variety of endogenous small regulatory RNAs that regulate heterochromatin formation, developmental timing, defence against parasitic nucleic acids and genome rearrangement. Many small regulatory RNAs are thought to function in nuclei(1,2). For instance, in plants and fungi, short interfering RNA (siRNAs) associate with nascent transcripts and direct chromatin and/or DNA modifications(1,2). To understand further the biological roles of small regulatory RNAs, we conducted a genetic screen to identify factors required for RNA interference (RNAi) in Caenorhabditis elegans nuclei(3). Here we show that the gene nuclear RNAi defective-2 (nrde-2) encodes an evolutionarily conserved protein that is required for siRNA-mediated silencing in nuclei. NRDE-2 associates with the Argonaute protein NRDE-3 within nuclei and is recruited by NRDE-3/siRNA complexes to nascent transcripts that have been targeted by RNAi. We find that nuclear-localized siRNAs direct an NRDE-2-dependent silencing of pre-messenger RNAs (pre-mRNAs) 3' to sites of RNAi, an NRDE-2-dependent accumulation of RNA polymerase (RNAP) II at genomic loci targeted by RNAi, and NRDE-2-dependent decreases in RNAP II occupancy and RNAP II transcriptional activity 39 to sites of RNAi. These results define NRDE-2 as a component of the nuclear RNAi machinery and demonstrate that metazoan siRNAs can silence nuclear-localized RNAs co-transcriptionally. In addition, these results establish a novel mode of RNAP II regulation: siRNA-directed recruitment of NRDE factors that inhibit RNAP II during the elongation phase of transcription.	[Guang, Shouhong; Bochner, Aaron F.; Burkhart, Kirk B.; Burton, Nick; Kennedy, Scott] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; [Pavelec, Derek M.; Kennedy, Scott] Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kennedy, S (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.	sgkennedy@wisc.edu		Kennedy, Scott/0000-0002-7974-8155; Burton, Nicholas/0000-0002-5495-3988	Pew and Shaw scholars programmes; National Institutes of Health; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076619, R01GM088289] Funding Source: NIH RePORTER	Pew and Shaw scholars programmes; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Anderson, members of the Anderson laboratory, D. Wassarman and D. Brow for comments, and the Caenorhabditis Genetics Center for strains. This work was supported by grants from the Pew and Shaw scholars programmes, the National Institutes of Health and the American Heart Association.	Berezikov E, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh033; Bosher JM, 1999, GENETICS, V153, P1245; CLARK SG, 1994, GENETICS, V137, P987; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Duchaine TF, 2006, CELL, V124, P343, DOI 10.1016/j.cel.2005.11.036; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; ROGALSKI TM, 1990, GENETICS, V126, P889; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	20	207	218	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1097	U165		10.1038/nature09095	http://dx.doi.org/10.1038/nature09095			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20543824	Green Accepted			2022-12-01	WOS:000279056900057
J	Smith, LN; James, R; Barber, M; Ramsay, S; Gillespie, D; Chung, C				Smith, Lorraine N.; James, Roberta; Barber, Mark; Ramsay, Scott; Gillespie, David; Chung, Charlie		Guideline Dev Grp	Guidelines Rehabilitation of patients with stroke: summary of SIGN guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RECOVERY; PAIN		[Smith, Lorraine N.] Univ Glasgow, Fac Med, Glasgow G12 8LL, Lanark, Scotland; [James, Roberta] SIGN, Edinburgh EH7 5EA, Midlothian, Scotland; [Ramsay, Scott] St Johns Hosp, Livingston EH54 6PP, Scotland; [Gillespie, David] Astley Ainslie Hosp, Dept Clin Psychol, Edinburgh EH9 2HL, Midlothian, Scotland	University of Glasgow	Smith, LN (corresponding author), Univ Glasgow, Fac Med, Glasgow G12 8LL, Lanark, Scotland.	l.n.smith@clinmed.gla.ac.uk		Barber, Mark/0000-0002-2893-1566; Todhunter-Brown, Alex/0000-0003-4941-7985				Bernhardt J, 2004, STROKE, V35, P1005, DOI 10.1161/01.STR.0000120727.40792.40; De Wit L, 2007, STROKE, V38, P2101, DOI 10.1161/STROKEAHA.107.482869; Golderberg D, 1988, USERS GUIDE GEN HLTH; Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003689.pub3; Jensen MP, 2003, J PAIN, V4, P2, DOI 10.1054/jpai.2003.1; Kalra L, 2007, J REHABIL MED, V39, P97, DOI 10.2340/16501977-0043; Langhorne P, 2007, J REHABIL MED, V39, P103, DOI 10.2340/16501977-0042; LEIJON G, 1989, PAIN, V36, P27, DOI 10.1016/0304-3959(89)90108-5; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; *NHS NAT SERV SCOT, ANN PUBL SUMM NHS NA; Saunders DH, 2009, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003316.PUB2; Scottish Intercollegiate Guidelines Network (SIGN), 2008, SIGN PUBL, V108; Scottish Intercollegiate Guidelines Network (SIGN), 2010, SIGN PUBL, V119; Scottish Intercollegiate Guidelines Network (SIGN), 2010, SIGN PUBL, V118; Sutcliffe LM, 1998, CLIN REHABIL, V12, P506, DOI 10.1191/026921598672167702; Teasell RW, 2005, STROKE, V36, P215, DOI 10.1161/01.STR.0000153061.02375.04	16	6	7	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2010	340								c2845	10.1136/bmj.c2845	http://dx.doi.org/10.1136/bmj.c2845			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JA	20551122	Green Accepted			2022-12-01	WOS:000279051800005
J	Yeh, RW; Sidney, S; Chandra, M; Sorel, M; Selby, JV; Go, AS				Yeh, Robert W.; Sidney, Stephen; Chandra, Malini; Sorel, Michael; Selby, Joseph V.; Go, Alan S.			Population Trends in the Incidence and Outcomes of Acute Myocardial Infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR EVENTS; UNITED-STATES; CHOLESTEROL LEVELS; TEMPORAL TRENDS; MEDICAL-CARE; US; MORTALITY; PREVENTION; RISK	Background: Few studies have characterized recent population trends in the incidence and outcomes of myocardial infarction. Methods: We identified patients 30 years of age or older in a large, diverse, community-based population who were hospitalized for incident myocardial infarction between 1999 and 2008. Age- and sex-adjusted incidence rates were calculated for myocardial infarction overall and separately for ST-segment elevation and non-ST-segment elevation myocardial infarction. Patient characteristics, outpatient medications, and cardiac biomarker levels during hospitalization were identified from health plan databases, and 30-day mortality was ascertained from administrative databases, state death data, and Social Security Administration files. Results: We identified 46,086 hospitalizations for myocardial infarctions during 18,691,131 person-years of follow-up from 1999 to 2008. The age- and sex-adjusted incidence of myocardial infarction increased from 274 cases per 100,000 person-years in 1999 to 287 cases per 100,000 person-years in 2000, and it decreased each year thereafter, to 208 cases per 100,000 person-years in 2008, representing a 24% relative decrease over the study period. The age- and sex-adjusted incidence of ST-segment elevation myocardial infarction decreased throughout the study period (from 133 cases per 100,000 person-years in 1999 to 50 cases per 100,000 person-years in 2008, P<0.001 for linear trend). Thirty-day mortality was significantly lower in 2008 than in 1999 (adjusted odds ratio, 0.76; 95% confidence interval, 0.65 to 0.89). Conclusions: Within a large community-based population, the incidence of myocardial infarction decreased significantly after 2000, and the incidence of ST-segment elevation myocardial infarction decreased markedly after 1999. Reductions in short-term case fatality rates for myocardial infarction appear to be driven, in part, by a decrease in the incidence of ST-segment elevation myocardial infarction and a lower rate of death after non-ST-segment elevation myocardial infarction. N Engl J Med 2010;362:2155-65.	[Sidney, Stephen; Chandra, Malini; Sorel, Michael; Selby, Joseph V.; Go, Alan S.] Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; [Yeh, Robert W.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Cardiol Div, Boston, MA USA; [Sidney, Stephen; Selby, Joseph V.; Go, Alan S.] Permanente Med Grp Inc, Oakland, CA USA; [Go, Alan S.] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94143 USA; [Go, Alan S.] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA; [Go, Alan S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Kaiser Permanente; Harvard University; Harvard Medical School; Massachusetts General Hospital; Permanente Medical Groups; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Go, AS (corresponding author), Kaiser Permanente No Calif, Div Res, 2000 Broadway St,3rd Fl, Oakland, CA 94612 USA.	alan.s.go@kp.org	Yeh, Robert/AAJ-3463-2020; Go, Alan S./AAE-7745-2019; s, s/GYR-2278-2022		Permanente Medical Group; Schering-Plough Future Leaders in Cardiovascular Medical Research	Permanente Medical Group; Schering-Plough Future Leaders in Cardiovascular Medical Research	Supported by research funding from the Permanente Medical Group and by a Schering-Plough Future Leaders in Cardiovascular Medical Research grant.	*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; ANDERSON JL, 2008, J AM COLL CARDIOL, V51, P974; [Anonymous], 1981, JAMA-J AM MED ASSOC, V246, P2073; [Anonymous], 2008, KAIS PERM 2008 HEDIS; Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; ANTMAN EM, 2008, CIRCULATION, V117, pE162; Arciero TJ, 2004, AM J MED, V117, P228, DOI 10.1016/j.amjmed.2004.04.008; ARELLANO MG, 1984, AM J PUBLIC HEALTH, V74, P1324, DOI 10.2105/AJPH.74.12.1324; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fireman BH, 2000, J NATL CANCER I, V92, P136, DOI 10.1093/jnci/92.2.136; Fox CS, 2006, CIRCULATION, V113, P2914, DOI 10.1161/CIRCULATIONAHA.106.613828; Fox CS, 2004, CIRCULATION, V110, P522, DOI 10.1161/01.CIR.0000136993.34344.41; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Go AS, 2006, JAMA-J AM MED ASSOC, V296, P2105, DOI 10.1001/jama.296.17.2105; Go AS, 2006, ANN INTERN MED, V144, P229, DOI 10.7326/0003-4819-144-4-200602210-00004; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goldberg RJ, 2004, AM J CARDIOL, V94, P1373, DOI 10.1016/j.amjcard.2004.07.142; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Henry TD, 2007, CIRCULATION, V116, P721, DOI 10.1161/CIRCULATIONAHA.107.694141; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Levey AS, 2008, ANN INTERN MED, V149, P519, DOI 10.7326/0003-4819-149-7-200810070-00023; Mann D, 2008, ANN PHARMACOTHER, V42, P1208, DOI 10.1345/aph.1L181; Masoudi FA, 2006, CIRCULATION, V114, P2806, DOI 10.1161/CIRCULATIONAHA.106.611707; McGovern PG, 2001, CIRCULATION, V104, P19, DOI 10.1161/01.CIR.104.1.19; McWilliams JM, 2009, ANN INTERN MED, V150, P505, DOI 10.7326/0003-4819-150-8-200904210-00005; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503; Myerson M, 2009, CIRCULATION, V119, P503, DOI 10.1161/CIRCULATIONAHA.107.693879; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233, DOI 10.1136/jamia.1997.0040233; Parikh NI, 2009, CIRCULATION, V119, P1203, DOI 10.1161/CIRCULATIONAHA.108.825364; PEDERSEN TR, 1994, LANCET, V344, P1383; Pottenger BC, 2008, ANN EMERG MED, V52, P677, DOI 10.1016/j.annemergmed.2008.06.004; Roger VL, 2002, ANN INTERN MED, V136, P341, DOI 10.7326/0003-4819-136-5-200203050-00005; Selby JV, 2010, MED CARE, V48, P133, DOI 10.1097/MLR.0b013e3181c15a6e; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Steinberg BA, 2008, AM HEART J, V156, P719, DOI 10.1016/j.ahj.2008.05.020; Sytkowski PA, 1996, AM J EPIDEMIOL, V143, P338, DOI 10.1093/oxfordjournals.aje.a008748; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Yusuf S, 2001, NEW ENGL J MED, V345, P1716; Yusuf S, 2000, NEW ENGL J MED, V342, P145; YUSUF S, 2000, NEW ENGL J MED, V342, P1376; [No title captured]; 2003, JAMA, V289, P176	55	1181	1233	0	73	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2010	362	23					2155	2165		10.1056/NEJMoa0908610	http://dx.doi.org/10.1056/NEJMoa0908610			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608AL	20558366				2022-12-01	WOS:000278551500004
J	Saugstad, OD				Saugstad, Ola Didrik			Resuscitation of newborn infants: from oxygen to room air	LANCET			English	Editorial Material							100-PERCENT OXYGEN; NEONATAL RESUSCITATION; HYPOXANTHINE; METAANALYSIS; 21-PERCENT; INCREASES; HYPOXIA; PIGLETS; INJURY; TRIAL		Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Paediat Res, N-0027 Oslo, Norway	University of Oslo; National Hospital Norway	Saugstad, OD (corresponding author), Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Paediat Res, N-0027 Oslo, Norway.	odsaugstad@rr-research.no	Saugstad, Ola/AAS-9041-2021	Saugstad, Ola/0000-0002-3166-5254				[Anonymous], 2006, PEDIATRICS, V117, pe978; Davis PG, 2004, LANCET, V364, P1329, DOI 10.1016/S0140-6736(04)17189-4; Escrig R, 2008, PEDIATRICS, V121, P875, DOI 10.1542/peds.2007-1984; Hansmann G, 2004, LANCET, V364, P1293, DOI 10.1016/S0140-6736(04)17203-6; Koch JD, 2008, J CEREBR BLOOD F MET, V28, P1294, DOI 10.1038/jcbfm.2008.15; Lakshminrusimha S, 2006, PEDIATR RES, V59, P137, DOI 10.1203/01.pdr.0000191136.69142.8c; MCCORD JM, 1968, J BIOL CHEM, V243, P5753; Munkeby BH, 2004, PEDIATR RES, V56, P783, DOI 10.1203/01.PDR.0000141988.89820.E3; Naumburg E, 2002, ACTA PAEDIATR, V91, P1328, DOI 10.1080/08035250216105; Paneth N, 2005, J PEDIATR-US, V147, P4, DOI 10.1016/j.jpeds.2005.04.058; RAMJI S, 1993, PEDIATR RES, V34, P809, DOI 10.1203/00006450-199312000-00023; ROOTWELT T, 1992, PEDIATR RES, V32, P107, DOI 10.1203/00006450-199207000-00021; Saugstad OD, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.1.e1; SAUGSTAD OD, 1980, EUR SURG RES, V12, P123, DOI 10.1159/000128117; SAUGSTAD OD, 1975, PEDIATR RES, V9, P158, DOI 10.1203/00006450-197504000-00002; Saugstad OD, 2008, NEONATOLOGY, V94, P176, DOI 10.1159/000143397; Sejersted Y, 2009, PEDIATR RES, V66, P533, DOI 10.1203/PDR.0b013e3181ba1a42; Solberg R, 2007, PEDIATR RES, V62, P559, DOI 10.1203/PDR.0b013e318156e8aa; Spector LG, 2005, J PEDIATR-US, V147, P27, DOI 10.1016/j.jpeds.2005.03.008; Tarnow-Mordi WO, 1998, LANCET, V352, P341, DOI 10.1016/S0140-6736(05)60464-3; Vento M, 2005, AM J RESP CRIT CARE, V172, P1393, DOI 10.1164/rccm.200412-1740OC; Wang CL, 2008, PEDIATRICS, V121, P1083, DOI 10.1542/peds.2007-1460; *WHO, 1997, BAS NEWB RES PRACT G	23	60	61	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 11	2010	376	9757					1970	1971		10.1016/S0140-6736(10)60543-0	http://dx.doi.org/10.1016/S0140-6736(10)60543-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	701GZ	20663546				2022-12-01	WOS:000285807700008
J	Guo, HL; Ingolia, NT; Weissman, JS; Bartel, DP				Guo, Huili; Ingolia, Nicholas T.; Weissman, Jonathan S.; Bartel, David P.			Mammalian microRNAs predominantly act to decrease target mRNA levels	NATURE			English	Article							GENOME-WIDE ANALYSIS; POSTTRANSCRIPTIONAL REGULATION; PROTEIN-SYNTHESIS; IN-VIVO; TRANSLATION; INITIATION; DEADENYLATION; DEGRADATION; ELEGANS; MIRNAS	MicroRNAs (miRNAs) are endogenous similar to 22-nucleotide RNAs that mediate important gene-regulatory events by pairing to the mRNAs of protein-coding genes to direct their repression. Repression of these regulatory targets leads to decreased translational efficiency and/or decreased mRNA levels, but the relative contributions of these two outcomes have been largely unknown, particularly for endogenous targets expressed at low-to-moderate levels. Here, we use ribosome profiling to measure the overall effects on protein production and compare these to simultaneously measured effects on mRNA levels. For both ectopic and endogenous miRNA regulatory interactions, lowered mRNA levels account for most (>= 84%) of the decreased protein production. These results show that changes in mRNA levels closely reflect the impact of miRNAs on gene expression and indicate that destabilization of target mRNAs is the predominant reason for reduced protein output.	[Guo, Huili; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Guo, Huili; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Guo, Huili; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Ingolia, Nicholas T.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Ingolia, Nicholas T.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Ingolia, Nicholas T.; Weissman, Jonathan S.] Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu		Weissman, Jonathan/0000-0003-2445-670X; Guo, Huili/0000-0002-2294-5684	NIH; Agency for Science, Technology and Research, Singapore; Ruth L. Kirschstein National Research Service Award [GM080853]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080853, R01GM067031] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Camargo, C. Jan, J. Kim and C. Petersen for advice and discussions, R. Green and O. Rissland for comments on the manuscript, and the Whitehead Institute's Genome Technology Core for sequencing and microarray profiling. This work was supported by grants from the NIH (D. P. B. and J. S. W.). H. G. was supported by the Agency for Science, Technology and Research, Singapore. N.T.I. was supported by a Ruth L. Kirschstein National Research Service Award (GM080853). D. P. B and J. S. W. are investigators of the Howard Hughes Medical Institute.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Eulalio A, 2007, GENE DEV, V21, P2558, DOI 10.1101/gad.443107; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Rehwinkel J, 2006, MOL CELL BIOL, V26, P2965, DOI 10.1128/MCB.26.8.2965-2975.2006; Sachs MS, 2002, METHODS, V26, P105, DOI 10.1016/S1046-2023(02)00013-0; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103	34	2932	3045	11	337	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2010	466	7308					835	U66		10.1038/nature09267	http://dx.doi.org/10.1038/nature09267			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20703300	Green Submitted, Green Accepted			2022-12-01	WOS:000280766100029
J	Kollman, JM; Polka, JK; Zelter, A; Davis, TN; Agard, DA				Kollman, Justin M.; Polka, Jessica K.; Zelter, Alex; Davis, Trisha N.; Agard, David A.			Microtubule nucleating gamma-TuSC assembles structures with 13-fold microtubule-like symmetry	NATURE			English	Article							TUBULIN RING COMPLEX; ALPHA-BETA-TUBULIN; SPINDLE POLE BODY; ELECTRON-MICROSCOPY; CENTROSOME; TEMPLATE; RECONSTITUTION; LATTICE	Microtubules are nucleated in vivo by gamma-tubulin complexes. The 300-kDa gamma-tubulin small complex (gamma-TuSC), consisting of two molecules of gamma-tubulin and one copy each of the accessory proteins Spc97 and Spc98, is the conserved, essential core of the microtubule nucleating machinery(1,2). In metazoa multiple gamma-TuSCs assemble with other proteins into gamma-tubulin ring complexes (gamma-TuRCs). The structure of gamma-TuRC indicated that it functions as a microtubule template(2-5). Because each gamma-TuSC contains two molecules of gamma-tubulin, it was assumed that the gamma-TuRC-specific proteins are required to organize gamma-TuSCs to match 13-fold microtubule symmetry. Here we show that Saccharomyces cerevisiae gamma-TuSC forms rings even in the absence of other gamma-TuRC components. The yeast adaptor protein Spc110 stabilizes the rings into extended filaments and is required for oligomer formation under physiological buffer conditions. The 8-angstrom cryo-electron microscopic reconstruction of the filament reveals 13 gamma-tubulins per turn, matching microtubule symmetry, with plus ends exposed for interaction with microtubules, implying that one turn of the filament constitutes a microtubule template. The domain structures of Spc97 and Spc98 suggest functions for conserved sequence motifs, with implications for the gamma-TuRC-specific proteins. The gamma-TuSC filaments nucleate microtubules at a low level, and the structure provides a strong hypothesis for how nucleation is regulated, converting this less active form to a potent nucleator.	[Kollman, Justin M.; Agard, David A.] Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Kollman, Justin M.; Agard, David A.] Univ Calif San Francisco, Keck Adv Microscopy Ctr, San Francisco, CA 94158 USA; [Zelter, Alex; Davis, Trisha N.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle	Agard, DA (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	agard@msg.ucsf.edu	Davis, Trisha/F-8584-2010; Kollman, Justin/F-3012-2012	Davis, Trisha/0000-0003-4797-3152	National Institutes of Health (NIH) through the National Center for Research Resources'; NIH; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031627, F32GM078790, R01GM040506] Funding Source: NIH RePORTER	National Institutes of Health (NIH) through the National Center for Research Resources'(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Braunfeld and A. Avila-Sakar for microscopy assistance; Y. Cheng, E. Muller, M. Moritz and K. Huang for helpful discussions; and B. Carragher, C. Potter and J. Quispe for the use of their electron microscopy facilities and technical assistance with data collection. Some of the work presented here was conducted at the National Resource for Automated Molecular Microscopy, which is supported by the National Institutes of Health (NIH) through the National Center for Research Resources' P41 program. This work was supported by the NIH (D. A. A. and T.N.D.) and the Howard Hughes Medical Institute (D. A. A.). J. M. K. was a NIH Ruth L. Kirschstein National Research Service Award (NRSA) postdoctoral fellow.	Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; BYERS B, 1978, J CELL SCI, V30, P331; Choy RM, 2009, J STRUCT BIOL, V168, P571, DOI 10.1016/j.jsb.2009.08.012; CHRETIEN D, 1991, BIOL CELL, V71, P161, DOI 10.1016/0248-4900(91)90062-R; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Erickson HP, 2000, NAT CELL BIOL, V2, pE93, DOI 10.1038/35014084; EVANS L, 1985, J CELL BIOL, V100, P1185, DOI 10.1083/jcb.100.4.1185; Frank J., 1996, 3 DIMENSIONAL ELECT; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Gunawardane RN, 2000, J CELL BIOL, V151, P1513, DOI 10.1083/jcb.151.7.1513; Keating TJ, 2000, NAT CELL BIOL, V2, P352, DOI 10.1038/35014045; Knop M, 1997, EMBO J, V16, P6985, DOI 10.1093/emboj/16.23.6985; Kollman JM, 2008, MOL BIOL CELL, V19, P207, DOI 10.1091/mbc.E07-09-0879; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Moritz M, 2000, NAT CELL BIOL, V2, P365, DOI 10.1038/35014058; MORITZ M, 1995, J CELL BIOL, V130, P1149, DOI 10.1083/jcb.130.5.1149; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; OAKLEY BR, 1990, CELL, V61, P1289, DOI 10.1016/0092-8674(90)90693-9; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quispe J, 2007, MICROSC MICROANAL, V13, P365, DOI 10.1017/S1431927607070791; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088; Verollet C, 2006, J CELL BIOL, V172, P517, DOI 10.1083/jcb.200511071; Vinh DBN, 2002, MOL BIOL CELL, V13, P1144, DOI 10.1091/mbc.02-01-0607; Wiese C, 2000, NAT CELL BIOL, V2, P358, DOI 10.1038/35014051; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	30	174	174	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2010	466	7308					879	U114		10.1038/nature09207	http://dx.doi.org/10.1038/nature09207			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20631709	Green Accepted			2022-12-01	WOS:000280766100039
J	Schirmer, A; Rude, MA; Li, XZ; Popova, E; del Cardayre, SB				Schirmer, Andreas; Rude, Mathew A.; Li, Xuezhi; Popova, Emanuela; del Cardayre, Stephen B.			Microbial Biosynthesis of Alkanes	SCIENCE			English	Article							RIBONUCLEOTIDE REDUCTASE; HYDROCARBONS; ALGAE; ACID; GENE	Alkanes, the major constituents of gasoline, diesel, and jet fuel, are naturally produced by diverse species; however, the genetics and biochemistry behind this biology have remained elusive. Here we describe the discovery of an alkane biosynthesis pathway from cyanobacteria. The pathway consists of an acyl-acyl carrier protein reductase and an aldehyde decarbonylase, which together convert intermediates of fatty acid metabolism to alkanes and alkenes. The aldehyde decarbonylase is related to the broadly functional nonheme diiron enzymes. Heterologous expression of the alkane operon in Escherichia coli leads to the production and secretion of C13 to C17 mixtures of alkanes and alkenes. These genes and enzymes can now be leveraged for the simple and direct conversion of renewable raw materials to fungible hydrocarbon fuels.	[Schirmer, Andreas; Rude, Mathew A.; Li, Xuezhi; Popova, Emanuela; del Cardayre, Stephen B.] LS9 Inc, San Francisco, CA 94080 USA		Schirmer, A (corresponding author), LS9 Inc, 600 Gateway Blvd, San Francisco, CA 94080 USA.	aschirmer@ls9.com			LS9, Inc.	LS9, Inc.	We thank M. Alibhai for homology modeling, S. Brubaker for bioinformatics work, T. Baron for technical assistance, and C. Chang for help with preparing Fig. 3. The patent applications WO 2009/140695 and WO 2009/140696 are relevant to this paper. All authors have a financial interest in LS9, Inc. We would like to dedicate this paper to the memory of C. Richard Hutchinson, who died on 5 January 2010. "Hutch" was an important mentor for A.S. and S.B.d.C. He will be missed.	Aarts MGM, 1995, PLANT CELL, V7, P2115, DOI 10.1105/tpc.7.12.2115; CHEESBROUGH TM, 1984, P NATL ACAD SCI-BIOL, V81, P6613, DOI 10.1073/pnas.81.21.6613; Dembitsky VM, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1276, DOI 10.1023/A:1021309623541; DENNIS M, 1992, P NATL ACAD SCI USA, V89, P5306, DOI 10.1073/pnas.89.12.5306; Doan TTP, 2009, J PLANT PHYSIOL, V166, P787, DOI 10.1016/j.jplph.2008.10.003; FEHLER SWG, 1970, BIOCHEMISTRY-US, V9, P418, DOI 10.1021/bi00804a032; Fortman JL, 2008, TRENDS BIOTECHNOL, V26, P375, DOI 10.1016/j.tibtech.2008.03.008; Jiang W, 2007, SCIENCE, V316, P1188, DOI 10.1126/science.1141179; Ladygina N, 2006, PROCESS BIOCHEM, V41, P1001, DOI 10.1016/j.procbio.2005.12.007; MCINNES AG, 1980, LIPIDS, V15, P609, DOI 10.1007/BF02534009; Metzger P, 2005, APPL MICROBIOL BIOT, V66, P486, DOI 10.1007/s00253-004-1779-z; Muller J, 2002, BIOCHEMISTRY-US, V41, P42, DOI 10.1021/bi015668k; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; Regalbuto JR, 2009, SCIENCE, V325, P822, DOI 10.1126/science.1174581; Reiser S, 1997, J BACTERIOL, V179, P2969, DOI 10.1128/jb.179.9.2969-2975.1997; Rude MA, 2009, CURR OPIN MICROBIOL, V12, P274, DOI 10.1016/j.mib.2009.04.004; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; SHIEA J, 1990, ORG GEOCHEM, V15, P223, DOI 10.1016/0146-6380(90)90001-G; Strobel GA, 2008, MICROBIOL-SGM, V154, P3319, DOI 10.1099/mic.0.2008/022186-0; Stubbe J, 1998, TRENDS BIOCHEM SCI, V23, P438, DOI 10.1016/S0968-0004(98)01296-1; Tillman JA, 1999, INSECT BIOCHEM MOLEC, V29, P481, DOI 10.1016/S0965-1748(99)00016-8; TORNABENE TG, 1982, EXPERIENTIA, V38, P43, DOI 10.1007/BF01944525; Wackett LP, 2007, APPL ENVIRON MICROB, V73, P7192, DOI 10.1128/AEM.01785-07; WINTERS K, 1969, SCIENCE, V163, P467, DOI 10.1126/science.163.3866.467; Wu CH, 2007, BIOCHEMISTRY-US, V46, P11577, DOI 10.1021/bi7012454	25	715	800	11	354	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					559	562		10.1126/science.1187936	http://dx.doi.org/10.1126/science.1187936			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671186				2022-12-01	WOS:000280483500035
J	Kapranov, P; Ozsolak, F; Kim, SW; Foissac, S; Lipson, D; Hart, C; Roels, S; Borel, C; Antonarakis, SE; Monaghan, AP; John, B; Milos, PM				Kapranov, Philipp; Ozsolak, Fatih; Kim, Sang Woo; Foissac, Sylvain; Lipson, Doron; Hart, Chris; Roels, Steve; Borel, Christelle; Antonarakis, Stylianos E.; Monaghan, A. Paula; John, Bino; Milos, Patrice M.			New class of gene-termini-associated human RNAs suggests a novel RNA copying mechanism	NATURE			English	Article							POLYMERASE-II; TRANSCRIPTION	Small (<200 nucleotide) RNA (sRNA) profiling of human cells using various technologies demonstrates unexpected complexity of sRNAs with hundreds of thousands of sRNA species present(1-4). Genetic and in vitro studies show that these RNAs are not merely degradation products of longer transcripts but could indeed have a function(1,2,5). Furthermore, profiling of RNAs, including the sRNAs, can reveal not only novel transcripts, but also make clear predictions about the existence and properties of novel biochemical pathways operating in a cell. For example, sRNA profiling in human cells indicated the existence of an unknown capping mechanism operating on cleaved RNA(2), a biochemical component of which was later identified(6). Here we show that human cells contain a novel type of sRNA that has non-genomically encoded 5' poly(U) tails. The presence of these RNAs at the termini of genes, specifically at the very 3' ends of known mRNAs, strongly argues for the presence of a yet uncharacterized endogenous biochemical pathway in cells that can copy RNA. We show that this pathway can operate on multiple genes, with specific enrichment towards transcript-encoding components of the translational machinery. Finally, we show that genes are also flanked by sense, 3' polyadenylated sRNAs that are likely to be capped.	[Kapranov, Philipp; Ozsolak, Fatih; Lipson, Doron; Hart, Chris; Roels, Steve; Milos, Patrice M.] Helicos BioSci Corp, Cambridge, MA 02139 USA; [Kim, Sang Woo; John, Bino] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA; [Foissac, Sylvain] Integromics SL, Madrid 28760, Spain; [Borel, Christelle; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Monaghan, A. Paula] Univ Pittsburgh, Dept Neurobiol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Geneva; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kapranov, P (corresponding author), Helicos BioSci Corp, 1 Kendall Sq,Ste B7301, Cambridge, MA 02139 USA.	philippk08@gmail.com; pmilos@helicosbio.com	borel, christelle/AAC-9645-2019; Antonarakis, Stylianos E/N-8866-2014	Antonarakis, Stylianos E/0000-0001-8907-5823; Kim, Sang Woo/0000-0002-3144-4822; Kapranov, Philipp/0000-0003-2647-4856; Foissac, Sylvain/0000-0002-2631-5356	Swiss National Science Foundation; NIH [GM079756, MH60774]; American Cancer Society [RSG0905401]; Comunidad de Madrid; European Union [Exp. 11/2009]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060774] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Comunidad de Madrid(Comunidad de Madrid); European Union(European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We wish to thank A. Willingham, J. Thompson and Z. Li for discussions and help in the preparation of the manuscript. S. E. A. is supported by the Swiss National Science Foundation, B. J. by the NIH (GM079756) and American Cancer Society (RSG0905401), and A. P. M. by the NIH (MH60774). S. F. acknowledges support by a grant from the Comunidad de Madrid and European Union (Exp. 11/2009).	Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132; Aspegren A, 2004, NUCLEIC ACIDS RES, V32, P4646, DOI 10.1093/nar/gkh804; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Fodor E, 2000, EMBO REP, V1, P513; GILADI E, J COMPUT BI IN PRESS; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Lai MMC, 2005, J VIROL, V79, P7951, DOI 10.1128/JVI.79.13.7951-7958.2005; Lehmann E, 2007, NATURE, V450, P445, DOI 10.1038/nature06290; Lipson D, 2009, NAT BIOTECHNOL, V27, P652, DOI 10.1038/nbt.1551; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Otsuka Y, 2009, MOL CELL BIOL, V29, P2155, DOI 10.1128/MCB.01325-08; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; Volloch V, 1996, P NATL ACAD SCI USA, V93, P2476, DOI 10.1073/pnas.93.6.2476	19	61	69	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2010	466	7306					642	646		10.1038/nature09190	http://dx.doi.org/10.1038/nature09190			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20671709	Green Accepted			2022-12-01	WOS:000280412100057
J	Haukoos, JS; Hopkins, E; Conroy, AA; Silverman, M; Byyny, RL; Eisert, S; Thrun, MW; Wilson, ML; Hutchinson, AB; Forsyth, J; Johnson, SC; Heffelfinger, JD				Haukoos, Jason S.; Hopkins, Emily; Conroy, Amy A.; Silverman, Morgan; Byyny, Richard L.; Eisert, Sheri; Thrun, Mark W.; Wilson, Michael L.; Hutchinson, Angela B.; Forsyth, Jessica; Johnson, Steven C.; Heffelfinger, James D.		Denver Emergency Dept HIV Opt-Out	Routine Opt-Out Rapid HIV Screening and Detection of HIV Infection in Emergency Department Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FOR-DISEASE-CONTROL; CARE; PROGRAM; HEALTH; RECOMMENDATIONS; IMPLEMENTATION; EXPERIENCE; TESTS; MODEL	Context The Centers for Disease Control and Prevention (CDC) recommends routine (nontargeted) opt-out HIV screening in health care settings, including emergency departments (EDs), where the prevalence of undiagnosed infection is 0.1% or greater. The utility of this approach in EDs remains unknown. Objective To determine whether nontargeted opt-out rapid HIV screening in the ED was associated with identification of more patients with newly diagnosed HIV infection than physician-directed diagnostic rapid HIV testing. Design, Setting, and Patients Quasi-experimental equivalent time-samples design in an urban public safety-net hospital with an approximate annual ED census of 55 000 patient visits. Patients were 16 years or older and capable of providing consent for rapid HIV testing. Interventions Nontargeted opt-out rapid HIV screening and physician-directed diagnostic rapid HIV testing alternated in sequential 4-month time intervals between April 15, 2007, and April 15, 2009. Main Outcome Measures Number of patients with newly identified HIV infection and the association between nontargeted opt-out rapid HIV screening and identification of HIV infection. Results In the opt-out phase, of 28 043 eligible ED patients, 6933 patients (25%) completed HIV testing (6702 patients were screened; 231 patients were diagnostically tested). Ten of 6702 patients (0.15%; 95% CI, 0.07%-0.27%) who did not decline HIV screening in the opt-out phase had new HIV diagnoses, and 5 of 231 patients (2.2%; 95% CI, 0.7%-5.0%) who were diagnostically tested during the opt-out phase had new HIV diagnoses. In the diagnostic phase, of 29 925 eligible patients, 243 (0.8%) completed HIV testing. Of these, 4 patients (1.6%; 95% CI, 0.5%-4.2%) had new diagnoses. The prevalence of new HIV diagnoses in the opt-out phase (including those diagnostically tested) and in the diagnostic phase was 15 in 28 043 (0.05%; 95% CI, 0.03%-0.09%) and 4 in 29 925 (0.01%; 95% CI, 0.004%-0.03%), respectively. Nontargeted opt-out HIV screening was independently associated with new HIV diagnoses (risk ratio, 3.6; 95% CI, 1.2-10.8) when adjusting for patient demographics, insurance status, and whether diagnostic testing was performed in the opt-out phase. The median CD4 cell count for those with new HIV diagnoses in the opt-out phase (including those diagnostically tested) and in the diagnostic phase was 69/mu L (IQR, 17-430) and 13/mu L (IQR, 11-15), respectively (P=.02). Conclusion Nontargeted opt-out rapid HIV screening in the ED, vs diagnostic testing, was associated with identification of a modestly increased number of patients with new HIV diagnoses, most of whom were identified late in the course of disease. JAMA. 2010;304(3):284-292 www.jama.com	[Haukoos, Jason S.; Hopkins, Emily; Byyny, Richard L.] Denver Hlth Med Ctr, Dept Emergency Med, Denver, CO 80204 USA; [Silverman, Morgan] Denver Hlth Med Ctr, Dept Clin Social Work, Denver, CO 80204 USA; [Eisert, Sheri] Denver Hlth Med Ctr, Dept Hlth Serv Res, Denver, CO 80204 USA; [Wilson, Michael L.] Denver Hlth Med Ctr, Dept Pathol, Denver, CO 80204 USA; [Haukoos, Jason S.; Byyny, Richard L.; Thrun, Mark W.; Wilson, Michael L.; Johnson, Steven C.] Univ Colorado, Sch Med, Aurora, CO USA; [Haukoos, Jason S.] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA; [Eisert, Sheri] Colorado Sch Publ Hlth, Dept Hlth Syst Management & Policy, Aurora, CO USA; [Conroy, Amy A.] Univ Colorado Denver, Dept Hlth & Behav Sci, Denver, CO USA; [Thrun, Mark W.] Denver Publ Hlth, Denver, CO USA; [Hutchinson, Angela B.; Heffelfinger, James D.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA; [Forsyth, Jessica] Childrens Hosp, Childrens Immunodeficiency Program, Aurora, CO USA; [Johnson, Steven C.] Univ Colorado, Univ Colorado Hosp, HIV AIDS Clin Program, Aurora, CO USA	Denver Health Medical Center; Denver Health Medical Center; Denver Health Medical Center; Denver Health Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; Colorado School of Public Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Centers for Disease Control & Prevention - USA; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Hospital	Haukoos, JS (corresponding author), Denver Hlth Med Ctr, Dept Emergency Med, 777 Bannock St,Mail Code 0108, Denver, CO 80204 USA.	jason.haukoos@dhha.org		Byyny, Richard/0000-0002-9145-7457	Abbott Laboratories; Centers for Disease Control and Prevention (CDC) [U18 PS000314]; Agency for Healthcare Research and Quality (AHRQ) [K02 HS017526]; Colorado Department of Public Health and Environment (CDPHE); Colorado Center for AIDS Research; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K02HS017526] Funding Source: NIH RePORTER; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U18PS000314] Funding Source: NIH RePORTER	Abbott Laboratories(Abbott Laboratories); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Colorado Department of Public Health and Environment (CDPHE); Colorado Center for AIDS Research; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Dr Haukoos reported receiving unrestricted research support from Abbott Laboratories and being supported in part by the Centers for Disease Control and Prevention (CDC) and the Agency for Healthcare Research and Quality (AHRQ). Ms Hopkins reported being supported previously by an unrestricted research grant from Abbott Laboratories and supported in full during the course of this project by the CDC. Dr Thrun reported receiving support from the Colorado Department of Public Health and Environment (CDPHE) and the CDC and having been a paid consultant for the CDC on issues related to HIV prevention. Dr Johnson reported participating in advisory boards and serving as a consultant for both ViiV Healthcare and Gilead Sciences Inc. No other disclosures were reported.; This study was funded by a cooperative agreement (U18 PS000314) with the CDC (J.S.H.) and supported in part by an Independent Scientist Award (K02 HS017526) from the AHRQ (J.S.H.) and a Career Development Award from the Colorado Center for AIDS Research (R.L.B.).	Centers of Disease Control and Prevention, 2001, MMWR Recomm Rep, V50, P1; Bernstein SL, 2003, ACAD EMERG MED, V10, P938, DOI 10.1197/S1069-6563(03)00311-7; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brown J, 2007, JAIDS-J ACQ IMM DEF, V46, P395, DOI 10.1097/QAI.0b013e3181582d82; Campbell D. T., 1963, EXPT QUASIEXPERIMENT; *CDCP, 2006, NEW EST US HIV PREV; Chou R, 2007, SCREENING HUMAN IMMU; Ehrenkranz PD, 2008, ACAD EMERG MED, V15, P144, DOI 10.1111/j.1553-2712.2008.00028.x; Gabow P, 2003, ANN INTERN MED, V138, P143, DOI 10.7326/0003-4819-138-2-200301210-00016; Glick NR, 2004, AIDS EDUC PREV, V16, P126, DOI 10.1521/aeap.16.2.126.29391; Goggin MA, 2000, J EMERG MED, V19, P13, DOI 10.1016/S0736-4679(00)00175-X; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Haukoos JS, 2008, ANN EMERG MED, V51, P303, DOI 10.1016/j.annemergmed.2007.10.028; Haukoos JS, 2007, ACAD EMERG MED, V14, P1149, DOI [10.1197/j.aem.2007.07.015, 10.1111/j.1553-2712.2007.tb02335.x]; Haukoos JS, 2009, ACAD EMERG MED, V16, P1044, DOI 10.1111/j.1553-2712.2009.00556.x; Haukoos JS, 2009, ACAD EMERG MED, V16, P800, DOI 10.1111/j.1553-2712.2009.00477.x; Hsieh YH, 2008, AIDS, V22, P2127, DOI 10.1097/QAD.0b013e328310e066; Irvin CB, 2007, ANN EMERG MED, V49, P722, DOI 10.1016/j.annemergmed.2007.03.011; Kelen GD, 2009, ANN EMERG MED, V54, P65, DOI 10.1016/j.annemergmed.2009.03.027; Kelen GD, 1999, ANN EMERG MED, V33, P147, DOI 10.1016/S0196-0644(99)70387-2; Kelen GD, 1996, ANN EMERG MED, V27, P687, DOI 10.1016/S0196-0644(96)70184-1; KELEN GD, 1991, AM J EMERG MED, V9, P416, DOI 10.1016/0735-6757(91)90205-X; Lyons MS, 2009, J MED SCREEN, V16, P29, DOI 10.1258/jms.2009.008086; Lyons MS, 2005, ANN EMERG MED, V46, P22, DOI 10.1016/j.annemergmed.2004.12.022; Lyss S, 2004, ANN EMERG MED, V44, pS56, DOI 10.1016/j.annemergmed.2004.07.184; Lyss SB, 2007, JAIDS-J ACQ IMM DEF, V44, P435, DOI 10.1097/QAI.0b013e31802f83d0; Mollen C, 2008, AIDS PATIENT CARE ST, V22, P505, DOI 10.1089/apc.2007.0098; Owens SD, 2008, VET CLIN PATH, V37, P49, DOI 10.1111/j.1939-165X.2008.00003.x; Rothman RE, 2007, ACAD EMERG MED, V14, P653, DOI 10.1197/j.aem.2007.04.004; Silva A, 2007, ANN EMERG MED, V49, P564, DOI 10.1016/j.annemergmed.2006.09.028; Telzak E. E., 2007, Morbidity and Mortality Weekly Report, V56, P597; Torres GW, 2009, PUBLIC HEALTH REP, V124, P400, DOI 10.1177/003335490912400309; Walensky RP, 2008, ANN INTERN MED, V149, P153, DOI 10.7326/0003-4819-149-3-200808050-00003; White DAE, 2009, ANN EMERG MED, V54, P56, DOI 10.1016/j.annemergmed.2008.09.027	34	138	139	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					284	292		10.1001/jama.2010.953	http://dx.doi.org/10.1001/jama.2010.953			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639562	Bronze			2022-12-01	WOS:000280107500018
J	Karagas, MR; Waterboer, T; Li, ZZ; Nelson, HH; Michael, KM; Bavinck, JNB; Perry, AE; Spencer, SK; Daling, J; Green, AC; Pawlita, M				Karagas, Margaret R.; Waterboer, Tim; Li, Zhongze; Nelson, Heather H.; Michael, Kristina M.; Bavinck, Jan Nico Bouwes; Perry, Ann E.; Spencer, Steven K.; Daling, Janet; Green, Adele C.; Pawlita, Michael		New Hampshire Skin Canc Study Grp	Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study	BRITISH MEDICAL JOURNAL			English	Article							GLUTATHIONE-S-TRANSFERASE; VIRUS-LIKE PARTICLES; ACTINIC KERATOSES; SUN EXPOSURE; CANCER; RISK; ANTIBODIES; INFECTION; PROTEINS; SEROREACTIVITY	Objective To investigate the association between genus beta human papillomaviruses and the incidence of nonmelanocytic skin cancer in the general population. Design Population based case-control study. Setting New Hampshire, USA. Participants 2366 skin cancer cases and controls from the general population aged 25 to 74 years (663 squamous cell carcinoma, 898 basal cell carcinoma, 805 controls), with plasma samples tested for L1 antibodies to 16 genus beta human papillomaviruses by multiplex serology. Main outcome measures Odds ratios for squamous cell carcinoma and basal cell carcinoma associated with seropositivity to beta human papillomaviruses. Results Squamous cell carcinoma, but not basal cell carcinoma, cases had a higher prevalence of each of the individual beta human papillomaviruses assayed compared with controls. The odds ratios for squamous cell carcinoma increased with the number of beta types positive (odds ratio for one type positive 0.99 (95% confidence interval 0.74 to 1.33); two to three types positive 1.44 (1.03 to 2.01); four to eight types positive 1.51 (1.03 to 2.20); more than eight types positive 1.71 (1.12 to 2.62); P for trend (categorical)<0.001; P for trend (continuous)=0.003). With limited statistical power, the association was stronger among long term users of systemic glucocorticoids (odds ratio 3.21, 1.22 to 8.44) than among non-users (1.23, 0.97 to 1.55). Conclusions These findings support a relation between genus beta human papillomavirus infection and the incidence of squamous cell carcinoma of the skin in the general population, as well as potential enhancement of risk by immunosuppression.	[Karagas, Margaret R.; Li, Zhongze; Perry, Ann E.; Spencer, Steven K.] Dartmouth Med Sch, Dept Community & Family Med, Epidemiol & Biostat Sect, Lebanon, NH 03756 USA; [Karagas, Margaret R.; Li, Zhongze; Perry, Ann E.; Spencer, Steven K.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA; [Waterboer, Tim; Michael, Kristina M.; Pawlita, Michael] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Nelson, Heather H.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Bavinck, Jan Nico Bouwes] Leiden Univ, Med Ctr, NL-2300 RC Leiden, Netherlands; [Daling, Janet] Univ Washington, Seattle, WA 98109 USA; [Green, Adele C.] PO Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Daling, Janet] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); University of Minnesota System; University of Minnesota Twin Cities; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Washington; University of Washington Seattle; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; Fred Hutchinson Cancer Center	Karagas, MR (corresponding author), Dartmouth Med Sch, Dept Community & Family Med, Epidemiol & Biostat Sect, Lebanon, NH 03756 USA.	margaret.karagas@dartmouth.edu	Waterboer, Tim/G-1252-2010; Green, Adele C/B-5324-2011; Green, Adele C/P-2736-2014; Pawlita, Labor/C-9720-2011	Green, Adele C/0000-0002-2753-4841; Mittleman, Murray/0000-0001-9788-7274; Pawlita, Michael/0000-0002-4720-8306; Nelson, Heather/0000-0003-1901-9513	US National Institutes of Health, National Cancer Institute [CA118443, CA57494]; European Community [QLK2-CT-2002-01179]; NATIONAL CANCER INSTITUTE [P30CA023108, R01CA118443, R01CA057494] Funding Source: NIH RePORTER	US National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Community(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded in part by grants CA118443 and CA57494 of the US National Institutes of Health, National Cancer Institute and grant QLK2-CT-2002-01179 of the European Community. The NCI and the EC were not involved in the design and conduct of the study or the collection, management, analysis, and interpretation of the data. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the NIH, NCI or the EC.	Andersson K, 2008, CANCER EPIDEM BIOMAR, V17, P189, DOI 10.1158/1055-9965.EPI-07-0405; Bavinck JNB, 1996, TRANSPLANTATION, V61, P715, DOI 10.1097/00007890-199603150-00008; Bavinck JNB, 2000, BRIT J DERMATOL, V142, P103, DOI 10.1046/j.1365-2133.2000.03248.x; BRESLOW NE, 1980, STATISTICAL METHODS, V1, P1; Casabonne D, 2007, INT J CANCER, V121, P1862, DOI 10.1002/ijc.22885; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Dondog B, 2008, CANCER EPIDEM BIOMAR, V17, P1731, DOI 10.1158/1055-9965.EPI-07-2796; Feltkamp MCW, 2003, CANCER RES, V63, P2695; GREENBERG ER, 1990, NEW ENGL J MED, V323, P789, DOI 10.1056/NEJM199009203231204; *INT AG RES CTR, 2007, IARC MON, V90; Karagas MR, 2007, AM J EPIDEMIOL, V165, P719, DOI 10.1093/aje/kwk055; Karagas MR, 2006, J NATL CANCER I, V98, P389, DOI 10.1093/jnci/djj092; Karagas MR, 1996, J NATL CANCER I, V88, P1848, DOI 10.1093/jnci/88.24.1848; Karagas MR, 2001, BRIT J CANCER, V85, P683, DOI 10.1054/bjoc.2001.1931; Karagas MR, 1999, INT J CANCER, V81, P555, DOI 10.1002/(SICI)1097-0215(19990517)81:4<555::AID-IJC9>3.0.CO;2-R; Karagas MR, 2001, AM J EPIDEMIOL, V153, P559, DOI 10.1093/aje/153.6.559; Karagas MR, 2006, CANC EPIDEMIOLOGY PR; KRICKER A, 1994, CANCER CAUSE CONTROL, V5, P367, DOI 10.1007/BF01804988; KRICKER A, 1991, INT J CANCER, V48, P650, DOI 10.1002/ijc.2910480504; Masini C, 2003, ARCH DERMATOL, V139, P890, DOI 10.1001/archderm.139.7.890; Michael KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000091; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; Nindl I, 2007, DIS MARKERS, V23, P247, DOI 10.1155/2007/942650; Sehr P, 2002, J VIROL METHODS, V106, P61, DOI 10.1016/S0166-0934(02)00134-9; Sehr P, 2001, J IMMUNOL METHODS, V253, P153, DOI 10.1016/S0022-1759(01)00376-3; Sorensen HT, 2004, JNCI-J NATL CANCER I, V96, P709, DOI 10.1093/jnci/djh118; Stark S, 1998, J INVEST DERMATOL, V111, P696, DOI 10.1046/j.1523-1747.1998.00360.x; STEGER G, 1990, J VIROL, V64, P4399, DOI 10.1128/JVI.64.9.4399-4406.1990; Struijk L, 2006, CANCER EPIDEM BIOMAR, V15, P529, DOI 10.1158/1055-9965.EPI-05-0747; Underbrink MP, 2008, J VIROL, V82, P10408, DOI 10.1128/JVI.00902-08; Waterboer T, 2008, BRIT J DERMATOL, V159, P457, DOI 10.1111/j.1365-2133.2008.08621.x; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381	32	64	64	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 8	2010	341								c2986	10.1136/bmj.c2986	http://dx.doi.org/10.1136/bmj.c2986			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625DM	20616098	Green Published, hybrid			2022-12-01	WOS:000279874400001
J	Zeng, L; Zhang, Q; Li, S; Plotnikov, AN; Walsh, MJ; Zhou, MM				Zeng, Lei; Zhang, Qiang; Li, Side; Plotnikov, Alexander N.; Walsh, Martin J.; Zhou, Ming-Ming			Mechanism and regulation of acetylated histone binding by the tandem PHD finger of DPF3b	NATURE			English	Article							LYSINE-4 TRIMETHYLATION; AUTOIMMUNE REGULATOR; PLANT HOMEODOMAIN; H3; RECOGNITION; METHYLATION; BROMODOMAIN; NMR; DOMAIN; H3K4ME3	Histone lysine acetylation and methylation have an important role during gene transcription in a chromatin context(1,2). Knowledge concerning the types of protein modules that can interact with acetyl-lysine has so far been limited to bromodomains(1). Recently, a tandem plant homeodomain (PHD) finger(3) (PHD1-PHD2, or PHD12) of human DPF3b, which functions in association with the BAF chromatin remodelling complex to initiate gene transcription during heart and muscle development, was reported to bind histones H3 and H4 in an acetylation-sensitive manner(4), making it the first alternative to bromodomains for acetyl-lysine binding(5). Here we report the structural mechanism of acetylated histone binding by the double PHD fingers of DPF3b. Our three-dimensional solution structures and biochemical analysis of DPF3b highlight the molecular basis of the integrated tandem PHD finger, which acts as one functional unit in the sequence-specific recognition of lysine-14-acetylated histone H3 (H3K14ac). Whereas the interaction with H3 is promoted by acetylation at lysine 14, it is inhibited by methylation at lysine 4, and these opposing influences are important during transcriptional activation of the mouse DPF3b target genes Pitx2 and Jmjd1c. Binding of this tandem protein module to chromatin can thus be regulated by different histone modifications during the initiation of gene transcription.	[Zeng, Lei; Zhang, Qiang; Plotnikov, Alexander N.; Walsh, Martin J.; Zhou, Ming-Ming] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Li, Side; Walsh, Martin J.] Mt Sinai Sch Med, Dept Paediat, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Zhou, MM (corresponding author), Mt Sinai Sch Med, Dept Struct & Chem Biol, 1425 Madison Ave,Box 1677, New York, NY 10029 USA.	ming-ming.zhou@mssm.edu			National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA087658] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We acknowledge the use of the NMR Facility at the New York Structural Biology Center. We thank S. Hearn of Cold Spring Harbor Laboratory microscopy facility for help with confocal microscopy study, and A. Buku and G. Gerona-Navarro for technical advice on peptide binding analysis. This work was supported by grants from the National Institutes of Health (M.-M.Z.).	Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chakravarty S, 2009, STRUCTURE, V17, P670, DOI 10.1016/j.str.2009.02.017; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Furlan-Magaril M, 2009, METHODS MOL BIOL, V543, P253, DOI 10.1007/978-1-60327-015-1_17; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Org T, 2008, EMBO REP, V9, P370, DOI 10.1038/sj.embor.2008.11; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Phanstiel D, 2008, P NATL ACAD SCI USA, V105, P4093, DOI 10.1073/pnas.0710515105; Portier GL, 1999, IN VITRO CELL DEV-AN, V35, P219, DOI 10.1007/s11626-999-0030-8; Qian CM, 2005, NAT STRUCT MOL BIOL, V12, P1078, DOI 10.1038/nsmb1022; Ramon-Maiques S, 2007, P NATL ACAD SCI USA, V104, P18993, DOI 10.1073/pnas.0709170104; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sanchez R, 2009, CURR OPIN DRUG DISC, V12, P659; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010; Zeng L, 2008, NAT STRUCT MOL BIOL, V15, P626, DOI 10.1038/nsmb.1416	30	211	214	3	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					258	U138		10.1038/nature09139	http://dx.doi.org/10.1038/nature09139			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613843	Green Accepted			2022-12-01	WOS:000279580800041
J	Jena, AB; Goldman, DP; Kamdar, A; Lakdawalla, DN; Lu, Y				Jena, Anupam B.; Goldman, Dana P.; Kamdar, Amee; Lakdawalla, Darius N.; Lu, Yang			Sexually Transmitted Diseases Among Users of Erectile Dysfunction Drugs: Analysis of Claims Data	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; SILDENAFIL USE; RISK BEHAVIORS; HIV-INFECTION; SAN-FRANCISCO; OLDER-PEOPLE; MEN; ATTITUDES; VIAGRA; ADULTS	Background: Pharmacologic treatments for erectile dysfunction (ED) have gained popularity among middle-aged and older men. Increased sexual activity among those who use these drugs raises concerns about sexually transmitted diseases (STDs). Objective: To examine the rates of STDs in men who use and do not use ED drugs. Design: Retrospective cohort study. Setting: Database of claims from 1997 to 2006 for 1 410 806 men older than age 40 years with private, employer-based insurance from 44 large companies. Patients: 33 968 men with at least 1 filled prescription for an ED drug and 1 376 838 patients with no prescription. Measurements: STD prevalence among users and nonusers of ED drugs. Results: Users of ED drugs had higher rates of STDs than nonusers the year before initiating ED drug therapy (214 vs. 106 annually per 100 000 persons; P = 0.003) and the year after (105 vs. 65; P = 0.004). After adjustment for age and other comorbid conditions, users of ED drugs had an odds ratio (OR) for an STD of 2.80 (95% CI, 2.10 to 3.75) in the year before initiating drug therapy; the OR was 2.65 (CI, 1.84 to 3.81) in the year after. These differences were largely due to infections with HIV. The OR for HIV infection was 3.32 (CI, 2.38 to 4.36) in the year before and 3.19 (CI, 2.11 to 4.83) in the year after an ED drug prescription was filled. Significant changes in STD rates from the year before to the year after the first ED drug prescription was filled were not documented (adjusted OR for STD for users before vs. after the first ED drug prescription was filled, 0.96 [CI, 0.87 to 1.06]). Limitation: Selection bias precludes conclusions about whether use of ED treatments directly leads to increases in STDs. Conclusion: Men who use ED drugs have higher rates of STDs, particularly HIV infection, both in the year before and after use of these drugs. The observed association between ED drug use and STDs may have more to do with the types of patients using ED drugs rather than a direct effect of ED drug availability on STD rates. Counseling about safe sexual practices and screening for STDs should accompany the prescription of ED drugs.	Harvard Univ, Sch Med, Boston, MA USA; Univ So Calif, Los Angeles, CA USA; Univ Chicago, Booth Grad Sch Business, Chicago, IL 60637 USA; RAND Corp, Santa Monica, CA USA	Harvard University; Harvard Medical School; University of Southern California; University of Chicago; RAND Corporation	Jena, AB (corresponding author), Massachusetts Gen Hosp, Dept Med, Wang Ambulatory Care Ctr, 15 Parkman St, Boston, MA 02114 USA.	jena.anupam@mgh.harvard.edu	Goldman, Dana P/E-7667-2013; Lakdawalla, Darius/B-4409-2011	Goldman, Dana P/0000-0001-8498-6396; Lakdawalla, Darius/0000-0001-5934-8042; Lu, Yang/0000-0003-2905-7302	RAND Roybal Center; National Institutes of Health; Agency for Healthcare Research and Quality; Bing Center for Health Economics; RAND Roybal Center for Health Policy Simulation [P30AG024968]; National Institutes of Health [5 T32 GM07281]; Agency for Healthcare Research and Quality through a University of California, Los Angeles [T32 HS 000046]; National Institute for Child Health and Human Development [1R01HD054877]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000046, F32HS000046] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024968] Funding Source: NIH RePORTER	RAND Roybal Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Bing Center for Health Economics; RAND Roybal Center for Health Policy Simulation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality through a University of California, Los Angeles; National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Primary Funding Source: RAND Roybal Center, National Institutes of Health, and Agency for Healthcare Research and Quality.; By the Bing Center for Health Economics and RAND Roybal Center for Health Policy Simulation (grant P30AG024968), a National Institutes of Health Medical Scientist National Research Award (grant 5 T32 GM07281 to Dr. Jena), the Agency for Healthcare Research and Quality through a University of California, Los Angeles/RAND Training Grant (grant T32 HS 000046 to Dr. Jena), and the National Institute for Child Health and Human Development (grant 1R01HD054877 to Dr. Jena).	Araujo AB, 2004, J AM GERIATR SOC, V52, P1502, DOI 10.1111/j.0002-8614.2004.52413.x; Armstrong K, 1999, NEW ENGL J MED, V341, P1389, DOI 10.1056/NEJM199910283411810; BACON CG, 2003, ANN INTERN MED, V50, P139; Bodley-Tickell AT, 2008, SEX TRANSM INFECT, V84, P312, DOI 10.1136/sti.2007.027847; Cachay E, 2004, AIDS PATIENT CARE ST, V18, P349, DOI 10.1089/1087291041444050; Chu PL, 2003, JAIDS-J ACQ IMM DEF, V33, P191, DOI 10.1097/00126334-200306010-00012; Delate T, 2004, INT J IMPOT RES, V16, P313, DOI 10.1038/sj.ijir.3901191; Enzlin P, 2004, INT J IMPOT RES, V16, P512, DOI 10.1038/sj.ijir.3901221; Goldman DP, 2006, HEALTH AFFAIR, V25, P1319, DOI 10.1377/hlthaff.25.5.1319; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; Johannes CB, 2000, J UROLOGY, V163, P460, DOI 10.1016/S0022-5347(05)67900-1; Joyce GF, 2002, JAMA-J AM MED ASSOC, V288, P1733, DOI 10.1001/jama.288.14.1733; Karlovsky M, 2004, SCAND J UROL NEPHROL, V38, P247, DOI 10.1080/00365590410025488; Kim AA, 2002, AIDS, V16, P1425, DOI 10.1097/00002030-200207050-00017; Kuehn BM, 2008, JAMA-J AM MED ASSOC, V300, P1285, DOI 10.1001/jama.300.11.1285; Laumann EO, 2005, INT J IMPOT RES, V17, P39, DOI 10.1038/sj.ijir.3901250; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; Lindau ST, 2006, J WOMENS HEALTH, V15, P747, DOI 10.1089/jwh.2006.15.747; Moreira ED, 2005, INT J CLIN PRACT, V59, P6, DOI 10.1111/j.1742-1241.2005.00382.x; Nicolosi A, 2004, UROLOGY, V64, P991, DOI 10.1016/j.urology.2004.06.055; Ory MG, 1998, RES AGING, V20, P653, DOI 10.1177/0164027598206002; Patel D, 2003, SEX TRANSM DIS, V30, P216, DOI 10.1097/00007435-200303000-00008; Paul JP, 2005, SEX TRANSM DIS, V32, P531, DOI 10.1097/01.olq.0000175294.76494.77; Schmid GP, 2009, B WORLD HEALTH ORGAN, V87, P162, DOI 10.2471/BLT.09.064030; SHARPLES T, 2008, TIME            0702; Skiest DJ, 1997, ARCH FAM MED, V6, P289, DOI 10.1001/archfami.6.3.289; Smith KP, 2009, AM J PUBLIC HEALTH, V99, P2055, DOI 10.2105/AJPH.2009.160119; STALL R, 1994, ARCH INTERN MED, V154, P57, DOI 10.1001/archinte.154.1.57; Swearingen SG, 2005, AM J MED, V118, P571, DOI 10.1016/j.amjmed.2005.01.042	30	39	40	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 6	2010	153	1					1	+		10.7326/0003-4819-153-1-201007060-00003	http://dx.doi.org/10.7326/0003-4819-153-1-201007060-00003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	620GS	20621899				2022-12-01	WOS:000279487700001
J	Wang, ZX; Song, JK; Milne, TA; Wang, GG; Li, HT; Allis, CD; Patel, DJ				Wang, Zhanxin; Song, Jikui; Milne, Thomas A.; Wang, Gang G.; Li, Haitao; Allis, C. David; Patel, Dinshaw J.			Pro Isomerization in MLL1 PHD3-Bromo Cassette Connects H3K4me Readout to CyP33 and HDAC-Mediated Repression	CELL			English	Article							HISTONE MODIFICATIONS; PHD FINGERS; PROLINE ISOMERIZATION; CIS/TRANS ISOMERASES; BINDING MODULES; PROTEIN; METHYLTRANSFERASE; RECOGNITION; BROMODOMAIN; LEUKEMIA	The MLL1 gene is a frequent target for recurrent chromosomal translocations, resulting in transformation of hematopoietic precursors into leukemia stem cells. Here, we report on structure-function studies that elucidate molecular events in MLL1 binding of histone H3K4me3/2 marks and recruitment of the cyclophilin CyP33. CyP33 contains a PPIase and a RRM domain and regulates MLL1 function through HDAC recruitment. We find that the PPIase domain of CyP33 regulates the conformation of MLL1 through proline isomerization within the PHD3-Bromo linker, thereby disrupting the PHD3-Bromo interface and facilitating binding of the MLL1-PHD3 domain to the CyP33-RRM domain. H3K4me3/2 and CyP33-RRM target different surfaces of MLL1-PHD3 and can bind simultaneously to form a ternary complex. Furthermore, the MLL1-CyP33 interaction is required for repression of HOXA9 and HOXC8 genes in vivo. Our results highlight the role of PHD3-Bromo cassette as a regulatory platform, orchestrating MLL1 binding of H3K4me3/2 marks and cyclophilin-mediated repression through HDAC recruitment.	[Wang, Zhanxin; Song, Jikui; Li, Haitao; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Milne, Thomas A.; Wang, Gang G.; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Rockefeller University	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	pateld@mskcc.org	Milne, Tom/E-1872-2016; Wang, G Greg/L-6666-2014; Li, Haitao/B-2668-2012	Milne, Tom/0000-0002-0413-4271; Wang, G Greg/0000-0002-7210-9940; Li, Haitao/0000-0001-6741-293X	Leukemia and Lymphoma Society [LLS-SCOR 7132-08]; Starr Foundation; NATIONAL CANCER INSTITUTE [K99CA151683, P30CA008748] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Starr Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the Leukemia and Lymphoma Society Program Project grant LLS-SCOR 7132-08 and a Starr Foundation grant, both of them jointly to D.J.P. and C.D.A. D.J.P. is a consultant in GlaxoSmithKline's epigenetic programs.	Andreotti AH, 2003, BIOCHEMISTRY-US, V42, P9515, DOI 10.1021/bi0350710; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen J, 2008, CANCER RES, V68, P6199, DOI 10.1158/0008-5472.CAN-07-6514; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst P, 2004, CURR BIOL, V14, P2063, DOI 10.1016/j.cub.2004.11.012; Fair K, 2001, MOL CELL BIOL, V21, P3589, DOI 10.1128/MCB.21.10.3589-3597.2001; Fanghanel J, 2004, FRONT BIOSCI-LANDMRK, V9, P3453, DOI 10.2741/1494; Fiedler M, 2008, MOL CELL, V30, P507, DOI 10.1016/j.molcel.2008.03.011; GALAT A, 1995, PROG BIOPHYS MOL BIO, V63, P67, DOI 10.1016/0079-6107(94)00009-X; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hsieh JJD, 2003, MOL CELL BIOL, V23, P186, DOI 10.1128/MCB.23.1.186-194.2003; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Linggi BE, 2005, J CELL BIOCHEM, V96, P938, DOI 10.1002/jcb.20604; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mi HF, 1996, FEBS LETT, V398, P201, DOI 10.1016/S0014-5793(96)01248-3; Milne TA, 2005, P NATL ACAD SCI USA, V102, P14765, DOI 10.1073/pnas.0503630102; Milne TA, 2010, MOL CELL, V38, P853, DOI 10.1016/j.molcel.2010.05.011; Milne Thomas A., 2009, V538, P409, DOI 10.1007/978-1-59745-418-6_21; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Muntean AG, 2008, BLOOD, V112, P4690, DOI 10.1182/blood-2008-01-134056; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wang T, 2005, BIOCHEM BIOPH RES CO, V333, P845, DOI 10.1016/j.bbrc.2005.06.006; Wang Y, 2008, FEBS LETT, V582, P835, DOI 10.1016/j.febslet.2008.01.055; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xia ZB, 2003, P NATL ACAD SCI USA, V100, P8342, DOI 10.1073/pnas.1436338100; YU BD, 1995, NATURE, V378, P505, DOI 10.1038/378505a0; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9	47	137	142	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 25	2010	141	7					1183	U151		10.1016/j.cell.2010.05.016	http://dx.doi.org/10.1016/j.cell.2010.05.016			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20541251	Bronze, Green Accepted			2022-12-01	WOS:000279148100015
J	Ayoya, MA				Ayoya, Mohamed Ag			Personal View G8 leaders must seize their chance to tackle undernutrition	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Unicef Country Off, New Delhi, India		Ayoya, MA (corresponding author), Unicef Country Off, New Delhi, India.	mayoya@unicef.org						Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Unicef, 2009, TRACK PROGR CHILD MA; United Nations, 2008, MILL DEV GOALS REP; Wardlaw T, 2010, LANCET, V375, P870, DOI 10.1016/S0140-6736(09)61798-0; *WHO STAT INF SYST, 2008, DAT AN	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2010	340								c3289	10.1136/bmj.c3289	http://dx.doi.org/10.1136/bmj.c3289			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	618IP	20573765				2022-12-01	WOS:000279346400007
J	Goldkind, SF; Sahin, L; Gallauresi, B				Goldkind, Sara F.; Sahin, Leyla; Gallauresi, Beverly			Enrolling Pregnant Women in Research - Lessons from the H1N1 Influenza Pandemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Goldkind, Sara F.; Gallauresi, Beverly] US FDA, Off Commissioner, Silver Spring, MD USA; [Goldkind, Sara F.] US FDA, Off Good Clin Practice, Silver Spring, MD USA; [Sahin, Leyla] US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Sahin, Leyla] US FDA, Maternal Hlth Team, Silver Spring, MD USA; [Gallauresi, Beverly] US FDA, Off Womens Hlth, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Goldkind, SF (corresponding author), US FDA, Off Commissioner, Silver Spring, MD USA.							Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; Andrew MA, 2007, CLIN PHARMACOL THER, V81, P547, DOI 10.1038/sj.clpt.6100126; Coverdale JH, 2008, OBSTET GYNECOL, V112, P1361, DOI 10.1097/AOG.0b013e31818c2a27; McCullough LB, 2005, AM J OBSTET GYNECOL, V193, P901, DOI 10.1016/j.ajog.2005.06.020; Saleeby E, 2009, OBSTET GYNECOL, V114, P885, DOI 10.1097/AOG.0b013e3181bb44bb	5	63	64	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 17	2010	362	24					2241	2243		10.1056/NEJMp1003462	http://dx.doi.org/10.1056/NEJMp1003462			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611LJ	20554981				2022-12-01	WOS:000278816300001
J	McCartney, M				McCartney, Margaret			Medical Screening Smear fears	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaretmccartney@doctors.org.uk	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				*AM C OBST GYNC, 2009, ACOG PRACT B, P109	1	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 14	2010	340								c2830	10.1136/bmj.c2830	http://dx.doi.org/10.1136/bmj.c2830			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614IZ	20547686				2022-12-01	WOS:000279051600002
J	Baker, M				Baker, Monya			STRUCTURAL BIOLOGY The gatekeepers revealed	NATURE			English	Editorial Material							PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; RESOLUTION; MEMBRANE; RHODOPSIN											Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Oberai A, 2006, PROTEIN SCI, V15, P1723, DOI 10.1110/ps.062109706; Oberai A, 2009, P NATL ACAD SCI USA, V106, P17747, DOI 10.1073/pnas.0906390106; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; SCHERTLER GFX, 1993, NATURE, V362, P770, DOI 10.1038/362770a0; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101	12	13	13	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					823	828		10.1038/465823a	http://dx.doi.org/10.1038/465823a			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535212				2022-12-01	WOS:000278551800054
J	Parvatiyar, K; Harhaj, EW				Parvatiyar, Kislay; Harhaj, Edward W.			Anchors Away for Ubiquitin Chains	SCIENCE			English	Editorial Material							UNANCHORED POLYUBIQUITIN CHAINS; ANTIVIRAL RESPONSES; RIG-I; ACTIVATION; KINASES; LIGASE		[Parvatiyar, Kislay; Harhaj, Edward W.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Miami	Parvatiyar, K (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA.	eharhaj@med.miami.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083143] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM083143, R01 GM083143-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		*EWH, RO1CA135362 EWH NIH; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zeng WW, 2009, MOL CELL, V36, P315, DOI 10.1016/j.molcel.2009.09.037; Zhang MY, 2008, J BIOL CHEM, V283, P18621, DOI 10.1074/jbc.M801451200; Zou WG, 2006, J BIOL CHEM, V281, P3989, DOI 10.1074/jbc.M510787200	11	7	7	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1244	1245		10.1126/science.1192296	http://dx.doi.org/10.1126/science.1192296			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522767	Green Accepted			2022-12-01	WOS:000278318600024
J	Kagey, MH; Newman, JJ; Bilodeau, S; Zhan, Y; Orlando, DA; van Berkum, NL; Ebmeier, CC; Goossens, J; Rahl, PB; Levine, SS; Taatjes, DJ; Dekker, J; Young, RA				Kagey, Michael H.; Newman, Jamie J.; Bilodeau, Steve; Zhan, Ye; Orlando, David A.; van Berkum, Nynke L.; Ebmeier, Christopher C.; Goossens, Jesse; Rahl, Peter B.; Levine, Stuart S.; Taatjes, Dylan J.; Dekker, Job; Young, Richard A.			Mediator and cohesin connect gene expression and chromatin architecture	NATURE			English	Article							EMBRYONIC STEM-CELLS; DE-LANGE-SYNDROME; TRANSCRIPTIONAL REGULATORY CIRCUITRY; INTEGRATION HOST FACTOR; NIPPED-B; COACTIVATOR; ACTIVATION; PROTEINS; COMPLEX; MED12	Transcription factors control cell-specific gene expression programs through interactions with diverse coactivators and the transcription apparatus. Gene activation may involve DNA loop formation between enhancer-bound transcription factors and the transcription apparatus at the core promoter, but this process is not well understood. Here we report that mediator and cohesin physically and functionally connect the enhancers and core promoters of active genes in murine embryonic stem cells. Mediator, a transcriptional coactivator, forms a complex with cohesin, which can form rings that connect two DNA segments. The cohesin-loading factor Nipbl is associated with mediator-cohesin complexes, providing a means to load cohesin at promoters. DNA looping is observed between the enhancers and promoters occupied by mediator and cohesin. Mediator and cohesin co-occupy different promoters in different cells, thus generating cell-type-specific DNA loops linked to the gene expression program of each cell.	[Kagey, Michael H.; Newman, Jamie J.; Bilodeau, Steve; Orlando, David A.; Rahl, Peter B.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Newman, Jamie J.; Levine, Stuart S.; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Zhan, Ye; van Berkum, Nynke L.; Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Zhan, Ye; van Berkum, Nynke L.; Dekker, Job] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Ebmeier, Christopher C.; Goossens, Jesse; Taatjes, Dylan J.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Colorado System; University of Colorado Boulder	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	Dylan.Taatjes@Colorado.EDU; young@wi.mit.edu	Taatjes, Dylan J/G-2027-2011; Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Goossens, Jesse/0000-0002-9078-8182; Bilodeau, Steve/0000-0002-9799-3832; Levine, Stuart/0000-0001-7363-562X	NIH [HG003143, HG002668]; Canadian Institutes of Health Research; American Cancer Society; Keck Distinguished young scholar award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143, R01HG002668] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); American Cancer Society(American Cancer Society); Keck Distinguished young scholar award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank T. Lee for discussions; D. Root, S. Silver, T. Neiland and H. Le at the RNAi Screening Platform at the Broad Institute for screening advice and technical support; and J.-A. Kwon, J. Love, S. Gupta and T. Volkert for assistance with ChIP-Seq. Immunofluorescence images were collected using the W. M. Keck Foundation Biological Imagining Facility at the Whitehead Institute and Whitehead-MIT Bioimaging Center. This work was supported by Susan Whitehead and Landon and Lavinia Clay, an NIH Fellowship (M. H. K.), a Canadian Institutes of Health Research Fellowship (S. B.), the American Cancer Society (D. J. T.), a Keck Distinguished young scholar award (J. D.) and by NIH grants HG003143 (J. D.) and HG002668 (R.A.Y.).	ADHYA S, 1989, ANNU REV GENET, V23, P227, DOI 10.1146/annurev.ge.23.120189.001303; Bose T, 2010, J CELL BIOL, V189, P201, DOI 10.1083/jcb.200912129; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; CLAVERIEMARTIN F, 1991, P NATL ACAD SCI USA, V88, P1631, DOI 10.1073/pnas.88.5.1631; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Dorsett D, 2007, CHROMOSOMA, V116, P1, DOI 10.1007/s00412-006-0072-6; Ebmeier CC, 2010, P NATL ACAD SCI USA, V107, P11283, DOI 10.1073/pnas.0914215107; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; HOOVER TR, 1990, CELL, V63, P11, DOI 10.1016/0092-8674(90)90284-L; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jiang HM, 2008, MOL CELL BIOL, V28, P907, DOI 10.1128/MCB.00909-07; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Liu JL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000119; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luijsterburg MS, 2008, CRIT REV BIOCHEM MOL, V43, P393, DOI [10.1080/10409230802528488, 10.1080/10409230802528488 ]; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; MATTHEWS KS, 1992, MICROBIOL REV, V56, P123, DOI 10.1128/MMBR.56.1.123-136.1992; Miele A, 2008, MOL BIOSYST, V4, P1046, DOI 10.1039/b803580f; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; Philiber RA, 2007, PHARMACOGENOMICS, V8, P909, DOI 10.2217/14622416.8.8.909; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; Ptashne M., 2002, GENES SIGNALS; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Roeder RG, 1998, COLD SPRING HARB SYM, V63, P201, DOI 10.1101/sqb.1998.63.201; Saiz L, 2006, CURR OPIN STRUC BIOL, V16, P344, DOI 10.1016/j.sbi.2006.05.008; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schwartz CE, 2007, J MED GENET, V44, P472, DOI 10.1136/jmg.2006.048637; Strachan T, 2005, CURR OPIN GENET DEV, V15, P258, DOI 10.1016/j.gde.2005.04.005; Taatjes DJ, 2002, SCIENCE, V295, P1058, DOI 10.1126/science.1065249; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wood AJ, 2010, NAT REV GENET, V11, P391, DOI 10.1038/nrg2794; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yeom YI, 1996, DEVELOPMENT, V122, P881	50	1315	1347	2	181	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2010	467	7314					430	435		10.1038/nature09380	http://dx.doi.org/10.1038/nature09380			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KO	20720539	Green Accepted, Green Submitted			2022-12-01	WOS:000282090200036
J	Gao, J; Wang, WY; Mao, YW; Graff, J; Guan, JS; Pan, L; Mak, G; Kim, D; Su, SC; Tsai, LH				Gao, Jun; Wang, Wen-Yuan; Mao, Ying-Wei; Graeff, Johannes; Guan, Ji-Song; Pan, Ling; Mak, Gloria; Kim, Dohoon; Su, Susan C.; Tsai, Li-Huei			A novel pathway regulates memory and plasticity via SIRT1 and miR-134	NATURE			English	Article							LONG-TERM-MEMORY; SYNAPTIC PLASTICITY; BDNF TRANSCRIPTION; NEURONAL-ACTIVITY; CIRCADIAN CONTROL; RECOGNITION; HIPPOCAMPUS; EXPRESSION; NEURODEGENERATION; INHIBITION	The NAD-dependent deacetylase Sir2 was initially identified as a mediator of replicative lifespan in budding yeast and was subsequently shown to modulate longevity in worms and flies(1,2). Its mammalian homologue, SIRT1, seems to have evolved complex systemic roles in cardiac function, DNA repair and genomic stability. Recent studies suggest a functional relevance of SIRT1 in normal brain physiology and neurological disorders. However, it is unknown if SIRT1 has a role in higher-order brain functions. We report that SIRT1 modulates synaptic plasticity and memory formation via a microRNA-mediated mechanism. Activation of SIRT1 enhances, whereas its loss-of-function impairs, synaptic plasticity. Surprisingly, these effects were mediated via post-transcriptional regulation of cAMP response binding protein (CREB) expression by a brain-specific microRNA, miR-134. SIRT1 normally functions to limit expression of miR-134 via a repressor complex containing the transcription factor YY1, and unchecked miR-134 expression following SIRT1 deficiency results in the downregulated expression of CREB and brain-derived neurotrophic factor (BDNF), thereby impairing synaptic plasticity. These findings demonstrate a new role for SIRT1 in cognition and a previously unknown microRNA-based mechanism by which SIRT1 regulates these processes. Furthermore, these results describe a separate branch of SIRT1 signalling, in which SIRT1 has a direct role in regulating normal brain function in a manner that is disparate from its cell survival functions, demonstrating its value as a potential therapeutic target for the treatment of central nervous system disorders.	[Gao, Jun; Wang, Wen-Yuan; Mao, Ying-Wei; Graeff, Johannes; Guan, Ji-Song; Pan, Ling; Mak, Gloria; Kim, Dohoon; Su, Susan C.; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Gao, Jun; Wang, Wen-Yuan; Mao, Ying-Wei; Guan, Ji-Song; Pan, Ling; Mak, Gloria; Kim, Dohoon; Su, Susan C.; Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Gao, Jun] Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing 210061, Peoples R China; [Graeff, Johannes; Tsai, Li-Huei] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Nanjing University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	lhtsai@mit.edu	wang, wenyuan/F-7218-2011; Pan, Ling/K-9333-2013	Pan, Ling/0000-0001-9947-9071; Graff, Johannes/0000-0002-3219-3578; Mao, Yingwei/0000-0001-7339-1565; Gao, Jun/0000-0002-5925-537X; Guan, Ji-Song/0000-0001-5219-0289	NIH [PO1 AG027916]; Simons Foundation; Swiss National Science Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE ON AGING [P01AG027916] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R. Jaenisch and M. Rios for providing BDNF knockout frozen brains, L. Guarente and D. Cohen for providing SIRT1 Delta and SIRT1 knockout mice, Y. Shi for providing the plasmids expressing YY1 and YY1 shRNA, A. Mungenast for manuscript editing, K. Singh and M. Dobbin for critical reading of the manuscript, M. Dobbin for help with Supplementary Fig. 5, X. Ge for help with model illustration, and N. Joseph for help with mouse colony maintenance. This work is partially supported by an NIH grant, PO1 AG027916, to L.-H.T.; W.-Y.W. is supported by a Postdoctoral Fellowship from the Simons Foundation; J.Gr. is supported by a Prospective Researchers Fellowship from the Swiss National Science Foundation; J.Gao is supported by the Howard Hughes Medical Institute. L.-H.T. is an investigator of the Howard Hughes Medical Institute.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chiaruttini C, 2008, MOL CELL NEUROSCI, V37, P11, DOI 10.1016/j.mcn.2007.08.011; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Fanselow MS, 2003, ANN NY ACAD SCI, V985, P125; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fiore R, 2008, BBA-GENE REGUL MECH, V1779, P471, DOI 10.1016/j.bbagrm.2007.12.006; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; SHI Y, 1997, BIOCHIM BIOPHYS ACTA, V1332, P49; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200	30	711	752	6	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2010	466	7310					1105	U120		10.1038/nature09271	http://dx.doi.org/10.1038/nature09271			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20622856	Green Submitted, Green Published, Green Accepted			2022-12-01	WOS:000281203600040
J	Johannes, L; Mayor, S				Johannes, Ludger; Mayor, Satyajit			Induced Domain Formation in Endocytic Invagination, Lipid Sorting, and Scission	CELL			English	Article							CLATHRIN-INDEPENDENT ENDOCYTOSIS; GPI-ANCHORED PROTEINS; PLASMA-MEMBRANE; MEDIATED ENDOCYTOSIS; CURVATURE; ACTIN; VESICLES; DRIVEN; REORGANIZATION; CELL	Lipid segregation occurs in biological membranes, but how this plays into cellular processes like endocytosis has been unclear. Here, we discuss how the active or passive induction of lipid-protein domain formation in membranes can alter membrane mechanics and thus affect processes such as the generation of curvature, the scission of buds and tubules, and lipid sorting.	[Johannes, Ludger] Inst Curie, Ctr Rech, Traff Signaling & Delivery Lab, F-75248 Paris 05, France; [Johannes, Ludger] CNRS, UMR144, F-75700 Paris, France; [Mayor, Satyajit] Natl Ctr Biol Sci, Cellular Org & Signaling Grp, Bangalore 560065, Karnataka, India	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Johannes, L (corresponding author), Inst Curie, Ctr Rech, Traff Signaling & Delivery Lab, F-75248 Paris 05, France.	johannes@curie.fr; mayor@ncbs.res.in	Johannes, Ludger/M-9778-2017; Johannes, Ludger/W-8593-2019	Johannes, Ludger/0000-0002-2168-0004; Johannes, Ludger/0000-0002-2168-0004	Human Frontier Science Program; Indo-French Centre for the Promotion of Advanced Research (CEFIPRA) [3803]	Human Frontier Science Program(Human Frontier Science Program); Indo-French Centre for the Promotion of Advanced Research (CEFIPRA)(French National Research Agency (ANR))	We thank Patricia Bassereau, Madan Rao, Robert Parton, Pierre Sens, Winfried Romer, and Christophe Lamaze for stimulating discussions. The authors are supported by the Human Frontier Science Program and a grant from the Indo-French Centre for the Promotion of Advanced Research (CEFIPRA Project No. 3803).	Allain JM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.158104; Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Baumgart T, 2003, NATURE, V425, P821, DOI 10.1038/nature02013; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Chiantia S, 2007, LANGMUIR, V23, P7659, DOI 10.1021/la7010919; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Heimburg T, 2005, P NATL ACAD SCI USA, V102, P9790, DOI 10.1073/pnas.0503823102; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Howes MT, 2010, CURR OPIN CELL BIOL, V22, P519, DOI 10.1016/j.ceb.2010.04.001; Idrissi FZ, 2008, J CELL BIOL, V180, P1219, DOI 10.1083/jcb.200708060; Johannes L, 2002, TRAFFIC, V3, P443, DOI 10.1034/j.1600-0854.2002.30701.x; JULICHER F, 1993, PHYS REV LETT, V70, P2964, DOI 10.1103/PhysRevLett.70.2964; Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kirchhausen T, 2002, CELL, V109, P413, DOI 10.1016/S0092-8674(02)00751-1; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Liu AP, 2006, BIOPHYS J, V91, P4064, DOI 10.1529/biophysj.106.090852; Liu J, 2006, P NATL ACAD SCI USA, V103, P10277, DOI 10.1073/pnas.0601045103; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000204; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Mukherjee S, 1999, J CELL BIOL, V144, P1271, DOI 10.1083/jcb.144.6.1271; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Polozov IV, 2008, NAT CHEM BIOL, V4, P248, DOI 10.1038/nchembio.77; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Reynwar BJ, 2007, NATURE, V447, P461, DOI 10.1038/nature05840; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Roux A, 2008, CELL, V135, P1163, DOI 10.1016/j.cell.2008.12.003; Sarasij RC, 2007, BIOPHYS J, V92, P3140, DOI 10.1529/biophysj.106.085662; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Sorre B, 2009, P NATL ACAD SCI USA, V106, P5622, DOI 10.1073/pnas.0811243106; Souza CM, 2007, BBA-MOL CELL BIOL L, V1771, P442, DOI 10.1016/j.bbalip.2006.08.006; Tian A, 2009, BIOPHYS J, V96, P2676, DOI 10.1016/j.bpj.2008.11.067; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Windschiegl B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006238	42	57	57	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 20	2010	142	4					507	510		10.1016/j.cell.2010.08.007	http://dx.doi.org/10.1016/j.cell.2010.08.007			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20723749	Bronze			2022-12-01	WOS:000281115900002
J	Park, J; Myong, S; Niedziela-Majka, A; Lee, KS; Yu, J; Lohman, TM; Ha, T				Park, Jeehae; Myong, Sua; Niedziela-Majka, Anita; Lee, Kyung Suk; Yu, Jin; Lohman, Timothy M.; Ha, Taekjip			PcrA Helicase Dismantles RecA Filaments by Reeling in DNA in Uniform Steps	CELL			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI RECBCD; VIRUS NS3 HELICASE; UVRD HELICASE; REP HELICASE; NUCLEOPROTEIN FILAMENTS; UNWINDING MECHANISM; CRYSTAL-STRUCTURES; TRANSLOCATION; RNA	Translocation of helicase-like proteins on nucleic acids underlies key cellular functions. However, it is still unclear how translocation can drive removal of DNA-bound proteins, and basic properties like the elementary step size remain controversial. Using single-molecule fluorescence analysis on a prototypical superfamily 1 helicase, Bacillus stearothermophilus PcrA, we discovered that PcrA preferentially translocates on the DNA lagging strand instead of unwinding the template duplex. PcrA anchors itself to the template duplex using the 2B subdomain and reels in the lagging strand, extruding a single-stranded loop. Static disorder limited previous ensemble studies of a PcrA stepping mechanism. Here, highly repetitive looping revealed that PcrA translocates in uniform steps of 1 nt. This reeling-in activity requires the open conformation of PcrA and can rapidly dismantle a preformed RecA filament even at low PcrA concentrations, suggesting a mode of action for eliminating potentially deleterious recombination intermediates.	[Park, Jeehae; Ha, Taekjip] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Myong, Sua; Ha, Taekjip] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Lee, Kyung Suk; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Lee, Kyung Suk; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Niedziela-Majka, Anita; Lohman, Timothy M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA; [Yu, Jin] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Washington University (WUSTL); Howard Hughes Medical Institute; University of California System; University of California Berkeley	Ha, T (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA.	tjha@illinois.edu	Ha, Taekjip/B-9506-2009; Yu, Jin/X-6895-2019	Ha, Taekjip/0000-0003-2195-6258; Yu, Jin/0000-0001-8224-1374	National Institutes of Health [GM-065367, GM-045948]; National Science Foundation [0822613, 0646550]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367, R01GM045948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Joo, R. Roy, M. Schlierf, S. Syed, M.C. McKinney, M.K. Nahas, B. Okumus, S.A. McKinney, E. Bozek, and J.D. Smith for experimental help; S. Arslan, J. Yodh, H. Balci, I. Cisse, B.C. Stevens, G. Lee, M. Brenner, E. Tomko, C. Fischer, and M. Spies for helpful discussion; I. Cann and his lab for providing Staphylococcus aureus PcrA for the initial studies; R. Pugh for help on ExoIII footprint assay; M. Schlierf, J. Yodh, H. Balci, and E. Tomko for careful reading of the manuscript. Funds were provided by the National Institutes of Health (GM-065367 to T.H. and GM-045948 to T.M.L.) and by the National Science Foundation (0822613 and 0646550 to T.H.). T.H. is an investigator with the Howard Hughes Medical Institute.	Adelman K, 2002, P NATL ACAD SCI USA, V99, P13538, DOI 10.1073/pnas.212358999; Ail JA, 1999, J MOL BIOL, V293, P815, DOI 10.1006/jmbi.1999.3185; Ali JA, 1997, SCIENCE, V275, P377, DOI 10.1126/science.275.5298.377; Anand SP, 2004, NUCLEIC ACIDS RES, V32, P3190, DOI 10.1093/nar/gkh641; Antony E, 2009, MOL CELL, V35, P105, DOI 10.1016/j.molcel.2009.05.026; ARAMENDIA PF, 1994, J PHYS CHEM-US, V98, P3165, DOI 10.1021/j100063a020; Bianco PR, 2001, NATURE, V409, P374, DOI 10.1038/35053131; Bidnenko V, 2006, MOL MICROBIOL, V62, P382, DOI 10.1111/j.1365-2958.2006.05382.x; Brendza KM, 2005, P NATL ACAD SCI USA, V102, P10076, DOI 10.1073/pnas.0502886102; Cheng W, 2002, P NATL ACAD SCI USA, V99, P16006, DOI 10.1073/pnas.242479399; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Dillingham MS, 2002, BIOCHEMISTRY-US, V41, P643, DOI 10.1021/bi011137k; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Eoff RL, 2006, NAT STRUCT MOL BIOL, V13, P242, DOI 10.1038/nsmb1055; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Flores MJ, 2005, MOL MICROBIOL, V57, P1664, DOI 10.1111/j.1365-2958.2005.04753.x; Galletto R, 2004, J MOL BIOL, V343, P83, DOI 10.1016/j.jmb.2004.07.055; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha T, 2002, NATURE, V419, P638, DOI 10.1038/nature01083; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; Korolev S, 1997, CELL, V90, P635, DOI 10.1016/S0092-8674(00)80525-5; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lestini R, 2007, EMBO J, V26, P3804, DOI 10.1038/sj.emboj.7601804; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Lucius AL, 2002, J MOL BIOL, V324, P409, DOI 10.1016/S0022-2836(02)01067-7; Luo G, 2007, P NATL ACAD SCI USA, V104, P12610, DOI 10.1073/pnas.0700920104; MOREL P, 1993, NUCLEIC ACIDS RES, V21, P3205, DOI 10.1093/nar/21.14.3205; Murphy MC, 2004, BIOPHYS J, V86, P2530, DOI 10.1016/S0006-3495(04)74308-8; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Niedziela-Majka A, 2007, J BIOL CHEM, V282, P27076, DOI 10.1074/jbc.M704399200; Perkins TT, 2004, BIOPHYS J, V86, P1640, DOI 10.1016/S0006-3495(04)74232-0; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; RANEY KD, 1995, J BIOL CHEM, V270, P22236, DOI 10.1074/jbc.270.38.22236; Sanborn ME, 2007, J PHYS CHEM B, V111, P11064, DOI 10.1021/jp072912u; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Slatter AF, 2009, BIOCHEMISTRY-US, V48, P6326, DOI 10.1021/bi900101h; Spies M, 2003, CELL, V114, P647, DOI 10.1016/S0092-8674(03)00681-0; Tan E, 2003, P NATL ACAD SCI USA, V100, P9308, DOI 10.1073/pnas.1233536100; Tomko EJ, 2007, MOL CELL, V26, P335, DOI 10.1016/j.molcel.2007.03.024; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Wu CG, 2008, J MOL BIOL, V382, P312, DOI 10.1016/j.jmb.2008.07.012; Yang Y, 2008, NUCLEIC ACIDS RES, V36, P1976, DOI 10.1093/nar/gkm1174; Zhuang XW, 2002, SCIENCE, V296, P1473, DOI 10.1126/science.1069013; ZIEG J, 1978, J BACTERIOL, V134, P958, DOI 10.1128/JB.134.3.958-966.1978	56	133	133	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2010	142	4					544	555		10.1016/j.cell.2010.07.016	http://dx.doi.org/10.1016/j.cell.2010.07.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20723756	Green Accepted, Bronze			2022-12-01	WOS:000281115900009
J	Sigmund, K; De Silva, H; Traulsen, A; Hauert, C				Sigmund, Karl; De Silva, Hannelore; Traulsen, Arne; Hauert, Christoph			Social learning promotes institutions for governing the commons	NATURE			English	Article							PUBLIC-GOODS GAMES; ALTRUISTIC PUNISHMENT; COSTLY PUNISHMENT; COOPERATION; EVOLUTION; RECIPROCITY; ADVANTAGE; SOCIETIES; HUMANS	Theoretical and empirical research highlights the role of punishment in promoting collaborative efforts(1-5). However, both the emergence and the stability of costly punishment are problematic issues. It is not clear how punishers can invade a society of defectors by social learning or natural selection, or how second-order free-riders (who contribute to the joint effort but not to the sanctions) can be prevented from drifting into a coercion-based regime and subverting cooperation. Here we compare the prevailing model of peer-punishment(6-8) with pool-punishment, which consists in committing resources, before the collaborative effort, to prepare sanctions against free-riders. Pool-punishment facilitates the sanctioning of second-order free-riders, because these are exposed even if everyone contributes to the common good. In the absence of such second-order punishment, peer-punishers do better than pool-punishers; but with second-order punishment, the situation is reversed. Efficiency is traded for stability. Neither other-regarding tendencies or preferences for reciprocity and equity, nor group selection or prescriptions from higher authorities, are necessary for the emergence and stability of rudimentary forms of sanctioning institutions regulating common pool resources and enforcing collaborative efforts.	[Sigmund, Karl] Univ Vienna, Fac Math, A-1090 Vienna, Austria; [Sigmund, Karl] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [De Silva, Hannelore] WU Vienna Univ Econ & Business, A-1090 Vienna, Austria; [Traulsen, Arne] Max Planck Inst Evolutionary Biol, D-24306 Plon, Germany; [Hauert, Christoph] Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z2, Canada	University of Vienna; International Institute for Applied Systems Analysis (IIASA); Vienna University of Economics & Business; Max Planck Society; University of British Columbia	Sigmund, K (corresponding author), Univ Vienna, Fac Math, Waehringer Guertel 18, A-1090 Vienna, Austria.	karl.sigmund@univie.ac.at	Hauert, Christoph/E-5369-2011; Traulsen, Arne/A-4955-2009	Hauert, Christoph/0000-0002-1239-281X; Traulsen, Arne/0000-0002-0669-5267				Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Egas M, 2008, P ROY SOC B-BIOL SCI, V275, P871, DOI 10.1098/rspb.2007.1558; Ertan A, 2009, EUR ECON REV, V53, P495, DOI 10.1016/j.euroecorev.2008.09.007; Falk A, 2002, DRAMA COMMONS, P157; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V422, P137, DOI 10.1038/nature01474; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; FRANK SA, 1995, NATURE, V377, P520, DOI 10.1038/377520a0; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Gardner A, 2004, AM NAT, V164, P753, DOI 10.1086/425623; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Kiyonari T, 2004, INT J PSYCHOL, V39, P329; Kosfeld M, 2009, AM ECON REV, V99, P1335, DOI 10.1257/aer.99.4.1335; Lehmann L, 2007, AM NAT, V170, P21, DOI 10.1086/518568; Levin SA, 2009, SPRINGER SER GAME TH, P1, DOI 10.1007/978-3-540-85436-4; Mathew S, 2009, P R SOC B, V276, P1167, DOI 10.1098/rspb.2008.1623; Maynard Smith J., 1997, MAJOR TRANSITIONS EV; Nakamaru M, 2006, J THEOR BIOL, V240, P475, DOI 10.1016/j.jtbi.2005.10.011; ORBELL JM, 1993, AM SOCIOL REV, V58, P787, DOI 10.2307/2095951; Ostrom E., 1992, CRAFTING I SELF GOVE; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Semmann D, 2003, NATURE, V425, P390, DOI 10.1038/nature01986; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110	30	334	340	7	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2010	466	7308					861	863		10.1038/nature09203	http://dx.doi.org/10.1038/nature09203			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	636TT	20631710	Green Submitted			2022-12-01	WOS:000280766100035
J	Zhang, APP; Pigli, YZ; Rice, PA				Zhang, Adrianna P. P.; Pigli, Ying Z.; Rice, Phoebe A.			Structure of the LexA-DNA complex and implications for SOS box measurement	NATURE			English	Article							NONCONTACTED BASES; CRYSTAL-STRUCTURE; OPERATOR COMPLEX; BINDING DOMAIN; REPRESSOR; PROTEIN; AFFINITY; IDENTIFICATION; ROTATION; CONTACTS	The eubacterial SOS system is a paradigm of cellular DNA damage and repair, and its activation can contribute to antibiotic resistance(1-3). Under normal conditions, LexA represses the transcription of many DNA repair proteins by binding to SOS 'boxes' in their operators. Under genotoxic stress, accumulating complexes of RecA, ATP and single-stranded DNA (ssDNA) activate LexA for autocleavage. To address how LexA recognizes its binding sites, we determined three crystal structures of Escherichia coli LexA in complex with SOS boxes. Here we report the structure of these LexA-DNA complexes. The DNA-binding domains of the LexA dimer interact with the DNA in the classical fashion of a winged helix-turn-helix motif. However, the wings of these two DNA-binding domains bind to the same minor groove of the DNA. These wing-wing contacts may explain why the spacing between the two half-sites of E. coli SOS boxes is invariant.	[Pigli, Ying Z.; Rice, Phoebe A.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Zhang, Adrianna P. P.] Univ Chicago, Dept Chem, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Rice, PA (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.	price@uchicago.edu			National Institutes of Health [GM058827]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Harris and O. Adekeye for help with crystal growth and optimization; Y.-L.C. Leung for advice on DNA-binding assays; S. Montano and other members of the Rice laboratory for help and discussions; the staffs at beamlines BioCARS 14, SBC 19-ID and 19-BM, and LS-CAT 21-ID-F at the Advanced Photon Source, Argonne National Laboratory, for helping with the synchrotron X-ray data collection. The research is supported in part by National Institutes of Health grant GM058827.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butala M, 2009, CELL MOL LIFE SCI, V66, P82, DOI 10.1007/s00018-008-8378-6; Butala M, 2007, FEBS LETT, V581, P4816, DOI 10.1016/j.febslet.2007.09.006; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; DUMOULIN P, 1993, P NATL ACAD SCI USA, V90, P2030, DOI 10.1073/pnas.90.5.2030; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; Garnett JA, 2008, J MOL BIOL, V379, P284, DOI 10.1016/j.jmb.2008.03.007; Giese KC, 2008, J MOL BIOL, V377, P148, DOI 10.1016/j.jmb.2007.12.025; Groban ES, 2005, NUCLEIC ACIDS RES, V33, P6287, DOI 10.1093/nar/gki939; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; HURSTEL S, 1988, EMBO J, V7, P269, DOI 10.1002/j.1460-2075.1988.tb02809.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KNEGTEL RMA, 1995, PROTEINS, V21, P226, DOI 10.1002/prot.340210305; KOUDELKA GB, 1992, NATURE, V355, P89, DOI 10.1038/355089a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEWIS LK, 1994, J MOL BIOL, V241, P507, DOI 10.1006/jmbi.1994.1528; Littlefield O, 1999, NAT STRUCT BIOL, V6, P464; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mohana-Borges R, 2000, J BIOL CHEM, V275, P4708, DOI 10.1074/jbc.275.7.4708; Neher SB, 2003, GENE DEV, V17, P1084, DOI 10.1101/gad.1078003; OERTELBUCHHEIT P, 1990, MOL GEN GENET, V223, P40, DOI 10.1007/BF00315795; OERTELBUCHHEIT P, 1992, J MOL BIOL, V225, P609, DOI 10.1016/0022-2836(92)90389-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Shinagawa H, 1996, EXS, V77, P221; THLIVERIS AT, 1992, P NATL ACAD SCI USA, V89, P4500, DOI 10.1073/pnas.89.10.4500; THLIVERIS AT, 1991, BIOCHIMIE, V73, P449, DOI 10.1016/0300-9084(91)90112-E; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wade JT, 2005, GENE DEV, V19, P2619, DOI 10.1101/gad.1355605; WALKER GC, 1985, ANNU REV BIOCHEM, V54, P425, DOI 10.1146/annurev.bi.54.070185.002233; WU L, 1992, J BIOL CHEM, V267, P9134	39	69	76	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2010	466	7308					883	U119		10.1038/nature09200	http://dx.doi.org/10.1038/nature09200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20703307	Green Accepted			2022-12-01	WOS:000280766100040
J	Autier, P; Boniol, M; LaVecchia, C; Vatten, L; Gavin, A; Hery, C; Heanue, M				Autier, Philippe; Boniol, Mathieu; LaVecchia, Carlo; Vatten, Lars; Gavin, Anna; Hery, Clarisse; Heanue, Mary			Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CALMAN-HINE REPORT; RISK-FACTORS; TUMOR CHARACTERISTICS; SCREENING-PROGRAMS; TIME TRENDS; SURVIVAL; IMPACT; WOMEN; RATES; STAGE	Objective To examine changes in temporal trends in breast cancer mortality in women living in 30 European countries. Design Retrospective trend analysis. Data source WHO mortality database on causes of deaths Subjects reviewed Female deaths from breast cancer from 1989 to 2006 Main outcome measures Changes in breast cancer mortality for all women and by age group (<50, 50-69, and >= 70 years) calculated from linear regressions of log transformed, age adjusted death rates. Joinpoint analysis was used to identify the year when trends in all age mortality began to change. Results From 1989 to 2006, there was a median reduction in breast cancer mortality of 19%, ranging from a 45% reduction in Iceland to a 17% increase in Romania. Breast cancer mortality decreased by >= 20% in 15 countries, and the reduction tended to be greater in countries with higher mortality in 1987-9. England and Wales, Northern Ireland, and Scotland had the second, third, and fourth largest decreases of 35%, 29%, and 30%, respectively. In France, Finland, and Sweden, mortality decreased by 11%, 12%, and 16%, respectively. In central European countries mortality did not decline or even increased during the period. Downward mortality trends usually started between 1988 and 1996, and the persistent reduction from 1999 to 2006 indicates that these trends may continue. The median changes in the age groups were -37% (range -76% to -14%) in women aged <50, -21% (-40% to 14%) in 50-69 year olds, and -2% (-42% to 80%) in >= 70 year olds. Conclusions Changes in breast cancer mortality after 1988 varied widely between European countries, and the UK is among the countries with the largest reductions. Women aged <50 years showed the greatest reductions in mortality, also in countries where screening at that age is uncommon. The increasing mortality in some central European countries reflects avoidable mortality.	[Autier, Philippe; Boniol, Mathieu] Int Prevent Res Inst, F-69006 Lyon, France; [Autier, Philippe; Boniol, Mathieu; Hery, Clarisse; Heanue, Mary] Int Agcy Res Canc, F-69372 Lyon, France; [LaVecchia, Carlo] Univ Milan, Mario Negri Inst, Milan, Italy; [LaVecchia, Carlo] Univ Milan, Sch Med, Milan, Italy; [Vatten, Lars] Norwegian Univ Sci & Technol, Dept Publ Hlth, N-7034 Trondheim, Norway; [Gavin, Anna] Queens Univ, No Ireland Canc Registry, Belfast, Antrim, North Ireland	World Health Organization; International Agency for Research on Cancer (IARC); Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan; University of Milan; Norwegian University of Science & Technology (NTNU); Queens University Belfast	Autier, P (corresponding author), Int Prevent Res Inst, 95 Cours Lafayette, F-69006 Lyon, France.	philippe.autier@i-pri.org	Autier, Philippe/A-4402-2014; Vatten, Lars/AFK-2073-2022; Vatten, Lars/AAF-9380-2022; Boniol, Mathieu/F-9623-2011	Autier, Philippe/0000-0003-1538-5321; Boniol, Mathieu/0000-0003-1052-5604; La Vecchia, Carlo/0000-0003-1441-897X	Public Health Agency for Northern Ireland	Public Health Agency for Northern Ireland	Institutions in which authors work had no influence in the conduct of the research or in the writing of the paper. The work of the Northern Ireland Cancer Registry is funded by the Public Health Agency for Northern Ireland	ABADIE C, 2002, REV MED ASS MALADIE, V33, P267; [Anonymous], 2007, LANCET, V369, P1665, DOI 10.1093/annonc/mdm096; [Anonymous], 1988, NEW ENGL J MED, V319, P1681; AUGUST DA, 1994, ANN SURG ONCOL, V1, P45, DOI 10.1007/BF02303540; Autier P, 2008, BRIT J CANCER, V99, P1185, DOI 10.1038/sj.bjc.6604657; Autier P, 2007, LANCET ONCOL, V8, P1050, DOI 10.1016/S1470-2045(07)70354-6; Autier P, 2009, J CLIN ONCOL, V27, P5919, DOI 10.1200/JCO.2009.22.7041; Barnett GC, 2008, J CLIN ONCOL, V26, P3310, DOI 10.1200/JCO.2006.10.3168; Bernardi D, 2008, ACTA ONCOL, V47, P187, DOI 10.1080/02841860701630234; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; Bradburn MJ, 1998, BRIT J CANCER, V77, P1944, DOI 10.1038/bjc.1998.322; Burke JP, 2008, EJSO-EUR J SURG ONC, V34, P149, DOI 10.1016/j.ejso.2007.03.025; Chiu C, 2006, CANCER CAUSE CONTROL, V17, P153, DOI 10.1007/s10552-005-2368-x; Coebergh JW, 2008, EUR J CANCER, V44, P1341, DOI 10.1016/j.ejca.2008.04.010; DAY NE, 1989, BRIT J CANCER, V59, P954, DOI 10.1038/bjc.1989.203; Doll R, 1981, CAUSES CANC; Duffy SW, 2006, CANCER EPIDEM BIOMAR, V15, P45, DOI 10.1158/1055-9965.EPI-05-0349; Duffy SW, 2006, CANCER EPIDEM BIOMAR, V15, P52, DOI 10.1158/1055-9965.EPI-05-0953; Eaker S, 2006, PLOS MED, V3, P321, DOI 10.1371/journal.pmed.0030025; *EUR COMM, 2008, CANC SCREEN EUR UN E; Fracheboud J, 2004, BRIT J CANCER, V91, P861, DOI 10.1038/sj.bjc.6602075; Fritsch B, 2007, PRESSE MED, V36, P1712, DOI 10.1016/j.lpm.2007.03.046; Hermon C, 1996, BRIT J CANCER, V73, P955, DOI 10.1038/bjc.1996.171; Hery C, 2008, ANN ONCOL, V19, P1009, DOI 10.1093/annonc/mdm593; Hery C, 2008, ANN ONCOL, V19, P1187, DOI 10.1093/annonc/mdn025; Hofvind S, 2008, ACTA ONCOL, V47, P225, DOI 10.1080/02841860701518041; Jemal A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1672; Jonsson B, 2007, ANN ONCOL, V18, P1, DOI 10.1093/annonc/mdm095; Jonsson B, 2009, EUR J CANCER, V45, P1100, DOI 10.1016/j.ejca.2009.01.035; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Klug SJ, 2005, EUR J PUBLIC HEALTH, V15, P70, DOI 10.1093/eurpub/cki118; Kumle M, 2008, LANCET, V372, P608, DOI 10.1016/S0140-6736(08)61255-6; Levi F, 2005, EUR J CANCER PREV, V14, P497, DOI 10.1097/00008469-200512000-00002; Lutz JM, 2004, EUR J CANCER PREV, V13, P77, DOI 10.1097/00008469-200402000-00012; Madhavan KS, 2002, BREAST, V11, P265, DOI 10.1054/brst.2001.0410; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; McCann J, 1998, J MED SCREEN, V5, P42, DOI 10.1136/jms.5.1.42; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Micheli A, 2003, ANN ONCOL, V14, pV41, DOI 10.1093/annonc/mdg753; Monaghan P, 2005, J PUBLIC HEALTH, V27, P171, DOI 10.1093/pubmed/fdi003; Morrell S, 2010, CANCER CAUSE CONTROL, V21, P275, DOI 10.1007/s10552-009-9459-z; Morris E, 2008, ANN ONCOL, V19, P284, DOI 10.1093/annonc/mdm432; Morris E, 2007, EUR J CANCER CARE, V16, P150, DOI 10.1111/j.1365-2354.2006.00723.x; *NAT CANC I, 2009, JOIPOINT REGR PROGR; *NAT EV TEAM BREAS, 2005, NAT EV BREAST CANC S; NYSTROM L, 1995, ACTA ONCOL, V34, P145, DOI 10.3109/02841869509093948; Pisani P, 2004, BRIT J CANCER, V90, P652, DOI 10.1038/sj.bjc.6601614; Ray-Coquard I, 2005, J CLIN ONCOL, V23, P4414, DOI 10.1200/JCO.2005.01.040; Siebel Marisa F, 2005, Curr Oncol Rep, V7, P23, DOI 10.1007/s11912-005-0022-0; Sobotka T, 2003, POPULATION, V58, P511, DOI 10.2307/3271307; Spyckerelle Y, 2002, B CANCER, V89, P957; Sukel MPP, 2008, EUR J CANCER, V44, P1846, DOI 10.1016/j.ejca.2008.06.001; Valentini M, 1999, ANN ONCOL, V10, P789, DOI 10.1023/A:1008355014886; Veronesi U, 2005, LANCET, V365, P1727, DOI 10.1016/S0140-6736(05)66546-4; Vervoort MM, 2004, BRIT J CANCER, V91, P242, DOI 10.1038/sj.bjc.6601969; Waterhouse J., 1976, IARC SCI PUBLICATION, V15; *WOM HLTH COUNC, 2008, BREAT CANC TREATM RE; World Health Organization, 2009, MORT DAT; World Health Organization, 2009, WHO STAT INF SYST; Zahl PH, 2008, ARCH INTERN MED, V168, P2311, DOI 10.1001/archinte.168.21.2311; 2007, LANCET ONCOL, V8, P747	62	245	251	3	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2010	341								c3620	10.1136/bmj.c3620	http://dx.doi.org/10.1136/bmj.c3620			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	640DR	20702548	hybrid, Green Published			2022-12-01	WOS:000281028900002
J	Conacci-Sorrell, M; Ngouenet, C; Eisenman, RN				Conacci-Sorrell, Maralice; Ngouenet, Celine; Eisenman, Robert N.			Myc-Nick: A Cytoplasmic Cleavage Product of Myc that Promotes alpha-Tubulin Acetylation and Cell Differentiation	CELL			English	Article							C-MYC; IN-VIVO; CYTOSKELETAL ORGANIZATION; ESSENTIAL COFACTOR; SELF-RENEWAL; STEM-CELLS; PROTEIN; CALPAIN; TRANSCRIPTION; INVOLVEMENT	The Myc oncoprotein family comprises transcription factors that control multiple cellular functions and are widely involved in oncogenesis. Here we report the identification of Myc-nick, a cytoplasmic form of Myc generated by calpain-dependent proteolysis at lysine 298 of full-length Myc. Myc-nick retains conserved Myc box regions but lacks nuclear localization signals and the bHLHZ domain essential for heterodimerization with Max and DNA binding. Myc-nick induces alpha-tubulin acetylation and altered cell morphology by recruiting histone acetyltransferase GCN5 to microtubules. During muscle differentiation, while the levels of full-length Myc diminish, Myc-nick and acetylated alpha-tubulin levels are increased. Ectopic expression of Myc-nick accelerates myoblast fusion, triggers the expression of myogenic markers, and permits Myc-deficient fibroblasts to transdifferentiate in response to MyoD. We propose that the cleavage of Myc by calpain abrogates the transcriptional inhibition of differentiation by fulllength Myc and generates Myc-nick, a driver of cytoplasmic reorganization and differentiation.	[Conacci-Sorrell, Maralice; Ngouenet, Celine; Eisenman, Robert N.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Eisenman, RN (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	eisenman@fhcrc.org	Sorrell, Maralice/ABD-6764-2021		EMBO; NIH/NCI [CA20525]; NATIONAL CANCER INSTITUTE [R01CA020525, R37CA020525] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Nao Ikegaki, William Tansey, John Sedivy, and Peter Hurlin for reagents essential for this work. We also thank Stephen Tapscott, Maura Parker, Hector Rincon, Bill Carter, Linda Wordeman, and members of the Eisenman lab for advice and discussion. M.C.-S. was a recipient of an EMBO Long-Term Fellowship. This work was supported by NIH/NCI grant CA20525 (R.N.E.).	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; ALEXANDROVA N, 1995, MOL CELL BIOL, V15, P5188; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; BAI MK, 1994, ONCOLOGY, V51, P314; Calcagno DQ, 2009, ANTICANCER RES, V29, P2479; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Clement CA, 2009, J CELL SCI, V122, P3070, DOI 10.1242/jcs.049676; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Dedieu S, 2004, EXP CELL RES, V292, P187, DOI 10.1016/j.yexcr.2003.08.014; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Faiola F, 2005, MOL CELL BIOL, V25, P10220, DOI 10.1128/MCB.25.23.10220-10234.2005; Frank SR, 2003, EMBO REP, V4, P575, DOI 10.1038/sj.embor.embor861; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gebhardt A, 2006, J CELL BIOL, V172, P139, DOI 10.1083/jcb.200506057; Gonen H, 1997, FEBS LETT, V406, P17, DOI 10.1016/S0014-5793(97)00225-1; GUNDERSEN GG, 1989, J CELL BIOL, V109, P2275, DOI 10.1083/jcb.109.5.2275; Habib T, 2007, J CELL BIOL, V179, P717, DOI 10.1083/jcb.200704173; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Iezzi S, 2004, DEV CELL, V6, P673, DOI 10.1016/S1534-5807(04)00107-8; Ivanov AI, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-12; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kleine-Kohlbrecher D, 2006, CURR TOP MICROBIOL, V302, P51; Koch HB, 2007, CELL CYCLE, V6, P205, DOI 10.4161/cc.6.2.3742; KUMAR A, 1992, CELL MOL BIOL, V38, P477; Mailhes John B, 2002, Cell Chromosome, V1, P2, DOI 10.1186/1475-9268-1-2; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Moyen C, 2004, INT J BIOCHEM CELL B, V36, P728, DOI 10.1016/S1357-2725(03)00265-6; Niklinski J, 2000, MOL CELL BIOL, V20, P5276, DOI 10.1128/MCB.20.14.5276-5284.2000; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Okano HJ, 1999, GENE DEV, V13, P2087, DOI 10.1101/gad.13.16.2087; PIETILAINEN T, 1995, ANTICANCER RES, V15, P959; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Small GW, 2002, ARCH BIOCHEM BIOPHYS, V400, P151, DOI 10.1016/S0003-9861(02)00005-X; Spotts GD, 1997, MOL CELL BIOL, V17, P1459, DOI 10.1128/MCB.17.3.1459; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Taira T, 1998, GENES CELLS, V3, P549, DOI 10.1046/j.1365-2443.1998.00206.x; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Tonami K, 2007, MOL CELL BIOL, V27, P2548, DOI 10.1128/MCB.00992-06; Tworkowski KA, 2002, ONCOGENE, V21, P8515, DOI 10.1038/sj.onc.1205976; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; WAKAMATSU Y, 1993, NEURON, V10, P1, DOI 10.1016/0896-6273(93)90236-K; Wakamatsu Y, 1997, DEVELOPMENT, V124, P1953; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Xiao QR, 1998, GENE DEV, V12, P3803, DOI 10.1101/gad.12.24.3803; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482	51	159	163	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					480	493		10.1016/j.cell.2010.06.037	http://dx.doi.org/10.1016/j.cell.2010.06.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691906	Green Accepted, Bronze			2022-12-01	WOS:000280609100024
J	Rama, P; Matuska, S; Paganoni, G; Spinelli, A; De Luca, M; Pellegrini, G				Rama, Paolo; Matuska, Stanislav; Paganoni, Giorgio; Spinelli, Alessandra; De Luca, Michele; Pellegrini, Graziella			Limbal Stem-Cell Therapy and Long-Term Corneal Regeneration	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN OCULAR SURFACE; CULTURED EPITHELIUM; TRANSPLANTATION; FIBRIN; BURNS; P63; KERATINOCYTES; ISOFORMS; CYCLE	BACKGROUND Corneal renewal and repair are mediated by stem cells of the limbus, the narrow zone between the cornea and the bulbar conjunctiva. Ocular burns may destroy the limbus, causing limbal stem-cell deficiency. We investigated the long-term clinical results of cell therapy in patients with burn-related corneal destruction associated with limbal stem-cell deficiency, a highly disabling ocular disease. METHODS We used autologous limbal stem cells cultivated on fibrin to treat 112 patients with corneal damage, most of whom had burn-dependent limbal stem-cell deficiency. Clinical results were assessed by means of Kaplan-Meier, Kruskal-Wallis, and univariate and multivariate logistic-regression analyses. We also assessed the clinical outcome according to the percentage of holoclone-forming stem cells, detected as cells that stain intensely (p63-bright cells) in the cultures. RESULTS Permanent restoration of a transparent, renewing corneal epithelium was attained in 76.6% of eyes. The failures occurred within the first year. Restored eyes remained stable over time, with up to 10 years of follow-up (mean, 2.91 +/- 1.99; median, 1.93). In post hoc analyses, success - that is, the generation of normal epithelium on donor stroma - was associated with the percentage of p63-bright holoclone-forming stem cells in culture. Cultures in which p63-bright cells constituted more than 3% of the total number of clonogenic cells were associated with successful transplantation in 78% of patients. In contrast, cultures in which such cells made up 3% or less of the total number of cells were associated with successful transplantation in only 11% of patients. Graft failure was also associated with the type of initial ocular damage and postoperative complications. CONCLUSIONS Cultures of limbal stem cells represent a source of cells for transplantation in the treatment of destruction of the human cornea due to burns.	[De Luca, Michele; Pellegrini, Graziella] Univ Modena & Reggio Emilia, Ctr Regenerat Med Stefano Ferrari, Modena, Italy; [Rama, Paolo; Matuska, Stanislav; Paganoni, Giorgio; Spinelli, Alessandra] Ist Sci San Raffaele, Ophthalmol Unit, I-20132 Milan, Italy	Universita di Modena e Reggio Emilia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Pellegrini, G (corresponding author), Univ Modena & Reggio Emilia, Ctr Regenerat Med Stefano Ferrari, Via Glauco Gottardi 100, Modena, Italy.	graziella.pellegrini@unimore.it	Pellegrini, Graziella/E-1189-2015; De Luca, Michele/N-5883-2014; Rama, Paolo/S-5150-2019; Spinelli, Antonello E/K-1256-2018	Pellegrini, Graziella/0000-0001-9861-0736; De Luca, Michele/0000-0002-0850-8445; Rama, Paolo/0000-0002-2429-159X; Spinelli, Antonello E/0000-0001-5762-3426	Italian Ministry for Education, University and Research and Ministry of Health; l'Association Francaise contre les Myopathies et les Maladies Neuromusculaires (AFM) Telethon; European Commission; Optimization of Stem Cell Therapy for Degenerative Epithelial and Muscle Diseases (OptiStem) [HEALTH-F5-2009-223098]; Regione Emilia-Romagna	Italian Ministry for Education, University and Research and Ministry of Health(Ministry of Education, Universities and Research (MIUR)); l'Association Francaise contre les Myopathies et les Maladies Neuromusculaires (AFM) Telethon(Association Francaise contre les Myopathies); European Commission(European CommissionEuropean Commission Joint Research Centre); Optimization of Stem Cell Therapy for Degenerative Epithelial and Muscle Diseases (OptiStem); Regione Emilia-Romagna(Regione Emilia Romagna)	Supported by grants from the Italian Ministry for Education, University and Research and Ministry of Health; l'Association Francaise contre les Myopathies et les Maladies Neuromusculaires (AFM) Telethon; the European Commission Sixth Framework Program for Research and Technological Development (corneal engineering) and Seventh Framework Program; Optimization of Stem Cell Therapy for Degenerative Epithelial and Muscle Diseases (OptiStem, HEALTH-F5-2009-223098); Regione Emilia-Romagna (area 1b, medicina rigenerativa); and the Italian Ministry of Health.	Barbaro V, 2007, J CELL BIOL, V177, P1037, DOI 10.1083/jcb.200703003; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Daya SM, 2005, OPHTHALMOLOGY, V112, P470, DOI 10.1016/j.ophtha.2004.09.023; De Luca M, 2006, REGEN MED, V1, P45, DOI 10.2217/17460751.1.1.45; DELUCA M, 1989, BURNS, V15, P303, DOI 10.1016/0305-4179(89)90007-7; DELUCA M, 1992, ARCH DERMATOL, V128, P633, DOI 10.1001/archderm.128.5.633; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; Di Iorio E, 2006, MICROSC RES TECHNIQ, V69, P983, DOI 10.1002/jemt.20375; Dua HS, 2000, SURV OPHTHALMOL, V44, P415, DOI 10.1016/S0039-6257(00)00109-0; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665; Green H, 2008, BIOESSAYS, V30, P897, DOI 10.1002/bies.20797; Henderson TRM, 2001, BRIT J OPHTHALMOL, V85, P604, DOI 10.1136/bjo.85.5.604; KENYON KR, 1989, OPHTHALMOLOGY, V96, P709; LINDBERG K, 1993, INVEST OPHTH VIS SCI, V34, P2672; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Pellegrini G, 1999, TRANSPLANTATION, V68, P868, DOI 10.1097/00007890-199909270-00021; Pellegrini G, 2004, NEW ENGL J MED, V351, P1170, DOI 10.1056/NEJMp048199; Pellegrini G, 2009, J PATHOL, V217, P217, DOI 10.1002/path.2441; Rama P, 2001, TRANSPLANTATION, V72, P1478, DOI 10.1097/00007890-200111150-00002; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Ronfard V, 2000, TRANSPLANTATION, V70, P1588, DOI 10.1097/00007890-200012150-00009; Schwab IR, 2006, ARCH OPHTHALMOL-CHIC, V124, P1734, DOI 10.1001/archopht.124.12.1734; Shortt AJ, 2007, SURV OPHTHALMOL, V52, P483, DOI 10.1016/j.survophthal.2007.06.013; Wagoner MD, 1997, SURV OPHTHALMOL, V41, P275, DOI 10.1016/S0039-6257(96)00007-0; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	30	774	811	2	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 8	2010	363	2					147	155		10.1056/NEJMoa0905955	http://dx.doi.org/10.1056/NEJMoa0905955			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621JY	20573916	Green Published			2022-12-01	WOS:000279574100007
J	Kerr, E; Arulraj, N; Scott, M; McDowall, M; van Dijke, M; Keir, S; Sandercock, P; Dennis, M				Kerr, Enda; Arulraj, Nolan; Scott, Maggie; McDowall, Mike; van Dijke, Margrethe; Keir, Sarah; Sandercock, Peter; Dennis, Martin			Quality Improvement Report A telephone hotline for transient ischaemic attack and stroke: prospective audit of a model to improve rapid access to specialist stroke care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK	Problem Patients with transient ischaemic attack or stroke benefit from early diagnosis, specialist assessment, and treatment with thrombolysis, and from stroke unit care and secondary prevention. The challenge with such patients is to minimise delays and ensure that treatment is appropriate, and to provide this care with the available resources. Design An ongoing prospective audit of a transient ischaemic attack and stroke clinic (1 January 2005 to 30 September 2009), as part of the Scottish Stroke Care Audit, and a three month targeted audit of immediate telephone access to a specialist stroke consultant (1 February 2009 to 30 April 2009). Setting Stroke and transient ischaemic attack services in Lothian, a region of Scotland with a population of 810 000. Key measures for improvement Delays to assessment at a rapid access transient ischaemic attack and stroke clinic; delays to appropriate treatment. Strategy for change In February 2007 we introduced a 24 hours a day, seven days a week hotline to a consultant, who provided immediate advice on diagnosis, investigation, and emergency treatment for patients with transient ischaemic attack or stroke, and suggested the most appropriate care pathway, which might include an early appointment in a transient ischaemic attack and stroke clinic. Effects of change The introduction of the hotline was associated with an immediate and sustained reduction in delays to assessment (from 13 to three days) and treatment. The proportion of participants taking statins at the time of visiting the clinic increased from 40% before the introduction of the hotline to 60% after the hotline was in place. Also, the hotline contributed to a reduction in the delay from last event to carotid surgery, from 58 days to 21.5 days. A total of 376 calls were received during the three month audit. Of the 273 (88%) referrers who responded to our questionnaire, 257 (94%) were very satisfied with the advice given over the hotline. Lessons learnt Although associated with some disruption to the activities of the consultants, a 24 hours a day, seven days a week telephone hotline to a consultant is a feasible and effective means of reducing delays to specialist assessment and treatment of patients with transient ischaemic attack or stroke.	[Scott, Maggie; Dennis, Martin] Western Gen Hosp, Dept Clin Neurosci, Transient Ischaem Attack Clin, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Dennis, M (corresponding author), Western Gen Hosp, Dept Clin Neurosci, Transient Ischaem Attack Clin, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	martin.dennis@ed.ac.uk		dennis, martin/0000-0003-1148-8972; Sandercock, Peter/0000-0001-8484-0135				Department of Health, 2007, NAT STROK STRAT; Giles MF, 2007, LANCET NEUROL, V6, P1063, DOI 10.1016/S1474-4422(07)70274-0; Henderson GR, 2008, QUAL SAF HEALTH CARE, V17, P301, DOI 10.1136/qshc.2006.020784; Johnston SC, 2006, ANN NEUROL, V60, P301, DOI 10.1002/ana.20942; Kennedy J, 2007, LANCET NEUROL, V6, P961, DOI 10.1016/S1474-4422(07)70250-8; Lavallee PC, 2007, LANCET NEUROL, V6, P953, DOI 10.1016/S1474-4422(07)70248-X; *NAT AUD OFF, 2005, 452 HC NAT AUD OFF; National Institute for Health and Clinical Excellence, 2008, DIAGN IN MAN AC STRO; *NHS QUAL IMPR SCO, 2004, CLIN STAND STROK SER; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; Royal College of Physicians of England and Wales, 2007, NAT SENT STROK AUD 2; *SCOTT STROK CAR A, 2009, 2009 NAT REP STROK S; *STROK FDN NZ INC, 2008, NZ GUID ASS MAN PAT	14	9	9	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2010	341								c3265	10.1136/bmj.c3265	http://dx.doi.org/10.1136/bmj.c3265			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NY	20601699				2022-12-01	WOS:000279586800001
J	Glover, JD; Reganold, JP; Bell, LW; Borevitz, J; Brummer, EC; Buckler, ES; Cox, CM; Cox, TS; Crews, TE; Culman, SW; DeHaan, LR; Eriksson, D; Gill, BS; Holland, J; Hu, F; Hulke, BS; Ibrahim, AMH; Jackson, W; Jones, SS; Murray, SC; Paterson, AH; Ploschuk, E; Sacks, EJ; Snapp, S; Tao, D; Van Tassel, DL; Wade, LJ; Wyse, DL; Xu, Y				Glover, J. D.; Reganold, J. P.; Bell, L. W.; Borevitz, J.; Brummer, E. C.; Buckler, E. S.; Cox, C. M.; Cox, T. S.; Crews, T. E.; Culman, S. W.; DeHaan, L. R.; Eriksson, D.; Gill, B. S.; Holland, J.; Hu, F.; Hulke, B. S.; Ibrahim, A. M. H.; Jackson, W.; Jones, S. S.; Murray, S. C.; Paterson, A. H.; Ploschuk, E.; Sacks, E. J.; Snapp, S.; Tao, D.; Van Tassel, D. L.; Wade, L. J.; Wyse, D. L.; Xu, Y.			Increased Food and Ecosystem Security via Perennial Grains	SCIENCE			English	Editorial Material									[Glover, J. D.; Cox, C. M.; Cox, T. S.; DeHaan, L. R.; Jackson, W.; Van Tassel, D. L.] Land Inst, Salina, KS 67401 USA; [Reganold, J. P.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Bell, L. W.] Commonwealth Sci & Ind Res Org Australia, Sustainable Ecosyst Agr Prod Syst Res Unit, Toowoomba, Qld 4350, Australia; [Borevitz, J.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Brummer, E. C.] Univ Georgia, Inst Plant Breeding Genet & Genom, Athens, GA 30602 USA; [Buckler, E. S.] ARS, USDA, Ithaca, NY 14853 USA; [Buckler, E. S.] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Crews, T. E.] Prescott Coll, Prescott, AZ 86301 USA; [Culman, S. W.; Snapp, S.] Michigan State Univ, Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Eriksson, D.] Swedish Univ Agr Sci, Dept Plant Breeding & Biotechnol, Alnarp, Sweden; [Gill, B. S.] Kansas State Univ, Wheat Genet & Genom Resources Ctr, Manhattan, KS 66506 USA; [Holland, J.] N Carolina State Univ, USDA ARS, Plant Sci Res Unit, Raleigh, NC 27695 USA; [Hu, F.; Tao, D.] Yunnan Acad Agr Sci, Food Crops Res Inst, Kunming 650205, Peoples R China; [Hulke, B. S.] USDA ARS, Sunflower Res Unit, No Crop Sci Lab, Fargo, ND 58105 USA; [Ibrahim, A. M. H.; Murray, S. C.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Jones, S. S.] Washington State Univ, Dept Crop & Soil Sci, Mt Vernon, WA 98273 USA; [Paterson, A. H.] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Ploschuk, E.] Univ Buenos Aires, Fac Agron, Catedra Cultivos Ind, Buenos Aires, DF, Argentina; [Sacks, E. J.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Wade, L. J.] Charles Sturt Univ, EH Graham Ctr Agr Innovat, Wagga Wagga, NSW 2678, Australia; [Wyse, D. L.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55108 USA; [Xu, Y.] Int Maize & Wheat Improvement Ctr, Global Maize Program, Mexico City, DF, Mexico	Washington State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Chicago; University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); Cornell University; Michigan State University; Swedish University of Agricultural Sciences; Kansas State University; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; Yunnan Academy of Agricultural Sciences; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; Washington State University; University System of Georgia; University of Georgia; University of Buenos Aires; University of Illinois System; University of Illinois Urbana-Champaign; Charles Sturt University; University of Minnesota System; University of Minnesota Twin Cities; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Glover, JD (corresponding author), Land Inst, Salina, KS 67401 USA.	glover@landinstitute.org	Borevitz, Justin/B-5423-2012; Snapp, Sieg/GWQ-5774-2022; Ploschuk, Edmundo/AAO-7875-2020; Wade, Len J/A-8872-2008; Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019; Eriksson, Dennis/J-4592-2012; Tao, Dayun/AAI-8321-2020; Bell, Lindsay/B-9769-2008; Eriksson, Dennis/ABF-5510-2020; Snapp, Sieglinde/AAU-8121-2020; Hulke, Brent/GZG-4449-2022; Snapp, Sieglinde S/D-5109-2013; DeHaan, Lee R./AAF-5048-2019	Borevitz, Justin/0000-0001-8408-3699; Wade, Len J/0000-0002-1321-4310; Buckler, Edward/0000-0002-3100-371X; Eriksson, Dennis/0000-0002-5205-3396; Snapp, Sieglinde/0000-0002-9738-0649; DeHaan, Lee R./0000-0002-6368-5241; Holland, James/0000-0002-4341-9675; Murray, Seth/0000-0002-2960-8226; Bell, Lindsay/0000-0002-5064-2947; Culman, Steve/0000-0003-3985-257X; Tao, Dayun/0000-0002-8884-1589				Bell LW, 2008, AGR SYST, V96, P166, DOI 10.1016/j.agsy.2007.07.007; Cox CM, 2005, PLANT DIS, V89, P1235, DOI 10.1094/PD-89-1235; Cox TS, 2006, BIOSCIENCE, V56, P649, DOI 10.1641/0006-3568(2006)56[649:PFDPGC]2.0.CO;2; Dohleman FG, 2009, PLANT PHYSIOL, V150, P2104, DOI 10.1104/pp.109.139162; Eriksson D., 2009, THESIS SWEDISH U AGR; Eswaran H., 1999, American Journal of Alternative Agriculture, V14, P129, DOI 10.1017/S0889189300008250; Food and Agriculture Organization of the United Nations (FAO), 2009, STAT FOOD INS WORLD; Glover JD, 2007, SCI AM, V297, P82, DOI 10.1038/scientificamerican0807-82; Glover JD, 2010, AGR ECOSYST ENVIRON, V137, P3, DOI 10.1016/j.agee.2009.11.001; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Pimm S. L., 2001, WORLD ACCORDING PIMM; Ploschuk EL, 2005, ANN BOT-LONDON, V96, P127, DOI 10.1093/aob/mci158; Qi LL, 2007, CHROMOSOME RES, V15, P3, DOI 10.1007/s10577-006-1108-8; Randall GW, 1997, J ENVIRON QUAL, V26, P1240, DOI 10.2134/jeq1997.00472425002600050007x; Sacks EJ, 2003, CROP SCI, V43, P120, DOI 10.2135/cropsci2003.0120; Snapp S, 2003, HORTSCIENCE, V38, P187, DOI 10.21273/HORTSCI.38.2.187; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; Wallace JS, 2000, AGR ECOSYST ENVIRON, V82, P105, DOI 10.1016/S0167-8809(00)00220-6; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191	20	280	291	15	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2010	328	5986					1638	1639		10.1126/science.1188761	http://dx.doi.org/10.1126/science.1188761			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	615BY	20576874				2022-12-01	WOS:000279107400024
J	Uemura, T; Lee, SJ; Yasumura, M; Takeuchi, T; Yoshida, T; Ra, M; Taguchi, R; Sakimura, K; Mishina, M				Uemura, Takeshi; Lee, Sung-Jin; Yasumura, Misato; Takeuchi, Tomonori; Yoshida, Tomoyuki; Ra, Moonjin; Taguchi, Ryo; Sakimura, Kenji; Mishina, Masayoshi			Trans-Synaptic Interaction of GluR delta 2 and Neurexin through Cbln1 Mediates Synapse Formation in the Cerebellum	CELL			English	Article							LONG-TERM DEPRESSION; GLUTAMATE-RECEPTOR DELTA-2; PURKINJE-CELLS; ALPHA-NEUREXINS; BETA-NEUREXINS; MUTANT MICE; 2 SUBUNIT; NEUROLIGINS; EXPRESSION; PARALLEL	Elucidation of molecular mechanisms that regulate synapse formation is required for the understanding of neural wiring, higher brain functions, and mental disorders. Despite the wealth of in vitro information, fundamental questions about how glutamatergic synapses are formed in the mammalian brain remain unanswered. Glutamate receptor (GluR) delta 2 is essential for cerebellar synapse formation in vivo. Here, we show that the N-terminal domain (NTD) of GluR delta 2 interacts with presynaptic neurexins (NRXNs) through cerebellin 1 precursor protein (Cbln1). The synaptogenic activity of GluR delta 2 is abolished in cerebellar primary cultures from Cbln1 knockout mice and is restored by recombinant Cbln1. Knockdown of NRXNs in cerebellar granule cells also hinders the synaptogenic activity of GluR delta 2. Both the NTD of GluR delta 2 and the extracellular domain of NRXN1 beta suppressed the synaptogenic activity of Cbln1 in cerebellar primary cultures and in vivo. These results suggest that GluR delta 2 mediates cerebellar synapse formation by interacting with presynaptic NRXNs through Cbln1.	[Uemura, Takeshi; Lee, Sung-Jin; Yasumura, Misato; Takeuchi, Tomonori; Yoshida, Tomoyuki; Mishina, Masayoshi] Univ Tokyo, Dept Mol Neurobiol & Pharmacol, Grad Sch Med, Tokyo 1130033, Japan; [Ra, Moonjin; Taguchi, Ryo] Univ Tokyo, Dept Metabolome, Grad Sch Med, Tokyo 1130033, Japan; [Sakimura, Kenji] Niigata Univ, Dept Cellular Neurobiol, Brain Res Inst, Niigata 9518585, Japan	University of Tokyo; University of Tokyo; Niigata University	Mishina, M (corresponding author), Univ Tokyo, Dept Mol Neurobiol & Pharmacol, Grad Sch Med, Tokyo 1130033, Japan.	mishina@m.u-tokyo.ac.jp	Takeuchi, Tomonori/P-5988-2016; ra, moonjin/AAK-3816-2021	Takeuchi, Tomonori/0000-0002-9981-4260; Yasumura, Misato/0000-0003-1965-4867; Yoshida, Tomoyuki/0000-0002-8476-3798	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Grants-in-Aid for Scientific Research [22700392] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. We thank M. Watanabe for antibodies against Cbln1, GluR alpha 1, GluR alpha 2, GluR alpha 2, VGluT1 and calbindin, J. Miyazaki for CAG-cre transgenic mice and pCAGCS, M. Kataoka for pEGFP-VAMP2, and Y. Miwa for pEB6-CAGMCS. We are grateful to H. Sagara, T. Miyazaki, and Y. Mikami for helpful advice on electron microscopy, T. Shimizu and S. Tokuoka for use of Biacore 3000 biosensor, T. Fuse for advice on cerebellar culture, A. Maeda for technical assistance, K. Osaki and R. Natsume for help in knockout mouse generation, and Y. Nakajima for help in preparation of the manuscript.	ARAKI K, 1993, BIOCHEM BIOPH RES CO, V197, P1267, DOI 10.1006/bbrc.1993.2614; Bao DS, 2005, J NEUROCHEM, V95, P618, DOI 10.1111/j.1471-4159.2005.03385.x; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Comoletti D, 2003, J BIOL CHEM, V278, P50497, DOI 10.1074/jbc.M306803200; Comoletti D, 2006, BIOCHEMISTRY-US, V45, P12816, DOI 10.1021/bi0614131; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dudanova I, 2007, J COMP NEUROL, V502, P261, DOI 10.1002/cne.21305; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Ito-Ishida A, 2008, J NEUROSCI, V28, P5920, DOI 10.1523/JNEUROSCI.1030-08.2008; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Katayama H, 2004, RAPID COMMUN MASS SP, V18, P2388, DOI 10.1002/rcm.1637; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kishimoto Y, 2001, EUR J NEUROSCI, V13, P1249, DOI 10.1046/j.0953-816x.2001.01488.x; Koehnke J, 2008, STRUCTURE, V16, P410, DOI 10.1016/j.str.2007.12.024; Kurihara H, 1997, J NEUROSCI, V17, P9613; Landsend AS, 1997, J NEUROSCI, V17, P834, DOI 10.1523/jneurosci.17-02-00834.1997; Ledda F, 2007, NAT NEUROSCI, V10, P293, DOI 10.1038/nn1855; Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002; LOMELI H, 1993, FEBS LETT, V315, P318, DOI 10.1016/0014-5793(93)81186-4; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; Mishina M, 2003, INT CONGR SER, V1250, P473, DOI 10.1016/S0531-5131(03)00186-9; Mishina M, 2007, NEUROSCI RES, V58, P105, DOI 10.1016/j.neures.2007.01.004; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Miura E, 2006, EUR J NEUROSCI, V24, P750, DOI 10.1111/j.1460-9568.2006.04950.x; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SLEMMON JR, 1984, P NATL ACAD SCI-BIOL, V81, P6866, DOI 10.1073/pnas.81.21.6866; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Takayama C, 1996, DEV BRAIN RES, V92, P147, DOI 10.1016/0165-3806(95)00212-X; Takeuchi T, 2005, J NEUROSCI, V25, P2146, DOI 10.1523/JNEUROSCI.4740-04.2005; Takeuchi T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002297; Tsujita M, 1999, J NEUROSCI, V19, P10318; Uemura T, 2004, MOL CELL NEUROSCI, V26, P330, DOI 10.1016/j.mcn.2004.02.007; Uemura T, 2007, J NEUROSCI, V27, P12096, DOI 10.1523/JNEUROSCI.2680-07.2007; Uemura T, 2008, BIOCHEM BIOPH RES CO, V377, P1315, DOI 10.1016/j.bbrc.2008.10.170; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; YAMAZAKI M, 1992, BIOCHEM BIOPH RES CO, V183, P886, DOI 10.1016/0006-291X(92)90566-4	46	333	337	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					1068	1079		10.1016/j.cell.2010.04.035	http://dx.doi.org/10.1016/j.cell.2010.04.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20537373	Green Submitted, Bronze			2022-12-01	WOS:000278618800020
J	Kamerow, D				Kamerow, Douglas			Yankee Doodling What I learnt from Mom	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC 27709 USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957					0	0	0	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 8	2010	340								c2973	10.1136/bmj.c2973	http://dx.doi.org/10.1136/bmj.c2973			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611MB	20530558				2022-12-01	WOS:000278818300011
J	Renehan, A; Smith, U; Kirkman, MS				Renehan, Andrew; Smith, Ulf; Kirkman, M. Sue			Linking diabetes and cancer: a consensus on complexity	LANCET			English	Editorial Material							METAANALYSIS; MELLITUS; RISK; MORTALITY		[Kirkman, M. Sue] Amer Diabet Assoc, Alexandria, VA 22311 USA; [Renehan, Andrew] Univ Manchester, Manchester Acad Hlth Sci Ctr, Christie NHS Fdn Trust, Sch Canc & Enabling Sci, Manchester, Lancs, England; [Smith, Ulf] Sahlgrens Univ Hosp, Dept Mol & Clin Med, Lundberg Lab Diabet Res, Gothenburg, Sweden	American Diabetes Association; Christie NHS Foundation Trust; University of Manchester; Sahlgrenska University Hospital	Kirkman, MS (corresponding author), Amer Diabet Assoc, Alexandria, VA 22311 USA.	skirkman@diabetes.org	Renehan, Andrew/K-5992-2015	Renehan, Andrew/0000-0003-4309-4396				*AM CANC SOC, 2008, CANC STAT 2008; Barone BB, 2010, DIABETES CARE, V33, P931, DOI 10.2337/dc09-1721; Barone BB, 2008, JAMA-J AM MED ASSOC, V300, P2754, DOI 10.1001/jama.2008.824; *ECCO, 2007, CANC SCAL PROBL; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; Friberg E, 2007, DIABETOLOGIA, V50, P1365, DOI 10.1007/s00125-007-0681-5; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; International Diabetes Federation, 2009, IDF DIAB ATL; Kasper JS, 2006, CANCER EPIDEM BIOMAR, V15, P2056, DOI 10.1158/1055-9965.EPI-06-0410; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Larsson SC, 2008, EUR J CANCER, V44, P2655, DOI 10.1016/j.ejca.2008.07.012; Lipscombe LL, 2005, ARCH INTERN MED, V165, P2090, DOI 10.1001/archinte.165.18.2090; Mitri J, 2008, DIABETES CARE, V31, P2391, DOI 10.2337/dc08-1034; Pocock SJ, 2009, LANCET, V374, P511, DOI 10.1016/S0140-6736(09)61307-6; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Smith U, 2009, DIABETOLOGIA, V52, P1699, DOI 10.1007/s00125-009-1441-5; World Cancer Research Fund International/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	19	72	76	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2010	375	9733					2201	2202		10.1016/S0140-6736(10)60706-4	http://dx.doi.org/10.1016/S0140-6736(10)60706-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	622HS	20609959				2022-12-01	WOS:000279652900008
J	Caplan, AL; Moreno, JD				Caplan, Arthur L.; Moreno, Jonathan D.			The Havasu 'Baaja tribe and informed consent	LANCET			English	Editorial Material									[Caplan, Arthur L.; Moreno, Jonathan D.] Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Caplan, AL (corresponding author), Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA.	caplan@mail.med.upenn.edu						Caplan AL, 2009, TRAFFICKING ORGANS T; Elger BS, 2006, EMBO REP, V7, P661, DOI 10.1038/sj.embor.7400740; Eriksson S, 2005, EUR J HUM GENET, V13, P1071, DOI 10.1038/sj.ejhg.5201458; Harmon A, 2010, NY TIMES        0422, P17; MARKOW T, 1993, AM J HUM GENET, V53, P943; MARKOW TA, 1993, ANN HUM BIOL, V20, P389, DOI 10.1080/03014469300002792; Skloot R., 2010, IMMORTAL LIFE HENRIE; Solbakk JH, 2009, ETHICS OF RESEARCH BIOBANKING, P1, DOI 10.1007/978-0-387-93872-1; Wadman M, 2009, NATURE, V462, P837, DOI 10.1038/462837a	9	3	3	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2011	377	9766					621	622		10.1016/S0140-6736(10)60818-5	http://dx.doi.org/10.1016/S0140-6736(10)60818-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	727DB	20630579				2022-12-01	WOS:000287776600009
J	Burkle, FM; Hsu, EB				Burkle, Frederick M., Jr.; Hsu, Edbert B.			Ram Janki Temple: understanding human stampedes	LANCET			English	Editorial Material									[Burkle, Frederick M., Jr.] Harvard Univ, Sch Publ Hlth, Harvard Humanitarian Initiat, Cambridge, MA 02138 USA; [Hsu, Edbert B.] Johns Hopkins Univ, Inst Med, Dept Emergency Med, Baltimore, MD USA	Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University	Burkle, FM (corresponding author), Harvard Univ, Sch Publ Hlth, Harvard Humanitarian Initiat, Cambridge, MA 02138 USA.	fburkle@hsph.harvard.edu	Burkle, Frederick/AAE-5423-2020					Ahmed QA, 2006, LANCET, V367, P1008, DOI 10.1016/S0140-6736(06)68429-8; Burkle FM, 2010, PREHOSPITAL DISASTER, V25, P34, DOI [10.1017/S1049023X00007639, 10.1017/S1049023X00007998]; EM-DAT, 2010, INT DIS DAT; Evans A, 2009, MANAGING SCARCITY I; Helbing D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046109; Hsieh YH, 2009, DISASTER MED PUBLIC, V3, P217, DOI 10.1097/DMP.0b013e3181c5b4ba; Ngai KM, 2009, DISASTER MED PUBLIC, V3, P191, DOI 10.1097/DMP.0b013e3181c5b494; Singh HS, 2010, CNN             0305	8	38	38	1	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 8	2011	377	9760					106	107		10.1016/S0140-6736(10)60442-4	http://dx.doi.org/10.1016/S0140-6736(10)60442-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	707NH	20655584				2022-12-01	WOS:000286292800008
J	Moreno, JGB; Licea, JAI; Ajenjo, CR				Bustamante Moreno, Jose Guadalupe; Izazola Licea, Jose Antonio; Ajenjo, Carlos Rodriguez			Tackling HIV and drug addiction in Mexico	LANCET			English	Editorial Material							TIJUANA		[Bustamante Moreno, Jose Guadalupe] Ctr Civ, Mexicali 21000, Baja California, Mexico; [Izazola Licea, Jose Antonio] Ctr Nacl Prevenc & Control VIH SIDA, Mexico City, DF, Mexico; [Ajenjo, Carlos Rodriguez] Consejo Nacl Contras Adicc, Mexico City, DF, Mexico		Moreno, JGB (corresponding author), Ctr Civ, Mexicali 21000, Baja California, Mexico.	jbustamante@baja.gob.mx			NIDA NIH HHS [R21 DA024381-01, R21 DA024381, R01 DA019829-01A1, R01 DA019829] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024381, R01DA019829] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Beyrer C, 2010, LANCET, V376, P551, DOI 10.1016/S0140-6736(10)60928-2; *CENSIDA, 2009, ACT REDD US DROG INF; Iniguez-Stevens E, 2009, GAC MED MEX, V145, P189; MORENO JGB, 2008, INT C AIDS MEX CIT M; *NAT I PSYCH RAM F, 2009, 2008 NAT HOUS SURV A; Patterson TL, 2009, AIDS, V23, P1763, DOI 10.1097/QAD.0b013e32832f08a1; Philbin MM, 2009, INT J DRUG POLICY, V20, P329, DOI 10.1016/j.drugpo.2008.09.002; *SECR SAL, 2009, CAS SIDA MEX; Strathdee SA, 2008, JAMA-J AM MED ASSOC, V300, P571, DOI 10.1001/jama.300.5.571; Strathdee SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002690	10	28	28	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 14	2010	376	9740					493	495		10.1016/S0140-6736(10)60883-5	http://dx.doi.org/10.1016/S0140-6736(10)60883-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	643BE	20650521	Green Accepted			2022-12-01	WOS:000281266800007
J	Gregg, C; Zhang, JW; Weissbourd, B; Luo, SJ; Schroth, GP; Haig, D; Dulac, C				Gregg, Christopher; Zhang, Jiangwen; Weissbourd, Brandon; Luo, Shujun; Schroth, Gary P.; Haig, David; Dulac, Catherine			High-Resolution Analysis of Parent-of-Origin Allelic Expression in the Mouse Brain	SCIENCE			English	Article							IMPRINTED GENE; H19; IGF2; POLYADENYLATION; IDENTIFICATION; MECHANISMS; MUTATION; CELLS	Genomic imprinting results in preferential expression of the paternal or maternal allele of certain genes. We have performed a genome-wide characterization of imprinting in the mouse embryonic and adult brain. This approach uncovered parent-of-origin allelic effects of more than 1300 loci. We identified parental bias in the expression of individual genes and of specific transcript isoforms, with differences between brain regions. Many imprinted genes are expressed in neural systems associated with feeding and motivated behaviors, and parental biases preferentially target genetic pathways governing metabolism and cell adhesion. We observed a preferential maternal contribution to gene expression in the developing brain and a major paternal contribution in the adult brain. Thus, parental expression bias emerges as a major mode of epigenetic regulation in the brain.	[Gregg, Christopher; Weissbourd, Brandon; Dulac, Catherine] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Gregg, Christopher; Weissbourd, Brandon; Dulac, Catherine] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Zhang, Jiangwen] Harvard Univ, FAS Res Comp, Cambridge, MA 02138 USA; [Haig, David] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Luo, Shujun; Schroth, Gary P.] Illumina Inc, Hayward, CA 94545 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Illumina	Gregg, C (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	cgregg@mcb.harvard.edu; dulac@fas.harvard.edu	Zhang, Jiangwen/A-7654-2013	Zhang, Jiangwen/0000-0002-2911-8446; Dulac, Catherine/0000-0001-5024-5418	Klarman Foundation for Eating Disorders; Howard Hughes Medical Institute (HHMI); Human Frontiers long-term fellowship; Alberta Heritage Foundation for Medical Research	Klarman Foundation for Eating Disorders; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Human Frontiers long-term fellowship; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	We thank L. Luo, T. Maniatis, R. Losick, S. Hippenmeyer, and members of the Maniatis and Dulac labs for critical comments on the manuscript. We thank R. Hellmiss for help with figures and R. Jaenisch for X<SUP>egfp</SUP> mice. This work was supported by the Klarman Foundation for Eating Disorders and the Howard Hughes Medical Institute (HHMI). C. G. is supported by a Human Frontiers long-term fellowship and Alberta Heritage Foundation for Medical Research Incentive Award. C. D. is an HHMI investigator. All data can be found in GEO: GSE22131.	ALLEN ND, 1995, P NATL ACAD SCI USA, V92, P10782, DOI 10.1073/pnas.92.23.10782; Arnaud P, 2003, HUM MOL GENET, V12, P1005, DOI 10.1093/hmg/ddg110; Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Barel O, 2008, AM J HUM GENET, V83, P193, DOI 10.1016/j.ajhg.2008.07.010; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bhalla K, 2008, AM J HUM GENET, V83, P703, DOI 10.1016/j.ajhg.2008.10.020; Caqueret A, 2005, HORM RES, V64, P222, DOI 10.1159/000088977; Cassidy SB, 2009, EUR J HUM GENET, V17, P3, DOI 10.1038/ejhg.2008.165; Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; Delaval K, 2006, BIOESSAYS, V28, P453, DOI 10.1002/bies.20407; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Haig D, 2004, ANNU REV GENET, V38, P553, DOI 10.1146/annurev.genet.37.110801.142741; HALL JG, 1990, AM J HUM GENET, V46, P857; Hemberger M, 1998, DEV GENES EVOL, V208, P393, DOI 10.1007/s004270050195; Hernandez A, 2002, ENDOCRINOLOGY, V143, P4483, DOI 10.1210/en.2002-220800; HU JF, 1995, MOL ENDOCRINOL, V9, P628, DOI 10.1210/me.9.5.628; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Keverne EB, 2007, ADV GENET, V59, P217, DOI 10.1016/S0065-2660(07)59008-5; Keverne EB, 1996, DEV BRAIN RES, V92, P91, DOI 10.1016/0165-3806(95)00209-X; Keverne EB, 2001, HORM BEHAV, V40, P146, DOI 10.1006/hbeh.2001.1685; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; MCEWEN KR, 2009, GENOMIC IMPRINTING M, P235; Mochida GH, 2009, AM J HUM GENET, V85, P897, DOI 10.1016/j.ajhg.2009.10.027; Nguyen DK, 2006, BRAIN RES, V1126, P46, DOI 10.1016/j.brainres.2006.08.053; Ono R, 2003, GENOME RES, V13, P1696, DOI 10.1101/gr.906803; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Schulz R, 2008, EPIGENETICS-US, V3, P89, DOI 10.4161/epi.3.2.5900; Smit MA, 2005, MAMM GENOME, V16, P801, DOI 10.1007/s00335-004-2415-z; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Van Buggenhout G, 2009, EUR J HUM GENET, V17, P1367, DOI 10.1038/ejhg.2009.67; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Wang YD, 2004, MOL CELL BIOL, V24, P270, DOI 10.1128/MCB.24.1.270-279.2004; Webber AL, 1998, NATURE, V391, P711, DOI 10.1038/35655; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Wood AJ, 2008, GENE DEV, V22, P1141, DOI 10.1101/gad.473408; Wood AJ, 2007, NUCLEIC ACIDS RES, V35, P7031, DOI 10.1093/nar/gkm742; Yamasaki Y, 2005, HUM MOL GENET, V14, P2511, DOI 10.1093/hmg/ddi255	46	391	398	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2010	329	5992					643	648		10.1126/science.1190830	http://dx.doi.org/10.1126/science.1190830			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20616232	Green Accepted			2022-12-01	WOS:000280602700029
J	Hobbs, RM; Seandel, M; Falciatori, I; Rafii, S; Pandolfi, PP				Hobbs, Robin M.; Seandel, Marco; Falciatori, Ilaria; Rafii, Shahin; Pandolfi, Pier Paolo			Plzf Regulates Germline Progenitor Self-Renewal by Opposing mTORC1	CELL			English	Article							SPERMATOGONIAL STEM-CELLS; ACUTE PROMYELOCYTIC LEUKEMIA; UNDIFFERENTIATED SPERMATOGONIA; RETINOIC ACID; MOUSE TESTIS; ZINC-FINGER; BONE-MARROW; MAMMALIAN TARGET; INITIATING CELLS; LIFE-SPAN	Hyperactivity of mTORC1, a key mediator of cell growth, leads to stem cell depletion, although the underlying mechanisms are poorly defined. Using spermatogonial progenitor cells (SPCs) as a model system, we show that mTORC1 impairs stem cell maintenance by a negative feedback from mTORC1 to receptors required to transduce niche-derived signals. We find that SPCs lacking Plzf, a transcription factor essential for SPC maintenance, have enhanced mTORC1 activity. Aberrant mTORC1 activation in Plzf(-/-) SPCs inhibits their response to GDNF, a growth factor critical for SPC self-renewal, via negative feedback at the level of the GDNF receptor. Plzf opposes mTORC1 activity by inducing expression of the mTORC1 inhibitor Redd1. Thus, we identify the mTORC1-Plzf functional interaction as a critical rheostat for maintenance of the spermatogonial pool and propose a model whereby negative feedback from mTORC1 to the GDNF receptor balances SPC growth with self-renewal.	[Hobbs, Robin M.; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr,Canc Genet Program, Boston, MA 02115 USA; [Seandel, Marco] Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA; [Falciatori, Ilaria; Rafii, Shahin] Weill Cornell Med Coll, Dept Med Genet, Howard Hughes Med Inst, New York, NY 10065 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Cornell University; Cornell University; Howard Hughes Medical Institute	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Beth Israel Deaconess Canc Ctr,Canc Genet Program, Boston, MA 02115 USA.	ppandolf@bidmc.harvard.edu	Hobbs, Robin/I-2577-2014	Hobbs, Robin/0000-0002-3853-2614	NIH; NATIONAL CANCER INSTITUTE [R01CA102142] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank current and past members of the Pandolfi lab and in particular Takahiro Maeda and Rosa Bernardi for helpful discussion and advice. We would also like to thank Antonella Papa for generating luciferase reporters, Sharmila Fagoonee for experimental help, Leif Ellisen for Redd1 promoter constructs, and the flow cytometry facilities of BIDMC and MSKCC for expert support. M.S. is a Stanley and Fiona Druckenmiller Fellow of the New York Stem Cell Foundation. This work was supported by NIH grants to P.P.P.	Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Costoya JA, 2008, ONCOGENE, V27, P3789, DOI 10.1038/onc.2008.7; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; David G, 1998, ONCOGENE, V16, P2549, DOI 10.1038/sj.onc.1202043; De Rooij DG, 2000, J ANDROL, V21, P776; Doulatov S, 2009, GENE DEV, V23, P2076, DOI 10.1101/gad.1788109; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Encinas M, 2001, J NEUROSCI, V21, P1464, DOI 10.1523/JNEUROSCI.21-05-01464.2001; Fan QW, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000014; Filipponi D, 2007, MOL CELL BIOL, V27, P6770, DOI 10.1128/MCB.00479-07; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fischer S, 2008, J MED GENET, V45, P731, DOI 10.1136/jmg.2008.059451; Gan B, 2009, CELL CYCLE, V8, P1003, DOI 10.4161/cc.8.7.8045; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Gery S, 2007, EXP HEMATOL, V35, P572, DOI 10.1016/j.exphem.2007.01.049; Guo W, 2008, NATURE, V453, P529, DOI 10.1038/nature06933; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; He LZ, 2000, MOL CELL, V6, P1131, DOI 10.1016/S1097-2765(00)00111-8; Hennige AM, 2000, MOL CELL ENDOCRINOL, V167, P69, DOI 10.1016/S0303-7207(00)00283-5; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Ito K, 2009, CURR OPIN GENET DEV, V19, P51, DOI 10.1016/j.gde.2009.01.004; Kanatsu-Shinohara M, 2004, BIOL REPROD, V70, P70, DOI 10.1095/biolreprod.103.020867; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Hamra FK, 2007, J BIOL CHEM, V282, P721, DOI 10.1074/jbc.M608398200; Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kubota Y, 2008, BIOCHEM BIOPH RES CO, V366, P335, DOI 10.1016/j.bbrc.2007.11.086; Labbaye C, 2002, ONCOGENE, V21, P6669, DOI 10.1038/sj.onc.1205884; Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Lin L, 2005, BIOCHEM J, V392, P93, DOI 10.1042/BJ20050553; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Martelli AM, 2007, CURR MED CHEM, V14, P2009; McConnell MJ, 2007, CURR TOP MICROBIOL, V313, P31; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Nishioka C, 2009, INT J CANCER, V125, P1710, DOI 10.1002/ijc.24472; Oatley JM, 2007, J BIOL CHEM, V282, P25842, DOI 10.1074/jbc.M703474200; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Ohbo K, 2003, DEV BIOL, V258, P209, DOI 10.1016/S0012-1606(03)00111-8; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Ryu BY, 2006, STEM CELLS, V24, P1505, DOI 10.1634/stemcells.2005-0580; Schieke SM, 2006, BIOL CHEM, V387, P1357, DOI 10.1515/BC.2006.170; Schrans-Stassen BHGJ, 1999, ENDOCRINOLOGY, V140, P5894, DOI 10.1210/en.140.12.5894; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Takubo K, 2008, CELL STEM CELL, V2, P170, DOI 10.1016/j.stem.2007.10.023; VIRTANEN I, 1986, ANAT RECORD, V215, P10, DOI 10.1002/ar.1092150103; Wu X, 2010, BIOL REPROD, V82, P1103, DOI 10.1095/biolreprod.109.083097; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zhang XF, 2006, BIOL REPROD, V74, P119, DOI 10.1095/biolreprod.105.045591	76	183	196	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					468	479		10.1016/j.cell.2010.06.041	http://dx.doi.org/10.1016/j.cell.2010.06.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691905	Bronze, Green Accepted			2022-12-01	WOS:000280609100023
J	Pletcher, MJ; Bibbins-Domingo, K; Liu, KA; Sidney, S; Lin, F; Vittinghoff, E; Hulley, SB				Pletcher, Mark J.; Bibbins-Domingo, Kirsten; Liu, Kiang; Sidney, Steve; Lin, Feng; Vittinghoff, Eric; Hulley, Stephen B.			Nonoptimal Lipids Commonly Present in Young Adults and Coronary Calcium Later in Life: The CARDIA (Coronary Artery Risk Development in Young Adults) Study	ANNALS OF INTERNAL MEDICINE			English	Article							DENSITY-LIPOPROTEIN-CHOLESTEROL; INTIMA-MEDIA THICKNESS; CARDIOVASCULAR RISK; HEART-DISEASE; BLOOD-PRESSURE; COMPUTED-TOMOGRAPHY; SERUM-CHOLESTEROL; FOLLOW-UP; ATHEROSCLEROSIS; CHILDHOOD	Background: Dyslipidemia causes coronary heart disease in middle-aged and elderly adults, but the consequences of lipid exposure during young adulthood are unclear. Objective: To assess whether nonoptimal lipid levels during young adulthood cause atherosclerotic changes that persist into middle age. Design: Prospective cohort study. Setting: 4 cities in the United States. Participants: 3258 participants from the 5115 black and white men and women recruited at age 18 to 30 years in 1985 to 1986 for the CARDIA (Coronary Artery Risk Development in Young Adults) study. Measurements: Low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol, triglycerides, and coronary calcium. Time-averaged cumulative exposures to lipids between age 20 and 35 years were estimated by using repeated serum lipid measurements over 20 years in the CARDIA study; these measurements were then related to coronary calcium scores assessed later in life (45 years [SD, 4]). Results: 2824 participants (87%) had nonoptimal levels of LDL cholesterol (>= 2.59 mmol/L [>= 100 mg/dL]), HDL cholesterol (<1.55 mmol/L [<60 mg/dL]), or triglycerides (>= 1.70 mmol/L [>= 150 mg/dL]) during young adulthood. Coronary calcium prevalence 2 decades later was 8% in participants who maintained optimal LDL levels (<1.81 mmol/L [<70 mg/dL]), and 44% in participants with LDL cholesterol levels of 4.14 mmol/L (160 mg/dL) or greater (P < 0.001). The association was similar across race and sex and strongly graded, with odds ratios for coronary calcium of 1.5 (95% CI, 0.7 to 3.3) for LDL cholesterol levels of 1.81 to 2.56 mmol/L (70 to 99 mg/dL), 2.4 (CI, 1.1 to 5.3) for levels of 2.59 to 3.34 mmol/L (100 to 129 mg/dL), 3.3 (CI, 1.3 to 7.8) for levels of 3.37 to 4.12 mmol/L (130 to 159 mg/dL), and 5.6 (CI, 2.0 to 16) for levels of 4.14 mmol/L (160 mg/dL) or greater, compared with levels less than 1.81 mmol/L (<70 mg/dL), after adjustment for lipid exposure after age 35 years and other coronary risk factors. Both LDL and HDL cholesterol levels were independently associated with coronary calcium after participants who were receiving lipid-lowering medications or had clinically abnormal lipid levels were excluded. Limitation: Coronary calcium, although a strong predictor of future coronary heart disease, is not a clinical outcome. Conclusion: Nonoptimal levels of LDL and HDL cholesterol during young adulthood are independently associated with coronary atherosclerosis 2 decades later.	[Pletcher, Mark J.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; Kaiser Permanente, Div Res, Oakland, CA USA; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	University of California System; University of California San Francisco; Kaiser Permanente; Northwestern University; Feinberg School of Medicine	Pletcher, MJ (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, 185 Berry St,Suite 5700, San Francisco, CA 94107 USA.	mpletcher@epi.ucsf.edu			National Heart, Lung, and Blood Institute [N01-HC-45204]; University of Alabama at Birmingham Coordinating Center [N01-HC-95095]; University of Alabama at Birmingham Field Center [N01-HC-48047]; University of Minnesota Field Center and Diet Reading Center [N01-HC-48048]; Northwestern University Field Center [N01-HC-48049]; Kaiser Foundation Research Institute [N01-HC-48050]; University of California, Irvine, Echocardiography Reading Center [N01-HC-45134]; Harbor-University of California, Los Angeles, Research Education Institute, Computed Tomography Reading Center [N01-HC-05187]; Wake Forest University [N01-HC-45205]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048048, N01HC095095, N01HC048047, N01HC048049, N01HC048050, N01HC005187, N01HC045134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL048048, R01HL048049, R01HL048048, R01HL048050] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Alabama at Birmingham Coordinating Center; University of Alabama at Birmingham Field Center; University of Minnesota Field Center and Diet Reading Center(University of Minnesota System); Northwestern University Field Center; Kaiser Foundation Research Institute; University of California, Irvine, Echocardiography Reading Center(University of California System); Harbor-University of California, Los Angeles, Research Education Institute, Computed Tomography Reading Center; Wake Forest University; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute.; By the University of Alabama at Birmingham Coordinating Center (grant N01-HC-95095); University of Alabama at Birmingham Field Center (grant N01-HC-48047); University of Minnesota Field Center and Diet Reading Center (year 20 examination) (grant N01-HC-48048); Northwestern University Field Center (grant N01-HC-48049); Kaiser Foundation Research Institute (grant N01-HC-48050); University of California, Irvine, Echocardiography Reading Center (years 5 and 10) (grant N01-HC-45134); Harbor-University of California, Los Angeles, Research Education Institute, Computed Tomography Reading Center (year 15 examination) (grant N01-HC-05187); Wake Forest University (year 20 examination) (grant N01-HC-45205); and New England Medical Center (year 20 examination) (grant N01-HC-45204 from the National Heart, Lung and Blood Institute).	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; ANDERSON KM, 1987, JAMA-J AM MED ASSOC, V257, P2176, DOI 10.1001/jama.257.16.2176; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bao WH, 1996, ARCH INTERN MED, V156, P1315, DOI 10.1001/archinte.156.12.1315; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Bild DE, 1996, ANN EPIDEMIOL, V6, P235, DOI 10.1016/1047-2797(96)00005-1; Blaha M, 2009, JACC-CARDIOVASC IMAG, V2, P692, DOI 10.1016/j.jcmg.2009.03.009; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Carr JJ, 2000, AM J ROENTGENOL, V174, P915, DOI 10.2214/ajr.174.4.1740915; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; Chhatriwalla AK, 2009, J AM COLL CARDIOL, V53, P1110, DOI 10.1016/j.jacc.2008.09.065; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; DAWBER T. R., 1957, AMER JOUR PUBL HEALTH, V47, P4, DOI 10.2105/AJPH.47.4_Pt_2.4; Detrano RC, 2005, RADIOLOGY, V236, P477, DOI 10.1148/radiol.2362040513; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Greenland P, 2007, CIRCULATION, V115, P402, DOI 10.1161/CIRCULATIONAHA..107.181425; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; HULLEY SB, 1980, NEW ENGL J MED, V302, P1383, DOI 10.1056/NEJM198006193022503; HULLEY SB, 1992, BRIT MED J, V304, P394, DOI 10.1136/bmj.304.6824.394; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; KLAG MJ, 1993, NEW ENGL J MED, V328, P313, DOI 10.1056/NEJM199302043280504; Knoflach M, 2003, CIRCULATION, V108, P1064, DOI 10.1161/01.CIR.0000085996.95532.FF; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Li SX, 2003, JAMA-J AM MED ASSOC, V290, P2271, DOI 10.1001/jama.290.17.2271; Loria CM, 2007, J AM COLL CARDIOL, V49, P2013, DOI 10.1016/j.jacc.2007.03.009; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; McGill HC, 1997, ARTERIOSCL THROM VAS, V17, P95, DOI 10.1161/01.ATV.17.1.95; MCGILL HC, 1990, JAMA-J AM MED ASSOC, V264, P3018; *NAT CHOL ED PROGR, 2004, DET EV TREATM HIGH B; NEWMAN WP, 1986, NEW ENGL J MED, V314, P138, DOI 10.1056/NEJM198601163140302; Nieto FJ, 1999, J CLIN EPIDEMIOL, V52, P559, DOI 10.1016/S0895-4356(99)00030-X; Pletcher MJ, 2008, ANN INTERN MED, V149, P91, DOI 10.7326/0003-4819-149-2-200807150-00005; Pletcher MJ, 2004, ARCH INTERN MED, V164, P1285, DOI 10.1001/archinte.164.12.1285; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Sanchez A, 2000, ATHEROSCLEROSIS, V152, P265, DOI 10.1016/S0021-9150(00)00532-3; Sarwar A, 2009, JACC-CARDIOVASC IMAG, V2, P675, DOI 10.1016/j.jcmg.2008.12.031; Stamler J, 2000, JAMA-J AM MED ASSOC, V284, P311, DOI 10.1001/jama.284.3.311; Tonstad S, 1996, ARTERIOSCL THROM VAS, V16, P984, DOI 10.1161/01.ATV.16.8.984; *US PREV SERV TASK, 2008, SCREEN LIP DIS AD; Wilson PWF, 1997, NEW ENGL J MED, V337, P516, DOI 10.1056/NEJM199708213370802	46	79	82	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2010	153	3					137	U18		10.7326/0003-4819-153-3-201008030-00004	http://dx.doi.org/10.7326/0003-4819-153-3-201008030-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634CR	20679558	Green Accepted			2022-12-01	WOS:000280557600001
J	Unroe, M; Kahn, JM; Carson, SS; Govert, JA; Martinu, T; Sathy, SJ; Clay, AS; Chia, J; Gray, A; Tulsky, JA; Cox, CE				Unroe, Mark; Kahn, Jeremy M.; Carson, Shannon S.; Govert, Joseph A.; Martinu, Tereza; Sathy, Shailaja J.; Clay, Alison S.; Chia, Jessica; Gray, Alice; Tulsky, James A.; Cox, Christopher E.			One-Year Trajectories of Care and Resource Utilization for Recipients of Prolonged Mechanical Ventilation A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							LENGTH-OF-STAY; INTENSIVE-CARE; ECONOMIC-EVALUATION; TRACHEOSTOMY; OUTCOMES; ILLNESS; SURVIVORS; BURDEN; COST; ICU	Background: Growing numbers of critically ill patients receive prolonged mechanical ventilation. Little is known about the patterns of care as patients transition from acute care hospitals to postacute care facilities or about the associated resource utilization. Objective: To describe 1-year trajectories of care and resource utilization for patients receiving prolonged mechanical ventilation. Design: 1-year prospective cohort study. Setting: 5 intensive care units at Duke University Medical Center, Durham, North Carolina. Participants: 126 patients receiving prolonged mechanical ventilation (defined as ventilation for >= 4 days with tracheostomy placement or ventilation for >= 21 days without tracheostomy), as well as their 126 surrogates and 54 intensive care unit physicians, enrolled consecutively over 1 year. Measurements: Patients and surrogates were interviewed in the hospital, as well as 3 and 12 months after discharge, to determine patient survival, functional status, and facility type and duration of postdischarge care. Physicians were interviewed in the hospital to elicit prognoses. Institutional billing records were used to assign costs for acute care, outpatient care, and interfacility transportation. Medicare claims data were used to assign costs for postacute care. Results: 103 (82%) hospital survivors had 457 separate transitions in postdischarge care location (median, 4 transitions [interquartile range, 3 to 5 transitions]), including 68 patients (67%) who were readmitted at least once. Patients spent an average of 74% (95% CI, 68% to 80%) of all days alive in a hospital or postacute care facility or receiving home health care. At 1 year, 11 patients (9%) had a good outcome (alive with no functional dependency), 33 (26%) had a fair outcome (alive with moderate dependency), and 82 (65%) had a poor outcome (either alive with complete functional dependency [4 patients; 21%] or dead [56 patients; 44%]). Patients with poor outcomes were older, had more comorbid conditions, and were more frequently discharged to a postacute care facility than patients with either fair or good outcomes (P < 0.05 for all). The mean cost per patient was $306 135 (SD, $285 467), and total cohort cost was $38.1 million, for an estimated $3.5 million per independently functioning survivor at 1 year. Limitation: The results of this single-center study may not be applicable to other centers. Conclusion: Patients receiving prolonged mechanical ventilation have multiple transitions of care, resulting in substantial health care costs and persistent, profound disability. The optimism of surrogate decision makers should be balanced by discussions of these outcomes when considering a course of prolonged life support.	[Cox, Christopher E.] Duke Univ, Med Ctr, Div Pulm & Crit Care Med, Durham, NC 27710 USA; Univ N Carolina, Chapel Hill, NC USA; Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania	Cox, CE (corresponding author), Duke Univ, Med Ctr, Div Pulm & Crit Care Med, Box 102043, Durham, NC 27710 USA.	christopher.cox@duke.edu	Cox, Christopher/ABH-7957-2020	Cox, Christopher/0000-0002-4486-0681; Kahn, Jeremy/0000-0001-9688-5576	National Institutes of Health [K23 HL081048, K23 HL082650, K23 HL067068]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL082650, K23HL067068, K23HL081048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By the National Institutes of Health (grants K23 HL081048, K23 HL082650, and K23 HL067068).	Angus DC, 2001, AM J RESP CRIT CARE, V163, P1389, DOI 10.1164/ajrccm.163.6.2005123; Angus DC, 2003, INTENS CARE MED, V29, P368, DOI 10.1007/s00134-002-1624-8; Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Carson SS, 2008, CRIT CARE MED, V36, P2061, DOI 10.1097/CCM.0b013e31817b8925; Carson SS, 2002, CRIT CARE CLIN, V18, P461, DOI 10.1016/S0749-0704(02)00015-5; Carson SS, 2001, CHEST, V120, P928, DOI 10.1378/chest.120.3.928; Centers for Medicare & Medicaid Services, OV PROSP PAYM SYST; Christakis NA, 1998, ARCH INTERN MED, V158, P2389, DOI 10.1001/archinte.158.21.2389; Chudgar SM, 2009, CRIT CARE MED, V37, P49, DOI 10.1097/CCM.0b013e31819265c8; Cooper LM, 2004, CRIT CARE MED, V32, P2247, DOI 10.1097/01.CCM.0000146301.47334.BD; COVINSKY KE, 1994, JAMA-J AM MED ASSOC, V272, P1839, DOI 10.1001/jama.272.23.1839; Cox CE, 2004, CRIT CARE MED, V32, P2219, DOI 10.1097/01.CCM.0000145232.46143.40; Cox CE, 2007, CRIT CARE MED, V35, P1918, DOI 10.1097/01.CCM.0000275391.35834.10; Cox CE, 2007, CRIT CARE, V11, DOI 10.1186/cc5667; Cox CE, 2009, CRIT CARE MED, V37, P2888, DOI 10.1097/CCM.0b013e3181ab86ed; Davis K, 2007, NEW ENGL J MED, V356, P1166, DOI 10.1056/NEJMe078007; Dewar DM, 1999, CRIT CARE MED, V27, P2640, DOI 10.1097/00003246-199912000-00006; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; El-Jawahri A, 2010, J CLIN ONCOL, V28, P305, DOI 10.1200/JCO.2009.24.7502; ELLIS SG, 1995, CIRCULATION, V92, P741, DOI 10.1161/01.CIR.92.4.741; Engoren M, 2004, CHEST, V125, P220, DOI 10.1378/chest.125.1.220; Evans LR, 2009, AM J RESP CRIT CARE, V179, P48, DOI 10.1164/rccm.200806-969OC; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Griffiths J, 2005, BMJ-BRIT MED J, V330, P1243, DOI 10.1136/bmj.38467.485671.E0; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Heyland DK, 1998, CHEST, V114, P192, DOI 10.1378/chest.114.1.192; Kahn JM, 2008, MED CARE, V46, P1226, DOI 10.1097/MLR.0b013e31817d9342; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kind P., 1999, UK POPULATION NORMS; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Luo N, 2005, MED CARE, V43, P1078, DOI 10.1097/01.mlr.0000182493.57090.c1; MacIntyre NR, 2005, CHEST, V128, P3937, DOI 10.1378/chest.128.6.3937; Nasraway SA, 2000, CRIT CARE MED, V28, P19, DOI 10.1097/00003246-200001000-00004; Nathens AB, 2006, CRIT CARE MED, V34, P2919, DOI 10.1097/01.CCM.0000243800.28251.AE; Nelson JE, 2004, CRIT CARE MED, V32, P1527, DOI 10.1097/01.CCM.0000129485.08835.5A; Nelson JE, 2007, ARCH INTERN MED, V167, P2509, DOI 10.1001/archinte.167.22.2509; Nelson JE, 2006, ARCH INTERN MED, V166, P1993, DOI 10.1001/archinte.166.18.1993; Rapoport J, 2003, MED CARE, V41, P386, DOI 10.1097/00005650-200303000-00007; *RTI INT, POST CAR PAYM REF DE; Taira DA, 2003, AM HEART J, V145, P452, DOI 10.1067/mhj.2003.3; Terragni PP, 2010, JAMA-J AM MED ASSOC, V303, P1483, DOI 10.1001/jama.2010.447; Van Pelt DC, 2007, AM J RESP CRIT CARE, V175, P167, DOI 10.1164/rccm.200604-493OC; White DB, 2007, ARCH INTERN MED, V167, P461, DOI 10.1001/archinte.167.5.461; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wunsch H, 2010, JAMA-J AM MED ASSOC, V303, P849, DOI 10.1001/jama.2010.216; Zilberberg MD, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-242	46	308	316	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2010	153	3					167	U62		10.7326/0003-4819-153-3-201008030-00007	http://dx.doi.org/10.7326/0003-4819-153-3-201008030-00007			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634CR	20679561	Green Accepted			2022-12-01	WOS:000280557600005
J	Gourine, AV; Kasymov, V; Marina, N; Tang, FG; Figueiredo, MF; Lane, S; Teschemacher, AG; Spyer, KM; Deisseroth, K; Kasparov, S				Gourine, Alexander V.; Kasymov, Vitaliy; Marina, Nephtali; Tang, Feige; Figueiredo, Melina F.; Lane, Samantha; Teschemacher, Anja G.; Spyer, K. Michael; Deisseroth, Karl; Kasparov, Sergey			Astrocytes Control Breathing Through pH-Dependent Release of ATP	SCIENCE			English	Article							IN-VIVO; RETROTRAPEZOID NUCLEUS; SYNAPTIC-TRANSMISSION; NEURONS; POTENTIATION; RATS	Astrocytes provide structural and metabolic support for neuronal networks, but direct evidence demonstrating their active role in complex behaviors is limited. Central respiratory chemosensitivity is an essential mechanism that, via regulation of breathing, maintains constant levels of blood and brain pH and partial pressure of CO(2). We found that astrocytes of the brainstem chemoreceptor areas are highly chemosensitive. They responded to physiological decreases in pH with vigorous elevations in intracellular Ca(2+) and release of adenosine triphosphate (ATP). ATP propagated astrocytic Ca(2+) excitation, activated chemoreceptor neurons, and induced adaptive increases in breathing. Mimicking pH-evoked Ca(2+) responses by means of optogenetic stimulation of astrocytes expressing channelrhodopsin-2 activated chemoreceptor neurons via an ATP-dependent mechanism and triggered robust respiratory responses in vivo. This demonstrates a potentially crucial role for brain glial cells in mediating a fundamental physiological reflex.	[Gourine, Alexander V.; Kasymov, Vitaliy; Marina, Nephtali; Spyer, K. Michael] UCL, London WC1E 6BT, England; [Tang, Feige; Figueiredo, Melina F.; Lane, Samantha; Teschemacher, Anja G.; Kasparov, Sergey] Univ Bristol, Dept Physiol & Pharmacol, Bristol BS8 1TD, Avon, England; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	University of London; University College London; University of Bristol; Stanford University	Gourine, AV (corresponding author), UCL, Mortimer St, London WC1E 6BT, England.	a.gourine@ucl.ac.uk; sergey.kasparov@bristol.ac.uk	Kasparov, Sergey/AAH-5286-2019; Kasparov, Sergey/C-4932-2014	Kasparov, Sergey/0000-0002-1824-1764; Kasparov, Sergey/0000-0002-1824-1764	British Heart Foundation [PG/09/064/27886] Funding Source: Medline; Wellcome Trust [079040] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)		Abbott SBG, 2009, J NEUROSCI, V29, P5806, DOI 10.1523/JNEUROSCI.1106-09.2009; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; FUKUDA Y, 1978, PFLUG ARCH EUR J PHY, V376, P229, DOI 10.1007/BF00584955; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Gourine AV, 2005, NATURE, V436, P108, DOI 10.1038/nature03690; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Halassa MM, 2007, J NEUROSCI, V27, P6473, DOI 10.1523/JNEUROSCI.1419-07.2007; Halassa MM, 2009, NEURON, V61, P213, DOI 10.1016/j.neuron.2008.11.024; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hwang DY, 2001, HUM GENE THER, V12, P1731, DOI 10.1089/104303401750476230; Iadecola C, 2007, NAT NEUROSCI, V10, P1369, DOI 10.1038/nn2003; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; LOESCHCKE HH, 1982, J PHYSIOL-LONDON, V332, P1; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Mulkey DK, 2004, NAT NEUROSCI, V7, P1360, DOI 10.1038/nn1357; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Ritucci NA, 2005, AM J PHYSIOL-REG I, V289, pR851, DOI 10.1152/ajpregu.00132.2005; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Shcherbo D, 2009, BIOCHEM J, V418, P567, DOI 10.1042/BJ20081949; Souslova EA, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-37; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	26	595	610	4	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					571	575		10.1126/science.1190721	http://dx.doi.org/10.1126/science.1190721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20647426	Green Accepted			2022-12-01	WOS:000280483500039
J	Zhang, CL; Frias, MA; Mele, A; Ruggiu, M; Eom, T; Marney, CB; Wang, HD; Licatalosi, DD; Fak, JJ; Darnell, RB				Zhang, Chaolin; Frias, Maria A.; Mele, Aldo; Ruggiu, Matteo; Eom, Taesun; Marney, Christina B.; Wang, Huidong; Licatalosi, Donny D.; Fak, John J.; Darnell, Robert B.			Integrative Modeling Defines the Nova Splicing-Regulatory Network and Its Combinatorial Controls	SCIENCE			English	Article							PROTEIN INTERACTIONS; INSIGHTS; INCLUSION; SWITCH; MOTIF	The control of RNA alternative splicing is critical for generating biological diversity. Despite emerging genome-wide technologies to study RNA complexity, reliable and comprehensive RNA-regulatory networks have not been defined. Here, we used Bayesian networks to probabilistically model diverse data sets and predict the target networks of specific regulators. We applied this strategy to identify similar to 700 alternative splicing events directly regulated by the neuron-specific factor Nova in the mouse brain, integrating RNA-binding data, splicing microarray data, Nova-binding motifs, and evolutionary signatures. The resulting integrative network revealed combinatorial regulation by Nova and the neuronal splicing factor Fox, interplay between phosphorylation and splicing, and potential links to neurologic disease. Thus, we have developed a general approach to understanding mammalian RNA regulation at the systems level.	[Zhang, Chaolin; Frias, Maria A.; Mele, Aldo; Ruggiu, Matteo; Eom, Taesun; Marney, Christina B.; Wang, Huidong; Licatalosi, Donny D.; Fak, John J.; Darnell, Robert B.] Rockefeller Univ, Howard Hughes Med Inst, Mol Neurooncol Lab, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Zhang, CL (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Neurooncol Lab, 1230 York Ave, New York, NY 10021 USA.	czhang@rockefeller.edu; darnelr@rockefeller.edu	Darnell, Robert B/B-9022-2008; Marney, Christina Beate/AAK-2494-2021	Darnell, Robert B/0000-0002-5134-8088; Marney, Christina Beate/0000-0001-5475-9811; Frias, Maria A/0000-0001-7753-6290; Ruggiu, Matteo/0000-0002-6404-1210	NIH [NS34389]; Rockefeller University Hospital CTSA [UL1 RR024143]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM095713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034389, R56NS034389] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller University Hospital CTSA; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. R. Krainer for Fox1/2 expression constructs, S. Dewell for Illumina sequencing, and all Darnell lab members for helpful discussions. This work was supported by grants from the NIH to R. B. D. (NS34389) and the Rockefeller University Hospital CTSA (UL1 RR024143). R. B. D. is an Investigator of the Howard Hughes Medical Institute. The HITS-CLIP and microarray data have been deposited to the National Center for Biotechnology Information Sequence Read Archive (SRA019982) and Gene Expression Omnibus (GSE22115) databases, respectively.	Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Bark C, 2004, J NEUROSCI, V24, P8796, DOI 10.1523/JNEUROSCI.1940-04.2004; Blencowe BJ, 2009, GENE DEV, V23, P1379, DOI 10.1101/gad.1788009; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; Dredge BK, 2003, MOL CELL BIOL, V23, P4687, DOI 10.1128/MCB.23.13.4687-4700.2003; Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Martin CL, 2007, AM J MED GENET B, V144B, P869, DOI 10.1002/ajmg.b.30530; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Ponthier JL, 2006, J BIOL CHEM, V281, P12468, DOI 10.1074/jbc.M511556200; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Y, 2009, NUCLEIC ACIDS RES, V37, P5943, DOI 10.1093/nar/gkp625; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108	27	206	211	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2010	329	5990					439	443		10.1126/science.1191150	http://dx.doi.org/10.1126/science.1191150			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20558669	Green Accepted			2022-12-01	WOS:000280196500037
J	Gudasz, C; Bastviken, D; Steger, K; Premke, K; Sobek, S; Tranvik, LJ				Gudasz, Cristian; Bastviken, David; Steger, Kristin; Premke, Katrin; Sobek, Sebastian; Tranvik, Lars J.			Temperature-controlled organic carbon mineralization in lake sediments	NATURE			English	Article							TERRESTRIAL CARBON; CLIMATE-CHANGE; BOREAL FOREST; SOIL CARBON; BURIAL; CYCLE; ACCUMULATION; RESPIRATION; RESERVOIRS; DYNAMICS	Peatlands, soils and the ocean floor are well-recognized as sites of organic carbonaccumulation andrepresentimportant global carbon sinks(1,2). Although the annual burial of organic carbon in lakes and reservoirs exceeds that of ocean sediments(3), these inland waters are components of the global carbon cycle that receive only limited attention(4-6). Of the organic carbon that is being deposited onto the sediments, a certain proportion will be mineralized and the remainder will be buried over geological timescales. Here we assess the relationship between sediment organic carbon mineralization and temperature in a cross-system survey of boreal lakes in Sweden, and with input froma compilation of published data from awide range of lakes that differ with respect to climate, productivity and organic carbon source. We find that the mineralization of organic carbon in lake sediments exhibits a strongly positive relationship with temperature, which suggests that warmer water temperatures lead to more mineralization and less organic carbon burial. Assuming that future organic carbon delivery to the lake sediments will be similar to that under present-day conditions, we estimate that temperature increases following the latest scenarios presented by the Intergovernmental Panel on Climate Change(7) could result in a 4-27 per cent (0.9-6.4 Tg Cyr(-1)) decrease in annual organic carbon burial in boreal lakes.	[Gudasz, Cristian; Steger, Kristin; Premke, Katrin; Sobek, Sebastian; Tranvik, Lars J.] Uppsala Univ, Dept Ecol & Evolut, SE-75236 Uppsala, Sweden; [Bastviken, David] Linkoping Univ, Dept Themat Studies Water & Environm Studies, SE-58662 Linkoping, Sweden	Uppsala University; Linkoping University	Gudasz, C (corresponding author), Uppsala Univ, Dept Ecol & Evolut, Norbyvagen 18D, SE-75236 Uppsala, Sweden.	cristian.gudasz@ebc.uu.se	Steger, Kristin/F-4187-2014; Steger, Kristin/F-3000-2014; Tranvik, Lars J/H-2222-2011	Steger, Kristin/0000-0001-6446-8022; Bastviken, David/0000-0003-0038-2152; Tranvik, Lars J./0000-0003-3509-8266; Steger, Kristin/0000-0002-7737-0697; Premke, Katrin/0000-0001-6216-5386	FORMAS (the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning); VR (the Swedish Research Council)	FORMAS (the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning)(Swedish Research Council Formas); VR (the Swedish Research Council)(Swedish Research Council)	The study was part of the research environment LEREC (Lake Ecosystem Response to Environmental Change), financially supported by FORMAS (the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning). Additional funding from VR (the Swedish Research Council) to L.J.T. and to D.B., and from FORMAS to S.S., is acknowledged.	ANDERSEN JM, 1976, WATER RES, V10, P329, DOI 10.1016/0043-1354(76)90175-5; Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Benoy G, 2007, ENVIRON REV, V15, P175, DOI 10.1139/A07-006; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Dean WE, 1998, GEOLOGY, V26, P535, DOI 10.1130/0091-7613(1998)026<0535:MASOCB>2.3.CO;2; den Heyer C, 1998, LIMNOL OCEANOGR, V43, P695, DOI 10.4319/lo.1998.43.4.0695; DeStasio BT, 1996, LIMNOL OCEANOGR, V41, P1136, DOI 10.4319/lo.1996.41.5.1136; Dorrepaal E, 2009, NATURE, V460, P616, DOI 10.1038/nature08216; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; Downing JA, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002854; Einsele G, 2001, GLOBAL PLANET CHANGE, V30, P167, DOI 10.1016/S0921-8181(01)00105-9; Emerson S, 1988, PALEOCEANOGRAPHY, V3, P621, DOI 10.1029/PA003i005p00621; Fang X, 1999, CLIMATIC CHANGE, V42, P377, DOI 10.1023/A:1005431523281; Girard R. E., 2007, HIST CHEM PHYS BIOL; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; GRANELI W, 1979, Holarctic Ecology, V2, P51; Hansen J, 1999, J GEOPHYS RES-ATMOS, V104, P30997, DOI 10.1029/1999JD900835; HARDEN JW, 1992, SCIENCE, V258, P1921, DOI 10.1126/science.258.5090.1921; Hu┬skuldsson A., 1988, J CHEMOMETR, V2, P211, DOI DOI 10.1002/CEM.1180020306; Jankowski T, 2006, LIMNOL OCEANOGR, V51, P815, DOI 10.4319/lo.2006.51.2.0815; Kortelainen P, 2006, GLOBAL CHANGE BIOL, V12, P1554, DOI 10.1111/j.1365-2486.2006.01167.x; Molot LA, 1996, GLOBAL BIOGEOCHEM CY, V10, P483, DOI 10.1029/96GB01666; MULHOLLAND PJ, 1982, TELLUS, V34, P490, DOI 10.1111/j.2153-3490.1982.tb01837.x; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; PACE ML, 2004, RESP AQUATIC SYSTEMS, P103; PERSSON G, 2009, 4552 NAT SWED EPA; Rapalee G, 1998, GLOBAL BIOGEOCHEM CY, V12, P687, DOI 10.1029/98GB02336; SCHLESINGER WH, 1990, NATURE, V348, P232, DOI 10.1038/348232a0; Sobek S, 2009, LIMNOL OCEANOGR, V54, P2243, DOI 10.4319/lo.2009.54.6.2243; Solomon S., 2007, ADV CLIM CHANG RES; Stallard RF, 1998, GLOBAL BIOGEOCHEM CY, V12, P231, DOI 10.1029/98GB00741; Tranvik LJ, 2009, LIMNOL OCEANOGR, V54, P2298, DOI 10.4319/lo.2009.54.6_part_2.2298; Trumbore SE, 1997, J GEOPHYS RES-ATMOS, V102, P28817, DOI 10.1029/97JD02231; Wetzel R. G, 1990, VERH INT VEREIN LIMN, V24, P6, DOI DOI 10.1080/03680770.1989.11898687; ZAR JH, 1984, BIOSTAT ANAL, P292	35	351	376	20	403	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					478	U3		10.1038/nature09186	http://dx.doi.org/10.1038/nature09186			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20651689	Green Submitted			2022-12-01	WOS:000280141200033
J	Pujades-Rodriguez, M; Balkan, S; Arnould, L; Brinkhof, MAW; Calmy, A				Pujades-Rodriguez, Mar; Balkan, Suna; Arnould, Line; Brinkhof, Martin A. W.; Calmy, Alexandra		AIDS Working Grp MSF	Treatment Failure and Mortality Factors in Patients Receiving Second-Line HIV Therapy in Resource-Limited Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANTIRETROVIRAL THERAPY; MULTIPLE IMPUTATION; MISSING VALUES; POOR SETTINGS; VIRAL LOAD; REGIMEN; ADHERENCE; SURVIVAL; RESISTANCE; PROGRAM	Context Long-term antiretroviral therapy (ART) use in resource-limited countries leads to increasing numbers of patients with HIV taking second-line therapy. Limited access to further therapeutic options makes essential the evaluation of second-line regimen efficacy in these settings. Objectives To investigate failure rates in patients receiving second-line therapy and factors associated with failure and death. Design, Setting, and Participants Multicohort study of 632 patients >14 years old receiving second-line therapy for more than 6 months in 27 ART programs in Africa and Asia between January 2001 and October 2008. Main Outcome Measures Clinical, immunological, virological, and immunovirological failure (first diagnosed episode of immunological or virological failure) rates, and mortality after 6 months of second-line therapy use. Sensitivity analyses were performed using alternative CD4 cell count thresholds for immunological and immunovirological definitions of failure and for cohort attrition instead of death. Results The 632 patients provided 740.7 person-years of follow-up; 119 (18.8%) met World Health Organization failure criteria after a median 11.9 months following the start of second-line therapy (interquartile range [IQR], 8.7-17.0 months), and 34 (5.4%) died after a median 15.1 months (IQR, 11.9-25.7 months). Failure rates were lower in those who changed 2 nucleoside reverse transcriptase inhibitors (NRTIs) instead of 1 (179.2 vs 251.6 per 1000 person-years; incidence rate ratio [IRR], 0.64; 95% confidence interval [CI], 0.42-0.96), and higher in those with lowest adherence index (383.5 vs 176.0 per 1000 person-years; IRR, 3.14; 95% CI, 1.67-5.90 for <80% vs >= 95% [percentage adherent, as represented by percentage of appointments attended with no delay]). Failure rates increased with lower CD4 cell counts when second-line therapy was started, from 156.3 vs 96.2 per 1000 person-years; IRR, 1.59 (95% CI, 0.78-3.25) for 100 to 199/mu L to 336.8 per 1000 person-years; IRR, 3.32 (95% CI, 1.81-6.08) for less than 50/mu L vs 200/mu L or higher; and decreased with time using second-line therapy, from 250.0 vs 123.2 per 1000 person-years; IRR, 1.90 (95% CI, 1.19-3.02) for 6 to 11 months to 212.0 per 1000 person-years; 1.71 (95% CI, 1.01-2.88) for 12 to 17 months vs 18 or more months. Mortality for those taking second-line therapy was lower in women (32.4 vs 68.3 per 1000 person-years; hazard ratio [HR], 0.45; 95% CI, 0.23-0.91); and higher in patients with treatment failure of any type (91.9 vs 28.1 per 1000 person-years; HR, 2.83; 95% CI, 1.38-5.80). Sensitivity analyses showed similar results. Conclusions Among patients in Africa and Asia receiving second-line therapy for HIV, treatment failure was associated with low CD4 cell counts at second-line therapy start, use of suboptimal second-line regimens, and poor adherence. Mortality was associated with diagnosed treatment failure. JAMA. 2010;304(3):303-312 www.jama.com	[Pujades-Rodriguez, Mar] Med Sans Frontieres, Epictr, F-75011 Paris, France; [Arnould, Line] Med Sans Frontieres, Brussels, Belgium; [Brinkhof, Martin A. W.] Inst Social & Prevent Med, Bern, Switzerland; [Calmy, Alexandra] Med Sans Frontieres Campaign Access Essential Med, Geneva, Switzerland	Doctors Without Borders; Doctors Without Borders; Doctors Without Borders	Pujades-Rodriguez, M (corresponding author), Med Sans Frontieres, Epictr, 42 Bis,Bd,8 Rue St Sabin, F-75011 Paris, France.	mar.pujades@epicentre.msf.org	Pujades-Rodriguez, Mar/G-4388-2014; Pujades-Rodriguez, Mar/T-1129-2018	Pujades-Rodriguez, Mar/0000-0002-7778-3520; Pujades-Rodriguez, Mar/0000-0002-1375-1028; Brinkhof, Martin/0000-0002-9319-665X	Swiss National Science Foundation [32473B-122116]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was partly supported by grant 32473B-122116 from the Swiss National Science Foundation, from which external funds for this particular project were provided. Salaries of Drs Pujades-Rodriguez, Balkan, and Arnould are ensured by MSF (Drs Balkan and Arnould are employed by the Medical Department of MSF; Dr Pujades-Rodriguez is employed by Epicentre, a satellite nongovernmental organization closely linked to and funded by MSF). Role of the Sponsor: The sponsor did not participate in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript. Online-Only Material: eTables 1 through 4 are available at http://www.jama.com.	Ananworanich J, 2007, FUTURE HIV THERAPY, V1, P81; [Anonymous], 2009, RAP ADV ANT THER HIV; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Calmy A, 2004, AIDS, V18, P2353; Calmy A, 2006, AIDS, V20, P1163, DOI 10.1097/01.aids.0000226957.79847.d6; Carlin JB, 2008, STATA J, V8, P49, DOI 10.1177/1536867X0800800104; Chen SCC, 2008, TROP MED INT HEALTH, V13, P513, DOI 10.1111/j.1365-3156.2008.02029.x; Crowley S, 2010, LANCET, V375, P874, DOI 10.1016/S0140-6736(09)62064-X; FEIVESON A, CALCULATING POWER SI; Feiveson AH, 2002, STATA J, V2, P107, DOI 10.1177/1536867X0200200201; Fox MP, 2010, JAIDS-J ACQ IMM DEF, V53, P500, DOI 10.1097/QAI.0b013e3181bcdac1; Gutierrez RG, 2002, STATA J, V2, P22, DOI 10.1177/1536867X0200200102; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; *HIV AIDS DEP WHO, UN ACC SCAL PRIOR HI; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Katlama C, 2009, AIDS, V23, P2289, DOI 10.1097/QAD.0b013e3283316a5e; Keiding N, 1997, STAT MED, V16, P215; Keiser O, 2009, AIDS, V23, P1867, DOI 10.1097/QAD.0b013e32832e05b2; LEWDEN C, 2009, SURVIVAL LOSS TO FOL; Lima VD, 2008, J INFECT DIS, V198, P51, DOI 10.1086/588675; Martin M, 2008, AIDS RES HUM RETROV, V24, P1263, DOI 10.1089/aid.2008.0141; Mocroft A, 2001, AIDS, V15, P201, DOI 10.1097/00002030-200101260-00009; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Petersen ML, 2008, AIDS, V22, P2097, DOI 10.1097/QAD.0b013e32830f97e2; Pujades-Rodriguez M, 2008, AIDS, V22, P1305, DOI 10.1097/QAD.0b013e3282fa75b9; PUJADESRODRIGUE.M, 2010, 18 INT AIDS C JUL 18; Rabe-Hesketh S, 2002, STATA J, V2, P1, DOI 10.1177/1536867X0200200101; Rougemont Mathieu, 2009, AIDS Res Ther, V6, P21, DOI 10.1186/1742-6405-6-21; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Royston P, 2009, STATA J, V9, P252, DOI 10.1177/1536867X0900900205; Rubin D.B., 1987, MULTIPLE IMPUTATION, P1; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; Willig JH, 2008, AIDS, V22, P1951, DOI 10.1097/QAD.0b013e32830efd79; World Health Organization, 2003, SCAL ANT THER RES LT; World Health Organization, 2006, ANT THER HIV INF AD; YAZDANPANAH Y, 2008, 17 INT AIDS C AUG 3; Zhou J, 2010, HIV MED, V11, P31, DOI 10.1111/j.1468-1293.2009.00738.x	39	75	79	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					303	312		10.1001/jama.2010.980	http://dx.doi.org/10.1001/jama.2010.980			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639564	Bronze			2022-12-01	WOS:000280107500020
J	DeWeerdt, S				DeWeerdt, Sarah			Dancing with an escape artist	NATURE			English	Editorial Material							HIV-1											Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Levesque MC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000107	3	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S6	S7		10.1038/nature09237	http://dx.doi.org/10.1038/nature09237			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631705	Bronze			2022-12-01	WOS:000279867100026
J	Cuello, LG; Jogini, V; Cortes, DM; Pan, AC; Gagnon, DG; Dalmas, O; Cordero-Morales, JF; Chakrapani, S; Roux, B; Perozo, E				Cuello, Luis G.; Jogini, Vishwanath; Cortes, D. Marien; Pan, Albert C.; Gagnon, Dominique G.; Dalmas, Olivier; Cordero-Morales, Julio F.; Chakrapani, Sudha; Roux, Benoit; Perozo, Eduardo			Structural basis for the coupling between activation and inactivation gates in K+ channels	NATURE			English	Article							MOLECULAR ARCHITECTURE; EXTERNAL K+; POTASSIUM; ION; DYNAMICS; KCSA; PORE; MECHANISMS; MUTATIONS; STATE	The coupled interplay between activation and inactivation gating is a functional hallmark of K+ channels(1,2). This coupling has been experimentally demonstrated through ion interaction effects(3,4) and cysteine accessibility(1), and is associated with a well defined boundary of energetically coupled residues(2). The structure of the K+ channel KcsA in its fully open conformation, in addition to four other partial channel openings, richly illustrates the structural basis of activation-inactivation gating(5). Here, we identify the mechanistic principles by which movements on the inner bundle gate trigger conformational changes at the selectivity filter, leading to the non-conductive C-type inactivated state. Analysis of a series of KcsA open structures suggests that, as a consequence of the hinge-bending and rotation of the TM2 helix, the aromatic ring of Phe 103 tilts towards residues Thr 74 and Thr 75 in the pore-helix and towards Ile 100 in the neighbouring subunit. This allows the network of hydrogen bonds among residues Trp 67, Glu 71 and Asp 80 to destabilize the selectivity filter(6,7), allowing entry to its non-conductive conformation. Mutations at position 103 have a size-dependent effect on gating kinetics: small side-chain substitutions F103A and F103C severely impair inactivation kinetics, whereas larger side chains such as F103W have more subtle effects. This suggests that the allosteric coupling between the inner helical bundle and the selectivity filter might rely on straightforward mechanical deformation propagated through a network of steric contacts. Average interactions calculated from molecular dynamics simulations show favourable open-state interaction-energies between Phe 103 and the surrounding residues. We probed similar interactions in the Shaker K+ channel where inactivation was impaired in the mutant I470A. We propose that side-chain rearrangements at position 103 mechanically couple activation and inactivation in KcsA and a variety of other K+ channels.	[Cuello, Luis G.; Jogini, Vishwanath; Cortes, D. Marien; Pan, Albert C.; Gagnon, Dominique G.; Dalmas, Olivier; Cordero-Morales, Julio F.; Chakrapani, Sudha; Roux, Benoit; Perozo, Eduardo] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Roux, Benoit; Perozo, Eduardo] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Perozo, E (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 E 57th St, Chicago, IL 60637 USA.	eperozo@uchcicago.edu	Pan, Albert/G-1475-2013	Cordero Morales, Julio/0000-0002-6505-5403; chakrapani, sudha/0000-0003-0722-2338; Pan, Albert/0000-0001-5050-5603	NIH [R01-GM57846]; Palmer family [R01-GM62342]; NRSA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062342, R01GM057846] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Palmer family; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Bezanilla, H Mchaourab and R. Nakamoto for discussions and comments on the manuscript. We also thank K. Locher for comments on the manuscript. R. Mackinnon provided the Fab-expressing hybridoma cells. We thank the members of the Perozo laboratory for comments on the manuscript. We thank K. R. Rajashankar, R. Sanishvili and the staff at the NE-CAT 24ID and GM-CA 23ID beamlines at the Advanced Photon Source, Argonne National Laboratory for assistance during data collection. This work was supported in part by NIH grant R01-GM57846 and a gift from the Palmer family to E.P., by grant R01-GM62342 to B.R. and by an NRSA postdoctoral fellowship to A.C.P.	Ader C, 2009, EMBO J, V28, P2825, DOI 10.1038/emboj.2009.218; Alagem N, 2003, BIOPHYS J, V85, P300, DOI 10.1016/S0006-3495(03)74475-0; Armstrong Clay M, 2003, Sci STKE, V2003, pre10, DOI 10.1126/stke.2003.188.re10; Baukrowitz T, 1996, SCIENCE, V271, P653, DOI 10.1126/science.271.5249.653; Ben-Abu Y, 2009, NAT STRUCT MOL BIOL, V16, P71, DOI 10.1038/nsmb.1525; Berneche S, 2000, BIOPHYS J, V78, P2900, DOI 10.1016/S0006-3495(00)76831-7; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chakrapani S, 2007, J GEN PHYSIOL, V130, P465, DOI 10.1085/jgp.200709843; Chapman M, 2006, PFLUG ARCH EUR J PHY, V451, P776, DOI 10.1007/s00424-005-1515-2; Chen J, 2002, P NATL ACAD SCI USA, V99, P12461, DOI 10.1073/pnas.192367299; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Cortes DM, 2001, J GEN PHYSIOL, V117, P165, DOI 10.1085/jgp.117.2.165; Cortes DM, 1997, BIOCHEMISTRY-US, V36, P10343, DOI 10.1021/bi971018y; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Cuello LG, 1998, BIOCHEMISTRY-US, V37, P3229, DOI 10.1021/bi972997x; DELCOUR AH, 1989, BIOPHYS J, V56, P631, DOI 10.1016/S0006-3495(89)82710-9; DEMO SD, 1992, BIOPHYS J, V61, P639, DOI 10.1016/S0006-3495(92)81869-6; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jogini V, 2007, BIOPHYS J, V93, P3070, DOI 10.1529/biophysj.107.112540; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; Klement G, 2008, BIOPHYS J, V94, P3014, DOI 10.1529/biophysj.107.119842; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Liu YS, 2001, NAT STRUCT BIOL, V8, P883, DOI 10.1038/nsb1001-883; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Olcese R, 2001, J GEN PHYSIOL, V117, P149, DOI 10.1085/jgp.117.2.149; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panyi G, 2006, J GEN PHYSIOL, V128, P547, DOI 10.1085/jgp.200609644; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Proks P, 2001, J GEN PHYSIOL, V118, P341, DOI 10.1085/jgp.118.4.341; Rotem D, 2010, J GEN PHYSIOL, V135, P29, DOI 10.1085/jgp.200910305; Sadovsky E, 2007, P NATL ACAD SCI USA, V104, P19813, DOI 10.1073/pnas.0708120104; Schulte U, 2001, J PHYSIOL-LONDON, V534, P49, DOI 10.1111/j.1469-7793.2001.t01-1-00049.x; SWENSON RP, 1981, NATURE, V291, P427, DOI 10.1038/291427a0; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	44	223	224	1	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2010	466	7303					272	U154		10.1038/nature09136	http://dx.doi.org/10.1038/nature09136			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613845	Green Accepted			2022-12-01	WOS:000279580800044
J	Borthwick, E; Ferguson, A				Borthwick, Emma; Ferguson, Andrew			Perioperative acute kidney injury: risk factors, recognition, management, and outcomes	BMJ-BRITISH MEDICAL JOURNAL			English	Review							GELATINASE-ASSOCIATED LIPOCALIN; ACUTE-RENAL-FAILURE; CARDIAC-SURGERY; PREDICT; MORTALITY		[Ferguson, Andrew] Craigavon Area Hosp, Portadown BT63 5QQ, North Ireland; [Borthwick, Emma] Belfast City Hosp, Belfast BT12 7BA, Antrim, North Ireland	Belfast City Hospital	Ferguson, A (corresponding author), Craigavon Area Hosp, Portadown BT63 5QQ, North Ireland.	fergua@yahoo.ca	Ferguson, Andrew J/B-8878-2012	Ferguson, Andrew J/0000-0002-4081-1567	Northern Ireland Kidney Research Fund; Northern Ireland Research and Development Office	Northern Ireland Kidney Research Fund; Northern Ireland Research and Development Office	All authors have completed the Unified Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that (1) EB and AF have had no support from any company for the submitted work; (2) AF has no relationships with any company that might have an interest in the submitted work in the previous 3 years. EB received travel and accommodation expenses for conference attendance in 2009 from Biosite (Inverness Medical), who manufacture a point of care testing device for NGAL. EB's salary was funded by the Northern Ireland Kidney Research Fund from August 2008 to August 2009. EB received a bursary for part time MPhil fees from the Northern Ireland Research and Development Office; (3) their spouses, partners, or children have no financial relationships that may be relevant to the submitted work; and (4) EB and AF have no non-financial interests that may be relevant to the submitted work.	Abelha FJ, 2009, NEFROLOGIA, V29, P404, DOI 10.3265/Nefrologia.2009.29.5.5456.en.full; Abelha FJ, 2009, CRIT CARE, V13, DOI 10.1186/cc7894; Awad AS, 2007, AM J PHYSIOL-RENAL, V293, pF28, DOI 10.1152/ajprenal.00159.2007; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; Brienza N, 2009, CRIT CARE MED, V37, P2079, DOI 10.1097/CCM.0b013e3181a00a43; Briguori C, 2004, EUR HEART J, V25, P206, DOI 10.1016/j.ehj.2003.11.016; Cerda J, 2008, CLIN J AM SOC NEPHRO, V3, P881, DOI 10.2215/CJN.04961107; De Santo LS, 2010, J HEART VALVE DIS, V19, P139; Dent CL, 2007, CRIT CARE, V11, DOI 10.1186/cc6192; Englberger L, 2011, J THORAC CARDIOV SUR, V141, P552, DOI 10.1016/j.jtcvs.2010.02.045; Friedrich JO, 2005, ANN INTERN MED, V142, P510, DOI 10.7326/0003-4819-142-7-200504050-00010; Haase M, 2009, ANN THORAC SURG, V88, P124, DOI 10.1016/j.athoracsur.2009.04.023; Haase-Fielitz A, 2009, CRIT CARE MED, V37, P553, DOI 10.1097/CCM.0b013e318195846e; Kagan A, 2010, CLIN CARDIOL, V33, P62, DOI 10.1002/clc.20687; Kheterpal S, 2007, ANESTHESIOLOGY, V107, P892, DOI 10.1097/01.anes.0000290588.29668.38; Kheterpal S, 2009, ANESTHESIOLOGY, V110, P505, DOI 10.1097/ALN.0b013e3181979440; Kolhe Nitin V, 2008, Crit Care, V12 Suppl 1, pS2, DOI 10.1186/cc7003; Landoni G, 2008, J CARDIOTHOR VASC AN, V22, P27, DOI 10.1053/j.jvca.2007.07.015; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Levy MM, 2005, CRIT CARE MED, V33, P2194, DOI 10.1097/01.CCM.0000182798.39709.84; Macedo E, 2008, RENAL FAILURE, V30, P287, DOI 10.1080/08860220701857522; McCullough PA, 2005, CRIT CARE CLIN, V21, P261, DOI 10.1016/j.ccc.2004.12.003; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Nickolas TL, 2008, ANN INTERN MED, V148, P810, DOI 10.7326/0003-4819-148-11-200806030-00003; Stewart J, 2009, ADDING INSULT INJURY; Sward K, 2004, CRIT CARE MED, V32, P1310; Uchino S, 2010, NEPHROL DIAL TRANSPL, V25, P1833, DOI 10.1093/ndt/gfp624; Zappitelli M, 2007, CRIT CARE, V11, DOI 10.1186/cc6089	29	83	87	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2010	341								c3365	10.1136/bmj.c3365	http://dx.doi.org/10.1136/bmj.c3365			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625DJ	20603317				2022-12-01	WOS:000279874000002
J	Chudler, EH				Chudler, Eric H.			Resources for Anyone Interested in the Brain	SCIENCE			English	Editorial Material									Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Chudler, EH (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	chudler@u.washington.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [R25RR012312] Funding Source: NIH RePORTER; NCRR NIH HHS [R25RR12312] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		American Association for the Advancement of Science (AAAS), 1993, BENCHM SCI LIT; Cameron W, 2003, NAT REV NEUROSCI, V4, P763, DOI 10.1038/nrn1200; CHUDLER EH, 2002, NEUR ABSTR; CHUDLER EH, 2007, NEUR ABSTR; *DANA, DANA ALL BRAIN IN; Illes J, 2010, NAT REV NEUROSCI, V11, P61, DOI 10.1038/nrn2773; Moore RW, 1997, J RES SCI TEACH, V34, P327, DOI 10.1002/(SICI)1098-2736(199704)34:4<327::AID-TEA3>3.3.CO;2-V; *NIH, 1997, R25RR12312 NIH NAT C; Society for Neuroscience, 2008, BRAIN FACTS PRIM BRA	9	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1648	1649		10.1126/science.1186935	http://dx.doi.org/10.1126/science.1186935			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	615BY	20576881				2022-12-01	WOS:000279107400031
J	Zhang, Y; Zhu, XL; Torelli, AT; Lee, M; Dzikovski, B; Koralewski, RM; Wang, E; Freed, J; Krebs, C; Ealick, SE; Lin, HN				Zhang, Yang; Zhu, Xuling; Torelli, Andrew T.; Lee, Michael; Dzikovski, Boris; Koralewski, Rachel M.; Wang, Eileen; Freed, Jack; Krebs, Carsten; Ealick, Steven E.; Lin, Hening			Diphthamide biosynthesis requires an organic radical generated by an iron-sulphur enzyme	NATURE			English	Article							TOXIN-RESISTANT MUTANTS; S-ADENOSYLMETHIONINE; CRYSTAL-STRUCTURE; DIPHTHERIA-TOXIN; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; SAM; PROTEINS; SYNTHASE; LOCALIZATION	Archaeal and eukaryotic translation elongation factor 2 contain a unique post-translationally modified histidine residue called diphthamide, which is the target of diphtheria toxin. The biosynthesis of diphthamide was proposed to involve three steps, with the first being the formation of a C-C bond between the histidine residue and the 3-amino-3-carboxypropyl group of S-adenosyl-L-methionine (SAM). However, further details of the biosynthesis remain unknown. Here we present structural and biochemical evidence showing that the first step of diphthamide biosynthesis in the archaeon Pyrococcus horikoshii uses a novel iron-sulphur-cluster enzyme, Dph2. Dph2 is a homodimer and each of its monomers can bind a [4Fe-4S] cluster. Biochemical data suggest that unlike the enzymes in the radical SAM superfamily, Dph2 does not form the canonical 59-deoxyadenosyl radical. Instead, it breaks the Cc, Met-S bond of SAM and generates a 3-amino-3-carboxypropyl radical. Our results suggest that P. horikoshii Dph2 represents a previously unknown, SAM-dependent, [4Fe-4S]-containing enzyme that catalyses unprecedented chemistry.	[Zhang, Yang; Zhu, Xuling; Torelli, Andrew T.; Dzikovski, Boris; Koralewski, Rachel M.; Wang, Eileen; Freed, Jack; Ealick, Steven E.; Lin, Hening] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Lee, Michael; Krebs, Carsten] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Krebs, Carsten] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Lin, HN (corresponding author), Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA.	see3@cornell.edu; hl379@cornell.edu	Krebs, Carsten/D-4773-2009	Krebs, Carsten/0000-0002-3302-7053	Dreyfus Foundation; NIH/NIGMS [R01GM088276]; NIH/NCRR [P41-RR016292]; US National Center for Research Resources at the US National Institutes of Health [RR-15301]; US Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR016292, P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088276] Funding Source: NIH RePORTER	Dreyfus Foundation; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US National Center for Research Resources at the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Kinsland for assistance with manuscript preparation, the Dreyfus Foundation for a New Faculty Award to H. L., NIH/NIGMS R01GM088276 to H. L. and S. E. E., and NIH/NCRR P41-RR016292 for the ACERT Center Grant to J.F. This work is based upon research conducted at the Advanced Photon Source (APS), Argonne National Laboratory, on the Northeastern Collaborative Access Team beamlines, which are supported by award RR-15301 from the US National Center for Research Resources at the US National Institutes of Health. Use of the APS is supported by the US Department of Energy, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; *CDCP, 2005, DIPHTH DIS LIST DIPH; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; CHEN JYC, 1985, MOL CELL BIOL, V5, P3357, DOI 10.1128/MCB.5.12.3357; Cicchillo RM, 2005, J AM CHEM SOC, V127, P7310, DOI 10.1021/ja051369x; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Hanzelmann P, 2004, P NATL ACAD SCI USA, V101, P12870, DOI 10.1073/pnas.0404624101; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Layer G, 2003, EMBO J, V22, P6214, DOI 10.1093/emboj/cdg598; Lepore BW, 2005, P NATL ACAD SCI USA, V102, P13819, DOI 10.1073/pnas.0505726102; Lieder KW, 1998, BIOCHEMISTRY-US, V37, P2578, DOI 10.1021/bi972417w; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; MAKINEN GB, 1987, ENDOR EPR ELECT SPIN, P129; Marinoni I, 2008, FEBS J, V275, P5090, DOI 10.1111/j.1742-4658.2008.06641.x; MATTHEAKIS LC, 1992, MOL CELL BIOL, V12, P4026, DOI 10.1128/MCB.12.9.4026; MATTHEAKIS LC, 1993, GENE, V132, P149, DOI 10.1016/0378-1119(93)90528-B; McGlynn SE, 2010, J BACTERIOL, V192, P595, DOI 10.1128/JB.01125-09; MOEHRING JM, 1980, P NATL ACAD SCI-BIOL, V77, P1010, DOI 10.1073/pnas.77.2.1010; MOEHRING TJ, 1984, MOL CELL BIOL, V4, P642, DOI 10.1128/MCB.4.4.642; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ortiz PA, 2006, J BIOL CHEM, V281, P32639, DOI 10.1074/jbc.M607076200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips NJ, 1996, CANCER LETT, V102, P85, DOI 10.1016/0304-3835(96)04169-9; Proudfoot M, 2008, J MOL BIOL, V375, P301, DOI 10.1016/j.jmb.2007.10.060; Rekittke I, 2008, J AM CHEM SOC, V130, P17206, DOI 10.1021/ja806668q; Sakuraba H, 2005, J BIOL CHEM, V280, P26645, DOI 10.1074/jbc.C500192200; Saunders AH, 2008, BIOCHEMISTRY-US, V47, P10999, DOI 10.1021/bi801268f; Schultz DC, 1998, GENOMICS, V52, P186, DOI 10.1006/geno.1998.5420; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105; Walsby CJ, 2002, J AM CHEM SOC, V124, P11270, DOI 10.1021/ja027078v; Walsby CJ, 2002, J AM CHEM SOC, V124, P3143, DOI 10.1021/ja012034s; WALSH CT, 2006, POSTTRANSLATIONAL MO, P321	47	141	145	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2010	465	7300					891	U4		10.1038/nature09138	http://dx.doi.org/10.1038/nature09138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559380	Green Accepted			2022-12-01	WOS:000278804500030
J	Bongaarts, J; Over, M				Bongaarts, John; Over, Mead			Global HIV/AIDS Policy in Transition	SCIENCE			English	Editorial Material							HEALTH; AID		[Bongaarts, John] Populat Council, New York, NY 10017 USA; [Over, Mead] Ctr Global Dev, Washington, DC 20036 USA	Population Council	Bongaarts, J (corresponding author), Populat Council, New York, NY 10017 USA.	jbongaarts@popcouncil.org						[Anonymous], AIDS EP UPD DEC 2007; [Anonymous], 2009, RAP ADV ANT THER HIV; Bongaarts J, 2010, LANCET, V375, P103, DOI 10.1016/S0140-6736(09)61756-6; Clinton Hillary, 2010, COMMUNICATION   0106; Denny CC, 2008, JAMA-J AM MED ASSOC, V300, P2048, DOI 10.1001/jama.2008.556; England R, 2008, BRIT MED J, V336, P1072, DOI 10.1136/bmj.39569.497708.94; *I MED, 2007, PEPFAR IMPL PROGR PR; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; *OFF US GLOB AIDS, 2008, US PRES EM PLAN AIDS; Over M, 2004, MACROECONOMICS OF HIV/AIDS, P311; Over M., 2010, USING INCENTIVES PRE; OVER M, 2009, REV EC DEV, V23, P107; Over M., 2010, GLOBAL AIDS TRANSITI; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Shiffman J, 2008, HEALTH POLICY PLANN, V23, P95, DOI 10.1093/heapol/czm045; UNAIDS, 2009, AIDS EP UPD NOV 2009; WHO, 2009, UN ACC; World Bank, 2009, IMPROVING EFFECTIVENESS AND OUTCOMES FOR THE POOR IN HEALTH, NUTRITION, AND POPULATION: AN EVALUATION OF WORLD BANK GROUP SUPPORT SINCE 1997, P1, DOI 10.1596/978-0-8213-7542-6; World Health Organization, 2020, GLOBAL REPORT EPIDEM	20	33	33	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 11	2010	328	5984					1359	1360		10.1126/science.1191804	http://dx.doi.org/10.1126/science.1191804			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608PO	20538936				2022-12-01	WOS:000278598400023
J	Oreskes, N; Conway, EM				Oreskes, Naomi; Conway, Erik M.			Defeating the merchants of doubt	NATURE			English	Editorial Material									[Oreskes, Naomi] Univ Calif San Diego, La Jolla, CA 92093 USA; [Conway, Erik M.] CALTECH, Pasadena, CA 91109 USA	University of California System; University of California San Diego; California Institute of Technology	Oreskes, N (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	naoreskes@ucsd.edu						Gleick PH, 2010, SCIENCE, V328, P689, DOI 10.1126/science.328.5979.689; GWYNNE P, 1975, NEWSWEEK        0428, V64; HANSEN J, 1981, SCIENCE, V213, P957, DOI 10.1126/science.213.4511.957; Leiserowitz A., 2003, THESIS U OREGON; Michaels David, 2008, ENVIRON HEALTH PERSP, DOI DOI 10.1289/EHP.117-A218A; *NAT AC SCI ARCH, 1979, EV EV CO2 IND CLIM C; Nisbet MC, 2007, PUBLIC OPIN QUART, V71, P444, DOI 10.1093/poq/nfm031; Nisbet MC, 2007, SCIENCE, V316, P56, DOI 10.1126/science.1142030; Oreskes N., 2010, MERCHANTS DOUBT; Peterson TC, 2008, B AM METEOROL SOC, V89, P1325, DOI 10.1175/2008BAMS2370.1	10	92	93	6	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					686	687		10.1038/465686a	http://dx.doi.org/10.1038/465686a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608AM	20535183				2022-12-01	WOS:000278551800017
J	Gustafson, JL; Lim, D; Miller, SJ				Gustafson, Jeffrey L.; Lim, Daniel; Miller, Scott J.			Dynamic Kinetic Resolution of Biaryl Atropisomers via Peptide-Catalyzed Asymmetric Bromination	SCIENCE			English	Article							ORGANIC-SYNTHESIS; N-BROMOSUCCINIMIDE; METAL-COMPLEXES; DIMETHYLFORMAMIDE; STEREOCHEMISTRY; RACEMIZATION; DERIVATIVES; CONVERSION; DIPHENYLS; MILD	Despite the widespread use of axially chiral, or atropisomeric, biaryl ligands in modern synthesis and the occurrence of numerous natural products exhibiting axial chirality, few catalytic methods have emerged for the direct asymmetric preparation of this compound class. Here, we present a tripeptide-derived small-molecule catalyst for the dynamic kinetic resolution of racemic biaryl substrates. The reaction proceeds via an atropisomer-selective electrophilic aromatic substitution reaction using simple bromination reagents. The result is an enantioselective synthesis that delivers chiral nonracemic biaryl compounds with excellent optical purity and good isolated chemical yields (in most cases a >95:5 enantiomer ratio and isolated yields of 65 to 87%). A mechanistic model is advanced that accounts for the basis of selectivity observed.	[Gustafson, Jeffrey L.; Lim, Daniel; Miller, Scott J.] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University	Miller, SJ (corresponding author), Yale Univ, Dept Chem, 225 Prospect St,POB 208107, New Haven, CT 06520 USA.	scott.miller@yale.edu	Miller, Scott/N-7761-2017	Miller, Scott/0000-0001-7817-1318	National Institute of General Medical Sciences of the NIH [GM068649]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM068649, R01GM068649] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the National Institute of General Medical Sciences of the NIH for support (GM068649). Metrical parameters for the solid state structure of compound 3d are available free of charge from the Cambridge Crystallographic Data Centre under CCDC-773872.	Adams R, 1933, CHEM REV, V12, P261, DOI 10.1021/cr60042a003; Ahmad SM, 2007, TETRAHEDRON LETT, V48, P915, DOI 10.1016/j.tetlet.2006.12.042; BOTT G, 1980, J AM CHEM SOC, V102, P5618, DOI 10.1021/ja00537a036; Bringmann G, 2001, ACCOUNTS CHEM RES, V34, P615, DOI 10.1021/ar000106z; Bringmann G, 2005, ANGEW CHEM INT EDIT, V44, P5384, DOI 10.1002/anie.200462661; Clayden J, 2009, ANGEW CHEM INT EDIT, V48, P6398, DOI 10.1002/anie.200901719; Clayden J, 2009, J AM CHEM SOC, V131, P5331, DOI 10.1021/ja900722q; Davie EAC, 2007, CHEM REV, V107, P5759, DOI 10.1021/cr068377w; Denmark SE, 2008, ANGEW CHEM INT EDIT, V47, P1560, DOI 10.1002/anie.200604943; Eliel E. N., 1994, STEREOCHEMISTRY ORGA; France S, 2005, EUR J ORG CHEM, V2005, P475, DOI 10.1002/ejoc.200400517; Haque TS, 1996, J AM CHEM SOC, V118, P6975, DOI 10.1021/ja960429j; HAYASHI T, 1988, J AM CHEM SOC, V110, P8153, DOI 10.1021/ja00232a030; JOHNSON F, 1968, CHEM REV, V68, P375, DOI 10.1021/cr60254a001; Kakiuchi F, 2000, TETRAHEDRON-ASYMMETR, V11, P2647, DOI 10.1016/S0957-4166(00)00244-5; KENDE AS, 1976, J AM CHEM SOC, V98, P267, DOI 10.1021/ja00417a060; Kenner J, 1921, J CHEM SOC, V119, P593, DOI 10.1039/ct9211900593; Lewis CA, 2008, J AM CHEM SOC, V130, P16358, DOI 10.1021/ja807120z; Li XL, 2003, J ORG CHEM, V68, P5500, DOI 10.1021/jo0340206; Littke AF, 2000, J AM CHEM SOC, V122, P4020, DOI 10.1021/ja0002058; Martin R, 2009, ANGEW CHEM INT EDIT, V48, P8042, DOI 10.1002/anie.200903743; MEYERS AI, 1985, J AM CHEM SOC, V107, P682, DOI 10.1021/ja00289a023; Miller SJ, 2004, ACCOUNTS CHEM RES, V37, P601, DOI 10.1021/ar030061c; MITCHELL RH, 1979, J ORG CHEM, V44, P4733, DOI 10.1021/jo00393a066; NOYORI R, 1995, B CHEM SOC JPN, V68, P36, DOI 10.1246/bcsj.68.36; NOYORI R, 1990, ACCOUNTS CHEM RES, V23, P345, DOI 10.1021/ar00178a005; Sakakura A, 2007, NATURE, V445, P900, DOI 10.1038/nature05553; Seebach D, 1997, TETRAHEDRON, V53, P7539, DOI 10.1016/S0040-4020(97)00456-0; SHINDO M, 1992, J AM CHEM SOC, V114, P8732, DOI 10.1021/ja00048a074; Steinreiber J, 2008, CHEM-EUR J, V14, P8060, DOI 10.1002/chem.200701643; Stoughton RW, 1932, J AM CHEM SOC, V54, P4426, DOI 10.1021/ja01350a046; Watson DA, 2009, SCIENCE, V325, P1661, DOI 10.1126/science.1178239; Yin JJ, 2000, J AM CHEM SOC, V122, P12051, DOI 10.1021/ja005622z; Zhang W, 2009, J AM CHEM SOC, V131, P3832, DOI 10.1021/ja8099008	34	311	311	6	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1251	1255		10.1126/science.1188403	http://dx.doi.org/10.1126/science.1188403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	605AC	20522769	Green Accepted			2022-12-01	WOS:000278318600027
J	Kahn, R; Gale, EAM				Kahn, Richard; Gale, Edwin A. M.			Gridlocked guidelines for diabetes	LANCET			English	Editorial Material									[Kahn, Richard] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Gale, Edwin A. M.] Univ Bristol, Fac Med, Bristol BS8 1TH, Avon, England	University of North Carolina; University of North Carolina Chapel Hill; University of Bristol	Kahn, R (corresponding author), Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA.	rak6200@gmail.com						*AACE DIAB MELL CL, 2007, ENDOCR PRACT S1, V13, P1; [Anonymous], 1989, DIABETES CARE, V12, P365; Burgers JS, 2002, DIABETES CARE, V25, P1933, DOI 10.2337/diacare.25.11.1933; Ferket BS, 2010, ARCH INTERN MED, V170, P27, DOI 10.1001/archinternmed.2009.434; International Diabetes Federation, 2005, GLOB GUID TYP 2 DIAB; Matthys J, 2007, ANN FAM MED, V5, P436, DOI 10.1370/afm.741; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Shaneyfelt TM, 2009, JAMA-J AM MED ASSOC, V301, P868, DOI 10.1001/jama.2009.225; Sniderman AD, 2009, JAMA-J AM MED ASSOC, V301, P429, DOI 10.1001/jama.2009.15; Stone MA, 2010, DIABETES RES CLIN PR, V87, P252, DOI 10.1016/j.diabres.2009.10.020	10	21	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2010	375	9733					2203	2204		10.1016/S0140-6736(10)60714-3	http://dx.doi.org/10.1016/S0140-6736(10)60714-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	622HS	20609960				2022-12-01	WOS:000279652900009
J	Solomon, GM; Janssen, S				Solomon, Gina M.; Janssen, Sarah			Health Effects of the Gulf Oil Spill	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Solomon, Gina M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94104 USA; [Solomon, Gina M.] Nat Resources Def Council, San Francisco, CA 94104 USA	University of California System; University of California San Francisco	Solomon, GM (corresponding author), Univ Calif San Francisco, Dept Med, 111 Sutter St,20th Floor, San Francisco, CA 94104 USA.	gsolomon@nrdc.org		Solomon, Gina/0000-0001-6004-0387				ATSDR (Agency for Toxic Substances and Disease Registry), 1999, TOX PROF TOT PETR HY; GORMA RW, 1991, HETA 89 200 89 273 2; Law R.J., 1999, ENV GEOSCI, V6, P90, DOI [10.1046/j.1526-0984.1999.08039.x, DOI 10.1046/J.1526-0984.1999.08039.X]; *NAT TOX PROGR, 2005, REP CARC; ONEILL AK, 2003, SELF REPORTED EXPOSU; PALINKAS LA, 1993, AM J PSYCHIAT, V150, P1517; Rodriguez-Trigo G, 2007, ARCH BRONCONEUMOL, V43, P628; Sabucedo JM, 2010, DISASTERS, V34, P809, DOI 10.1111/j.1467-7717.2010.01170.x; *US EPA, OD BP OIL SPILL; Zock JP, 2007, AM J RESP CRIT CARE, V176, P610, DOI 10.1164/rccm.200701-016OC	10	68	67	0	25	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2010	304	10					1118	1119		10.1001/jama.2010.1254	http://dx.doi.org/10.1001/jama.2010.1254			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646RM	20713544				2022-12-01	WOS:000281559800024
J	Bieling, P; Telley, IA; Surrey, T				Bieling, Peter; Telley, Ivo A.; Surrey, Thomas			A Minimal Midzone Protein Module Controls Formation and Length of Antiparallel Microtubule Overlaps	CELL			English	Article							EGG EXTRACT SPINDLES; MITOTIC SPINDLE; FISSION YEAST; DYNAMIC INSTABILITY; ANAPHASE-B; PRC1; CYTOKINESIS; MOTORS; FORCE; ASE1P	During cell division, microtubules are arranged in a large bipolar structure, the mitotic spindle, to segregate the duplicated chromosomes. Antiparallel microtubule overlaps in the spindle center are essential for establishing bipolarity and maintaining spindle stability throughout mitosis. In anaphase, this antiparallel microtubule array is tightly bundled forming the midzone, which serves as a hub for the recruitment of proteins essential for late mitotic events. The molecular mechanism of midzone formation and the control of its size are not understood. Using an in vitro reconstitution approach, we show here that PRC1 autonomously bundles antiparallel microtubules and recruits Xklp1, a kinesin-4, selectively to overlapping antiparallel microtubules. The processive motor Xklp1 controls overlap size by overlap length-dependent microtubule growth inhibition. Our results mechanistically explain how the two conserved, essential midzone proteins PRC1 and Xklp1 cooperate to constitute a minimal protein module capable of dynamically organizing the core structure of the central anaphase spindle.	[Bieling, Peter; Telley, Ivo A.; Surrey, Thomas] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Surrey, T (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	surrey@embl.de	Telley, Ivo Andreas/D-2063-2011; Surrey, Thomas/AAC-4608-2021	Telley, Ivo Andreas/0000-0003-4444-1046; Bieling, Peter/0000-0002-7458-4358; Surrey, Thomas/0000-0001-9082-1870	DFG; HFSPO; European Commission; Swiss National Science Foundation	DFG(German Research Foundation (DFG)); HFSPO(Human Frontier Science Program); European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank Vladimir Rybin for analytical ultracentrifugation, Jan Ellenberg, Elmar Schiebel, Johanna Roostalu, and Scott Hansen for critically reading the manuscript, and the DFG, HFSPO, the European Commission (STREP "Active Biomics''), and the Swiss National Science Foundation for financial support.	Arnal I, 2004, CURR BIOL, V14, P2086, DOI 10.1016/j.cub.2004.11.055; Bieling P, 2010, METHOD CELL BIOL, V95, P555, DOI 10.1016/S0091-679X(10)95028-0; Bieling P, 2010, CURR BIOL, V20, P763, DOI 10.1016/j.cub.2010.02.067; Bratman SV, 2007, DEV CELL, V13, P812, DOI 10.1016/j.devcel.2007.10.015; Bringmann H, 2004, SCIENCE, V303, P1519, DOI 10.1126/science.1094838; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Cheerambathur DK, 2007, J CELL BIOL, V177, P995, DOI 10.1083/jcb.200611113; Cottingham FR, 1999, J CELL BIOL, V147, P335, DOI 10.1083/jcb.147.2.335; DRECHSEL DN, 1992, MOL BIOL CELL, V3, P1141, DOI 10.1091/mbc.3.10.1141; Fu CH, 2009, DEV CELL, V17, P257, DOI 10.1016/j.devcel.2009.06.012; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Janson ME, 2003, J CELL BIOL, V161, P1029, DOI 10.1083/jcb.200301147; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapitein LC, 2008, CURR BIOL, V18, P1713, DOI 10.1016/j.cub.2008.09.046; Kapoor TM, 2001, J CELL BIOL, V154, P1125, DOI 10.1083/jcb.200106011; Khmelinskii A, 2008, CELL CYCLE, V7, P283, DOI 10.4161/cc.7.3.5349; Khmelinskii A, 2007, J CELL BIOL, V177, P981, DOI 10.1083/jcb.200702145; Khmelinskii A, 2009, DEV CELL, V17, P244, DOI 10.1016/j.devcel.2009.06.011; Kinoshita K, 2001, SCIENCE, V294, P1340, DOI 10.1126/science.1064629; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Kwon M, 2004, MOL BIOL CELL, V15, P219, DOI 10.1091/mbc.E03-07-0489; Lee YM, 2004, EXP MOL MED, V36, P93, DOI 10.1038/emm.2004.13; Liu J, 2009, J BIOL CHEM, V284, P23059, DOI 10.1074/jbc.M109.009670; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; MASTRONARDE DN, 1993, J CELL BIOL, V123, P1475, DOI 10.1083/jcb.123.6.1475; Miyamoto DT, 2004, J CELL BIOL, V167, P813, DOI 10.1083/jcb.200407126; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Muller S, 2004, CURR BIOL, V14, P412, DOI 10.1016/j.cub.2004.02.032; OTHMER HG, 1988, J MATH BIOL, V26, P263, DOI 10.1007/BF00277392; Pearson CG, 2006, MOL BIOL CELL, V17, P4069, DOI 10.1091/mbc.E06-04-0312; Powers J, 2004, J CELL BIOL, V166, P991, DOI 10.1083/jcb.200403036; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; Sagolla MJ, 2003, J CELL SCI, V116, P4891, DOI 10.1242/jcs.00796; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Telley IA, 2009, BIOPHYS J, V96, P3341, DOI 10.1016/j.bpj.2009.01.015; Tischer C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.5; Tournebize R, 1997, EMBO J, V16, P5537, DOI 10.1093/emboj/16.18.5537; TRANQUILLO RT, 1987, J MATH BIOL, V25, P229, DOI 10.1007/BF00276435; Uteng M, 2008, J CELL BIOL, V182, P715, DOI 10.1083/jcb.200801125; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; Verbrugghe KJC, 2004, CURR BIOL, V14, P1755, DOI 10.1016/j.cub.2004.09.055; Verni F, 2004, CURR BIOL, V14, P1569, DOI 10.1016/j.cub.2004.08.054; VERNOS I, 1995, CELL, V81, P117, DOI 10.1016/0092-8674(95)90376-3; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; West RR, 2001, MOL BIOL CELL, V12, P3919, DOI 10.1091/mbc.12.12.3919; Zhu CJ, 2005, P NATL ACAD SCI USA, V102, P343, DOI 10.1073/pnas.0408438102; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167	57	204	206	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					420	432		10.1016/j.cell.2010.06.033	http://dx.doi.org/10.1016/j.cell.2010.06.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691901	Bronze			2022-12-01	WOS:000280609100019
J	Kim, Y; Holland, AJ; Lan, W; Cleveland, DW				Kim, Yumi; Holland, Andrew J.; Lan, Weijie; Cleveland, Don W.			Aurora Kinases and Protein Phosphatase 1 Mediate Chromosome Congression through Regulation of CENP-E	CELL			English	Article							SMALL-MOLECULE INHIBITOR; MITOTIC CHECKPOINT; OUTER KINETOCHORE; KINESIN MOTOR; CELL-DIVISION; SPINDLE POLE; B KINASE; A KINASE; MICROTUBULE; ANEUPLOIDY	Opposing roles of Aurora kinases and protein phosphatase 1 (PP1) during mitosis have long been suggested. Here, we demonstrate that Aurora kinases A and B phosphorylate a conserved residue on the kinetochore motor CENP-E. PP1 binds CENP-E via a motif overlapping this phosphorylation site and binding is disrupted by Aurora phosphorylation. Phosphorylation of CENP-E by the Auroras is enriched at spindle poles, disrupting binding of PP1 and reducing CENP-E's affinity for individual microtubules. This phosphorylation is required for CENP-E-mediated towing of initially polar chromosomes toward the cell center. Kinetochores on such chromosomes cannot make subsequent stable attachment to spindle microtubules when dephosphorylation of CENP-E or rebinding of PP1 to CENP-E is blocked. Thus, an Aurora/PP1 phosphorylation switch modulates CENP-E motor activity as an essential feature of chromosome congression from poles and localized PP1 delivery by CENP-E to the outer kinetochore is necessary for stable microtubule capture by those chromosomes.	[Kim, Yumi; Holland, Andrew J.; Lan, Weijie; Cleveland, Don W.] Univ Calif Berkeley, Ludwig Inst Canc Res, Berkeley, CA 94720 USA; [Kim, Yumi] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Cleveland, Don W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Diego	Cleveland, DW (corresponding author), Univ Calif Berkeley, Ludwig Inst Canc Res, Berkeley, CA 94720 USA.	dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021	Cleveland, Don/0000-0002-1934-3682	National Institutes of Health [GM29513]; Ludwig Institute for Cancer Research; European Molecular Biology Organization (EMBO); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029513, R37GM029513] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute for Cancer Research; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to thank Stephen Taylor, Patrick Eyers, Todd Stukenberg, and Arshad Desai for providing reagents. This work was supported by a grant (GM29513) from the National Institutes of Health to D. W.C., who receives salary support from the Ludwig Institute for Cancer Research. A.J.H. is supported by a European Molecular Biology Organization (EMBO) Long-Term Fellowship.	Akiyoshi B, 2009, GENE DEV, V23, P2887, DOI 10.1101/gad.1865909; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cimini D, 2005, TRENDS CELL BIOL, V15, P442, DOI 10.1016/j.tcb.2005.06.008; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Emanuele MJ, 2008, J CELL BIOL, V181, P241, DOI 10.1083/jcb.200710019; Espeut J, 2008, MOL CELL, V29, P637, DOI 10.1016/j.molcel.2008.01.004; FRANCISCO L, 1994, MOL CELL BIOL, V14, P4731, DOI 10.1128/MCB.14.7.4731; Gestaut DR, 2008, NAT CELL BIOL, V10, P407, DOI 10.1038/ncb1702; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Hendrickx A, 2009, CHEM BIOL, V16, P365, DOI 10.1016/j.chembiol.2009.02.012; Hoar K, 2007, MOL CELL BIOL, V27, P4513, DOI 10.1128/MCB.02364-06; Holland AJ, 2010, J CELL BIOL, V188, P191, DOI 10.1083/jcb.200911102; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; HUBBARD MJ, 1989, EUR J BIOCHEM, V186, P701, DOI 10.1111/j.1432-1033.1989.tb15263.x; HYMAN AA, 1991, NATURE, V351, P206, DOI 10.1038/351206a0; Kapoor TM, 2006, SCIENCE, V311, P388, DOI 10.1126/science.1122142; Kim Y, 2008, J CELL BIOL, V181, P411, DOI 10.1083/jcb.200802189; Kunitoku N, 2003, DEV CELL, V5, P853, DOI 10.1016/S1534-5807(03)00364-2; Lampson MA, 2004, NAT CELL BIOL, V6, P232, DOI 10.1038/ncb1102; LIAO H, 1994, SCIENCE, V265, P394, DOI 10.1126/science.8023161; Liu D, 2010, J CELL BIOL, V188, P809, DOI 10.1083/jcb.201001006; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Ovechkina Y, 2002, J CELL BIOL, V159, P557, DOI 10.1083/jcb.200205089; Putkey FR, 2002, DEV CELL, V3, P351, DOI 10.1016/S1534-5807(02)00255-1; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Trinkle-Mulcahy L, 2006, J CELL BIOL, V172, P679, DOI 10.1083/jcb.200508154; Trinkle-Mulcahy L, 2003, MOL BIOL CELL, V14, P107, DOI 10.1091/mbc.E02-07-0376; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; Weaver BAA, 2003, J CELL BIOL, V162, P551, DOI 10.1083/jcb.200303167; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Yucel JK, 2000, J CELL BIOL, V150, P1, DOI 10.1083/jcb.150.1.1; Zecevic M, 1998, J CELL BIOL, V142, P1547, DOI 10.1083/jcb.142.6.1547	52	174	176	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					444	455		10.1016/j.cell.2010.06.039	http://dx.doi.org/10.1016/j.cell.2010.06.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691903	Green Accepted, Bronze			2022-12-01	WOS:000280609100021
J	Ito, T; Kwon, HY; Zimdahl, B; Congdon, KL; Blum, J; Lento, WE; Zhao, C; Lagoo, A; Gerrard, G; Foroni, L; Goldman, J; Goh, H; Kim, SH; Kim, DW; Chuah, C; Oehler, VG; Radich, JP; Jordan, CT; Reya, T				Ito, Takahiro; Kwon, Hyog Young; Zimdahl, Bryan; Congdon, Kendra L.; Blum, Jordan; Lento, William E.; Zhao, Chen; Lagoo, Anand; Gerrard, Gareth; Foroni, Letizia; Goldman, John; Goh, Harriet; Kim, Soo-Hyun; Kim, Dong-Wook; Chuah, Charles; Oehler, Vivian G.; Radich, Jerald P.; Jordan, Craig T.; Reya, Tannishtha			Regulation of myeloid leukaemia by the cell-fate determinant Musashi	NATURE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; BINDING PROTEIN MUSASHI-1; CML BLAST CRISIS; STEM-CELLS; BCR-ABL; GENE-EXPRESSION; TRANSLATIONAL REPRESSION; MURINE MODEL; NUMB; RNA	Chronic myelogenous leukaemia (CML) can progress from a slow growing chronic phase to an aggressive blast crisis phase(1), but the molecular basis of this transition remains poorly understood. Here we have used mouse models of CML(2,3) to show that disease progression is regulated by the Musashi-Numb signalling axis(4,5). Specifically, we find that the chronic phase is marked by high levels of Numb expression whereas the blast crisis phase has low levels of Numb expression, and that ectopic expression of Numb promotes differentiation and impairs advanced-phase disease in vivo. As a possible explanation for the decreased levels of Numb in the blast crisis phase, we show that NUP98-HOXA9, an oncogene associated with blast crisis CML(6,7), can trigger expression of the RNA-binding protein Musashi2 (Msi2), which in turn represses Numb. Notably, loss of Msi2 restores Numb expression and significantly impairs the development and propagation of blast crisis CML in vitro and in vivo. Finally we show that Msi2 expression is not only highly upregulated during human CML progression but is also an early indicator of poorer prognosis. These data show that the Musashi-Numb pathway can control the differentiation of CML cells, and raise the possibility that targeting this pathway may provide a new strategy for the therapy of aggressive leukaemias.	[Ito, Takahiro; Kwon, Hyog Young; Zimdahl, Bryan; Congdon, Kendra L.; Blum, Jordan; Lento, William E.; Zhao, Chen; Reya, Tannishtha] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Lagoo, Anand] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Gerrard, Gareth; Foroni, Letizia; Goldman, John] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Haematol, London W12 0NN, England; [Goh, Harriet; Kim, Soo-Hyun; Kim, Dong-Wook] Catholic Univ Korea, Seoul St Marys Hosp, Div Hematol, Seoul, South Korea; [Chuah, Charles] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore Gen Hosp, Dept Haematol, Singapore, Singapore; [Oehler, Vivian G.; Radich, Jerald P.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Jordan, Craig T.] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY 14642 USA	Duke University; Duke University; Imperial College London; Catholic University of Korea; Seoul St. Mary's Hospital; National University of Singapore; Singapore General Hospital; Fred Hutchinson Cancer Center; University of Rochester	Reya, T (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	t.reya@duke.edu	Kwon, Hyog/T-7915-2019; Gerrard, Gareth/B-4375-2009; Ito, Takahiro/F-5006-2011; jordan, craig/D-7666-2014	Kwon, Hyog/0000-0003-1663-5118; Gerrard, Gareth/0000-0002-4614-227X; Ito, Takahiro/0000-0001-7165-0412; jordan, craig/0000-0003-0869-3465	Astellas Foundation for Research on Metabolic Disorders; American Heart Association; Leukemia and Lymphoma Society; ASH; NIH [CA18029, CA140371, CA122206, DK63031, DK072234, AI067798, HL097767, DP1OD006430]; Alexander and Margaret Stewart Fund; Lisa Stafford Research Prize;  [T32 GM007184-33]; NATIONAL CANCER INSTITUTE [P01CA018029, R01CA122206, DP1CA174422, R01CA140371] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063031, R01DK072234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007184] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006430] Funding Source: NIH RePORTER	Astellas Foundation for Research on Metabolic Disorders; American Heart Association(American Heart Association); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); ASH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander and Margaret Stewart Fund; Lisa Stafford Research Prize; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. M. Pendergast, J. Chute, K. Itahana, L. Penalva and L. Grimes for advice and reagents; K.-i. Yamamura for the Msi2 gene-trap mice; T. Honjo for the Rbpj conditional mice; N. Gaiano for the TNR mice; D. Baltimore for the lentiviral shRNA constructs; and A. Means and B. Hogan for comments on the manuscript. We also thank M. Cook, B. Harvat and L. Martinek for cell sorting; M. Fereshteh for advice on analysis of patient samples; D. McDonnell and H. Wade for advice on ChIP experiments; S. W. Tian for help in collecting patient samples and A. Chen and S. Honeycutt for technical help. The BCR-ABL construct was a gift from W. Pear and the NUP98-HOXA9 construct a gift from G. Gilliland. T. I. is the recipient of a postdoctoral fellowship from the Astellas Foundation for Research on Metabolic Disorders, K. L. C. is the recipient of an American Heart Association predoctoral award, B.Z. received support from T32 GM007184-33 and T. R. is the recipient of a Leukemia and Lymphoma Society Scholar Award. This work was also supported by an LLS Translational Research grant and an ASH Junior Faculty Award to V.G.O., as well as NIH grants CA18029 to J. P. R., CA140371 to V.G.O., CA122206 to C. T. J. and DK63031, DK072234, AI067798, HL097767, DP1OD006430 and an Alexander and Margaret Stewart Fund grant to T. R. We are grateful for the support received from the Lisa Stafford Research Prize.	Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Calabretta B, 2004, BLOOD, V103, P4010, DOI 10.1182/blood-2003-12-4111; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Dash AB, 2002, P NATL ACAD SCI USA, V99, P7622, DOI 10.1073/pnas.102583199; Goldman JM, 2008, ACTA HAEMATOL-BASEL, V119, P212, DOI 10.1159/000140633; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Jegga AG, 2002, GENOME RES, V12, P1408, DOI 10.1101/gr.255002; Justice N, 2003, CURR BIOL, V13, P778, DOI 10.1016/S0960-9822(03)00288-4; Knoblich JA, 1997, CURR OPIN CELL BIOL, V9, P833, DOI 10.1016/S0955-0674(97)80085-3; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Mayotte N, 2002, BLOOD, V100, P4177, DOI 10.1182/blood-2002-04-1244; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Nakahara F, 2010, BLOOD, V115, P2872, DOI 10.1182/blood-2009-05-222836; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; Neering SJ, 2007, BLOOD, V110, P2578, DOI 10.1182/blood-2007-02-073031; Okabe M, 2001, NATURE, V411, P94, DOI 10.1038/35075094; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Shen Q, 2002, DEVELOPMENT, V129, P4843; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Taniwaki T, 2005, DEV GROWTH DIFFER, V47, P163; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; Wakamatsu Y, 1999, NEURON, V23, P71, DOI 10.1016/S0896-6273(00)80754-0; Wang HY, 2007, NATURE, V449, P96, DOI 10.1038/nature06056; Witte O, 2001, SEMIN HEMATOL, V38, P3, DOI 10.1016/S0037-1963(01)90111-8; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhao LP, 2001, P NATL ACAD SCI USA, V98, P5631, DOI 10.1073/pnas.101013198	35	260	276	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2010	466	7307					765	U13		10.1038/nature09171	http://dx.doi.org/10.1038/nature09171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20639863	Green Accepted			2022-12-01	WOS:000280562500041
J	Volavka, J; Swanson, J				Volavka, Jan; Swanson, Jeffrey			Violent Behavior in Mental Illness: The Role of Substance Abuse	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SCHIZOPHRENIA; DISORDER; CRIME		[Volavka, Jan] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Swanson, Jeffrey] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC USA	New York University; Duke University	Volavka, J (corresponding author), POB 160663, Big Sky, MT 59716 USA.	janvolavka@gmail.com	Volavka, Jan/E-9529-2019	Volavka, Jan/0000-0002-4178-8207	NIMH NIH HHS [KO2-MH67864, K02 MH067864] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH067864] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brennan PA, 2000, ARCH GEN PSYCHIAT, V57, P494, DOI 10.1001/archpsyc.57.5.494; Elbogen EB, 2009, ARCH GEN PSYCHIAT, V66, P152, DOI 10.1001/archgenpsychiatry.2008.537; Fazel S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000120; Fazel S, 2009, JAMA-J AM MED ASSOC, V301, P2016, DOI 10.1001/jama.2009.675; Krakowski MI, 2006, ARCH GEN PSYCHIAT, V63, P622, DOI 10.1001/archpsyc.63.6.622; Nolan KA, 2003, PSYCHIAT SERV, V54, P1012, DOI 10.1176/appi.ps.54.7.1012; Swanson JW, 2008, LAW HUMAN BEHAV, V32, P228, DOI 10.1007/s10979-007-9095-7; SWANSON JW, 1990, HOSP COMMUNITY PSYCH, V41, P761; Volavka J, 2008, INT J CLIN PRACT, V62, P1237, DOI 10.1111/j.1742-1241.2008.01797.x; Yates KF, 2010, J FORENSIC PSYCHI PS, V21, P167, DOI 10.1080/14789940903174238	10	41	41	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2010	304	5					563	564		10.1001/jama.2010.1097	http://dx.doi.org/10.1001/jama.2010.1097			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	633SQ	20682936	Green Accepted			2022-12-01	WOS:000280525700024
J	Cantagrel, V; Lefeber, DJ; Ng, BG; Guan, ZQ; Silhavy, JL; Bielas, SL; Lehle, L; Hombauer, H; Adamowicz, M; Swiezewska, E; De Brouwer, AP; Blumel, P; Sykut-Cegielska, J; Houliston, S; Swistun, D; Ali, BR; Dobyns, WB; Babovic-Vuksanovic, D; van Bokhoven, H; Wevers, RA; Raetz, CRH; Freeze, HH; Morava, E; Al-Gazali, L; Gleeson, JG				Cantagrel, Vincent; Lefeber, Dirk J.; Ng, Bobby G.; Guan, Ziqiang; Silhavy, Jennifer L.; Bielas, Stephanie L.; Lehle, Ludwig; Hombauer, Hans; Adamowicz, Maciej; Swiezewska, Ewa; De Brouwer, Arjan P.; Bluemel, Peter; Sykut-Cegielska, Jolanta; Houliston, Scott; Swistun, Dominika; Ali, Bassam R.; Dobyns, William B.; Babovic-Vuksanovic, Dusica; van Bokhoven, Hans; Wevers, Ron A.; Raetz, Christian R. H.; Freeze, Hudson H.; Morava, Eva; Al-Gazali, Lihadh; Gleeson, Joseph G.			SRD5A3 Is Required for Converting Polyprenol to Dolichol and Is Mutated in a Congenital Glycosylation Disorder	CELL			English	Article							IONIZATION-MASS-SPECTROMETRY; AUTOSOMAL RECESSIVE SYNDROME; RATE-LIMITING STEP; STEROID 5-ALPHA-REDUCTASE; SACCHAROMYCES-CEREVISIAE; N-GLYCOSYLATION; RAT-LIVER; BIOSYNTHESIS; PHOSPHATE; CDG	N-linked glycosylation is the most frequent modification of secreted and membrane-bound proteins in eukaryotic cells, disruption of which is the basis of the congenital disorders of glycosylation (CDGs). We describe a new type of CDG caused by mutations in the steroid 5 alpha-reductase type 3 (SRD5A3) gene. Patients have mental retardation and ophthalmologic and cerebellar defects. We found that SRD5A3 is necessary for the reduction of the alpha-isoprene unit of polyprenols to form dolichols, required for synthesis of dolichol-linked monosaccharides, and the oligosaccharide precursor used for N-glycosylation. The presence of residual dolichol in cells depleted for this enzyme suggests the existence of an unexpected alternative pathway for dolichol de novo biosynthesis. Our results thus suggest that SRD5A3 is likely to be the long-sought polyprenol reductase and reveal the genetic basis of one of the earliest steps in protein N-linked glycosylation.	[Ali, Bassam R.; Al-Gazali, Lihadh] United Arab Emirates Univ, Sch Med & Hlth Sci, Dept Pathol, Al Ain 17666, U Arab Emirates; [Al-Gazali, Lihadh] United Arab Emirates Univ, Sch Med & Hlth Sci, Dept Pediat, Al Ain 17666, U Arab Emirates; [Cantagrel, Vincent; Silhavy, Jennifer L.; Bielas, Stephanie L.; Swistun, Dominika; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci & Pediat, Inst Genom Med,Neurogenet Lab, La Jolla, CA 92093 USA; [Lefeber, Dirk J.; Wevers, Ron A.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Dept Lab Med, NL-6500 HB Nijmegen, Netherlands; [Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; [De Brouwer, Arjan P.; van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, NL-6500 HB Nijmegen, Netherlands; [Morava, Eva] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Dept Paediat, NL-6500 HB Nijmegen, Netherlands; [Ng, Bobby G.; Houliston, Scott; Freeze, Hudson H.] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, Genet Dis Program, La Jolla, CA 92037 USA; [Guan, Ziqiang; Raetz, Christian R. H.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Lehle, Ludwig] Univ Regensburg, Lehrstuhl Zellbiol & Pflanzenbiochem, D-93053 Regensburg, Germany; [Hombauer, Hans] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Ludwig Inst Canc Res,Dept Med, La Jolla, CA 92093 USA; [Hombauer, Hans] Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA; [Adamowicz, Maciej] Childrens Mem Hlth Inst, Dept Biochem & Expt Med, PL-04730 Warsaw, Poland; [Sykut-Cegielska, Jolanta] Childrens Mem Hlth Inst, Dept Metab Dis Endocrinol & Diabetol, PL-04730 Warsaw, Poland; [Swiezewska, Ewa] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Bluemel, Peter] Preyersches Kinderspital, A-1100 Vienna, Austria; [Dobyns, William B.] Univ Chicago, Dept Human Genet Neurol & Pediat, Chicago, IL 60637 USA; [Babovic-Vuksanovic, Dusica] Mayo Clin, Dept Med Genet, Rochester, MN 55905 USA; [Babovic-Vuksanovic, Dusica] Mayo Clin, Dept Pediat Neurol, Rochester, MN 55905 USA; [Babovic-Vuksanovic, Dusica] Mayo Clin, Dept Lab Genet, Rochester, MN 55905 USA; [Babovic-Vuksanovic, Dusica] Mayo Clin, Dept Pediat Endocrinol, Rochester, MN 55905 USA; [Babovic-Vuksanovic, Dusica] Mayo Clin, Dept Dermatol, Rochester, MN 55905 USA	United Arab Emirates University; United Arab Emirates University; Howard Hughes Medical Institute; University of California System; University of California San Diego; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Sanford Burnham Prebys Medical Discovery Institute; Duke University; University of Regensburg; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Children's Memorial Health Institute; Children's Memorial Health Institute; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Chicago; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Al-Gazali, L (corresponding author), United Arab Emirates Univ, Sch Med & Hlth Sci, Dept Pathol, Al Ain 17666, U Arab Emirates.	algazali@hotmail.com; jogleeson@ucsd.edu	van Bokhoven, Hans/D-8764-2012; Dobyns, William Brian/ABC-6525-2021; de Brouwer, Arjan PM/P-5949-2015; Bokhoven, J.H.L.M. van van/H-8015-2014; Ali, Bassam/J-7014-2012; Dobyns, William/AAI-2768-2020; Sykut-Cegielska, Jolanta/V-4253-2019; Guan, Ziqiang/AAE-5110-2019; lefeber, dirk/G-5063-2012; Lefeber, Dirk DJ/A-2146-2014; Wevers, Ron A./H-8116-2014; Vincent, Cantagrel/H-8698-2017; Morava, E./L-4529-2015; Hombauer, Hans/B-9712-2019	Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Dobyns, William/0000-0002-7681-2844; Sykut-Cegielska, Jolanta/0000-0003-0762-3721; Wevers, Ron A./0000-0003-2278-9746; Vincent, Cantagrel/0000-0002-5180-4848; Swiezewska, Ewa/0000-0002-3439-8948; Hombauer, Hans/0000-0002-2100-564X; Ali, Bassam R/0000-0003-1306-6618; Freeze, Hudson/0000-0001-6316-0501; Bielas, Stephanie/0000-0003-0567-5632	Rocket Fund [R01 DK55615]; Sanford Children's Health Research Center; Euroglycanet [LSHM-CT2005-512131]; Metakids and the Netherlands Brain Foundation; Deutsche Forschungsgemeinschaft; Korber-Stiftung; National Institutes of Health [GM-069338]; Fondation pour la Recherche Medicale; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080506, R01DK055615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453, P30NS047101, R01NS052455] Funding Source: NIH RePORTER	Rocket Fund; Sanford Children's Health Research Center; Euroglycanet; Metakids and the Netherlands Brain Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Korber-Stiftung; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. R. Fink, A. Jansen, F. Karst, K. Gable, T. M. Dunn, and R. Kolodner for providing yeast strains and helpful advice. We are grateful to J.H. Lin for valuable discussion. We thank D. Matern and the Mayo Clinic for providing complete results of patients' transferrin analysis and also C. Sault for additional clinical results from family CVH-385. We thank the University of California, San Francisco, microscopy core (P30 NS047101 and DK80506) and the Biomedical Genomics Core for help in imaging and microarray data analysis. A. de Rooij and K. Huyben are gratefully acknowledged for technical assistance. H. H. F. is a Sanford Research Professor. He and B.N. are supported by the Rocket Fund, R01 DK55615, and the Sanford Children's Health Research Center. Financial support from Euroglycanet (LSHM-CT2005-512131) to R. W. and Metakids and the Netherlands Brain Foundation to D. L. are kindly acknowledged. L. L. was supported by grants from the Deutsche Forschungsgemeinschaft and the Korber-Stiftung. The mass-spectrometry facility in the Department of Biochemistry of the Duke University Medical Center and Z.G. are supported by the LIPID MAPS Large Scale Collaborative Grant GM-069338 from the National Institutes of Health. V. C. is supported by a fellowship from Fondation pour la Recherche Medicale, and J.G.G. is an Investigator of the Howard Hughes Medical Institute. L.A.-G. ascertained and phenotyped family CVH-385 and MR3 and proposed the collaboration to identify the defective gene. W. B. D. reviewed brain imaging and suggested CDG defects, and H. F. suggested SRD5A3 as the polyprenol reductase. D. S., A. P. D. B., and H. v. B. coordinated homozygosity mapping. J.L.S. identified the SRD5A3 mutation, and S. L. B. performed linkage analysis and initiated generation of the gene trap mouse line. E. M. performed CDG Ix phenotype assessment on the remaining patients. D.J.L. performed biochemical diagnosis, functional studies, and dolichol analysis. R. A. W. coordinated biochemical analysis and homozygosity mapping. L. L. suggested a defect in dolichol biosynthesis and performed dolichol rescue experiments. E. S. helped with dolichol standards. D. B.-V., M. A., P. B., and J.S.C. contributed patients. Mass-spectrometry analysis was performed by Z.G. under the guidance of C.R.H.R. B.G.N. performed lipid extraction and patient LLO analysis. S. H. and B. R. A. provided technical assistance, discussions, and control samples. H. H. provided assistance with standard yeast techniques. V. C. performed all other experiments. J.G.G. directed the project. V. C. and J.G.G. wrote the manuscript, with help from the other authors.	Acosta-Serrano A, 2004, EUKARYOT CELL, V3, P255, DOI 10.1128/EC.3.2.255-263.2004; Aebi M, 2001, TRENDS CELL BIOL, V11, P136, DOI 10.1016/S0962-8924(01)01925-0; Aggarwal S, 2010, STEROIDS, V75, P109, DOI 10.1016/j.steroids.2009.10.005; Al-Gazali L, 2008, AM J MED GENET A, V146A, P813, DOI 10.1002/ajmg.a.32114; ALBER T, 1982, Journal of Molecular and Applied Genetics, V1, P419; ALLEN CM, 1978, BIOCHEMISTRY-US, V17, P5020, DOI 10.1021/bi00616a025; ANDERSSON S, 1991, NATURE, V354, P159, DOI 10.1038/354159a0; BEHRENS NH, 1970, P NATL ACAD SCI USA, V66, P153, DOI 10.1073/pnas.66.1.153; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chavan M, 2006, TRENDS BIOCHEM SCI, V31, P17, DOI 10.1016/j.tibs.2005.11.010; CHOJNACKI T, 1988, BIOCHEM J, V251, P1; D'Alexandri FL, 2006, ANAL BIOCHEM, V355, P189, DOI 10.1016/j.ab.2006.06.014; DEJONG G, 1994, ADV EXP MED BIOL, V356, P51; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Eklund Erik A, 2006, NeuroRx, V3, P254; EKSTROM TJ, 1987, J BIOL CHEM, V262, P4090; EKSTROM TJ, 1984, J BIOL CHEM, V259, P460; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Garrett TA, 2007, METHOD ENZYMOL, V432, P117, DOI 10.1016/S0076-6879(07)32005-3; Grunewald S, 2000, NEUROPEDIATRICS, V31, P57, DOI 10.1055/s-2000-7487; Haeuptle MA, 2009, HUM MUTAT, V30, P1628, DOI 10.1002/humu.21126; HASILIK A, 1978, EUR J BIOCHEM, V91, P567, DOI 10.1111/j.1432-1033.1978.tb12710.x; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HELLER L, 1992, P NATL ACAD SCI USA, V89, P7013, DOI 10.1073/pnas.89.15.7013; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; Jaeken J, 2009, BBA-MOL BASIS DIS, V1792, P825, DOI 10.1016/j.bbadis.2009.08.005; Jones MB, 2009, BBA-GEN SUBJECTS, V1790, P485, DOI 10.1016/j.bbagen.2009.03.030; Kahrizi K, 2009, EUR J HUM GENET, V17, P125, DOI 10.1038/ejhg.2008.159; KATO S, 1980, BIOCHEM BIOPH RES CO, V95, P770, DOI 10.1016/0006-291X(80)90853-0; KELLER RK, 1982, J BIOL CHEM, V257, P8985; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; Kranz C, 2007, AM J HUM GENET, V80, P433, DOI 10.1086/512130; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Mahendroo MS, 1999, REV REPROD, V4, P179, DOI 10.1530/revreprod/4.3.179; Marek KW, 1999, GLYCOBIOLOGY, V9, P1263; Morava E, 2008, J INHERIT METAB DIS, V31, P450, DOI 10.1007/s10545-008-0822-0; Morava E, 2009, BRIT J OPHTHALMOL, V93, P350, DOI 10.1136/bjo.2008.145359; Mosch HU, 1997, GENETICS, V145, P671; Murray SS, 2004, NAT METHODS, V1, P113, DOI 10.1038/NMETH712; Nishikawa A, 2001, BIOCHEM J, V355, P245, DOI 10.1042/0264-6021:3550245; O'Brien JF, 2007, CURR PROTOC HUM GENE; RENARD JP, 1984, J EXP ZOOL, V230, P443, DOI 10.1002/jez.1402300313; RIP JW, 1985, PROG LIPID RES, V24, P269, DOI 10.1016/0163-7827(85)90008-6; ROSENWALD AG, 1993, GLYCOBIOLOGY, V3, P481, DOI 10.1093/glycob/3.5.481; ROSSIGNOL DP, 1983, J BIOL CHEM, V258, P9122; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; SAGAMI H, 1993, J BIOL CHEM, V268, P10109; Sagami H, 1996, J BIOL CHEM, V271, P9560, DOI 10.1074/jbc.271.16.9560; SHARMA CB, 1982, EUR J BIOCHEM, V126, P319; Sidbury R, 2001, PEDIATR DERMATOL, V18, P252, DOI 10.1046/j.1525-1470.2001.018003252.x; Swiezewska E, 2005, PROG LIPID RES, V44, P235, DOI 10.1016/j.plipres.2005.05.002; Thiel C, 2002, BIOCHEM J, V367, P195, DOI 10.1042/BJ20020794; Uemura M, 2008, CANCER SCI, V99, P81, DOI 10.1111/j.1349-7006.2007.00656.x; Vermeer S, 2007, J NEUROL, V254, P1356, DOI 10.1007/s00415-007-0546-3; Vleugels W, 2009, HUM MUTAT, V30, P1428, DOI 10.1002/humu.21085; WIGLEY WC, 1994, BIOCHEMISTRY-US, V33, P1265, DOI 10.1021/bi00171a029; WOLF M J, 1991, Glycobiology, V1, P405, DOI 10.1093/glycob/1.4.405; YASUGI E, 1994, BBA-LIPID LIPID MET, V1211, P107, DOI 10.1016/0005-2760(94)90144-9	60	198	211	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					203	217		10.1016/j.cell.2010.06.001	http://dx.doi.org/10.1016/j.cell.2010.06.001			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20637498	Green Accepted, Bronze			2022-12-01	WOS:000280204300013
J	Contreras, JL				Contreras, Jorge L.			Prepublication Data Release, Latency, and Genome Commons	SCIENCE			English	Editorial Material							GENETICS; PROJECT		Washington Univ, Sch Law, St Louis, MO 63130 USA	Washington University (WUSTL)	Contreras, JL (corresponding author), Washington Univ, Sch Law, St Louis, MO 63130 USA.	jlcontreras@wulaw.wustl.edu		Contreras, Jorge/0000-0002-7899-3060				[Anonymous], 2009, NATURE, V461, P168, DOI DOI 10.1038/461168A; Blumenthal D, 2006, ACAD MED, V81, P137, DOI 10.1097/00001888-200602000-00008; Brumfiel G, 2008, NATURE, V453, P139, DOI 10.1038/453139a; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Collins F., 2010, LANGUAGE LIFE; DOE, 1993, HUMAN GENOME NEW JAN, P4; *GAIN, DAT US CERT AGR VERS; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; HEFFERNAN O, NATURE; Hess C, 2006, INT SOC SCI J, V58, P335, DOI 10.1111/j.1468-2451.2006.00622.x; HOLDEN AL, 2002, BIOTECHNIQUES, V32, pS22; *INT HAPMAP PROJ, DAT REL POL; *ISAEC, INT PROP PROGR; Kaye J, 2009, NAT REV GENET, V10, P331, DOI 10.1038/nrg2573; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Madison MJ, 2010, CORNELL LAW REV, V95, P657; Merrill Stephen A., 2006, REAP BEN GEN PROT RE; National Academy of Sciences National Academy of Engineering & Institute of Medicine, 2009, ENS INT ACC STEW RES; National Research Council, 1997, BITS POW ISS GLOB AC; Natl. Res. Council, 1988, MAPP SEQ HUM GEN; *NHGRI, 2008, ENCODE CONS DAT REL; *NHGRI, 2000, POL REL DAT DEP SEQ; *NIH, 2008, NOTOD08033 NIH; Ostrom E., 2007, UNDERSTANDING KNOWLE; Rai A., 2003, LAW CONTEMP PROBL, V66, P289; Schofield PN, 2009, NATURE, V461, P171, DOI 10.1038/461171a; WATSON JD, 1990, SCIENCE, V248, P44, DOI 10.1126/science.2181665; 2007, FED REG, V72, P49290; 2003, WELLC TRUST SHAR DAT; 1996, SUMM PRINC AGR INT S; ENCODE PROJECT DATA	31	19	19	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					393	394		10.1126/science.1189253	http://dx.doi.org/10.1126/science.1189253			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	629KJ	20651137				2022-12-01	WOS:000280196500019
J	Ferron, M; Wei, JW; Yoshizawa, T; Del Fattore, A; DePinho, RA; Teti, A; Ducy, P; Karsenty, G				Ferron, Mathieu; Wei, Jianwen; Yoshizawa, Tatsuya; Del Fattore, Andrea; DePinho, Ronald A.; Teti, Anna; Ducy, Patricia; Karsenty, Gerard			Insulin Signaling in Osteoblasts Integrates Bone Remodeling and Energy Metabolism	CELL			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; OSTEOCLAST FORMATION; GLUCOSE-TOLERANCE; BETA-CELL; OSTEOCALCIN; RECEPTOR; MICE; EXPRESSION; KNOCKOUT; DELETION	The broad expression of the insulin receptor suggests that the spectrum of insulin function has not been fully described. A cell type expressing this receptor is the osteoblast, a bone-specific cell favoring glucose metabolism through a hormone, osteocalcin, that becomes active once uncarboxylated. We show here that insulin signaling in osteoblasts is necessary for whole-body glucose homeostasis because it increases osteocalcin activity. To achieve this function insulin signaling in osteoblasts takes advantage of the regulation of osteoclastic bone resorption exerted by osteoblasts. Indeed, since bone resorption occurs at a pH acidic enough to decarboxylate proteins, osteoclasts determine the carboxylation status and function of osteocalcin. Accordingly, increasing or decreasing insulin signaling in osteoblasts promotes or hampers glucose metabolism in a bone resorption-dependent manner in mice and humans. Hence, in a feed-forward loop, insulin signals in osteoblasts activate a hormone, osteocalcin, that promotes glucose metabolism.	[Ferron, Mathieu; Wei, Jianwen; Yoshizawa, Tatsuya; Karsenty, Gerard] Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; [Ducy, Patricia] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Del Fattore, Andrea; Teti, Anna] Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Med & Genet, Boston, MA 02115 USA	Columbia University; Columbia University; University of L'Aquila; Harvard University; Harvard Medical School	Karsenty, G (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA.	gk2172@columbia.edu	Del Fattore, Andrea/H-4409-2015; Del Fattore, Andrea/AAP-2045-2020; Ferron, Mathieu/M-7794-2013	Del Fattore, Andrea/0000-0003-3848-412X; Del Fattore, Andrea/0000-0003-3848-412X; Yoshizawa, Tatsuya/0000-0002-5728-1996; DePinho, Ronald/0000-0002-5625-577X; Teti, Anna Maria/0000-0002-5887-4419	Fond de la recherche en sante du Quebec; National Institutes of Health; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078042] Funding Source: NIH RePORTER	Fond de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. S. Kousteni, T. Zee, R. L. Levine, M. Tremblay, and J. Vacher for reagents; Dr. J. Lacombe for help with transplantations; Drs. K. Henriksen and J. Bollerslev for generously sharing patient serum samples; Dr. T. Lam at the W. M. Keck Foundation Biotechnology Resource Laboratory, Yale University, for FT-ICR mass spectral analyses; and Drs. J. K. Kim and F. Mauvais-Jarvis for critical reading of the manuscript. This work was supported by a fellowship from the Fond de la recherche en sante du Quebec (M. F.), grants from the National Institutes of Health (G. K.), and the Juvenile Diabetes Research Foundation (P. D.). G. K. is a founder and member of the scientific advisory board of Escoublac Inc. P. D. is a founder and consultant of Escoublac Inc.	Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Chengalvala MV, 2001, BIOCHEMISTRY-US, V40, P814, DOI 10.1021/bi0019996; Cousin W, 2004, BIOCHEM BIOPH RES CO, V321, P259, DOI 10.1016/j.bbrc.2004.06.137; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Delibegovic M, 2007, MOL CELL BIOL, V27, P7727, DOI 10.1128/MCB.00959-07; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; Ducy P, 1996, NATURE, V382, P448, DOI 10.1038/382448a0; ENGELKE JA, 1991, BIOCHIM BIOPHYS ACTA, V1078, P31, DOI 10.1016/0167-4838(91)90088-H; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Fisher JE, 1999, P NATL ACAD SCI USA, V96, P133, DOI 10.1073/pnas.96.1.133; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fukumoto S, 2009, TRENDS ENDOCRIN MET, V20, P230, DOI 10.1016/j.tem.2009.02.001; Hinoi E, 2008, J CELL BIOL, V183, P1235, DOI 10.1083/jcb.200809113; Hwang YC, 2009, DIABETES-METAB RES, V25, P768, DOI 10.1002/dmrr.1045; Kaji H, 2009, J BONE MINER METAB, V27, P76, DOI 10.1007/s00774-008-0005-y; Kanazawa I, 2009, J CLIN ENDOCR METAB, V94, P45, DOI 10.1210/jc.2008-1455; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; KASUGA M, 1983, J BIOL CHEM, V258, P973; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Pittas AG, 2009, J CLIN ENDOCR METAB, V94, P827, DOI 10.1210/jc.2008-1422; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Rached MT, 2010, CELL METAB, V11, P147, DOI 10.1016/j.cmet.2010.01.001; Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901; Sadler JE, 2004, NATURE, V427, P493, DOI 10.1038/427493a; Schaller S, 2005, DRUG NEWS PERSPECT, V18, P489, DOI 10.1358/dnp.2005.18.8.944546; Scheen AJ, 2005, DRUG SAFETY, V28, P601, DOI 10.2165/00002018-200528070-00004; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Scimeca JC, 2000, BONE, V26, P207, DOI 10.1016/S8756-3282(99)00278-1; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Yamauchi M, 2010, CLIN NUTR, V29, P761, DOI 10.1016/j.clnu.2010.02.010; Yoshizawa T, 2009, J CLIN INVEST, V119, P2807, DOI 10.1172/JCI39366	37	779	835	4	93	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					296	308		10.1016/j.cell.2010.06.003	http://dx.doi.org/10.1016/j.cell.2010.06.003			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655470	Green Accepted, Bronze			2022-12-01	WOS:000280204300020
J	Hunte, C; Zickermann, V; Brandt, U				Hunte, Carola; Zickermann, Volker; Brandt, Ulrich			Functional Modules and Structural Basis of Conformational Coupling in Mitochondrial Complex I	SCIENCE			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; YARROWIA-LIPOLYTICA; ESCHERICHIA-COLI; 3-DIMENSIONAL STRUCTURE; QUINONE OXIDOREDUCTASE; ELECTRON-TRANSFER; OXIDATIVE STRESS; 49-KDA SUBUNIT; BINDING; SYSTEM	Proton-pumping respiratory complex I is one of the largest and most complicated membrane protein complexes. Its function is critical for efficient energy supply in aerobic cells, and malfunctions are implicated in many neurodegenerative disorders. Here, we report an x-ray crystallographic analysis of mitochondrial complex I. The positions of all iron-sulfur clusters relative to the membrane arm were determined in the complete enzyme complex. The ubiquinone reduction site resides close to 30 angstroms above the membrane domain. The arrangement of functional modules suggests conformational coupling of redox chemistry with proton pumping and essentially excludes direct mechanisms. We suggest that a similar to 60-angstrom-long helical transmission element is critical for transducing conformational energy to proton-pumping elements in the distal module of the membrane arm.	[Zickermann, Volker; Brandt, Ulrich] Goethe Univ Frankfurt, Ctr Membrane Prote, Sch Med, Mol Bioenerget Grp, D-60596 Frankfurt, Germany; [Hunte, Carola] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Hunte, Carola] Univ Leeds, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England; [Hunte, Carola] Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60438 Frankfurt, Germany	Goethe University Frankfurt; University of Freiburg; University of Leeds; Max Planck Society	Brandt, U (corresponding author), Goethe Univ Frankfurt, Ctr Membrane Prote, Sch Med, Mol Bioenerget Grp, D-60596 Frankfurt, Germany.	brandt@zbc.kgu.de	Hunte, Carola/E-4071-2015; Brandt, Ulrich/C-4406-2008; Brandt, Ulrich/GLV-1242-2022	Hunte, Carola/0000-0002-0826-3986; Brandt, Ulrich/0000-0003-1869-6811; Brandt, Ulrich/0000-0003-1869-6811	Deutsche Forschungsgemeinschaft [P2, P17]; Excellence Initiative of the German Federal and State Governments [EXC 115, EXC 294]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments	Excellent technical assistance by K. Siegmund and technical support by A. Duchene, F. Streb, and B. Wenzel are gratefully acknowledged. We thank S. Kerscher for his essential contributions regarding all aspects of Y. lipolytica genetics and B. Wrzesniewska for testing the impact of antibody fragments to improve crystallization. We are indebted to H. Michel for valuable advice during the initial stages of the project and for his continuous support. We thank the European Synchrotron Radiation Facility and the Swiss Light Source (SLS) for granting beam time, many scientists especially at SLS beamlines X06SA and X10SA for constantly supporting our work, and the staff of the Helmholtz Zentrum fur Infektionsforschung (HZI)/Gesellschaft fur Biotechnologische Forschung, Braunschweig for large-scale fermentation of Y. lipolytica. Funding by the Deutsche Forschungsgemeinschaft (SFB 472 Projects P2 and P17) is gratefully acknowledged. This study was supported by the Excellence Initiative of the German Federal and State Governments (EXC 115 and EXC 294). Electron density maps are available on request.	Abdrakhmanova A, 2004, BBA-BIOENERGETICS, V1658, P148, DOI 10.1016/j.bbabio.2004.04.019; Baranova EA, 2007, J STRUCT BIOL, V159, P238, DOI 10.1016/j.jsb.2007.01.009; Belevich G, 2007, BIOCHEMISTRY-US, V46, P526, DOI 10.1021/bi062062t; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Clason T, 2010, J STRUCT BIOL, V169, P81, DOI 10.1016/j.jsb.2009.08.017; Clason T, 2007, J STRUCT BIOL, V159, P433, DOI 10.1016/j.jsb.2007.05.002; Esterhazy D, 2008, BIOCHEMISTRY-US, V47, P3964, DOI 10.1021/bi702243b; Fendel U, 2008, BBA-BIOENERGETICS, V1777, P660, DOI 10.1016/j.bbabio.2008.04.033; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008; Galkin A, 2005, J BIOL CHEM, V280, P30129, DOI 10.1074/jbc.M504709200; Galkin A, 2006, BBA-BIOENERGETICS, V1757, P1575, DOI 10.1016/j.bbabio.2006.10.001; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; Kerscher S, 2002, BBA-BIOENERGETICS, V1555, P83, DOI 10.1016/S0005-2728(02)00259-1; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Morgan DJ, 2008, BBA-BIOENERGETICS, V1777, P711, DOI 10.1016/j.bbabio.2008.03.023; Morgner N, 2008, BBA-BIOENERGETICS, V1777, P1384, DOI 10.1016/j.bbabio.2008.08.001; Radermacher M, 2006, J STRUCT BIOL, V154, P269, DOI 10.1016/j.jsb.2006.02.011; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Tocilescu MA, 2007, J BIOL CHEM, V282, P29514, DOI 10.1074/jbc.M704519200; Tocilescu MA, 2010, BBA-BIOENERGETICS, V1797, P625, DOI 10.1016/j.bbabio.2010.01.029; Verkhovskaya ML, 2008, P NATL ACAD SCI USA, V105, P3763, DOI 10.1073/pnas.0711249105; WIKSTROM M, 1984, FEBS LETT, V169, P300, DOI 10.1016/0014-5793(84)80338-5; Zickermann V, 2003, J BIOL CHEM, V278, P29072, DOI 10.1074/jbc.M302713200; Zickermann V, 2009, BBA-BIOENERGETICS, V1787, P574, DOI 10.1016/j.bbabio.2009.01.012; Zwicker K, 2006, J BIOL CHEM, V281, P23013, DOI 10.1074/jbc.M603442200	31	294	300	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					448	451		10.1126/science.1191046	http://dx.doi.org/10.1126/science.1191046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20595580				2022-12-01	WOS:000280196500039
J	Marris, E				Marris, Emma			On high alert	NATURE			English	Editorial Material							T-CELL DEPLETION; IMMUNE ACTIVATION; INFECTION											Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Sodora DL, 2008, AIDS, V22, P439, DOI 10.1097/QAD.0b013e3282f2dbe7	8	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2010	466	7304					S2	S3		10.1038/nature09234	http://dx.doi.org/10.1038/nature09234			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631700				2022-12-01	WOS:000279867100023
J	Gahlay, G; Gauthier, L; Baibakov, B; Epifano, O; Dean, J				Gahlay, Gagandeep; Gauthier, Lyn; Baibakov, Boris; Epifano, Olga; Dean, Jurrien			Gamete Recognition in Mice Depends on the Cleavage Status of an Egg's Zona Pellucida Protein	SCIENCE			English	Article							SPERM RECEPTOR ACTIVITY; MOUSE SPERM; FERTILIZATION; ZP3; BINDING; INACTIVATION; FERTILITY; GLYCANS; GENE	At fertilization, mouse sperm bind to the zona pellucida (which consists of glycoproteins ZP1, ZP2, and ZP3) that surrounds eggs. A ZP2 cleavage model of gamete recognition requires intact ZP2, and a glycan release model postulates that zona glycans are ligands for sperm. These two models were tested by replacing endogenous protein with ZP2 that cannot be cleaved (Zp2(Mut)) or with ZP3 lacking implicated O glycans (Zp3(Mut)). Sperm bound to two-cell Zp2(Mut) embryos despite fertilization and cortical granule exocytosis. Contrary to prediction, sperm fertilized Zp3(Mut) eggs. Sperm at the surface of the zona pellucida remained acrosome-intact for more than 2 hours and were displaced by additional sperm. These data indicate that sperm-egg recognition depends on the cleavage status of ZP2 and that binding at the surface of the zona is not sufficient to induce sperm acrosome exocytosis.	[Gahlay, Gagandeep; Gauthier, Lyn; Baibakov, Boris; Epifano, Olga; Dean, Jurrien] NIDDKD, Cellular & Dev Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Dean, J (corresponding author), NIDDKD, Cellular & Dev Biol Lab, NIH, Bethesda, MD 20892 USA.	jurrien@helix.nih.gov	Gahlay, Gagandeep/F-3975-2010; Gahlay, Gagandeep/AAO-7928-2020	Gahlay, Gagandeep/0000-0002-0058-2827; 	NIH, National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015603] Funding Source: NIH RePORTER	NIH, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of NIH, National Institute of Diabetes and Digestive and Kidney Diseases.	Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Baibakov B, 2007, DEVELOPMENT, V134, P933, DOI 10.1242/dev.02752; Boja ES, 2003, J BIOL CHEM, V278, P34189, DOI 10.1074/jbc.M304026200; Chen J, 1998, P NATL ACAD SCI USA, V95, P6193, DOI 10.1073/pnas.95.11.6193; EAST IJ, 1985, DEV BIOL, V109, P268, DOI 10.1016/0012-1606(85)90454-3; FLORMAN HM, 1985, CELL, V41, P313, DOI 10.1016/0092-8674(85)90084-4; Jungnickel MK, 2003, CELL, V114, P401, DOI 10.1016/S0092-8674(03)00648-2; LEYTON L, 1989, J CELL BIOL, V108, P2163, DOI 10.1083/jcb.108.6.2163; LOPEZ LC, 1985, J CELL BIOL, V101, P1501, DOI 10.1083/jcb.101.4.1501; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Rankin T, 1996, DEVELOPMENT, V122, P2903; Rankin T, 1999, DEVELOPMENT, V126, P3847; Rankin TL, 2003, DEV CELL, V5, P33, DOI 10.1016/S1534-5807(03)00195-3; Rankin TL, 1998, DEVELOPMENT, V125, P2415; Shi SL, 2004, MOL CELL BIOL, V24, P9920, DOI 10.1128/MCB.24.22.9920-9929.2004; THALL AD, 1995, J BIOL CHEM, V270, P21437, DOI 10.1074/jbc.270.37.21437; Tulsiani DRP, 1997, BIOL REPROD, V57, P487, DOI 10.1095/biolreprod57.3.487; Williams SA, 2007, J CELL SCI, V120, P1341, DOI 10.1242/jcs.004291	18	123	131	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					216	219		10.1126/science.1188178	http://dx.doi.org/10.1126/science.1188178			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616279	Green Accepted			2022-12-01	WOS:000279635200049
J	Saitz, R				Saitz, Richard			Candidate Performance Measures for Screening for, Assessing, and Treating Unhealthy Substance Use in Hospitals: Advocacy or Evidence-Based Practice?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BRIEF INTERVENTIONS; CONTROLLED-TRIAL; TRAUMA CENTER; ALCOHOL-USE; CARE; DRINKING; INJURY; RISK	The Joint Commission recently proposed candidate performance measures addressing unhealthy substance use in hospitalized patients. The proposed measures of screening and brief intervention (SBI) assume that interventions that work in one setting (primary care outpatient practice) would work in another (hospital); treatment would have the same benefits for persons identified by screening as for those with symptoms who seek help; treatments that work for persons less severely affected by substance use would also work for those with more severe illness; and an approach that works for nondependent, unhealthy alcohol use would work for drug use. However, these assumptions extrapolate evidence of the effectiveness of SBI for primary care outpatients with nondependent, unhealthy alcohol use to the inpatient setting, persons with dependence, and other substances. Although quality of care for unhealthy substance use in all medical settings needs to improve, the evidence base for SBI in the hospital is too limited for the implementation of performance measures assessing this care.	[Saitz, Richard] Boston Univ, Gen Internal Med Sect, Clin Addict Res & Educ Unit, Boston Med Ctr,Sch Med, Boston, MA 02118 USA; [Saitz, Richard] Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA	Boston Medical Center; Boston University; Boston University	Saitz, R (corresponding author), Boston Univ, Gen Internal Med Sect, Clin Addict Res & Educ Unit, Boston Med Ctr,Sch Med, 801 Massachusetts Ave,2nd Floor, Boston, MA 02118 USA.	rsaitz@bu.edu		/0000-0002-2535-1427				*AM COLL SURG COMM, 2006, FAQ RES OPT CAR INJ; [Anonymous], National Drug Control Strategy 2016; Bernstein J, 2005, DRUG ALCOHOL DEPEN, V77, P49, DOI 10.1016/j.drugalcdep.2004.07.006; Center for Medicare & Medicaid Services, PHYS QUAL REP IN; De Micheli Denise, 2004, Rev. Assoc. Med. Bras., V50, P305, DOI 10.1590/S0104-42302004000300040; ELVY GA, 1988, BRIT J ADDICT, V83, P83; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; *JOINT COMM, CAND MEAS PROF ASS T; *JOINT COMM, ATTR COR PERF MEAS A; Madras BK, 2009, DRUG ALCOHOL DEPEN, V99, P280, DOI 10.1016/j.drugalcdep.2008.08.003; McQueen J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005191.pub2; Saitz R, 2007, ANN INTERN MED, V146, P167, DOI 10.7326/0003-4819-146-3-200702060-00005; Schermer CR, 2006, J TRAUMA, V60, P29, DOI 10.1097/01.ta.0000199420.12322.5d; SMITH PC, 2010, ARCH INTERN IN PRESS; Soderstrom CA, 2007, J TRAUMA, V62, P1102, DOI 10.1097/TA.0b013e31804bdb26; Sommers MS, 2006, J TRAUMA, V61, P523, DOI 10.1097/01.ta.0000221756.67126.91; Whitlock EP, 2004, ANN INTERN MED, V140, P557, DOI 10.7326/0003-4819-140-7-200404060-00017; Zatzick D, 2004, ARCH GEN PSYCHIAT, V61, P498, DOI 10.1001/archpsyc.61.5.498	18	31	31	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 6	2010	153	1					40	43		10.7326/0003-4819-153-1-201007060-00008	http://dx.doi.org/10.7326/0003-4819-153-1-201007060-00008			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620GS	20621901				2022-12-01	WOS:000279487700006
J	Spence, D				Spence, Des			From the Frontline Medicalisation of ageing: plastic people	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 30	2010	340								c3494	10.1136/bmj.c3494	http://dx.doi.org/10.1136/bmj.c3494			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NT	20591946				2022-12-01	WOS:000279586300016
J	Jin, H; White, SR; Shida, T; Schulz, S; Aguiar, M; Gygi, SP; Bazan, JF; Nachury, MV				Jin, Hua; White, Susan Roehl; Shida, Toshinobu; Schulz, Stefan; Aguiar, Mike; Gygi, Steven P.; Bazan, J. Fernando; Nachury, Maxence V.			The Conserved Bardet-Biedl Syndrome Proteins Assemble a Coat that Traffics Membrane Proteins to Cilia	CELL			English	Article							COMPLEX; IDENTIFICATION; MUTATIONS; DEFECTS; BBSOME; CARGO; LOCALIZATION; TRANSPORT; VESICLES; INPP5E	The BBSome is a complex of Bardet-Biedl Syndrome (BBS) proteins that shares common structural elements with COPI, COPII, and clathrin coats. Here, we show that the BBSome constitutes a coat complex that sorts membrane proteins to primary cilia. The BBSome is the major effector of the Arf-like GTPase Arl6/BBS3, and the BBSome and GTP-bound Arl6 colocalize at ciliary punctae in an interdependent manner. Strikingly, Arl6(GTP)-mediated recruitment of the BBSome to synthetic liposomes produces distinct patches of polymerized coat apposed onto the lipid bilayer. Finally, the ciliary targeting signal of somatostatin receptor 3 needs to be directly recognized by the BBSome in order to mediate targeting of membrane proteins to cilia. Thus, we propose that trafficking of BBSome cargoes to cilia entails the coupling of BBSome coat polymerization to the recognition of sorting signals by the BBSome.	[Jin, Hua; White, Susan Roehl; Shida, Toshinobu; Nachury, Maxence V.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Schulz, Stefan] Univ Jena, Inst Pharmacol & Toxicol, D-07743 Jena, Germany; [Aguiar, Mike; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Bazan, J. Fernando] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Stanford University; Friedrich Schiller University of Jena; Harvard University; Harvard Medical School; Roche Holding; Genentech	Nachury, MV (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	nachury@stanford.edu	Schulz, Stefan/A-6928-2017; Nachury, Maxence/H-3695-2019; Nachury, Maxence/A-8759-2008; Bazan, J. Fernando/B-4562-2010	Schulz, Stefan/0000-0002-5997-8885; Nachury, Maxence/0000-0003-4918-1562; Nachury, Maxence/0000-0003-4918-1562; Aguiar, Mike/0000-0001-8175-010X	American Heart Association [AHA-0930365N]; March of Dimes [5-FY09-112]; National Institutes of Health/National Institute of General Medical Sciences [R01GM089933]; Sloan Research Fellowship [BR-5014]; Klingenstein Fellowship; NIH/NIGMS [F32GM089218]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM089218, R01GM089933] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); March of Dimes(March of Dimes); National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Sloan Research Fellowship(Alfred P. Sloan Foundation); Klingenstein Fellowship(Klingenstein Philanthropies); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Suzanne Pfeffer and Scott Seeley for comments on the manuscript; Randy Schekman, Sean Studer, Susan Hamamoto, Ken Matsuoka and Chris Fromme for advice on liposome preparation and processing for EM; John Perrino and Jon Mulholland for assistance with EM; members of Dick Tsien's laboratory for help with hippocampal neuron culture; Brian Kobilka and Juan Jose Fung for help with liposome preparation; Val Sheffield for the BBS1 antibody; Melanie Tallent for the SSTR3 knockout; Joachim Seemann for the CD8 alpha cDNA; and Applied Precision for OMX imaging. This work was supported in part by grants to M.V.N. from the American Heart Association (AHA-0930365N), the March of Dimes (5-FY09-112), National Institutes of Health/National Institute of General Medical Sciences (R01GM089933), a Sloan Research Fellowship (BR-5014) and a Klingenstein Fellowship and by an NIH/NIGMS fellowship to S.R.W (F32GM089218). J.F.B. is an employee of Genentech, Inc.	Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Chaudhuri I, 2008, PROTEINS, V71, P795, DOI 10.1002/prot.21764; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Christoforidis S, 2000, METHODS, V20, P403, DOI 10.1006/meth.2000.0953; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Einstein EB, 2010, J NEUROSCI, V30, P4306, DOI 10.1523/JNEUROSCI.5295-09.2010; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Follit JA, 2010, J CELL BIOL, V188, P21, DOI 10.1083/jcb.200910096; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Jacoby M, 2009, NAT GENET, V41, P1027, DOI 10.1038/ng.427; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Mykytyn K, 2004, P NATL ACAD SCI USA, V101, P8664, DOI 10.1073/pnas.0402354101; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Shimoni Y, 2002, METHOD ENZYMOL, V351, P258; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199; Stagg SM, 2007, CURR OPIN STRUC BIOL, V17, P221, DOI 10.1016/j.sbi.2007.03.010; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wang CW, 2006, J CELL BIOL, V174, P973, DOI 10.1083/jcb.200605106; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpps.20, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	52	406	414	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1208	U198		10.1016/j.cell.2010.05.015	http://dx.doi.org/10.1016/j.cell.2010.05.015			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20603001	Bronze, Green Accepted			2022-12-01	WOS:000279148100017
J	McPherson, K				McPherson, Klim			Screening for breast cancer-balancing the debate	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED-TRIAL; OVERDIAGNOSIS; WOMEN				McPherson, K (corresponding author), Univ Oxford, Oxford OX1 2JD, England.	klim.mcpherson@obs-gyn.ox.ac.uk						Banks E, 2001, J MED SCREEN, V8, P29, DOI 10.1136/jms.8.1.29; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; *CANC RES UK, BREAST CANC FACTS; Duffy SW, 2010, J MED SCREEN, V17, P25, DOI 10.1258/jms.2009.009094; *EL RESP, 2009, ANN INT MED; Flanders J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b958; Gotzsche PC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub3; Gotzsche PC, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b86; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Jorgensen KJ, 2010, BMJ; Kamerow D, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5175; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; Moser K, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2025; Moss S, 2005, BREAST CANCER RES, V7, P230, DOI 10.1186/bcr1314; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Olsen O, 2001, LANCET, V358, P1340, DOI 10.1016/S0140-6736(01)06449-2; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Thompson A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1983; Welch HG, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b1425; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C	20	36	37	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2010	340								c3106	10.1136/bmj.c3106	http://dx.doi.org/10.1136/bmj.c3106			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	618IQ	20576707				2022-12-01	WOS:000279346500001
J	Dorrn, AL; Yuan, K; Barker, AJ; Schreiner, CE; Froemke, RC				Dorrn, Anja L.; Yuan, Kexin; Barker, Alison J.; Schreiner, Christoph E.; Froemke, Robert C.			Developmental sensory experience balances cortical excitation and inhibition	NATURE			English	Article							PRIMARY AUDITORY-CORTEX; VISUAL-CORTEX; SYNAPTIC DEPRESSION; RECEPTIVE-FIELDS; BARREL CORTEX; IN-VIVO; PLASTICITY; RAT; NEURONS; COMPETITION	Early in life, neural circuits are highly susceptible to outside influences. The organization of the primary auditory cortex (A1) in particular is governed by acoustic experience during the critical period, an epoch near the beginning of postnatal development throughout which cortical synapses and networks are especially plastic(1-8). This neonatal sensitivity to the pattern of sensory inputs is believed to be essential for constructing stable and adequately adapted representations of the auditory world and for the acquisition of language skills by children(5,9,10). One important principle of synaptic organization in mature brains is the balance between excitation and inhibition, which controls receptive field structure and spatiotemporal flow of neural activity(11-15), but it is unknown how and when this excitatory-inhibitory balance is initially established and calibrated. Here we use whole-cell recording to determine the processes underlying the development of synaptic receptive fields in rat A1. We find that, immediately after the onset of hearing, sensory-evoked excitatory and inhibitory responses are equally strong, although inhibition is less stimulus-selective and mismatched with excitation. However, during the third week of postnatal development, excitation and inhibition become highly correlated. Patterned sensory stimulation drives coordinated synaptic changes across receptive fields, rapidly improves excitatory-inhibitory coupling and prevents further exposure-induced modifications. Thus, the pace of cortical synaptic receptive field development is set by progressive, experience-dependent refinement of intracortical inhibition.	[Dorrn, Anja L.; Yuan, Kexin; Barker, Alison J.; Schreiner, Christoph E.; Froemke, Robert C.] Univ Calif San Francisco, Coleman Mem Lab, San Francisco, CA 94143 USA; [Dorrn, Anja L.; Yuan, Kexin; Barker, Alison J.; Schreiner, Christoph E.; Froemke, Robert C.] Univ Calif San Francisco, Coleman Mem Lab, WM Keck Fdn Ctr Integrat Neurosci, Neurosci Grad Program,Dept Otolaryngol, San Francisco, CA 94143 USA; [Dorrn, Anja L.] Max Delbruck Ctr Mol Med, Dept Neurosci, D-13125 Berlin, Germany; [Dorrn, Anja L.] NeuroCure Neurosci Res Ctr NWFZ, D-13125 Berlin, Germany; [Froemke, Robert C.] NYU, Sch Med, Mol Neurobiol Program, Helen & Martin Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Froemke, Robert C.] NYU, Sch Med, Skirball Inst Biomol Med, Dept Otolaryngol, New York, NY 10016 USA; [Froemke, Robert C.] NYU, Sch Med, Dept Physiol, New York, NY 10016 USA; [Froemke, Robert C.] NYU, Sch Med, Dept Neurosci, New York, NY 10016 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Helmholtz Association; Max Delbruck Center for Molecular Medicine; New York University; New York University; New York University; New York University	Froemke, RC (corresponding author), Univ Calif San Francisco, Coleman Mem Lab, San Francisco, CA 94143 USA.	robert.froemke@med.nyu.edu	Barker, Alison/AAH-1905-2021	Barker, Alison/0000-0001-9103-9258; Schreiner, Christoph/0000-0002-4571-4328; Dorrn, Anja L./0000-0002-4215-3609; Froemke, Robert/0000-0002-1230-6811	National Institute on Deafness and Other Communication Disorders [K99/R00]; Silvio O. Conte Center for Neuroscience Research at the University of California, San Francisco; Hearing Research Inc.; John C. and Edward Coleman Fund; Jane Coffin Childs Postdoctoral Research Fellowship; Sandler Translational Research Fellowship; National Science Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC009635, R01DC002260] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Silvio O. Conte Center for Neuroscience Research at the University of California, San Francisco(University of California System); Hearing Research Inc.; John C. and Edward Coleman Fund; Jane Coffin Childs Postdoctoral Research Fellowship; Sandler Translational Research Fellowship; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank C. A. Atencio, T. Babcock, E. Chang, E. de Villers-Sidani, M. R. DeWeese, G. Ehret, S. Gandhi, K. Imaizumi, M. M. Merzenich, C. Niell, A.-M. Oswald, and A. Y. Tan for comments, discussions and technical assistance. This work was supported by the National Institute on Deafness and Other Communication Disorders, the Silvio O. Conte Center for Neuroscience Research at the University of California, San Francisco, Hearing Research Inc. and the John C. and Edward Coleman Fund. R. C. F. is a recipient of a National Institute on Deafness and Other Communication Disorders K99/R00 Career Award, a Jane Coffin Childs Postdoctoral Research Fellowship and a Sandler Translational Research Fellowship. A.J.B. is a recipient of a National Science Foundation Graduate Research Fellowship.	Chang EF, 2005, P NATL ACAD SCI USA, V102, P16460, DOI 10.1073/pnas.0508239102; Chang EF, 2003, SCIENCE, V300, P498, DOI 10.1126/science.1082163; de Villers-Sidani E, 2007, J NEUROSCI, V27, P180, DOI 10.1523/JNEUROSCI.3227-06.2007; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Froemke RC, 2006, J NEUROPHYSIOL, V95, P1620, DOI 10.1152/jn.00910.2005; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Jacob V, 2007, J NEUROSCI, V27, P1271, DOI 10.1523/JNEUROSCI.4264-06.2007; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kenet T, 2007, P NATL ACAD SCI USA, V104, P7646, DOI 10.1073/pnas.0701944104; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Oswald AMM, 2008, J NEUROPHYSIOL, V99, P2998, DOI 10.1152/jn.01160.2007; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Smith SL, 2007, NAT NEUROSCI, V10, P370, DOI 10.1038/nn1844; SPITZER NC, 1979, ANNU REV NEUROSCI, V2, P363, DOI 10.1146/annurev.ne.02.030179.002051; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; Tallal P, 2002, DEV PSYCHOPATHOL, V14, P559, DOI 10.1017/S0954579402003097; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745	29	194	196	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 17	2010	465	7300					932	U9		10.1038/nature09119	http://dx.doi.org/10.1038/nature09119			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559387	Green Accepted, Green Submitted			2022-12-01	WOS:000278804500039
J	Moretti, A; Bellin, M; Welling, A; Jung, CB; Lam, JT; Bott-Flugel, L; Dorn, T; Goedel, A; Hohnke, C; Hofmann, F; Seyfarth, M; Sinnecker, D; Schomig, A; Laugwitz, KL				Moretti, Alessandra; Bellin, Milena; Welling, Andrea; Jung, Christian Billy; Lam, Jason T.; Bott-Fluegel, Lorenz; Dorn, Tatjana; Goedel, Alexander; Hoehnke, Christian; Hofmann, Franz; Seyfarth, Melchior; Sinnecker, Daniel; Schoemig, Albert; Laugwitz, Karl-Ludwig			Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOMYOCYTES; GENERATION; MUTATIONS; KVLQT1; PATHOGENESIS; PROGENITORS; CHANNELS; HEART	Background: Long-QT syndromes are heritable diseases associated with prolongation of the QT interval on an electrocardiogram and a high risk of sudden cardiac death due to ventricular tachyarrhythmia. In long-QT syndrome type 1, mutations occur in the KCNQ1 gene, which encodes the repolarizing potassium channel mediating the delayed rectifier I(sub Ks) current. Methods: We screened a family affected by long-QT syndrome type 1 and identified an autosomal dominant missense mutation (R190Q) in the KCNQ1 gene. We obtained dermal fibroblasts from two family members and two healthy controls and infected them with retroviral vectors encoding the human transcription factors OCT3/4, SOX2, KLF4, and c-MYC to generate pluripotent stem cells. With the use of a specific protocol, these cells were then directed to differentiate into cardiac myocytes. Results: Induced pluripotent stem cells maintained the disease genotype of long-QT syndrome type 1 and generated functional myocytes. Individual cells showed a ``ventricular,'' ``atrial,'' or ``nodal'' phenotype, as evidenced by the expression of cell-type-specific markers and as seen in recordings of the action potentials in single cells. The duration of the action potential was markedly prolonged in ``ventricular'' and ``atrial'' cells derived from patients with long-QT syndrome type 1, as compared with cells from control subjects. Further characterization of the role of the R190Q-KCNQ1 mutation in the pathogenesis of long-QT syndrome type 1 revealed a dominant negative trafficking defect associated with a 70 to 80% reduction in I(sub Ks) current and altered channel activation and deactivation properties. Moreover, we showed that myocytes derived from patients with long-QT syndrome type 1 had an increased susceptibility to catecholamine-induced tachyarrhythmia and that beta-blockade attenuated this phenotype. Conclusions: We generated patient-specific pluripotent stem cells from members of a family affected by long-QT syndrome type 1 and induced them to differentiate into functional cardiac myocytes. The patient-derived cells recapitulated the electrophysiological features of the disorder. (Funded by the European Research Council and others.) N Engl J Med 2010;363:1397-1409.	[Moretti, Alessandra; Bellin, Milena; Jung, Christian Billy; Lam, Jason T.; Bott-Fluegel, Lorenz; Dorn, Tatjana; Goedel, Alexander; Seyfarth, Melchior; Sinnecker, Daniel; Schoemig, Albert; Laugwitz, Karl-Ludwig] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 1, Div Cardiol, D-81675 Munich, Germany; [Hoehnke, Christian] Tech Univ Munich, Klinikum Rechts Isar, Dept Plast Surg, D-81675 Munich, Germany; [Moretti, Alessandra; Bellin, Milena; Jung, Christian Billy; Lam, Jason T.; Bott-Fluegel, Lorenz; Dorn, Tatjana; Goedel, Alexander; Seyfarth, Melchior; Sinnecker, Daniel; Schoemig, Albert; Laugwitz, Karl-Ludwig] Tech Univ Munich, German Heart Ctr Munich, Dept Cardiol, D-81675 Munich, Germany; [Welling, Andrea; Hofmann, Franz] Tech Univ Munich, Inst Pharmacol & Toxicol, D-81675 Munich, Germany	Technical University of Munich; Technical University of Munich; German Heart Centre Munich; Technical University of Munich; Technical University of Munich	Laugwitz, KL (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Med 1, Div Cardiol, Ismaninger Str 22, D-81675 Munich, Germany.	klaugwitz@med1.med.tum.de	Goedel, Alexander/AAX-3900-2020; Bellin, Milena/M-2311-2014; Welling, Andrea/K-6674-2017; Moretti, Alessandra/O-9271-2015; Dorn, Tatjana/O-6817-2015	Goedel, Alexander/0000-0002-5980-2257; Bellin, Milena/0000-0001-5380-6743; Welling, Andrea/0000-0002-5364-4980; Moretti, Alessandra/0000-0001-5782-7832; Sinnecker, Daniel/0000-0002-8116-9750; Bott-Flugel, Lorenz/0000-0003-0932-1241	European Research Council (Marie Curie Excellence Team) [MEXT-23208]; German Research Foundation [923, La 1238 3-1/4-1]; German Ministry for Education and Research [01 GN 0826]	European Research Council (Marie Curie Excellence Team)(European Research Council (ERC)European Commission); German Research Foundation(German Research Foundation (DFG)); German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	Supported by grants from the European Research Council (Marie Curie Excellence Team Grant, MEXT-23208), the German Research Foundation (Research Unit 923 and La 1238 3-1/4-1), and the German Ministry for Education and Research (01 GN 0826).	Brunner M, 2008, J CLIN INVEST, V118, P2246, DOI 10.1172/JCI33578; Chouabe C, 2000, CARDIOVASC RES, V45, P971, DOI 10.1016/S0008-6363(99)00411-3; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Donger C, 1997, CIRCULATION, V96, P2778, DOI 10.1161/01.CIR.96.9.2778; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Freund C, 2010, NETH HEART J, V18, P51; Gai H, 2009, CELL BIOL INT, V33, P1184, DOI 10.1016/j.cellbi.2009.08.008; Hofmann F, 1999, REV PHYSIOL BIOCH P, V139, P33, DOI 10.1007/BFb0033648; Imredy JP, 2008, AM J PHYSIOL-HEART C, V295, pH1867, DOI 10.1152/ajpheart.433.2008; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Laugwitz KL, 2007, NATURE, V446, P934, DOI 10.1038/nature05790; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Lerche C, 2007, MOL PHARMACOL, V72, P796; Lerche C, 2007, MOL PHARMACOL, V71, P1503, DOI 10.1124/mol.106.031682; Li GR, 1996, CIRC RES, V78, P689, DOI 10.1161/01.RES.78.4.689; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Moretti A, 2010, FASEB J, V24, P700, DOI 10.1096/fj.09-139477; Moss AJ, 2007, CIRCULATION, V115, P2481, DOI 10.1161/CIRCULATIONAHA.106.665406; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Pan N, 2009, CELL SIGNAL, V21, P349, DOI 10.1016/j.cellsig.2008.11.006; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534; Priori SG, 2003, NEW ENGL J MED, V348, P1866, DOI 10.1056/NEJMoa022147; Priori SG, 2001, EUROPACE, V3, P16, DOI 10.1053/eupc.2000.0141; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Roden DM, 2008, NEW ENGL J MED, V358, P169, DOI 10.1056/NEJMcp0706513; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Voigt P, 2006, J BIOL CHEM, V281, P9977, DOI 10.1074/jbc.M512502200; Vyas H, 2006, CIRCULATION, V113, P1385, DOI 10.1161/CIRCULATIONAHA.105.600445; Wang Z, 1999, J CARDIOVASC ELECTR, V10, P817, DOI 10.1111/j.1540-8167.1999.tb00262.x; Wilson AJ, 2005, CARDIOVASC RES, V67, P476, DOI 10.1016/j.cardiores.2005.04.036; Yokoo N, 2009, BIOCHEM BIOPH RES CO, V387, P482, DOI 10.1016/j.bbrc.2009.07.052; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	41	868	899	0	85	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 7	2010	363	15					1397	1409		10.1056/NEJMoa0908679	http://dx.doi.org/10.1056/NEJMoa0908679			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	659NV	20660394	Green Published			2022-12-01	WOS:000282575100005
J	Kim, K; Doi, A; Wen, B; Ng, K; Zhao, R; Cahan, P; Kim, J; Aryee, MJ; Ji, H; Ehrlich, LIR; Yabuuchi, A; Takeuchi, A; Cunniff, KC; Hongguang, H; Mckinney-Freeman, S; Naveiras, O; Yoon, TJ; Irizarry, RA; Jung, N; Seita, J; Hanna, J; Murakami, P; Jaenisch, R; Weissleder, R; Orkin, SH; Weissman, IL; Feinberg, AP; Daley, GQ				Kim, K.; Doi, A.; Wen, B.; Ng, K.; Zhao, R.; Cahan, P.; Kim, J.; Aryee, M. J.; Ji, H.; Ehrlich, L. I. R.; Yabuuchi, A.; Takeuchi, A.; Cunniff, K. C.; Hongguang, H.; Mckinney-Freeman, S.; Naveiras, O.; Yoon, T. J.; Irizarry, R. A.; Jung, N.; Seita, J.; Hanna, J.; Murakami, P.; Jaenisch, R.; Weissleder, R.; Orkin, S. H.; Weissman, I. L.; Feinberg, A. P.; Daley, G. Q.			Epigenetic memory in induced pluripotent stem cells	NATURE			English	Article							MAMMALIAN-CELLS; DNA METHYLATION; IPS CELLS; DIFFERENTIATION; TISSUE; GENERATION; MICE; ACTIVATION; MICROARRAY; SYSTEM	Somatic cell nuclear transfer and transcription-factor-based reprogramming revert adult cells to an embryonic state, and yield pluripotent stem cells that can generate all tissues. Through different mechanisms and kinetics, these two reprogramming methods reset genomic methylation, an epigenetic modification of DNA that influences gene expression, leading us to hypothesize that the resulting pluripotent stem cells might have different properties. Here we observe that low-passage induced pluripotent stem cells (iPSCs) derived by factor-based reprogramming of adult murine tissues harbour residual DNA methylation signatures characteristic of their somatic tissue of origin, which favours their differentiation along lineages related to the donor cell, while restricting alternative cell fates. Such an 'epigenetic memory' of the donor tissue could be reset by differentiation and serial reprogramming, or by treatment of iPSCs with chromatin-modifying drugs. In contrast, the differentiation and methylation of nuclear-transfer-derived pluripotent stem cells were more similar to classical embryonic stem cells than were iPSCs. Our data indicate that nuclear transfer more readily establishes the ground state of pluripotency than factor-based reprogramming, which can leave an epigenetic memory of the tissue of origin that may influence efforts at directed differentiation for applications in disease modelling or treatment.	[Doi, A.; Wen, B.; Ji, H.; Irizarry, R. A.; Jung, N.; Murakami, P.; Feinberg, A. P.] Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD 21205 USA; [Doi, A.; Wen, B.; Ji, H.; Irizarry, R. A.; Jung, N.; Murakami, P.; Feinberg, A. P.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Kim, K.; Ng, K.; Zhao, R.; Cahan, P.; Yabuuchi, A.; Takeuchi, A.; Cunniff, K. C.; Hongguang, H.; Mckinney-Freeman, S.; Naveiras, O.; Daley, G. Q.] Childrens Hosp, Howard Hughes Med Inst, Manton Ctr Orphan Dis Res, Div Pediat Hematol Oncol,Stem Cell Transplantat P, Boston, MA 02115 USA; [Kim, K.; Ng, K.; Zhao, R.; Cahan, P.; Kim, J.; Yabuuchi, A.; Takeuchi, A.; Cunniff, K. C.; Hongguang, H.; Mckinney-Freeman, S.; Naveiras, O.; Orkin, S. H.; Daley, G. Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Kim, K.; Ng, K.; Zhao, R.; Cahan, P.; Yabuuchi, A.; Takeuchi, A.; Cunniff, K. C.; Hongguang, H.; Mckinney-Freeman, S.; Naveiras, O.; Daley, G. Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Kim, K.; Ng, K.; Zhao, R.; Cahan, P.; Yabuuchi, A.; Takeuchi, A.; Cunniff, K. C.; Hongguang, H.; Mckinney-Freeman, S.; Naveiras, O.; Daley, G. Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kim, K.; Ng, K.; Zhao, R.; Cahan, P.; Yabuuchi, A.; Takeuchi, A.; Cunniff, K. C.; Hongguang, H.; Mckinney-Freeman, S.; Naveiras, O.; Daley, G. Q.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Kim, J.; Orkin, S. H.] Childrens Hosp, Howard Hughes Med Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Aryee, M. J.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Ehrlich, L. I. R.; Seita, J.; Weissman, I. L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Yoon, T. J.; Weissleder, R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA 02114 USA; [Hanna, J.; Jaenisch, R.] MIT, Dept Biol, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Johns Hopkins University; Johns Hopkins University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins Medicine; Stanford University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute	Feinberg, AP (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD 21205 USA.	afeinberg@jhu.edu; george.daley@childrens.harvard.edu	Wen, Bo/P-5332-2019; Hanna, Jacob/K-1339-2012; Seita, Jun/AAM-1478-2020; McKinney-Freeman, Shannon/N-8161-2018; jia, xu/A-8386-2016; Feinberg, Andrew/AAY-7666-2020; Aryee, Martin/AAC-8113-2020; Kim, Jonghwan/AAR-2815-2021	Wen, Bo/0000-0003-0394-7366; Hanna, Jacob/0000-0003-2042-9974; Seita, Jun/0000-0002-3008-3615; McKinney-Freeman, Shannon/0000-0001-8061-2557; Naveiras, Olaia/0000-0003-3434-0022; Ehrlich, Lauren/0000-0002-1697-1755; Kim, Jonghwan/0000-0002-9919-9843; Feinberg, Andrew/0000-0002-8364-1991; /0000-0003-0828-4143; Ji, Hong/0000-0002-9558-0620; Cahan, Patrick/0000-0003-3652-2540	NIH [RO1-DK70055, RO1-DK59279, K99HL093212-01, R37CA054358, P50HG003233, R01AI047457, R01AI047458, CA86065, HL099999]; American Recovery and Reinvestment Act [RC2-HL102815]; LLS [3567-07]; Cooley's Anemia Foundation; Thomas and Stacey Siebel Foundation; Leukemia and Lymphoma Society; California Institute for Regenerative Medicine [T1-00001]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA086065, R37CA054358] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL093212, RC2HL102815, U01HL099999] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047458, R01AI047457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070055, R01DK059279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083084] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000256] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act; LLS; Cooley's Anemia Foundation; Thomas and Stacey Siebel Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	G.Q.D is an investigator of the Howard Hughes Medical Institute and was supported by NIH grants RO1-DK70055 and RO1-DK59279, and special funds received under the American Recovery and Reinvestment Act (RC2-HL102815). K. K. was supported by NIH (K99HL093212-01), LLS (3567-07) and Cooley's Anemia Foundation. A.P.F was funded by NIH grants R37CA054358 and P50HG003233. I.L.W. was funded by NIH grants R01AI047457, R01AI047458, CA86065 and HL099999, and the Thomas and Stacey Siebel Foundation. L.I.R.E. was supported by a Special Fellow Career Development award from the Leukemia and Lymphoma Society. J.S. is supported by a fellowship from the California Institute for Regenerative Medicine (T1-00001). We acknowledge K. Hochedlinger for sharing his manuscript before publication.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Bourne S, 2004, TISSUE ENG, V10, P796, DOI 10.1089/1076327041348293; Brambrink T, 2006, P NATL ACAD SCI USA, V103, P933, DOI 10.1073/pnas.0510485103; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; CHIU CP, 1985, CELL, V40, P417, DOI 10.1016/0092-8674(85)90155-2; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; HOOD RCWS, 1948, STAIN TECHNOL, V23, P209, DOI 10.3109/10520294809106251; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kirov G, 2003, GENOMICS, V82, P433, DOI 10.1016/S0888-7543(03)00167-8; Koh EY, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf142; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Markoulaki S, 2009, NAT BIOTECHNOL, V27, P169, DOI 10.1038/nbt.1520; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Nadin BM, 2003, BLOOD, V102, P2436, DOI 10.1182/blood-2003-01-0118; NOMIZU T, 1994, ANAL CHEM, V66, P3000, DOI 10.1021/ac00091a004; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pavlidis P, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-10-research0042; Perez-Iratxeta C, 2005, FEBS LETT, V579, P1795, DOI 10.1016/j.febslet.2005.02.020; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Schiedlmeier B, 2007, P NATL ACAD SCI USA, V104, P16952, DOI 10.1073/pnas.0703082104; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; SKOW LC, 1983, CELL, V34, P1043, DOI 10.1016/0092-8674(83)90562-7; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Turker MS, 2002, ONCOGENE, V21, P5388, DOI 10.1038/sj.onc.1205599; WDZIEKONSKI B, 2007, CURR PROTOC CELL BIO, V23; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	54	1562	1623	2	499	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2010	467	7313					285	U60		10.1038/nature09342	http://dx.doi.org/10.1038/nature09342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650CF	20644535	Green Accepted, Green Submitted			2022-12-01	WOS:000281824900030
J	Tooley, CES; Petkowski, JJ; Muratore-Schroeder, TL; Balsbaugh, JL; Shabanowitz, J; Sabat, M; Minor, W; Hunt, DF; Macara, IG				Tooley, Christine E. Schaner; Petkowski, Janusz J.; Muratore-Schroeder, Tara L.; Balsbaugh, Jeremy L.; Shabanowitz, Jeffrey; Sabat, Michal; Minor, Wladek; Hunt, Donald F.; Macara, Ian G.			NRMT is an alpha-N-methyltransferase that methylates RCC1 and retinoblastoma protein	NATURE			English	Article							AMINO-ACID; RIBOSOME; DIMETHYLPROLINE; SUBUNIT; H2B	The post-translational methylation of alpha-amino groups was first discovered over 30 years ago on the bacterial ribosomal proteins L16 and L33 (refs 1, 2), but almost nothing is known about the function or enzymology of this modification. Several other bacterial and eukaryotic proteins have since been shown to be alpha-N-methylated(3-10). However, the Ran guanine nucleotide-exchange factor, RCC1, is the only protein for which any biological function of alpha-N-methylation has been identified(3,11). Methylation-defective mutants of RCC1 have reduced affinity for DNA and cause mitotic defects(3,11), but further characterization of this modification has been hindered by ignorance of the responsible methyltransferase. All fungal and animal N-terminally methylated proteins contain a unique N-terminal motif, Met-(Ala/Pro/Ser)Pro-Lys, indicating that they may be targets of the same, unknown enzyme(3,12). The initiating Met is cleaved, and the exposed alpha-amino group is mono-, di- or trimethylated. Here we report the discovery of the first alpha-N-methyltransferase, which we named N-terminal RCC1 methyltransferase (NRMT). Substrate docking and mutational analysis of RCC1 defined the NRMT recognition sequence and enabled the identification of numerous new methylation targets, including SET (also known as TAF-I or PHAPII) and the retinoblastoma protein, RB. Knockdown of NRMT recapitulates the multi-spindle phenotype seen with methylation-defective RCC1 mutants(3), demonstrating the importance of alpha-N-methylation for normal bipolar spindle formation and chromosome segregation.	[Tooley, Christine E. Schaner; Petkowski, Janusz J.; Macara, Ian G.] Univ Virginia, Sch Med, Dept Microbiol, Ctr Cell Signaling, Charlottesville, VA 22908 USA; [Petkowski, Janusz J.; Minor, Wladek] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Muratore-Schroeder, Tara L.; Balsbaugh, Jeremy L.; Shabanowitz, Jeffrey; Sabat, Michal; Hunt, Donald F.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Hunt, Donald F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia	Tooley, CES (corresponding author), Univ Virginia, Sch Med, Dept Microbiol, Ctr Cell Signaling, Charlottesville, VA 22908 USA.	ces5g@virginia.edu	Minor, Wladek/F-3096-2014; Hunt, Donald F/I-6936-2012; Petkowski, Janusz Jurand/T-4792-2019; Petkowski, Janusz Jurand/GPT-0474-2022	Minor, Wladek/0000-0001-7075-7090; Hunt, Donald F/0000-0003-2815-6368; Petkowski, Janusz Jurand/0000-0002-1921-4848; Petkowski, Janusz Jurand/0000-0002-1921-4848; BALSBAUGH, JEREMY/0000-0002-1852-8749	National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050526, R01GM037537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by research grants from the National Institutes of Health to I.G.M., D.F.H., and W.M.; C.E.S.T. was the recipient of a post-doctoral fellowship from the National Institutes of Health.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BLOOM KS, 1978, J BIOL CHEM, V253, P4446; Boyer SN, 1996, CANCER RES, V56, P4620; BROSIUS J, 1976, FEBS LETT, V68, P105, DOI 10.1016/0014-5793(76)80415-2; Carroll AJ, 2008, MOL CELL PROTEOMICS, V7, P347, DOI 10.1074/mcp.M700052-MCP200; Chen T, 2007, NAT CELL BIOL, V9, P596, DOI 10.1038/ncb1572; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Grimm R, 1997, FEBS LETT, V408, P350, DOI 10.1016/S0014-5793(97)00462-6; Hao Y, 2008, J CELL BIOL, V182, P827, DOI 10.1083/jcb.200803110; HENRY GD, 1982, FEBS LETT, V144, P11, DOI 10.1016/0014-5793(82)80558-9; Hu RM, 2000, P NATL ACAD SCI USA, V97, P9543, DOI 10.1073/pnas.160270997; MARTINAGE A, 1985, EUR J BIOCHEM, V147, P351, DOI 10.1111/j.1432-1033.1985.tb08757.x; Meng FY, 2004, ANAL CHEM, V76, P2852, DOI 10.1021/ac0354903; NOMOTO M, 1982, J BIOCHEM-TOKYO, V91, P897, DOI 10.1093/oxfordjournals.jbchem.a133778; PETTIGREW GW, 1977, NATURE, V265, P661, DOI 10.1038/265661a0; Sadaie M, 2008, J BIOL CHEM, V283, P7185, DOI 10.1074/jbc.M709429200; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; SIMON RH, 1979, NUCLEIC ACIDS RES, V6, P689, DOI 10.1093/nar/6.2.689; STOCK A, 1987, FEBS LETT, V220, P8, DOI 10.1016/0014-5793(87)80866-9; WITTMANNLIEBOLD B, 1976, FEBS LETT, V68, P115, DOI 10.1016/0014-5793(76)80417-6; Yamamoto H, 1999, CLIN CANCER RES, V5, P1805; Yu WS, 2008, MOL CELLS, V26, P443	23	80	93	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2010	466	7310					1125	1128		10.1038/nature09343	http://dx.doi.org/10.1038/nature09343			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20668449	Green Accepted			2022-12-01	WOS:000281203600044
J	Radoshevich, L; Murrow, L; Chen, N; Fernandez, E; Roy, S; Fung, C; Debnath, J				Radoshevich, Lilliana; Murrow, Lyndsay; Chen, Nan; Fernandez, Estefania; Roy, Srirupa; Fung, Christopher; Debnath, Jayanta			ATG12 Conjugation to ATG3 Regulates Mitochondrial Homeostasis and Cell Death	CELL			English	Article							PROTEIN-ACTIVATING ENZYME; UBIQUITIN-LIKE PROTEINS; CRYSTAL-STRUCTURE; MAMMALIAN HOMOLOG; E2 ENZYME; AUTOPHAGY; LIPIDATION; APOPTOSIS; FISSION; SYSTEM	ATG12, an ubiquitin-like modifier required for macroautophagy, has a single known conjugation target, another autophagy regulator called ATG5. Here, we identify ATG3 as a substrate for ATG12 conjugation. ATG3 is the E2-like enzyme necessary for ATG8/LC3 lipidation during autophagy. ATG12-ATG3 complex formation requires ATG7 as the E1 enzyme and ATG3 autocatalytic activity as the E2, resulting in the covalent linkage of ATG12 onto a single lysine on ATG3. Surprisingly, disrupting ATG12 conjugation to ATG3 does not affect starvation-induced autophagy. Rather, the lack of ATG12-ATG3 complex formation produces an expansion in mitochondrial mass and inhibits cell death mediated by mitochondrial pathways. Overall, these results unveil a role for ATG12-ATG3 in mitochondrial homeostasis and implicate the ATG12 conjugation system in cellular functions distinct from the early steps of autophagosome formation.	[Radoshevich, Lilliana; Murrow, Lyndsay; Chen, Nan; Fernandez, Estefania; Roy, Srirupa; Fung, Christopher; Debnath, Jayanta] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Radoshevich, Lilliana; Murrow, Lyndsay; Chen, Nan; Fernandez, Estefania; Roy, Srirupa; Fung, Christopher; Debnath, Jayanta] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Radoshevich, Lilliana; Murrow, Lyndsay; Debnath, Jayanta] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Debnath, J (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.	jayanta.debnath@ucsf.edu	Fung, Christopher/AFM-0101-2022	Fung, Christopher/0000-0003-3585-1385; Debnath, Jayanta/0000-0002-8745-4069; Murrow, Lyndsay/0000-0002-5935-8977; Radoshevich, Lilliana/0000-0003-0294-9300	NIH [RO1CA126792, KO8CA098419]; Culpeper Medical Scholar Award; AACR-Genentech BioOncology Award; HHMI Physician-Scientist Early Career Award; Stewart Family Trust Award; NATIONAL CANCER INSTITUTE [K08CA098419, R01CA126792] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Culpeper Medical Scholar Award; AACR-Genentech BioOncology Award; HHMI Physician-Scientist Early Career Award(Howard Hughes Medical Institute); Stewart Family Trust Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs. Noboru Mizushima, Masaaki Komatsu, and Patrick Dennis for generously providing reagents and Drs. Gerard Evan, Don Ganem, Abul Abbas, and Feroz Papa for critically reading the manuscript. Confocal microscopy was performed in the Biological Imaging Development Center at UCSF. Grant support to J.D. includes the NIH (RO1CA126792, KO8CA098419), a Culpeper Medical Scholar Award (Partnership For Cures), an AACR-Genentech BioOncology Award, a HHMI Physician-Scientist Early Career Award, and a Stewart Family Trust Award. L R. was a Genentech/Sandler Graduate Student Fellow, and E.F. was an HHMI Summer Undergraduate Research Fellow.	Berman SB, 2009, J CELL BIOL, V184, P707, DOI 10.1083/jcb.200809060; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brenner D, 2009, CURR OPIN CELL BIOL, V21, P871, DOI 10.1016/j.ceb.2009.09.004; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2009, HUM MOL GENET, V18, pR169, DOI 10.1093/hmg/ddp326; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; de Graaf AO, 2004, EXP CELL RES, V299, P533, DOI 10.1016/j.yexcr.2004.06.024; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Dennis PB, 2009, METHOD ENZYMOL, V452, P97, DOI 10.1016/S0076-6879(08)03607-0; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; GWOZD CS, 1995, BIOCHEMISTRY-US, V34, P6296, DOI 10.1021/bi00019a006; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hanada T, 2005, AUTOPHAGY, V1, P110, DOI 10.4161/auto.1.2.1858; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lutz AK, 2009, J BIOL CHEM, V284, P22938, DOI 10.1074/jbc.M109.035774; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nemoto T, 2003, J BIOL CHEM, V278, P39517, DOI 10.1074/jbc.M300550200; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Rohas LM, 2007, P NATL ACAD SCI USA, V104, P7933, DOI 10.1073/pnas.0702683104; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Suzuki NN, 2005, AUTOPHAGY, V1, P119, DOI 10.4161/auto.1.2.1859; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Tanida I, 2002, BIOCHEM BIOPH RES CO, V296, P1164, DOI 10.1016/S0006-291X(02)02057-0; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Walter J, 2001, EMBO J, V20, P3124, DOI 10.1093/emboj/20.12.3124; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Yamada Y, 2007, J BIOL CHEM, V282, P8036, DOI 10.1074/jbc.M611473200; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697	46	204	218	1	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 20	2010	142	4					590	600		10.1016/j.cell.2010.07.018	http://dx.doi.org/10.1016/j.cell.2010.07.018			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20723759	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000281115900013
J	Vinck, P; Pham, PN				Vinck, Patrick; Pham, Phuong N.			Association of Exposure to Violence and Potential Traumatic Events With Self-reported Physical and Mental Health Status in the Central African Republic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HOPKINS SYMPTOM CHECKLIST-25; MORTALITY; DEPRESSION; RATES; WAR; QUESTIONNAIRE; PREVALENCE; ATTITUDES; VALIDITY; DARFUR	Context For decades, the Central African Republic (CAR) has experienced violence, economic stagnation, and institutional failure. The latest wave of violence erupted in 2001 and continues to this day in some areas. Yet there has been little attention to the conflict and even less research to document and quantify the conflict's human cost. Objective To study levels of violence in CAR, including mortality levels, and the association between exposure to violence and traumatic events with self-reported physical and mental health status. Design, Setting, and Participants Multistage stratified cluster random survey of 1879 adults 18 years or older in selected households conducted in 5 administrative units of CAR (3 in the south, which has been free from recent violence, and 2 in the north, in which violence continues) between October and December 2009. Main Outcome Measures Mortality, morbidity, exposure to potential traumatic events, sense of insecurity, and meeting of symptom criteria for depression and anxiety using the Hopkins Symptom Checklist-25 with a cut-off score of 1.75. Results The crude mortality rate (CMR) was 4.9 deaths (95% confidence interval [CI], 4.6-5.1) per 1000 population per month and self-reported CMR due to violence was 0.8 deaths(95% CI, 0.6-1.0) per 1000 population per month. Thirty-five percent reported their physical health status as being good or very good while 29% described it as bad or very bad. Respondents in northern prefectures reported higher rates of mortality, exposure to trauma, and insecurity and lower levels of physical health and access to health services compared with those in the south. The estimated prevalences of symptoms of depression and anxiety were 55.3% (95% CI, 51.6%-59.0%) and 52.5% (95% CI, 48.1%-56.8%), respectively. Exposure to violence and self-reported physical health were statistically associated with mental health outcomes (P<.001). Anxiety symptom scores were higher for respondents in the northern prefectures than those in the south (t=2.54, P=.01). Conclusion A high proportion of adult respondents in CAR reported witnessing or having personally experienced traumatic events over the course of the conflicts, and more than half met symptom criteria for depression and anxiety. JAMA. 2010;304(5):544-552 www.jama.com	[Vinck, Patrick; Pham, Phuong N.] Univ Calif Berkeley, Human Rights Ctr, Berkeley, CA 94720 USA; [Pham, Phuong N.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Vinck, Patrick; Pham, Phuong N.] Tulane Univ, Payson Ctr Int Dev, New Orleans, LA 70118 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Tulane University	Vinck, P (corresponding author), Univ Calif Berkeley, Human Rights Ctr, 460 Stephens Hall 2300, Berkeley, CA 94720 USA.	pvinck@berkeley.edu		Pham, Phuong/0000-0002-5696-2933	John D. and Catherine T. MacArthur Foundation, Chicago, Illinois; Humanity United, Redwood City, California; Vulnerable Populations Initiative at University of California, Berkeley	John D. and Catherine T. MacArthur Foundation, Chicago, Illinois; Humanity United, Redwood City, California; Vulnerable Populations Initiative at University of California, Berkeley	The work was supported by grants from the John D. and Catherine T. MacArthur Foundation, Chicago, Illinois, and Humanity United, Redwood City, California.; The study was part of the Vulnerable Populations Initiative at University of California, Berkeley. We thank the respondents, interviewers, and partners in the field for their support. Neil Hendrick, BA, contributed to field supervision. Roger Sherwin, MD, Tulane University; Jennie Sherwin, BA; and Alexander Truong, MD, MPH, Johns Hopkins University, provided invaluable comments on the manuscript. Mr Hendrick was paid to assist with field work. Dr Sherwin, Ms Sherwin, and Dr Truong did not receive compensation for their contributions.	ADLER RJ, 1994, STOCH PROC APPL, V49, P1, DOI 10.1016/0304-4149(94)90109-0; ANTONOVSKY A, 1967, MILBANK FUND Q, V45, P31, DOI 10.2307/3348839; BERMAN EG, 2006, CENTRAL AFRICAN REPU; BOGUE DJ, 1950, J AM STAT ASSOC, V45, P149, DOI 10.2307/2280675; Bolton P, 2004, SOC PSYCH PSYCH EPID, V39, P442, DOI 10.1007/s00127-004-0763-3; Bolton P, 2001, J NERV MENT DIS, V189, P238, DOI 10.1097/00005053-200104000-00005; Cardozo BL, 2000, JAMA-J AM MED ASSOC, V284, P569, DOI 10.1001/jama.284.5.569; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; de Jong JTVM, 2001, JAMA-J AM MED ASSOC, V286, P555, DOI 10.1001/jama.286.5.555; Debos M, 2008, AFR AFFAIRS, V107, P225, DOI 10.1093/afraf/adn004; Degomme O, 2010, LANCET, V375, P294, DOI 10.1016/S0140-6736(09)61967-X; DEJONG J, 2004, TRAUMA WAR VIOLENCE; Depoortere E, 2004, LANCET, V364, P1315, DOI 10.1016/S0140-6736(04)17187-0; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Fergusson DM, 2002, PSYCHOL MED, V32, P991, DOI 10.1017/S0033291702005986; Iacopino V, 2001, AM J PUBLIC HEALTH, V91, P2013, DOI 10.2105/AJPH.91.12.2013; International Crisis Group, 2007, 136 INT CRIS GROUP; International Federation for Human Rights, 2003, WAR CRIM CENTR AFR R; Kaaya SF, 2002, ACTA PSYCHIAT SCAND, V106, P9, DOI 10.1034/j.1600-0447.2002.01205.x; KESSLER RC, 1993, J AFFECT DISORDERS, V29, P85, DOI 10.1016/0165-0327(93)90026-G; Lhewa D, 2007, ASSESSMENT, V14, P223, DOI 10.1177/1073191106298876; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Mollica RF, 1998, ADVERSITY, STRESS AND PSYCHOPATHOLOGY, P34; Oruc L., 2008, INT J CULTURE MENTAL, V1, P105, DOI [10.1080/17542860802456620, DOI 10.1080/17542860802456620]; Pham PN, 2004, JAMA-J AM MED ASSOC, V292, P602, DOI 10.1001/jama.292.5.602; Roberts L, 2004, LANCET, V364, P1857, DOI 10.1016/S0140-6736(04)17441-2; ROSENFIELD S, 1980, J HEALTH SOC BEHAV, V21, P33, DOI 10.2307/2136692; Salama P, 2001, JAMA-J AM MED ASSOC, V286, P563, DOI 10.1001/jama.286.5.563; SCHAEFER C, 1981, Journal of Behavioral Medicine, V4, P381, DOI 10.1007/BF00846149; Silove D, 2007, J NERV MENT DIS, V195, P152, DOI 10.1097/01.nmd.0000254747.03333.70; SPITTAELS S, MAPPING CONFLICT MOT; Toole MJ, 1997, ANNU REV PUBL HEALTH, V18, P283, DOI 10.1146/annurev.publhealth.18.1.283; Vinck P, 2007, JAMA-J AM MED ASSOC, V298, P543, DOI 10.1001/jama.298.5.543; Vinck P, 2008, INT J TRANSIT JUST, V2, P398, DOI 10.1093/ijtj/ijn033; Wakabi W, 2008, LANCET, V371, P15, DOI 10.1016/S0140-6736(08)60051-3	35	26	26	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2010	304	5					544	552		10.1001/jama.2010.1065	http://dx.doi.org/10.1001/jama.2010.1065			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	633SQ	20682934	Bronze			2022-12-01	WOS:000280525700022
J	Argos, M; Kalra, T; Rathouz, PJ; Chen, Y; Pierce, B; Parvez, F; Islam, T; Ahmed, A; Rakibuz-Zaman, M; Hasan, R; Sarwar, G; Slavkovich, V; van Geen, A; Graziano, J; Ahsan, H				Argos, Maria; Kalra, Tara; Rathouz, Paul J.; Chen, Yu; Pierce, Brandon; Parvez, Faruque; Islam, Tariqul; Ahmed, Alauddin; Rakibuz-Zaman, Muhammad; Hasan, Rabiul; Sarwar, Golam; Slavkovich, Vesna; van Geen, Alexander; Graziano, Joseph; Ahsan, Habibul			Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study	LANCET			English	Article							BLADDER-CANCER MORTALITY; PERIPHERAL VASCULAR-DISEASE; ENDEMIC AREA; SUPPLY-SYSTEM; SOUTHWESTERN TAIWAN; SKIN-LESIONS; LUNG; REDUCTION; RISK; INSTALLATION	Background Millions of people worldwide are chronically exposed to arsenic through drinking water, including 35-77 million people in Bangladesh. The association between arsenic exposure and mortality rate has not been prospectively investigated by use of individual-level data. We therefore prospectively assessed whether chronic and recent changes in arsenic exposure are associated with all-cause and chronic-disease mortalities in a Bangladeshi population. Methods In the prospective cohort Health Effects of Arsenic Longitudinal Study (HEALS), trained physicians unaware of arsenic exposure interviewed in person and clinically assessed 11 746 population-based participants (aged 18-75 years) from Araihazar, Bangladesh. Participants were recruited from October, 2000, to May, 2002, and followed-up biennially. Data for mortality rates were available throughout February, 2009. We used Cox proportional hazards model to estimate hazard ratios (HRs) of mortality, with adjustment for potential confounders, at different doses of arsenic exposure. Findings 407 deaths were ascertained between October, 2000, and February, 2009. Multivariate adjusted HRs for all-cause mortality in a comparison of arsenic at concentrations of 10.1-50.0 mu g/L, 501-1500 mu g/L, and 150.1-864.0 mu g/L with at least 10.0 mu g/L in well water were 1.34 (95% CI 0.99-1.82), 1.09 (0.81-1.47), and 1.68 (1.26-2.23), respectively. Results were similar with daily arsenic dose and total arsenic concentration in urine. Recent change in exposure, measurement of total arsenic concentrations in urine repeated biennially, did not have much effect on the mortality rate. Interpretation Chronic arsenic exposure through drinking water was associated with an increase in the mortality rate. Follow-up data from this cohort will be used to assess the long-term effects of arsenic exposure and how they might be affected by changes in exposure. However, solutions and resources are urgently needed to mitigate the resulting health effects of arsenic exposure.	[Argos, Maria; Kalra, Tara; Rathouz, Paul J.; Pierce, Brandon; Ahsan, Habibul] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Canc Res Ctr, Chicago, IL 60637 USA; [Argos, Maria; Ahsan, Habibul] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Parvez, Faruque; Slavkovich, Vesna; Graziano, Joseph] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY USA; [Chen, Yu] NYU, Dept Environm Med, New York, NY 10016 USA; [Islam, Tariqul; Ahmed, Alauddin; Rakibuz-Zaman, Muhammad; Hasan, Rabiul; Sarwar, Golam] Columbia Univ, Dhaka, Bangladesh; [Islam, Tariqul; Ahmed, Alauddin; Rakibuz-Zaman, Muhammad; Hasan, Rabiul; Sarwar, Golam] Univ Chicago, Res Off Bangladesh, Dhaka, Bangladesh; [van Geen, Alexander] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; Columbia University; Columbia University; New York University; Columbia University	Ahsan, H (corresponding author), Univ Chicago, Ctr Canc Epidemiol & Prevent, 5841 S Maryland Ave,Suite N102, Chicago, IL 60637 USA.	habib@uchicago.edu	Hug, Balthasar L./G-1568-2010	Chen, Yu/0000-0002-1519-4894; Pierce, Brandon/0000-0002-7829-952X	National Institute of Health, Bethesda, MD, USA [P42ES010349, R01CA102484, R01CA107431, P30ES009089, P30CA014599]; NATIONAL CANCER INSTITUTE [R01CA107431, P30CA014599, R01CA102484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010349, P30ES009089] Funding Source: NIH RePORTER	National Institute of Health, Bethesda, MD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The research is supported by National Institute of Health, Bethesda, MD, USA (grants P42ES010349, R01CA102484, R01CA107431, P30ES009089, and P30CA014599).	Ahsan H, 2006, J EXPO SCI ENV EPID, V16, P191, DOI 10.1038/sj.jea.7500449; Ahsan H, 2000, J OCCUP ENVIRON MED, V42, P1195, DOI 10.1097/00043764-200012000-00016; Ahsan H, 2007, CANCER EPIDEM BIOMAR, V16, P1270, DOI 10.1158/1055-9965.EPI-06-0676; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Chang CC, 2004, J TOXICOL ENV HEAL A, V67, P1353, DOI 10.1080/15287390490471451; CHEN CJ, 1986, BRIT J CANCER, V53, P399, DOI 10.1038/bjc.1986.65; Cheng Z, 2004, ANAL BIOANAL CHEM, V379, P512, DOI 10.1007/s00216-004-2618-x; Ferreccio C, 2000, EPIDEMIOLOGY, V11, P673, DOI 10.1097/00001648-200011000-00010; Harbut MR, 2000, ARCH ENVIRON HEALTH, V55, P285; Hopenhayn-Rich C, 1998, INT J EPIDEMIOL, V27, P561, DOI 10.1093/ije/27.4.561; Lewis DR, 1999, ENVIRON HEALTH PERSP, V107, P359, DOI 10.2307/3434539; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Morales KH, 2000, ENVIRON HEALTH PERSP, V108, P655, DOI 10.2307/3434887; Nermell B, 2008, ENVIRON RES, V106, P212, DOI 10.1016/j.envres.2007.08.005; NIXON DE, 1991, CLIN CHEM, V37, P1575; Ronsmans C, 1998, INT J EPIDEMIOL, V27, P660, DOI 10.1093/ije/27.4.660; Smith AH, 2000, B WORLD HEALTH ORGAN, V78, P1093; Sohel N, 2009, EPIDEMIOLOGY, V20, P824, DOI 10.1097/EDE.0b013e3181bb56ec; Taeger D, 2004, J OCCUP ENVIRON MED, V46, P1007, DOI 10.1097/01.jom.0000141655.00168.0d; Tsai SM, 1999, ARCH ENVIRON HEALTH, V54, P186, DOI 10.1080/00039899909602258; Tseng CH, 1996, ATHEROSCLEROSIS, V120, P125, DOI 10.1016/0021-9150(95)05693-9; Tseng CS, 2002, ANGIOLOGY, V53, P529, DOI 10.1177/000331970205300505; TSUDA T, 1995, AM J EPIDEMIOL, V141, P198, DOI 10.1093/oxfordjournals.aje.a117421; World Health Organization; Water Sanitation and Health Team, 2004, WATER SANITATION HYG; WU MM, 1989, AM J EPIDEMIOL, V130, P1123, DOI 10.1093/oxfordjournals.aje.a115439; Yang CY, 2008, J TOXICOL ENV HEAL A, V71, P533, DOI 10.1080/15287390801907509; Yang CY, 2004, ARCH ENVIRON HEALTH, V59, P484, DOI 10.1080/00039890409603430; Yang CY, 2005, ENVIRON RES, V98, P127, DOI 10.1016/j.envres.2004.07.013; Yuan Y, 2007, AM J EPIDEMIOL, V166, P1381, DOI 10.1093/aje/kwm238; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	30	464	476	6	166	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2010	376	9737					252	258		10.1016/S0140-6736(10)60481-3	http://dx.doi.org/10.1016/S0140-6736(10)60481-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632VM	20646756	Green Accepted			2022-12-01	WOS:000280457200034
J	Grabbe, KL; Bunnell, R				Grabbe, Kristina L.; Bunnell, Rebecca			Reframing HIV Prevention in Sub-Saharan Africa Using Couple-Centered Approaches	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRANSMISSION		[Grabbe, Kristina L.] US Ctr Dis Control & Prevent, Div Global HIV AIDS, Atlanta, GA 30333 USA; [Bunnell, Rebecca] US Ctr Dis Control & Prevent, Div Adult & Community Hlth, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Grabbe, KL (corresponding author), US Ctr Dis Control & Prevent, Div Global HIV AIDS, 1600 Clifton Rd NE,MS E04, Atlanta, GA 30333 USA.	kgrabbe@cdc.gov						Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Kenya National AIDS/STI Control Programme (NASCOP), 2009, 2007 KEN AIDS IND SU; *MEAS DHS MACRO IN, DEM HLTH SURV; Semrau K, 2005, AIDS, V19, P603, DOI 10.1097/01.aids.0000163937.07026.a0; UNAIDS, UN ACC SCAL PRIOR HI; UNAIDS, AIDS EP UPD DEC 2009; WASHERNA NU, 2010, REG M ARUSH TANZ MAY	10	18	18	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					346	347		10.1001/jama.2010.1011	http://dx.doi.org/10.1001/jama.2010.1011			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639571				2022-12-01	WOS:000280107500027
J	Horton, R				Horton, Richard			Science will never be the same again	LANCET			English	Editorial Material							CLIMATE-CHANGE; HEALTH		The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Costello A, 2009, LANCET, V373, P1693, DOI 10.1016/S0140-6736(09)60929-6; Haines A, 2007, LANCET, V370, P1264, DOI 10.1016/S0140-6736(07)61257-4; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; PEARCE R, 2010, CLIMATE FILES; [No title captured]	5	5	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 17	2010	376	9736					143	144		10.1016/S0140-6736(10)61091-4	http://dx.doi.org/10.1016/S0140-6736(10)61091-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	630YP	20638553				2022-12-01	WOS:000280313100004
J	Viner, RM; Roche, E; Maguire, SA; Nicholls, DE				Viner, Russell M.; Roche, Edna; Maguire, Sabine A.; Nicholls, Dasha E.			Childhood protection and obesity: framework for practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SEXUAL-ABUSE; BIRTH COHORT; ADULTHOOD; NEGLECT; CARE; MALTREATMENT; OUTCOMES; CHILDREN; ISSUE; RISK		[Viner, Russell M.] UCL Inst Child Hlth, London WC1N 3EH, England; [Roche, Edna] Univ Dublin Trinity Coll, Dublin 2, Ireland; [Maguire, Sabine A.] Cardiff Univ, Sch Med, Cardiff, Wales; [Nicholls, Dasha E.] Great Ormond St Hosp Sick Children, London, England	University of London; University College London; Trinity College Dublin; Cardiff University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Viner, RM (corresponding author), UCL Inst Child Hlth, London WC1N 3EH, England.	rviner@ich.ucl.ac.uk	Viner, Russell/A-1441-2009	Viner, Russell/0000-0003-3047-2247				Alexander SM, 2009, MED J AUSTRALIA, V190, P136, DOI 10.5694/j.1326-5377.2009.tb02313.x; Bentley T, 2009, OBESITY, V17, P1900, DOI 10.1038/oby.2009.160; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Cole A, 2007, BRIT MED J, V334, P1343, DOI 10.1136/bmj.39259.668565.DB; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Edwards C, 2006, EUR J CLIN NUTR, V60, P587, DOI 10.1038/sj.ejcn.1602353; FISHER BA, 2006, DEPAUL L REV, V55, P711; Fitzpatrick M, 2008, BRIT J GEN PRACT, V58, P742, DOI 10.3399/bjgp08X342589; FREEMAN S, 2009, DAILY MAIL      1207; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Greenfield EA, 2009, SOC SCI MED, V68, P791, DOI 10.1016/j.socscimed.2008.12.004; Grilo CM, 2006, OBES SURG, V16, P454, DOI 10.1381/096089206776327288; Hadfield SC, 2008, CHILD CARE HLTH DEV, V34, P710, DOI 10.1111/j.1365-2214.2008.00874.x; HENDERSON M, 2009, TIMES           1207; JEFFREYS B, 2007, BBC NEWS        0614; Kamath CC, 2008, J CLIN ENDOCR METAB, V93, P4606, DOI 10.1210/jc.2006-2411; LISSAU I, 1994, LANCET, V343, P324, DOI 10.1016/S0140-6736(94)91163-0; Lobstein T, 2007, TACKLING OBESITIES F; Mamun AA, 2007, OBESITY, V15, P2103, DOI 10.1038/oby.2007.250; Pinhas-Hamiel O, 2009, ACTA PAEDIATR, V98, P144, DOI 10.1111/j.1651-2227.2008.01044.x; ROBERTS B, 2008, MIRROR          1008; SHERMAN J, 2008, TIMES           0816; Varness T, 2009, PEDIATRICS, V123, P399, DOI 10.1542/peds.2008-0712; Viner R, 2005, ARCH DIS CHILD, V90, P385, DOI 10.1136/adc.2004.062224; Viner RM, 2005, BRIT MED J, V330, P1354, DOI 10.1136/bmj.38453.422049.E0; Whitaker RC, 2007, CHILD ABUSE NEGLECT, V31, P1187, DOI 10.1016/j.chiabu.2007.04.008	27	21	21	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 15	2010	341								c3074	10.1136/bmj.c3074	http://dx.doi.org/10.1136/bmj.c3074			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628XD	20634344	Green Accepted			2022-12-01	WOS:000280156800001
J	MacKay, C; Declais, AC; Lundin, C; Agostinho, A; Deans, AJ; MacArtney, TJ; Hofmann, K; Gartner, A; West, SC; Helleday, T; Lilley, DMJ; Rouse, J				MacKay, Craig; Declais, Anne-Cecile; Lundin, Cecilia; Agostinho, Ana; Deans, Andrew J.; MacArtney, Thomas J.; Hofmann, Kay; Gartner, Anton; West, Stephen C.; Helleday, Thomas; Lilley, David M. J.; Rouse, John			Identification of KIAA1018/FAN1, a DNA Repair Nuclease Recruited to DNA Damage by Monoubiquitinated FANCD2	CELL			English	Article							HOLLIDAY JUNCTION RESOLVASE; FANCONI-ANEMIA; CROSS-LINKS; REPLICATION; PROTEIN; ACTIVATION; KINETICS; DOMAINS; FAAP24; BRCA1	DNA interstrand crosslinks (ICLs) are highly toxic because they block the progression of replisomes. The Fanconi Anemia (FA) proteins, encoded by genes that are mutated in FA, are important for repair of ICLs. The FA core complex catalyzes the monoubiquitination of FANCD2, and this event is essential for several steps of ICL repair. However, how monoubiquitination of FANCD2 promotes ICL repair at the molecular level is unknown. Here, we describe a highly conserved protein, KIAA1018/MTMR15/FAN1, that interacts with, and is recruited to sites of DNA damage by, the monoubiquitinated form of FANCD2. FAN1 exhibits endonuclease activity toward 50 flaps and has 5' exonuclease activity, and these activities are mediated by an ancient VRR_nuc domain. Depletion of FAN1 from human cells causes hypersensitivity to ICLs, defects in ICL repair, and genome instability. These data at least partly explain how ubiquitination of FANCD2 promotes DNA repair.	[MacKay, Craig; MacArtney, Thomas J.; Rouse, John] Univ Dundee, Coll Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [MacKay, Craig; Lilley, David M. J.] Univ Dundee, Coll Life Sci, CRUK Nucle Acids Struct Res Grp, Dundee DD1 5EH, Scotland; [Agostinho, Ana; Gartner, Anton] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland; [Lundin, Cecilia; Helleday, Thomas] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford OX3 7DQ, England; [Hofmann, Kay] Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, Germany; [Deans, Andrew J.; West, Stephen C.] Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; [Helleday, Thomas] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden	University of Dundee; University of Dundee; University of Dundee; University of Oxford; Miltenyi Biotec; Cancer Research UK; Stockholm University	Rouse, J (corresponding author), Univ Dundee, Coll Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland.	j.rouse@dundee.ac.uk	Deans, Andrew/U-3515-2019; Deans, Andrew J/E-5817-2011; Hofmann, Kay/D-6714-2011; Helleday, Thomas/D-5224-2013	Deans, Andrew/0000-0002-5271-4422; Deans, Andrew J/0000-0002-5271-4422; Hofmann, Kay/0000-0002-2289-9083; Helleday, Thomas/0000-0002-7384-092X; Agostinho, Ana/0000-0001-6270-7384; West, Stephen/0000-0001-8848-9418; Declais, Anne-Cecile/0000-0002-1904-6469; Gartner, Anton/0000-0003-4639-9902	UK Medical Research Council; Cancer Research UK; Fanconi Anemia Research Fund; BBSRC [BB/E001777/1] Funding Source: UKRI; MRC [MC_U127070192, G0700730] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E001777/1] Funding Source: researchfish; Cancer Research UK [11582] Funding Source: researchfish; Medical Research Council [G0700730, MC_U127070192] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Fanconi Anemia Research Fund; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to Katja Kratz and Joe Jiricny for experimental advice, for helping us with the purification of FAN1, and for communicating results prior to publication. We thank K.J. Patel, Johan de Winter, and Maureen Hoatlin for kind gifts of antibodies. pDEST40-V5-FANCD2 wild-type and pDEST40-V5-FANCD2 K561R plasmids were kind gifts from Niall Howlett and Thomas Glover. We thank Alan d'Andrea for the kind gifts of FANCD2<SUP>-/-</SUP> fibroblasts (PD20 cells) corrected with vector, FANCD2 wild-type, or FANCD2 K561R. We are grateful to James Hastie, Hilary MacLauchlan, and the Antibody Production Team at Division of Signal Transduction Therapy, University of Dundee, to Bob Gourlay, Sanjay Kothiya, and Nick Morrice for help with mass spectrometry, and to the DNA Sequencing Service at the College of Life Sciences (CLS), University of Dundee. We are grateful to the microscopy facility, CLS, University of Dundee for assistance with microscopy. We thank Jim Haber and the J.R. lab for critical reading of the manuscript. This work was funded by the UK Medical Research Council (C.M., T.J.H., and J.R.), Cancer Research UK (A.C.D, A.G., and D.M.J.L.), and the Fanconi Anemia Research Fund (A.J.D. and S.C.W.).	Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Bhagwat N, 2009, MOL CELL BIOL, V29, P6427, DOI 10.1128/MCB.00086-09; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; BRENNER S, 1974, GENETICS, V77, P71; Cannavo E, 2007, J BIOL CHEM, V282, P2976, DOI 10.1074/jbc.M609989200; Ciccia A, 2007, MOL CELL, V25, P331, DOI 10.1016/j.molcel.2007.01.003; Collis SJ, 2008, MOL CELL, V32, P313, DOI 10.1016/j.molcel.2008.10.014; Deans AJ, 2009, MOL CELL, V36, P943, DOI 10.1016/j.molcel.2009.12.006; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Iyer LM, 2006, CELL CYCLE, V5, P775, DOI 10.4161/cc.5.7.2629; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kosinski J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-172; Leskovac A, 2010, TOHOKU J EXP MED, V221, P69, DOI 10.1620/tjem.221.69; Ling C, 2007, EMBO J, V26, P2104, DOI 10.1038/sj.emboj.7601666; Mccabe KM, 2009, J CELL PHYSIOL, V220, P569, DOI 10.1002/jcp.21811; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Patel KJ, 2007, DNA REPAIR, V6, P885, DOI 10.1016/j.dnarep.2007.02.002; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159	32	230	238	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2010	142	1					65	76		10.1016/j.cell.2010.06.021	http://dx.doi.org/10.1016/j.cell.2010.06.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603015	Bronze, Green Accepted			2022-12-01	WOS:000279637300013
J	Hotchkiss, RS; Opal, S				Hotchkiss, Richard S.; Opal, Steven			Immunotherapy for Sepsis - A New Approach against an Ancient Foe	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63130 USA; [Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63130 USA; [Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63130 USA; [Opal, Steven] Mem Hosp Rhode Isl, Div Infect Dis, Providence, RI USA; [Opal, Steven] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Brown University	Hotchkiss, RS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63130 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044118] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM044118] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Opal SM, 2009, JAMA-J AM MED ASSOC, V302, P2367, DOI 10.1001/jama.2009.1774; Said EA, 2010, NAT MED, V16, P452, DOI 10.1038/nm.2106	5	267	302	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2010	363	1					87	89		10.1056/NEJMcibr1004371	http://dx.doi.org/10.1056/NEJMcibr1004371			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618HR	20592301	Green Accepted, Green Published			2022-12-01	WOS:000279343000016
J	Biertumpfel, C; Zhao, Y; Kondo, Y; Ramon-Maiques, S; Gregory, M; Lee, JY; Masutani, C; Lehmann, AR; Hanaoka, F; Yang, W				Biertuempfel, Christian; Zhao, Ye; Kondo, Yuji; Ramon-Maiques, Santiago; Gregory, Mark; Lee, Jae Young; Masutani, Chikahide; Lehmann, Alan R.; Hanaoka, Fumio; Yang, Wei			Structure and mechanism of human DNA polymerase eta	NATURE			English	Article							SYN THYMINE DIMER; TRANSLESION SYNTHESIS; CRYSTAL-STRUCTURE; MOLECULAR ANALYSIS; BYPASS; LESION; RECOGNITION; REPLICATION; MUTATIONS; CISPLATIN	The variant form of the human syndrome xeroderma pigmentosum (XPV) is caused by a deficiency in DNA polymerase eta (Pol eta), a DNA polymerase that enables replication through ultraviolet-induced pyrimidine dimers. Here we report high-resolution crystal structures of human Pol eta at four consecutive steps during DNA synthesis through cis-syn cyclobutane thymine dimers. Pol eta acts like a 'molecular splint' to stabilize damaged DNA in a normal B-form conformation. An enlarged active site accommodates the thymine dimer with excellent stereochemistry for two-metal ion catalysis. Two residues conserved among Pol eta orthologues form specific hydrogen bonds with the lesion and the incoming nucleotide to assist translesion synthesis. On the basis of the structures, eight Pol eta missense mutations causing XPV can be rationalized as undermining the molecular splint or perturbing the active-site alignment. The structures also provide an insight into the role of Pol eta in replicating through D loop and DNA fragile sites.	[Biertuempfel, Christian; Zhao, Ye; Ramon-Maiques, Santiago; Gregory, Mark; Lee, Jae Young; Yang, Wei] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Zhao, Ye] Zhejiang Univ, Inst Nucl Agr Sci, Hangzhou 310029, Zhejiang, Peoples R China; [Kondo, Yuji; Masutani, Chikahide; Hanaoka, Fumio] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Lehmann, Alan R.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Hanaoka, Fumio] Gakushuin Univ, Fac Sci, Toshima Ku, Tokyo 1718588, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Zhejiang University; Osaka University; University of Sussex; Gakushuin University	Yang, W (corresponding author), NIDDK, Mol Biol Lab, NIH, 9000 Rockville Pike,Bldg 5,Room B103, Bethesda, MD 20892 USA.	fumio.hanaoka@gakushuin.ac.jp; wei.yang@nih.gov	Masutani, Chikahide/I-6160-2014; Ramon-Maiques, Santiago/R-2533-2019; Yang, Wei/D-4926-2011; Yang, Wei/ABB-4785-2020; Zhao, Ye/I-2936-2014	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195; Zhao, Ye/0000-0002-5455-2586; Ramon-Maiques, Santiago/0000-0001-9674-8088; Masutani, Chikahide/0000-0002-8600-8227; Biertumpfel, Christian/0000-0002-7528-6547	NIDDK, NIH; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Chinese Ministry of Education; NIH-Zhejiang University; Human Frontiers Science Program; MRC [G0501450] Funding Source: UKRI; Medical Research Council [G0801130B, G0501450] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036119, ZIADK036146] Funding Source: NIH RePORTER	NIDDK, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Chinese Ministry of Education(Ministry of Education, China); NIH-Zhejiang University; Human Frontiers Science Program(Human Frontier Science Program); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Leahy, M. Gellert and R. Craigie for critical reading of the manuscript. The research was funded by the intramural research program of NIDDK, NIH, and grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Y.Z. is the recipient of a Chinese Ministry of Education scholarship and joint PhD student in NIH-Zhejiang University Graduate Partnership Program. S.R.-M. received a fellowship from the Human Frontiers Science Program.	Alt A, 2007, SCIENCE, V318, P967, DOI 10.1126/science.1148242; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bassett E, 2003, BIOCHEMISTRY-US, V42, P14197, DOI 10.1021/bi035359p; Bauer J, 2007, P NATL ACAD SCI USA, V104, P14905, DOI 10.1073/pnas.0700717104; Brash DE, 1997, TRENDS GENET, V13, P410, DOI 10.1016/S0168-9525(97)01246-8; Broughton BC, 2002, P NATL ACAD SCI USA, V99, P815, DOI 10.1073/pnas.022473899; Broyde S, 2008, TRENDS BIOCHEM SCI, V33, P209, DOI 10.1016/j.tibs.2008.02.004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bugreev DV, 2007, NAT STRUCT MOL BIOL, V14, P746, DOI 10.1038/nsmb1268; Chaney SG, 2005, CRIT REV ONCOL HEMAT, V53, P3, DOI 10.1016/j.critrevonc.2004.08.008; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Di Lucca J, 2009, EUR J CANCER, V45, P3228, DOI 10.1016/j.ejca.2009.04.034; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Glick E, 2001, EMBO J, V20, P7303, DOI 10.1093/emboj/20.24.7303; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hishida T, 2009, NATURE, V457, P612, DOI 10.1038/nature07580; Inui H, 2008, J INVEST DERMATOL, V128, P2055, DOI 10.1038/jid.2008.48; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; Jia L, 2008, NUCLEIC ACIDS RES, V36, P6571, DOI 10.1093/nar/gkn719; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawamoto T, 2005, MOL CELL, V20, P793, DOI 10.1016/j.molcel.2005.10.016; Kokoska RJ, 2003, J BIOL CHEM, V278, P50537, DOI 10.1074/jbc.M308515200; Kusumoto R, 2004, GENES CELLS, V9, P1139, DOI 10.1111/j.1365-2443.2004.00797.x; Kusumoto R, 2002, BIOCHEMISTRY-US, V41, P6090, DOI 10.1021/bi025549k; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Li Y, 2004, NAT STRUCT MOL BIOL, V11, P784, DOI 10.1038/nsmb792; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McCulloch SD, 2004, NATURE, V428, P97, DOI 10.1038/nature02352; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park H, 2002, P NATL ACAD SCI USA, V99, P15965, DOI 10.1073/pnas.242422699; Rey L, 2009, MOL CELL BIOL, V29, P3344, DOI 10.1128/MCB.00115-09; Saribasak H, 2009, PHILOS T R SOC B, V364, P605, DOI 10.1098/rstb.2008.0188; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; Sugasawa K, 2008, ADV EXP MED BIOL, V637, P47; Tanioka M, 2007, J INVEST DERMATOL, V127, P1745, DOI 10.1038/sj.jid.5700759; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; VASSYLYEV DG, 1995, CELL, V83, P773, DOI 10.1016/0092-8674(95)90190-6; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang F, 2009, CELL, V139, P1279, DOI 10.1016/j.cell.2009.11.043; Wang LH, 2009, J MOL BIOL, V389, P787, DOI 10.1016/j.jmb.2009.04.029; Wilson RC, 2008, MOL CELL, V29, P767, DOI 10.1016/j.molcel.2008.01.014; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yang W, 2006, DNA REPAIR, V5, P654, DOI 10.1016/j.dnarep.2006.02.004; Yao JQ, 2001, ENVIRON MOL MUTAGEN, V38, P19, DOI 10.1002/em.1046	58	248	249	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					1044	U102		10.1038/nature09196	http://dx.doi.org/10.1038/nature09196			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577208	Green Accepted			2022-12-01	WOS:000279056900045
J	Kautz, T; Bendavid, E; Bhattacharya, J; Miller, G				Kautz, Tim; Bendavid, Eran; Bhattacharya, Jay; Miller, Grant			AIDS and declining support for dependent elderly people in Africa: retrospective analysis using demographic and health surveys	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IMPACT; HIV/AIDS	Objectives To determine the relation between the HIV/AIDS epidemic and support for dependent elderly people in Africa. Design Retrospective analysis using data from Demographic and Health Surveys. Setting 22 African countries between 1991 and 2006. Participants 123 176 individuals over the age of 60. Main outcome measures We investigated how three measures of the living arrangements of older people have been affected by the HIV/AIDS epidemic: the number of older individuals living alone (that is, the number of unattended elderly people); the number of older individuals living with only dependent children under the age of 10 (that is, in missing generation households); and the number of adults age 18-59 (that is, prime age adults) per household where an older person lives. Results An increase in annual AIDS mortality of one death per 1000 people was associated with a 1.5% increase in the proportion of older individuals living alone (95% CI 1.2% to 1.9%) and a 0.4% increase in the number of older individuals living in missing generation households (95% CI 0.3% to 0.6%). Increases in AIDS mortality were also associated with fewer prime age adults in households with at least one older person and at least one prime age adult (P<0.001). These findings suggest that in our study countries, which encompass 70% of the sub-Saharan population, the HIV/AIDS epidemic could be responsible for 582 200-917 000 older individuals living alone without prime age adults and 141 000-323 100 older individuals being the sole caregivers for young children. Conclusions Africa's HIV/AIDS epidemic might be responsible for a large number of older people losing their support and having to care for young children. This population has previously been under-recognised. Efforts to reduce HIV/AIDS deaths could have large "spillover" benefits for elderly people in Africa.	[Bendavid, Eran; Bhattacharya, Jay; Miller, Grant] Stanford Univ, CHP, Stanford, CA 94305 USA; [Bendavid, Eran; Bhattacharya, Jay; Miller, Grant] Stanford Univ, Ctr Primary Care & Outcomes Res PCOR, Stanford, CA 94305 USA; [Kautz, Tim] Univ Chicago, Dept Econ, Chicago, IL 60637 USA	Stanford University; Stanford University; University of Chicago	Miller, G (corresponding author), Stanford Univ, CHP, Stanford, CA 94305 USA.	ngmiller@stanford.edu			National Institute on Aging [K02-AG024237]; National Institute of Child Health and Human Development [K01-HD053504]; Agency for Healthcare Research and Quality [T32-HS000028]; National Institute of Allergy and Infectious Diseases [K01-AI084582]; Stanford Center for Demography and Economics of Aging [P30-AG017253]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000028] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K01HD053504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI084582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG024237, P30AG017253] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Stanford Center for Demography and Economics of Aging; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the National Institute on Aging (K02-AG024237), the National Institute of Child Health and Human Development (K01-HD053504), the Agency for Healthcare Research and Quality (T32-HS000028), the National Institute of Allergy and Infectious Diseases (K01-AI084582), and the Stanford Center for Demography and Economics of Aging (P30-AG017253). The supporting agencies had no part in formulating, analysing, or writing this work.	Aboderin I, 2004, J GERONTOL B-PSYCHOL, V59, pS128, DOI 10.1093/geronb/59.3.S128; Agesa R.U, 2004, REV ECON HOUSEHOLD, V2, P161, DOI DOI 10.1023/B:REHO.0000031612.77882.29; [Anonymous], WORLD URB PROSP 2005; Barrientos A, 2003, WORLD DEV, V31, P555, DOI 10.1016/S0305-750X(02)00211-5; CATTELL M G, 1990, Journal of Cross-Cultural Gerontology, V5, P375, DOI 10.1007/BF00057646; DAYTON J, 2002, POLICY RES DIVISION, V160; GHYS PD, 2004, SEX TRANSM INFECT S1, V80, P5; Gregson S, 2007, P NATL ACAD SCI USA, V104, P14586, DOI 10.1073/pnas.0611540104; Knodel J, 2001, SOC SCI MED, V52, P1313, DOI 10.1016/S0277-9536(00)00233-1; KNODEL J, 2002, AIDS S3, V16, P77; Merli M. G, 2006, AGING SUBSAHARAN AFR, P117; Newell ML, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406002-00004; Ntozi James P. M., 1999, CONTINUING AFRICAN H, P193; Nyambedha EO, 2003, SOC SCI MED, V57, P301, DOI 10.1016/S0277-9536(02)00359-3; Nyirenda M, 2007, AIDS, V21, pS73, DOI 10.1097/01.aids.0000299413.82893.2b; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; SMITH J, 2007, AIDS S6, V21, P81; Ssengonzi R, 2007, J CROSS-CULT GERONTO, V22, P339, DOI 10.1007/s10823-007-9043-5; *UNAIDS, 2008, REP GLOB AIDS EP; Unanka GO, 2002, J SOC ISSUES, V58, P681, DOI 10.1111/1540-4560.00040; United Nations. Department of Economic and Social Affairs. Population Division, 2007, WORLD POP PROSP 2006; *US BUR CENS, 2008, INT DAT; Wachter KW, 2003, J ECONOMETRICS, V112, P193, DOI 10.1016/S0304-4076(02)00160-4; Wachter KW, 2002, DEMOGRAPHY, V39, P25, DOI 10.1353/dem.2002.0012; WILLIAMS A, 1996, ASIAN STUDIES REV, V20, P98; ZIMMER Z, 2000, POPUL STUD CAMB, V59, P295	26	46	46	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 16	2010	340								c2841	10.1136/bmj.c2841	http://dx.doi.org/10.1136/bmj.c2841			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614JB	20554660	Green Published, hybrid			2022-12-01	WOS:000279051900002
J	Davies, AA; Neiss, A; Ulrich, HD				Davies, Adelina A.; Neiss, Andrea; Ulrich, Helle D.			Ubiquitylation of the 9-1-1 Checkpoint Clamp Is Independent of Rad6-Rad18 and DNA Damage	CELL			English	Article							REPLICATION PROTEIN-A; SACCHAROMYCES-CEREVISIAE; RAD6 PATHWAY; SOS RESPONSE; UBIQUITIN; REPAIR; PCNA; POLYMERASE; CELLS; SUMO	A recent report proposed a function of the ubiquitin conjugation factors Rad6 and Rad18 comparable to the bacterial SOS response, controlling damage-induced transcriptional activation and contributing to checkpoint signaling. The relevant ubiquitylation target was identified as budding yeast Rad17, a subunit of the PCNA-like 9-1-1 checkpoint clamp. We report here that in fact all three subunits of the 9-1-1 complex are ubiquitylated. However, in contrast to previous results, we found modification of Rad17 to be independent of DNA damage, the Rad6-Rad18 complex, the putative acceptor site (lysine 197), and loading of the complex onto DNA. Consistently, we were unable to observe enhanced damage sensitivity or defects in checkpoint signaling in a rad17(K197R) mutant. Instead, our findings suggest that ubiquitylation of the 9-1-1 complex may be a background reaction that in some cases can mediate proteasomal degradation.	[Davies, Adelina A.; Ulrich, Helle D.] Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK London Res Inst, S Mimms EN6 3LD, Herts, England; [Neiss, Andrea] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany	Cancer Research UK; Max Planck Society	Ulrich, HD (corresponding author), Imperial Canc Res Fund, Clare Hall Labs, Canc Res UK London Res Inst, Blanche Lane, S Mimms EN6 3LD, Herts, England.	helle.ulrich@cancer.org.uk		Ulrich, Helle D./0000-0003-0431-2223	Cancer Research UK; Deutsche Forschungsgemeinschaft	Cancer Research UK(Cancer Research UK); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Susan Gasser and Wolfram Siede for yeast strains. This work was supported by Cancer Research UK and a grant from the Deutsche Forschungsgemeinschaft.	Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Chen S, 2005, NUCLEIC ACIDS RES, V33, P5878, DOI 10.1093/nar/gki902; Cobb JA, 2003, EMBO J, V22, P4325, DOI 10.1093/emboj/cdg391; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; Dore AS, 2009, MOL CELL, V34, P735, DOI 10.1016/j.molcel.2009.04.027; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Frei C, 2000, GENE DEV, V14, P81; Friedl AA, 2001, MUTAT RES-DNA REPAIR, V486, P137, DOI 10.1016/S0921-8777(01)00086-6; Fu Y, 2008, CELL, V133, P601, DOI 10.1016/j.cell.2008.02.050; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huttner D, 2008, CELL CYCLE, V7, P3629, DOI 10.4161/cc.7.23.7166; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; Pages V, 2002, ONCOGENE, V21, P8957, DOI 10.1038/sj.onc.1206006; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Sutton MD, 2000, ANNU REV GENET, V34, P479, DOI 10.1146/annurev.genet.34.1.479; Szuts D, 2006, MOL CELL BIOL, V26, P8032, DOI 10.1128/MCB.01291-06; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Ulrich HD, 2001, NUCLEIC ACIDS RES, V29, P3487, DOI 10.1093/nar/29.17.3487; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Yamashita YM, 2002, EMBO J, V21, P5558, DOI 10.1093/emboj/cdf534; Zhang H, 2001, J BIOL CHEM, V276, P26715, DOI 10.1074/jbc.M103682200; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100	32	10	10	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					1080	1087		10.1016/j.cell.2010.04.039	http://dx.doi.org/10.1016/j.cell.2010.04.039			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550940	Bronze			2022-12-01	WOS:000278618800021
J	Singh, R; Cresswell, P				Singh, Reshma; Cresswell, Peter			Defective Cross-Presentation of Viral Antigens in GILT-Free Mice	SCIENCE			English	Article							MHC CLASS-I; HERPES-SIMPLEX-VIRUS; THIOL REDUCTASE GILT; DENDRITIC CELLS; ENDOPLASMIC-RETICULUM; DISULFIDE BONDS; INFLUENZA-VIRUS; GLYCOPROTEIN-B; CROSSPRESENTATION; LYSOSOMES	Gamma-interferon-inducible lysosomal thiolreductase (GILT) promotes major histocompatibility complex (MHC) class II-restricted presentation of exogenous antigens containing disulfide bonds. Here, we show that GILT also facilitates MHC class I-restricted recognition of such antigens by CD8(+) T cells, or cross-presentation. GILT is essential for cross-presentation of a CD8(+) T cell epitope of glycoprotein B (gB) from herpes simplex virus 1 (HSV-1) but not for its presentation by infected cells. Initiation of the gB-specific CD8(+) T cell response during HSV-1 infection, or cross-priming, is highly GILT-dependent, as is initiation of the response to the envelope glycoproteins of influenza A virus. Efficient cross-presentation of disulfide-rich antigens requires a complex pathway involving GILT-mediated reduction, unfolding, and partial proteolysis, followed by translocation into the cytosol for proteasomal processing.	[Singh, Reshma; Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06250 USA	Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, 300 Cedar St,POB 208011, New Haven, CT 06250 USA.	peter.cresswell@yale.edu			Howard Hughes Medical Institute; NIH [R37AI23081]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023081] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Howard Hughes Medical Institute and NIH grant R37AI23081 (P.C.).	Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belizaire R, 2009, P NATL ACAD SCI USA, V106, P17463, DOI 10.1073/pnas.0908583106; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; COLLINS DS, 1991, J IMMUNOL, V147, P4054; Giodini A, 2008, EMBO J, V27, P201, DOI 10.1038/sj.emboj.7601941; HANKE T, 1991, J VIROL, V65, P1177, DOI 10.1128/JVI.65.3.1177-1186.1991; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Jutras I, 2005, ANNU REV CELL DEV BI, V21, P511, DOI 10.1146/annurev.cellbio.20.010403.102755; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Lin ML, 2008, P NATL ACAD SCI USA, V105, P3029, DOI 10.1073/pnas.0712394105; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; MCCOY KL, 1989, J IMMUNOL, V143, P29; Norbury CC, 1997, EUR J IMMUNOL, V27, P280, DOI 10.1002/eji.1830270141; Phan UT, 2000, J BIOL CHEM, V275, P25907, DOI 10.1074/jbc.M003459200; Rajasagi NK, 2009, J VIROL, V83, P5256, DOI 10.1128/JVI.01997-08; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Schafer A, 2009, EMBO J, V28, P2874, DOI 10.1038/emboj.2009.231; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Singh R, 2008, NATURE, V455, P1244, DOI 10.1038/nature07344; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Zhong WM, 2003, J BIOL CHEM, V278, P45135, DOI 10.1074/jbc.M307417200	29	107	112	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1394	1398		10.1126/science.1189176	http://dx.doi.org/10.1126/science.1189176			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20538950	Green Accepted			2022-12-01	WOS:000278598400038
J	Singhal, N; Graumann, J; Wu, GM; Arauzo-Bravo, MJ; Han, DW; Greber, B; Gentile, L; Mann, M; Scholer, HR				Singhal, Nishant; Graumann, Johannes; Wu, Guangming; Arauzo-Bravo, Marcos J.; Han, Dong Wook; Greber, Boris; Gentile, Luca; Mann, Matthias; Schoeler, Hans R.			Chromatin-Remodeling Components of the BAF Complex Facilitate Reprogramming	CELL			English	Article							PLURIPOTENT STEM-CELLS; HUMAN SOMATIC-CELLS; SWI/SNF COMPLEX; GENE-EXPRESSION; SELF-RENEWAL; AMINO-ACIDS; FIBROBLASTS; INDUCTION; REQUIRES; EXTRACT	Reprogramming of somatic cells achieved by combination of the four transcription factors Oct4, Sox2, Klf4, and c-Myc has very low efficiency. To increase the reprogramming efficiency and better understand the process, we sought to identify factors that mediate reprogramming with higher efficiency. We established an assay to screen nuclear fractions from extracts of pluripotent mouse cells based on Oct4 reactivation. Using proteomics, we identified components of the ATP-dependent BAF chromatin-remodeling complex, which significantly increases reprogramming efficiency when used together with the four factors. The reprogrammed cells could transmit to the germline and exhibited pluripotency. Reprogramming remained highly efficient when c-Myc was not present but BAF components were overexpressed. BAF complex components mediate this effect by facilitating enhanced Oct4 binding to target promoters during reprogramming. Thus, somatic cell reprogramming using chromatin-remodeling molecules represents an efficient method of generating reprogrammed cells.	[Singhal, Nishant; Wu, Guangming; Arauzo-Bravo, Marcos J.; Han, Dong Wook; Greber, Boris; Gentile, Luca; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Graumann, Johannes; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; Max Planck Society; University of Munster	Scholer, HR (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Rontgenstr 20, D-48149 Munster, Germany.	office@mpi-muenster.mpg.de	Gentile, Luca/L-4473-2014; Graumann, Johannes/C-5241-2008; Marcos, Arauzo-Bravo/A-1706-2011; Han, Dong Wook/D-6041-2011; Mann, Matthias/A-3454-2013; Gentile, Luca/E-4908-2019; , HS/AAB-4434-2019	Graumann, Johannes/0000-0002-3015-5850; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Mann, Matthias/0000-0003-1292-4799; Gentile, Luca/0000-0002-7393-7502; , HS/0000-0003-2643-5136; Wu, Guangming/0000-0003-1923-7609; Greber, Boris/0000-0002-9404-7293; Singhal, Nishant/0000-0002-7988-5125	Max Planck Society; Deutsche Forschungsgemeinschaft DFG [SPP 1356, SCHO 340/5-1]; Federal Ministry of Education and Research BMBF [01GN0934]	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Federal Ministry of Education and Research BMBF(Federal Ministry of Education & Research (BMBF))	editing the manuscript. The project was partly funded by the Max Planck Society for the advancement of Sciences, by the Deutsche Forschungsgemeinschaft DFG within the Priority Programme SPP 1356 "Pluripotency and Cellular Reprogramming" (grant SCHO 340/5-1), and by the Federal Ministry of Education and Research BMBF "Cell-based regenerative medicine-Pluripotent cells for heart therapies" (grant 01GN0934).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banine F, 2005, CANCER RES, V65, P3542, DOI 10.1158/0008-5472.CAN-04-3554; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Datta J, 2005, CANCER RES, V65, P10891, DOI 10.1158/0008-5472.CAN-05-1455; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Hansis C, 2004, CURR BIOL, V14, P1475, DOI 10.1016/j.cub.2004.08.031; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Markoulaki S, 2008, METHODS, V45, P101, DOI 10.1016/j.ymeth.2008.04.002; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Miyamoto K, 2007, MOL REPROD DEV, V74, P1268, DOI 10.1002/mrd.20691; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Neri T, 2007, CLONING STEM CELLS, V9, P394, DOI 10.1089/clo.2006.0011; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taranger CK, 2005, MOL BIOL CELL, V16, P5719, DOI 10.1091/mbc.e05-06-0572; Wang W, 2003, CURR TOP MICROBIOL, V274, P143; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yan Z, 2008, STEM CELLS, V26, P1155, DOI 10.1634/stemcells.2007-0846; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	45	283	302	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					943	955		10.1016/j.cell.2010.04.037	http://dx.doi.org/10.1016/j.cell.2010.04.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550931	Bronze			2022-12-01	WOS:000278618800010
J	Yao, NY; O'Donnell, M				Yao, Nina Y.; O'Donnell, Mike			SnapShot: The Replisome	CELL			English	Editorial Material							REPLICATION FORK		[Yao, Nina Y.] Rockefeller Univ, New York, NY 10065 USA; HHMI, New York, NY 10065 USA	Rockefeller University; Howard Hughes Medical Institute	Yao, NY (corresponding author), Rockefeller Univ, New York, NY 10065 USA.			O'Donnell, Michael/0000-0001-9002-4214	NIGMS NIH HHS [R01 GM038839] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038839] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Benkovic SJ, 2001, ANNU REV BIOCHEM, V70, P181, DOI 10.1146/annurev.biochem.70.1.181; Kornberg A., 1992, DNA REPLICATION; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; SINHA NK, 1980, J BIOL CHEM, V255, P4290; Stillman B, 2008, MOL CELL, V30, P259, DOI 10.1016/j.molcel.2008.04.011; Yao NY, 2009, CURR OPIN CELL BIOL, V21, P336, DOI 10.1016/j.ceb.2009.02.008	6	39	40	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 11	2010	141	6					1088	U181	1088.e1	10.1016/j.cell.2010.05.042	http://dx.doi.org/10.1016/j.cell.2010.05.042			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550941	Bronze, Green Accepted			2022-12-01	WOS:000278618800022
J	Rodriguez-Munoz, R; Bretman, A; Slate, J; Walling, CA; Tregenza, T				Rodriguez-Munoz, R.; Bretman, A.; Slate, J.; Walling, C. A.; Tregenza, T.			Natural and Sexual Selection in a Wild Insect Population	SCIENCE			English	Article							FEMALES; DOMINANCE	The understanding of natural and sexual selection requires both field and laboratory studies to exploit the advantages and avoid the disadvantages of each approach. However, studies have tended to be polarized among the types of organisms studied, with vertebrates studied in the field and invertebrates in the lab. We used video monitoring combined with DNA profiling of all of the members of a wild population of field crickets across two generations to capture the factors predicting the reproductive success of males and females. The factors that predict a male's success in gaining mates differ from those that predict how many offspring he has. We confirm the fundamental prediction that males vary more in their reproductive success than females, and we find that females as well as males leave more offspring when they mate with more partners.	[Rodriguez-Munoz, R.; Bretman, A.; Tregenza, T.] Univ Exeter, Sch Biosci, Ctr Ecol & Conservat, Penryn TR10 EZ, England; [Bretman, A.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Slate, J.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Walling, C. A.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland	University of Exeter; University of East Anglia; University of Sheffield; University of Edinburgh	Tregenza, T (corresponding author), Univ Exeter, Sch Biosci, Ctr Ecol & Conservat, Cornwall Campus, Penryn TR10 EZ, England.	t.tregenza@exeter.ac.uk	Slate, Jon/D-2925-2012; Tregenza, Tom/B-1078-2014	Slate, Jon/0000-0003-3356-5123; Tregenza, Tom/0000-0003-4182-2222; Bretman, Amanda/0000-0002-4421-3337	Natural Environment Research Council (NERC) [NE/E005403/1]; NERC Sheffield Biomolecular Analysis Facility; Leverhulme Trust; Royal Society; Natural Environment Research Council [NBAF010001, NE/H02364X/1, NE/E005403/1] Funding Source: researchfish; NERC [NE/H02364X/1, NBAF010001] Funding Source: UKRI	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC Sheffield Biomolecular Analysis Facility; Leverhulme Trust(Leverhulme Trust); Royal Society(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environment Research Council (NERC) (grant NE/E005403/1), the NERC Sheffield Biomolecular Analysis Facility, the Leverhulme Trust, and a Royal Society Fellowship to T. T. We thank L. Rodriguez and M. C. Munoz for providing access and facilities at the study site; J. M. Lopez, C. Lopez, E. Gonzalez, C. R. del Valle, and F. Gonzalez for assistance with the field work; and D. J. Hodgson and A. Wetherelt for assistance with data analysis and surveying.	Bailey WJ, 1998, J ZOOL, V244, P505, DOI 10.1111/j.1469-7998.1998.tb00056.x; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Bilde T, 2009, SCIENCE, V324, P1705, DOI 10.1126/science.1171675; Bretman A, 2004, P ROY SOC B-BIOL SCI, V271, P159, DOI 10.1098/rspb.2003.2563; Bretman A, 2006, BIOL LETT-UK, V2, P409, DOI 10.1098/rsbl.2006.0493; Bretman A, 2009, MOL ECOL, V18, P3340, DOI 10.1111/j.1365-294X.2009.04301.x; CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0; Clutton-Brock T. H., 1988, REPROD SUCCESS; Darwin C., 1871, P423; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; FINCKE OM, 1986, EVOLUTION, V40, P791, DOI 10.1111/j.1558-5646.1986.tb00539.x; Hack MA, 1998, J INSECT BEHAV, V11, P853, DOI 10.1023/A:1020864111073; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Kokko H, 1999, AM NAT, V154, P358, DOI 10.1086/303235; Kortet R, 2005, BEHAV ECOL SOCIOBIOL, V59, P77, DOI 10.1007/s00265-005-0011-1; Qvarnstrom A, 1998, TRENDS ECOL EVOL, V13, P498, DOI 10.1016/S0169-5347(98)01513-4; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Schwarzenbach GA, 2005, J EVOLUTION BIOL, V18, P455, DOI 10.1111/j.1420-9101.2004.00820.x; SHUSTER SM, 2003, MG BEH ECOL, pR7; Snyder BF, 2007, EVOLUTION, V61, P2457, DOI 10.1111/j.1558-5646.2007.00212.x; Tregenza T, 1998, EVOLUTION, V52, P1726, DOI 10.1111/j.1558-5646.1998.tb02252.x; Wedell N, 1999, EVOLUTION, V53, P620, DOI 10.1111/j.1558-5646.1999.tb03797.x; ZUK M, 1993, BEHAV ECOL SOCIOBIOL, V33, P339; Zuk Marlene, 1997, P89, DOI 10.1017/CBO9780511721946.006	25	157	157	0	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2010	328	5983					1269	1272		10.1126/science.1188102	http://dx.doi.org/10.1126/science.1188102			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522773				2022-12-01	WOS:000278318600032
J	Unwin, N; Whiting, D; Roglic, G				Unwin, Nigel; Whiting, David; Roglic, Gojka			Social determinants of diabetes and challenges of prevention	LANCET			English	Editorial Material							HEALTH; CHINA		[Unwin, Nigel] Newcastle Univ, Inst Hlth & Soc, WHO Collaborating Ctr Res & Training Diabet, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Whiting, David] Int Diabet Federat, Brussels, Belgium; [Roglic, Gojka] WHO, Dept Chron Dis & Hlth Promot, CH-1211 Geneva, Switzerland	Newcastle University - UK; World Health Organization	Unwin, N (corresponding author), Newcastle Univ, Inst Hlth & Soc, WHO Collaborating Ctr Res & Training Diabet, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.	n.c.unwin@ncl.ac.uk		Roglic, Gojka/0000-0003-0872-0689; Whiting, David/0000-0001-9827-2896; Unwin, Nigel/0000-0002-1368-1648				Goldstein J, 2005, PREV MED, V41, P800, DOI 10.1016/j.ypmed.2005.06.001; Hawkes C, 2005, PUBLIC HEALTH NUTR, V8, P357, DOI 10.1079/PHN2004706; *INT DIAB FED, 2010, DIAB ATL; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Normile D, 2010, SCIENCE, V328, P422, DOI 10.1126/science.328.5977.422; Shobhana R, 2000, DIABETES RES CLIN PR, V48, P37, DOI 10.1016/S0168-8227(99)00130-8; Simmons RK, 2010, DIABETES RES CLIN PR, V87, P143, DOI 10.1016/j.diabres.2009.10.003; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; Whiting D, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P77; World Health Organization, 2004, GLOB STRAT DIET PHYS; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	12	18	19	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2010	375	9733					2204	2205		10.1016/S0140-6736(10)60840-9	http://dx.doi.org/10.1016/S0140-6736(10)60840-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	622HS	20609961				2022-12-01	WOS:000279652900010
J	Cami, J; Bernard-Salas, J; Peeters, E; Malek, SE				Cami, Jan; Bernard-Salas, Jeronimo; Peeters, Els; Malek, Sarah Elizabeth			Detection of C-60 and C-70 in a Young Planetary Nebula	SCIENCE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; SPITZER-SPACE-TELESCOPE; GIANT BRANCH STARS; CIRCUMSTELLAR ENVELOPES; DUST FORMATION; CARBON; EMISSION; FULLERENES; SPECTRUM; FEATURES	In recent decades, a number of molecules and diverse dust features have been identified by astronomical observations in various environments. Most of the dust that determines the physical and chemical characteristics of the interstellar medium is formed in the outflows of asymptotic giant branch stars and is further processed when these objects become planetary nebulae. We studied the environment of Tc 1, a peculiar planetary nebula whose infrared spectrum shows emission from cold and neutral C-60 and C-70. The two molecules amount to a few percent of the available cosmic carbon in this region. This finding indicates that if the conditions are right, fullerenes can and do form efficiently in space.	[Cami, Jan; Peeters, Els; Malek, Sarah Elizabeth] Univ Western Ontario, Dept Phys & Astron, London, ON N6A 3K7, Canada; [Cami, Jan; Peeters, Els] SETI Inst, Mountain View, CA 94043 USA; [Bernard-Salas, Jeronimo] Cornell Univ, Ithaca, NY 14853 USA; [Bernard-Salas, Jeronimo] Univ Paris 11, CNRS, Inst Astrophys Spatiale, F-91405 Orsay, France	Western University (University of Western Ontario); Cornell University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay	Cami, J (corresponding author), Univ Western Ontario, Dept Phys & Astron, London, ON N6A 3K7, Canada.	jcami@uwo.ca	Cami, Jan/AAK-9178-2020	Cami, Jan/0000-0002-2666-9234	National Science and Engineering Research Council of Canada; Spitzer Space Telescope General Observer Program	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Spitzer Space Telescope General Observer Program	We thank M. Houde and A. Tielens for commenting on earlier versions of the manuscript, G. Fanchini for stimulating discussions on various properties of fullerene materials, and G. C. Sloan for discussions on carbonaceous species in PNe. Supported by a Discovery grant from the National Science and Engineering Research Council of Canada (J.C., E. P., and S. E. M.) and by the Spitzer Space Telescope General Observer Program.	Acker A, 2002, ASTRON ASTROPHYS, V384, P620, DOI 10.1051/0004-6361:20020009; Bernard-Salas J, 2009, ASTROPHYS J, V699, P1541, DOI 10.1088/0004-637X/699/2/1541; Cernicharo J, 2001, ASTROPHYS J, V546, pL123, DOI 10.1086/318871; Cherchneff I, 2000, ASTRON ASTROPHYS, V357, P572; CLAYTON GC, 1995, ASTRON J, V109, P2096, DOI 10.1086/117435; DEVRIES MS, 1993, GEOCHIM COSMOCHIM AC, V57, P933, DOI 10.1016/0016-7037(93)90179-Z; Fabian J, 1996, PHYS REV B, V53, P13864, DOI 10.1103/PhysRevB.53.13864; FOING BH, 1994, NATURE, V369, P296, DOI 10.1038/369296a0; FRENKLACH M, 1989, ASTROPHYS J, V341, P372, DOI 10.1086/167501; FRUM CI, 1991, CHEM PHYS LETT, V176, P504, DOI 10.1016/0009-2614(91)90245-5; FULARA J, 1993, CHEM PHYS LETT, V211, P227, DOI 10.1016/0009-2614(93)85190-Y; Habing HJ, 1996, ASTRON ASTROPHYS REV, V7, P97, DOI 10.1007/PL00013287; Herbig GH, 2000, ASTROPHYS J, V542, P334, DOI 10.1086/309523; Herbst E, 2009, ANNU REV ASTRON ASTR, V47, P427, DOI 10.1146/annurev-astro-082708-101654; Herwig F, 2005, ANNU REV ASTRON ASTR, V43, P435, DOI 10.1146/annurev.astro.43.072103.150600; Hony S, 2002, ASTRON ASTROPHYS, V390, P533, DOI 10.1051/0004-6361:20020603; Houck JR, 2004, ASTROPHYS J SUPPL S, V154, P18, DOI 10.1086/423134; KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Kwok S, 2009, INT J ASTROBIOL, V8, P161, DOI 10.1017/S1473550409004492; MARTIN MC, 1993, PHYS REV B, V47, P14607, DOI 10.1103/PhysRevB.47.14607; Milanova YV, 2009, ASTRON LETT+, V35, P518, DOI 10.1134/S1063773709080027; Moutou C, 1999, ASTRON ASTROPHYS, V347, P949; NEMES L, 1994, CHEM PHYS LETT, V218, P295, DOI 10.1016/0009-2614(93)E1488-3; Pardo JR, 2007, ASTROPHYS J, V661, P250, DOI 10.1086/513734; Scott A, 1997, ASTROPHYS J, V489, pL193, DOI 10.1086/316789; Sogoshi N, 2000, J PHYS CHEM A, V104, P3733, DOI 10.1021/jp9938718; Speck AK, 2009, ASTROPHYS J, V691, P1202, DOI 10.1088/0004-637X/691/2/1202; Stratmann RE, 1998, J RAMAN SPECTROSC, V29, P483, DOI 10.1002/(SICI)1097-4555(199806)29:6<483::AID-JRS268>3.0.CO;2-Q; Tielens AGGM, 2005, PHYSICS AND CHEMISTRY OF THE INTERSTELLAR MEDIUM, P1, DOI 10.1017/CBO9780511819056; VONCZARNOWSKI A, 1995, CHEM PHYS LETT, V246, P321, DOI 10.1016/0009-2614(95)01106-J; WANG XK, 1995, J MATER RES, V10, P1977, DOI 10.1557/JMR.1995.1977; Werner MW, 2004, ASTROPHYS J SUPPL S, V154, P1, DOI 10.1086/422992; Willson LA, 2000, ANNU REV ASTRON ASTR, V38, P573, DOI 10.1146/annurev.astro.38.1.573	34	527	531	5	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 3	2010	329	5996					1180	1182		10.1126/science.1192035	http://dx.doi.org/10.1126/science.1192035			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645SG	20651118				2022-12-01	WOS:000281485600028
J	Wijffels, RH; Barbosa, MJ				Wijffels, Rene H.; Barbosa, Maria J.			An Outlook on Microalgal Biofuels	SCIENCE			English	Editorial Material							GENOME REVEALS; BIODIESEL; EVOLUTION	Microalgae are considered one of the most promising feedstocks for biofuels. The productivity of these photosynthetic microorganisms in converting carbon dioxide into carbon-rich lipids, only a step or two away from biodiesel, greatly exceeds that of agricultural oleaginous crops, without competing for arable land. Worldwide, research and demonstration programs are being carried out to develop the technology needed to expand algal lipid production from a craft to a major industrial process. Although microalgae are not yet produced at large scale for bulk applications, recent advances-particularly in the methods of systems biology, genetic engineering, and biorefining-present opportunities to develop this process in a sustainable and economical way within the next 10 to 15 years.	[Wijffels, Rene H.] Wageningen Univ, NL-6700 EV Wageningen, Netherlands; [Barbosa, Maria J.] Univ Wageningen & Res Ctr, NL-6700 AA Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Wijffels, RH (corresponding author), Wageningen Univ, POB 8129, NL-6700 EV Wageningen, Netherlands.	rene.wijffels@wur.nl; maria.barbosa@wur.nl	Barbosa, Maria/K-7574-2018	Barbosa, Maria/0000-0002-8246-0777; Wijffels, Rene/0000-0001-7630-4295				Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Banerjee A, 2002, CRIT REV BIOTECHNOL, V22, P245, DOI 10.1080/07388550290789513; Benemann JR, 2000, J APPL PHYCOL, V12, P291, DOI 10.1023/A:1008175112704; Bosma R, 2010, INT SUGAR J, V112, P74; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; de Fraiture C, 2008, WATER POLICY, V10, P67, DOI 10.2166/wp.2008.054; Deng MD, 1999, APPL ENVIRON MICROB, V65, P523; *EUR ENV AG, 2008, 5 EEA; Hersbach G.J.M., 1984, BIOTECHNOLOGY IND AN, VVolume 22, P45; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; International Energy Agency (IEA), 2010, OIL MARK REP; Kliphuis AMJ, 2010, BIOTECHNOL PROGR, V26, P687, DOI 10.1002/btpr.379; Lardon L, 2009, ENVIRON SCI TECHNOL, V43, P6475, DOI 10.1021/es900705j; Lestari S, 2009, CHEMSUSCHEM, V2, P1109, DOI 10.1002/cssc.200900107; Melis A, 2009, PLANT SCI, V177, P272, DOI 10.1016/j.plantsci.2009.06.005; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; OSWALD WILLIAM J., 1960, ADVANCES APPL MICROBIOL, V2, P223, DOI 10.1016/S0065-2164(08)70127-8; Pulz O, 2004, APPL MICROBIOL BIOT, V65, P635, DOI 10.1007/s00253-004-1647-x; Qiang H, 1996, J APPL PHYCOL, V8, P139, DOI 10.1007/BF02186317; Reijnders L, 2008, TRENDS BIOTECHNOL, V26, P349, DOI 10.1016/j.tibtech.2008.04.001; Sheehan J., 1998, LOOK BACK US DEP ENE; Tredici MR, 2010, BIOFUELS-UK, V1, P143, DOI 10.4155/BFS.09.10; Usui N, 1997, ENERG CONVERS MANAGE, V38, pS487, DOI 10.1016/S0196-8904(96)00315-9; van Egmond K, 2002, AMBIO, V31, P72, DOI 10.1639/0044-7447(2002)031[0072:TENC]2.0.CO;2; Walker TL, 2005, J PHYCOL, V41, P1077, DOI 10.1111/j.1529-8817.2005.00133.x; Wijffels RH, 2010, BIOFUEL BIOPROD BIOR, V4, P287, DOI 10.1002/bbb.215; Zijffers JWF, 2010, MAR BIOTECHNOL, V12, P708, DOI 10.1007/s10126-010-9258-2	28	1318	1386	12	779	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2010	329	5993					796	799		10.1126/science.1189003	http://dx.doi.org/10.1126/science.1189003			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705853				2022-12-01	WOS:000280809900039
J	Gregg, C; Zhang, JW; Butler, JE; Haig, D; Dulac, C				Gregg, Christopher; Zhang, Jiangwen; Butler, James E.; Haig, David; Dulac, Catherine			Sex-Specific Parent-of-Origin Allelic Expression in the Mouse Brain	SCIENCE			English	Article							X-CHROMOSOME INACTIVATION; DOSAGE COMPENSATION; INTERLEUKIN-18; EVOLUTION; GENES	Genomic imprinting results in preferential gene expression from paternally versus maternally inherited chromosomes. We used a genome-wide approach to uncover sex-specific parent-of-origin allelic effects in the adult mouse brain. Our study identified preferential selection of the maternally inherited X chromosome in glutamatergic neurons of the female cortex. Moreover, analysis of the cortex and hypothalamus identified 347 autosomal genes with sex-specific imprinting features. In the hypothalamus, sex-specific imprinted genes were mostly found in females, which suggests parental influence over the hypothalamic function of daughters. We show that interleukin-18, a gene linked to diseases with sex-specific prevalence, is subject to complex, regional, and sex-specific parental effects in the brain. Parent-of-origin effects thus provide new avenues for investigation of sexual dimorphism in brain function and disease.	[Gregg, Christopher; Butler, James E.; Dulac, Catherine] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Gregg, Christopher; Butler, James E.; Dulac, Catherine] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Zhang, Jiangwen] Harvard Univ, FAS Res Comp, Cambridge, MA 02138 USA; [Haig, David] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University	Dulac, C (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	dulac@fas.harvard.edu	Zhang, Jiangwen/A-7654-2013	Zhang, Jiangwen/0000-0002-2911-8446; Dulac, Catherine/0000-0001-5024-5418	Klarman Foundation for Eating Disorders; Howard Hughes Medical Institute (HHMI); Human Frontiers long-term fellowship; Alberta Heritage Foundation for Medical Research	Klarman Foundation for Eating Disorders; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Human Frontiers long-term fellowship; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	We thank L. Luo, T. Maniatis, R. Losick, S. Hippenmeyer, and members of the Maniatis and Dulac labs for critical comments on the manuscript. We thank R. Hellmiss for help with figures and R. Jaenisch for X<SUP>egfp</SUP> mice. This work was supported by the Klarman Foundation for Eating Disorders and the Howard Hughes Medical Institute (HHMI). C. G. is supported by a Human Frontiers long-term fellowship and Alberta Heritage Foundation for Medical Research Incentive Award. C. D. is an HHMI investigator. All data can be found in GEO: GSE22131.	Alboni S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-9; [Anonymous], 2008, SEX DIFFERENCES BRAI; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; Baysal BE, 2004, AM J MED GENET C, V129C, P85, DOI 10.1002/ajmg.c.30018; Chadwick LH, 2005, MAMM GENOME, V16, P691, DOI 10.1007/s00335-005-0059-2; Davies W, 2005, NAT GENET, V37, P625, DOI 10.1038/ng1577; FALCONER DS, 1982, GENET RES, V39, P237, DOI 10.1017/S0016672300020930; FOWLIS DJ, 1991, GENET RES, V58, P63, DOI 10.1017/S001667230002961X; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Hager R, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-303; Haig D, 2006, CYTOGENET GENOME RES, V113, P68, DOI 10.1159/000090816; Haig D, 2006, EVOLUTION, V60, P440; HALL JG, 1990, AM J HUM GENET, V46, P857; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Herrera BM, 2008, NEUROLOGY, V71, P799, DOI 10.1212/01.wnl.0000312377.50395.00; Keverne EB, 2007, ADV GENET, V59, P217, DOI 10.1016/S0065-2660(07)59008-5; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Raefski AS, 2005, NAT GENET, V37, P620, DOI 10.1038/ng1567; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; TAN SS, 1993, NAT GENET, V3, P170, DOI 10.1038/ng0293-170; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574; Zechner U, 2001, TRENDS GENET, V17, P697, DOI 10.1016/S0168-9525(01)02446-5; Zorriila EP, 2007, P NATL ACAD SCI USA, V104, P11097, DOI 10.1073/pnas.0611523104	27	245	250	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2010	329	5992					682	685		10.1126/science.1190831	http://dx.doi.org/10.1126/science.1190831			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20616234	Green Accepted			2022-12-01	WOS:000280602700039
J	Liu, T; Ghosal, G; Yuan, JS; Chen, JJ; Huang, J				Liu, Ting; Ghosal, Gargi; Yuan, Jingsong; Chen, Junjie; Huang, Jun			FAN1 Acts with FANCI-FANCD2 to Promote DNA Interstrand Cross-Link Repair	SCIENCE			English	Article							FANCONI-ANEMIA PATHWAY; DAMAGE RESPONSE; PROTEIN; IDENTIFICATION; FANCD2; BREAKS; BRCA1	Fanconi anemia (FA) is caused by mutations in 13 Fanc genes and renders cells hypersensitive to DNA interstrand cross-linking (ICL) agents. A central event in the FA pathway is mono-ubiquitylation of the FANCI-FANCD2 (ID) protein complex. Here, we characterize a previously unrecognized nuclease, Fanconi anemia-associated nuclease 1 (FAN1), that promotes ICL repair in a manner strictly dependent on its ability to accumulate at or near sites of DNA damage and that relies on mono-ubiquitylation of the ID complex. Thus, the mono-ubiquitylated ID complex recruits the downstream repair protein FAN1 and facilitates the repair of DNA interstrand cross-links.	[Liu, Ting; Huang, Jun] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Ghosal, Gargi; Yuan, Jingsong; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	Zhejiang University; University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jchen8@mdanderson.org; jhuang@zju.edu.cn	Yuan, Jingsong/G-4527-2011	Ghosal, Gargi/0000-0001-8399-5354	Life Sciences Institute, Zhejiang University; Fundamental Research Funds for the Central Universities, China; NIH; U.S. Department of Defense	Life Sciences Institute, Zhejiang University; Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense)	This work was supported in part by grants from Startup Fund (Life Sciences Institute, Zhejiang University to J.H.), the Fundamental Research Funds for the Central Universities, China (to J.H.), and the NIH (to J.C.). We thank L. Li, X. Shen, and Y. Zhang for reagents. J.H. would like to thank J.C. for his continuous support and mentoring. J.C. is a recipient of an Era of Hope Scholar award from the U.S. Department of Defense and is a member of M.D. Anderson Cancer Center.	Alpi AF, 2009, DNA REPAIR, V8, P430, DOI 10.1016/j.dnarep.2009.01.019; Alpi AF, 2008, MOL CELL, V32, P767, DOI 10.1016/j.molcel.2008.12.003; Bhagwat N, 2009, MOL CELL BIOL, V29, P6427, DOI 10.1128/MCB.00086-09; Ciccia A, 2007, MOL CELL, V25, P331, DOI 10.1016/j.molcel.2007.01.003; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Huang J, 2009, NAT CELL BIOL, V11, P592, DOI 10.1038/ncb1865; Ishiai M, 2008, NAT STRUCT MOL BIOL, V15, P1138, DOI 10.1038/nsmb.1504; Iyer LM, 2006, CELL CYCLE, V5, P775, DOI 10.4161/cc.5.7.2629; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kinch LN, 2005, NUCLEIC ACIDS RES, V33, P3598, DOI 10.1093/nar/gki676; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Moldovan GL, 2009, CELL, V139, P1222, DOI 10.1016/j.cell.2009.12.006; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159	22	195	201	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					693	696		10.1126/science.1192656	http://dx.doi.org/10.1126/science.1192656			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20671156				2022-12-01	WOS:000280602700042
J	Ton-Hoang, B; Pastemak, C; Siguier, P; Guynet, C; Hickman, AB; Dyda, F; Sommer, S; Chandler, M				Ton-Hoang, Bao; Pastemak, Cecile; Siguier, Patricia; Guynet, Catherine; Hickman, Alison Burgess; Dyda, Fred; Sommer, Suzanne; Chandler, Michael			Single-Stranded DNA Transposition Is Coupled to Host Replication	CELL			English	Article							ESCHERICHIA-COLI MUTANTS; YERSINIA-PESTIS; INSERTION-SEQUENCE; GENOME SEQUENCE; PROTEIN; ARREST; TRANSCRIPTION; RECONSTITUTION; TERMINATION; MECHANISM	DNA transposition has contributed significantly to evolution of eukaryotes and prokaryotes. Insertion sequences (ISs) are the simplest prokaryotic trans-posons and are divided into families on the basis of their organization and transposition mechanism. Here, we describe a link between transposition of IS608 and ISDra2, both members of the IS200/IS605 family, which uses obligatory single-stranded DNA intermediates, and the host replication fork. Replication direction through the IS plays a crucial role in excision: activity is maximal when the "top'' IS strand is located on the lagging-strand template. Excision is stimulated upon transient inactivation of replicative helicase function or inhibition of Okazaki fragment synthesis. IS608 insertions also exhibit an orientation preference for the lagging-strand template and insertion can be specifically directed to stalled replication forks. An in silico genomic approach provides evidence that dissemination of other IS200/IS605 family members is also linked to host replication.	[Ton-Hoang, Bao; Siguier, Patricia; Guynet, Catherine; Chandler, Michael] CNRS, Lab Microbiol & Genet Mol, UMR 5100, F-31062 Toulouse, France; [Pastemak, Cecile; Sommer, Suzanne] Univ Paris 11, CNRS, Inst Genet & Microbiol,UMR 8621, Lab Rech Correspondant Commissariat Energie Atom, F-91405 Orsay, France; [Hickman, Alison Burgess; Dyda, Fred] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Ton-Hoang, B (corresponding author), CNRS, Lab Microbiol & Genet Mol, UMR 5100, 118 Route Narbonne, F-31062 Toulouse, France.	bao.tonhoang@ibcg.biotoul.fr; michael.chandler@ibcg.biotoul.fr	Guynet, Catherine/GPX-0917-2022; Guynet, Catherine/A-4815-2011	Chandler, Michael/0000-0002-0292-6662; Pasternak, Cecile/0000-0002-7884-2422	Centre National de Recherche Scientifique (France); ANR; European contract [LSHM-CT-2005-019023]; Commissariat a l'Energie Atomique and Electricite de France (France); National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036154] Funding Source: NIH RePORTER	Centre National de Recherche Scientifique (France); ANR(French National Research Agency (ANR)); European contract; Commissariat a l'Energie Atomique and Electricite de France (France); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank members of the "Mobile Genetic Elements'' group, A. Bailone, P. Polard, and D. Lane for discussions, G. Coste and B. Marty for expert technical assistance, L. Lavatine for guiding us through the mysteries of statistics, A. Varani for identifying a representative oligonucleotide sequence used in the PCR mapping for the D. radiodurans genome, and the Institut Curie for the use of the <SUP>137</SUP>Cs irradiation system. This work was supported by: intramural funding from the Centre National de Recherche Scientifique (France), in its later stages by ANR grant Mobigen (M.C. and S.S.), European contract LSHM-CT-2005-019023 (M.C.), and the Commissariat a l'Energie Atomique and Electricite de France (France; S.S.). At the National Institutes of Health, this work was supported by the Intramural Program of the National Institute of Diabetes and Digestive and Kidney Diseases.	Bao TH, 2005, EMBO J, V24, P3325, DOI 10.1038/sj.emboj.7600787; Barabas O, 2008, CELL, V132, P208, DOI 10.1016/j.cell.2007.12.029; Belle JJ, 2007, J BACTERIOL, V189, P5452, DOI 10.1128/JB.00408-07; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; BIERNE H, 1994, J BACTERIOL, V176, P4165, DOI 10.1128/JB.176.13.4165-4167.1994; BIERNE H, 1994, MOL MICROBIOL, V13, P17, DOI 10.1111/j.1365-2958.1994.tb00398.x; CARL PL, 1970, MOL GEN GENET, V109, P107, DOI 10.1007/BF00269647; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chandler M, 2009, CELL, V138, P621, DOI 10.1016/j.cell.2009.08.003; Curcio MJ, 2003, NAT REV MOL CELL BIO, V4, P865, DOI 10.1038/nrm1241; de Almeida CB, 2002, MOL GENET GENOMICS, V268, P28, DOI 10.1007/s00438-002-0718-x; Demarre G, 2005, RES MICROBIOL, V156, P245, DOI 10.1016/j.resmic.2004.09.007; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; DODSON KW, 1989, GENE, V76, P207, DOI 10.1016/0378-1119(89)90161-3; EliasArnanz M, 1997, EMBO J, V16, P5775, DOI 10.1093/emboj/16.18.5775; FOUSER L, 1983, J BACTERIOL, V154, P1174, DOI 10.1128/JB.154.3.1174-1183.1983; GALAS DJ, 1982, J MOL BIOL, V154, P245, DOI 10.1016/0022-2836(82)90063-8; Garcia E, 2007, ADV EXP MED BIOL, V603, P17; Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286; Guynet C, 2008, MOL CELL, V29, P302, DOI 10.1016/j.molcel.2007.12.008; Guynet C, 2009, MOL CELL, V34, P612, DOI 10.1016/j.molcel.2009.05.017; Hendrickson H, 2006, J MOL EVOL, V62, P615, DOI 10.1007/s00239-005-0192-2; HILL TM, 1990, P NATL ACAD SCI USA, V87, P2481, DOI 10.1073/pnas.87.7.2481; Hu WY, 1998, J BACTERIOL, V180, P3039, DOI 10.1128/JB.180.12.3039-3048.1998; Islam MS, 2003, GENES GENET SYST, V78, P319, DOI 10.1266/ggs.78.319; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kaplan DL, 2009, MOL MICROBIOL, V72, P279, DOI 10.1111/j.1365-2958.2009.06656.x; Karpinets TV, 2010, FUNCT INTEGR GENOMIC, V10, P97, DOI 10.1007/s10142-009-0142-y; Kersulyte D, 2002, J BACTERIOL, V184, P992, DOI 10.1128/jb.184.4.992-1002.2002; Kornberg A., 1992, DNA REPLICATION; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; LOUARN JM, 1974, MOL GEN GENET, V133, P193, DOI 10.1007/BF00267668; Mennecier S, 2006, MOL MICROBIOL, V59, P317, DOI 10.1111/j.1365-2958.2005.04936.x; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; Mirkin EV, 2006, P NATL ACAD SCI USA, V103, P7276, DOI 10.1073/pnas.0601127103; Mohanty BK, 1998, J BIOL CHEM, V273, P3051, DOI 10.1074/jbc.273.5.3051; Neylon C, 2005, MICROBIOL MOL BIOL R, V69, P501, DOI 10.1128/MMBR.69.3.501-526.2005; Parks AR, 2009, CELL, V138, P685, DOI 10.1016/j.cell.2009.06.011; Pasternak C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000799; Peters JE, 2001, GENE DEV, V15, P737, DOI 10.1101/gad.870201; ROBERTS D, 1985, CELL, V43, P117, DOI 10.1016/0092-8674(85)90017-0; Ronning DR, 2005, MOL CELL, V20, P143, DOI 10.1016/j.molcel.2005.07.026; Sanders GM, 2010, MOL CELL, V37, P273, DOI 10.1016/j.molcel.2009.12.025; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Turlan C, 2000, TRENDS MICROBIOL, V8, P268, DOI 10.1016/S0966-842X(00)01757-1; Vezzi A, 2005, SCIENCE, V307, P1459, DOI 10.1126/science.1103341; WECHSLER JA, 1971, MOL GEN GENET, V113, P273, DOI 10.1007/BF00339547; YIN JCP, 1988, J MOL BIOL, V199, P35, DOI 10.1016/0022-2836(88)90377-4; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; ZECHNER EL, 1992, J BIOL CHEM, V267, P4045	52	46	49	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					398	408		10.1016/j.cell.2010.06.034	http://dx.doi.org/10.1016/j.cell.2010.06.034			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691900	Green Accepted, Bronze			2022-12-01	WOS:000280609100017
J	Williamson, CE; Rose, KC				Williamson, Craig E.; Rose, Kevin C.			When UV Meets Fresh Water	SCIENCE			English	Editorial Material							ULTRAVIOLET-RADIATION; INFECTIVITY; MIGRATION; PATTERNS; LAKES		[Williamson, Craig E.; Rose, Kevin C.] Miami Univ, Dept Zool, Oxford, OH 45056 USA	University System of Ohio; Miami University	Williamson, CE (corresponding author), Miami Univ, Dept Zool, Oxford, OH 45056 USA.	craig.williamson@muohio.edu; rosekc@muohio.edu						Andrady A, 2010, PHOTOCH PHOTOBIO SCI, V9, P275, DOI 10.1039/b923342n; Connelly SJ, 2007, ENVIRON SCI TECHNOL, V41, P7101, DOI 10.1021/es071324r; Cooke SL, 2008, CAN J FISH AQUAT SCI, V65, P1144, DOI 10.1139/F08-039; Jordan R, 2006, J FISH BIOL, V68, P1291, DOI 10.1111/j.0022-1112.2006.00992.x; King BJ, 2008, J APPL MICROBIOL, V104, P1311, DOI 10.1111/j.1365-2672.2007.03658.x; Kodric-Brown A, 2002, ANIM BEHAV, V63, P391, DOI 10.1006/anbe.2001.1917; Leech DM, 2009, LIMNOL OCEANOGR, V54, P1152, DOI 10.4319/lo.2009.54.4.1152; McKenzie RL, 2009, PHOTOCHEM PHOTOBIOL, V85, P88, DOI 10.1111/j.1751-1097.2008.00400.x; ROBERTS L, 1989, SCIENCE, V244, P288, DOI 10.1126/science.244.4902.288; Rose KC, 2009, PHOTOCH PHOTOBIO SCI, V8, P1244, DOI 10.1039/b905616e; Rose KC, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000816; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Siebeck UE, 2010, CURR BIOL, V20, P407, DOI 10.1016/j.cub.2009.12.047; Tucker AJ, 2010, ECOLOGY, V91, P882, DOI 10.1890/09-0554.1; Zhang J, 2010, LIMNOL OCEANOGR, V55, P30, DOI 10.4319/lo.2010.55.1.0030	15	49	51	2	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2010	329	5992					637	639		10.1126/science.1191192	http://dx.doi.org/10.1126/science.1191192			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689007				2022-12-01	WOS:000280602700025
J	Onodera, T; Sakai, T; Hsu, JC; Matsumoto, K; Chiorini, JA; Yamada, KM				Onodera, Tomohiro; Sakai, Takayoshi; Hsu, Jeff Chi-feng; Matsumoto, Kazue; Chiorini, John A.; Yamada, Kenneth M.			Btbd7 Regulates Epithelial Cell Dynamics and Branching Morphogenesis	SCIENCE			English	Article							FIBRONECTIN; TUBULOGENESIS; LUNG; POLARITY; DOMAIN; ROLES	During embryonic development, many organs form by extensive branching of epithelia through the formation of clefts and buds. In cleft formation, buds are delineated by the conversion of epithelial cell-cell adhesions to cell-matrix adhesions, but the mechanisms of cleft formation are not clear. We have identified Btbd7 as a dynamic regulator of branching morphogenesis. Btbd7 provides a mechanistic link between the extracellular matrix and cleft propagation through its highly focal expression leading to local regulation of Snail2 (Slug), E-cadherin, and epithelial cell motility. Inhibition experiments show that Btbd7 is required for branching of embryonic mammalian salivary glands and lungs. Hence, Btbd7 is a regulatory gene that promotes epithelial tissue remodeling and formation of branched organs.	[Onodera, Tomohiro; Sakai, Takayoshi; Hsu, Jeff Chi-feng; Matsumoto, Kazue; Yamada, Kenneth M.] Natl Inst Dent & Craniofacial Res, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA; [Sakai, Takayoshi] Osaka Univ, Grad Sch Dent, Dept Oral Facial Disorders, Suita, Osaka 5650871, Japan; [Chiorini, John A.] Natl Inst Dent & Craniofacial Res, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Osaka University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Sakai, T (corresponding author), Natl Inst Dent & Craniofacial Res, Lab Cell & Dev Biol, NIH, Bethesda, MD 20892 USA.	sakai@dent.osaka-u.ac.jp; kyamada@mail.nih.gov	Sakai, Takayoshi/L-1456-2019; Onodera, Tomohiro/G-1686-2012	Sakai, Takayoshi/0000-0003-4348-4896; Yamada, Kenneth/0000-0003-1512-6805	Japan Society for the Promotion of Science (JSPS) [21390534]; NIH, NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000525, ZIADE000695] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank M. Hoffman, M. Larsen, and K. Musselmann for advice. T.O. was supported by a fellowship from the Japan Society for the Promotion of Science (JSPS). This work was supported in part by the Intramural Research Program of the NIH, NIDCR, and by Grants-in-Aid for Scientific Research (B) (21390534) from the JSPS to T. S. The SAGE data sets are available at the Gene Expression Omnibus (GEO) database under accession number GSE22374.	Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Daley WP, 2009, DEV BIOL, V336, P169, DOI 10.1016/j.ydbio.2009.09.037; Davies JA, 2002, BIOESSAYS, V24, P937, DOI 10.1002/bies.10161; De Langhe SP, 2005, DEV BIOL, V277, P316, DOI 10.1016/j.ydbio.2004.09.023; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Fata JE, 2004, BREAST CANCER RES, V6, P1, DOI 10.1186/bcr634; Gill SE, 2006, DEV BIOL, V298, P540, DOI 10.1016/j.ydbio.2006.07.004; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GROBSTEIN C, 1953, NATURE, V172, P869, DOI 10.1038/172869a0; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; Larsen M, 2006, J CELL SCI, V119, P3376, DOI 10.1242/jcs.03079; Leroy P, 2007, MOL BIOL CELL, V18, P1943, DOI 10.1091/mbc.E06-09-0823; Martin-Belmonte F, 2008, CURR OPIN CELL BIOL, V20, P227, DOI 10.1016/j.ceb.2008.01.001; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x; Perez-Torrado R, 2006, BIOESSAYS, V28, P1194, DOI 10.1002/bies.20500; Que JW, 2006, DIFFERENTIATION, V74, P422, DOI 10.1111/j.1432-0436.2006.00096.x; Roman J, 1997, EXP LUNG RES, V23, P147, DOI 10.3109/01902149709074027; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Shah MM, 2004, DEVELOPMENT, V131, P1449, DOI 10.1242/dev.01089; Spooner B S, 1986, Dev Biol (N Y 1985), V3, P225; Walker JL, 2008, DEV DYNAM, V237, P3128, DOI 10.1002/dvdy.21717; Widelitz RB, 2007, SEMIN CELL DEV BIOL, V18, P255, DOI 10.1016/j.semcdb.2007.02.005; Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	25	114	117	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					562	565		10.1126/science.1191880	http://dx.doi.org/10.1126/science.1191880			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671187	Green Accepted			2022-12-01	WOS:000280483500036
J	Reeves, GK; Travis, RC; Green, J; Bull, D; Tipper, S; Baker, K; Beral, V; Peto, R; Bell, J; Zelenika, D; Lathrop, M				Reeves, Gillian K.; Travis, Ruth C.; Green, Jane; Bull, Diana; Tipper, Sarah; Baker, Krys; Beral, Valerie; Peto, Richard; Bell, John; Zelenika, Diana; Lathrop, Mark		Million Women Study Collaborators	Incidence of Breast Cancer and Its Subtypes in Relation to Individual and Multiple Low-Penetrance Genetic Susceptibility Loci	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; CONFER SUSCEPTIBILITY; COMMON VARIANTS; RISK; ALLELES; FGFR2; WOMEN	Context There is limited evidence on how the risk of breast cancer and its subtypes depend on low-penetrance susceptibility loci, individually or in combination. Objective To analyze breast cancer risk, overall and by tumor subtype, in relation to 14 individual single-nucleotide polymorphisms (SNPs) previously linked to the disease, and in relation to a polygenic risk score. Design, Setting, and Participants Study of 10 306 women with breast cancer (mean age at diagnosis, 58 years) and 10 393 women without breast cancer who in 2005-2008 provided blood samples for genotyping in a large prospective study of UK women; and meta-analysis of these results and of other published results. Main Outcome Measures Estimated per-allele odds ratio (OR) for individual SNPs, and cumulative incidence of breast cancer to age 70 years in relation to a polygenic risk score based on the 4, 7, or 10 SNPs most strongly associated with risk. Results Odds ratios for breast cancer were greatest for FGFR2-rs2981582 and TNRC9-rs3803662 and, for these 2 SNPs, were significantly greater for estrogen receptor (ER)-positive than for ER-negative disease, both in our data and in meta-analyses of all published data (pooled per-allele ORs [95% confidence intervals] for ER-positive vs ER-negative disease: 1.30 [1.26-1.33] vs 1.05 [1.01-1.10] for FGFR2; interaction P<.001; and 1.24 [1.21-1.28] vs 1.12 [1.07-1.17] for TNRC9; interaction P<.001). The next strongest association was for 2q-rs13387042, for which the per-allele OR was significantly greater for bilateral than unilateral disease (1.39 [1.21-1.60] vs 1.15 [1.11-1.20]; interaction P=.008) and for lobular than ductal tumors (1.35 [1.23-1.49] vs 1.10 [1.05-1.15]; interaction P<.001). The estimated cumulative incidence (95% confidence interval) of breast cancer to age 70 years among women in the top and bottom fifths of a polygenic risk score based on 7 SNPs was 8.8% (8.3%-9.4%) and 4.4% (4.2%-4.8%), respectively. For ER-positive disease the corresponding risks were 7.4% (6.9%-8.0%) and 3.4% (3.1%-3.8%), respectively; while for ER-negative disease they were 1.4% (1.2%-1.6%) and 1.0% (0.8%-1.2%). The findings did not differ materially according to the number of SNPs included in the polygenic risk model. Conclusions The polygenic risk score was substantially more predictive of ER-positive than of ER-negative breast cancer, particularly for absolute risk. JAMA. 2010; 304(4): 426-434	[Reeves, Gillian K.; Travis, Ruth C.; Green, Jane; Bull, Diana; Tipper, Sarah; Baker, Krys; Beral, Valerie] Univ Oxford, Canc Epidemiol Unit, Oxford OX3 7LF, England; [Peto, Richard] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Peto, Richard] Univ Oxford, Epidemiol Studies Unit CTSU, Oxford OX3 7LF, England; [Bell, John] Univ Oxford, Dept Regius Prof Med, Oxford OX3 7LF, England; [Zelenika, Diana; Lathrop, Mark] CEA, Ctr Natl Genotypage 1G, Paris, France; [Zelenika, Diana; Lathrop, Mark] Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, Paris, France	University of Oxford; University of Oxford; University of Oxford; University of Oxford; CEA; Foundation Jean Dausset-CEPH	Reeves, GK (corresponding author), Univ Oxford, Canc Epidemiol Unit, Richard Doll Bldg,Old Rd Campus, Oxford OX3 7LF, England.	gill.reeves@ceu.ox.ac.uk		Balkwill, Angela/0000-0002-6327-6245	UK Medical Research Council; Cancer Research UK; MRC [G0700474, MC_U137686850] Funding Source: UKRI; Medical Research Council [MC_U137686850, G1000800b, G0700474] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Million Women Study is supported by the UK Medical Research Council and Cancer Research UK. Genotyping of blood samples was supported by the Institut National du Cancer, France.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; CURADO MP, 2007, SCI PUBLICATION, V160; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Garcia-Closas M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000054; Garcia-Closas M, 2008, CLIN CANCER RES, V14, P8000, DOI 10.1158/1078-0432.CCR-08-0975; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Milne RL, 2009, JNCI-J NATL CANCER I, V101, P1012, DOI 10.1093/jnci/djp167; *NAT CANC INT NETW, ALL BREAST CANC REP; National Centre for Classification in Health, 2010, INT STAT CLASS DIS R; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Rebbeck TR, 2009, CARCINOGENESIS, V30, P269, DOI 10.1093/carcin/bgn247; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; The Million Women Study Collaborative Group, 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Townsend P, 1988, HLTH DEPRIVATION INE; Travis RC, 2010, LANCET, V375, P2143, DOI 10.1016/S0140-6736(10)60636-8; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727; *WHO, 2000, INT CLSAS DIS ONC; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	23	87	92	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2010	304	4					426	434		10.1001/jama.2010.1042	http://dx.doi.org/10.1001/jama.2010.1042			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631MA	20664043	Bronze			2022-12-01	WOS:000280350100026
J	Hyppa, RW; Smith, GR				Hyppa, Randy W.; Smith, Gerald R.			Crossover Invariance Determined by Partner Choice for Meiotic DNA Break Repair	CELL			English	Article							SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; SISTER CHROMATIDS; STRAND EXCHANGE; RECOMBINATION REPAIR; JOINT MOLECULES; PROTEIN COMPLEX; RAD52 HOMOLOGS; DMC1; MEIOSIS	Crossovers between meiotic homologs are crucial for their proper segregation, and crossover number and position are carefully controlled. Crossover homeostasis in budding yeast maintains crossovers at the expense of noncrossovers when double-strand DNA break (DSB) frequency is reduced. The mechanism of maintaining constant crossover levels in other species has been unknown. Here we investigate in fission yeast a different aspect of crossover control-the near invariance of crossover frequency per kb of DNA despite large variations in DSB intensity across the genome. Crossover invariance involves the choice of sister chromatid versus homolog for DSB repair. At strong DSB hotspots, intersister repair outnumbers interhomolog repair similar to 3:1, but our genetic and physical data indicate the converse in DSB-cold regions. This unanticipated mechanism of crossover control may operate in many species and explain, for example, the large excess of DSBs over crossovers and the repair of DSBs on unpaired chromosomes in diverse species.	[Hyppa, Randy W.; Smith, Gerald R.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Smith, GR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	gsmith@fhcrc.org		Smith, Gerald/0000-0002-8747-1352	National Institutes of Health [GM031693]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM031693, R01GM031693] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Hiroshi Iwasaki for strains; Chad Ellermeier, Joseph Farah, and Emily Higuchi for unpublished recombination data; Michael Lichten and Hiroshi Iwasaki for unpublished information; Gareth Cromie for critical discussions and unpublished DSB data from the mbs1-19 mutant; and Sue Amundsen, Michael Lichten, and Naina Phadnis for helpful comments on the manuscript. This work was supported by research grant GM031693 from the National Institutes of Health to G.R.S.	ABOUSSEKHRA A, 1992, MOL CELL BIOL, V12, P3224, DOI 10.1128/MCB.12.7.3224; Akamatsu Y, 2003, P NATL ACAD SCI USA, V100, P15770, DOI 10.1073/pnas.2632890100; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; ASHLEY T, 1995, CHROMOSOMA, V104, P19, DOI 10.1007/s004120050088; Baudat F, 2007, CHROMOSOME RES, V15, P565, DOI 10.1007/s10577-007-1140-3; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Cervantes MD, 2000, MOL CELL, V5, P883, DOI 10.1016/S1097-2765(00)80328-7; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Cromie GA, 2005, GENETICS, V169, P595, DOI 10.1534/genetics.104.037176; Cromie Gareth, 2008, V3, P195, DOI 10.1007/7050_2007_025; Cromie GA, 2007, PLOS GENET, V3, P1496, DOI 10.1371/journal.pgen.0030141; Cromie GA, 2006, CELL, V127, P1167, DOI 10.1016/j.cell.2006.09.050; DEVEAUX LC, 1992, GENETICS, V130, P251; Egel R, 2008, RECOMBINATION MEIOSI; Ellermeier C, 2004, GENETICS, V168, P1891, DOI 10.1534/genetics.104.034280; Farah JA, 2009, P NATL ACAD SCI USA, V106, P9356, DOI 10.1073/pnas.0902793106; Ferrari SR, 2009, J BIOL CHEM, V284, P11766, DOI 10.1074/jbc.C900023200; Franklin AE, 1999, PLANT CELL, V11, P809, DOI 10.1105/tpc.11.5.809; Fukushima K, 2000, NUCLEIC ACIDS RES, V28, P2709, DOI 10.1093/nar/28.14.2709; Grishchuk AL, 2003, GENETICS, V165, P1031; GUTZ H, 1971, GENETICS, V69, P331; Haruta N, 2006, NAT STRUCT MOL BIOL, V13, P823, DOI 10.1038/nsmb1136; Hayase A, 2004, CELL, V119, P927, DOI 10.1016/j.cell.2004.10.031; Hyppa RW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000267; Jaramillo-Lambert A, 2010, GENETICS, V184, P613, DOI 10.1534/genetics.109.110338; Jessop L, 2008, MOL CELL, V31, P313, DOI 10.1016/j.molcel.2008.05.021; KADYK LC, 1992, GENETICS, V132, P387; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Khasanov FK, 1999, GENETICS, V152, P1557; Khasanov FK, 2008, CURR GENET, V54, P197, DOI 10.1007/s00294-008-0212-z; Kurokawa Y, 2008, PLOS BIOL, V6, P836, DOI 10.1371/journal.pbio.0060088; Latypov V, 2010, MOL CELL BIOL, V30, P1570, DOI 10.1128/MCB.00919-09; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Mercier R, 2005, CURR BIOL, V15, P692, DOI 10.1016/j.cub.2005.02.056; Milman N, 2009, MOL CELL BIOL, V29, P5998, DOI 10.1128/MCB.01127-09; MOENS PB, 1987, MEIOSIS; MUNZ P, 1994, GENETICS, V137, P701; Muris DFR, 1997, CURR GENET, V31, P248, DOI 10.1007/s002940050202; Niu H, 2007, MOL CELL BIOL, V27, P5456, DOI 10.1128/MCB.00416-07; Niu HY, 2009, MOL CELL, V36, P393, DOI 10.1016/j.molcel.2009.09.029; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; Octobre G, 2008, GENETICS, V178, P2399, DOI 10.1534/genetics.107.085696; Oh SD, 2008, MOL CELL, V31, P324, DOI 10.1016/j.molcel.2008.07.006; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Rothenberg M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000722; SCHMIDT H, 1987, CURR GENET, V11, P303, DOI 10.1007/BF00355404; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; Shinohara A, 1997, GENES CELLS, V2, P615, DOI 10.1046/j.1365-2443.1997.1480347.x; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Steiner WW, 2002, MOL CELL, V9, P847, DOI 10.1016/S1097-2765(02)00489-6; Steiner WW, 2005, GENETICS, V169, P1973, DOI 10.1534/genetics.104.039230; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; TEASE C, 1979, CHROMOSOMA, V73, P75, DOI 10.1007/BF00294847; Tsubouchi H, 2004, GENETICS, V168, P1219, DOI 10.1534/genetics.103.025700; Tsubouchi H, 2002, MOL CELL BIOL, V22, P3078, DOI 10.1128/MCB.22.9.3078-3088.2002; Tsutsui Y, 2001, GENETICS, V159, P91; Tsutsui Y, 2000, GENETICS, V154, P1451; van den Bosch M, 2001, MUTAT RES-DNA REPAIR, V461, P311, DOI 10.1016/S0921-8777(00)00060-4; Webber HA, 2004, J CELL BIOL, V164, P819, DOI 10.1083/jcb.200310077; Young JA, 2004, GENETICS, V167, P593, DOI 10.1534/genetics.103.023762; Young JA, 2002, MOL CELL, V9, P253, DOI 10.1016/S1097-2765(02)00452-5	65	59	60	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					243	255		10.1016/j.cell.2010.05.041	http://dx.doi.org/10.1016/j.cell.2010.05.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655467	Bronze, Green Accepted			2022-12-01	WOS:000280204300016
J	Hacein-Bey-Abina, S; Hauer, J; Lim, A; Picard, C; Wang, GP; Berry, CC; Martinache, C; Rieux-Laucat, F; Latour, S; Belohradsky, BH; Leiva, L; Sorensen, R; Debre, M; Casanova, JL; Blanche, S; Durandy, A; Bushman, FD; Fischer, A; Cavazzana-Calvo, M				Hacein-Bey-Abina, Salima; Hauer, Julia; Lim, Annick; Picard, Capucine; Wang, Gary P.; Berry, Charles C.; Martinache, Chantal; Rieux-Laucat, Frederic; Latour, Sylvain; Belohradsky, Bernd H.; Leiva, Lily; Sorensen, Ricardo; Debre, Marianne; Casanova, Jean Laurent; Blanche, Stephane; Durandy, Anne; Bushman, Frederic D.; Fischer, Alain; Cavazzana-Calvo, Marina			Efficacy of Gene Therapy for X-Linked Severe Combined Immunodeficiency	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEM-CELL TRANSPLANTATION; INTERLEUKIN-2-RECEPTOR GAMMA-CHAIN; INSERTIONAL MUTAGENESIS; B-CELLS; SCID-X1; RECEPTOR; DISEASE; HUMANS	BACKGROUND The outcomes of gene therapy to correct congenital immunodeficiencies are unknown. We reviewed long-term outcomes after gene therapy in nine patients with X-linked severe combined immunodeficiency (SCID-X1), which is characterized by the absence of the cytokine receptor common gamma chain. METHODS The nine patients, who lacked an HLA-identical donor, underwent ex vivo retrovirus-mediated transfer of gamma chain to autologous CD34+ bone marrow cells between 1999 and 2002. We assessed clinical events and immune function on long-term follow-up. RESULTS Eight patients were alive after a median follow-up period of 9 years (range, 8 to 11). Gene therapy was initially successful at correcting immune dysfunction in eight of the nine patients. However, acute leukemia developed in four patients, and one died. Transduced T cells were detected for up to 10.7 years after gene therapy. Seven patients, including the three survivors of leukemia, had sustained immune reconstitution; three patients required immunoglobulin-replacement therapy. Sustained thymopoiesis was established by the persistent presence of naive T cells, even after chemotherapy in three patients. The T-cell-receptor repertoire was diverse in all patients. Transduced B cells were not detected. Correction of the immunodeficiency improved the patients' health. CONCLUSIONS After nearly 10 years of follow-up, gene therapy was shown to have corrected the immunodeficiency associated with SCID-X1. Gene therapy may be an option for patients who do not have an HLA-identical donor for hematopoietic stem-cell transplantation and for whom the risks are deemed acceptable. This treatment is associated with a risk of acute leukemia.	[Hacein-Bey-Abina, Salima; Martinache, Chantal; Cavazzana-Calvo, Marina] Hop Necker Enfants Malad, Dept Biotherapy, F-75015 Paris, France; [Hacein-Bey-Abina, Salima; Hauer, Julia; Rieux-Laucat, Frederic; Latour, Sylvain; Durandy, Anne; Fischer, Alain; Cavazzana-Calvo, Marina] Hop Necker Enfants Malad, INSERM, U768, F-75015 Paris, France; [Picard, Capucine] Hop Necker Enfants Malad, Ctr Etud Deficits Immunitaires, F-75015 Paris, France; [Hacein-Bey-Abina, Salima; Martinache, Chantal; Cavazzana-Calvo, Marina] Grp Hosp Univ Ouest, AP HP, Clin Invest Ctr Biotherapy, Paris, France; [Hacein-Bey-Abina, Salima; Picard, Capucine; Casanova, Jean Laurent; Blanche, Stephane; Fischer, Alain; Cavazzana-Calvo, Marina] Paris Descartes Univ, Paris, France; [Lim, Annick] Inst Pasteur, Unite Dev Lymphocytes, Paris, France; [Lim, Annick] INSERM, U668, Paris, France; [Casanova, Jean Laurent] INSERM, Lab Human Genet Infect Dis, Necker Branch, U550, Paris, France; [Wang, Gary P.; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Berry, Charles C.] Univ Calif San Diego, Sch Med, Dept Family & Prevent Med, San Diego, CA 92103 USA; [Belohradsky, Bernd H.] Univ Childrens Hosp, Dept Immunol & Infect Dis, Munich, Germany; [Leiva, Lily; Sorensen, Ricardo] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat, New Orleans, LA USA; [Casanova, Jean Laurent] Rockefeller Univ, Lab Human Genet Infect Dis, Rockefeller Branch, New York, NY 10021 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania; University of California System; University of California San Diego; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Rockefeller University	Hacein-Bey-Abina, S (corresponding author), Hop Necker Enfants Malad, Dept Biotherapy, 149 Rue Sevres, F-75015 Paris, France.	salima.hacein-bey@nck.ap-hop-paris.fr	Durandy, Anne/H-7475-2017; Picard, Capucine/H-3914-2017; Casanova, Jean-Laurent/I-3418-2017; Rieux-Laucat, Frédéric/A-7916-2017; Latour, Sylvain/H-3652-2017	Durandy, Anne/0000-0001-7706-8466; Picard, Capucine/0000-0001-8788-5056; Rieux-Laucat, Frédéric/0000-0001-7858-7866; Latour, Sylvain/0000-0001-8238-4391; Casanova, Jean-Laurent/0000-0002-7782-4169; Bushman, Frederic/0000-0003-4740-4056; Cavazzana, Marina/0000-0002-0264-0891	INSERM; Association Francaise contre les Myopathies [AT0203]; European Commission [QLK3-CT-1999-00859]; Concerted Safety and Efficiency Evaluation of Retroviral Transgenesis in Gene Therapy of Inherited Diseases [005242]; Gene Therapy of Hematopoietic Stem Cells for Inherited Diseases [QLK3-CT-2001-00427]; Agence Nationale de la Recherche [05-MRAR-004]; Programme Hospitalier de Recherche Clinique of the Health Ministry [PHRC AOM 08064-P071204]; Assistance Publique-Hopitaux de Paris; Fondation de l'Avenir; Institut Pasteur and College de France; National Institutes of Health [AI52845, AI082020]; Akademie der Naturforscher Leopoldina [BMBF-LPD 9901/8-149]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052845, R01AI082020] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); European Commission(European CommissionEuropean Commission Joint Research Centre); Concerted Safety and Efficiency Evaluation of Retroviral Transgenesis in Gene Therapy of Inherited Diseases; Gene Therapy of Hematopoietic Stem Cells for Inherited Diseases; Agence Nationale de la Recherche(French National Research Agency (ANR)); Programme Hospitalier de Recherche Clinique of the Health Ministry; Assistance Publique-Hopitaux de Paris; Fondation de l'Avenir; Institut Pasteur and College de France; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Akademie der Naturforscher Leopoldina; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from INSERM, Association Francaise contre les Myopathies (AT0203), the European Commission (QLK3-CT-1999-00859), the Concerted Safety and Efficiency Evaluation of Retroviral Transgenesis in Gene Therapy of Inherited Diseases (005242), Gene Therapy of Hematopoietic Stem Cells for Inherited Diseases (QLK3-CT-2001-00427), Agence Nationale de la Recherche (05-MRAR-004), Programme Hospitalier de Recherche Clinique of the Health Ministry (PHRC AOM 08064-P071204), Assistance Publique-Hopitaux de Paris, Fondation de l'Avenir, Institut Pasteur and College de France, and the National Institutes of Health (AI52845 and AI082020, to Dr. Bushman). Dr. Hauer was supported by a scholarship from the Akademie der Naturforscher Leopoldina (BMBF-LPD 9901/8-149).	Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Antoine C, 2003, LANCET, V361, P553, DOI 10.1016/S0140-6736(03)12513-5; Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; Baum C, 2007, CURR OPIN HEMATOL, V14, P337, DOI 10.1097/MOH.0b013e3281900f01; BRIERE F, 1994, J EXP MED, V179, P757, DOI 10.1084/jem.179.2.757; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Cavazzana-Calvo M, 2007, BLOOD, V109, P4575, DOI 10.1182/blood-2006-07-029090; Gaspar HB, 2004, LANCET, V364, P2181, DOI 10.1016/S0140-6736(04)17590-9; GENNERY AR, J ALLERGY C IN PRESS; Ginn SL, 2005, MED J AUSTRALIA, V182, P458, DOI 10.5694/j.1326-5377.2005.tb06785.x; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Leonard WJ, 2001, NAT REV IMMUNOL, V1, P200, DOI 10.1038/35105066; Neven B, 2009, BLOOD, V113, P4114, DOI 10.1182/blood-2008-09-177923; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; Sarzotti-Kelsoe M, 2009, BLOOD, V114, P1445, DOI 10.1182/blood-2009-01-199323; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; TANNER JM, 1986, CLIN ENDOCRINOL META, V15, P411, DOI 10.1016/S0300-595X(86)80005-6; WANG GP, 2010, BLOOD           0312; Weerkamp F, 2006, BLOOD, V107, P3131, DOI 10.1182/blood-2005-08-3412	23	425	449	0	76	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2010	363	4					355	364		10.1056/NEJMoa1000164	http://dx.doi.org/10.1056/NEJMoa1000164			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628RU	20660403	Green Accepted			2022-12-01	WOS:000280139300008
J	Qi, HH; Sarkissian, M; Hu, GQ; Wang, ZB; Bhattacharjee, A; Gordon, DB; Gonzales, M; Lan, F; Ongusaha, PP; Huarte, M; Yaghi, NK; Lim, H; Garcia, BA; Brizuela, L; Zhao, KJ; Roberts, TM; Shi, Y				Qi, Hank H.; Sarkissian, Madathia; Hu, Gang-Qing; Wang, Zhibin; Bhattacharjee, Arindam; Gordon, D. Benjamin; Gonzales, Michelle; Lan, Fei; Ongusaha, Pat P.; Huarte, Maite; Yaghi, Nasser K.; Lim, Huijun; Garcia, Benjamin A.; Brizuela, Leonardo; Zhao, Keji; Roberts, Thomas M.; Shi, Yang			Histone H4K20/H3K9 demethylase PHF8 regulates zebrafish brain and craniofacial development	NATURE			English	Article							STRUCTURAL INSIGHTS; MENTAL-RETARDATION; GENES; TRANSCRIPTION; METHYLATION; FAMILY; IDENTIFICATION; LYSINE-20; GENOME; MUTATIONS	X-linked mental retardation (XLMR) is a complex human disease that causes intellectual disability(1). Causal mutations have been found in approximately 90 X-linked genes(2); however, molecular and biological functions of many of these genetically defined XLMR genes remain unknown. PHF8 (PHD (plant homeo domain) finger protein 8) is a JmjC domain-containing protein and its mutations have been found in patients with XLMR and craniofacial deformities. Here we provide multiple lines of evidence establishing PHF8 as the first mono-methyl histone H4 lysine 20 (H4K20me1) demethylase, with additional activities towards histone H3K9me1 and me2. PHF8 is located around the transcription start sites (TSS) of similar to 7,000 RefSeq genes and in gene bodies and intergenic regions (non-TSS). PHF8 depletion resulted in upregulation of H4K20me1 and H3K9me1 at the TSS and H3K9me2 in the non-TSS sites, respectively, demonstrating differential substrate specificities at different target locations. PHF8 positively regulates gene expression, which is dependent on its H3K4me3-binding PHD and catalytic domains. Importantly, patient mutations significantly compromised PHF8 catalytic function. PHF8 regulates cell survival in the zebrafish brain and jaw development, thus providing a potentially relevant biological context for understanding the clinical symptoms associated with PHF8 patients. Lastly, genetic and molecular evidence supports a model whereby PHF8 regulates zebrafish neuronal cell survival and jaw development in part by directly regulating the expression of the homeodomain transcription factor MSX1/MSXB, which functions downstream of multiple signalling and developmental pathways(3). Our findings indicate that an imbalance of histone methylation dynamics has a critical role in XLMR.	[Qi, Hank H.; Lan, Fei; Huarte, Maite; Yaghi, Nasser K.; Lim, Huijun; Shi, Yang] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Qi, Hank H.; Lim, Huijun; Shi, Yang] Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA 02115 USA; [Sarkissian, Madathia; Roberts, Thomas M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Hu, Gang-Qing; Wang, Zhibin; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Bhattacharjee, Arindam; Gordon, D. Benjamin; Brizuela, Leonardo] Agilent Technol, Santa Clara, CA 95051 USA; [Gonzales, Michelle; Garcia, Benjamin A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Ongusaha, Pat P.] Brigham & Womens Hosp, Vasc Med Res Unit, Cambridge, MA 02139 USA; [Ongusaha, Pat P.] Harvard Univ, Sch Med, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Agilent Technologies; Princeton University; Harvard University; Brigham & Women's Hospital; Harvard University	Shi, Y (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	Thomas_Roberts@dfci.harvard.edu; yshi@hms.harvard.edu	Yaghi, Nasser/AAL-7001-2021; Huarte, Maite/J-6903-2014; Hu, Gangqing/ABA-3507-2020; HU, GANGQING/K-5849-2012	Huarte, Maite/0000-0003-3753-6493; HU, GANGQING/0000-0001-5453-6888; Yaghi, Nasser/0000-0003-0810-8502; Qi, Hank/0000-0002-3401-4940	Ruth L. Kirschstein-National Service [T32 NS007473, T32 CA09031-32]; Harvard SHURP; Agency for Science, Technology and Research (A*STAR); National Science Foundation [CBET-0941143]; NIH [GM 071004, NCI118487, CA50661]; Ellison Foundation; NATIONAL CANCER INSTITUTE [P01CA050661, T32CA009031] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006031, ZIAHL006030, ZIAHL005801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007473] Funding Source: NIH RePORTER	Ruth L. Kirschstein-National Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard SHURP; Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Shi laboratory members for helpful discussions and N. Mosammaparast and S. Chen for providing the nucleosomes. We thank G. Rosenfeld for sharing unpublished PHF8 results, and G. Rosenfeld, A. Schier and P. Hinds for discussions. H.H.Q. is a recipient of Ruth L. Kirschstein-National Service Research Award (T32 NS007473 and T32 CA09031-32). N.K.Y. was supported by Harvard SHURP (Summer Honors Undergraduate Research Program). H.L. is a recipient of the Agency for Science, Technology and Research (A*STAR) National Science Scholarship. This work was supported by grants from the National Science Foundation (CBET-0941143) to B.A.G.; NIH (GM 071004 and NCI118487) to Y. S.; a Senior Scholar Grant from the Ellison Foundation, and an NIH PO1 grant (CA50661) to T.M.R.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Cau E, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-36; Chiurazzi P, 2008, EUR J HUM GENET, V16, P422, DOI 10.1038/sj.ejhg.5201994; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; DARZYNKIEWICZ Z, 1999, CURR PROTOC CELL BIO, V1; Di Fonzo A, 2009, NEUROLOGY, V72, P240, DOI 10.1212/01.wnl.0000338144.10967.2b; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Fortschegger K, 2010, MOL CELL BIOL, V30, P3286, DOI 10.1128/MCB.01520-09; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Houston SI, 2008, J BIOL CHEM, V283, P19478, DOI 10.1074/jbc.M710579200; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Kalakonda N, 2008, ONCOGENE, V27, P4293, DOI 10.1038/onc.2008.67; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Koivisto AM, 2007, CLIN GENET, V72, P145, DOI 10.1111/j.1399-0004.2007.00836.x; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Loenarz C, 2010, HUM MOL GENET, V19, P217, DOI 10.1093/hmg/ddp480; Lupo G, 2006, NAT REV NEUROSCI, V7, P103, DOI 10.1038/nrn1843; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Phillips BT, 2006, DEV BIOL, V294, P376, DOI 10.1016/j.ydbio.2006.03.001; Plazas-Mayorca MD, 2009, J PROTEOME RES, V8, P5367, DOI 10.1021/pr900777e; Postlethwait JH, 2006, GENOME DYN, V2, P183, DOI 10.1159/000095104; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Ramos C, 2005, TRENDS GENET, V21, P624, DOI 10.1016/j.tig.2005.09.001; Rappsilber J, 2003, ANAL CHEM, V75, P3107, DOI 10.1021/ac026283q; Ropers HH, 2006, CURR OPIN GENET DEV, V16, P260, DOI 10.1016/j.gde.2006.04.017; Tetel MJ, 2009, J NEUROENDOCRINOL, V21, P229, DOI 10.1111/j.1365-2826.2009.01827.x; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Yu L, 2010, CELL RES, V20, P166, DOI 10.1038/cr.2010.8; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340	39	212	222	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					503	U11		10.1038/nature09261	http://dx.doi.org/10.1038/nature09261			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20622853	Green Accepted			2022-12-01	WOS:000280141200039
J	Hurley, R				Hurley, Richard			HIV/AIDS How Ukraine is tackling Europe's worst HIV epidemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England			rhurley@bmj.com						[Anonymous], 2008, EP FACT SHEET HIV AI; Gowing L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004145.pub3; *MIN HLTH WHO UKR, 2009, INT HIV AIDS ALL UKR; Ministry of Health of Ukraine, 2010, UKR NAT REP MON PROG; *UNAIDS, 2008, E EUR CENTR AS FACTS	5	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 13	2010	341								c3538	10.1136/bmj.c3538	http://dx.doi.org/10.1136/bmj.c3538			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628XB	20627980				2022-12-01	WOS:000280156600007
J	Elliott, P; Toledano, MB; Bennett, J; Beale, L; de Hoogh, K; Best, N; Briggs, DJ				Elliott, Paul; Toledano, Mireille B.; Bennett, J.; Beale, L.; de Hoogh, K.; Best, N.; Briggs, D. J.			Mobile phone base stations and early childhood cancers: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CENTRAL-NERVOUS-SYSTEM; TELEVISION TRANSMITTERS; GREAT-BRITAIN; ELECTROMAGNETIC-FIELDS; EXPOSURE METRICS; RADIO; LEUKEMIA; HEALTH; BRAIN; EPIDEMIOLOGY	Objective To investigate the risk of early childhood cancers associated with the mother's exposure to radiofrequency from and proximity to macrocell mobile phone base stations (masts) during pregnancy. Design Case-control study. Setting Cancer registry and national birth register data in Great Britain. Participants 1397 cases of cancer in children aged 0-4 from national cancer registry 1999-2001 and 5588 birth controls from national birth register, individually matched by sex and date of birth (four controls per case). Main outcome measures Incidence of cancers of the brain and central nervous system, leukaemia, and non-Hodgkin's lymphomas, and all cancers combined, adjusted for small area measures of education level, socioeconomic deprivation, population density, and population mixing. Results Mean distance of registered address at birth from a macrocell base station, based on a national database of 76890 base station antennas in 1996-2001, was similar for cases and controls (1107 (SD 1131) m v 1073 (SD 1130) m, P=0.31), as was total power output of base stations within 700 m of the address (2.89 (SD 5.9) kW v 3.00 (SD 6.0) kW, P=0.54) and modelled power density (-30.3 (SD 21.7) dBm v-29.7 (SD 21.5) dBm, P=0.41). For modelled power density at the address at birth, compared with the lowest exposure category the adjusted odds ratios were 1.01 (95% confidence interval 0.87 to 1.18) in the intermediate and 1.02 (0.88 to 1.20) in the highest exposure category for all cancers (P=0.79 for trend), 0.97 (0.69 to 1.37) and 0.76 (0.51 to 1.12), respectively, for brain and central nervous system cancers (P=0.33 for trend), and 1.16 (0.90 to 1.48) and 1.03 (0.79 to 1.34) for leukaemia and non-Hodgkin's lymphoma (P=0.51 for trend). Conclusions There is no association between risk of early childhood cancers and estimates of the mother's exposure to mobile phone base stations during pregnancy.	[Elliott, Paul; Toledano, Mireille B.; Bennett, J.; Beale, L.; de Hoogh, K.; Best, N.; Briggs, D. J.] Univ London Imperial Coll Sci Technol & Med, Small Area Hlth Stat Unit, MRC HPA Ctr Environm & Hlth, Dept Epidemiol & Biostat,Sch Publ Hlth, London W2 1PG, England	Imperial College London	Elliott, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Small Area Hlth Stat Unit, MRC HPA Ctr Environm & Hlth, Dept Epidemiol & Biostat,Sch Publ Hlth, St Marys Campus, London W2 1PG, England.	p.elliott@imperial.ac.uk		Bennett, James Elston/0000-0002-9616-6878; Elliott, Paul/0000-0002-7511-5684	UK Mobile Telecommunications Health Research (MTHR); UK Department of Health; Medical Research Council [G0801056B, G0801056] Funding Source: researchfish; MRC [G0801056] Funding Source: UKRI	UK Mobile Telecommunications Health Research (MTHR); UK Department of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: The study was funded through the UK Mobile Telecommunications Health Research (MTHR) Programme (www.mthr.org.uk), an independent body set up to provide funding for research into the possible health effects of mobile telecommunications. The MTHR is jointly funded by the UK Department of Health and the mobile telecommunications industry. Members of the independent MTHR programme management committee approved the study design and commented on a draft manuscript. Data collection and analysis, interpretation of data, and the decision to submit the paper for publication were the sole responsibility of the authors.	Adair RK, 2003, RADIAT RES, V159, P128, DOI 10.1667/0033-7587(2003)159[0128:EOTTPP]2.0.CO;2; Ahlbom A, 1998, HEALTH PHYS, V74, P494; Belson M, 2007, ENVIRON HEALTH PERSP, V115, P138, DOI 10.1289/ehp.9023; Berg-Beckhoff G, 2009, OCCUP ENVIRON MED, V66, P124, DOI 10.1136/oem.2008.039834; Blettner M, 2009, OCCUP ENVIRON MED, V66, P118, DOI 10.1136/oem.2007.037721; Canfield MA, 2006, J EXPO SCI ENV EPID, V16, P538, DOI 10.1038/sj.jes.7500501; CARSTAIRS V, 1989, BRIT MED J, V299, P886, DOI 10.1136/bmj.299.6704.886; Cooper D, 2001, AM J EPIDEMIOL, V153, P202, DOI 10.1093/aje/153.2.202; Dolk H, 1997, AM J EPIDEMIOL, V145, P10, DOI 10.1093/oxfordjournals.aje.a009026; Dolk H, 1997, AM J EPIDEMIOL, V145, P1, DOI 10.1093/oxfordjournals.aje.a009025; Eaton N, 1997, BRIT J CANCER, V75, P1080, DOI 10.1038/bjc.1997.184; Eger H, 2004, UMWELT MED GESELLSCH, V17, P325; Elliott P, 2004, ENVIRON HEALTH PERSP, V112, P998, DOI 10.1289/ehp.6735; Ha M, 2008, AM J EPIDEMIOL, V167, P884, DOI 10.1093/aje/kwn013; Ha M, 2007, AM J EPIDEMIOL, V166, P270, DOI 10.1093/aje/kwm083; Hocking B, 1996, MED J AUSTRALIA, V165, P601, DOI 10.5694/j.1326-5377.1996.tb138661.x; Independent Expert Group on Mobile Phones, 2000, MOB PHON HLTH; Kheifets L, 2005, PEDIATRICS, V116, pE303, DOI 10.1542/peds.2004-2541; Khurana VG, 2009, SURG NEUROL, V72, P205, DOI 10.1016/j.surneu.2009.01.019; Krewski D, 2007, J TOXICOL ENV HEAL B, V10, P287, DOI 10.1080/15287390600974973; Kundi Michael, 2009, Pathophysiology, V16, P123, DOI 10.1016/j.pathophys.2009.01.008; Kundi M, 2009, ENVIRON HEALTH PERSP, V117, P316, DOI 10.1289/ehp.11902; MANN SM, 2000, R321 NRPB; Maskarinec Gertraud, 1994, Journal of Environmental Pathology Toxicology and Oncology, V13, P33; McKenzie DR, 1998, AUST NZ J PUBL HEAL, V22, P360, DOI 10.1111/j.1467-842X.1998.tb01392.x; Merzenich H, 2008, AM J EPIDEMIOL, V168, P1169, DOI 10.1093/aje/kwn230; Michelozzi P, 2002, AM J EPIDEMIOL, V155, P1096, DOI 10.1093/aje/155.12.1096; *NAT COUNC RAD PRO, 2003, BIOL EFF MOD RAD FIE; Nelson PD, 2006, NEUROLOGY, V66, P284, DOI 10.1212/01.wnl.0000194218.79519.ea; Neubauer G, 2007, BIOELECTROMAGNETICS, V28, P224, DOI 10.1002/bem.20298; OBERFELD G, 2008, UMWELTEPIDEMIOLOGISC; *ORDN SURV, 2010, ADDR POINT; Otitoloju AA, 2010, B ENVIRON CONTAM TOX, V84, P51, DOI 10.1007/s00128-009-9894-2; Park SK, 2004, INT ARCH OCC ENV HEA, V77, P387, DOI 10.1007/s00420-004-0512-7; *R FDN STAT COMP, 2010, R PROJ STAT CMP; Regel SJ, 2006, ENVIRON HEALTH PERSP, V114, P1270, DOI 10.1289/ehp.8934; Rodrigues L, 1991, STUDIES MED POPULATI, P47; Schmiedel S, 2009, BIOELECTROMAGNETICS, V30, P81, DOI 10.1002/bem.20460; Schuz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004389; Schuz J, 2000, J EXPO ANAL ENV EPID, V10, P600, DOI 10.1038/sj.jea.7500115; Schuz J, 2009, BIOELECTROMAGNETICS, V30, P511, DOI 10.1002/bem.20510; Siegrist M, 2005, RISK ANAL, V25, P1253, DOI 10.1111/j.1539-6924.2005.00672.x; Wolf R, 2004, INT J CANC PREVENTIO, V1, P1; [No title captured]	44	30	31	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2010	340								c3077	10.1136/bmj.c3077	http://dx.doi.org/10.1136/bmj.c3077			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618IO	20570865	hybrid, Green Published			2022-12-01	WOS:000279346300005
J	Johansson, M; Relton, C; Ueland, PM; Vollset, SE; Midttun, O; Nygard, O; Slimani, N; Boffetta, P; Jenab, M; Clavel-Chapelon, F; Boutron-Ruault, MC; Fagherazzi, G; Kaaks, R; Rohrmann, S; Boeing, H; Weikert, C; Bueno-de-Mesquita, HB; Ros, MM; van Gils, CH; Peeters, PHM; Agudo, A; Barricarte, A; Navarro, C; Rodriguez, L; Sanchez, MJ; Larranaga, N; Khaw, KT; Wareham, N; Allen, NE; Crowe, F; Gallo, V; Norat, T; Krogh, V; Masala, G; Panico, S; Sacerdote, C; Tumino, R; Trichopoulou, A; Lagiou, P; Trichopoulos, D; Rasmuson, T; Hallmans, G; Riboli, E; Vineis, P; Brennan, P				Johansson, Mattias; Relton, Caroline; Ueland, Per Magne; Vollset, Stein Emil; Midttun, Oivind; Nygard, Ottar; Slimani, Nadia; Boffetta, Paolo; Jenab, Mazda; Clavel-Chapelon, Francoise; Boutron-Ruault, Marie-Christine; Fagherazzi, Guy; Kaaks, Rudolf; Rohrmann, Sabine; Boeing, Heiner; Weikert, Cornelia; Bueno-de-Mesquita, H. Bas; Ros, Martine M.; van Gils, Carla H.; Peeters, Petra H. M.; Agudo, Antonio; Barricarte, Aurelio; Navarro, Carmen; Rodriguez, Laudina; Sanchez, Maria-Jose; Larranaga, Nerea; Khaw, Kay-Tee; Wareham, Nick; Allen, Naomi E.; Crowe, Francesca; Gallo, Valentina; Norat, Teresa; Krogh, Vittorio; Masala, Giovanna; Panico, Salvatore; Sacerdote, Carlotta; Tumino, Rosario; Trichopoulou, Antonia; Lagiou, Pagona; Trichopoulos, Dimitrios; Rasmuson, Torgny; Hallmans, Goeran; Riboli, Elio; Vineis, Paolo; Brennan, Paul			Serum B Vitamin Levels and Risk of Lung Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ONE-CARBON METABOLISM; GENOME-WIDE ASSOCIATION; COLORECTAL-CANCER; PLASMA FOLATE; FOLIC-ACID; MICROBIOLOGICAL ASSAY; BREAST-CANCER; NEVER SMOKERS; HOMOCYSTEINE; PREVENTION	Context B vitamins and factors related to 1-carbonmetabolism help to maintain DNA integrity and regulate gene expression and may affect cancer risk. Objective To investigate if 1-carbon metabolism factors are associated with onset of lung cancer. Design, Setting, and Participants The European Prospective Investigation into Cancer and Nutrition (EPIC) recruited 519 978 participants from 10 countries between 1992 and 2000, of whom 385 747 donated blood. By 2006, 899 lung cancer cases were identified and 1770 control participants were individually matched by country, sex, date of birth, and date of blood collection. Serum levels were measured for 6 factors of 1-carbon metabolism and cotinine. Main Outcome Measure Odds ratios (ORs) of lung cancer by serum levels of 4 B vitamins (B-2, B-6, folate [B-9], and B-12), methionine, and homocysteine. Results Within the entire EPIC cohort, the age-standardized incidence rates of lung cancer (standardized to the world population, aged 35-79 years) were 6.6, 44.9, and 156.1 per 100 000 person-years among never, former, and current smokers for men, respectively. The corresponding incidence rates for women were 7.1, 23.9, and 100.9 per 100 000 person-years, respectively. After accounting for smoking, a lower risk for lung cancer was seen for elevated serum levels of B6 (fourth vs first quartile OR, 0.44; 95% confidence interval [CI], 0.33-0.60; P for trend<.000001), as well as for serum methionine (fourth vs first quartile OR, 0.52; 95% CI, 0.39-0.69; P for trend<.000001). Similar and consistent decreases in risk were observed in never, former, and current smokers, indicating that results were not due to confounding by smoking. The magnitude of risk was also constant with increasing length of follow-up, indicating that the associations were not explained by preclinical disease. A lower risk was also seen for serum folate (fourth vs first quartile OR, 0.68; 95% CI, 0.51-0.90; P for trend=.001), although this was apparent only for former and current smokers. When participants were classified by median levels of serum methionine and B6, having above-median levels of both was associated with a lower lung cancer risk overall (OR, 0.41; 95% CI, 0.31-0.54), as well as separately among never (OR, 0.36; 95% CI, 0.18-0.72), former(OR, 0.51; 95% CI, 0.34-0.76), and current smokers(OR, 0.42; 95% CI, 0.27-0.65). Conclusion Serum levels of vitamin B6 and methionine were inversely associated with risk of lung cancer. JAMA. 2010; 303(23): 2377-2385	[Brennan, Paul] Int Agcy Res Canc, Genet Epidemiol Grp, F-69372 Lyon, France	World Health Organization; International Agency for Research on Cancer (IARC)	Brennan, P (corresponding author), Int Agcy Res Canc, Genet Epidemiol Grp, 150 Cours Albert Thomas, F-69372 Lyon, France.	Brennan@iarc.fr	Agudo, Antonio/J-1805-2016; Krogh, Vittorio/K-2628-2016; Relton, Caroline/AAC-5904-2019; Gallo, Valentina/X-1139-2018; Johansson, Mattias/ABF-3365-2020; Fagherazzi, Guy/P-3534-2017; Panico, Salvatore/K-6506-2016; Rohrmann, Sabine/D-2113-2012; Gallo, Valentina/J-3089-2012; Khaw, Kay-Tee/AAZ-3209-2021; Boutron-Ruault, Marie-Christine/H-3936-2014; Fagherazzi, Guy/ABB-2555-2020; Clavel-Chapelon, Francoise/G-6733-2014; Sánchez, Maria-José/D-1087-2011; Krogh, Vittorio/AAA-9171-2019; Ueland, Per M/C-7340-2013; Masala, Giovanna/AAC-5474-2022; Boffetta, Paolo/AAI-7767-2021; TRICHOPOULOU, ANTONIA/ABF-8727-2021	Agudo, Antonio/0000-0001-9900-5677; Krogh, Vittorio/0000-0003-0122-8624; Gallo, Valentina/0000-0002-1268-8629; Fagherazzi, Guy/0000-0001-5033-5966; Panico, Salvatore/0000-0002-5498-8312; Rohrmann, Sabine/0000-0002-2215-1200; Boutron-Ruault, Marie-Christine/0000-0002-5956-5693; Fagherazzi, Guy/0000-0001-5033-5966; Sánchez, Maria-José/0000-0003-4817-0757; Krogh, Vittorio/0000-0003-0122-8624; Masala, Giovanna/0000-0002-5758-9069; Boffetta, Paolo/0000-0002-3811-2791; TRICHOPOULOU, ANTONIA/0000-0002-7204-6396; Sacerdote, Carlotta/0000-0002-8008-5096; Navarro, Carmen/0000-0001-8896-7483; Relton, Caroline/0000-0003-2052-4840; Crowe, Francesca/0000-0003-4026-1726; Riboli, Elio/0000-0001-6795-6080; Johansson, Mattias/0000-0002-3116-5081; Jenab, Mazda/0000-0002-0573-1852; tumino, rosario/0000-0003-2666-414X; Larranaga, Nerea/0000-0002-9993-9880; Ueland, Per Magne/0000-0002-1903-0571	World Cancer Research Fund (United Kingdom); European Commission (SANCO); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum, German Federal Ministry of Education and Research; Danish Cancer Society; Spanish Ministry of Health, Spanish Regional Government of Andalucia; Spanish Ministry of Health, Spanish Regional Government of Asturias; Spanish Ministry of Health, Spanish Regional Government of Basque Country; Spanish Ministry of Health, Spanish Regional Government of Murcia; Spanish Ministry of Health, Spanish Regional Government of Navarra; ISCIII Network RCESP, Spain [C03/09]; ISCIII of the Spanish Ministry of Health [RETICC DR06/0020]; Cancer Research UK; Medical Research Council, United Kingdom; Greek Ministry of Health; Stavros Niarchos Foundation; Hellenic Health Foundation; Italian Association for Research on Cancer (AIRC); Italian National Research Council, Fondazione-Istituto Banco Napoli, Italy; Compagnia di San Paolo; Dutch Ministry of Public Health, Welfare and Sports; World Cancer Research Fund; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Vasterbotten, Sweden; Norwegian Cancer Society; Research Council of Norway; French League against Cancer (LNCC); National Institute for Health and Medical Research (INSERM), France; Mutuelle Generale de l'Education Nationale (MGEN), France; 3M Co, France; Gustave Roussy Institute (IGR), France; General Councils of France; Medical Research Council [G0401527, MC_U106179471] Funding Source: researchfish	World Cancer Research Fund (United Kingdom); European Commission (SANCO)(European CommissionEuropean Commission Joint Research Centre); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum, German Federal Ministry of Education and Research(Deutsche KrebshilfeFederal Ministry of Education & Research (BMBF)); Danish Cancer Society(Danish Cancer Society); Spanish Ministry of Health, Spanish Regional Government of Andalucia; Spanish Ministry of Health, Spanish Regional Government of Asturias; Spanish Ministry of Health, Spanish Regional Government of Basque Country; Spanish Ministry of Health, Spanish Regional Government of Murcia; Spanish Ministry of Health, Spanish Regional Government of Navarra; ISCIII Network RCESP, Spain; ISCIII of the Spanish Ministry of Health(Spanish Government); Cancer Research UK(Cancer Research UK); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Greek Ministry of Health(Greek Ministry of Development-GSRT); Stavros Niarchos Foundation; Hellenic Health Foundation; Italian Association for Research on Cancer (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian National Research Council, Fondazione-Istituto Banco Napoli, Italy(Consiglio Nazionale delle Ricerche (CNR)); Compagnia di San Paolo(Compagnia di San Paolo); Dutch Ministry of Public Health, Welfare and Sports; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); Swedish Cancer Society(Swedish Cancer Society); Swedish Scientific Council; Regional Government of Vasterbotten, Sweden; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); French League against Cancer (LNCC); National Institute for Health and Medical Research (INSERM), France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Mutuelle Generale de l'Education Nationale (MGEN), France; 3M Co, France(3M); Gustave Roussy Institute (IGR), France; General Councils of France; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	World Cancer Research Fund (United Kingdom) funded the biochemical analyses for the study. The EPIC study has been supported by the Europe Against Cancer Program of the European Commission (SANCO); Deutsche Krebshilfe, Deutsches Krebsforschungszentrum, German Federal Ministry of Education and Research; Danish Cancer Society; Health Research Fund (FIS) of the Spanish Ministry of Health, Spanish Regional Governments of Andalucia, Asturias, Basque Country, Murcia and Navarra; the ISCIII Network RCESP (C03/09), Spain; the ISCIII of the Spanish Ministry of Health (RETICC DR06/0020); Cancer Research UK; Medical Research Council, United Kingdom; Greek Ministry of Health; Stavros Niarchos Foundation; Hellenic Health Foundation; Italian Association for Research on Cancer (AIRC); Italian National Research Council, Fondazione-Istituto Banco Napoli, Italy; Compagnia di San Paolo; Dutch Ministry of Public Health, Welfare and Sports; World Cancer Research Fund; Swedish Cancer Society; Swedish Scientific Council; Regional Government of Vasterbotten, Sweden; Norwegian Cancer Society; Research Council of Norway; French League against Cancer (LNCC); National Institute for Health and Medical Research (INSERM), France; Mutuelle Generale de l'Education Nationale (MGEN), France; 3M Co, France; Gustave Roussy Institute (IGR), France; and General Councils of France.	Ames BN, 2002, NAT REV CANCER, V2, P694, DOI 10.1038/nrc886; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Bray F., 2002, CANC INCIDENCE 5 CON, VVIII; Chou YC, 2007, BREAST CANCER RES TR, V101, P199, DOI 10.1007/s10549-006-9278-9; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; Dahlin AM, 2008, INT J CANCER, V122, P2057, DOI 10.1002/ijc.23299; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Dierkes J, 2007, AM J CLIN NUTR, V86, P214; Drake BF, 2009, JAMA-J AM MED ASSOC, V302, P2152, DOI 10.1001/jama.2009.1691; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622; Figueiredo JC, 2008, CANCER EPIDEM BIOMAR, V17, P2136, DOI 10.1158/1055-9965.EPI-07-2895; Gibson A, 2008, QJM-INT J MED, V101, P881, DOI 10.1093/qjmed/hcn112; Hartman TJ, 2001, AM J EPIDEMIOL, V153, P688, DOI 10.1093/aje/153.7.688; Johansson M, 2008, CANCER EPIDEM BIOMAR, V17, P279, DOI 10.1158/1055-9965.EPI-07-0657; Johansson M, 2009, CANCER EPIDEM BIOMAR, V18, P1538, DOI 10.1158/1055-9965.EPI-08-1193; KELLEHER BP, 1991, J CLIN PATHOL, V44, P592, DOI 10.1136/jcp.44.7.592; Kim YI, 2003, J NUTR, V133, p3731S, DOI 10.1093/jn/133.11.3731S; Kim YI, 2007, MOL NUTR FOOD RES, V51, P267, DOI 10.1002/mnfr.200600191; Laufer EM, 2004, EUR J CLIN NUTR, V58, P1518, DOI 10.1038/sj.ejcn.1602002; Le Marchand L, 2009, CANCER EPIDEM BIOMAR, V18, P2195, DOI 10.1158/1055-9965.EPI-09-0141; Lee JE, 2009, CANCER EPIDEM BIOMAR, V18, P1197, DOI 10.1158/1055-9965.EPI-08-1001; Lin J, 2008, AM J CLIN NUTR, V87, P734, DOI 10.1093/ajcn/87.3.734; Logan RFA, 2008, GASTROENTEROLOGY, V134, P29, DOI 10.1053/j.gastro.2007.10.014; Midttun O, 2009, RAPID COMMUN MASS SP, V23, P1371, DOI 10.1002/rcm.4013; Molloy AM, 1997, METHOD ENZYMOL, V281, P43; National Institution of Health Office of Dietary Supplements, DIET SUPPL FACT SHEE; Olsen A, 2009, EUR J CLIN NUTR, V63, pS122, DOI 10.1038/ejcn.2009.78; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394; Rudin CM, 2009, CLIN CANCER RES, V15, P5622, DOI 10.1158/1078-0432.CCR-09-0373; Schernhammer E, 2007, CANCER RES, V67, P5553, DOI 10.1158/0008-5472.CAN-06-4463; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Tanaka T, 2009, AM J HUM GENET, V84, P477, DOI 10.1016/j.ajhg.2009.02.011; Ueland P., FOLATE SERUM; Ueland PM, 2007, CLIN CHEM LAB MED, V45, P1737, DOI 10.1515/CCLM.2007.339; Ulrich CM, 2007, JAMA-J AM MED ASSOC, V297, P2408, DOI 10.1001/jama.297.21.2408; Verkleij-Hagoort AC, 2007, EUR J CLIN NUTR, V61, P610, DOI 10.1038/sj.ejcn.1602581; Vollset SE, 2007, CANCER EPIDEM BIOMAR, V16, P2416, DOI 10.1158/1055-9965.EPI-07-0256; Wei EK, 2005, J NATL CANCER I, V97, P684, DOI 10.1093/jnci/dji116; Weinstein SJ, 2008, CANCER EPIDEM BIOMAR, V17, P3233, DOI 10.1158/1055-9965.EPI-08-0459; Weisberg IS, 2001, ATHEROSCLEROSIS, V156, P409, DOI 10.1016/S0021-9150(00)00671-7; WILLET W, 1998, NUTR EPIDEMIOLOGY, P124; Yoshino K, 2010, INT J FOOD SCI NUTR, V61, P61, DOI 10.3109/09637480903286363; Zhang SM, 2003, J NATL CANCER I, V95, P373, DOI 10.1093/jnci/95.5.373	47	116	118	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2010	303	23					2377	2385		10.1001/jama.2010.808	http://dx.doi.org/10.1001/jama.2010.808			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	610TE	20551408	Bronze, Green Accepted			2022-12-01	WOS:000278759200027
J	Spence, D				Spence, Des			From The Frontline Bad medicine: chronic kidney disease	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						[Anonymous], 2000, LANCET, V355, P253; Hallan SI, 2006, BMJ-BRIT MED J, V333, P1047, DOI 10.1136/bmj.39001.657755.BE; Ku E, 2009, ARCH INTERN MED, V169, P1015, DOI 10.1001/archinternmed.2009.128; Strippoli GFM, 2008, BMJ-BRIT MED J, V336, P645, DOI 10.1136/bmj.39472.580984.AE	4	12	12	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 16	2010	340								c3188	10.1136/bmj.c3188	http://dx.doi.org/10.1136/bmj.c3188			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614JB	20554677				2022-12-01	WOS:000279051900022
J	Doucet, CM; Talamas, JA; Hetzer, MW				Doucet, Christine M.; Talamas, Jessica A.; Hetzer, Martin W.			Cell Cycle-Dependent Differences in Nuclear Pore Complex Assembly in Metazoa	CELL			English	Article							MEMBRANE-PROTEINS; DE-NOVO; ENVELOPE; NUCLEOPORIN; CHROMATIN; NDC1; ARCHITECTURE; RECRUITMENT; CONTAINS; DYNAMICS	In metazoa, nuclear pore complexes (NPCs) assemble from disassembled precursors into a reforming nuclear envelope (NE) at the end of mitosis and into growing intact NEs during interphase. Here, we show via RNAi-mediated knockdown that ELYS, a nucleoporin critical for the recruitment of the essential Nup107/160 complex to chromatin, is required for NPC assembly at the end of mitosis but not during interphase. Conversely, the transmembrane nucleoporin POM121 is critical for the incorporation of the Nup107/160 complex into new assembly sites specifically during interphase. Strikingly, recruitment of the Nup107/160 complex to an intact NE involves a membrane curvature-sensing domain of its constituent Nup133, which is not required for postmitotic NPC formation. Our results suggest that in organisms with open mitosis, NPCs assemble via two distinct mechanisms to accommodate cell cycle-dependent differences in NE topology.	[Doucet, Christine M.; Talamas, Jessica A.; Hetzer, Martin W.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Hetzer, MW (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hetzer@salk.edu		Doucet, Christine/0000-0002-1611-8279	National Institute of General Medical Sciences [R01GM057438];  [CA14195]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057438] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Hunter lab for antibodies and the H2B-tdTomato reporter construct; and the Hetzer lab for critical discussion and reading of the manuscript, in particular Roberta Schulte for help with the Xenopus egg extract depletion experiments. J.T. performed experiments regarding Pom121 and Elys. C.D. performed live imaging assays and experiments describing the ALPS domain of Nup133. M.H performed Xenopus in vitro experiments. Paper was written by all authors. We also thank Stephane Richard for help with design of the EGFP-ALPS fusion protein. This work was supported by Award Number R01GM057438 from the National Institute of General Medical Sciences and a Core Cancer Grant (CA14195).	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Anderson DJ, 2008, J CELL BIOL, V182, P911, DOI 10.1083/jcb.200805140; Anderson DJ, 2008, CURR OPIN CELL BIOL, V20, P386, DOI 10.1016/j.ceb.2008.03.016; Anderson DJ, 2009, J CELL BIOL, V186, P183, DOI 10.1083/jcb.200901106; Antonin W, 2005, MOL CELL, V17, P83, DOI 10.1016/j.molcel.2004.12.010; Antonin W, 2008, FEBS LETT, V582, P2004, DOI 10.1016/j.febslet.2008.02.067; Antonin W, 2009, CURR BIOL, V19, pR410, DOI 10.1016/j.cub.2009.03.053; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Berke IC, 2004, J CELL BIOL, V167, P591, DOI 10.1083/jcb.200408109; Boehmer T, 2008, MOL CELL, V30, P721, DOI 10.1016/j.molcel.2008.04.022; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014; Chial HJ, 1998, J CELL BIOL, V143, P1789, DOI 10.1083/jcb.143.7.1789; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; D'Angelo MA, 2006, SCIENCE, V312, P440, DOI 10.1126/science.1124196; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; Dawson TR, 2009, J CELL BIOL, V184, P659, DOI 10.1083/jcb.200806174; De Craene JO, 2006, MOL BIOL CELL, V17, P3009, DOI 10.1091/mbc.E06-01-0080; Debler EW, 2008, MOL CELL, V32, P815, DOI 10.1016/j.molcel.2008.12.001; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; Eriksson C, 2004, FEBS LETT, V572, P261, DOI 10.1016/j.febslet.2004.07.044; Franz C, 2007, EMBO REP, V8, P165, DOI 10.1038/sj.embor.7400889; Gillespie PJ, 2007, CURR BIOL, V17, P1657, DOI 10.1016/j.cub.2007.08.041; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; HALLBERG E, 1993, J CELL BIOL, V122, P513, DOI 10.1083/jcb.122.3.513; Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3; Hetzer M, 2000, MOL CELL, V5, P1013, DOI 10.1016/S1097-2765(00)80266-X; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; Lu L, 2009, MOL BIOL CELL, V20, P3471, DOI 10.1091/mbc.E09-04-0327; Lupu F, 2008, DEV CELL, V14, P831, DOI 10.1016/j.devcel.2008.03.011; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Macaulay C, 1996, J CELL BIOL, V132, P5, DOI 10.1083/jcb.132.1.5; Mansfeld J, 2006, MOL CELL, V22, P93, DOI 10.1016/j.molcel.2006.02.015; MAUL GG, 1971, J CELL BIOL, V51, P558, DOI 10.1083/jcb.51.2.558; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rasala BA, 2008, MOL BIOL CELL, V19, P3982, DOI 10.1091/mbc.E08-01-0012; Rasala BA, 2006, P NATL ACAD SCI USA, V103, P17801, DOI 10.1073/pnas.0608484103; Schulte R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002061; Stavru F, 2006, J CELL BIOL, V173, P509, DOI 10.1083/jcb.200601001; Stavru F, 2006, J CELL BIOL, V173, P477, DOI 10.1083/jcb.200601002; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Walther TC, 2003, NATURE, V424, P689, DOI 10.1038/nature01898; Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5	49	175	177	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					1030	1041		10.1016/j.cell.2010.04.036	http://dx.doi.org/10.1016/j.cell.2010.04.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550937	Bronze, Green Accepted			2022-12-01	WOS:000278618800017
J	Kan, ZY; Jaiswal, BS; Stinson, J; Janakiraman, V; Bhatt, D; Stern, HM; Yue, P; Haverty, PM; Bourgon, R; Zheng, JB; Moorhead, M; Chaudhuri, S; Tomsho, LP; Peters, BA; Pujara, K; Cordes, S; Davis, DP; Carlton, VEH; Yuan, WL; Li, L; Wang, WR; Eigenbrot, C; Kaminker, JS; Eberhard, DA; Waring, P; Schuster, SC; Modrusan, Z; Zhang, ZM; Stokoe, D; de Sauvage, FJ; Faham, M; Seshagiri, S				Kan, Zhengyan; Jaiswal, Bijay S.; Stinson, Jeremy; Janakiraman, Vasantharajan; Bhatt, Deepali; Stern, Howard M.; Yue, Peng; Haverty, Peter M.; Bourgon, Richard; Zheng, Jianbiao; Moorhead, Martin; Chaudhuri, Subhra; Tomsho, Lynn P.; Peters, Brock A.; Pujara, Kanan; Cordes, Shaun; Davis, David P.; Carlton, Victoria E. H.; Yuan, Wenlin; Li, Li; Wang, Weiru; Eigenbrot, Charles; Kaminker, Joshua S.; Eberhard, David A.; Waring, Paul; Schuster, Stephan C.; Modrusan, Zora; Zhang, Zemin; Stokoe, David; de Sauvage, Frederic J.; Faham, Malek; Seshagiri, Somasekar			Diverse somatic mutation patterns and pathway alterations in human cancers	NATURE			English	Article							HUMAN BREAST; IDENTIFICATION; MELANOMA; INSIGHTS; REVEALS	The systematic characterization of somatic mutations in cancer genomes is essential for understanding the disease and for developing targeted therapeutics(1). Here we report the identification of 2,576 somatic mutations across similar to 1,800 megabases of DNA representing 1,507 coding genes from 441 tumours comprising breast, lung, ovarian and prostate cancer types and subtypes. We found that mutation rates and the sets of mutated genes varied substantially across tumour types and subtypes. Statistical analysis identified 77 significantly mutated genes including protein kinases, G-protein-coupled receptors such as GRM8, BAI3, AGTRL1 (also called APLNR) and LPHN3, and other druggable targets. Integrated analysis of somatic mutations and copy number alterations identified another 35 significantly altered genes including GNAS, indicating an expanded role for G alpha subunits in multiple cancer types. Furthermore, our experimental analyses demonstrate the functional roles of mutant GNAO1 (a G alpha subunit) and mutant MAP2K4 (a member of the JNK signalling pathway) in oncogenesis. Our study provides an overview of the mutational spectra across major human cancers and identifies several potential therapeutic targets.	[Kan, Zhengyan; Jaiswal, Bijay S.; Stinson, Jeremy; Janakiraman, Vasantharajan; Bhatt, Deepali; Chaudhuri, Subhra; Peters, Brock A.; Pujara, Kanan; Cordes, Shaun; Davis, David P.; Yuan, Wenlin; Modrusan, Zora; Stokoe, David; de Sauvage, Frederic J.; Seshagiri, Somasekar] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Kan, Zhengyan; Yue, Peng; Haverty, Peter M.; Bourgon, Richard; Li, Li; Kaminker, Joshua S.; Zhang, Zemin] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Stern, Howard M.; Eberhard, David A.; Waring, Paul] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Zheng, Jianbiao; Moorhead, Martin; Carlton, Victoria E. H.; Faham, Malek] Affymetrix Inc, Santa Clara, CA 95051 USA; [Tomsho, Lynn P.; Schuster, Stephan C.] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Wang, Weiru; Eigenbrot, Charles] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Affymetrix; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Roche Holding; Genentech	Seshagiri, S (corresponding author), Genentech Inc, Dept Mol Biol, 1 DNA Way, San Francisco, CA 94080 USA.	sekar@gene.com	de Sauvage, Frederic/ABE-8400-2020	de Sauvage, Frederic/0000-0002-5275-2584; Peters, Brock/0000-0002-5137-3902; Seshagiri, Somasekar/0000-0003-4272-6443; Wang, Weiru/0000-0001-8845-301X; Bourgon, Richard/0000-0002-5890-4374				Bairoch A, 2004, BRIEF BIOINFORM, V5, P39, DOI 10.1093/bib/5.1.39; Bastida Eizaguirre M, 2001, An Esp Pediatr, V54, P598; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Cazillis M, 2004, ONCOGENE, V23, P4735, DOI 10.1038/sj.onc.1207619; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Clifford RJ, 2004, BIOINFORMATICS, V20, P1006, DOI 10.1093/bioinformatics/bth029; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fakhrai-Rad H, 2004, GENOME RES, V14, P1404, DOI 10.1101/gr.2373904; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kaminker JS, 2007, NUCLEIC ACIDS RES, V35, pW595, DOI 10.1093/nar/gkm405; Kaminker JS, 2007, CANCER RES, V67, P465, DOI 10.1158/0008-5472.CAN-06-1736; Kidd KK, 2006, FORENSIC SCI INT, V164, P20, DOI 10.1016/j.forsciint.2005.11.017; Marson VJ, 2004, HISTOPATHOLOGY, V45, P125, DOI 10.1111/j.1365-2559.2004.01893.x; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Parmigiani G, 2009, GENOMICS, V93, P17, DOI 10.1016/j.ygeno.2008.07.005; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Peters BA, 2007, NAT METHODS, V4, P713, DOI 10.1038/NMETH1081; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Ram PT, 2000, SCIENCE, V287, P142, DOI 10.1126/science.287.5450.142; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rubin AF, 2007, SCIENCE, V317, DOI 10.1126/science.1138956; Sanchez JJ, 2006, ELECTROPHORESIS, V27, P1713, DOI 10.1002/elps.200500671; Shiratsuchi T, 1997, CYTOGENET CELL GENET, V79, P103, DOI 10.1159/000134693; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Teng DHF, 1997, CANCER RES, V57, P4177; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; WEINSTEIN LS, 1993, CLIN BIOCHEM, V26, P333, DOI 10.1016/0009-9120(93)90109-J; Whitmarsh AJ, 2007, ONCOGENE, V26, P3172, DOI 10.1038/sj.onc.1210410; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yue P, 2010, HUM MUTAT, V31, P264, DOI 10.1002/humu.21194; Zheng JB, 2009, P NATL ACAD SCI USA, V106, P6712, DOI 10.1073/pnas.0901902106	43	767	809	2	103	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2010	466	7308					869	U103		10.1038/nature09208	http://dx.doi.org/10.1038/nature09208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20668451				2022-12-01	WOS:000280766100037
J	Lee, CH; Cook, JL; Mendelson, A; Moioli, EK; Yao, H; Mao, JJ				Lee, Chang H.; Cook, James L.; Mendelson, Avital; Moioli, Eduardo K.; Yao, Hai; Mao, Jeremy J.			Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study	LANCET			English	Article							MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; UNITED-STATES; TISSUE; CARTILAGE; OSTEOARTHRITIS; CHONDROCYTES; GROWTH; REPAIR	Background A common approach for tissue regeneration is cell delivery, for example by direct transplantation of stem or progenitor cells. An alternative, by recruitment of endogenous cells, needs experimental evidence. We tested the hypothesis that the articular surface of the synovial joint can regenerate with a biological cue spatially embedded in an anatomically correct bioscaffold. Methods In this proof of concept study, the surface morphology of a rabbit proximal humeral joint was captured with laser scanning and reconstructed by computer-aided design. We fabricated an anatomically correct bioscaffold using a composite of poly-e-caprolactone and hydroxyapatite. The entire articular surface of unilateral proximal humeral condyles of skeletally mature rabbits was surgically excised and replaced with bioscaffolds spatially infused with transforming growth factor beta 3 (TGF beta 3)-adsorbed or TGF beta 3-free collagen hydrogel. Locomotion and weightbearing were assessed 1-2, 3-4, and 5-8 weeks after surgery. At 4 months, regenerated cartilage samples were retrieved from in vivo and assessed for surface fissure, thickness, density, chondrocyte numbers, collagen type II and aggrecan, and mechanical properties. Findings Ten rabbits received TGF beta 3-infused bioscaffolds, ten received TGF beta 3-free bioscaffolds, and three rabbits underwent humeral-head excision without bioscaffold replacement. All animals in the TGF beta 3-delivery group fully resumed weightbearing and locomotion 3-4 weeks after surgery, more consistently than those in the TGF beta 3-free group. Defect-only rabbits limped at all times. 4 months after surgery, TGF beta 3-infused bioscaffolds were fully covered with hyaline cartilage in the articular surface. TGF beta 3-free bioscaffolds had only isolated cartilage formation, and no cartilage formation occurred in defect-only rabbits. TGF beta 3 delivery yielded uniformly distributed chondrocytes in a matrix with collagen type II and aggrecan and had significantly greater thickness (p=0.044) and density (p<0.0001) than did cartilage formed without TGF beta 3. Compressive and shear properties of TGF beta 3-mediated articular cartilage did not differ from those of native articular cartilage, and were significantly greater than those of cartilage formed without TGF beta 3. Regenerated cartilage was avascular and integrated with regenerated subchondral bone that had well defined blood vessels. TGF beta 3 delivery recruited roughly 130% more cells in the regenerated articular cartilage than did spontaneous cell migration without TGF beta 3. Interpretation Our findings suggest that the entire articular surface of the synovial joint can regenerate without cell transplantation. Regeneration of complex tissues is probable by homing of endogenous cells, as exemplified by stratified avascular cartilage and vascularised bone. Whether cell homing acts as an adjunctive or alternative approach of cell delivery for regeneration of tissues with different organisational complexity warrants further investigation.	[Lee, Chang H.; Mendelson, Avital; Moioli, Eduardo K.; Mao, Jeremy J.] Columbia Univ, Med Ctr, Tissue Engn & Regenerat Med Lab, New York, NY 10032 USA; [Cook, James L.] Univ Missouri, Coll Vet Med, Columbia, MO USA; [Cook, James L.] Univ Missouri, Sch Med, Comparat Orthopaed Lab, Columbia, MO USA; [Yao, Hai] Clemson Univ, Clemson, SC 29631 USA; [Yao, Hai] Med Univ S Carolina, Dept Bioengn, Charleston, SC 29425 USA	Columbia University; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Clemson University; Medical University of South Carolina	Mao, JJ (corresponding author), Columbia Univ, Med Ctr, Tissue Engn & Regenerat Med Lab, 630 W 168 St,PH7E, New York, NY 10032 USA.	jmao@columbia.edu		Cook, James/0000-0002-0862-995X; Mendelson, Avital/0000-0002-1120-9593	New York State Stem Cell Science; US National Institutes of Health [R01EB002332]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002332] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC2DE020767] Funding Source: NIH RePORTER	New York State Stem Cell Science; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a research grant from the New York State Stem Cell Science and US National Institutes of Health grant R01EB002332. We thank ICM staff at Columbia University Medical Center for veterinary assistance, and members of J J M laboratory for administrative and additional technical support. Synovium cells were a generous gift from Elena Jones of University of Leeds, UK.	Agrawal V, 2010, P NATL ACAD SCI USA, V107, P3351, DOI 10.1073/pnas.0905851106; Alhadlaq A, 2005, J BONE JOINT SURG AM, V87A, P936, DOI 10.2106/JBJS.D.02104; Almarza AJ, 2004, ANN BIOMED ENG, V32, P2, DOI 10.1023/B:ABME.0000007786.37957.65; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Boschetti F, 2008, BIORHEOLOGY, V45, P337, DOI 10.3233/BIR-2008-0479; Buckwalter JA, 2006, ADV DRUG DELIVER REV, V58, P150, DOI 10.1016/j.addr.2006.01.006; Chu CR, 2010, TISSUE ENG PART B-RE, V16, P105, DOI 10.1089/ten.TEB.2009.0452; Djouad F, 2005, ARTHRITIS RES THER, V7, pR1304, DOI 10.1186/ar1827; Erggelet C, 2009, J ORTHOP RES, V27, P1353, DOI 10.1002/jor.20879; Fodor William L, 2003, Reprod Biol Endocrinol, V1, P102, DOI 10.1186/1477-7827-1-102; Gao RZ, 2002, TISSUE ENG, V8, P827, DOI 10.1089/10763270260424187; GOLDBERG VM, 2004, ORTHOPEDIC TISSUE EN; Hunziker EB, 2001, OSTEOARTHR CARTILAGE, V9, P22, DOI 10.1053/joca.2000.0346; Jain RK, 2005, NAT BIOTECHNOL, V23, P821, DOI 10.1038/nbt0705-821; Jiang CC, 2007, J ORTHOP RES, V25, P1277, DOI 10.1002/jor.20442; Jones EA, 2008, ARTHRITIS RHEUM-US, V58, P1731, DOI 10.1002/art.23485; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Koga H, 2007, STEM CELLS, V25, P689, DOI 10.1634/stemcells.2006-0281; Laird DJ, 2008, CELL, V132, P612, DOI 10.1016/j.cell.2008.01.041; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Lee CH, 2009, TISSUE ENG PT A, V15, P3923, DOI 10.1089/ten.TEA.2008.0653; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109; Mao JJ, 2005, BIOL CELL, V97, P289, DOI 10.1042/BC20040100; Marion NW, 2006, METHOD ENZYMOL, V420, P339, DOI 10.1016/S0079-6879(06)20016-8; Moioli EK, 2007, WOUND REPAIR REGEN, V15, P413, DOI 10.1111/j.1524-475X.2007.00244.x; Moioli EK, 2006, TISSUE ENG, V12, P537, DOI 10.1089/ten.2006.12.537; Muschler GF, 2010, TISSUE ENG PART B-RE, V16, P123, DOI [10.1089/ten.teb.2009.0658, 10.1089/ten.TEB.2009.0658]; Noh MJ, 2010, CYTOTHERAPY, V12, P384, DOI 10.3109/14653240903470639; Park DK, 2009, J BONE JOINT SURG AM, V91A, P350, DOI 10.2106/JBJS.H.00302; PERRIN DE, 1997, HDB BIODEGRADABLE PO, P63; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Scotti C, 2010, P NATL ACAD SCI USA, V107, P7251, DOI 10.1073/pnas.1000302107; Si Y, 2010, J CLIN INVEST, V120, P1192, DOI 10.1172/JCI40310; Wood JJ, 2006, J BONE JOINT SURG AM, V88A, P503, DOI 10.2106/JBJS.E.00103; Woodfield TBF, 2009, CELL PROLIFERAT, V42, P485, DOI 10.1111/j.1365-2184.2009.00608.x; YANG R, PLOS ONE IN PRESS; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394	38	444	478	4	185	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2010	376	9739					440	448		10.1016/S0140-6736(10)60668-X	http://dx.doi.org/10.1016/S0140-6736(10)60668-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639YK	20692530	Green Accepted			2022-12-01	WOS:000281012900029
J	Birkmeyer, NJO; Dimick, JB; Share, D; Hawasli, A; English, WJ; Genaw, J; Finks, JF; Carlin, AM; Birkmeyer, JD				Birkmeyer, Nancy J. O.; Dimick, Justin B.; Share, David; Hawasli, Abdelkader; English, Wayne J.; Genaw, Jeffrey; Finks, Jonathan F.; Carlin, Arthur M.; Birkmeyer, John D.		Michigan Bariatric Surg Collaborat	Hospital Complication Rates With Bariatric Surgery in Michigan	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LAPAROSCOPIC GASTRIC BYPASS; MORBID-OBESITY; SURGICAL QUALITY; PROVIDER VOLUME; OUTCOMES; EXCELLENCE; CENTERS; PROGRAMS; PAYERS; IMPACT	Context Despite the growing popularity of bariatric surgery, there remain concerns about perioperative safety and variation in outcomes across hospitals. Objective To assess complication rates of different bariatric procedures and variability in rates of serious complications across hospitals and according to procedure volume and center of excellence (COE) status. Design, Setting, and Patients Involving 25 hospitals and 62 surgeons statewide, the Michigan Bariatric Surgery Collaborative (MBSC) administers an externally audited, prospective clinical registry. We evaluated short-term morbidity in 15 275 Michigan patients undergoing 1 of 3 common bariatric procedures between 2006 and 2009. We used multilevel regression models to assess variation in risk-adjusted complication rates across hospitals and the effects of procedure volume and COE designation (by the American College of Surgeons or American Society for Metabolic and Bariatric Surgery) status. Main Outcome Measure Complications occurring within 30 days of surgery. Results Overall, 7.3% of patients experienced perioperative complications, most of which were wound problems and other minor complications. Serious complications were most common after gastric bypass (3.6%; 95% confidence interval [CI], 3.2%-4.0%), followed by sleeve gastrectomy (2.2%; 95% CI, 1.2%-3.2%), and laparoscopic adjustable gastric band (0.9%; 95% CI, 0.6%-1.1%) procedures (P<.001). Mortality occurred in 0.04% (95% CI, 0.001%-0.13%) of laparoscopic adjustable gastric band, 0 sleeve gastrectomy, and 0.14% (95% CI, 0.08%-0.25%) of the gastric bypass patients. After adjustment for patient characteristics and procedure mix, rates of serious complications varied from 1.6% (95% CI, 1.3-2.0) to 3.5% (95% CI, 2.4-5.0) (risk difference, 1.9; 95% CI, 0.08-3.7) across hospitals. Average annual procedure volume was inversely associated with rates of serious complications at both the hospital level (<150 cases, 4.1%; 95% CI, 3.0%-5.1%; 150-299 cases, 2.7%; 95% CI, 2.2-3.2; and >= 300 cases, 2.3%; 95% CI, 2.0%-2.6%; P=.003) and surgeon level (<100 cases, 3.8%; 95% CI, 3.2%-4.5%; 100-249 cases, 2.4%; 95% CI, 2.1%-2.8%; >= 250 cases, 1.9%; 95% CI, 1.4%-2.3%; P=.001). Adjusted rates of serious complications were similar in COE and non-COE hospitals (COE, 2.7%; 95% CI, 2.5%-3.1%; non-COE, 2.0%; 95% CI, 1.5%-2.4%; P=.41). Conclusions The frequency of serious complications among patients undergoing bariatric surgery in Michigan was relatively low. Rates of serious complications are inversely associated with hospital and surgeon procedure volume, but unrelated to COE accreditation by professional organizations. JAMA. 2010; 304(4): 435-442	[Birkmeyer, Nancy J. O.] Univ Michigan, Dept Surg, Michigan Surg Collaborat Outcomes Res & Evaluat, Ann Arbor, MI 48104 USA; [Birkmeyer, Nancy J. O.; Dimick, Justin B.; Finks, Jonathan F.; Birkmeyer, John D.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48104 USA; [Share, David] Univ Michigan, Dept Family Med, Ann Arbor, MI 48104 USA; [Hawasli, Abdelkader] St John Hosp & Med Ctr, Dept Surg, Detroit, MI USA; [English, Wayne J.] Marquette Gen Hosp, Dept Surg, Marquette, MI USA; [Genaw, Jeffrey; Carlin, Arthur M.] Henry Ford Hosp, Dept Surg, Detroit, MI 48202 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; St. John Hospital & Medical Center; Henry Ford Health System; Henry Ford Hospital	Birkmeyer, NJO (corresponding author), Univ Michigan, Dept Surg, Michigan Surg Collaborat Outcomes Res & Evaluat, 211 N 4th Ave,Ste 2A & 2B, Ann Arbor, MI 48104 USA.	nbirkmey@umich.edu			Blue Cross and Blue Shield of Michigan; Blue Care Network; Agency for Healthcare Research and Quality [1R01HS018050, 1R01HS018728]; National Institute of Diabetes and Digestive and Kidney Diseases [1R21DK084397]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018050, R01HS018728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK084397] Funding Source: NIH RePORTER	Blue Cross and Blue Shield of Michigan; Blue Care Network; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Michigan Bariatric Surgery Collaborative is funded by an unrestricted longitudinal research contract from Blue Cross and Blue Shield of Michigan and Blue Care Network. Drs N. Birkmeyer and Dimick also receive support for research related to the Michigan Bariatric Surgery Collaborative from the Agency for Healthcare Research and Quality (1R01HS018050 and 1R01HS018728) and the National Institute of Diabetes and Digestive and Kidney Diseases (1R21DK084397).	Biertho L, 2003, J AM COLL SURGEONS, V197, P536, DOI 10.1016/S1072-7515(03)00730-0; Birkmeyer NJO, 2006, NEW ENGL J MED, V354, P864, DOI 10.1056/NEJMsb053364; Birkmeyer NJO, 2005, SURGERY, V138, P815, DOI 10.1016/j.surg.2005.06.037; Cottam DR, 2006, OBES SURG, V16, P534, DOI 10.1381/096089206776944913; Courcoulas A, 2003, SURGERY, V134, P613, DOI 10.1016/S0039-6060(03)00306-4; Encinosa WE, 2009, MED CARE, V47, P531, DOI 10.1097/MLR.0b013e31819434c6; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Flum DR, 2004, J AM COLL SURGEONS, V199, P543, DOI 10.1016/j.jamcollsurg.2004.06.014; Hofer TP, 1999, JAMA-J AM MED ASSOC, V281, P2098, DOI 10.1001/jama.281.22.2098; Jan JC, 2005, J GASTROINTEST SURG, V9, P30, DOI 10.1016/j.gassur.2004.09.043; Kim TH, 2006, SURG ENDOSC, V20, P202, DOI 10.1007/s00464-005-0243-1; Latts L, 2010, ARCH SURG-CHICAGO, V145, P106, DOI 10.1001/archsurg.2009.256; Liu JH, 2003, AM SURGEON, V69, P823; Livingston EH, 2009, ARCH SURG-CHICAGO, V144, P319, DOI 10.1001/archsurg.2009.23; Murr MM, 2007, ANN SURG, V245, P699, DOI 10.1097/01.sla.0000256392.04141.04; Nguyen NT, 2004, ANN SURG, V240, P586, DOI 10.1097/01.sla.0000140752.74893.24; Pratt GM, 2010, ARCH SURG-CHICAGO, V145, P105, DOI 10.1001/archsurg.2009.254; Santry HP, 2005, JAMA-J AM MED ASSOC, V294, P1909, DOI 10.1001/jama.294.15.1909; Shikora SA, 2010, ARCH SURG-CHICAGO, V145, P105, DOI 10.1001/archsurg.2009.255; te Riele WW, 2008, OBES SURG, V18, P11, DOI 10.1007/s11695-007-9254-4; Tice JA, 2008, AM J MED, V121, P885, DOI 10.1016/j.amjmed.2008.05.036; Weber M, 2004, ANN SURG, V240, P975, DOI 10.1097/01.sla.0000145924.64932.8f; Weller WE, 2006, J AM COLL SURGEONS, V202, P753, DOI 10.1016/j.jamcollsurg.2006.02.002; Zingmond DS, 2005, JAMA-J AM MED ASSOC, V294, P1918, DOI 10.1001/jama.294.15.1918	24	290	294	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2010	304	4					435	442		10.1001/jama.2010.1034	http://dx.doi.org/10.1001/jama.2010.1034			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631MA	20664044	Bronze			2022-12-01	WOS:000280350100027
J	Fulzele, K; Riddle, RC; DiGirolamo, DJ; Cao, XM; Wan, C; Chen, DQ; Faugere, MC; Aja, S; Hussain, MA; Bruning, JC; Clemens, TL				Fulzele, Keertik; Riddle, Ryan C.; DiGirolamo, Douglas J.; Cao, Xuemei; Wan, Chao; Chen, Dongquan; Faugere, Marie-Claude; Aja, Susan; Hussain, Mehboob A.; Bruening, Jens C.; Clemens, Thomas L.			Insulin Receptor Signaling in Osteoblasts Regulates Postnatal Bone Acquisition and Body Composition	CELL			English	Article							TRANSCRIPTION FACTOR FOXO1; BETA-CELL FUNCTION; DIABETES-MELLITUS; COLLAGEN-SYNTHESIS; GLUCOSE-TOLERANCE; ENERGY-METABOLISM; RAT BONE; BB RATS; OSTEOCALCIN; GROWTH	Global energy balance in mammals is controlled by the actions of circulating hormones that coordinate fuel production and utilization in metabolically active tissues. Bone-derived osteocalcin, in its undercarboxylated, hormonal form, regulates fat deposition and is a potent insulin secretagogue. Here, we show that insulin receptor (IR) signaling in osteoblasts controls osteoblast development and osteocalcin expression by suppressing the Runx2 inhibitor Twist2. Mice lacking IR in osteoblasts have low circulating undercarboxylated osteocalcin and reduced bone acquisition due to decreased bone formation and deficient numbers of osteoblasts. With age, these mice develop marked peripheral adiposity and hyperglycemia accompanied by severe glucose intolerance and insulin resistance. The metabolic abnormalities in these mice are improved by infusion of undercarboxylated osteocalcin. These results indicate the existence of a bone-pancreas endocrine loop through which insulin signaling in the osteoblast ensures osteoblast differentiation and stimulates osteocalcin production, which in turn regulates insulin sensitivity and pancreatic insulin secretion.	[Fulzele, Keertik; Riddle, Ryan C.; DiGirolamo, Douglas J.; Wan, Chao; Clemens, Thomas L.] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21205 USA; [Aja, Susan] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Aja, Susan] Johns Hopkins Univ, Sch Med, Ctr Metab & Obes Res, Baltimore, MD 21205 USA; [Hussain, Mehboob A.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Hussain, Mehboob A.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Hussain, Mehboob A.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Faugere, Marie-Claude] Univ Kentucky, Dept Med, Lexington, KY 40536 USA; [Cao, Xuemei] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA; [Chen, Dongquan] W Virginia Univ, Sch Med, Dept Med, Clin Translat Sci Inst, Morgantown, WV 26506 USA; [Bruening, Jens C.] Univ Cologne, Cologne Excellence Ctr Cellular Stress Responses, Ctr Mol Med, Inst Genet,Dept Mouse Genet & Metab, D-50937 Cologne, Germany; [Bruening, Jens C.] Univ Hosp Cologne, Dept Internal Med, D-50937 Cologne, Germany; [Bruening, Jens C.] Max Planck Inst Biol Aging, D-50937 Cologne, Germany; [Clemens, Thomas L.] Vet Adm Med Ctr, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Kentucky; University of Alabama System; University of Alabama Birmingham; West Virginia University; University of Cologne; University of Cologne; Max Planck Society; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Clemens, TL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21205 USA.	tclemen5@jhmi.edu	Wan, Chao/J-9277-2013	Wan, Chao/0000-0001-6780-2006	Veterans Administration; NIH [DK081472]; Baltimore Diabetes Research and Training Center [DK079637]; DFG [Br1492/7-1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081472, P60DK079637, P30DK079637] Funding Source: NIH RePORTER	Veterans Administration(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baltimore Diabetes Research and Training Center; DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful for the assistance of the Small Animal Phenotyping Core and Metabolism Core Laboratory at the University of Alabama at Birmingham. We thank Dr. D. Accili for providing the tTR-IRKO mice and Dr. M. Bouxsein for assistance in analyzing the skeletal phenotype by micro-CT. We also thank Drs. T. Nagy and T. Garvey for helpful suggestions during the completion of this work. Support was provided by a Merit Review Grant from the Veterans Administration (T. L. C.) and grants from the NIH (M. H., DK081472), the Baltimore Diabetes Research and Training Center (M. H., DK079637), and DFG (J.C.B., Br1492/7-1). T. L. C. is also the recipient of a Research Career Scientist Award from the Veterans Administration.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; DELMAS PD, 1983, J CLIN ENDOCR METAB, V57, P1028, DOI 10.1210/jcem-57-5-1028; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Ferron M, 2008, P NATL ACAD SCI USA, V105, P5266, DOI 10.1073/pnas.0711119105; Fukumoto S, 2009, TRENDS ENDOCRIN MET, V20, P230, DOI 10.1016/j.tem.2009.02.001; Fulzele K, 2007, J BIOL CHEM, V282, P25649, DOI 10.1074/jbc.M700651200; Gandhi A, 2005, BONE, V37, P482, DOI 10.1016/j.bone.2005.04.039; GOODMAN WG, 1984, DIABETES, V33, P825, DOI 10.2337/diabetes.33.9.825; Herrero S, 1998, CALCIFIED TISSUE INT, V62, P260, DOI 10.1007/s002239900427; Hinoi E, 2008, J CELL BIOL, V183, P1235, DOI 10.1083/jcb.200809113; Hussain MA, 2006, MOL CELL BIOL, V26, P7747, DOI 10.1128/MCB.02353-05; Hwang YC, 2009, DIABETES-METAB RES, V25, P768, DOI 10.1002/dmrr.1045; Irwin R, 2006, ENDOCRINOLOGY, V147, P5760, DOI 10.1210/en.2006-0700; ITUARTE EA, 1989, CALCIFIED TISSUE INT, V45, P27, DOI 10.1007/BF02556657; Janghorbani M, 2006, DIABETES CARE, V29, P1573, DOI 10.2337/dc06-0440; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Kemink SAG, 2000, J ENDOCRINOL INVEST, V23, P295, DOI 10.1007/BF03343726; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; KREAM BE, 1985, ENDOCRINOLOGY, V116, P296, DOI 10.1210/endo-116-1-296; Lee NK, 2008, TRENDS ENDOCRIN MET, V19, P161, DOI 10.1016/j.tem.2008.02.006; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; LODER RT, 1988, CLIN ORTHOP RELAT R, P210; Lusk G, 1928, ELEMENTS SCI NUTR; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nicodemus KK, 2001, DIABETES CARE, V24, P1192, DOI 10.2337/diacare.24.7.1192; Okamoto H, 2004, J CLIN INVEST, V114, P214, DOI 10.1172/JCI200421645; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pittas AG, 2009, J CLIN ENDOCR METAB, V94, P827, DOI 10.1210/jc.2008-1422; PUN KK, 1989, J BONE MINER RES, V4, P853; Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901; ROSEN DM, 1983, ENDOCRINOLOGY, V112, P992, DOI 10.1210/endo-112-3-992; SHIRES R, 1981, J LAB CLIN MED, V97, P231; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Thrailkill K M, 2000, Diabetes Technol Ther, V2, P69, DOI 10.1089/152091599316775; VERHAEGHE J, 1992, J ENDOCRINOL, V134, P485, DOI 10.1677/joe.0.1340485; VERHAEGHE J, 1990, DIABETES, V39, P477, DOI 10.2337/diabetes.39.4.477; WEINREB M, 1990, J BONE MINER RES, V5, P831; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200	43	525	559	2	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					309	319		10.1016/j.cell.2010.06.002	http://dx.doi.org/10.1016/j.cell.2010.06.002			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655471	Bronze, Green Accepted			2022-12-01	WOS:000280204300021
J	Minamishima, YA; Kaelin, WG				Minamishima, Yoji Andrew; Kaelin, William G., Jr.			Reactivation of Hepatic EPO Synthesis in Mice After PHD Loss	SCIENCE			English	Article							INACTIVATION; ERYTHROPOIESIS; FAILURE		[Kaelin, William G., Jr.] Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital	Kaelin, WG (corresponding author), Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA.	william_kaelin@dfci.harvard.edu	Minamishima, Yoji Andrew/E-5380-2010	Minamishima, Yoji Andrew/0000-0001-7995-9318	NATIONAL CANCER INSTITUTE [R01CA068490] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA068490] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bohlius J, 2009, LANCET, V373, P1532, DOI 10.1016/S0140-6736(09)60502-X; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kim WY, 2006, EMBO J, V25, P4650, DOI 10.1038/sj.emboj.7601300; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Minamishima YA, 2009, MOL CELL BIOL, V29, P5729, DOI 10.1128/MCB.00331-09; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561	8	131	137	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					407	407		10.1126/science.1192811	http://dx.doi.org/10.1126/science.1192811			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651146	Green Accepted			2022-12-01	WOS:000280196500028
J	Cantin, NE; Cohen, AL; Karnauskas, KB; Tarrant, AM; McCorkle, DC				Cantin, Neal E.; Cohen, Anne L.; Karnauskas, Kristopher B.; Tarrant, Ann M.; McCorkle, Daniel C.			Ocean Warming Slows Coral Growth in the Central Red Sea	SCIENCE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; TEMPERATURE; CALCIFICATION; MECHANISM; PHOTOSYNTHESIS; PORITES; RATES	Sea surface temperature (SST) across much of the tropics has increased by 0.4 degrees to 1 degrees C since the mid-1970s. A parallel increase in the frequency and extent of coral bleaching and mortality has fueled concern that climate change poses a major threat to the survival of coral reef ecosystems worldwide. Here we show that steadily rising SSTs, not ocean acidification, are already driving dramatic changes in the growth of an important reef-building coral in the central Red Sea. Three-dimensional computed tomography analyses of the massive coral Diploastrea heliopora reveal that skeletal growth of apparently healthy colonies has declined by 30% since 1998. The same corals responded to a short-lived warm event in 1941/1942, but recovered within 3 years as the ocean cooled. Combining our data with climate model simulations by the Intergovernmental Panel on Climate Change, we predict that should the current warming trend continue, this coral could cease growing altogether by 2070.	[Cantin, Neal E.; Cohen, Anne L.; Karnauskas, Kristopher B.; Tarrant, Ann M.; McCorkle, Daniel C.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Cantin, NE (corresponding author), Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA.		Tarrant, Ann/AAU-8263-2021	Tarrant, Ann/0000-0002-1909-7899	KAUST [USA 00002/KSA 00011]	KAUST(King Abdullah University of Science & Technology)	The authors thank G. P. Lohmann, C. Saenger, M. X. Weber, and A. Venti for their assistance with fieldwork. A. Al Suwailem; Y. Kattan; H. Al Jahdali; W. Moazen; Nageeb from King Abdullah University of Science and Technology (KAUST); and E. Mason, R. Maravilla, and the staff at Dream Divers provided logistical support in Saudi Arabia. D. Ketten and J. Arruda provided invaluable technical support and advice for the CAT scanning of our coral cores. Comments from D. Oppo and two anonymous reviewers helped to improve the original manuscript. This research was funded by award no. USA 00002/KSA 00011 from KAUST to A.L.C. and D.C.M.	Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; BURTON EA, 1987, GEOLOGY, V15, P111, DOI 10.1130/0091-7613(1987)15<111:RPROAA>2.0.CO;2; Clement AC, 2010, NAT GEOSCI, V3, P8, DOI 10.1038/ngeo728; Cohen AL, 2003, REV MINERAL GEOCHEM, V54, P151, DOI 10.2113/0540151; Cooper TF, 2008, GLOBAL CHANGE BIOL, V14, P529, DOI 10.1111/j.1365-2486.2007.01520.x; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; Devantier L, 2000, STATUS CORAL REEFS S; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Fitt WK, 2009, J EXP MAR BIOL ECOL, V373, P102, DOI 10.1016/j.jembe.2009.03.011; Furla P, 2000, J EXP BIOL, V203, P3445; GLEESON MW, 1995, ADV SPACE RES, V16, P151, DOI 10.1016/0273-1177(95)00396-V; Hart DE, 2007, CORAL REEFS, V26, P53, DOI 10.1007/s00338-006-0168-8; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kleypas JA, 2006, CORAL REEFS CLIMATE, V61, P73, DOI DOI 10.1029/61CE06; Kleypas JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032257; Liu G., 2003, EOS, V84, P137, DOI [10.1029/2003EO150001, DOI 10.1029/2003E0150001]; Lough JM, 2000, J EXP MAR BIOL ECOL, V245, P225, DOI 10.1016/S0022-0981(99)00168-9; Marshall AT, 2004, CORAL REEFS, V23, P218, DOI 10.1007/s00338-004-0369-y; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Saenger C, 2009, NAT GEOSCI, V2, P492, DOI 10.1038/ngeo552; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1	28	315	324	36	572	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					322	325		10.1126/science.1190182	http://dx.doi.org/10.1126/science.1190182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647466				2022-12-01	WOS:000279925900041
J	Cao, L; Liu, XL; Lin, EJD; Wang, CS; Choi, EY; Riban, V; Lin, B; During, MJ				Cao, Lei; Liu, Xianglan; Lin, En-Ju D.; Wang, Chuansong; Choi, Eugene Y.; Riban, Veronique; Lin, Benjamin; During, Matthew J.			Environmental and Genetic Activation of a Brain-Adipocyte BDNF/Leptin Axis Causes Cancer Remission and Inhibition	CELL			English	Article							NEUROTROPHIC FACTOR; STRESS; LEPTIN; EXERCISE; OBESITY; BDNF; HYPOTHALAMUS; ADAPTATION; PLASTICITY; ENRICHMENT	Cancer is influenced by its microenvironment, yet broader, environmental effects also play a role but remain poorly defined. We report here that mice living in an enriched housing environment show reduced tumor growth and increased remission. We found this effect in melanoma and colon cancer models, and that it was not caused by physical activity alone. Serum from animals held in an enriched environment (EE) inhibited cancer proliferation in vitro and was markedly lower in leptin. Hypothalamic brain-derived neurotrophic factor (BDNF) was selectively upregulated by EE, and its genetic overexpression reduced tumor burden, whereas BDNF knockdown blocked the effect of EE. Mechanistically, we show that hypothalamic BDNF downregulated leptin production in adipocytes via sympathoneural beta-adrenergic signaling. These results suggest that genetic or environmental activation of this BDNF/leptin axis may have therapeutic significance for cancer.	[Cao, Lei; Liu, Xianglan; Lin, En-Ju D.; Wang, Chuansong; Choi, Eugene Y.; Riban, Veronique; During, Matthew J.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Cao, Lei; Liu, Xianglan; Lin, En-Ju D.; Wang, Chuansong; Choi, Eugene Y.; Riban, Veronique; During, Matthew J.] Ohio State Univ, Dept Neurosci & Neurol Surg, Columbus, OH 43210 USA; [Cao, Lei; Liu, Xianglan; Lin, En-Ju D.; Wang, Chuansong; Choi, Eugene Y.; Riban, Veronique; During, Matthew J.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Cao, Lei; Lin, Benjamin; During, Matthew J.] Cornell Univ, Weill Med Coll, Dept Neurol Surg, New York, NY 10021 USA; [During, Matthew J.] Univ Auckland, Ctr Brain Res, Dept Mol Med & Pathol, Fac Med & Hlth Sci, Auckland 1023, New Zealand	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Cornell University; University of Auckland	Cao, L (corresponding author), Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	cao.76@osu.edu; during.1@osu.edu	During, Matthew/E-3003-2011; During, Matthew/AAC-1388-2020; Cao, Lei/H-3185-2019; Cao, Lei/E-2841-2011	During, Matthew/0000-0002-3797-5026; Cao, Lei/0000-0003-0322-4985	National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. F. Lee of Weill Medical College of Cornell University for providing the BDNF<SUP>+/-</SUP> mice and Professors C. Croce, J. Groden, and M. Caligiuri for helpful comments and discussion on the manuscript. We appreciate the technical assistance of Michael Cahill and Adam Martin. This work was supported in part by the National Institutes of Health.	AARONSON SA, 1991, SCIENCE, V254, P1146, DOI 10.1126/science.1659742; [Anonymous], 2008, ANN ONCOL, V19, P384, DOI 10.1093/annonc/mdm464; Barb D, 2007, AM J CLIN NUTR, V86, p858S, DOI 10.1093/ajcn/86.3.858S; Bariohay B, 2005, ENDOCRINOLOGY, V146, P5612, DOI 10.1210/en.2005-0419; Bartness TJ, 2007, PHYSIOL BEHAV, V91, P343, DOI 10.1016/j.physbeh.2007.04.002; Benaroya-Milshtein N, 2004, EUR J NEUROSCI, V20, P1341, DOI 10.1111/j.1460-9568.2004.03587.x; Brandon EL, 2009, CANCER BIOL THER, V8, P1871, DOI 10.4161/cbt.8.19.9650; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Cao L, 2009, NAT MED, V15, P447, DOI 10.1038/nm.1933; Cirillo D, 2008, J CELL BIOCHEM, V105, P956, DOI 10.1002/jcb.21911; Darnell RB, 2006, SEMIN ONCOL, V33, P270, DOI 10.1053/j.seminoncol.2006.03.008; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillo WS, 2007, THYROID, V17, P433, DOI 10.1089/thy.2007.0018; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Evans BA, 1999, FEBS LETT, V444, P149, DOI 10.1016/S0014-5793(99)00049-6; Fujisawa T, 2008, GUT, V57, P1531, DOI 10.1136/gut.2008.159293; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Hahn S, 2006, EUR J ENDOCRINOL, V154, P287, DOI 10.1530/eje.1.02078; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HUGHES P, 1993, NEUROSCIENCE, V57, P319, DOI 10.1016/0306-4522(93)90065-N; Jenkins PJ, 2004, EUR J ENDOCRINOL, V151, pS17, DOI 10.1530/eje.0.151S017; Jonsdottir IH, 2000, INT J SPORTS MED, V21, pS20; Larsson F, 2002, PHARMACOL BIOCHEM BE, V73, P193, DOI 10.1016/S0091-3057(02)00782-7; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Lu YP, 2006, P NATL ACAD SCI USA, V103, P16301, DOI 10.1073/pnas.0607789103; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; McDougall SJ, 2005, AUTON NEUROSCI-BASIC, V123, P1, DOI 10.1016/j.autneu.2005.09.005; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Mehl KA, 2005, J APPL PHYSIOL, V98, P2219, DOI 10.1152/japplphysiol.00975.2004; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; MILSUM JH, 1985, BEHAV SCI, V30, P179, DOI 10.1002/bs.3830300402; Naert G, 2006, NEUROSCIENCE, V139, P779, DOI 10.1016/j.neuroscience.2005.12.028; Nagatomi R, 2006, EXERC IMMUNOL REV, V12, P54; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; PELLEYMOUNTER MA, 1995, EXP NEUROL, V131, P229, DOI 10.1016/0014-4886(95)90045-4; Rage F, 2002, NEUROSCIENCE, V112, P309, DOI 10.1016/S0306-4522(02)00072-6; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Selye H, 1974, STRESS DISTRESS; Sterling P., 1988, HDB LIFE STRESS COGN, P629, DOI DOI 10.1016/0005-7967(90)90076-U; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Suzuki K, 2005, EUR J APPL PHYSIOL, V94, P514, DOI 10.1007/s00421-005-1378-4; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wauters M, 2000, EUR J ENDOCRINOL, V143, P293, DOI 10.1530/eje.0.1430293; Wisse BE, 2003, NAT NEUROSCI, V6, P655, DOI 10.1038/nn0703-655; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449	49	230	239	2	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2010	142	1					52	64		10.1016/j.cell.2010.05.029	http://dx.doi.org/10.1016/j.cell.2010.05.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603014	Bronze, Green Accepted			2022-12-01	WOS:000279637300012
J	Jaenike, J; Unckless, R; Cockburn, SN; Boelio, LM; Perlman, SJ				Jaenike, John; Unckless, Robert; Cockburn, Sarah N.; Boelio, Lisa M.; Perlman, Steve J.			Adaptation via Symbiosis: Recent Spread of a Drosophila Defensive Symbiont	SCIENCE			English	Article							MYCOPHAGOUS DROSOPHILA; IMMUNE-SYSTEM; EVOLUTION; WOLBACHIA; NEMATODE; HOST; ASSOCIATIONS; ENDOSYMBIONT; SPIROPLASMA; PROTECTION	Recent studies have shown that some plants and animals harbor microbial symbionts that protect them against natural enemies. Here we demonstrate that a maternally transmitted bacterium, Spiroplasma, protects Drosophila neotestacea against the sterilizing effects of a parasitic nematode, both in the laboratory and the field. This nematode parasitizes D. neotestacea at high frequencies in natural populations, and, until recently, almost all infections resulted in complete sterility. Several lines of evidence suggest that Spiroplasma is spreading in North American populations of D. neotestacea and that a major adaptive change to a symbiont-based mode of defense is under way. These findings demonstrate the profound and potentially rapid effects of defensive symbionts, which are increasingly recognized as major players in the ecology of species interactions.	[Jaenike, John; Unckless, Robert; Boelio, Lisa M.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Cockburn, Sarah N.; Perlman, Steve J.] Univ Victoria, Dept Biol, Victoria, BC V8W 3N5, Canada	University of Rochester; University of Victoria	Jaenike, J (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	john.jaenike@rochester.edu			NSF [DEB-0542094, DEB-0918872]; Natural Sciences and Engineering Research Council of Canada; Direct For Biological Sciences [0918872] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF grants DEB-0542094 and DEB-0918872 to J.J. and a Natural Sciences and Engineering Research Council of Canada Discovery Grant to S.J.P. S.J.P. is a Scholar in the Canadian Institute for Advanced Research. We thank C. Cornish, P. Gibas, and K. Dyer for collecting some of the North American D. neotestacea used in this study; A. Marshall and L. Harris for technical assistance; N. Polet for the cloning work; D. Grimaldi for providing museum specimens of D. neotestacea; and J. Coyne, R. Minckley, K. Oliver, and D. Presgraves for comments on the manuscript. Sequences have been deposited in GenBank under accession numbers GU552299 to GU552304, HM126644 to HM126667, and HM133591 to HM133593.	Allen JE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000217; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Bird DM, 2009, ANNU REV PHYTOPATHOL, V47, P333, DOI 10.1146/annurev-phyto-080508-081839; Dobson A, 2008, P NATL ACAD SCI USA, V105, P11482, DOI 10.1073/pnas.0803232105; Dyer KA, 2005, EVOLUTION, V59, P1518; Dyer KA, 2004, GENETICS, V168, P1443, DOI 10.1534/genetics.104.027854; Flainik MF, 2004, TRENDS IMMUNOL, V25, P640, DOI 10.1016/j.it.2004.10.001; GILTURNES MS, 1989, SCIENCE, V246, P116, DOI 10.1126/science.2781297; Haselkorn TS, 2009, MOL ECOL, V18, P1294, DOI 10.1111/j.1365-294X.2009.04085.x; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hughes AL, 1997, MOL BIOL EVOL, V14, P1, DOI 10.1093/oxfordjournals.molbev.a025694; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Jaenike J, 1996, EVOLUTION, V50, P2241, DOI [10.1111/j.1558-5646.1996.tb03613.x, 10.2307/2410694]; Jaenike J, 2002, ECOLOGY, V83, P917, DOI 10.2307/3071901; Jaenike J, 2002, AM NAT, V160, pS23, DOI 10.1086/342137; Jaenike J, 2010, MOL ECOL, V19, P414, DOI 10.1111/j.1365-294X.2009.04448.x; Johnstone RA, 1996, BIOL J LINN SOC, V58, P453, DOI 10.1111/j.1095-8312.1996.tb01446.x; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; Mateos M, 2006, GENETICS, V174, P363, DOI 10.1534/genetics.106.058818; MONTAGUE JR, 1985, ECOLOGY, V66, P624, DOI 10.2307/1940412; NICKLE W.R., 1974, INSECT DISEASES, VII, P327; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Parkinson J, 2004, NAT GENET, V36, P1259, DOI 10.1038/ng1472; Perlman SJ, 2003, EVOLUTION, V57, P1543, DOI 10.1111/j.0014-3820.2003.tb00362.x; Perlman SJ, 2003, MOL ECOL, V12, P237, DOI 10.1046/j.1365-294X.2003.01721.x; Poinar GO., 1983, NATURAL HIST NEMATOD; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Regassa LB, 2006, FRONT BIOSCI-LANDMRK, V11, P2983, DOI 10.2741/2027; Rosenstiel P, 2009, J INNATE IMMUN, V1, P291, DOI 10.1159/000211193; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; WILLIAMSON DL, 1965, J INVERTEBR PATHOL, V7, P493, DOI 10.1016/0022-2011(65)90126-6	36	358	370	2	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988					212	215		10.1126/science.1188235	http://dx.doi.org/10.1126/science.1188235			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616278				2022-12-01	WOS:000279635200048
J	Surolia, I; Pirnie, SP; Chellappa, V; Taylor, KN; Cariappa, A; Moya, J; Liu, H; Bell, DW; Driscoll, DR; Diederichs, S; Haider, K; Netravali, I; Le, S; Elia, R; Dow, E; Lee, A; Freudenberg, J; De Jager, PL; Chretien, Y; Varki, A; MacDonald, ME; Gillis, T; Behrens, TW; Bloch, D; Collier, D; Korzenik, J; Podolsky, DK; Hafler, D; Murali, M; Sands, B; Stone, JH; Gregersen, PK; Pillai, S				Surolia, Ira; Pirnie, Stephan P.; Chellappa, Vasant; Taylor, Kendra N.; Cariappa, Annaiah; Moya, Jesse; Liu, Haoyuan; Bell, Daphne W.; Driscoll, David R.; Diederichs, Sven; Haider, Khaleda; Netravali, Ilka; Le, Sheila; Elia, Roberto; Dow, Ethan; Lee, Annette; Freudenberg, Jan; De Jager, Philip L.; Chretien, Yves; Varki, Ajit; MacDonald, Marcy E.; Gillis, Tammy; Behrens, Timothy W.; Bloch, Donald; Collier, Deborah; Korzenik, Joshua; Podolsky, Daniel K.; Hafler, David; Murali, Mandakolathur; Sands, Bruce; Stone, John H.; Gregersen, Peter K.; Pillai, Shiv			Functionally defective germline variants of sialic acid acetylesterase in autoimmunity	NATURE			English	Article							MUTATIONS; DISEASE; MARKER	Sialic acid acetylesterase (SIAE) is an enzyme that negatively regulates B lymphocyte antigen receptor signalling and is required for the maintenance of immunological tolerance in mice(1,2). Heterozygous loss-of-function germline rare variants and a homozygous defective polymorphic variant of SIAE were identified in 24/923 subjects of European origin with relatively common autoimmune disorders and in 2/648 controls of European origin. All heterozygous loss-of-function SIAE mutations tested were capable of functioning in a dominant negative manner. Ahomozygous secretion-defective polymorphic variant of SIAE was catalytically active, lacked the ability to function in a dominant negative manner, and was seen in eight autoimmune subjects but in no control subjects. The odds ratio for inheriting defective SIAE alleles was 8.6 in all autoimmune subjects, 8.3 in subjects with rheumatoid arthritis, and 7.9 in subjects with type I diabetes. Functionally defective SIAE rare and polymorphic variants represent a strong genetic link to susceptibility in relatively common human autoimmune disorders.	[Surolia, Ira; Pirnie, Stephan P.; Chellappa, Vasant; Taylor, Kendra N.; Cariappa, Annaiah; Moya, Jesse; Liu, Haoyuan; Bell, Daphne W.; Driscoll, David R.; Diederichs, Sven; Haider, Khaleda; Netravali, Ilka; Le, Sheila; Elia, Roberto; Dow, Ethan; Pillai, Shiv] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA; [Lee, Annette; Freudenberg, Jan; Gregersen, Peter K.] N Shore LIJ Hlth Syst, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [De Jager, Philip L.; Hafler, David] Brigham & Womens Hosp, Ctr Neurol Dis, Div Mol Immunol, Boston, MA 02115 USA; [De Jager, Philip L.; Hafler, David] Partners Ctr Personalized Genet Med, Boston, MA 02115 USA; [De Jager, Philip L.; Hafler, David] Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [De Jager, Philip L.; Hafler, David] MIT, Cambridge, MA 02142 USA; [Chretien, Yves] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; [Varki, Ajit] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Varki, Ajit] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [MacDonald, Marcy E.; Gillis, Tammy] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02114 USA; [Behrens, Timothy W.] Genentech Inc, San Francisco, CA 94080 USA; [Bloch, Donald; Collier, Deborah; Stone, John H.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Rheumatol, Boston, MA 02114 USA; [Korzenik, Joshua; Podolsky, Daniel K.; Sands, Bruce] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Murali, Mandakolathur] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Clin Immunol Lab, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Northwell Health; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Massachusetts General Hospital; Roche Holding; Genentech; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Pillai, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA.	pillai@helix.mgh.harvard.edu	Sands, Bruce/R-7887-2019; Diederichs, Sven/J-6237-2012	Sands, Bruce/0000-0001-5762-5042; Diederichs, Sven/0000-0001-7901-4752; Bloch, Donald/0000-0002-6828-4754	Alliance for Lupus Research; Center for the Study of Inflammatory Bowel Disease at MGH; NIH [AI 064930, AI 076505, AR 058481, NS 32765]; NIH for NARAC [AR 044422, AR 022263]; MADGC [AI 068759]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200338] Funding Source: NIH RePORTER	Alliance for Lupus Research; Center for the Study of Inflammatory Bowel Disease at MGH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH for NARAC; MADGC; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank M. Cohen for coordinating the recall of inflammatory bowel disease patients, and K. Pedrick and E. Chung for their contributions. These studies were supported by grants from the Alliance for Lupus Research, the Center for the Study of Inflammatory Bowel Disease at MGH, and the NIH (AI 064930, AI 076505, and AR 058481) to S. P. and a grant to M.E.M. (NS 32765). P.K.G. acknowledges NIH support for NARAC (AR 044422 and AR 022263) and MADGC (AI 068759). The NIDDK is acknowledged for making samples available from the EDIC collection of its DNA repository. D. W. B. acknowledges the Intramural program of the National Human Genome Research Institute at NIH.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Bell DW, 1999, CANCER RES, V59, P3883; Cariappa A, 2009, J EXP MED, V206, P125, DOI 10.1084/jem.20081399; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Gregersen PK, 2006, NAT REV GENET, V7, P917, DOI 10.1038/nrg1944; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Jessani N, 2005, ANGEW CHEM INT EDIT, V44, P2400, DOI 10.1002/anie.200463098; Krishna M, 1997, J EXP MED, V185, P1997, DOI 10.1084/jem.185.11.1997; Kwak EL, 2006, CLIN CANCER RES, V12, P4283, DOI 10.1158/1078-0432.CCR-06-0189; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Nassir R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-39; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Pillai S, 2009, TRENDS IMMUNOL, V30, P488, DOI 10.1016/j.it.2009.07.006; SHUKLA AK, 1982, H-S Z PHYSIOL CHEM, V363, P255, DOI 10.1515/bchm2.1982.363.1.255; Tian C, 2009, MOL MED, V15, P371, DOI 10.2119/molmed.2009.00094; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	16	129	134	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					243	U118		10.1038/nature09115	http://dx.doi.org/10.1038/nature09115			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20555325	Green Accepted			2022-12-01	WOS:000279580800038
J	Haga, S; Hattori, T; Sato, T; Sato, K; Matsuda, S; Kobayakawa, R; Sakano, H; Yoshihara, Y; Kikusui, T; Touhara, K				Haga, Sachiko; Hattori, Tatsuya; Sato, Toru; Sato, Koji; Matsuda, Soichiro; Kobayakawa, Reiko; Sakano, Hitoshi; Yoshihara, Yoshihiro; Kikusui, Takefumi; Touhara, Kazushige			The male mouse pheromone ESP1 enhances female sexual receptive behaviour through a specific vomeronasal receptor	NATURE			English	Article							GENES; ORGANIZATION; EXPRESSION; NUCLEUS; NEURONS; CONVERGENCE; PROJECTIONS; PATHWAYS; FAMILIES; PEPTIDE	Various social behaviours in mice are regulated by chemical signals called pheromones that act through the vomeronasal system(1-3). Exocrine gland-secreting peptide 1 (ESP1) is a 7-kDa peptide that is released intomale tear fluids and stimulates vomeronasal sensory neurons in female mice(4). Here, we describe the molecular and neural mechanisms that are involved in the decoding of ESP1 signals in the vomeronasal system, which leads to behavioural output in female mice. ESP1 is recognized by a specific vomeronasal receptor, V2Rp5, and the ligand-receptor interaction results in sex-specific signal transmission to the amygdaloid and hypothalamic nuclei via the accessory olfactory bulb. Consequently, ESP1 enhances female sexual receptive behaviour upon male mounting (lordosis), allowing successful copulation. In V2Rp5-deficient mice, ESP1 induces neither neural activation nor sexual behaviour. These findings show that ESP1 is a crucial male pheromone that regulates female reproductive behaviour through a specific receptor in the mouse vomeronasal system.	[Haga, Sachiko; Sato, Toru; Sato, Koji; Matsuda, Soichiro; Touhara, Kazushige] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Hattori, Tatsuya; Kikusui, Takefumi] Azabu Univ, Sch Vet Med, Kanagawa 2298501, Japan; [Kobayakawa, Reiko] Osaka Biosci Inst, Dept Funct Neurosci, Suita, Osaka 5650874, Japan; [Sakano, Hitoshi] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan; [Yoshihara, Yoshihiro] RIKEN, Brain Sci Inst, Lab Neurobiol Synapse, Wako, Saitama 3510198, Japan	University of Tokyo; Azabu University; University of Tokyo; RIKEN	Touhara, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan.	ktouhara@mail.ecc.u-tokyo.ac.jp	Yoshihara, Yoshihiro/N-6481-2015	Yoshihara, Yoshihiro/0000-0002-0319-7166; Kobayakawa, Reiko/0000-0001-6613-5969; xing zhi, zuo teng/0000-0001-6198-6406	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank R. Axel, C. R. Yu, M. Cappechi, M. Sugita and T. Shiroishi for mice and plasmids; RIKEN BSI Research Resource Center, Y. Zhang, J. He, C. R. Yu, H. Kimoto, N. Matsumoto, M. Ohmoto, K. Abe, S. Mitsui, T. Kaneko-Goto, and T. Abe for experimental help and advice; and Y. Sakuma, Y. Mori, M. Ichikawa and H. Terasawa for valuable comments and discussions. This work was supported by grants from the Program for Promotion of Basic Research Activities for Innovative Biosciences, Japan Society for the Promotion of Science, and Ministry of Education, Culture, Sports, Science and Technology, Japan.	Blaustein J. D., 2002, HORMONES BRAIN BEHAV, P139; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; CANTERAS NS, 1995, J COMP NEUROL, V360, P213, DOI 10.1002/cne.903600203; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Del Punta K, 2002, NEURON, V35, P1057, DOI 10.1016/S0896-6273(02)00904-2; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Haga S, 2007, PURE APPL CHEM, V79, P775, DOI 10.1351/pac200779040775; Halem HA, 1999, J NEUROBIOL, V39, P249, DOI 10.1002/(SICI)1097-4695(199905)39:2<249::AID-NEU9>3.3.CO;2-I; He J, 2008, SCIENCE, V320, P535, DOI 10.1126/science.1154476; Ishii T, 2003, CURR BIOL, V13, P394, DOI 10.1016/S0960-9822(03)00092-7; Ishii T, 2008, J NEUROSCI, V28, P2332, DOI 10.1523/JNEUROSCI.4807-07.2008; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Kimoto H, 2007, CURR BIOL, V17, P1879, DOI 10.1016/j.cub.2007.09.042; Kudwa AE, 2005, P NATL ACAD SCI USA, V102, P4608, DOI 10.1073/pnas.0500752102; Lalioti MD, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e14; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Meredith M, 1998, ANN NY ACAD SCI, V855, P349, DOI 10.1111/j.1749-6632.1998.tb10593.x; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; PFAFF DW, 1979, J PHYSIOL-LONDON, V288, P189; Pierman S, 2008, EUR J NEUROSCI, V27, P423, DOI 10.1111/j.1460-9568.2007.06016.x; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; SIMERLY RB, 1986, J COMP NEUROL, V246, P312, DOI 10.1002/cne.902460304; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Touhara K, 2007, ADV GENET, V59, P147, DOI 10.1016/S0065-2660(07)59006-1; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; von Campenhausen H, 2000, EUR J NEUROSCI, V12, P33, DOI 10.1046/j.1460-9568.2000.00879.x; Wu MV, 2009, CELL, V139, P61, DOI 10.1016/j.cell.2009.07.036; Wyatt T.D., 2003, PHEROMONES ANIMAL BE; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	35	258	264	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					118	U136		10.1038/nature09142	http://dx.doi.org/10.1038/nature09142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596023				2022-12-01	WOS:000279343800046
J	Christen, M; Kulasekara, HD; Christen, B; Kulasekara, BR; Hoffman, LR; Miller, SI				Christen, Matthias; Kulasekara, Hemantha D.; Christen, Beat; Kulasekara, Bridget R.; Hoffman, Lucas R.; Miller, Samuel I.			Asymmetrical Distribution of the Second Messenger c-di-GMP upon Bacterial Cell Division	SCIENCE			English	Article							CAULOBACTER-CRESCENTUS; ALLOSTERIC CONTROL; STRUCTURAL BASIS; PROTEINS	The bacterial second messenger cyclic diguanosine monophosphate (c-di-GMP) regulates cellular motility and the synthesis of organelles and molecules that promote adhesion to a variety of biological and nonbiological surfaces. These properties likely require tight spatial and temporal regulation of c-di-GMP concentration. We have developed genetically encoded fluorescence resonance energy transfer (FRET)-based biosensors to monitor c-di-GMP concentrations within single bacterial cells by microscopy. Fluctuations of c-di-GMP were visualized in diverse Gram-negative bacterial species and observed to be cell cycle dependent. Asymmetrical distribution of c-di-GMP in the progeny correlated with the time of cell division and polarization for Caulobacter crescentus and Pseudomonas aeruginosa. Thus, asymmetrical distribution of c-di-GMP was observed as part of cell division, which may indicate an important regulatory step in extracellular organelle biosynthesis or function.	[Christen, Matthias; Kulasekara, Hemantha D.; Miller, Samuel I.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Christen, Beat] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Kulasekara, Bridget R.] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Hoffman, Lucas R.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Miller, Samuel I.] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Stanford University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Miller, SI (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	millersi@uw.edu	Hoffman, Lucas/AAX-1853-2021; Christen, Beat/AAC-2974-2021	Christen, Matthias/0000-0001-7724-4562; Christen, Beat/0000-0002-9528-3685	National Institute of Allergy and Infectious Diseases, NIH [1R21NS067579-01, U54AI057141, KO8AI066251]; NSF; Swiss National Foundation [PA00P3-124140, PBBSA-120489, PA00P3-126243]; Novartis Foundation; Cystic Fibrosis Foundation [HOFFMA04L0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL105543, R01HL098084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057141, K08AI066251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067579] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NSF(National Science Foundation (NSF)); Swiss National Foundation(Swiss National Science Foundation (SNSF)); Novartis Foundation(Novartis); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Jones from Rutgers University, Piscataway, NJ, for c-di-GMP and T. Ohashi from Duke University, Durham, NC, for the pET15b::mCYPet_12AA_mYPet plasmids. This research was supported by the National Institute of Allergy and Infectious Diseases, NIH (1R21NS067579-01 and U54AI057141 to S.I.M; KO8AI066251 to L.R.H and 1R21NS067579-01 to H. D. K), NSF (Graduate Research Fellowship to B.R.K), Swiss National Foundation (PA00P3-124140 and PBBSA-120489 to M.C. and PA00P3-126243 to B.C), Novartis Foundation to M.C., and Cystic Fibrosis Foundation (HOFFMA04L0 to L.R.H).	Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Christen M, 2007, P NATL ACAD SCI USA, V104, P4112, DOI 10.1073/pnas.0607738104; Guvener ZT, 2007, MOL MICROBIOL, V66, P1459, DOI 10.1111/j.1365-2958.2007.06008.x; HECHT GB, 1995, J BACTERIOL, V177, P6223, DOI 10.1128/jb.177.21.6223-6229.1995; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Huitema E, 2006, CELL, V124, P1025, DOI 10.1016/j.cell.2006.01.019; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Leduc JL, 2009, J BACTERIOL, V191, P7121, DOI 10.1128/JB.00845-09; Ohashi T, 2007, PROTEIN SCI, V16, P1429, DOI 10.1110/ps.072845607; Paul K, 2010, MOL CELL, V38, P128, DOI 10.1016/j.molcel.2010.03.001; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2	16	194	197	3	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1295	1297		10.1126/science.1188658	http://dx.doi.org/10.1126/science.1188658			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522779	Green Accepted			2022-12-01	WOS:000278318600040
J	Signore, LB; Mulvihill, JJ; Green, DM; Munro, HM; Stovall, M; Weathers, RE; Mertens, AC; Whitton, JA; Robison, LL; Boice, JD				Signore, Lisa B.; Mulvihill, John J.; Green, Daniel M.; Munro, Heather M.; Stovall, Marilyn; Weathers, Rita E.; Mertens, Ann C.; Whitton, John A.; Robison, Leslie L.; Boice, John D., Jr.			Stillbirth and neonatal death in relation to radiation exposure before conception: a retrospective cohort study	LANCET			English	Article							CHILDHOOD-CANCER SURVIVORS; ATOMIC-BOMB SURVIVORS; POPULATION-BASED COHORT; WILMS-TUMOR; CONGENITAL-MALFORMATIONS; RADIOTHERAPY; CHILDREN; PREGNANCY; WORKERS	Background The reproductive implications of mutagenic treatments given to children with cancer are not clear. By studying the risk of untoward pregnancy outcomes, we indirectly assessed the risk of transmission of germline damage to the offspring of survivors of childhood cancer who were given radiotherapy and chemotherapy. Methods We did a retrospective cohort analysis, within the Childhood Cancer Survivor Study (CCSS), of the risk of stillbirth and neonatal death among the offspring of men and women who had survived childhood cancer. Patients in CCSS were younger than 21 years at initial diagnosis of an eligible cancer, were treated at 25 US institutions and one Canadian institution, and had survived for at least 5 years after diagnosis. We quantified the chemotherapy given to patients, and the preconception radiation doses to the testes, ovaries, uterus, and pituitary gland, and related these to the risk of stillbirth or neonatal death using Poisson regression analysis. Findings Among 1148 men and 1657 women who had survived childhood cancer, there were 4946 pregnancies. Irradiation of the testes (16 [1%] of 1270; adjusted relative risk 0.8 [95% CI 0.4-1.6]; mean dose 0.53 Gy [SD 1.40]) and pituitary gland (17 [3%] of 510, 1.1 [0.5-2.4] for more than 20.00 Gy; mean dose 10.20 Gy [13.0] for women), and chemotherapy with alkylating drugs (26 [2%] of 1195 women, 0.9 [0.5-1.5]; ten [1%] of 732 men, 1.2 [0.5-2.5]) were not associated with an increased risk of stillbirth or neonatal death. Uterine and ovarian irradiation significantly increased risk of stillbirth and neonatal death at doses greater than 10.00 Gy (five [18%] of 28, 9.1 [3.4-24.6]). For girls treated before menarche, irradiation of the uterus and ovaries at doses as low as 1.00-2.49 Gy significantly increased the risk of stillbirth or neonatal death (three [4%] of 69, 4.7 [1.2-19.0]). Interpretation Our findings do not support concern about heritable genetic changes affecting the risk of stillbirth and neonatal death in the offspring of men exposed to gonadal irradiation. However, uterine and ovarian irradiation had serious adverse effects on the offspring that were probably related to uterine damage. Careful management is warranted of pregnancies in women given high doses of pelvic irradiation before puberty.	[Signore, Lisa B.; Munro, Heather M.; Boice, John D., Jr.] Int Epidemiol Inst, Rockville, MD 20850 USA; [Signore, Lisa B.; Boice, John D., Jr.] Vanderbilt Univ, Med Ctr, Dept Med, Div Epidemiol, Nashville, TN USA; [Signore, Lisa B.; Boice, John D., Jr.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Mulvihill, John J.] Univ Oklahoma, Dept Pediat, Oklahoma City, OK USA; [Green, Daniel M.; Robison, Leslie L.] St Jude Childrens Hosp, Dept Epidemiol & Canc Control, Memphis, TN 38105 USA; [Stovall, Marilyn; Weathers, Rita E.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; [Mertens, Ann C.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Whitton, John A.] Fred Hutchinson Canc Res Ctr, Dept Biostat, Seattle, WA 98104 USA	Vanderbilt University; Vanderbilt University; University of Oklahoma System; University of Oklahoma Health Sciences Center; St Jude Children's Research Hospital; University of Texas System; UTMD Anderson Cancer Center; Emory University; Fred Hutchinson Cancer Center	Signore, LB (corresponding author), Int Epidemiol Inst, 1455 Res Blvd,Suite 550, Rockville, MD 20850 USA.	lisa@iei.us	Robison, Leslie/N-8122-2018		Westlakes Research Institute [01/12/99 DC]; National Cancer Institute [U24 CA55727, 5RO1 CA104666]; University of Minnesota, Minneapolis, MN, USA; NATIONAL CANCER INSTITUTE [R01CA104666, U24CA055727] Funding Source: NIH RePORTER	Westlakes Research Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Minnesota, Minneapolis, MN, USA(University of Minnesota System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was partly supported by contracts and grants from Westlakes Research Institute (agreement number 01/12/99 DC), the National Cancer Institute (U24 CA55727 and 5RO1 CA104666), and the Children's Cancer Research Fund (University of Minnesota, Minneapolis, MN, USA). The programme of studies would not have been possible without the efforts of the many participating survivors of cancer, data abstractors, a large field staff, central clerical and data-processing staff, and clinical collaborators. We gratefully acknowledge the advice and guidance of Gerald Draper (Childhood Cancer Research Group, Oxford, UK) and Godfrey Oakley (Emory University, Atlanta, GA, USA) during the preparation of this report.	Abrahamson Seymour, 2001, Journal of Radiological Protection, V21, P133, DOI 10.1088/0952-4746/21/2/303; Boice JD, 2003, HEALTH PHYS, V85, P65, DOI 10.1097/00004032-200307000-00013; Byrne J, 1998, AM J HUM GENET, V62, P45, DOI 10.1086/301677; *COMARE, 2004, PAR OCC EXP RAD PRIO; Doll R, 2000, LANCET, V355, P493, DOI 10.1016/S0140-6736(00)82044-9; Doyle P, 2000, LANCET, V356, P1293, DOI 10.1016/S0140-6736(00)02812-9; Doyle P, 2000, LANCET, V355, P492, DOI 10.1016/S0140-6736(00)82041-3; Green DM, 2002, J CLIN ONCOL, V20, P2506, DOI 10.1200/JCO.2002.07.159; Inskip H, 1999, LANCET, V354, P1400, DOI 10.1016/S0140-6736(99)00289-5; Larsen EC, 2004, ACTA OBSTET GYN SCAN, V83, P96, DOI 10.1111/j.1600-0412.2004.00332.x; Leisenring WM, 2009, J CLIN ONCOL, V27, P2319, DOI 10.1200/JCO.2008.21.1813; LI FP, 1987, JAMA-J AM MED ASSOC, V257, P216, DOI 10.1001/jama.257.2.216; Nakamura N, 2006, J RADIAT RES, V47, pB67, DOI 10.1269/jrr.47.B67; NEEL JV, 1990, ANNU REV GENET, V24, P327; Nicholson HS, 1996, CANCER, V78, P887; OTAKE M, 1990, RADIAT RES, V122, P1, DOI 10.2307/3577576; Parker L, 1999, LANCET, V354, P1407, DOI 10.1016/S0140-6736(99)04138-0; Robison LL, 2009, J CLIN ONCOL, V27, P2308, DOI 10.1200/JCO.2009.22.3339; Russell WL, 1998, GENETICS, V148, P1567; Schull WJ, 2003, J RADIOL PROT, V23, P369, DOI 10.1088/0952-4746/23/4/R302; Selby PB, 2000, LANCET, V355, P492, DOI 10.1016/S0140-6736(00)82042-5; Signorello LB, 2006, JNCI-J NATL CANCER I, V98, P1453, DOI 10.1093/jnci/djj394; Stovall M, 2004, INT J RADIAT ONCOL, V60, P542, DOI 10.1016/j.ijrobp.2004.03.017; Tawn EJ, 2000, LANCET, V355, P493, DOI 10.1016/S0140-6736(00)82045-0; United Nations Scientific Committee on the Effects of Atomic Radiation, 2001, REP GEN ASS SCI ANN; Winther JF, 2009, CLIN GENET, V75, P50, DOI 10.1111/j.1399-0004.2008.01109.x; Winther JF, 2008, J CLIN ONCOL, V26, P4340, DOI 10.1200/JCO.2007.15.2884; Winther JF, 2004, AM J HUM GENET, V74, P1282, DOI 10.1086/421473; Wo JY, 2009, INT J RADIAT ONCOL, V73, P1304, DOI 10.1016/j.ijrobp.2008.12.016; Wyrobek AJ, 2007, ENVIRON MOL MUTAGEN, V48, P71, DOI 10.1002/em.20284	30	101	105	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 21	2010	376	9741					624	630		10.1016/S0140-6736(10)60752-0	http://dx.doi.org/10.1016/S0140-6736(10)60752-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643PB	20655585	Green Accepted			2022-12-01	WOS:000281309100033
J	Wang, G; Chen, HW; Oktay, Y; Zhang, J; Allen, EL; Smith, GM; Fan, KC; Hong, JS; French, SW; McCaffery, JM; Lightowlers, RN; Morse, HC; Koehler, CM; Teitell, MA				Wang, Geng; Chen, Hsiao-Wen; Oktay, Yavuz; Zhang, Jin; Allen, Eric L.; Smith, Geoffrey M.; Fan, Kelly C.; Hong, Jason S.; French, Samuel W.; McCaffery, J. Michael; Lightowlers, Robert N.; Morse, Herbert C., III; Koehler, Carla M.; Teitell, Michael A.			PNPASE Regulates RNA Import into Mitochondria	CELL			English	Article							HUMAN POLYNUCLEOTIDE PHOSPHORYLASE; HELA-CELL MITOCHONDRIA; POLY(A) POLYMERASE; P-ACTIVITY; PROTEIN; LIVER; CONTAINS; BINDING	RNA import into mammalian mitochondria is considered essential for replication, transcription, and translation of the mitochondrial genome but the pathway(s) and factors that control this import are poorly understood. Previously, we localized polynucleotide phosphorylase (PNPASE), a 3' -> 5' exoribonuclease and poly-A polymerase, in the mitochondrial intermembrane space, a location lacking resident RNAs. Here, we show a new role for PNPASE in regulating the import of nuclear-encoded RNAs into the mitochondrial matrix. PNPASE reduction impaired mitochondrial RNA processing and polycistronic transcripts accumulated. Augmented import of RNase P, 5S rRNA, and MRP RNAs depended on PNPASE expression and PNPASE-imported RNA interactions were identified. PNPASE RNA processing and import activities were separable and a mitochondrial RNA targeting signal was isolated that enabled RNA import in a PNPASE-dependent manner. Combined, these data strongly support an unanticipated role for PNPASE in mediating the translocation of RNAs into mitochondria.	[Wang, Geng; Oktay, Yavuz; Koehler, Carla M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Koehler, Carla M.; Teitell, Michael A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Calif NanoSyst Inst, Broad Stem Cell Res Ctr, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Teitell, Michael A.] Univ Calif Los Angeles, Ctr Cell Control, Los Angeles, CA 90095 USA; [Chen, Hsiao-Wen] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA; [Zhang, Jin; Allen, Eric L.; Smith, Geoffrey M.; Fan, Kelly C.; Hong, Jason S.; French, Samuel W.; Teitell, Michael A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [McCaffery, J. Michael] Johns Hopkins Univ, Dept Biol, Integrated Imaging Ctr, Baltimore, MD 21218 USA; [Lightowlers, Robert N.] Newcastle Univ, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Morse, Herbert C., III] NIAID, Immunopathol Lab, NIH, Rockville, MD 20852 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Johns Hopkins University; Newcastle University - UK; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Koehler, CM (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	koehler@chem.ucla.edu; mteitell@mednet.ucla.edu	Oktay, Yavuz/G-4794-2015; ZHANG, JIN/D-1435-2013	Oktay, Yavuz/0000-0002-0158-2693; Morse, Herbert/0000-0002-9331-3705	NIH [R01GM061721, R01GM073981, R01CA90571, PN2EY018228, K22CA120147]; NIH, National Institute of Allergy and Infectious Diseases; Muscular Dystrophy Association [022398]; American Heart Association [0640076N]; California Institute of Regenerative Medicine [RS1-00313, RB1-01397]; NATIONAL CANCER INSTITUTE [R01CA107300, R01CA090571, R01CA156674, K22CA120147] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY018228] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000858, ZIAAI001057, ZIAAI001024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073981, R01GM061721] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Muscular Dystrophy Association(Muscular Dystrophy Association); American Heart Association(American Heart Association); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Michelle Husain for expertise in TEM. Supported by NIH grants R01GM061721 and R01GM073981 (C.M.K.), R01CA90571 (M.A.T.) and PN2EY018228 (Roadmap for Medical Research Nanomedicine Initiative) (M.A.T.), and K22CA120147 (S.W.F.), the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases (H.C.M. III), the Muscular Dystrophy Association 022398 (C.M.K.), the American Heart Association 0640076N (C.M.K.), and the California Institute of Regenerative Medicine (RS1-00313 and RB1-01397, M.A.T.). C.M.K. is an Established Investigator of the American Heart Association and M.A.T. is a Scholar of the Leukemia and Lymphoma Society.	Alfonzo JD, 2009, BIOL CHEM, V390, P717, DOI 10.1515/BC.2009.101; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Carpousis AJ, 2002, BIOCHEM SOC T, V30, P150, DOI 10.1042/bst0300150; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; CHANG DD, 1987, SCIENCE, V235, P1178, DOI 10.1126/science.2434997; Chen HW, 2007, TRENDS CELL BIOL, V17, P600, DOI 10.1016/j.tcb.2007.09.006; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Diaz F, 2008, GUT, V57, P232, DOI 10.1136/gut.2006.119180; DOERSEN CJ, 1985, J BIOL CHEM, V260, P5942; Duchene AM, 2009, CURR GENET, V55, P1, DOI 10.1007/s00294-008-0223-9; Entelis NS, 2001, ADV DRUG DELIVER REV, V49, P199, DOI 10.1016/S0169-409X(01)00135-1; French SW, 2007, CANCER LETT, V248, P198, DOI 10.1016/j.canlet.2006.07.006; HOLLINGSWORTH MJ, 1986, MOL CELL BIOL, V6, P1058, DOI 10.1128/MCB.6.4.1058; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369; Kolesnikova OA, 2004, HUM MOL GENET, V13, P2519, DOI 10.1093/hmg/ddh267; Kren BT, 2009, RNA BIOL, V6, P65, DOI 10.4161/rna.6.1.7534; Lisitsky I, 1996, P NATL ACAD SCI USA, V93, P13398, DOI 10.1073/pnas.93.23.13398; Mandel H, 2001, HEPATOLOGY, V34, P776, DOI 10.1053/jhep.2001.27664; Mukherjee S, 2007, EMBO REP, V8, P589, DOI 10.1038/sj.embor.7400979; Portnoy V, 2008, RNA, V14, P297, DOI 10.1261/rna.698108; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Puranam RS, 2001, MOL CELL BIOL, V21, P548, DOI 10.1128/MCB.21.2.548-561.2001; Rainey RN, 2006, MOL CELL BIOL, V26, P8488, DOI 10.1128/MCB.01006-06; Rubio MAT, 2008, P NATL ACAD SCI USA, V105, P9186, DOI 10.1073/pnas.0804283105; Smirnov AV, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1418, DOI 10.1134/S000629790813004X; Symmons MF, 2002, TRENDS BIOCHEM SCI, V27, P11, DOI 10.1016/S0968-0004(01)01999-5; Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9; Szczesny RJ, 2010, NUCLEIC ACIDS RES, V38, P279, DOI 10.1093/nar/gkp903; TARASSOV I, 1995, J MOL BIOL, V245, P315, DOI 10.1006/jmbi.1994.0026; TOLLERVEY D, 1987, EMBO J, V6, P4169, DOI 10.1002/j.1460-2075.1987.tb02763.x; Walker SC, 2008, CELL, V135, P412, DOI 10.1016/j.cell.2008.10.010; Wang DDH, 2009, J BIOL CHEM, V284, P20812, DOI 10.1074/jbc.M109.009605; Yehudai-Resheff S, 2000, NUCLEIC ACIDS RES, V28, P1139, DOI 10.1093/nar/28.5.1139; Yehudai-Resheff S, 2001, MOL CELL BIOL, V21, P5408, DOI 10.1128/MCB.21.16.5408-5416.2001; [No title captured]	37	238	247	3	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					456	467		10.1016/j.cell.2010.06.035	http://dx.doi.org/10.1016/j.cell.2010.06.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691904	Green Accepted, Bronze			2022-12-01	WOS:000280609100022
J	Petersen, TH; Calle, EA; Zhao, LP; Lee, EJ; Gui, LQ; Raredon, MB; Gavrilov, K; Yi, T; Zhuang, ZW; Breuer, C; Herzog, E; Niklason, LE				Petersen, Thomas H.; Calle, Elizabeth A.; Zhao, Liping; Lee, Eun Jung; Gui, Liqiong; Raredon, MichaSam B.; Gavrilov, Kseniya; Yi, Tai; Zhuang, Zhen W.; Breuer, Christopher; Herzog, Erica; Niklason, Laura E.			Tissue-Engineered Lungs for in Vivo Implantation	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; II CELLS; VITRO; TRANSPLANTATION; MATRIX; ACID	Because adult lung tissue has limited regeneration capacity, lung transplantation is the primary therapy for severely damaged lungs. To explore whether lung tissue can be regenerated in vitro, we treated lungs from adult rats using a procedure that removes cellular components but leaves behind a scaffold of extracellular matrix that retains the hierarchical branching structures of airways and vasculature. We then used a bioreactor to culture pulmonary epithelium and vascular endothelium on the acellular lung matrix. The seeded epithelium displayed remarkable hierarchical organization within the matrix, and the seeded endothelial cells efficiently repopulated the vascular compartment. In vitro, the mechanical characteristics of the engineered lungs were similar to those of native lung tissue, and when implanted into rats in vivo for short time intervals (45 to 120 minutes) the engineered lungs participated in gas exchange. Although representing only an initial step toward the ultimate goal of generating fully functional lungs in vitro, these results suggest that repopulation of lung matrix is a viable strategy for lung regeneration.	[Petersen, Thomas H.; Calle, Elizabeth A.; Raredon, MichaSam B.; Niklason, Laura E.] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA; [Petersen, Thomas H.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA; [Zhao, Liping; Lee, Eun Jung; Gui, Liqiong; Niklason, Laura E.] Yale Univ, Dept Anesthesia, New Haven, CT 06520 USA; [Gavrilov, Kseniya] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Yi, Tai; Breuer, Christopher] Yale Univ, Dept Surg, New Haven, CT 06520 USA; [Zhuang, Zhen W.; Herzog, Erica] Yale Univ, Dept Internal Med, New Haven, CT 06520 USA	Yale University; Duke University; Yale University; Yale University; Yale University; Yale University	Niklason, LE (corresponding author), Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.	laura.niklason@yale.edu	aksel, hacer/H-1572-2015	Petersen, Thomas/0000-0002-4667-7493; Raredon, Micha Sam/0000-0003-1441-6122; Breuer, Christopher/0000-0003-0987-3898	Yale University Department of Anesthesia; NIH [HL 098220, T32 GM007171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER	Yale University Department of Anesthesia; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Colehour for help with bioreactor development and Western blotting, R. Homer for histologic assessment, and B. Stripp for the CCSP antibody. This work was funded by Yale University Department of Anesthesia and by NIH grant HL 098220 (to L.E.N.). T.H.P. is supported by NIH T32 GM007171. L.E.N. holds stock in Humacyte, a regenerative medicine company. The authors (L.E.N., T.H.P., and E.A.C.) and Yale University have filed a patent application related to tissue engineering of lungs.	*AM LUNG ASS, LUND DIS DAT 2008; Andrade CF, 2007, AM J PHYSIOL-LUNG C, V292, pL510, DOI 10.1152/ajplung.00175.2006; Baptista PM, 2009, IEEE ENG MED BIO, P6526, DOI 10.1109/IEMBS.2009.5333145; Bittar EE, 2002, PULMONARY BIOL HLTH; Cortiella J, 2006, TISSUE ENG, V12, P1213, DOI 10.1089/ten.2006.12.1213; DEFOUW DO, 1983, AM REV RESPIR DIS, V127, pS9; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Inanlou MR, 2005, HISTOL HISTOPATHOL, V20, P1261, DOI 10.14670/HH-20.1261; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Lin YM, 2006, J BIOMATER APPL, V21, P109, DOI 10.1177/0885328206057952; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; MASSARO D, 1985, J CLIN INVEST, V76, P1297, DOI 10.1172/JCI112103; Mondrinos MJ, 2006, TISSUE ENG, V12, P717, DOI 10.1089/ten.2006.12.717; Orens Jonathan B, 2009, Proc Am Thorac Soc, V6, P13, DOI 10.1513/pats.200807-072GO; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Rippon Helen J, 2008, Proc Am Thorac Soc, V5, P717, DOI 10.1513/pats.200801-008AW; Roszell B, 2009, TISSUE ENG PT A, V15, P3351, DOI 10.1089/ten.TEA.2008.0664; Sporty JL, 2008, EXPERT OPIN DRUG MET, V4, P333, DOI [10.1517/17425255.4.4.333, 10.1517/17425255.4.4.333 ]; STAUB NC, 1998, PHYSIOLOGY, pCH32; SUGIHARA H, 1993, AM J PATHOL, V142, P783; Wang DC, 2010, MOL THER, V18, P625, DOI 10.1038/mt.2009.317; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	23	836	884	2	330	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2010	329	5991					538	541		10.1126/science.1189345	http://dx.doi.org/10.1126/science.1189345			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20576850	Green Accepted			2022-12-01	WOS:000280483500028
J	Taniguchi, Y; Choi, PJ; Li, GW; Chen, HY; Babu, M; Hearn, J; Emili, A; Xie, XS				Taniguchi, Yuichi; Choi, Paul J.; Li, Gene-Wei; Chen, Huiyi; Babu, Mohan; Hearn, Jeremy; Emili, Andrew; Xie, X. Sunney			Quantifying E-coli Proteome and Transcriptome with Single-Molecule Sensitivity in Single Cells	SCIENCE			English	Article							STOCHASTIC GENE-EXPRESSION; REGULATORY NETWORKS; NOISE; REVEALS; LEVEL; YEAST; TIME	Protein and messenger RNA (mRNA) copy numbers vary from cell to cell in isogenic bacterial populations. However, these molecules often exist in low copy numbers and are difficult to detect in single cells. We carried out quantitative system-wide analyses of protein and mRNA expression in individual cells with single-molecule sensitivity using a newly constructed yellow fluorescent protein fusion library for Escherichia coli. We found that almost all protein number distributions can be described by the gamma distribution with two fitting parameters which, at low expression levels, have clear physical interpretations as the transcription rate and protein burst size. At high expression levels, the distributions are dominated by extrinsic noise. We found that a single cell's protein and mRNA copy numbers for any given gene are uncorrelated.	[Taniguchi, Yuichi; Choi, Paul J.; Li, Gene-Wei; Chen, Huiyi; Hearn, Jeremy; Xie, X. Sunney] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Li, Gene-Wei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Chen, Huiyi] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Babu, Mohan; Emili, Andrew] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Emili, Andrew] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	Harvard University; Harvard University; Harvard University; University of Toronto; University of Toronto	Xie, XS (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	xie@chemistry.harvard.edu	Taniguchi, Yuichi/N-5986-2015; Mohan, Babu P./I-7362-2019; Li, Gene-Wei/E-7657-2010	Taniguchi, Yuichi/0000-0001-5677-8901; Li, Gene-Wei/0000-0001-7036-8511	Gates Foundation; NIH; Canadian Institutes of Health Research [MOP-77639]; Japan Society for the Promotion of Science; Uehara Memorial Foundation; Marubun Research Promotion Foundation; John and Fannie Hertz Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000277] Funding Source: NIH RePORTER	Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); Marubun Research Promotion Foundation; John and Fannie Hertz Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Xun, N. K. Lee, D. Court, C. Zong, R. Roy, and J. Agresti for experimental assistance; and E. Rubin, L. Cai, and J. Elf for helpful discussions. This work was supported by the Gates Foundation (X.S.X.), the NIH Pioneer Director's Award (X.S.X.), and the Canadian Institutes of Health Research (MOP-77639) (A.E.). Y.T. acknowledges additional support from the Japan Society for the Promotion of Science, the Uehara Memorial Foundation, and the Marubun Research Promotion Foundation, and P.J.C. from the John and Fannie Hertz Foundation.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Butland G, 2008, NAT METHODS, V5, P789, DOI 10.1038/NMETH.1239; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Choi PJ, 2008, SCIENCE, V322, P442, DOI 10.1126/science.1161427; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Paulsson J, 2000, PHYS REV LETT, V84, P5447, DOI 10.1103/PhysRevLett.84.5447; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	31	1374	1396	11	491	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					533	538		10.1126/science.1188308	http://dx.doi.org/10.1126/science.1188308			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671182	Green Accepted			2022-12-01	WOS:000280483500027
J	Furukawa, H; Ko, N; Go, YB; Aratani, N; Choi, SB; Choi, E; Yazaydin, AO; Snurr, RQ; O'Keeffe, M; Kim, J; Yaghi, OM				Furukawa, Hiroyasu; Ko, Nakeun; Go, Yong Bok; Aratani, Naoki; Choi, Sang Beom; Choi, Eunwoo; Yazaydin, A. Oezguer; Snurr, Randall Q.; O'Keeffe, Michael; Kim, Jaheon; Yaghi, Omar M.			Ultrahigh Porosity in Metal-Organic Frameworks	SCIENCE			English	Article							HYDROGEN STORAGE; SURFACE-AREAS; COORDINATION POLYMERS; ADSORPTION; DESIGN; ROUTE; SITES	Crystalline solids with extended non-interpenetrating three-dimensional crystal structures were synthesized that support well-defined pores with internal diameters of up to 48 angstroms. The Zn(4)O(CO(2))(6) unit was joined with either one or two kinds of organic link, 4,4',4 ''-[benzene-1,3,5-triyl-tris (ethyne-2,1-diyl)]tribenzoate (BTE), 4,4',44 ''-[benzene-1,3,5-triyl-tris(benzene-4,1-diyl)]tribenzoate (BBC), 4,4',44 ''-benzene-1,3,5-triyl-tribenzoate (BTB)/2,6-naphthalenedicarboxylate (NDC), and BTE/biphenyl-4,4'-dicarboxylate (BPDC), to give four metal-organic frameworks (MOFs), MOF-180, -200, -205, and -210, respectively. Members of this series of MOFs show exceptional porosities and gas (hydrogen, methane, and carbon dioxide) uptake capacities. For example, MOF-210 has Brunauer-Emmett-Teller and Langmuir surface areas of 6240 and 10,400 square meters per gram, respectively, and a total carbon dioxide storage capacity of 2870 milligrams per gram. The volume-specific internal surface area of MOF-210 (2060 square meters per cubic centimeter) is equivalent to the outer surface of nanoparticles (3-nanometer cubes) and near the ultimate adsorption limit for solid materials.	[Ko, Nakeun; Choi, Sang Beom; Kim, Jaheon] Soongsil Univ, Dept Chem, Seoul 156743, South Korea; [Furukawa, Hiroyasu; Go, Yong Bok; Aratani, Naoki; Choi, Eunwoo; O'Keeffe, Michael; Yaghi, Omar M.] Univ Calif Los Angeles, Calif NanoSyst Inst, Ctr Reticular Chem, Los Angeles, CA 90095 USA; [Furukawa, Hiroyasu; Go, Yong Bok; Aratani, Naoki; Choi, Eunwoo; O'Keeffe, Michael; Yaghi, Omar M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Yazaydin, A. Oezguer; Snurr, Randall Q.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Yaghi, Omar M.] Univ Calif Los Angeles, Inst Genom & Prote, Dept Energy, Los Angeles, CA 90095 USA	Soongsil University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Northwestern University; University of California System; University of California Los Angeles	Kim, J (corresponding author), Soongsil Univ, Dept Chem, Seoul 156743, South Korea.	jaheon@ssu.ac.kr; yaghi@chem.ucla.edu	Yaghi, Omar M/C-6749-2013; Yazaydin, A. Ozgur/F-4075-2019; Furukawa, Hiroyasu/C-5910-2008; Aratani, Naoki/D-1626-2011; Snurr, Randall Q/B-6699-2009; Snurr, Randall Q/E-4900-2011	Yazaydin, A. Ozgur/0000-0001-8562-723X; Furukawa, Hiroyasu/0000-0002-6082-1738; Aratani, Naoki/0000-0002-3181-6526; Snurr, Randall Q/0000-0003-2925-9246; Yaghi, Omar/0000-0002-5611-3325	BASF SE; DOE Office of Basic Energy Sciences [DE-FG02-08ER15935]; DOE [FG36-05GO15001]; Ministry of Education, Science and Technology of Korea; Defense Threat Reduction Agency [HDTRA1-08-C-005]	BASF SE(BASF); DOE Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work is partially supported by BASF SE. The synthesis, characterization of MOF-200, and nitrogen, methane, and carbon dioxide adsorption measurements of the MOFs are supported by the DOE Office of Basic Energy Sciences (DE-FG02-08ER15935 to O.M.Y.), and hydrogen adsorption measurements are supported by the DOE (DE-FG36-05GO15001 to O.M.Y.). We thank the Hydrogen Energy R&D Center, one of the 21st Century Frontier R&D Programs (the Ministry of Education, Science and Technology of Korea to J.K.), and the Defense Threat Reduction Agency (HDTRA1-08-C-005 to R. Q. S.). We thank N. W. Ockwig (Sandia National Laboratories) for his initial work, S. Khan (UCLA) for his help in single-crystal x-ray structure collection and analysis of MOF-200, Y. K. Park and E. Jo (Soongsil University) for their synthesis work of organic links, Accelrys Korea for MS Modeling support, and Pohang Accelerator Laboratory, Korea (2009-2063-12, 2009-2063-18). Crystallographic data for the structures reported in this paper have been deposited with the Cambridge Crystallographic Data Centre under reference numbers CCDC 775690 to 775693. These data can be obtained free of charge via www.ccdc.cam.ac.uk/conts/retrieving.html (or from the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK).	Chae HK, 2004, NATURE, V427, P523, DOI 10.1038/nature02311; Chae HK, 2003, ANGEW CHEM INT EDIT, V42, P3907, DOI 10.1002/anie.200351546; Chen BL, 2001, SCIENCE, V291, P1021, DOI 10.1126/science.1056598; Dinca M, 2008, ANGEW CHEM INT EDIT, V47, P6766, DOI 10.1002/anie.200801163; Doonan CJ, 2009, J AM CHEM SOC, V131, P9492, DOI 10.1021/ja903251e; El-Kaderi HM, 2007, SCIENCE, V316, P268, DOI 10.1126/science.1139915; Ferey G, 2005, SCIENCE, V309, P2040, DOI 10.1126/science.1116275; Furukawa H, 2007, J MATER CHEM, V17, P3197, DOI 10.1039/b703608f; Kaye SS, 2007, J AM CHEM SOC, V129, P14176, DOI 10.1021/ja076877g; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Klein N, 2009, ANGEW CHEM INT EDIT, V48, P9954, DOI 10.1002/anie.200904599; Koh K, 2009, J AM CHEM SOC, V131, P4184, DOI 10.1021/ja809985t; Lee J, 2009, CHEM SOC REV, V38, P1450, DOI 10.1039/b807080f; Li H, 1999, NATURE, V402, P276, DOI 10.1038/46248; Lin X, 2007, CRYSTENGCOMM, V9, P438, DOI 10.1039/b706207a; Llewellyn PL, 2008, LANGMUIR, V24, P7245, DOI 10.1021/la800227x; Ma SQ, 2008, J AM CHEM SOC, V130, P1012, DOI 10.1021/ja0771639; Mueller U, 2006, J MATER CHEM, V16, P626, DOI 10.1039/b511962f; Nelson AP, 2009, J AM CHEM SOC, V131, P458, DOI 10.1021/ja808853q; O'Keeffe M, 2008, ACCOUNTS CHEM RES, V41, P1782, DOI 10.1021/ar800124u; Rowsell JLC, 2005, SCIENCE, V309, P1350, DOI 10.1126/science.1113247; Schnobrich JK, 2010, LANGMUIR, V26, P5808, DOI 10.1021/la9037292; Walton KS, 2007, J AM CHEM SOC, V129, P8552, DOI 10.1021/ja071174k; Wong-Foy AG, 2006, J AM CHEM SOC, V128, P3494, DOI 10.1021/ja058213h; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650; Yan Y, 2009, CHEM COMMUN, P1025, DOI 10.1039/b900013e; Zhao XB, 2004, SCIENCE, V306, P1012, DOI 10.1126/science.1101982	27	2863	2975	84	3732	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					424	428		10.1126/science.1192160	http://dx.doi.org/10.1126/science.1192160			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20595583				2022-12-01	WOS:000280196500033
J	Ye, J; Lenain, C; Bauwens, S; Rizzo, A; Saint-Leger, A; Poulet, A; Benarroch, D; Magdinier, F; Morere, J; Amiard, S; Verhoeyen, E; Britton, S; Calsou, P; Salles, B; Bizard, A; Nadal, M; Salvati, E; Sabatier, L; Wu, YL; Biroccio, A; Londono-Vallejo, A; Giraud-Panis, MJ; Gilson, E				Ye, Jing; Lenain, Christelle; Bauwens, Serge; Rizzo, Angela; Saint-Leger, Adelaide; Poulet, Anais; Benarroch, Delphine; Magdinier, Frederique; Morere, Julia; Amiard, Simon; Verhoeyen, Els; Britton, Sebastien; Calsou, Patrick; Salles, Bernard; Bizard, Anna; Nadal, Marc; Salvati, Erica; Sabatier, Laure; Wu, Yunlin; Biroccio, Annamaria; Londono-Vallejo, Arturo; Giraud-Panis, Marie-Josephe; Gilson, Eric			TRF2 and Apollo Cooperate with Topoisomerase 2 alpha to Protect Human Telomeres from Replicative Damage	CELL			English	Article							DNA-REPLICATION; ATM; MAINTENANCE; INTERACTS; NUCLEASE; BINDING; END	Human telomeres are protected from DNA damage by a nucleoprotein complex that includes the repeat-binding factor TRF2. Here, we report that TRF2 regulates the 5' exonuclease activity of its binding partner, Apollo, a member of the metallo-beta-lactamase family that is required for telomere integrity during S phase. TRF2 and Apollo also suppress damage to engineered interstitial telomere repeat tracts that were inserted far away from chromosome ends. Genetic data indicate that DNA topoisomerase 2 alpha acts in the same pathway of telomere protection as TRF2 and Apollo. Moreover, TRF2, which binds preferentially to positively supercoiled DNA substrates, together with Apollo, negatively regulates the amount of TOP1, TOP2 alpha, and TOP2 beta at telomeres. Our data are consistent with a model in which TRF2 and Apollo relieve topological stress during telomere replication. Our work also suggests that cellular senescence may be caused by topological problems that occur during the replication of the inner portion of telomeres.	[Ye, Jing; Lenain, Christelle; Bauwens, Serge; Saint-Leger, Adelaide; Poulet, Anais; Benarroch, Delphine; Magdinier, Frederique; Morere, Julia; Amiard, Simon; Salvati, Erica; Giraud-Panis, Marie-Josephe; Gilson, Eric] Univ Lyon, Ecole Normale Super Lyon, CNRS, Lab Biol Mol Cellule,UMR 5239, F-69364 Lyon, France; [Ye, Jing; Wu, Yunlin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Ruijin Hosp, Shanghai 200025, Peoples R China; [Ye, Jing; Saint-Leger, Adelaide; Benarroch, Delphine; Giraud-Panis, Marie-Josephe; Gilson, Eric] Univ Nice Sophia Antipolis, CNRS, UMR 6267, Lab Biol & Pathol Genomes,INSERM,U998, F-06107 Nice, France; [Rizzo, Angela; Amiard, Simon; Salvati, Erica; Biroccio, Annamaria] Regina Elena Inst Canc Res, Expt Chemotherapy Lab, I-00158 Rome, Italy; [Poulet, Anais; Benarroch, Delphine; Amiard, Simon; Giraud-Panis, Marie-Josephe] Univ Lyon, Ecole Normale Super Lyon, CNRS, Lab Joliot Curie,USR 3010, F-69364 Lyon, France; [Verhoeyen, Els] Univ Lyon, Ecole Normale Super Lyon, INSERM, U758, F-69364 Lyon, France; [Britton, Sebastien; Calsou, Patrick; Salles, Bernard] Univ Toulouse, CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France; [Bizard, Anna; Nadal, Marc] Univ Paris 11, CNRS, Inst Genet & Microbiol, UMR 8621, F-91405 Orsay, France; [Sabatier, Laure] Inst Radiobiol Cellulaire & Mol, Direct Sci Vivant, Commissariat Energie Atom, Lab Radiobiol & Oncol, F-92265 Fontenay Aux Roses, France; [Londono-Vallejo, Arturo] Univ Paris 06, CNRS, UMR 3244, Inst Curie,Telomeres & Canc Lab, F-75248 Paris, France; [Gilson, Eric] Ctr Hosp Univ Nice, Dept Med Genet, F-06202 Nice, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Shanghai Jiao Tong University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Universite Paris Cite; CHU Nice	Gilson, E (corresponding author), Univ Lyon, Ecole Normale Super Lyon, CNRS, Lab Biol Mol Cellule,UMR 5239, F-69364 Lyon, France.	eric.gilson@ens-lyon.fr	Londono-Vallejo, Arturo/ABH-5555-2020; Biroccio, Annamaria/B-2861-2018; calsou, patrick/AAB-5123-2020; Rizzo, Angela/ABH-6753-2020; Benarroch, Delphine/E-9983-2017; Britton, Sébastien/AAL-1862-2020; Benarroch-Popivker, Delphine/T-1990-2019; Verhoeyen, Els/H-6360-2016; Magdinier, Frederique/I-4735-2016; Verhoeyen, Els/AAW-4853-2021; amiard, simon/J-6951-2015	Londono-Vallejo, Arturo/0000-0003-3535-7563; Biroccio, Annamaria/0000-0003-3198-3532; Rizzo, Angela/0000-0001-5421-3085; Britton, Sébastien/0000-0002-7008-5316; Magdinier, Frederique/0000-0002-0159-9559; Verhoeyen, Els/0000-0001-9224-5491; amiard, simon/0000-0002-0427-1647; ye, jing/0000-0002-9471-3321; Calsou, Patrick/0000-0001-7951-9806; Sabatier, Laure/0000-0003-0552-6549; Bizard, Anna/0000-0003-1858-3999; Giraud-Panis, Marie-Josephe/0000-0001-7941-2873; NADAL, Marc/0000-0001-9637-7694; Salvati, Erica/0000-0002-3373-7442	Ligue Nationale contre le Cancer; Institut National du Cancer; Agence Nationale de la Recherche; European Community [RISC-RAD FI6R-CT-2003-508842, TELOMARKER Health-F2-2007-200950]; Italian Association for Cancer Research; Association pour la Recherche sur le Cancer	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche(French National Research Agency (ANR)); European Community(European Commission); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council)	We thank S. Gasser and F. Palladino for critical reading and also M. Foiani and T. Weinert for stimulating discussions. We are also grateful to E. Giulotto for advice concerning the choice of the natural ITS sequences, J.P. de Villartay for the primary fibroblast cells, and J.P. Murnane for SNG28 cell line. This work was supported by grants from the Ligue Nationale contre le Cancer (E. G., "equipe labellisee"), from the Institut National du Cancer (E. G., B. S., A. L. V., and L. S., program TELINCA), from Agence Nationale de la Recherche (E. G., programs TELOREG and TELOREP) and from the European Community (E. G. and L. S., RISC-RAD FI6R-CT-2003-508842; E. G., TELOMARKER Health-F2-2007-200950). The work of A. Biroccio's group was supported by grants from Italian Association for Cancer Research. Microscopy and image processing and analysis were performed at the imaging facility Plateau Technique Imagerie/Microscopie of IFR128. J.Y. and C. L. were supported by a fellowship from the Association pour la Recherche sur le Cancer.	Amiard S, 2007, NAT STRUCT MOL BIOL, V14, P147, DOI 10.1038/nsmb1192; ARNOULT N, 2009, GENE DEV, V15, P1915; Bae JB, 2008, ONCOGENE, V27, P5045, DOI 10.1038/onc.2008.139; Bankhead T, 2006, MOL MICROBIOL, V62, P895, DOI 10.1111/j.1365-2958.2006.05423.x; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [DOI 10.1038/NATURE02118, 10.1038/nature02118]; Damelin M, 2007, BRIT J CANCER, V96, P201, DOI 10.1038/sj.bjc.6603537; Demuth I, 2004, ONCOGENE, V23, P8611, DOI 10.1038/sj.onc.1207895; Demuth I, 2008, DNA REPAIR, V7, P1192, DOI 10.1016/j.dnarep.2008.03.020; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Desmaze C, 2004, CYTOGENET GENOME RES, V104, P123, DOI 10.1159/000077476; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Freibaum BD, 2008, J BIOL CHEM, V283, P23671, DOI 10.1074/jbc.M800388200; GASSER SM, 1986, J MOL BIOL, V188, P613, DOI 10.1016/S0022-2836(86)80010-9; Germe T, 2009, EMBO J, V28, P2803, DOI 10.1038/emboj.2009.223; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HECK MMS, 1988, P NATL ACAD SCI USA, V85, P1086, DOI 10.1073/pnas.85.4.1086; Hejna J, 2007, NUCLEIC ACIDS RES, V35, P6115, DOI 10.1093/nar/gkm530; Lam YC, 2010, EMBO J, V29, P2230, DOI 10.1038/emboj.2010.58; Lenain C, 2006, CURR BIOL, V16, P1303, DOI 10.1016/j.cub.2006.05.021; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lundblad V, 2000, MUTAT RES-FUND MOL M, V451, P227, DOI 10.1016/S0027-5107(00)00052-X; Mattern KA, 2004, MOL CELL BIOL, V24, P5587, DOI 10.1128/MCB.24.12.5587-5594.2004; Mignon-Ravix C, 2002, EUR J HUM GENET, V10, P107, DOI 10.1038/sj.ejhg.5200775; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pannicke U, 2004, EMBO J, V23, P1987, DOI 10.1038/sj.emboj.7600206; Pawelczak KS, 2010, DNA REPAIR, V9, P670, DOI 10.1016/j.dnarep.2010.03.002; Poinsignon C, 2004, J EXP MED, V199, P315, DOI 10.1084/jem.20031142; Postow L, 2001, P NATL ACAD SCI USA, V98, P8219, DOI 10.1073/pnas.111006998; Salvati E, 2007, J CLIN INVEST, V117, P3236, DOI 10.1172/JCI32461; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Stansel RM, 2001, EMBO J, V20, P5532; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; Tourriere H, 2007, DNA REPAIR, V6, P900, DOI 10.1016/j.dnarep.2007.02.004; van Overbeek M, 2006, CURR BIOL, V16, P1295, DOI 10.1016/j.cub.2006.05.022; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Vannier JB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000380; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	51	136	140	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					230	242		10.1016/j.cell.2010.05.032	http://dx.doi.org/10.1016/j.cell.2010.05.032			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655466	Bronze			2022-12-01	WOS:000280204300015
J	Behr, MA; Divangahi, M; Lalande, JD				Behr, Marcel A.; Divangahi, Maziar; Lalande, Jean-Daniel			What's in a name? The (mis)labelling of Crohn's as an autoimmune disease	LANCET			English	Editorial Material							ACUTE-INFLAMMATION; AUTOANTIBODIES; INFECTIONS; ANTIBODIES		[Behr, Marcel A.; Divangahi, Maziar; Lalande, Jean-Daniel] McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; [Divangahi, Maziar] McGill Univ, Meakins Christie Labs, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University	Behr, MA (corresponding author), McGill Univ, Dept Med, Ctr Hlth, A5-156,1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	marcel.behr@mcgill.ca			Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; CROHN BB, 1984, JAMA-J AM MED ASSOC, V251, P73, DOI 10.1001/jama.251.1.73; Desplat-Jego S, 2007, WORLD J GASTROENTERO, V13, P2312, DOI 10.3748/wjg.v13.i16.2312; Dinarello CA, 2007, SEMIN NEPHROL, V27, P98, DOI 10.1016/j.semnephrol.2006.09.013; Dos KM, 2008, INFLAMM BOWEL DIS, V14, pS97, DOI 10.1002/ibd.20723; Lettre G, 2008, HUM MOL GENET, V17, pR116, DOI 10.1093/hmg/ddn246; Lidar M, 2009, ANN NY ACAD SCI, V1173, P640, DOI 10.1111/j.1749-6632.2009.04673.x; Lowe AM, 2008, LANCET INFECT DIS, V8, P720, DOI 10.1016/S1473-3099(08)70257-3; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; ROSE NR, 1993, IMMUNOL TODAY, V14, P426, DOI 10.1016/0167-5699(93)90244-F; Rothman KJ, 2005, AM J PUBLIC HEALTH, V95, pS144, DOI 10.2105/AJPH.2004.059204; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schoepfer AM, 2009, INFLAMM BOWEL DIS, V15, P1358, DOI 10.1002/ibd.20892; Seibold F, 1997, GUT, V40, P481, DOI 10.1136/gut.40.4.481; Seidelin JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007794; Sirota M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000792; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233; Stetson DB, 2007, IMMUNITY, V27, P546, DOI 10.1016/j.immuni.2007.10.005; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816	20	18	19	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 17	2010	376	9736					202	203		10.1016/S0140-6736(10)60282-6	http://dx.doi.org/10.1016/S0140-6736(10)60282-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	630YP	20638565				2022-12-01	WOS:000280313100028
J	Wozny, M				Wozny, Michael			The biological passport and doping in athletics	LANCET			English	Editorial Material									Loma Linda Univ, Sch Med, Loma Linda, CA 92350 USA	Loma Linda University	Wozny, M (corresponding author), Loma Linda Univ, Sch Med, Loma Linda, CA 92350 USA.	mwozny@llu.edu						MCGRATH M, 2010, BBC NEWS CHANNE 0701; NIILER E, 2010, DISCOVERY NEWS  0507; *WORLD AN AG, 2009, QUEST ANSW ATHL BIOL; 2010, BRIT ATHLETES GET BI	4	10	10	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 10	2010	376	9735					79	79		10.1016/S0140-6736(10)61058-6	http://dx.doi.org/10.1016/S0140-6736(10)61058-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	626CJ	20621224				2022-12-01	WOS:000279943200009
J	Kratz, K; Schopf, B; Kaden, S; Sendoel, A; Eberhard, R; Lademann, C; Cannavo, E; Sartori, AA; Hengartner, MO; Jiricny, J				Kratz, Katja; Schoepf, Barbara; Kaden, Svenja; Sendoel, Ataman; Eberhard, Ralf; Lademann, Claudio; Cannavo, Elda; Sartori, Alessandro A.; Hengartner, Michael O.; Jiricny, Josef			Deficiency of FANCD2-Associated Nuclease KIAA1018/FAN1 Sensitizes Cells to Interstrand Crosslinking Agents	CELL			English	Article							STRUCTURE-SPECIFIC ENDONUCLEASE; FANCONI-ANEMIA PATHWAY; DNA; PROTEINS; REPAIR; IDENTIFICATION; REPLICATION; RECOMBINATION; BREAKS; ALPHA	Cytotoxicity of cisplatin and mitomycin C (MMC) is ascribed largely to their ability to generate interstrand crosslinks (ICLs) in DNA, which block the progression of replication forks. The processing of ICLs requires the Fanconi anemia (FA) pathway, excision repair, and translesion DNA synthesis (TLS). It also requires homologous recombination (HR), which repairs double-strand breaks (DSBs) generated by cleavage of the blocked replication forks. Here we describe KIAA1018, an evolutionarily conserved protein that has an N-terminal ubiquitin-binding zinc finger (UBZ) and a C-terminal nuclease domain. KIAA1018 is a 5' -> 3' exonuclease and a structure-specific endonuclease that preferentially incises 50 flaps. Like cells from FA patients, human cells depleted of KIAA1018 are sensitized to ICL-inducing agents and display chromosomal instability. The link of KIAA1018 to the FA pathway is further strengthened by its recruitment to DNA damage through interaction of its UBZ domain with monoubiquitylated FANCD2. We therefore propose to name KIAA1018 FANCD2-associated nuclease, FAN1.	[Kratz, Katja; Schoepf, Barbara; Kaden, Svenja; Lademann, Claudio; Cannavo, Elda; Sartori, Alessandro A.; Jiricny, Josef] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Sendoel, Ataman; Eberhard, Ralf; Hengartner, Michael O.] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Jiricny, Josef] ETH, Dept Biol, CH-8057 Zurich, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Jiricny, J (corresponding author), Univ Zurich, Inst Mol Canc Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	jiricny@imcr.uzh.ch	Hengartner, Michael O/E-6235-2011; Sartori, Alessandro/AAK-7840-2021	Sartori, Alessandro/0000-0003-2770-0333; Hengartner, Michael/0000-0002-7584-596X; Sendoel, Ataman/0000-0002-0381-9965; Port, Barbara/0000-0002-8941-954X	Swiss National Science Foundation [3100A0-118158, 3100A0-128675]; Bonizzi-Theler; Ernst Hadorn	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bonizzi-Theler; Ernst Hadorn	We express our gratitude to John Rouse for the KIAA1018 antibody and for sharing unpublished information, to Milica Enoiu for discussions and for critical reading of the manuscript, Stephanie Felscher for help with evaluation of chromosomal instability, Myriam Marti for help with western blot analyses, Ian Hickson for MUS81/EME1, Ulrich Hubscher for FEN1, Pavel Janscak and Rajakrishnan Kanagaraj for the oligonucleotides, Jordi Surralles for the FANCD2-deficient and WT- or K561R- complemented PD20 cells, Petr Cejka for the Sf9 expression system, and Stefano Ferrari for MG132. We also acknowledge collaborations with Johan de Winter and Hans Joenje and with the group of Shunichi Takeda. The C01G5.8(tm423) deletion allele was kindly provided by Dr. Shohei Mitani (Japanese National Bioresource Project). This work was supported by Swiss National Science Foundation grants nr. 3100A0-118158 (J.J.) and 3100A0-128675 (M.H.). The generous support of the Bonizzi-Theler (J.J.) and Ernst Hadorn (M.H.) Foundations is also gratefully acknowledged.	Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Cannavo E, 2007, J BIOL CHEM, V282, P2976, DOI 10.1074/jbc.M609989200; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; De Silva IU, 2000, MOL CELL BIOL, V20, P7980, DOI 10.1128/MCB.20.21.7980-7990.2000; Ermolova NV, 2003, PROTEIN EXPRES PURIF, V29, P123, DOI 10.1016/S1046-5928(03)00014-7; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gari K, 2008, MOL CELL, V29, P141, DOI 10.1016/j.molcel.2007.11.032; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Kinch LN, 2005, NUCLEIC ACIDS RES, V33, P3598, DOI 10.1093/nar/gki676; Kosinski J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-172; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Peng M, 2007, EMBO J, V26, P3238, DOI 10.1038/sj.emboj.7601754; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Zhang NX, 2002, MOL CELL BIOL, V22, P2388, DOI 10.1128/MCB.22.7.2388-2397.2002	29	204	213	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 9	2010	142	1					77	88		10.1016/j.cell.2010.06.022	http://dx.doi.org/10.1016/j.cell.2010.06.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603016	Bronze			2022-12-01	WOS:000279637300014
J	Yi, JJ; Barnes, AP; Hand, R; Polleux, F; Ehlers, MD				Yi, Jason J.; Barnes, Anthony P.; Hand, Randal; Polleux, Franck; Ehlers, Michael D.			TGF-beta Signaling Specifies Axons during Brain Development	CELL			English	Article							GROWTH-FACTOR-BETA; POLARITY PROTEIN PAR6; TRANSFORMING GROWTH-FACTOR-BETA-1; TARGETED DISRUPTION; NEUROTROPHIC FACTOR; NERVOUS-SYSTEM; CELL-POLARITY; RECEPTOR; NEURONS; EXPRESSION	In the mammalian brain, the specification of a single axon and multiple dendrites occurs early in the differentiation of most neuron types. Numerous intracellular signaling events for axon specification have been described in detail. However, the identity of the extracellular factor(s) that initiate neuronal polarity in vivo is unknown. Here, we report that transforming growth factor beta (TGF-beta) initiates signaling pathways both in vivo and in vitro to fate naive neurites into axons. Neocortical neurons lacking the type II TGF-beta receptor (T beta R2) fail to initiate axons during development. Exogenous TGF-beta is sufficient to direct the rapid growth and differentiation of an axon, and genetic enhancement of receptor activity promotes the formation of multiple axons. Finally, we show that the bulk of these TGF-beta-dependent events are mediated by site-specific phosphorylation of Par6. These results define an extrinsic cue for neuronal polarity in vivo that patterns neural circuits in the developing brain.	[Yi, Jason J.; Ehlers, Michael D.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Yi, Jason J.; Ehlers, Michael D.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Ehlers, Michael D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Barnes, Anthony P.; Hand, Randal; Polleux, Franck] Univ N Carolina, Dept Pharmacol, Ctr Neurosci, Chapel Hill, NC 27599 USA	Duke University; Duke University; Duke University; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	ehlers@neuro.duke.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022; Polleux, Franck/H-9948-2014	Barnes, Anthony/0000-0002-4598-9591; Polleux, Franck/0000-0003-4313-0481	NIMH; NINDS; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH080259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047574] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Irina Lebedeva and Marguerita Klein for excellent technical assistance and Ben Arenkiel, Ian Davison, Juliet Hernandez, Matt Kennedy, and Fan Wang for helpful discussion and critical review of the manuscript. We thank Irwin Liu and Xiao-Fan Wang for the Tgfbr1 shRNA constructs. This work was supported by grants from the NIMH and NINDS to M.D.E. and a Ruth K. Broad Biomedical Foundation fellowship to J.J.Y. M.D.E. is an Investigator of the Howard Hughes Medical Institute.	Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Charron F, 2005, DEVELOPMENT, V132, P2251, DOI 10.1242/dev.01830; Chen ZL, 2009, DEV BIOL, V327, P158, DOI 10.1016/j.ydbio.2008.12.006; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.neuro.17.1.267; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Falk S, 2008, CELL STEM CELL, V2, P472, DOI 10.1016/j.stem.2008.03.006; GREENBURG G, 1982, J CELL BIOL, V95, P333, DOI 10.1083/jcb.95.1.333; Gripp KW, 2000, NAT GENET, V25, P205, DOI 10.1038/76074; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hatanaka Y, 2002, J COMP NEUROL, V454, P1, DOI 10.1002/cne.10421; HEINE UI, 1987, J CELL BIOL, V105, P2861, DOI 10.1083/jcb.105.6.2861; Hung TJ, 1999, DEVELOPMENT, V126, P127; Ikegami R, 2004, DEV CELL, V6, P383, DOI 10.1016/S1534-5807(04)00057-7; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254; Kawano H, 1999, J COMP NEUROL, V408, P147, DOI 10.1002/(SICI)1096-9861(19990531)408:2<147::AID-CNE1>3.0.CO;2-L; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Li M, 2008, J BIOL CHEM, V283, P36257, DOI 10.1074/jbc.M806786200; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Mecha M, 2008, DEV DYNAM, V237, P1709, DOI 10.1002/dvdy.21558; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Ng J, 2008, DEVELOPMENT, V135, P4025, DOI 10.1242/dev.028209; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Polleux F, 1997, J COMP NEUROL, V385, P95; POLLEUX F, 2002, SCI STKE, pPL9; Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541; SAAD B, 1991, J CELL BIOL, V115, P473, DOI 10.1083/jcb.115.2.473; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Scherner O, 2007, J BIOL CHEM, V282, P13934, DOI 10.1074/jbc.M611062200; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shelly M, 2010, SCIENCE, V327, P547, DOI 10.1126/science.1179735; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sometani A, 2001, J NEUROSCI RES, V66, P369, DOI 10.1002/jnr.1229; SONG Y, 2002, TECHNOL CANCER RES T, V1, P1; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; Tomoda T, 1996, DEV BIOL, V179, P79, DOI 10.1006/dbio.1996.0242; Vicario-Abejon C, 2004, NEUROREPORT, V15, P2769; WALTER J, 1987, DEVELOPMENT, V101, P685; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	51	198	200	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2010	142	1					144	157		10.1016/j.cell.2010.06.010	http://dx.doi.org/10.1016/j.cell.2010.06.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603020	Green Published, Green Accepted, Bronze			2022-12-01	WOS:000279637300020
J	Benazeraf, B; Francois, P; Baker, RE; Denans, N; Little, CD; Pourquie, O				Benazeraf, Bertrand; Francois, Paul; Baker, Ruth E.; Denans, Nicolas; Little, Charles D.; Pourquie, Olivier			A random cell motility gradient downstream of FGF controls elongation of an amniote embryo	NATURE			English	Article							CHICK-EMBRYO; MOVEMENT; SOMITOGENESIS; GASTRULATION; BOUNDARY; DYNAMICS; MATRIX	Vertebrate embryos are characterized by an elongated anteroposterior (AP) body axis, which forms by progressive cell deposition from a posterior growth zone in the embryo. Here, we used tissue ablation in the chicken embryo to demonstrate that the caudal presomitic mesoderm (PSM) has a key role in axis elongation. Using time-lapse microscopy, we analysed the movements of fluorescently labelled cells in the PSM during embryo elongation, which revealed a clear posterior-to-anterior gradient of cell motility and directionality in the PSM. We tracked the movement of the PSM extracellular matrix in parallel with the labelled cells and subtracted the extracellular matrix movement from the global motion of cells. After subtraction, cell motility remained graded but lacked directionality, indicating that the posterior cell movements associated with axis elongation in the PSM are not intrinsic but reflect tissue deformation. The gradient of cell motion along the PSM parallels the fibroblast growth factor (FGF)/mitogenactivated protein kinase (MAPK) gradient(1), which has been implicated in the control of cell motility in this tissue(2). Both FGF signalling gain-and loss-of-function experiments lead to disruption of the motility gradient and a slowing down of axis elongation. Furthermore, embryos treated with cell movement inhibitors (blebbistatin or RhoK inhibitor), but not cell cycle inhibitors, show a slower axis elongation rate. We propose that the gradient of random cell motility downstream of FGF signalling in the PSM controls posterior elongation in the amniote embryo. Our data indicate that tissue elongation is an emergent property that arises from the collective regulation of graded, random cell motion rather than by the regulation of directionality of individual cellular movements.	[Benazeraf, Bertrand; Pourquie, Olivier] Howard Hughes Med Inst, Kansas City, MO 64110 USA; [Benazeraf, Bertrand; Denans, Nicolas; Pourquie, Olivier] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Benazeraf, Bertrand; Denans, Nicolas; Pourquie, Olivier] Univ Strasbourg, CNRS, INSERM, IGBMC,UMR 7104,U964, F-67400 Illkirch Graffenstaden, France; [Francois, Paul] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10065 USA; [Baker, Ruth E.] Univ Oxford, Math Inst, Ctr Math Biol, Oxford OX1 3LB, England; [Little, Charles D.; Pourquie, Olivier] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Howard Hughes Medical Institute; Stowers Institute for Medical Research; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Rockefeller University; University of Oxford; University of Kansas; University of Kansas Medical Center	Pourquie, O (corresponding author), Howard Hughes Med Inst, Kansas City, MO 64110 USA.	pourquie@igbmc.fr	Benazeraf, Bertrand/X-9968-2019; Pourquié, Olivier/CAJ-5443-2022; Francois, Paul/G-5673-2010	Pourquié, Olivier/0000-0001-5189-1227; Francois, Paul/0000-0002-2223-839X; denans, nicolas/0000-0002-1875-0841; Baker, Ruth/0000-0002-6304-9333	Howard Hughes Medical Institute; Stowers Institute for Medical Research; NIH [R02 HD043158]; Chaire d'excellence; NSF [DMR-0129848]; Lavoisier Fellowship; RCUK Fellowship in Mathematical Biology; Microsoft European Postdoctoral Research Fellowship; Mathers Charitable Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076692] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Stowers Institute for Medical Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chaire d'excellence(French National Research Agency (ANR)); NSF(National Science Foundation (NSF)); Lavoisier Fellowship; RCUK Fellowship in Mathematical Biology; Microsoft European Postdoctoral Research Fellowship(Microsoft); Mathers Charitable Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank R. Li, D. Roellig and members of the Pourquie laboratory for critical reading of the manuscript. The authors acknowledge E. Siggia for support, B. Rongish, M. Filla, C. Cui, A. Peterson, K. Perko, R. Alexander, R. Fender, J. D. Fauny, T. Cheuvront, and members of the IGBMC imaging center for assistance with imaging-related techniques. We thank L. Kennedy and T. Iimura for help with the experiments, and the members of the Cytometry Facility at the Stowers Institute for Medical Research for assistance. We thank S. Leblanc, H. Li, N. Wicker and P. Moncuquet for help with statistical analysis. The authors thank S. Esteban for artwork and J. Chatfield for editorial assistance. This research was supported by the Howard Hughes Medical Institute, the Stowers Institute for Medical Research, NIH grant R02 HD043158 and a Chaire d'excellence to O.P.; P.F. is supported by NSF grant DMR-0129848 (attributed to E. Siggia) and Lavoisier Fellowship. R. E. B. is supported by an RCUK Fellowship in Mathematical Biology and a Microsoft European Postdoctoral Research Fellowship. C. D. L. is supported by the Mathers Charitable Foundation.	AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Araki I, 1999, DEVELOPMENT, V126, P5127; BEDDINGTON RSP, 1994, DEVELOPMENT, V120, P613; BELLAIRS R, 1963, J EMBRYOL EXP MORPH, V11, P697; Berg, 2018, RANDOM WALKS BIOL; Cai AQ, 2006, B MATH BIOL, V68, P25, DOI 10.1007/s11538-005-9028-x; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Charrier JB, 1999, DEVELOPMENT, V126, P4771; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Czirok A, 2002, J MICROSC-OXFORD, V206, P209, DOI 10.1046/j.1365-2818.2002.01032.x; Czirok A, 2006, CURR TOP DEV BIOL, V73, P237, DOI 10.1016/S0070-2153(05)73008-8; Delfini MC, 2005, P NATL ACAD SCI USA, V102, P11343, DOI 10.1073/pnas.0502933102; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; HAMBURGER V, 1992, DEV DYNAM, V195, P273, DOI 10.1002/dvdy.1001950405; Keller R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015007; Kulesa PM, 2002, SCIENCE, V298, P991, DOI 10.1126/science.1075544; Lawson A, 2001, ANAT RECORD, V262, P238, DOI 10.1002/1097-0185(20010301)262:3<238::AID-AR1041>3.0.CO;2-8; MARTIN P, 1992, NATURE, V360, P179, DOI 10.1038/360179a0; Rifes P, 2007, DEVELOPMENT, V134, P3155, DOI 10.1242/dev.003665; Rupp PA, 2003, BIOTECHNIQUES, V34, P274, DOI 10.2144/03342st01; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; SPRATT NT, 1955, J EXP ZOOL, V128, P121, DOI 10.1002/jez.1401280106; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; Waddington CH, 1932, PHILOS T R SOC LON B, V221, P179, DOI 10.1098/rstb.1932.0003; Watanabe T, 2007, DEV BIOL, V305, P625, DOI 10.1016/j.ydbio.2007.01.042; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3; Zamir EA, 2006, P NATL ACAD SCI USA, V103, P19806, DOI 10.1073/pnas.0606100103; Zamir EA, 2008, PLOS BIOL, V6, P2163, DOI 10.1371/journal.pbio.0060247	30	194	196	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2010	466	7303					248	252		10.1038/nature09151	http://dx.doi.org/10.1038/nature09151			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613841	Green Accepted			2022-12-01	WOS:000279580800039
J	Hollander, JA; Im, HI; Amelio, AL; Kocerha, J; Bali, P; Lu, Q; Willoughby, D; Wahlestedt, C; Conkright, MD; Kenny, PJ				Hollander, Jonathan A.; Im, Heh-In; Amelio, Antonio L.; Kocerha, Jannet; Bali, Purva; Lu, Qun; Willoughby, David; Wahlestedt, Claes; Conkright, Michael D.; Kenny, Paul J.			Striatal microRNA controls cocaine intake through CREB signalling	NATURE			English	Article							ADDICTION-LIKE BEHAVIOR; GENE-EXPRESSION; DORSAL STRIATUM; DRUG-ADDICTION; RAF INHIBITOR; ACTIVATION; SEEKING; BRAIN; NEUROPLASTICITY; PLASTICITY	Cocaine addiction is characterized by a gradual loss of control over drug use, but the molecular mechanisms regulating vulnerability to this process remain unclear. Here we report that microRNA-212 (miR-212) is upregulated in the dorsal striatum of rats with a history of extended access to cocaine. Striatal miR-212 decreases responsiveness to the motivational properties of cocaine by markedly amplifying the stimulatory effects of the drug on cAMP response element binding protein (CREB) signalling. This action occurs through miR-212-enhanced Raf1 activity, resulting in adenylyl cyclase sensitization and increased expression of the essential CREB co-activator TORC (transducer of regulated CREB; also known as CRTC). Our findings indicate that striatal miR-212 signalling has a key role in determining vulnerability to cocaine addiction, reveal new molecular regulators that control the complex actions of cocaine in brain reward circuitries and provide an entirely new direction for the development of anti-addiction therapeutics based on the modulation of noncoding RNAs.	[Hollander, Jonathan A.; Im, Heh-In; Bali, Purva; Lu, Qun; Kenny, Paul J.] Scripps Res Inst, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL 33458 USA; [Amelio, Antonio L.; Conkright, Michael D.] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Kocerha, Jannet; Wahlestedt, Claes] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA; [Kocerha, Jannet; Wahlestedt, Claes] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Willoughby, David] Ocean Ridge Biosci, Palm Beach Gardens, FL 33410 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Kenny, PJ (corresponding author), Scripps Res Inst, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL 33458 USA.	pjkenny@scripps.edu		Amelio, Antonio L./0000-0002-6295-2694	National Institute on Drug Abuse (NIDA); NATIONAL CANCER INSTITUTE [F32CA134121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025983, F32DA024932] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a grant from the National Institute on Drug Abuse (NIDA) to P.J.K. and C.W., and NIDA post-doctoral awards to J.A.H. and H.-I.I. We thank M. Fallahi-Sichani for help with miRNA expression analysis and T. Balla for the Raf1 expression constructs. We also thank C. Fowler and P. Griffin for comments on the manuscript, and NIDA for supplying the cocaine used in these studies. This is manuscript 19873 from Scripps Florida.	Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Amelio AL, 2007, P NATL ACAD SCI USA, V104, P20314, DOI 10.1073/pnas.0707999105; Anthony JC, 1994, EXP CLIN PSYCHOPHARM, V2, P244, DOI 10.1037/1064-1297.2.3.244; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beazely MA, 2005, MOL PHARMACOL, V67, P250, DOI 10.1124/mol.104.001370; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Belin D, 2009, BIOL PSYCHIAT, V65, P863, DOI 10.1016/j.biopsych.2008.05.031; Bondeva T, 2002, MOL BIOL CELL, V13, P2323, DOI 10.1091/mbc.E02-01-0019; Brems H, 2007, NAT GENET, V39, P1120, DOI 10.1038/ng2113; Caine S. B., 1993, BEHAV NEUROSCIENCE P, V2, P117; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Chandrasekar V, 2009, MOL CELL NEUROSCI, V42, P350, DOI 10.1016/j.mcn.2009.08.009; Chin PC, 2004, J NEUROCHEM, V90, P595, DOI 10.1111/j.1471-4159.2004.02530.x; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Ding QM, 2004, MOL PHARMACOL, V66, P921, DOI 10.1124/mol.66.4.921; DiNieri JA, 2009, J NEUROSCI, V29, P1855, DOI 10.1523/JNEUROSCI.5104-08.2009; DUMAN RS, 1988, J PHARMACOL EXP THER, V246, P1033; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Hall-Jackson CA, 1999, CHEM BIOL, V6, P559, DOI 10.1016/S1074-5521(99)80088-X; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Ito R, 2002, J NEUROSCI, V22, P6247; Kalivas PW, 2008, NEUROPSYCHOPHARMACOL, V33, P166, DOI 10.1038/sj.npp.1301564; Kenny PJ, 2006, NEUROPSYCHOPHARMACOL, V31, P1203, DOI 10.1038/sj.npp.1300905; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Kovacs KA, 2007, P NATL ACAD SCI USA, V104, P4700, DOI 10.1073/pnas.0607524104; Li SA, 2009, J NEUROSCI, V29, P2334, DOI 10.1523/JNEUROSCI.2296-08.2009; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; McClung CA, 2008, NEUROPSYCHOPHARMACOL, V33, P3, DOI 10.1038/sj.npp.1301544; Nishi A, 2008, J NEUROSCI, V28, P10460, DOI 10.1523/JNEUROSCI.2518-08.2008; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Paterson NE, 2003, NEUROREPORT, V14, P2229, DOI 10.1097/00001756-200312020-00019; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Perkins DO, 2005, MOL PSYCHIATR, V10, P69, DOI 10.1038/sj.mp.4001577; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Piazza PV, 2000, J NEUROSCI, V20, P4226; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Rogaev EI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1404, DOI 10.1007/s10541-005-0276-z; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Varga EV, 2002, EUR J PHARMACOL, V451, P101, DOI 10.1016/S0014-2999(02)02220-3; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Zhou Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000016	59	292	325	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					197	U66		10.1038/nature09202	http://dx.doi.org/10.1038/nature09202			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613834	Green Accepted			2022-12-01	WOS:000279580800028
J	Budd, AF; Pandolfi, JM				Budd, Ann F.; Pandolfi, John M.			Evolutionary Novelty Is Concentrated at the Edge of Coral Species Distributions	SCIENCE			English	Article							MONTASTRAEA-ANNULARIS; REEF CORAL; CLIMATE-CHANGE; BIODIVERSITY HOTSPOTS; HYBRIDIZATION; CONSERVATION; SPECIATION; COMPLEX; PLEISTOCENE; POPULATIONS	Conservation priorities are calculated on the basis of species richness, endemism, and threats. However, areas ranked highly for these factors may not represent regions of maximal evolutionary potential. The relationship between geography and evolutionary innovation was analyzed in a dominant complex of Caribbean reef corals, in which morphological and genetic data concur on species differences. Based on geometric morphometrics of Pleistocene corals and genetically characterized modern colonies, we found that morphological disparity varies from the center to the edge of the Caribbean, and we show that lineages are static at well-connected central locations but split or fuse in edge zones where gene flow is limited. Thus, conservation efforts in corals should focus not only on the centers of diversity but also on peripheral areas of species ranges and population connectivity.	[Budd, Ann F.] Univ Iowa, Dept Geosci, Iowa City, IA 52242 USA; [Pandolfi, John M.] Univ Queensland, Sch Biol Sci, Ctr Marine Studies, Brisbane, Qld, Australia; [Pandolfi, John M.] Univ Queensland, Australian Res Council, Ctr Excellence Coral Reef Studies, Brisbane, Qld, Australia	University of Iowa; University of Queensland; University of Queensland	Budd, AF (corresponding author), Univ Iowa, Dept Geosci, Iowa City, IA 52242 USA.	ann-budd@uiowa.edu	Pandolfi, John M/A-3121-2009	Pandolfi, John M/0000-0003-3047-6694	NSF [EAR97-25273, DEB-0343208]; Smithsonian Institution Marine Science Network; Smithsonian Tropical Research Institute; Australian Research Council Centre of Excellence	NSF(National Science Foundation (NSF)); Smithsonian Institution Marine Science Network; Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Australian Research Council Centre of Excellence(Australian Research Council)	We thank T. Fadiga for assistance with measurements; N. Knowlton and H. Fukami for genetic analyses; and D. Carlon, N. Knowlton, and R. Steneck for comments. The specimens that were analyzed are listed in appendix S1. This research was supported by NSF grants EAR97-25273 and DEB-0343208 to A. F. B. and Smithsonian Institution Marine Science Network and Biodiversity grants, a Smithsonian Tropical Research Institute Tupper Fellowship, and an Australian Research Council Centre of Excellence grant to J.M.P.	Arnold ML, 1997, NATURAL HYBRIDIZATIO; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Budd AE, 2004, PALEOBIOLOGY, V30, P396, DOI 10.1666/0094-8373(2004)030<0396:OSBAHW>2.0.CO;2; Budd AF, 2001, J PALEONTOL, V75, P527, DOI 10.1666/0022-3360(2001)075<0527:TOAEEO>2.0.CO;2; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chiba S, 2005, EVOLUTION, V59, P1712, DOI 10.1111/j.0014-3820.2005.tb01820.x; Draper G., 1994, CARIBBEAN GEOLOGY IN, P129; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Galindo HM, 2006, CURR BIOL, V16, P1622, DOI 10.1016/j.cub.2006.06.052; Hatta M, 1999, MOL BIOL EVOL, V16, P1607, DOI 10.1093/oxfordjournals.molbev.a026073; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 2002, ECOL LETT, V5, P775, DOI 10.1046/j.1461-0248.2002.00383.x; Jackson JBC, 1999, TRENDS ECOL EVOL, V14, P72, DOI 10.1016/S0169-5347(98)01504-3; KNOWLTON N, 1992, SCIENCE, V255, P330, DOI 10.1126/science.255.5042.330; Levitan DR, 2004, EVOLUTION, V58, P308, DOI 10.1111/j.0014-3820.2004.tb01647.x; Lister A, 2004, PHILOS T R SOC B, V359, P195; Lough JM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034634; Malay MCD, 2010, EVOLUTION, V64, P634, DOI 10.1111/j.1558-5646.2009.00848.x; MANN P, 1999, SED BAS WOR, V4, P3; Miller KJ, 2004, HEREDITY, V92, P557, DOI 10.1038/sj.hdy.6800459; Palumbi SR, 1997, CORAL REEFS, V16, pS47, DOI 10.1007/s003380050241; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pandolfi JM, 2002, EVOLUTION, V56, P479; Pandolfi JM, 2008, MAR ECOL PROG SER, V369, P89, DOI 10.3354/meps07570; Pandolfi JM, 2007, J PALEONTOL, V81, P472, DOI 10.1666/pleo05046.1; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Rocha LA, 2008, J FISH BIOL, V72, P1101, DOI 10.1111/j.1095-8649.2007.01770.x; Severance EG, 2006, MAR BIOL, V150, P57, DOI 10.1007/s00227-006-0332-2; Veron J.E.N., 2000, CORALS WORLD, V1-3; Vollmer SV, 2002, SCIENCE, V296, P2023, DOI 10.1126/science.1069524; Willis BL, 2006, ANNU REV ECOL EVOL S, V37, P489, DOI 10.1146/annurev.ecolsys.37.091305.110136	35	72	74	0	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2010	328	5985					1558	1561		10.1126/science.1188947	http://dx.doi.org/10.1126/science.1188947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558718				2022-12-01	WOS:000278859200046
J	Swain, S; Krause, T; Laramee, P; Stewart, S				Swain, Sharon; Krause, Taryn; Laramee, Phillipe; Stewart, Stephen		Guideline Dev Grp	Guidelines Diagnosis and clinical management of alcohol related physical complications: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material							WITHDRAWAL		[Swain, Sharon; Krause, Taryn; Laramee, Phillipe] Royal Coll Phys London, Natl Clin Guideline Ctr, London NW1 4LE, England; [Stewart, Stephen] Freeman Rd Hosp, Liver Unit, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle Freeman Hospital; Newcastle University - UK	Swain, S (corresponding author), Royal Coll Phys London, Natl Clin Guideline Ctr, London NW1 4LE, England.	Sharon.swain@rcplondon.co.uk		Mortimore, Gerri/0000-0001-6890-4346	National Institute for Health and Clinical Excellence; NIHR-HTA; National Institute for Health Research	National Institute for Health and Clinical Excellence; NIHR-HTA; National Institute for Health Research(National Institute for Health Research (NIHR))	The National Clinical Guideline Centre was commissioned and funded by the National Institute for Health and Clinical Excellence to write this summary.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that (1) All of the authors have no financial support for the submitted work from anyone other than their employers; (2) In the previous three years S Stewart has been a member of the trial management group for a study (steroids or pentoxifylline in alcoholic hepatitis) funded by the NIHR-HTA, the Health Technology Assessment programme, which is part of the National Institute for Health Research; (3) All authors have no spouses, partners, or children with financial relationships that may be relevant to the submitted work; and (4) All authors were members of the Guideline Development Group for the NICE guideline (S Swain the systematic reviewer, PL the health economist, TK the project manager, and S Stewart the clinical lead) but have no other non-financial interests that may be relevant to the submitted work.	CARITHERS RL, 1989, ANN INTERN MED, V110, P685, DOI 10.7326/0003-4819-110-9-685; *CTR PUBL HLTH EXC, 2010, ALC US DIS PREV DEV; *CTR PUBL HLTH EXC, ALC US DIS IN PRESS; Department of Health, 2003, COST ALC HARM NHS EN; *INF CTR HLTH SOC, 2009, STAT ALC ENGL; National Institute for Health and Clinical Excellence, 2010, ALC US DIS DIAGN CLI; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353; UK Liver Transplant Group, 2005, LIV ADV GROUP ALC GU; Ward D, 2009, QJM-INT J MED, V102, P773, DOI 10.1093/qjmed/hcp116; 2010, BRIT NATL FORMULARLY	10	0	0	1	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 16	2010	340								c2942	10.1136/bmj.c2942	http://dx.doi.org/10.1136/bmj.c2942			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JB	20554661				2022-12-01	WOS:000279051900003
J	Bungard, D; Fuerth, BJ; Zeng, PY; Faubert, B; Maas, NL; Viollet, B; Carling, D; Thompson, CB; Jones, RG; Berger, SL				Bungard, David; Fuerth, Benjamin J.; Zeng, Ping-Yao; Faubert, Brandon; Maas, Nancy L.; Viollet, Benoit; Carling, David; Thompson, Craig B.; Jones, Russell G.; Berger, Shelley L.			Signaling Kinase AMPK Activates Stress-Promoted Transcription via Histone H2B Phosphorylation	SCIENCE			English	Article							PROTEIN-KINASE; METABOLIC CHECKPOINT; METHYLATION; COMPLEX; ENERGY; LKB1	The mammalian adenosine monophosphate-activated protein kinase (AMPK) is a serine-threonine kinase protein complex that is a central regulator of cellular energy homeostasis. However, the mechanisms by which AMPK mediates cellular responses to metabolic stress remain unclear. We found that AMPK activates transcription through direct association with chromatin and phosphorylation of histone H2B at serine 36. AMPK recruitment and H2B Ser(36) phosphorylation colocalized within genes activated by AMPK-dependent pathways, both in promoters and in transcribed regions. Ectopic expression of H2B in which Ser(36) was substituted by alanine reduced transcription and RNA polymerase II association to AMPK-dependent genes, and lowered cell survival in response to stress. Our results place AMPK-dependent H2B Ser(36) phosphorylation in a direct transcriptional and chromatin regulatory pathway leading to cellular adaptation to stress.	[Bungard, David; Zeng, Ping-Yao; Maas, Nancy L.; Berger, Shelley L.] Univ Penn, Sch Med, Dept Cellular & Dev Biol, Philadelphia, PA 19104 USA; [Fuerth, Benjamin J.; Faubert, Brandon; Jones, Russell G.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada; [Fuerth, Benjamin J.; Faubert, Brandon; Jones, Russell G.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Zeng, Ping-Yao] Fudan Univ, Inst Biomed Sci Epigenet Program, Shanghai 200032, Peoples R China; [Viollet, Benoit] Univ Paris 05, CNRS, UMR 8104, Inst Cochin, F-75014 Paris, France; [Viollet, Benoit] INSERM, U1016, F-75014 Paris, France; [Carling, David] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Ctr Clin Sci, MRC,Cellular Stress Grp, London W12 0NN, England; [Thompson, Craig B.; Jones, Russell G.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Thompson, Craig B.; Jones, Russell G.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Berger, Shelley L.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Berger, Shelley L.] Univ Penn, Sch Arts & Sci, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; McGill University; McGill University; Fudan University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Imperial College London; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania	Jones, RG (corresponding author), Univ Penn, Sch Med, Dept Cellular & Dev Biol, Philadelphia, PA 19104 USA.	russell.jones@mcgill.ca; bergers@mail.med.upenn.edu	Jones, Russell/AAC-2861-2022; Jones, Russell Graham/ABD-5261-2021; Carling, David/F-1943-2014; Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017	Jones, Russell Graham/0000-0003-2250-4675; Carling, David/0000-0002-2316-1830; Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Faubert, Brandon/0000-0002-2886-886X; Berger, Shelley/0000-0001-5398-4400	NIH [CA078831, CA105463, CA09171]; Canadian Institutes of Health Research [MOP-93799]; McGill Integrated Cancer Research Training Program; Leukemia and Lymphoma Society, NIH, National Cancer Institute; American Association for Cancer Research (AACR); Medical Research Council [MC_U120027537] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA104838, R55CA078831, R01CA078831, T32CA009171, R01CA105463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031862] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); McGill Integrated Cancer Research Training Program; Leukemia and Lymphoma Society, NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)Leukemia and Lymphoma Society); American Association for Cancer Research (AACR); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by NIH grants CA078831 (S. L. B.) and CA105463 (C. B. T.), NIH Training Program in Basic Cancer Research grant CA09171 (D. B.), Canadian Institutes of Health Research grant MOP-93799 (R.G.J.), the McGill Integrated Cancer Research Training Program (B. F.), and the Leukemia and Lymphoma Society, NIH, National Cancer Institute, and American Association for Cancer Research (AACR)/Stand Up to Cancer (C. B. T.). C. B. T. reports the filing of patent applications exploiting the use of AMPK activators in cancer therapy. He is also a member of the board of directors of Merck, the scientific advisory board of Agios Pharmaceuticals, and the medical advisory board of the Howard Hughes Medical Institute.	Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2005, CURR OPIN CELL BIOL, V17, P167, DOI 10.1016/j.ceb.2005.01.006; Hardie DG, 2000, METH MOL B, V99, P63; Ivaldi MS, 2007, GENE DEV, V21, P2818, DOI 10.1101/gad.1604007; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Mcgee SL, 2008, FRONT BIOSCI-LANDMRK, V13, P3022, DOI 10.2741/2907; Salt I, 1998, BIOCHEM J, V334, P177, DOI 10.1042/bj3340177; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; WEEKES J, 1993, FEBS LETT, V334, P335, DOI 10.1016/0014-5793(93)80706-Z; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Zeng PY, 2006, CANCER RES, V66, P10701, DOI 10.1158/0008-5472.CAN-06-0999	19	267	295	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 3	2010	329	5996					1201	1205		10.1126/science.1191241	http://dx.doi.org/10.1126/science.1191241			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645SG	20647423	Green Accepted			2022-12-01	WOS:000281485600035
J	May, M; Boulle, A; Phiri, S; Messou, E; Myer, L; Wood, R; Keiser, O; Sterne, JAC; Dabis, F; Egger, M				May, Margaret; Boulle, Andrew; Phiri, Sam; Messou, Eugene; Myer, Landon; Wood, Robin; Keiser, Olivia; Sterne, Jonathan A. C.; Dabis, Francois; Egger, Matthias		IeDEA So Africa W Africa	Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes	LANCET			English	Article							HIV-1-INFECTED PATIENTS; POSITIVE PATIENTS; SURVIVAL; ANEMIA; MORTALITY; ADULTS; SETTINGS; GENDER; MODEL; ERA	Background Prognostic models have been developed for patients infected with HIV-1 who start combination antiretroviral therapy (ART) in high-income countries, but not for patients in sub-Saharan Africa. We developed two prognostic models to estimate the probability of death in patients starting ART in sub-Saharan Africa. Methods We analysed data for adult patients who started ART in four scale-up programmes in Cote d'Ivoire, South Africa, and Malawi from 2004 to 2007. Patients lost to follow-up in the first year were excluded. We used Weibull survival models to construct two prognostic models: one with CD4 cell count, clinical stage, bodyweight, age, and sex (CD4 count model); and one that replaced CD4 cell count with total lymphocyte count and severity of anaemia (total lymphocyte and haemoglobin model), because CD4 cell count is not routinely measured in many African ART programmes. Death from all causes in the first year of ART was the primary outcome. Findings 912 (8.2%) of 11 153 patients died in the first year of ART. 822 patients were lost to follow-up and not included in the main analysis; 10331 patients were analysed. Mortality was strongly associated with high baseline CD4 cell count (>= 200 cells per mu L vs <25; adjusted hazard ratio 0.21, 95% CI 0.17-0.27), WHO clinical stage (stages III-IV vs I-II; 3.45, 2.43-4.90), bodyweight (60 kg vs <45 kg; 0.23, 0.18-0.30), and anaemia status (none vs severe: 0.27, 0.20-0.36). Other independent risk factors for mortality were low total lymphocyte count, advanced age, and male sex. Probability of death at 1 year ranged from 0.9% (95% CI 0.6-1.4) to 52.5% (43.8-61.7) with the CD4 model, and from 0.9% (0.5-1.4) to 59.6% (48.2-71.4) with the total lymphocyte and haemoglobin model. Both models accurately predict early mortality in patients starting ART in sub-Saharan Africa compared with observed data. Interpretation Prognostic models should be used to counsel patients, plan health services, and predict outcomes for patients with HIV-1 infection in sub-Saharan Africa.	[Keiser, Olivia; Egger, Matthias] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; [May, Margaret; Sterne, Jonathan A. C.] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Boulle, Andrew; Myer, Landon] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Myer, Landon] Columbia Univ, Int Ctr AIDS Care & Treatment Programs, New York, NY USA; [Myer, Landon] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Phiri, Sam] Lighthouse Trust Kamuzu Cent Hosp, Lilongwe, Malawi; [Messou, Eugene] CEPREF Clin, Abidjan, Cote Ivoire; [Messou, Eugene] Programme PAC CI, Abidjan, Cote Ivoire; [Wood, Robin] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Dabis, Francois] Univ Victor Segalen, ISPED, INSERM, U897, Bordeaux, France	University of Bern; University of Bristol; University of Cape Town; Columbia University; Columbia University; University of Cape Town; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Egger, M (corresponding author), Univ Bern, Inst Social & Prevent Med, Finkenhubelweg 11, CH-3012 Bern, Switzerland.	egger@ispm.unibe.ch	DABIS, FRANCOIS/S-9298-2019; May, Margaret T/E-8099-2013; Sterne, Jonathan/Z-3106-2019; Boulle, Andrew/C-1413-2008; Wood, Robin/G-8509-2011	DABIS, FRANCOIS/0000-0002-1614-8857; May, Margaret T/0000-0002-9733-1003; Sterne, Jonathan/0000-0001-8496-6053; Boulle, Andrew/0000-0002-7713-8062; Egger, Matthias/0000-0001-7462-5132; Keiser, Olivia/0000-0001-8191-2789	National Institute of Allergy And Infectious Diseases (NIAID) [1U01AI069924, 5U01AI069919]; National Cancer Institute (NCI); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); United Kingdom Medical Research Council [G0700820]; French Agence Nationale de Recherches sur le SIDA et les Hepatites Virales [ANRS 12101, ANRS 12138]; Swiss National Science Foundation [32473B-122116]; Office of AIDS Research of the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069919, U01AI069924] Funding Source: NIH RePORTER; Medical Research Council [G0100221, G0700820] Funding Source: researchfish; MRC [G0700820, G0100221] Funding Source: UKRI	National Institute of Allergy And Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); French Agence Nationale de Recherches sur le SIDA et les Hepatites Virales(ANRS); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Office of AIDS Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all patients, doctors, and study nurses associated with the four cohort studies. The International epidemiologic Databases to Evaluate AIDS (IeDEA) is supported by the National Institute of Allergy And Infectious Diseases (NIAID) (grant 1U01AI069924 to the Southern African Region and 5U01AI069919 to the West African Region), the National Cancer Institute (NCI) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). MM and JACS were supported by the United Kingdom Medical Research Council (grant G0700820), FD was supported by the French Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (grants ANRS 12101 and 12138) and ME was supported by the Swiss National Science Foundation (grant 32473B-122116) and the Office of AIDS Research of the National Institutes of Health.	Beadles WI, 2009, TROP DOCT, V39, P78, DOI 10.1258/td.2008.080213; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Clark TG, 2003, J CLIN EPIDEMIOL, V56, P28, DOI 10.1016/S0895-4356(02)00539-5; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Harris RJ, 2008, ANTIVIR THER, V13, P959; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Keiser O, 2008, PLOS MED, V5, P1102, DOI 10.1371/journal.pmed.0050148; Lau B, 2005, JAIDS-J ACQ IMM DEF, V39, P620; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lewis DK, 2005, T ROY SOC TROP MED H, V99, P561, DOI 10.1016/j.trstmh.2005.01.002; Lundgren JD, 2002, J INFECT DIS, V185, P178, DOI 10.1086/338267; Madec Y, 2009, AIDS, V23, P853, DOI 10.1097/QAD.0b013e32832913ee; Mangili A, 2006, CLIN INFECT DIS, V42, P836, DOI 10.1086/500398; May M, 2004, STAT MED, V23, P2375, DOI 10.1002/sim.1825; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010; Moore RD, 1998, J ACQ IMMUN DEF SYND, V19, P29, DOI 10.1097/00042560-199809010-00004; Moses A, 1998, BLOOD, V91, P1479, DOI 10.1182/blood.V91.5.1479.1479_1479_1495; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Mwamburi DM, 2005, CLIN INFECT DIS, V40, P167, DOI 10.1086/426591; Ojikutu B, 2008, SAMJ S AFR MED J, V98, P204; Royston P, 2004, STAT MED, V23, P907, DOI 10.1002/sim.1691; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Semba RD, 2002, CLIN INFECT DIS, V34, P260, DOI 10.1086/338151; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; Volberding PA, 2004, CLIN INFECT DIS, V38, P1459, DOI 10.1086/383031; *WHO, UN ACC SCAL PRIOR HI; World Health Organization, 2004, SCAL ANT THER RES LT	34	179	179	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2010	376	9739					449	457		10.1016/S0140-6736(10)60666-6	http://dx.doi.org/10.1016/S0140-6736(10)60666-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639YK	20638120	Green Accepted			2022-12-01	WOS:000281012900030
J	Al-Jabri, S; Malus, M; Tulandi, T				Al-Jabri, Sheikha; Malus, Michael; Tulandi, Togas			Easily Missed? Ectopic pregnancy	BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICAL-EXAMINATION; DIAGNOSIS; EMERGENCY; HISTORY; RISK		[Al-Jabri, Sheikha; Malus, Michael] McGill Univ, Dept Family Med, Montreal, PQ H3A 1A1, Canada	McGill University	Al-Jabri, S (corresponding author), McGill Univ, Dept Family Med, Montreal, PQ H3A 1A1, Canada.	s_umreem@hotmail.com						Buckley RG, 1999, ANN EMERG MED, V34, P589, DOI 10.1016/S0196-0644(99)70160-5; Dart RG, 1999, ANN EMERG MED, V33, P283, DOI 10.1016/S0196-0644(99)70364-1; Job-Spira N, 1999, AM J OBSTET GYNECOL, V180, P938, DOI 10.1016/S0002-9378(99)70665-4; Lewis G, 2007, 7 CEMACH, P92; Lipscomb GH, 1999, NEW ENGL J MED, V341, P1974, DOI 10.1056/NEJM199912233412604; Mol BWJ, 1998, HUM REPROD, V13, P3220, DOI 10.1093/humrep/13.11.3220; Robson SJ, 1996, AUST NZ J OBSTET GYN, V36, P182, DOI 10.1111/j.1479-828X.1996.tb03282.x; STOVALL TG, 1990, ANN EMERG MED, V19, P1098, DOI 10.1016/S0196-0644(05)81511-2; Wong TW, 1998, J ACCID EMERG MED, V15, P155	9	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 30	2010	341								c3770	10.1136/bmj.c3770	http://dx.doi.org/10.1136/bmj.c3770			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634HB	20675392				2022-12-01	WOS:000280570300001
J	Stringer, EM; Ekouevi, DK; Coetzee, D; Tih, PM; Creek, TL; Stinson, K; Giganti, MJ; Welty, TK; Chintu, N; Chi, BH; Wilfert, CM; Shaffer, N; Dabis, F; Stringer, JSA				Stringer, Elizabeth M.; Ekouevi, Didier K.; Coetzee, David; Tih, Pius M.; Creek, Tracy L.; Stinson, Kathryn; Giganti, Mark J.; Welty, Thomas K.; Chintu, Namwinga; Chi, Benjamin H.; Wilfert, Catherine M.; Shaffer, Nathan; Dabis, Francois; Stringer, Jeffrey S. A.		PEARL Study Team	Coverage of Nevirapine-Based Services to Prevent Mother-to-Child HIV Transmission in 4 African Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SINGLE-DOSE NEVIRAPINE; RANDOMIZED-TRIAL; MASS-SPECTROMETRY; PROGRAMS; UGANDA; WOMEN; QUANTIFICATION; SURVEILLANCE; PERFORMANCE	Context Few studies have objectively evaluated the coverage of services to prevent transmission of human immunodeficiency virus (HIV) from mother to child. Objective To measure the coverage of services to prevent mother-to-child HIV transmission in 4 African countries. Design, Setting, and Patients Cross-sectional surveillance study of mother-infant pairs using umbilical cord blood samples collected between June 10, 2007, and October 30, 2008, from 43 randomly selected facilities (grouped as 25 service clusters) providing delivery services in Cameroon, Cote d'Ivoire, South Africa, and Zambia. All sites used at least single-dose nevirapine to prevent mother-to-child HIV transmission and some sites used additional prophylaxis drugs. Main Outcome Measure Population nevirapine coverage, defined as the proportion of HIV-exposed infants in the sample with both maternal nevirapine ingestion (confirmed by cord blood chromatography) and infant nevirapine ingestion (confirmed by direct observation). Results A total of 27 893 cord blood specimens were tested, of which 3324 were HIV seropositive (12%). Complete data for cord blood nevirapine results were available on 3196 HIV-seropositive mother-infant pairs. Nevirapine coverage varied significantly by site (range: 0%-82%). Adjusted for country, the overall coverage estimate was 51% (95% confidence interval [CI], 49%-53%). In multivariable analysis, failed coverage of nevirapine-based services was significantly associated with maternal age younger than 20 years (adjusted odds ratio [AOR], 1.44; 95% CI, 1.18-1.76) and maternal age between 20 and 25 years (AOR, 1.28; 95% CI, 1.07-1.54) vs maternal age of older than 30 years; 1 or fewer antenatal care visits (AOR, 2.91; 95% CI, 2.40-3.54), 2 or 3 antenatal care visits (AOR, 1.93; 95% CI, 1.60-2.33), and 4 or 5 antenatal care visits (AOR, 1.56; 95% CI, 1.34-1.80) vs 6 or more antenatal care visits; vaginal delivery (AOR, 1.22; 95% CI, 1.03-1.44) vs cesarean delivery; and infant birth weight of less than 2500 g (AOR, 1.34; 95% CI, 1.11-1.62) vs birth weight of 3500 g or greater. Conclusion In this random sampling of sites with services to prevent mother-to-child HIV transmission, only 51% of HIV-exposed infants received the minimal regimen of single-dose nevirapine. JAMA. 2010;304(3):293-302 www.jama.com	[Stringer, Elizabeth M.; Giganti, Mark J.; Chintu, Namwinga; Chi, Benjamin H.; Stringer, Jeffrey S. A.] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Ekouevi, Didier K.] Programme PAC CI, Abidjan, Cote Ivoire; [Coetzee, David; Stinson, Kathryn] Univ Cape Town, Sch Publ Hlth & Community Med, Infect Dis & Epidemiol Unit, ZA-7925 Cape Town, South Africa; [Tih, Pius M.; Welty, Thomas K.] Cameroon Baptist Hlth Convent Hlth Board, Bamenda, Cameroon; [Creek, Tracy L.] Ctr Dis Control & Prevent, Ctr HIV AIDS Viral Hepatitis STD & TB Prevent, Global AIDS Program, Atlanta, GA USA; [Wilfert, Catherine M.] Elizabeth Glaser Pediat AIDS Fdn, Santa Monica, CA USA; [Shaffer, Nathan] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland; [Dabis, Francois] Univ Bordeaux 2, Inst Sante Publ Epidemiol & Dev, F-33076 Bordeaux, France	University of Cape Town; Centers for Disease Control & Prevention - USA; World Health Organization; UDICE-French Research Universities; Universite de Bordeaux	Stringer, JSA (corresponding author), Ctr Infect Dis Res Zambia, Plot 1275,Lubutu Rd,POB 34681, Lusaka, Zambia.	stringer@cidrz.org	Stringer, Jeffrey S. A./AAU-2342-2021; DABIS, FRANCOIS/S-9298-2019; EKOUEVI, Didier K/E-7960-2014	DABIS, FRANCOIS/0000-0002-1614-8857; Stringer, Jeffrey/0000-0002-9590-7216	US Centers for Disease Control and Prevention [T0906150021]; Bill and Melinda Gates Foundation [351-07]; Elizabeth Glaser Pediatric AIDS Foundation	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Elizabeth Glaser Pediatric AIDS Foundation	The Zambia, South Africa, and Cote d'Ivoire work was supported by contract T0906150021 from the US Centers for Disease Control and Prevention Global AIDS Program. The Cameroon work was supported by the Bill and Melinda Gates Foundation grant 351-07, which was awarded to the Elizabeth Glaser Pediatric AIDS Foundation.	Chi BH, 2006, HIV CLIN TRIALS, V7, P263, DOI 10.1310/hct0705-263; Cressey TR, 2007, ANTIMICROB AGENTS CH, V51, P3361, DOI 10.1128/AAC.00445-07; Ekouevi DK, 2004, AIDS, V18, P697, DOI 10.1097/00002030-200403050-00018; Gray RH, 2005, LANCET, V366, P1182, DOI 10.1016/S0140-6736(05)67481-8; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Kagaayi J, 2005, JAIDS-J ACQ IMM DEF, V39, P121, DOI 10.1097/01.qai.0000148530.66587.7c; Koal T, 2005, RAPID COMMUN MASS SP, V19, P2995, DOI 10.1002/rcm.2158; Laurito TL, 2002, J MASS SPECTROM, V37, P434, DOI 10.1002/jms.300; Mate KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005483; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Megazzini KM, 2010, AIDS, V24, P447, DOI 10.1097/QAD.0b013e328334b285; Mirochnick M, 2000, CLIN PHARMACOKINET, V39, P281, DOI 10.2165/00003088-200039040-00004; *OFF US GLOB AIDS, CEL LIF; Orne-Gliemann J, 2008, AIDS, V22, P797, DOI 10.1097/QAD.0b013e3282f4f45a; Painter TM, 2004, BMJ-BRIT MED J, V329, P543, DOI 10.1136/bmj.329.7465.543; Plipat T, 2007, AIDS, V21, P145, DOI 10.1097/QAD.0b013e328010e02d; Rollins N, 2007, AIDS, V21, P1341, DOI 10.1097/QAD.0b013e32814db7d4; Shapiro RL, 2006, AIDS, V20, P1281, DOI 10.1097/01.aids.0000232236.26630.35; Songok EM, 2003, AM J TROP MED HYG, V69, P8, DOI 10.4269/ajtmh.2003.69.8; Stringer EM, 2008, B WORLD HEALTH ORGAN, V86, P57, DOI 10.2471/BLT.07.043117; Stringer JSA, 2005, AIDS, V19, P1309, DOI 10.1097/01.aids.0000180102.88511.7d; Stringer JSA, 2004, AIDS, V18, P939, DOI 10.1097/00002030-200404090-00012; *UNAIDS, 2001, UN GEN ASS SPEC SESS; UNAIDS, REP GLOB HIV AIDS EP; Vassall A, 2022, BMJ, V378, DOI [10.1136/bmj.o2320, DOI 10.1136/BMJ.O2320]; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; WEERAHANDI S, 2006, WILEY SERIES PROBABI; *WHO, 2006, ANT DRUGS TREAT WOM; WHO, RAP ADV US ANT DRUGS; WHO, UN ACC	30	113	114	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					293	302		10.1001/jama.2010.990	http://dx.doi.org/10.1001/jama.2010.990			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639563	Bronze			2022-12-01	WOS:000280107500019
J	Perkins, EA; Moran, JA				Perkins, Elizabeth A.; Moran, Julie A.			Aging Adults With Intellectual Disabilities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH-CARE ACCESS; DISPARITIES		[Perkins, Elizabeth A.] Univ S Florida, Coll Behav & Community Sci, Dept Child & Family Studies, Florida Ctr Inclus Communities UCEDD, Tampa, FL 33612 USA; [Moran, Julie A.] Beth Israel Deaconess Med Ctr, Div Gerontol, Boston, MA 02215 USA	State University System of Florida; University of South Florida; Harvard University; Beth Israel Deaconess Medical Center	Perkins, EA (corresponding author), Univ S Florida, Coll Behav & Community Sci, Dept Child & Family Studies, Florida Ctr Inclus Communities UCEDD, 13301 Bruce B Downs Blvd,MHC 2113A, Tampa, FL 33612 USA.	eperkins@mail.usf.edu			PHS HHS [K01-HP00007-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bittles AH, 2002, J GERONTOL A-BIOL, V57, pM470, DOI 10.1093/gerona/57.7.M470; Haveman M, 2010, J POLICY PRACT INTEL, V7, P59, DOI 10.1111/j.1741-1130.2010.00248.x; Havercamp SM, 2004, PUBLIC HEALTH REP, V119, P418, DOI 10.1016/j.phr.2004.05.006; Janicki MP, 2008, DISABIL HEALTH J, V1, P116, DOI 10.1016/j.dhjo.2008.02.004; Janicki MP, 1999, DISABIL REHABIL, V21, P284; Krahn GL, 2006, MENT RETARD DEV D R, V12, P70, DOI 10.1002/mrdd.20098; Krahn GL, 2007, MENT RETARD DEV D R, V13, P160, DOI 10.1002/mrdd.20149; Office of the Surgeon General (US) Office on Disability (US), 2005, SURG GEN CALL ACTION; *US BUR CENS, TABL 2A PROJ POP US; US Public Health Service, 2002, CLOS GAP NAT BLUEPR	10	63	65	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2010	304	1					91	92		10.1001/jama.2010.906	http://dx.doi.org/10.1001/jama.2010.906			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	620SJ	20606156				2022-12-01	WOS:000279519600028
J	Behrends, C; Sowa, ME; Gygi, SP; Harper, JW				Behrends, Christian; Sowa, Mathew E.; Gygi, Steven P.; Harper, J. Wade			Network organization of the human autophagy system	NATURE			English	Article							PROTEIN; UBIQUITIN; ACCUMULATION; COMPLEXES; RUBICON; ATG14L; LC3	Autophagy, the process by which proteins and organelles are sequestered in autophagosomal vesicles and delivered to the lysosome/vacuole for degradation, provides a primary route for turnover of stable and defective cellular proteins. Defects in this system are linked with numerous human diseases. Although conserved protein kinase, lipid kinase and ubiquitin-like protein conjugation subnetworks controlling autophagosome formation and cargo recruitment have been defined, our understanding of the global organization of this system is limited. Here we report a proteomic analysis of the autophagy interaction network in human cells under conditions of ongoing (basal) autophagy, revealing a network of 751 interactions among 409 candidate interacting proteins with extensive connectivity among subnetworks. Many new autophagy interaction network components have roles in vesicle trafficking, protein or lipid phosphorylation and protein ubiquitination, and affect autophagosome number or flux when depleted by RNA interference. The six ATG8 orthologues in humans (MAP1LC3/GABARAP proteins) interact with a cohort of 67 proteins, with extensive binding partner overlap between family members, and frequent involvement of a conserved surface on ATG8 proteins known to interact with LC3-interacting regions in partner proteins. These studies provide a global view of the mammalian autophagy interaction landscape and a resource for mechanistic analysis of this critical protein homeostasis pathway.	[Behrends, Christian; Sowa, Mathew E.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu	Behrends, Christian/AAX-4201-2021	Behrends, Christian/0000-0002-9184-7607; Harper, Jeffrey/0000-0002-6944-7236	Millennium Pharmaceuticals; National Institutes of Health; Paul F. Glenn Foundation on Aging; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070565, R01GM054137, R01GM095567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul F. Glenn Foundation on Aging; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank I. Dikic for discussions and for sharing unpublished data, D. Bowman and J. Ringeling for assistance with Acapela software, N. Perrimon, S. Mohr and M. Ocana for access to the Opera microscope, and N. Gray for Torin1. This work was supported by grants to J. W. H. from Millennium Pharmaceuticals, the National Institutes of Health, and the Paul F. Glenn Foundation on Aging. C. B. is a Humboldt Postdoctoral Fellow.	Cardoso CMP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004424; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jeffries TR, 2004, MOL BIOL CELL, V15, P2652, DOI 10.1091/mbc.E03-10-0732; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.E04-08-0669; KARNITZ LM, 2007, SCI STKE, pPE22; Kinchen JM, 2010, NATURE, V464, P778, DOI 10.1038/nature08853; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Legakis JE, 2007, AUTOPHAGY, V3, P422, DOI 10.4161/auto.4129; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lippai M, 2008, AUTOPHAGY, V4, P476, DOI 10.4161/auto.5719; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Sadler KC, 2005, DEVELOPMENT, V132, P3561, DOI 10.1242/dev.01918; Sakata T, 2004, CURR BIOL, V14, P2228, DOI 10.1016/j.cub.2004.12.028; Sardiu ME, 2008, P NATL ACAD SCI USA, V105, P1454, DOI 10.1073/pnas.0706983105; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Shvets E, 2009, METHOD ENZYMOL, V452, P131, DOI 10.1016/S0076-6879(08)03609-4; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wang CW, 2003, J CELL BIOL, V163, P973, DOI 10.1083/jcb.200308071; Wang Z, 2001, MOL CELL BIOL, V21, P5742, DOI 10.1128/MCB.21.17.5742-5752.2001; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	38	1116	1166	9	200	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					68	U84		10.1038/nature09204	http://dx.doi.org/10.1038/nature09204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20562859	Green Accepted			2022-12-01	WOS:000279343800036
J	Chen, M; Galvao, RM; Li, MN; Burger, B; Bugea, J; Bolado, J; Chory, J				Chen, Meng; Galvao, Rafaelo M.; Li, Meina; Burger, Brian; Bugea, Jane; Bolado, Jack; Chory, Joanne			Arabidopsis HEMERA/pTAC12 Initiates Photomorphogenesis by Phytochromes	CELL			English	Article							BHLH TRANSCRIPTION FACTORS; E3 UBIQUITIN LIGASE; LIGHT CONTROL; INTERACTING FACTORS; BINDING PROTEIN; NUCLEAR-BODIES; DEGRADATION; DNA; PROTEASOME; EXPRESSION	Light plays a profound role in plant development, yet how photoreceptor excitation directs phenotypic plasticity remains elusive. One of the earliest effects of light is the regulated translocation of the red/far-red photoreceptors, phytochromes, from the cytoplasm to subnuclear foci called phytochrome nuclear bodies. The function of these nuclear bodies is unknown. We report the identification of hemera, a seedling lethal mutant of Arabidopsis with altered phytochrome nuclear body patterns. hemera mutants are impaired in all phytochrome responses examined, including proteolysis of phytochrome A and phytochrome-interacting transcription factors. HEMERA was identified previously as pTAC12, a component of a plastid complex associated with transcription. Here, we show that HEMERA has a function in the nucleus, where it acts specifically in phytochrome signaling, is predicted to be structurally similar to the multiubiquitin-binding protein, RAD23, and can partially rescue yeast rad23mutants. Together, these results implicate phytochrome nuclear bodies as sites of proteolysis.	[Chen, Meng; Burger, Brian; Bugea, Jane; Bolado, Jack; Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Bolado, Jack; Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Chen, Meng; Galvao, Rafaelo M.; Li, Meina] Duke Univ, Dept Biol, Durham, NC 27708 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; Duke University	Chen, M (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	chen.meng@duke.edu; chory@salk.edu	Chen, Meng/C-7109-2014	Chen, Meng/0000-0003-0351-5897	National Institutes of Health [R01GM52413]; Duke University [4314268]; National Science Foundation [IOS-0923722]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087388, R01GM052413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke University; National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Akira Nagatani for providing the PBG line, Clark Lagarias for the PHYBYH line, Peter Quail and Sabine Heinhorst for anti-PHYA and anti-SiR antibodies, Kiran Madura for the yeast rad23 Delta rpn10 Delta double mutant, and Enamul Huq for pif1-2 seeds. Benjamin Cole and Kazumasa Nito made critical comments and suggestions regarding this manuscript. The work was supported by a grant from the National Institutes of Health (R01GM52413) to J.C., the Howard Hughes Medical Institute (J.C.), a startup fund (4314268) to M. C. from Duke University, and a grant from the National Science Foundation to M. C. (IOS-0923722).	Al-Sady B, 2006, MOL CELL, V23, P439, DOI 10.1016/j.molcel.2006.06.011; Al-Sady B, 2008, P NATL ACAD SCI USA, V105, P2232, DOI 10.1073/pnas.0711675105; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ANG LH, 1994, PLANT CELL, V6, P613, DOI 10.1105/tpc.6.5.613; Bauer D, 2004, PLANT CELL, V16, P1433, DOI 10.1105/tpc.021568; Castillon A, 2007, TRENDS PLANT SCI, V12, P514, DOI 10.1016/j.tplants.2007.10.001; Chen HD, 2006, PLANT CELL, V18, P1991, DOI 10.1105/tpc.106.043224; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Chen M, 2005, CURR BIOL, V15, P637, DOI 10.1016/j.cub.2005.02.028; Chen M, 2003, P NATL ACAD SCI USA, V100, P14493, DOI 10.1073/pnas.1935989100; Chen M, 2000, PLANT J, V22, P303, DOI 10.1046/j.1365-313x.2000.00738.x; Chen M, 2008, CURR OPIN PLANT BIOL, V11, P503, DOI 10.1016/j.pbi.2008.06.012; Chi-Ham CL, 2002, PLANT MOL BIOL, V49, P621, DOI 10.1023/A:1015500431421; CHORY J, 1993, TRENDS GENET, V9, P167, DOI 10.1016/0168-9525(93)90163-C; Clough RC, 1997, PLANT CELL ENVIRON, V20, P713, DOI 10.1046/j.1365-3040.1997.d01-107.x; Desveaux D, 2004, DEV CELL, V6, P229, DOI 10.1016/S1534-5807(04)00028-0; Elich TD, 1997, PLANT CELL, V9, P2271, DOI 10.1105/tpc.9.12.2271; Farmer LM, 2010, PLANT CELL, V22, P124, DOI 10.1105/tpc.109.072660; Huq E, 2004, SCIENCE, V305, P1937, DOI 10.1126/science.1099728; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; Jeong SY, 2003, NUCLEIC ACIDS RES, V31, P5175, DOI 10.1093/nar/gkg693; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Khanna R, 2006, PLANT CELL, V18, P2157, DOI 10.1105/tpc.106.042200; Kircher S, 2002, PLANT CELL, V14, P1541, DOI 10.1105/tpc.001156; Lafarga M, 2002, MOL BIOL CELL, V13, P2771, DOI 10.1091/mbc.E02-03-0122; Lambertson D, 1999, GENETICS, V153, P69; Lee J, 2008, J NEUROSCI RES, V86, P961, DOI 10.1002/jnr.21564; Leivar P, 2008, CURR BIOL, V18, P1815, DOI 10.1016/j.cub.2008.10.058; Leivar P, 2008, PLANT CELL, V20, P337, DOI 10.1105/tpc.107.052142; Leivar P, 2009, PLANT CELL, V21, P3535, DOI 10.1105/tpc.109.070672; Lorrain S, 2008, PLANT J, V53, P312, DOI 10.1111/j.1365-313X.2007.03341.x; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; MACKENZIE JM, 1975, P NATL ACAD SCI USA, V72, P799, DOI 10.1073/pnas.72.3.799; Maloof JN, 2001, NAT GENET, V29, P441, DOI 10.1038/ng777; Mas P, 2000, NATURE, V408, P207, DOI 10.1038/35041583; Meier I, 1996, PLANT CELL, V8, P2105, DOI 10.1105/tpc.8.11.2105; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; PARKS BM, 1991, PLANT CELL, V3, P1177, DOI 10.1105/tpc.3.11.1177; Pfalz J, 2006, PLANT CELL, V18, P176, DOI 10.1105/tpc.105.036392; PRATT LH, 1974, BIOCHIM BIOPHYS ACTA, V365, P93, DOI 10.1016/0005-2795(74)90253-0; Prikryl J, 2008, NUCLEIC ACIDS RES, V36, P5152, DOI 10.1093/nar/gkn492; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Reed Jason W., 1994, Seminars in Cell Biology, V5, P327, DOI 10.1006/scel.1994.1039; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Romero-Perez L, 2007, J BIOL CHEM, V282, P35574, DOI 10.1074/jbc.M704857200; Rosler J, 2007, P NATL ACAD SCI USA, V104, P10737, DOI 10.1073/pnas.0703855104; Sauer M, 2006, NAT PROTOC, V1, P98, DOI 10.1038/nprot.2006.15; Schroeder DF, 2002, CURR BIOL, V12, P1462, DOI 10.1016/S0960-9822(02)01106-5; Seo HS, 2004, GENE DEV, V18, P617, DOI 10.1101/gad.1187804; Sessions A, 1999, PLANT J, V20, P259, DOI 10.1046/j.1365-313x.1999.00594.x; Shen H, 2008, PLANT CELL, V20, P1586, DOI 10.1105/tpc.108.060020; Su YS, 2007, PLANT CELL, V19, P2124, DOI 10.1105/tpc.107.051516; Wei N, 1996, PLANT PHYSIOL, V112, P871, DOI 10.1104/pp.112.3.871; Yamaguchi R, 1999, J CELL BIOL, V145, P437, DOI 10.1083/jcb.145.3.437; Yoo HH, 2007, PLANT J, V49, P442, DOI 10.1111/j.1365-313X.2006.02974.x; Yoo SY, 2005, PLANTA, V221, P523, DOI 10.1007/s00425-004-1466-4; Yu XH, 2009, PLANT CELL, V21, P118, DOI 10.1105/tpc.108.061663; Zhang Y, 2008, PLANT CELL, V20, P1437, DOI 10.1105/tpc.108.058891	59	166	176	1	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 25	2010	141	7					1230	U237		10.1016/j.cell.2010.05.007	http://dx.doi.org/10.1016/j.cell.2010.05.007			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20603003	Green Accepted, Bronze			2022-12-01	WOS:000279148100019
J	Clayton, J				Clayton, Julie			The promise of T-cruzi genomics	NATURE			English	Editorial Material																		ELSAYED NM, SCIENCE, V309, P409; ELSAYED NM, SCIENCE, V309, P404	2	6	6	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					S16	S17		10.1038/nature09225	http://dx.doi.org/10.1038/nature09225			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20571549	Bronze			2022-12-01	WOS:000279056900029
J	Lubchenco, J; Sutley, N				Lubchenco, Jane; Sutley, Nancy			Proposed US Policy for Ocean, Coast, and Great Lakes Stewardship	SCIENCE			English	Editorial Material							MANAGEMENT		[Lubchenco, Jane] Under Secretary Commerce Oceans & Atmosphere, Washington, DC 20230 USA; [Lubchenco, Jane] NOAA, Washington, DC 20230 USA; [Sutley, Nancy] Council Environm Qual & Interagency Ocean Policy, Washington, DC 20050 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Lubchenco, J (corresponding author), Under Secretary Commerce Oceans & Atmosphere, Washington, DC 20230 USA.	jane.lubchenco@noaa.gov						[Anonymous], 2006, MARINE COASTAL ECOSY; *COUNC ENV QUAL, 2009, INT OC POL TASK FORC; Crowder LB, 2006, SCIENCE, V313, P617, DOI 10.1126/science.1129706; Daily GC., 1997, ISSUES ECOL, V2, P1; Douvere F, 2008, MAR POLICY, V32, P762, DOI 10.1016/j.marpol.2008.03.021; Lester SE, 2010, BIOL CONSERV, V143, P576, DOI 10.1016/j.biocon.2009.11.021; Lubchenco J, 2010, OCEANOGRAPHY, V23, P115, DOI 10.5670/oceanog.2010.55; McLeod K., 2009, ECOSYSTEM BASED MANA; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Murawski SA, 2007, MAR POLICY, V31, P681, DOI 10.1016/j.marpol.2007.03.011; Obama B., 2009, COMMUNICATION   0612; Pew Oceans Commission, 2003, AM LIV OC CHART COUR; Rosenberg A. A., 2009, ECOSYSTEM BASED MANA, P294; Stokstad E, 2009, SCIENCE, V326, P1618, DOI 10.1126/science.326.5960.1618; *US COMM OC POL, 2004, OC BLUEPR 21 CENT FI	15	70	72	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1485	1486		10.1126/science.1190041	http://dx.doi.org/10.1126/science.1190041			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	611XW	20558691				2022-12-01	WOS:000278859200019
J	Lee, VJ; Yap, J; Cook, AR; Chen, MI; Tay, JK; Tan, BH; Loh, JP; Chew, SW; Koh, WH; Lin, R; Cui, L; Lee, CWH; Sung, W; Wong, CW; Hibberd, ML; Kang, WL; Seet, B; Tambyah, PA				Lee, Vernon J.; Yap, Jonathan; Cook, Alex R.; Chen, Mark I.; Tay, Joshua K.; Tan, Boon Huan; Loh, Jin Phang; Chew, Seok Wei; Koh, Wee Hong; Lin, Raymond; Cui, Lin; Lee, Charlie W. H.; Sung, Wing-Kin; Wong, Christopher W.; Hibberd, Martin L.; Kang, Wee Lee; Seet, Benjamin; Tambyah, Paul A.			Oseltamivir Ring Prophylaxis for Containment of 2009 H1N1 Influenza Outbreaks.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PANDEMIC INFLUENZA; AMANTADINE	Background: From June 22 through June 25, 2009, four outbreaks of infection with the pandemic influenza A (H1N1) virus occurred in Singapore military camps. We report the efficacy of ring chemoprophylaxis (geographically targeted containment by means of prophylaxis) with oseltamivir to control outbreaks of 2009 H1N1 influenza in semiclosed environments. Methods: All personnel with suspected infection were tested and clinically isolated if infection was confirmed. In addition, we administered postexposure ring chemoprophylaxis with oseltamivir and segregated the affected military units to contain the spread of the virus. All personnel were screened three times weekly both for virologic infection, by means of nasopharyngeal swabs and reverse-transcriptase-polymerase-chain-reaction assay with sequencing, and for clinical symptoms, by means of questionnaires. Results: A total of 1175 personnel were at risk across the four sites, with 1100 receiving oseltamivir prophylaxis. A total of 75 personnel (6.4%) were infected before the intervention, and 7 (0.6%) after the intervention. There was a significant reduction in the overall reproductive number (the number of new cases attributable to the index case), from 1.91 (95% credible interval, 1.50 to 2.36) before the intervention to 0.11 (95% credible interval, 0.05 to 0.20) after the intervention. Three of the four outbreaks showed a significant reduction in the rate of infection after the intervention. Molecular analysis revealed that all four outbreaks were derived from the New York lineage of the 2009 H1N1 virus and that cases within each outbreak were due to transmission rather than unrelated episodes of infection. Of the 816 personnel treated with oseltamivir who were surveyed, 63 (7.7%) reported mild, nonrespiratory side effects of the drug, with no severe adverse events. Conclusions: Oseltamivir ring chemoprophylaxis, together with prompt identification and isolation of infected personnel, was effective in reducing the impact of outbreaks of 2009 H1N1 influenza in semiclosed settings. N Engl J Med 2010;362:2166-74.	[Lee, Vernon J.; Yap, Jonathan; Tay, Joshua K.] Minist Def, Biodef Ctr, Singapore, Singapore; [Lee, Vernon J.] Natl Univ Singapore, Ctr Hlth Serv Res, Singapore 117548, Singapore; [Lee, Vernon J.; Chen, Mark I.] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117548, Singapore; [Cook, Alex R.] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117548, Singapore; [Tambyah, Paul A.] Natl Univ Singapore, Div Infect Dis, Singapore 117548, Singapore; [Chen, Mark I.] Tan Tock Seng Hosp, Dept Clin Epidemiol, Singapore, Singapore; [Tan, Boon Huan; Loh, Jin Phang; Chew, Seok Wei; Koh, Wee Hong] DSO Natl Labs, Def Med & Environm Res Inst, Singapore, Singapore; [Lin, Raymond; Cui, Lin] Minist Hlth, Natl Publ Hlth Lab, Singapore, Singapore; [Lee, Charlie W. H.; Sung, Wing-Kin; Wong, Christopher W.; Hibberd, Martin L.] Genome Inst Singapore, Singapore, Singapore; [Kang, Wee Lee; Seet, Benjamin] Headquarters Med Corps, Singapore Armed Forces, Singapore, Singapore; [Lee, Vernon J.] Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Tan Tock Seng Hospital; Ministry of Health-Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Australian National University	Lee, VJ (corresponding author), 42 How Sun Dr, Singapore 538611, Singapore.	vernonljm@hotmail.com	Yap, Jonathan/AAJ-7266-2020; Hibberd, Martin L/D-5050-2009; Chen, Mark/CAG-2949-2022; Cook, Alex/S-3576-2019; Chen, Mark/AGC-5338-2022; Cook, Alex/B-5941-2011; Wong, Christopher/C-5830-2008; Tan, Boon Huan/ABB-8381-2021	Yap, Jonathan/0000-0002-5227-8536; Chen, Mark/0000-0001-9369-5830; Chen, Mark/0000-0001-9369-5830; Cook, Alex/0000-0002-6271-5832; Tan, Boon Huan/0000-0002-4976-7988; Sung, Wing-Kin/0000-0001-7806-7086; Hibberd, Martin/0000-0001-8587-1849	Singapore Ministry of Defence; National University of Singapore; Singapore Agency for Science, Research, and Technology	Singapore Ministry of Defence(Ministry of Defence, Singapore); National University of Singapore(National University of Singapore); Singapore Agency for Science, Research, and Technology	Supported by the Singapore Ministry of Defence, the National University of Singapore (for the statistical analysis), and the Singapore Agency for Science, Research, and Technology (for the genetic sequencing).	Anderson RM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2897; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P213; Cauchemez S, 2006, EMERG INFECT DIS, V12, P110; *CDC DEP HLTH ROC, 2009, INFL PAND STRAT PLAN; *CDCP, 2009, INT GUID ANT REC PAT; Chan KH, 2008, J CLIN VIROL, V42, P65, DOI 10.1016/j.jcv.2007.12.003; DAVIES JR, 1988, J ROY COLL GEN PRACT, V38, P346; DELBIN DJ, 1979, J R COLL GEN PRACT, V29, P151; Earhart KC, 2001, EMERG INFECT DIS, V7, P463, DOI 10.3201/eid0703.017320; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; LEE CW, 2010, NUCL ACIDS RES  0225; Lee PM, 2009, BAYESIAN STAT INTRO; Lee VJ, 2007, EMERG INFECT DIS, V13, P449, DOI 10.3201/eid1303.060309; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Liu PY, 2009, J MICROBIOL IMMUNOL, V42, P114; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; MILNE DG, 1949, BRIT MED J, V1, P571, DOI 10.1136/bmj.1.4604.571; *MIN HLTH SING, 2009, 16 NEW CONF CAS INFL; *MIN HLTH SING, 2009, 1 CONF CAS INFL A H1; *MIN HLTH SING, 2009, CONF NEW CAS INFL H1; Ministry of Health Singapore, 2009, INFL PAND READ RESP; *MOH SING, 2009, 792009 MOH; *MOH SING, CAS DEF MAN HUM INF; *MOH SING, 2009, 442009 MOH; R Core Team,, 2021, R LANG ENV STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Rubin MS, 2008, CLIN INFECT DIS, V47, P47, DOI 10.1086/588658; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Schreiber MJ, 2009, J VIROL, V83, P4163, DOI 10.1128/JVI.02445-08; *STAT SING, KEY ANN IND; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vynnycky E, 2007, INT J EPIDEMIOL, V36, P881, DOI 10.1093/ije/dym071; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; *WHO, 2009, DG DIR GEN STAT FOLL; WHO, 2009, CDC PROT REALT RT PC; World Health Organization, 2009, PROD AV PAND H1N1 20	36	64	65	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 10	2010	362	23					2166	2174		10.1056/NEJMoa0908482	http://dx.doi.org/10.1056/NEJMoa0908482			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608AL	20558367	Green Accepted			2022-12-01	WOS:000278551500005
J	Kelly, AE; Ghenoiu, C; Xue, JZ; Zierhut, C; Kimura, H; Funabiki, H				Kelly, Alexander E.; Ghenoiu, Cristina; Xue, John Z.; Zierhut, Christian; Kimura, Hiroshi; Funabiki, Hironori			Survivin Reads Phosphorylated Histone H3 Threonine 3 to Activate the Mitotic Kinase Aurora B	SCIENCE			English	Article							CHROMOSOMAL PASSENGERS; STRUCTURAL BASIS; SMAC/DIABLO; CHROMATIN; SPINDLE; INCENP; INHIBITION; MECHANISM; BINDING; COMPLEX	A hallmark of mitosis is the appearance of high levels of histone phosphorylation, yet the roles of these modifications remain largely unknown. Here, we demonstrate that histone H3 phosphorylated at threonine 3 is directly recognized by an evolutionarily conserved binding pocket in the BIR domain of Survivin, which is a member of the chromosomal passenger complex (CPC). This binding mediates recruitment of the CPC to chromosomes and the resulting activation of its kinase subunit Aurora B. Consistently, modulation of the kinase activity of Haspin, which phosphorylates H3T3, leads to defects in the Aurora B-dependent processes of spindle assembly and inhibition of nuclear reformation. These findings establish a direct cellular role for mitotic histone H3T3 phosphorylation, which is read and translated by the CPC to ensure accurate cell division.	[Kelly, Alexander E.; Ghenoiu, Cristina; Xue, John Z.; Zierhut, Christian; Funabiki, Hironori] Rockefeller Univ, Lab Chromosome & Cell Biol, New York, NY 10065 USA; [Ghenoiu, Cristina] Cornell Med Sch, Dept Mol Biol, Weill Cornell Grad Sch Biomed Sci, New York, NY 10021 USA; [Kimura, Hiroshi] Osaka Univ, Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Rockefeller University; Cornell University; Osaka University	Kelly, AE (corresponding author), Rockefeller Univ, Lab Chromosome & Cell Biol, New York, NY 10065 USA.	akelly@rockefeller.edu; funabih@rockefeller.edu	Kimura, Hiroshi/B-9524-2015; Kelly, Alexander/AAZ-8425-2021	Kimura, Hiroshi/0000-0003-0854-083X; KELLY, ALEXANDER/0000-0002-3395-6012; Zierhut, Christian/0000-0003-3501-603X; Funabiki, Hironori/0000-0003-4831-4087; Xue, John/0000-0002-7334-0589	Charles H. Revson Biomedical Fellowship; Marie-Josee and Henry Kravis postdoctoral fellowship; Erwin Schrodinger postdoctoral fellowship; Ministry of Education, Culture, Sports, Science and Technology of Japan; NIH [GM075249]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075249] Funding Source: NIH RePORTER	Charles H. Revson Biomedical Fellowship; Marie-Josee and Henry Kravis postdoctoral fellowship; Erwin Schrodinger postdoctoral fellowship(Austrian Science Fund (FWF)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The GenBank accession number for X. laevis Haspin is HM559585. We thank M. Dasso, J. Higgins, and S. Mochida for reagents; T. Maniar and K. Yap for technical assistance; J. Higgins for sharing results; and the Rockefeller University Bio-Imaging Resource Center. This work was supported by a Charles H. Revson Biomedical Fellowship (A. E. K), Marie-Josee and Henry Kravis and Erwin Schrodinger postdoctoral fellowships (C.Z.), grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (H. K.) and NIH (GM075249, H.F.).	Adams RR, 2000, CURR BIOL, V10, P1075, DOI 10.1016/S0960-9822(00)00673-4; Cao LH, 2006, BIOCHEM BIOPH RES CO, V346, P400, DOI 10.1016/j.bbrc.2006.05.131; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Kelly AE, 2007, DEV CELL, V12, P31, DOI 10.1016/j.devcel.2006.11.001; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Markaki Y, 2009, J CELL SCI, V122, P2809, DOI 10.1242/jcs.043810; Polioudaki H, 2004, FEBS LETT, V560, P39, DOI 10.1016/S0014-5793(04)00060-2; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; Sun CH, 2005, BIOCHEMISTRY-US, V44, P11, DOI 10.1021/bi0485171; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Yue ZJ, 2008, J CELL BIOL, V183, P279, DOI 10.1083/jcb.200806118	20	351	363	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					235	239		10.1126/science.1189505	http://dx.doi.org/10.1126/science.1189505			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20705815	Green Accepted			2022-12-01	WOS:000282644600046
J	Rosen, CJ				Rosen, Clifford J.			Revisiting the Rosiglitazone Story - Lessons Learned	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Maine Med Ctr, Res Inst, Scarborough, ME USA	Maine Medical Center	Rosen, CJ (corresponding author), Maine Med Ctr, Res Inst, Scarborough, ME USA.							GRAHAM DJ, 2010, JAMA            0628; Nissen SE, 2007, NEW ENGL J MED, V357, P100; Nissen SE, 2010, ARCH INTERN MED 0628; Rosen CJ, 2007, NEW ENGL J MED, V357, P844, DOI 10.1056/NEJMp078167	4	99	101	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 26	2010	363	9					803	806		10.1056/NEJMp1008233	http://dx.doi.org/10.1056/NEJMp1008233			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642HG	20660395				2022-12-01	WOS:000281196600002
J	Gray, DC; Mahrus, S; Wells, JA				Gray, Daniel C.; Mahrus, Sami; Wells, James A.			Activation of Specific Apoptotic Caspases with an Engineered Small-Molecule-Activated Protease	CELL			English	Article							CELL-DEATH; KEY MEDIATORS; GRANZYME-B; CLEAVAGE; INHIBITION; DROSOPHILA; PATHWAYS; PROTEINS; NEURONS; MYELOMA	Apoptosis is a conserved cellular pathway that results in the activation of cysteine-aspartyl proteases, or caspases. To dissect the nonredundant roles of the executioner caspase-3, -6, and -7 in orchestrating apoptosis, we have developed an orthogonal protease to selectively activate each isoform in human cells. Our approach uses a split-tobacco etch virus (TEV) protease under small-molecule control, which we call the SNIPer, with caspase alleles containing genetically encoded TEV cleavage sites. These studies reveal that all three caspases are transiently activated but only activation of caspase-3 or -7 is sufficient to induce apoptosis. Proteomic analysis shown here and from others reveals that 20 of the 33 subunits of the 26S proteasome can be cut by caspases, and we demonstrate synergy between proteasome inhibition and dose-dependent caspase activation. We propose a model of proteolytic reciprocal negative regulation with mechanistic implications for the combined clinical use of proteasome inhibitors and proapoptotic drugs.	[Gray, Daniel C.; Mahrus, Sami; Wells, James A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Wells, James A.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; [Gray, Daniel C.] Univ Calif San Francisco, Grad Grp Chem & Chem Biol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Wells, JA (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA.	jim.wells@ucsf.edu	Wells, Jim A/O-9854-2016		NIH [R01 GM081051, CA136779]; Hartwell Foundation; University of California [2008-23]; NATIONAL CANCER INSTITUTE [R01CA136779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081051] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hartwell Foundation; University of California(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to members of the Wells lab for useful discussions and to Emily Crawford for curation of the laboratory caspase substrate database. We also thank the UCSF NIKON Imaging Center and Dr. Kurt Thorn for assistance with live-cell imaging. We also thank Drs. Al Burlingame, David Maltby, and Jon Trinidad for use of the Mass Spectrometry Facility at the Mission Bay Campus of UCSF. This work was supported by NIH R01 GM081051 and CA136779 (J.A.W.), The Hartwell Foundation (J.A.W.), and the University of California Systemwide Biotechnology Research & Education Program GREAT Training Grant 2008-23 (D.C.G.).	Adrain C, 2004, J BIOL CHEM, V279, P36923, DOI 10.1074/jbc.M402638200; Albeck JG, 2008, MOL CELL, V30, P11, DOI 10.1016/j.molcel.2008.02.012; Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Casciola-Rosen L, 2007, J BIOL CHEM, V282, P4545, DOI 10.1074/jbc.M606564200; Choi YE, 2009, J BIOL CHEM, V284, P12772, DOI 10.1074/jbc.M807550200; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Ernst JD, 1998, ANAL BIOCHEM, V260, P18, DOI 10.1006/abio.1998.2677; Feeney B, 2006, BIOCHEMISTRY-US, V45, P13249, DOI 10.1021/bi0611964; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Hell K, 2003, CELL DEATH DIFFER, V10, P1234, DOI 10.1038/sj.cdd.4401298; Jang M, 2007, BIOCHEM BIOPH RES CO, V363, P388, DOI 10.1016/j.bbrc.2007.08.183; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Rehm M, 2002, J BIOL CHEM, V277, P24506, DOI 10.1074/jbc.M110789200; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804; Sun XM, 2004, MOL CELL, V14, P81, DOI 10.1016/S1097-2765(04)00156-X; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thiede B, 2005, PROTEOMICS, V5, P2123, DOI 10.1002/pmic.200401110; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Van Damme P, 2005, NAT METHODS, V2, P771, DOI 10.1038/NMETH792; Wang JJ, 2008, J CELL BIOL, V180, P1177, DOI 10.1083/jcb.200709080; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967; Williams DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007474; Wolan DW, 2009, SCIENCE, V326, P853, DOI 10.1126/science.1177585; Yi CH, 2009, DEV CELL, V16, P21, DOI 10.1016/j.devcel.2008.12.012	38	147	160	3	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2010	142	4					637	646		10.1016/j.cell.2010.07.014	http://dx.doi.org/10.1016/j.cell.2010.07.014			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20723762	Bronze, Green Accepted, Green Published			2022-12-01	WOS:000281115900017
J	Muller, MP; Peters, H; Blumer, J; Blankenfeldt, W; Goody, RS; Itzen, A				Mueller, Matthias P.; Peters, Heide; Bluemer, Julia; Blankenfeldt, Wulf; Goody, Roger S.; Itzen, Aymelt			The Legionella Effector Protein DrrA AMPylates the Membrane Traffic Regulator Rab1b	SCIENCE			English	Article							GLUTAMINE-SYNTHETASE; STRUCTURAL BASIS; GTP HYDROLYSIS; ACTIVATION; GTPASES	In the course of Legionnaires' disease, the bacterium Legionella pneumophila affects the intracellular vesicular trafficking of infected eukaryotic cells by recruiting the small guanosine triphosphatase (GTPase) Rab1 to the cytosolic face of the Legionella-containing vacuole. In order to accomplish this, the Legionella protein DrrA contains a specific guanine nucleotide exchange activity for Rab1 activation that exchanges guanosine triphosphate (GTP) for guanosine diphosphate on Rab1. We found that the amino-terminal domain of DrrA possesses adenosine monophosphorylation (AMPylation) activity toward the switch II region of Rab1b, leading to posttranslational covalent modification of tyrosine 77. AMPylation of switch II by DrrA restricts the access of GTPase activating proteins, thereby rendering Rab1b constitutively active.	[Mueller, Matthias P.; Peters, Heide; Bluemer, Julia; Blankenfeldt, Wulf; Goody, Roger S.; Itzen, Aymelt] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, NRW, Germany	Max Planck Society	Blankenfeldt, W (corresponding author), Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, NRW, Germany.	wulf.blankenfeldt@mpi-dortmund.mpg.de; roger.goody@mpi-dortmund.mpg.de; aymelt.itzen@mpi-dortmund.mpg.de	Blankenfeldt, Wulf/F-8877-2010; Itzen, Aymelt/F-5157-2014; Goody, Roger S/J-8845-2014	Blankenfeldt, Wulf/0000-0001-9886-9668; Itzen, Aymelt/0000-0002-4249-5617; Goody, Roger S/0000-0002-0772-0444; Muller, Matthias/0000-0002-1529-8933; Behrmann, Heide/0000-0002-1769-7049	German research foundation [SFB 642]; International Max Planck Research School in Chemical Biology (Dortmund)	German research foundation(German Research Foundation (DFG)); International Max Planck Research School in Chemical Biology (Dortmund)	We thank P. Janning for guidance in tandem mass spectrometry, N. Bleimling for invaluable technical assistance, M. Sulc for help in flow cytometry, the staff of Beamline X10SA at the Paul Scherrer Institute (Villingen, Switzerland), the x-ray communities at the Max Planck Institute (MPI) Dortmund and the MPI Heidelberg (Germany), and M. Machner and A. Barnekow for LidA and MICAL-3 plasmids, respectively. R.S.G. thanks the German research foundation (SFB 642). M.P.M. is grateful to the International Max Planck Research School in Chemical Biology (Dortmund) for financial support. Coordinates of DrrA<INF>9-218</INF> and Rab1b-AMP have been deposited in the Protein Data Bank (Brookhaven National Laboratory) with accession numbers 3NKU and 3NKV, respectively.	Brombacher E, 2009, J BIOL CHEM, V284, P4846, DOI 10.1074/jbc.M807505200; BROWN MS, 1971, P NATL ACAD SCI USA, V68, P2949, DOI 10.1073/pnas.68.12.2949; Cai YY, 2008, CELL, V133, P1202, DOI 10.1016/j.cell.2008.04.049; DATE T, 1991, BIOCHEMISTRY-US, V30, P5286, DOI 10.1021/bi00235a023; Derre I, 2004, INFECT IMMUN, V72, P3048, DOI 10.1128/IAI.72.5.3048-3053.2004; Dumas JJ, 1999, STRUCTURE, V7, P413, DOI 10.1016/S0969-2126(99)80054-9; Fischer J, 2005, BIOCHEM BIOPH RES CO, V328, P415, DOI 10.1016/j.bbrc.2004.12.182; Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225; Ingmundson A, 2007, NATURE, V450, P365, DOI 10.1038/nature06336; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Kagan JC, 2004, J EXP MED, V199, P1201, DOI 10.1084/jem.20031706; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; KINGDON HS, 1967, P NATL ACAD SCI USA, V58, P1703, DOI 10.1073/pnas.58.4.1703; Machner MP, 2006, DEV CELL, V11, P47, DOI 10.1016/j.devcel.2006.05.013; Murata T, 2006, NAT CELL BIOL, V8, P971, DOI 10.1038/ncb1463; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Schoebel S, 2009, MOL CELL, V36, P1060, DOI 10.1016/j.molcel.2009.11.014; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Xu YB, 2010, J MOL BIOL, V396, P773, DOI 10.1016/j.jmb.2009.12.011; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382	20	252	260	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 20	2010	329	5994					946	949		10.1126/science.1192276	http://dx.doi.org/10.1126/science.1192276			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640WN	20651120				2022-12-01	WOS:000281084800035
J	Montaner, JSG; Lima, VD; Barrios, R; Yip, B; Wood, E; Kerr, T; Shannon, K; Harrigan, PR; Hogg, RS; Daly, P; Kendall, P				Montaner, Julio S. G.; Lima, Viviane D.; Barrios, Rolando; Yip, Benita; Wood, Evan; Kerr, Thomas; Shannon, Kate; Harrigan, P. Richard; Hogg, Robert S.; Daly, Patricia; Kendall, Peny			Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study	LANCET			English	Article							SEXUAL TRANSMISSION; PREVENTION; RNA; ACCESS; CURB; AIDS; GROWTH; POLICY	Background Results of cohort studies and mathematical models have suggested that increased coverage with highly active antiretroviral therapy (HAART) could reduce HIV transmission. We aimed to estimate the association between plasma HIV-1 viral load, HAART coverage, and number of new cases of HIV in the population of a Canadian province. Methods We undertook a population-based study of HAART coverage and HIV transmission in British Columbia, Canada. Data for number of HIV tests done and new HIV diagnoses were obtained from the British Columbia Centre for Disease Control. Data for viral load, CD4 cell count, and HAART use were extracted from the British Columbia Centre for Excellence in HIV/AIDS population-based registries. We modelled trends of new HIV-positive tests and number of individuals on HAART using generalised additive models. Poisson log-linear regression models were used to estimate the association between new HIV diagnoses and viral load, year, and number of individuals on HAART. Findings Between 1996 and 2009, the number of individuals actively receiving HAART increased from 837 to 5413 (547% increase; p=0.002), and the number of new HIV diagnoses fell from 702 to 338 per year (52% decrease; p=0.001). The overall correlation between number of individuals on HAART and number of individuals newly testing positive for HIV per year was 0.89 (p<0.0001). For every 100 additional individuals on HAART, the number of new HIV cases decreased by a factor of 0.97 (95% CI 0.96-0.98), and per 1 log,o decrease in viral load, the number of new HIV cases decreased by a factor of 0.86 (0.75-0.98). Interpretation We have shown a strong population-level association between increasing HAART coverage, decreased viral load, and decreased number of new HIV diagnoses per year. Our results support the proposed secondary benefit of HAART used within existing medical guidelines to reduce HIV transmission.	[Montaner, Julio S. G.; Lima, Viviane D.; Barrios, Rolando; Yip, Benita; Wood, Evan; Kerr, Thomas; Shannon, Kate; Harrigan, P. Richard; Hogg, Robert S.] Providence Hlth Care, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Montaner, Julio S. G.; Lima, Viviane D.; Wood, Evan; Kerr, Thomas; Shannon, Kate; Harrigan, P. Richard] Univ British Columbia, Div Aids, Vancouver, BC V5Z 1M9, Canada; [Montaner, Julio S. G.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Hogg, Robert S.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Daly, Patricia] Vancouver Coastal Hlth Author, Vancouver, BC, Canada; [Kendall, Peny] Govt British Columbia, Minist Healthy Living & Sport, Off Prov Hlth Officer, Victoria, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of California System; University of California San Diego; Simon Fraser University; Vancouver Coastal Health Research Institute	Montaner, JSG (corresponding author), Providence Hlth Care, British Columbia Ctr Excellence HIV AIDS, 1081 Burrard St,Room 667, Vancouver, BC V6Z 1Y6, Canada.	jmontaner@cfenet.ubc.ca	Hogg, Robert S/B-2783-2012; Montaner, Julio/K-7621-2012; Kendall, Carl/F-9002-2012	Hogg, Robert S/0000-0003-3463-5488; Kendall, Carl/0000-0002-0794-4333	Merck; Gilead and ViiV Healthcare; GlaxoSmithKline/Canadian Institutes of Health Research Chair in Clinical Virology; GlaxoSmithKline; Abbott; Viiv; Pfizer; Ministry of Health Services; Ministry of Healthy Living and Sport, Province of British Columbia through Canadian Institutes of Health Research (CIHR); National Institute on Drug Abuse at the US National Institutes of Health [1DP1DA026182-01]; CIHR [MOP-79297, RAA-79918]; Michael Smith Foundation for Health Research; US National Institutes of Health [R01DA021525]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021525, DP1DA026182] Funding Source: NIH RePORTER	Merck(Merck & Company); Gilead and ViiV Healthcare; GlaxoSmithKline/Canadian Institutes of Health Research Chair in Clinical Virology(Canadian Institutes of Health Research (CIHR)GlaxoSmithKline); GlaxoSmithKline(GlaxoSmithKline); Abbott(Abbott Laboratories); Viiv; Pfizer(Pfizer); Ministry of Health Services; Ministry of Healthy Living and Sport, Province of British Columbia through Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institute on Drug Abuse at the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); CIHR(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	JSGM has received funding from Merck, Gilead and ViiV Healthcare to support research into Treatment as Prevention, consultancy fees from Merck, and speakers' fees from Clinical Care Options. PRH holds the GlaxoSmithKline/Canadian Institutes of Health Research Chair in Clinical Virology. RSH has received a research grant from Merck and a conference travel grant from GlaxoSmithKline. PRH has received honoraria from Viiv, Virco, Quest, and Merck, travel grants to attend conferences from Viiv and Quest, research grants from Abbott, Viiv, Pfizer, and Merck, and speakers' fees from Viiv. VDL, TK, EW, KS, RB, PD, PK, and BY declare that they have no conflicts of interest.; JSGM is supported by the Ministry of Health Services and the Ministry of Healthy Living and Sport, from the Province of British Columbia; through a Knowledge Translation Award from the Canadian Institutes of Health Research (CIHR); and through an Avant-Garde Award (No 1DP1DA026182-01) from the National Institute on Drug Abuse, at the US National Institutes of Health. TK is supported by CIHR and the Michael Smith Foundation for Health Research. VDL is supported through Fellowship Awards by CIHR and Michael Smith Foundation for Health Research. The study was further supported by the US National Institutes of Health (R01DA021525) and CIHR (MOP-79297, RAA-79918). Merck, Gilead and ViiV Healthcare support research into Treatment as Prevention. We thank Kelly Hsu for her assistance with preparation of the report, and Tom Patterson and Steffanie Strathdee for their helpful comments and advice.	[Anonymous], 2008, SCHWEIZ ARZTEZTG; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; *BC CTR DIS CONTR, 2008, ANN SUMM REP DIS; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Breslow NE, 1987, IARC SCI PUBL; Coates TJ, 2008, LANCET, V372, P669, DOI 10.1016/S0140-6736(08)60886-7; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Cu-Uvin S, 2000, AIDS, V14, P415, DOI 10.1097/00002030-200003100-00015; Das M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011068; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; Fideli OS, 2001, AIDS RES HUM RETROV, V17, P901, DOI 10.1089/088922201750290023; Gill VS, 2010, CLIN INFECT DIS, V50, P98, DOI 10.1086/648729; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hogg RS, 1997, LANCET, V349, P1294, DOI 10.1016/S0140-6736(05)62505-6; Kerr T, 2009, J ADOLESCENT HEALTH, V45, P300, DOI 10.1016/j.jadohealth.2009.03.007; Lima VD, 2008, J INFECT DIS, V198, P59, DOI 10.1086/588673; Lima VD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010991; Lloyd-Smith E, 2009, ANN EPIDEMIOL, V19, P404, DOI 10.1016/j.annepidem.2009.03.007; Lorello G, 2009, HIV MED, V10, P548, DOI 10.1111/j.1468-1293.2009.00725.x; Marcelin AG, 2008, AIDS, V22, P1677, DOI 10.1097/QAD.0b013e32830abdc8; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Neely MN, 2007, JAIDS-J ACQ IMM DEF, V44, P38, DOI 10.1097/01.qai.0000248352.18007.1f; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Salomon JA, 2005, PLOS MED, V2, P50, DOI 10.1371/journal.pmed.0020016; SHANNON K, 2009, BMJ-BRIT MED J, V11, pB2939; Sheth PM, 2009, AIDS, V23, P2050, DOI 10.1097/QAD.0b013e3283303e04; SIDIBE M, 2010, COMMUNICATION; Smith RJ, 2010, SCIENCE, V327, P697, DOI 10.1126/science.1180556; *US CDCP, QUEST ANSW 15 INCR H; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Vernazza PL, 1997, AIDS, V11, P1249, DOI 10.1097/00002030-199710000-00008; Volkow ND, 2010, JAMA-J AM MED ASSOC, V303, P1423, DOI 10.1001/jama.2010.421; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Wood E, 2000, LANCET, V355, P2095, DOI 10.1016/S0140-6736(00)02375-8; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; Wood S., 2006, GEN ADDITIVE MODELS	41	588	602	2	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 14	2010	376	9740					532	539		10.1016/S0140-6736(10)60936-1	http://dx.doi.org/10.1016/S0140-6736(10)60936-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643BE	20638713	Green Accepted			2022-12-01	WOS:000281266800032
J	Manicassamy, S; Reizis, B; Ravindran, R; Nakaya, H; Salazar-Gonzalez, RM; Wang, YC; Pulendran, B				Manicassamy, Santhakumar; Reizis, Boris; Ravindran, Rajesh; Nakaya, Helder; Salazar-Gonzalez, Rosa Maria; Wang, Yi-chong; Pulendran, Bali			Activation of beta-Catenin in Dendritic Cells Regulates Immunity Versus Tolerance in the Intestine	SCIENCE			English	Article							TOLL-LIKE RECEPTORS; T-HELPER-CELLS; RETINOIC-ACID; INNATE IMMUNITY; RESPONSES; DIFFERENTIATION; MACROPHAGES; DISEASE; EXPRESSION; INDUCTION	Dendritic cells (DCs) play a vital role in initiating robust immunity against pathogens as well as maintaining immunological tolerance to self antigens. However, the intracellular signaling networks that program DCs to become tolerogenic remain unknown. We report here that the Wnt-beta-catenin signaling in intestinal dendritic cells regulates the balance between inflammatory versus regulatory responses in the gut. beta-catenin in intestinal dendritic cells was required for the expression of anti-inflammatory mediators such as retinoic acid-metabolizing enzymes, interleukin-10, and transforming growth factor-beta, and the stimulation of regulatory T cell induction while suppressing inflammatory effector T cells. Furthermore, ablation of beta-catenin expression in DCs enhanced inflammatory responses and disease in a mouse model of inflammatory bowel disease. Thus, beta-catenin signaling programs DCs to a tolerogenic state, limiting the inflammatory response.	[Manicassamy, Santhakumar; Ravindran, Rajesh; Nakaya, Helder; Salazar-Gonzalez, Rosa Maria; Wang, Yi-chong; Pulendran, Bali] Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Manicassamy, Santhakumar; Ravindran, Rajesh; Nakaya, Helder; Salazar-Gonzalez, Rosa Maria; Wang, Yi-chong; Pulendran, Bali] Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA; [Salazar-Gonzalez, Rosa Maria] Cincinnati Childrens Hosp, Med Ctr, Mol Immunol Div, Cincinnati, OH 45229 USA; [Pulendran, Bali] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA	Emory University; Columbia University; Cincinnati Children's Hospital Medical Center; Emory University	Pulendran, B (corresponding author), Emory Vaccine Ctr, 954 Gatewood Rd, Atlanta, GA 30329 USA.	bpulend@emory.edu	Nakaya, Helder/AAF-1738-2020; Nakaya, Helder I/A-1397-2010; Pulendran, Bali/AAW-9550-2021	Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder I/0000-0001-5297-9108; Reizis, Boris/0000-0003-1140-7853; Pulendran, Bali/0000-0001-6517-4333	National Institutes of Health [U54AI057157, R37AI48638, R01DK057665, U19AI057266, HHSN266 200700006C, NO1 AI50019, NO1 AI50025]; Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057266, N01AI050025, R01AI056499, U54AI057157, R37AI048638, R01AI048638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057665, R01DK057665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. A. Mertens and L. Bronner for assistance with cell sorting and D. Levesque (Emory Vaccine Center) and D. Bonenberger for assistance with maintenance of mice strains at the Emory Vaccine Center vivarium. The work in the laboratory of BP was supported by grants U54AI057157, R37AI48638, R01DK057665, U19AI057266, HHSN266 200700006C, NO1 AI50019, and NO1 AI50025 from the National Institutes of Health and a grant from the Bill & Melinda Gates Foundation. Microarray accession number is GSE2213 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE22136).	Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Brault V, 2001, DEVELOPMENT, V128, P1253; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Cho JH, 2007, GASTROENTEROLOGY, V133, P1327, DOI 10.1053/j.gastro.2007.08.032; Clement-Lacroix P, 2005, P NATL ACAD SCI USA, V102, P17406, DOI 10.1073/pnas.0505259102; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lehtonen A, 2007, J LEUKOCYTE BIOL, V82, P710, DOI 10.1189/jlb.0307194; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Manicassamya S, 2009, SEMIN IMMUNOL, V21, P22, DOI 10.1016/j.smim.2008.07.007; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Matteoli G, 2010, GUT, V59, P595, DOI 10.1136/gut.2009.185108; Pulendran B, 2004, IMMUNOL REV, V199, P227, DOI 10.1111/j.0105-2896.2004.00144.x; Rescigno M, 2008, CURR OPIN IMMUNOL, V20, P669, DOI 10.1016/j.coi.2008.09.007; Siddiqui KRR, 2010, IMMUNITY, V32, P557, DOI 10.1016/j.immuni.2010.03.017; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720; Zhou J, 2009, IMMUNITY, V30, P845, DOI 10.1016/j.immuni.2009.03.021	34	385	397	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					849	853		10.1126/science.1188510	http://dx.doi.org/10.1126/science.1188510			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705860	Green Accepted			2022-12-01	WOS:000280809900053
J	Gehrke, S; Imai, Y; Sokol, N; Lu, BW				Gehrke, Stephan; Imai, Yuzuru; Sokol, Nicholas; Lu, Bingwei			Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression	NATURE			English	Article							LET-7 MICRORNA; DISTINCT ROLES; CELL-DEATH; DROSOPHILA; MUTATIONS; 4E-BP; GENE; IDENTIFICATION; GROWTH	Gain-of-function mutations in leucine-rich repeat kinase 2 (LRRK2) cause familial as well as sporadic Parkinson's disease characterized by age-dependent degeneration of dopaminergic neurons(1,2). The molecular mechanism of LRRK2 action is not known. Here we show that LRRK2 interacts with the microRNA (miRNA) pathway to regulate protein synthesis. Drosophila e2f1 and dp messenger RNAs are translationally repressed by let-7 and miR-184*, respectively. Pathogenic LRRK2 antagonizes these miRNAs, leading to the overproduction of E2F1/DP, previously implicated in cell cycle and survival control 3 and shown here to be critical for LRRK2 pathogenesis. Genetic deletion of let-7, antagomir-mediated blockage of let-7 and miR-184* action, transgenic expression of dp target protector, or replacement of endogenous dp with a dp transgene non-responsive to let-7 each had toxic effects similar to those of pathogenic LRRK2. Conversely, increasing the level of let-7 or miR-184* attenuated pathogenic LRRK2 effects. LRRK2 associated with Drosophila Argonaute-1 (dAgo1) or human Argonaute-2 (hAgo2) of the RNA-induced silencing complex (RISC). In aged fly brain, dAgo1 protein level was negatively regulated by LRRK2. Further, pathogenic LRRK2 promoted the association of phospho-4E-BP1 with hAgo2. Our results implicate deregulated synthesis of E2F1/DP caused by the miRNA pathway impairment as a key event in LRRK2 pathogenesis and suggest novel miRNA-based therapeutic strategies.	[Gehrke, Stephan; Lu, Bingwei] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Imai, Yuzuru] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Sokol, Nicholas] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Stanford University; Tohoku University; Indiana University System; Indiana University Bloomington	Gehrke, S (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	sgehrke@stanford.edu; bingwei@stanford.edu	Sokol, Nicholas N/K-2761-2012; Imai, Yuzuru/AAA-6472-2019	Imai, Yuzuru/0000-0003-2924-5231; Lu, Bingwei/0000-0002-5807-7014; Sokol, Nicholas/0000-0002-2768-4102	National Institutes of Health [R01AR054926, R01MH080378, R21NS056878]; McKnight Foundation; Beckman Foundation; Sloan Foundation; MEXT in Japan; Asahi Glass Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS056878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation; Beckman Foundation; Sloan Foundation(Alfred P. Sloan Foundation); MEXT in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Asahi Glass Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. W. Carthew, B. Dickson, B. Edgar, D. St Johnston, N. Sonenberg, W. Smith, Z. Zhang, H. Siomi, B. Hay, S. Cohen, the Vienna Drosophila RNAi Center and the Bloomington Drosophila Stock Center for fly stocks and cell line, and Bestgene Inc. for help with making gDPwt and gDPmut transgenics; N.J. Dyson, R. P. Wharton, C. Zeng, G. Meister and Y. Liu for antibodies; T. Tuschl, P. A. Sharp and Y. Tomari for plasmids; P. Sarnow and R. Cevallos for advice on polysome preparation; S. Guo and A. Fire for reading the manuscript; W. Lee and G. Silverio for technical support; and members of the Lu laboratory for discussions. This work was supported by the National Institutes of Health (R01AR054926, R01MH080378 and R21NS056878), the McKnight, Beckman and Sloan Foundations (B. L.), and the Program for Young Researchers from Special Coordination Funds for Promoting Science and Technology commissioned by MEXT in Japan and an Asahi Glass Foundation Research Grant (Y.I).	Asano M, 1996, GENE DEV, V10, P1422, DOI 10.1101/gad.10.11.1422; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chan SP, 2008, RNA, V14, P2104, DOI 10.1261/rna.551208; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Du W, 1996, GENE DEV, V10, P1206, DOI 10.1101/gad.10.10.1206; GIRLING R, 1993, NATURE, V362, P83, DOI 10.1038/362083a0; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Hoglinger GU, 2007, P NATL ACAD SCI USA, V104, P3585, DOI 10.1073/pnas.0611671104; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Liu Z, 2008, P NATL ACAD SCI USA, V105, P2693, DOI 10.1073/pnas.0708452105; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Tettweiler G, 2005, GENE DEV, V19, P1840, DOI 10.1101/gad.1311805; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	30	301	312	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2010	466	7306					637	U9		10.1038/nature09191	http://dx.doi.org/10.1038/nature09191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20671708	Green Accepted			2022-12-01	WOS:000280412100056
J	Wu, H; Coskun, V; Tao, JF; Xie, W; Ge, WH; Yoshikawa, K; Li, E; Zhang, Y; Sun, YE				Wu, Hao; Coskun, Volkan; Tao, Jifang; Xie, Wei; Ge, Weihong; Yoshikawa, Kazuaki; Li, En; Zhang, Yi; Sun, Yi Eve			Dnmt3a-Dependent Nonpromoter DNA Methylation Facilitates Transcription of Neurogenic Genes	SCIENCE			English	Article							DE-NOVO METHYLATION; METHYLTRANSFERASES DNMT3A; NERVOUS-SYSTEM; HUMAN GENOME; HISTONE H3; HYPERMETHYLATION; EXPRESSION; DOMAIN; CELLS	DNA methylation at proximal promoters facilitates lineage restriction by silencing cell type-specific genes. However, euchromatic DNA methylation frequently occurs in regions outside promoters. The functions of such nonproximal promoter DNA methylation are unclear. Here we show that the de novo DNA methyltransferase Dnmt3a is expressed in postnatal neural stem cells (NSCs) and is required for neurogenesis. Genome-wide analysis of postnatal NSCs indicates that Dnmt3a occupies and methylates intergenic regions and gene bodies flanking proximal promoters of a large cohort of transcriptionally permissive genes, many of which encode regulators of neurogenesis. Surprisingly, Dnmt3a-dependent nonproximal promoter methylation promotes expression of these neurogenic genes by functionally antagonizing Polycomb repression. Thus, nonpromoter DNA methylation by Dnmt3a may be used for maintaining active chromatin states of genes critical for development.	[Wu, Hao; Ge, Weihong; Sun, Yi Eve] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Coskun, Volkan; Tao, Jifang; Sun, Yi Eve] Univ Calif Los Angeles, Semel Inst Neurosci, Intellectual Dev & Disabil Res Ctr, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Xie, Wei] Univ Calif Los Angeles, Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA; [Yoshikawa, Kazuaki] Osaka Univ, Inst Prot Res, Lab Regulat Neuronal Dev, Suita, Osaka 5650871, Japan; [Li, En] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Zhang, Yi] Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Osaka University; Novartis; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill	Wu, H (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	haowu7@gmail.com; ysun@mednet.ucla.edu	Xie, Wei/J-1380-2017; feng, jian/G-9313-2011; Wu, Hao/G-4145-2013	Xie, Wei/0000-0003-2126-3849; Wu, Hao/0000-0002-1256-6891; Wu, Hao/0000-0003-4395-6929; Zhang, Yi/0000-0002-2789-0811	NIH	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Carey (UCLA) for technical assistance on in vitro chromatin recruitment assays and J. Rubenstein (University of California San Francisco) for providing the pCAG-Dlx2 expression plasmid. This work was supported by NIH RO1 grants to Y.E.S. All microarray data are deposited in Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/) under accession number GSE22476.	Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen TP, 2004, MOL CELL BIOL, V24, P9048, DOI 10.1128/MCB.24.20.9048-9058.2004; Feng J, 2005, J NEUROSCI RES, V79, P734, DOI 10.1002/jnr.20404; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Lindroth AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000145; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Nguyen' S, 2007, DEV DYNAM, V236, P1663, DOI 10.1002/dvdy.21176; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Otani J, 2009, EMBO REP, V10, P1235, DOI 10.1038/embor.2009.218; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Rush Margaret, 2009, Epigenetics, V4, P404; Smallwood A, 2007, GENE DEV, V21, P1169, DOI 10.1101/gad.1536807; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Waclaw RR, 2006, NEURON, V49, P503, DOI 10.1016/j.neuron.2006.01.018; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990	26	439	452	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					444	448		10.1126/science.1190485	http://dx.doi.org/10.1126/science.1190485			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651149	Green Accepted, Green Published			2022-12-01	WOS:000280196500038
J	Bento, G; Ogawa, A; Sommer, RJ				Bento, Gilberto; Ogawa, Akira; Sommer, Ralf J.			Co-option of the hormone-signalling module dafachronic acid-DAF-12 in nematode evolution	NATURE			English	Article							PHENOTYPIC PLASTICITY; NUCLEAR RECEPTOR; DAUER FORMATION; DAF-12; IDENTIFICATION; ORIGINS	Morphological novelties are lineage-specific traits that serve new functions(1,2). Developmental polyphenisms have been proposed to be facilitators of phenotypic evolution, but little is known about the interplay between the associated genetic and environmental factors(3-11). Here, we study two alternative morphologies in the mouth of the nematode Pristionchus pacificus and the formation of teeth-like structures that are associated with bacteriovorous feeding and predatory behaviour on fungi and other worms(12-16). These teeth-like denticles represent an evolutionary novelty, which is restricted to some members of the nematode family Diplogastridae but is absent from Caenorhabditis elegans and related nematodes(14). We show that the mouth dimorphism is a polyphenism that is controlled by starvation and the co-option of an endocrine switch mechanism. Mutations in the nuclear hormone receptor DAF-12 and application of its ligand, the sterol hormone dafachronic acid, strongly influence this switch mechanism. The dafachronic acid-DAF-12 module has been shown to control the formation of arrested dauer larvae in both C. elegans and P. pacificus, as well as related life-history decisions in distantly related nematodes(17-20). The comparison of dauer formation and mouth morphology switch reveals that different thresholds of dafachronic acid signalling provide specificity. This study shows how hormonal signalling acts by coupling environmental change and genetic regulation and identifies dafachronic acid as a key hormone in nematode evolution.	[Bento, Gilberto; Ogawa, Akira; Sommer, Ralf J.] Max Planck Inst Dev Biol, Dept Evolutionary Biol, D-72076 Tubingen, Germany	Max Planck Society	Sommer, RJ (corresponding author), Max Planck Inst Dev Biol, Dept Evolutionary Biol, Spemannstr 37, D-72076 Tubingen, Germany.	ralf.sommer@tuebingen.mpg.de	Bento, Gilberto/AAY-8654-2020	Bento, Gilberto/0000-0002-8455-6625				Antebi A, 2000, GENE DEV, V14, P1512; Brakefield PM, 1998, AM NAT, V152, P853, DOI 10.1086/286213; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; CREELMAN RA, 1995, P NATL ACAD SCI USA, V92, P4114, DOI 10.1073/pnas.92.10.4114; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; Herrmann M, 2007, ZOOL SCI, V24, P883, DOI 10.2108/zsj.24.883; Hirschmann H., 1951, Zoologische Jahrbuecher (Systematik), V80, P132; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Mayr E., 1960, EVOLUTION DARWIN; Moczek AP, 2002, EVOL DEV, V4, P252, DOI 10.1046/j.1525-142X.2002.02014.x; Moczek AP, 2008, BIOESSAYS, V30, P432, DOI 10.1002/bies.20754; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; NIJHOUT HF, 1994, INSECT PHEROMONES; Ogawa A, 2009, CURR BIOL, V19, P67, DOI 10.1016/j.cub.2008.11.063; PIGLIUCCI M, 2001, SYN ECO EVO, pR13; Pigliucci M, 2006, J EXP BIOL, V209, P2362, DOI 10.1242/jeb.02070; Quinn G.P., 2002, EXPT DESIGN DATA ANA; Saenko SV, 2008, PHILOS T R SOC B, V363, P1549, DOI 10.1098/rstb.2007.2245; Schlichting CD, 2003, EVOL DEV, V5, P98, DOI 10.1046/j.1525-142X.2003.03015.x; Sommer RJ, 1996, FUND APPL NEMATOL, V19, P511; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Suzuki Y, 2006, SCIENCE, V311, P650, DOI 10.1126/science.1118888; von Lieven AF, 2000, J ZOOL SYST EVOL RES, V38, P37, DOI 10.1046/j.1439-0469.2000.381125.x; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; Wang Z, 2009, P NATL ACAD SCI USA, V106, P9138, DOI 10.1073/pnas.0904064106; West-Eberhard Mary Jane, 2003, pi	31	142	142	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					494	U9		10.1038/nature09164	http://dx.doi.org/10.1038/nature09164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20592728				2022-12-01	WOS:000280141200037
J	Young, RC				Young, Robert C.			Cancer Clinical Trials - A Chronic but Curable Crisis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									RCY Med, Philadelphia, PA USA		Young, RC (corresponding author), RCY Med, Philadelphia, PA USA.							Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Editorial, 2010, NY TIMES        0424; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Institute of Medicine, 2010, NAT CANC CLIN TRIALS; National Cancer Institute, 1997, REP NAT CANC I CLIN	5	35	35	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2010	363	4					306	309		10.1056/NEJMp1005843	http://dx.doi.org/10.1056/NEJMp1005843			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628RU	20554976				2022-12-01	WOS:000280139300003
J	Chiao, EY; Dezube, BJ; Krown, SE; Wachsman, W; Brock, MV; Giordano, TP; Mitsuyasu, R; Pantanowitz, L				Chiao, Elizabeth Y.; Dezube, Bruce J.; Krown, Susan E.; Wachsman, William; Brock, Malcolm V.; Giordano, Thomas P.; Mitsuyasu, Ronald; Pantanowitz, Liron			Time for Oncologists to Opt In for Routine Opt-Out HIV Testing?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; AIDS-RELATED MALIGNANCIES; SQUAMOUS-CELL CARCINOMA; HEALTH-CARE SETTINGS; LUNG-CANCER; INFECTED PATIENTS; UNITED-STATES; ANAL CANCER; DEFINING CANCERS	Human immunodeficiency virus (HIV)-infected individuals are at high risk of malignancies. However, it is not currently the standard of care to routinely test cancer patients for HIV. In 2006, the Centers for Disease Control and Prevention recommended HIV testing in all health care settings, calling for standard nontargeted "opt-out" HIV screening. For a variety of reasons, routine opt-out HIV testing is still not widely used in the United States. Although many barriers to routine opt-out HIV testing have been addressed, such opt-out HIV testing continues to be conducted primarily in venues that target specific patient populations such as pregnant women. Although opt-out testing has been piloted in emergency departments, less emphasis has been placed on opt-out HIV testing in other clinical settings. In this article, the background, rationale, and evidence for supporting opt-out HIV testing as routine care for cancer patients are presented. In addition, evidence is discussed for the potential of opt-out HIV testing to improve clinical outcomes by facilitating appropriate HIV management during cancer treatment for individuals who are found to be HIV positive. JAMA. 2010;304(3):334-339 www.jama.com	[Chiao, Elizabeth Y.; Giordano, Thomas P.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Chiao, Elizabeth Y.; Giordano, Thomas P.] Dept Vet Affairs Med Ctr, Houston, TX USA; [Dezube, Bruce J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hematol Oncol, Boston, MA 02215 USA; [Krown, Susan E.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Wachsman, William] Univ Calif San Diego, Med Ctr, San Diego, CA 92103 USA; [Brock, Malcolm V.] Johns Hopkins Med Ctr, Baltimore, MD USA; [Mitsuyasu, Ronald] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles Ctr Clin AIDS Res & Educ, Los Angeles, CA 90095 USA; [Pantanowitz, Liron] Tufts Univ, Sch Med, Baystate Med Ctr, Dept Pathol, Springfield, MA 01199 USA	Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Diego; Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Baystate Medical Center; Tufts University	Chiao, EY (corresponding author), Michael E DeBakey VA Med Ctr 152, Houston VA Hlth Serv Res & Dev, 2002 Holcombe Blvd, Houston, TX 77030 USA.	echiao@bcm.edu	Pantanowitz, Liron/AFP-8163-2022	Giordano, Thomas/0000-0002-9346-5530; Chiao, Elizabeth/0000-0001-5752-2916	National Cancer Institute [UO1 CA 121947]; Houston VA Health Services Research and Development Center of Excellence [HFP90-020]; National Cancer Institute, National Institutes of Health [K23CA124318]; NATIONAL CANCER INSTITUTE [K23CA124318, U01CA121947] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Houston VA Health Services Research and Development Center of Excellence; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This material is based on work supported by National Cancer Institute grant UO1 CA 121947 to the AIDS Malignancy Consortium. This work was also supported in part by the Houston VA Health Services Research and Development Center of Excellence (grant HFP90-020). Dr Chiao received support from the National Cancer Institute, National Institutes of Health, grant K23CA124318.	Abramowitz L, 2009, ALIMENT PHARM THER, V30, P414, DOI 10.1111/j.1365-2036.2009.04026.x; Appleby P, 2000, JNCI-J NATL CANCER I, V92, P1823, DOI 10.1093/jnci/92.22.1823; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bartlett JG, 2008, JAMA-J AM MED ASSOC, V300, P945, DOI 10.1001/jama.300.8.945; Berenguer J, 2008, JAIDS-J ACQ IMM DEF, V47, P422, DOI 10.1097/QAI.0b013e31815e722b; Besson C, 2001, BLOOD, V98, P2339, DOI 10.1182/blood.V98.8.2339; Bower M, 2004, JAIDS-J ACQ IMM DEF, V37, P1563, DOI 10.1097/00126334-200412150-00004; Bower M, 2006, CURR OPIN INFECT DIS, V19, P14, DOI 10.1097/01.qco.0000200295.30285.13; Bower M, 2009, AIDS, V23, P1701, DOI 10.1097/QAD.0b013e32832d080d; Brau N, 2007, J HEPATOL, V47, P527, DOI 10.1016/j.jhep.2007.06.010; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brock MV, 2006, JAIDS-J ACQ IMM DEF, V43, P47, DOI 10.1097/01.qai.0000232260.95288.93; Burke RC, 2007, AIDS, V21, P1617, DOI 10.1097/QAD.0b013e32823f91ff; Cave J, 2009, CLIN MED, V9, P320, DOI 10.7861/clinmedicine.9-4-320; *CDCP, 2005, HIV AIDS SURV REP CA, V16; Chiao EY, 2008, J CLIN ONCOL, V26, P474, DOI 10.1200/JCO.2007.14.2810; Clarke CA, 2004, JAIDS-J ACQ IMM DEF, V36, P1083, DOI 10.1097/00126334-200408150-00012; Cunningham CO, 2009, AIDS PATIENT CARE ST, V23, P619, DOI 10.1089/apc.2009.0005; Deeken JF, 2009, CURR OPIN ONCOL, V21, P445, DOI 10.1097/CCO.0b013e32832f3e04; Frisch M, 2001, JAMA-J AM MED ASSOC, V285, P1736, DOI 10.1001/jama.285.13.1736; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Hakimian R, 2007, J THORAC ONCOL, V2, P268, DOI 10.1097/01.JTO.0000263707.31202.d7; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hoffmann C, 2004, BRIT J HAEMATOL, V125, P455, DOI 10.1111/j.1365-2141.2004.04934.x; Hogg ME, 2009, DIS COLON RECTUM, V52, P891, DOI 10.1007/DCR.0b013e31819eefa6; KAPLAN L D, 1989, Journal of the American Medical Association, V261, P719, DOI 10.1001/jama.261.5.719; Kirk GD, 2007, CLIN INFECT DIS, V45, P103, DOI 10.1086/518606; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; KNOWLES DM, 1988, ANN INTERN MED, V108, P744, DOI 10.7326/0003-4819-108-5-744; Lavole A, 2009, LUNG CANCER, V65, P345, DOI 10.1016/j.lungcan.2008.11.018; Levine AM, 2008, CURR OPIN ONCOL, V20, P522, DOI 10.1097/CCO.0b013e3283094ec7; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Mocroft A, 2004, CANCER-AM CANCER SOC, V100, P2644, DOI 10.1002/cncr.20309; Oehler-Jaenne C, 2008, J CLIN ONCOL, V26, P2550, DOI 10.1200/JCO.2007.15.2348; Owens DK, 2007, AM J PUBLIC HEALTH, V97, P2173, DOI 10.2105/AJPH.2007.110700; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Powles T, 2003, BRIT J CANCER, V89, P457, DOI 10.1038/sj.bjc.6601111; Qaseem A, 2009, ANN INTERN MED, V150, P125, DOI 10.7326/0003-4819-150-2-200901200-00300; Remick SC, 1996, HEMATOL ONCOL CLIN N, V10, P1203, DOI 10.1016/S0889-8588(05)70394-4; Seo Y, 2009, INT J RADIAT ONCOL, V75, P143, DOI 10.1016/j.ijrobp.2008.10.046; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Shouse R. L., 2009, Morbidity and Mortality Weekly Report, V58, P661; Spano JP, 2008, J CLIN ONCOL, V26, P4834, DOI 10.1200/JCO.2008.16.8252; SRIDHAR KS, 1992, CHEST, V102, P1704, DOI 10.1378/chest.102.6.1704; Stadler RF, 2004, DIS COLON RECTUM, V47, P1305, DOI 10.1007/s10350-004-0584-1; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Sturtevant D, 2009, CAN J PUBLIC HEALTH, V100, P116, DOI 10.1007/BF03405519; Telzak E. E., 2007, Morbidity and Mortality Weekly Report, V56, P597; Tirelli U, 2000, CANCER-AM CANCER SOC, V88, P563, DOI 10.1002/(SICI)1097-0142(20000201)88:3<563::AID-CNCR11>3.0.CO;2-D; *US DEP HHS, 2009, MED EXP LIST COV PRE	50	29	29	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					334	339		10.1001/jama.2010.752	http://dx.doi.org/10.1001/jama.2010.752			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639567	Green Submitted, Green Accepted			2022-12-01	WOS:000280107500023
J	Sabin, M; Lo, YR				Sabin, Miriam; Lo, Ying-Ru			Progress in Providing HIV Testing and Counseling in Health Facilities WHO/UNAIDS Guidance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sabin, Miriam; Lo, Ying-Ru] WHO, HIV Dept, CH-1211 Geneva, Switzerland	World Health Organization	Sabin, M (corresponding author), WHO, HIV Dept, 20 Ave Apia, CH-1211 Geneva, Switzerland.	sabinm@unaids.org		Sabin, Miriam/0000-0002-7758-8338				Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Leon N, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-8; Volkow ND, 2010, JAMA-J AM MED ASSOC, V303, P1423, DOI 10.1001/jama.2010.421; *WHO, 2009, PREV MOTH TO CHILD T; WHO, 2011, DEL HIV TEST RES MES; WHO, UN ACC; *WHO, HIV TEST COUNS PRIS; WHO, GUID PROV IN HIV TES	10	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					342	343		10.1001/jama.2010.995	http://dx.doi.org/10.1001/jama.2010.995			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639569				2022-12-01	WOS:000280107500025
J	Comita, LS; Muller-Landau, HC; Aguilar, S; Hubbell, SP				Comita, Liza S.; Muller-Landau, Helene C.; Aguilar, Salomon; Hubbell, Stephen P.			Asymmetric Density Dependence Shapes Species Abundances in a Tropical Tree Community	SCIENCE			English	Article							LOCAL NEIGHBORHOOD; NEOTROPICAL FOREST; SHADE TOLERANCE; DIVERSITY; SURVIVAL; COEXISTENCE; RECRUITMENT; PATHOGENS; SEEDLINGS; GROWTH	The factors determining species commonness and rarity are poorly understood, particularly in highly diverse communities. Theory predicts that interactions with neighbors of the same (conspecific) and other (heterospecific) species can influence a species' relative abundance, but empirical tests are lacking. By using a hierarchical model of survival for more than 30,000 seedlings of 180 tropical tree species on Barro Colorado Island, Panama, we tested whether species' sensitivity to neighboring individuals relates to their relative abundance in the community. We found wide variation among species in the effect of conspecific, but not heterospecific, neighbors on survival, and we found a significant relationship between the strength of conspecific neighbor effects and species abundance. Specifically, rare species suffered more from the presence of conspecific neighbors than common species did, suggesting that conspecific density dependence shapes species abundances in diverse communities.	[Comita, Liza S.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Comita, Liza S.; Muller-Landau, Helene C.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Muller-Landau, Helene C.; Aguilar, Salomon; Hubbell, Stephen P.] Smithsonian Trop Res Inst, Balboa Ancon, Panama; [Hubbell, Stephen P.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90024 USA	National Center for Ecological Analysis & Synthesis; University of Minnesota System; University of Minnesota Twin Cities; Smithsonian Institution; Smithsonian Tropical Research Institute; University of California System; University of California Los Angeles	Comita, LS (corresponding author), Natl Ctr Ecol Anal & Synth, 735 State St,Suite 300, Santa Barbara, CA 93101 USA.	comita@nceas.ucsb.edu		Muller-Landau, Helene C./0000-0002-3526-9021; Comita, Liza/0000-0002-9169-1331	Packard Fellowship for Science and Engineering; NSF [DEB-0075102, 0425651, 0710211, 0823728]; Andrew W. Mellon Foundation; HSBC	Packard Fellowship for Science and Engineering; NSF(National Science Foundation (NSF)); Andrew W. Mellon Foundation; HSBC	We thank the dozens of field assistants who conducted the seedling and tree censuses; R. Perez for assistance with species identifications; S. Lao for help with data management; and S. Banerjee, S. M. Lee, M. Schofield, and A. Gelman for statistical advice. The study was financially supported by a Packard Fellowship for Science and Engineering (to H.C.M.), NSF (grants DEB-0075102, 0425651, 0710211, and 0823728 to S. P. H.), the Andrew W. Mellon Foundation, and the HSBC Climate Partnership, with logistical support from the Center of Tropical Forest Science, Smithsonian Tropical Research Institute, and University of Georgia.	Alonso D, 2008, ECOL LETT, V11, P93, DOI 10.1111/j.1461-0248.2007.01127.x; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; Condit R, 2006, SCIENCE, V313, P98, DOI 10.1126/science.1124712; CONNELL J H, 1971, P298; CONNELL JH, 1984, ECOL MONOGR, V54, P141, DOI 10.2307/1942659; Freckleton RP, 2006, P R SOC B, V273, P2909, DOI 10.1098/rspb.2006.3660; Gaston K.J., 1994, RARITY, P1, DOI [10.1007/978-94-011-0701-3_1, DOI 10.1007/978-94-011-0701-3_1, 10.1007/978-94-011-0701-3]; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; Harpole WS, 2006, ECOL LETT, V9, P15, DOI 10.1111/j.1461-0248.2005.00836.x; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; Hubbell SP, 1986, CONSERVATION BIOL SC, P205; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Kunin W.E., 1997, J ANIM ECOL, DOI DOI 10.2307/6011; MANGAN SA, 2010, NATURE; May R, 1999, PHILOS T R SOC B, V354, P1951, DOI 10.1098/rstb.1999.0534; McCarthy-Neumann S, 2008, ECOLOGY, V89, P1883, DOI 10.1890/07-0211.1; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; McGill BJ, 2006, SCIENCE, V314, P770, DOI 10.1126/science.1134920; Novotny V, 2007, SCIENCE, V315, DOI 10.1126/science.1139702; Paine CET, 2008, BIOTROPICA, V40, P432, DOI 10.1111/j.1744-7429.2007.00390.x; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Queenborough SA, 2007, ECOLOGY, V88, P2248, DOI 10.1890/06-0737.1; SCHUPP EW, 1992, AM NAT, V140, P526, DOI 10.1086/285426; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Webb CO, 1999, ECOLOGY, V80, P2006, DOI 10.1890/0012-9658(1999)080[2006:SDDPCO]2.0.CO;2; Wills C, 1997, P NATL ACAD SCI USA, V94, P1252, DOI 10.1073/pnas.94.4.1252; Wills C, 2006, SCIENCE, V311, P527, DOI 10.1126/science.1117715	32	467	489	17	339	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					330	332		10.1126/science.1190772	http://dx.doi.org/10.1126/science.1190772			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20576853				2022-12-01	WOS:000279925900044
J	Pronovost, PJ				Pronovost, Peter J.			Learning Accountability for Patient Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BLOOD-STREAM INFECTIONS; QUALITY; SAFETY		[Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Dept Hlth Policy & Management, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Pronovost, PJ (corresponding author), Qual & Safety Res Grp, 1909 Thames St,2nd Floor, Baltimore, MD 21231 USA.	ppronovo@jhmi.edu						Berenholtz SM, 2004, CRIT CARE MED, V32, P2014, DOI 10.1097/01.CCM.0000142399.70913.2F; *COMM QUAL HLTH CA, 1999, ERR IS HUM BUID SAF; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Miller MR, 2010, PEDIATRICS, V125, P206, DOI 10.1542/peds.2009-1382; Pronovost PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c309; Pronovost PJ, 2009, JAMA-J AM MED ASSOC, V301, P1273, DOI 10.1001/jama.2009.388; U.S. Department of Health and Human Services Office of the Secretary Office of the Assistant Secretary for Health, HHS ACT PLAN PREV HE; Wachter RM, 2009, NEW ENGL J MED, V361, P1401, DOI 10.1056/NEJMsb0903885	10	25	25	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2010	304	2					204	205		10.1001/jama.2010.979	http://dx.doi.org/10.1001/jama.2010.979			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624IN	20628135				2022-12-01	WOS:000279811000028
J	Baarlink, C; Brandt, D; Grosse, R				Baarlink, Christian; Brandt, Dominique; Grosse, Robert			SnapShot: Formins	CELL			English	Editorial Material							ACTIN; ASSOCIATION; NUCLEATION; MECHANISM; PROFILIN		[Baarlink, Christian; Brandt, Dominique; Grosse, Robert] Univ Marburg, D-35032 Marburg, Germany	Philipps University Marburg	Baarlink, C (corresponding author), Univ Marburg, D-35032 Marburg, Germany.			Grosse, Robert/0000-0002-3380-5273				Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Kitzing TM, 2010, ONCOGENE, V29, P2441, DOI 10.1038/onc.2009.515; Madrid R, 2010, DEV CELL, V18, P814, DOI [10.1016/j.devce1.2010.04.001, 10.1016/j.devcel.2010.04.001]; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044	10	22	22	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 9	2010	142	1							172.e1	10.1016/j.cell.2010.06.030	http://dx.doi.org/10.1016/j.cell.2010.06.030			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603022	Bronze			2022-12-01	WOS:000279637300023
J	Jewkes, R				Jewkes, Rachel			Gender Inequities Must Be Addressed in HIV Prevention	SCIENCE			English	Editorial Material							INTIMATE-PARTNER VIOLENCE; SEXUALLY-TRANSMITTED INFECTION; RURAL SOUTH-AFRICA; RELATIONSHIP POWER; WOMEN; RISK; ABUSE; HIV/AIDS; TRIAL; MEN		MRC, Gender & Hlth Res Unit, ZA-0001 Pretoria, South Africa		Jewkes, R (corresponding author), MRC, Gender & Hlth Res Unit, ZA-0001 Pretoria, South Africa.	rjewkes@mrc.ac.za		Jewkes, Rachel/0000-0002-4330-6267				Bennet, 2000, AIDS BEHAV, V4, P261, DOI [https://doi.org/10.1023/A:1009568718804, DOI 10.1023/A:1009568718804, 10.1023/A:1009568718804.]; Campbell JC, 2008, INT J INJ CONTROL SA, V15, P221, DOI 10.1080/17457300802423224; Caspi A, 2002, SCIENCE, V297, P851, DOI 10.1126/science.1072290; Decker MR, 2009, JAIDS-J ACQ IMM DEF, V51, P593, DOI 10.1097/QAI.0b013e3181a255d6; DUDE AM, 2009, AIDS BEHAV; Dude A, 2007, STUD FAMILY PLANN, V38, P89, DOI 10.1111/j.1728-4465.2007.00120.x; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; El-Bassel N, 2001, J SUBST ABUSE, V13, P29, DOI 10.1016/S0899-3289(01)00068-2; Gielen AC, 2007, TRAUMA VIOLENCE ABUS, V8, P178, DOI 10.1177/1524838007301476; *GLOB COAL WOM AID, VIOL WOM; Greig A, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000327435.28538.18; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Jewkes Rachel, 2009, UNDERSTANDING MENS H; JEWKES RK, CHILD ABUSE IN PRESS; JEWKES RK, LANCET; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2010, AG ACC COUNTR ACT WO; Maman S, 2002, AM J PUBLIC HEALTH, V92, P1331, DOI 10.2105/AJPH.92.8.1331; Martin SL, 1999, JAMA-J AM MED ASSOC, V282, P1967, DOI 10.1001/jama.282.20.1967; Nascimento, 2007, ENGAGING MEN BOYS TR; PETTIFOR AE, 1996, EMERG INFECT DIS, V10, P2004; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; Silverman JG, 2007, SEX TRANSM INFECT, V83, P211, DOI 10.1136/sti.2006.023366; VANDERSTRATEN A, 1998, AIDS BEHAV, V2, P61, DOI DOI 10.1023/A:1022311424652; Wang S. K., 2007, RAPE WOMEN COMMUNITY; Wingood GM, 1997, AM J PREV MED, V13, P380, DOI 10.1016/S0749-3797(18)30158-2; World Health Organization Joint United Nations Programme on HIV/AIDS, 2010, ADDR VIOL WOM HIV AI	28	54	55	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					145	147		10.1126/science.1193794	http://dx.doi.org/10.1126/science.1193794			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	622CB	20616253				2022-12-01	WOS:000279635200020
J	Grashoff, C; Hoffman, BD; Brenner, MD; Zhou, RB; Parsons, M; Yang, MT; McLean, MA; Sligar, SG; Chen, CS; Ha, T; Schwartz, MA				Grashoff, Carsten; Hoffman, Brenton D.; Brenner, Michael D.; Zhou, Ruobo; Parsons, Maddy; Yang, Michael T.; McLean, Mark A.; Sligar, Stephen G.; Chen, Christopher S.; Ha, Taekjip; Schwartz, Martin A.			Measuring mechanical tension across vinculin reveals regulation of focal adhesion dynamics	NATURE			English	Article							CELL-MATRIX ADHESIONS; FORCE; ACTIN; TALIN; MECHANOSENSORS; COMPLEX; SWITCH	Mechanical forces are central to developmental, physiological and pathological processes(1). However, limited understanding of force transmission within sub-cellular structures is a major obstacle to unravelling molecular mechanisms. Here we describe the development of a calibrated biosensor that measures forces across specific proteins in cells with piconewton (pN) sensitivity, as demonstrated by single molecule fluorescence force spectroscopy(2). The method is applied to vinculin, a protein that connects integrins to actin filaments and whose recruitment to focal adhesions (FAs) is force-dependent(3). We show that tension across vinculin in stable FAs is similar to 2.5 pN and that vinculin recruitment to FAs and force transmission across vinculin are regulated separately. Highest tension across vinculin is associated with adhesion assembly and enlargement. Conversely, vinculin is under low force in disassembling or sliding FAs at the trailing edge of migrating cells. Furthermore, vinculin is required for stabilizing adhesions under force. Together, these data reveal that FA stabilization under force requires both vinculin recruitment and force transmission, and that, surprisingly, these processes can be controlled independently.	[Grashoff, Carsten; Hoffman, Brenton D.; Schwartz, Martin A.] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Grashoff, Carsten; Hoffman, Brenton D.; Schwartz, Martin A.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Brenner, Michael D.; Zhou, Ruobo; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Brenner, Michael D.; Zhou, Ruobo; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Brenner, Michael D.; Ha, Taekjip] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Yang, Michael T.; Chen, Christopher S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [McLean, Mark A.; Sligar, Stephen G.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA; [Schwartz, Martin A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of London; King's College London; University of Pennsylvania; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Virginia	Schwartz, MA (corresponding author), Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA.	tjha@illinois.edu; maschwartz@virginia.edu	Chen, Christopher S./ABD-8499-2021; Parsons, Maddy/B-2203-2013; Ha, Taekjip/B-9506-2009	Chen, Christopher S./0000-0003-2445-8449; Parsons, Maddy/0000-0002-2021-8379; Ha, Taekjip/0000-0003-2195-6258; schwartz, martin/0000-0002-2071-1243; Zhou, Ruobo/0000-0001-8628-0282; McLean, Mark/0000-0001-9125-293X	USPHS [U54 GM64346, 5T32-HL007284, R21 RR025341]; Deutsche Forschungsgemeinschaft (DFG) [GR3399/1-1]; AHA; US National Science Foundation Physics Frontier Center [0822613]; Royal Society; National Science Foundation [DGE-0221664]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025341] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346, R01GM033775] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); AHA(American Heart Association); US National Science Foundation Physics Frontier Center; Royal Society(Royal Society of London); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Horwitz, M. Vicente-Manzanares, D. Schafer, L.K. Tamm and K.A. DeMali for reagents and M. Gardel for critical reading of the manuscript. This work was supported by USPHS grant U54 GM64346 to M.A.S., C.G. was supported by a Research Fellowship from the Deutsche Forschungsgemeinschaft (DFG, GR3399/1-1). B.D.H. was supported by USPHS training grant 5T32-HL007284 and an AHA Postdoctoral Fellowship. M.D.B., R.Z. and T.H. were supported by the US National Science Foundation Physics Frontier Center grant 0822613 and by USPHS grant R21 RR025341. T.H. is an investigator with the Howard Hughes Medical Institute. M.P. was supported by a Royal Society University Research Fellowship (UK). M.T.Y. was supported by an IGERT fellowship from the National Science Foundation (DGE-0221664).	Alenghat FJ, 2000, BIOCHEM BIOPH RES CO, V277, P93, DOI 10.1006/bbrc.2000.3636; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Chen H, 2005, J CELL BIOL, V169, P459, DOI 10.1083/jcb.200410100; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Crocker JC, 2007, METHOD CELL BIOL, V83, P141, DOI 10.1016/S0091-679X(07)83007-X; Day RN, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2939094; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Hohng S, 2007, SCIENCE, V318, P279, DOI 10.1126/science.1146113; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Kolega J, 2003, MOL BIOL CELL, V14, P4745, DOI 10.1091/mbc.E03-04-0205; Meng F, 2008, FEBS J, V275, P3072, DOI 10.1111/j.1742-4658.2008.06461.x; Mierke CT, 2008, BIOPHYS J, V94, P661, DOI 10.1529/biophysj.107.108472; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Periasamy A, 2008, METHOD CELL BIOL, V89, P569, DOI 10.1016/S0091-679X(08)00622-5; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Shemesh T, 2005, P NATL ACAD SCI USA, V102, P12383, DOI 10.1073/pnas.0500254102; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Xu WM, 1998, DEVELOPMENT, V125, P327; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zamir E, 1999, J CELL SCI, V112, P1655; Ziegler WH, 2008, BIOCHEM SOC T, V36, P235, DOI 10.1042/BST0360235	30	981	998	9	371	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					263	U143		10.1038/nature09198	http://dx.doi.org/10.1038/nature09198			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613844	Green Accepted			2022-12-01	WOS:000279580800042
J	Yi, X; Liang, Y; Huerta-Sanchez, E; Jin, X; Cuo, ZXP; Pool, JE; Xu, X; Jiang, H; Vinckenbosch, N; Korneliussen, TS; Zheng, HC; Liu, T; He, WM; Li, K; Luo, RB; Nie, XF; Wu, HL; Zhao, MR; Cao, HZ; Zou, J; Shan, Y; Li, SZ; Yang, Q; Asan; Ni, PX; Tian, G; Xu, JM; Liu, XA; Jiang, T; Wu, RH; Zhou, GY; Tang, MF; Qin, JJ; Wang, T; Feng, SJ; Li, GH; Huasang; Luosang, JB; Wang, W; Chen, F; Wang, YD; Zheng, XG; Li, Z; Bianba, ZM; Yang, G; Wang, XP; Tang, SH; Gao, GY; Chen, Y; Luo, Z; Gusang, L; Cao, Z; Zhang, QH; Ouyang, WH; Ren, XL; Liang, HQ; Zheng, HS; Huang, YB; Li, JX; Bolund, L; Kristiansen, K; Li, YR; Zhang, Y; Zhang, XQ; Li, RQ; Li, SG; Yang, HM; Nielsen, R; Wang, J; Wang, JA				Yi, Xin; Liang, Yu; Huerta-Sanchez, Emilia; Jin, Xin; Cuo, Zha Xi Ping; Pool, John E.; Xu, Xun; Jiang, Hui; Vinckenbosch, Nicolas; Korneliussen, Thorfinn Sand; Zheng, Hancheng; Liu, Tao; He, Weiming; Li, Kui; Luo, Ruibang; Nie, Xifang; Wu, Honglong; Zhao, Meiru; Cao, Hongzhi; Zou, Jing; Shan, Ying; Li, Shuzheng; Yang, Qi; Asan; Ni, Peixiang; Tian, Geng; Xu, Junming; Liu, Xiao; Jiang, Tao; Wu, Renhua; Zhou, Guangyu; Tang, Meifang; Qin, Junjie; Wang, Tong; Feng, Shuijian; Li, Guohong; Huasang; Luosang, Jiangbai; Wang, Wei; Chen, Fang; Wang, Yading; Zheng, Xiaoguang; Li, Zhuo; Bianba, Zhuoma; Yang, Ge; Wang, Xinping; Tang, Shuhui; Gao, Guoyi; Chen, Yong; Luo, Zhen; Gusang, Lamu; Cao, Zheng; Zhang, Qinghui; Ouyang, Weihan; Ren, Xiaoli; Liang, Huiqing; Zheng, Huisong; Huang, Yebo; Li, Jingxiang; Bolund, Lars; Kristiansen, Karsten; Li, Yingrui; Zhang, Yong; Zhang, Xiuqing; Li, Ruiqiang; Li, Songgang; Yang, Huanming; Nielsen, Rasmus; Wang, Jun; Wang, Jian			Sequencing of 50 Human Exomes Reveals Adaptation to High Altitude	SCIENCE			English	Article							HEMOGLOBIN LEVELS; POINT MUTATIONS; GENE; TIBETAN; ASSOCIATION; HIF-1-ALPHA; SELECTION; LHASA; LOCI	Residents of the Tibetan Plateau show heritable adaptations to extreme altitude. We sequenced 50 exomes of ethnic Tibetans, encompassing coding sequences of 92% of human genes, with an average coverage of 18x per individual. Genes showing population-specific allele frequency changes, which represent strong candidates for altitude adaptation, were identified. The strongest signal of natural selection came from endothelial Per-Arnt-Sim (PAS) domain protein 1 (EPAS1), a transcription factor involved in response to hypoxia. One single-nucleotide polymorphism (SNP) at EPAS1 shows a 78% frequency difference between Tibetan and Han samples, representing the fastest allele frequency change observed at any human gene to date. This SNP's association with erythrocyte abundance supports the role of EPAS1 in adaptation to hypoxia. Thus, a population genomic survey has revealed a functionally important locus in genetic adaptation to high altitude.	[Yi, Xin; Liang, Yu; Jin, Xin; Xu, Xun; Jiang, Hui; Zheng, Hancheng; Liu, Tao; He, Weiming; Luo, Ruibang; Nie, Xifang; Wu, Honglong; Zhao, Meiru; Cao, Hongzhi; Zou, Jing; Shan, Ying; Li, Shuzheng; Yang, Qi; Asan; Ni, Peixiang; Tian, Geng; Xu, Junming; Liu, Xiao; Jiang, Tao; Wu, Renhua; Zhou, Guangyu; Tang, Meifang; Qin, Junjie; Wang, Tong; Feng, Shuijian; Li, Guohong; Huasang; Luosang, Jiangbai; Wang, Wei; Chen, Fang; Wang, Yading; Zheng, Xiaoguang; Li, Zhuo; Cao, Zheng; Zhang, Qinghui; Ouyang, Weihan; Ren, Xiaoli; Liang, Huiqing; Zheng, Huisong; Huang, Yebo; Li, Jingxiang; Bolund, Lars; Kristiansen, Karsten; Li, Yingrui; Zhang, Yong; Zhang, Xiuqing; Li, Ruiqiang; Li, Songgang; Yang, Huanming; Nielsen, Rasmus; Wang, Jun; Wang, Jian] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Yi, Xin; Liang, Yu; Cuo, Zha Xi Ping; Li, Kui; Tian, Geng; Zheng, Xiaoguang] Chinese Acad Sci, Grad Univ, Beijing 100062, Peoples R China; [Huerta-Sanchez, Emilia; Pool, John E.; Vinckenbosch, Nicolas; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94820 USA; [Huerta-Sanchez, Emilia; Pool, John E.; Vinckenbosch, Nicolas; Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94820 USA; [Jin, Xin; Zheng, Hancheng; Luo, Ruibang; Shan, Ying] S China Univ Technol, Innovat Program Undergrad Students, Sch Biosci & Biotechnol, Guangzhou 510641, Guangdong, Peoples R China; [Cuo, Zha Xi Ping; Li, Kui; Chen, Yong; Luo, Zhen; Gusang, Lamu] Peoples Hosp Tibet Autonomous Reg, Lhasa 850000, Peoples R China; [Pool, John E.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Korneliussen, Thorfinn Sand; Kristiansen, Karsten; Li, Ruiqiang; Nielsen, Rasmus; Wang, Jun] Univ Copenhagen, Dept Biol, DK-1165 Copenhagen, Denmark; [He, Weiming] S China Univ Technol, Sch Sci, Innovat Program Undergrad Students, Guangzhou 510641, Guangdong, Peoples R China; [Wu, Honglong; Cao, Hongzhi; Jiang, Tao] Shenzhen Univ, Genome Res Inst, Sch Med, Shenzhen 518060, Peoples R China; [Bianba, Zhuoma; Yang, Ge] Peoples Hosp Lhasa, Lhasa 850000, Peoples R China; [Wang, Xinping; Tang, Shuhui] Mil Gen Hosp Tibet, Lhasa 850007, Peoples R China; [Gao, Guoyi] Hosp XiShuangBanNa Dai Nationalities, Autonomous Jinghong 666100, Yunnan, Peoples R China	Beijing Genomics Institute (BGI); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Berkeley; University of California System; University of California Berkeley; South China University of Technology; University of California System; University of California Davis; University of Copenhagen; South China University of Technology; Shenzhen University	Nielsen, R (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	rasmus_nielsen@berkeley.edu; wangj@genomics.org; wangjian@genomics.org.cn	Xu, Xun/AAI-6763-2020; Kristiansen, Karsten/J-5148-2014; Li, Yingrui/K-1064-2015; Jin, Xin/ABF-1329-2020; Liu, Xiao/P-2732-2015; Nielsen, Rasmus/D-4405-2009; Korneliussen, Thorfinn Sand/ABB-7656-2021; wang, jian/GVS-0711-2022; Korneliussen, Thorfinn Sand/F-6421-2014; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Xu, Xun/0000-0002-5338-5173; Kristiansen, Karsten/0000-0002-6024-0917; Jin, Xin/0000-0001-7554-4975; Liu, Xiao/0000-0002-8073-0534; Nielsen, Rasmus/0000-0003-0513-6591; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Pool, John/0000-0003-2968-9545; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; Shan, Ying/0000-0003-3253-3197; Luo, Ruibang/0000-0001-9711-6533	National Natural Science Foundation of China [30890032, 30725008]; Ministry of Science and Technology of China [2006AA02A302, 2009AA022707, 2006CB504103]; Shenzhen Municipal Government of China [JC200903190772A, CXB200903110066A, ZYC200903240077A, ZYC200903240076A, ZYC200903240080A]; Danish Natural Science Research Council; Solexa project [272-07-0196]; Danish Strategic Research Council [2106-07-0021]; Lundbeck Foundation; Swiss National Science Foundation [PBLAP3-124318]; U.S. NIH [R01MHG084695, R01HG003229]; U.S. NSF [DBI-0906065]; Chinese Academy of Sciences [KSCX2-YW-R-76]; Tibet Autonomous Region [2007-2-18]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084695] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shenzhen Municipal Government of China; Danish Natural Science Research Council(Danish Natural Science Research Council); Solexa project; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Lundbeck Foundation(Lundbeckfonden); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. NSF(National Science Foundation (NSF)); Chinese Academy of Sciences(Chinese Academy of Sciences); Tibet Autonomous Region; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded by the National Natural Science Foundation of China (grants 30890032 and 30725008), the Ministry of Science and Technology of China (863 program, grants 2006AA02A302 and 2009AA022707; 973 program, grant 2006CB504103), the Shenzhen Municipal Government of China (grants JC200903190772A, CXB200903110066A, ZYC200903240077A, ZYC200903240076A, and ZYC200903240080A), the Ole Romer grant from the Danish Natural Science Research Council, the Solexa project (272-07-0196), the Danish Strategic Research Council grant (2106-07-0021), the Lundbeck Foundation, the Swiss National Science Foundation (PBLAP3-124318), the U.S. NIH R01MHG084695 and R01HG003229), the U.S. NSF (DBI-0906065), the Chinese Academy of Sciences (KSCX2-YW-R-76), and the Science and Technology Plan of the Tibet Autonomous Region (no. 2007-2-18). We are also indebted to many additional faculty and staff of BGI-Shenzhen who contributed to this teamwork and to X. Wang (South China University of Technology). The data have NCBI Short Read Archive accession no. SRA012603.	Acampora D, 1996, NAT GENET, V14, P218, DOI 10.1038/ng1096-218; Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Bigham Abigail W., 2009, Human Genomics, V4, P79; Choudhury K, 2007, AM J HUM GENET, V80, P664, DOI 10.1086/513475; Gaetani M, 2008, BLOOD, V111, P5712, DOI 10.1182/blood-2007-11-122457; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Henderson J, 2005, HUM GENET, V118, P416, DOI 10.1007/s00439-005-0066-0; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hodgkinson CA, 2004, AM J HUM GENET, V75, P862, DOI 10.1086/425586; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491; Jain S, 1998, MECH DEVELOP, V73, P117, DOI 10.1016/S0925-4773(98)00038-0; KANNO H, 1992, BLOOD, V79, P1347, DOI 10.1182/blood.V79.5.1347.bloodjournal7951347; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Moore LG, 2001, HIGH ALT MED BIOL, V2, P257, DOI 10.1089/152702901750265341; NIERMEYER S, 1995, NEW ENGL J MED, V333, P1248, DOI 10.1056/NEJM199511093331903; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Rottgardt I, 2010, ANTHROPOL SCI, V118, P41, DOI 10.1537/ase.090402; Shriver Mark D, 2004, Hum Genomics, V1, P274; Storz JF, 2009, P NATL ACAD SCI USA, V106, P14450, DOI 10.1073/pnas.0905224106; To KKW, 2005, J BIOL CHEM, V280, P38102, DOI 10.1074/jbc.M504342200; Wu TY, 2005, J APPL PHYSIOL, V98, P598, DOI 10.1152/japplphysiol.01034.2002; Zhang XL, 2005, BLOOD, V106, P75, DOI 10.1182/blood-2004-08-3033; Zhuang JG, 1996, RESP PHYSIOL, V103, P75, DOI 10.1016/0034-5687(95)00041-0	25	976	1056	12	503	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2010	329	5987					75	78		10.1126/science.1190371	http://dx.doi.org/10.1126/science.1190371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595611	Green Accepted			2022-12-01	WOS:000279402700035
J	Smith-Bindman, R				Smith-Bindman, Rebecca			Is Computed Tomography Safe?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Smith-Bindman, Rebecca] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Smith-Bindman, Rebecca] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Smith-Bindman, Rebecca] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Smith-Bindman, R (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.							Board of Radiation Effects Research Division on Earth and Life Sciences National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Eisenberg RL, 2010, RADIOLOGY, V255, P218, DOI 10.1148/radiol.09091556; Giovagnoni A, 2007, EUR RADIOL, V17, pB18, DOI 10.1007/s10406-007-0209-6; *MED PAYM ADV COMM, 2009, HEALTHC SPEND MED PR; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427	5	220	224	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2010	363	1					1	4		10.1056/NEJMp1002530	http://dx.doi.org/10.1056/NEJMp1002530			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618HR	20573919				2022-12-01	WOS:000279343000001
J	Kwon, OH; Zewail, AH				Kwon, Oh-Hoon; Zewail, Ahmed H.			4D Electron Tomography	SCIENCE			English	Article							CARBON NANOTUBES; YOUNGS MODULUS; MICROSCOPY; 3D; RECONSTRUCTION; IRRADIATION; MICROGRAPHS; SCIENCES; CELLS; BEAM	Electron tomography provides three-dimensional (3D) imaging of noncrystalline and crystalline equilibrium structures, as well as elemental volume composition, of materials and biological specimens, including those of viruses and cells. We report the development of 4D electron tomography by integrating the fourth dimension (time resolution) with the 3D spatial resolution obtained from a complete tilt series of 2D projections of an object. The different time frames of tomograms constitute a movie of the object in motion, thus enabling studies of nonequilibrium structures and transient processes. The method was demonstrated using carbon nanotubes of a bracelet-like ring structure for which 4D tomograms display different modes of motion, such as breathing and wiggling, with resonance frequencies up to 30 megahertz. Applications can now make use of the full space-time range with the nanometer-femtosecond resolution of ultrafast electron tomography.	[Kwon, Oh-Hoon; Zewail, Ahmed H.] CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA	California Institute of Technology	Zewail, AH (corresponding author), CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.	zewail@caltech.edu	Kwon, Oh-Hoon/B-3324-2015	Kwon, Oh-Hoon/0000-0001-7114-8617; gaber, sarah/0000-0002-5995-7291	NSF [DMR-0964886]; Air Force Office of Scientific Research [FA9550-07-1-0484]; Gordon and Betty Moore Foundation at Caltech	NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Gordon and Betty Moore Foundation at Caltech(Gordon and Betty Moore Foundation)	Supported by NSF (grant DMR-0964886) and Air Force Office of Scientific Research (grant FA9550-07-1-0484) in the Physical Biology Center for Ultrafast Science and Technology supported by Gordon and Betty Moore Foundation at Caltech. A patent application has been filed by Caltech based on the methodology presented	Banhart F, 2006, J MATER SCI, V41, P4505, DOI 10.1007/s10853-006-0081-0; Barwick B, 2008, SCIENCE, V322, P1227, DOI 10.1126/science.1164000; Cha JJ, 2007, NANO LETT, V7, P3770, DOI 10.1021/nl072251c; Colliex C, 2009, PHILOS T R SOC A, V367, P3845, DOI 10.1098/rsta.2009.0128; Crespi VH, 1996, PHYS REV B, V54, P5927, DOI 10.1103/PhysRevB.54.5927; CROWTHER RA, 1970, NATURE, V226, P421, DOI 10.1038/226421a0; DEROSIER DJ, 1968, NATURE, V217, P130, DOI 10.1038/217130a0; Frank J., 2010, ELECT TOMOGRAPHY MET; Friedrich H, 2009, CHEM REV, V109, P1613, DOI 10.1021/cr800434t; Gass MH, 2006, NANO LETT, V6, P376, DOI [10.1021/nl052120g, 10.1021/nl521020g]; HART RG, 1968, SCIENCE, V159, P1464, DOI 10.1126/science.159.3822.1464; Hartland GV, 2006, ANNU REV PHYS CHEM, V57, P403, DOI 10.1146/annurev.physchem.57.032905.104533; HAWKES PW, 2006, SCI MICROSCOPY, V1; HOPPE W, 1968, NATURWISSENSCHAFTEN, V55, P333, DOI 10.1007/BF00600449; Jonic S, 2009, CURR OPIN PHARMACOL, V9, P636, DOI 10.1016/j.coph.2009.04.006; Kwon OH, 2008, NANO LETT, V8, P3557, DOI 10.1021/nl8029866; Li HY, 2009, SCIENCE, V326, P1244, DOI 10.1126/science.1178583; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Meirovich L, 1986, ELEMENTS VIBRATION A; Messaoudil C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-288; Midgley PA, 2003, ULTRAMICROSCOPY, V96, P413, DOI 10.1016/S0304-3991(03)00105-0; Midgley PA, 2007, CHEM SOC REV, V36, P1477, DOI 10.1039/b701569k; Midgley PA, 2009, NAT MATER, V8, P271, DOI 10.1038/nmat2406; Nakamiya T, 2009, THIN SOLID FILMS, V517, P3854, DOI 10.1016/j.tsf.2009.01.097; Ni C, 2009, CARBON, V47, P2898, DOI 10.1016/j.carbon.2009.06.038; Poncharal P, 1999, SCIENCE, V283, P1513, DOI 10.1126/science.283.5407.1513; Sorzano COS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-124; Thomas JM, 2004, ANGEW CHEM INT EDIT, V43, P6745, DOI 10.1002/anie.200461453; Treacy MMJ, 1996, NATURE, V381, P678, DOI 10.1038/381678a0; Wei XL, 2008, ADV FUNCT MATER, V18, P1555, DOI 10.1002/adfm.200701105; Zewail AH., 2009, 4D ELECT MICROSCOPY; Zewail AH, 2010, SCIENCE, V328, P187, DOI 10.1126/science.1166135; Zheng QXS, 2004, J STRUCT BIOL, V147, P91, DOI 10.1016/j.jsb.2004.02.005	34	89	94	8	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1668	1673		10.1126/science.1190470	http://dx.doi.org/10.1126/science.1190470			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576886				2022-12-01	WOS:000279107400036
J	Clarke, OB; Caputo, AT; Hill, AP; Vandenberg, JI; Smith, BJ; Gulbis, JM				Clarke, Oliver B.; Caputo, Alessandro T.; Hill, Adam P.; Vandenberg, Jamie I.; Smith, Brian J.; Gulbis, Jacqueline M.			Domain Reorientation and Rotation of an Intracellular Assembly Regulate Conduction in Kir Potassium Channels	CELL			English	Article							RECTIFIER K+ CHANNEL; CRYSTAL-STRUCTURE; MOLECULAR DETERMINANTS; INWARD RECTIFICATION; QUATERNARY AMMONIUM; SELECTIVITY FILTER; ION CONDUCTION; BINDING-SITES; GATING HINGES; C-TERMINUS	Potassium channels embedded in cell membranes employ gates to regulate K+ current. While a specific constriction in the permeation pathway has historically been implicated in gating, recent reports suggest that the signature ion selectivity filter located in the outer membrane leaflet may be equally important. Inwardly rectifying K+ channels also control the directionality of flow, using intracellular polyamines to stem ion efflux by a valve-like action. This study presents crystallographic evidence of interdependent gates in the conduction pathway and reveals the mechanism of polyamine block. Reorientation of the intracellular domains, concomitant with activation, instigates polyamine release from intracellular binding sites to block the permeation pathway. Conformational adjustments of the slide helices, achieved by rotation of the cytoplasmic assembly relative to the pore, are directly correlated to the ion configuration in the selectivity filter. Ion redistribution occurs irrespective of the constriction, suggesting a more expansive role of the selectivity filter in gating than previously appreciated.	[Clarke, Oliver B.; Caputo, Alessandro T.; Smith, Brian J.; Gulbis, Jacqueline M.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Clarke, Oliver B.; Caputo, Alessandro T.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Hill, Adam P.; Vandenberg, Jamie I.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia	Walter & Eliza Hall Institute; University of Melbourne; Victor Chang Cardiac Research Institute	Gulbis, JM (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.	jgulbis@wehi.edu.au	Smith, Brian J/F-8282-2011; Vandenberg, Jamie I/B-6608-2013; Caputo, Alessandro/AFM-4954-2022	Smith, Brian J/0000-0003-0498-1910; Vandenberg, Jamie I/0000-0002-3859-3716; Caputo, Alessandro/0000-0001-5007-6896	Australian National Health and Medical Research Council (NHMRC) [361646]; Victorian State Government; Wellcome Trust; Australian Research Council Centre of Excellence	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government; Wellcome Trust(Wellcome TrustEuropean Commission); Australian Research Council Centre of Excellence(Australian Research Council)	We thank Janet Newman at the Bio21 C3 crystallization facility, Clemens Schulze-Briese, support staff at the Swiss Light Source, support staff at the Australian Synchrotron, Marc Kvansakul and Peter Czabotar for help with data collection, Peter Colman, Pauline Crewther, and James Blake for input on the manuscript, and Declan Doyle for the KirBac3.1 construct. We acknowledge assistance from the Australian Synchrotron Research Program for travel to the Swiss Light Source, the Australian National Health and Medical Research Council (NHMRC) for project funding, NHMRC Independent Research Institutes Infrastructure Support Scheme grant number 361646, and Victorian State Government Operational Infrastructure Support grants. J.M.G. thanks the Wellcome Trust for an International Senior Research Fellowship and the Australian Research Council Centre of Excellence in Coherent X-ray Science for travel assistance. O.B.C. is supported by an Australian Postgraduate Award.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ader C, 2009, EMBO J, V28, P2825, DOI 10.1038/emboj.2009.218; ARMSTRON.CM, 1969, J GEN PHYSIOL, V54, P553, DOI 10.1085/jgp.54.5.553; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; ASHCROFT FM, 1988, J PHYSIOL-LONDON, V400, P501, DOI 10.1113/jphysiol.1988.sp017134; Battle AR, 2009, FEBS LETT, V583, P407, DOI 10.1016/j.febslet.2008.12.033; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Blunck R, 2006, J GEN PHYSIOL, V128, P569, DOI 10.1085/jgp.200609638; Cheng WWL, 2009, J GEN PHYSIOL, V133, P295, DOI 10.1085/jgp.200810125; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Decher N, 2007, CARDIOVASC RES, V75, P748, DOI 10.1016/j.cardiores.2007.05.010; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gao LZ, 2005, P NATL ACAD SCI USA, V102, P17630, DOI 10.1073/pnas.0505158102; Gazzarrini S, 2009, BIOCHEM J, V420, P295, DOI 10.1042/BJ20090095; Gribble FM, 1998, DIABETES, V47, P1412, DOI 10.2337/diabetes.47.9.1412; Guo DL, 2003, J GEN PHYSIOL, V121, P261, DOI 10.1085/jgp.200208771; Hardman RM, 2007, J BIOL CHEM, V282, P31972, DOI 10.1074/jbc.M705835200; Hille B., 1992, IONIC CHANNELS EXCIT; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jones PA, 2001, FEBS LETT, V508, P85, DOI 10.1016/S0014-5793(01)03023-X; Kollewe A, 2009, J GEN PHYSIOL, V134, P53, DOI 10.1085/jgp.200910235; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kubo Y, 2001, J PHYSIOL-LONDON, V531, P645, DOI 10.1111/j.1469-7793.2001.0645h.x; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Loussouarn G, 2005, MOL PHARMACOL, V68, P298, DOI 10.1124/mol.105.012377; Lu T, 2001, NAT NEUROSCI, V4, P239, DOI 10.1038/85080; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; MILLER C, 1987, BIOPHYS J, V52, P123, DOI 10.1016/S0006-3495(87)83196-X; Osawa M, 2009, J BIOL CHEM, V284, P26117, DOI 10.1074/jbc.M109.029355; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Shang L, 2008, EUR BIOPHYS J BIOPHY, V37, P165, DOI 10.1007/s00249-007-0206-7; Shin HG, 2005, J GEN PHYSIOL, V126, P123, DOI 10.1085/jgp.200509296; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; TAGLIALATELA M, 1995, EMBO J, V14, P5532, DOI 10.1002/j.1460-2075.1995.tb00240.x; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Thompson AN, 2009, NAT STRUCT MOL BIOL, V16, P1317, DOI 10.1038/nsmb.1703; Tucker SJ, 1998, EMBO J, V17, P3290, DOI 10.1093/emboj/17.12.3290; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; Wilkens CM, 2006, J GEN PHYSIOL, V128, P347, DOI 10.1085/jgp.200609579; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; Yohannan S, 2007, J MOL BIOL, V366, P806, DOI 10.1016/j.jmb.2006.11.081; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	53	119	120	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					1018	1029		10.1016/j.cell.2010.05.003	http://dx.doi.org/10.1016/j.cell.2010.05.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20564790	Bronze			2022-12-01	WOS:000278618800016
J	Lu, WJ; Chapo, J; Roig, I; Abrams, JM				Lu, Wan-Jin; Chapo, Joseph; Roig, Ignasi; Abrams, John M.			Meiotic Recombination Provokes Functional Activation of the p53 Regulatory Network	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; DNA-DAMAGE; SUPPRESSOR GENE; MICE; CHECKPOINT; OOGENESIS; SYNAPSIS; HOMOLOG; COMPLEX; REPAIR	The evolutionary appearance of p53 protein probably preceded its role in tumor suppression, suggesting that there may be unappreciated functions for this protein. Using genetic reporters as proxies to follow in vivo activation of the p53 network in Drosophila, we discovered that the process of meiotic recombination instigates programmed activation of p53 in the germ line. Specifically, double-stranded breaks in DNA generated by the topoisomerase Spo11 provoked functional p53 activity, which was prolonged in cells defective for meiotic DNA repair. This intrinsic stimulus for the p53 regulatory network is highly conserved because Spo11-dependent activation of p53 also occurs in mice. Our findings establish a physiological role for p53 in meiosis and suggest that tumor-suppressive functions may have been co-opted from primordial activities linked to recombination.	[Lu, Wan-Jin; Chapo, Joseph; Abrams, John M.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Roig, Ignasi] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Memorial Sloan Kettering Cancer Center	Abrams, JM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	john.abrams@utsouthwestern.edu	Roig, Ignasi/A-9697-2012	Roig, Ignasi/0000-0003-0313-3581; Lu, Wan-Jin/0000-0002-2186-9800	National Institute of General Medical Sciences [R01GM072124]; National Institute on Alcohol Abuse and Alcoholism [R01AA017328]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA017328] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank S. Keeney for helpful discussions and reading of the manuscript and A. Ali, A. D'Brot, and A. Olivo for assisting experiments. We also thank the following individuals, laboratories, or facilities for helpful discussions, access to instruments, or providing reagents: S. Barolo, M. Buszczak, D. Castrillon, O. Cleaver, K. Hamra, J. Maines, D. McKearin, T. Schupbach, Y. Rong, J. Shelton, T. Wilkie, R. Bachoo, T. Mashimo, B. Thaden, Live Cell Imaging Facility (Univ. of Texas Southwestern), Bloomington Stock Center (Indiana Univ.), Developmental Studies Hybridoma Bank (Univ. of Iowa). This work was supported by the National Institute of General Medical Sciences (grant R01GM072124) and the National Institute on Alcohol Abuse and Alcoholism (grant R01AA017328).	Abdu U, 2002, CURR BIOL, V12, P1645, DOI 10.1016/S0960-9822(02)01165-X; Akdemir F, 2007, ONCOGENE, V26, P5184, DOI 10.1038/sj.onc.1210328; ALMON E, 1993, DEV BIOL, V156, P107, DOI 10.1006/dbio.1993.1062; Aranda-Anzaldo A, 2007, MECH AGEING DEV, V128, P293, DOI 10.1016/j.mad.2007.01.001; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Beumer TL, 1998, CELL DEATH DIFFER, V5, P669, DOI 10.1038/sj.cdd.4400396; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Gersten KM, 1997, NAT GENET, V17, P378, DOI 10.1038/ng1297-378; Ghafari F, 2009, HUM REPROD, V24, P1460, DOI 10.1093/humrep/dep022; Habu T, 2004, CARCINOGENESIS, V25, P889, DOI 10.1093/carcin/bgh099; Hu WW, 2007, NATURE, V450, P721, DOI 10.1038/nature05993; Jin SK, 2000, P NATL ACAD SCI USA, V97, P7301, DOI 10.1073/pnas.97.13.7301; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Klovstad M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040031; Lee JH, 2003, FEBS LETT, V550, P5, DOI 10.1016/S0014-5793(03)00771-3; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lu WJ, 2009, NAT REV CANCER, V9, P758, DOI 10.1038/nrc2732; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; McKim KS, 1998, GENE DEV, V12, P2932, DOI 10.1101/gad.12.18.2932; Nedelcu AM, 2007, DEV GENES EVOL, V217, P801, DOI 10.1007/s00427-007-0185-9; Peters M, 2002, P NATL ACAD SCI USA, V99, P11305, DOI 10.1073/pnas.172382899; ROTTER V, 1993, P NATL ACAD SCI USA, V90, P9075, DOI 10.1073/pnas.90.19.9075; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037	29	70	70	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1278	1281		10.1126/science.1185640	http://dx.doi.org/10.1126/science.1185640			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522776	Green Accepted			2022-12-01	WOS:000278318600035
J	Lee, LK; Ginsburg, MA; Crovace, C; Donohoe, M; Stock, D				Lee, Lawrence K.; Ginsburg, Michael A.; Crovace, Claudia; Donohoe, Mhairi; Stock, Daniela			Structure of the torque ring of the flagellar motor and the molecular basis for rotational switching	NATURE			English	Article							SALMONELLA-TYPHIMURIUM; PROTEIN FLIG; 3-DIMENSIONAL STRUCTURE; CONFORMATIONAL SPREAD; MUTATIONAL ANALYSIS; CHARGED RESIDUES; ROTOR; REGION; LOCALIZATION; GENERATION	The flagellar motor drives the rotation of flagellar filaments at hundreds of revolutions per second(1,2), efficiently propelling bacteria through viscous media(3). The motor uses the potential energy from an electrochemical gradient of cations(4,5) across the cytoplasmic membrane to generate torque. A rapid switch from anticlockwise to clockwise rotation determines whether a bacterium runs smoothly forward or tumbles to change its trajectory(6,7). A protein called FliG forms a ring in the rotor of the flagellar motor that is involved in the generation of torque(8-13) through an interaction with the cation-channel-forming stator subunit MotA(12). FliG has been suggested to adopt distinct conformations that induce switching but these structural changes and the molecular mechanism of switching are unknown. Here we report the molecular structure of the full-length FliG protein, identify conformational changes that are involved in rotational switching and uncover the structural basis for the formation of the FliG torque ring. This allows us to propose a model of the complete ring and switching mechanism in which conformational changes in FliG reverse the electrostatic charges involved in torque generation.	[Lee, Lawrence K.; Ginsburg, Michael A.; Donohoe, Mhairi; Stock, Daniela] Victor Chang Cardiac Res Inst, Struct & Computat Biol Div, Darlinghurst, NSW 2010, Australia; [Crovace, Claudia] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Stock, Daniela] Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia	Victor Chang Cardiac Research Institute; MRC Laboratory Molecular Biology; University of New South Wales Sydney	Stock, D (corresponding author), Victor Chang Cardiac Res Inst, Struct & Computat Biol Div, Lowy Packer Bldg,405 Liverpool St, Darlinghurst, NSW 2010, Australia.	d.stock@victorchang.edu.au		Lee, Lawrence/0000-0002-4453-4886	US Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; National Institutes of Health, National Center for Research Resources [RR007707]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; Australian Nuclear Science Technology Organization; MRC; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707] Funding Source: NIH RePORTER; Medical Research Council [MC_U105170645] Funding Source: researchfish; MRC [MC_U105170645] Funding Source: UKRI	US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Australian Nuclear Science Technology Organization; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the staff at beamline ID14-1 at the ESRF, and at beamlines 14-ID (BioCARS) and 23-ID (General Medicine and Cancer Institutes Collaborative Access Team (GM/CA-CAT)) at the APS for their support. Use of the APS was supported by the US Department of Energy, Basic Energy Sciences, Office of Science (contract DE-AC02-06CH11357), and use of the BioCARS Sector 14 was supported by the National Institutes of Health, National Center for Research Resources (grant RR007707). GM/CA-CAT was funded in whole or in part with federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104). This work was supported by the Australian Synchrotron Research Program of the Australian Nuclear Science Technology Organization. D. Thomas is acknowledged for providing us with the electron microscopy density map of the clockwise-locked S. typhimurium mutant and O. Perisic and H. Huber are acknowledged for cloning vectors (pOPT-GST) and A. aeolicus genomic DNA, respectively. D. S. was initially funded by an MRC Career development award (UK) and C. C. by an MRC predoctoral fellowship (UK).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Bai F, 2010, SCIENCE, V327, P685, DOI 10.1126/science.1182105; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Brown PN, 2007, J BACTERIOL, V189, P305, DOI 10.1128/JB.01281-06; Brown PN, 2002, EMBO J, V21, P3225, DOI 10.1093/emboj/cdf332; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Duke TAJ, 2001, J MOL BIOL, V308, P541, DOI 10.1006/jmbi.2001.4610; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRANCIS NR, 1992, P NATL ACAD SCI USA, V89, P6304, DOI 10.1073/pnas.89.14.6304; HIROTA N, 1983, J BIOL CHEM, V258, P577; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IRIKURA VM, 1993, J BACTERIOL, V175, P802, DOI 10.1128/JB.175.3.802-810.1993; Kihara M, 2000, J BACTERIOL, V182, P3022, DOI 10.1128/JB.182.11.3022-3028.2000; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Liu J, 2009, J BACTERIOL, V191, P5026, DOI 10.1128/JB.00340-09; Lloyd SA, 1997, J MOL BIOL, V266, P733, DOI 10.1006/jmbi.1996.0836; Lloyd SA, 1999, NATURE, V400, P472, DOI 10.1038/22794; Lloyd SA, 1996, J BACTERIOL, V178, P223, DOI 10.1128/jb.178.1.223-231.1996; LOWE G, 1987, NATURE, V325, P637, DOI 10.1038/325637a0; MAGARIYAMA Y, 1994, NATURE, V371, P752, DOI 10.1038/371752b0; MANSON MD, 1977, P NATL ACAD SCI USA, V74, P3060, DOI 10.1073/pnas.74.7.3060; Marykwas DL, 1996, J BACTERIOL, V178, P1289, DOI 10.1128/jb.178.5.1289-1294.1996; Murphy GE, 2006, NATURE, V442, P1062, DOI 10.1038/nature05015; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Thomas D, 2001, J BACTERIOL, V183, P6404, DOI 10.1128/JB.183.21.6404-6412.2001; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; Togashi F, 1997, J BACTERIOL, V179, P2994, DOI 10.1128/jb.179.9.2994-3003.1997; Turner L, 2000, J BACTERIOL, V182, P2793, DOI 10.1128/JB.182.10.2793-2801.2000; UENO T, 1992, J MOL BIOL, V227, P672, DOI 10.1016/0022-2836(92)90216-7; Van Way SM, 2004, J BACTERIOL, V186, P3173, DOI 10.1128/JB.186.10.3173-3181.2004; Yorimitsu T, 2003, J MOL BIOL, V334, P567, DOI 10.1016/j.jmb.2003.09.052; Zhou JD, 1998, P NATL ACAD SCI USA, V95, P6436, DOI 10.1073/pnas.95.11.6436	40	129	130	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2010	466	7309					996	U129		10.1038/nature09300	http://dx.doi.org/10.1038/nature09300			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20676082	Green Accepted			2022-12-01	WOS:000281030300039
J	Mangan, SA; Schnitzer, SA; Herre, EA; Mack, KML; Valencia, MC; Sanchez, EI; Bever, JD				Mangan, Scott A.; Schnitzer, Stefan A.; Herre, Edward A.; Mack, Keenan M. L.; Valencia, Mariana C.; Sanchez, Evelyn I.; Bever, James D.			Negative plant-soil feedback predicts tree-species relative abundance in a tropical forest	NATURE			English	Article							LOCAL NEIGHBORHOOD; DENSITY-DEPENDENCE; SEEDLING MORTALITY; MAINTAIN DIVERSITY; SPATIAL-PATTERNS; PATHOGENS; COMMUNITY; GROWTH; RECRUITMENT; COEXISTENCE	The accumulation of species-specific enemies around adults is hypothesized to maintain plant diversity by limiting the recruitment of conspecific seedlings relative to heterospecific seedlings(1-6). Although previous studies in forested ecosystems have documented patterns consistent with the process of negative feedback(7-16), these studies are unable to address which classes of enemies (for example, pathogens, invertebrates, mammals) exhibit species-specific effects strong enough to generate negative feedback(17), and whether negative feedback at the level of the individual tree is sufficient to influence community-wide forest composition. Here we use fully reciprocal shade-house and field experiments to test whether the performance of conspecific tree seedlings (relative to heterospecific seedlings) is reduced when grown in the presence of enemies associated with adult trees. Both experiments provide strong evidence for negative plant-soil feedback mediated by soil biota. In contrast, above-ground enemies (mammals, foliar herbivores and foliar pathogens) contributed little to negative feedback observed in the field. In both experiments, we found that tree species that showed stronger negative feedback were less common as adults in the forest community, indicating that susceptibility to soil biota may determine species relative abundance in these tropical forests. Finally, our simulation models confirm that the strength of local negative feedback that we measured is sufficient to produce the observed community-wide patterns in tree-species relative abundance. Our findings indicate that plant-soil feedback is an important mechanism that can maintain species diversity and explain patterns of tree-species relative abundance in tropical forests.	[Mangan, Scott A.; Schnitzer, Stefan A.] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; [Mangan, Scott A.; Schnitzer, Stefan A.; Herre, Edward A.; Sanchez, Evelyn I.] Smithsonian Trop Res Inst, MRC 0580 06, Dpo, AA 34002 USA; [Mack, Keenan M. L.; Bever, James D.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Valencia, Mariana C.] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA	University of Wisconsin System; University of Wisconsin Milwaukee; Smithsonian Institution; Smithsonian Tropical Research Institute; Indiana University System; Indiana University Bloomington; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mangan, SA (corresponding author), Univ Wisconsin, Dept Biol Sci, POB 413, Milwaukee, WI 53201 USA.	smangan37@gmail.com		Schnitzer, Stefan/0000-0002-2715-9455	Smithsonian Tropical Research Institute (STRI); University of Wisconsin-Milwaukee (UWM) Research Growth Initiative; UWM Research Foundation; National Science Foundation; STRI Soil Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092660] Funding Source: NIH RePORTER	Smithsonian Tropical Research Institute (STRI)(Smithsonian InstitutionSmithsonian Tropical Research Institute); University of Wisconsin-Milwaukee (UWM) Research Growth Initiative; UWM Research Foundation; National Science Foundation(National Science Foundation (NSF)); STRI Soil Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Adler, M. Kaspari, E. Leigh, T. Lambert, I. Rubinoff, E. Tanner, M. Tobin, B. Turner, S. Van Bael and N. Wurzburger for providing discussions and comments on the manuscript. R. Kolodziej, K. Meyer, K. McElligott and T. Shirshac provided greenhouse and field assistance. Logistical support was provided by the Smithsonian Tropical Research Institute. The Center of Tropical Forest Science provided BCI tree abundance data published online at https://ctfs.arnarb.harvard.edu/webatlas/datasets/bci/abundance. This study was supported by a Smithsonian Tropical Research Institute (STRI) postdoctoral fellowship to S. A. M., a University of Wisconsin-Milwaukee (UWM) Research Growth Initiative grant to S. A. S., a fellowship from the UWM Research Foundation, and a grant from the National Science Foundation to J.D.B. We thank I. Rubinoff for his support of the STRI Soil Initiative.	Adler FR, 2005, ECOL LETT, V8, P438, DOI 10.1111/j.1461-0248.2005.00741.x; AUGSPURGER CK, 1984, OECOLOGIA, V61, P211, DOI 10.1007/BF00396763; Bell T, 2006, ECOL LETT, V9, P569, DOI 10.1111/j.1461-0248.2006.00905.x; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Bever JD, 2002, P ROY SOC B-BIOL SCI, V269, P2595, DOI 10.1098/rspb.2002.2162; BEVER JD, 1994, ECOLOGY, V75, P1965, DOI 10.2307/1941601; Carson W.P., 2008, CHALLENGES ASS TESTI, V210, P241; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; COMITA LS, SCIENCE IN PRESS, DOI DOI 10.1126/SCIENCE.1190772; CONNELL J H, 1971, P298; CONNELL JH, 1984, ECOL MONOGR, V54, P141, DOI 10.2307/1942659; De Deyn GB, 2003, NATURE, V422, P711, DOI 10.1038/nature01548; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; Hood LA, 2004, J ECOL, V92, P816, DOI 10.1111/j.0022-0477.2004.00917.x; HUBBELI SP, 2001, UNIFIED NEUTRAL THEO; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Kardol P, 2007, ECOL MONOGR, V77, P147, DOI 10.1890/06-0502; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; McCarthy-Neumann S, 2010, J ECOL, V98, P396, DOI 10.1111/j.1365-2745.2009.01619.x; Mills KE, 1998, ECOLOGY, V79, P1595, DOI 10.1890/0012-9658(1998)079[1595:MODWPC]2.0.CO;2; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Petermann JS, 2008, ECOLOGY, V89, P2399, DOI 10.1890/07-2056.1; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Webb CO, 1999, ECOLOGY, V80, P2006, DOI 10.1890/0012-9658(1999)080[2006:SDDPCO]2.0.CO;2; Wills C, 2006, SCIENCE, V311, P527, DOI 10.1126/science.1117715	30	700	722	18	661	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2010	466	7307					752	U10		10.1038/nature09273	http://dx.doi.org/10.1038/nature09273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20581819	Green Submitted			2022-12-01	WOS:000280562500038
J	Whitaker, DL; Edwards, J				Whitaker, Dwight L.; Edwards, Joan			Sphagnum Moss Disperses Spores with Vortex Rings	SCIENCE			English	Article									[Whitaker, Dwight L.] Pomona Coll, Dept Phys & Astron, Claremont, CA 91711 USA; [Edwards, Joan] Williams Coll, Dept Biol, Williamstown, MA 01267 USA	Claremont Colleges; Pomona College; Williams College	Whitaker, DL (corresponding author), Pomona Coll, Dept Phys & Astron, Claremont, CA 91711 USA.	dwight.whitaker@pomona.edu; joan.edwards@williams.edu			NSF [0722532]	NSF(National Science Foundation (NSF))	This work was supported in part by NSF Major Research Instrumentation award 0722532. The authors thank D. C. Smith and C. D. Mitescu for comments; R. Andrus for species identification; and E. Chang, A. Conwill, C. Hard, M. Hirai, N. Mitchell, and N. Piatczyc for technical assistance.	Batchelor G. K., 2000, INTRO FLUID DYNAMICS; Clymo RS, 1982, BRYOPHYTE ECOLOGY; Dabiri JO, 2009, ANNU REV FLUID MECH, V41, P17, DOI 10.1146/annurev.fluid.010908.165232; Gregory P. H., 1973, MICROBIOLOGY ATMOSPH, V2nd; MAXWORTHY T, 1974, J FLUID MECH, V64, P227, DOI 10.1017/S0022112074002370; McQueen C. B., 2007, FLORA N AM N MEXICO, V27, P45; Nawaschin S., 1897, FLORA, V83, P151; Rydin H, 2006, BIOL PEATLANDS; Sundberg S, 2010, ANN BOT-LONDON, V105, P291, DOI 10.1093/aob/mcp288	9	45	49	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					406	406		10.1126/science.1190179	http://dx.doi.org/10.1126/science.1190179			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651145				2022-12-01	WOS:000280196500027
J	Orkin, SH; Higgs, DR				Orkin, Stuart H.; Higgs, Douglas R.			MEDICINE Sickle Cell Disease at 100 Years	SCIENCE			English	Editorial Material							FETAL-HEMOGLOBIN; BETA-THALASSEMIA; RISK-FACTORS; ANEMIA; BCL11A; EXPRESSION; BURDEN		[Orkin, Stuart H.] Childrens Hosp, Boston, MA 02115 USA; [Orkin, Stuart H.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dana Farber Canc Inst, Boston, MA 02115 USA; [Higgs, Douglas R.] John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford 0X3 9DS, England	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu		Higgs, Douglas/0000-0003-3579-8705	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL032259] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL032259] Funding Source: NIH RePORTER; Medical Research Council [G1000801b] Funding Source: researchfish	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Bradner JE, 2006, NAT PROTOC, V1, P2344, DOI 10.1038/nprot.2006.282; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Herrick J.B., 1910, ARCH INTERN MED, V6, P517; Kaiser J, 2009, SCIENCE, V326, P1468, DOI 10.1126/science.326.5959.1468-b; Makani J, 2010, BLOOD, V115, P215, DOI 10.1182/blood-2009-07-233528; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Menzel S, 2007, BLOOD, V110, P3624, DOI 10.1182/blood-2007-05-093419; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Schechter AN, 2008, BLOOD, V112, P3927, DOI 10.1182/blood-2008-04-078188; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Tanguturi S. K., 2010, P NATL ACAD SCI US; Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; WATSON J, 1948, AM J MED SCI, V215, P419, DOI 10.1097/00000441-194804000-00008; Weatherall DJ, 2010, BLOOD, V115, P4331, DOI 10.1182/blood-2010-01-251348	21	27	29	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					291	292		10.1126/science.1194035	http://dx.doi.org/10.1126/science.1194035			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647458				2022-12-01	WOS:000279925900030
J	Siegel, JB; Zanghellini, A; Lovick, HM; Kiss, G; Lambert, AR; Clair, JLS; Gallaher, JL; Hilvert, D; Gelb, MH; Stoddard, BL; Houk, KN; Michael, FE; Baker, D				Siegel, Justin B.; Zanghellini, Alexandre; Lovick, Helena M.; Kiss, Gert; Lambert, Abigail R.; Clair, Jennifer L. St.; Gallaher, Jasmine L.; Hilvert, Donald; Gelb, Michael H.; Stoddard, Barry L.; Houk, Kendall N.; Michael, Forrest E.; Baker, David			Computational Design of an Enzyme Catalyst for a Stereoselective Bimolecular Diels-Alder Reaction	SCIENCE			English	Article							MACROPHOMATE SYNTHASE; CYCLODEXTRINS; ANTIBODIES; ORIGINS	The Diels-Alder reaction is a cornerstone in organic synthesis, forming two carbon-carbon bonds and up to four new stereogenic centers in one step. No naturally occurring enzymes have been shown to catalyze bimolecular Diels-Alder reactions. We describe the de novo computational design and experimental characterization of enzymes catalyzing a bimolecular Diels-Alder reaction with high stereoselectivity and substrate specificity. X-ray crystallography confirms that the structure matches the design for the most active of the enzymes, and binding site substitutions reprogram the substrate specificity. Designed stereoselective catalysts for carbon-carbon bond-forming reactions should be broadly useful in synthetic chemistry.	[Siegel, Justin B.; Zanghellini, Alexandre; Clair, Jennifer L. St.; Gallaher, Jasmine L.; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Siegel, Justin B.; Zanghellini, Alexandre; Baker, David] Univ Washington, Biomol Struct & Design Program, Seattle, WA 98195 USA; [Lovick, Helena M.; Gelb, Michael H.; Michael, Forrest E.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Kiss, Gert; Houk, Kendall N.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Lambert, Abigail R.; Stoddard, Barry L.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Hilvert, Donald] ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; Fred Hutchinson Cancer Center; Swiss Federal Institutes of Technology Domain; ETH Zurich; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; gelb, michael/0000-0001-7000-5219; Michael, Forrest/0000-0001-8071-4676	Defense Advanced Research Projects Agency (DARPA); Howard Hughes Medical Institute (HHMI); NIH; Lawrence Livermore National Laboratory; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075962, T32GM008268] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Defense Advanced Research Projects Agency (DARPA), the Howard Hughes Medical Institute (HHMI), a Molecular Biophysics traineeship from the NIH for J.B.S., and the Lawrence Livermore National Laboratory Lawrence Scholars program for G. K. We thank M. Toscano (ETH) and C. Rosewall (University of Washington) for chemical synthesis and B. Siegel and Y.-h. Lam for helpful comments on the manuscript. The x-ray crystallographic coordinates have been deposited in the Protein Data Bank with accession ID 3I1C. The University of Washington has submitted a patent application on the protein sequence coding for the engineered enzymes reported here as well as some of the design methodology.	[Anonymous], PYMOL MOL GRAPH SYST; BLAKE JF, 1994, J ORG CHEM, V59, P803, DOI 10.1021/jo00083a021; Boger D., 1999, MODERN ORGANIC SYNTH, P213; Breslow R, 1998, CHEM REV, V98, P1997, DOI 10.1021/cr970011j; Cannizzaro CE, 2003, J AM CHEM SOC, V125, P2489, DOI 10.1021/ja020879d; GOUVERNEUR VE, 1993, SCIENCE, V262, P204, DOI 10.1126/science.8211138; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kim SP, 2002, J ORG CHEM, V67, P4250, DOI 10.1021/jo011180d; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Ose T, 2003, NATURE, V422, P185, DOI 10.1038/nature01454; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Serafimov JM, 2008, J AM CHEM SOC, V130, P7798, DOI 10.1021/ja8017994; YLIKAUHALUOMA JT, 1995, J AM CHEM SOC, V117, P7041, DOI 10.1021/ja00132a001; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106	15	607	640	9	455	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					309	313		10.1126/science.1190239	http://dx.doi.org/10.1126/science.1190239			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	625VW	20647463	Green Accepted			2022-12-01	WOS:000279925900037
J	Alic, J; Sarewitz, D; Weiss, C; Bonvillian, W				Alic, John; Sarewitz, Daniel; Weiss, Charles; Bonvillian, William			A new strategy for energy innovation	NATURE			English	Editorial Material									[Sarewitz, Daniel] Arizona State Univ, Consortium Sci Policy & Outcomes, Tempe, AZ 85287 USA; [Weiss, Charles] Georgetown Univ, Sch Foreign Serv, Washington, DC 20057 USA; [Bonvillian, William] MIT, Washington Off, Washington, DC 20002 USA	Arizona State University; Arizona State University-Tempe; Georgetown University; Massachusetts Institute of Technology (MIT)		john_alic@earthlink.net						Alic JA, 2007, TRILLIONS FOR MILITARY TECHNOLOGY: HOW THE PENTAGON INNOVATES AND WHY IT COSTS SO MUCH, P1, DOI 10.1057/9780230606876; [Anonymous], 2009, INN POL CLIM CHANG; BIRKLER JL, 1982, DEV PRODUCTION COST; BONVILLIAN WB, 2009, INNOVATIONS, P289; Vane HR, 2009, J ECON PERSPECT, V23, P109, DOI 10.1257/jep.23.3.109; Weiss C., 2009, STRUCT EN TECHN REV; YOUNOSSI O, 2002, MILITARY JET ENGINE, P66	7	20	20	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2010	466	7304					316	317		10.1038/466316a	http://dx.doi.org/10.1038/466316a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	625BP	20631780				2022-12-01	WOS:000279867100018
J	Loxterkamp, DA				Loxterkamp, David A.			Old Men and the Sea	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												dr.loxterkamp@myfairpoint.net							0	1	1	3	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2010	304	1					18	19		10.1001/jama.2010.902	http://dx.doi.org/10.1001/jama.2010.902			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620SJ	20606138				2022-12-01	WOS:000279519600001
J	Carter, J; Poulet, F; Bibring, JP; Murchie, S				Carter, J.; Poulet, F.; Bibring, J. -P.; Murchie, S.			Detection of Hydrated Silicates in Crustal Outcrops in the Northern Plains of Mars	SCIENCE			English	Article							SPECTRAL EVIDENCE; PHYLLOSILICATES; DIVERSITY; EVOLUTION; LOWLANDS; HISTORY; WATER	The composition of the ancient martian crust is a key ingredient in deciphering the environment and evolution of early Mars. We present an analysis of the composition of large craters in the martian northern plains based on data from spaceborne imaging spectrometers. Nine of the craters have excavated assemblages of phyllosilicates from ancient, Noachian crust buried beneath the plains' cover. The phyllosilicates are indistinguishable from those exposed in widespread locations in the southern highlands, demonstrating that liquid water once altered both hemispheres of Mars.	[Carter, J.; Poulet, F.; Bibring, J. -P.] Univ Paris 11, CNRS, IAS, F-91405 Orsay, France; [Murchie, S.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Carter, J (corresponding author), Univ Paris 11, CNRS, IAS, F-91405 Orsay, France.	John.carter@ias.u-psud.fr	Murchie, Scott L/E-8030-2015	Murchie, Scott L/0000-0002-1616-8751				Abramov O, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002453; BAKER VR, 1991, NATURE, V352, P589, DOI 10.1038/352589a0; Bandfield JL, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001510; Baratoux D, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2007JE002890; Bibring J.-P., 2004, EUR SPACE AGENCY SPE, P37; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Bishop JL, 2008, CLAY MINER, V43, P35, DOI 10.1180/claymin.2008.043.1.03; CARTER J, 2009, P LUNAR PLANET SCI C, V40; Christensen PR, 2005, NATURE, V436, P504, DOI 10.1038/nature03639; Clark R.N., 2007, USGS DIGITAL DATA SE, V231; Dickson JL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037472; Ehlmann BL, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003339; Frey M., 1999, LOW GRADE METAMORPHI; GONDET B, 2007, 7 INT C MARS LUN PLA; Head JW, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001445; Kreslavsky MA, 2006, METEORIT PLANET SCI, V41, P1633, DOI 10.1111/j.1945-5100.2006.tb00441.x; Kreslavsky MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015392; Kreslavsky MA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001831; Murchie SL, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003344; Murchie SL, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003342; Mustard JF, 2005, SCIENCE, V307, P1594, DOI 10.1126/science.1109098; Mustard JF, 2008, NATURE, V454, P305, DOI 10.1038/nature07097; Pelkey SM, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002831; Picardi G, 2005, SCIENCE, V310, P1925, DOI 10.1126/science.1122165; Poulet F, 2005, NATURE, V438, P623, DOI 10.1038/nature04274; Rathbun JA, 2002, ICARUS, V157, P362, DOI 10.1006/icar.2002.6838; Rogers D, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001913; Ruff SW, 2004, ICARUS, V168, P131, DOI 10.1016/j.icarus.2003.11.003; SALVATORE MR, 2009, P LUNAR PLANET SCI C, V40; Schwenzer SP, 2009, GEOLOGY, V37, P1091, DOI 10.1130/G30340A.1; Stockstill-Cahill KR, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003036; Tanaka KL, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001908; Wyatt MB, 2002, NATURE, V417, P263, DOI 10.1038/417263a; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788	35	115	116	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2010	328	5986					1682	1686		10.1126/science.1189013	http://dx.doi.org/10.1126/science.1189013			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576889				2022-12-01	WOS:000279107400040
J	Kasanetz, F; Deroche-Gamonet, V; Berson, N; Balado, E; Lafourcade, M; Manzoni, O; Piazza, PV				Kasanetz, Fernando; Deroche-Gamonet, Veronique; Berson, Nadege; Balado, Eric; Lafourcade, Mathieu; Manzoni, Olivier; Piazza, Pier Vincenzo			Transition to Addiction Is Associated with a Persistent Impairment in Synaptic Plasticity	SCIENCE			English	Article							LONG-TERM DEPRESSION; DRUG-SEEKING; COCAINE ADDICTION; NEURAL MECHANISMS; NUCLEUS-ACCUMBENS; BEHAVIOR; LTD; VTA	Chronic exposure to drugs of abuse induces countless modifications in brain physiology. However, the neurobiological adaptations specifically associated with the transition to addiction are unknown. Cocaine self-administration rapidly suppresses long-term depression (LTD), an important form of synaptic plasticity in the nucleus accumbens. Using a rat model of addiction, we found that animals that progressively develop the behavioral hallmarks of addiction have permanently impaired LTD, whereas LTD is progressively recovered in nonaddicted rats maintaining a controlled drug intake. By making drug seeking consistently resistant to modulation by environmental contingencies and consequently more and more inflexible, a persistently impaired LTD could mediate the transition to addiction.	[Kasanetz, Fernando; Deroche-Gamonet, Veronique; Berson, Nadege; Balado, Eric; Lafourcade, Mathieu; Manzoni, Olivier; Piazza, Pier Vincenzo] INSERM, U862, NeuroCtr Magendie, F-33077 Bordeaux, France; [Kasanetz, Fernando; Deroche-Gamonet, Veronique; Berson, Nadege; Balado, Eric; Lafourcade, Mathieu; Manzoni, Olivier; Piazza, Pier Vincenzo] Univ Bordeaux, F-33077 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Manzoni, O (corresponding author), INSERM, U862, NeuroCtr Magendie, 147 Rue Leo Saignat, F-33077 Bordeaux, France.	olivier.manzoni@inserm.fr; pier-vincenzo.piazza@inserm.fr	Deroche-Gamonet, Véronique/E-5728-2010; Manzoni, Olivier/M-7899-2016; Lafourcade, Mathieu/GQZ-7267-2022	Manzoni, Olivier/0000-0002-5579-6208; Lafourcade, Mathieu/0000-0001-6117-1194; Kasanetz, Fernando/0000-0003-4585-2314; Deroche-Gamonet, Veronique/0000-0002-9704-6624	ANR [2005]; EU-STREPPheCOMP; MILDT/INCa/Inserm [2008]	ANR(French National Research Agency (ANR)); EU-STREPPheCOMP; MILDT/INCa/Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)Institut National du Cancer (INCA) France)	Supported by ANR (2005), EU-STREPPheCOMP (FP6), MILDT/INCa/Inserm (2008) grants to P. V. P., O.M., and V. D.-G. The authors report no conflict of interest.	Belin D, 2009, BIOL PSYCHIAT, V65, P863, DOI 10.1016/j.biopsych.2008.05.031; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kalivas PW, 2005, NAT NEUROSCI, V8, P1440, DOI 10.1038/nn1105-1440; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Martin M, 2006, NAT NEUROSCI, V9, P868, DOI 10.1038/nn1713; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; Nestler EJ, 2008, PHILOS T R SOC B, V363, P3245, DOI 10.1098/rstb.2008.0067; OBrien CP, 1997, SCIENCE, V278, P66, DOI 10.1126/science.278.5335.66; Panlilio LV, 2007, ADDICTION, V102, P1863, DOI 10.1111/j.1360-0443.2007.02011.x; Robbe D, 2002, J NEUROSCI, V22, P4346, DOI 10.1523/JNEUROSCI.22-11-04346.2002; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Sanchis-Segura C, 2006, ADDICT BIOL, V11, P2, DOI 10.1111/j.1369-1600.2006.00012.x; Shaham Y, 2005, NAT NEUROSCI, V8, P1437, DOI 10.1038/nn1105-1437; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; WARNER LA, 1995, ARCH GEN PSYCHIAT, V52, P219; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261	30	270	274	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1709	1712		10.1126/science.1187801	http://dx.doi.org/10.1126/science.1187801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576893				2022-12-01	WOS:000279107400048
J	Lee, JH; Yu, WH; Kumar, A; Lee, S; Mohan, PS; Peterhoff, CM; Wolfe, DM; Martinez-Vicente, M; Massey, AC; Sovak, G; Uchiyama, Y; Westaway, D; Cuervo, AM; Nixon, RA				Lee, Ju-Hyun; Yu, W. Haung; Kumar, Asok; Lee, Sooyeon; Mohan, Panaiyur S.; Peterhoff, Corrinne M.; Wolfe, Devin M.; Martinez-Vicente, Marta; Massey, Ashish C.; Sovak, Guy; Uchiyama, Yasuo; Westaway, David; Cuervo, Ana Maria; Nixon, Ralph A.			Lysosomal Proteolysis and Autophagy Require Presenilin 1 and Are Disrupted by Alzheimer-Related PS1 Mutations	CELL			English	Article							POSTTRANSLATIONAL N-GLYCOSYLATION; INTRACELLULAR PROTEIN-DEGRADATION; CATHEPSIN-D; MOUSE MODELS; ACIDIC ORGANELLES; DISEASE; ATPASE; ACIDIFICATION; NEURONS; CELLS	Macroautophagy is a lysosomal degradative pathway essential for neuron survival. Here, we show that macroautophagy requires the Alzheimer's disease (AD)-related protein presenilin-1 (PS1). In PS1 null blastocysts, neurons from mice hypomorphic for PS1 or conditionally depleted of PS1, substrate proteolysis and autophagosome clearance during macroautophagy are prevented as a result of a selective impairment of autolysosome acidification and cathepsin activation. These deficits are caused by failed PS1-dependent targeting of the v-ATPase V0a1 subunit to lysosomes. N-glycosylation of the V0a1 subunit, essential for its efficient ER-to-lysosome delivery, requires the selective binding of PS1 holoprotein to the unglycosylated subunit and the Sec61alpha/oligosaccharyltransferase complex. PS1 mutations causing early-onset AD produce a similar lysosomal/autophagy phenotype in fibroblasts from AD patients. PS1 is therefore essential for v-ATPase targeting to lysosomes, lysosome acidification, and proteolysis during autophagy. Defective lysosomal proteolysis represents a basis for pathogenic protein accumulations and neuronal cell death in AD and suggests previously unidentified therapeutic targets.	[Lee, Ju-Hyun; Yu, W. Haung; Kumar, Asok; Lee, Sooyeon; Mohan, Panaiyur S.; Peterhoff, Corrinne M.; Wolfe, Devin M.; Nixon, Ralph A.] Nathan S Kline Inst, Ctr Dementia Res, Orangeburg, NY 10962 USA; [Lee, Ju-Hyun; Yu, W. Haung; Mohan, Panaiyur S.; Nixon, Ralph A.] NYU, Langone Med Ctr, Dept Psychiat, New York, NY 10016 USA; [Kumar, Asok] NYU, Langone Med Ctr, Dept Pathol, New York, NY 10016 USA; [Lee, Sooyeon] NYU, Langone Med Ctr, Dept Neurosci, New York, NY 10016 USA; [Nixon, Ralph A.] NYU, Langone Med Ctr, Dept Cell Biol, New York, NY 10016 USA; [Martinez-Vicente, Marta; Massey, Ashish C.; Sovak, Guy; Cuervo, Ana Maria] Albert Einstein Coll Med, Inst Aging Res, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Uchiyama, Yasuo] Juntendo Univ, Grad Sch Med, Dept Cell Biol & Neurosci, Bunkyo Ku, Tokyo 1138421, Japan; [Westaway, David] Univ Alberta, Dept Med, Edmonton, AB T6G 2B7, Canada	Nathan Kline Institute for Psychiatric Research; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Yeshiva University; Albert Einstein College of Medicine; Juntendo University; University of Alberta	Nixon, RA (corresponding author), Nathan S Kline Inst, Ctr Dementia Res, 140 Old Orangeburg Rd, Orangeburg, NY 10962 USA.	nixon@nki.rfmh.org	Martinez-Vicente, Marta/K-4312-2014	Martinez-Vicente, Marta/0000-0001-7053-2625; Lee, Ju-hyun/0000-0002-0280-8375; Yu, Wai Haung/0000-0001-7186-6731; Cuervo, Ana Maria/0000-0002-0771-700X	National Institutes of Health [P01AG017617]; Alzheimer's Association; NATIONAL INSTITUTE ON AGING [P01AG017617] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are very grateful to Alan Bernstein (Global HIV Vaccine Enterprise, Seattle) for blastocysts, Tamotsu Yoshimori (Osaka University) for the tandem-tagged LC3 construct, Samuel E. Gandy (Mount Sinai Medical Center) for PS1 antibody, Satoshi Sato (Kyoto University) for the rabbit pAb against 116 kDa subunit of the v-ATPase, Jean Gruenberg (Universite de Geneve) for anti-LBPA antibody, and Richard Cowburn (Karolinska Institute), Ralph Martins (Cornell University), Sandro Sorbi (Universita degli studi di Firenze) for PS1-FAD human fibroblasts, and Sangram S. Sisodia (University of Chicago) for PS cKO mice. We also thank Gert Kreibich (New York University Langone Medical Center) and members of the Nixon laboratory for valuable discussions and Nicole Piorkowski for assistance with manuscript preparation. This work was supported by National Institutes of Health grant number P01AG017617 (R.A.N) and the Alzheimer's Association (R.A.N).	ANDERSON RGW, 1984, P NATL ACAD SCI-BIOL, V81, P4838, DOI 10.1073/pnas.81.15.4838; AUTERI JS, 1983, J CELL PHYSIOL, V115, P167, DOI 10.1002/jcp.1041150210; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bolt G, 2005, GLYCOBIOLOGY, V15, P541, DOI 10.1093/glycob/cwi032; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cataldo AM, 2004, J NEUROPATH EXP NEUR, V63, P821, DOI 10.1093/jnen/63.8.821; Chen CS, 2000, J BIOCHEM BIOPH METH, V42, P137, DOI 10.1016/S0165-022X(00)00048-8; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Diwu ZJ, 1999, CHEM BIOL, V6, P411, DOI 10.1016/S1074-5521(99)80059-3; DOTTAVIOMARTIN D, 1978, ANAL BIOCHEM, V87, P562, DOI 10.1016/0003-2697(78)90706-6; Esselens C, 2004, J CELL BIOL, V166, P1041, DOI 10.1083/jcb.200406060; GILLESPIE J, 1991, FEBS LETT, V282, P69, DOI 10.1016/0014-5793(91)80446-A; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; ISIDORO C, 1991, BIOCHEM J, V273, P363, DOI 10.1042/bj2730363; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kim TW, 1997, CURR OPIN NEUROBIOL, V7, P683, DOI 10.1016/S0959-4388(97)80089-X; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Kokkonen N, 2004, J BIOL CHEM, V279, P39982, DOI 10.1074/jbc.M406698200; Lai MT, 2003, J BIOL CHEM, V278, P22475, DOI 10.1074/jbc.M300974200; Laudon H, 2004, J NEUROCHEM, V89, P44, DOI 10.1046/j.1471-4159.2003.02298.x; MARZELLA L, 1982, J CELL BIOL, V93, P144, DOI 10.1083/jcb.93.1.144; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; NAKANISHI H, 1994, EXP NEUROL, V126, P119, DOI 10.1006/exnr.1994.1048; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2008, AUTOPHAGY, V4, P590, DOI 10.4161/auto.6259; Nixon RA, 2006, J ALZHEIMERS DIS, V9, P277; Ramachandran N, 2009, CELL, V137, P235, DOI 10.1016/j.cell.2009.01.054; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rozmahel R, 2002, NEUROBIOL AGING, V23, P187, DOI 10.1016/S0197-4580(01)00267-6; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Samari HR, 1998, J BIOL CHEM, V273, P23758, DOI 10.1074/jbc.273.37.23758; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Shioi J, 2007, J NEUROCHEM, V101, P674, DOI 10.1111/j.1471-4159.2006.04391.x; U.S. Office of Science and Technology Policy, 1985, Fed Regist, V50, P20864; Wilson CA, 2004, J CELL BIOL, V165, P335, DOI 10.1083/jcb.200403061; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zhang JM, 1998, J BIOL CHEM, V273, P12436, DOI 10.1074/jbc.273.20.12436	53	806	827	6	131	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1146	U91		10.1016/j.cell.2010.05.008	http://dx.doi.org/10.1016/j.cell.2010.05.008			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20541250	Green Accepted, Bronze			2022-12-01	WOS:000279148100012
J	Heidenreich, KD				Heidenreich, Katherine D.			Benign Paroxysmal Positional Vertigo.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Michigan Hlth Syst, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Heidenreich, KD (corresponding author), Univ Michigan Hlth Syst, Ann Arbor, MI USA.	kheidenr@med.umich.edu							0	1	1	5	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 24	2010	362	25					e70	e70		10.1056/NEJMicm0907386	http://dx.doi.org/10.1056/NEJMicm0907386			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614GO	20573921				2022-12-01	WOS:000279043800011
J	Dang, L; White, DW; Gross, S; Bennett, BD; Bittinger, MA; Driggers, EM; Fantin, VR; Jang, HG; Jin, SF; Keenan, MC; Marks, KM; Prins, RM; Ward, PS; Yen, KE; Liau, LM; Rabinowitz, JD; Cantley, LC; Thompson, CB; Vander Heiden, MG; Su, SM				Dang, Lenny; White, David W.; Gross, Stefan; Bennett, Bryson D.; Bittinger, Mark A.; Driggers, Edward M.; Fantin, Valeria R.; Jang, Hyun Gyung; Jin, Shengfang; Keenan, Marie C.; Marks, Kevin M.; Prins, Robert M.; Ward, Patrick S.; Yen, Katharine E.; Liau, Linda M.; Rabinowitz, Joshua D.; Cantley, Lewis C.; Thompson, Craig B.; Vander Heiden, Matthew G.; Su, Shinsan M.			Cancer-associated IDH1 mutations produce 2-hydroxyglutarate (vol 462, pg 739, 2010)	NATURE			English	Correction													Cantley, Lewis C/D-1800-2014; Prins, Robert/AAX-1155-2021; Ward, Patrick/H-2361-2014	Cantley, Lewis C/0000-0002-1298-7653; Dang, Lenny/0000-0002-2073-6109; Liau, Linda/0000-0002-4053-0052; Prins, Robert/0000-0002-6282-6583; Ward, Patrick/0000-0001-6437-8174	NCI NIH HHS [R01 CA105463] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA105463] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Dang L, 2010, NATURE, V465, P966, DOI 10.1038/nature09132; Struys EA, 2005, AM J HUM GENET, V76, P358, DOI 10.1086/427890	2	307	319	2	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 17	2010	465	7300					966	966		10.1038/nature09132	http://dx.doi.org/10.1038/nature09132			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559394	Green Accepted, Bronze			2022-12-01	WOS:000278804500046
J	Hayes, KS; Bancroft, AJ; Goldrick, M; Portsmouth, C; Roberts, IS; Grencis, RK				Hayes, K. S.; Bancroft, A. J.; Goldrick, M.; Portsmouth, C.; Roberts, I. S.; Grencis, R. K.			Exploitation of the Intestinal Microflora by the Parasitic Nematode Trichuris muris	SCIENCE			English	Article							ESCHERICHIA-COLI; HYGIENE HYPOTHESIS; IMMUNE-SYSTEM; MATURATION; CELLS; GUT; ADHERENCE; RESPONSES; BACTERIA	The inhabitants of the mammalian gut are not always relatively benign commensal bacteria but may also include larger and more parasitic organisms, such as worms and protozoa. At some level, all these organisms are capable of interacting with each other. We found that successful establishment of the chronically infecting parasitic nematode Trichuris muris in the large intestine of mice is dependent on microflora and coincident with modulation of the host immune response. By reducing the number of bacteria in the host animal, we significantly reduced the number of hatched T. muris eggs. Critical interactions between bacteria (microflora) and parasites (macrofauna) introduced a new dynamic to the intestinal niche, which has fundamental implications for our current concepts of intestinal homeostasis and regulation of immunity.	[Hayes, K. S.; Bancroft, A. J.; Goldrick, M.; Portsmouth, C.; Roberts, I. S.; Grencis, R. K.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Roberts, IS (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	ian.s.roberts@manchester.ac.uk; richard.k.grencis@manchester.ac.uk	hayes, kelly/GVT-8455-2022		UK Biotechnology and Biological Sciences Research Council; Wellcome Trust [083620Z]; University of Manchester; UK Medical Research Council [G0601205]; MRC [G0601205] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Manchester; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank L. Cliffe for numerous helpful discussions; J. Kott and R. Fernandez for help with microscopy; the staff in the Faculty of Life Sciences EM Facility for their assistance, particularly A. Mironov and the Wellcome Trust for equipment grant support to the EM Facility; the Faculty of Life Sciences Mass Spectrometry Unit and E. Keevill for help with protein identification; and P. Klemm for bacterial strains and plasmids. The Bioimaging Facility microscopes used in this study were purchased with grants from the UK Biotechnology and Biological Sciences Research Council, Wellcome, and the University of Manchester Strategic Fund. Accession numbers for proteins identified by mass spectrometry are Q9N5A6 CAEEL, TMP00496_1, TMP00827_1, TMP00007_1, and TMP00821_1 and can be found at www.nematodes.org/nembase4. Supported by Wellcome Trust grant 083620Z and UK Medical Research Council grant G0601205.	[Anonymous], [No title captured]; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bouckaert J, 2006, MOL MICROBIOL, V61, P1556, DOI 10.1111/j.1365-2958.2006.05352.x; BREINES DM, 1994, J ANTIMICROB CHEMOTH, V34, P205, DOI 10.1093/jac/34.2.205; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Edelman SM, 2008, CURR OPIN GASTROEN, V24, P720, DOI 10.1097/MOG.0b013e32830c4355; Eto DS, 2007, PLOS PATHOG, V3, P949, DOI 10.1371/journal.ppat.0030100; Fumagalli M, 2009, J EXP MED, V206, P1395, DOI 10.1084/jem.20082779; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; OFEK I, 1978, INFECT IMMUN, V22, P247, DOI 10.1128/IAI.22.1.247-254.1978; Reisner A, 2003, MOL MICROBIOL, V48, P933, DOI 10.1046/j.1365-2958.2003.03490.x; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8; Thumbikat P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000415; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wold AE, 1998, ALLERGY, V53, P20, DOI 10.1111/j.1398-9995.1998.tb04953.x; Yazdanbakhsh M, 2004, CLIN REV ALLERG IMMU, V26, P15, DOI 10.1385/CRIAI:26:1:15	22	202	208	0	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1391	1394		10.1126/science.1187703	http://dx.doi.org/10.1126/science.1187703			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20538949	Green Accepted			2022-12-01	WOS:000278598400037
J	Forrest, CB; Bartek, RJ; Rubinstein, Y; Groft, SC				Forrest, Christopher B.; Bartek, Ronald J.; Rubinstein, Yaffa; Groft, Stephen C.			The case for a global rare-diseases registry	LANCET			English	Editorial Material									[Forrest, Christopher B.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Forrest, Christopher B.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Bartek, Ronald J.] Friedreichs Ataxia Res Alliance, Springfield, VA USA; [Rubinstein, Yaffa; Groft, Stephen C.] NIH, Off Rare Dis Res, Bethesda, MD 20892 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS)	Forrest, CB (corresponding author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.	forrestc@email.chop.edu	Forrest, Christopher/CAF-1379-2022	Forrest, Christopher/0000-0003-1252-068X				Butcher J, 2007, LANCET NEUROL, V6, P298, DOI 10.1016/S1474-4422(07)70067-4; Dator DP, 2010, J UROLOGY, V183, P1280, DOI 10.1016/j.juro.2010.01.049; European Commission, RAR DIS; GLIKLICH RE, 2007, REG EV PAT OUTC US G; Haffner ME, 2006, NEW ENGL J MED, V354, P445, DOI 10.1056/NEJMp058317; McCormick J, 2010, LANCET, V375, P1007, DOI 10.1016/S0140-6736(09)62161-9; National Institutes of Health Office of Rare Diseases Research, RAR DIS REL TERMS; *NIH OFF RAR DIS R, ADV RAR DIS RES INT; Schieppati A, 2008, LANCET, V371, P2039, DOI 10.1016/S0140-6736(08)60872-7; Watson MS, 2008, GENET MED, V10, P325, DOI 10.1097/GIM.0b013e31817b80fd; Wrobel P, 2009, WORKSH PAT REG RAR D	11	65	66	2	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2011	377	9771					1057	1059		10.1016/S0140-6736(10)60680-0	http://dx.doi.org/10.1016/S0140-6736(10)60680-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	743QY	20674966				2022-12-01	WOS:000289035000009
J	Boitano, AE; Wang, JA; Romeo, R; Bouchez, LC; Parker, AE; Sutton, SE; Walker, JR; Flaveny, CA; Perdew, GH; Denison, MS; Schultz, PG; Cooke, MP				Boitano, Anthony E.; Wang, Jian; Romeo, Russell; Bouchez, Laure C.; Parker, Albert E.; Sutton, Sue E.; Walker, John R.; Flaveny, Colin A.; Perdew, Gary H.; Denison, Michael S.; Schultz, Peter G.; Cooke, Michael P.			Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells	SCIENCE			English	Article							UMBILICAL-CORD BLOOD; EX-VIVO EXPANSION; BONE-MARROW; TRANSPLANTATION; ENGRAFTMENT; MICE; BIOLOGY; BINDING	Although practiced clinically for more than 40 years, the use of hematopoietic stem cell (HSC) transplants remains limited by the ability to expand these cells ex vivo. An unbiased screen with primary human HSCs identified a purine derivative, StemRegenin 1 (SR1), that promotes the ex vivo expansion of CD34(+) cells. Culture of HSCs with SR1 led to a 50-fold increase in cells expressing CD34 and a 17-fold increase in cells that retain the ability to engraft immunodeficient mice. Mechanistic studies show that SR1 acts by antagonizing the aryl hydrocarbon receptor (AHR). The identification of SR1 and AHR modulation as a means to induce ex vivo HSC expansion should facilitate the clinical use of HSC therapy.	[Boitano, Anthony E.; Wang, Jian; Bouchez, Laure C.; Schultz, Peter G.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Boitano, Anthony E.; Romeo, Russell; Parker, Albert E.; Sutton, Sue E.; Walker, John R.; Cooke, Michael P.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Flaveny, Colin A.; Perdew, Gary H.] Penn State Univ, University Pk, PA 16803 USA; [Denison, Michael S.] Univ Calif Davis, Davis, CA 95616 USA	Scripps Research Institute; Novartis; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Davis	Schultz, PG (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schultz@scripps.edu; mcooke@gnf.org	wang, jian/GVS-0711-2022	bouchez, laure/0000-0003-4583-6760	California Institute for Regenerative Medicine; Skaggs Institute for Chemical Biology; National Institutes of Environmental Health Sciences [ES007685, ES04699]; NIH [ES004869]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007685, R01ES004869, P42ES004699, R29ES004869] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Skaggs Institute for Chemical Biology; National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank C. Trussell, D. Rines, and M. Hull for assistance with flow cytometry and screen development; J. E. Tellew, S. Pan, Y. Wan, and X. Wang for synthesis of LGC006; and J. Hogenesch for helpful discussions. A. E. B was funded by grants from the California Institute for Regenerative Medicine and the Skaggs Institute for Chemical Biology. M.S.D. was funded by grants from the National Institutes of Environmental Health Sciences (ES007685 and ES04699). G.H.P. was funded by a grant from the NIH (ES004869). A patent application has been filed on SR1 for applications related to HSC expansion.	Brunstein CG, 2007, BRIT J HAEMATOL, V137, P20, DOI 10.1111/j.1365-2141.2007.06521.x; Campbell TB, 2007, STEM CELLS DEV, V16, P347, DOI 10.1089/scd.2007.9995; Ding S, 2002, J AM CHEM SOC, V124, P1594, DOI 10.1021/ja0170302; Flaveny CA, 2009, MOL PHARMACOL, V75, P1412, DOI 10.1124/mol.109.054825; Frericks M, 2007, TOXICOL APPL PHARM, V220, P320, DOI 10.1016/j.taap.2007.01.014; Garrison PM, 1996, FUND APPL TOXICOL, V30, P194, DOI 10.1006/faat.1996.0056; Hofmeister CC, 2007, BONE MARROW TRANSPL, V39, P11, DOI 10.1038/sj.bmt.1705538; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jang JY, 2007, REPROD TOXICOL, V24, P303, DOI 10.1016/j.reprotox.2007.08.002; Kelly SS, 2009, BONE MARROW TRANSPL, V44, P673, DOI 10.1038/bmt.2009.284; Kim SH, 2006, MOL PHARMACOL, V69, P1871, DOI 10.1124/mol.105.021832; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; McGuire J, 2001, J BIOL CHEM, V276, P41841, DOI 10.1074/jbc.M105607200; Mimeault M, 2007, CLIN PHARMACOL THER, V82, P252, DOI 10.1038/sj.clpt.6100301; Mogul MJ, 2000, BONE MARROW TRANSPL, V25, pS58, DOI 10.1038/sj.bmt.1702372; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Sakai R, 2003, TOXICOL SCI, V72, P84, DOI 10.1093/toxsci/kfg002; Singh KP, 2009, BIOCHEM PHARMACOL, V77, P577, DOI 10.1016/j.bcp.2008.10.001; Singh KP, 2009, CARCINOGENESIS, V30, P11, DOI 10.1093/carcin/bgn224; Smith BG, 1908, BIOL BULL-US, V15, P9, DOI 10.2307/1535560; Wagner JE, 2002, BLOOD, V100, P1611, DOI 10.1182/blood-2002-01-0294; Xia LJ, 2004, BLOOD, V104, P3091, DOI 10.1182/blood-2004-02-0650	22	713	786	2	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 10	2010	329	5997					1345	1348		10.1126/science.1191536	http://dx.doi.org/10.1126/science.1191536			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20688981	Green Accepted			2022-12-01	WOS:000281657300039
J	Cui, JX; Yao, Q; Li, S; Ding, XJ; Lu, QH; Mao, HB; Liu, LP; Zheng, N; Chen, S; Shao, F				Cui, Jixin; Yao, Qing; Li, Shan; Ding, Xiaojun; Lu, Qiuhe; Mao, Haibin; Liu, Liping; Zheng, Ning; Chen, She; Shao, Feng			Glutamine Deamidation and Dysfunction of Ubiquitin/NEDD8 Induced by a Bacterial Effector Family	SCIENCE			English	Article							HOST-CELL CYCLE; ESCHERICHIA-COLI; CYCLOMODULIN CIF; PROTEIN; LIGASE; DEGRADATION; CONJUGATION; ACTIVATION; INSIGHTS; BLOCKS	A family of bacterial effectors including Cif homolog from Burkholderia pseudomallei (CHBP) and Cif from Enteropathogenic Escherichia coli (EPEC) adopt a functionally important papain-like hydrolytic fold. We show here that CHBP was a potent inhibitor of the eukaryotic ubiquitination pathway. CHBP acted as a deamidase that specifically and efficiently deamidated Gln(40) in ubiquitin and ubiquitin-like protein NEDD8 both in vitro and during Burkholderia infection. Deamidated ubiquitin was impaired in supporting ubiquitin-chain synthesis. Cif selectively deamidated NEDD8, which abolished the activity of neddylated Cullin-RING ubiquitin ligases (CRLs). Ubiquitination and ubiquitin-dependent degradation of multiple CRL substrates were impaired by Cif in EPEC-infected cells. Mutations of substrate-contacting residues in Cif abolished or attenuated EPEC-induced cytopathic phenotypes of cell cycle arrest and actin stress fiber formation.	[Cui, Jixin; Yao, Qing; Li, Shan; Ding, Xiaojun; Lu, Qiuhe; Liu, Liping; Chen, She; Shao, Feng] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Cui, Jixin] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Cui, Jixin] Beijing Union Med Coll, Beijing 100730, Peoples R China; [Mao, Haibin; Zheng, Ning] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Zheng, Ning] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Shao, F (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	shaofeng@nibs.ac.cn	Yao, Qing/AAE-1680-2020; Mao, Haibin/B-7609-2011	Li, Shan/0000-0001-8646-3193; Lu, Qiuhe/0000-0002-0202-7448	Chinese Ministry of Science and Technology [2008AA022309]; National Basic Research Plan of China 973; National Institutes of Health [R01 CA107134]; NATIONAL CANCER INSTITUTE [R01CA107134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA022309] Funding Source: NIH RePORTER	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Basic Research Plan of China 973(National Basic Research Program of China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank Y. Ye, C. Fathman, Z. Pan, D. Haas, V. Yu, E. Boedeker, and Z. Chen for providing reagents. We are grateful to F. Du and X. Wang for their assistance in obtaining reagents. We also thank members of the Shao laboratory for helpful discussions and technical assistance. This work was supported by Chinese Ministry of Science and Technology grant 2008AA022309 and National Basic Research Plan of China 973 grants to F. S. and National Institutes of Health grant R01 CA107134 to N.Z. and H. M. N.Z. is a Howard Hughes Medical Institute investigator.	Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Fu NY, 2007, P NATL ACAD SCI USA, V104, P10051, DOI 10.1073/pnas.0700007104; Haraga A, 2008, INFECT IMMUN, V76, P5402, DOI 10.1128/IAI.00626-08; Hsu Y, 2008, J MOL BIOL, V384, P465, DOI 10.1016/j.jmb.2008.09.051; Huang J, 2008, NATURE, V456, P112, DOI 10.1038/nature07355; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Marches O, 2003, MOL MICROBIOL, V50, P1553, DOI 10.1046/j.1365-2958.2003.03821.x; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Roy CR, 2007, NAT IMMUNOL, V8, P1179, DOI 10.1038/ni1528; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Samba-Louaka A, 2008, CELL MICROBIOL, V10, P2496, DOI 10.1111/j.1462-5822.2008.01224.x; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Yao Q, 2009, P NATL ACAD SCI USA, V106, P3716, DOI 10.1073/pnas.0900212106; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105	21	152	162	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 3	2010	329	5996					1215	1218		10.1126/science.1193844	http://dx.doi.org/10.1126/science.1193844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645SG	20688984	Green Accepted			2022-12-01	WOS:000281485600038
J	Bax, BD; Chan, PF; Eggleston, DS; Fosberry, A; Gentry, DR; Gorrec, F; Giordano, I; Hann, MM; Hennessy, A; Hibbs, M; Huang, JZ; Jones, E; Jones, J; Brown, KK; Lewis, CJ; May, EW; Saunders, MR; Singh, O; Spitzfaden, CE; Shen, C; Shillings, A; Theobald, AJ; Wohlkonig, A; Pearson, ND; Gwynn, MN				Bax, Benjamin D.; Chan, Pan F.; Eggleston, Drake S.; Fosberry, Andrew; Gentry, Daniel R.; Gorrec, Fabrice; Giordano, Ilaria; Hann, Michael M.; Hennessy, Alan; Hibbs, Martin; Huang, Jianzhong; Jones, Emma; Jones, Jo; Brown, Kristin Koretke; Lewis, Ceri J.; May, Earl W.; Saunders, Martin R.; Singh, Onkar; Spitzfaden, Claus E.; Shen, Carol; Shillings, Anthony; Theobald, Andrew J.; Wohlkonig, Alexandre; Pearson, Neil D.; Gwynn, Michael N.			Type IIA topoisomerase inhibition by a new class of antibacterial agents	NATURE			English	Article							INFECTIOUS-DISEASES-SOCIETY; BREAKAGE-REUNION DOMAIN; DNA GYRASE; CRYSTAL-STRUCTURE; BAD BUGS; FUSION PROTEIN; MECHANISM; CLEAVAGE; IA; DRUGS	Despite the success of genomics in identifying new essential bacterial genes, there is a lack of sustainable leads in antibacterial drug discovery to address increasing multidrug resistance. Type IIA topoisomerases cleave and religate DNA to regulate DNA topology and are a major class of antibacterial and anticancer drug targets, yet there is no well developed structural basis for understanding drug action. Here we report the 2.1 angstrom crystal structure of a potent, new class, broad-spectrum antibacterial agent in complex with Staphylococcus aureus DNA gyrase and DNA, showing a new mode of inhibition that circumvents fluoroquinolone resistance in this clinically important drug target. The inhibitor 'bridges' the DNA and a transient non-catalytic pocket on the two-fold axis at the GyrA dimer interface, and is close to the active sites and fluoroquinolone binding sites. In the inhibitor complex the active site seems poised to cleave the DNA, with a single metal ion observed between the TOPRIM (topoisomerase/primase) domain and the scissile phosphate. This work provides new insights into the mechanism of topoisomerase action and a platform for structure-based drug design of a new class of antibacterial agents against a clinically proven, but conformationally flexible, enzyme class.	[Bax, Benjamin D.; Hann, Michael M.; Saunders, Martin R.; Singh, Onkar; Spitzfaden, Claus E.] GlaxoSmithKline, Med Res Ctr, Mol Discovery Res, Stevenage SG1 2NY, Herts, England; [Chan, Pan F.; Gentry, Daniel R.; Huang, Jianzhong; May, Earl W.; Shen, Carol; Pearson, Neil D.; Gwynn, Michael N.] GlaxoSmithKline, Infect Dis Ctr Excellence Drug Discovery, Antibacterial Discovery Performance Unit, Collegeville, PA 19426 USA; [Eggleston, Drake S.; Fosberry, Andrew; Gorrec, Fabrice; Hibbs, Martin; Jones, Emma; Jones, Jo; Lewis, Ceri J.; Shillings, Anthony; Theobald, Andrew J.] GlaxoSmithKline, Mol Discovery Res, Harlow CM19 5AW, Essex, England; [Giordano, Ilaria; Hennessy, Alan; Wohlkonig, Alexandre] GlaxoSmithKline, Med Res Ctr, Antibacterial Discovery Performance Unit, Stevenage SG1 2NY, Herts, England; [Brown, Kristin Koretke] GlaxoSmithKline, Mol Discovery Res, Collegeville, PA 19426 USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Bax, BD (corresponding author), GlaxoSmithKline, Med Res Ctr, Mol Discovery Res, Gunnels Wood Rd, Stevenage SG1 2NY, Herts, England.	benjamin.d.bax@gsk.com; mick.gwynn@gsk.com		Bax, Ben/0000-0003-1940-3785; Gorrec, Fabrice/0000-0002-9998-3611; Wohlkonig, Alexandre/0000-0003-3103-5022	Wellcome Trust Seeding Drug Discovery Initiative; US Department of Defense (DoD) [HDTRA1-07-9-0002]; Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD) [HDTRA1-07-9-0002]; Defense Threat Reduction Agency (DTRA); Transformational Medical Technologies (TMT)	Wellcome Trust Seeding Drug Discovery Initiative(Wellcome Trust); US Department of Defense (DoD)(United States Department of Defense); Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD)(United States Department of DefenseDefense Threat Reduction Agency); Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); Transformational Medical Technologies (TMT)	We thank H. Hiasa, A. Maxwell, J. C. Wang and D. B. Wigley for discussions. We thank S. Erskine, A. West and S. Brooks for experimental work that helped initiate this project. We thank P. Rowland for help with data collection and processing, the antimicrobial profiling group at GlaxoSmithKline (GSK) for antibacterial data, and K. Smith and D. Payne and members of the project team for discussions. A. W. was supported by the Wellcome Trust Seeding Drug Discovery Initiative and contract HDTRA1-07-9-0002 with the US Department of Defense (DoD) Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD), and the Defense Threat Reduction Agency (DTRA) Transformational Medical Technologies (TMT). The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the DoD or the US Government.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Berger JM, 1998, P NATL ACAD SCI USA, V95, P7876, DOI 10.1073/pnas.95.14.7876; Black MT, 2008, ANTIMICROB AGENTS CH, V52, P3339, DOI 10.1128/AAC.00496-08; Bock CW, 1999, J AM CHEM SOC, V121, P7360, DOI 10.1021/ja9906960; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Changela A, 2001, NATURE, V411, P1077, DOI 10.1038/35082615; Changela A, 2007, J MOL BIOL, V368, P105, DOI 10.1016/j.jmb.2007.01.065; Clinical and Laboratory Standards Institute, 2008, METH DIL ANT SUSC TE; COATES WJ, 1999, Patent No. 1051413; Critchlow SE, 1996, BIOCHEMISTRY-US, V35, P7387, DOI 10.1021/bi9603175; Delano W, 2002, PYMOL MOL GRAPHICS S; Deweese JE, 2008, NUCLEIC ACIDS RES, V36, P4883, DOI 10.1093/nar/gkn466; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Edwards MJ, 2009, SCIENCE, V326, P1415, DOI 10.1126/science.1179123; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fu GS, 2009, NUCLEIC ACIDS RES, V37, P5908, DOI 10.1093/nar/gkp586; GELLERT M, 1979, P NATL ACAD SCI USA, V76, P6289, DOI 10.1073/pnas.76.12.6289; Gmunder H, 1997, NUCLEIC ACIDS RES, V25, P604, DOI 10.1093/nar/25.3.604; Gomez L, 2007, BIOORG MED CHEM LETT, V17, P2723, DOI 10.1016/j.bmcl.2007.03.003; Hansen CL, 2002, P NATL ACAD SCI USA, V99, P16531, DOI 10.1073/pnas.262485199; HOROWITZ DS, 1987, J BIOL CHEM, V262, P5339; Jeffrey G.A., 1991, HYDROGEN BONDING BIO; KLEYWEGT GJ, 1995, STRUCTURE, V3, P535, DOI 10.1016/S0969-2126(01)00187-3; Laponogov I, 2009, NAT STRUCT MOL BIOL, V16, P667, DOI 10.1038/nsmb.1604; Lavasani LS, 2001, BIOCHEMISTRY-US, V40, P8438, DOI 10.1021/bi0155201; LESLIE AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Liu QY, 1998, J BIOL CHEM, V273, P20252, DOI 10.1074/jbc.273.32.20252; Liu QY, 1999, P NATL ACAD SCI USA, V96, P881, DOI 10.1073/pnas.96.3.881; MILLER WH, 2010, Patent No. 7691850; Mitscher LA, 2005, CHEM REV, V105, P559, DOI 10.1021/cr030101q; Mueller-Planitz F, 2008, J BIOL CHEM, V283, P17463, DOI 10.1074/jbc.M710014200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Noble CG, 2002, J MOL BIOL, V318, P361, DOI 10.1016/S0022-2836(02)00049-9; Nollmann M, 2007, NAT STRUCT MOL BIOL, V14, P264, DOI 10.1038/nsmb1213; Oezguen N, 2007, PROTEINS, V68, P313, DOI 10.1002/prot.21397; Pan XS, 2009, ANTIMICROB AGENTS CH, V53, P3822, DOI 10.1128/AAC.00113-09; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; REECE RJ, 1991, J BIOL CHEM, V266, P3540; Schmidt BH, 2010, NATURE, V465, P641, DOI 10.1038/nature08974; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Sissi C, 2009, NUCLEIC ACIDS RES, V37, P702, DOI 10.1093/nar/gkp024; Talbot GH, 2006, CLIN INFECT DIS, V42, P657, DOI 10.1086/499819; Tanaka M, 2000, J Infect Chemother, V6, P131, DOI 10.1007/s101560070010; Tretter EM, 2010, PROTEINS, V78, P492, DOI 10.1002/prot.22600; Trigueros S, 2002, GENES CELLS, V7, P249, DOI 10.1046/j.1365-2443.2002.00516.x; Wiener JJM, 2007, BIOORG MED CHEM LETT, V17, P2718, DOI 10.1016/j.bmcl.2007.03.004; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0	53	501	514	1	165	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2010	466	7309					935	U51		10.1038/nature09197	http://dx.doi.org/10.1038/nature09197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20686482				2022-12-01	WOS:000281030300026
J	Shargorodsky, J; Curhan, SG; Curhan, GC; Eavey, R				Shargorodsky, Josef; Curhan, Sharon G.; Curhan, Gary C.; Eavey, Roland			Change in Prevalence of Hearing Loss in US Adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; NOISE EXPOSURE; UNITED-STATES; CHILDREN 6; PERFORMANCE; IMPAIRMENT; AGE; EPIDEMIOLOGY	Context Hearing loss is common and, in young persons, can compromise social development, communication skills, and educational achievement. Objective To examine the current prevalence of hearing loss in US adolescents and determine whether it has changed over time. Design Cross-sectional analyses of US representative demographic and audiometric data from the 1988 through 1994 and 2005 through 2006 time periods. Setting The Third National Health and Nutrition Examination Survey (NHANES Ill), 1988-1994, and NHANES 2005-2006. Participants NHANES III examined 2928 participants and NHANES 2005-2006 examined 1771 participants, aged 12 to 19 years. Main Outcome Measures We calculated the prevalence of hearing loss in participants aged 12 to 19 years after accounting for the complex survey design. Audiometrically determined hearing loss was categorized as either unilateral or bilateral for low frequency (0.5, 1, and 2 kHz) or high frequency (3, 4, 6, and 8 kHz), and as slight loss (>15 to <25 dB) or mild or greater loss (25 dB) according to hearing sensitivity in the worse ear. The prevalence of hearing loss from NHANES 2005-2006 was compared with the prevalence from NHANES III (1988-1994). We also examined the cross-sectional relations between several potential risk factors and hearing loss. Logistic regression was used to calculate multivariate adjusted odds ratios (ORs) and 95% confidence intervals (CIs). Results The prevalence of any hearing loss increased significantly from 14.9% (95% CI, 13.0%-16.9%) in 1988-1994 to 19.5% (95% CI, 15.2%-23.8%) in 2005-2006 (P=.02). In 2005-2006, hearing loss was more commonly unilateral (prevalence, 14.0%; 95% CI, 10.4%-17.6%, vs 11.1%; 95% CI, 9.5%-12.8% in 1988-1994; P=.005) and involved the high frequencies (prevalence, 16.4%; 95% CI, 13.2%-19.7%, vs 12.8%; 95% CI, 11.1%-14.5% in 1988-1994; P=.02). Individuals from families below the federal poverty threshold (prevalence, 23.6%; 95% CI, 18.5%-28.7%) had significantly higher odds of hearing loss (multivariate adjusted OR, 1.60; 95% CI, 1.10-2.32) than those above the threshold (prevalence, 18.4%; 95% CI, 13.6%-23.2%). Conclusion The prevalence of hearing loss among a sample of US adolescents aged 12 to 19 years was greater in 2005-2006 compared with 1988-1994. JAMA. 2010;304(7):772-778 www.jama.com	[Shargorodsky, Josef; Curhan, Sharon G.; Curhan, Gary C.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Curhan, Gary C.] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; [Shargorodsky, Josef] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; [Eavey, Roland] Vanderbilt Univ, Sch Med, Vanderbilt Bill Wilkerson Ctr Otolaryngol & Commu, Nashville, TN 37212 USA; [Curhan, Gary C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Eye & Ear Infirmary; Vanderbilt University; Harvard University; Harvard T.H. Chan School of Public Health	Shargorodsky, J (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, 181 Longwood Ave, Boston, MA 02115 USA.	josef_shargorodsky@meei.harvard.edu			Massachusetts Eye and Ear Infirmary Foundation; Vanderbilt University School of Medicine	Massachusetts Eye and Ear Infirmary Foundation; Vanderbilt University School of Medicine	This work was supported by the Massachusetts Eye and Ear Infirmary Foundation and Vanderbilt University School of Medicine Development Funds.	Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; ANDERSON KL, 1992, P ASHA AUD SUP, V21, P38; BAILEY BJ, HEAD NECK SURG OTOLA, P2006; Bainbridge KE, 2008, ANN INTERN MED, V149, P1, DOI 10.7326/0003-4819-149-1-200807010-00231; Bess FH, 1998, EAR HEARING, V19, P339, DOI 10.1097/00003446-199810000-00001; BLAIR JC, 1985, VOLTA REV, V87, P87; Chung JH, 2005, PEDIATRICS, V115, P861, DOI 10.1542/peds.2004-0173; Cone BK, 2010, EAR HEARING, V31, P202, DOI 10.1097/AUD.0b013e3181c62263; Czechowicz JA, 2010, OTOLARYNG HEAD NECK, V142, P272, DOI 10.1016/j.otohns.2009.10.040; Knight KRG, 2005, J CLIN ONCOL, V23, P8588, DOI 10.1200/JCO.2004.00.5355; Mehra S, 2009, OTOLARYNG HEAD NECK, V140, P461, DOI 10.1016/j.otohns.2008.12.022; National Center for Health Statistics, 1988, NAT HLTH NUTR EX SUR; National Center for Health Statistics, 1994, PLAN OP 3 NAT HLTH N; Niskar AS, 1998, JAMA-J AM MED ASSOC, V279, P1071, DOI 10.1001/jama.279.14.1071; Niskar AS, 2001, PEDIATRICS, V108, P40, DOI 10.1542/peds.108.1.40; Nondahl DA, 2009, EAR HEARING, V30, P696, DOI 10.1097/AUD.0b013e3181b1d418; Northern JL, 2002, HEARING CHILDREN; PLEIS JR, 2006, VITAL HLTH STAT, V10, P1; Quintanilla-Dieck MD, 2009, J PEDIATR-US, V155, P550, DOI 10.1016/j.jpeds.2009.04.053; Sadhra S, 2002, ANN OCCUP HYG, V46, P455, DOI 10.1093/annhyg/mef051; SCHMIDT JM, 1994, AUDIOLOGY, V33, P185; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Stone SI, 2008, AM J PUBLIC HEALTH, V98, P2223, DOI 10.2105/AJPH.2007.110239; Tharpe AM, 1999, PEDIATR CLIN N AM, V46, P65, DOI 10.1016/S0031-3955(05)70081-X; *US BUR CESNS, CURR POP SURV CPS DE; [No title captured]	26	321	332	3	48	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 18	2010	304	7					772	778		10.1001/jama.2010.1124	http://dx.doi.org/10.1001/jama.2010.1124			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639SB	20716740				2022-12-01	WOS:000280993700024
J	Lee, ER; Baker, JL; Weinberg, Z; Sudarsan, N; Breaker, RR				Lee, Elaine R.; Baker, Jenny L.; Weinberg, Zasha; Sudarsan, Narasimhan; Breaker, Ronald R.			An Allosteric Self-Splicing Ribozyme Triggered by a Bacterial Second Messenger	SCIENCE			English	Article							GROUP-I INTRONS; METABOLITE-BINDING RIBOSWITCHES; CYCLIC DI-GMP; LIGAND-BINDING; RNA; BACTERIOPHAGE-T4	Group I self-splicing ribozymes commonly function as components of selfish mobile genetic elements. We identified an allosteric group I ribozyme, wherein self-splicing is regulated by a distinct riboswitch class that senses the bacterial second messenger c-di-GMP. The tandem RNA sensory system resides in the 5' untranslated region of the messenger RNA for a putative virulence gene in the pathogenic bacterium Clostridium difficile. c-di-GMP binding by the riboswitch induces folding changes at atypical splice site junctions to modulate alternative RNA processing. Our findings indicate that some self-splicing ribozymes are not selfish elements but are harnessed by cells as metabolite sensors and genetic regulators.	[Lee, Elaine R.; Weinberg, Zasha; Sudarsan, Narasimhan; Breaker, Ronald R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Baker, Jenny L.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Weinberg, Zasha; Sudarsan, Narasimhan; Breaker, Ronald R.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Breaker, Ronald R.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Breaker, RR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, Box 208103, New Haven, CT 06520 USA.	ronald.breaker@yale.edu	Breaker, Ronald/E-9679-2010	Weinberg, Zasha/0000-0002-6681-3624; Breaker, Ronald/0000-0002-2165-536X	NIH [PO1 GM022778]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Davis for assistance with genetic experiments and members of the Breaker laboratory for helpful discussions. We also thank L. Sonenshein for supplying C. difficile 630 spores and for training N.S. in C. difficile techniques. This work was supported by NIH grant PO1 GM022778 and by the Howard Hughes Medical Institute. Z.W. advises BioRelix. R.R.B. is a cofounder and Scientific Advisory Board member of BioRelix. Yale University has filed a provisional patent application on this riboswitch technology.	Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Dambach MD, 2009, CURR OPIN MICROBIOL, V12, P161, DOI 10.1016/j.mib.2009.01.012; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Kulshina N, 2009, NAT STRUCT MOL BIOL, V16, P1212, DOI 10.1038/nsmb.1701; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; Nielsen H, 2009, RNA BIOL, V6, P375, DOI 10.4161/rna.6.4.9334; Poiata E, 2009, RNA, V15, P2046, DOI 10.1261/rna.1824209; Regulski Elizabeth E., 2008, V419, P53, DOI 10.1007/978-1-59745-033-1_4; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Sandegren L, 2007, J BACTERIOL, V189, P980, DOI 10.1128/JB.01287-06; SHUB DA, 1987, COLD SPRING HARB SYM, V52, P193, DOI 10.1101/SQB.1987.052.01.024; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Smith KD, 2009, NAT STRUCT MOL BIOL, V16, P1218, DOI 10.1038/nsmb.1702; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Sudarsan N, 2006, SCIENCE, V314, P300, DOI 10.1126/science.1130716; Thompson Kristin M, 2002, BMC Biotechnol, V2, P21, DOI 10.1186/1472-6750-2-21; Tseng Huei-Hun, 2009, Journal of Bioinformatics and Computational Biology, V7, P373, DOI 10.1142/S0219720009004126; Weinberg Z, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r31; Welz R, 2007, RNA, V13, P573, DOI 10.1261/rna.407707	21	261	288	3	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					845	848		10.1126/science.1190713	http://dx.doi.org/10.1126/science.1190713			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705859	Green Accepted			2022-12-01	WOS:000280809900052
J	Zhang, XZ; Saaddine, JB; Chou, CF; Cotch, MF; Cheng, YJ; Geiss, LS; Gregg, EW; Albright, AL; Klein, BEK; Klein, R				Zhang, Xinzhi; Saaddine, Jinan B.; Chou, Chin-Fang; Cotch, Mary Frances; Cheng, Yiling J.; Geiss, Linda S.; Gregg, Edward W.; Albright, Ann L.; Klein, Barbara E. K.; Klein, Ronald			Prevalence of Diabetic Retinopathy in the United States, 2005-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; EYE CARE; POPULATION; DISEASE; PEOPLE; ADULTS; AGE; HEALTH	Context The prevalence of diabetes in the United States has increased. People with diabetes are at risk for diabetic retinopathy. No recent national population-based estimate of the prevalence and severity of diabetic retinopathy exists. Objectives To describe the prevalence and risk factors of diabetic retinopathy among US adults with diabetes aged 40 years and older. Design, Setting, and Participants Analysis of a cross-sectional, nationally representative sample of the National Health and Nutrition Examination Survey 2005-2008 (N=1006). Diabetes was defined as a self-report of a previous diagnosis of the disease (excluding gestational diabetes mellitus) or glycated hemoglobin A(1c) of 6.5% or greater. Two fundus photographs were taken of each eye with a digital nonmydriatic camera and were graded using the Airlie House classification scheme and the Early Treatment Diabetic Retinopathy Study severity scale. Prevalence estimates were weighted to represent the civilian, noninstitutionalized US population aged 40 years and older. Main Outcome Measurements Diabetic retinopathy and vision-threatening diabetic retinopathy. Results The estimated prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy was 28.5% (95% confidence interval [Cl], 24.9%-32.5%) and 4.4% (95% Cl, 3.5%-5.7%) among US adults with diabetes, respectively. Diabetic retinopathy was slightly more prevalent among men than women with diabetes (31.6%; 95% Cl, 26.8%-36.8%; vs 25.7%; 95% Cl, 21.7%-30.1%; P=.04). Non-Hispanic black individuals had a higher crude prevalence than non-Hispanic white individuals of diabetic retinopathy (38.8%; 95% Cl, 31.9%-46.1%; vs 26.4%; 95% Cl, 21.4%-32.2%; P=.01) and vision-threatening diabetic retinopathy (9.3%; 95% Cl, 5.9%-14.4%; vs 3.2%; 95% Cl, 2.0%-5.1%; P=.01). Male sex was independently associated with the presence of diabetic retinopathy (odds ratio [OR], 2.07; 95% Cl, 1.39-3.10), as well as higher hemoglobin A(1c) level (OR, 1.45; 95% Cl, 1.20-1.75), longer duration of diabetes (OR, 1.06 per year duration; 95% Cl, 1.03-1.10), insulin use (OR, 3.23; 95% Cl, 1.99-5.26), and higher systolic blood pressure (OR, 1.03 per mm Hg; 95% Cl, 1.02-1.03). Conclusion In a nationally representative sample of US adults with diabetes aged 40 years and older, the prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy was high, especially among Non-Hispanic black individuals. JAMA. 2010;304(6):649-656	[Zhang, Xinzhi; Saaddine, Jinan B.; Chou, Chin-Fang; Cheng, Yiling J.; Geiss, Linda S.; Gregg, Edward W.; Albright, Ann L.] Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA; [Cotch, Mary Frances] NEI, Div Epidemiol & Clin Applicat, NIH, Bethesda, MD 20892 USA; [Klein, Barbara E. K.; Klein, Ronald] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI USA	Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Wisconsin System; University of Wisconsin Madison	Zhang, XZ (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Natl Ctr Chron Dis Prevent & Hlth Promot, 4770 Buford Hwy,NE K-10, Atlanta, GA 30341 USA.	XZhang4@cdc.gov	Cheng, Yiling J/A-6547-2009	Cheng, Yiling J/0000-0002-5053-0814; Gregg, Edward/0000-0003-2381-6822; Cotch, Mary Frances/0000-0002-2046-4350; Klein, Ronald/0000-0002-4428-6237	National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC); Division of Diabetes Translation, CDC [05FED47304]; National Eye Institute, National Institutes of Health [Z01EY000402]; Division of Diabetes Translation; NATIONAL EYE INSTITUTE [Z01EY000402, ZIAEY000402] Funding Source: NIH RePORTER	National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Division of Diabetes Translation, CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Division of Diabetes Translation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC). Funding for the National Health and Nutrition Examination Survey (NHANES) retinal component was provided by the Intra Agency Agreement 05FED47304 from the Division of Diabetes Translation, CDC. Funding for the vision component was provided by the National Eye Institute, National Institutes of Health, Intramural Research Program grant Z01EY000402.; The NCHS was involved in the design and conduct of the NHANES study and in data collection, but was not involved in the analysis or interpretation of the study results or in the preparation of the manuscript. The Division of Diabetes Translation provided funding support for the retinal component and was involved in the design and conduct of the study; in the collection, analysis, and interpretation of the data; and in the preparation, review, and approval of this article before submission.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; [Anonymous], 1991, Ophthalmology, V98, P786; Burrows NR, 2010, DIABETES CARE, V33, P73, DOI 10.2337/dc09-0343; Centers for Disease Control and Prevention, 2004, ANTIBIOTIC RESISTANC; Centers for Disease Control and Prevention National Center for Health Statistics, NAT HLTH NUTR EX SUR; Cheng YJ, 2009, DIABETES CARE, V32, P2027, DOI 10.2337/dc09-0440; Cheung N, 2008, PROG RETIN EYE RES, V27, P161, DOI 10.1016/j.preteyeres.2007.12.001; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Geiss Linda, 2005, Diabetes Technol Ther, V7, P198, DOI 10.1089/dia.2005.7.198; Harris MI, 1998, DIABETES CARE, V21, P1230, DOI 10.2337/diacare.21.8.1230; Hirsch IB, 2010, JAMA-J AM MED ASSOC, V303, P2291, DOI 10.1001/jama.2010.785; HOLT D, 1991, STATISTICIAN, V40, P333, DOI 10.2307/2348286; Hovind P, 2003, DIABETES CARE, V26, P1258, DOI 10.2337/diacare.26.4.1258; Javitt JC, 1996, ANN INTERN MED, V124, P164, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00017; JAVITT JC, 1994, DIABETES CARE, V17, P909, DOI 10.2337/diacare.17.8.909; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; Klein R, 2004, ARCH OPHTHALMOL-CHIC, V122, P1642, DOI 10.1001/archopht.122.11.1642; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P520, DOI 10.1001/archopht.1984.01040030398010; KLEIN R, 1986, OPHTHALMOLOGY, V93, P1183; KLEIN R, 1992, OPHTHALMOLOGY, V99, P58; KLEIN R, 1995, DIABETES AM, P293; Klein R, 2009, OPHTHALMOLOGY, V116, P1937, DOI 10.1016/j.ophtha.2009.03.012; Korn E, 1999, ANAL HLTH SURVEYS; LEUREDUPREE AE, 1981, INVEST OPHTH VIS SCI, V21, P1; Liew G, 2009, HEART, V95, P391, DOI 10.1136/hrt.2008.146670; Mitchell P, 1998, OPHTHALMOLOGY, V105, P406, DOI 10.1016/S0161-6420(98)93019-6; *NAT DIAB DAT GROU, 1995, DIAB AM; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Nkondi Mbadi ANsunguJ, 2009, MALI MED, V24, P17; Nordwall M, 2004, DIABETOLOGIA, V47, P1266, DOI 10.1007/s00125-004-1431-6; Nsiah-Kumi P, 2009, J NATL MED ASSOC, V101, P430, DOI 10.1016/S0027-9684(15)30929-9; Saaddine JB, 2008, ARCH OPHTHALMOL-CHIC, V126, P1740, DOI 10.1001/archopht.126.12.1740; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sloan FA, 2009, OPHTHALMOLOGY, V116, P1515, DOI 10.1016/j.ophtha.2009.03.010; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Vijan S, 2000, JAMA-J AM MED ASSOC, V283, P889, DOI 10.1001/jama.283.7.889; Wang CY, 2010, AM J EPIDEMIOL, V171, P426, DOI 10.1093/aje/kwp412; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Zhang XZ, 2007, ARCH OPHTHALMOL-CHIC, V125, P411, DOI 10.1001/archopht.125.3.411	42	684	720	0	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2010	304	6					649	656		10.1001/jama.2010.1111	http://dx.doi.org/10.1001/jama.2010.1111			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637PA	20699456	Bronze, Green Accepted			2022-12-01	WOS:000280829200020
J	Cvetkovic, A; Menon, AL; Thorgersen, MP; Scott, JW; Poole, FL; Jenney, FE; Lancaster, WA; Praissman, JL; Shanmukh, S; Vaccaro, BJ; Trauger, SA; Kalisiak, E; Apon, JV; Siuzdak, G; Yannone, SM; Tainer, JA; Adams, MWW				Cvetkovic, Aleksandar; Menon, Angeli Lal; Thorgersen, Michael P.; Scott, Joseph W.; Poole, Farris L., II; Jenney, Francis E., Jr.; Lancaster, W. Andrew; Praissman, Jeremy L.; Shanmukh, Saratchandra; Vaccaro, Brian J.; Trauger, Sunia A.; Kalisiak, Ewa; Apon, Junefredo V.; Siuzdak, Gary; Yannone, Steven M.; Tainer, John A.; Adams, Michael W. W.			Microbial metalloproteomes are largely uncharacterized	NATURE			English	Article							ARCHAEON PYROCOCCUS-FURIOSUS; HYPERTHERMOPHILIC ARCHAEON; MASS-SPECTROMETRY; TRACE-ELEMENTS; KEY ROLE; PROTEINS; METABOLISM; RUBREDOXIN; INSIGHTS; DATABASE	Metal ion cofactors afford proteins virtually unlimited catalytic potential, enable electron transfer reactions and have a great impact on protein stability(1,2). Consequently, metalloproteins have key roles in most biological processes, including respiration (iron and copper), photosynthesis (manganese) and drug metabolism (iron). Yet, predicting from genome sequence the numbers and types of metal an organism assimilates from its environment or uses in its metalloproteome is currently impossible because metal coordination sites are diverse and poorly recognized(2-4). We present here a robust, metal-based approach to determine all metals an organism assimilates and identify its metalloproteins on a genome-wide scale. This shifts the focus from classical protein-based purification to metal-based identification and purification by liquid chromatography, high-throughput tandem mass spectrometry (HT-MS/MS) and inductively coupled plasma mass spectrometry (ICP-MS) to characterize cytoplasmic metalloproteins from an exemplary microorganism (Pyrococcus furiosus). Of 343 metal peaks in chromatography fractions, 158 did not match any predicted metalloprotein. Unassigned peaks included metals known to be used (cobalt, iron, nickel, tungsten and zinc; 83 peaks) plus metals the organism was not thought to assimilate (lead, manganese, molybdenum, uranium and vanadium; 75 peaks). Purification of eight of 158 unexpected metal peaks yielded four novel nickel- and molybdenum-containing proteins, whereas four purified proteins contained sub-stoichiometric amounts of misincorporated lead and uranium. Analyses of two additional microorganisms (Escherichia coli and Sulfolobus solfataricus) revealed species-specific assimilation of yet more unexpected metals. Metalloproteomes are therefore much more extensive and diverse than previously recognized, and promise to provide key insights for cell biology, microbial growth and toxicity mechanisms.	[Cvetkovic, Aleksandar; Menon, Angeli Lal; Thorgersen, Michael P.; Scott, Joseph W.; Poole, Farris L., II; Jenney, Francis E., Jr.; Lancaster, W. Andrew; Praissman, Jeremy L.; Shanmukh, Saratchandra; Vaccaro, Brian J.; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Trauger, Sunia A.; Kalisiak, Ewa; Apon, Junefredo V.; Siuzdak, Gary] Scripps Res Inst, Scripps Ctr Mass Spectrometry, La Jolla, CA 92037 USA; [Trauger, Sunia A.; Kalisiak, Ewa; Apon, Junefredo V.; Siuzdak, Gary] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Trauger, Sunia A.; Kalisiak, Ewa; Apon, Junefredo V.; Siuzdak, Gary] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Yannone, Steven M.; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	University System of Georgia; University of Georgia; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Adams, MWW (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	adams@bmb.uga.edu	Yannone, Steven/ABA-3524-2021; Tainer, John/GWQ-4878-2022; Vaccaro, Brian/F-8526-2017; Yannone, Steven/G-1927-2011	Tainer, John/0000-0003-1659-2429; Thorgersen, Michael/0000-0001-9552-762X; Jenney, Francis/0000-0002-1667-6924; Trauger, Sunia/0000-0002-1678-8715; Siuzdak, Gary/0000-0002-4749-0014; Adams, Michael/0000-0002-9796-5014	Department of Energy [DE-FG0207ER64326]	Department of Energy(United States Department of Energy (DOE))	This research is part of the MAGGIE (Molecular Assemblies, Genes and Genomes Integrated Efficiently) project supported by Department of Energy grant (DE-FG0207ER64326). We thank S. Hammond, L. Wells, R. Hopkins and D. Phillips for help with in-gel MS analyses.	Adams MWW, 2001, J BACTERIOL, V183, P716, DOI 10.1128/JB.183.2.716-724.2001; Agarwal G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005736; Aiuppa A, 2000, J VOLCANOL GEOTH RES, V98, P189, DOI 10.1016/S0377-0273(99)00156-0; Andreini C, 2009, BIOINFORMATICS, V25, P2088, DOI 10.1093/bioinformatics/btp256; Atanassova Anelia, 2008, V426, P319, DOI 10.1007/978-1-60327-058-8_20; BLAKE PR, 1991, BIOCHEMISTRY-US, V30, P10885, DOI 10.1021/bi00109a012; Bressler JP, 2007, HUM EXP TOXICOL, V26, P221, DOI 10.1177/0960327107070573; Cai Y, 2000, SPECTROCHIM ACTA B, V55, P1411, DOI 10.1016/S0584-8547(00)00247-0; Castagnetto JM, 2002, NUCLEIC ACIDS RES, V30, P379, DOI 10.1093/nar/30.1.379; Chai SC, 2008, J BIOL CHEM, V283, P26879, DOI 10.1074/jbc.M804345200; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; Gray H.B., 2006, BIOL INORGANIC CHEM; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jenney FE, 2001, METHOD ENZYMOL, V334, P45; Karthikeyan S, 2006, ANAL CHIM ACTA, V576, P23, DOI 10.1016/j.aca.2006.05.051; Kasampalidis IN, 2007, PROTEINS, V68, P123, DOI 10.1002/prot.21384; Kosnett MJ, 2007, BASIC CLIN PHARMACOL, V10th, P945; Lobinski R, 2006, MASS SPECTROM REV, V25, P255, DOI 10.1002/mas.20069; Luttringer F, 2009, J BIOL INORG CHEM, V14, P923, DOI 10.1007/s00775-009-0505-9; Menon AL, 2009, MOL CELL PROTEOMICS, V8, P735, DOI 10.1074/mcp.M800246-MCP200; Messerschmidt A., 2005, HDB METALLOPROTEINS, V1-3; Perry JJP, 2010, BBA-PROTEINS PROTEOM, V1804, P245, DOI 10.1016/j.bbapap.2009.11.004; Poole FL, 2005, J BACTERIOL, V187, P7325, DOI 10.1128/JB.187.21.7325-7332.2005; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Ragsdale SW, 2009, J BIOL CHEM, V284, P18571, DOI 10.1074/jbc.R900020200; Sambrook J., 1989, MOL CLONING LAB MANU, P3; Sanz-Medel A, 2008, ANAL BIOANAL CHEM, V390, P3, DOI 10.1007/s00216-007-1615-2; Schut GJ, 2007, J BACTERIOL, V189, P4431, DOI 10.1128/JB.00031-07; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Shi WX, 2005, STRUCTURE, V13, P1473, DOI 10.1016/j.str.2005.07.014; Shu NJ, 2008, BIOINFORMATICS, V24, P775, DOI 10.1093/bioinformatics/btm618; Splan KE, 2008, METHODS, V44, P119, DOI 10.1016/j.ymeth.2007.10.009; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Weinberg MV, 2005, J BACTERIOL, V187, P336, DOI 10.1128/JB.187.1.336-348.2005; Zhang Y, 2010, J BIOL CHEM, V285, P3393, DOI 10.1074/jbc.M109.071746; ZILLIG W, 1980, ARCH MICROBIOL, V125, P259, DOI 10.1007/BF00446886	37	276	280	5	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2010	466	7307					779	U18		10.1038/nature09265	http://dx.doi.org/10.1038/nature09265			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20639861	Green Submitted			2022-12-01	WOS:000280562500044
J	Young, J; Murthy, L; Westby, M; Akunne, A; O'Mahony, R				Young, John; Murthy, Lakshmi; Westby, Maggie; Akunne, Anayo; O'Mahony, Rachel		Guideline Dev Grp	Guidelines Diagnosis, prevention, and management of delirium: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material							CONFUSION ASSESSMENT METHOD		[Young, John] Bradford Royal Infirm, Bradford Inst Hlth Res, Bradford BD9 6RJ, W Yorkshire, England; [Murthy, Lakshmi; Westby, Maggie; Akunne, Anayo; O'Mahony, Rachel] Royal Coll Physicians, Natl Clin Guideline Ctr, London, England	Bradford Royal Infirmary; Royal College of Physicians	Young, J (corresponding author), Bradford Royal Infirm, Bradford Inst Hlth Res, Bradford BD9 6RJ, W Yorkshire, England.	john.young@bradfordhospitals.nhs.uk	Westby, Maggie/GWZ-2119-2022; Westby, Maggie/O-8794-2014	Westby, Maggie/0000-0003-4273-3942; young, john/0000-0003-4085-9306				American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; *JOINT FORM COMM, 2009, BRIT NAT FORM; National Clinical Guideline Centre, 2010, PAT DEL EXP VID; National Clinical Guideline Centre, 2010, DEL DIAGN PREV MAN; National Collaborating Centre for Acute Care, 2006, NUTR SUPP AD OR NUTR; National Institute for Clinical Excellence, 2003, INF CONTR PREV HEALT; National Institute for Health and Clinical Excellence, 2006, PARK DIS NAT CLIN GU, V35; National Institute for Health and Clinical Excellence, 2005, VIOL SHORT TERM MAN; National Institute for Health and Clinical Excellence, 2007, AC ILL PAT HOSP REC; National Institute for Health and Clinical Excellence, 2007, DEM SUPP PEOPL DEM T, V42	12	150	154	3	24	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2010	341								c3704	10.1136/bmj.c3704	http://dx.doi.org/10.1136/bmj.c3704			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	634GZ	20667955	Green Accepted			2022-12-01	WOS:000280570100002
J	Somani, BK; Watson, G; Townell, N				Somani, Bhaskar K.; Watson, Graham; Townell, Nick			Easily Missed? Testicular torsion	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE SCROTUM; PEDIATRIC-PATIENTS; SPERMATIC CORD; ISCHEMIA; SALVAGE		[Somani, Bhaskar K.; Townell, Nick] Ninewells Hosp, Dundee DD1 9SY, Scotland	University of Dundee	Townell, N (corresponding author), Ninewells Hosp, Dundee DD1 9SY, Scotland.	nicktownell@nhs.net	Somani, B. K./I-8429-2019	Somani, B. K./0000-0002-6248-6478				ANDERSON JB, 1988, BRIT J SURG, V75, P988, DOI 10.1002/bjs.1800751015; BARADA JH, 1989, J UROLOGY, V142, P746, DOI 10.1016/S0022-5347(17)38875-4; BENNETT S, 1987, BMJ-BRIT MED J, V294, P824, DOI 10.1136/bmj.294.6575.824; BRASSO K, 1993, SCAND J UROL NEPHROL, V27, P1; BURKS DD, 1990, RADIOLOGY, V175, P815, DOI 10.1148/radiology.175.3.2188301; CATTOLICA EV, 1982, J UROLOGY, V128, P66, DOI 10.1016/S0022-5347(17)52758-5; Ciftci AO, 2004, EUR J PEDIATR SURG, V14, P333, DOI 10.1055/s-2004-821210; Eaton SH, 2005, J UROLOGY, V174, P1532, DOI 10.1097/01.ju.0000177726.84913.cc; Jefferson RH, 1997, J UROLOGY, V158, P1198, DOI 10.1016/S0022-5347(01)64426-4; LEWIS AG, 1995, J PEDIATR SURG, V30, P277, DOI 10.1016/0022-3468(95)90574-X; Makela E, 2007, SCAND J SURG, V96, P62; MOLOKWU CN, 2010, BJU INT IN PRESS; Mushtaq I, 2003, ANZ J SURG, V73, P55, DOI 10.1046/j.1445-2197.2003.02612.x; Sessions AE, 2003, J UROLOGY, V169, P663, DOI 10.1016/S0022-5347(05)63987-0; SMITH GI, 1955, J UROLOGY, V73, P355, DOI 10.1016/S0022-5347(17)67408-1; Visser AJ, 2003, BJU INT, V92, P200, DOI 10.1046/j.1464-410X.2003.04307.x	16	8	11	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2010	341								c3213	10.1136/bmj.c3213	http://dx.doi.org/10.1136/bmj.c3213			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634GX	20663836				2022-12-01	WOS:000280569900001
J	Clark, RH; McTaggart, JS; Webster, R; Mannikko, R; Iberl, M; Sim, XL; Rorsman, P; Glitsch, M; Beeson, D; Ashcroft, FM				Clark, Rebecca H.; McTaggart, James S.; Webster, Richard; Mannikko, Roope; Iberl, Michaela; Sim, Xiu Li; Rorsman, Patrik; Glitsch, Maike; Beeson, David; Ashcroft, Frances M.			Muscle Dysfunction Caused by a K-ATP Channel Mutation in Neonatal Diabetes Is Neuronal in Origin	SCIENCE			English	Article							SULFONYLUREA RECEPTOR; KIR6.2; INSULIN; KCNJ11; THERAPY; SUBUNIT; MYOCARDIUM; PATIENT; GENE	Gain-of-function mutations in Kir6.2 (KCNJ11), the pore-forming subunit of the adenosine triphosphate (ATP)-sensitive potassium (K-ATP) channel, cause neonatal diabetes. Many patients also suffer from hypotonia (weak and flaccid muscles) and balance problems. The diabetes arises from suppressed insulin secretion by overactive K-ATP channels in pancreatic beta-cells, but the source of the motor phenotype is unknown. By using mice carrying a human Kir6.2 mutation (Val(59)-> Met(59)) targeted to either muscle or nerve, we show that analogous motor impairments originate in the central nervous system rather than in muscle or peripheral nerves. We also identify locomotor hyperactivity as a feature of K-ATP channel overactivity. These findings suggest that drugs targeted against neuronal, rather than muscle, K-ATP channels are needed to treat the motor deficits and that such drugs require high blood-brain barrier permeability.	[Clark, Rebecca H.; McTaggart, James S.; Mannikko, Roope; Iberl, Michaela; Sim, Xiu Li; Glitsch, Maike; Ashcroft, Frances M.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Webster, Richard; Beeson, David] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Rorsman, Patrik] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England	University of Oxford; University of Oxford; University of Oxford	Ashcroft, FM (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England.	frances.ashcroft@dpag.ox.ac.uk	Mannikko, Roope/Q-3567-2016; Rorsman, Patrik/A-4331-2016	Mannikko, Roope/0000-0002-8727-9184; Rorsman, Patrik/0000-0001-7578-0767; Webster, Richard/0000-0001-7893-1348; Glitsch, Maike/0000-0003-0723-3117	Wellcome Trust; Medical Research Council; Royal Society; European Union [LHSB-CT-2004-005137, HEALTH-F4-2007-201924]; Muscular Dystrophy Campaign; Myasthenia Gravis Association; MRC [G0701521] Funding Source: UKRI; Medical Research Council [G0701521] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); European Union(European Commission); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Myasthenia Gravis Association; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank C. Girard for generating the ROSA mouse and help with early experiments; J. Bruning for the Mck-Cre mice; R. Deacon for help with the mouse behavioral tests and for the use of the OXION mouse behavior facility; and the Wellcome Trust, the Medical Research Council, the Royal Society, the European Union (LHSB-CT-2004-005137 and HEALTH-F4-2007-201924), the Muscular Dystrophy Campaign, and Myasthenia Gravis Association for support. R. H. C. holds an OXION Wellcome Trust prize studentship and J. S. M. holds a Medical Research Council studentship. F. M. A. is a Royal Society University Research Professor.	Ashcroft FM, 2007, AM J PHYSIOL-ENDOC M, V293, pE880, DOI 10.1152/ajpendo.00348.2007; Ghosh S, 2001, J AM COLL CARDIOL, V37, P711, DOI 10.1016/S0735-1097(00)01161-X; Girard CA, 2009, J CLIN INVEST, V119, P80, DOI 10.1172/JCI35772; Gribble FM, 2003, DIABETOLOGIA, V46, P875, DOI 10.1007/s00125-003-1143-3; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; Karschin C, 1997, FEBS LETT, V401, P59, DOI 10.1016/S0014-5793(96)01438-X; Koster JC, 2008, J CLIN ENDOCR METAB, V93, P1054, DOI 10.1210/jc.2007-1826; Mlynarski WC, 2007, NAT CLIN PRACT NEURO, V3, P640, DOI 10.1038/ncpneuro0640; MOURRE C, 1990, BRAIN RES, V519, P29, DOI 10.1016/0006-8993(90)90057-I; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Quast U, 2004, DIABETES, V53, pS156, DOI 10.2337/diabetes.53.suppl_3.S156; Simpson SH, 2006, CAN MED ASSOC J, V174, P169, DOI 10.1503/cmaj.050748; Slingerland AS, 2008, DIABETIC MED, V25, P277, DOI 10.1111/j.1464-5491.2007.02373.x; Slingerland AS, 2006, DIABETOLOGIA, V49, P2559, DOI 10.1007/s00125-006-0407-0; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	19	70	72	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					458	461		10.1126/science.1186146	http://dx.doi.org/10.1126/science.1186146			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20595581	Green Accepted			2022-12-01	WOS:000280196500042
J	Moseley, JB; Nurse, P				Moseley, James B.; Nurse, Paul			Cell Division Intersects with Cell Geometry	CELL			English	Article							BACILLUS-SUBTILIS; SPINDLE ORIENTATION; CHROMOSOME SEGREGATION; MICROTUBULE BUNDLES; SELF-ORGANIZATION; PROTEIN DIVIVA; AURORA-A; KINASE; LOCALIZATION; SHAPE		[Moseley, James B.; Nurse, Paul] Rockefeller Univ, New York, NY 10065 USA	Rockefeller University	Moseley, JB (corresponding author), Rockefeller Univ, New York, NY 10065 USA.	jmoseley@rockefeller.edu			Wellcome Trust [093917] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bahler J, 1998, GENE DEV, V12, P1356, DOI 10.1101/gad.12.9.1356; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Bowman GR, 2008, CELL, V134, P945, DOI 10.1016/j.cell.2008.07.015; Bramkamp M, 2008, MOL MICROBIOL, V70, P1556, DOI 10.1111/j.1365-2958.2008.06501.x; Campbell CS, 2007, J CELL BIOL, V179, P1059, DOI 10.1083/jcb.200708206; Carazo-Salas RE, 2006, NAT CELL BIOL, V8, P1102, DOI 10.1038/ncb1479; Celton-Morizur S, 2006, J CELL SCI, V119, P4710, DOI 10.1242/jcs.03261; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Cheng KCC, 2009, CELL, V139, P560, DOI 10.1016/j.cell.2009.08.047; Corbin BD, 2002, EMBO J, V21, P1998, DOI 10.1093/emboj/21.8.1998; Daga RR, 2008, J CELL SCI, V121, P1973, DOI 10.1242/jcs.011825; Daga RR, 2006, NAT CELL BIOL, V8, P1108, DOI 10.1038/ncb1480; Ebersbach G, 2008, CELL, V134, P956, DOI 10.1016/j.cell.2008.07.016; Edwards DH, 2000, EMBO J, V19, P2719, DOI 10.1093/emboj/19.11.2719; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gray D, 2004, CURR BIOL, V14, P397, DOI 10.1016/j.cub.2004.02.031; Gregory JA, 2008, GENE DEV, V22, P3475, DOI 10.1101/gad.1732408; Hirota T, 2000, J CELL BIOL, V149, P1073, DOI 10.1083/jcb.149.5.1073; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Huang YY, 2007, DEV CELL, V12, P987, DOI 10.1016/j.devcel.2007.03.015; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Keaton MA, 2006, CURR OPIN MICROBIOL, V9, P540, DOI 10.1016/j.mib.2006.10.004; Kruse K, 2007, MOL MICROBIOL, V63, P1279, DOI 10.1111/j.1365-2958.2007.05607.x; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; Lutkenhaus J, 2008, ADV EXP MED BIOL, V641, P49; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; Maruyama R, 2007, CURR BIOL, V17, P1555, DOI 10.1016/j.cub.2007.08.011; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Padte NN, 2006, CURR BIOL, V16, P2480, DOI 10.1016/j.cub.2006.11.024; Pang KM, 2004, DEV BIOL, V265, P127, DOI 10.1016/j.ydbio.2003.09.024; Patrick JE, 2008, MOL MICROBIOL, V70, P1166, DOI 10.1111/j.1365-2958.2008.06469.x; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Ramamurthi KS, 2009, P NATL ACAD SCI USA, V106, P13541, DOI 10.1073/pnas.0906851106; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; Raskin DM, 1997, CELL, V91, P685, DOI 10.1016/S0092-8674(00)80455-9; Rivers DM, 2008, J CELL BIOL, V180, P877, DOI 10.1083/jcb.200710018; Rupes I, 2002, TRENDS GENET, V18, P479, DOI 10.1016/S0168-9525(02)02745-2; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Stahlberg H, 2004, MOL MICROBIOL, V52, P1281, DOI 10.1111/j.1365-2958.2004.04074.x; Stitzel ML, 2007, CURR BIOL, V17, P1545, DOI 10.1016/j.cub.2007.08.049; Strauss B, 2006, DEVELOPMENT, V133, P3883, DOI 10.1242/dev.02578; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Tsou MFB, 2003, J CELL BIOL, V160, P845, DOI 10.1083/jcb.200209079; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Vogel SK, 2007, CURR BIOL, V17, P438, DOI 10.1016/j.cub.2007.01.047; Wu LJ, 2009, EMBO J, V28, P1940, DOI 10.1038/emboj.2009.144; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035	52	36	39	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					189	193		10.1016/j.cell.2010.07.004	http://dx.doi.org/10.1016/j.cell.2010.07.004			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655459	Bronze			2022-12-01	WOS:000280204300007
J	Swierczek, M; Cieluch, E; Sarewicz, M; Borek, A; Moser, CC; Dutton, PL; Osyczka, A				Swierczek, Monika; Cieluch, Ewelina; Sarewicz, Marcin; Borek, Arkadiusz; Moser, Christopher C.; Dutton, P. Leslie; Osyczka, Artur			An Electronic Bus Bar Lies in the Core of Cytochrome bc(1)	SCIENCE			English	Article							Q(O) SITE; Q-CYCLE; RHODOBACTER-CAPSULATUS; SUPEROXIDE-PRODUCTION; COMPLEX; MITOCHONDRIAL; MECHANISM; DOMAIN; OXIDATION; MOVEMENT	The ubiquinol-cytochrome c oxidoreductases, central to cellular respiration and photosynthesis, are homodimers. High symmetry has frustrated resolution of whether cross-dimer interactions are functionally important. This has resulted in a proliferation of contradictory models. Here, we duplicated and fused cytochrome b subunits, and then broke symmetry by introducing independent mutations into each monomer. Electrons moved freely within and between monomers, crossing an electron-transfer bridge between two hemes in the core of the dimer. This revealed an H-shaped electron-transfer system that distributes electrons between four quinone oxidation-reduction terminals at the corners of the dimer within the millisecond time scale of enzymatic turnover. Free and unregulated distribution of electrons acts like a molecular-scale bus bar, a design often exploited in electronics.	[Swierczek, Monika; Cieluch, Ewelina; Sarewicz, Marcin; Borek, Arkadiusz; Osyczka, Artur] Jagiellonian Univ, Dept Biophys, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Moser, Christopher C.; Dutton, P. Leslie] Univ Penn, Dept Biochem & Biophys, Johnson Res Fdn, Philadelphia, PA 19104 USA	Jagiellonian University; University of Pennsylvania	Osyczka, A (corresponding author), Jagiellonian Univ, Dept Biophys, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	artur.osyczka@uj.edu.pl	Moser, Christopher C/O-6559-2014	Moser, Christopher C/0000-0003-4814-8568; Sarewicz, Marcin/0000-0001-6813-5997; Osyczka, Artur/0000-0002-1637-2365; Borek, Arkadiusz/0000-0003-3195-3579	Wellcome Trust; United States National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027309, R01GM041048] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to F. Daldal (University of Pennsylvania, Philadelphia, USA) for the genetic system for cytochrome bc1 in R. capsulatus. This work was supported by The Wellcome Trust International Senior Research Fellowship (A.O.) and by the United States National Institutes of Health (P.L.D.)	Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; Berry EA, 2004, PHOTOSYNTH RES, V81, P251, DOI 10.1023/B:PRES.0000036888.18223.0e; Borek A, 2008, BIOCHEMISTRY-US, V47, P12365, DOI 10.1021/bi801207f; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; Castellani M, 2010, J BIOL CHEM, V285, P502, DOI 10.1074/jbc.M109.072959; Cooley JW, 2009, BIOCHEMISTRY-US, V48, P1888, DOI 10.1021/bi802216h; Covian R, 2008, BBA-BIOENERGETICS, V1777, P1079, DOI 10.1016/j.bbabio.2008.04.022; Cramer WA, 2006, ANNU REV BIOCHEM, V75, P769, DOI 10.1146/annurev.biochem.75.103004.142756; Crofts AR, 2008, BBA-BIOENERGETICS, V1777, P1001, DOI 10.1016/j.bbabio.2008.04.037; Darrouzet E, 2001, TRENDS BIOCHEM SCI, V26, P445, DOI 10.1016/S0968-0004(01)01897-7; Ding H, 1995, BIOCHEMISTRY-US, V34, P15979, DOI 10.1021/bi00049a012; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Gopta OA, 1998, FEBS LETT, V431, P291, DOI 10.1016/S0014-5793(98)00768-6; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; KSENZENKO M, 1983, FEBS LETT, V155, P19, DOI 10.1016/0014-5793(83)80200-2; Lee DW, 2008, J BIOL CHEM, V283, P13973, DOI 10.1074/jbc.M800091200; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Moser CC, 2008, BBA-BIOENERGETICS, V1777, P1032, DOI 10.1016/j.bbabio.2008.04.021; Moser CC, 2006, PHILOS T R SOC B, V361, P1295, DOI 10.1098/rstb.2006.1868; Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e; Osyczka A, 2004, NATURE, V427, P607, DOI 10.1038/nature02242; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Sarewicz M, 2008, J BIOL CHEM, V283, P24826, DOI 10.1074/jbc.M802174200; Shinkarev VP, 2007, FEBS LETT, V581, P1535, DOI 10.1016/j.febslet.2007.03.037; Yu CA, 2008, BBA-BIOENERGETICS, V1777, P1038, DOI 10.1016/j.bbabio.2008.03.033; Zhang HB, 2007, BBA-BIOENERGETICS, V1767, P883, DOI 10.1016/j.bbabio.2007.04.004	27	99	99	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					451	454		10.1126/science.1190899	http://dx.doi.org/10.1126/science.1190899			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651150	Green Accepted			2022-12-01	WOS:000280196500040
J	Paal, P; Braun, P; Brugger, H; Strappazzon, G; Falk, M				Paal, Peter; Braun, Patrick; Brugger, Hermann; Strappazzon, Giacomo; Falk, Markus			Medicine and the Media How the media and animal rights activists put avalanche burial study on ice	BRITISH MEDICAL JOURNAL			English	Editorial Material							SURVIVAL; HYPOTHERMIA		[Paal, Peter; Braun, Patrick] Innsbruck Med Univ, Dept Anesthesiol & Crit Care Med, Innsbruck, Austria; [Brugger, Hermann; Strappazzon, Giacomo] EURAC Inst Mt Emergency Med, Bolzano, Italy; [Falk, Markus] Inova Q, Brunico, Italy	Medical University of Innsbruck; European Academy of Bozen-Bolzano	Paal, P (corresponding author), Innsbruck Med Univ, Dept Anesthesiol & Crit Care Med, Innsbruck, Austria.	peter.paal@uki.at	Paal, Peter/E-2110-2011	Brugger, Hermann/0000-0003-2752-6929; Paal, Peter/0000-0002-2939-4782; Falk, Markus/0000-0002-5297-0776				Boyd J, 2009, CAN MED ASSOC J, V180, P507, DOI 10.1503/cmaj.081327; Brugger H, 2003, RESUSCITATION, V58, P81, DOI 10.1016/S0300-9572(03)00113-8; Brugger H, 2001, RESUSCITATION, V51, P7, DOI 10.1016/S0300-9572(01)00383-5; Brugger H, 2010, NATURE, V463, P877, DOI 10.1038/463877a; FALK M, 1994, NATURE, V368, P21, DOI 10.1038/368021a0; GRAY R, LORD DRAYSON WINNING; Gunga HC, 2009, RESP PHYSIOL NEUROBI, V169, pS63, DOI 10.1016/j.resp.2009.04.005; Han YS, 2010, AM J PHYSIOL-HEART C, V298, pH890, DOI 10.1152/ajpheart.00805.2009; Oberhammer R, 2008, RESUSCITATION, V76, P474, DOI 10.1016/j.resuscitation.2007.09.004; *PROT, PROT STAND UP SCI	10	7	7	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 14	2010	341								c3778	10.1136/bmj.c3778	http://dx.doi.org/10.1136/bmj.c3778			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628XC	20630957				2022-12-01	WOS:000280156700013
J	Lee, C; Goldberg, J				Lee, Changwook; Goldberg, Jonathan			Structure of Coatomer Cage Proteins and the Relationship among COPI, COPII, and Clathrin Vesicle Coats	CELL			English	Article							ADP-RIBOSYLATION FACTOR; MOLECULAR ARCHITECTURE; ENDOPLASMIC-RETICULUM; ALPHA-COP; IN-VITRO; COMPLEX; CARGO; MEMBRANE; SUBUNITS; EXCHANGE	COPI-coated vesicles form at the Golgi apparatus from two cytosolic components, ARF G protein and coatomer, a heptameric complex that can polymerize into a cage to deform the membrane into a bud. Although coatomer shares a common evolutionary origin with COPII and clathrin vesicle coat proteins, the architectural relationship among the three cages is unclear. Strikingly, the alpha beta'-COP core of coatomer crystallizes as a triskelion in which three copies of a beta'-COP beta-propeller domain converge through their axial ends. We infer that the trimer constitutes the vertex of the COPI cage. Our model proposes that the COPI cage is intermediate in design between COPII and clathrin: COPI shares with clathrin an arrangement of three curved alpha-solenoid legs radiating from a common center, and COPI shares with COPII highly similar vertex interactions involving the axial ends of beta-propeller domains.	[Lee, Changwook; Goldberg, Jonathan] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Lee, Changwook; Goldberg, Jonathan] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Goldberg, J (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, 1275 York Ave, New York, NY 10065 USA.	jonathan@ximpact4.ski.mskcc.org	Lee, Changwook/D-6010-2011		Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank staff at beamline X25 of the NSLS and beamline 24ID of the APS for use of and assistance with synchrotron facilities. We thank Felix Wieland and Marianna Breitman for providing full-length cDNA and baculoviruses for expression of COPI subunits. This work was supported by a grant from the Howard Hughes Medical Institute.	Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Brohawn SG, 2009, NAT STRUCT MOL BIOL, V16, P1173, DOI 10.1038/nsmb.1713; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; DUDEN R, 1994, J BIOL CHEM, V269, P24486; Duden R, 1998, EMBO J, V17, P985, DOI 10.1093/emboj/17.4.985; Eugster A, 2004, MOL BIOL CELL, V15, P1011, DOI 10.1091/mbc.E03-10-0724; Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; HARAKUGE S, 1994, J CELL BIOL, V124, P883, DOI 10.1083/jcb.124.6.883; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Hsia KC, 2007, CELL, V131, P1313, DOI 10.1016/j.cell.2007.11.038; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lederkremer GZ, 2001, P NATL ACAD SCI USA, V98, P10704, DOI 10.1073/pnas.191359398; Lowe M, 1995, J BIOL CHEM, V270, P31364, DOI 10.1074/jbc.270.52.31364; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Nickel W, 1998, J CELL SCI, V111, P3081; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Pavel J, 1998, P NATL ACAD SCI USA, V95, P2140, DOI 10.1073/pnas.95.5.2140; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Schledzewski K, 1999, J MOL EVOL, V48, P770, DOI 10.1007/PL00006521; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Stagg SM, 2007, CURR OPIN STRUC BIOL, V17, P221, DOI 10.1016/j.sbi.2007.03.010; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; Zhao LY, 1997, P NATL ACAD SCI USA, V94, P4418, DOI 10.1073/pnas.94.9.4418; ZLOTNICK A, 1994, J MOL BIOL, V241, P59, DOI 10.1006/jmbi.1994.1473	41	136	140	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2010	142	1					123	132		10.1016/j.cell.2010.05.030	http://dx.doi.org/10.1016/j.cell.2010.05.030			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20579721	Bronze, Green Accepted			2022-12-01	WOS:000279637300018
J	D'Angiolella, V; Donato, V; Vijayakumar, S; Saraf, A; Florens, L; Washburn, MP; Dynlacht, B; Pagano, M				D'Angiolella, Vincenzo; Donato, Valerio; Vijayakumar, Sangeetha; Saraf, Anita; Florens, Laurence; Washburn, Michael P.; Dynlacht, Brian; Pagano, Michele			SCFCyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation	NATURE			English	Article							PROTEOMIC ANALYSIS; UBIQUITIN LIGASE; CYCLIN-F; IDENTIFICATION; BIOGENESIS; MECHANISMS; SUBSTRATE	Generally, F-box proteins are the substrate recognition subunits of SCF (Skp1-Cul1-F-box protein) ubiquitin ligase complexes, which mediate the timely proteolysis of important eukaryotic regulatory proteins(1,2). Mammalian genomes encode roughly 70 F-box proteins, but only a handful have established functions(3,4). The F-box protein family obtained its name from Cyclin F (also called Fbxo1), in which the F-box motif (the similar to 40-amino-acid domain required for binding to Skp1) was first described(5). Cyclin F, which is encoded by an essential gene, also contains a cyclin box domain, but in contrast to most cyclins, it does not bind or activate any cyclin-dependent kinases (CDKs)(5-7). However, like other cyclins, Cyclin F oscillates during the cell cycle, with protein levels peaking in G2. Despite its essential nature and status as the founding member of the F-box protein family, Cyclin F remains an orphan protein, whose functions are unknown. Starting from an unbiased screen, we identified CP110, a protein that is essential for centrosome duplication, as an interactor and substrate of Cyclin F. Using a mode of substrate binding distinct from other F-box protein-substrate pairs, CP110 and Cyclin F physically associate on the centrioles during the G2 phase of the cell cycle, and CP110 is ubiquitylated by the SCFCyclin F ubiquitin ligase complex, leading to its degradation. siRNA-mediated depletion of Cyclin F in G2 induces centrosomal and mitotic abnormalities, such as multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes. These phenotypes were reverted by co-silencing CP110 and were recapitulated by expressing a stable mutant of CP110 that cannot bind Cyclin F. Finally, expression of a stable CP110 mutant in cultured cells also promotes the formation of micronuclei, a hallmark of chromosome instability. We propose that SCFCyclin F-mediated degradation of CP110 is required for the fidelity of mitosis and genome integrity.	[D'Angiolella, Vincenzo; Donato, Valerio; Vijayakumar, Sangeetha; Dynlacht, Brian; Pagano, Michele] NYU, Sch Med, Inst Canc, Dept Pathol, New York, NY 10016 USA; [Saraf, Anita; Florens, Laurence; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Pagano, Michele] Howard Hughes Med Inst, Chevy Chase, MD USA	New York University; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Howard Hughes Medical Institute	Pagano, M (corresponding author), NYU, Sch Med, Inst Canc, Dept Pathol, 522 1st Ave,SRB 1107, New York, NY 10016 USA.	michele.pagano@nyumc.org		pagano, michele/0000-0003-3210-2442; Florens, Laurence/0000-0002-9310-6650; Washburn, Michael/0000-0001-7568-2585	American Italian Cancer Foundation; March of Dimes [1-FY08-372]; National Institutes of Health [R01-GM057587, R37-CA076584, R21-AG032560]; Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE [R37CA076584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032560] Funding Source: NIH RePORTER	American Italian Cancer Foundation; March of Dimes(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Elledge for Cyclin F<SUP>Flox/-</SUP> and Cyclin F<SUP>-/-</SUP> MEFs, J.R. Skaar for reading the manuscript and F. M. Forrester for technical help. M. P. is grateful to T. M. Thor for continuous support. This work was funded by fellowships from the American Italian Cancer Foundation to V.D'A. and V. D., a grant from the March of Dimes (1-FY08-372) to B. D. and grants from the National Institutes of Health (R01-GM057587, R37-CA076584 and R21-AG032560) to M. P. A. S., L. F. and M. P. W. are supported by the Stowers Institute for Medical Research. V.D'A. is a Leukemia & Lymphoma Society Fellow. M. P. is an Investigator with the Howard Hughes Medical Institute.	Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BAI C, 1994, EMBO J, V13, P6087, DOI 10.1002/j.1460-2075.1994.tb06955.x; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carrano AC, 2001, J CELL BIOL, V153, P1381, DOI 10.1083/jcb.153.7.1381; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Florens Laurence, 2006, V328, P159; Fung TK, 2002, J BIOL CHEM, V277, P35140, DOI 10.1074/jbc.M205503200; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Loncarek J, 2009, MOL CELLS, V27, P135, DOI 10.1007/s10059-009-0017-z; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Quintyne NJ, 2005, SCIENCE, V307, P127, DOI 10.1126/science.1104905; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tetzlaff MT, 2004, MOL CELL BIOL, V24, P2487, DOI 10.1128/MCB.24.6.2487-2498.2004; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	34	173	179	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					138	U161		10.1038/nature09140	http://dx.doi.org/10.1038/nature09140			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596027	Green Accepted			2022-12-01	WOS:000279343800050
J	Smith, J; Van Dyken, JD; Zee, PC				Smith, Jeff; Van Dyken, J. David; Zee, Peter C.			A Generalization of Hamilton's Rule for the Evolution of Microbial Cooperation	SCIENCE			English	Article							SOCIAL EVOLUTION; KIN SELECTION; BACTERIAL-POPULATIONS; CONFLICT; MICROORGANISMS; COMPETITION; AMEBA; MODEL	Hamilton's rule states that cooperation will evolve if the fitness cost to actors is less than the benefit to recipients multiplied by their genetic relatedness. This rule makes many simplifying assumptions, however, and does not accurately describe social evolution in organisms such as microbes where selection is both strong and nonadditive. We derived a generalization of Hamilton's rule and measured its parameters in Myxococcus xanthus bacteria. Nonadditivity made cooperative sporulation remarkably resistant to exploitation by cheater strains. Selection was driven by higher-order moments of population structure, not relatedness. These results provide an empirically testable cooperation principle applicable to both microbes and multicellular organisms and show how nonlinear interactions among cells insulate bacteria against cheaters.	[Smith, Jeff; Van Dyken, J. David; Zee, Peter C.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Smith, J (corresponding author), Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77005 USA.	smith74@indiana.edu	smith, jeff/A-7486-2011	smith, jeff/0000-0001-8445-586X	NIH [GM07690, R01GM084238]; Genetics, Cellular and Molecular Sciences Training Grant [T32GM007757]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007757, R01GM079690, R01GM084238] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genetics, Cellular and Molecular Sciences Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Velicer for funding and laboratory support through NIH grant GM07690 and S. Alizon, W. Castle, D. Queller, and W. Ratcliff for discussion and comments on the manuscript. J.D.V.D. was supported by NIH grant R01GM084238 to M.J. Wade. P.C.Z. was supported by the Genetics, Cellular and Molecular Sciences Training Grant (T32GM007757). All authors conceived the project, discussed the results, and commented on the paper. j.s. and D. V. D. designed the theoretical approach. j.s. did the math, designed and performed the experiments, and wrote the paper. j.s. and P.C.Z. analyzed the data.	Brown SP, 2009, PHILOS T R SOC B, V364, P3157, DOI 10.1098/rstb.2009.0055; Crozier R.H., 1996, EVOLUTION SOCIAL INS; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Gardner A, 2007, AM NAT, V169, P207, DOI 10.1086/510602; Gilbert OM, 2007, P NATL ACAD SCI USA, V104, P8913, DOI 10.1073/pnas.0702723104; Godfrey-Smith P, 2009, AM NAT, V174, P906, DOI 10.1086/646605; Grafen A., 1985, Oxford Surveys in Evolutionary Biology, V2, P28; Griffin AS, 2002, TRENDS ECOL EVOL, V17, P15, DOI 10.1016/S0169-5347(01)02355-2; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Keller L, 1999, LEVELS SELECTION EVO; Kummerli R, 2010, J EVOLUTION BIOL, V23, P699, DOI 10.1111/j.1420-9101.2010.01936.x; Leimar O, 2006, J EVOLUTION BIOL, V19, P1403, DOI 10.1111/j.1420-9101.2006.01156.x; LEIMAR O, 2006, J EVOLUTION BIOL, V19, P1426; MacLean RC, 2006, NATURE, V441, P498, DOI 10.1038/nature04624; Maynard Smith J., 1995, MAJOR TRANSITIONS EV; QUELLER DC, 1992, EVOLUTION, V46, P376, DOI [10.2307/2409858, 10.1111/j.1558-5646.1992.tb02045.x]; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Ross-Gillespie A, 2007, AM NAT, V170, P331, DOI 10.1086/519860; Smith J, 2001, P ROY SOC B-BIOL SCI, V268, P61, DOI 10.1098/rspb.2000.1330; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; Taylor PD, 1996, J THEOR BIOL, V180, P27, DOI 10.1006/jtbi.1996.0075; Turner PE, 1999, NATURE, V398, P441, DOI 10.1038/18913; Velicer GJ, 2000, NATURE, V404, P598, DOI 10.1038/35007066; Velicer GJ, 2009, ANNU REV MICROBIOL, V63, P599, DOI 10.1146/annurev.micro.091208.073158; Wenseleers T, 2006, J EVOLUTION BIOL, V19, P1419, DOI 10.1111/j.1420-9101.2006.01144.x; WENSELEERS T, 2006, J EVOLUTION BIOL, V19, P1426; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Whitlock MC, 2002, GENETICS, V160, P1191; Wright S, 1931, GENETICS, V16, P0097	30	56	58	2	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1700	1703		10.1126/science.1189675	http://dx.doi.org/10.1126/science.1189675			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576891	Green Accepted			2022-12-01	WOS:000279107400045
J	Dasenbrook, EC; Checkley, W; Merlo, CA; Konstan, MW; Lechtzin, N; Boyle, MP				Dasenbrook, Elliott C.; Checkley, William; Merlo, Christian A.; Konstan, Michael W.; Lechtzin, Noah; Boyle, Michael P.			Association Between Respiratory Tract Methicillin-Resistant Staphylococcus aureus and Survival in Cystic Fibrosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MULTIPLE IMPUTATION; PULMONARY-FUNCTION; CHOICE	Context The prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in the respiratory tract of individuals with cystic fibrosis (CF) has increased dramatically; however, its impact on outcomes in CF is unclear. Because the time between infection with bacteria in CF and death can be decades, observational studies with long periods of follow-up are well suited to address the current gap in knowledge. Objective To determine whether isolation of MRSA from the respiratory tract of CF patients is associated with worse survival compared with patients who never have a culture positive for MRSA. Design, Setting, and Participants Cohort study of 19 833 CF patients aged 6 to 45 years seen at centers accredited by the Cystic Fibrosis Foundation in the United States. Patients entered between January 1996 and December 2006 and were followed up through December 2008. Cox regression models with time-varying covariates were used to compare survival between CF patients with and without respiratory tract MRSA. Main Outcome Measure Time from age at entry until age at death from any cause. Results In 137 819 patient-years of observation (median, 7.3 years/patient), 2537 CF patients died and 5759 patients had MRSA detected. The mortality rate was 18.3 deaths (95% confidence interval [CI], 17.5-19.1) per 1000 patient-years in patients without MRSA and 27.7 deaths (95% CI, 25.3-30.4) per 1000 patient-years in those with MRSA. Among those with MRSA, the attributable risk percentage of death associated with MRSA was 34.0% (95% CI, 26.7%-40.4%). The unadjusted hazard ratio associated with MRSA was 1.47 (95% CI, 1.32-1.62). After adjustment for time-varying covariates associated with severity of illness, MRSA remained associated with a higher risk of death (1.27; 95% CI, 1.11-1.45). Conclusion Detection of MRSA in the respiratory tract of CF patients was associated with worse survival. JAMA. 2010; 303(23): 2386-2392	[Dasenbrook, Elliott C.] Univ Hosp Case Med Ctr, Cleveland, OH 44106 USA; [Dasenbrook, Elliott C.] Case Western Reserve Univ, Sch Med, Dept Med, Div Pulm Crit Care & Sleep Med, Cleveland, OH 44106 USA; [Dasenbrook, Elliott C.; Konstan, Michael W.] Case Western Reserve Univ, Sch Med, Dept Pediat, Div Pediat Pulmonol & Allergy Immunol, Cleveland, OH 44106 USA; [Dasenbrook, Elliott C.; Konstan, Michael W.] Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; [Checkley, William; Merlo, Christian A.; Lechtzin, Noah; Boyle, Michael P.] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care, Baltimore, MD 21205 USA; [Checkley, William] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Program Global Dis Epidemiol & Control, Baltimore, MD USA	Case Western Reserve University; Case Western Reserve University Hospital; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Dasenbrook, EC (corresponding author), Univ Hosp Case Med Ctr, 11100 Euclid Ave,Mailstop WRN 5067, Cleveland, OH 44106 USA.	ecd28@case.edu		Checkley, William/0000-0003-1106-8812; Dasenbrook, Elliott/0000-0001-9811-8004; Konstan, Michael/0000-0002-0557-7277; Boyle, Michael/0000-0002-9740-1630	Cystic Fibrosis Foundation [DASENB08D0]; Johns Hopkins University; National Heart, Lung, and Blood Institute [K99HL096955]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL096955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Johns Hopkins University(Johns Hopkins University); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grant DASENB08D0 from the Cystic Fibrosis Foundation and a Research Development Program grant to Case Western Reserve University from the Cystic Fibrosis Foundation. Dr Checkley is supported by a Clinician Scientist Award from Johns Hopkins University and a Pathway to Independence Award (K99HL096955) from the National Heart, Lung, and Blood Institute.	Boyle MP, 2007, JAMA-J AM MED ASSOC, V298, P1787, DOI 10.1001/jama.298.15.1787; Collett D., 1994, MODELING SURVIVAL DA; *CYST FIBR FDN PAT, 2009, 2008 ANN DAT REP; Dasenbrook EC, 2008, AM J RESP CRIT CARE, V178, P814, DOI 10.1164/rccm.200802-327OC; Elizur A, 2007, CHEST, V131, P1718, DOI 10.1378/chest.06-2756; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Moran A., 1999, Diabetes Research and Clinical Practice, V45, P61, DOI 10.1016/S0168-8227(99)00058-3; Razvi S, 2009, CHEST, V136, P1554, DOI 10.1378/chest.09-0132; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Sawicki GS, 2008, PEDIATR PULM, V43, P1117, DOI 10.1002/ppul.20914; Schechter MS, 2001, AM J RESP CRIT CARE, V163, P1331, DOI 10.1164/ajrccm.163.6.9912100; THERNEAU TM, 2000, STAT BIOL HEALTH, pR7; Thiebaut ACM, 2004, STAT MED, V23, P3803, DOI 10.1002/sim.2098; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.3.CO;2-I; VANDENBRANDEN SL, 2007, PEDIAT PULMONOL S30, V42, pS365; WANG XB, 1993, PEDIATR PULM, V15, P75, DOI 10.1002/ppul.1950150204; Yankaskas JR, 2004, CHEST, V125, p1S, DOI 10.1378/chest.125.1_suppl.1S	21	249	251	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 16	2010	303	23					2386	2392		10.1001/jama.2010.791	http://dx.doi.org/10.1001/jama.2010.791			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	610TE	20551409	Bronze			2022-12-01	WOS:000278759200028
J	Spence, D				Spence, Des			From the Frontline Compulsive doing: sport in childhood	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2010	340								c3071	10.1136/bmj.c3071	http://dx.doi.org/10.1136/bmj.c3071			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611MD	20534680				2022-12-01	WOS:000278818500008
J	Aragao, LEOC; Shimabukuro, YE				Aragao, Luiz E. O. C.; Shimabukuro, Yosio E.			The Incidence of Fire in Amazonian Forests with Implications for REDD	SCIENCE			English	Article							CLIMATE-CHANGE; DEFORESTATION; EMISSIONS; REGROWTH; BIOMASS; DIEBACK; CARBON	Reducing emissions from deforestation and degradation (REDD) may curb carbon emissions, but the consequences for fire hazard are poorly understood. By analyzing satellite-derived deforestation and fire data from the Brazilian Amazon, we show that fire occurrence has increased in 59% of the area that has experienced reduced deforestation rates. Differences in fire frequencies across two land-use gradients reveal that fire-free land-management can substantially reduce fire incidence by as much as 69%. If sustainable fire-free land-management of deforested areas is not adopted in the REDD mechanism, then the carbon savings achieved by avoiding deforestation may be partially negated by increased emissions from fires.	[Aragao, Luiz E. O. C.] Univ Exeter, Sch Geog, Landscape & Ecosyst Dynam Grp, Exeter EX4 4RJ, Devon, England; [Shimabukuro, Yosio E.] Natl Inst Space Res, Remote Sensing Div, BR-12227010 Sao Paulo, Brazil	University of Exeter; Instituto Nacional de Pesquisas Espaciais (INPE)	Aragao, LEOC (corresponding author), Univ Exeter, Sch Geog, Landscape & Ecosyst Dynam Grp, Amory Bldg,Rennes Dr, Exeter EX4 4RJ, Devon, England.	l.aragao@exeter.ac.uk	Shimabukuro, Yosio E/F-2956-2012; aragao, luiz eoc/G-8387-2012	Shimabukuro, Yosio E/0000-0002-1469-8433; aragao, luiz eoc/0000-0002-4134-6708	U.K. Natural Environment Research Council [NE/F015356/2]; NERC [NE/F015356/2] Funding Source: UKRI; Natural Environment Research Council [NE/F015356/2] Funding Source: researchfish	U.K. Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the U.K. Natural Environment Research Council for providing funds to L.E.O.C.A. (NE/F015356/2). We acknowledge the valuable discussions with L. Anderson, T. Quine, and P. Cox during elaboration of this manuscript and thank A. Lima for providing the MODIS fire data set for the supporting analysis. We thank the Brazilian Institute for Space Research for making available their deforestation and fire data sets and the European Commission's Joint Research Centre for making available their land cover map.	Alves DS, 2002, INT J REMOTE SENS, V23, P2903, DOI 10.1080/01431160110096791; Aragao LEOC, 2008, PHILOS T R SOC B, V363, P1779, DOI 10.1098/rstb.2007.0026; Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946, 10.1029/2006GL028946.]; Barlow J, 2008, PHILOS T R SOC B, V363, P1787, DOI 10.1098/rstb.2007.0013; Broadbent EN, 2008, BIOL CONSERV, V141, P1745, DOI 10.1016/j.biocon.2008.04.024; Carvalho GO, 2002, ENVIRONMENT, V44, P34, DOI 10.1080/00139150209605606; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Cochrane MA, 2003, NATURE, V421, P913, DOI 10.1038/nature01437; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; DeFries RS, 2002, P NATL ACAD SCI USA, V99, P14256, DOI 10.1073/pnas.182560099; Denich M, 2005, AGR ECOSYST ENVIRON, V110, P43, DOI 10.1016/j.agee.2005.05.005; Eva H, 2000, J BIOGEOGR, V27, P765, DOI 10.1046/j.1365-2699.2000.00441.x; Eva HD, 2004, GLOBAL CHANGE BIOL, V10, P731, DOI 10.1111/j.1529-8817.2003.00774.x; Ewers RM, 2008, ENVIRON CONSERV, V35, P303, DOI 10.1017/S0376892908005122; Fearnside PM, 2007, FOREST ECOL MANAG, V242, P678, DOI 10.1016/j.foreco.2007.02.002; Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; Houghton RA, 2000, NATURE, V403, P301, DOI 10.1038/35002062; *INPE, PRODES PROGR DEF ASS; *INPE, 2006, QUEIM PROJ; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Morton DC, 2008, GLOBAL CHANGE BIOL, V14, P2262, DOI 10.1111/j.1365-2486.2008.01652.x; Neeff T, 2006, ECOSYSTEMS, V9, P609, DOI 10.1007/s10021-006-0001-9; Nepstad D, 2004, GLOBAL CHANGE BIOL, V10, P704, DOI 10.1111/j.1529-8817.2003.00772.x; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Rodrigues ASL, 2009, SCIENCE, V324, P1435, DOI 10.1126/science.1174002; Saatchi SS, 2007, GLOBAL CHANGE BIOL, V13, P816, DOI 10.1111/j.1365-2486.2007.01323.x; van der Werf GR, 2009, NAT GEOSCI, V2, P737, DOI 10.1038/ngeo671	29	200	205	6	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2010	328	5983					1275	1278		10.1126/science.1186925	http://dx.doi.org/10.1126/science.1186925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522775				2022-12-01	WOS:000278318600034
J	Garaj, S; Hubbard, W; Reina, A; Kong, J; Branton, D; Golovchenko, JA				Garaj, S.; Hubbard, W.; Reina, A.; Kong, J.; Branton, D.; Golovchenko, J. A.			Graphene as a subnanometre trans-electrode membrane	NATURE			English	Article							CARBON NANOTUBES; LARGE-AREA; DNA; NANOPORES; MOLECULES; WATER	Isolated, atomically thin conducting membranes of graphite, called graphene, have recently been the subject of intense research with the hope that practical applications in fields ranging from electronics to energy science will emerge(1). The atomic thinness, stability and electrical sensitivity of graphene motivated us to investigate the potential use of graphene membranes and graphene nanopores to characterize single molecules of DNA in ionic solution. Here we show that when immersed in an ionic solution, a layer of graphene becomes a new electrochemical structure that we call a transelectrode. The trans-electrode's unique properties are the consequence of the atomic-scale proximity of its two opposing liquid-solid interfaces together with graphene's well known inplane conductivity. We show that several trans-electrode properties are revealed by ionic conductance measurements on a graphene membrane that separates two aqueous ionic solutions. Although our membranes are only one to two atomic layers(2,3) thick, we find they are remarkable ionic insulators with a very small stable conductance that depends on the ion species in solution. Electrical measurements on graphene membranes in which a single nanopore has been drilled show that the membrane's effective insulating thickness is less than one nanometre. This small effective thickness makes graphene an ideal substrate for very high resolution, high throughput nanopore-based single-molecule detectors. The sensitivity of graphene's in-plane electronic conductivity to its immediate surface environment and trans-membrane solution potentials will offer new insights into atomic surface processes and sensor development opportunities.	[Garaj, S.; Golovchenko, J. A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Hubbard, W.; Golovchenko, J. A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Reina, A.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Kong, J.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Branton, D.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University	Golovchenko, JA (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	sgaraj@fas.harvard.edu; golovchenko@physics.harvard.edu	Garaj, Slaven/B-9782-2013; Garaj, Slaven/AAA-9824-2020	Garaj, Slaven/0000-0001-5529-4040; Hubbard, William/0000-0002-2924-0820	National Human Genome Research Institute, National Institutes of Health [R01 HG003703]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003703] Funding Source: NIH RePORTER	National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by a grant (number R01 HG003703) to J.A.G. and D.B. from the National Human Genome Research Institute, National Institutes of Health.	Alexiadis A, 2008, CHEM REV, V108, P5014, DOI 10.1021/cr078140f; Bard A.J., 2001, ELECTROCHEMICAL METH, P534; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; HALL JE, 1975, J GEN PHYSIOL, V66, P531, DOI 10.1085/jgp.66.4.531; Hille B., 2001, ION CHANNELS EXCITAB; Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298; Hoogerheide DP, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.256804; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Li JL, 2003, NAT MATER, V2, P611, DOI 10.1038/nmat965; Liu HT, 2010, SCIENCE, V327, P64, DOI 10.1126/science.1181799; MERCHANT CA, 2010, NANO LETT, DOI DOI 10.1021/NL101046T; Reina A, 2009, NANO RES, V2, P509, DOI 10.1007/s12274-009-9059-y; Reina A, 2009, NANO LETT, V9, P30, DOI 10.1021/nl801827v; Schneider GF, 2010, NANO LETT, V10, P3163, DOI [10.1021/nl102069z, 10.1021/nl101046t]; Sint K, 2008, J AM CHEM SOC, V130, P16448, DOI 10.1021/ja804409f; Storm AJ, 2003, NAT MATER, V2, P537, DOI 10.1038/nmat941; Werder T, 2003, J PHYS CHEM B, V107, P1345, DOI 10.1021/jp0268112; Zwolak M, 2008, REV MOD PHYS, V80, P141, DOI 10.1103/RevModPhys.80.141; Zwolak M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.128102	21	1083	1179	31	1051	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 9	2010	467	7312					190	U73		10.1038/nature09379	http://dx.doi.org/10.1038/nature09379			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20720538	Green Submitted, Green Accepted			2022-12-01	WOS:000281616300030
J	Lee, CC; Hu, YL; Ribbe, MW				Lee, Chi Chung; Hu, Yilin; Ribbe, Markus W.			Vanadium Nitrogenase Reduces CO	SCIENCE			English	Article							CHEMISTRY; MECHANISM		[Lee, Chi Chung; Hu, Yilin; Ribbe, Markus W.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Hu, YL (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.	yilinh@uci.edu; mribbe@uci.edu			Herman Frasch Foundation [617-HF07]; NIH [GM-67626]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067626] Funding Source: NIH RePORTER	Herman Frasch Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. C. Rees of Caltech (Pasadena) for help on the GC-MS analysis. This work was supported by Herman Frasch Foundation grant 617-HF07 (M. W. R.) and NIH grant GM-67626 (M.W.R.).	Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Hill HGM, 2003, ASTROBIOLOGY, V3, P291, DOI 10.1089/153110703769016389; ROBSON RL, 1986, NATURE, V322, P388, DOI 10.1038/322388a0; ROFERDEPOORTER CK, 1981, CHEM REV, V81, P447, DOI 10.1021/cr00045a002; Schlogl R, 2003, ANGEW CHEM INT EDIT, V42, P2004, DOI 10.1002/anie.200301553	6	186	187	3	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					642	642		10.1126/science.1191455	http://dx.doi.org/10.1126/science.1191455			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689010	Green Accepted			2022-12-01	WOS:000280602700028
J	Krumholz, HM; Hayward, RA				Krumholz, Harlan M.; Hayward, Rodney A.			Shifting views on lipid lowering therapy	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; STATIN THERAPY; HEART-FAILURE; CANCER-RISK; METAANALYSIS; DISEASE; CHOLESTEROL; PREVENTION; EZETIMIBE; HYPERCHOLESTEROLEMIA		[Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Hayward, Rodney A.] VA Med Ctr, Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA; [Hayward, Rodney A.] Univ Michigan, Dept Internal Med, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Hayward, Rodney A.] Univ Michigan, Dept Internal Med, Sch Med, Ann Arbor, MI 48109 USA	Yale University; Yale University; Yale University; Yale University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Krumholz, HM (corresponding author), Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06510 USA.	harlan.krumholz@yale.edu	, Harlan/AAI-2875-2020					Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Blum A, 2009, ATHEROSCLEROSIS, V203, P325, DOI 10.1016/j.atherosclerosis.2008.08.022; Bonovas S, 2006, J CLIN ONCOL, V24, P4808, DOI 10.1200/JCO.2006.06.3560; *BRIDG EXC, COR ART DIS CAR LINK; Brugts JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2376; Cannon CP, 2010, LANCET, V375, P700, DOI 10.1016/S0140-6736(10)60234-6; Dale KM, 2006, JAMA-J AM MED ASSOC, V295, P74, DOI 10.1001/jama.295.1.74; Hayward RA, 2006, ANN INTERN MED, V145, P520, DOI 10.7326/0003-4819-145-7-200610030-00010; Hayward RA, 2010, ANN INTERN MED, V152, P69, DOI 10.7326/0003-4819-152-2-201001190-00004; Jackevicius CA, 2008, NEW ENGL J MED, V358, P1819, DOI 10.1056/NEJMsa0801461; Josan K, 2008, CAN MED ASSOC J, V178, P576, DOI 10.1503/cmaj.070675; Kashani A, 2006, CIRCULATION, V114, P2788, DOI 10.1161/CIRCULATIONAHA.106.624890; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Kjekshus J, 2007, NEW ENGL J MED, V357, P2248, DOI 10.1056/NEJMoa0706201; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lee TH, 2000, JAMA-J AM MED ASSOC, V283, P94, DOI 10.1001/jama.283.1.94; *NAT HEART LUNG BL, 2001, DET EV TREATM HIGH B; PETTYPIECE S, 2008, BLOOMBERG       0116; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Steinberg D, 2008, CIRCULATION, V118, P672, DOI 10.1161/CIRCULATIONAHA.107.753152; Tavazzi L, 2008, LANCET, V372, P1231, DOI 10.1016/S0140-6736(08)61240-4; Zulman DM, 2008, MILBANK Q, V86, P557, DOI 10.1111/j.1468-0009.2008.00534.x; 1988, ARCH INTERN MED, V148, P36	25	12	12	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 28	2010	341								c3531	10.1136/bmj.c3531	http://dx.doi.org/10.1136/bmj.c3531			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	634GZ	20667950				2022-12-01	WOS:000280570100001
J	Holzel, M; Huang, SD; Koster, J; Ora, I; Lakeman, A; Caron, H; Nijkamp, W; Xie, J; Callens, T; Asgharzadeh, S; Seeger, RC; Messiaen, L; Versteeg, R; Bernards, R				Holzel, Michael; Huang, Sidong; Koster, Jan; Ora, Ingrid; Lakeman, Arjan; Caron, Huib; Nijkamp, Wouter; Xie, Jing; Callens, Tom; Asgharzadeh, Shahab; Seeger, Robert C.; Messiaen, Ludwine; Versteeg, Rogier; Bernards, Rene			NF1 Is a Tumor Suppressor in Neuroblastoma that Determines Retinoic Acid Response and Disease Outcome	CELL			English	Article							HIGH-RISK NEUROBLASTOMA; NEUROFIBROMATOSIS TYPE-1; NOONAN-SYNDROME; INDUCED DIFFERENTIATION; 13-CIS-RETINOIC ACID; GENE-MUTATIONS; CHROMOSOME 1P; NIH3T3 CELLS; RAR-ALPHA; EXPRESSION	Retinoic acid (RA) induces differentiation of neuroblastoma cells in vitro and is used with variable success to treat aggressive forms of this disease. This variability in clinical response to RA is enigmatic, as no mutations in components of the RA signaling cascade have been found. Using a large-scale RNAi genetic screen, we identify crosstalk between the tumor suppressor NF1 and retinoic acid-induced differentiation in neuroblastoma. Loss of NF1 activates RAS-MEK signaling, which in turn represses ZNF423, a critical transcriptional coactivator of the retinoic acid receptors. Neuroblastomas with low levels of both NF1 and ZNF423 have extremely poor outcome. We find NF1 mutations in neuroblastoma cell lines and in primary tumors. Inhibition of MEK signaling downstream of NF1 restores responsiveness to RA, suggesting a therapeutic strategy to overcome RA resistance in NF1-deficient neuroblastomas.	[Holzel, Michael; Huang, Sidong; Nijkamp, Wouter; Bernards, Rene] Netherlands Canc Inst, Ctr Biomed Genet, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; [Holzel, Michael; Huang, Sidong; Nijkamp, Wouter; Bernards, Rene] Netherlands Canc Inst, Ctr Biomed Genet, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Holzel, Michael; Huang, Sidong; Nijkamp, Wouter; Bernards, Rene] Netherlands Canc Inst, Canc Genom Ctr, NL-1066 CX Amsterdam, Netherlands; [Koster, Jan; Ora, Ingrid; Lakeman, Arjan; Versteeg, Rogier] Univ Amsterdam, Acad Med Ctr, Dept Human Genet, NL-1100 DE Amsterdam, Netherlands; [Caron, Huib] Univ Amsterdam, Acad Med Ctr, Dept Pediat Oncol, NL-1100 DE Amsterdam, Netherlands; [Asgharzadeh, Shahab; Seeger, Robert C.] Univ So Calif, Childrens Hosp Los Angeles, Div Hematol Oncol, Dept Pediat, Los Angeles, CA 90027 USA; [Asgharzadeh, Shahab; Seeger, Robert C.] Univ So Calif, Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Xie, Jing; Callens, Tom; Messiaen, Ludwine] Univ Alabama, Med Genom Lab, Dept Genet, Birmingham, AL 35294 USA	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California; University of Alabama System; University of Alabama Birmingham	Bernards, R (corresponding author), Netherlands Canc Inst, Ctr Biomed Genet, Div Mol Carcinogenesis, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.bernards@nki.nl	Øra, Ingrid/J-2596-2013; Koster, Jan/C-5934-2008; Versteeg, Rogier/AAQ-1765-2020	Øra, Ingrid/0000-0002-3931-4125; Koster, Jan/0000-0002-0890-7585; Huang, Sidong/0000-0002-2838-4726; Asgharzadeh, Shahab/0000-0002-0510-3848; Bernards, Rene/0000-0001-8677-3423; Versteeg, Rogier/0000-0001-7172-0388	Netherlands Genomics Initiative (NGI); US National Institutes of Health [R01-CA60104, K12-CA60104]; Dutch Cancer Society; NATIONAL CANCER INSTITUTE [R01CA060104] Funding Source: NIH RePORTER	Netherlands Genomics Initiative (NGI); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Cancer Society(KWF Kankerbestrijding); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Hauptmann for statistical advice, the NKI microarray facility for supporting gene expression studies, and C. Sun for assistance. This work was supported by The Netherlands Genomics Initiative (NGI), grants from the US National Institutes of Health R01-CA60104 (R.C.S.) and K12-CA60104 (S.A.), and a grant from the Dutch Cancer Society (KWF).	Antonyak MA, 2003, J BIOL CHEM, V278, P15859, DOI 10.1074/jbc.M300037200; Asgharzadeh S, 2006, JNCI-J NATL CANCER I, V98, P1193, DOI 10.1093/jnci/djj330; Attiyeh EF, 2005, NEW ENGL J MED, V353, P2243, DOI 10.1056/NEJMoa052399; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Bruck N, 2009, EMBO J, V28, P34, DOI 10.1038/emboj.2008.256; Brummelkamp TR, 2006, NAT CHEM BIOL, V2, P202, DOI 10.1038/nchembio774; BUNONE G, 1995, EXP CELL RES, V217, P92, DOI 10.1006/excr.1995.1067; Caron H, 1996, NEW ENGL J MED, V334, P225, DOI 10.1056/NEJM199601253340404; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; COTTON JL, 1995, ARCH PEDIAT ADOL MED, V149, P1280, DOI 10.1001/archpedi.1995.02170240098019; Delaune A, 2008, J NEUROCHEM, V104, P89, DOI 10.1111/j.1471-4159.2007.05019.x; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Epping MT, 2005, CELL, V122, P835, DOI 10.1016/j.cell.2005.07.003; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; Gianni M, 2006, EMBO J, V25, P739, DOI 10.1038/sj.emboj.7600981; Griffiths S, 2007, FAM CANCER, V6, P21, DOI 10.1007/s10689-006-9001-3; Huang SD, 2009, CANCER CELL, V15, P328, DOI 10.1016/j.ccr.2009.02.023; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; KOSA K, 1995, CANCER RES, V55, P4850; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Martinsson T, 1997, CANCER GENET CYTOGEN, V95, P183, DOI 10.1016/S0165-4608(96)00259-2; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; McCaffery PJ, 2003, EUR J NEUROSCI, V18, P457, DOI 10.1046/j.1460-9568.2003.02765.x; McGillicuddy LT, 2009, CANCER CELL, V16, P44, DOI 10.1016/j.ccr.2009.05.009; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N; MOLEY JF, 1991, CANCER RES, V51, P1596; Mosse YP, 2009, CLIN CANCER RES, V15, P5609, DOI 10.1158/1078-0432.CCR-08-2762; Oberthuer A, 2006, J CLIN ONCOL, V24, P5070, DOI 10.1200/JCO.2006.06.1879; Origone P, 2003, AM J MED GENET A, V118A, P309, DOI 10.1002/ajmg.a.10167; Quinlan MP, 2008, MOL CELL BIOL, V28, P2659, DOI 10.1128/MCB.01661-07; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; SIDELL N, 1983, EXP CELL RES, V148, P21, DOI 10.1016/0014-4827(83)90184-2; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; THE I, 1993, NAT GENET, V3, P62, DOI 10.1038/ng0193-62; Tong JY, 2002, NAT NEUROSCI, V5, P95, DOI 10.1038/nn792; van Limpt V, 2004, ONCOGENE, V23, P9280, DOI 10.1038/sj.onc.1208157; Verheijen MHG, 1999, J BIOL CHEM, V274, P1487, DOI 10.1074/jbc.274.3.1487; Wimmer K, 2006, GENE CHROMOSOME CANC, V45, P265, DOI 10.1002/gcc.20289; Zatkova A, 2004, HUM MUTAT, V24, P491, DOI 10.1002/humu.20103	45	130	137	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					218	229		10.1016/j.cell.2010.06.004	http://dx.doi.org/10.1016/j.cell.2010.06.004			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655465	Bronze, Green Accepted			2022-12-01	WOS:000280204300014
J	Power, M; Wigglesworth, N; Donaldson, E; Chadwick, P; Gillibrand, S; Goldmann, D				Power, Maxine; Wigglesworth, Neil; Donaldson, Emma; Chadwick, Paul; Gillibrand, Stephen; Goldmann, Donald			Quality Improvement Report Reducing Clostridium difficile infection in acute care by using an improvement collaborative	BRITISH MEDICAL JOURNAL			English	Article							DIARRHEA	Problem In 2006, despite a focus on infection control, Salford Royal had the fourth highest rate of Clostridium difficile infection in north west England. Design Interrupted time series in five collaborative wards ( intervention group) and 35 non-collaborative wards ( control group). Setting University teaching hospital with 850 acute beds. Key measures for improvement Number of cases of C difficile infection per 1000 occupied bed days. Strategies for change In February 2007, a newly formed antimicrobial team led the implementation of revised guidelines in all wards and departments. From March to December 2007, five wards participated in an improvement collaborative. Since December 2007, the changes from the collaborative have been collated and implemented throughout the organisation. Effects of change At baseline the non-collaborative wards had 1.15 (95% CI 1.03 to 1.29) cases per 1000 occupied bed days. In August 2007 cases reduced 56% from baseline (0.51, 0.44 to 0.60), which has been maintained since that time. In the collaborative wards, there were 2.60 (2.11 to 3.17) cases per 1000 occupied bed days at baseline. A shift occurred in April 2007 representing a reduction of 73% (0.69, 0.50 to 0.91) from baseline, which has been maintained. Lessons learnt Careful use of antimicrobial drugs is important in reducing the number of cases of C difficile infection. A collaborative learning model can enable teams to test and implement changes that can accelerate, amplify, and sustain control of C difficile.	[Power, Maxine] Dept Hlth, London SE1 6LH, England; [Wigglesworth, Neil] NHS E Lancashire, Nelson BB9 8AS, Lancs, England; [Donaldson, Emma; Chadwick, Paul; Gillibrand, Stephen] Salford Royal NHS Fdn Trust, Salford M6 8HD, Lancs, England; [Goldmann, Donald] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Goldmann, Donald] Inst Healthcare Improvement, Cambridge, MA 02138 USA	Salford Royal NHS Foundation Trust; Harvard University; Harvard T.H. Chan School of Public Health; Institute for Healthcare Improvement	Power, M (corresponding author), Dept Hlth, London SE1 6LH, England.	maxine.power@dh.gsi.gov.uk	Donaldson, Emma/AAT-4254-2021	Donaldson, Emma/0000-0002-8052-6744				[Anonymous], 2003, BREAKTHR SER IHIS CO; *DEP HLTH, 1994, CLOSTR DIFF INF PREV; *DEP HLTH HLTH PRO, 2009, CLOSTR DIFF INF DEAL; Health Protection Agency, RES MAND CLOSTR DIFF; *HLTH PROT AG, 2009, C DIFF MAND SURV N W; Hurley BW, 2002, ARCH INTERN MED, V162, P2177, DOI 10.1001/archinte.162.19.2177; Langley G, 2009, IMPROVEMENT GUIDE PR; Mohammed MA, 2008, QUAL SAF HEALTH CARE, V17, P137, DOI 10.1136/qshc.2004.012047; Mylonakis E, 2001, ARCH INTERN MED, V161, P525, DOI 10.1001/archinte.161.4.525	9	14	14	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2010	341								c3359	10.1136/bmj.c3359	http://dx.doi.org/10.1136/bmj.c3359			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632GW	20659985				2022-12-01	WOS:000280411700001
J	Wang, J; Chen, PJ; Wang, GJ; Keller, L				Wang, John; Chen, Pei-Jiun; Wang, George J.; Keller, Laurent			Chromosome Size Differences May Affect Meiosis and Genome Size	SCIENCE			English	Article									[Wang, John; Keller, Laurent] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Chen, Pei-Jiun] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Wang, George J.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Wang, George J.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	University of Lausanne; University of Lausanne; Howard Hughes Medical Institute; Stanford University; Stanford University	Wang, J (corresponding author), Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland.	John.Wang@unil.ch; Laurent.Keller@unil.ch	Wang, John/C-3690-2012; keller, laurent/AAI-7175-2020	Wang, John/0000-0002-6179-775X; keller, laurent/0000-0002-5046-9953	NIH National Center for Research Resources; University of Lausanne Cellular Imaging Facility; Vital-IT Center for high-performance computing; Swiss National Science Foundation	NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of Lausanne Cellular Imaging Facility; Vital-IT Center for high-performance computing; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank W. Herr, P. Gonczy, A. W. Murray, and A. M. Villeneuve for comments on the manuscript; S. K. Kim and R. E. Ellis for discussions; W. Herr, in whose laboratory the experiments were performed; the Caenorhabditis Genetics Center, funded by the NIH National Center for Research Resources, for strains; the University of Lausanne Cellular Imaging Facility; and the Vital-IT Center for high-performance computing. Supported by grants from the Swiss National Science Foundation to L.K. and W. Herr. L.K. thanks S. Leibler for hosting him during his sabbatical at Rockefeller University.	Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Haag ES, 2007, TRENDS GENET, V23, P101, DOI 10.1016/j.tig.2007.01.002; Kiontke K, 2004, P NATL ACAD SCI USA, V101, P9003, DOI 10.1073/pnas.0403094101; LYTTLE TW, 1991, ANNU REV GENET, V25, P511, DOI 10.1146/annurev.ge.25.120191.002455; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045	6	27	30	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2010	329	5989					293	293		10.1126/science.1190130	http://dx.doi.org/10.1126/science.1190130			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647459	Green Published			2022-12-01	WOS:000279925900031
J	Trivedi, B				Trivedi, Bijal			Learning from the elite	NATURE			English	Editorial Material																		Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609	3	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S4	S4		10.1038/nature09235	http://dx.doi.org/10.1038/nature09235			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631703				2022-12-01	WOS:000279867100024
J	Garcia-Pino, A; Balasubramanian, S; Wyns, L; Gazit, E; De Greve, H; Magnuson, RD; Charlier, D; van Nuland, NAJ; Loris, R				Garcia-Pino, Abel; Balasubramanian, Sreeram; Wyns, Lode; Gazit, Ehud; De Greve, Henri; Magnuson, Roy D.; Charlier, Daniel; van Nuland, Nico A. J.; Loris, Remy			Allostery and Intrinsic Disorder Mediate Transcription Regulation by Conditional Cooperativity	CELL			English	Article							PLASMID ADDICTION SYSTEM; SCATTERING DATA-ANALYSIS; X-RAY-SCATTERING; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; YEFM ANTITOXIN; TOXIN; PHD; PROTEIN; REPRESSOR	Regulation of the phd/doc toxin-antitoxin operon involves the toxin Doc as co- or derepressor depending on the ratio between Phd and Doc, a phenomenon known as conditional cooperativity. The mechanism underlying this observed behavior is not understood. Here we show that monomeric Doc engages two Phd dimers on two unrelated binding sites. The binding of Doc to the intrinsically disordered C-terminal domain of Phd structures its N-terminal DNA-binding domain, illustrating allosteric coupling between highly disordered and highly unstable domains. This allosteric effect also couples Doc neutralization to the conditional regulation of transcription. In this way, higher levels of Doc tighten repression up to a point where the accumulation of toxin triggers the production of Phd to counteract its action. Our experiments provide the basis for understanding the mechanism of conditional cooperative regulation of transcription typical of toxin-antitoxin modules. This model may be applicable for the regulation of other biological systems.	[Garcia-Pino, Abel; Wyns, Lode; De Greve, Henri; Charlier, Daniel; van Nuland, Nico A. J.; Loris, Remy] Vrije Univ Brussel, B-1050 Brussels, Belgium; [Garcia-Pino, Abel; Wyns, Lode; De Greve, Henri; van Nuland, Nico A. J.; Loris, Remy] Free Univ Brussels VIB, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium; [Balasubramanian, Sreeram; Magnuson, Roy D.] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA; [Gazit, Ehud] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; University of Alabama System; University of Alabama Huntsville; Tel Aviv University	Garcia-Pino, A (corresponding author), Vrije Univ Brussel, Pl Laan 2, B-1050 Brussels, Belgium.	agarciap@vub.ac.be; reloris@vub.ac.be	Gazit, Ehud/AHE-9332-2022; Gazit, Ehud/M-8026-2019; Loris, Remy/GPG-0894-2022; Gazit, Ehud/C-3715-2011	Gazit, Ehud/0000-0001-5764-1720; Gazit, Ehud/0000-0001-5764-1720; Charlier, Daniel/0000-0002-6844-376X; Garcia-Pino, Abel/0000-0002-0634-0300; Loris, Remy/0000-0002-8862-3338	Vlaams Interuniversitair Instituut voor Biotechnologie (VIB); Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO); Onderzoeksraad of the Vrije Universiteit Brussel; NIH NIGMS [2R15GM067668-03, 2R15GM067668-04]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM067668] Funding Source: NIH RePORTER	Vlaams Interuniversitair Instituut voor Biotechnologie (VIB); Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); Onderzoeksraad of the Vrije Universiteit Brussel; NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge financial support from the Vlaams Interuniversitair Instituut voor Biotechnologie (VIB), the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO), the Onderzoeksraad of the Vrije Universiteit Brussel, and NIH NIGMS grants 2R15GM067668-03 and 2R15GM067668-04. The authors acknowledge the use of beamtime at the EMBL beamlines at the DESY (Hamburg, Germany) synchrotron and at the ESRF (Grenoble, France) and SOLEIL (Gif-sur-Yvette, France) synchrotrons. The authors thank Dr. P. Pernot (ESRF) for assistance with the collection of SAXS data and K. Wahni and S. Haesarts for technical support with protein purification.	Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; Afonine P., 2005, CCP4 NEWSL, V42, P1; Albright RA, 1998, P NATL ACAD SCI USA, V95, P3431, DOI 10.1073/pnas.95.7.3431; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Dao-Thi MH, 2002, J BIOL CHEM, V277, P3733, DOI 10.1074/jbc.M105505200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Jonge N, 2009, MOL CELL, V35, P154, DOI 10.1016/j.molcel.2009.05.025; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia-Pino A, 2008, J BIOL CHEM, V283, P30821, DOI 10.1074/jbc.M805654200; Gazit E, 1999, J BIOL CHEM, V274, P2652, DOI 10.1074/jbc.274.5.2652; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kumar P, 2008, J MOL BIOL, V383, P482, DOI 10.1016/j.jmb.2008.08.067; Lawrence JG, 2003, ANNU REV MICROBIOL, V57, P419, DOI 10.1146/annurev.micro.57.030502.090816; LEHNHERR H, 1993, J MOL BIOL, V233, P414, DOI 10.1006/jmbi.1993.1521; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; Madl T, 2006, J MOL BIOL, V364, P170, DOI 10.1016/j.jmb.2006.08.082; Magnuson R, 1998, J BACTERIOL, V180, P6342; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McKinley JE, 2005, J BACTERIOL, V187, P765, DOI 10.1128/JB.187.2.765-770.2005; Monti MC, 2007, NUCLEIC ACIDS RES, V35, P1737, DOI 10.1093/nar/gkm073; Oberer M, 2007, PROTEIN SCI, V16, P1676, DOI 10.1110/ps.062680707; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pollack L, 1999, P NATL ACAD SCI USA, V96, P10115, DOI 10.1073/pnas.96.18.10115; Porod G., 1982, GEN THEORY SMALL ANG; Smith JA, 2004, J BACTERIOL, V186, P2692, DOI 10.1128/JB.186.9.2692-2698.2004; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Zhao XY, 2005, J BACTERIOL, V187, P1901, DOI 10.1128/JB.187.6.1901-1912.2005	38	187	191	0	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 9	2010	142	1					101	111		10.1016/j.cell.2010.05.039	http://dx.doi.org/10.1016/j.cell.2010.05.039			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603017	Bronze			2022-12-01	WOS:000279637300016
J	Girard, F; Ford, N; Montaner, J; Cahn, P; Katabira, E				Girard, Francoise; Ford, Nathan; Montaner, Julio; Cahn, Pedro; Katabira, Elly			Universal Access in the Fight Against HIV/AIDS	SCIENCE			English	Editorial Material							GLOBAL HEALTH INITIATIVES; ANTIRETROVIRAL THERAPY; PROSPECTIVE COHORT; HIV TRANSMISSION; SYSTEMS; CHILDREN; POLICY		[Girard, Francoise] Open Soc Inst, Publ Hlth Program, New York, NY 10019 USA; [Ford, Nathan] Med Sans Frontieres, ZA-2017 Cape Town, South Africa; [Montaner, Julio] Univ British Columbia, Div Aids, Vancouver, BC V6Z 1Y6, Canada; [Cahn, Pedro] Fdn Huesped, Buenos Aires, DF, Argentina; [Katabira, Elly] Makerere Med Sch, Dept Res, Kampala, Uganda	University of British Columbia; Makerere University	Girard, F (corresponding author), Open Soc Inst, Publ Hlth Program, New York, NY 10019 USA.	fgirard@sorosny.org	Montaner, Julio/K-7621-2012		NIDA NIH HHS [DP1 DA026182] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026182] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bendavid E, 2009, ANN INTERN MED, V150, P688, DOI 10.7326/0003-4819-150-10-200905190-00117; Bender MA, 2010, CLIN INFECT DIS, V50, P416, DOI 10.1086/649884; Biesma RG, 2009, HEALTH POLICY PLANN, V24, P239, DOI 10.1093/heapol/czp025; Braitstein P, 2009, PEDIATR INFECT DIS J, V28, P626, DOI 10.1097/INF.0b013e31819665c5; BUFFERY V, 2010, REUTERS         0217; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; England R, 2007, BRIT MED J, V335, P565, DOI 10.1136/bmj.39335.520463.94; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; *GFATM, GFATM REP SPEND 30 I; *GFATM, 2009, SCAL IMP RES REP; *GFATM, 2010, RES SCEN 2011 2013 F; *GFATM, 2010, GLOB FUND 2010 INN I; Goemaere E, 2002, LANCET, V360, P86, DOI 10.1016/S0140-6736(02)09343-1; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Lima VD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010991; Mccoy D, 2010, B WORLD HEALTH ORGAN, V88, P478, DOI 10.2471/BLT.09.074419; MCNEILL DG, 2010, NY TIMES        0510, pA10; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; MIDDELKOOP K, 2009, 5 INT AIDS SOC C HIV; MSF, 2009, PUN SUCC EARL SIGNS; Piot P, 2009, LANCET, V374, P260, DOI 10.1016/S0140-6736(09)60321-4; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; STOCKMAN F, 2010, BOSTON GLOBE    0411, pA1; UNAIDS, 2009, WHAT COUNTR NEED INV; United Nations, 2006, ARES60262 UN; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; *WHO UNAIDS UNICEF, 2009, UN ACC SCAL PRIOR IN, P26; World Bank, 2009, IMPROVING EFFECTIVENESS AND OUTCOMES FOR THE POOR IN HEALTH, NUTRITION, AND POPULATION: AN EVALUATION OF WORLD BANK GROUP SUPPORT SINCE 1997, P1, DOI 10.1596/978-0-8213-7542-6; World Health Organisation (WHO), 2007, TOP 10 CAUS DEATH FA	32	5	6	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988					147	149		10.1126/science.1193294	http://dx.doi.org/10.1126/science.1193294			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	622CB	20616254				2022-12-01	WOS:000279635200021
J	Ricklefs, RE; Outlaw, DC				Ricklefs, Robert E.; Outlaw, Diana C.			A Molecular Clock for Malaria Parasites	SCIENCE			English	Article							AVIAN MALARIA; CO-SPECIATION; EVOLUTION; PLASMODIUM; PREVALENCE; PHYLOGENY; PATTERNS; ORIGIN; GENERA	The evolutionary origins of new lineages of pathogens are fundamental to understanding emerging diseases. Phylogenetic reconstruction based on DNA sequences has revealed the sister taxa of human pathogens, but the timing of host-switching events, including the human malaria pathogen Plasmodium falciparum, remains controversial. Here, we establish a rate for cytochrome b evolution in avian malaria parasites relative to its rate in birds. We found that the parasite cytochrome b gene evolves about 60% as rapidly as that of host cytochrome b, corresponding to similar to 1.2% sequence divergence per million years. This calibration puts the origin of P. falciparum at 2.5 million years ago (Ma), the initial radiation of mammalian Plasmodium at 12.8 Ma, and the contemporary global diversity of the Haemosporida across terrestrial vertebrates at 16.2 Ma.	[Ricklefs, Robert E.; Outlaw, Diana C.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA	University of Missouri System; University of Missouri Saint Louis	Ricklefs, RE (corresponding author), Univ Missouri, Dept Biol, 1 Univ Blvd, St Louis, MO 63121 USA.	ricklefs@umsl.edu			NSF [DEB 0542390]; University of Missouri; Alexander von Humboldt Foundation	NSF(National Science Foundation (NSF)); University of Missouri; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We thank S. S. Renner and two anonymous reviewers for constructive comments on the manuscript. The study was supported by NSF DEB 0542390 to R.E.R., who also acknowledges the generous support of the Curators of the University of Missouri and the Alexander von Humboldt Foundation.	Arbogast BS, 2002, ANNU REV ECOL SYST, V33, P707, DOI 10.1146/annurev.ecolsys.33.010802.150500; Beadell JS, 2004, MOL ECOL, V13, P3829, DOI 10.1111/j.1365-294X.2004.02363.x; Fallon SM, 2005, AM NAT, V165, P466, DOI 10.1086/428430; Fallon SM, 2004, P ROY SOC B-BIOL SCI, V271, P493, DOI 10.1098/rspb.2003.2621; Fallon SM, 2003, EVOLUTION, V57, P606, DOI 10.1111/j.0014-3820.2003.tb01552.x; Haag-Liautard C, 2008, PLOS BIOL, V6, P1706, DOI 10.1371/journal.pbio.0060204; Hayakawa T, 2008, MOL BIOL EVOL, V25, P2233, DOI 10.1093/molbev/msn171; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Kumar S, 2005, P NATL ACAD SCI USA, V102, P18842, DOI 10.1073/pnas.0509585102; Latta SC, 2010, J AVIAN BIOL, V41, P25, DOI 10.1111/j.1600-048X.2009.04685.x; Lovette IJ, 2004, AUK, V121, P1, DOI 10.1642/0004-8038(2004)121[0001:MDAMSF]2.0.CO;2; Martin MJ, 2005, P NATL ACAD SCI USA, V102, P12819, DOI 10.1073/pnas.0503819102; Martinsen ES, 2008, MOL PHYLOGENET EVOL, V47, P261, DOI 10.1016/j.ympev.2007.11.012; Nerlich AG, 2008, EMERG INFECT DIS, V14, P1317, DOI 10.3201/eid1408.080235; Ollomo B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000446; Outlaw DC, 2010, MOL BIOL EVOL, V27, P537, DOI 10.1093/molbev/msp283; Page RDM, 2003, TANGLED TREES: PHYLOGENY, COSPECIATION AND COEVOLUTION, P1; Page Roderic D. M., 1996, P255; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.1645/0022-3395(2002)088[0972:AMPOMP]2.0.CO;2; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Rector A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r57; Rich SM, 2000, P NATL ACAD SCI USA, V97, P6994, DOI 10.1073/pnas.97.13.6994; Rich SM, 2009, P NATL ACAD SCI USA, V106, P14902, DOI 10.1073/pnas.0907740106; Ricklefs RE, 2002, P ROY SOC B-BIOL SCI, V269, P885, DOI 10.1098/rspb.2001.1940; Sallares R, 2004, MED HIST, V48, P311, DOI 10.1017/S0025727300007651; Stewart CB, 1998, CURR BIOL, V8, pR582, DOI 10.1016/S0960-9822(07)00367-3; Waldenstrom J, 2002, MOL ECOL, V11, P1545, DOI 10.1046/j.1365-294X.2002.01523.x; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Garamszegi LZ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-110; Zuckerkandl E., 1962, HORIZONS BIOCH, P189, DOI DOI 10.1038/NCHEMBIO.2477	31	105	105	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988					226	229		10.1126/science.1188954	http://dx.doi.org/10.1126/science.1188954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616281				2022-12-01	WOS:000279635200052
J	Behar, DM; Yunusbayev, B; Metspalu, M; Metspalu, E; Rosset, S; Parik, J; Rootsi, S; Chaubey, G; Kutuev, I; Yudkovsky, G; Khusnutdinova, EK; Balanovsky, O; Semino, O; Pereira, L; Comas, D; Gurwitz, D; Bonne-Tamir, B; Parfitt, T; Hammer, MF; Skorecki, K; Villems, R				Behar, Doron M.; Yunusbayev, Bayazit; Metspalu, Mait; Metspalu, Ene; Rosset, Saharon; Parik, Jueri; Rootsi, Siiri; Chaubey, Gyaneshwer; Kutuev, Ildus; Yudkovsky, Guennady; Khusnutdinova, Elza K.; Balanovsky, Oleg; Semino, Ornella; Pereira, Luisa; Comas, David; Gurwitz, David; Bonne-Tamir, Batsheva; Parfitt, Tudor; Hammer, Michael F.; Skorecki, Karl; Villems, Richard			The genome-wide structure of the Jewish people	NATURE			English	Article							POPULATION STRATIFICATION; EUROPEAN AMERICANS; MIDDLE-EASTERN; ANCESTRY; INDIVIDUALS; ASSOCIATION; GENOTYPE; PATTERNS	Contemporary Jews comprise an aggregate of ethno-religious communities whose worldwide members identify with each other through various shared religious, historical and cultural traditions(1,2). Historical evidence suggests common origins in the Middle East, followed by migrations leading to the establishment of communities of Jews in Europe, Africa and Asia, in what is termed the Jewish Diaspora(3-5). This complex demographic history imposes special challenges in attempting to address the genetic structure of the Jewish people(6). Although many genetic studies have shed light on Jewish origins and on diseases prevalent among Jewish communities, including studies focusing on uniparentally and biparentally inherited markers(7-16), genome-wide patterns of variation across the vast geographic span of Jewish Diaspora communities and their respective neighbours have yet to be addressed. Here we use high-density bead arrays to genotype individuals from 14 Jewish Diaspora communities and compare these patterns of genome-wide diversity with those from 69 Old World non-Jewish populations, of which 25 have not previously been reported. These samples were carefully chosen to provide comprehensive comparisons between Jewish and non-Jewish populations in the Diaspora, as well as with non-Jewish populations from the Middle East and north Africa. Principal component and structure-like analyses identify previously unrecognized genetic substructure within the Middle East. Most Jewish samples form a remarkably tight subcluster that overlies Druze and Cypriot samples but not samples from other Levantine populations or paired Diaspora host populations. In contrast, Ethiopian Jews (Beta Israel) and Indian Jews (Bene Israel and Cochini) cluster with neighbouring autochthonous populations in Ethiopia and western India, respectively, despite a clear paternal link between the Bene Israel and the Levant. These results cast light on the variegated genetic architecture of the Middle East, and trace the origins of most Jewish Diaspora communities to the Levant.	[Behar, Doron M.; Yudkovsky, Guennady; Skorecki, Karl] Mol Med Lab, IL-31096 Haifa, Israel; [Behar, Doron M.; Yunusbayev, Bayazit; Metspalu, Mait; Metspalu, Ene; Parik, Jueri; Rootsi, Siiri; Chaubey, Gyaneshwer; Kutuev, Ildus; Villems, Richard] Univ Tartu, Estonian Bioctr, EE-51010 Tartu, Estonia; [Behar, Doron M.; Yunusbayev, Bayazit; Metspalu, Mait; Metspalu, Ene; Parik, Jueri; Rootsi, Siiri; Chaubey, Gyaneshwer; Kutuev, Ildus; Villems, Richard] Univ Tartu, Dept Evolutionary Biol, EE-51010 Tartu, Estonia; [Yunusbayev, Bayazit; Kutuev, Ildus; Khusnutdinova, Elza K.] Russian Acad Sci, Ufa Res Ctr, Inst Biochem & Genet, Ufa 450054, Russia; [Rosset, Saharon] Tel Aviv Univ, Sch Math Sci, Dept Stat & Operat Res, IL-69978 Tel Aviv, Israel; [Yudkovsky, Guennady; Skorecki, Karl] Technion Israel Inst Technol, Rappaport Fac Med & Res Inst, IL-31096 Haifa, Israel; [Balanovsky, Oleg] Russian Acad Med Sci, Med Genet Res Ctr, Moscow 115478, Russia; [Semino, Ornella] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; [Pereira, Luisa] IPATIMUP, P-4200465 Oporto, Portugal; [Pereira, Luisa] Univ Porto, Fac Med, P-4200319 Oporto, Portugal; [Comas, David] CEXS UPF PRBB, Inst Evolutionary Biol, CSIC, Barcelona 08003, Spain; [Comas, David] CIBER Epidemiol & Salud Publ, Barcelona 08003, Spain; [Gurwitz, David; Bonne-Tamir, Batsheva] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Parfitt, Tudor] Univ London Sch Oriental & African Studies, Fac Languages & Cultures, Dept Languages & Cultures Near & Middle E, London WC1H 0XG, England; [Hammer, Michael F.] Univ Arizona, ARL Div Biotechnol, Tucson, AZ 85721 USA	Rambam Health Care Campus; Estonian Biocentre; University of Tartu; University of Tartu; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; Tel Aviv University; Technion Israel Institute of Technology; Research Centre for Medical Genetics; Russian Academy of Medical Sciences; University of Pavia; Universidade do Porto; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Tel Aviv University; Sackler Faculty of Medicine; University of London; University of London School Oriental & African Studies (SOAS); University of Arizona	Behar, DM (corresponding author), Mol Med Lab, Rambam Hlth Care Campus, IL-31096 Haifa, Israel.	behardm@usernet.com; skorecki@tx.technion.ac.il; rvillems@ebc.ee	Pereira, Luisa/H-3050-2011; Gurwitz, David/E-7642-2013; Yunusbaev, Bayazit/T-5444-2019; Khusnutdinova, Elza Kamilevna/A-4810-2013; Metspalu, Mait/G-8671-2015; Chaubey, Gyaneshwer/AAC-6409-2019; Comas, David/D-5382-2014; Chaubey, Gyaneshwer/H-2753-2012; Balanovsky, Oleg/G-1549-2014	Pereira, Luisa/0000-0002-4271-1527; Gurwitz, David/0000-0002-9363-1869; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Metspalu, Mait/0000-0003-3099-9161; Chaubey, Gyaneshwer/0000-0003-2899-3852; Comas, David/0000-0002-5075-0956; Chaubey, Gyaneshwer/0000-0003-2899-3852; Yunusbayev, Bayazit/0000-0002-6035-8763; SEMINO, Ornella/0000-0002-9675-9403	European Commission [205419]; European Union through a Centre of Excellence in Genomics; Swedish Collegium for Advanced Studies; Estonian Science Foundation [7858, 7445]; Arthur and Rosalinde Gilbert Foundation; American Technion Society; European Union for Marie Curie International Reintegration [CT-2007-208019]; Israeli Science Foundation [1227/09]; Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education; Fundacao para a Ciencia ea Tecnologia; Portuguese Foundation for Science and Technology	European Commission(European CommissionEuropean Commission Joint Research Centre); European Union through a Centre of Excellence in Genomics; Swedish Collegium for Advanced Studies; Estonian Science Foundation; Arthur and Rosalinde Gilbert Foundation; American Technion Society; European Union for Marie Curie International Reintegration; Israeli Science Foundation(Israel Science Foundation); Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education; Fundacao para a Ciencia ea Tecnologia(Portuguese Foundation for Science and Technology); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	We thank the individuals who provided DNA samples for this study, including the National Laboratory for the Genetics of Israeli Populations; Mari Nelis, Georgi Hudjashov and Viljo Soo for conducting the autosomal genotyping; Lauri Anton for computational help. R. V. and D. M. B. thank the European Commission, Directorate-General for Research for FP7 Ecogene grant 205419. R. V. thanks the European Union, Regional Development Fund through a Centre of Excellence in Genomics grant and the Swedish Collegium for Advanced Studies for support during the initial stage of this study. E. M. and Si. R. thank the Estonian Science Foundation for grants 7858 and 7445, respectively. K. S. thanks the Arthur and Rosalinde Gilbert Foundation fund of the American Technion Society. Sa. R. thanks the European Union for Marie Curie International Reintegration grant CT-2007-208019, and the Israeli Science Foundation for grant 1227/09. IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partly supported by Fundacao para a Ciencia ea Tecnologia, the Portuguese Foundation for Science and Technology.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Behar DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002062; Ben-Sasson HH, 1976, HIST JEWISH PEOPLE; Biswas S, 2009, AM J HUM GENET, V84, P641, DOI 10.1016/j.ajhg.2009.04.015; CAVALLISFORZA LL, 1994, HIST GEOGRAPHY HUMAN, V4; De Lange N, 1984, ATLAS JEWISH WORLD; Gao XY, 2009, HUM HERED, V68, P182, DOI 10.1159/000224638; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; Hourani Albert, 1991, HIST ARAB PEOPLES; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kopelman NM, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-80; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Mahler Raphael, 1971, HIST MODERN JEWRY; Need AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r7; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Olshen AB, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-14; Ostrer H, 2001, NAT REV GENET, V2, P891, DOI 10.1038/35098506; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Sergio DellaPergola, 1997, PAPERS JEWISH DEMOGR, P11; Stillman, 1979, JEWS ARAB LANDS HIST; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Weiss KM, 2009, GENOME RES, V19, P703, DOI 10.1101/gr.076539.108	30	269	274	1	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					238	U112		10.1038/nature09103	http://dx.doi.org/10.1038/nature09103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20531471				2022-12-01	WOS:000279580800037
J	Cahill, JF; McNickle, GG; Haag, JJ; Lamb, EG; Nyanumba, SM; Clair, CCS				Cahill, James F., Jr.; McNickle, Gordon G.; Haag, Joshua J.; Lamb, Eric G.; Nyanumba, Samson M.; Clair, Colleen Cassady St.			Plants Integrate Information About Nutrients and Neighbors	SCIENCE			English	Article							ROOT; COMMUNICATION		[Cahill, James F., Jr.; McNickle, Gordon G.; Haag, Joshua J.; Nyanumba, Samson M.; Clair, Colleen Cassady St.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Lamb, Eric G.] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK S7N 5A8, Canada	University of Alberta; University of Saskatchewan	Cahill, JF (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.	jc.cahill@ualberta.ca; joshua.j.haag@gmail.com	McNickle, Gord/AAB-4871-2019; Lamb, Eric G/D-9319-2011; McNickle, Gordon G/F-3699-2017; St. Clair, Colleen Cassady/A-3756-2014; Cahill, James/B-6147-2015	McNickle, Gord/0000-0002-7188-7265; Lamb, Eric G/0000-0001-5201-4541; McNickle, Gordon G/0000-0002-7188-7265; Cahill, James/0000-0002-4110-1516	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank G. Law for assistance with the Biotron plant growth facility, C. Wild for explanations of behavioral theory and trait correlations, and three anonymous reviewers for helpful comments. Supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant to J.F.C.	Gersani M, 2001, J ECOL, V89, P660, DOI 10.1046/j.0022-0477.2001.00609.x; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Holzapfel C, 2003, OECOLOGIA, V134, P72, DOI 10.1007/s00442-002-1062-x; Karban R, 2008, ECOL LETT, V11, P727, DOI 10.1111/j.1461-0248.2008.01183.x; Kembel SW, 2005, AM NAT, V166, P216, DOI 10.1086/431287; MAHALL BE, 1991, P NATL ACAD SCI USA, V88, P874, DOI 10.1073/pnas.88.3.874; Stephens DW, 2007, FORAGING BEHAV ECOLO	7	208	233	17	278	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1657	1657		10.1126/science.1189736	http://dx.doi.org/10.1126/science.1189736			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576883				2022-12-01	WOS:000279107400033
J	Cho, EJ; Senecal, TD; Kinzel, T; Zhang, Y; Watson, DA; Buchwald, SL				Cho, Eun Jin; Senecal, Todd D.; Kinzel, Tom; Zhang, Yong; Watson, Donald A.; Buchwald, Stephen L.			The Palladium-Catalyzed Trifluoromethylation of Aryl Chlorides	SCIENCE			English	Article							FORMING REDUCTIVE ELIMINATION; CONVENIENT METHOD; ACTIVE CATALYST; PD; (TRIFLUOROMETHYL)COPPER; REACTIVITY; COMPLEXES; HALIDES	The trifluoromethyl group can dramatically influence the properties of organic molecules, thereby increasing their applicability as pharmaceuticals, agrochemicals, or building blocks for organic materials. Despite the importance of this substituent, no general method exists for its installment onto functionalized aromatic substrates. Current methods either require the use of harsh reaction conditions or suffer from a limited substrate scope. Here we report the palladium-catalyzed trifluoromethylation of aryl chlorides under mild conditions, allowing the transformation of a wide range of substrates, including heterocycles, in excellent yields. The process tolerates functional groups such as esters, amides, ethers, acetals, nitriles, and tertiary amines and, therefore, should be applicable to late-stage modifications of advanced intermediates. We have also prepared all the putative intermediates in the catalytic cycle and demonstrated their viability in the process.	[Cho, Eun Jin; Senecal, Todd D.; Kinzel, Tom; Zhang, Yong; Watson, Donald A.; Buchwald, Stephen L.] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Buchwald, SL (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	sbuchwal@mit.edu	Cho, Eun Jin/F-2406-2013	Senecal, Todd/0000-0002-5673-5538	NIH [GM46059]; Merck; Nippon Chemical; Boehringer Ingelheim; BASF; Alexander von Humboldt Foundation; NSF [CHE 9808061, DBI 9729592]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046059, R37GM046059] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck(Merck & Company); Nippon Chemical; Boehringer Ingelheim(Boehringer Ingelheim); BASF(BASF); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the NIH for financial support of this project (grant GM46059) and Merck, Nippon Chemical, Boehringer Ingelheim, and BASF for gifts of chemicals and additional funds. T. K. thanks the Alexander von Humboldt Foundation for a Feodor Lynen postdoctoral fellowship. The Varian NMR instrument that we used was supported by the NSF (grants CHE 9808061 and DBI 9729592). We also thank P. Muller (MIT Chemistry Department, X-Ray Diffraction Facility) for obtaining the crystal structures of 13a and 13b. Cambridge Crystallographic Data Centre (CCDC) 771779 and 771780 contain the supplementary crystallographic data for this paper. These data can be obtained free of charge from the CCDC via www.ccdc.cam.ac.uk/data_request/cif.	Ball ND, 2010, J AM CHEM SOC, V132, P2878, DOI 10.1021/ja100955x; CARR GE, 1988, PERKIN T 1, P921; Cartwright D., 1994, ORGANOFLUORINE CHEM, P237; Chen Q.-Y., 1989, CHEM COMMUN, P705; CLARK JH, 1988, CHEM COMMUN, P638; Cottet F, 2002, EUR J ORG CHEM, V2002, P327; Culkin DA, 2004, ORGANOMETALLICS, V23, P3398, DOI 10.1021/om049726k; Dubinina GG, 2008, J AM CHEM SOC, V130, P8600, DOI 10.1021/ja802946s; Fors BP, 2008, J AM CHEM SOC, V130, P13552, DOI 10.1021/ja8055358; Frisch M., 2016, GAUSSIAN16; Grushin VV, 2006, J AM CHEM SOC, V128, P12644, DOI 10.1021/ja064935c; Grushin VV, 2006, J AM CHEM SOC, V128, P4632, DOI 10.1021/ja0602389; Kirsch P., 2013, MODERN FLUOROORGANIC; KOBAYASHI Y, 1969, TETRAHEDRON LETT, P4095; KONDRATENKO NV, 1980, SYNTHESIS-STUTTGART, P932; MATSUI K, 1981, CHEM LETT, P1719, DOI 10.1246/cl.1981.1719; MCLOUGHL.VC, 1969, TETRAHEDRON, V25, P5921, DOI 10.1016/S0040-4020(01)83100-8; Milne JE, 2004, J AM CHEM SOC, V126, P13028, DOI 10.1021/ja0474493; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Naumann D, 2004, Z ANORG ALLG CHEM, V630, P746, DOI 10.1002/zaac.200400020; Oishi M, 2009, CHEM COMMUN, P1909, DOI 10.1039/b823249k; Swarts F., 1892, B ACAD R BELG, V24, P309; Thayer AM, 2006, CHEM ENG NEWS, V84, P15, DOI 10.1021/cen-v084n033.p015; Tyrra W, 2005, CHEM-EUR J, V11, P6514, DOI 10.1002/chem.200500799; URATA H, 1991, TETRAHEDRON LETT, V32, P91, DOI 10.1016/S0040-4039(00)71226-3; Wang XS, 2010, J AM CHEM SOC, V132, P3648, DOI 10.1021/ja909522s; Watson DA, 2009, SCIENCE, V325, P1661, DOI 10.1126/science.1178239; WIEMERS DM, 1986, J AM CHEM SOC, V108, P832, DOI 10.1021/ja00264a043	28	592	602	1	251	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2010	328	5986					1679	1681		10.1126/science.1190524	http://dx.doi.org/10.1126/science.1190524			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	615BY	20576888	Green Submitted, Green Accepted			2022-12-01	WOS:000279107400039
J	Silverstein, TD; Johnson, RE; Jain, R; Prakash, L; Prakash, S; Aggarwal, AK				Silverstein, Timothy D.; Johnson, Robert E.; Jain, Rinku; Prakash, Louise; Prakash, Satya; Aggarwal, Aneel K.			Structural basis for the suppression of skin cancers by DNA polymerase eta	NATURE			English	Article							XERODERMA-PIGMENTOSUM-VARIANT; CRYSTAL-STRUCTURE; LESION-BYPASS; NUCLEOTIDE INCORPORATION; MOLECULAR ANALYSIS; YEAST; MECHANISM; REPLICATION; MUTATIONS; TEMPLATE	DNA polymerase eta (Pol eta) is unique among eukaryotic polymerases in its proficient ability for error-free replication through ultraviolet-induced cyclobutane pyrimidine dimers, and inactivation of Pol eta (also known as POLH) in humans causes the variant form of xeroderma pigmentosum (XPV). We present the crystal structures of Saccharomyces cerevisiae Pol eta (also known as RAD30) in ternary complex with a cis-syn thymine-thymine (T-T) dimer and with undamaged DNA. The structures reveal that the ability of Pol eta to replicate efficiently through the ultraviolet-induced lesion derives from a simple and yet elegant mechanism, wherein the two Ts of the T-T dimer are accommodated in an active site cleft that is much more open than in other polymerases. We also show by structural, biochemical and genetic analysis that the two Ts are maintained in a stable configuration in the active site via interactions with Gln 55, Arg 73 and Met 74. Together, these features define the basis for Pol eta's action on ultraviolet-damaged DNA that is crucial in suppressing the mutagenic and carcinogenic consequences of sun exposure, thereby reducing the incidence of skin cancers in humans.	[Silverstein, Timothy D.; Jain, Rinku; Aggarwal, Aneel K.] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Johnson, Robert E.; Prakash, Louise; Prakash, Satya] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77755 USA	Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Medical Branch Galveston	Aggarwal, AK (corresponding author), Mt Sinai Sch Med, Dept Struct & Chem Biol, Box 1677,1425 Madison Ave, New York, NY 10029 USA.	saprakas@utmb.edu; aneel.aggarwal@mssm.edu	Prakash, Satya/C-6420-2013; Prakash, Louise/C-7891-2012	Prakash, Louise/0000-0001-9143-6261; Prakash, Satya/0000-0001-7228-1444; Silverstein, Timothy/0000-0003-0931-6274	NIH; NATIONAL CANCER INSTITUTE [R01CA107650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017767] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the staff at Brookhaven National Laboratory (beamlines X6A and X29) and the Advanced Photon Source (24ID) for facilitating X-ray data collection. We thank D. T. Nair, S. Lone, R. Vasquez-Del Carpio and M. Swan for discussions. This work was supported by NIH grants to A.K.A., S.P. and L.P.	Alt A, 2007, SCIENCE, V318, P967, DOI 10.1126/science.1148242; Broughton BC, 2002, P NATL ACAD SCI USA, V99, P815, DOI 10.1073/pnas.022473899; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gratchev A, 2003, EXP DERMATOL, V12, P529, DOI 10.1034/j.1600-0625.2003.00124.x; Inui H, 2008, J INVEST DERMATOL, V128, P2055, DOI 10.1038/jid.2008.48; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2006, METHOD ENZYMOL, V408, P390, DOI 10.1016/S0076-6879(06)08024-4; Kondratick CM, 2001, MOL CELL BIOL, V21, P2018, DOI 10.1128/MCB.21.6.2018-2025.2001; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Tanioka M, 2007, J INVEST DERMATOL, V127, P1745, DOI 10.1038/sj.jid.5700759; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Washington MT, 2001, CELL, V107, P917, DOI 10.1016/S0092-8674(01)00613-4; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	31	119	120	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1039	U96		10.1038/nature09104	http://dx.doi.org/10.1038/nature09104			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577207	Green Accepted			2022-12-01	WOS:000279056900044
J	Devireddy, LR; Hart, DO; Goetz, DH; Green, MR				Devireddy, Laxminarayana R.; Hart, Daniel O.; Goetz, David H.; Green, Michael R.			A Mammalian Siderophore Synthesized by an Enzyme with a Bacterial Homolog Involved in Enterobactin Production	CELL			English	Article							RNA-BINDING PROTEIN; MITOCHONDRIAL IRON; ESCHERICHIA-COLI; LABILE IRON; DEHYDROGENASE; LIPOCALIN; APOPTOSIS; ACONITASE; MITOFERRIN; INDUCTION	Intracellular iron homeostasis is critical for survival and proliferation. Lipocalin 24p3 is an iron-trafficking protein that binds iron through association with a bacterial siderophore, such as enterobactin, or a postulated mammalian siderophore. Here, we show that the iron-binding moiety of the 24p3-associated mammalian siderophore is 2,5-dihydroxybenzoic acid (2,5-DHBA), which is similar to 2,3-DHBA, the iron-binding component of enterobactin. We find that the murine enzyme responsible for 2,5-DHBA synthesis, BDH2, is the homolog of bacterial EntA, which catalyzes 2,3-DHBA production during enterobactin biosynthesis. RNA interference-mediated knockdown of BDH2 results in siderophore depletion. Mammalian cells lacking the siderophore accumulate abnormally high amounts of cytoplasmic iron, resulting in elevated levels of reactive oxygen species, whereas the mitochondria are iron deficient. Siderophore-depleted mammalian cells and zebrafish embryos fail to synthesize heme, an iron-dependent mitochondrial process. Our results reveal features of intracellular iron homeostasis that are conserved from bacteria through humans.	[Devireddy, Laxminarayana R.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Devireddy, Laxminarayana R.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Hart, Daniel O.; Green, Michael R.] Univ Massachusetts, Howard Hughes Med Inst, Program Gene Funct & Express, Sch Med, Worcester, MA 01605 USA; [Hart, Daniel O.; Green, Michael R.] Univ Massachusetts, Howard Hughes Med Inst, Program Mol Med, Sch Med, Worcester, MA 01605 USA; [Goetz, David H.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	Case Western Reserve University; Case Western Reserve University; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco	Devireddy, LR (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.	laxminarayana.devireddy@case.edu; michael.green@umassmed.edu			National Institutes of Health (NIH) [R01 DK081395-01, R01 CA115817-04]; Case Western Reserve University; March of Dimes and American Society of Hematology; NATIONAL CANCER INSTITUTE [R01CA115817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081395] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Case Western Reserve University; March of Dimes and American Society of Hematology(March of Dimes); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Andrew Gulick, Michael Mueller, Udo Oppermann, Kostas Panto-poulos, Barry Paw, Arthur Skoultchi, David Plas, Sonia Levi, Jerry Kaplan, Maurice Burg, and David Turner for providing reagents; Andy Dancis, Heidi O'Neill, Yavuz Oktay, Stacy Dalheimer, Jon Donze, David Yao, Wei-Dong Chen, Marvin Neiman, Kiran Velpula, and Jun Liu for assistance with various experimental procedures; Jim and Barbara Evans from the University of Massachusetts Medical School Proteomics and Mass Spectrometry Facility for GC-MS analysis; and Sara Evans for editorial assistance. This work is supported by National Institutes of Health (NIH) grant R01 DK081395-01 and Case Western Reserve University start-up funds to L.R.D. and NIH grant R01 CA115817-04 to M.R.G. L.R.D. is also a recipient of career developmental awards from March of Dimes and American Society of Hematology. M.R.G. is an Investigator of the Howard Hughes Medical Institute.	Akerstrom B, 2000, BBA-PROTEIN STRUCT M, V1482, P1, DOI 10.1016/S0167-4838(00)00137-0; Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; Blat D, 2008, J MED CHEM, V51, P126, DOI 10.1021/jm070800l; Breuer W, 2008, INT J BIOCHEM CELL B, V40, P350, DOI 10.1016/j.biocel.2007.03.010; Brownlie A, 1998, NAT GENET, V20, P244, DOI 10.1038/3049; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Campanella A, 2009, HUM MOL GENET, V18, P1, DOI 10.1093/hmg/ddn308; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Devireddy LR, 2001, SCIENCE, V293, P829, DOI 10.1126/science.1061075; Emerit J, 2001, BIOMED PHARMACOTHER, V55, P333, DOI 10.1016/S0753-3322(01)00068-3; FERNANDEZPOL JA, 1978, CELL, V14, P489, DOI 10.1016/0092-8674(78)90235-0; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Guo K, 2006, J BIOL CHEM, V281, P10291, DOI 10.1074/jbc.M511346200; Hart DO, 2007, NATURE, V450, P1082, DOI 10.1038/nature06349; IUCHI I, 1983, J EXP ZOOL, V226, P409, DOI 10.1002/jez.1402260311; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; JONES RL, 1980, J EXP MED, V151, P418, DOI 10.1084/jem.151.2.418; Kakhlon O, 2002, FREE RADICAL BIO MED, V33, P1037, DOI 10.1016/S0891-5849(02)01006-7; LIU J, 1989, J BACTERIOL, V171, P791, DOI 10.1128/jb.171.2.791-798.1989; Lukinova N, 2009, INVEST OPHTH VIS SCI, V50, P1440, DOI 10.1167/iovs.08-2545; Napier I, 2005, BLOOD, V105, P1867, DOI 10.1182/blood-2004-10-3856; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Powell CS, 2003, AM J PHYSIOL-LUNG C, V285, pL189, DOI 10.1152/ajplung.00253.2002; Rauen U, 2007, CHEMBIOCHEM, V8, P341, DOI 10.1002/cbic.200600311; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; ROUAULT TA, 1991, CELL, V64, P881, DOI 10.1016/0092-8674(91)90312-M; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Sundlov JA, 2006, ACTA CRYSTALLOGR D, V62, P734, DOI 10.1107/S0907444906015824; Yang J, 2002, MOL CELL, V10, P1045, DOI 10.1016/S1097-2765(02)00710-4	37	212	222	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					1006	1017		10.1016/j.cell.2010.04.040	http://dx.doi.org/10.1016/j.cell.2010.04.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550936	Green Accepted, Bronze, Green Submitted			2022-12-01	WOS:000278618800015
J	Carvajal-Vergara, X; Sevilla, A; D'Souza, SL; Ang, YS; Schaniel, C; Lee, DF; Yang, L; Kaplan, AD; Adler, ED; Rozov, R; Ge, YC; Cohen, N; Edelmann, LJ; Chang, B; Waghray, A; Su, J; Pardo, S; Lichtenbelt, KD; Tartaglia, M; Gelb, BD; Lemischka, IR				Carvajal-Vergara, Xonia; Sevilla, Ana; D'Souza, Sunita L.; Ang, Yen-Sin; Schaniel, Christoph; Lee, Dung-Fang; Yang, Lei; Kaplan, Aaron D.; Adler, Eric D.; Rozov, Roye; Ge, YongChao; Cohen, Ninette; Edelmann, Lisa J.; Chang, Betty; Waghray, Avinash; Su, Jie; Pardo, Sherly; Lichtenbelt, Klaske D.; Tartaglia, Marco; Gelb, Bruce D.; Lemischka, Ihor R.			Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome	NATURE			English	Article							SOMATIC PTPN11 MUTATIONS; SHP2 MUTATIONS; HUMAN ES; DIFFERENTIATION; HEMATOPOIESIS; EXPRESSION; LEUKEMIA	The generation of reprogrammed induced pluripotent stem cells (iPSCs) from patients with defined genetic disorders holds the promise of increased understanding of the aetiologies of complex diseases and may also facilitate the development of novel therapeutic interventions. We have generated iPSCs from patients with LEOPARD syndrome (an acronym formed from its main features; that is, lentigines, electrocardiographic abnormalities, ocular hypertelorism, pulmonary valve stenosis, abnormal genitalia, retardation of growth and deafness), an autosomal-dominant developmental disorder belonging to a relatively prevalent class of inherited RAS-mitogen-activated protein kinase signalling diseases, which also includes Noonan syndrome, with pleomorphic effects on several tissues and organ systems(1,2). The patient-derived cells have a mutation in the PTPN11 gene, which encodes the SHP2 phosphatase. The iPSCs have been extensively characterized and produce multiple differentiated cell lineages. A major disease phenotype in patients with LEOPARD syndrome is hypertrophic cardiomyopathy. We show that in vitro-derived cardiomyocytes from LEOPARD syndrome iPSCs are larger, have a higher degree of sarcomeric organization and preferential localization of NFATC4 in the nucleus when compared with cardiomyocytes derived from human embryonic stem cells or wild-type iPSCs derived from a healthy brother of one of the LEOPARD syndrome patients. These features correlate with a potential hypertrophic state. We also provide molecular insights into signalling pathways that may promote the disease phenotype.	[Carvajal-Vergara, Xonia; Sevilla, Ana; D'Souza, Sunita L.; Ang, Yen-Sin; Schaniel, Christoph; Lee, Dung-Fang; Yang, Lei; Rozov, Roye; Chang, Betty; Waghray, Avinash; Su, Jie; Lemischka, Ihor R.] Mt Sinai Sch Med, Black Family Stem Cell Inst, Dept Dev & Regenerat Biol, Dept Gene & Cell Med, New York, NY 10029 USA; [Carvajal-Vergara, Xonia] Ctr Nacl Invest Cardiovasc, Dept Regenerat Cardiol, Madrid 28029, Spain; [Kaplan, Aaron D.; Adler, Eric D.] Mt Sinai Sch Med, Dept Med, Cardiovasc Inst, New York, NY 10029 USA; [Ge, YongChao] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Cohen, Ninette; Edelmann, Lisa J.; Pardo, Sherly; Gelb, Bruce D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Pardo, Sherly; Gelb, Bruce D.] Mt Sinai Sch Med, Child Hlth & Dev Inst, New York, NY 10029 USA; [Lichtenbelt, Klaske D.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 EA Utrecht, Netherlands; [Tartaglia, Marco] Ist Super Sanita, Dipartimento Ematol Oncol & Med Mol, I-00161 Rome, Italy; [Gelb, Bruce D.] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Utrecht University; Utrecht University Medical Center; Istituto Superiore di Sanita (ISS); Icahn School of Medicine at Mount Sinai	Carvajal-Vergara, X (corresponding author), Mt Sinai Sch Med, Black Family Stem Cell Inst, Dept Dev & Regenerat Biol, Dept Gene & Cell Med, New York, NY 10029 USA.		Sevilla, Ana/N-8579-2017; CARVAJAL-VERGARA, XONIA/N-2939-2014; Carvajal-Vergara, Xonia/ABD-1094-2021; Ge, Yongchao/AAG-9317-2021; Schaniel, Chrisoph/C-9655-2012; Waghray, Avinash/AAD-5292-2021; Yang, Lei/D-7462-2015; Schaniel, Christoph/P-3836-2019; Tartaglia, Marco/K-2955-2018	Sevilla, Ana/0000-0002-9251-4759; CARVAJAL-VERGARA, XONIA/0000-0002-6475-3701; Carvajal-Vergara, Xonia/0000-0002-6475-3701; Ge, Yongchao/0000-0001-6448-5703; Waghray, Avinash/0000-0003-3242-2227; Schaniel, Christoph/0000-0002-1343-4858; Tartaglia, Marco/0000-0001-7736-9672; Lee, Dung-Fang/0000-0003-2387-597X; Su, Jie/0000-0002-3071-7139	National Institutes of Health (NIH) [5R01GM078465]; New York State Department of Health (NYSTEM) [C024410, C024176, C024407]; American College of Cardiology/Pfizer; ERA; Ministerio de Ciencia e Innovacion/Instituto de Salud Carlos III; New York Stem Cell Foundation; Ruth L. Kirschstein National Research Service Award (NRSA) [T32]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078465] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Department of Health (NYSTEM); American College of Cardiology/Pfizer(Pfizer); ERA; Ministerio de Ciencia e Innovacion/Instituto de Salud Carlos III(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); New York Stem Cell Foundation; Ruth L. Kirschstein National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. James, X. Niu and D. York for their technical support and laboratory management, and B. MacArthur for support in microarray analysis. We also would like to thank K. Moore and her laboratory, and S. Mulero-Navarro from B.D.G.'s laboratory for their help, and V. Fuster and A. Bernad for their support. This research was funded by grants from the National Institutes of Health (NIH) to I. R. L (5R01GM078465), the Empire State Stem Cell Fund through New York State Department of Health (NYSTEM) C024410 to I. R. L. and C.S., C024176 (HESC-SRF) to I.R.L. and S.L.D., C024407 to B D.G., American College of Cardiology/Pfizer Research Fellowship to E. D. A., and ERA-Net for research programmes on rare diseases 2009 to M. T. X. C.-V. is a recipient of a Postdoctoral Fellowship from the Ministerio de Ciencia e Innovacion/Instituto de Salud Carlos III, D.-F.L. is a New York Stem Cell Foundation Stanley and Fiona Druckenmiller Fellow and S. P. is a recipient of a Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (T32).	Aoki H, 2000, NAT MED, V6, P183, DOI 10.1038/72287; Buitrago M, 2005, NAT MED, V11, P837, DOI 10.1038/nm1272; Carvajal-Vergara X, 2005, BLOOD, V105, P4492, DOI 10.1182/blood-2004-08-2985; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Edouard T, 2007, CELL MOL LIFE SCI, V64, P1585, DOI 10.1007/s00018-007-6509-0; FAN ST, 1991, J CLIN INVEST, V87, P50, DOI 10.1172/JCI115000; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; GORLIN R J, 1971, Birth Defects Original Article Series, V7, P110; Grigoriadis AE, 2010, BLOOD, V115, P2769, DOI 10.1182/blood-2009-07-234690; Jopling C, 2007, PLOS GENET, V3, P2468, DOI 10.1371/journal.pgen.0030225; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Laux D, 2008, J PEDIAT HEMATOL ONC, V30, P602, DOI 10.1097/MPH.0b013e31817588fb; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Loh ML, 2004, BLOOD, V103, P2325, DOI 10.1182/blood-2003-09-3287; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Oishi K, 2009, HUM MOL GENET, V18, P193, DOI 10.1093/hmg/ddn336; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; Sarkozy A, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-13; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2004, BLOOD, V104, P307, DOI 10.1182/blood-2003-11-3876; Ucar C, 2006, J PEDIAT HEMATOL ONC, V28, P123; Wu CJ, 2005, BLOOD, V106, P3639, DOI 10.1182/blood-2005-04-1376; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406	31	515	540	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					808	U12		10.1038/nature09005	http://dx.doi.org/10.1038/nature09005			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535210	Green Accepted			2022-12-01	WOS:000278551800051
J	Petronis, A				Petronis, Arturas			Epigenetics as a unifying principle in the aetiology of complex traits and diseases	NATURE			English	Article							DNA METHYLATION; TWINS; ENVIRONMENT; HERITABILITY; INHERITANCE; GENETICS; CLONING; ANTICIPATION; EPIMUTATION; EXPRESSION	Epigenetic modifications of DNA and histones might be crucial for understanding the molecular basis of complex phenotypes. One reason for this is that epigenetic factors are sometimes malleable and plastic enough to react to cues from the external and internal environments. Such induced epigenetic changes can be solidified and propagated during cell division, resulting in permanent maintenance of the acquired phenotype. In addition, the finding that there is partial epigenetic stability in somatic and germline cells allows insight into the molecular mechanisms of heritability. Epigenetics can provide a new framework for the search of aetiological factors in complex traits and diseases.	Ctr Addict & Mental Hlth, Krembil Family Epigenet Lab, Toronto, ON M5T 1R8, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Petronis, A (corresponding author), Ctr Addict & Mental Hlth, Krembil Family Epigenet Lab, 250 Coll St, Toronto, ON M5T 1R8, Canada.	arturas_petronis@camh.net	Petronis, Art/AAD-4491-2019		Canadian Institutes of Health Research [199170, 186007]; US National Institutes of Health [MH074127, MH088413, DP3DK085698, HG004535]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK085698] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH088413, R01MH074127] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	I thank A. Wong, I. Gottesman, A. Paterson and C. Ptak for editorial suggestions, A. Schumacher for figure design, and the reviewers for their comments. Work in my laboratory has been supported by the Canadian Institutes of Health Research (grants 199170 and 186007) and the US National Institutes of Health (grants MH074127, MH088413, DP3DK085698 and HG004535). I am Tapscott Chair in Schizophrenia Studies at the University of Toronto and a senior fellow of the Ontario Mental Health Foundation.	ALBERG AJ, 2003, CHEST S1, V123, P21; ALLEN ND, 1990, CELL, V61, P853, DOI 10.1016/0092-8674(90)90195-K; Austin Jehannine, 2005, J Genet Couns, V14, P329, DOI 10.1007/s10897-005-1622-4; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Boomsma D, 2002, NAT REV GENET, V3, P872, DOI 10.1038/nrg932; BOUCHARD TJ, 1990, SCIENCE, V250, P223, DOI 10.1126/science.2218526; Bouchard TJ, 2003, J NEUROBIOL, V54, P4, DOI 10.1002/neu.10160; Chong S, 2007, NAT GENET, V39, P574, DOI 10.1038/ng0507-574; Collins A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004330; De Vries H., 1904, SPECIES VARIETIES TH; Edwards JL, 2003, AM J REPROD IMMUNOL, V50, P113, DOI 10.1034/j.1600-0897.2003.00064.x; Fagiolini M, 2009, CURR OPIN NEUROBIOL, V19, P207, DOI 10.1016/j.conb.2009.05.009; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Finch C., 2000, CHANCE DEV AGING; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; GARTNER K, 1990, LAB ANIM, V24, P71, DOI 10.1258/002367790780890347; GARTNER K, 1981, NATURE, V292, P646, DOI 10.1038/292646a0; Gottesman II, 1997, SCIENCE, V276, P1522, DOI 10.1126/science.276.5318.1522; Haaf T, 2006, CURR TOP MICROBIOL, V310, P13; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; HARRIS JR, 1999, NURTURE ASSUMPTION W, P462; Heath A C, 1998, Twin Res, V1, P119, DOI 10.1375/136905298320566249; Heijmans BT, 2007, HUM MOL GENET, V16, P547, DOI 10.1093/hmg/ddm010; Hemminki K, 2006, NAT REV GENET, V7, P958, DOI 10.1038/nrg2009; Hong LE, 2008, ARCH GEN PSYCHIAT, V65, P1008, DOI 10.1001/archpsyc.65.9.1008; Jablonka E., 2007, BEHAV BRAIN SCI, V30, P365; Jablonka E, 2007, BEHAV BRAIN SCI, V30, P353, DOI 10.1017/S0140525X07002221; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jockin V, 1996, J PERS SOC PSYCHOL, V71, P288, DOI 10.1037/0022-3514.71.2.288; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Kendler KS, 2007, PSYCHOL MED, V37, P615, DOI 10.1017/S0033291706009524; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P886, DOI 10.1001/archpsyc.57.9.886; Kendler KS, 1997, PSYCHOL MED, V27, P539, DOI 10.1017/S0033291797004716; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kuhn, 1962, STRUCTURE SCI REVOLU, P172; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Macleod D, 1999, NAT GENET, V23, P139, DOI 10.1038/13767; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Martin N, 1997, NAT GENET, V17, P387, DOI 10.1038/ng1297-387; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; McFaul CD, 2006, GUT, V55, P252, DOI 10.1136/gut.2005.065045; Pal C, 1999, J THEOR BIOL, V200, P19, DOI 10.1006/jtbi.1999.0974; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; Petronis A, 2001, TRENDS GENET, V17, P142, DOI 10.1016/S0168-9525(00)02213-7; PETRONIS A, 1995, AM J PSYCHIAT, V152, P164; Petronis A, 1997, LANCET, V350, P1403, DOI 10.1016/S0140-6736(05)65184-7; Pigliucci M, 1996, HEREDITY, V77, P453, DOI 10.1038/hdy.1996.171; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; PLOMIN R, 1991, BEHAV BRAIN SCI, V14, P373, DOI 10.1017/S0140525X00070278; PLOMIN R, 1989, AM PSYCHOL, V44, P105, DOI 10.1037/0003-066X.44.2.105; Rhind SM, 2003, NAT BIOTECHNOL, V21, P744, DOI 10.1038/nbt0703-744; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; RISCH N, 1990, GENET EPIDEMIOL, V7, P3, DOI 10.1002/gepi.1370070103; RISCH N, 1990, NATURE REV GENET, V7, P17; SILVA AJ, 1988, CELL, V54, P145, DOI 10.1016/0092-8674(88)90546-6; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Stokstad E, 1997, SCIENCE, V275, P1882, DOI 10.1126/science.275.5308.1882; Surani MA, 2008, COLD SH Q B, V73, P9, DOI 10.1101/sqb.2008.73.015; Suter CM, 2007, NAT GENET, V39, P573, DOI 10.1038/ng0507-573a; Suter CM, 2007, NAT GENET, V39, P575, DOI 10.1038/ng0507-575; TAUBES G, 1995, SCIENCE, V269, P164, DOI 10.1126/science.7618077; Timshel S, 2009, CANCER EPIDEMIOL, V33, P231, DOI 10.1016/j.canep.2009.06.007; Turkheimer E, 2003, PSYCHOL SCI, V14, P623, DOI 10.1046/j.0956-7976.2003.psci_1475.x; Turkheimer E, 2000, PSYCHOL BULL, V126, P78, DOI 10.1037/0033-2909.126.1.78; Ushijima T, 2003, GENOME RES, V13, P868, DOI 10.1101/gr.969603; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; VOGEL F, 1997, HUMAN GENETICS PROBL, P851; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wong AHC, 2005, HUM MOL GENET, V14, pR11, DOI 10.1093/hmg/ddi116; Yanagimachi R, 2002, MOL CELL ENDOCRINOL, V187, P241, DOI 10.1016/S0303-7207(01)00697-9; Youngson NA, 2008, ANNU REV GENOM HUM G, V9, P233, DOI 10.1146/annurev.genom.9.081307.164445	77	480	497	5	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					721	727		10.1038/nature09230	http://dx.doi.org/10.1038/nature09230			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535201				2022-12-01	WOS:000278551800034
J	Bloom, JD; Gong, LI; Baltimore, D				Bloom, Jesse D.; Gong, Lizhi Ian; Baltimore, David			Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance	SCIENCE			English	Article							NEURAMINIDASE INHIBITORS; A VIRUS; ANTIBIOTIC-RESISTANCE; PROTEIN; TRANSMISSION; REPLICATION; STABILITY; SEGMENTS; MUTANTS	The His(274)-> Tyr(274) (H274Y) mutation confers oseltamivir resistance on N1 influenza neuraminidase but had long been thought to compromise viral fitness. However, beginning in 2007-2008, viruses containing H274Y rapidly became predominant among human seasonal H1N1 isolates. We show that H274Y decreases the amount of neuraminidase that reaches the cell surface and that this defect can be counteracted by secondary mutations that also restore viral fitness. Two such mutations occurred in seasonal H1N1 shortly before the widespread appearance of H274Y. The evolution of oseltamivir resistance was therefore enabled by "permissive" mutations that allowed the virus to tolerate subsequent occurrences of H274Y. An understanding of this process may provide a basis for predicting the evolution of oseltamivir resistance in other influenza strains.	[Bloom, Jesse D.; Gong, Lizhi Ian; Baltimore, David] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu	Bloom, Jesse D/K-3695-2019; Bloom, Jesse D/C-6837-2013	Bloom, Jesse D/0000-0003-1267-3408	Cancer Research Institute; California Institute of Technology; NATIONAL CANCER INSTITUTE [P01CA132681] Funding Source: NIH RePORTER	Cancer Research Institute; California Institute of Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J.D.B. was supported by a Beckman Institute Postdoctoral Fellowship and the Irvington Institute Fellowship Program of the Cancer Research Institute. L.I.G. was supported by a Summer Undergraduate Research Fellowship from the California Institute of Technology. Oseltamivir carboxylate was kindly provided by Roche.	Abed Y, 2004, ANTIVIR THER, V9, P577; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000349; Collins PJ, 2008, NATURE, V453, P1258, DOI 10.1038/nature06956; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Ives JAL, 2002, ANTIVIR RES, V55, P307, DOI 10.1016/S0166-3542(02)00053-0; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kelleher AD, 2001, J EXP MED, V193, P375, DOI 10.1084/jem.193.3.375; Kramarz P, 2009, EUROSURVEILLANCE, V14; Liang YY, 2005, J VIROL, V79, P10348, DOI 10.1128/JVI.79.16.10348-10355.2005; LIU CG, 1995, J VIROL, V69, P1099, DOI 10.1128/JVI.69.2.1099-1106.1995; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; MITRAKI A, 1991, SCIENCE, V253, P54, DOI 10.1126/science.1648264; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Muramoto Y, 2006, J VIROL, V80, P2318, DOI 10.1128/JVI.80.5.2318-2325.2006; Nayak DP, 2009, VIRUS RES, V143, P147, DOI 10.1016/j.virusres.2009.05.010; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000133; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Po ALW, 2009, EMERG INFECT DIS, V15, P1686, DOI 10.3201/eid1510.090844; Poteete AR, 1997, PROTEIN SCI, V6, P2418; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Rameix-Welti MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000103; Russell RJ, 2006, NATURE, V443, P45, DOI 10.1038/nature05114; Schrag SJ, 1997, P ROY SOC B-BIOL SCI, V264, P1287, DOI 10.1098/rspb.1997.0178; Simonsen L, 2007, MOL BIOL EVOL, V24, P1811, DOI 10.1093/molbev/msm103; Suzuki T, 2005, J VIROL, V79, P11705, DOI 10.1128/JVI.79.18.11705-11715.2005; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; Wang XJ, 2002, J MOL BIOL, V320, P85, DOI 10.1016/S0022-2836(02)00400-X; 2010, WKLY EPIDEMIOL REC, V85, P37	32	472	493	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 4	2010	328	5983					1272	1275		10.1126/science.1187816	http://dx.doi.org/10.1126/science.1187816			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522774	Green Accepted			2022-12-01	WOS:000278318600033
J	Branco, T; Clark, BA; Hausser, M				Branco, Tiago; Clark, Beverley A.; Haeusser, Michael			Dendritic Discrimination of Temporal Input Sequences in Cortical Neurons	SCIENCE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; BASAL DENDRITES; SYNAPTIC INTEGRATION; ACTION-POTENTIALS; SPIKES; PLASTICITY; REPRESENTATION; MECHANISM; NETWORK; CELLS	The detection and discrimination of temporal sequences is fundamental to brain function and underlies perception, cognition, and motor output. By applying patterned, two-photon glutamate uncaging, we found that single dendrites of cortical pyramidal neurons exhibit sensitivity to the sequence of synaptic activation. This sensitivity is encoded by both local dendritic calcium signals and somatic depolarization, leading to sequence-selective spike output. The mechanism involves dendritic impedance gradients and nonlinear synaptic N-methyl-D-aspartate receptor activation and is generalizable to dendrites in different neuronal types. This enables discrimination of patterns delivered to a single dendrite, as well as patterns distributed randomly across the dendritic tree. Pyramidal cell dendrites can thus act as processing compartments for the detection of synaptic sequences, thereby implementing a fundamental cortical computation.	[Haeusser, Michael] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Hausser, M (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	m.hausser@ucl.ac.uk	Clark, Beverley/C-1519-2008; Branco, Tiago/C-1503-2008; Hausser, Michael/AAW-6827-2020	Hausser, Michael/0000-0002-2673-8957	Wellcome Trust; Gatsby Charitable Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Gatsby Charitable Foundation	We thank M. London, A. Roth, P. Dayan, J. Jack, and S. Smith for discussions; B. Judkewitz for help with image acquisition software; and C. Schmidt-Hieber for help with hippocampal granule cell experiments. This work was supported by grants from the Wellcome Trust and the Gatsby Charitable Foundation.	BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Borg-Graham L.J., 1992, SINGLE NEURON COMPUT, P347; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Gordon U, 2006, J NEUROSCI, V26, P12717, DOI 10.1523/JNEUROSCI.3502-06.2006; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Han F, 2008, NEURON, V60, P321, DOI 10.1016/j.neuron.2008.08.026; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; Johnston D, 2008, TRENDS NEUROSCI, V31, P309, DOI 10.1016/j.tins.2008.03.004; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Lazar A, 2009, FRONT COMPUT NEUROSC, V3, DOI 10.3389/neuro.10.023.2009; Lee SH, 2005, NAT NEUROSCI, V8, P22, DOI 10.1038/nn1365; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Major G, 2008, J NEUROPHYSIOL, V99, P2584, DOI 10.1152/jn.00011.2008; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MEISTER M, 1995, SCIENCE, V270, P1207, DOI 10.1126/science.270.5239.1207; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Rall W., 1964, NEURAL THEORY MODELI, P73; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 2001, CURR OPIN NEUROBIOL, V11, P343, DOI 10.1016/S0959-4388(00)00217-8; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Thorpe S, 2001, NEURAL NETWORKS, V14, P715, DOI 10.1016/S0893-6080(01)00083-1; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3	34	272	274	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2010	329	5999					1671	1675		10.1126/science.1189664	http://dx.doi.org/10.1126/science.1189664			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653NK	20705816	Green Accepted			2022-12-01	WOS:000282098100049
J	Alvarado, D; Klein, DE; Lemmon, MA				Alvarado, Diego; Klein, Daryl E.; Lemmon, Mark A.			Structural Basis for Negative Cooperativity in Growth Factor Binding to an EGF Receptor	CELL			English	Article							AFFINITY INSULIN-BINDING; EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; LIGAND-BINDING; ALLOSTERIC REGULATION; ACTIVATION; DIMERIZATION; REGION; MODEL; OLIGOMERIZATION	Transmembrane signaling by the epidermal growth factor receptor (EGFR) involves ligand-induced dimerization and allosteric regulation of the intracellular tyrosine kinase domain. Crystallographic studies have shown how ligand binding induces dimerization of the EGFR extracellular region but cannot explain the "high-affinity" and "low-affinity" classes of cell-surface EGF-binding sites inferred from curved Scatchard plots. From a series of crystal structures of the Drosophila EGFR extracellular region, we show here how Scatchard plot curvature arises from negatively cooperative ligand binding. The first ligand-binding event induces formation of an asymmetric dimer with only one bound ligand. The unoccupied site in this dimer is structurally restrained, leading to reduced affinity for binding of the second ligand, and thus negative cooperativity. Our results explain the cell-surface binding characteristics of EGF receptors and suggest how individual EGFR ligands might stabilize distinct dimeric species with different signaling properties.	[Alvarado, Diego; Klein, Daryl E.; Lemmon, Mark A.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania	Lemmon, MA (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	mlemmon@mail.med.upenn.edu	Garzon-Alvarado, Diego/AAD-6607-2019	Lemmon, Mark/0000-0002-3379-5319; Klein, Daryl/0000-0002-7188-0450	NCRR [RR-01646]; NCI [Y1-CO-1020]; NIGMS [Y1-GM-1104]; U.S. Department of Energy; NIH [R01-CA125432, R01-CA079992, T32HD007516]; U.S. Army Breast Cancer Research Program; Damon Runyon Cancer Research Foundation [DRG-1884-05]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007516] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA079992, R01CA125432] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER	NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Breast Cancer Research Program(United States Department of Defense); Damon Runyon Cancer Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Kate Ferguson, Jim Shorter, Jason Davis, Greg Van Duyne, Ben Black, Steve Stayrook, and members of the Lemmon and Ferguson laboratories for valuable comments. Crystallographic data were collected at Cornell High Energy Synchrotron Source (CHESS) beamline F1, supported by the NSF and NIH/NIGMS under NSF award DMR-0225180, using the Macromolecular Diffraction at CHESS (MacCHESS) facility supported by the NCRR (RR-01646). Additional data were collected at the GM/CA Collaborative Access Team at the Advanced Photon Source (APS), funded by the NCI (Y1-CO-1020), NIGMS (Y1-GM-1104), and the U.S. Department of Energy (contract W-31-109-ENG-38). This work was funded by NIH grants R01-CA125432 and R01-CA079992 (M.A.L.) and predoctoral fellowship W81XWH-04-1-0328 from the U.S. Army Breast Cancer Research Program (D.E.K.). D.A. was supported by NIH postdoctoral training grant T32HD007516 and a postdoctoral fellowship from the Damon Runyon Cancer Research Foundation (DRG-1884-05).	Adams TE, 2009, GROWTH FACTORS, V27, P141, DOI 10.1080/08977190902843565; Alvarado D, 2009, NATURE, V461, P287, DOI 10.1038/nature08297; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bass J, 1996, J BIOL CHEM, V271, P19367, DOI 10.1074/jbc.271.32.19367; BELLOT F, 1990, J CELL BIOL, V110, P491, DOI 10.1083/jcb.110.2.491; Bouyain S, 2005, P NATL ACAD SCI USA, V102, P15024, DOI 10.1073/pnas.0507591102; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DEFIZE LHK, 1989, J CELL BIOL, V109, P2495, DOI 10.1083/jcb.109.5.2495; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson KM, 2008, ANNU REV BIOPHYS, V37, P353, DOI 10.1146/annurev.biophys.37.032807.125829; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; GROENEN LC, 1994, GROWTH FACTORS, V11, P235, DOI 10.3109/08977199409010997; Hoyne PA, 2000, FEBS LETT, V479, P15, DOI 10.1016/S0014-5793(00)01872-X; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Klein P, 2004, P NATL ACAD SCI USA, V101, P929, DOI 10.1073/pnas.0307285101; Koshland DE, 1996, CURR OPIN STRUC BIOL, V6, P757, DOI 10.1016/S0959-440X(96)80004-2; LAX I, 1991, J BIOL CHEM, V266, P13828; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; LEVITZKI A, 1971, BIOCHEMISTRY-US, V10, P3371, DOI 10.1021/bi00794a009; LIVNEH E, 1986, J BIOL CHEM, V261, P2490; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; Macdonald-Obermann JL, 2009, J BIOL CHEM, V284, P13570, DOI 10.1074/jbc.M109.001487; MAGUN BE, 1980, J BIOL CHEM, V255, P6373; Odaka M, 1997, J BIOCHEM-TOKYO, V122, P116; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; SCHLESSINGER J, 1986, J CELL BIOL, V103, P2067, DOI 10.1083/jcb.103.6.2067; Schnepp B, 1998, GENE DEV, V12, P908, DOI 10.1101/gad.12.7.908; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; SHOYAB M, 1979, NATURE, V279, P387, DOI 10.1038/279387a0; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI 10.1016/j.yexcr.2008.08.013; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; WOFSY C, 1992, BIOPHYS J, V63, P98, DOI 10.1016/S0006-3495(92)81572-2; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035	48	131	133	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2010	142	4					568	579		10.1016/j.cell.2010.07.015	http://dx.doi.org/10.1016/j.cell.2010.07.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20723758	Green Accepted, Bronze			2022-12-01	WOS:000281115900011
J	Wu, XL; Yang, ZY; Li, YX; Hogerkorp, CM; Schief, WR; Seaman, MS; Zhou, TQ; Schmidt, SD; Wu, L; Xu, L; Longo, NS; McKee, K; O'Dell, S; Louder, MK; Wycuff, DL; Feng, Y; Nason, M; Doria-Rose, N; Connors, M; Kwong, PD; Roederer, M; Wyatt, RT; Nabel, GJ; Mascola, JR				Wu, Xueling; Yang, Zhi-Yong; Li, Yuxing; Hogerkorp, Carl-Magnus; Schief, William R.; Seaman, Michael S.; Zhou, Tongqing; Schmidt, Stephen D.; Wu, Lan; Xu, Ling; Longo, Nancy S.; McKee, Krisha; O'Dell, Sijy; Louder, Mark K.; Wycuff, Diane L.; Feng, Yu; Nason, Martha; Doria-Rose, Nicole; Connors, Mark; Kwong, Peter D.; Roederer, Mario; Wyatt, Richard T.; Nabel, Gary J.; Mascola, John R.			Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1	SCIENCE			English	Article							TYPE-1 INFECTION; HIGH-AFFINITY; VIRUS; GP120; BREADTH; GLYCOPROTEIN; INDIVIDUALS; PANEL; IMMUNOGENICITY; SPECIFICITIES	Cross-reactive neutralizing antibodies (NAbs) are found in the sera of many HIV-1-infected individuals, but the virologic basis of their neutralization remains poorly understood. We used knowledge of HIV-1 envelope structure to develop antigenically resurfaced glycoproteins specific for the structurally conserved site of initial CD4 receptor binding. These probes were used to identify sera with NAbs to the CD4-binding site (CD4bs) and to isolate individual B cells from such an HIV-1-infected donor. By expressing immunoglobulin genes from individual cells, we identified three monoclonal antibodies, including a pair of somatic variants that neutralized over 90% of circulating HIV-1 isolates. Exceptionally broad HIV-1 neutralization can be achieved with individual antibodies targeted to the functionally conserved CD4bs of glycoprotein 120, an important insight for future HIV-1 vaccine design.	[Wu, Xueling; Yang, Zhi-Yong; Li, Yuxing; Hogerkorp, Carl-Magnus; Zhou, Tongqing; Schmidt, Stephen D.; Wu, Lan; Xu, Ling; Longo, Nancy S.; McKee, Krisha; O'Dell, Sijy; Louder, Mark K.; Wycuff, Diane L.; Feng, Yu; Kwong, Peter D.; Roederer, Mario; Wyatt, Richard T.; Nabel, Gary J.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Nason, Martha] NIAID, Biostat Res Branch, Div Clin Res, NIH, Bethesda, MD 20892 USA; [Doria-Rose, Nicole; Connors, Mark] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Schief, William R.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Seaman, Michael S.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Nabel, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	gnabel@nih.gov; jmascola@nih.gov	Zhou, Tongqing/A-6880-2010; Schief, William/ABF-3645-2020; Roederer, Mario/G-1887-2011; Feng, Yu/A-3396-2012; Schmidt, Stephen/AAC-6967-2019; Mascola, John/AAI-7193-2021; Schmidt, Stephen/B-5398-2012	Zhou, Tongqing/0000-0002-3935-4637; Schief, William/0000-0002-1120-0150; 	Vaccine Research Center; Division of Clinical Research; Laboratory of Immunoregulation of National Institute of Allergy and Infectious Diseases, NIH; Bill and Melinda Gates Foundation; International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005089, ZIAAI005095, ZIAAI005022, ZIAAI001090, ZIAAI005010, ZIAAI005002, ZIAAI005067] Funding Source: NIH RePORTER	Vaccine Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Clinical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Laboratory of Immunoregulation of National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the Vaccine Research Center, the Division of Clinical Research and the Laboratory of Immunoregulation of National Institute of Allergy and Infectious Diseases, NIH. M.S.S. was supported in part by the Bill and Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery, Comprehensive Antibody-Vaccine Immune Monitoring Consortium, grant number 38619. W.R.S. was supported by the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery through a grant to Seattle Biomedical Research Institute and by the International AIDS Vaccine Initiative. Nucleotide sequences of VRC01, VRC02, and VRC03 variable regions are available under GenBank accession numbers GU980702 to GU980707. Patent applications have been filed by the NIH on mAbs VRC01, VRC02, and VRC03 (listed investigators are X.W., Z.Y.Y., Y.L., C.M.H, W.R.S., T.Z., M.C., P.D.K., M.R., R.T.W., G.J.N., and J.R.M.) and on the RSC3 probe (listed investigators are Z.Y.Y., W.R.S., T.Z., P.D.K. and G.J.N.). We thank M. Nussenzweig and J. Scheid (Laboratory of Molecular Immunology, Howard Hughes Medical Institute, Rockefeller University, New York, NY) for sharing expertise and reagents for IgG cloning and expression; B. Haynes (Duke University Medical Center, Durham, NC) for sharing reagents and PCR methods; S. Perfetto, R. Nguyen, and D. Ambrozak for assistance with cell sorting; E. Lybarger for neutralization assays; J. Stuckey and B. Hartman for assistance with figures; A. Tislerics for manuscript preparation; D. Follman for statistical advice; C. Carrico for discussions on resurfacing; Y.-E.A. Ban and L. Kong for glycan modeling; P. Chattopadhyay and J. Yu for fluorescent antibody production and qualification; C. Williamson (University of Capetown, Capetown, South Africa), M. Thomson (Instituto de Salud Carlos III, Madrid, Spain), J. Overbaugh (Fred Hutchinson Cancer Research Center, Seattle, WA), and S. Tovanabutra and E. Sanders-Buell (Henry M. Jackson Foundation and the U. S. Military HIV Research Program, Rockville, MD) for contributing HIV-1 Env plasmids for pseudovirus production.	Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Decks SG, 2006, J VIROL, V80, P6155, DOI 10.1128/JVI.00093-06; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Forsman A, 2008, J VIROL, V82, P12069, DOI 10.1128/JVI.01379-08; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Korber B, 2009, CURR OPIN HIV AIDS, V4, P408, DOI 10.1097/COH.0b013e32832f129e; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Montefiori DC, 2007, CURR OPIN HIV AIDS, V2, P169, DOI 10.1097/COH.0b013e3280ef691e; Moore JP, 1996, J VIROL, V70, P1863, DOI 10.1128/JVI.70.3.1863-1872.1996; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shen XY, 2009, J VIROL, V83, P3617, DOI 10.1128/JVI.02631-08; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Smith DM, 2006, VIROLOGY, V355, P1, DOI 10.1016/j.virol.2006.08.009; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Yuste E, 2006, J VIROL, V80, P3030, DOI 10.1128/JVI.80.6.3030-3041.2006; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307	33	1276	1395	2	184	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2010	329	5993					856	861		10.1126/science.1187659	http://dx.doi.org/10.1126/science.1187659			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20616233	Green Accepted			2022-12-01	WOS:000280809900055
J	Mendez-Ferrer, S; Michurina, TV; Ferraro, F; Mazloom, AR; MacArthur, BD; Lira, SA; Scadden, DT; Ma'ayan, A; Enikolopov, GN; Frenette, PS				Mendez-Ferrer, Simon; Michurina, Tatyana V.; Ferraro, Francesca; Mazloom, Amin R.; MacArthur, Ben D.; Lira, Sergio A.; Scadden, David T.; Ma'ayan, Avi; Enikolopov, Grigori N.; Frenette, Paul S.			Mesenchymal and haematopoietic stem cells form a unique bone marrow niche	NATURE			English	Article							PROGENITOR CELLS; SELF-RENEWAL; NEURAL STEM; EXPRESSION; DIFFERENTIATION; OSTEOPONTIN; OSTEOBLASTS; COOPERATION; RECEPTORS; COMPONENT	The cellular constituents forming the haematopoietic stem cell (HSC) niche in the bone marrow are unclear, with studies implicating osteoblasts, endothelial and perivascular cells. Here we demonstrate that mesenchymal stem cells (MSCs), identified using nestin expression, constitute an essential HSC niche component. Nestin(+) MSCs contain all the bone-marrow colony-forming-unit fibroblastic activity and can be propagated as non-adherent 'mesenspheres' that can self-renew and expand in serial transplantations. Nestin(+) MSCs are spatially associated with HSCs and adrenergic nerve fibres, and highly express HSC maintenance genes. These genes, and others triggering osteoblastic differentiation, are selectively downregulated during enforced HSC mobilization or beta 3 adrenoreceptor activation. Whereas parathormone administration doubles the number of bone marrow nestin(+) cells and favours their osteoblastic differentiation, in vivo nestin(+) cell depletion rapidly reduces HSC content in the bone marrow. Purified HSCs home near nestin(+) MSCs in the bone marrow of lethally irradiated mice, whereas in vivo nestin(+) cell depletion significantly reduces bone marrow homing of haematopoietic progenitors. These results uncover an unprecedented partnership between two distinct somatic stem-cell types and are indicative of a unique niche in the bone marrow made of heterotypic stem-cell pairs.	[Mendez-Ferrer, Simon; Lira, Sergio A.; Frenette, Paul S.] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Mendez-Ferrer, Simon; Frenette, Paul S.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Michurina, Tatyana V.; Enikolopov, Grigori N.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Ferraro, Francesca; Scadden, David T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; [Mazloom, Amin R.; MacArthur, Ben D.; Ma'ayan, Avi] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Frenette, Paul S.] Yeshiva Univ Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cold Spring Harbor Laboratory; Harvard University; Harvard Medical School; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine	Frenette, PS (corresponding author), Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA.	simon.mendez-ferrer@cnic.es; paul.frenette@einstein.yu.edu	Ma'ayan, Avi/AAG-3131-2019; Méndez-Ferrer, Simón/ABG-8547-2020; Enikolopov, Grigori/P-5731-2019; Frenette, Paul S/J-8272-2012; Méndez-Ferrer, Simón/L-8088-2014	Ma'ayan, Avi/0000-0002-6904-1017; Méndez-Ferrer, Simón/0000-0002-9805-9988; Enikolopov, Grigori/0000-0001-8178-8917; Frenette, Paul S/0000-0003-0862-9922; Méndez-Ferrer, Simón/0000-0002-9805-9988; MacArthur, Ben/0000-0002-5396-9750	National Institutes of Health [DK056638, HL69438, HL097819]; Department of Defence [PC060271]; National Institute of Mental Health; Ira Hazan Fund; American Society of Hematology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069438, R01HL097819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defence; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ira Hazan Fund; American Society of Hematology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Garcia-Fernandez, Y. Kunisaki, C. Scheiermann, J. Isern, E. Nistal-Villan and D. Lucas for help with some experiments; M. Kiel and S. Morrison for advice about immunohistological analysis of HSCs; C. Lin for help with intravital microscopy imaging; G. Fishell for the gift of Nes-cre<SUP>ERT2</SUP> and RCE:loxP transgenic mice; J. Ahmed, W. Kao and J. Godbold for help with immunofluorescence and statistical analyses; S. Lymperi for advice about LT-CIC; L. Silberstein, G. Khitrov and W. Zhang for help with microarray experiments; M. Grisotto for help with cell sorting; and L. Shang, A. J. Peired and C. Prophete for help with animals. This work was supported by the National Institutes of Health (R01 grants DK056638, HL69438, HL097819) and the Department of Defence (Idea Development Award PC060271) to P. S. F. and by the National Institute of Mental Health and Ira Hazan Fund to G.N.E. S.M.-F. is the recipient of a Scholar Award by the American Society of Hematology. P. S. F. is an Established Investigator of the American Heart Association.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Balordi F, 2007, J NEUROSCI, V27, P14248, DOI 10.1523/JNEUROSCI.4531-07.2007; Berger SI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-372; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; CRISAN M, 2008, CURR PROTOC STEM CEL, V2; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; Katayama Y, 2003, BLOOD, V102, P2060, DOI 10.1182/blood-2003-04-1212; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Lymperi S, 2008, BLOOD, V111, P1173, DOI 10.1182/blood-2007-03-082800; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2007, ANN NY ACAD SCI, V1116, P392, DOI 10.1196/annals.1402.086; Mendez-Ferrer S, 2010, ANN NY ACAD SCI, V1192, P139, DOI 10.1111/j.1749-6632.2010.05390.x; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mignone JL, 2007, CELL CYCLE, V6, P2161, DOI 10.4161/cc.6.17.4593; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; Pardal R, 2007, CELL, V131, P364, DOI 10.1016/j.cell.2007.07.043; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SOUSA VH, 2009, CEREB CORTEX S1, V19, P1, DOI DOI 10.1093/CERCOR/BHP038; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; YAMAZAKI K, 1990, AM J ANAT, V187, P261, DOI 10.1002/aja.1001870306; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	43	2292	2393	14	376	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2010	466	7308					829	U59		10.1038/nature09262	http://dx.doi.org/10.1038/nature09262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20703299	Green Accepted			2022-12-01	WOS:000280766100028
J	Moore, CI; Carlen, M; Knoblich, U; Cardin, JA				Moore, Christopher I.; Carlen, Marie; Knoblich, Ulf; Cardin, Jessica A.			Neocortical Interneurons: From Diversity, Strength	CELL			English	Article							RAT SOMATOSENSORY CORTEX; GAMMA-OSCILLATIONS; CORTICAL INTERNEURONS; BASKET CELLS; INHIBITION; NETWORKS; DYNAMICS; HIPPOCAMPUS; NEURONS; SCHIZOPHRENIA		[Moore, Christopher I.; Carlen, Marie; Knoblich, Ulf; Cardin, Jessica A.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Moore, CI (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cim@mit.edu	Carlen, Marie Carlen/C-9112-2014; Knoblich, Ulf/A-1762-2010	Carlen, Marie Carlen/0000-0003-1658-1631; Knoblich, Ulf/0000-0002-0756-5587; Moore, Christopher/0000-0003-4534-1602	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045130] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS045130] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bacci A, 2005, TRENDS NEUROSCI, V28, P602, DOI 10.1016/j.tins.2005.08.007; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Borgers C, 2008, P NATL ACAD SCI USA, V105, P18023, DOI 10.1073/pnas.0809511105; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Fanselow EE, 2008, J NEUROPHYSIOL, V100, P2640, DOI 10.1152/jn.90691.2008; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Goldberg JH, 2005, TRENDS NEUROSCI, V28, P158, DOI 10.1016/j.tins.2005.01.005; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Klausberger T, 2003, NATURE, V421, P844, DOI 10.1038/nature01374; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Moore CI, 2008, J NEUROPHYSIOL, V99, P2035, DOI 10.1152/jn.01366.2006; Moore CI, 1999, TRENDS NEUROSCI, V22, P513, DOI 10.1016/S0166-2236(99)01452-6; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Olah S, 2009, NATURE, V461, P1278, DOI 10.1038/nature08503; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Sirota A, 2008, NEURON, V60, P683, DOI 10.1016/j.neuron.2008.09.014; Somogyi J, 2004, EUR J NEUROSCI, V19, P552, DOI 10.1111/j.0953-816X.2003.03091.x; SOMOGYI P, 1983, NEUROSCIENCE, V10, P261, DOI 10.1016/0306-4522(83)90133-1; Spence SJ, 2009, PEDIATR RES, V65, P599, DOI 10.1203/PDR.0b013e31819e7168; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Suzuki N, 2010, CEREB CORTEX, V20, P2971, DOI 10.1093/cercor/bhq046; Swadlow HA, 2003, CEREB CORTEX, V13, P25, DOI 10.1093/cercor/13.1.25; Tort ABL, 2007, P NATL ACAD SCI USA, V104, P13490, DOI 10.1073/pnas.0705708104; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Vierling-Claassen D, 2008, J NEUROPHYSIOL, V99, P2656, DOI 10.1152/jn.00870.2007; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Wilent WB, 2005, NAT NEUROSCI, V8, P1364, DOI 10.1038/nn1545; Woodruff A, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.015.2009; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	42	63	63	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 23	2010	142	2					184	188		10.1016/j.cell.2010.07.005	http://dx.doi.org/10.1016/j.cell.2010.07.005			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655460	Bronze, Green Accepted, Green Published			2022-12-01	WOS:000280204300008
J	Cai, JM; Ruffieux, P; Jaafar, R; Bieri, M; Braun, T; Blankenburg, S; Muoth, M; Seitsonen, AP; Saleh, M; Feng, XL; Mullen, K; Fasel, R				Cai, Jinming; Ruffieux, Pascal; Jaafar, Rached; Bieri, Marco; Braun, Thomas; Blankenburg, Stephan; Muoth, Matthias; Seitsonen, Ari P.; Saleh, Moussa; Feng, Xinliang; Muellen, Klaus; Fasel, Roman			Atomically precise bottom-up fabrication of graphene nanoribbons	NATURE			English	Article							CARBON; FORM	Graphene nanoribbons-narrow and straight-edged stripes of graphene, or single-layer graphite-are predicted to exhibit electronic properties that make them attractive for the fabrication of nanoscale electronic devices(1-3). In particular, although the twodimensional parent material graphene(4,5) exhibits semimetallic behaviour, quantum confinement and edge effects(2,6) should render all graphene nanoribbons with widths smaller than 10 nm semiconducting. But exploring the potential of graphene nanoribbons is hampered by their limited availability: although they have been made using chemical(7-9), sonochemical(10) and lithographic(11,12) methods as well as through the unzipping of carbon nanotubes(13-16), the reliable production of graphene nanoribbons smaller than 10 nm with chemical precision remains a significant challenge. Here we report a simple method for the production of atomically precise graphene nanoribbons of different topologies and widths, which uses surface-assisted coupling(17,18) of molecular precursors into linear polyphenylenes and their subsequent cyclodehydrogenation(19,20). The topology, width and edge periphery of the graphene nanoribbon products are defined by the structure of the precursor monomers, which can be designed to give access to a wide range of different graphene nanoribbons. We expect that our bottom-up approach to the atomically precise fabrication of graphene nanoribbons will finally enable detailed experimental investigations of the properties of this exciting class of materials. It should even provide a route to graphene nanoribbon structures with engineered chemical and electronic properties, including the theoretically predicted intraribbon quantum dots(21), superlattice structures(22) and magnetic devices based on specific graphene nanoribbon edge states(3).	[Cai, Jinming; Ruffieux, Pascal; Jaafar, Rached; Bieri, Marco; Braun, Thomas; Blankenburg, Stephan; Fasel, Roman] Empa, Swiss Fed Labs Mat Sci & Technol, Nanotech Surfaces Lab, CH-3602 Thun, Switzerland; [Cai, Jinming; Ruffieux, Pascal; Jaafar, Rached; Bieri, Marco; Braun, Thomas; Blankenburg, Stephan; Fasel, Roman] Empa, Swiss Fed Labs Mat Sci & Technol, Nanotech Surfaces Lab, CH-8600 Dubendorf, Switzerland; [Muoth, Matthias] ETH, Dept Mech & Proc Engn Micro & Nanosyst, CH-8092 Zurich, Switzerland; [Seitsonen, Ari P.] Univ Zurich, Inst Phys Chem, CH-8057 Zurich, Switzerland; [Seitsonen, Ari P.] CNRS, IMPMC, F-75252 Paris, France; [Seitsonen, Ari P.] Univ Paris 06, F-75252 Paris, France; [Saleh, Moussa; Feng, Xinliang; Muellen, Klaus] Max Planck Inst Polymer Res, D-55124 Mainz, Germany; [Fasel, Roman] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Max Planck Society; University of Bern	Fasel, R (corresponding author), Empa, Swiss Fed Labs Mat Sci & Technol, Nanotech Surfaces Lab, CH-3602 Thun, Switzerland.	muellen@mpip-mainz.mpg.de; roman.fasel@empa.ch	cai, jinming/G-7604-2015; Fasel, Roman/B-5396-2011; Seitsonen, Ari P/B-1552-2009; Fasel, Roman/M-9992-2019; Ruffieux, Pascal/E-8227-2010	cai, jinming/0000-0003-0869-1515; Fasel, Roman/0000-0002-1553-6487; Seitsonen, Ari P/0000-0003-4331-0650; Fasel, Roman/0000-0002-1553-6487; Ruffieux, Pascal/0000-0001-5729-5354; Bieri, Marco/0000-0002-9831-2146; Feng, Xinliang/0000-0003-3885-2703	Swiss National Science Foundation; NCCR Nanoscale Science; Max Planck Society; German Science Foundation (Korean-German IRTG); DFG [SPP 1355, DFG MU 334/32-1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR Nanoscale Science(Swiss National Science Foundation (SNSF)European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); German Science Foundation (Korean-German IRTG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	This work was supported by the Swiss National Science Foundation and the NCCR Nanoscale Science. R.F. and P.R. thank O. Groning and P. Groning for stimulating discussions and continued support. A. P. S. acknowledges discussions with F. Mauri and M. Lazzeri. The Mainz group acknowledges financial support from the Max Planck Society through the program ENERCHEM, the German Science Foundation (Korean-German IRTG), the DFG Priority Program SPP 1355 and DFG MU 334/32-1.	Barone V, 2006, NANO LETT, V6, P2748, DOI 10.1021/nl0617033; BRIGGS D, 1992, HIGH RESOLUTION XPS; Caldwell JD, 2010, ACS NANO, V4, P1108, DOI 10.1021/nn901585p; Campos-Delgado J, 2008, NANO LETT, V8, P2773, DOI 10.1021/nl801316d; Canas-Ventura ME, 2007, ANGEW CHEM INT EDIT, V46, P1814, DOI 10.1002/anie.200604083; Chen ZH, 2007, PHYSICA E, V40, P228, DOI 10.1016/j.physe.2007.06.020; Classen T, 2005, ANGEW CHEM INT EDIT, V44, P6142, DOI 10.1002/anie.200502007; Datta SS, 2008, NANO LETT, V8, P1912, DOI 10.1021/nl080583r; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Gourdon A, 2008, ANGEW CHEM INT EDIT, V47, P6950, DOI 10.1002/anie.200802229; Grill L, 2007, NAT NANOTECHNOL, V2, P687, DOI 10.1038/nnano.2007.346; Han MY, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206805; Huang L, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/34/344203; Jiao LY, 2010, NAT NANOTECHNOL, V5, P321, DOI [10.1038/nnano.2010.54, 10.1038/NNANO.2010.54]; Jiao LY, 2009, NATURE, V458, P877, DOI 10.1038/nature07919; Kosynkin DV, 2009, NATURE, V458, P872, DOI 10.1038/nature07872; Elias AL, 2010, NANO LETT, V10, P366, DOI 10.1021/nl901631z; Lee Y, 2010, NANO LETT, V10, P490, DOI 10.1021/nl903272n; Li XL, 2008, SCIENCE, V319, P1229, DOI 10.1126/science.1150878; Malard LM, 2009, PHYS REP, V473, P51, DOI 10.1016/j.physrep.2009.02.003; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Otero G, 2008, NATURE, V454, P865, DOI 10.1038/nature07193; Rim KT, 2007, ANGEW CHEM INT EDIT, V46, P7891, DOI 10.1002/anie.200701117; Sevincli H, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.245402; Son YW, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.216803; Son YW, 2006, NATURE, V444, P347, DOI 10.1038/nature05180; Vandescuren M, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195401; Wakabayashi K, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.125428; Yang L, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.186801; Yang XY, 2008, J AM CHEM SOC, V130, P4216, DOI 10.1021/ja710234t	30	2588	2661	53	2180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					470	473		10.1038/nature09211	http://dx.doi.org/10.1038/nature09211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	628SJ	20651687				2022-12-01	WOS:000280141200031
J	Pedchenko, V; Bondar, O; Fogo, AB; Vanacore, R; Voziyan, P; Kitching, AR; Wieslander, J; Kashtan, C; Borza, DB; Neilson, EG; Wilson, CB; Hudson, BG				Pedchenko, Vadim; Bondar, Olga; Fogo, Agnes B.; Vanacore, Roberto; Voziyan, Paul; Kitching, A. Richard; Wieslander, Joergen; Kashtan, Clifford; Borza, Dorin-Bogdan; Neilson, Eric G.; Wilson, Curtis B.; Hudson, Billy G.			Molecular Architecture of the Goodpasture Autoantigen in Anti-GBM Nephritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BASEMENT-MEMBRANE ANTIBODY; IV COLLAGEN; ALPHA-3 CHAIN; GRAVES-DISEASE; RENAL-TRANSPLANTATION; NONCOLLAGENOUS DOMAIN; CRYPTIC EPITOPES; IMMUNE PRIVILEGE; ALPORT-SYNDROME; NC1 DOMAIN	BACKGROUND In Goodpasture's disease, circulating autoantibodies bind to the noncollagenous-1 (NC1) domain of type IV collagen in the glomerular basement membrane (GBM). The specificity and molecular architecture of epitopes of tissue-bound autoantibodies are unknown. Alport's post-transplantation nephritis, which is mediated by allo-antibodies against the GBM, occurs after kidney transplantation in some patients with Alport's syndrome. We compared the conformations of the antibody epitopes in Goodpasture's disease and Alport's post-transplantation nephritis with the intention of finding clues to the pathogenesis of anti-GBM glomerulonephritis. METHODS We used an enzyme-linked immunosorbent assay to determine the specificity of circulating autoantibodies and kidney-bound antibodies to NC1 domains. Circulating antibodies were analyzed in 57 patients with Goodpasture's disease, and kidney-bound antibodies were analyzed in 14 patients with Goodpasture's disease and 2 patients with Alport's post-transplantation nephritis. The molecular architecture of key epitope regions was deduced with the use of chimeric molecules and a three-dimensional model of the alpha 345NC1 hexamer. RESULTS In patients with Goodpasture's disease, both autoantibodies to the alpha 3NC1 monomer and antibodies to the alpha 5NC1 monomer (and fewer to the alpha 4NC1 monomer) were bound in the kidneys and lungs, indicating roles for the alpha 3NC1 and alpha 5NC1 monomers as autoantigens. High antibody titers at diagnosis of anti-GBM disease were associated with ultimate loss of renal function. The antibodies bound to distinct epitopes encompassing region Ea in the alpha 5NC1 monomer and regions E-A and Eb in the alpha 3NC1 monomer, but they did not bind to the native cross-linked alpha 345NC1 hexamer. In contrast, in patients with Alport's post-transplantation nephritis, allo-antibodies bound to the E-A region of the alpha 5NC1 subunit in the intact hexamer, and binding decreased on dissociation. CONCLUSIONS The development of Goodpasture's disease may be considered an autoimmune "conformeropathy" that involves perturbation of the quaternary structure of the alpha 345NC1 hexamer, inducing a pathogenic conformational change in the alpha 3NC1 and alpha 5NC1 subunits, which in turn elicits an autoimmune response.	[Pedchenko, Vadim; Bondar, Olga; Fogo, Agnes B.; Vanacore, Roberto; Voziyan, Paul; Borza, Dorin-Bogdan; Neilson, Eric G.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Div Nephrol, Ctr Matrix Biol,Dept Med, Nashville, TN 37232 USA; [Fogo, Agnes B.; Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Fogo, Agnes B.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Kitching, A. Richard] Monash Univ, Ctr Inflammatory Dis, Dept Med, Clayton, Vic, Australia; [Wieslander, Joergen] Univ Lund Hosp, Dept Nephrol, S-22185 Lund, Sweden; [Kashtan, Clifford] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; [Wilson, Curtis B.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Monash University; Lund University; Skane University Hospital; University of Minnesota System; University of Minnesota Twin Cities; Scripps Research Institute	Hudson, BG (corresponding author), Vanderbilt Univ, Med Ctr, Div Nephrol, Ctr Matrix Biol,Dept Med, S 3223 MCN,1161 21st Ave S, Nashville, TN 37232 USA.	billy.hudson@vanderbilt.edu	Vanacore, Roberto/C-9763-2012; Vanacore, Roberto/AAD-6399-2020; Kitching, A Richard/B-6947-2013; Borza, Dorin-Bogdan/AAF-2156-2020	Vanacore, Roberto/0000-0002-2886-0606; Vanacore, Roberto/0000-0002-2886-0606; Kitching, A Richard/0000-0002-2713-2391; Borza, Dorin-Bogdan/0000-0003-4568-279X; Hudson, Billy/0000-0002-5420-4100	National Institute of Diabetes and Digestive and Kidney Diseases [DK18381-37]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080799, R37DK018381, R01DK018381] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by a grant (DK18381-37) from the National Institute of Diabetes and Digestive and Kidney Diseases (to Dr. Hudson). Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.	Abbate M, 1998, KIDNEY INT, V54, P1550, DOI 10.1046/j.1523-1755.1998.00153.x; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Bondar O, 2002, J AM SOC NEPHROL, V13, p173A; Borza DB, 2000, J BIOL CHEM, V275, P6030, DOI 10.1074/jbc.275.8.6030; Borza DB, 2005, J BIOL CHEM, V280, P27147, DOI 10.1074/jbc.M504050200; BUTKOWSKI RJ, 1987, J BIOL CHEM, V262, P7874; Calvete JJ, 2006, PROTEOMICS, V6, pS237, DOI 10.1002/pmic.200500495; Chazenbalk GD, 2002, J CLIN INVEST, V110, P209, DOI 10.1172/JCI200215745; Chen CR, 2003, J CLIN INVEST, V111, P1897, DOI 10.1172/JCI200317069; Clyne S, 2009, AM J KIDNEY DIS, V54, P1116, DOI 10.1053/j.ajkd.2009.04.026; de Laat B, 2006, BLOOD, V107, P1916, DOI 10.1182/blood-2005-05-1943; GUNWAR S, 1991, J BIOL CHEM, V266, P14088; HELLMARK T, 1994, KIDNEY INT, V46, P823, DOI 10.1038/ki.1994.338; Hellmark T, 1999, J BIOL CHEM, V274, P25862, DOI 10.1074/jbc.274.36.25862; HUDSON BG, 1992, KIDNEY INT, V42, P179, DOI 10.1038/ki.1992.276; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Kalluri R, 1996, J BIOL CHEM, V271, P9062, DOI 10.1074/jbc.271.15.9062; Kalluri R, 1996, P ASSOC AM PHYSICIAN, V108, P134; KALLURI R, 1994, P NATL ACAD SCI USA, V91, P6201, DOI 10.1073/pnas.91.13.6201; KALLURI R, 1995, J AM SOC NEPHROL, V6, P1178; Kang JS, 2007, J BIOL CHEM, V282, P10670, DOI 10.1074/jbc.M611892200; Kasahara H, 2005, INT IMMUNOL, V17, P1533, DOI 10.1093/intimm/dxh330; Kashtan CE, 2006, PEDIATR TRANSPLANT, V10, P651, DOI 10.1111/j.1399-3046.2006.00528.x; Khoshnoodi J, 2006, J BIOL CHEM, V281, P6058, DOI 10.1074/jbc.M506555200; LERNER RA, 1967, J EXP MED, V126, P989, DOI 10.1084/jem.126.6.989; MARQUARDT H, 1973, KIDNEY INT, V3, P57, DOI 10.1038/ki.1973.12; Netzer KO, 1999, J BIOL CHEM, V274, P11267, DOI 10.1074/jbc.274.16.11267; Sado Y, 1998, KIDNEY INT, V54, P311; Sado Y, 1998, KIDNEY INT, V53, P664, DOI 10.1046/j.1523-1755.1998.00795.x; Salama AD, 2001, LANCET, V358, P917, DOI 10.1016/S0140-6736(01)06077-9; SAUS J, 1988, J BIOL CHEM, V263, P13374; SAXENA R, 1989, CLIN EXP IMMUNOL, V78, P31; Schott M, 2005, TRENDS ENDOCRIN MET, V16, P243, DOI 10.1016/j.tem.2005.05.009; Segelmark M, 2003, NEPHRON CLIN PRACT, V94, pC59, DOI 10.1159/000072022; TURNER N, 1992, J CLIN INVEST, V89, P592, DOI 10.1172/JCI115625; Vanacore R, 2009, SCIENCE, V325, P1230, DOI 10.1126/science.1176811; Vanacore RM, 2008, J BIOL CHEM, V283, P22737, DOI 10.1074/jbc.M803451200; WIESLANDER J, 1985, J BIOL CHEM, V260, P8564; WILSON CB, 1973, KIDNEY INT, V3, P74, DOI 10.1038/ki.1973.14; Zhao J, 2009, KIDNEY INT, V76, P1108, DOI 10.1038/ki.2009.348	40	210	221	2	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2010	363	4					343	354		10.1056/NEJMoa0910500	http://dx.doi.org/10.1056/NEJMoa0910500			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628RU	20660402	Green Accepted			2022-12-01	WOS:000280139300007
J	Seymour, JR; Simo, R; Ahmed, T; Stocker, R				Seymour, Justin R.; Simo, Rafel; Ahmed, Tanvir; Stocker, Roman			Chemoattraction to Dimethylsulfoniopropionate Throughout the Marine Microbial Food Web	SCIENCE			English	Article							CHEMICAL DEFENSE; DIMETHYL SULFIDE; OXYRRHIS-MARINA; DMSP; CHEMOTAXIS; SULFUR; BEHAVIOR; PLANKTON; ECOLOGY; FLUX	Phytoplankton-produced dimethylsulfoniopropionate (DMSP) provides underwater and atmospheric foraging cues for several species of marine invertebrates, fish, birds, and mammals. However, its role in the chemical ecology of marine planktonic microbes is largely unknown, and there is evidence for contradictory functions. By using microfluidics and image analysis of swimming behavior, we observed attraction toward microscale pulses of DMSP and related compounds among several motile strains of phytoplankton, heterotrophic bacteria, and bacterivore and herbivore microzooplankton. Because microbial DMSP cycling is the main natural source of cloud-forming sulfur aerosols, our results highlight how adaptations to microscale chemical seascapes shape planktonic food webs, while potentially influencing climate at the global scale.	[Seymour, Justin R.; Ahmed, Tanvir; Stocker, Roman] MIT, Ralph M Parsons Lab, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Seymour, Justin R.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Seymour, Justin R.] Univ Technol Sydney, Sydney, NSW 2007, Australia; [Simo, Rafel] CSIC, ICM, Barcelona 08003, Catalonia, Spain	Massachusetts Institute of Technology (MIT); Flinders University South Australia; University of Technology Sydney; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Seymour, JR (corresponding author), MIT, Ralph M Parsons Lab, Dept Civil & Environm Engn, Cambridge, MA 02139 USA.	Justin.Seymour@uts.edu.au	Ahmed, Tanvir/AAL-3026-2020; Stocker, Roman/T-9456-2017; Stocker, Roman/N-8987-2019	Stocker, Roman/0000-0002-3199-0508; Seymour, Justin/0000-0002-3745-6541; Simo, Rafel/0000-0003-3276-7663	Australian Research Council [DP0772186]; Martin Fellowship for Sustainability; Spanish Ministry of Science and Innovation; La Cambra de Barcelona; Hayashi Fund; NSF;  [OCE-0744641-CAREER]	Australian Research Council(Australian Research Council); Martin Fellowship for Sustainability; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); La Cambra de Barcelona; Hayashi Fund; NSF(National Science Foundation (NSF)); 	This research was funded by Australian Research Council grant DP0772186 to J.R.S., a Martin Fellowship for Sustainability to T. A., the Spanish Ministry of Science and Innovation project SUMMER to R. Si., funding from La Cambra de Barcelona to R. Si. and R. S., and support from the Hayashi Fund, a Doherty Professorship and NSF grant OCE-0744641-CAREER to R. S. We thank P. Jimenez and A. Calbet for growing and providing O. marina, W. M. Durham for preparing M. pusilla, Marcos for preparing N. designis, and R. Belas for providing Silicibacter. We thank S. Strom and J. G. Mitchell for comments on an earlier version of the manuscript.	Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Blackburn N, 1998, SCIENCE, V282, P2254, DOI 10.1126/science.282.5397.2254; Cunningham GB, 2008, J EXP BIOL, V211, P3123, DOI 10.1242/jeb.018325; DeBose JL, 2008, SCIENCE, V319, P1356, DOI 10.1126/science.1151109; Evans C, 2008, LIMNOL OCEANOGR, V53, P2035, DOI 10.4319/lo.2008.53.5.2035; Fenchel T, 2002, SCIENCE, V296, P1068, DOI 10.1126/science.1070118; FUSE H, 1995, BIOSCI BIOTECH BIOCH, V59, P1773, DOI 10.1271/bbb.59.1773; Hartz AJ, 2008, J EUKARYOT MICROBIOL, V55, P18, DOI 10.1111/j.1550-7408.2007.00297.x; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; Kiene RP, 2000, J SEA RES, V43, P209, DOI 10.1016/S1385-1101(00)00023-X; Kiene RP, 2006, LIMNOL OCEANOGR-METH, V4, P80, DOI 10.4319/lom.2006.4.80; LEDYARD KM, 1993, ARCH MICROBIOL, V160, P312, DOI 10.1007/BF00292083; Malmstrom RR, 2005, LIMNOL OCEANOGR, V50, P1924, DOI 10.4319/lo.2005.50.6.1924; Miller TR, 2004, APPL ENVIRON MICROB, V70, P4692, DOI 10.1128/AEM.70.8.4692-4701.2004; Miller TR, 2004, APPL ENVIRON MICROB, V70, P3383, DOI 10.1128/AEM.70.6.3383-3391.2004; Nevitt GA, 2008, J EXP BIOL, V211, P1706, DOI 10.1242/jeb.015412; Salo V, 2009, ENVIRON MICROBIOL, V11, P3063, DOI 10.1111/j.1462-2920.2009.02011.x; Seymour JR, 2008, LIMNOL OCEANOGR-METH, V6, P477, DOI 10.4319/lom.2008.6.477; Simo R, 2001, TRENDS ECOL EVOL, V16, P287, DOI 10.1016/S0169-5347(01)02152-8; Simo R, 2009, AQUAT MICROB ECOL, V57, P43, DOI 10.3354/ame01325; Stefels J, 2007, BIOGEOCHEMISTRY, V83, P245, DOI 10.1007/s10533-007-9091-5; Stocker R, 2008, P NATL ACAD SCI USA, V105, P4209, DOI 10.1073/pnas.0709765105; Strom S, 2003, LIMNOL OCEANOGR, V48, P230, DOI 10.4319/lo.2003.48.1.0230; Van Alstyne KL, 2001, MAR ECOL PROG SER, V213, P53, DOI 10.3354/meps213053; Vila-Costa M, 2006, SCIENCE, V314, P652, DOI 10.1126/science.1131043; Welsh DT, 2000, FEMS MICROBIOL REV, V24, P263, DOI 10.1111/j.1574-6976.2000.tb00542.x; Wolfe GV, 1997, NATURE, V387, P894, DOI 10.1038/43168; Wolfe GV, 2000, BIOL BULL-US, V198, P225, DOI 10.2307/1542526; ZimmerFaust RK, 1996, LIMNOL OCEANOGR, V41, P1330, DOI 10.4319/lo.1996.41.6.1330	30	245	249	5	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2010	329	5989					342	345		10.1126/science.1188418	http://dx.doi.org/10.1126/science.1188418			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647471				2022-12-01	WOS:000279925900048
J	Reulen, RC; Winter, DL; Frobisher, C; Lancashire, ER; Stiller, CA; Jenney, ME; Skinner, R; Stevens, MC; Hawkins, MM				Reulen, Raoul C.; Winter, David L.; Frobisher, Clare; Lancashire, Emma R.; Stiller, Charles A.; Jenney, Meriel E.; Skinner, Roderick; Stevens, Michael C.; Hawkins, Michael M.		British Childhood Canc Survivor	Long-term Cause-Specific Mortality Among Survivors of Childhood Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							2ND MALIGNANT NEOPLASMS; 5-YEAR SURVIVORS; LATE DEATHS; ADOLESCENCE; OUTCOMES; COHORT	Context Survivors of childhood cancer are at increased risk of premature mortality compared with the general population, but little is known about the long-term risks of specific causes of death, particularly beyond 25 years from diagnosis at ages when background mortality in the general population starts to increase substantially. Objective To investigate long-term cause-specific mortality among 5-year survivors of childhood cancer in a large-scale population-based cohort. Design, Setting, and Patients British Childhood Cancer Survivor Study, a population-based cohort of 17 981 5-year survivors of childhood cancer diagnosed with cancer before age 15 years between 1940 and 1991 in Britain and followed up until the end of 2006. Main Outcome Measures Cause-specific standardized mortality ratios (SMRs) and absolute excess risks (AERs). Results Overall, 3049 deaths were observed, which was 11 times the number expected (SMR, 10.7; 95% confidence interval [CI], 10.3-11.1). The SMR declined with follow-up but was still 3-fold higher than expected (95% CI, 2.5-3.9) 45 years from diagnosis. The AER for deaths from recurrence declined from 97 extra deaths (95% CI, 92-101) per 10 000 person-years at 5 to 14 years from diagnosis, to 8 extra deaths (95% CI, 3-22) beyond 45 years from diagnosis. In contrast, during the same periods of follow-up, the AER for deaths from second primary cancers and circulatory causes increased from 8 extra deaths (95% CI, 7-10) and 2 extra deaths (95% CI, 2-3) to 58 extra deaths (95% CI, 38-90) and 29 extra deaths (95% CI, 16-56), respectively. Beyond 45 years from diagnosis, recurrence accounted for 7% of the excess number of deaths observed while second primary cancers and circulatory deaths together accounted for 77%. Conclusion Among a cohort of British survivors of childhood cancer, excess mortality from second primary cancers and circulatory diseases continued to occur beyond 25 years from diagnosis. JAMA. 2010; 304(2): 172-179 www.jama.com	[Reulen, Raoul C.; Winter, David L.; Frobisher, Clare; Lancashire, Emma R.; Hawkins, Michael M.] Univ Birmingham, Ctr Childhood Canc Survivor Studies, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England; [Stiller, Charles A.] Univ Oxford, Childhood Canc Res Grp, Oxford, England; [Jenney, Meriel E.] Childrens Hosp Wales, Cardiff, Wales; [Skinner, Roderick] Newcastle Upon Tyne Hosp NHS Fdn Trust, Royal Victoria Infirm, Dept Paediat & Adolescent Oncol, Newcastle Upon Tyne, Tyne & Wear, England; [Stevens, Michael C.] Univ Bristol, Inst Child Life & Hlth, Bristol, Avon, England	University of Birmingham; University of Oxford; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Bristol	Reulen, RC (corresponding author), Univ Birmingham, Ctr Childhood Canc Survivor Studies, Sch Hlth & Populat Sci, Publ Hlth Bldg, Birmingham B15 2TT, W Midlands, England.	r.c.reulen@bham.ac.uk	Frobisher, Clare/AAC-5728-2020; Pritchard-Jones, Kathy/F-4286-2014; Reulen, Raoul/AAO-1033-2020	Frobisher, Clare/0000-0003-1099-163X; Pritchard-Jones, Kathy/0000-0002-2384-9475; Reulen, Raoul/0000-0002-7328-0467; Stevens, Michael/0000-0001-6466-551X; Stiller, Charles/0000-0002-3006-7869	Cancer Research UK; Kay Kendall Leukaemia Fund; Department of Health; Scottish Ministers	Cancer Research UK(Cancer Research UK); Kay Kendall Leukaemia Fund; Department of Health; Scottish Ministers	This work was supported by Cancer Research UK and the Kay Kendall Leukaemia Fund. Dr Reulen was supported by a Cancer Research UK Graduate Training Fellowship. The Childhood Cancer Research Group receives funding from the Department of Health and the Scottish Ministers.; Cancer Research UK, the Kay Kendall Leukaemia Fund, the Department of Health, and the Scottish Ministers had no role in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	Bowers DC, 2006, J CLIN ONCOL, V24, P5277, DOI 10.1200/JCO.2006.07.2884; Breslow NE, 1987, STAT METHODS CANC RE, VII; Cardous-Ubbink MC, 2004, PEDIATR BLOOD CANCER, V42, P563, DOI 10.1002/pbc.20028; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; Dama E, 2006, HAEMATOLOGICA, V91, P1084; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Hawkins MM, 2008, PEDIATR BLOOD CANCER, V50, P1018, DOI 10.1002/pbc.21335; HAWKINS MM, 1990, ARCH DIS CHILD, V65, P1356, DOI 10.1136/adc.65.12.1356; Jenkinson HC, 2004, BRIT J CANCER, V91, P1905, DOI 10.1038/sj.bjc.6602226; LIPSHULTZ SE, 1995, NEW ENGL J MED, V332, P1738, DOI 10.1056/NEJM199506293322602; Lipshultz SE, 2008, HEART, V94, P525, DOI 10.1136/hrt.2007.136093; MacArthur AC, 2007, PEDIATR BLOOD CANCER, V48, P460, DOI 10.1002/pbc.20922; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Mertens AC, 2007, PEDIATR BLOOD CANCER, V48, P723, DOI 10.1002/pbc.21114; Moller TR, 2001, J CLIN ONCOL, V19, P3173; Morris B, 2009, NEUROLOGY, V73, P1906, DOI 10.1212/WNL.0b013e3181c17ea8; MULROONEY DA, 2009, BMJ-BRIT MED J, V339, DOI DOI 10.1136/BMJ.B4606; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; *OFF NAT STAT, 2006, MORT STAT; Olsen JH, 2009, JNCI-J NATL CANCER I, V101, P806, DOI 10.1093/jnci/djp104; ROBERTSON CM, 1994, BRIT MED J, V309, P162, DOI 10.1136/bmj.309.6948.162; Taylor A, 2004, PEDIATR BLOOD CANCER, V42, P161, DOI 10.1002/pbc.10482; van Dalen EC, 2006, EUR J CANCER, V42, P3191, DOI 10.1016/j.ejca.2006.08.005; Yeh JM, 2010, ANN INTERN MED, V152, P409, DOI 10.7326/0003-4819-152-7-201004060-00005; Yu CL, 2009, JNCI-J NATL CANCER I, V101, P581, DOI 10.1093/jnci/djp046	26	294	296	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2010	304	2					172	179		10.1001/jama.2010.923	http://dx.doi.org/10.1001/jama.2010.923			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624IN	20628130	Bronze			2022-12-01	WOS:000279811000023
J	Chakraborty, K; Chatila, M; Sinha, J; Shi, QY; Poschner, BC; Sikor, M; Jiang, GX; Lamb, DC; Hartl, FU; Hayer-Hartl, M				Chakraborty, Kausik; Chatila, Manal; Sinha, Jyoti; Shi, Qiaoyun; Poschner, Bernhard C.; Sikor, Martin; Jiang, Guoxin; Lamb, Don C.; Hartl, F. Ulrich; Hayer-Hartl, Manajit			Chaperonin-Catalyzed Rescue of Kinetically Trapped States in Protein Folding	CELL			English	Article							IN-VIVO; ENTROPIC BARRIERS; MALTOSE-BINDING; DISULFIDE BONDS; GROEL; CONFINEMENT; MECHANISM; TMAO	GroEL and GroES form a chaperonin nano-cage for single protein molecules to fold in isolation. The folding properties that render a protein chaperonin dependent are not yet understood. Here, we address this question using a double mutant of the maltose-binding protein DM-MBP as a substrate. Upon spontaneous refolding, DM-MBP populates a kinetically trapped intermediate that is collapsed but structurally disordered. Introducing two long-range disulfide bonds into DM-MBP reduces the entropic folding barrier of this intermediate and strongly accelerates native state formation. Strikingly, steric confinement of the protein in the chaperonin cage mimics the kinetic effect of constraining disulfides on folding, in a manner mediated by negative charge clusters in the cage wall. These findings suggest that chaperonin dependence correlates with the tendency of proteins to populate entropically stabilized folding intermediates. The capacity to rescue proteins from such folding traps may explain the uniquely essential role of chaperonin cages within the cellular chaperone network.	[Chakraborty, Kausik; Chatila, Manal; Sinha, Jyoti; Shi, Qiaoyun; Poschner, Bernhard C.; Jiang, Guoxin; Hartl, F. Ulrich; Hayer-Hartl, Manajit] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; [Sikor, Martin; Lamb, Don C.] Univ Munich, Dept Chem, Ctr Nanosci, D-81377 Munich, Germany; [Sikor, Martin; Lamb, Don C.] Univ Munich, Munich Ctr Integrated Prot Sci CiPSM, D-81377 Munich, Germany; [Lamb, Don C.] Univ Illinois, Dept Phys, Urbana, IL 61801 USA	Max Planck Society; University of Munich; University of Munich; University of Illinois System; University of Illinois Urbana-Champaign	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de; mhartl@biochem.mpg.de	Chakraborty, Kausik/AAL-5748-2021; Hartl, F. Ulrich/Y-8206-2019; Sinha, Jyoti/AAW-6161-2020; Hayer-Hartl, Manajit/V-8078-2017; Lamb, Don C/G-9501-2014	Sinha, Jyoti/0000-0001-9202-1789; Hayer-Hartl, Manajit/0000-0001-8213-6742; Lamb, Don C/0000-0002-0232-1903; chakraborty, kausik/0000-0001-6000-8379	Deutsche Forschungsgemeinschaft [SFB 596, SFB 749]; Ludwig-Maximi-lians-University Munich; Nanosystems Initiative Munich (NIM); Ernst-Jung Foundation; Korber Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ludwig-Maximi-lians-University Munich; Nanosystems Initiative Munich (NIM); Ernst-Jung Foundation; Korber Foundation	We thank J.R. Engen for sharing with us the blueprints of his home-built micro-flow HPLC system and A.R. Lange for technical assistance. We gratefully acknowledge financial support from Deutsche Forschungsgemeinschaft (SFB 596 to F.U.H. and M.H.-H., and SFB 749 to D.C.L.), the Ludwig-Maximi-lians-University Munich (LMUInnovativ BioImaging Network), Nanosystems Initiative Munich (NIM), the Ernst-Jung Foundation, and the Korber Foundation.	Apetri AC, 2008, P NATL ACAD SCI USA, V105, P17351, DOI 10.1073/pnas.0809794105; Bartlett AI, 2009, NAT STRUCT MOL BIOL, V16, P582, DOI 10.1038/nsmb.1592; Baumketner A, 2003, J MOL BIOL, V332, P701, DOI 10.1016/S0022-2836(03)00929-X; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; CAMACHO CJ, 1995, PROTEINS, V22, P27, DOI 10.1002/prot.340220105; CHUN SY, 1993, J BIOL CHEM, V268, P20855; CONNELLY GP, 1993, PROTEINS, V17, P87, DOI 10.1002/prot.340170111; England JL, 2008, BIOPHYS J, V95, P3391, DOI [10.1529/biophysj.108.131037, 10.1529/biophysj.l08.131037]; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hayer-Hartl M, 2006, BIOCHEMISTRY-US, V45, P13356, DOI 10.1021/bi061597j; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; Horwich AL, 2009, FEBS LETT, V583, P2654, DOI 10.1016/j.febslet.2009.06.049; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Jewett AI, 2010, CELL MOL LIFE SCI, V67, P255, DOI 10.1007/s00018-009-0164-6; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Lucent D, 2007, P NATL ACAD SCI USA, V104, P10430, DOI 10.1073/pnas.0608256104; Mainathambika BS, 2008, ANNU REV CELL DEV BI, V24, P211, DOI 10.1146/annurev.cellbio.24.110707.175333; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Qu YX, 2003, BIOCHEMISTRY-US, V42, P5837, DOI 10.1021/bi0206457; Sharma S, 2008, CELL, V133, P142, DOI 10.1016/j.cell.2008.01.048; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Tang YC, 2008, EMBO J, V27, P1458, DOI 10.1038/emboj.2008.77; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Vendruscolo M, 2003, P NATL ACAD SCI USA, V100, P14817, DOI 10.1073/pnas.2036516100; Wallin S, 2006, J PHYS-CONDENS MAT, V18, pS307, DOI 10.1088/0953-8984/18/14/S14; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zou Q, 2002, J AM CHEM SOC, V124, P1192, DOI 10.1021/ja004206b	39	105	108	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2010	142	1					112	122		10.1016/j.cell.2010.05.027	http://dx.doi.org/10.1016/j.cell.2010.05.027			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603018	Bronze			2022-12-01	WOS:000279637300017
J	Lambert, O; Bianucci, G; Post, K; de Muizon, C; Salas-Gismondi, R; Urbina, M; Reumer, J				Lambert, Olivier; Bianucci, Giovanni; Post, Klaas; de Muizon, Christian; Salas-Gismondi, Rodolfo; Urbina, Mario; Reumer, Jelle			The giant bite of a new raptorial sperm whale from the Miocene epoch of Peru	NATURE			English	Article							MARINE MAMMALS; CETACEA	The modern giant sperm whale Physeter macrocephalus, one of the largest known predators, preys upon cephalopods at great depths(1,2). Lacking a functional upper dentition, it relies on suction for catching its prey(3); in contrast, several smaller Miocene sperm whales (Physeteroidea) have been interpreted as raptorial (versus suction) feeders(4,5), analogous to the modern killer whale Orcinus orca. Whereas very large physeteroid teeth have been discovered in various Miocene localities, associated diagnostic cranial remains have not been found so far(6-8). Here we report the discovery of a new giant sperm whale from the Middle Miocene of Peru (approximately 12-13 million years ago), Leviathan melvillei, described on the basis of a skull with teeth and mandible. With a 3-m-long head, very large upper and lower teeth (maximum diameter and length of 12 cm and greater than 36 cm, respectively), robust jaws and a temporal fossa considerably larger than in Physeter, this stem physeteroid represents one of the largest raptorial predators and, to our knowledge, the biggest tetrapod bite ever found. The appearance of gigantic raptorial sperm whales in the fossil record coincides with a phase of diversification and size-range increase of the baleen-bearing mysticetes in the Miocene. We propose that Leviathan fed mostly on high-energy content medium-size baleen whales. As a top predator, together with the contemporaneous giant shark Carcharocles megalodon, it probably had a profound impact on the structuring of Miocene marine communities. The development of a vast supracranial basin in Leviathan, extending on the rostrum as in Physeter, might indicate the presence of an enlarged spermaceti organ in the former that is not associated with deep diving or obligatory suction feeding.	[Lambert, Olivier] Inst Royal Sci Nat Belgique, Dept Paleontol, B-1000 Brussels, Belgium; [Bianucci, Giovanni] Univ Pisa, Dipartimento Sci Terra, I-56126 Pisa, Italy; [Post, Klaas; Reumer, Jelle] Nat Hist Museum Rotterdam, NL-3001 KL Rotterdam, Netherlands; [de Muizon, Christian] Museum Natl Hist Nat, Dept Hist Terre, F-75005 Paris, France; [Salas-Gismondi, Rodolfo; Urbina, Mario] Univ Nacl Mayor San Marcos, Museo Hist Nat, Lima 14, Peru; [Reumer, Jelle] Univ Utrecht, Dept Geosci, NL-3508 TA Utrecht, Netherlands	University of Pisa; Museum National d'Histoire Naturelle (MNHN); Universidad Nacional Mayor de San Marcos; Utrecht University	Lambert, O (corresponding author), Museum Natl Hist Nat, Dept Hist Terre, F-75005 Paris, France.	olambert@mnhn.fr; bianucci@dst.unipi.it	De Muizon, Christian/P-4335-2017; Lambert, Olivier/AEN-2469-2022; De Muizon, Christian/Q-7986-2019	De Muizon, Christian/0000-0002-1247-8867; Lambert, Olivier/0000-0003-0740-5791; De Muizon, Christian/0000-0002-1247-8867; Salas-Gismondi, Rodolfo/0000-0001-9990-8841	Board of the Natuurhistorisch Museum Rotterdam Foundation; Belgian Federal Science Policy Office	Board of the Natuurhistorisch Museum Rotterdam Foundation; Belgian Federal Science Policy Office(Belgian Federal Science Policy Office)	We thank W. Aguirre, A. Altamirano, E. Diaz, A. Martinez and N. Valencia for assistance during fieldwork and preparation of the specimen; C. Letenneur for the reconstruction of Leviathan; P. Loubry for the photo of the tooth of Orcinus; D. J. Bohaska, G. Lenglet, J. G. Mead, C. Potter, H. van der Es, R. van Zelst and A. Varola for access to collections; M. D. Uhen for his compilation of cetacean data in The Paleobiology Database, and the Board of the Natuurhistorisch Museum Rotterdam Foundation for financial support of our research on fossil cetaceans in Peru. The work of O.L. at IRSNB was funded by the Belgian Federal Science Policy Office.	Abel O., 1905, MEMOIRES MUSEE ROYAL, V3, P1; Bianucci G, 2006, ZOOL J LINN SOC-LOND, V148, P103, DOI 10.1111/j.1096-3642.2006.00228.x; Brand LR, 2004, GEOLOGY, V32, P165, DOI 10.1130/G20079.1; Caldwell D.K., 1989, P235; Carrier DR, 2002, J EXP BIOL, V205, P1755; Cranford TW, 1999, MAR MAMMAL SCI, V15, P1133, DOI 10.1111/j.1748-7692.1999.tb00882.x; DALHEIM ME, 1999, HDB MARINE MAMMALS, V6, P281; Fordyce RE., 2001, SECONDARY ADAPTATION, P169; HIROTA K, 1996, ISL ARC, V3, P453; Hohn AA, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P11; Hone DWE, 2005, TRENDS ECOL EVOL, V20, P4, DOI 10.1016/j.tree.2004.10.012; JEFFERSON TA, 1991, MAMMAL REV, V21, P151, DOI 10.1111/j.1365-2907.1991.tb00291.x; KATO S, 1984, BIOPHYS J, V46, P35, DOI 10.1016/S0006-3495(84)83996-X; Kellogg AR, 1925, CONTRIBUTIONS PALAEO, V348, P1; Lambert O, 2008, CR PALEVOL, V7, P361, DOI 10.1016/j.crpv.2008.06.002; Leidy J., 1877, J ACAD NATURAL SCI P, V8, P209; Lindberg DR, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P67; Marx FG, 2009, P ROY SOC B-BIOL SCI, V276, P887, DOI 10.1098/rspb.2008.1473; Purdy RW, 1996, GREAT WHITE SHARKS, P67, DOI 10.1016/B978-012415031-7/50009-4; Reeves RR, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P174; RICE DW, 1989, HDB MARINE MAMMALS, V56, P177; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; TAYLOR MA, 1992, PHILOS T ROY SOC B, V335, P247, DOI 10.1098/rstb.1992.0022; Uhen MD, 2007, PALAEONTOL ELECTRON, V10; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Werth Alexander, 2000, P487, DOI 10.1016/B978-012632590-4/50017-4; Werth Alexander J., 2004, Aquatic Mammals, V30, P405, DOI 10.1578/AM.30.3.2004.405; Whitehead H., 2003, SPERM WHALES SOCIAL; Williams TM, 2004, ECOLOGY, V85, P3373, DOI 10.1890/03-0696; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	30	138	144	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					105	108		10.1038/nature09067	http://dx.doi.org/10.1038/nature09067			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596020				2022-12-01	WOS:000279343800043
J	Binder, A; Ellis, S				Binder, Allan; Ellis, Spencer			Rational Testing Investigating symmetrical polyarthritis of recent origin	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RHEUMATOID-ARTHRITIS; DISEASE; RECOMMENDATIONS; PROTEIN				Binder, A (corresponding author), Lister Hosp, Stevenage SG1 4AB, Herts, England.	allan.binder@nhs.net						ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Mjaavatten MD, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2820; Mjaavatten MD, 2009, J RHEUMATOL, V36, P1401, DOI 10.3899/jrheum.081217; *NAT I HLTH CLIN E, 2009, CLIN GUID NAT I HTLH, V79; Ostergaard M, 2008, BEST PRACT RES CL RH, V22, P1019, DOI 10.1016/j.berh.2008.09.014; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Soderlin MK, 2002, ANN RHEUM DIS, V61, P911, DOI 10.1136/ard.61.10.911; Sokka T, 2009, J RHEUMATOL, V36, P1387, DOI 10.3899/jrheum.080770; SYMMONS DPM, 1994, BRIT J RHEUMATOL, V33, P735; Syversen SW, 2008, ANN RHEUM DIS, V67, P212, DOI 10.1136/ard.2006.068247; van Dongen H, 2007, ARTHRITIS RHEUM-US, V56, P1424, DOI 10.1002/art.22525; Visser H, 2002, ARTHRITIS RHEUM, V46, P357, DOI 10.1002/art.10117	14	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2010	340								c3110	10.1136/bmj.c3110	http://dx.doi.org/10.1136/bmj.c3110			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NT	20591966				2022-12-01	WOS:000279586300014
J	Kmech, J				Kmech, Jonn			A blow to the fight against snakebite	LANCET			English	Editorial Material									Univ Alberta, Edmonton, AB T6G 2J7, Canada	University of Alberta	Kmech, J (corresponding author), Univ Alberta, Edmonton, AB T6G 2J7, Canada.							WHO (World Health Organization), 2016, WHO GUID PROD CONTR; Williams D, 2010, LANCET, V375, P89, DOI 10.1016/S0140-6736(09)61159-4; World Health Organization, VEN SNAK DISTR SPEC; 2010, FIRE DESTROYS WORLDS	4	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 12	2010	375	9731					2061	2061		10.1016/S0140-6736(10)60941-5	http://dx.doi.org/10.1016/S0140-6736(10)60941-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614OK	20542157				2022-12-01	WOS:000279069300009
J	Baylis, F				Baylis, Francoise			Pregnant women deserve better	NATURE			English	Editorial Material									[Baylis, Francoise] Dalhousie Univ, Dept Bioeth, Halifax, NS B3H 3P7, Canada; [Baylis, Francoise] Dalhousie Univ, Dept Philosophy, Halifax, NS B3H 3P7, Canada; [Baylis, Francoise] Dalhousie Univ, Dept Obstet & Gynaecol, Halifax, NS B3H 3P7, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Baylis, F (corresponding author), Dalhousie Univ, Dept Bioeth, Halifax, NS B3H 3P7, Canada.	francoise.baylis@dal.ca	Baylis, Francoise/AAP-4565-2021	Baylis, Francoise/0000-0003-2961-5802				Baylis F, 2010, J OBSTET GYNAECOL CA, V32, P473, DOI 10.1016/S1701-2163(16)34502-9; Council for International Organizations of Medical Sciences (CIOMS), INT ETH GUID BIOM RE; Lyerly Anne Drapkin, 2008, Int J Fem Approaches Bioeth, V1, P5, DOI 10.2979/FAB.2008.1.2.5	3	62	62	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					689	690		10.1038/465689a	http://dx.doi.org/10.1038/465689a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608AM	20535185				2022-12-01	WOS:000278551800019
J	Sims, M; Maxwell, R; Bauld, L; Gilmore, A				Sims, Michelle; Maxwell, Roy; Bauld, Linda; Gilmore, Anna			Short term impact of smoke-free legislation in England: retrospective analysis of hospital admissions for myocardial infarction	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; PARTICULATE AIR-POLLUTION; PASSIVE SMOKING; SECONDHAND SMOKE; YOUNG-ADULTS; SEASONAL-VARIATION; EUROPEAN-SOCIETY; WORKING GROUP; BAN; MORTALITY	Objective To measure the short term impact on hospital admissions for myocardial infarction of the introduction of smoke-free legislation in England on 1 July 2007. Design An interrupted time series design with routinely collected hospital episode statistics data. Analysis of admissions from July 2002 to September 2008 (providing five years' data from before the legislation and 15 months' data from after) using segmented Poisson regression. Setting England. Population All patients aged 18 or older living in England with an emergency admission coded with a primary diagnosis of myocardial infarction. Main outcome measures Weekly number of completed hospital admissions. Results After adjustment for secular and seasonal trends and variation in population size, there was a small but significant reduction in the number of emergency admissions for myocardial infarction after the implementation of smoke-free legislation (-2.4%, 95% confidence interval -4.06% to -0.66%, P=0.007). This equates to 1200 fewer emergency admissions for myocardial infarction (1600 including readmissions) in the first year after legislation. The reduction in admissions was significant in men (3.1%, P=0.001) and women (3.8%, P=0.007) aged 60 and over, and men (3.5%, P<0.01) but not women (2.5% P=0.38) aged under 60. Conclusion This study adds to a growing body of evidence that smoke-free legislation leads to reductions in myocardial infarctions. It builds on previous work by showing that such declines are observed even when underlying reductions in admissions and potential confounders are controlled for. The considerably smaller decline in admissions observed in England compared with many other jurisdictions probably reflects aspects of the study design and the relatively low levels of exposure to secondhand smoke in England before the legislation.	[Sims, Michelle; Gilmore, Anna] Univ Bath, Sch Hlth, Bath BA2 7AY, Avon, England; [Sims, Michelle; Bauld, Linda; Gilmore, Anna] Univ Bath, UK Ctr Tobacco Control Studies, Bath BA2 7AY, Avon, England; [Maxwell, Roy] SW Publ Hlth Observ, Bristol BS8 2RA, Avon, England; [Bauld, Linda] Univ Bath, Dept Social & Policy Sci, Bath BA2 7AY, Avon, England; [Gilmore, Anna] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of Bath; University of Bath; University of Bath; University of London; London School of Hygiene & Tropical Medicine	Gilmore, A (corresponding author), Univ Bath, Sch Hlth, Bath BA2 7AY, Avon, England.	a.gilmore@bath.ac.uk	gilmore, anna B/I-7130-2012	gilmore, anna B/0000-0003-0281-1248	Department of Health; Health Foundation; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish	Department of Health; Health Foundation; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was undertaken by the University of Bath, which received funding from the Department of Health's Policy Research Programme. The views expressed in the publication are those of the authors and not necessarily those of the Department of Health. AG is supported by a Health Foundation Clinician Scientist Fellowship. MS, LB, and AG are members of the UK Centre for Tobacco Control, a UKCRC Public Health Research: Centre of Excellence. Funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council and the Department of Health, under the auspices of the UK Clinical Research Collaboration is gratefully acknowledged. The funders played no role in the study design, analysis, and interpretation of data nor in the writing of the report or the decision to submit the article for publication.	Akaike H., 1973, 2 INT S INF THEOR, P267; Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Barone-Adesi F, 2006, EUR HEART J, V27, P2468, DOI 10.1093/eurheartj/ehl201; Bartecchi C, 2006, CIRCULATION, V114, P1490, DOI 10.1161/CIRCULATIONAHA.106.615245; Cesaroni G, 2008, CIRCULATION, V117, P1183, DOI 10.1161/CIRCULATIONAHA.107.729889; Crawford VLS, 2003, QJM-INT J MED, V96, P45, DOI 10.1093/qjmed/hcg005; Croxton PJ, 2006, INT J CLIMATOL, V26, P2287, DOI 10.1002/joc.1378; *DEP HLTH, 2009, SMOK ENGL ON YEAR; Dinno A, 2007, PREV MED, V45, P9, DOI 10.1016/j.ypmed.2007.03.013; Douglas AS, 1995, J EPIDEMIOL COMMUN H, V49, P575, DOI 10.1136/jech.49.6.575; Edwards E, 2006, SMOKE HAS CLEARED EV; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; Fox KAA, 2004, HEART, V90, P603, DOI 10.1136/hrt.2004.038679; Gemmell I, 2000, INT J EPIDEMIOL, V29, P274, DOI 10.1093/ije/29.2.274; GLANTZ SA, 1995, JAMA-J AM MED ASSOC, V273, P1047, DOI 10.1001/jama.273.13.1047; GLANTZ SA, 1991, CIRCULATION, V83, P1, DOI 10.1161/01.CIR.83.1.1; Haw SJ, 2007, BRIT MED J, V335, P549, DOI 10.1136/bmj.39315.670208.47; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; *IARC, 2009, IARC HDB CANC PREV T; Institute of Medicine, 2009, SEC SMOK EXP CARD EF; Juster HR, 2007, AM J PUBLIC HEALTH, V97, P2035, DOI 10.2105/AJPH.2006.099994; Khuder SA, 2007, PREV MED, V45, P3, DOI 10.1016/j.ypmed.2007.03.011; Kloner RA, 2004, CIRCULATION, V110, P3744, DOI 10.1161/01.CIR.0000151786.03797.18; Koek HL, 2006, HEART, V92, P162, DOI 10.1136/hrt.2004.054486; Law MR, 1997, BMJ-BRIT MED J, V315, P973, DOI 10.1136/bmj.315.7114.973; Lemstra M, 2008, CAN J PUBLIC HEALTH, V99, P62, DOI 10.1007/BF03403743; Lightwood JM, 2009, CIRCULATION, V120, P1373, DOI 10.1161/CIRCULATIONAHA.109.870691; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; MacIntyre K, 2006, HEART, V92, P691, DOI 10.1136/hrt.2005.068742; Marques-Vidal P, 2000, HEART, V84, P171, DOI 10.1136/heart.84.2.171; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1249, DOI 10.1016/j.jacc.2009.07.022; Murphy NF, 2004, BMJ-BRIT MED J, V328, P1413, DOI 10.1136/bmj.38111.650741.F7; National Centre for Classification in Health, 2010, INT STAT CLASS DIS R; *NHS INF CTR HLTH, 2010, HOSP EP STAT ONL; O'Flaherty M, 2008, HEART, V94, P178, DOI 10.1136/hrt.2007.118323; O'Flaherty M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2613; OFARRELL AM, 2004, HOSP DISCHARGE RATES; Otsuka R, 2001, JAMA-J AM MED ASSOC, V286, P436, DOI 10.1001/jama.286.4.436; PARKER DE, 1992, INT J CLIMATOL, V12, P317, DOI 10.1002/joc.3370120402; Pechacek TF, 2004, BRIT MED J, V328, P980, DOI 10.1136/bmj.328.7446.980; Pell JP, 2008, NEW ENGL J MED, V359, P482, DOI 10.1056/NEJMsa0706740; Pell JP, 1999, QJM-INT J MED, V92, P689, DOI 10.1093/qjmed/92.12.689; Peters A, 2001, CIRCULATION, V103, P2810; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Raupach T, 2006, EUR HEART J, V27, P386, DOI 10.1093/eurheartj/ehi601; Richiardi L, 2009, PREV MED, V48, P167, DOI 10.1016/j.ypmed.2008.11.013; Royal College of Physicians, 2005, GOING SMOK FREE MED; Sargent RP, 2004, BMJ-BRIT MED J, V328, P977, DOI 10.1136/bmj.38055.715683.55; SEMPLE S, 2010, ANN OCCUP HYG   0219; Seo DC, 2007, J DRUG EDUC, V37, P217, DOI 10.2190/DE.37.3.a; Sims M, 2010, ADDICTION, V105, P543, DOI 10.1111/j.1360-0443.2009.02805.x; Thun M, 1999, ENVIRON HEALTH PERSP, V107, P841, DOI 10.2307/3434563; Tu JV, 2009, CAN MED ASSOC J, V180, pE118, DOI 10.1503/cmaj.081197; *UK MET OFF, 2009, HIST CENTR ENGL TEMP; Vasselli S, 2008, Minerva Cardioangiol, V56, P197; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; WARDIE H, 2008, HLTH SURVEY ENGLAND, V1; WARDLE H, 2009, IMPACT SMOKEFREE LEG; WELLS AJ, 1994, J AM COLL CARDIOL, V24, P546, DOI 10.1016/0735-1097(94)90315-8; Whincup PH, 2004, BRIT MED J, V329, P200, DOI 10.1136/bmj.38146.427188.55; Wood S., 2006, GEN ADDITIVE MODELS	63	110	114	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 8	2010	340								c2161	10.1136/bmj.c2161	http://dx.doi.org/10.1136/bmj.c2161			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611MB	20530563	hybrid, Green Accepted, Green Published, Green Submitted			2022-12-01	WOS:000278818300002
J	Ji, H; Ehrlich, LIR; Seita, J; Murakami, P; Doi, A; Lindau, P; Lee, H; Aryee, MJ; Irizarry, RA; Kim, K; Rossi, DJ; Inlay, MA; Serwold, T; Karsunky, H; Ho, LN; Daley, GQ; Weissman, IL; Feinberg, AP				Ji, Hong; Ehrlich, Lauren I. R.; Seita, Jun; Murakami, Peter; Doi, Akiko; Lindau, Paul; Lee, Hwajin; Aryee, Martin J.; Irizarry, Rafael A.; Kim, Kitai; Rossi, Derrick J.; Inlay, Matthew A.; Serwold, Thomas; Karsunky, Holger; Ho, Lena; Daley, George Q.; Weissman, Irving L.; Feinberg, Andrew P.			Comprehensive methylome map of lineage commitment from haematopoietic progenitors	NATURE			English	Article							DNA METHYLTRANSFERASE; TRANSCRIPTION FACTOR; STEM; METHYLATION; CELLS; MICE; MEIS1	Epigenetic modifications must underlie lineage-specific differentiation as terminally differentiated cells express tissue-specific genes, but their DNA sequence is unchanged. Haematopoiesis provides a well-defined model to study epigenetic modifications during cell-fate decisions, as multipotent progenitors (MPPs) differentiate into progressively restricted myeloid or lymphoid progenitors. Although DNA methylation is critical for myeloid versus lymphoid differentiation, as demonstrated by the myeloerythroid bias in Dnmt1 hypomorphs(1), a comprehensive DNA methylation map of haematopoietic progenitors, or of any multipotent/oligopotent lineage, does not exist. Here we examined 4.6 million CpG sites throughout the genome for MPPs, common lymphoid progenitors (CLPs), common myeloid progenitors (CMPs), granulocyte/macrophage progenitors (GMPs), and thymocyte progenitors (DN1, DN2, DN3). Marked epigenetic plasticity accompanied both lymphoid and myeloid restriction. Myeloid commitment involved less global DNA methylation than lymphoid commitment, supported functionally by myeloid skewing of progenitors following treatment with a DNA methyltransferase inhibitor. Differential DNA methylation correlated with gene expression more strongly at CpG island shores than CpG islands. Many examples of genes and pathways not previously known to be involved in choice between lymphoid/myeloid differentiation have been identified, such as Arl4c and Jdp2. Several transcription factors, including Meis1, were methylated and silenced during differentiation, indicating a role in maintaining an undifferentiated state. Additionally, epigenetic modification of modifiers of the epigenome seems to be important in haematopoietic differentiation. Our results directly demonstrate that modulation of DNA methylation occurs during lineage-specific differentiation and defines a comprehensive map of the methylation and transcriptional changes that accompany myeloid versus lymphoid fate decisions.	[Ji, Hong; Murakami, Peter; Doi, Akiko; Lee, Hwajin; Irizarry, Rafael A.; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Ctr Epigenet, Baltimore, MD 21205 USA; [Ji, Hong; Murakami, Peter; Doi, Akiko; Lee, Hwajin; Irizarry, Rafael A.; Feinberg, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Ehrlich, Lauren I. R.; Seita, Jun; Lindau, Paul; Rossi, Derrick J.; Inlay, Matthew A.; Serwold, Thomas; Karsunky, Holger; Ho, Lena; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Aryee, Martin J.; Irizarry, Rafael A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Aryee, Martin J.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Kim, Kitai; Daley, George Q.] Childrens Hosp, Howard Hughes Med Inst, Manton Ctr Orphan Dis Res, Div Pediat Hematol Oncol,Stem Cell Transplantat P, Boston, MA 02115 USA; [Kim, Kitai; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Kim, Kitai; Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Kim, Kitai; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kim, Kitai; Daley, George Q.] Harvard Stem Cell Inst, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins University; Stanford University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University	Feinberg, AP (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Epigenet, 570 Rangos,725 N Wolfe St, Baltimore, MD 21205 USA.	afeinberg@jhu.edu	Seita, Jun/AAM-1478-2020; Feinberg, Andrew/AAY-7666-2020; Aryee, Martin/AAC-8113-2020; Grieshaber-Bouyer, Ricardo/R-7512-2016	Seita, Jun/0000-0002-3008-3615; Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135; Ho, Lena/0000-0002-9358-621X; Ji, Hong/0000-0002-9558-0620; Ehrlich, Lauren/0000-0002-1697-1755; Feinberg, Andrew/0000-0002-8364-1991	National Institutes of Health [R37CA053458, P50HG003233, R01AI047457, R01AI047458, R00AGO29760, CA09151, F32AI058521]; Thomas and Stacey Siebel Foundation; Leukemia and Lymphoma Society; California Institute for Regenerative Medicine [T1-00001]; NATIONAL CANCER INSTITUTE [R37CA054358, R01CA086065, T32CA009151] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290, F32AI058521, R01AI047458, R01AI047457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG029760] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thomas and Stacey Siebel Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank L. Jerabek for laboratory management, C. Richter and N. Teja for antibody production, A. Mosley, J. Dollaga and D. Escoto for animal care, E. Zuo and the Stanford PAN facility for microarray processing, and E. Briem and A. N. Allen for CHARM array processing. This investigation was supported by National Institutes of Health grants R37CA053458 and P50HG003233 (to A. P. F), R01AI047457 and R01AI047458 (to I.L.W.), and a grant from the Thomas and Stacey Siebel Foundation (to I.L.W). L.I.R.E. was supported by Special Fellow Career Development award from the Leukemia and Lymphoma Society; J. S. was supported by a fellowship from the California Institute for Regenerative Medicine (T1-00001); D.J.R. was supported by National Institutes of Health grant R00AGO29760; M.A.I. was supported by National Institutes of Health grant CA09151 and a fellowship from the California Institute for Regenerative Medicine (T1-00001); T.S. was supported by a fellowship from the National Institutes of Health (F32AI058521).	Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; Chadwick K, 2005, BLOOD, V105, P1905, DOI 10.1182/blood-2004-03-0881; Chao MP, 2008, COLD SH Q B, V73, P439, DOI 10.1101/sqb.2008.73.031; Claus R, 2005, SEMIN ONCOL, V32, P511, DOI 10.1053/j.seminoncol.2005.07.024; Crable SC, 2003, BLOOD, V101, P4757, DOI 10.1182/blood-2002-09-2702; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Du Y, 2005, BLOOD, V106, P3932, DOI 10.1182/blood-2005-03-1113; Engel N, 2009, EPIGENETICS-US, V4, P98, DOI 10.4161/epi.4.2.7858; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gupta SK, 2006, ONCOGENE, V25, P5537, DOI 10.1038/sj.onc.1209555; Hu YL, 2009, MOL CELL BIOL, V29, P5181, DOI 10.1128/MCB.00545-09; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jin CY, 2006, NAT STRUCT MOL BIOL, V13, P331, DOI 10.1038/nsmb1063; Kim K., 2010, NATURE, V467, P285, DOI [10.1038/nature09342, DOI 10.1038/NATURE09342]; King AG, 2002, P NATL ACAD SCI USA, V99, P4508, DOI 10.1073/pnas.072087899; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; Pillay LM, 2010, DEV BIOL, V340, P306, DOI 10.1016/j.ydbio.2010.01.033; Popov VM, 2010, TRENDS ENDOCRIN MET, V21, P41, DOI 10.1016/j.tem.2009.08.002; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Trowbridge JJ, 2009, CELL STEM CELL, V5, P442, DOI 10.1016/j.stem.2009.08.016; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Wei SM, 2009, BIOCHEM BIOPH RES CO, V384, P352, DOI 10.1016/j.bbrc.2009.04.125	30	464	473	1	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2010	467	7313					338	U120		10.1038/nature09367	http://dx.doi.org/10.1038/nature09367			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650CF	20720541	Green Accepted, Green Submitted			2022-12-01	WOS:000281824900041
J	Gilbert, PM; Havenstrite, KL; Magnusson, KEG; Sacco, A; Leonardi, NA; Kraft, P; Nguyen, NK; Thrun, S; Lutolf, MP; Blau, HM				Gilbert, P. M.; Havenstrite, K. L.; Magnusson, K. E. G.; Sacco, A.; Leonardi, N. A.; Kraft, P.; Nguyen, N. K.; Thrun, S.; Lutolf, M. P.; Blau, H. M.			Substrate Elasticity Regulates Skeletal Muscle Stem Cell Self-Renewal in Culture	SCIENCE			English	Article							SATELLITE CELLS; REGENERATION; EXPANSION; FATES	Stem cells that naturally reside in adult tissues, such as muscle stem cells (MuSCs), exhibit robust regenerative capacity in vivo that is rapidly lost in culture. Using a bioengineered substrate to recapitulate key biophysical and biochemical niche features in conjunction with a highly automated single-cell tracking algorithm, we show that substrate elasticity is a potent regulator of MuSC fate in culture. Unlike MuSCs on rigid plastic dishes (similar to 10(6) kilopascals), MuSCs cultured on soft hydrogel substrates that mimic the elasticity of muscle (12 kilopascals) self-renew in vitro and contribute extensively to muscle regeneration when subsequently transplanted into mice and assayed histologically and quantitatively by noninvasive bioluminescence imaging. Our studies provide novel evidence that by recapitulating physiological tissue rigidity, propagation of adult muscle stem cells is possible, enabling future cell-based therapies for muscle-wasting diseases.	[Gilbert, P. M.; Havenstrite, K. L.; Magnusson, K. E. G.; Sacco, A.; Leonardi, N. A.; Kraft, P.; Nguyen, N. K.; Blau, H. M.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Baxter Lab Stem Cell Biol,Dept Microbiol & Immuno, Stanford, CA 94305 USA; [Havenstrite, K. L.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Magnusson, K. E. G.] Royal Inst Technol KTH, Signal Proc Lab, Sch Elect Engn, SE-10044 Stockholm, Sweden; [Leonardi, N. A.; Lutolf, M. P.] Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Leonardi, N. A.; Lutolf, M. P.] Ecole Polytech Fed Lausanne, Lab Stem Cell Bioengn, CH-1015 Lausanne, Switzerland; [Thrun, S.] Stanford Univ, Dept Comp Sci, Stanford Artificial Intelligence Lab, Stanford, CA 94305 USA	Stanford University; Stanford University; Royal Institute of Technology; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Stanford University	Blau, HM (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Baxter Lab Stem Cell Biol,Dept Microbiol & Immuno, Stanford, CA 94305 USA.	hblau@stanford.edu	Lutolf, Matthias P/E-5914-2010	Gilbert, Penney/0000-0001-5509-9616	PHS [CA09151]; CIRM [TG2-01159, RT1-01001]; Leukemia and Lymphoma Society; European Young Investigator Award; NSF; NIH [2 T32 HD007249, HL096113, AG009521, AG020961, U01 HL100397]; Muscular Dystrophy Association (MDA) [4063, 4320]; EPFL; Swiss Study Foundation; John och Karin Engbloms Stipendiefond; Bio X Undergraduate Research Award; Howard Hughes Medical Institute [52005886]; JDRF [34-2008-623]; LLS [TR6025-09]; Stanford Bio-X Award [IIP3-34]; Baxter Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007249] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096113, U01HL100397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG009521, R01AG020961, R01AG009521] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); CIRM(California Institute for Regenerative Medicine); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); European Young Investigator Award; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); EPFL; Swiss Study Foundation; John och Karin Engbloms Stipendiefond; Bio X Undergraduate Research Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); JDRF(Juvenile Diabetes Research Foundation); LLS; Stanford Bio-X Award; Baxter Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank K. Koleckar, R. Tran, IBM Almaden, the Stanford Center for Innovation in In-Vivo Imaging, and the Stanford Shared FACS Facility core facilities for technical support; J. Sly, R. D. Miller, S. Kobal, S. Gobaa, R. Doyonnas, and A. Barron for valuable discussions; and F. Rossi and M. Kyba for providing alpha-7 integrin antibody and Pax7-ZsGreen mice, respectively. This work was financially supported by PHS CA09151 and CIRM TG2-01159 (P.M.G.); Leukemia and Lymphoma Society Fellow and European Young Investigator Award (M.P.L.); NSF and NIH Training Grant 2 T32 HD007249 (K.H.); Muscular Dystrophy Association (MDA) grant 4063 (A.S.); EPFL Excellence Scholarship and the Swiss Study Foundation (N.A.L.); John och Karin Engbloms Stipendiefond (K.E.G.M.); Bio X Undergraduate Research Award and Howard Hughes Medical Institute grant 52005886 (N.K.N.); and NIH grants HL096113, AG009521, AG020961, U01 HL100397, JDRF 34-2008-623, MDA grant 4320, LLS grant TR6025-09, CIRM grant RT1-01001, Stanford Bio-X Award IIP3-34, and the Baxter Foundation (H.M.B.).	Abou-Khalil R, 2009, CELL STEM CELL, V5, P298, DOI 10.1016/j.stem.2009.06.001; Bosnakovski D, 2008, STEM CELLS, V26, P3194, DOI 10.1634/stemcells.2007-1017; Callister W. D., 2000, FUNDAMENTALS MAT SCI, V471660817; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy MJ, 2007, PLOS BIOL, V5, P1120, DOI 10.1371/journal.pbio.0050102; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fukada S, 2004, EXP CELL RES, V296, P245, DOI 10.1016/j.yexcr.2004.02.018; GUSSONI E, 1992, NATURE, V356, P435, DOI 10.1038/356435a0; HARRIS JB, 1978, CLIN EXP PHARMACOL P, V5, P587, DOI 10.1111/j.1440-1681.1978.tb00714.x; Heslop L, 2000, J CELL SCI, V113, P2299; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Partridge T A, 1997, Methods Mol Biol, V75, P131; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Tajbakhsh S, 1996, DEV DYNAM, V206, P291, DOI 10.1002/(SICI)1097-0177(199607)206:3<291::AID-AJA6>3.0.CO;2-D; WAKEFORD S, 1991, MUSCLE NERVE, V14, P42, DOI 10.1002/mus.880140108; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	26	1116	1144	19	397	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 27	2010	329	5995					1078	1081		10.1126/science.1191035	http://dx.doi.org/10.1126/science.1191035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20647425	Green Accepted			2022-12-01	WOS:000281253500041
J	van Ham, TJ; Holmberg, MA; van der Goot, AT; Teuling, E; Garcia-Arencibia, M; Kim, HE; Du, D; Thijssen, KL; Wiersma, M; Burggraaff, R; van Bergeijk, P; van Rheenen, J; van Veluw, GJ; Hofstra, RMW; Rubinsztein, DC; Nollen, EAA				van Ham, Tjakko J.; Holmberg, Mats A.; van der Goot, Annemieke T.; Teuling, Eva; Garcia-Arencibia, Moises; Kim, Hyun-eui; Du, Deguo; Thijssen, Karen L.; Wiersma, Marit; Burggraaff, Rogier; van Bergeijk, Petra; van Rheenen, Jeroen; van Veluw, G. Jerre; Hofstra, Robert M. W.; Rubinsztein, David C.; Nollen, Ellen A. A.			Identification of MOAG-4/SERF as a Regulator of Age-Related Proteotoxicity	CELL			English	Article							INCLUSION-BODY FORMATION; POLYGLUTAMINE EXPANSIONS; CAENORHABDITIS-ELEGANS; PROTEIN-DEGRADATION; CELLULAR TOXICITY; MUTANT HUNTINGTIN; AGGREGATION; NEURODEGENERATION; TRANSCRIPTION; LONGEVITY	Fibrillar protein aggregates are the major pathological hallmark of several incurable, age-related, neurodegenerative disorders. These aggregates typically contain aggregation-prone pathogenic proteins, such as amyloid-beta in Alzheimer's disease and alpha-synuclein in Parkinson's disease. It is, however, poorly understood how these aggregates are formed during cellular aging. Here we identify an evolutionarily highly conserved modifier of aggregation, MOAG-4, as a positive regulator of aggregate formation in C. elegans models for polyglutamine diseases. Inactivation of MOAG-4 suppresses the formation of compact polyglutamine aggregation intermediates that are required for aggregate formation. The role of MOAG-4 in driving aggregation extends to amyloid-beta and alpha-synuclein and is evolutionarily conserved in its human orthologs SERF1A and SERF2. MOAG-4/SERF appears to act independently from HSF-1-induced molecular chaperones, proteasomal degradation, and autophagy. Our results suggest that MOAG-4/SERF regulates age-related proteotoxicity through a previously unexplored pathway, which will open up new avenues for research on age-related, neurodegenerative diseases.	[van Ham, Tjakko J.; Holmberg, Mats A.; van der Goot, Annemieke T.; Teuling, Eva; Thijssen, Karen L.; Wiersma, Marit; Burggraaff, Rogier; van Bergeijk, Petra; van Rheenen, Jeroen; van Veluw, G. Jerre; Hofstra, Robert M. W.; Nollen, Ellen A. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Garcia-Arencibia, Moises; Rubinsztein, David C.] Univ Cambridge, Dept Med Genet, Cambridge Inst Med Res, Addenbrookes Hosp, Cambridge CB2 0XY, England; [Kim, Hyun-eui] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Du, Deguo] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Du, Deguo] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Du, Deguo] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	University of Groningen; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Salk Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Nollen, EAA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	e.a.a.nollen@medgen.umcg.nl	van Ham, Tjakko/W-8614-2019; Garcia-Arencibia, Moises/B-5538-2012; Kim, Hyun-Eui/GOV-5988-2022; van Ham, Tjakko/A-1989-2015; van Ham, Tjakko/I-2382-2013; Garcia-Arencibia, Moises/K-9920-2013; Rubinsztein, David C/C-3472-2011	van Ham, Tjakko/0000-0002-2175-8713; Kim, Hyun-Eui/0000-0003-1495-1993; van Ham, Tjakko/0000-0002-2175-8713; Garcia-Arencibia, Moises/0000-0002-1618-4487; Hofstra, Robert/0000-0001-7498-3829	GUIDE; Wellcome Trust; MRC Program; NIA [P01 AG031097]; ZonMw Research Institute of the Elderly; Prinses Beatrix Fonds; de Vereniging van Huntington; Nederlandse Hersenstichting; UMCG Rosalind Franklin Fellowship; NATIONAL INSTITUTE ON AGING [P01AG031097] Funding Source: NIH RePORTER; Medical Research Council [G0600194] Funding Source: researchfish; MRC [G0600194] Funding Source: UKRI	GUIDE; Wellcome Trust(Wellcome TrustEuropean Commission); MRC Program(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ZonMw Research Institute of the Elderly; Prinses Beatrix Fonds; de Vereniging van Huntington; Nederlandse Hersenstichting; UMCG Rosalind Franklin Fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the Caenorhabditis Genetics Center, funded by the NIH National Center for Research Resources, Rick Morimoto, Tali Gidalevitz, Chris Link, and the Mitani lab for C. elegans strains, Ronald Plasterk for advice, Lieke Geerts for assistance, Andy Dillin and Jeff Kelly for reagents and support, and Jackie Senior for editing the manuscript. We thank Klaas Sjollema from the UMCG Microscopy and Imaging Center (UMIC) and Anke Terwisscha van Scheltinga for advice, Ritsert Jansen and Cisca Wijmenga for reading the manuscript, and the anonymous reviewers for suggestions. This project was funded by a GUIDE Top Master's fellowship (to A.T.v.d.G.), a Wellcome Trust Senior Fellowship (to D.C.R.), an MRC Program Grant (to D.C.R.), NIA P01 AG031097 (A.D. and J.W.K.), the ZonMw Research Institute of the Elderly, the Prinses Beatrix Fonds, de Vereniging van Huntington, the Nederlandse Hersenstichting, and a UMCG Rosalind Franklin Fellowship (to E.A.A.N.).	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; BRENNER S, 1974, GENETICS, V77, P71; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Cohen E, 2009, CELL, V139, P1157, DOI 10.1016/j.cell.2009.11.014; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Garcia SM, 2007, GENE DEV, V21, P3006, DOI 10.1101/gad.1575307; Gidalevitz T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000399; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Jorgensen EM, 2002, NAT REV GENET, V3, P356, DOI 10.1038/nrg794; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Muchowski PJ, 2002, P NATL ACAD SCI USA, V99, P727, DOI 10.1073/pnas.022628699; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Narain Y, 1999, J MED GENET, V36, P739, DOI 10.1136/jmg.36.10.739; Nollen EAA, 2001, P NATL ACAD SCI USA, V98, P12038, DOI 10.1073/pnas.201112398; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ofran Y, 2003, FEBS LETT, V544, P236, DOI 10.1016/S0014-5793(03)00456-3; Ofran Y, 2007, BIOINFORMATICS, V23, pI347, DOI 10.1093/bioinformatics/btm174; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scharf JM, 1998, NAT GENET, V20, P83, DOI 10.1038/1753; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sittler A, 1998, MOL CELL, V2, P427, DOI 10.1016/S1097-2765(00)80142-2; Spillantini MG, 2000, ANN NY ACAD SCI, V920, P16; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tissenbaum HA, 1998, GENETICS, V148, P703; van Ham TJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000027; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zhai RG, 2008, NATURE, V452, P887, DOI 10.1038/nature06721	55	76	81	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2010	142	4					601	612		10.1016/j.cell.2010.07.020	http://dx.doi.org/10.1016/j.cell.2010.07.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20723760	Bronze			2022-12-01	WOS:000281115900014
J	Frick, WF; Pollock, JF; Hicks, AC; Langwig, KE; Reynolds, DS; Turner, GG; Butchkoski, CM; Kunz, TH				Frick, Winifred F.; Pollock, Jacob F.; Hicks, Alan C.; Langwig, Kate E.; Reynolds, D. Scott; Turner, Gregory G.; Butchkoski, Calvin M.; Kunz, Thomas H.			An Emerging Disease Causes Regional Population Collapse of a Common North American Bat Species	SCIENCE			English	Article							WHITE-NOSE SYNDROME; ECOLOGY; CHYTRIDIOMYCOSIS; BIODIVERSITY; CONSERVATION; MORTALITY; DECLINES; BEHAVIOR; THREATS	White-nose syndrome (WNS) is an emerging disease affecting hibernating bats in eastern North America that causes mass mortality and precipitous population declines in winter hibernacula. First discovered in 2006 in New York State, WNS is spreading rapidly across eastern North America and currently affects seven species. Mortality associated with WNS is causing a regional population collapse and is predicted to lead to regional extinction of the little brown myotis (Myotis lucifugus), previously one of the most common bat species in North America. Novel diseases can have serious impacts on naive wildlife populations, which in turn can have substantial impacts on ecosystem integrity.	[Frick, Winifred F.; Langwig, Kate E.; Reynolds, D. Scott; Kunz, Thomas H.] Boston Univ, Dept Biol, CECB, Boston, MA 02215 USA; [Frick, Winifred F.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA; [Pollock, Jacob F.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Hicks, Alan C.; Langwig, Kate E.] New York State Dept Environm Conservat, Endangered Species Unit, Albany, NY 12233 USA; [Reynolds, D. Scott] St Pauls Sch, Concord, NH 03301 USA; [Turner, Gregory G.; Butchkoski, Calvin M.] Penn Game Commiss, Wildlife Divers Div, Harrisburg, PA 16669 USA	Boston University; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Frick, WF (corresponding author), Boston Univ, Dept Biol, CECB, 5 Cummington St, Boston, MA 02215 USA.	wfrick@batresearch.org	Frick, Winifred/ABA-3519-2020; Frick, Winifred F/G-3501-2012	Frick, Winifred/0000-0002-9469-1839; 	U.S. Fish and Wildlife Service (USFWS); USFWS Section 6; State Wildlife Grants; Federal Aid in Wildlife Restoration [WE-173-G]	U.S. Fish and Wildlife Service (USFWS)(US Fish & Wildlife Service); USFWS Section 6(US Fish & Wildlife Service); State Wildlife Grants; Federal Aid in Wildlife Restoration	Funding was provided by grants from the U.S. Fish and Wildlife Service (USFWS) to W. F. F., J.F.P., D. S. R., T. H. K., and G. G. T. We thank three anonymous reviewers, J. P. Hayes, and D. F. Doak for helpful reviews and A. M. Kilpatrick for fruitful discussion. Funding for winter counts of bats at hibernacula was provided by USFWS Section 6 and State Wildlife Grants issued to the Pennsylvania Game Commission, and by Federal Aid in Wildlife Restoration Grant WE-173-G issued to the New York State Department of Environmental Conservation. Count data from hibernating colonies were kindly provided by the Connecticut Department of Environmental Protection; the Pennsylvania Game Commission; the New York Department of Environmental Conservation; Vermont Fish and Game; the Massachusetts Division of Fisheries and Wildlife; and K. Berner, State University of New York at Cobleskill. We are grateful to the many individuals who were involved in conducting annual counts of bats at hibernacula over the past 30 years. Data are available upon request from the authors.	Barbour R.W., 1969, BATS AM; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Courchamp F, 1999, P ROY SOC B-BIOL SCI, V266, P557, DOI 10.1098/rspb.1999.0672; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davis W. H., 1965, Journal of Mammalogy, V46, P296, DOI 10.2307/1377850; Fenner F, 2000, FEMS MICROBIOL REV, V24, P123, DOI 10.1111/j.1574-6976.2000.tb00536.x; Frick WF, 2010, J ANIM ECOL, V79, P128, DOI 10.1111/j.1365-2656.2009.01615.x; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; GELUSO KN, 1976, SCIENCE, V194, P184, DOI 10.1126/science.959845; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kunz TH, 2003, BAT ECOLOGY, P3; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Luck GW, 2003, TRENDS ECOL EVOL, V18, P331, DOI 10.1016/S0169-5347(03)00100-9; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; McCallum H, 2008, TRENDS ECOL EVOL, V23, P631, DOI 10.1016/j.tree.2008.07.001; Morris W.F., 2002, QUANTITATIVE CONSERV; OSHEA TJ, 2003, USGSBRDITR2003003; POSLUSZNY ET, 2000, P BAT CONS MIN TECHN, P159; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559; Tuttle M.D., 1993, Bats (Austin), V11, P3	25	583	608	5	574	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					679	682		10.1126/science.1188594	http://dx.doi.org/10.1126/science.1188594			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689016	Green Submitted			2022-12-01	WOS:000280602700038
J	Huarte, M; Guttman, M; Feldser, D; Garber, M; Koziol, MJ; Kenzelmann-Broz, D; Khalil, AM; Zuk, O; Amit, I; Rabani, M; Attardi, LD; Regev, A; Lander, ES; Jacks, T; Rinn, JL				Huarte, Maite; Guttman, Mitchell; Feldser, David; Garber, Manuel; Koziol, Magdalena J.; Kenzelmann-Broz, Daniela; Khalil, Ahmad M.; Zuk, Or; Amit, Ido; Rabani, Michal; Attardi, Laura D.; Regev, Aviv; Lander, Eric S.; Jacks, Tyler; Rinn, John L.			A Large Intergenic Noncoding RNA Induced by p53 Mediates Global Gene Repression in the p53 Response	CELL			English	Article							BINDING-SITE; TRANSCRIPTION; APOPTOSIS; PROTEINS; PATHWAY	Recently, more than 1000 large intergenic noncoding RNAs (lincRNAs) have been reported. These RNAs are evolutionarily conserved in mammalian genomes and thus presumably function in diverse biological processes. Here, we report the identification of lincRNAs that are regulated by p53. One of these lincRNAs (lincRNA-p21) serves as a repressor in p53-dependent transcriptional responses. Inhibition of lincRNA-p21 affects the expression of hundreds of gene targets enriched for genes normally repressed by p53. The observed transcriptional repression by lincRNA-p21 is mediated through the physical association with hnRNP-K. This interaction is required for proper genomic localization of hnRNP-K at repressed genes and regulation of p53 mediates apoptosis. We propose a model whereby transcription factors activate lincRNAs that serve as key repressors by physically associating with repressive complexes and modulate their localization to sets of previously active genes.	[Huarte, Maite; Guttman, Mitchell; Garber, Manuel; Koziol, Magdalena J.; Khalil, Ahmad M.; Zuk, Or; Amit, Ido; Rabani, Michal; Regev, Aviv; Lander, Eric S.; Rinn, John L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Huarte, Maite; Koziol, Magdalena J.; Khalil, Ahmad M.; Rinn, John L.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Guttman, Mitchell; Feldser, David; Regev, Aviv; Lander, Eric S.; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Feldser, David; Jacks, Tyler] Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Kenzelmann-Broz, Daniela; Attardi, Laura D.] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA; [Kenzelmann-Broz, Daniela; Attardi, Laura D.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Massachusetts Institute of Technology (MIT); Stanford University; Stanford University; Harvard University; Harvard Medical School	Huarte, M (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	mhuarte@broadinstitute.org; jrinn@broadinstitute.org	Huarte, Maite/J-6903-2014	Huarte, Maite/0000-0003-3753-6493; Rinn, John/0000-0002-7231-7539; Koziol, Magdalena/0000-0002-4123-4343	National Institutes of Health (NIH) [1R01CA119176-01]; Smith Family Foundation; Damon Runyon Cancer Foundation; Searle Scholar Program; NATIONAL CANCER INSTITUTE [R01CA119176] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006670, DP1OD003958] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Smith Family Foundation; Damon Runyon Cancer Foundation; Searle Scholar Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Loyal A. Goff (Massachusetts Institute of Technology [MIT]) for bioinformatic support, Nadya Dimitrova (MIT) for input on the manuscript, David Garcia (MIT) for experimental assistance, and Sigrid Hart (Broad Institute) for illustration support. J.L.R. is a Damon Runyon-Rachleff, Searle, and Smith Family Foundation Scholar. J.L.R. and A. R. are Richard Merkin Foundation Scholars. This work was supported by the National Institutes of Health (NIH) Director's New Innovator Award, Smith Family Foundation, Damon Runyon Cancer Foundation, Searle Scholar Program, and NIH 1R01CA119176-01.	BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Carninci P, 2008, NAT CELL BIOL, V10, P1023, DOI 10.1038/ncb0908-1023; Denisenko ON, 1997, MOL CELL BIOL, V17, P4707, DOI 10.1128/MCB.17.8.4707; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; Garber M, 2009, BIOINFORMATICS, V25, pI54, DOI 10.1093/bioinformatics/btp190; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim K, 2008, J BIOL CHEM, V283, P9113, DOI 10.1074/jbc.M708205200; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moumen A, 2005, CELL, V123, P1065, DOI 10.1016/j.cell.2005.09.032; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; Shevchenko A, 1996, BIOCHEM SOC T, V24, P893, DOI 10.1042/bst0240893; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; vanEngeland M, 1996, CYTOMETRY, V24, P131, DOI 10.1002/(SICI)1097-0320(19960601)24:2<131::AID-CYTO5>3.0.CO;2-M; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	32	1581	1716	8	195	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					409	419		10.1016/j.cell.2010.06.040	http://dx.doi.org/10.1016/j.cell.2010.06.040			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20673990	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000280609100018
J	Potrykus, I				Potrykus, Ingo			Regulation must be revolutionized	NATURE			English	Editorial Material											Potrykus, I (corresponding author), Stigler 54, CH-4312 Magden, Switzerland.	ingo@potrykus.ch						POTRYKUS I, TRANSGENIC IN PRESS	1	54	54	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 29	2010	466	7306					561	561		10.1038/466561a	http://dx.doi.org/10.1038/466561a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	632HA	20671692	hybrid			2022-12-01	WOS:000280412100018
J	Hu, QC; Milenkovic, L; Jin, H; Scott, MP; Nachury, MV; Spiliotis, ET; Nelson, WJ				Hu, Qicong; Milenkovic, Ljiljana; Jin, Hua; Scott, Matthew P.; Nachury, Maxence V.; Spiliotis, Elias T.; Nelson, W. James			A Septin Diffusion Barrier at the Base of the Primary Cilium Maintains Ciliary Membrane Protein Distribution	SCIENCE			English	Article							CHLAMYDOMONAS-REINHARDTII; PLASMA-MEMBRANE; COMPARTMENTALIZATION; TRANSPORT; ORGANIZATION; POLARITY	In animal cells, the primary cilium transduces extracellular signals through signaling receptors localized in the ciliary membrane, but how these ciliary membrane proteins are retained in the cilium is unknown. We found that ciliary membrane proteins were highly mobile, but their diffusion was impeded at the base of the cilium by a diffusion barrier. Septin 2 (SEPT2), a member of the septin family of guanosine triphosphatases that form a diffusion barrier in budding yeast, localized at the base of the ciliary membrane. SEPT2 depletion resulted in loss of ciliary membrane protein localization and Sonic hedgehog signal transduction, and inhibited ciliogenesis. Thus, SEPT2 is part of a diffusion barrier at the base of the ciliary membrane and is essential for retaining receptor-signaling pathways in the primary cilium.	[Spiliotis, Elias T.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Hu, Qicong; Nelson, W. James] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Milenkovic, Ljiljana; Scott, Matthew P.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Milenkovic, Ljiljana; Scott, Matthew P.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Jin, Hua; Nachury, Maxence V.; Nelson, W. James] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Scott, Matthew P.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Scott, Matthew P.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Scott, Matthew P.] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Scott, Matthew P.] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA	Drexel University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Spiliotis, ET (corresponding author), Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA.	ets33@drexel.edu; wjnelson@stanford.edu	Nachury, Maxence/A-8759-2008; Nachury, Maxence/H-3695-2019	Nachury, Maxence/0000-0003-4918-1562; Nachury, Maxence/0000-0003-4918-1562	NIH [GM35527, GM089933]; Department of Defense [BC083077]; State of Pennsylvania Tobacco Settlement Funds; American Heart Association; March of Dimes; Sloan Foundation; Klingenstein Foundation; Searle Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035527, R37GM035527, R01GM089933] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); State of Pennsylvania Tobacco Settlement Funds; American Heart Association(American Heart Association); March of Dimes(March of Dimes); Sloan Foundation(Alfred P. Sloan Foundation); Klingenstein Foundation(Klingenstein Philanthropies); Searle Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Kinoshita, S. Munro, G. J. Pazour, K. Mykytyn, D. R. Beier, C. Janke, J. Christianson, R. Kopito, and T. Stearns for reagents, and J. Atkins (Applied Precision, Inc.) for technical support. Supported by NIH grant GM35527 (W.J.N.), Department of Defense Breast Cancer Research Program Predoctoral Fellowship BC083077 (Q. H.), and Drexel CURE award from the State of Pennsylvania Tobacco Settlement Funds (E. T. S.). Supported in part by grants (M.V.N.) from the American Heart Association, the March of Dimes, NIH (GM089933), and the Sloan, Klingenstein and Searle Foundations. L. M. is a Research Specialist, and M. P. S. an Investigator of the Howard Hughes Medical Institute.	Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Calvert PD, 2010, J GEN PHYSIOL, V135, P173, DOI 10.1085/jgp.200910322; Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Emmer BT, 2010, J CELL SCI, V123, P529, DOI 10.1242/jcs.062968; Follit JA, 2010, J CELL BIOL, V188, P21, DOI 10.1083/jcb.200910096; Gillingham AK, 2000, EMBO REP, V1, P524; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Hu QC, 2008, J BIOL CHEM, V283, P29563, DOI 10.1074/jbc.M804962200; Huang K, 2007, J CELL BIOL, V179, P501, DOI 10.1083/jcb.200704069; HUNNICUTT GR, 1990, J CELL BIOL, V111, P1605, DOI 10.1083/jcb.111.4.1605; Ihara M, 2005, DEV CELL, V8, P343, DOI 10.1016/j.devcel.2004.12.005; Ishikawa H, 2005, NAT CELL BIOL, V7, P517, DOI 10.1038/ncb1251; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kissel H, 2005, DEV CELL, V8, P353, DOI 10.1016/j.devcel.2005.01.021; Lancaster MA, 2009, CURR OPIN GENET DEV, V19, P220, DOI 10.1016/j.gde.2009.04.008; Marshall WF, 2006, CURR BIOL, V16, pR604, DOI 10.1016/j.cub.2006.07.012; MUSGRAVE A, 1986, PLANTA, V167, P544, DOI 10.1007/BF00391231; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Sloboda RD, 2007, J CELL BIOL, V179, P575, DOI 10.1083/jcb.200709039; Spiliotis ET, 2008, J CELL BIOL, V180, P295, DOI 10.1083/jcb.200710039; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tanaka-Takiguchi Y, 2009, CURR BIOL, V19, P140, DOI 10.1016/j.cub.2008.12.030; Tran PV, 2008, NAT GENET, V40, P403, DOI 10.1038/ng.105; Vieira OV, 2006, P NATL ACAD SCI USA, V103, P18556, DOI 10.1073/pnas.0608291103; Zhang JS, 1999, CURR BIOL, V9, P1458, DOI 10.1016/S0960-9822(00)80115-3	30	331	343	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2010	329	5990					436	439		10.1126/science.1191054	http://dx.doi.org/10.1126/science.1191054			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20558667	Green Accepted			2022-12-01	WOS:000280196500036
J	Spence, D				Spence, Des			From the Frontline Bad medicine: medicated minors	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 21	2010	341								c3907	10.1136/bmj.c3907	http://dx.doi.org/10.1136/bmj.c3907			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632GW	20659982				2022-12-01	WOS:000280411700022
J	Utne-Palm, AC; Salvanes, AGV; Currie, B; Kaartvedt, S; Nilsson, GE; Braithwaite, VA; Stecyk, JAW; Hundt, M; van der Bank, M; Flynn, B; Sandvik, GK; Klevjer, TA; Sweetman, AK; Bruchert, V; Pittman, K; Peard, KR; Lunde, IG; Strandabo, RAU; Gibbons, MJ				Utne-Palm, Anne C.; Salvanes, Anne G. V.; Currie, Bronwen; Kaartvedt, Stein; Nilsson, Goran E.; Braithwaite, Victoria A.; Stecyk, Jonathan A. W.; Hundt, Matthias; van der Bank, Megan; Flynn, Bradley; Sandvik, Guro K.; Klevjer, Thor A.; Sweetman, Andrew K.; Bruchert, Volker; Pittman, Karin; Peard, Kathleen R.; Lunde, Ida G.; Strandabo, Ronnaug A. U.; Gibbons, Mark J.			Trophic Structure and Community Stability in an Overfished Ecosystem	SCIENCE			English	Article							COASTAL UPWELLING SYSTEM; HYDROGEN-SULFIDE; BENGUELA ECOSYSTEM; NAMIBIAN SHELF; HYPOXIA; OCEAN; DETOXIFICATION; ASSOCIATION; EMISSIONS; ERUPTIONS	Since the collapse of the pelagic fisheries off southwest Africa in the late 1960s, jellyfish biomass has increased and the structure of the Benguelan fish community has shifted, making the bearded goby (Sufflogobius bibarbatus) the new predominant prey species. Despite increased predation pressure and a harsh environment, the gobies are thriving. Here we show that physiological adaptations and antipredator and foraging behaviors underpin the success of these fish. In particular, body-tissue isotope signatures reveal that gobies consume jellyfish and sulphidic diatomaceous mud, transferring "dead-end" resources back into the food chain.	[Utne-Palm, Anne C.; Salvanes, Anne G. V.; Braithwaite, Victoria A.; Hundt, Matthias; Pittman, Karin] Univ Bergen, Dept Biol, Bergen, Norway; [Currie, Bronwen] Natl Marine Informat & Res Ctr, Swakopmund, Namibia; [Kaartvedt, Stein; Klevjer, Thor A.] Univ Oslo, Dept Biol, Oslo, Norway; [Nilsson, Goran E.; Stecyk, Jonathan A. W.; Sandvik, Guro K.; Lunde, Ida G.; Strandabo, Ronnaug A. U.] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Braithwaite, Victoria A.] Penn State Univ, Sch Forest Resources, State Coll, PA USA; [Braithwaite, Victoria A.] Penn State Univ, Dept Biol, State Coll, PA USA; [Peard, Kathleen R.] Minist Fisheries & Marine Resources, Luderitz, Namibia; [van der Bank, Megan; Flynn, Bradley; Gibbons, Mark J.] Univ Western Cape, Dept Biodivers & Conservat Biol, ZA-7535 Bellville, South Africa; [Sweetman, Andrew K.] Norwegian Inst Water Res NIVA, Reg Off Bergen, Bergen, Norway; [Bruchert, Volker] Stockholm Univ, Dept Sci, S-10691 Stockholm, Sweden; [Kaartvedt, Stein] King Abdullah Univ Sci & Technol, Thuwai, Saudi Arabia	University of Bergen; University of Oslo; University of Oslo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University of the Western Cape; Norwegian Institute for Water Research (NIVA); Stockholm University; King Abdullah University of Science & Technology	Utne-Palm, AC (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	anne.palm@bio.uib.no	Gibbons, Mark/A-8806-2008; Nilsson, Göran Erik/Q-6129-2019; Lunde, Ida Gjervold/ABN-5567-2022; Nilsson, Goran E/K-7668-2012; Stecyk, Jonathan/B-4530-2013	Gibbons, Mark/0000-0002-8320-8151; Nilsson, Goran E/0000-0002-3195-3053; Stecyk, Jonathan/0000-0002-0973-9472; Bruchert, Volker/0000-0002-8956-3840; Lunde, Ida Gjervold/0000-0001-9502-6841	National Research Foundation of South Africa; Research Council of Norway; Natural Sciences and Engineering Reserach Council of Canada	National Research Foundation of South Africa(National Research Foundation - South Africa); Research Council of Norway(Research Council of Norway); Natural Sciences and Engineering Reserach Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank the crew of the G. O. Sars; F. Midtoy for assistance; and P. Ellitson, M. Hordnes, R. Jones, R. Amundsen and the rest of the scientific crew. We thank the National Research Foundation of South Africa, the Research Council of Norway, and our home institutions for funding and support. We thank BENEFIT (Benguela Environment Fisheries Interaction and Training), S. Sundby, D. C. Boyer, J. Otto Krakstad, and the crew of the research vessel Dr. Fridtjof Nansen for support with earlier goby cruises, laying the basis for the present study. We thank K. Helge Jensen for statistical support. We appreciate the comments on this manuscript by J. Giske, C. Jorgensen, M. P. Heino, and the anonymous reviewers. Care and handling of experimental animals were performed in accordance with institutional guidelines. J. A. W. S. was a postdoctoral researcher funded by the Natural Sciences and Engineering Reserach Council of Canada at the time when the research was conducted.	BAGARINAO T, 1992, AQUAT TOXICOL, V24, P21, DOI 10.1016/0166-445X(92)90015-F; BAGARINAO T, 1990, J COMP PHYSIOL B, V160, P519; Bakun A, 2004, ECOL LETT, V7, P1015, DOI 10.1111/j.1461-0248.2004.00665.x; BAKUN A, 1990, SCIENCE, V247, P198, DOI 10.1126/science.247.4939.198; Boyer DC, 2001, S AFR J MARINE SCI, V23, P5; Bruchert V, 2006, NATO SCI S SS IV EAR, V64, P161; Bruchert V, 2009, PROG OCEANOGR, V83, P169, DOI 10.1016/j.pocean.2009.07.017; Carr ME, 2001, DEEP-SEA RES PT II, V49, P59; CRAWFORD RJM, 1987, OCEANOGR MAR BIOL, V25, P353; Cury P, 2004, PROG OCEANOGR, V60, P223, DOI 10.1016/j.pocean.2004.02.007; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Domenici P, 2007, PHILOS T R SOC B, V362, P2105, DOI 10.1098/rstb.2007.2103; Freon P, 2009, PROG OCEANOGR, V83, P1, DOI 10.1016/j.pocean.2009.08.001; Gibbons MJ, 2000, S AFR J MARINE SCI, V22, P1, DOI 10.2989/025776100784125708; Hamukuaya H, 1998, S AFR J MARINE SCI, V19, P57; Heymans JJ, 2004, ECOL MODEL, V172, P175, DOI 10.1016/j.ecolmodel.2003.09.006; Kaartvedt S, 2009, MAR ECOL PROG SER, V390, P237, DOI 10.3354/meps08196; Lavik G, 2009, NATURE, V457, P581, DOI 10.1038/nature07588; Lynam CP, 2006, CURR BIOL, V16, P1976, DOI 10.1016/j.cub.2006.09.012; MATIKAINEN N, 1992, J EXP BIOL, V167, P203; MILLERO FJ, 1988, LIMNOL OCEANOGR, V33, P269, DOI 10.4319/lo.1988.33.2.0269; Monteiro PMS, 2008, DEEP-SEA RES PT I, V55, P435, DOI 10.1016/j.dsr.2007.12.010; Pang HP, 2005, AM J PHYSIOL-CELL PH, V289, pC982, DOI 10.1152/ajpcell.00364.2004; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Prosser C.L., 1961, COMP ANIMAL PHYSL; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; ROGERS J, 1991, OCEANOGR MAR BIOL, V29, P1; Schulz HN, 1999, SCIENCE, V284, P493, DOI 10.1126/science.284.5413.493; TODD ES, 1976, COPEIA, P374; van der Lingen D, 2006, LAR MAR ECOSYST, V14, P147; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Weeks SJ, 2004, DEEP-SEA RES PT I, V51, P153, DOI 10.1016/j.dsr.2003.10.004; Weeks SJ, 2002, NATURE, V415, P493, DOI 10.1038/415493b; Yamamoto J, 2008, MAR BIOL, V153, P311, DOI 10.1007/s00227-007-0807-9	34	106	109	2	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2010	329	5989					333	336		10.1126/science.1190708	http://dx.doi.org/10.1126/science.1190708			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20647468				2022-12-01	WOS:000279925900045
J	Muoio, DM				Muoio, Deborah M.			Metabolism and Vascular Fatty Acid Transport.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VEGF		[Muoio, Deborah M.] Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA; [Muoio, Deborah M.] Duke Univ, Dept Med & Pharmacol, Durham, NC USA; [Muoio, Deborah M.] Duke Univ, Dept Canc Biol, Durham, NC USA	Duke University; Duke University; Duke University	Muoio, DM (corresponding author), Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA.		Muoio, Debbie Marie/E-1147-2012	Muoio, Deborah/0000-0003-3760-9277				Breen EC, 2007, J CELL BIOCHEM, V102, P1358, DOI 10.1002/jcb.21579; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Olfert IM, 2009, J PHYSIOL-LONDON, V587, P1755, DOI 10.1113/jphysiol.2008.164384	5	8	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 15	2010	363	3					291	293		10.1056/NEJMcibr1005397	http://dx.doi.org/10.1056/NEJMcibr1005397			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625AR	20647206				2022-12-01	WOS:000279864200016
J	Pinto, D; Pagnamenta, AT; Klei, L; Anney, R; Merico, D; Regan, R; Conroy, J; Magalhaes, TR; Correia, C; Abrahams, BS; Almeida, J; Bacchelli, E; Bader, GD; Bailey, AJ; Baird, G; Battaglia, A; Berney, T; Bolshakova, N; Bolte, S; Bolton, PF; Bourgeron, T; Brennan, S; Brian, J; Bryson, SE; Carson, AR; Casallo, G; Casey, J; Chung, BHY; Cochrane, L; Corsello, C; Crawford, EL; Crossett, A; Cytrynbaum, C; Dawson, G; de Jonge, M; Delorme, R; Drmic, I; Duketis, E; Duque, F; Estes, A; Farrar, P; Fernandez, BA; Folstein, SE; Fombonne, E; Freitag, CM; Gilbert, J; Gillberg, C; Glessner, JT; Goldberg, J; Green, A; Green, J; Guter, SJ; Hakonarson, H; Heron, EA; Hill, M; Holt, R; Howe, JL; Hughes, G; Hus, V; Igliozzi, R; Kim, C; Klauck, SM; Kolevzon, A; Korvatska, O; Kustanovich, V; Lajonchere, CM; Lamb, JA; Laskawiec, M; Leboyer, M; Le Couteur, A; Leventhal, BL; Lionel, AC; Liu, XQ; Lord, C; Lotspeich, L; Lund, SC; Maestrini, E; Mahoney, W; Mantoulan, C; Marshall, CR; McConachie, H; McDougle, CJ; McGrath, J; McMahon, WM; Merikangas, A; Migita, O; Minshew, NJ; Mirza, GK; Munson, J; Nelson, SF; Noakes, C; Noor, A; Nygren, G; Oliveira, G; Papanikolaou, K; Parr, JR; Parrini, B; Paton, T; Pickles, A; Pilorge, M; Piven, J; Ponting, CP; Posey, DJ; Poustka, A; Poustka, F; Prasad, A; Ragoussis, J; Renshaw, K; Rickaby, J; Roberts, W; Roeder, K; Roge, B; Rutter, ML; Bierut, LJ; Rice, JP; Salt, J; Sansom, K; Sato, D; Segurado, R; Sequeira, AF; Senman, L; Shah, N; Sheffield, VC; Soorya, L; Sousa, I; Stein, O; Sykes, N; Stoppioni, V; Strawbridge, C; Tancredi, R; Tansey, K; Thiruvahindrapduram, B; Thompson, AP; Thomson, S; Tryfon, A; Tsiantis, J; Van Engeland, H; Vincent, JB; Volkmar, F; Wallace, S; Wang, K; Wang, ZZ; Wassink, TH; Webber, C; Weksberg, R; Wing, K; Wittemeyer, K; Wood, S; Wu, J; Yaspan, BL; Zurawiecki, D; Zwaigenbaum, L; Buxbaum, JD; Cantor, RM; Cook, EH; Coon, H; Cuccaro, ML; Devlin, B; Ennis, S; Gallagher, L; Geschwind, DH; Gill, M; Haines, JL; Hallmayer, J; Miller, J; Monaco, AP; Nurnberger, JI; Paterson, AD; Pericak-Vance, MA; Schellenberg, GD; Szatmari, P; Vicente, AM; Vieland, VJ; Wijsman, EM; Scherer, SW; Sutcliffe, JS; Betancur, C				Pinto, Dalila; Pagnamenta, Alistair T.; Klei, Lambertus; Anney, Richard; Merico, Daniele; Regan, Regina; Conroy, Judith; Magalhaes, Tiago R.; Correia, Catarina; Abrahams, Brett S.; Almeida, Joana; Bacchelli, Elena; Bader, Gary D.; Bailey, Anthony J.; Baird, Gillian; Battaglia, Agatino; Berney, Tom; Bolshakova, Nadia; Boelte, Sven; Bolton, Patrick F.; Bourgeron, Thomas; Brennan, Sean; Brian, Jessica; Bryson, Susan E.; Carson, Andrew R.; Casallo, Guillermo; Casey, Jillian; Chung, Brian H. Y.; Cochrane, Lynne; Corsello, Christina; Crawford, Emily L.; Crossett, Andrew; Cytrynbaum, Cheryl; Dawson, Geraldine; de Jonge, Maretha; Delorme, Richard; Drmic, Irene; Duketis, Eftichia; Duque, Frederico; Estes, Annette; Farrar, Penny; Fernandez, Bridget A.; Folstein, Susan E.; Fombonne, Eric; Freitag, Christine M.; Gilbert, John; Gillberg, Christopher; Glessner, Joseph T.; Goldberg, Jeremy; Green, Andrew; Green, Jonathan; Guter, Stephen J.; Hakonarson, Hakon; Heron, Elizabeth A.; Hill, Matthew; Holt, Richard; Howe, Jennifer L.; Hughes, Gillian; Hus, Vanessa; Igliozzi, Roberta; Kim, Cecilia; Klauck, Sabine M.; Kolevzon, Alexander; Korvatska, Olena; Kustanovich, Vlad; Lajonchere, Clara M.; Lamb, Janine A.; Laskawiec, Magdalena; Leboyer, Marion; Le Couteur, Ann; Leventhal, Bennett L.; Lionel, Anath C.; Liu, Xiao-Qing; Lord, Catherine; Lotspeich, Linda; Lund, Sabata C.; Maestrini, Elena; Mahoney, William; Mantoulan, Carine; Marshall, Christian R.; McConachie, Helen; McDougle, Christopher J.; McGrath, Jane; McMahon, William M.; Merikangas, Alison; Migita, Ohsuke; Minshew, Nancy J.; Mirza, Ghazala K.; Munson, Jeff; Nelson, Stanley F.; Noakes, Carolyn; Noor, Abdul; Nygren, Gudrun; Oliveira, Guiomar; Papanikolaou, Katerina; Parr, Jeremy R.; Parrini, Barbara; Paton, Tara; Pickles, Andrew; Pilorge, Marion; Piven, Joseph; Ponting, Chris P.; Posey, David J.; Poustka, Annemarie; Poustka, Fritz; Prasad, Aparna; Ragoussis, Jiannis; Renshaw, Katy; Rickaby, Jessica; Roberts, Wendy; Roeder, Kathryn; Roge, Bernadette; Rutter, Michael L.; Bierut, Laura J.; Rice, John P.; Salt, Jeff; Sansom, Katherine; Sato, Daisuke; Segurado, Ricardo; Sequeira, Ana F.; Senman, Lili; Shah, Naisha; Sheffield, Val C.; Soorya, Latha; Sousa, Ines; Stein, Olaf; Sykes, Nuala; Stoppioni, Vera; Strawbridge, Christina; Tancredi, Raffaella; Tansey, Katherine; Thiruvahindrapduram, Bhooma; Thompson, Ann P.; Thomson, Susanne; Tryfon, Ana; Tsiantis, John; Van Engeland, Herman; Vincent, John B.; Volkmar, Fred; Wallace, Simon; Wang, Kai; Wang, Zhouzhi; Wassink, Thomas H.; Webber, Caleb; Weksberg, Rosanna; Wing, Kirsty; Wittemeyer, Kerstin; Wood, Shawn; Wu, Jing; Yaspan, Brian L.; Zurawiecki, Danielle; Zwaigenbaum, Lonnie; Buxbaum, Joseph D.; Cantor, Rita M.; Cook, Edwin H.; Coon, Hilary; Cuccaro, Michael L.; Devlin, Bernie; Ennis, Sean; Gallagher, Louise; Geschwind, Daniel H.; Gill, Michael; Haines, Jonathan L.; Hallmayer, Joachim; Miller, Judith; Monaco, Anthony P.; Nurnberger, John I., Jr.; Paterson, Andrew D.; Pericak-Vance, Margaret A.; Schellenberg, Gerard D.; Szatmari, Peter; Vicente, Astrid M.; Vieland, Veronica J.; Wijsman, Ellen M.; Scherer, Stephen W.; Sutcliffe, James S.; Betancur, Catalina			Functional impact of global rare copy number variation in autism spectrum disorders	NATURE			English	Article							HIDDEN-MARKOV MODEL; SNP GENOTYPING DATA; GENETIC DISORDER; ASSOCIATION; MUTATIONS; LINKAGE; LOCI; ANCESTRY; REVEALS; COMPLEX	The autism spectrum disorders (ASDs) are a group of conditions characterized by impairments in reciprocal social interaction and communication, and the presence of restricted and repetitive behaviours(1). Individuals with an ASD vary greatly in cognitive development, which can range from above average to intellectual disability(2). Although ASDs are known to be highly heritable (similar to 90%)(3), the underlying genetic determinants are still largely unknown. Here we analysed the genome-wide characteristics of rare (<1% frequency) copy number variation in ASD using dense genotyping arrays. When comparing 996 ASD individuals of European ancestry to 1,287 matched controls, cases were found to carry a higher global burden of rare, genic copy number variants (CNVs) (1.19 fold, P=0.012), especially so for loci previously implicated in either ASD and/or intellectual disability (1.69 fold, P=3.4 x 10(-4)). Among the CNVs there were numerous de novo and inherited events, sometimes in combination in a given family, implicating many novel ASD genes such as SHANK2, SYNGAP1, DLGAP2 and the X-linked DDX53-PTCHD1 locus. We also discovered an enrichment of CNVs disrupting functional gene sets involved in cellular proliferation, projection and motility, and GTPase/Ras signalling. Our results reveal many new genetic and functional targets in ASD that may lead to final connected pathways.	[Pinto, Dalila; Carson, Andrew R.; Casallo, Guillermo; Chung, Brian H. Y.; Cytrynbaum, Cheryl; Howe, Jennifer L.; Lionel, Anath C.; Liu, Xiao-Qing; Marshall, Christian R.; Migita, Ohsuke; Paton, Tara; Prasad, Aparna; Rickaby, Jessica; Sansom, Katherine; Sato, Daisuke; Thiruvahindrapduram, Bhooma; Wang, Zhouzhi; Weksberg, Rosanna; Paterson, Andrew D.; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada; [Pinto, Dalila; Carson, Andrew R.; Casallo, Guillermo; Chung, Brian H. Y.; Cytrynbaum, Cheryl; Howe, Jennifer L.; Lionel, Anath C.; Liu, Xiao-Qing; Marshall, Christian R.; Migita, Ohsuke; Paton, Tara; Prasad, Aparna; Rickaby, Jessica; Sansom, Katherine; Sato, Daisuke; Thiruvahindrapduram, Bhooma; Wang, Zhouzhi; Weksberg, Rosanna; Paterson, Andrew D.; Scherer, Stephen W.] Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1L7, Canada; [Pagnamenta, Alistair T.; Farrar, Penny; Holt, Richard; Mirza, Ghazala K.; Ragoussis, Jiannis; Sousa, Ines; Sykes, Nuala; Wing, Kirsty; Monaco, Anthony P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Klei, Lambertus; Wood, Shawn; Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA; [Anney, Richard; Bolshakova, Nadia; Brennan, Sean; Cochrane, Lynne; Heron, Elizabeth A.; Hill, Matthew; Hughes, Gillian; McGrath, Jane; Merikangas, Alison; Segurado, Ricardo; Tansey, Katherine; Gallagher, Louise; Gill, Michael] Trinity Coll Dublin, Sch Med, Dept Psychiat, Autism Genet Grp, Dublin 8, Ireland; [Merico, Daniele; Bader, Gary D.] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Regan, Regina; Conroy, Judith; Casey, Jillian; Green, Andrew; Shah, Naisha; Ennis, Sean] Univ Coll Dublin, Sch Med & Med Sci, Dublin 4, Ireland; [Magalhaes, Tiago R.; Correia, Catarina; Sequeira, Ana F.; Vicente, Astrid M.] Inst Nacl Saude Dr Ricardo Jorge, P-1649016 Lisbon, Portugal; [Magalhaes, Tiago R.; Correia, Catarina; Sequeira, Ana F.; Vicente, Astrid M.] Gulbenkian Inst Sci, P-2780156 Oeiras, Portugal; [Magalhaes, Tiago R.; Correia, Catarina; Sequeira, Ana F.; Vicente, Astrid M.] BioFIG Ctr Biodivers Funct & Integrat Genom, P-1749016 Lisbon, Portugal; [Abrahams, Brett S.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Program Neurogenet, Dept Neurol, Los Angeles, CA 90095 USA; [Abrahams, Brett S.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Autism Res & Treatment, Semel Inst, Los Angeles, CA 90095 USA; [Almeida, Joana; Duque, Frederico; Oliveira, Guiomar] Hosp Pediat Coimbra, P-3000076 Coimbra, Portugal; [Bacchelli, Elena; Maestrini, Elena] Univ Bologna, Dept Biol, I-40126 Bologna, Italy; [Bailey, Anthony J.; Laskawiec, Magdalena; Renshaw, Katy; Wallace, Simon] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England; [Baird, Gillian] Guys Hosp, Newcomen Ctr, London SE1 9RT, England; [Battaglia, Agatino; Igliozzi, Roberta; Parrini, Barbara; Tancredi, Raffaella] Stella Maris Inst Child & Adolescent Neuropsychia, I-56128 Pisa, Italy; [Berney, Tom; Le Couteur, Ann; McConachie, Helen] Univ Newcastle, Sir James Spence Inst, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Boelte, Sven; Duketis, Eftichia; Freitag, Christine M.; Poustka, Fritz] Goethe Univ Frankfurt, Dept Child & Adolescent Psychiat, D-60528 Frankfurt, Germany; [Bolton, Patrick F.] Inst Psychiat, Dept Child & Adolescent Psychiat, London SE5 8AF, England; [Bourgeron, Thomas] Univ Paris 07, CNRS, URA 2182, Inst Pasteur, F-75015 Paris, France; [Brian, Jessica; Drmic, Irene; Noakes, Carolyn; Roberts, Wendy; Senman, Lili] Univ Toronto, Hosp Sick Children & Bloorview Kids Rehab, Autism Res Unit, Toronto, ON M5G 1X8, Canada; [Bryson, Susan E.] Dalhousie Univ, Dept Pediat & Psychol, Halifax, NS B3K 6R8, Canada; [Corsello, Christina; Hus, Vanessa; Lord, Catherine] Univ Michigan, Autism & Communicat Disorders Ctr, Ann Arbor, MI 48109 USA; [Crawford, Emily L.; Lund, Sabata C.; Thomson, Susanne; Yaspan, Brian L.; Sutcliffe, James S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Vanderbilt Kennedy Ctr, Nashville, TN 37232 USA; [Crawford, Emily L.; Lund, Sabata C.; Thomson, Susanne; Yaspan, Brian L.; Sutcliffe, James S.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37232 USA; [Crawford, Emily L.; Lund, Sabata C.; Thomson, Susanne; Yaspan, Brian L.; Sutcliffe, James S.] Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA; [Crossett, Andrew; Roeder, Kathryn; Wu, Jing] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Dawson, Geraldine] Autism Speaks, New York, NY 10016 USA; [Dawson, Geraldine] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA; [de Jonge, Maretha; Van Engeland, Herman] Univ Med Ctr, Dept Child Psychiat, NL-3508 GA Utrecht, Netherlands; [Delorme, Richard] Hop Robert Debre, AP HP, Fdn FondaMental, INSERM,U955, F-75019 Paris, France; [Estes, Annette] Univ Washington, Dept Speech & Hearing Sci, Seattle, WA 98195 USA; [Fernandez, Bridget A.] Mem Univ Newfoundland, Discipline Genet, St John, NF A1B 3V6, Canada; [Fernandez, Bridget A.] Mem Univ Newfoundland, Discipline Med, St John, NF A1B 3V6, Canada; [Folstein, Susan E.; Gilbert, John; Cuccaro, Michael L.; Pericak-Vance, Margaret A.] Univ Miami, John P Hussman Inst Human Genom, Miami, FL 33101 USA; [Fombonne, Eric] McGill Univ, Div Psychiat, Montreal, PQ H3A 1A1, Canada; [Gillberg, Christopher; Nygren, Gudrun] Univ Gothenburg, Dept Child & Adolescent Psychiat, S-41345 Gothenburg, Sweden; [Glessner, Joseph T.; Hakonarson, Hakon; Kim, Cecilia; Wang, Kai] Childrens Hosp Philadelphia, Ctr Appl Genom, Div Human Genet, Philadelphia, PA 19104 USA; [Goldberg, Jeremy; Strawbridge, Christina; Thompson, Ann P.; Szatmari, Peter] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON L8N 3Z5, Canada; [Green, Jonathan] Booth Hall Childrens Hosp, Acad Dept Child Psychiat, Manchester M9 7AA, Lancs, England; [Guter, Stephen J.; Salt, Jeff; Cook, Edwin H.] Univ Illinois, Dept Psychiat, Inst Juvenile Res, Chicago, IL 60612 USA; [Hakonarson, Hakon] Univ Penn, Sch Med, Dept Pediat, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Klauck, Sabine M.; Poustka, Annemarie] German Canc Res Ctr, Div Mol Genome Anal, D-69120 Heidelberg, Germany; [Kolevzon, Alexander; Soorya, Latha; Tryfon, Ana; Zurawiecki, Danielle; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Korvatska, Olena] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Kustanovich, Vlad; Lajonchere, Clara M.] Autism Speaks, Autism Genet Resource Exchange, Los Angeles, CA 90036 USA; [Lamb, Janine A.] Univ Manchester, Ctr Integrated Genom Med Res, Manchester M13 9PT, Lancs, England; [Leboyer, Marion] Univ Paris 12, AP HP, Grp Hosp Henri Mondor Albert Chenevier, INSERM,U995,Dept Psychiat,Fdn FondaMental, F-94000 Creteil, France; [Leventhal, Bennett L.] Nathan S Kline Inst Psychiat Res NKI, Orangeburg, NY 10962 USA; [Leventhal, Bennett L.] NYU, Dept Child & Adolescent Psychiat, New York, NY 10016 USA; [Leventhal, Bennett L.] NYU, Ctr Child Study, New York, NY 10016 USA; [Lotspeich, Linda; Hallmayer, Joachim] Stanford Univ, Sch Med, Dept Psychiat, Div Child & Adolescent Psychiat & Child Dev, Palo Alto, CA 94304 USA; [Mahoney, William] McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada; [Mantoulan, Carine; Roge, Bernadette; Wittemeyer, Kerstin] Univ Toulouse Le Mirail, Ctr Eudes & Rech Psychopathol, F-31200 Toulouse, France; [McDougle, Christopher J.; Posey, David J.; Nurnberger, John I., Jr.] Indiana Univ, Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [McMahon, William M.; Coon, Hilary; Miller, Judith] Univ Utah, Sch Med, Dept Psychiat, Salt Lake City, UT 84108 USA; [Minshew, Nancy J.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA; [Minshew, Nancy J.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15213 USA; [Munson, Jeff] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Nelson, Stanley F.; Cantor, Rita M.] Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Noor, Abdul; Vincent, John B.] Univ Toronto, Ctr Addict & Mental Hlth, Clarke Inst, Toronto, ON M5G 1X8, Canada; [Noor, Abdul; Vincent, John B.] Univ Toronto, Dept Psychiat, Toronto, ON M5G 1X8, Canada; [Papanikolaou, Katerina; Tsiantis, John] Univ Athens, Sch Med, Agia Sophia Childrens Hosp, Univ Dept Child Psychiat, GR-11527 Athens, Greece; [Berney, Tom; Le Couteur, Ann; McConachie, Helen; Parr, Jeremy R.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Berney, Tom; Le Couteur, Ann; McConachie, Helen; Parr, Jeremy R.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Pickles, Andrew] Univ Manchester, Sch Epidemiol & Hlth Sci, Dept Med, Manchester M13 9PT, Lancs, England; [Pilorge, Marion; Betancur, Catalina] INSERM, U952, F-75005 Paris, France; [Pilorge, Marion; Betancur, Catalina] CNRS, UMR 7224, F-75005 Paris, France; [Pilorge, Marion; Betancur, Catalina] UPMC, F-75005 Paris, France; [Piven, Joseph] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA; [Ponting, Chris P.; Webber, Caleb] Univ Oxford, MRC Funct Genom Unit, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Rutter, Michael L.] Inst Psychiat, Social Genet & Dev Psychiat Ctr, London SE5 8AF, England; [Bierut, Laura J.; Rice, John P.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63130 USA; [Sheffield, Val C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Sheffield, Val C.] Univ Iowa, Howard Hughes Med Inst, Carver Coll Med, Iowa City, IA 52242 USA; [Stein, Olaf; Vieland, Veronica J.] Nationwide Childrens Hosp, Res Inst, Battelle Ctr Math Med, Columbus, OH 43205 USA; [Stein, Olaf; Vieland, Veronica J.] Ohio State Univ, Columbus, OH 43205 USA; [Stoppioni, Vera] Osped Santa Croce, I-61032 Fano, Italy; [Volkmar, Fred] Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; [Wassink, Thomas H.] Carver Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; [Zwaigenbaum, Lonnie] Univ Alberta, Dept Pediat, Edmonton, AB T6G 2J3, Canada; [Haines, Jonathan L.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN 37232 USA; [Schellenberg, Gerard D.] Univ Penn, Philadelphia, PA 19104 USA; [Wijsman, Ellen M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Wijsman, Ellen M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Bader, Gary D.; Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Oxford; Wellcome Centre for Human Genetics; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Trinity College Dublin; University of Toronto; University College Dublin; Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade de Lisboa; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); University of Bologna; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; IRCCS Fondazione Stella Maris; Newcastle University - UK; Goethe University Frankfurt; University of London; King's College London; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital; Hospital for Sick Children (SickKids); Dalhousie University; University of Michigan System; University of Michigan; Vanderbilt University; Vanderbilt University; Vanderbilt University; Carnegie Mellon University; University of North Carolina; University of North Carolina Chapel Hill; Utrecht University; Utrecht University Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); University of Washington; University of Washington Seattle; Memorial University Newfoundland; Memorial University Newfoundland; University of Miami; McGill University; University of Gothenburg; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; McMaster University; Royal Manchester Children's Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Helmholtz Association; German Cancer Research Center (DKFZ); Icahn School of Medicine at Mount Sinai; University of Washington; University of Washington Seattle; University of Manchester; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Nathan Kline Institute for Psychiatric Research; New York University; New York University; Stanford University; McMaster University; Universite de Toulouse; Universite de Toulouse - Jean Jaures; Indiana University System; Indiana University-Purdue University Indianapolis; Utah System of Higher Education; University of Utah; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; Athens Medical School; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; Newcastle University - UK; Newcastle University - UK; University of Manchester; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; University of North Carolina; University of North Carolina Chapel Hill; University of Oxford; University of London; King's College London; Washington University (WUSTL); University of Iowa; Howard Hughes Medical Institute; University of Iowa; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; Yale University; University of Alberta; Vanderbilt University; University of Pennsylvania; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Toronto	Scherer, SW (corresponding author), Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada.	stephen.scherer@sickkids.ca	Bierut, Laura Jean/W-6806-2019; Heron, Elizabeth/HCI-9636-2022; Nelson, Stanley F/D-4771-2009; Rutter, Michael/C-8570-2013; Paterson, Andrew/AAQ-7511-2020; Haines, Jonathan/C-3374-2012; Ponting, Chris/AAV-2621-2021; Bölte, Sven/AAH-8675-2019; De Jonge, Maretha V/F-4942-2013; Pinto, Dalila/C-4218-2016; Pickles, Andrew/A-9625-2011; Fombonne, Eric/M-4893-2018; Bailey, Anthony/J-2860-2014; Ragoussis, Ioannis/AAD-9790-2022; Maestrini, Elena/K-7508-2012; Leboyer, Marion/AAW-3648-2021; Oliveira, Guiomar/AAF-3911-2021; Battaglia, Agatino/AAG-1406-2020; Tancredi, Raffaella/C-3868-2018; Green, Andrew/AAJ-7592-2020; Paterson, Andrew D/A-4088-2011; Koo, Jawoo/F-9397-2010; Sutcliffe, James S/C-1348-2012; Tansey, Katherine E/B-1033-2013; Duque, Frederico/H-3692-2014; Prasad, Aparna/N-4253-2015; Vicente, Astrid/F-8692-2014; Hill, Matthew/E-7730-2010; Bal, Vanessa Hus/AAN-2381-2020; bacchelli, elena/R-3675-2016; Noor, Abdul/J-2345-2016; Oliveira, Guiomar/I-7255-2013; Monaco, Anthony P/A-4495-2010; Igliozzi, Roberta/AAA-4568-2021; Betancur, Catalina/K-3791-2017; Scherer, Stephen/B-3785-2013; Papanikolaou, Katerina/AAB-4771-2020; Mahoney, William/GQB-0802-2022; Volkmar, Fred/AEB-0666-2022; Bader, Gary/C-1176-2009; Buxbaum, Joseph D/G-6001-2010; Segurado, Ricardo/K-6116-2014	Bierut, Laura Jean/0000-0002-9952-4810; Nelson, Stanley F/0000-0002-2082-3114; Paterson, Andrew/0000-0002-9169-118X; Haines, Jonathan/0000-0002-4351-4728; Bölte, Sven/0000-0002-4579-4970; Pinto, Dalila/0000-0002-8769-0846; Pickles, Andrew/0000-0003-1283-0346; Fombonne, Eric/0000-0002-8605-3538; Bailey, Anthony/0000-0003-4257-972X; Maestrini, Elena/0000-0001-5924-3179; Leboyer, Marion/0000-0001-5473-3697; Oliveira, Guiomar/0000-0002-7049-1277; Battaglia, Agatino/0000-0002-7128-7606; Tancredi, Raffaella/0000-0003-3517-4919; Paterson, Andrew D/0000-0002-9169-118X; Koo, Jawoo/0000-0003-3424-9229; Sutcliffe, James S/0000-0001-5200-6007; Tansey, Katherine E/0000-0002-9663-3376; Duque, Frederico/0000-0001-5684-1472; Prasad, Aparna/0000-0002-6786-2313; Vicente, Astrid/0000-0001-7134-8037; Hill, Matthew/0000-0001-6776-8709; Bal, Vanessa Hus/0000-0003-0750-823X; bacchelli, elena/0000-0001-8800-9568; Monaco, Anthony P/0000-0001-7480-3197; Igliozzi, Roberta/0000-0002-1245-972X; Betancur, Catalina/0000-0002-3327-4804; Scherer, Stephen/0000-0002-8326-1999; Bader, Gary/0000-0003-0185-8861; Wassink, Thomas/0000-0002-0952-8333; Ponting, Chris/0000-0003-0202-7816; Correia, Catarina/0000-0001-5481-2010; McNeil, Kirsty/0000-0003-0437-3608; Gill, Michael/0000-0003-0206-5337; Dawson, Geraldine/0000-0003-1410-2764; Webber, Caleb/0000-0001-8063-7674; Gallagher, Louise/0000-0001-9462-2836; Girao Meireles de Sousa, Ines/0000-0001-6983-8870; Sequeira, Ana Filipa/0000-0001-8445-6221; Segurado, Ricardo/0000-0002-3547-6733; Simpson, Nuala/0000-0003-3390-9993; Merico, Daniele/0000-0002-3728-4401; Bourgeron, Thomas/0000-0001-8164-9220; McGrath, Jane/0000-0002-4894-4823; Ragoussis, Ioannis/0000-0002-8515-0934; Lund, Sabata/0000-0002-6092-5131; Nurnberger, John/0000-0002-7674-1767; Ennis, Sean/0000-0002-4330-1386; Sheffield, Val/0000-0002-6282-0835; Buxbaum, Joseph/0000-0001-8898-8313; Estes, Annette/0000-0003-2687-4155; Wijsman, Ellen/0000-0002-2725-6669; Roeder, Kathryn/0000-0002-8869-6254; Freitag, Christine Margarete/0000-0001-9676-4782; Green, Jonathan/0000-0002-0143-181X; R Magalhaes, Tiago/0000-0002-5528-2119; Guter, Stephen/0000-0002-4476-2045; Green, Andrew/0000-0002-1077-7417; Glessner, Joseph/0000-0001-5131-2811; Lamb, Janine/0000-0002-7248-0539; Oliveira, Guiomar Goncalves/0000-0003-4031-3880; Liu, Xiao-Qing/0000-0002-4034-5156; Merikangas, Alison/0000-0003-2253-839X; Delorme, Richard/0000-0002-5614-3663; Bolshakova, Nadia/0000-0003-2173-6562; Anney, Richard/0000-0002-6083-407X; Yaspan, Brian/0000-0002-3787-2510; Rutter, Michael Llewellyn/0000-0003-1577-7405; Heron, Elizabeth/0000-0003-2219-4005	Autism Genome Project Consortium (AGP): Autism Speaks (USA); Health Research Board (HRB; Ireland); Medical Research Council (MRC; UK); Genome Canada/Ontario Genomics Institute; Hilibrand Foundation (USA); US National Institutes of Health (NIH) [HD055751, HD055782, HD055784, HD35465, MH52708, MH55284, MH57881, MH061009, MH06359, MH066673, MH080647, MH081754, MH66766, NS026630, NS042165, NS049261]; Canadian Institute for Advanced Research (CIFAR); Canadian Institutes for Health Research (CIHR); Assistance Publique-Hopitaux de Paris (France); Autistica; Canada Foundation for Innovation/Ontario Innovation Trust; Deutsche Forschungsgemeinschaft (Germany) [Po 255/17-4]; EC; Fundacao Calouste Gulbenkian (Portugal); Fondation de France; Fondation FondaMental (France); Fondation Orange (France); Fondation pour la Recherche Medicale (France); Fundacao para a Ciencia e Tecnologia (Portugal); Hospital for Sick Children Foundation; University of Toronto (Canada); INSERM (France); Institut Pasteur (France); Italian Ministry of Health [181]; John P Hussman Foundation (USA); McLaughlin Centre (Canada); Ontario Ministry of Research and Innovation (Canada); Seaver Foundation (USA); Swedish Science Council; Centre for Applied Genomics (Canada); Utah Autism Foundation (USA); Wellcome Trust (UK) [075491/Z/04]; Royal Netherlands Academy of Arts and Sciences [TMF/DA/5801]; Netherlands Organization for Scientific Research [825.06.031]; GlaxoSmithKline-CIHR Pathfinder Chair in Genetics and Genomics at the University of Toronto; Hospital for Sick Children (Canada); MRC [MC_U137761446, G0601030] Funding Source: UKRI; Medical Research Council [MC_U137761446, G9817803B, G0601030] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055751, P01HD035465, P50HD055748, P50HD055782, U19HD035469] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA089392] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052708, R01MH080647, R37MH057881, R01MH057881, T32MH065215, U54MH066673, R01MH061009, R10MH055284, U10MH066766, R01MH081754, R01MH055284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049261, R01NS042165, P01NS026630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019963, R01DA013423] Funding Source: NIH RePORTER	Autism Genome Project Consortium (AGP): Autism Speaks (USA); Health Research Board (HRB; Ireland); Medical Research Council (MRC; UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Genome Canada/Ontario Genomics Institute(Genome Canada); Hilibrand Foundation (USA); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Assistance Publique-Hopitaux de Paris (France); Autistica(Autistica); Canada Foundation for Innovation/Ontario Innovation Trust(Canada Foundation for Innovation); Deutsche Forschungsgemeinschaft (Germany)(German Research Foundation (DFG)); EC(European CommissionEuropean Commission Joint Research Centre); Fundacao Calouste Gulbenkian (Portugal); Fondation de France(Fondation de France); Fondation FondaMental (France); Fondation Orange (France); Fondation pour la Recherche Medicale (France)(Fondation pour la Recherche Medicale); Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Hospital for Sick Children Foundation; University of Toronto (Canada)(University of Toronto); INSERM (France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Pasteur (France); Italian Ministry of Health(Ministry of Health, Italy); John P Hussman Foundation (USA); McLaughlin Centre (Canada); Ontario Ministry of Research and Innovation (Canada)(Ministry of Research and Innovation, Ontario); Seaver Foundation (USA); Swedish Science Council; Centre for Applied Genomics (Canada); Utah Autism Foundation (USA); Wellcome Trust (UK)(Wellcome Trust); Royal Netherlands Academy of Arts and Sciences; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); GlaxoSmithKline-CIHR Pathfinder Chair in Genetics and Genomics at the University of Toronto(Canadian Institutes of Health Research (CIHR)); Hospital for Sick Children (Canada); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors acknowledge the families participating in the study and the main funders of the Autism Genome Project Consortium (AGP): Autism Speaks (USA), the Health Research Board (HRB; Ireland), The Medical Research Council (MRC; UK), Genome Canada/Ontario Genomics Institute, and the Hilibrand Foundation (USA). Additional support for individual groups was provided by the US National Institutes of Health (NIH grants HD055751, HD055782, HD055784, HD35465, MH52708, MH55284, MH57881, MH061009, MH06359, MH066673, MH080647, MH081754, MH66766, NS026630, NS042165, NS049261), the Canadian Institute for Advanced Research (CIFAR), the Canadian Institutes for Health Research (CIHR), Assistance Publique-Hopitaux de Paris (France), Autistica, Canada Foundation for Innovation/Ontario Innovation Trust, Deutsche Forschungsgemeinschaft (grant Po 255/17-4) (Germany), EC Sixth FP AUTISM MOLGEN, Fundacao Calouste Gulbenkian (Portugal), Fondation de France, Fondation FondaMental (France), Fondation Orange (France), Fondation pour la Recherche Medicale (France), Fundacao para a Ciencia e Tecnologia (Portugal), the Hospital for Sick Children Foundation and University of Toronto (Canada), INSERM (France), Institut Pasteur (France), the Italian Ministry of Health (convention 181 of 19.10.2001), the John P Hussman Foundation (USA), McLaughlin Centre (Canada), Ontario Ministry of Research and Innovation (Canada), the Seaver Foundation (USA), the Swedish Science Council, The Centre for Applied Genomics (Canada), the Utah Autism Foundation (USA) and the Wellcome Trust core award 075491/Z/04 (UK). D. P. is supported by fellowships from the Royal Netherlands Academy of Arts and Sciences (TMF/DA/5801) and the Netherlands Organization for Scientific Research (Rubicon 825.06.031). S.W.S. holds the GlaxoSmithKline-CIHR Pathfinder Chair in Genetics and Genomics at the University of Toronto and the Hospital for Sick Children (Canada).	BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Bierut LJ, 2010, P NATL ACAD SCI USA, V107, P5082, DOI 10.1073/pnas.0911109107; Chakrabarti S, 2005, AM J PSYCHIAT, V162, P1133, DOI 10.1176/appi.ajp.162.6.1133; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lee AB, 2010, GENET EPIDEMIOL, V34, P51, DOI 10.1002/gepi.20434; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Meechan DW, 2009, P NATL ACAD SCI USA, V106, P16434, DOI 10.1073/pnas.0905696106; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; O'Dushlaine C, 2011, MOL PSYCHIATR, V16, P286, DOI 10.1038/mp.2010.7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Romorini S, 2004, J NEUROSCI, V24, P9391, DOI 10.1523/JNEUROSCI.3314-04.2004; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Skuse DH, 2007, TRENDS GENET, V23, P387, DOI 10.1016/j.tig.2007.06.003; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490	30	1413	1509	4	345	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					368	372		10.1038/nature09146	http://dx.doi.org/10.1038/nature09146			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20531469	Green Accepted, Green Submitted, Green Published, Bronze			2022-12-01	WOS:000279867100049
J	Rhodes, T; Sarang, A; Vickerman, P; Hickman, M				Rhodes, Tim; Sarang, Anya; Vickerman, Peter; Hickman, Matthew			Policy resistance to harm reduction for drug users and potential effect of change	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RUSSIAN-FEDERATION; TOGLIATTI CITY; INJECT DRUGS; HIV; PEOPLE; RISK; CARE		[Rhodes, Tim; Vickerman, Peter] London Sch Hyg & Trop Med, Ctr Res Drugs & Hlth Behav, London WC1E 8HT, England; [Sarang, Anya] Andrey Rylkov Fdn Hlth & Social Justice, Moscow, Russia; [Vickerman, Peter; Hickman, Matthew] Univ Bristol, Bristol BS8 1TH, Avon, England	University of London; London School of Hygiene & Tropical Medicine; University of Bristol	Rhodes, T (corresponding author), London Sch Hyg & Trop Med, Ctr Res Drugs & Hlth Behav, London WC1E 8HT, England.	tim.rhodes@lshtm.ac.uk	Hickman, Matthew/Y-2400-2019; Sarang, Anya/K-3359-2015; Rhodes, Tim/DNJ-9679-2022	Hickman, Matthew/0000-0001-9864-459X; Sarang, Anya/0000-0003-0361-1264; Rhodes, Tim/0000-0003-2400-9838; Vickerman, Peter/0000-0002-8291-5890	Medical Research Council [G0701627] Funding Source: Medline; Department of Health Funding Source: Medline; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; ESRC [ES/G007543/1] Funding Source: UKRI; MRC [G0701627] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2007, PREV HIV INF INJ DRU; BABAYAN EA, 1985, TXB ALCOHOLISM DRUG; Bobrik A, 2005, J PUBLIC HEALTH POL, V26, P30, DOI 10.1057/palgrave.jphp.3200002; DEGENHARDT L, 2010, LANCET IN PRESS; Elovich R, 2008, HARM REDUCT J, V5, DOI 10.1186/1477-7517-5-23; Gowing L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004145.pub3; Human Rights Watch, 2007, REH REQ RUSS HUM RIG; Jarlais DCD, 2007, AIDS, V21, pS109, DOI 10.1097/01.aids.0000304705.79541.34; LATYPOV A, 2010, INT J DRUG POLI 0223; Lert F, 2007, INT J DRUG POLICY, V18, P255, DOI 10.1016/j.drugpo.2007.05.002; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Mendelevich Vladimir, 2006, HIV AIDS Policy Law Rev, V11, P82; PLAVINSKY SL, 2009, SEXUALLY TRANSMITTED; PLAVINSKY SL, 2008, GLOBUS PROJECT NEWSL, V7; Rhodes T, 2004, JAIDS-J ACQ IMM DEF, V35, P293, DOI 10.1097/00126334-200403010-00011; Rhodes T, 2003, SOC SCI MED, V57, P39, DOI 10.1016/S0277-9536(02)00521-X; Roux P, 2008, ADDICTION, V103, P1828, DOI 10.1111/j.1360-0443.2008.02323.x; *SEC COUNC RUSS FE, 2009, STEN M IMPR STAT POL; STRATHDEE SA, 2010, LANCET IN PRESS; *UNAIDS, 2009, AIDS EP UPD; Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x; VICKERMAN P, 2006, J ACQ IMMUN DEF SYND, V42, P255; Wood E, 2009, LANCET, V373, P989, DOI 10.1016/S0140-6736(09)60455-4	24	36	36	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 13	2010	341								c3439	10.1136/bmj.c3439	http://dx.doi.org/10.1136/bmj.c3439			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628XB	20627977	Green Accepted			2022-12-01	WOS:000280156600006
J	Jernelov, A				Jernelov, Arne			How to defend against future oil spills	NATURE			English	Editorial Material									Inst Futures Studies, SE-10131 Stockholm, Sweden		Jernelov, A (corresponding author), Inst Futures Studies, Box 591, SE-10131 Stockholm, Sweden.	arne.jernelov@chello.at						JERNELOV A, 1981, NATURE, V10, P299	1	140	147	2	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					182	183		10.1038/466182a	http://dx.doi.org/10.1038/466182a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613822				2022-12-01	WOS:000279580800017
J	Hicks, WM; Kim, M; Haber, JE				Hicks, Wade M.; Kim, Minlee; Haber, James E.			Increased Mutagenesis and Unique Mutation Signature Associated with Mitotic Gene Conversion	SCIENCE			English	Article							STRAND-BREAK-REPAIR; DNA-POLYMERASE-EPSILON; SACCHAROMYCES-CEREVISIAE; HETERODUPLEX DNA; CANCER; RECOMBINATION; DELTA; MODEL; YEAST; REPLICATION	To examine the fidelity of DNA synthesis during double-strand break (DSB) repair in Saccharomyces cerevisiae we studied gene conversion in which both strands of DNA are newly synthesized. The mutation rate increases up to 1400 times over spontaneous events, with a significantly different mutation signature. Especially prominent are microhomology-mediated template switches. Recombination-induced mutations are largely independent of mismatch repair, by DNA polymerases Pol zeta, Pol eta, and Pol32, but result from errors made by Pol delta and Pol epsilon. These observations suggest that increased DSB frequencies in oncogene-activated mammalian cells may also increase the probability of acquiring mutations required for transition to a cancerous state.	[Haber, James E.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Rosenstiel Ctr, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Haber, JE (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.	haber@brandeis.edu		Haber, James/0000-0002-1878-0610	NIH [GM007122, GM20056]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020056, T32GM007122, R01GM020056] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Kl-URA3 (GenBank: Y00454) was a gift from O. Zill and J. Rine. pol30-K127,164R was a gift from H. Ulrich. NIH Genetics Training Grant GM007122 supported W.M.H. NIH grant GM20056 to J.E.H. supported the research.	Albertson TM, 2009, P NATL ACAD SCI USA, V106, P17101, DOI 10.1073/pnas.0907147106; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; BUDD ME, 1995, MOL CELL BIOL, V15, P2173; Datta A, 2000, MOL CELL, V6, P593, DOI 10.1016/S1097-2765(00)00058-7; Edwards S, 2003, MOL CELL BIOL, V23, P2733, DOI 10.1128/MCB.23.8.2733-2748.2003; Greenblatt MS, 1996, CANCER RES, V56, P2130; HABER JE, 1993, P NATL ACAD SCI USA, V90, P3363, DOI 10.1073/pnas.90.8.3363; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Halas A, 1999, ACTA BIOCHIM POL, V46, P863; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Holbeck SL, 1997, GENETICS, V147, P1017; Kunkel TA, 2003, DNA REPAIR, V2, P135, DOI 10.1016/S1568-7864(02)00224-0; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Loeb LA, 2008, CANCER RES, V68, P3551, DOI 10.1158/0008-5472.CAN-07-5835; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Maloisel L, 2008, MOL CELL BIOL, V28, P1373, DOI 10.1128/MCB.01651-07; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Payen C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000175; Rattray AJ, 2002, GENETICS, V162, P1063; RIPLEY LS, 1982, P NATL ACAD SCI-BIOL, V79, P4128, DOI 10.1073/pnas.79.13.4128; Smith CE, 2009, MOL CELL BIOL, V29, P1432, DOI 10.1128/MCB.01469-08; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200; STRATHERN JN, 1995, GENETICS, V140, P965; Wang X, 2004, MOL CELL BIOL, V24, P6891, DOI 10.1128/MCB.24.16.6891-6899.2004; Weinberg RA, 1996, SCI AM, V275, P62, DOI 10.1038/scientificamerican0996-62; Yang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000264	29	189	190	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2010	329	5987					82	85		10.1126/science.1191125	http://dx.doi.org/10.1126/science.1191125			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595613	Green Accepted			2022-12-01	WOS:000279402700037
J	Steele, A; McCubbin, FM; Fries, M; Glamoclija, M; Kater, L; Nekvasil, H				Steele, A.; McCubbin, F. M.; Fries, M.; Glamoclija, M.; Kater, L.; Nekvasil, H.			Graphite in an Apollo 17 Impact Melt Breccia	SCIENCE			English	Article							LUNAR REGOLITH; WHISKERS		[Steele, A.; McCubbin, F. M.; Glamoclija, M.] Carnegie Inst Washington, Geophys Lab, Washington, DC 20015 USA; [Fries, M.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Kater, L.] Witec GmbH, D-89081 Ulm, Germany; [Nekvasil, H.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA	Carnegie Institution for Science; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); WITec; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Steele, A (corresponding author), Carnegie Inst Washington, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.	asteele@ciw.edu	Glamoclija, Mihaela/GWQ-3360-2022; Steele, Andrew/A-3573-2013; McCubbin, Francis/AAG-1095-2020; McCubbin, Francis/D-1698-2009	Glamoclija, Mihaela/0000-0003-4327-6480; Steele, Andrew/0000-0001-9643-2841; 	NASA Astrobiology Science and Technology; Sample Return Laboratory; Data Analysis; Lunar Advanced Science and Exploration Research; Mars Fundamental Research	NASA Astrobiology Science and Technology; Sample Return Laboratory; Data Analysis; Lunar Advanced Science and Exploration Research; Mars Fundamental Research	We acknowledge support from NASA Astrobiology Science and Technology for Exploring Planets, Sample Return Laboratory Instrument and Data Analysis, Lunar Advanced Science and Exploration Research, and Mars Fundamental Research programs and thank Witec, J. Alton, and G. Lofgren. Dedicated to the memory of Annie Steele.	Dikov YP, 2002, SOLAR SYST RES+, V36, P1, DOI 10.1023/A:1014297009479; Fries M, 2008, SCIENCE, V320, P91, DOI 10.1126/science.1153578; Meyer C., 2009, LUNAR SAMPLE COMPEND; PILLINGER CT, 1977, PHILOS T R SOC A, V285, P369, DOI 10.1098/rsta.1977.0076; RYDER G, 1993, JSC PUBLICATION; Tan PH, 2004, PHILOS T R SOC A, V362, P2289, DOI 10.1098/rsta.2004.1442	6	35	35	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					51	51		10.1126/science.1190541	http://dx.doi.org/10.1126/science.1190541			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595608				2022-12-01	WOS:000279402700027
J	Moran, U; Phillips, R; Milo, R				Moran, Uri; Phillips, Rob; Milo, Ron			SnapShot: Key Numbers in Biology	CELL			English	Editorial Material									[Moran, Uri; Milo, Ron] Weizmann Inst Sci, Rehovot, Israel; [Phillips, Rob] CALTECH, Pasadena, CA USA	Weizmann Institute of Science; California Institute of Technology	Moran, U (corresponding author), Weizmann Inst Sci, Rehovot, Israel.		Milo, Hilla/C-8767-2016	Milo, Ron/0000-0003-1641-2299					0	121	122	2	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 25	2010	141	7					1262	1262	1262.e1	10.1016/j.cell.2010.06.019	http://dx.doi.org/10.1016/j.cell.2010.06.019			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20603006	Bronze			2022-12-01	WOS:000279148100022
J	Grubb, MS; Burrone, J				Grubb, Matthew S.; Burrone, Juan			Activity-dependent relocation of the axon initial segment fine-tunes neuronal excitability	NATURE			English	Article							ACTION-POTENTIAL INITIATION; CA1 PYRAMIDAL NEURONS; CA2+ CHANNELS; HOMEOSTASIS; GENERATION; HIPPOCAMPAL; PROPAGATION; NA(V)1.6; SITE	In neurons, the axon initial segment (AIS) is a specialized region near the start of the axon that is the site of action potential initiation(1-6). The precise location of the AIS varies across and within different neuronal types(7,8), and has been linked to cells' information-processing capabilities(8); however, the factors determining AIS position in individual neurons remain unknown. Here we show that changes in electrical activity can alter the location of the AIS. In dissociated hippocampal cultures, chronic depolarization with high extracellular potassium moves multiple components of the AIS, including voltage-gated sodium channels, up to 17 mu m away from the soma of excitatory neurons. This movement reverses when neurons are returned to non-depolarized conditions, and depends on the activation of T- and/or L-type voltage-gated calcium channels. The AIS also moved distally when we combined long-term LED (light-emitting diode) photostimulation with sparse neuronal expression of the light-activated cation channel channelrhodopsin-2; here, burst patterning of activity was successful where regular stimulation at the same frequency failed. Furthermore, changes in AIS position correlate with alterations in current thresholds for action potential spiking. Our results show that neurons can regulate the position of an entire subcellular structure according to their ongoing levels and patterns of electrical activity. This novel form of activity-dependent plasticity may fine-tune neuronal excitability during development.	[Grubb, Matthew S.; Burrone, Juan] Kings Coll London, MRC Ctr Dev Neurobiol, London SE1 1UL, England	University of London; King's College London	Grubb, MS (corresponding author), Kings Coll London, MRC Ctr Dev Neurobiol, 4th Floor,New Hunts House,Guys Campus, London SE1 1UL, England.	matthew.grubb@kcl.ac.uk; juan.burrone@kcl.ac.uk	Grubb, Matthew S/B-4939-2008	Grubb, Matthew S/0000-0002-2673-274X; Burrone, Juan/0000-0003-1233-668X	Wellcome Trust; Lister Institute; Medical Research Council [G0901899, G0901899B] Funding Source: researchfish; MRC [G0901899] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Lister Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Komada for the anti-bIV-spectrin antibody, K. Deisseroth for the ChR2 construct, N. Ben Fredj for assistance with cell culture, S. Poopalasundaramfor help with molecular biology, P. Degenaar and N. Grossman for assistance with LED photostimulation, and I. Thompson and K. Bender for comments on the manuscript. This work was supported by the Wellcome Trust and a Lister Institute Research Prize to J.B.	AKRITAS MG, 1990, J AM STAT ASSOC, V85, P73, DOI 10.2307/2289527; Bender KJ, 2009, NEURON, V61, P259, DOI 10.1016/j.neuron.2008.12.004; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Cendes F, 2005, CURR OPIN NEUROL, V18, P173, DOI 10.1097/01.wco.0000162860.49842.90; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P232, DOI 10.1113/jphysiol.1957.sp005888; Foust A, 2010, J NEUROSCI, V30, P6891, DOI 10.1523/JNEUROSCI.0552-10.2010; Fried SI, 2009, J NEUROPHYSIOL, V101, P1972, DOI 10.1152/jn.91081.2008; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Khalilov I, 2003, NAT NEUROSCI, V6, P1079, DOI 10.1038/nn1125; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kress GJ, 2010, HIPPOCAMPUS, V20, P558, DOI 10.1002/hipo.20667; Kuba H, 2006, NATURE, V444, P1069, DOI 10.1038/nature05347; LAUGHLIN SB, 1989, J EXP BIOL, V146, P39; Lee TS, 2006, PHARMACOLOGY, V78, P11, DOI 10.1159/000094900; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Marder E, 2002, BIOESSAYS, V24, P1145, DOI 10.1002/bies.10185; Meeks JP, 2007, J NEUROPHYSIOL, V97, P3460, DOI 10.1152/jn.01288.2006; O'Leary T, 2010, J PHYSIOL-LONDON, V588, P157, DOI 10.1113/jphysiol.2009.181024; Ogawa Y, 2008, CURR OPIN NEUROBIOL, V18, P307, DOI 10.1016/j.conb.2008.08.008; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; PALMER MN, 2010, J PHYSL, V588, P1709; Royeck M, 2008, J NEUROPHYSIOL, V100, P2361, DOI 10.1152/jn.90332.2008; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Yang Y, 2007, J CELL BIOL, V176, P509, DOI 10.1083/jcb.200610128; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295	32	404	405	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1070	U131		10.1038/nature09160	http://dx.doi.org/10.1038/nature09160			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20543823	Green Accepted			2022-12-01	WOS:000279056900051
J	McPhee, CK; Logan, MA; Freeman, MR; Baehrecke, EH				McPhee, Christina K.; Logan, Mary A.; Freeman, Marc R.; Baehrecke, Eric H.			Activation of autophagy during cell death requires the engulfment receptor Draper	NATURE			English	Article							STARVATION-INDUCED AUTOPHAGY; DROSOPHILA FAT-BODY; GENE-EXPRESSION; GROWTH ARREST; PHAGOCYTOSIS; DEGRADATION; INDUCTION; OOGENESIS; PATHWAY	Autophagy degrades cytoplasmic components that are required for cell survival in response to starvation(1). Autophagy has also been associated with cell death, but it is unclear how this is distinguished from autophagy during cell survival. Drosophila salivary glands undergo programmed cell death that requires autophagy genes(2), and engulfment of salivary gland cells by phagocytes does not appear to occur(3). Here we show that Draper (Drpr), the Drosophila melanogaster orthologue of the Caenorhabditis elegans engulfment receptor CED-1, is required for autophagy during cell death. Null mutations in, and salivary gland-specific knockdown of, drpr inhibit salivary gland degradation. Knockdown of drpr prevents the induction of autophagy in dying salivary glands, and expression of the Atg1 autophagy regulator in drpr mutants suppresses the failure in degradation of salivary glands. Surprisingly, drpr is required in the same dying salivary gland cells in which it regulates autophagy induction, but drpr knockdown does not prevent starvation-induced autophagy in the fat body, which is associated with survival. In addition, components of the conserved engulfment pathway are required for clearance of dying salivary glands. To our knowledge, this is the first example of an engulfment factor that is required for self-clearance of cells. Further, Drpr is the first factor that distinguishes autophagy that is associated with cell death from autophagy associated with cell survival.	[McPhee, Christina K.; Baehrecke, Eric H.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [McPhee, Christina K.] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA; [Logan, Mary A.; Freeman, Marc R.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Freeman, Marc R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University System of Maryland; University of Maryland College Park; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Baehrecke, EH (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA.	Eric.Baehrecke@umassmed.edu		Kary, Christina/0000-0002-2586-4185; Freeman, Marc/0000-0003-3481-3715	American Cancer Society [PF-07-258-01-CSM]; NIH [NS053538, GM079431]; Merck and Co. Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053538, R37NS053538] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck and Co. Inc.(Merck & Company); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Bergmann, U. Gaul, H. Kramer, E. Kurant, T. P. Neufeld, T. E. Rusten, H. Stenmark, the Bloomington Stock Center, the VDRC, and the Developmental Studies Hybridoma Bank for flies and antibodies, and R. Simin, T. Fortier and A. Sheehan for technical support. This work was supported by American Cancer Society Postdoctoral Fellowship PF-07-258-01-CSM to MAL, NIH grants NS053538 to M. R. F. and GM079431 to E. H. B., and Merck and Co. Inc. for E. H. B. E. H. B. is a member of the UMass DERC (DK32520).	Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; BRAND AH, 1993, DEVELOPMENT, V118, P401; Denton D, 2009, CURR BIOL, V19, P1741, DOI 10.1016/j.cub.2009.08.042; Dutta S, 2008, CURR BIOL, V18, P1466, DOI 10.1016/j.cub.2008.08.052; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hou YCC, 2008, J CELL BIOL, V182, P1127, DOI 10.1083/jcb.200712091; Jiang CG, 1997, DEVELOPMENT, V124, P4673; Joubert PE, 2009, CELL HOST MICROBE, V6, P354, DOI 10.1016/j.chom.2009.09.006; Kuraishi T, 2009, EMBO J, V28, P3868, DOI 10.1038/emboj.2009.343; Kurant E, 2008, CELL, V133, P498, DOI 10.1016/j.cell.2008.02.052; Lee CY, 2003, CURR BIOL, V13, P350, DOI 10.1016/S0960-9822(03)00085-X; Lee CY, 2001, DEVELOPMENT, V128, P1443; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Martin DN, 2004, DEVELOPMENT, V131, P275, DOI 10.1242/dev.00933; Mohseni N, 2009, AUTOPHAGY, V5, P329, DOI 10.4161/auto.5.3.7444; Muro I, 2006, DEVELOPMENT, V133, P3305, DOI 10.1242/dev.02495; Nezis IP, 2009, AUTOPHAGY, V5, P298, DOI 10.4161/auto.5.3.7454; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; YU L, 2010, NATURE IN PRESS, DOI DOI 10.1038/NATURE09076; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	29	107	108	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1093	U159		10.1038/nature09127	http://dx.doi.org/10.1038/nature09127			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577216	Green Accepted, Green Submitted			2022-12-01	WOS:000279056900056
J	Garcia, MS; De la Torre, MA; Morales, G; Pelaez, B; Tolon, MJ; Domingo, S; Candel, FJ; Andrade, R; Arribi, A; Garcia, N; Sagasti, FM; Fereres, J; Picazo, J				Sanchez Garcia, Miguel; Angeles De la Torre, Maria; Morales, Gracia; Pelaez, Beatriz; Jose Tolon, Maria; Domingo, Sara; Javier Candel, Francisco; Andrade, Raquel; Arribi, Ana; Garcia, Nicolas; Martinez Sagasti, Fernando; Fereres, Jose; Picazo, Juan			Clinical Outbreak of Linezolid-Resistant Staphylococcus aureus in an Intensive Care Unit	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FIELD GEL-ELECTROPHORESIS; ENTEROCOCCUS-FAECALIS; RIBOSOMAL-RNA; 1ST REPORT; GENE; EMERGENCE; INFECTION; EPIDERMIDIS; SITUATION; STRAINS	Context Linezolid resistance is extremely uncommon in Staphylococcus aureus. Objective To report an outbreak with linezolid and methicillin-resistant S aureus (LRSA) in an intensive care department and the effective control measures taken. Design, Setting, and Patients Outbreak study of consecutive critically ill patients colonized and/or infected with LRSA at an intensive care department of a 1000-bed tertiary care university teaching hospital in Madrid, Spain. Patients were placed under strict contact isolation. Daily updates of outbreak data and recommendations for the use of linezolid were issued. Extensive environmental sampling and screening of the hands of health care workers were performed. Main Outcome Measures Linezolid use and clinical and epidemiological characteristics and outcomes using minimal inhibitory concentrations, pulsed-field gel electrophoresis, and polymerase chain reaction of LRSA isolates. Results Between April 13 and June 26, 2008, 12 patients with LRSA were identified. In 6 patients, LRSA caused ventilator-associated pneumonia and in 3 patients it caused bacteremia. Isolates were susceptible to trimethoprim-sulfamethoxazole, glycopeptides, tigecycline, and daptomycin. Genotyping identified 1 predominant clone and 3 other types. Cfr-mediated linezolid resistance was demonstrated in all isolates. Potential hospital staff carriers and environmental samples were negative except for one. Six patients died, 5 of them in the intensive care unit, with 1 death attributed to LRSA infection. Linezolid use decreased from 202 defined daily doses in April 2008 to 25 defined daily doses in July 2008. Between July 2008 and April 2010, no new cases have been identified in the weekly surveillance cultures or diagnostic samples. Conclusions The first clinical outbreak, to our knowledge, with LRSA mediated by the cfr gene developed at our center, was associated with nosocomial transmission and extensive usage of linezolid. Reduction of linezolid use and infection-control measures were associated with the termination of the outbreak. JAMA. 2010; 303(22): 2260-2264	[Sanchez Garcia, Miguel; Angeles De la Torre, Maria; Jose Tolon, Maria; Domingo, Sara; Martinez Sagasti, Fernando] Hosp Clin San Carlos, Dept Intens Care, Madrid 28040, Spain; [Morales, Gracia; Javier Candel, Francisco; Arribi, Ana; Picazo, Juan] Hosp Clin San Carlos, Microbiol Serv, Madrid 28040, Spain; [Pelaez, Beatriz; Andrade, Raquel; Garcia, Nicolas; Fereres, Jose] Hosp Clin San Carlos, Prevent Med Serv, Madrid 28040, Spain; Univ Complutense, E-28040 Madrid, Spain	Hospital Clinico San Carlos; Hospital Clinico San Carlos; Hospital Clinico San Carlos; Complutense University of Madrid	Garcia, MS (corresponding author), Hosp Clin San Carlos, Dept Intens Care, Madrid 28040, Spain.	msanchezga.hcsc@salud.madrid.org	González, Francisco Javier Candel/Z-5068-2019	González, Francisco Javier Candel/0000-0002-9840-6556; arribi, ana/0000-0003-0716-1897; Martinez-Sagasti, Fernando/0000-0001-8599-1250	Fundacion para la Investigacion Biomedica del Hospital Clinico San Carlos	Fundacion para la Investigacion Biomedica del Hospital Clinico San Carlos	Dr Morales has a research contract of the Fundacion para la Investigacion Biomedica del Hospital Clinico San Carlos.	Álvarez-Lerma F., 2007, Med. Intensiva, V31, P6; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Burleson BS, 2004, PHARMACOTHERAPY, V24, P1225, DOI 10.1592/phco.24.13.1225.38086; CABEZASMARTIN MH, 2006, MED INTENSIVA, V30; *CLIN LAB STAND I, 2008, 17 INF SUPPL DOC; Cuevas O, 2008, ENFERM INFEC MICR CL, V26, P269, DOI 10.1157/13120413; Diekema DJ, 2001, LANCET, V358, P1975, DOI 10.1016/S0140-6736(01)06964-1; Gales AC, 2006, INT J ANTIMICROB AG, V27, P300, DOI 10.1016/j.ijantimicag.2005.11.008; Hentschke M, 2008, INFECTION, V36, P85, DOI 10.1007/s15010-007-7220-7; Howden BP, 2004, CLIN INFECT DIS, V38, P521, DOI 10.1086/381202; Jones RN, 2009, DIAGN MICR INFEC DIS, V64, P191, DOI 10.1016/j.diagmicrobio.2009.03.001; Jones RN, 2008, DIAGN MICR INFEC DIS, V62, P416, DOI 10.1016/j.diagmicrobio.2008.10.010; Kelly S, 2008, J ANTIMICROB CHEMOTH, V61, P901, DOI 10.1093/jac/dkn043; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kola A, 2007, SCAND J INFECT DIS, V39, P463, DOI 10.1080/00365540601071875; Kollef MH, 2004, INTENS CARE MED, V30, P388, DOI 10.1007/s00134-003-2088-1; Long KS, 2006, ANTIMICROB AGENTS CH, V50, P2500, DOI 10.1128/AAC.00131-06; MacKenzie FM, 2007, CLIN MICROBIOL INFEC, V13, P269, DOI 10.1111/j.1469-0691.2006.01592.x; Meka VG, 2004, J INFECT DIS, V190, P311, DOI 10.1086/421471; Meka VG, 2004, J ANTIMICROB CHEMOTH, V54, P818, DOI 10.1093/jac/dkh423; Mendes RE, 2008, ANTIMICROB AGENTS CH, V52, P2244, DOI 10.1128/AAC.00231-08; Miller K, 2008, ANTIMICROB AGENTS CH, V52, P1940, DOI 10.1128/AAC.01302-07; Morales G, 2010, CLIN INFECT DIS, V50, P821, DOI 10.1086/650574; Murchan S, 2003, J CLIN MICROBIOL, V41, P1574, DOI 10.1128/JCM.41.4.1574-1585.2003; Paterson DL, 2003, ANN INTERN MED, V139, P863, DOI 10.7326/0003-4819-139-10-200311180-00017; Peeters MJ, 2005, AM J MED SCI, V330, P102, DOI 10.1097/00000441-200508000-00007; Rahim S, 2003, CLIN INFECT DIS, V36, pE146, DOI 10.1086/374929; Roberts SM, 2006, PEDIATR INFECT DIS J, V25, P562, DOI 10.1097/01.inf.0000219401.70804.1a; Ruggero KA, 2003, DIAGN MICR INFEC DIS, V47, P511, DOI 10.1016/S0732-8893(03)00153-6; Scheetz MH, 2008, ANTIMICROB AGENTS CH, V52, P2256, DOI 10.1128/AAC.00070-08; Schulte B, 2008, EPIDEMIOL INFECT, V136, P1131, DOI 10.1017/S0950268807009508; STRUELENS MJ, 1992, J CLIN MICROBIOL, V30, P2599, DOI 10.1128/JCM.30.10.2599-2605.1992; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Toh SM, 2007, MOL MICROBIOL, V64, P1506, DOI 10.1111/j.1365-2958.2007.05744.x; Trevino M, 2009, EUR J CLIN MICROBIOL, V28, P527, DOI 10.1007/s10096-008-0657-5; Tsiodras S, 2001, LANCET, V358, P207, DOI 10.1016/S0140-6736(01)05410-1; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Wilson P, 2003, J ANTIMICROB CHEMOTH, V51, P186, DOI 10.1093/jac/dkg104	38	173	176	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2010	303	22					2260	2264		10.1001/jama.2010.757	http://dx.doi.org/10.1001/jama.2010.757			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	607IY	20530779	Bronze			2022-12-01	WOS:000278496800024
J	Wei, CJ; Boyington, JC; McTamney, PM; Kong, WP; Pearce, MB; Xu, L; Andersen, H; Rao, S; Tumpey, TM; Yang, ZY; Nabel, GJ				Wei, Chih-Jen; Boyington, Jeffrey C.; McTamney, Patrick M.; Kong, Wing-Pui; Pearce, Melissa B.; Xu, Ling; Andersen, Hanne; Rao, Srinivas; Tumpey, Terrence M.; Yang, Zhi-Yong; Nabel, Gary J.			Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination	SCIENCE			English	Article							RECOMBINANT ADENOVIRAL VECTORS; VIRUS; IMMUNIZATION; IMMUNOGENICITY; IMMUNITY; HIV-1	The rapid dissemination of the 2009 pandemic influenza virus underscores the need for universal influenza vaccines that elicit protective immunity to diverse viral strains. Here, we show that vaccination with plasmid DNA encoding H1N1 influenza hemagglutinin (HA) and boosting with seasonal vaccine or replication-defective adenovirus 5 vector encoding HA stimulated the production of broadly neutralizing influenza antibodies. This prime/boost combination increased the neutralization of diverse H1N1 strains dating from 1934 to 2007 as compared to either component alone and conferred protection against divergent H1N1 viruses in mice and ferrets. These antibodies were directed to the conserved stem region of HA and were also elicited in nonhuman primates. Cross-neutralization of H1N1 subtypes elicited by this approach provides a basis for the development of a universal influenza vaccine for humans.	[Wei, Chih-Jen; Boyington, Jeffrey C.; McTamney, Patrick M.; Kong, Wing-Pui; Xu, Ling; Rao, Srinivas; Yang, Zhi-Yong; Nabel, Gary J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Pearce, Melissa B.; Tumpey, Terrence M.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30333 USA; [Andersen, Hanne] BIOQUAL, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Centers for Disease Control & Prevention - USA; BIOQUAL Inc.	Nabel, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	gnabel@nih.gov	Wei, Chih/GVT-5734-2022	Elyard, Hanne/0000-0003-1103-9608	Vaccine Research Center, NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005003] Funding Source: NIH RePORTER	Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Ault, J.-P. Todd, A. Zajac, and C. Chiedi for help with the animal studies; K. Dai, W. Shi, and S. Y. Ko for technical support; M. Lewis (BIOQUAL), B. Sanders (BIOQUAL), and members of the Nabel lab for helpful discussions; A. Tislerics and B. Hartman for manuscript preparation; and Y. Okuno for providing the C179 mAb. NIH has filed a patent application (U.S. patent E-341-2008l; international patent WO 2010/036958 A2) on this work (authors: C-J.W., Z-y.Y, and G.J.N.), related to gene-and protein-based approaches to influenza vaccination. This research was supported by the Intramural Research Program of the Vaccine Research Center, NIAID, NIH. The findings and conclusions in this report are those of the authors and do not necessarily reflect the views of the funding agency.	Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Del Giudice G, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000564; Douek DC, 2006, CELL, V124, P677, DOI 10.1016/j.cell.2006.02.005; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Kong WP, 2006, P NATL ACAD SCI USA, V103, P15987, DOI 10.1073/pnas.0607564103; Koup RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009015; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Mascola JR, 2005, J VIROL, V79, P771, DOI 10.1128/JVI.79.2.771-779.2005; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; van der Laan JW, 2008, EXPERT REV VACCINES, V7, P783, DOI 10.1586/14760584.7.6.783; Wei CJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000799; *WHO, 2010, WHO GLOB INFL PROGR; Wu L, 2005, J VIROL, V79, P8024, DOI 10.1128/JVI.79.13.8024-8031.2005; Yang ZY, 2007, SCIENCE, V317, P825, DOI 10.1126/science.1135165; Yang ZY, 2004, J VIROL, V78, P4029, DOI 10.1128/JVI.78.8.4029-4036.2004	18	284	330	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2010	329	5995					1060	1064		10.1126/science.1192517	http://dx.doi.org/10.1126/science.1192517			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642WZ	20647428				2022-12-01	WOS:000281253500036
J	Tian, BZ; Cohen-Karni, T; Qing, Q; Duan, XJ; Xie, P; Lieber, CM				Tian, Bozhi; Cohen-Karni, Tzahi; Qing, Quan; Duan, Xiaojie; Xie, Ping; Lieber, Charles M.			Three-Dimensional, Flexible Nanoscale Field-Effect Transistors as Localized Bioprobes	SCIENCE			English	Article							CELLS; ELECTROPHYSIOLOGY; CHEMISTRY; DYNAMICS; ARRAYS; FUSION	Nanoelectronic devices offer substantial potential for interrogating biological systems, although nearly all work has focused on planar device designs. We have overcome this limitation through synthetic integration of a nanoscale field-effect transistor (nanoFET) device at the tip of an acute-angle kinked silicon nanowire, where nanoscale connections are made by the arms of the kinked nanostructure, and remote multilayer interconnects allow three-dimensional (3D) probe presentation. The acute-angle probe geometry was designed and synthesized by controlling cis versus trans crystal conformations between adjacent kinks, and the nanoFET was localized through modulation doping. 3D nanoFET probes exhibited conductance and sensitivity in aqueous solution, independent of large mechanical deflections, and demonstrated high pH sensitivity. Additionally, 3D nanoprobes modified with phospholipid bilayers can enter single cells to allow robust recording of intracellular potentials.	[Tian, Bozhi; Qing, Quan; Duan, Xiaojie; Xie, Ping; Lieber, Charles M.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Cohen-Karni, Tzahi; Lieber, Charles M.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Lieber, CM (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	cml@cmliris.harvard.edu	Cohen-Karni, Tzahi/CAG-1520-2022; Qing, Quan/R-8411-2017; Duan, Xiaojie/N-7667-2013	Cohen-Karni, Tzahi/0000-0001-5742-1007; Qing, Quan/0000-0002-4230-8244; Duan, xiaojie/0000-0001-7799-3897	NIH [5DP1OD003900]; National Security Science and Engineering Faculty Fellow (NSSEFF) [N00244-09-1-0078]; McKnight Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003900] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Security Science and Engineering Faculty Fellow (NSSEFF); McKnight Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank G. Yellen, W. C. Claycomb, B. P. Bean, P. T. Ellinor, G. H. Yu, D. Casanova, B. P. Timko, and T. Dvir for help with experiments and data analysis. C. M. L. acknowledges support from a NIH Director's Pioneer Award (5DP1OD003900), a National Security Science and Engineering Faculty Fellow (NSSEFF) award (N00244-09-1-0078), and the McKnight Foundation Neuroscience award.	Almquist BD, 2010, P NATL ACAD SCI USA, V107, P5815, DOI 10.1073/pnas.0909250107; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cohen-Karni T, 2009, P NATL ACAD SCI USA, V106, P7309, DOI 10.1073/pnas.0902752106; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Donoghue JP, 2002, NAT NEUROSCI, V5, P1085, DOI 10.1038/nn947; Eschermann JF, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3194138; EWING AG, 1992, ACCOUNTS CHEM RES, V25, P440, DOI 10.1021/ar00022a002; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Giljohann DA, 2009, NATURE, V462, P461, DOI 10.1038/nature08605; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Heller I, 2009, SMALL, V5, P2528, DOI 10.1002/smll.200900823; Ieong Meikei, 2004, Science, V306, P2057, DOI 10.1126/science.1100731; Leong TG, 2009, P NATL ACAD SCI USA, V106, P703, DOI 10.1073/pnas.0807698106; Lu W, 2007, NAT MATER, V6, P841, DOI 10.1038/nmat2028; Misra N, 2009, P NATL ACAD SCI USA, V106, P13780, DOI 10.1073/pnas.0904850106; MOLLEMAN A, 2003, PATCH CLAMPING INTRO; PURVES RD, 1981, MICROELECTRODE METHO; Qing Q, 2010, P NATL ACAD SCI USA, V107, P1882, DOI 10.1073/pnas.0914737107; SAKMANN B, 1984, ANNU REV PHYSIOL, V46, P455, DOI 10.1146/annurev.ph.46.030184.002323; Scanziani M, 2009, NATURE, V461, P930, DOI 10.1038/nature08540; Schrlau MG, 2009, ACS NANO, V3, P563, DOI 10.1021/nn800851d; Tian BZ, 2009, NAT NANOTECHNOL, V4, P824, DOI [10.1038/nnano.2009.304, 10.1038/NNANO.2009.304]; Wightman RM, 2006, SCIENCE, V311, P1570, DOI 10.1126/science.1120027; Zhou XJ, 2007, NAT NANOTECHNOL, V2, P185, DOI 10.1038/nnano.2007.34; Zipes DP., 2018, CARDIAC ELECTROPHYSI, V7	27	617	651	7	427	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2010	329	5993					830	834		10.1126/science.1192033	http://dx.doi.org/10.1126/science.1192033			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20705858	Green Accepted			2022-12-01	WOS:000280809900048
J	Cardwell, CR; Abnet, CC; Cantwell, MM; Murray, LJ				Cardwell, Chris R.; Abnet, Christian C.; Cantwell, Marie M.; Murray, Liam J.			Exposure to Oral Bisphosphonates and Risk of Esophageal Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GASTROESOPHAGEAL-REFLUX; VALIDATION; APOPTOSIS; THERAPY	Context Use of oral bisphosphonates has increased dramatically in the United States and elsewhere. Esophagitis is a known adverse effect of bisphosphonate use; and recent reports suggest a link between bisphosphonate use and esophageal cancer, but this has not been robustly investigated. Objective To investigate the association between bisphosphonate use and esophageal cancer. Design, Setting, and Participants Data were extracted from the UK General Practice Research Database to compare the incidence of esophageal and gastric cancer in a cohort of patients treated with oral bisphosphonates between January 1996 and December 2006 with incidence in a control cohort. Cancers were identified from relevant Read/Oxford Medical Information System codes in the patient's clinical files. Cox proportional hazards modeling was used to calculate hazard ratios and 95% confidence intervals for risk of esophageal and gastric cancer in bisphosphonate users compared with nonusers, with adjustment for potential confounders. Main Outcome Measure Hazard ratio for the risk of esophageal and gastric cancer in the bisphosphonate users compared with the bisphosphonate nonusers. Results Mean follow-up time was 4.5 and 4.4 years in the bisphosphonate and control cohorts, respectively. Excluding patients with less than 6 months' follow-up, there were 41 826 members in each cohort (81% women; mean age, 70.0 (SD, 11.4) years). One hundred sixteen esophageal or gastric cancers (79 esophageal) occurred in the bisphosphonate cohort and 115 (72 esophageal) in the control cohort. The incidence of esophageal and gastric cancer combined was 0.7 per 1000 person-years of risk in both the bisphosphonate and control cohorts; the incidence of esophageal cancer alone in the bisphosphonate and control cohorts was 0.48 and 0.44 per 1000 person-years of risk, respectively. There was no difference in risk of esophageal and gastric cancer combined between the cohorts for any bisphosphonate use (adjusted hazard ratio, 0.96 [95% confidence interval, 0.74-1.25]) or risk of esophageal cancer only (adjusted hazard ratio, 1.07 [95% confidence interval, 0.77-1.49]). There also was no difference in risk of esophageal or gastric cancer by duration of bisphosphonate intake. Conclusion Among patients in the UK General Practice Research Database, the use of oral bisphosphonates was not significantly associated with incident esophageal or gastric cancer. JAMA. 2010;304(6):657-663	[Cardwell, Chris R.; Cantwell, Marie M.; Murray, Liam J.] Queens Univ Belfast, Ctr Publ Hlth, Belfast BT12 6BJ, Antrim, North Ireland; [Abnet, Christian C.] NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Rockville, MD USA	Queens University Belfast; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cardwell, CR (corresponding author), Queens Univ Belfast, Ctr Publ Hlth, Grosvenor Rd, Belfast BT12 6BJ, Antrim, North Ireland.	c.cardwell@qub.ac.uk	Abnet, Christian C/C-4111-2015	Abnet, Christian C/0000-0002-3008-7843; Cardwell, Chris/0000-0002-2689-4335	Medical Research Council; UK Medicines and Healthcare Products Regulatory Agency; ESRC [ES/G007438/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIACP000185] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medicines and Healthcare Products Regulatory Agency; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Access to the GPRD database was funded through the Medical Research Council's license agreement with the UK Medicines and Healthcare Products Regulatory Agency. However, the interpretation and conclusions contained in this study are those of the authors alone.	Abrahamsen B, 2009, NEW ENGL J MED, V360, P1789, DOI 10.1056/NEJMc096026; Breslow NE, 1987, STAT METHODS CANC RE, VII; CHOW WH, 1995, JAMA-J AM MED ASSOC, V274, P474, DOI 10.1001/jama.274.6.474; Coxon JP, 2004, BJU INT, V94, P164, DOI 10.1111/j.1464-4096.2004.04831.x; Cramer JA, 2007, OSTEOPOROSIS INT, V18, P1023, DOI 10.1007/s00198-006-0322-8; deGroen PC, 1996, NEW ENGL J MED, V335, P1016, DOI 10.1056/NEJM199610033351403; Giraudo E, 2004, J CLIN INVEST, V114, P623, DOI 10.1172/JCI200422087; Guise TA, 2008, CANCER TREAT REV, V34, pS19, DOI 10.1016/j.ctrv.2008.03.006; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hollowell J, 1997, Popul Trends, P36; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H, 1997, LANCET, V349, P525, DOI 10.1016/S0140-6736(97)80084-0; KINN S, 1995, BRIT MED J, V311, P739, DOI 10.1136/bmj.311.7007.739; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lassen A, 2006, AM J GASTROENTEROL, V101, P1193, DOI 10.1111/j.1572-0241.2006.00550.x; Ribeiro A, 1998, GASTROINTEST ENDOSC, V47, P525, DOI 10.1016/S0016-5107(98)70256-1; Ryan JM, 1998, RADIOLOGY, V206, P389, DOI 10.1148/radiology.206.2.9457190; Shipman CM, 1997, BRIT J HAEMATOL, V98, P665, DOI 10.1046/j.1365-2141.1997.2713086.x; Solomon DH, 2009, NEW ENGL J MED, V360, P1789; Udell JA, 2006, J BONE MINER RES, V21, P765, DOI 10.1359/JBMR.060119; Usher C, 2006, EUR J CLIN PHARMACOL, V62, P307, DOI 10.1007/s00228-005-0083-x; Watson J, 2007, EUR J CLIN PHARMACOL, V63, P843, DOI 10.1007/s00228-007-0320-6; World Health Organization. WHO, AN THER CHEM CLASS S; Wysowski DK, 2009, NEW ENGL J MED, V360, P89, DOI 10.1056/NEJMc0808738	24	146	152	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2010	304	6					657	663		10.1001/jama.2010.1098	http://dx.doi.org/10.1001/jama.2010.1098			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637PA	20699457	Green Accepted, Bronze			2022-12-01	WOS:000280829200021
J	Profumo, D; Dinneen, M				Profumo, David; Dinneen, Michael			A Patient's Journey At sixes and sevens: prostate cancer	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Dinneen, Michael] Chelsea & Westminster Hosp, London SW10 9NH, England	Imperial College London		david.profumo@virgin.net							0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 9	2010	341								c3834	10.1136/bmj.c3834	http://dx.doi.org/10.1136/bmj.c3834			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	640DO	20696746				2022-12-01	WOS:000281028500001
J	Garcia-Perez, JL; Morell, M; Scheys, JO; Kulpa, DA; Morell, S; Carter, CC; Hammer, GD; Collins, KL; O'Shea, KS; Menendez, P; Moran, JV				Garcia-Perez, Jose L.; Morell, Maria; Scheys, Joshua O.; Kulpa, Deanna A.; Morell, Santiago; Carter, Christoph C.; Hammer, Gary D.; Collins, Kathleen L.; O'Shea, K. Sue; Menendez, Pablo; Moran, John V.			Epigenetic silencing of engineered L1 retrotransposition events in human embryonic carcinoma cells	NATURE			English	Article							STEM-CELLS; LINE-1 RETROTRANSPOSITION; SOMATIC MOSAICISM; PROTEIN; MOUSE; EXPRESSION; PATTERNS; VIRUS	Long interspersed element-1 (LINE-1 or L1) retrotransposition continues to affect human genome evolution(1,2). L1s can retrotranspose in the germline, during early development and in select somatic cells(3-8); however, the host response to L1 retrotransposition remains largely unexplored. Here we show that reporter genes introduced into the genome of various human embryonic carcinoma-derived cell lines (ECs) by L1 retrotransposition are rapidly and efficiently silenced either during or immediately after their integration. Treating ECs with histone deacetylase inhibitors rapidly reverses this silencing, and chromatin immunoprecipitation experiments revealed that reactivation of the reporter gene was correlated with changes in chromatin status at the L1 integration site. Under our assay conditions, rapid silencing was also observed when reporter genes were delivered into ECs by mouse L1s and a zebrafish LINE-2 element, but not when similar reporter genes were delivered into ECs by Moloney murine leukaemia virus or human immunodeficiency virus, suggesting that these integration events are silenced by distinct mechanisms. Finally, we demonstrate that subjecting ECs to culture conditions that promote differentiation attenuates the silencing of reporter genes delivered by L1 retrotransposition, but that differentiation, in itself, is not sufficient to reactivate previously silenced reporter genes. Thus, our data indicate that ECs differ from many differentiated cells in their ability to silence reporter genes delivered by L1 retrotransposition.	[Garcia-Perez, Jose L.; Moran, John V.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Garcia-Perez, Jose L.; Morell, Maria; Morell, Santiago; Menendez, Pablo] Univ Granada, Ctr Biomed Res, Consejeria Salud Junta Andalucia, Andalusian Stem Cell Bank, Granada 18100, Spain; [Morell, Maria; Hammer, Gary D.; O'Shea, K. Sue] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Scheys, Joshua O.; Carter, Christoph C.; Hammer, Gary D.; Collins, Kathleen L.; Moran, John V.] Univ Michigan, Sch Med, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; [Kulpa, Deanna A.; Hammer, Gary D.; Collins, Kathleen L.; Moran, John V.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Hammer, Gary D.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Collins, Kathleen L.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Moran, John V.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Michigan System; University of Michigan; University of Granada; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute	Moran, JV (corresponding author), Univ Michigan, Sch Med, Dept Human Genet, 1241 E Catherine St, Ann Arbor, MI 48109 USA.	josel.garcia.perez@juntadeandalucia.es; moranj@umich.edu	Bujan, Pablo Menendez/W-3736-2017; Kulpa, Deanna/ABE-2035-2020; Morell, Maria/ABF-8213-2020; Kulpa, Deanna A/O-5016-2019; Morell, Maria/C-4606-2017	Bujan, Pablo Menendez/0000-0001-9372-1007; Morell, Maria/0000-0001-9613-9741; Kulpa, Deanna A/0000-0002-0411-7295; Morell, Maria/0000-0002-3692-1333; Garcia-Perez, Jose Luis/0000-0002-8132-9849	National Institutes of Health (NIH) [GM060518, GM082970, NS-048187, GM-069985, AI051198]; Howard Hughes Medical Institute; Instituto de Salud Carlos III - Consejeria de Salud Junta de Andalucia (ISCIII-CSJA) [EMER07/056]; Marie Curie International Reintegration Grant action [FP7-PEOPLE-2007-4-3-IRG]; Junta de Andalucia (Spain) [P09-CTS-4980, PI0002/2009, P08-CTS-3678]; Spanish Ministry of Health [FIS PI08171, CP07/00065, FIS PI070026]; Spanish Ministry of Science and Innovation MICINN-PLANE [PLE-2009-0111]; Burroughs Wellcome Foundation; National Institute of Diabetes and Digestive and Kidney Diseases NIH [R01 (DK62027)]; Cellular and Molecular Approaches to Systems and Integrative Biology Training Grant [T32-GM08322]; Cancer Research Institute; University of Michigan; University of Michigan's Cancer Center [NIH 5 P30 CA46592]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM069985, R01GM082970, T32GM007315, T32GM008322, R01GM060518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048187] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Instituto de Salud Carlos III - Consejeria de Salud Junta de Andalucia (ISCIII-CSJA); Marie Curie International Reintegration Grant action; Junta de Andalucia (Spain)(Junta de Andalucia); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); Spanish Ministry of Science and Innovation MICINN-PLANE(Ministry of Science and Innovation, Spain (MICINN)); Burroughs Wellcome Foundation(Burroughs Wellcome Fund); National Institute of Diabetes and Digestive and Kidney Diseases NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cellular and Molecular Approaches to Systems and Integrative Biology Training Grant; Cancer Research Institute; University of Michigan(University of Michigan System); University of Michigan's Cancer Center(University of Michigan System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. W. Andrews for providing human EC lines, discussing unpublished data from his laboratory and giving advice during the course of this study. We thank A. Macia and M. Munoz-Lopez (Andalusian Stem Cell Bank) for sharing unpublished data; A. V. Furano, H. Kazazian, J. K. Kim, H. Kopera, A. Muotri, and members of the Moran and Garcia-Perez laboratories for critical reading of the manuscript; and G. Smith and L. Villa for help in creating the time-lapsed movie. We thank M. Velkey for providing plasmid pBSSK-pgk; H. Kazazian for providing plasmid pJCC5/LRE3; J. Boeke for providing synthetic mouse LINE-1 constructs; M. Kajikawa and N. Okada for providing the zebrafish LINE-2 expression plasmids; T. Fanning for providing the polyclonal ORF1 antibody; I. Damjanov for comments on the teratoma characterization; T. Lanigan for preparing Moloney murine leukaemia virus retroviral supernatants; C. Pigott for EC culture advice; and T. de la Cueva, P. Catalina and A. Nieto (Andalusian Stem Cell Bank) for their help with mouse experimentation, SKY-FISH and pathology analyses, respectively. J. V. M. is supported by the National Institutes of Health (NIH) (GM060518 and GM082970) and the Howard Hughes Medical Institute. J. L. G.-P. is supported by the Instituto de Salud Carlos III - Consejeria de Salud Junta de Andalucia (ISCIII-CSJA) (EMER07/056), by a Marie Curie International Reintegration Grant action (FP7-PEOPLE-2007-4-3-IRG), by CICE (P09-CTS-4980) and Proyectos en Salud (PI0002/2009) from Junta de Andalucia (Spain) and through the Spanish Ministry of Health (FIS PI08171 and Miguel Servet CP07/00065). M. M. is supported by the ISCIII-CSJA (EMER07/056). P. M. is supported by the Spanish Ministry of Science and Innovation MICINN-PLANE (PLE-2009-0111), by CICE (P08-CTS-3678) from Junta de Andalucia (Spain) and by the Spanish Ministry of Health (FIS PI070026). K.S.O'S. is supported by the NIH (NS-048187 and GM-069985). K. L. C. is supported by the Burroughs Wellcome Foundation and by an NIH Research Project Grant (R01) (AI051198). G. D. H is supported by a National Institute of Diabetes and Digestive and Kidney Diseases NIH R01 (DK62027). J.O.S. is supported by a Cellular and Molecular Approaches to Systems and Integrative Biology Training Grant (T32-GM08322). D. A. K. is supported by The Irvington Institute Fellowship Program of the Cancer Research Institute. S. M. is supported by a CICE (P08-CTS-3678) scholarship from Junta de Andalucia, Spain. C. C. C. is supported by a Rackham Predoctoral Fellowship from the University of Michigan. We defrayed the costs of DNA sequencing in part with the University of Michigan's Cancer Center Support Grant (NIH 5 P30 CA46592).	Bestor TH, 1996, NAT GENET, V12, P363, DOI 10.1038/ng0496-363; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brouha B, 2002, AM J HUM GENET, V71, P327, DOI 10.1086/341722; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Goodier JL, 2001, GENOME RES, V11, P1677, DOI 10.1101/gr.198301; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Gummow BM, 2006, MOL ENDOCRINOL, V20, P2711, DOI 10.1210/me.2005-0461; Han JS, 2004, NATURE, V429, P314, DOI 10.1038/nature02535; Hohjoh H, 1996, EMBO J, V15, P630, DOI 10.1002/j.1460-2075.1996.tb00395.x; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kubo S, 2006, P NATL ACAD SCI USA, V103, P8036, DOI 10.1073/pnas.0601954103; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; LOH TP, 1987, MOL CELL BIOL, V7, P3775, DOI 10.1128/MCB.7.10.3775; MATTHAEI KI, 1983, EXP CELL RES, V143, P471, DOI 10.1016/0014-4827(83)90076-9; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Ostertag EM, 2002, NAT GENET, V32, P655, DOI 10.1038/ng1022; Schumann GG, 2007, BIOCHEM SOC T, V35, P637, DOI 10.1042/BST0350637; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Sugano T, 2006, GENE, V365, P74, DOI 10.1016/j.gene.2005.09.037; Suzuki J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000461; TEICH NM, 1977, CELL, V12, P973, DOI 10.1016/0092-8674(77)90162-3; van den Hurk JAJM, 2007, HUM MOL GENET, V16, P1587, DOI 10.1093/hmg/ddm108; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844	30	113	114	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2010	466	7307					769	773		10.1038/nature09209	http://dx.doi.org/10.1038/nature09209			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20686575	Green Accepted			2022-12-01	WOS:000280562500042
J	Strachan, NJC; Forbes, KJ				Strachan, Norval J. C.; Forbes, Ken J.			The growing UK epidemic of human campylobacteriosis	LANCET			English	Editorial Material							GENERAL-PRACTICE; INFECTION		[Strachan, Norval J. C.] Univ Aberdeen, Sch Biol Sci, Inst Environm & Biol Sci, Aberdeen AB24 3UU, Scotland; [Forbes, Ken J.] Univ Aberdeen, Sch Med, Sect Immunol & Infect, Aberdeen AB24 3UU, Scotland	University of Aberdeen; University of Aberdeen	Strachan, NJC (corresponding author), Univ Aberdeen, Sch Biol Sci, Inst Environm & Biol Sci, Aberdeen AB24 3UU, Scotland.		Strachan, Norval J/D-4744-2009					Blaser MJ, 1997, J INFECT DIS, V176, pS103, DOI 10.1086/513780; Ethelberg S, 2005, AM J EPIDEMIOL, V162, P1008, DOI 10.1093/aje/kwi316; *FOOD STAND AG, 2009, Q PUBL ATT TRACK DEC; Food Standards Agency (FSA), 2009, FSA REP UK SURV CAMP; *FSA, 2010, CAMP EV PROGR; Gormley FJ, 2008, APPL ENVIRON MICROB, V74, P383, DOI 10.1128/AEM.01455-07; LOWMAN R, 2009, 15 INT C CAMP HEL RE; Mullner P, 2009, RISK ANAL, V29, P970, DOI 10.1111/j.1539-6924.2009.01224.x; POLLOCK K, 2010, HPS WKLY REP, V44, P38; *POP ENV HLTH GROU, 2009, NOT OTH DIS NZ 2008; Samuel MC, 2004, CLIN INFECT DIS, V38, pS165, DOI 10.1086/381583; Sheppard SK, 2009, CLIN INFECT DIS, V48, P1072, DOI 10.1086/597402; Tam CC, 2006, J INFECT DIS, V194, P95, DOI 10.1086/504294; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203; Zia S, 2003, RHEUMATOLOGY, V42, P1083, DOI 10.1093/rheumatology/keg303; 2006, DOMINION POST   0710, pA5; 2005, EFSA J, V297, P1; 2010, HLTH PROTECTION REP, V4, P5	19	23	23	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2010	376	9742					665	667		10.1016/S0140-6736(10)60708-8	http://dx.doi.org/10.1016/S0140-6736(10)60708-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646YW	20663545				2022-12-01	WOS:000281582900008
J	Graham, DJ; Ouellet-Hellstrom, R; MaCurdy, TE; Ali, F; Sholley, C; Worrall, C; Kelman, JA				Graham, David J.; Ouellet-Hellstrom, Rita; MaCurdy, Thomas E.; Ali, Farzana; Sholley, Christopher; Worrall, Christopher; Kelman, Jeffrey A.			Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITIVE PREDICTIVE-VALUE; CARDIOVASCULAR OUTCOMES; ADMINISTRATIVE DATA; CODING ACCURACY; UNITED-STATES; DATABASE; DISEASE; EVENTS; COHORT; THIAZOLIDINEDIONES	Context Studies have suggested that the use of rosiglitazone may be associated with an increased risk of serious cardiovascular events compared with other treatments for type 2 diabetes. Objective To determine if the risk of serious cardiovascular harm is increased by rosiglitazone compared with pioglitazone, the other thiazolidinedione marketed in the United States. Design, Setting, and Patients Nationwide, observational, retrospective, inception cohort of 227 571 Medicare beneficiaries aged 65 years or older (mean age, 74.4 years) who initiated treatment with rosiglitazone or pioglitazone through a Medicare Part D prescription drug plan from July 2006-June 2009 and who underwent follow-up for up to 3 years after thiazolidinedione initiation. Main Outcome Measures Individual end points of acute myocardial infarction (AMI), stroke, heart failure, and all-cause mortality (death), and composite end point of AMI, stroke, heart failure, or death, assessed using incidence rates by thiazolidinedione, attributable risk, number needed to harm, Kaplan-Meier plots of time to event, and Cox proportional hazard ratios for time to event, adjusted for potential confounding factors, with pioglitazone as reference. Results A total of 8667 end points were observed during the study period. The adjusted hazard ratio for rosiglitazone compared with pioglitazone was 1.06 (95% confidence interval [CI], 0.96-1.18) for AMI; 1.27 (95% CI, 1.12-1.45) for stroke; 1.25 (95% CI, 1.16-1.34) for heart failure; 1.14 (95% CI, 1.05-1.24) for death; and 1.18 (95% CI, 1.12-1.23) for the composite of AMI, stroke, heart failure, or death. The attributable risk for this composite end point was 1.68 (95% CI, 1.27-2.08) excess events per 100 person-years of treatment with rosiglitazone compared with pioglitazone. The corresponding number needed to harm was 60 (95% CI, 48-79) treated for 1 year. Conclusion Compared with prescription of pioglitazone, prescription of rosiglitazone was associated with an increased risk of stroke, heart failure, and all-cause mortality and an increased risk of the composite of AMI, stroke, heart failure, or all-cause mortality in patients 65 years or older. JAMA. 2010;304(4):411-418 www.jama.com	[Graham, David J.; Ouellet-Hellstrom, Rita] US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [MaCurdy, Thomas E.] Stanford Univ, Stanford, CA 94305 USA; [MaCurdy, Thomas E.; Ali, Farzana; Sholley, Christopher] Acumen LLC, Burlingame, CA USA; [Worrall, Christopher; Kelman, Jeffrey A.] Ctr Medicare Serv, Washington, DC USA; [Worrall, Christopher; Kelman, Jeffrey A.] Ctr Medicaid Serv, Washington, DC USA	US Food & Drug Administration (FDA); Stanford University; Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Graham, DJ (corresponding author), US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave,Bldg 22,Room 4314, Silver Spring, MD 20993 USA.	david.graham1@fda.hhs.gov			Office of the Assistant Secretary for Planning and Evaluation (ASPE); Centers for Medicare & Medicaid Services (CMS); US Food and Drug Administration (FDA); Office of the Assistant Secretary for Planning and Evaluation in the Department of Health and Human Services	Office of the Assistant Secretary for Planning and Evaluation (ASPE); Centers for Medicare & Medicaid Services (CMS); US Food and Drug Administration (FDA); Office of the Assistant Secretary for Planning and Evaluation in the Department of Health and Human Services	This study was funded by the Office of the Assistant Secretary for Planning and Evaluation (ASPE), the Centers for Medicare & Medicaid Services (CMS), and the US Food and Drug Administration (FDA).; We thank the Office of the Assistant Secretary for Planning and Evaluation in the Department of Health and Human Services for scientific contributions and financial support of this study and the SafeRx Project. We also extend special thanks to Mark Levenson, PhD, and Stephine Keeton, PhD (both with the FDA Office of Biostatistics), for providing statistical advice and to Pallavi Mukherji, MSc, Richard Domurat, BS, Jonathan Gibbs, BA, and Konrad Turski, MSc ( all with Acumen LLC), for assistance with programming and data analysis. These individuals are salaried employees of their respective organizations and received no additional compensation related to their contributions to this study.	Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Barsheshet A, 2010, EUR J HEART FAIL, V12, P833, DOI 10.1093/eurjhf/hfq079; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; Brownstein JS, 2010, DIABETES CARE, V33, P526, DOI 10.2337/dc09-1506; Centers for Medicare and Medicaid Services, MED PROGR GEN INF OV; Centers for Medicare & Medicaid Services, PRESCR DRUG COV GEN; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choma NN, 2009, PHARMACOEPIDEM DR S, V18, P1064, DOI 10.1002/pds.1821; Chung CP, 2010, PHARMACOEPIDEM DR S, V19, P563, DOI 10.1002/pds.1888; *CTR DIS CONTR PRE, 2007, NAT DIAB FACT SHEET; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Dormuth CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006080; Gerrits CM, 2007, PHARMACOEPIDEM DR S, V16, P1065, DOI 10.1002/pds.1470; *GLAXOSMITHKLINE, 2008, AV ROS PROD LAB; Goff DC, 2000, ARCH INTERN MED, V160, P197, DOI 10.1001/archinte.160.2.197; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Habib ZA, 2009, PHARMACOEPIDEM DR S, V18, P437, DOI 10.1002/pds.1722; Hennessy S, 2007, MED CARE, V45, P1216, DOI 10.1097/MLR.0b013e318148435a; Hill ME, 2001, SOC SECUR BULL, V64, P45; Jong P, 2003, CIRCULATION, V108, P184, DOI 10.1161/01.CIR.0000080290.39027.48; Juurlink DN, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2942; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; Lago RM, 2007, LANCET, V370, P1129, DOI 10.1016/S0140-6736(07)61514-1; Levy AR, 1999, CAN J CARDIOL, V15, P1277; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; *OFF ASS SECR PLAN, OV UN US AN 2005 CUR; Pantalone KM, 2009, ACTA DIABETOL, V46, P145, DOI 10.1007/s00592-008-0090-3; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Rournie CL, 2008, PHARMACOEPIDEM DR S, V17, P20, DOI 10.1002/pds.1518; *TAK PHARM AM INC, 2008, ACT PIOGL HYDR PROD; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Walker AM, 2008, PHARMACOEPIDEM DR S, V17, P760, DOI 10.1002/pds.1598; Winkelmayer WC, 2008, ARCH INTERN MED, V168, P2368, DOI 10.1001/archinte.168.21.2368; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254; Ziyadeh N, 2009, CLIN THER, V31, P2665, DOI 10.1016/j.clinthera.2009.11.003	39	386	405	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2010	304	4					411	418		10.1001/jama.2010.920	http://dx.doi.org/10.1001/jama.2010.920			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631MA	20584880	Bronze			2022-12-01	WOS:000280350100024
J	Neugut, AI; Lebwohl, B				Neugut, Alfred I.; Lebwohl, Benjamin			Colonoscopy vs Sigmoidoscopy Screening Getting It Right	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COLORECTAL-CANCER		[Neugut, Alfred I.] Columbia Univ, Coll Phys & Surg, Med Ctr, Dept Med, New York, NY 10032 USA; [Neugut, Alfred I.] Columbia Univ, Coll Phys & Surg, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Neugut, Alfred I.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Neugut, AI (corresponding author), Columbia Univ, Coll Phys & Surg, Med Ctr, Dept Med, 722 W 168th St,Room 725, New York, NY 10032 USA.	ain1@columbia.edu			NCI NIH HHS [T32 CA095929] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R43CA095929, T32CA009529] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Brenner H, 2010, J NATL CANCER I, V102, P89, DOI 10.1093/jnci/djp436; Hoff G, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1846; Jorgensen OD, 2002, GUT, V50, P29, DOI 10.1136/gut.50.1.29; Lieberman DA, 2009, NEW ENGL J MED, V361, P1179, DOI 10.1056/NEJMcp0902176; NEUGUT AI, 1988, AM J GASTROENTEROL, V83, P295; Newcomb PA, 2003, J NATL CANCER I, V95, P622, DOI 10.1093/jnci/95.8.622; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Singh H, 2010, AM J GASTROENTEROL, V105, P663, DOI 10.1038/ajg.2009.650	10	56	57	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2010	304	4					461	462		10.1001/jama.2010.1001	http://dx.doi.org/10.1001/jama.2010.1001			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631MA	20664047				2022-12-01	WOS:000280350100030
J	Cardenas, C; Miller, RA; Smith, I; Bui, T; Molgo, J; Muller, M; Vais, H; Cheung, KH; Yang, J; Parker, I; Thompson, CB; Birnbaum, MJ; Hallows, KR; Foskett, JK				Cardenas, Cesar; Miller, Russell A.; Smith, Ian; Bui, Thi; Molgo, Jordi; Mueller, Marioly; Vais, Horia; Cheung, King-Ho; Yang, Jun; Parker, Ian; Thompson, Craig B.; Birnbaum, Morris J.; Hallows, Kenneth R.; Foskett, J. Kevin			Essential Regulation of Cell Bioenergetics by Constitutive InsP(3) Receptor Ca2+ Transfer to Mitochondria	CELL			English	Article							ACTIVATED PROTEIN-KINASE; OXIDATIVE-PHOSPHORYLATION; ENDOPLASMIC-RETICULUM; MAMMALIAN-CELLS; CALCIUM SIGNALS; ATP SYNTHESIS; AUTOPHAGY; CHANNEL; APOPTOSIS; MTOR	Mechanisms that regulate cellular metabolism are a fundamental requirement of all cells. Most eukaryotic cells rely on aerobic mitochondrial metabolism to generate ATP. Nevertheless, regulation of mitochondrial activity is incompletely understood. Here we identified an unexpected and essential role for constitutive InsP(3)R-mediated Ca2+ release in maintaining cellular bioenergetics. Macroautophagy provides eukaryotes with an adaptive response to nutrient deprivation that prolongs survival. Constitutive InsP(3)R Ca2+ signaling is required for macroautophagy suppression in cells in nutrient-replete media. In its absence, cells become metabolically compromised due to diminished mitochondrial Ca2+ uptake. Mitochondrial uptake of InsP(3)R-released Ca2+ is fundamentally required to provide optimal bioenergetics by providing sufficient reducing equivalents to support oxidative phosphorylation. Absence of this Ca2+ transfer results in enhanced phosphorylation of pyruvate dehydrogenase and activation of AMPK, which activates prosurvival macroautophagy. Thus, constitutive InsP(3)R Ca2+ release to mitochondria is an essential cellular process that is required for efficient mitochondrial respiration and maintenance of normal cell bioenergetics.	[Cardenas, Cesar; Mueller, Marioly; Vais, Horia; Cheung, King-Ho; Yang, Jun; Foskett, J. Kevin] Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA; [Foskett, J. Kevin] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Miller, Russell A.; Birnbaum, Morris J.] Univ Penn, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Bui, Thi; Thompson, Craig B.] Univ Penn, Abramson Canc Inst, Philadelphia, PA 19104 USA; [Bui, Thi; Thompson, Craig B.] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Smith, Ian; Parker, Ian] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Molgo, Jordi] CNRS, Inst Neurobiol Alfred Fessard, FRC2118, Lab Neurobiol Cellulaire & Dev,UPR 3294, F-91198 Gif Sur Yvette, France; [Hallows, Kenneth R.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of California System; University of California Irvine; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Foskett, JK (corresponding author), Univ Penn, Dept Physiol, Philadelphia, PA 19104 USA.	foskett@mail.med.upenn.edu	Foskett, Kevin/R-2549-2019; Cardenas, Julio C/I-3221-2013; smith, ian/E-7528-2011; Muller, Marioly/J-5420-2014; Hallows, Kenneth/A-8477-2013; /B-3424-2011	Hallows, Kenneth/0000-0002-2964-2440; /0000-0001-8683-1654; Birnbaum, Morris/0000-0001-9972-8680; Foskett, J. Kevin/0000-0002-8854-0268	NIH [GM/DK56328, MH059937, DK075048, CA099179, CA092660, GM48071, GM065830]; American Heart Association;  [DK079572]; NATIONAL CANCER INSTITUTE [R01CA092660, R01CA099179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056328, R01DK075048, F32DK079572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056328, R01GM048071, R01GM065830, R37GM048071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059937] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Dr. Robert Balaban for helpful discussions. This work was supported by NIH grants GM/DK56328 and MH059937 (J.K.F.), DK075048 (K. R. H.), CA099179 and CA092660 (C. T.), GM48071 (I. P.), and GM065830 (J.K.F. and I. P.). We thank the University of Pennsylvania Institute for Diabetes, Obesity and Metabolism (P30-DK19535) for assistance. C. C. was supported by an award from the American Heart Association. R. A. M. was supported by DK079572.	Balaban RS, 2009, BBA-BIOENERGETICS, V1787, P1334, DOI 10.1016/j.bbabio.2009.05.011; BALABAN RS, 1990, AM J PHYSIOL, V258, pC377, DOI 10.1152/ajpcell.1990.258.3.C377; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bhalla V, 2006, J BIOL CHEM, V281, P26159, DOI 10.1074/jbc.M606045200; BROWN GC, 1992, BIOCHEM J, V284, P1; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Demuro A, 2006, CELL CALCIUM, V40, P413, DOI 10.1016/j.ceca.2006.08.006; Eskelinen EL, 2008, AUTOPHAGY, V4, P257, DOI 10.4161/auto.5179; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Gustafsson AB, 2008, CARDIOVASC RES, V77, P334, DOI 10.1093/cvr/cvm005; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hallows KR, 2009, AM J PHYSIOL-CELL PH, V296, pC672, DOI 10.1152/ajpcell.00004.2009; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huttemann M, 2008, NEUROSCIENCE, V151, P148, DOI 10.1016/j.neuroscience.2007.09.029; Jaimovich E, 2005, FEBS LETT, V579, P2051, DOI 10.1016/j.febslet.2005.02.053; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; Kimball SR, 2006, MED SCI SPORT EXER, V38, P1958, DOI 10.1249/01.mss.0000233796.16411.13; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Kochanowski N, 2006, ANAL BIOCHEM, V348, P243, DOI 10.1016/j.ab.2005.10.027; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; MAK DOD, 1994, J BIOL CHEM, V269, P29375; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Meijer Alfred J., 2008, V445, P89, DOI 10.1007/978-1-59745-157-4_5; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Smith IF, 2009, P NATL ACAD SCI USA, V106, P6404, DOI 10.1073/pnas.0810799106; Smith IF, 2009, CELL CALCIUM, V45, P65, DOI 10.1016/j.ceca.2008.06.001; Spat A, 2008, CELL CALCIUM, V44, P51, DOI 10.1016/j.ceca.2007.11.015; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; Vicencio JM, 2009, CELL DEATH DIFFER, V16, P1006, DOI 10.1038/cdd.2009.34; Wallace DC, 2005, COLD SH Q B, V70, P363, DOI 10.1101/sqb.2005.70.035; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Wojcikiewicz RJH, 1998, MOL PHARMACOL, V53, P656, DOI 10.1124/mol.53.4.656	48	719	738	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					270	283		10.1016/j.cell.2010.06.007	http://dx.doi.org/10.1016/j.cell.2010.06.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655468	Green Accepted, Bronze			2022-12-01	WOS:000280204300018
J	Kher, U				Kher, Unmesh			A call for collaboration	NATURE			English	Editorial Material																			0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S21	S22		10.1038/nature09245	http://dx.doi.org/10.1038/nature09245			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631702	Bronze			2022-12-01	WOS:000279867100034
J	Zhao, Z; Andersen, SU; Ljung, K; Dolezal, K; Miotk, A; Schultheiss, SJ; Lohmann, JU				Zhao, Zhong; Andersen, Stig U.; Ljung, Karin; Dolezal, Karel; Miotk, Andrej; Schultheiss, Sebastian J.; Lohmann, Jan U.			Hormonal control of the shoot stem-cell niche	NATURE			English	Article							AUXIN RESPONSE FACTORS; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CYTOKININ; MERISTEM; WUSCHEL; FATE; EMBRYOGENESIS; BIOSYNTHESIS	The classic phytohormones cytokinin and auxin play essential roles in the maintenance of stem-cell systems embedded in shoot and root meristems, and exhibit complex functional interactions(1-4). Here we show that the activity of both hormones directly converges on the promoters of two A-type ARABIDOPSIS RESPONSE REGULATOR (ARR) genes, ARR7 and ARR15, which are negative regulators of cytokinin signalling(5) and have important meristematic functions(3). Whereas ARR7 and ARR15 expression in the shoot apical meristem (SAM) is induced by cytokinin, auxin has a negative effect, which is, at least in part, mediated by the AUXIN RESPONSE FACTOR5/MONOPTEROS (MP) transcription factor(6). Our results provide a mechanistic framework for hormonal control of the apical stem-cell niche and demonstrate how root and shoot stem-cell systems differ in their response to phytohormones.	[Zhao, Zhong; Miotk, Andrej; Lohmann, Jan U.] Heidelberg Univ, Dept Stem Cell Biol, D-69120 Heidelberg, Germany; [Zhao, Zhong; Andersen, Stig U.; Miotk, Andrej; Schultheiss, Sebastian J.; Lohmann, Jan U.] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [Ljung, Karin; Dolezal, Karel] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden; [Dolezal, Karel] Palacky Univ, Lab Growth Regulators, Olomouc 78371, Czech Republic; [Dolezal, Karel] Acad Sci Czech Republ, Inst Expt Bot, Olomouc 78371, Czech Republic; [Schultheiss, Sebastian J.] Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany	Ruprecht Karls University Heidelberg; Max Planck Society; Swedish University of Agricultural Sciences; Umea University; Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Eberhard Karls University of Tubingen; Max Planck Society	Lohmann, JU (corresponding author), Heidelberg Univ, Dept Stem Cell Biol, D-69120 Heidelberg, Germany.	jlohmann@meristemania.org	Zhao, Zhong/N-1999-2013; Ljung, Karin/AAE-8691-2019; Lohmann, Jan/T-3776-2019; Doležal, Karel/H-2436-2014	Zhao, Zhong/0000-0001-8044-0409; Ljung, Karin/0000-0003-2901-189X; Lohmann, Jan/0000-0003-3667-187X; Doležal, Karel/0000-0003-4938-0350; Andersen, Stig U./0000-0002-1096-1468; Schultheiss, Sebastian J/0000-0001-8488-906X	Human Frontier Science Program; EMBO; Carlsberg Foundation; Czech Ministry of Education [MSM 6198959216]; Max Planck Society;  [SFB446]	Human Frontier Science Program(Human Frontier Science Program); EMBO(European Molecular Biology Organization (EMBO)); Carlsberg Foundation(Carlsberg Foundation); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Max Planck Society(Max Planck Society); 	We thank G. Jurgens, K. Schneitz and D. Weigel for reading the manuscript, and I. Weisswange for imaging. This work was supported by a Human Frontier Science Program Career Development Award, an EMBO Young Investigator Award, the SFB446 (all to J.U.L.), a Carlsberg Foundation fellowship (to S. U. A.), a Czech Ministry of Education grant (MSM 6198959216) (to K. D.) and the Max Planck Society.	Andersen SU, 2008, PLANT CELL, V20, P88, DOI 10.1105/tpc.107.054676; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Furutani M, 2004, DEVELOPMENT, V131, P5021, DOI 10.1242/dev.01388; Giulini A, 2004, NATURE, V430, P1031, DOI 10.1038/nature02778; Gordon SP, 2009, P NATL ACAD SCI USA, V106, P16529, DOI 10.1073/pnas.0908122106; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Jasinski S, 2005, CURR BIOL, V15, P1560, DOI 10.1016/j.cub.2005.07.023; KIEBER JJ, 2002, ARABIDOPSIS BOOK; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Nordstrom A, 2004, ANAL CHEM, V76, P2869, DOI 10.1021/ac0499017; Ohyama K, 2009, NAT CHEM BIOL, V5, P578, DOI 10.1038/nchembio.182; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Riou-Khamlichi C, 1999, SCIENCE, V283, P1541, DOI 10.1126/science.283.5407.1541; Schlereth A, 2010, NATURE, V464, P913, DOI 10.1038/nature08836; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Speed, 2003, STAT ANAL GENE EXPRE; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Vidaurre DP, 2007, DEVELOPMENT, V134, P2561, DOI 10.1242/dev.006759; Weigel D., 2002, ARABIDOPSIS LAB MANU; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yanai O, 2005, CURR BIOL, V15, P1566, DOI 10.1016/j.cub.2005.07.060	34	330	354	4	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					1089	U154		10.1038/nature09126	http://dx.doi.org/10.1038/nature09126			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577215				2022-12-01	WOS:000279056900055
J	Murray, SA; Kendall, M; Boyd, K; Grant, L; Highet, G; Sheikh, A				Murray, Scott A.; Kendall, Marilyn; Boyd, Kirsty; Grant, Liz; Highet, Gill; Sheikh, Aziz			Archetypal trajectories of social, psychological, and spiritual wellbeing and distress in family care givers of patients with lung cancer: secondary analysis of serial qualitative interviews	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SIGNIFICANT OTHERS; PALLIATIVE CARE; HEART-FAILURE; OF-LIFE; CAREGIVERS; ILLNESS; SURVIVORS; PATTERNS; DECLINE; HEALTH	Objective To assess if family care givers of patients with lung cancer experience the patterns of social, psychological, and spiritual wellbeing and distress typical of the patient, from diagnosis to death. Design Secondary analysis of serial qualitative interviews carried out every three months for up to a year or to bereavement. Setting South east Scotland. Participants 19 patients with lung cancer and their 19 family carers, totalling 88 interviews (42 with patients and 46 with carers). Results Carers followed clear patterns of social, psychological, and spiritual wellbeing and distress that mirrored the experiences of those for whom they were caring, with some carers also experiencing deterioration in physical health that impacted on their ability to care. Psychological and spiritual distress were particularly dynamic and commonly experienced. In addition to the "Why us?" response, witnessing suffering triggered personal reflections in carers on the meaning and purpose of life. Certain key time points in the illness tended to be particularly problematic for both carers and patients: at diagnosis, at home after initial treatment, at recurrence, and during the terminal stage. Conclusions Family carers witness and share much of the illness experience of the dying patient. The multidimensional experience of distress suffered by patients with lung cancer was reflected in the suffering of their carers in the social, psychological, and spiritual domains, with psychological and spiritual distress being most pronounced. Carers may need to be supported throughout the period of illness not just in the terminal phase and during bereavement, as currently tends to be the case.	[Murray, Scott A.; Kendall, Marilyn; Boyd, Kirsty; Grant, Liz; Highet, Gill; Sheikh, Aziz] Univ Edinburgh, Primary Palliat Care Res Grp, Ctr Populat Hlth Sci, Gen Practice Sect, Edinburgh EH8 9DX, Midlothian, Scotland	University of Edinburgh	Murray, SA (corresponding author), Univ Edinburgh, Primary Palliat Care Res Grp, Ctr Populat Hlth Sci, Gen Practice Sect, Edinburgh EH8 9DX, Midlothian, Scotland.	scott.murray@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056; Boyd, Kirsty/0000-0002-5526-1078; Grant, Liz/0000-0001-7248-7792	Chief Scientist's Office of the Scottish government	Chief Scientist's Office of the Scottish government	The Chief Scientist's Office of the Scottish government funded the studies.	Bowman KF, 2003, PSYCHO-ONCOLOGY, V12, P226, DOI 10.1002/pon.630; *DEP HLTH, 2008, END LIF STRAT; Department of Health, 2000, NHS CANC PLAN PLAN I; *FOR QUAL SOC RES, 2005, SEC AN QUAL DAT; Grant Elizabeth, 2004, Palliat Support Care, V2, P371; Heaton J., 2004, REWORKING QUALITATIV; Hodges LJ, 2005, SOC SCI MED, V60, P1, DOI 10.1016/j.socscimed.2004.04.018; Kendall M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4122; KIM Y, 2009, PSYCHOONCOLOGY; Kim Y, 2008, CANCER-AM CANCER SOC, V112, P2556, DOI 10.1002/cncr.23449; Kim Y, 2007, SUPPORT CARE CANCER, V15, P1367, DOI 10.1007/s00520-007-0265-4; KISSANE DW, 1994, PSYCHO-ONCOLOGY, V3, P47, DOI DOI 10.1002/P0N.2960030109; Kurtz ME, 2004, MED SCI MONITOR, V10, pCR447; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Lynn J, 2008, BRIT MED J, V336, P958, DOI 10.1136/bmj.39535.656319.94; Manne S.L., 2007, CANC INVEST, V16, P188; Moore N., 2007, HERITAGE MEMORY AND; MURRAY S, 2009, BRIT MED J, V3009, pB3702; Murray SA, 2004, PALLIATIVE MED, V18, P39, DOI 10.1191/0269216304pm837oa; Murray SA, 2002, BRIT MED J, V325, P929, DOI 10.1136/bmj.325.7370.929; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Murray SA, 2007, J PAIN SYMPTOM MANAG, V34, P393, DOI 10.1016/j.jpainsymman.2006.12.009; Murray SA, 2006, LANCET, V368, P901, DOI 10.1016/S0140-6736(06)69350-1; Northouse L, 1989, Oncol Nurs Forum, V16, P511; Ostlund U, 2010, PSYCHO-ONCOLOGY, V19, P29, DOI 10.1002/pon.1433; Persson C, 2008, PALLIATIVE MED, V22, P239, DOI 10.1177/0269216307085339; Pitceathly C, 2003, EUR J CANCER, V39, P1517, DOI 10.1016/S0959-8049(03)00309-5; *QSR, QSR NVIV VERS 7; Ryan PJ, 2008, PALLIATIVE MED, V22, P233, DOI 10.1177/0269216307087145; SAVAGE M, 2007, CHANGING SOCIAL CLAS; The AM, 2000, BRIT MED J, V321, P1376, DOI 10.1136/bmj.321.7273.1376; The Expert Advisory Group on Cancer to the Chief Medical Officers of England and Wales, 1995, POL FRAM COMM CANC S; Worth A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b183	33	110	111	0	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 10	2010	340								c2581	10.1136/bmj.c2581	http://dx.doi.org/10.1136/bmj.c2581			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611MF	20538635	Green Published, Green Submitted, hybrid			2022-12-01	WOS:000278818700003
J	Reynolds, LE; Watson, AR; Baker, M; Jones, TA; D'Amico, G; Robinson, SD; Joffre, C; Garrido-Urbani, S; Rodriguez-Manzaneque, JC; Martino-Echarri, E; Aurrand-Lions, M; Sheer, D; Dagna-Bricarelli, F; Nizetic, D; McCabe, CJ; Turnell, AS; Kermorgant, S; Imhof, BA; Adams, R; Fisher, EMC; Tybulewicz, VLJ; Hart, IR; Hodivala-Dilke, KM				Reynolds, Louise E.; Watson, Alan R.; Baker, Marianne; Jones, Tania A.; D'Amico, Gabriela; Robinson, Stephen D.; Joffre, Carine; Garrido-Urbani, Sarah; Carlos Rodriguez-Manzaneque, Juan; Martino-Echarri, Estefania; Aurrand-Lions, Michel; Sheer, Denise; Dagna-Bricarelli, Franca; Nizetic, Dean; McCabe, Christopher J.; Turnell, Andrew S.; Kermorgant, Stephanie; Imhof, Beat A.; Adams, Ralf; Fisher, Elizabeth M. C.; Tybulewicz, Victor L. J.; Hart, Ian R.; Hodivala-Dilke, Kairbaan M.			Tumour angiogenesis is reduced in the Tc1 mouse model of Down's syndrome	NATURE			English	Article							ENDOTHELIAL-CELL PROLIFERATION; GROWTH; MICE; APOPTOSIS; VEGF; ETS2; ADAMTS-1; CADHERIN; DSCR1; GENE	Down's syndrome (DS) is a genetic disorder caused by full or partial trisomy of human chromosome 21 and presents with many clinical phenotypes including a reduced incidence of solid tumours(1,2). Recent work with the Ts65Dn model of DS, which has orthologues of about 50% of the genes on chromosome 21 (Hsa21), has indicated that three copies of the ETS2 (ref. 3) or DS candidate region 1 (DSCR1) genes(4) (a previously known suppressor of angiogenesis(5,6)) is sufficient to inhibit tumour growth. Here we use the Tc1 transchromosomic mouse model of DS(7) to dissect the contribution of extra copies of genes on Hsa21 to tumour angiogenesis. This mouse expresses roughly 81% of Hsa21 genes but not the human DSCR1 region. We transplanted B16F0 and Lewis lung carcinoma tumour cells into Tc1 mice and showed that growth of these tumours was substantially reduced compared with wild-type littermate controls. Furthermore, tumour angiogenesis was significantly repressed in Tc1 mice. In particular, in vitro and in vivo angiogenic responses to vascular endothelial growth factor (VEGF) were inhibited. Examination of the genes on the segment of Hsa21 in Tc1 mice identified putative anti-angiogenic genes (ADAMTS1(8,9) and ERG(10)) and novel endothelial cell-specific genes(11), never previously shown to be involved in angiogenesis (JAM-B(12) and PTTG1IP), that, when overexpressed, are responsible for inhibiting angiogenic responses to VEGF. Three copies of these genes within the stromal compartment reduced tumour angiogenesis, explaining the reduced tumour growth in DS. Furthermore, we expect that, in addition to the candidate genes that we show to be involved in the repression of angiogenesis, the Tc1 mouse model of DS will permit the identification of other endothelium-specific anti-angiogenic targets relevant to a broad spectrum of cancer patients.	[Reynolds, Louise E.; Watson, Alan R.; Baker, Marianne; D'Amico, Gabriela; Robinson, Stephen D.; Hodivala-Dilke, Kairbaan M.] Queen Mary Univ London, John Vane Sci Ctr, Adhes & Angiogenesis Lab, Barts Inst Canc,Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Joffre, Carine; Kermorgant, Stephanie; Hart, Ian R.] Queen Mary Univ London, John Vane Sci Ctr, Tumor Biol Ctr, Inst Canc,Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Jones, Tania A.; Sheer, Denise] Queen Mary Univ London, Ctr Neurosci, Barts & London Sch Med & Dent, Inst Cell & Mol Sci, London E1 2AD, England; [Nizetic, Dean] Queen Mary Univ London, Paediat Ctr, Barts & London Sch Med & Dent, Inst Cell & Mol Sci, London E1 2AD, England; [Garrido-Urbani, Sarah; Imhof, Beat A.] Univ Geneva, Sch Med CMU, Dept Pathol & Immunol, Ctr Med Univ, CH-1211 Geneva, Switzerland; [Carlos Rodriguez-Manzaneque, Juan; Martino-Echarri, Estefania] GENYO, Granada, Spain; [Aurrand-Lions, Michel] INSERM, F-13009 Marseille, France; [Dagna-Bricarelli, Franca] Galliera Hosp, Inst Human Genet, I-16128 Genoa, Italy; [McCabe, Christopher J.] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Turnell, Andrew S.] Univ Birmingham, Sch Canc Sci, Birmingham B15 2TT, W Midlands, England; [Adams, Ralf] Max Planck Inst Mol Biomed, D-48149 Munster, Germany; [Fisher, Elizabeth M. C.] UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; [Tybulewicz, Victor L. J.] Natl Inst Med Res, MRC, Div Immune Cell Biol, London NW7 1AA, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm); Ente Ospedaliero Ospedali Galliera; University of Birmingham; University of Birmingham; Max Planck Society; University of London; University College London; MRC National Institute for Medical Research	Reynolds, LE (corresponding author), Queen Mary Univ London, John Vane Sci Ctr, Adhes & Angiogenesis Lab, Barts Inst Canc,Barts & London Sch Med & Dent, Charterhouse Sq, London EC1M 6BQ, England.	l.reynolds@qmul.ac.uk	Nizetic, Dean/F-9509-2015; JOFFRE, Carine/P-1551-2014; D'Amico, Gabriela/H-6310-2011; Rodriguez-Manzaneque, Juan Carlos/F-3899-2012; D'Amico, Gabriela/AAD-1182-2020; Kermorgant, Stephanie/AAB-4931-2020; Corbett-Jones, Tania A/E-4891-2013; Adams, Ralf H/AAE-9274-2019; Fisher, Elizabeth MC/C-2168-2008; Sheer, Denise/C-6705-2011; Aurrand-Lions, Michel/O-9953-2016; Jones, Tania/C-8912-2011	JOFFRE, Carine/0000-0002-7551-356X; Rodriguez-Manzaneque, Juan Carlos/0000-0001-5951-7029; Kermorgant, Stephanie/0000-0001-5921-479X; Corbett-Jones, Tania A/0000-0002-0067-3382; Fisher, Elizabeth MC/0000-0003-2850-9936; Sheer, Denise/0000-0001-9067-1796; Aurrand-Lions, Michel/0000-0002-8361-3034; Jones, Tania/0000-0002-0067-3382; Nizetic, Dean/0000-0001-5486-5761; Hodivala-Dilke, Kairbaan/0000-0002-2859-749X; Tybulewicz, Victor/0000-0003-2439-0798; Robinson, Stephen/0000-0002-6606-7588; D'Amico, Gabriela/0000-0002-5619-6749	Cancer Research UK [A3585, A12007, 12007] Funding Source: Medline; Medical Research Council [U.1175.02.001.00001(60485), G0601056, G0501003, G0901609, G0501003(75694), MC_U117527252] Funding Source: Medline; Wellcome Trust [080174] Funding Source: Medline; British Lung Foundation [CAN09-4] Funding Source: researchfish; MRC [G0501003, MC_U117527252, G0601056] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); British Lung Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aurrand-Lions M, 2001, J BIOL CHEM, V276, P2733, DOI 10.1074/jbc.M005458200; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Carbone GM, 2004, NUCLEIC ACIDS RES, V32, P4358, DOI 10.1093/nar/gkh744; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Harris CD, 2005, CELL MOL LIFE SCI, V62, P2477, DOI 10.1007/s00018-005-5085-4; Hasle H, 2001, LANCET ONCOL, V2, P429, DOI 10.1016/S1470-2045(00)00435-6; Herbert JMJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-153; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Iizuka M, 2004, J VASC RES, V41, P334, DOI 10.1159/000079832; Kelly PA, 2005, MOL BIOL CELL, V16, P3562, DOI 10.1091/mbc.E04-12-1085; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lee NV, 2006, EMBO J, V25, P5270, DOI 10.1038/sj.emboj.7601400; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Luque A, 2003, J BIOL CHEM, V278, P23656, DOI 10.1074/jbc.M212964200; MAHADEVAN V, 1989, CANCER RES, V49, P415; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Park JS, 2000, MOL BIOL CELL, V11, P2915, DOI 10.1091/mbc.11.9.2915; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Reynolds AR, 2004, CANCER RES, V64, P8643, DOI 10.1158/0008-5472.CAN-04-2760; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shozu M, 2005, J MOL ENDOCRINOL, V35, P343, DOI 10.1677/jme.1.01735; Sussan TE, 2008, NATURE, V451, P73, DOI 10.1038/nature06446; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Wolvetang EJ, 2003, HUM MOL GENET, V12, P247, DOI 10.1093/hmg/ddg015; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; Yang QH, 2002, LANCET, V359, P1019, DOI 10.1016/S0140-6736(02)08092-3	29	88	91	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					813	U13		10.1038/nature09106	http://dx.doi.org/10.1038/nature09106			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535211	Green Accepted, Green Submitted			2022-12-01	WOS:000278551800052
J	Ahn, YY; Bagrow, JP; Lehmann, S				Ahn, Yong-Yeol; Bagrow, James P.; Lehmann, Sune			Link communities reveal multiscale complexity in networks	NATURE			English	Article							HIERARCHICAL ORGANIZATION	Networks have become a key approach to understanding systems of interacting objects, unifying the study of diverse phenomena including biological organisms and human society(1-3). One crucial step when studying the structure and dynamics of networks is to identify communities(4,5): groups of related nodes that correspond to functional subunits such as protein complexes(6,7) or social spheres(8-10). Communities in networks often overlap(9,10) such that nodes simultaneously belong to several groups. Meanwhile, many networks are known to possess hierarchical organization, where communities are recursively grouped into a hierarchical structure(11-13). However, the fact that many real networks have communities with pervasive overlap, where each and every node belongs to more than one group, has the consequence that a global hierarchy of nodes cannot capture the relationships between overlapping groups. Here we reinvent communities as groups of links rather than nodes and show that this unorthodox approach successfully reconciles the antagonistic organizing principles of overlapping communities and hierarchy. In contrast to the existing literature, which has entirely focused on grouping nodes, link communities naturally incorporate overlap while revealing hierarchical organization. We find relevant link communities in many networks, including major biological networks such as protein-protein interaction(6,7,14) and metabolic networks(11,15,16), and show that a large social network(10,17,18) contains hierarchically organized community structures spanning inner-city to regional scales while maintaining pervasive overlap. Our results imply that link communities are fundamental building blocks that reveal overlap and hierarchical organization in networks to be two aspects of the same phenomenon.	[Lehmann, Sune] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA; [Ahn, Yong-Yeol; Bagrow, James P.] Northeastern Univ, Dept Phys, Ctr Complex Network Res, Boston, MA 02115 USA; [Ahn, Yong-Yeol; Bagrow, James P.] Harvard Univ, Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02215 USA; [Lehmann, Sune] Northeastern Univ, Coll Comp & Informat Sci, Boston, MA 02115 USA	Harvard University; Northeastern University; Harvard University; Dana-Farber Cancer Institute; Northeastern University	Lehmann, S (corresponding author), Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA.	sune.lehmann@gmail.com	Ahn, Yong-Yeol/C-6334-2011; Bagrow, James/E-1701-2016	Ahn, Yong-Yeol/0000-0002-4352-4301; Bagrow, James/0000-0002-4614-0792; Lehmann, Sune/0000-0001-6099-2345	James S. McDonnell Foundation; NSF-DDDAS [CNS-0540348]; NSF-ITR [DMR-0426737]; US ONR [N00014-07-C]; NIH [U01 A1070499-01, 111620-2]; DTRA [BRBAA07-J-2-0035]; US ARL [W911NF-09-2-0053]; NKTH NAP [KCKHA005]; Danish Natural Science Research Council;  [NSF-IIS-0513650]	James S. McDonnell Foundation; NSF-DDDAS(National Science Foundation (NSF)); NSF-ITR(National Science Foundation (NSF)); US ONR(Office of Naval Research); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DTRA(United States Department of DefenseDefense Threat Reduction Agency); US ARL; NKTH NAP; Danish Natural Science Research Council(Danish Natural Science Research Council); 	The authors thank A.-L. Barabasi, S. Ahnert, J. Park, D.-S. Lee, P.-J. Kim, N. Blumm, D. Wang, M. A. Yildirim and H. Yu. The authors acknowledge the Center for Complex Network Research, supported by the James S. McDonnell Foundation 21st Century Initiative in Studying Complex Systems; the NSF-DDDAS (CNS-0540348), NSF-ITR (DMR-0426737) and NSF-IIS-0513650 programmes; US ONR Award N00014-07-C; the NIH (U01 A1070499-01/Sub #:111620-2); the DTRA (BRBAA07-J-2-0035); the NS-CTA sponsored by US ARL (W911NF-09-2-0053); and NKTH NAP (KCKHA005). S. L. acknowledges support from the Danish Natural Science Research Council.	Caldarelli G., 2007, SCALE FREE NETWORKS; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; EVANS TS, 2009, EDGE PARTITIONS OVER; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LANCICHINETTI A, 2009, PHYS REV E 2, V80, DOI DOI 10.1103/PHYSREVE.80.056117; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Li D, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168701; Newman M.E., 2006, STRUCTURE DYNAMICS N; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reichardt J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.218701; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Wasserman S., 1994, SOCIAL NETWORK ANAL; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	30	1163	1305	18	303	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 5	2010	466	7307					761	U11		10.1038/nature09182	http://dx.doi.org/10.1038/nature09182			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20562860	Green Submitted			2022-12-01	WOS:000280562500040
J	Goldstein, AS; Huang, JT; Guo, CY; Garraway, IP; Witte, ON				Goldstein, Andrew S.; Huang, Jiaoti; Guo, Changyong; Garraway, Isla P.; Witte, Owen N.			Identification of a Cell of Origin for Human Prostate Cancer	SCIENCE			English	Article							STEM-CELLS; EPITHELIAL-CELLS; INTRAEPITHELIAL NEOPLASIA; BASAL; PTEN; EXPRESSION; CARCINOMA; LEADS; SUBPOPULATION; PROGENITORS	Luminal cells are believed to be the cells of origin for human prostate cancer, because the disease is characterized by luminal cell expansion and the absence of basal cells. Yet functional studies addressing the origin of human prostate cancer have not previously been reported because of a lack of relevant in vivo human models. Here we show that basal cells from primary benign human prostate tissue can initiate prostate cancer in immunodeficient mice. The cooperative effects of AKT, ERG, and androgen receptor in basal cells recapitulated the histological and molecular features of human prostate cancer, with loss of basal cells and expansion of luminal cells expressing prostate-specific antigen and alpha-methylacyl-CoA racemase. Our results demonstrate that histological characterization of cancers does not necessarily correlate with the cellular origins of the disease.	[Witte, Owen N.] Univ Calif Los Angeles, Howard Hughes Med Inst, David Geffen Sch Med,Dept Mol & Med Pharmacol, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Goldstein, Andrew S.; Witte, Owen N.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Huang, Jiaoti; Guo, Changyong; Garraway, Isla P.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Huang, Jiaoti] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Guo, Changyong; Garraway, Isla P.] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA 90095 USA; [Huang, Jiaoti; Witte, Owen N.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Witte, ON (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, David Geffen Sch Med,Dept Mol & Med Pharmacol, Dept Microbiol Mol Genet & Immunol, 675 Charles E Young Dr S,5-748 MRL, Los Angeles, CA 90095 USA.	owenwitte@mednet.ucla.edu		Goldstein, Andrew/0000-0003-0434-9149; Huang, Jiaoti/0000-0003-1195-1998	Ruth L. Kirschstein National Research Service [GM07185]; American Cancer Society; Department of Defense (DOD); UCLA SPORE in Prostate Cancer; Jean Perkins Foundation; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [P50CA092131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Department of Defense (DOD)(United States Department of Defense); UCLA SPORE in Prostate Cancer; Jean Perkins Foundation; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Anderson for manuscript preparation; D. Cheng for cell sorting; Y. Zong for vectors; H. Zhang for tissue preparation; and A. Chhabra, B. Van Handel, D. Mulholland, C. Soroudi, and T. Stoyanova for discussion and technical help. A.S.G. is supported by an institutional Ruth L. Kirschstein National Research Service Award (GM07185). J.H. is supported by the American Cancer Society, the Department of Defense (DOD) Prostate Cancer Research Program, and the UCLA SPORE in Prostate Cancer (principal investigator, R. Reiter). I.P.G is supported by the DOD and the Jean Perkins Foundation. O.N.W. is an Investigator of the Howard Hughes Medical Institute. J.H., I.P.G., and O.N.W. are supported by a Challenge Award from the Prostate Cancer Foundation.	Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304; Garraway IP, 2010, PROSTATE, V70, P491, DOI 10.1002/pros.21083; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Iwata T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009427; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; MCNEAL JE, 1986, HUM PATHOL, V17, P64, DOI 10.1016/S0046-8177(86)80156-3; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; OKADA H, 1992, VIRCHOWS ARCH A, V421, P157, DOI 10.1007/BF01607049; Parsons JK, 2001, UROLOGY, V58, P619, DOI 10.1016/S0090-4295(01)01311-5; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Pienta KJ, 2008, PROSTATE, V68, P629, DOI 10.1002/pros.20726; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Ruijter ET, 1996, J PATHOL, V180, P295; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; VERHAGEN APM, 1992, CANCER RES, V52, P6182; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; WOJNO KJ, 1995, AM J SURG PATHOL, V19, P251, DOI 10.1097/00000478-199503000-00002; Wu CL, 2004, HUM PATHOL, V35, P1008, DOI 10.1016/j.humpath.2004.03.019; Xin L, 2006, P NATL ACAD SCI USA, V103, P7789, DOI 10.1073/pnas.0602567103; Yoshimoto M, 2006, CANCER GENET CYTOGEN, V169, P128, DOI 10.1016/j.cancergencyto.2006.04.003; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zong Y, 2009, P NATL ACAD SCI USA, V106, P12465, DOI 10.1073/pnas.0905931106	31	395	409	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					568	571		10.1126/science.1189992	http://dx.doi.org/10.1126/science.1189992			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20671189	Green Accepted			2022-12-01	WOS:000280483500038
J	Babour, A; Bicknell, AA; Tourtellotte, J; Niwa, M				Babour, Anna; Bicknell, Alicia A.; Tourtellotte, Joel; Niwa, Maho			A Surveillance Pathway Monitors the Fitness of the Endoplasmic Reticulum to Control Its Inheritance	CELL			English	Article							CELL-WALL INTEGRITY; CORTICAL ER INHERITANCE; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; TRANSMEMBRANE PROTEIN; SEPTIN RING; MAP KINASE; YEAST; STRESS; GENE	The endoplasmic reticulum (ER) plays an essential role in the production of lipids and secretory proteins. Because the ER cannot be generated de novo, it must be faithfully transmitted or divided at each cell division. Little is known of how cells monitor the functionality of the ER during the cell cycle or how this regulates inheritance. We report here that ER stress in S. cerevisiae activates the MAP kinase Slt2 in a new ER stress surveillance (ERSU) pathway, independent of the unfolded protein response. Upon ER stress, ERSU alters the septin complex to delay ER inheritance and cytokinesis. In the absence of Slt2 kinase, the stressed ER is transmitted to the daughter cell, causing the death of both mother and daughter cells. Furthermore, Slt2 is activated via the cell surface receptor Wsc1 by a previously undescribed mechanism. We conclude that the ERSU pathway ensures inheritance of a functional ER.	[Babour, Anna; Bicknell, Alicia A.; Tourtellotte, Joel; Niwa, Maho] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Niwa, M (corresponding author), Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	niwa@ucsd.edu		Babour, Anna/0000-0002-0212-3528	American Cancer Society [RSG-05-01GMC]; CRCC [6-447140-34384]; NIH [RO1GM087415]; Searle [03-G107]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087415] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); CRCC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Douglass Forbes for critical reading, many insightful suggestions, and support throughout the study. We also thank Lorraine Pillus and Rei Otsuka for their help for generating a strain critical for the experiments and Lorraine Pillus for support throughout the study. We thank Randy Hampton, Jason Brickner, and Jim Umen for their suggestion and careful reading of the manuscript, David E. Levin, for providing the bck1 Delta, mkk1 Delta mkk2 Delta yeast strains, pkc1 Delta yeast strain, and plasmids p2188, p2190, and p2193, and Enrique Herrero for providing the pkc1D strain. We also thank Peter Novick for providing the sec1-1 strain and Yves Barral for providing the cdc12-6 strain and Gregory Payne for wsc1<SUP>AAA</SUP> mutant strain. We thank Randy Hampton, Jodi Nunnari, and Svetlana Dokudovskaya for providing plasmids pRH475 and pRH1827, pVT100-ds-RedT1, and Vph1-mCherry, respectively. A. B. was partially supported by the ARC. This work was supported by the American Cancer Society RSG-05-01GMC), CRCC (6-447140-34384), NIH (RO1GM087415), and Searle 03-G107 to M.N.	Bertin A, 2008, P NATL ACAD SCI USA, V105, P8274, DOI 10.1073/pnas.0803330105; Bicknell A.A., 2009, HDB CELL SIGNALING, P2511; Bicknell AA, 2007, J CELL BIOL, V177, P1017, DOI 10.1083/jcb.200702101; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Caviston JP, 2003, MOL BIOL CELL, V14, P4051, DOI 10.1091/mbc.E03-04-0247; Chen YJ, 2005, MOL CANCER RES, V3, P669, DOI 10.1158/1541-7786.MCR-05-0181; Cid VJ, 1998, MICROBIOL-SGM, V144, P3463, DOI 10.1099/00221287-144-12-3463; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; de Martin PE, 2005, BIOCHEM CELL BIOL, V83, P752, DOI 10.1139/O05-159; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; Dobbelaere J, 2003, DEV CELL, V4, P345, DOI 10.1016/S1534-5807(03)00061-3; Du YR, 2001, MOL BIOL CELL, V12, P2614, DOI 10.1091/mbc.12.9.2614; Du YR, 2006, EMBO J, V25, P4413, DOI 10.1038/sj.emboj.7601319; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Essary BD, 2009, J MICROBIOL METH, V78, P208, DOI 10.1016/j.mimet.2009.05.018; Estrada P, 2003, J CELL BIOL, V163, P1255, DOI 10.1083/jcb.200304030; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Gray JV, 1997, EMBO J, V16, P4924, DOI 10.1093/emboj/16.16.4924; Hampton RY, 1996, P NATL ACAD SCI USA, V93, P828, DOI 10.1073/pnas.93.2.828; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; HUANG KN, 1995, GENETICS, V141, P1275; HUFFAKER TC, 1988, J CELL BIOL, V106, P1997, DOI 10.1083/jcb.106.6.1997; Iwase M, 2006, MOL BIOL CELL, V17, P1110, DOI 10.1091/mbc.E05-08-0793; JACOBS CW, 1988, J CELL BIOL, V107, P1409, DOI 10.1083/jcb.107.4.1409; Jimenez J, 1998, J CELL BIOL, V143, P1617, DOI 10.1083/jcb.143.6.1617; Jin Y, 2009, MOL BIOL CELL, V20, P1312, DOI 10.1091/mbc.E08-09-0954; Ketela T, 1999, J BACTERIOL, V181, P3330, DOI 10.1128/JB.181.11.3330-3340.1999; KIM HB, 1991, J CELL BIOL, V112, P535, DOI 10.1083/jcb.112.4.535; Kim KY, 2008, MOL CELL BIOL, V28, P2579, DOI 10.1128/MCB.01795-07; Koning AJ, 2002, GENETICS, V160, P1335; Kozubowski L, 2005, MOL BIOL CELL, V16, P3455, DOI 10.1091/mbc.E04-09-0764; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Longtine MS, 1998, J CELL BIOL, V143, P719, DOI 10.1083/jcb.143.3.719; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; McMaster CR, 2001, BIOCHEM CELL BIOL, V79, P681, DOI 10.1139/bcb-79-6-681; McMurray MA, 2009, CELL CYCLE, V8, P195, DOI 10.4161/cc.8.2.7381; Merksamer PI, 2008, CELL, V135, P933, DOI 10.1016/j.cell.2008.10.011; Millard PJ, 1997, APPL ENVIRON MICROB, V63, P2897, DOI 10.1128/AEM.63.7.2897-2905.1997; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; MORI K, 1993, CELL, V74, P743; MURRAY AW, 1983, CELL, V34, P961, DOI 10.1016/0092-8674(83)90553-6; Nanduri J, 2001, MOL CELL, V8, P281, DOI 10.1016/S1097-2765(01)00312-4; NOVICK P, 1983, J CELL BIOL, V96, P541, DOI 10.1083/jcb.96.2.541; Peng YT, 2008, DEV CELL, V15, P478, DOI 10.1016/j.devcel.2008.07.007; Philip B, 2001, MOL CELL BIOL, V21, P271, DOI 10.1128/MCB.21.1.271-280.2001; Piao HL, 2007, MOL BIOL CELL, V18, P57, DOI 10.1091/mbc.e06-08-0721; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; PREUSS D, 1991, YEAST, V7, P891, DOI 10.1002/yea.320070902; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Roeder AD, 1998, MOL BIOL CELL, V9, P917, DOI 10.1091/mbc.9.4.917; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Scrimale T, 2009, MOL BIOL CELL, V20, P164, DOI 10.1091/mbc.E08-08-0809; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Tessarz P, 2009, MOL CELL BIOL, V29, P3738, DOI 10.1128/MCB.00201-09; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; WATANABE M, 1994, J BIOL CHEM, V269, P16829; Wiederkehr A, 2003, MOL BIOL CELL, V14, P4770, DOI 10.1091/mbc.E03-04-0229; Zu T, 2001, MOL GENET GENOMICS, V266, P142, DOI 10.1007/s004380100537	71	75	78	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					256	269		10.1016/j.cell.2010.06.006	http://dx.doi.org/10.1016/j.cell.2010.06.006			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20619447	Bronze, Green Accepted			2022-12-01	WOS:000280204300017
J	Harries, MJ; Sun, J; Paus, R; King, LE				Harries, M. J.; Sun, J.; Paus, R.; King, L. E., Jr.			Management of alopecia areata	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CLOBETASOL PROPIONATE 0.05-PERCENT; TRIAMCINOLONE ACETONIDE; DOUBLE-BLIND; TOPICAL MINOXIDIL; PULSE THERAPY; EFFICACY; GUIDELINES; ANTHRALIN; TRIAL; FOAM		[Harries, M. J.] Univ Manchester, Salford Royal NHS Fdn Trust, Sch Translat Med, Manchester M6 8HD, Lancs, England; [Sun, J.] Jackson Lab, Bar Harbor, ME 04609 USA; [Sun, J.] Jilin Univ, China Japan Union Hosp, Dept Dermatol, Changchun, Peoples R China; [Paus, R.] Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [King, L. E., Jr.] Vanderbilt Univ Sch Med, Div Dermatol, Skin Dis Res Ctr, Nashville, TN USA	Salford Royal NHS Foundation Trust; University of Manchester; Jackson Laboratory; Jilin University; University of Lubeck; Vanderbilt University	Harries, MJ (corresponding author), Univ Manchester, Salford Royal NHS Fdn Trust, Sch Translat Med, Manchester M6 8HD, Lancs, England.	mjharries@doctors.org.uk	Harries, Matthew J/I-4687-2015; Paus, Ralf/B-5279-2015	Harries, Matthew J/0000-0002-0563-8690; Paus, Ralf/0000-0002-3492-9358	University of Manchester, UK; British Association of Dermatologists; University of Lubeck; National Alopecia Areata Foundation; National Institute of Health [5P30AR041943]; British Skin Foundation; Cicatricial Alopecia Research Foundation; MSD, Germany; NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR041943] Funding Source: NIH RePORTER	University of Manchester, UK; British Association of Dermatologists; University of Lubeck; National Alopecia Areata Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Skin Foundation; Cicatricial Alopecia Research Foundation; MSD, Germany; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Professor C Griffiths (University of Manchester, UK) for support and advice and Professor R Happle (University of Marburg, Germany) for generously supplying clinical images.; Writing of this review was made possible in part by the Geoffrey-Dowling Fellowship from the British Association of Dermatologists (MJH), a grant from the University of Lubeck Research Focus Programme on Autoimmunity (RP), a grant from the National Alopecia Areata Foundation and National Institute of Health 5P30AR041943 (LEK), and a research grant from the British Skin Foundation (MJH, RP).; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: MH and RP have received research grants from the British Skin Foundation and Cicatricial Alopecia Research Foundation; RP has received research grants from the University of Lubeck, has been paid for developing and delivering educational presentations for MSD, Germany, and does consultancy for Hankel (Duesseldorf, Germany) and Dr Wolff (Bielefeld, Germany); LK has received research grants from the NIH and National Alopecia Areata Foundation; no other relationships or activities that could appear to have influenced the submitted work.	ABELL E, 1973, BRIT J DERMATOL, V88, P55; Agarwal A, 2006, J EUR ACAD DERMATOL, V20, P1375, DOI 10.1111/j.1468-3083.2006.01727.x; Chang KH, 2009, J DRUGS DERMATOL, V8, P909; Charuwichitratana S, 2000, ARCH DERMATOL, V136, P1276, DOI 10.1001/archderm.136.10.1276; Delamere FM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004413.pub2; FENTON DA, 1983, BRIT MED J, V287, P1015, DOI 10.1136/bmj.287.6398.1015; FIEDLER VC, 1990, ARCH DERMATOL, V126, P756, DOI 10.1001/archderm.126.6.756; FIEDLERWEISS VC, 1987, ARCH DERMATOL, V123, P1491, DOI 10.1001/archderm.123.11.1491; Georgala S, 2006, ACTA DERM-VENEREOL, V86, P422, DOI 10.2340/00015555-0138; Gilhar A, 2007, J CLIN INVEST, V117, P2019, DOI 10.1172/JCI31942; GIP L, 1969, ACTA DERM-VENEREOL, V49, P180; Hay IC, 1998, ARCH DERMATOL, V134, P1349, DOI 10.1001/archderm.134.11.1349; Hull SPM, 2003, BRIT J DERMATOL, V149, P692, DOI 10.1046/j.1365-2133.2003.05535.x; Kar BR, 2005, J AM ACAD DERMATOL, V52, P287, DOI 10.1016/j.jaad.2004.10.873; KUBEYINJE EP, 1994, E AFR MED J, V71, P674; Luggen P, 2008, J DTSCH DERMATOL GES, V6, P375, DOI 10.1111/j.1610-0387.2007.06608.x; Mancuso G, 2003, INT J DERMATOL, V42, P572, DOI 10.1046/j.1365-4362.2003.01862.x; Olsen EA, 2004, J AM ACAD DERMATOL, V51, P440, DOI 10.1016/j.jaad.2003.09.032; PASCHER F, 1970, DERMATOLOGICA, V141, P193, DOI 10.1159/000252466; PORTER D, 1971, BRIT J DERMATOL, V85, P272, DOI 10.1111/j.1365-2133.1971.tb07230.x; PRICE VH, 1987, J AM ACAD DERMATOL, V16, P730, DOI 10.1016/S0190-9622(87)70095-4; Rokhsar CK, 1998, J AM ACAD DERMATOL, V39, P751, DOI 10.1016/S0190-9622(98)70048-9; SAFAVI KH, 1995, MAYO CLIN PROC, V70, P628, DOI 10.4065/70.7.628; SCHMOECKEL C, 1979, ARCH DERMATOL, V115, P1254, DOI 10.1001/archderm.115.10.1254; Sharma Vinod Kumar, 1999, Journal of Dermatology (Tokyo), V26, P562; Talpur R, 2009, J AM ACAD DERMATOL, V61, P592, DOI 10.1016/j.jaad.2009.02.037; Tosti A, 2003, J AM ACAD DERMATOL, V49, P96, DOI 10.1067/mjd.2003.423; Tosti A, 2006, J EUR ACAD DERMATOL, V20, P1243, DOI 10.1111/j.1468-3083.2006.01781.x; WALKER SA, 1950, J INVEST DERMATOL, V14, P403, DOI 10.1038/jid.1950.52; Wiseman MC, 2001, ARCH DERMATOL, V137, P1063	30	63	64	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 23	2010	341								c3671	10.1136/bmj.c3671	http://dx.doi.org/10.1136/bmj.c3671			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632GY	20656774	Green Published			2022-12-01	WOS:000280411900001
J	Mueller, M; Ban, N				Mueller, Marcus; Ban, Nenad			SnapShot: Pore-Forming Toxins	CELL			English	Editorial Material							CRYSTAL-STRUCTURE; HEMOLYSIN; MECHANISM; ATTACK		[Mueller, Marcus; Ban, Nenad] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Mueller, Marcus] Paul Scherrer Inst, CH-5232 Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Mueller, M (corresponding author), Swiss Fed Inst Technol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.							CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; Lukoyanova N, 2008, TRENDS IMMUNOL, V29, P51, DOI 10.1016/j.it.2007.11.003; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; PARKER MW, 1994, BACTERIAL PROTEIN TO, V24, P302; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Tilley SJ, 2006, CURR OPIN STRUC BIOL, V16, P230, DOI 10.1016/j.sbi.2006.03.008; VAECK M, 1987, NATURE, V328, P33, DOI 10.1038/328033a0; Wallace AJ, 2000, CELL, V100, P265, DOI 10.1016/S0092-8674(00)81564-0	10	8	8	1	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 23	2010	142	2					334	U169		10.1016/j.cell.2010.07.010	http://dx.doi.org/10.1016/j.cell.2010.07.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655473	Bronze			2022-12-01	WOS:000280204300023
J	Kwon, ES; Narasimhan, D; Yen, K; Tissenbaum, HA				Kwon, Eun-Soo; Narasimhan, Devi; Yen, Kelvin; Tissenbaum, Heidi A.			A new DAF-16 isoform regulates longevity	NATURE			English	Article							C-ELEGANS DAF-16; LIFE-SPAN; CAENORHABDITIS-ELEGANS; STRESS; GENE; INSULIN/IGF-1; RESISTANCE	The insulin/IGF-1 signalling (IIS) pathway has diverse roles from metabolism to longevity(1-5). In Caenorhabditis elegans, the single forkhead box O (FOXO) homologue, DAF-16, functions as the major target of the IIS pathway(2,3,6,7). One of two isoforms(4,5,8), DAF-16a, is known to regulate longevity, stress response and dauer diapause(8-11). However, it remains unclear how DAF-16 achieves its specificity in regulating these various biological processes. Here we identify a new isoform, DAF-16d/f, as an important isoform regulating longevity. We show that DAF-16 isoforms functionally cooperate to modulate IIS-mediated processes through differential tissue enrichment, preferential modulation by upstream kinases, and regulating distinct and overlapping target genes. Promoter-swapping experiments show both the promoter and the coding region of DAF-16 are important for its function. Importantly, in mammals, four FOXO genes have overlapping and different functions(6,12), and in C. elegans, a single FOXO/DAF-16 uses distinct isoforms to fine-tune the IIS-mediated processes in the context of a whole organism.	[Kwon, Eun-Soo; Narasimhan, Devi; Yen, Kelvin; Tissenbaum, Heidi A.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Tissenbaum, Heidi A.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Tissenbaum, HA (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	heidi.tissenbaum@umassmed.edu	Yen, Kelvin/J-5378-2019	Yen, Kelvin/0000-0003-4595-971X	National Institutes of Health National Center for Research Resources; National Institute of Aging [AG025891, AG031237]; Glenn Foundation for Medical Research; Ellison Medical Foundation; William Randolph Hearst Foundation; NATIONAL INSTITUTE ON AGING [R01AG031237, R01AG025891] Funding Source: NIH RePORTER	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Glenn Foundation for Medical Research; Ellison Medical Foundation(Lawrence Ellison Foundation); William Randolph Hearst Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to A. Mukhopadhyay and S. Padmanabhan for advice, M. Green and M. Walhout for advice and comments on the manuscript and N. Bhabhalia for technical support. We thank M. Grabowski Auclair for generating several strains used in this manuscript and G. Ruvkun and M. Walhout for plasmids and strains. We apologize to all those whose original work was not cited because of space limitations. Some of the strains were provided by T. Stiernagle at the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources. H. A. T. is a William Randolph Hearst Young Investigator. This project was funded in part by grants from the National Institute of Aging AG025891 and AG031237), the Glenn Foundation for Medical Research, the Ellison Medical Foundation and an endowment from the William Randolph Hearst Foundation.	Antebi A, 2007, PLOS GENET, V3, P1565, DOI 10.1371/journal.pgen.0030129; Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Herman RK, 1995, METHOD CELL BIOL, V48, P123; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; HOSONO R, 1982, EXP GERONTOL, V17, P163, DOI 10.1016/0531-5565(82)90052-3; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mukhopadhyay A, 2006, EXP GERONTOL, V41, P928, DOI 10.1016/j.exger.2006.05.020; Murakami S, 1996, GENETICS, V143, P1207; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Narasimhan SD, 2009, CURR BIOL, V19, pR657, DOI 10.1016/j.cub.2009.06.013; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Riddle DL, 1997, C ELEGANS, P739; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Stiernagle Theresa, 2006, WormBook, P1	30	122	140	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					498	502		10.1038/nature09184	http://dx.doi.org/10.1038/nature09184			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20613724	Green Accepted			2022-12-01	WOS:000280141200038
J	Vijeyarasa, R; Stein, RA				Vijeyarasa, Ramona; Stein, Richard A.			HIV and Human Trafficking-Related Stigma Health Interventions for Trafficked Populations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Stein, Richard A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Vijeyarasa, Ramona] Univ New S Wales, Sch Social Sci & Int Studies, Sydney, NSW, Australia	Princeton University; University of New South Wales Sydney	Stein, RA (corresponding author), Princeton Univ, Dept Mol Biol, 1 Washington Rd,LTL320, Princeton, NJ 08544 USA.	ras2@princeton.edu		Vijeyarasa, Dr Ramona/0000-0003-4581-4924				Dharmadhikari AS, 2009, INT J INFECT DIS, V13, P543, DOI 10.1016/j.ijid.2008.11.010; Gupta J, 2009, INT J GYNECOL OBSTET, V107, P30, DOI 10.1016/j.ijgo.2009.06.009; *HIV MED ASS INF D, 2007, HIV TB COINF BAS FAC; Huda S, 2006, INT J GYNECOL OBSTET, V94, P374, DOI 10.1016/j.ijgo.2006.04.027; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Silverman JG, 2006, JAIDS-J ACQ IMM DEF, V43, P588; Tachover D, 2011, WORLD MED HEALTH POL, V3, DOI 10.2202/1948-4682.1135; United Nations, 2000, PROT PREV SUPPR PUN; Vijeyarasa R, 2010, CULT HEALTH SEX, V12, pS89, DOI 10.1080/13691050903359257; Zimmerman C, 2003, HLTH RISKS CONSEQUEN	10	7	7	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					344	345		10.1001/jama.2010.964	http://dx.doi.org/10.1001/jama.2010.964			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639570				2022-12-01	WOS:000280107500026
J	Hajkova, P; Jeffries, SJ; Lee, C; Miller, N; Jackson, SP; Surani, MA				Hajkova, Petra; Jeffries, Sean J.; Lee, Caroline; Miller, Nigel; Jackson, Stephen P.; Surani, M. Azim			Genome-Wide Reprogramming in the Mouse Germ Line Entails the Base Excision Repair Pathway	SCIENCE			English	Article							DNA METHYLATION; MAMMALIAN-CELLS; PATERNAL GENOME; DEMETHYLATION; CHROMATIN; 5-HYDROXYMETHYLCYTOSINE; POLY(ADP-RIBOSYL)ATION; EMBRYOGENESIS; ARABIDOPSIS; DEMETER	Genome-wide active DNA demethylation in primordial germ cells (PGCs), which reprograms the epigenome for totipotency, is linked to changes in nuclear architecture, loss of histone modifications, and widespread histone replacement. Here, we show that DNA demethylation in the mouse PGCs is mechanistically linked to the appearance of single-stranded DNA (ssDNA) breaks and the activation of the base excision repair (BER) pathway, as is the case in the zygote where the paternal pronucleus undergoes active DNA demethylation shortly after fertilization. Whereas BER might be triggered by deamination of a methylcytosine (5mC), cumulative evidence indicates other mechanisms in germ cells. We demonstrate that DNA repair through BER represents a core component of genome-wide DNA demethylation in vivo and provides a mechanistic link to the extensive chromatin remodeling in developing PGCs.	[Hajkova, Petra; Jeffries, Sean J.; Lee, Caroline; Jackson, Stephen P.; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Cambridge CB2 1QN, England; [Miller, Nigel] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Hajkova, Petra] MRC, Ctr Clin Sci, London W12 0NN, England; [Jeffries, Sean J.] Templeman Automat, Somerville, MA 02143 USA; [Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge; University of Cambridge; University of Cambridge	Hajkova, P (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Tennis Court Rd, Cambridge CB2 1QN, England.	petra.hajkova@csc.mrc.ac.uk; a.surani@gurdon.cam.ac.uk	Jackson, Stephen Philip/R-4548-2019; Dry, Kate/I-2328-2014	Jackson, Stephen Philip/0000-0001-9317-7937; Surani, Azim/0000-0002-8640-4318; Hajkova, Petra/0000-0003-4145-1468	Wellcome Trust; MRC [MC_U120092689, G0800784] Funding Source: UKRI; Cancer Research UK [11224] Funding Source: researchfish; Medical Research Council [MC_U120092689, G0800784, G0800784B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Y. Galanty, S. Polo, and members of the Surani lab for stimulating discussions. S.J.J. was a NIH-Cambridge Health Science Scholar. This work was funded by grants from the Wellcome Trust to M.A.S.	Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; HOWLETT SK, 1986, ROUX ARCH DEV BIOL, V195, P499, DOI 10.1007/BF00375890; HULETSKY A, 1989, J BIOL CHEM, V264, P8878; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; LENK R, 1977, CELL, V10, P67, DOI 10.1016/0092-8674(77)90141-6; Madhusudan S, 2005, NUCLEIC ACIDS RES, V33, P4711, DOI 10.1093/nar/gki781; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nazarkina ZK, 2007, DNA REPAIR, V6, P254, DOI 10.1016/j.dnarep.2006.10.002; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; PURNELL MR, 1980, BIOCHEM J, V185, P775, DOI 10.1042/bj1850775; Quenet D, 2009, INT J BIOCHEM CELL B, V41, P60, DOI 10.1016/j.biocel.2008.07.023; RODMAN TC, 1981, J CELL BIOL, V90, P351, DOI 10.1083/jcb.90.2.351; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Svetlova M, 1999, FEBS LETT, V463, P49, DOI 10.1016/S0014-5793(99)01592-6; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Wong E, 2002, P NATL ACAD SCI USA, V99, P14937, DOI 10.1073/pnas.232579299	29	347	358	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					78	82		10.1126/science.1187945	http://dx.doi.org/10.1126/science.1187945			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595612	Green Accepted			2022-12-01	WOS:000279402700036
J	Poliseno, L; Salmena, L; Zhang, JW; Carver, B; Haveman, WJ; Pandolfi, PP				Poliseno, Laura; Salmena, Leonardo; Zhang, Jiangwen; Carver, Brett; Haveman, William J.; Pandolfi, Pier Paolo			A coding-independent function of gene and pseudogene mRNAs regulates tumour biology	NATURE			English	Article							HUMAN GENOME; MICRORNAS; EXPRESSION; CANCER; TRANSFORMATION; AUTOIMMUNITY; RECOGNITION; SIGNATURE; REVEALS; TARGETS	The canonical role of messenger RNA (mRNA) is to deliver protein-coding information to sites of protein synthesis. However, given that microRNAs bind to RNAs, we hypothesized that RNAs could possess a regulatory role that relies on their ability to compete for microRNA binding, independently of their protein-coding function. As a model for the protein-coding-independent role of RNAs, we describe the functional relationship between the mRNAs produced by the PTEN tumour suppressor gene and its pseudogene PTENP1 and the critical consequences of this interaction. We find that PTENP1 is biologically active as it can regulate cellular levels of PTEN and exert a growth-suppressive role. We also show that the PTENP1 locus is selectively lost in human cancer. We extended our analysis to other cancer-related genes that possess pseudogenes, such as oncogenic KRAS. We also demonstrate that the transcripts of protein-coding genes such as PTEN are biologically active. These findings attribute a novel biological role to expressed pseudogenes, as they can regulate coding gene expression, and reveal a non-coding function for mRNAs.	[Poliseno, Laura; Salmena, Leonardo; Haveman, William J.; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Dept Med, Canc Genet Program,Beth Israel Deaconess Canc Ctr, Boston, MA 02215 USA; [Poliseno, Laura; Salmena, Leonardo; Haveman, William J.; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Dept Pathol, Canc Genet Program,Beth Israel Deaconess Canc Ctr, Boston, MA 02215 USA; [Zhang, Jiangwen] Harvard Univ, FAS Res Comp, Cambridge, MA 02138 USA; [Zhang, Jiangwen] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Carver, Brett] Mem Sloan Kettering Canc Ctr, Dept Surg, Human Oncol & Pathogenesis Program, New York, NY 10021 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard University; Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Dept Med, Canc Genet Program,Beth Israel Deaconess Canc Ctr, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Califano, Andrea/F-7239-2012; Chan, Edward K. L./B-5671-2009; Zhang, Jiangwen/A-7654-2013; Poliseno, Laura/B-5711-2012	Chan, Edward K. L./0000-0003-3938-9503; Zhang, Jiangwen/0000-0002-2911-8446; Poliseno, Laura/0000-0001-6557-955X; Salmena, Leonardo/0000-0003-4023-658X	Istituto Toscano Tumori; American Italian Cancer Foundation; Human Frontier Science Program; Canadian Institutes of Health Research; NIH [R01 CA-82328-09]; NATIONAL CANCER INSTITUTE [R01CA082328, R01CA102142] Funding Source: NIH RePORTER	Istituto Toscano Tumori; American Italian Cancer Foundation; Human Frontier Science Program(Human Frontier Science Program); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Pandolfi laboratory members for critical discussions, in particular A. Carracedo for critical input; S. Feng for technical assistance. We thank B. Vogelstein for DICER<SUP>-/-</SUP> cells; T. Yuan for assistance with FACS analysis; A. Tuccoli for assistance with miRNA RT-PCR; I. Osman for support and suggestions. L. P. was supported by fellowships from the Istituto Toscano Tumori and the American Italian Cancer Foundation. L.S. was supported by fellowships from the Human Frontier Science Program and the Canadian Institutes of Health Research. This work was supported by NIH grant R01 CA-82328-09 to P.P.P.	ALIMONTI A, 2010, NATURE GENET; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Balasubramanian S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r2; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BRISTOW J, 1993, J BIOL CHEM, V268, P12919; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; D'Errico Ilenia, 2004, Briefings in Functional Genomics & Proteomics, V3, P157, DOI 10.1093/bfgp/3.2.157; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Drabkin H, 2002, LEUKEMIA, V16, P186, DOI 10.1038/sj.leu.2402354; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Frith MC, 2006, PLOS GENET, V2, P504, DOI 10.1371/journal.pgen.0020023; Fujii GH, 1999, ONCOGENE, V18, P1765, DOI 10.1038/sj.onc.1202492; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Harrison PM, 2005, NUCLEIC ACIDS RES, V33, P2374, DOI 10.1093/nar/gki531; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; JIANG SL, 1995, J IMMUNOL, V154, P825; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim J, 2009, NAT BIOTECHNOL, V27, P472, DOI 10.1038/nbt.1540; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lee JJ, 2009, J FORAMIN RES, V39, P4, DOI 10.2113/gsjfr.39.1.4; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Okamura K, 2008, CELL CYCLE, V7, P2840, DOI 10.4161/cc.7.18.6734; Pain D, 2005, J BIOL CHEM, V280, P6265, DOI 10.1074/jbc.C400587200; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Plantaz D, 1997, AM J PATHOL, V150, P81; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Scaglioni PP, 2007, CURR TOP MICROBIOL, V313, P85; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Suo GL, 2005, BIOCHEM BIOPH RES CO, V337, P1047, DOI 10.1016/j.bbrc.2005.09.157; Takakura S, 2008, CANCER SCI, V99, P1147, DOI 10.1111/j.1349-7006.2008.00800.x; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; van der Wal JE, 2003, J CLIN PATHOL, V56, P26, DOI 10.1136/jcp.56.1.26; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Zimonjic DB, 1999, HEPATOLOGY, V29, P1208, DOI 10.1002/hep.510290410	52	1762	1888	5	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					1033	U90		10.1038/nature09144	http://dx.doi.org/10.1038/nature09144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577206	Green Accepted			2022-12-01	WOS:000279056900043
J	McClellan, J; King, MC				McClellan, Jon; King, Mary-Claire			Genomic Analysis of Mental Illness A Changing Landscape	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMMON VARIANTS; SCHIZOPHRENIA; ASSOCIATION; RISK		[McClellan, Jon] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [King, Mary-Claire] Univ Washington, Dept Med, Seattle, WA 98195 USA; [King, Mary-Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	McClellan, J (corresponding author), Univ Washington, Dept Psychiat, Box 356560, Seattle, WA 98195 USA.	drjack@uw.edu		King, Mary-Claire/0000-0001-9426-1743				McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Williams HJ, 2011, MOL PSYCHIATR, V16, P429, DOI 10.1038/mp.2010.36; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162	10	48	49	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2010	303	24					2523	2524		10.1001/jama.2010.869	http://dx.doi.org/10.1001/jama.2010.869			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	613VM	20571020				2022-12-01	WOS:000279010900032
J	Wills, TJ; Cacucci, F; Burgess, N; O'Keefe, J				Wills, Tom J.; Cacucci, Francesca; Burgess, Neil; O'Keefe, John			Development of the Hippocampal Cognitive Map in Preweanling Rats	SCIENCE			English	Article							FREELY MOVING RATS; ENTORHINAL CORTEX; SPATIAL REPRESENTATION; THETA-RHYTHM; GRID CELLS; NAVIGATION	Orienting in large-scale space depends on the interaction of environmental experience and preconfigured, possibly innate, constructs. Place, head-direction, and grid cells in the hippocampal formation provide allocentric representations of space. Here we show how these cognitive representations emerge and develop as rat pups first begin to explore their environment. Directional, locational, and rhythmic organization of firing are present during initial exploration, including adultlike directional firing. The stability and precision of place cell firing continue to develop throughout juvenility. Stable grid cell firing appears later but matures rapidly to adult levels. Our results demonstrate the presence of three neuronal representations of space before extensive experience and show how they develop with age.	[Wills, Tom J.; Cacucci, Francesca; O'Keefe, John] UCL, London WC1E 6BT, England; [Cacucci, Francesca] UCL, Div Psychol & Language Sci, UC Inst Behav Neurosci, London WC1H 0AP, England; [Burgess, Neil] UCL, UC Inst Cognit Neurosci, London WC1N 3AR, England; [Burgess, Neil] UCL, UC Inst Neurol, London WC1N 3BG, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Wills, TJ (corresponding author), UCL, Gower St, London WC1E 6BT, England.	t.wills@ucl.ac.uk; f.cacucci@ucl.ac.uk	Wills, Tom J/B-3621-2011; Burgess, Neil/B-2420-2009	Burgess, Neil/0000-0003-0646-6584; Cacucci, Francesca/0000-0002-1968-5156; Wills, Thomas/0000-0002-1331-2869	European Union; Wellcome Trust; U.K. Medical Research Council; U.K. Royal Society; Research Councils U.K.; Medical Research Council [G0501672] Funding Source: researchfish; MRC [G0501672] Funding Source: UKRI	European Union(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); U.K. Royal Society(Royal Society of London); Research Councils U.K.(UK Research & Innovation (UKRI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Barry for use of adult grid cell data, A. Jeewajee and C. Barry for assistance with data analysis, S. Burton and R. Varriale for technical assistance, and C. Lever and J. Krupic for helpful discussions. This work was supported by the European Union SpaceBrain grant, the Wellcome Trust, the U.K. Medical Research Council, the U.K. Royal Society and a Research Councils U.K. academic fellowship to F. C.	Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Brun VH, 2008, NEURON, V57, P290, DOI 10.1016/j.neuron.2007.11.034; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Burton BG, 2008, J NEUROPHYSIOL, V100, P3144, DOI 10.1152/jn.90424.2008; CHENG K, 1986, COGNITION, V23, P149, DOI 10.1016/0010-0277(86)90041-7; Gerrish CJ, 1996, DEV PSYCHOBIOL, V29, P483, DOI 10.1002/(SICI)1098-2302(199609)29:6<483::AID-DEV1>3.0.CO;2-I; Giocomo LM, 2007, SCIENCE, V315, P1719, DOI 10.1126/science.1139207; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; HERMER L, 1994, NATURE, V370, P57, DOI 10.1038/370057a0; Jeewajee A, 2008, HIPPOCAMPUS, V18, P1175, DOI 10.1002/hipo.20510; LEBLANC MO, 1979, EXP NEUROL, V66, P220, DOI 10.1016/0014-4886(79)90076-1; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; Martin PD, 2002, HIPPOCAMPUS, V12, P465, DOI 10.1002/hipo.10021; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; NADEL L, 2009, DEV TIME TIMING, P233; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Rivas J, 1996, EXP BRAIN RES, V108, P113; RUDY JW, 1987, BEHAV NEUROSCI, V101, P62, DOI 10.1037/0735-7044.101.1.62; Savelli F, 2008, HIPPOCAMPUS, V18, P1270, DOI 10.1002/hipo.20511; SCHENK F, 1985, BEHAV NEURAL BIOL, V43, P69, DOI 10.1016/S0163-1047(85)91510-9; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; TAUBE JS, 1990, J NEUROSCI, V10, P420; VANCAUTER T, 1933, EUR J NEUROSCI, V27, P2008	29	365	371	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 18	2010	328	5985					1573	1576		10.1126/science.1188224	http://dx.doi.org/10.1126/science.1188224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558720	Green Accepted			2022-12-01	WOS:000278859200051
J	Tahirov, TH; Babayeva, ND; Varzavand, K; Cooper, JJ; Sedore, SC; Price, DH				Tahirov, Tahir H.; Babayeva, Nigar D.; Varzavand, Katayoun; Cooper, Jeffrey J.; Sedore, Stanley C.; Price, David H.			Crystal structure of HIV-1 Tat complexed with human P-TEFb	NATURE			English	Article							POLYMERASE-II TRANSCRIPTION; HUMAN CYCLIN T1; DEPENDENT KINASE REGULATION; CARBOXYL-TERMINAL DOMAIN; ELONGATION-FACTOR-B; RNA-POLYMERASE; MUTATIONAL ANALYSIS; VIRUS-REPLICATION; 7SK SNRNA; IN-VITRO	Regulation of the expression of the human immunodeficiency virus (HIV) genome is accomplished in large part by controlling transcription elongation. The viral protein Tat hijacks the host cell's RNA polymerase II elongation control machinery through interaction with the positive transcription elongation factor, P-TEFb, and directs the factor to promote productive elongation of HIV mRNA. Here we describe the crystal structure of the Tat center dot P-TEFb complex containing HIV-1 Tat, human Cdk9 (also known as CDK9), and human cyclin T1 (also known as CCNT1). Tat adopts a structure complementary to the surface of P-TEFb and makes extensive contacts, mainly with the cyclin T1 subunit of P-TEFb, but also with the T-loop of the Cdk9 subunit. The structure provides a plausible explanation for the tolerance of Tat to sequence variations at certain sites. Importantly, Tat induces significant conformational changes in P-TEFb. This finding lays a foundation for the design of compounds that would specifically inhibit the Tat center dot P-TEFb complex and block HIV replication.	[Tahirov, Tahir H.; Babayeva, Nigar D.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Varzavand, Katayoun; Cooper, Jeffrey J.; Sedore, Stanley C.; Price, David H.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	University of Nebraska System; University of Nebraska Medical Center; University of Iowa	Tahirov, TH (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	ttahirov@unmc.edu	Price, David H/F-6173-2010	Tahirov, Tahir/0000-0002-1238-0069; Price, David/0000-0002-5597-385X	NIH [GM35500, AI074392, GM082923]; Department of Health and Human Services [LB506]; National Center for Research Resources at the National Institutes of Health [RR-15301]; US Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Cancer Center [P30CA036727]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI074392, R33AI074392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082923, R01GM035500] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Lovelace and G. E. Borgstahl for maintenance and management of the Eppley Institute's X-ray Crystallography facility; D. G. Vassylyev for the zonal scaling instruction files. This work is supported by the NIH grants GM35500 and AI074392 to D. H. P., by Nebraska Department of Health and Human Services grant LB506 and in part by NIH grant GM082923 to T. H. T. This work is also based on research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by award RR-15301 from the National Center for Research Resources at the National Institutes of Health. Use of the Advanced Photon Source is supported by the US Department of Energy, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. The Eppley Institute's X-ray Crystallography facility is supported by Cancer Center Support Grant P30CA036727.	Anand K, 2008, NAT STRUCT MOL BIOL, V15, P1287, DOI 10.1038/nsmb.1513; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Bieniasz PD, 1998, EMBO J, V17, P7056, DOI 10.1093/emboj/17.23.7056; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campbell GR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-50; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen RC, 2004, J BIOL CHEM, V279, P4153, DOI 10.1074/jbc.M310044200; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; D'Orso I, 2009, P NATL ACAD SCI USA, V106, P3101, DOI 10.1073/pnas.0900012106; DERSE D, 1993, VIROLOGY, V194, P530, DOI 10.1006/viro.1993.1291; Fu TJ, 1999, J BIOL CHEM, V274, P34527, DOI 10.1074/jbc.274.49.34527; Fujinaga K, 1998, J VIROL, V72, P7154, DOI 10.1128/JVI.72.9.7154-7159.1998; Garber ME, 1998, COLD SPRING HARB SYM, V63, P371, DOI 10.1101/sqb.1998.63.371; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Ippolito JA, 1998, P NATL ACAD SCI USA, V95, P9819, DOI 10.1073/pnas.95.17.9819; Jancarik J, 2004, ACTA CRYSTALLOGR D, V60, P1670, DOI 10.1107/S0907444904010972; Janin J, 1997, NAT STRUCT BIOL, V4, P973, DOI 10.1038/nsb1297-973; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Kuiken C, 2009, LAUR0903280 LOS AL N; KUPPUSWAMY M, 1989, NUCLEIC ACIDS RES, V17, P3551, DOI 10.1093/nar/17.9.3551; Letvin NL, 2009, SCIENCE, V326, P1196, DOI 10.1126/science.1183278; Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200; Mancebo HSY, 1997, GENE DEV, V11, P2633, DOI 10.1101/gad.11.20.2633; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003; Michels Annemieke A., 2008, Biotechnology Journal, V3, P1022, DOI 10.1002/biot.200800104; Onafuwa-Nuga A, 2009, MICROBIOL MOL BIOL R, V73, P451, DOI 10.1128/MMBR.00012-09; Otwinowski Z., 1997, PROCESSING XRAY DIFF; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Peng JM, 1998, GENE DEV, V12, P755, DOI 10.1101/gad.12.5.755; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; RICE AP, 1990, J VIROL, V64, P1864, DOI 10.1128/JVI.64.4.1864-1868.1990; Richter S, 2002, P NATL ACAD SCI USA, V99, P7928, DOI 10.1073/pnas.122119999; RUBEN S, 1989, J VIROL, V63, P1; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; SADAIE MR, 1990, AIDS RES HUM RETROV, V6, P1257, DOI 10.1089/aid.1990.6.1257; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Tahirov TH, 1998, J STRUCT BIOL, V121, P68, DOI 10.1006/jsbi.1997.3940; Taube R, 2000, J VIROL, V74, P892, DOI 10.1128/JVI.74.2.892-898.2000; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Wang Y, 2009, MINI-REV MED CHEM, V9, P379, DOI 10.2174/1389557510909030379; Wimmer J, 1999, VIROLOGY, V255, P182, DOI 10.1006/viro.1998.9589; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Zhou MS, 2000, MOL CELL BIOL, V20, P5077, DOI 10.1128/MCB.20.14.5077-5086.2000; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	48	213	221	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 10	2010	465	7299					747	U2		10.1038/nature09131	http://dx.doi.org/10.1038/nature09131			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608AM	20535204	Green Accepted			2022-12-01	WOS:000278551800037
J	Kim, SK; Shindo, A; Park, TJ; Oh, EC; Ghosh, S; Gray, RS; Lewis, RA; Johnson, CA; Attie-Bittach, T; Katsanis, N; Wallingford, JB				Kim, Su Kyoung; Shindo, Asako; Park, Tae Joo; Oh, Edwin C.; Ghosh, Srimoyee; Gray, Ryan S.; Lewis, Richard A.; Johnson, Colin A.; Attie-Bittach, Tania; Katsanis, Nicholas; Wallingford, John B.			Planar Cell Polarity Acts Through Septins to Control Collective Cell Movement and Ciliogenesis	SCIENCE			English	Article							CILIATED EPITHELIAL-CELLS; BARDET-BIEDL-SYNDROME; CONVERGENT EXTENSION; EMBRYONIC-DEVELOPMENT; XENOPUS GASTRULATION; ZEBRAFISH; FORCHLORFENURON; POLARIZATION; ORGANIZATION; DISRUPTION	The planar cell polarity (PCP) signaling pathway governs collective cell movements during vertebrate embryogenesis, and certain PCP proteins are also implicated in the assembly of cilia. The septins are cytoskeletal proteins controlling behaviors such as cell division and migration. Here, we identified control of septin localization by the PCP protein Fritz as a crucial control point for both collective cell movement and ciliogenesis in Xenopus embryos. We also linked mutations in human Fritz to Bardet-Biedl and Meckel-Gruber syndromes, a notable link given that other genes mutated in these syndromes also influence collective cell movement and ciliogenesis. These findings shed light on the mechanisms by which fundamental cellular machinery, such as the cytoskeleton, is regulated during embryonic development and human disease.	[Kim, Su Kyoung; Shindo, Asako; Park, Tae Joo; Ghosh, Srimoyee; Gray, Ryan S.; Wallingford, John B.] Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; [Kim, Su Kyoung; Shindo, Asako; Park, Tae Joo; Ghosh, Srimoyee; Gray, Ryan S.; Wallingford, John B.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Oh, Edwin C.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Dept Cell Biol, Durham, NC 27710 USA; [Oh, Edwin C.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Dept Pediat, Durham, NC 27710 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lewis, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Johnson, Colin A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol, Leeds LS9 7TF, W Yorkshire, England; [Johnson, Colin A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Neurosci, Leeds LS9 7TF, W Yorkshire, England; [Attie-Bittach, Tania] Univ Paris 05, Hop Necker Enfants Malad, INSERM, Dept Genet,U781, Paris, France; [Wallingford, John B.] Univ Texas Austin, Howard Hughes Med Inst, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Duke University; Duke University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Howard Hughes Medical Institute; University of Texas System; University of Texas Austin	Wallingford, JB (corresponding author), Univ Texas Austin, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA.	wallingford@mail.utexas.edu	ATTIE-BITACH, Tania/K-1453-2017; Gray, Ryan/L-3923-2019; Katsanis, Nicholas/E-1837-2012; Gray, Ryan/W-8366-2019; Park, Tae Joo/G-1460-2011; Gray, Ryan/G-2187-2010	ATTIE-BITACH, Tania/0000-0002-1155-3626; Gray, Ryan/0000-0001-9668-6497; Park, Tae Joo/0000-0003-3176-177X; Gray, Ryan/0000-0001-9668-6497; Johnson, Colin/0000-0002-2979-8234; Shindo, Asako/0000-0002-3314-7151; Katsanis, Nicholas/0000-0002-2480-0171	Uehara Memorial Foundation; National Institute of General Medcial Science (NIH); March of Dimes; Burroughs Wellcome Fund; Sandler Program for Asthma Research; Texas Advanced Research Program; National Institute of Child Health and Human Development; National Institute of Digestive Diseases and Kidney Disease (NIH); MRC [G0700073] Funding Source: UKRI; Medical Research Council [G0700073] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075972, R01DK072301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094268] Funding Source: NIH RePORTER	Uehara Memorial Foundation(Uehara Memorial Foundation); National Institute of General Medcial Science (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Sandler Program for Asthma Research; Texas Advanced Research Program; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Digestive Diseases and Kidney Disease (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank P. Abitua for technical assistance; E. Spiliotis for the antibodies; and A. Ewald, B. Mitchell, E. Brooks, and K. Smith for critical discussions and reading. This work was supported by grants from the Uehara Memorial Foundation (A.S.); National Institute of General Medcial Science (NIH), March of Dimes, Burroughs Wellcome Fund, the Sandler Program for Asthma Research, and the Texas Advanced Research Program (J.B.W.); National Institute of Child Health and Human Development and National Institute of Digestive Diseases and Kidney Disease (NIH) (N.K.). N.K. is the George W. Brumley Professor. J.B.W. is an Early Career Scientist of the Howard Hughes Medical Institute.	Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Collier S, 2005, GENETICS, V169, P2035, DOI 10.1534/genetics.104.033381; Ewald AJ, 2004, DEVELOPMENT, V131, P6195, DOI 10.1242/dev.01542; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gray RS, 2009, NAT CELL BIOL, V11, P1225, DOI 10.1038/ncb1966; Hayes JM, 2007, DEV BIOL, V312, P115, DOI 10.1016/j.ydbio.2007.09.031; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Hu QC, 2008, J BIOL CHEM, V283, P29563, DOI 10.1074/jbc.M804962200; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Iwase M, 2004, GENES GENET SYST, V79, P199, DOI 10.1266/ggs.79.199; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; KELLER R, 1992, DEV DYNAM, V193, P199, DOI 10.1002/aja.1001930302; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892; Park TJ, 2008, NAT GENET, V40, P871, DOI 10.1038/ng.104; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; SHIH J, 1992, DEVELOPMENT, V116, P901; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; Tanaka-Takiguchi Y, 2009, CURR BIOL, V19, P140, DOI 10.1016/j.cub.2008.12.030; Tissir F, 2010, NAT NEUROSCI, V13, P700, DOI 10.1038/nn.2555; Tooley AJ, 2009, NAT CELL BIOL, V11, P17, DOI 10.1038/ncb1808; TRINKAUS JP, 1969, CELL ORGANS FORCES S; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Weirich CS, 2008, NAT REV MOL CELL BIO, V9, P478, DOI 10.1038/nrm2407; Zeng HQ, 2010, DEV BIOL, V339, P418, DOI 10.1016/j.ydbio.2010.01.003	33	244	258	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 10	2010	329	5997					1337	1340		10.1126/science.1191184	http://dx.doi.org/10.1126/science.1191184			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647YR	20671153	Green Accepted			2022-12-01	WOS:000281657300037
J	Ito, S; D'Alessio, AC; Taranova, OV; Hong, K; Sowers, LC; Zhang, Y				Ito, Shinsuke; D'Alessio, Ana C.; Taranova, Olena V.; Hong, Kwonho; Sowers, Lawrence C.; Zhang, Yi			Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification	NATURE			English	Article							ZYGOTIC PATERNAL GENOME; EMBRYONIC STEM-CELLS; DNA METHYLATION; DEMETHYLATION; 5-HYDROXYMETHYLCYTOSINE; PLURIPOTENCY; PATTERNS; GENE	DNA methylation is one of the best-characterized epigenetic modifications(1-4). Although the enzymes that catalyse DNA methylation have been characterized, enzymes responsible for demethylation have been elusive(5). A recent study indicates that the human TET1 protein could catalyse the conversion of 5-methylcytosine (5mC) of DNA to 5-hydroxymethylcytosine (5hmC), raising the possibility that DNA demethylation may be a Tet1-mediated process(6). Here we extend this study by demonstrating that all three mouse Tet proteins (Tet1, Tet2 and Tet3) can also catalyse a similar reaction. Tet1 has an important role in mouse embryonic stem (ES) cell maintenance through maintaining the expression of Nanog in ES cells. Downregulation of Nanog via Tet1 knockdown correlates with methylation of the Nanog promoter, supporting a role for Tet1 in regulating DNA methylation status. Furthermore, knockdown of Tet1 in pre-implantation embryos results in a bias towards trophectoderm differentiation. Thus, our studies not only uncover the enzymatic activity of the Tet proteins, but also demonstrate a role for Tet1 in ES cell maintenance and inner cell mass cell specification.	[Ito, Shinsuke; D'Alessio, Ana C.; Taranova, Olena V.; Hong, Kwonho; Zhang, Yi] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; [Ito, Shinsuke; D'Alessio, Ana C.; Taranova, Olena V.; Hong, Kwonho; Zhang, Yi] Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Sowers, Lawrence C.] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA 92350 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Loma Linda University	Zhang, Y (corresponding author), Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	jia, xu/A-8386-2016	Zhang, Yi/0000-0002-2789-0811; Hong, Kwonho/0000-0001-7479-4091	NIH [GM68804, CA084487]; NATIONAL CANCER INSTITUTE [R01CA084487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Okano for the J1 and DNMT triple knockout ES cells; J. He and A. Nguyen for help in FACS sorting; and S. Wu for critical reading of the manuscript. This work was supported by NIH grants GM68804 (to Y.Z.) and CA084487 (to L.C.S.). S.I. is a research fellow of the Japan Society for the Promotion of Science. O.T. is a postdoctoral fellow of Juvenile Diabetes Research Foundation International. Y.Z. is an Investigator of the Howard Hughes Medical Institute.	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; CANNON SV, 1988, BIOCHEM BIOPH RES CO, V151, P1173, DOI 10.1016/S0006-291X(88)80489-3; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Hattori N, 2007, GENES CELLS, V12, P387, DOI 10.1111/j.1365-2443.2007.01058.x; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; TardyPlanechaud S, 1997, NUCLEIC ACIDS RES, V25, P553, DOI 10.1093/nar/25.3.553; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x	19	1812	1926	2	290	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2010	466	7310					1129	U151		10.1038/nature09303	http://dx.doi.org/10.1038/nature09303			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20639862	Green Accepted, Green Submitted			2022-12-01	WOS:000281203600045
J	Xu, YP; Ramu, Y; Lu, Z				Xu, Yanping; Ramu, Yajamana; Lu, Zhe			A Shaker K+ Channel with a Miniature Engineered Voltage Sensor	CELL			English	Article							POTASSIUM-CHANNEL; GATING-CHARGE; SODIUM-CHANNELS; SENSING RESIDUES; ACTIVATION GATE; MOLECULAR-BASIS; MOVEMENT; S4; PORE; CURRENTS	Voltage-gated ion channels sense transmembrane voltage changes via a paddle-shaped motif that includes the C-terminal part of the third transmembrane segment (S3b) and the N-terminal part of the fourth segment ((NT)S4) that harbors voltage-sensing arginines. Here, we find that residue triplets in S3b and (NT)S4 can be deleted individually, or even in some combinations, without compromising the channels' basic voltage-gating capability. Thus, a high degree of complementarity between these S3b and (NT)S4 regions is not required for basic voltage gating per se. Remarkably, the voltage-gated Shaker K+ channel remains voltage gated after a 43 residue paddle sequence is replaced by a glycine triplet. Therefore, the paddle motif comprises a minimal core that suffices to confer voltage gating in the physiological voltage range, and a larger, modulatory part. Our study also shows that the hydrophobic residues between the voltage-sensing arginines help set the sensor's characteristic chemical equilibrium between activated and deactivated states.	[Xu, Yanping; Ramu, Yajamana; Lu, Zhe] Univ Penn, Howard Hughes Med Inst, Dept Physiol, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania	Lu, Z (corresponding author), Univ Penn, Howard Hughes Med Inst, Dept Physiol, Philadelphia, PA 19104 USA.	zhelu@mail.med.upenn.edu			National Institutes of Health [GM55560]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. De Weer for critical review and discussion of our manuscript and K. Baek for help with figure preparation. Molecular models were prepared with PyMOL 1.0 (DeLano Scientific). This study was supported by grant GM55560 from the National Institutes of Health to Z.L. Z. L. is an investigator of the Howard Hughes Medical Institute.	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Ahern CA, 2004, J GEN PHYSIOL, V123, P205, DOI 10.1085/jgp.200308993; Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Broomand A, 2008, NEURON, V59, P770, DOI 10.1016/j.neuron.2008.07.008; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Freites JA, 2005, P NATL ACAD SCI USA, V102, P15059, DOI 10.1073/pnas.0507618102; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Gonzalez C, 2001, P NATL ACAD SCI USA, V98, P9617, DOI 10.1073/pnas.171306298; Grabe M, 2007, NATURE, V445, P550, DOI 10.1038/nature05494; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Khalili-Araghi F, 2010, BIOPHYS J, V98, P2189, DOI 10.1016/j.bpj.2010.02.056; Kitaguchi T, 2004, J GEN PHYSIOL, V124, P319, DOI 10.1085/jgp.200409098; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Li-Smerin Y, 2000, J GEN PHYSIOL, V115, P673, DOI 10.1085/jgp.115.6.673; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; LOPEZ GA, 1991, NEURON, V7, P327, DOI 10.1016/0896-6273(91)90271-Z; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Posson DJ, 2008, NEURON, V59, P98, DOI 10.1016/j.neuron.2008.05.006; RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P1664, DOI 10.1021/bi00405a042; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Silverman WR, 2003, P NATL ACAD SCI USA, V100, P2935, DOI 10.1073/pnas.0636603100; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Spassova MA, 1998, J GEN PHYSIOL, V112, P211, DOI 10.1085/jgp.112.2.211; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; STUHMER W, 1989, NATURE, V339, P597, DOI 10.1038/339597a0; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Tang CY, 1997, J GEN PHYSIOL, V109, P301, DOI 10.1085/jgp.109.3.301; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8	64	37	37	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 20	2010	142	4					580	589		10.1016/j.cell.2010.07.013	http://dx.doi.org/10.1016/j.cell.2010.07.013			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	641HR	20691466	Green Accepted, Bronze			2022-12-01	WOS:000281115900012
J	Subramanian, R; Wilson-Kubalek, EM; Arthur, CP; Bick, MJ; Campbell, EA; Darst, SA; Milligan, RA; Kapoor, TM				Subramanian, Radhika; Wilson-Kubalek, Elizabeth M.; Arthur, Christopher P.; Bick, Matthew J.; Campbell, Elizabeth A.; Darst, Seth A.; Milligan, Ronald A.; Kapoor, Tarun M.			Insights into Antiparallel Microtubule Crosslinking by PRC1, a Conserved Nonmotor Microtubule Binding Protein	CELL			English	Article							FISSION YEAST; NDC80 COMPLEX; MOTORS; CYTOKINESIS; ATTACHMENT; ASE1P; VISUALIZATION; MOVEMENTS; KINESIN-5; TRACKING	Formation of microtubule architectures, required for cell shape maintenance in yeast, directional cell expansion in plants and cytokinesis in eukaryotes, depends on antiparallel microtubule crosslinking by the conserved MAP65 protein family. Here, we combine structural and single molecule fluorescence methods to examine how PRC1, the human MAP65, crosslinks antiparallel microtubules. We find that PRC1's microtubule binding is mediated by a structured domain with a spectrin-fold and an unstructured Lys/Arg-rich domain. These two domains, at each end of a homodimer, are connected by a linkage that is flexible on single microtubules, but forms well-defined crossbridges between antiparallel filaments. Further, we show that PRC1 crosslinks are compliant and do not substantially resist filament sliding by motor proteins in vitro. Together, our data show how MAP65s, by combining structural flexibility and rigidity, tune microtubule associations to establish crosslinks that selectively "mark'' antiparallel overlap in dynamic cytoskeletal networks.	[Subramanian, Radhika; Kapoor, Tarun M.] Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA; [Wilson-Kubalek, Elizabeth M.; Arthur, Christopher P.; Milligan, Ronald A.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Bick, Matthew J.; Campbell, Elizabeth A.; Darst, Seth A.] Rockefeller Univ, Lab Mol Biophys, New York, NY 10065 USA	Rockefeller University; Scripps Research Institute; Rockefeller University	Kapoor, TM (corresponding author), Rockefeller Univ, Lab Chem & Cell Biol, New York, NY 10065 USA.	kapoor@mail.rockefeller.edu		Bick, Matthew/0000-0002-9585-859X; Campbell, Elizabeth/0000-0002-1332-128X	NIH [GM65933, GM65933-S1, GM52468]; Rockefeller Women and Science postdoctoral fellowship; National Resource for Automated Molecular Microscopy (NIH) [RR17573]; SBRC (NIH) [1S10RR022321-01]; Keck Facility at Yale University (NIH) [1S10RR023748-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573, S10RR022321, S10RR023748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065933, R01GM052468, R37GM052468] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rockefeller Women and Science postdoctoral fellowship; National Resource for Automated Molecular Microscopy (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SBRC (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Keck Facility at Yale University (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Rajashankar (Argonne Advanced Photon Source) and Deena Oren (Rockefeller University Structural Biology Resource Center (SBRC)) for technical assistance. T.M.K. is grateful to the NIH (GM65933 and GM65933-S1) for support. R.S. is a recipient of the Rockefeller Women and Science postdoctoral fellowship. R.A.M. acknowledges support from the NIH (GM52468). We also acknowledge the National Resource for Automated Molecular Microscopy (NIH RR17573), the SBRC (NIH 1S10RR022321-01), and the Keck Facility at Yale University (NIH 1S10RR023748-01) for instrument use.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Amos LA, 2005, ADV PROTEIN CHEM, V71, P257, DOI 10.1016/S0065-3233(04)71007-4; Bormuth V, 2009, SCIENCE, V325, P870, DOI 10.1126/science.1174923; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Chan J, 1999, P NATL ACAD SCI USA, V96, P14931, DOI 10.1073/pnas.96.26.14931; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Gaillard J, 2008, MOL BIOL CELL, V19, P4534, DOI 10.1091/mbc.E08-04-0341; Glotzer M, 2009, NAT REV MOL CELL BIO, V10, P9, DOI 10.1038/nrm2609; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Hentrich C, 2010, J CELL BIOL, V189, P465, DOI 10.1083/jcb.200910125; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0; Kapitein LC, 2008, CURR BIOL, V18, P1713, DOI 10.1016/j.cub.2008.09.046; Kapitein LC, 2008, J CELL BIOL, V182, P421, DOI 10.1083/jcb.200801145; Kashina AS, 1996, NATURE, V379, P270, DOI 10.1038/379270a0; Khmelinskii A, 2009, DEV CELL, V17, P244, DOI 10.1016/j.devcel.2009.06.011; Korneev MJ, 2007, EUR BIOPHYS J BIOPHY, V36, P675, DOI 10.1007/s00249-007-0134-6; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Loiodice I, 2005, MOL BIOL CELL, V16, P1756, DOI 10.1091/mbc.E04-10-0899; Manning AL, 2008, CURR OPIN CELL BIOL, V20, P101, DOI 10.1016/j.ceb.2007.11.004; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Miller SA, 2008, CURR BIOL, V18, P1785, DOI 10.1016/j.cub.2008.11.007; Millman BM, 1998, PHYSIOL REV, V78, P359, DOI 10.1152/physrev.1998.78.2.359; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ribbeck K, 2006, MOL BIOL CELL, V17, P2646, DOI 10.1091/mbc.E05-12-1178; Sasabe M, 2006, CURR OPIN PLANT BIOL, V9, P563, DOI 10.1016/j.pbi.2006.09.010; Schuyler SC, 2003, J CELL BIOL, V160, P517, DOI 10.1083/jcb.200210021; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Thadani R, 2009, CURR BIOL, V19, P1861, DOI 10.1016/j.cub.2009.09.063; Valentine MT, 2009, BIOPHYS J, V97, P1671, DOI 10.1016/j.bpj.2009.07.013; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; WHITTAKER M, 1995, ULTRAMICROSCOPY, V58, P245, DOI 10.1016/0304-3991(95)00057-8; Wilson-Kubalek EM, 2008, J CELL BIOL, V182, P1055, DOI 10.1083/jcb.200804170; Yamashita A, 2005, MOL BIOL CELL, V16, P1378, DOI 10.1091/mbc.e04-10-0859; Zeng CQ, 2000, MICROSC RES TECHNIQ, V49, P467, DOI 10.1002/(SICI)1097-0029(20000601)49:5<467::AID-JEMT9>3.3.CO;2-M; Zhu CJ, 2006, P NATL ACAD SCI USA, V103, P6196, DOI 10.1073/pnas.0506926103	40	198	201	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2010	142	3					433	443		10.1016/j.cell.2010.07.012	http://dx.doi.org/10.1016/j.cell.2010.07.012			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691902	Green Accepted, Bronze			2022-12-01	WOS:000280609100020
J	Musunuru, K; Strong, A; Frank-Kamenetsky, M; Lee, NE; Ahfeldt, T; Sachs, KV; Li, XY; Li, H; Kuperwasser, N; Ruda, VM; Pirruccello, JP; Muchmore, B; Prokunina-Olsson, L; Hall, JL; Schadt, EE; Morales, CR; Lund-Katz, S; Phillips, MC; Wong, J; Cantley, W; Racie, T; Ejebe, KG; Orho-Melander, M; Melander, O; Koteliansky, V; Fitzgerald, K; Krauss, RM; Cowan, CA; Kathiresan, S; Rader, DJ				Musunuru, Kiran; Strong, Alanna; Frank-Kamenetsky, Maria; Lee, Noemi E.; Ahfeldt, Tim; Sachs, Katherine V.; Li, Xiaoyu; Li, Hui; Kuperwasser, Nicolas; Ruda, Vera M.; Pirruccello, James P.; Muchmore, Brian; Prokunina-Olsson, Ludmila; Hall, Jennifer L.; Schadt, Eric E.; Morales, Carlos R.; Lund-Katz, Sissel; Phillips, Michael C.; Wong, Jamie; Cantley, William; Racie, Timothy; Ejebe, Kenechi G.; Orho-Melander, Marju; Melander, Olle; Koteliansky, Victor; Fitzgerald, Kevin; Krauss, Ronald M.; Cowan, Chad A.; Kathiresan, Sekar; Rader, Daniel J.			From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus	NATURE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; GENOME-WIDE ASSOCIATION; PROTEIN; GENE; SORTILIN; TRANSCRIPTION; DISEASE; DESIGN; RISK; MICE	Recent genome-wide association studies (GWASs) have identified a locus on chromosome 1p13 strongly associated with both plasma low-density lipoprotein cholesterol (LDL-C) and myocardial infarction (MI) in humans. Here we show through a series of studies in human cohorts and human-derived hepatocytes that a common noncoding polymorphism at the 1p13 locus, rs12740374, creates a C/EBP (CCAAT/enhancer binding protein) transcription factor binding site and alters the hepatic expression of the SORT1 gene. With small interfering RNA (siRNA) knockdown and viral overexpression in mouse liver, we demonstrate that Sort1 alters plasma LDL-C and very low-density lipoprotein (VLDL) particle levels by modulating hepatic VLDL secretion. Thus, we provide functional evidence for a novel regulatory pathway for lipoprotein metabolism and suggest that modulation of this pathway may alter risk for MI in humans. We also demonstrate that common noncoding DNA variants identified by GWASs can directly contribute to clinical phenotypes.	[Strong, Alanna; Sachs, Katherine V.; Li, Xiaoyu; Li, Hui; Rader, Daniel J.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Strong, Alanna; Sachs, Katherine V.; Li, Xiaoyu; Li, Hui; Rader, Daniel J.] Univ Penn, Sch Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Strong, Alanna; Sachs, Katherine V.; Li, Xiaoyu; Li, Hui; Rader, Daniel J.] Univ Penn, Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Musunuru, Kiran; Lee, Noemi E.; Ahfeldt, Tim; Kuperwasser, Nicolas; Ruda, Vera M.; Pirruccello, James P.; Ejebe, Kenechi G.; Cowan, Chad A.; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Musunuru, Kiran; Lee, Noemi E.; Ahfeldt, Tim; Kuperwasser, Nicolas; Ruda, Vera M.; Pirruccello, James P.; Ejebe, Kenechi G.; Cowan, Chad A.; Kathiresan, Sekar] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Musunuru, Kiran; Lee, Noemi E.; Kuperwasser, Nicolas; Ruda, Vera M.; Pirruccello, James P.; Ejebe, Kenechi G.; Cowan, Chad A.; Kathiresan, Sekar] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Musunuru, Kiran; Pirruccello, James P.; Hall, Jennifer L.; Ejebe, Kenechi G.; Cowan, Chad A.; Kathiresan, Sekar] Broad Inst, Cambridge, MA 02142 USA; [Musunuru, Kiran] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD 21287 USA; [Frank-Kamenetsky, Maria; Wong, Jamie; Cantley, William; Racie, Timothy; Koteliansky, Victor; Fitzgerald, Kevin] Alnylam Pharmaceut Inc, Cambridge, MA 02142 USA; [Ahfeldt, Tim] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Biol Mol Cell Biol 2, D-20246 Hamburg, Germany; [Muchmore, Brian; Prokunina-Olsson, Ludmila] NCI, Lab Translat Genom, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Hall, Jennifer L.] Univ Minnesota, Program Cardiovasc Translat Genom, Lillehei Heart Inst, Minneapolis, MN 55455 USA; [Schadt, Eric E.] Sage Bionetworks, Seattle, WA 98109 USA; [Morales, Carlos R.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada; [Lund-Katz, Sissel; Phillips, Michael C.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Philadelphia, PA 19104 USA; [Orho-Melander, Marju; Melander, Olle] Lund Univ, Skania Univ Hosp, Dept Clin Sci, SE-20502 Malmo, Sweden; [Krauss, Ronald M.] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Johns Hopkins University; University of Hamburg; University Medical Center Hamburg-Eppendorf; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Minnesota System; University of Minnesota Twin Cities; McGill University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Lund University; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Rader, DJ (corresponding author), Univ Penn, Sch Med, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA.	skathiresan@partners.org; rader@mail.med.upenn.edu	Prokunina-Olsson, Ludmila/A-8240-2019; Ahfeldt, Tim/E-2935-2017; Prokunina-Olsson, Ludmila/V-7960-2019; Ejebe, Kenechi/I-9238-2016; Morales, Carlos R./H-1055-2011	Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Prokunina-Olsson, Ludmila/0000-0002-9622-2091; Ejebe, Kenechi/0000-0002-6090-8657; Phillips, Michael/0000-0002-7147-8007; Ahfeldt, Tim/0000-0001-6377-7376; Pirruccello, James/0000-0001-6088-4037; Melander, Olle/0000-0002-2581-484X	United States National Institutes of Health (NIH); NIH [K99-HL098364, U01-HL069757, RC2-HL101864, P01-HL059407]; Harvard Stem Cell Institute; Division of Cancer Epidemiology & Genetics, National Cancer Institute, NIH; Swedish Medical Research Council; Heart-Lung Foundation; Pahlsson Foundation; Quest Diagnostics, Inc.; Bristol-Myers Squibb; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069757, P01HL059407, RC2HL101864, K99HL098364, T32HL007954] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Division of Cancer Epidemiology & Genetics, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Heart-Lung Foundation(Swedish Heart-Lung Foundation); Pahlsson Foundation; Quest Diagnostics, Inc.; Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank D. Altshuler, E. Fisher and J. Maraganore for advice and guidance, and A. Akinc, J. Billheimer, R. Brown, R. Camahort, D. Cromley, E. Eduoard, I. Fuki, C. Geaney, G. Hinkle, I. Kohaar, S. Kuchimanchi, W. Lagor, F. Lau, D. Lum, M. Maier, D. Marchadier, R. Meyers, J. Millar, S. Milstein, D. Nguyen, D. Perez, D. Peters, V. Redon, A. Rigamonti, R. Schinzel, M.-S. Sun, S.-A. Toh, A. Wilson and K. Wojnoonski for assistance and suggestions. We acknowledge the National Heart, Lung, and Blood Institute (NHLBI) Gene Therapy Resource Program for providing support for viral vector production as well as the Vector Core laboratory of the University of Pennsylvania for producing the vectors. We acknowledge the members of the NHLBI Candidate Gene Association Resource (CARe) lipids working group for the contribution of association data in African Americans. This work was supported in part by a T32 grant in Cell and Molecular Training for Cardiovascular Biology from the United States National Institutes of Health (NIH), K99-HL098364 from the NIH, and the Clinician Scientist Program of the Harvard Stem Cell Institute (K. M.); a Medical Scientist Training Program grant from the NIH (A. S.); the intramural research program of the Division of Cancer Epidemiology & Genetics, National Cancer Institute, NIH (L.P.-O.); the Swedish Medical Research Council, Heart-Lung Foundation, and Pahlsson Foundation (M.O.-M., O.M.); U01-HL069757 from the NIH and research support from Quest Diagnostics, Inc. (R. M. K.); RC2-HL101864 from the NIH (S. K.); and P01-HL059407 and RC2-HL101864 from the NIH and a "Freedom to Discover'' Unrestricted Cardiovascular Research Grant from Bristol-Myers Squibb (D.J.R.).	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Berneis KK, 2002, J LIPID RES, V43, P1363, DOI 10.1194/jlr.R200004-JLR200; Brown MS, 1996, SCIENCE, V272, P629, DOI 10.1126/science.272.5262.629; DARLINGTON GJ, 1995, CURR OPIN GENET DEV, V5, P565, DOI 10.1016/0959-437X(95)80024-7; Frank-Kamenetsky M, 2008, P NATL ACAD SCI USA, V105, P11915, DOI 10.1073/pnas.0805434105; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Keebler ME, 2009, CIRC-CARDIOVASC GENE, V2, P238, DOI 10.1161/CIRCGENETICS.108.829473; Kitajima K, 2006, ARTERIOSCL THROM VAS, V26, P1852, DOI 10.1161/01.ATV.0000231520.26490.54; Linsel-Nitschke P, 2010, ATHEROSCLEROSIS, V208, P183, DOI 10.1016/j.atherosclerosis.2009.06.034; Miller M, 2003, J BIOL CHEM, V278, P15178, DOI 10.1074/jbc.M300417200; Musunuru K, 2010, CIRC-CARDIOVASC GENE, V3, P267, DOI 10.1161/CIRCGENETICS.109.882696; Musunuru K, 2009, ARTERIOSCL THROM VAS, V29, P1975, DOI 10.1161/ATVBAHA.109.190405; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Olive M, 1996, J BIOL CHEM, V271, P2040, DOI 10.1074/jbc.271.4.2040; Osada S, 1996, J BIOL CHEM, V271, P3891; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; Reiner AP, 2008, AM J HUM GENET, V82, P1193, DOI 10.1016/j.ajhg.2008.03.017; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Siri-Tarino PW, 2009, OBESITY, V17, P1768, DOI 10.1038/oby.2009.146; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Tanigawa H, 2007, CIRCULATION, V116, P1267, DOI 10.1161/CIRCULATIONAHA.107.704254; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Waters DD, 2009, CIRCULATION, V120, P28, DOI 10.1161/CIRCULATIONAHA.108.838466; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zeng JB, 2009, EXP CELL RES, V315, P3112, DOI 10.1016/j.yexcr.2009.08.016	35	770	804	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2010	466	7307					714	U2		10.1038/nature09266	http://dx.doi.org/10.1038/nature09266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20686566	Green Accepted			2022-12-01	WOS:000280562500030
J	Shawcross, DL; O'Grady, JG				Shawcross, Debbie L.; O'Grady, John G.			The 6-month abstinence rule in liver transplantation	LANCET			English	Editorial Material							ALCOHOLIC HEPATITIS; DISEASE; SURVIVAL; STEROIDS; RELAPSE		[Shawcross, Debbie L.; O'Grady, John G.] Kings Coll Hosp London, Inst Liver Studies, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	O'Grady, JG (corresponding author), Kings Coll Hosp London, Inst Liver Studies, Denmark Hill, London SE5 9RS, England.	john.o'grady@kcl.ac.uk	Shawcross, Debbie Lindsay/H-9669-2012	Shawcross, Debbie Lindsay/0000-0001-6133-4619				Beresford TP, 2000, LIVER TRANSPLANT, V6, P777, DOI 10.1053/jlts.2000.19027; BIRD GLA, 1990, BRIT MED J, V301, P15, DOI 10.1136/bmj.301.6742.15; Castel H, 2009, HEPATOLOGY, V50, p307A; Dureja P, 2010, J HEPATOL, V52, P759, DOI 10.1016/j.jhep.2009.12.021; KUMAR S, 1990, HEPATOLOGY, V11, P159, DOI 10.1002/hep.1840110202; Louvet A, 2007, HEPATOLOGY, V45, P1348, DOI 10.1002/hep.21607; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Neuberger J, 2002, J HEPATOL, V36, P130, DOI 10.1016/S0168-8278(01)00278-1; O'Grady JG, 2006, GUT, V55, P1529, DOI 10.1136/gut.2005.090506; OSORIO RW, 1994, HEPATOLOGY, V20, P105, DOI 10.1016/0270-9139(94)90141-4; SHAWCROSS D, 2009, BRIT MED J, V338, P1081; Tandon P, 2009, AM J GASTROENTEROL, V104, P1700, DOI 10.1038/ajg.2009.226	12	40	40	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2010	376	9737					216	217		10.1016/S0140-6736(10)60487-4	http://dx.doi.org/10.1016/S0140-6736(10)60487-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632VM	20656110				2022-12-01	WOS:000280457200009
J	Brashares, JS				Brashares, Justin S.			Filtering Wildlife	SCIENCE			English	Editorial Material							EXTINCTION; MAMMALS; DECLINE		Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Brashares, JS (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	brashares@berkeley.edu						Balmford A, 1996, TRENDS ECOL EVOL, V11, P193, DOI 10.1016/0169-5347(96)10026-4; Davidson AD, 2009, P NATL ACAD SCI USA, V106, P10702, DOI 10.1073/pnas.0901956106; DIAMOND J M, 1975, Biological Conservation, V7, P129, DOI 10.1016/0006-3207(75)90052-X; Firth RSC, 2010, BIOL CONSERV, V143, P1193, DOI 10.1016/j.biocon.2010.02.027; Ford HA, 2009, BIOL CONSERV, V142, P3182, DOI 10.1016/j.biocon.2009.08.022; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Hebblewhite M, 2010, CONSERV BIOL, V24, P341, DOI 10.1111/j.1523-1739.2009.01343.x; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Karanth KK, 2010, P ROY SOC B-BIOL SCI, V277, P1971, DOI 10.1098/rspb.2010.0171; Marton-Lefevre J, 2010, SCIENCE, V327, P1179, DOI 10.1126/science.1188424; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Rodrigues ASL, 2006, SCIENCE, V313, P1051, DOI 10.1126/science.1131302; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; White J, 2003, MATER WORLD, V11, P2; Woinarski JCZ, 2010, WILDLIFE RES, V37, P116, DOI 10.1071/WR09125; WRIGHT GM, 1934, US DEP INT WILD DIV, V2	16	17	20	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					402	403		10.1126/science.1190095	http://dx.doi.org/10.1126/science.1190095			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651143				2022-12-01	WOS:000280196500025
J	Kale, SD; Gu, BA; Capelluto, DGS; Dou, DL; Feldman, E; Rumore, A; Arredondo, FD; Hanlon, R; Fudal, I; Rouxel, T; Lawrence, CB; Shan, WX; Tyler, BM				Kale, Shiv D.; Gu, Biao; Capelluto, Daniel G. S.; Dou, Daolong; Feldman, Emily; Rumore, Amanda; Arredondo, Felipe D.; Hanlon, Regina; Fudal, Isabelle; Rouxel, Thierry; Lawrence, Christopher B.; Shan, Weixing; Tyler, Brett M.			External Lipid PI3P Mediates Entry of Eukaryotic Pathogen Effectors into Plant and Animal Host Cells	CELL			English	Article							PHYTOPHTHORA-SOJAE; PLASMODIUM-FALCIPARUM; MOLECULAR-BASIS; PROTEINS; AVIRULENCE; GENE; RESISTANCE; VIRULENCE; RECOGNITION; DYNAMICS	Pathogens of plants and animals produce effector proteins that are transferred into the cytoplasm of host cells to suppress host defenses. One type of plant pathogens, oomycetes, produces effector proteins with N-terminal RXLR and dEER motifs that enable entry into host cells. We show here that effectors of another pathogen type, fungi, contain functional variants of the RXLR motif, and that the oomycete and fungal RXLR motifs enable binding to the phospholipid, phosphatidylinositol-3-phosphate (PI3P). We find that PI3P is abundant on the outer surface of plant cell plasma membranes and, furthermore, on some animal cells. All effectors could also enter human cells, suggesting that PI3P-mediated effector entry may be very widespread in plant, animal and human pathogenesis. Entry into both plant and animal cells involves lipid raft-mediated endocytosis. Blocking PI3P binding inhibited effector entry, suggesting new therapeutic avenues.	[Gu, Biao; Shan, Weixing] NW A&F Univ, Coll Plant Protect, Yangling 712100, Shaanxi, Peoples R China; [Gu, Biao; Shan, Weixing] NW A&F Univ, Shaanxi Key Lab Mol Biol Agr, Yangling 712100, Shaanxi, Peoples R China; [Kale, Shiv D.; Gu, Biao; Dou, Daolong; Feldman, Emily; Rumore, Amanda; Arredondo, Felipe D.; Hanlon, Regina; Lawrence, Christopher B.; Tyler, Brett M.] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Capelluto, Daniel G. S.; Rumore, Amanda; Lawrence, Christopher B.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; [Fudal, Isabelle; Rouxel, Thierry] INRA Bioger, F-78850 Thiverval Grignon, France	Northwest A&F University - China; Northwest A&F University - China; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Shan, WX (corresponding author), NW A&F Univ, Coll Plant Protect, Yangling 712100, Shaanxi, Peoples R China.	wxshan@nwsuaf.edu.cn; bmtyler@vt.edu	Dou, Daolong/AAW-1678-2021; Gu, Biao/AAT-8220-2021	Dou, Daolong/0000-0001-5226-6642; Fudal, Isabelle/0000-0002-9105-9432; Shan, Weixing/0000-0001-7286-4041	National Research Initiative of the USDA National Institute of Food and Agriculture [2007-35319-18100]; U.S. National Science Foundation [IOS-0924861]; Ministry of Science and Technology of China [2006CB101901]; Earmarked Fund for Modern Agro-industry Technology Research System of China; China Scholarship Council via NW A F University [2007U27066]; Direct For Biological Sciences [0924861] Funding Source: National Science Foundation	National Research Initiative of the USDA National Institute of Food and Agriculture; U.S. National Science Foundation(National Science Foundation (NSF)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Earmarked Fund for Modern Agro-industry Technology Research System of China; China Scholarship Council via NW A F University(China Scholarship Council); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The project was conceived by B. M. T, W. S., and D. D., and the experiments were planned by all authors. S. D. K. and B. G. conducted most of the experiments with contributions from D. G. S. C., D. D., E. F., A. C., R. H., and F. A. S. D. K and B. M. T wrote the paper with input from all authors. We thank Furong Sun and Vincenzo Antignani for technical assistance; Rays Jiang (Broad Institute) for bioinformatics assistance; John McDowell, Ryan Anderson (Virginia Tech), and Frank Takken (University of Amsterdam) for useful discussions; Joop Vermeer and Teun Munnik (University of Amsterdam) for the Hrs-2xFYVE biosensor gene; Michael Klemba (Virginia Tech) for human erythrocytes, Saghai Maroof (Virginia Tech) for soybean seed and Maureen Lawrence, Lisa Gunderman and Emily Alberts for manuscript preparation. This work was supported by the National Research Initiative of the USDA National Institute of Food and Agriculture, grant number #2007-35319-18100 (to B. M. T), by the U.S. National Science Foundation, grant number IOS-0924861 (to B. M. T), in part by the 973 program of the Ministry of Science and Technology of China, grant #2006CB101901 and by grant 15 from the Earmarked Fund for Modern Agro-industry Technology Research System of China (to W. S.). S. D. K. was supported in part by a U.S. National Science Foundation predoctoral fellowship and B. G. was supported by a China Scholarship Council fellowship, #2007U27066, via NW A & F University.	Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Bhattacharjee Souvik, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020050; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Blatner NR, 2004, J BIOL CHEM, V279, P53818, DOI 10.1074/jbc.M408408200; Boon JM, 2002, MED RES REV, V22, P251, DOI 10.1002/med.10009; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; Chang M, 2005, PLANT CELL PHYSIOL, V46, P482, DOI 10.1093/pcp/pci046; Chang M, 2007, NEW PHYTOL, V174, P46, DOI 10.1111/j.1469-8137.2007.01977.x; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Dou DL, 2008, PLANT CELL, V20, P1930, DOI 10.1105/tpc.107.056093; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Ellis J, 2006, TRENDS PLANT SCI, V11, P61, DOI 10.1016/j.tplants.2005.12.008; Ellis JG, 2007, ANNU REV PHYTOPATHOL, V45, P289, DOI 10.1146/annurev.phyto.45.062806.094331; Fudal I, 2007, MOL PLANT MICROBE IN, V20, P459, DOI 10.1094/MPMI-20-4-0459; Grouffaud S, 2008, MICROBIOL-SGM, V154, P3743, DOI 10.1099/mic.0.2008/021964-0; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Houterman PM, 2009, PLANT J, V58, P970, DOI 10.1111/j.1365-313X.2009.03838.x; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; KALE SD, 2009, METHODS MOL BIOL PLA; KHANG CH, 2010, PLANT CELL, V22, DOI DOI 10.1105/TPC.1109.069666; Lafont F, 2004, CURR OPIN MICROBIOL, V7, P4, DOI 10.1016/j.mib.2003.12.007; Langel U., 2006, HDB CELL PENETRATING; Lee SA, 2006, J BIOL CHEM, V281, P37091, DOI 10.1074/jbc.M608610200; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lord JM, 1999, CELL MICROBIOL, V1, P85, DOI 10.1046/j.1462-5822.1999.00015.x; Lou Y, 2006, PLANT MOL BIOL, V60, P729, DOI 10.1007/s11103-005-5548-x; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; QUINN PJ, 2002, SUBCELLULAR BIOCH, P39; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Sarma GN, 2005, PLANT CELL, V17, P3190, DOI 10.1105/tpc.105.034918; Shan WX, 2004, MOL PLANT MICROBE IN, V17, P394, DOI 10.1094/MPMI.2004.17.4.394; Tseng TT, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-S1-S2; Tyler BM, 2002, ANNU REV PHYTOPATHOL, V40, P137, DOI 10.1146/annurev.phyto.40.120601.125310; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Tyler BM, 2009, CELL MICROBIOL, V11, P13, DOI 10.1111/j.1462-5822.2008.01240.x; Vaid A, 2010, BLOOD, V115, P2500, DOI 10.1182/blood-2009-08-238972; Vermeer JEM, 2006, PLANT J, V47, P687, DOI 10.1111/j.1365-313X.2006.02830.x; Vermeer JEM, 2009, PLANT J, V57, P356, DOI 10.1111/j.1365-313X.2008.03679.x; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203	44	286	309	7	108	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					284	295		10.1016/j.cell.2010.06.008	http://dx.doi.org/10.1016/j.cell.2010.06.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20655469	Bronze			2022-12-01	WOS:000280204300019
J	Choi, JH; Banks, AS; Estall, JL; Kajimura, S; Bostrom, P; Laznik, D; Ruas, JL; Chalmers, MJ; Kamenecka, TM; Bluher, M; Griffin, PR; Spiegelman, BM				Choi, Jang Hyun; Banks, Alexander S.; Estall, Jennifer L.; Kajimura, Shingo; Bostroem, Pontus; Laznik, Dina; Ruas, Jorge L.; Chalmers, Michael J.; Kamenecka, Theodore M.; Blueher, Matthias; Griffin, Patrick R.; Spiegelman, Bruce M.			Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPAR gamma by Cdk5	NATURE			English	Article							ACTIVATED-RECEPTOR-GAMMA; INSULIN-RESISTANCE; LIGAND-BINDING; ADIPOSE-TISSUE; OLIGONUCLEOTIDE ARRAYS; EXPRESSION; ADIPOGENESIS; HORMONE; THIAZOLIDINEDIONES; STIMULATION	Obesity induced in mice by high-fat feeding activates the protein kinase Cdk5 (cyclin-dependent kinase 5) in adipose tissues. This results in phosphorylation of the nuclear receptor PPAR gamma (peroxisome proliferator-activated receptor c), a dominant regulator of adipogenesis and fat cell gene expression, at serine 273. This modification of PPAR gamma does not alter its adipogenic capacity, but leads to dysregulation of a large number of genes whose expression is altered in obesity, including a reduction in the expression of the insulin-sensitizing adipokine, adiponectin. The phosphorylation of PPAR gamma by Cdk5 is blocked by anti-diabetic PPAR gamma ligands, such as rosiglitazone and MRL24. This inhibition works both in vivo and in vitro, and is completely independent of classical receptor transcriptional agonism. Similarly, inhibition of PPAR gamma phosphorylation in obese patients by rosiglitazone is very tightly associated with the anti-diabetic effects of this drug. All these findings strongly suggest that Cdk5-mediated phosphorylation of PPAR gamma may be involved in the pathogenesis of insulin-resistance, and present an opportunity for development of an improved generation of anti-diabetic drugs through PPAR gamma.	[Choi, Jang Hyun; Banks, Alexander S.; Estall, Jennifer L.; Kajimura, Shingo; Bostroem, Pontus; Laznik, Dina; Ruas, Jorge L.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Choi, Jang Hyun; Banks, Alexander S.; Estall, Jennifer L.; Kajimura, Shingo; Bostroem, Pontus; Laznik, Dina; Ruas, Jorge L.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Metab & Chron Dis, Boston, MA 02115 USA; [Choi, Jang Hyun; Banks, Alexander S.; Estall, Jennifer L.; Kajimura, Shingo; Bostroem, Pontus; Laznik, Dina; Ruas, Jorge L.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Chalmers, Michael J.; Kamenecka, Theodore M.; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Blueher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Scripps Research Institute; Leipzig University	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, 44 Binney St, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Choi, Jang Hyun/B-3055-2012; Kajimura, Shingo/AAC-5090-2019; Banks, Alexander/B-4832-2012; Ruas, Jorge/AAE-6094-2019	Kajimura, Shingo/0000-0003-0672-5910; Banks, Alexander/0000-0003-1787-6925; Ruas, Jorge/0000-0002-1110-2606; Chalmers, Michael/0000-0002-2139-6089; Estall, Jennifer/0000-0002-9838-1440	NIH [DK31405, DK087853]; Deutsche Forschungsgemeinschaft (DFG); N National Institute of Mental Health [U54-MH084512]; NIH National Institute of General Medical Sciences [R01-GM084041]; Clinical Research group [KFO 152, BL 833/1-1]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK031405, K99DK087853, R00DK087853, R01DK031405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); N National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Clinical Research group; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank V. Mootha for help with the analysis of microarray data and for critical comments. We thank M. Kirschner for a critical reading of the manuscript and for comments. We are grateful to R. Gupta and P. Cohen for critical comments on the manuscript. J.H.C., A.S.B., J.L.E., P.B., D.L., J.L.R. and B.M.S are supported by NIH DK31405. S.K. is supported by NIH grant DK087853. M.B. is supported by a grant from Deutsche Forschungsgemeinschaft (DFG) and the Clinical Research group 'Atherobesity' KFO 152 (project BL 833/1-1). P.R.G., M.J.C. and T.M.K. are supported in part by the by the Intramural Research Program of the N National Institute of Mental Health (P.R.G., M.J.C., T.M.K., U54-MH084512; H. Rosen Principal Investigator) and by the NIH National Institute of General Medical Sciences (P.R.G. and M.J.C., R01-GM084041).	Acton JJ, 2005, BIOORG MED CHEM LETT, V15, P357, DOI 10.1016/j.bmcl.2004.10.068; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Berger JP, 2003, MOL ENDOCRINOL, V17, P662, DOI 10.1210/me.2002-0217; Bluher M, 2002, DIABETOLOGIA, V45, P210, DOI 10.1007/s00125-001-0723-3; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cinti S, 2005, PROSTAG LEUKOTR ESS, V73, P9, DOI 10.1016/j.plefa.2005.04.010; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; FLIER JS, 1987, SCIENCE, V237, P405, DOI 10.1126/science.3299706; Gregoire FM, 2009, MOL ENDOCRINOL, V23, P975, DOI 10.1210/me.2008-0473; Hakak Y, 2001, P NATL ACAD SCI USA, V98, P4746, DOI 10.1073/pnas.081071198; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Jimenez MA, 2007, MOL CELL BIOL, V27, P743, DOI 10.1128/MCB.01557-06; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Lagathu C, 2006, DIABETOLOGIA, V49, P2162, DOI 10.1007/s00125-006-0335-z; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lipscombe LL, 2007, JAMA-J AM MED ASSOC, V298, P2634, DOI 10.1001/jama.298.22.2634; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Maier CS, 2005, METHOD ENZYMOL, V402, P312, DOI 10.1016/S0076-6879(05)02010-0; Moreno-Navarrete JM, 2010, DIABETES, V59, P200, DOI 10.2337/db09-0700; Merino-Trigo A, 2004, J CELL SCI, V117, P6413, DOI 10.1242/jcs.01561; Morrison RF, 2000, J NUTR, V130, p3116S, DOI 10.1093/jn/130.12.3116S; Musa FRM, 2000, J ANDROL, V21, P392; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Ostberg T, 2004, J BIOL CHEM, V279, P41124, DOI 10.1074/jbc.M401552200; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Salim C, 2009, GLIA, V57, P535, DOI 10.1002/glia.20782; Sarraf P, 1999, MOL CELL, V3, P799, DOI 10.1016/S1097-2765(01)80012-5; Sharma AM, 2007, J CLIN ENDOCR METAB, V92, P386, DOI 10.1210/jc.2006-1268; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; TORTI FM, 1985, SCIENCE, V229, P867, DOI 10.1126/science.3839597; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Utreras E, 2009, J BIOL CHEM, V284, P2275, DOI 10.1074/jbc.M805052200; Walkey CJ, 2008, J BIOL CHEM, V283, P24290, DOI 10.1074/jbc.C800139200; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; Willson TM, 1996, J MED CHEM, V39, P665, DOI 10.1021/jm950395a; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	46	629	658	6	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					451	U1		10.1038/nature09291	http://dx.doi.org/10.1038/nature09291			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20651683	Green Accepted			2022-12-01	WOS:000280141200027
J	Fouyas, IP; Sandercock, PAG; Statham, PFX; Nikolaidis, I				Fouyas, Ioannis P.; Sandercock, Peter A. G.; Statham, Patrick F. X.; Nikolaidis, Ioannis			Uncertainties Page How beneficial is surgery for cervical radiculopathy and myelopathy?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SPONDYLOTIC MYELOPATHY; SURGICAL-TREATMENT; NATURAL-HISTORY; MULTICENTER; DISORDER		[Fouyas, Ioannis P.; Sandercock, Peter A. G.; Statham, Patrick F. X.] Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; [Nikolaidis, Ioannis] Tzaneio Gen State Hosp, Piraeus, Greece	University of Edinburgh	Fouyas, IP (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.	ioannisfouyas@nhs.net		Sandercock, Peter/0000-0001-8484-0135	Biomet	Biomet	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that (1) no authors have support from any company for the submitted work; (2) PFXS has received consultancy fees for the development of a cervical disc replacement, and has had travel and accommodation expenses covered by Biomet, which might have an interest in the submitted work in the previous three years; (3) none of the authors' spouses, partners, or children have financial relationships that may be relevant to the submitted work; and (4) no authors have non-financial interests that may be relevant to the submitted work.	BARNES MP, 1984, J NEUROL NEUROSUR PS, V47, P17, DOI 10.1136/jnnp.47.1.17; CAMPBELL AMG, 1960, BRIT MED J, V2, P481, DOI 10.1136/bmj.2.5197.481; Hilibrand AS, 1999, J BONE JOINT SURG AM, V81A, P519, DOI 10.2106/00004623-199904000-00009; IRVINE DH, 1965, LANCET, V1, P1089; Kadanka Z, 2002, SPINE, V27, P2205, DOI 10.1097/00007632-200210150-00003; King JT, 2005, J NEUROSURG-SPINE, V2, P526, DOI 10.3171/spi.2005.2.5.0526; LEES F, 1963, BRIT MED J, P1607, DOI 10.1136/bmj.2.5373.1607; Nikolaidis I, 2010, COCHRANE DB SYST REV, V1; NURICK S, 1972, BRAIN, V95, P101, DOI 10.1093/brain/95.1.101; Persson LCG, 1997, SPINE, V22, P751, DOI 10.1097/00007632-199704010-00007; RADHAKRISHNAN K, 1994, BRAIN, V117, P325, DOI 10.1093/brain/117.2.325; ROWLAND LP, 1992, NEUROLOGY, V42, P5, DOI 10.1212/WNL.42.1.5; Sampath P, 2000, SPINE, V25, P670, DOI 10.1097/00007632-200003150-00004; Sampath P, 1999, SPINE, V24, P591, DOI 10.1097/00007632-199903150-00021; Singh A, 2001, J NEUROSURG, V94, P189, DOI 10.3171/spi.2001.94.2.0189; TERESI LM, 1987, RADIOLOGY, V164, P83, DOI 10.1148/radiology.164.1.3588931	16	8	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 13	2010	341								c3108	10.1136/bmj.c3108	http://dx.doi.org/10.1136/bmj.c3108			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628XB	20627982				2022-12-01	WOS:000280156600002
J	Aaen, AM; Moller, K				Aaen, Anne-Marie; Moller, Kirsten			A Patient's Journey Through and beyond anaesthesia awareness	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Moller, Kirsten] Rigshosp, Dept Intens Care, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen		aaen@webspeed.dk; kirsten.moller@dadlnet.dk	Moller, Kirsten/A-4751-2009	Moller, Kirsten/0000-0003-3058-1072					0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 12	2010	341								c3669	10.1136/bmj.c3669	http://dx.doi.org/10.1136/bmj.c3669			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628WY	20624831				2022-12-01	WOS:000280156300001
J	Zhang, J; Wagh, P; Guay, D; Sanchez-Pulido, L; Padhi, BK; Korzh, V; Andrade-Navarro, MA; Akimenko, MA				Zhang, Jing; Wagh, Purva; Guay, Danielle; Sanchez-Pulido, Luis; Padhi, Bhaja K.; Korzh, Vladimir; Andrade-Navarro, Miguel A.; Akimenko, Marie-Andree			Loss of fish actinotrichia proteins and the fin-to-limb transition	NATURE			English	Article							APICAL ECTODERMAL RIDGE; IN-SITU HYBRIDIZATION; GENE-EXPRESSION; SONIC-HEDGEHOG; PECTORAL FIN; CAUDAL FIN; ZEBRAFISH; GLI3; MORPHOGENESIS; REGENERATION	The early development of teleost paired fins is strikingly similar to that of tetrapod limb buds and is controlled by similar mechanisms(1,2). One early morphological divergence between pectoral fins and limbs is in the fate of the apical ectodermal ridge (AER), the distal epidermis that rims the bud. Whereas the AER of tetrapods regresses after specification of the skeletal progenitors(3), the AER of teleost fishes forms a fold that elongates(4,5). Formation of the fin fold is accompanied by the synthesis of two rows of rigid, unmineralized fibrils called actinotrichia, which keep the fold straight(6,7) and guide the migration of mesenchymal cells within the fold(5,8). The actinotrichia are made of elastoidin, the components of which, apart from collagen, are unknown. Here we show that two zebrafish proteins, which we name actinodin 1 and 2 (And1 and And2), are essential structural components of elastoidin. The presence of actinodin sequences in several teleost fishes and in the elephant shark (Callorhinchus milii, which occupies a basal phylogenetic position), but not in tetrapods, suggests that these genes have been lost during tetrapod species evolution. Double gene knockdown of and1 and and2 in zebrafish embryos results in the absence of actinotrichia and impaired fin folds. Gene expression profiles in embryos lacking and1 and and2 function are consistent with pectoral fin truncation and may offer a potential explanation for the polydactyly observed in early tetrapod fossils. We propose that the loss of both actinodins and actinotrichia during evolution may have led to the loss of lepidotrichia and may have contributed to the fin-to-limb transition.	[Zhang, Jing; Wagh, Purva; Guay, Danielle; Akimenko, Marie-Andree] Univ Ottawa, Dept Biol, CAREG, Ottawa, ON K1N 6N5, Canada; [Sanchez-Pulido, Luis] Univ Oxford, Funct Genom Unit, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Padhi, Bhaja K.] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada; [Korzh, Vladimir] Inst Mol & Cell Biol, Singapore 138673, Singapore; [Andrade-Navarro, Miguel A.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	University of Ottawa; University of Oxford; Health Canada; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Akimenko, MA (corresponding author), Univ Ottawa, Dept Biol, CAREG, Ottawa, ON K1N 6N5, Canada.	makimen@uottawa.ca	Andrade, Miguel A/B-6565-2008; Korzh, Vladimir P/H-1596-2011	Andrade, Miguel A/0000-0001-6650-1711; Korzh, Vladimir P/0000-0002-6580-7986; Sanchez Pulido, Luis/0000-0002-2300-8502; Padhi, Bhaja Krushna/0000-0002-8705-9173	European Modular Biology Organization [ALT 325-2008]; Natural Science Engineering and Research Council of Canada; Canadian Institutes of Health Research; Canada Research Chairs; Helmholtz Alliance on Systems Biology; Agency for Science, Technology and Research of Singapore; MRC [MC_U137761446] Funding Source: UKRI; Medical Research Council [MC_U137761446] Funding Source: researchfish	European Modular Biology Organization; Natural Science Engineering and Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs(Canada Research ChairsCGIAR); Helmholtz Alliance on Systems Biology; Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors would like to thank I. Duran for technical advice, A. Maurya for assistance in the early stages of this work and M. Ekker, F. Avaron and M. Debiais for discussions and critical reading of the manuscript. L.S.-P. is supported by a European Modular Biology Organization Long-Term Fellowship (ALT 325-2008). This work was supported by grants to M.-A.A. from the Natural Science Engineering and Research Council of Canada and the Canadian Institutes of Health Research. M.A.A.-N. received funding from the Canada Research Chairs programme and from the Helmholtz Alliance on Systems Biology. V.K. received funding from the Agency for Science, Technology and Research of Singapore.	Ahn D, 2008, DEV BIOL, V322, P220, DOI 10.1016/j.ydbio.2008.06.032; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Avaron F, 2006, DEV DYNAM, V235, P478, DOI 10.1002/dvdy.20619; BOUVET J, 1974, ARCH ANAT MICROSC MO, V63, P79; Buscher D, 1997, MECH DEVELOP, V62, P175, DOI 10.1016/S0925-4773(97)00656-4; Choo BG, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-5; DAMODARAN M, 1956, BIOCHEM J, V62, P621, DOI 10.1042/bj0620621; DANE PJ, 1985, J EMBRYOL EXP MORPH, V87, P145; GARRAULT H, 1936, ARCH ANAT MICROSC, V130, P105; GERAUDIE J, 1977, J MORPHOL, V151, P353, DOI 10.1002/jmor.1051510304; GERAUDIE J, 1985, BIOL INVERTEBRATE LO, V451, P455; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; KIMURA S, 1966, J BIOCHEM-TOKYO, V60, P615, DOI 10.1093/oxfordjournals.jbchem.a128487; KIMURA S, 1986, COMP BIOCHEM PHYS B, V84, P305, DOI 10.1016/0305-0491(86)90081-7; KRUKENBERG CF, 1885, MITT ZOOL STAT NEAPE, V6, P286; Lang C, 1999, J CELL SCI, V112, P749; Long JA, 2004, PHYSIOL BIOCHEM ZOOL, V77, P700, DOI 10.1086/425183; Mao JH, 2009, DEV CELL, V16, P600, DOI 10.1016/j.devcel.2009.02.005; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Mercader N, 2007, DEV GROWTH DIFFER, V49, P421, DOI 10.1111/j.1440-169x.2007.00942.x; Nishidate M, 2007, DEV DYNAM, V236, P2685, DOI 10.1002/dvdy.21274; Padhi BK, 2004, DEV DYNAM, V231, P527, DOI 10.1002/dvdy.20153; Pizette S, 1999, DEVELOPMENT, V126, P883; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Smith A, 2008, DEV DYNAM, V237, P417, DOI 10.1002/dvdy.21417; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thummel R, 2006, DEV DYNAM, V235, P336, DOI 10.1002/dvdy.20630; Tyurina OV, 2005, DEV BIOL, V277, P537, DOI 10.1016/j.ydbio.2004.10.003; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; WOOD A, 1984, J CELL SCI, V66, P205; WOOD A, 1982, ANAT REC, V204, P349, DOI 10.1002/ar.1092040408; Zakany J, 2007, DEV BIOL, V306, P883, DOI 10.1016/j.ydbio.2007.03.517; Zhang Z, 2009, DEV CELL, V16, P607, DOI 10.1016/j.devcel.2009.02.008	35	92	95	3	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					234	U106		10.1038/nature09137	http://dx.doi.org/10.1038/nature09137			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20574421				2022-12-01	WOS:000279580800036
J	Knight, I; Bird, HA				Knight, Isobel; Bird, H. A.			A Patient's Journey Joint hypermobility syndrome	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bird, H. A.] Leeds Teaching Hosp NHS Trust, Leeds Gen Infirm, Leeds LS1 3EX, W Yorkshire, England	Leeds General Infirmary; University of Leeds		IKnight@laban.org; Howard.Bird@leedsth.nhs.uk							0	1	2	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 5	2010	341								c3044	10.1136/bmj.c3044	http://dx.doi.org/10.1136/bmj.c3044			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625DJ	20603316				2022-12-01	WOS:000279874000001
J	Humphries, NE; Queiroz, N; Dyer, JRM; Pade, NG; Musyl, MK; Schaefer, KM; Fuller, DW; Brunnschweiler, JM; Doyle, TK; Houghton, JDR; Hays, GC; Jones, CS; Noble, LR; Wearmouth, VJ; Southall, EJ; Sims, DW				Humphries, Nicolas E.; Queiroz, Nuno; Dyer, Jennifer R. M.; Pade, Nicolas G.; Musyl, Michael K.; Schaefer, Kurt M.; Fuller, Daniel W.; Brunnschweiler, Juerg M.; Doyle, Thomas K.; Houghton, Jonathan D. R.; Hays, Graeme C.; Jones, Catherine S.; Noble, Leslie R.; Wearmouth, Victoria J.; Southall, Emily J.; Sims, David W.			Environmental context explains Levy and Brownian movement patterns of marine predators	NATURE			English	Article							FLIGHT SEARCH PATTERNS; POWER-LAW DISTRIBUTIONS; WANDERING ALBATROSSES; STRATEGIES; BEHAVIOR; PACIFIC; SUCCESS; SPEED; OCEAN; PREY	An optimal search theory, the so-called Levy-flight foraging hypothesis(1), predicts that predators should adopt search strategies known as Levy flights where prey is sparse and distributed unpredictably, but that Brownian movement is sufficiently efficient for locating abundant prey(2-4). Empirical studies have generated controversy because the accuracy of statistical methods that have been used to identify Levy behaviour has recently been questioned(5,6). Consequently, whether foragers exhibit Levy flights in the wild remains unclear. Crucially, moreover, it has not been tested whether observed movement patterns across natural landscapes having different expected resource distributions conform to the theory's central predictions. Here we use maximum-likelihood methods to test for Levy patterns in relation to environmental gradients in the largest animal movement data set assembled for this purpose. Strong support was found for Levy search patterns across 14 species of open-ocean predatory fish (sharks, tuna, billfish and ocean sunfish), with some individuals switching between Levy and Brownian movement as they traversed different habitat types. We tested the spatial occurrence of these two principal patterns and found Levy behaviour to be associated with less productive waters (sparser prey) and Brownian movements to be associated with productive shelf or convergence-front habitats (abundant prey). These results are consistent with the Levy-flight foraging hypothesis(1,7), supporting the contention(8,9) that organism search strategies naturally evolved in such a way that they exploit optimal Levy patterns.	[Humphries, Nicolas E.; Queiroz, Nuno; Dyer, Jennifer R. M.; Pade, Nicolas G.; Wearmouth, Victoria J.; Southall, Emily J.; Sims, David W.] Marine Biol Assoc UK, The Lab, Plymouth PL1 2PB, Devon, England; [Humphries, Nicolas E.; Sims, David W.] Univ Plymouth, Sch Marine Sci & Engn, Inst Marine, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Queiroz, Nuno] Univ Porto, CIBIO, P-4485668 Vairao, Portugal; [Queiroz, Nuno; Pade, Nicolas G.; Jones, Catherine S.; Noble, Leslie R.] Univ Aberdeen, Sch Biol Sci, Inst Biol & Environm Sci, Aberdeen AB24 2TZ, Scotland; [Musyl, Michael K.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Kewalo Res Facil, NOAA Fisheries, Honolulu, HI 96814 USA; [Schaefer, Kurt M.; Fuller, Daniel W.] Interamer Trop Tuna Commiss, La Jolla, CA 92037 USA; [Brunnschweiler, Juerg M.] ETH, CH-8092 Zurich, Switzerland; [Doyle, Thomas K.] Univ Coll Cork, Glucksman Marine Facil, ERI, Coastal & Marine Resources Ctr, Cork, Ireland; [Houghton, Jonathan D. R.] Queens Univ Belfast, Ctr Med Biol, Sch Biol Sci, Belfast BT9 7BL, Antrim, North Ireland; [Hays, Graeme C.] Swansea Univ, Inst Environm Sustainabil, Dept Pure & Appl Ecol, Swansea SA2 8PP, W Glam, Wales	Marine Biological Association United Kingdom; University of Plymouth; Universidade do Porto; University of Aberdeen; National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; University of Hawaii Manoa; Swiss Federal Institutes of Technology Domain; ETH Zurich; University College Cork; Queens University Belfast; Swansea University	Sims, DW (corresponding author), Marine Biol Assoc UK, The Lab, Citadel Hill, Plymouth PL1 2PB, Devon, England.	dws@mba.ac.uk	Queiroz, Nuno/G-3850-2010; Brunnschweiler, Juerg/A-2110-2008; SOUTHALL, EMILY J/AGP-5395-2022; Humphries, Nick/AAE-7170-2019	Queiroz, Nuno/0000-0002-3860-7356; Brunnschweiler, Juerg/0000-0002-9901-3279; SOUTHALL, EMILY J/0000-0001-7246-278X; Humphries, Nick/0000-0003-3741-1594; Hays, Graeme/0000-0002-3314-8189; Sims, David/0000-0002-0916-7363; Pade, Nicolas/0000-0003-2733-9752; Noble, leslie/0000-0003-3076-0759; Doyle, Thomas/0000-0003-1616-5590	UK Natural Environment Research Council (NERC); Save Our Seas Foundation; Leverhulme Trust; UK Department for Environment Food and Rural Affairs, Fundacao para a Ciencia e a Tecnologia [SFRH/BD/21354/2005]; UK Royal Society; Fisheries Society of the British Isles; Udaras na Gaeltachta; Taighde Mara Teo; Marine Institute (Ireland); Irish Research Council for Science Engineering and Technology; Shark Foundation Switzerland; University of Aberdeen; PADI Project; Japan Fisheries Agency; US Tuna Foundation; Tagging of Pacific Pelagics programme in the Census of Marine Life; National Oceanic and Atmospheric Administration (US Department of Commerce) [NA37RJ0199, NA67RJ0154]; University of Hawaii [NA37RJ0199, NA67RJ0154]; Royal Society; Marine Biological Association of the UK; UK NERC; NERC [mba010004] Funding Source: UKRI; Natural Environment Research Council [mba010004] Funding Source: researchfish	UK Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Save Our Seas Foundation; Leverhulme Trust(Leverhulme Trust); UK Department for Environment Food and Rural Affairs, Fundacao para a Ciencia e a Tecnologia(Department for Environment, Food & Rural Affairs (DEFRA)Portuguese Foundation for Science and Technology); UK Royal Society(Royal Society of London); Fisheries Society of the British Isles; Udaras na Gaeltachta; Taighde Mara Teo; Marine Institute (Ireland); Irish Research Council for Science Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); Shark Foundation Switzerland; University of Aberdeen; PADI Project; Japan Fisheries Agency(Fisheries Research Agency - Japan); US Tuna Foundation; Tagging of Pacific Pelagics programme in the Census of Marine Life; National Oceanic and Atmospheric Administration (US Department of Commerce)(National Oceanic Atmospheric Admin (NOAA) - USA); University of Hawaii; Royal Society(Royal Society of London); Marine Biological Association of the UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was facilitated through the European Tracking of Predators in the Atlantic programme in the European Census of Marine Life. Funding was provided by the UK Natural Environment Research Council (NERC) Oceans 2025 Strategic Research Programme (Theme 6 Science for Sustainable Marine Resources), the Save Our Seas Foundation, the Leverhulme Trust, the UK Department for Environment Food and Rural Affairs, Fundacao para a Ciencia e a Tecnologia grant SFRH/BD/21354/2005, the UK Royal Society, the Fisheries Society of the British Isles, the Udaras na Gaeltachta, the Taighde Mara Teo, the Marine Institute (Ireland), the Irish Research Council for Science Engineering and Technology, the Shark Foundation Switzerland, a University of Aberdeen Scholarship and PADI Project Aware. The tuna research of K. M. S. and D. W. F. was made possible through financial contributions by the Japan Fisheries Agency, the US Tuna Foundation and the Tagging of Pacific Pelagics programme in the Census of Marine Life. M. K. M. was funded by Cooperative Agreements NA37RJ0199 and NA67RJ0154 between the National Oceanic and Atmospheric Administration (US Department of Commerce) and the Pelagic Fisheries Research Program (University of Hawaii). The authors or their agencies do not necessarily approve, recommend or endorse any proprietary hardware or software mentioned in this publication. The views expressed herein are those of the authors and do not necessarily reflect the views of their agencies. For field assistance, D. W. S. thanks P. Harris and D. Uren; T. K. D. thanks V. Roantree, M. Norman, M. Lilley and P. F. O'Suilleabhain; J. M. B. thanks G. Adkison, J.-P. Botha, H. Baensch and A. Cumming. D. W. S. and N. E. H. thank A. Clauset and J. Pitchford for help with maximum-likelihood estimation and log-likelihoods, and E. P. White for manuscript comments. This research complied with all animal welfare laws of the countries or sovereign territories in which it was conducted. C. S. J. was supported by a Royal Society of Edinburgh Sabbatical Fellowship, G. C. H. by a Ray Lankester Investigatorship from the Marine Biological Association of the UK (MBA) and D. W. S. by a UK NERC-funded MBA Senior Research Fellowship.	Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Bartumeus F, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/43/434002; Bartumeus F, 2007, FRACTALS, V15, P151, DOI 10.1142/S0218348X07003460; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Buchanan M, 2008, NATURE, V453, P714, DOI 10.1038/453714a; CLARKE MR, 1974, J MAR BIOL ASSOC UK, V54, P949, DOI 10.1017/S0025315400057672; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; CORNELIUS JM, 1991, ECOLOGY, V72, P2057, DOI 10.2307/1941559; Edwards AM, 2008, J ANIM ECOL, V77, P1212, DOI 10.1111/j.1365-2656.2008.01428.x; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Kashtan N, 2007, P NATL ACAD SCI USA, V104, P13711, DOI 10.1073/pnas.0611630104; Moteki M, 2001, FISHERIES SCI, V67, P1063, DOI 10.1046/j.1444-2906.2001.00362.x; POWELL TM, 1975, SCIENCE, V189, P1088, DOI 10.1126/science.189.4208.1088; Shlesinger M. F., 1986, On Growth and Form - Fractal and Non-Fractal Patterns in Physics. Proceedings of the NATO Advanced Study Institute, P279; SHLESINGER MF, 1993, NATURE, V363, P31, DOI 10.1038/363031a0; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sims DW, 2007, J ANIM ECOL, V76, P222, DOI 10.1111/j.1365-2656.2006.01208.x; Sims DW, 2006, P ROY SOC B-BIOL SCI, V273, P1195, DOI 10.1098/rspb.2005.3444; Travis J, 2007, SCIENCE, V318, P742, DOI 10.1126/science.318.5851.742; Viswanathan GM, 2008, PHYS LIFE REV, V5, P133, DOI 10.1016/j.plrev.2008.03.002; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Viswanathan GM, 2000, PHYSICA A, V282, P1, DOI 10.1016/S0378-4371(00)00071-6; White EP, 2008, ECOLOGY, V89, P905, DOI 10.1890/07-1288.1; Zainuddin M, 2006, DEEP-SEA RES PT II, V53, P419, DOI 10.1016/j.dsr2.2006.01.007	29	598	605	10	258	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1066	1069		10.1038/nature09116	http://dx.doi.org/10.1038/nature09116			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20531470	Green Accepted			2022-12-01	WOS:000279056900050
J	Kuba, H; Oichi, Y; Ohmori, H				Kuba, Hiroshi; Oichi, Yuki; Ohmori, Harunori			Presynaptic activity regulates Na+ channel distribution at the axon initial segment	NATURE			English	Article							STEM AUDITORY NUCLEI; ACTION-POTENTIAL INITIATION; AFFERENT INFLUENCES; PYRAMIDAL NEURONS; INTRINSIC EXCITABILITY; N-MAGNOCELLULARIS; COCHLEA REMOVAL; SODIUM-CHANNELS; CHICKEN; SYSTEM	Deprivation of afferent inputs in neural circuits leads to diverse plastic changes in both pre- and postsynaptic elements that restore neural activity(1). The axon initial segment (AIS) is the site at which neural signals arise(2,3), and should be the most efficient site to regulate neural activity. However, none of the plasticity currently known involves the AIS. We report here that deprivation of auditory input in an avian brainstem auditory neuron leads to an increase in AIS length, thus augmenting the excitability of the neuron. The length of the AIS, defined by the distribution of voltage-gated Na+ channels and the AIS anchoring protein, increased by 1.7 times in seven days after auditory input deprivation. This was accompanied by an increase in the whole-cell Na+ current, membrane excitability and spontaneous firing. Our work demonstrates homeostatic regulation of the AIS, which may contribute to the maintenance of the auditory pathway after hearing loss. Furthermore, plasticity at the spike initiation site suggests a powerful pathway for refining neuronal computation in the face of strong sensory deprivation.	[Kuba, Hiroshi; Oichi, Yuki] Kyoto Univ, Grad Sch Med, Career Path Promot Unit Young Life Scientists, Kyoto 6068501, Japan; [Ohmori, Harunori] Kyoto Univ, Grad Sch Med, Dept Physiol, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Kuba, H (corresponding author), Kyoto Univ, Grad Sch Med, Career Path Promot Unit Young Life Scientists, Kyoto 6068501, Japan.	kuba@nbiol.med.kyoto-u.ac.jp	Kuba, Hiroshi/I-7519-2014	Ohmori, Harunori/0000-0002-4319-4947	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank G. Alcaraz for providing ankyrin-G antibody. We also thank L. O. Trussell for advice and for editing the manuscript; M. N. Rasband, T. M. Ishii and R. Yamada for reading the manuscript; and K. Bender for discussions. This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan, to H.K. and H.O.	Bender KJ, 2009, NEURON, V61, P259, DOI 10.1016/j.neuron.2008.12.004; Berardi N, 2000, CURR OPIN NEUROBIOL, V10, P138, DOI 10.1016/S0959-4388(99)00047-1; BORN DE, 1991, BRAIN RES, V557, P37, DOI 10.1016/0006-8993(91)90113-A; BORN DE, 1985, J COMP NEUROL, V231, P435, DOI 10.1002/cne.902310403; Bouzidi M, 2002, J BIOL CHEM, V277, P28996, DOI 10.1074/jbc.M201760200; Cerminara NL, 2004, J NEUROSCI, V24, P4510, DOI 10.1523/JNEUROSCI.4530-03.2004; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; JHAVERI S, 1982, NEUROSCIENCE, V7, P809, DOI 10.1016/0306-4522(82)90045-8; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Khaliq ZM, 2006, J NEUROSCI, V26, P1935, DOI 10.1523/JNEUROSCI.4664-05.2006; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Kuba H, 2006, NATURE, V444, P1069, DOI 10.1038/nature05347; Kuba H, 2009, J PHYSIOL-LONDON, V587, P87, DOI 10.1113/jphysiol.2008.162651; KUBKE MF, 1998, HEARING RES, V147, P1; Lu Y, 2004, J COMP NEUROL, V470, P93, DOI 10.1002/cne.11037; Lu Y, 2007, J NEUROPHYSIOL, V97, P635, DOI 10.1152/jn.00915.2006; Nelson SB, 2008, NEURON, V60, P477, DOI 10.1016/j.neuron.2008.10.020; Ogawa Y, 2008, CURR OPIN NEUROBIOL, V18, P307, DOI 10.1016/j.conb.2008.08.008; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; RUBEL EW, 1975, J COMP NEUROL, V164, P411, DOI 10.1002/cne.901640403; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; SHERMAN SJ, 1984, P NATL ACAD SCI-BIOL, V81, P262, DOI 10.1073/pnas.81.1.262; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; TUCCI DL, 1985, J COMP NEUROL, V238, P371, DOI 10.1002/cne.902380402; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Xu J, 2005, J NEUROSCI, V25, P1750, DOI 10.1523/JNEUROSCI.4217-04.2005; Zeng CH, 2009, J NEUROSCI, V29, P4210, DOI 10.1523/JNEUROSCI.0208-09.2009	30	286	287	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1075	U136		10.1038/nature09087	http://dx.doi.org/10.1038/nature09087			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20543825				2022-12-01	WOS:000279056900052
J	Stulberg, JJ; Delaney, CP; Neuhauser, DV; Aron, DC; Fu, PF; Koroukian, SM				Stulberg, Jonah J.; Delaney, Conor P.; Neuhauser, Duncan V.; Aron, David C.; Fu, Pingfu; Koroukian, Siran M.			Adherence to Surgical Care Improvement Project Measures and the Association With Postoperative Infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERFORMANCE-MEASURES; COLORECTAL SURGERY; CLINICAL-OUTCOMES; HOSPITAL QUALITY; MORTALITY-RATES; SITE INFECTION; CO-MORBIDITY; COMPLICATIONS; PREVENTION; ICD-9-CM	Context The Surgical Care Improvement Project (SCIP) aims to reduce surgical infectious complication rates through measurement and reporting of 6 infection-prevention process-of-care measures. However, an association between SCIP performance and clinical outcomes has not been demonstrated. Objective To examine the relationship between SCIP infection-prevention process-of-care measures and postoperative infection rates. Design, Setting, Participants A retrospective cohort study, using Premier Inc's Perspective Database for discharges between July 1, 2006 and March 31, 2008, of 405 720 patients (69% white and 11% black; 46% Medicare patients; and 68% elective surgical cases) from 398 hospitals in the United States for whom SCIP performance was recorded and submitted for public report on the Hospital Compare Web site. Three original infection-prevention measures (S-INF-Core) and all 6 infection-prevention measures (S-INF) were aggregated into 2 separate all-or-none composite scores. Hierarchical logistical models were used to assess process-of-care relationships at the patient level while accounting for hospital characteristics. Main Outcome Measure The ability of reported adherence to SCIP infection-prevention process-of-care measures (using the 2 composite scores of S-INF and S-INF-Core) to predict postoperative infections. Results There were 3996 documented postoperative infections. The S-INF composite process-of-care measure predicted a decrease in postoperative infection rates from 14.2 to 6.8 per 1000 discharges (adjusted odds ratio, 0.85; 95% confidence interval, 0.76-0.95). The S-INF-Core composite process-of-care measure predicted a decrease in postoperative infection rates from 11.5 to 5.3 per 1000 discharges (adjusted odds ratio, 0.86; 95% confidence interval, 0.74-1.01), which was not a statistically significantly lower probability of infection. None of the individual SCIP measures were significantly associated with a lower probability of infection. Conclusions Among hospitals in the Premier Inc Perspective Database reporting SCIP performance, adherence measured through a global all-or-none composite infection-prevention score was associated with a lower probability of developing a postoperative infection. However, adherence reported on individual SCIP measures, which is the only form in which performance is publicly reported, was not associated with a significantly lower probability of infection. JAMA. 2010; 303(24): 2479-2485 www.jama.com	[Stulberg, Jonah J.; Neuhauser, Duncan V.; Aron, David C.; Fu, Pingfu; Koroukian, Siran M.] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Stulberg, Jonah J.; Delaney, Conor P.] Univ Hosp, Case Med Ctr, Dept Surg, Div Colorectal Surg, Cleveland, OH 44106 USA; [Aron, David C.] Vet Affairs Med Ctr, Louis Stokes Cleveland Dept, VA HSR&D Ctr Qual Improvement Res, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Stulberg, JJ (corresponding author), Univ Hosp, Case Med Ctr, Dept Surg, Div Colorectal Surg, 11100 Euclid Ave,LKS 7,MS 5047, Cleveland, OH 44106 USA.	Jonah.Stulberg@case.edu	Fu, Pingfu/O-5415-2019; Koroukian, Siran/S-9127-2019; Stulberg, Jonah/I-7434-2012; Stulberg, Jonah/J-8713-2019	Fu, Pingfu/0000-0002-2334-5218; Koroukian, Siran/0000-0002-8106-9581; Stulberg, Jonah/0000-0001-9971-8693	Agency for Healthcare Research and Quality [T32 HS00059]; National Cancer Institute [K07 CA96705]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000059] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K07CA096705] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding/Support: Dr Stulberg was supported, in part, by grant T32 HS00059 from the Agency for Healthcare Research and Quality. Dr Koroukian was supported by career development award K07 CA96705 from the National Cancer Institute at the time this study was conducted.	Birkmeyer JD, 2004, J AM COLL SURGEONS, V198, P626, DOI 10.1016/j.jamcollsurg.2003.11.017; Birkmeyer JD, 2009, ANNU REV MED, V60, P405, DOI 10.1146/annurev.med.60.062107.101214; Bratzler DW, 2006, AM SURGEON, V72, P1010; Bratzler DW, 2006, CLIN INFECT DIS, V43, P322, DOI 10.1086/505220; Bratzler DW, 2005, AM J SURG, V189, P395, DOI 10.1016/j.amjsurg.2005.01.015; Centers for Medicare & Medicaid Services, SPEC MAN NAT HOSP IN; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chung ES, 2008, AM J MED QUAL, V23, P168, DOI 10.1177/1062860608315337; Clancy Carolyn M, 2008, AORN J, V87, P621, DOI 10.1016/j.aorn.2008.02.007; Delaney CP, 2008, ANN SURG, V247, P819, DOI 10.1097/SLA.0b013e31816d950e; Delaney CP, 2001, BRIT J SURG, V88, P1533, DOI 10.1046/j.0007-1323.2001.01905.x; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dimick JB, 2003, SURGERY, V134, P534, DOI 10.1016/S0039-6060(03)00273-3; Dimick JB, 2004, JAMA-J AM MED ASSOC, V292, P847, DOI 10.1001/jama.292.7.847; ELBADAWI K, 2009, ANN M AM SOC COL REC; Fonarow Gregg C, 2007, Congest Heart Fail, V13, P342, DOI 10.1111/j.1527-5299.2007.07233.x; Hawn MT, 2008, J AM COLL SURGEONS, V206, P814, DOI 10.1016/j.jamcollsurg.2007.12.013; Jha AK, 2007, HEALTH AFFAIR, V26, P1104, DOI 10.1377/hlthaff.26.4.1104; *JOINT COMM, 2008 CERT QUAL REP U; Lawthers AG, 2000, MED CARE, V38, P785, DOI 10.1097/00005650-200008000-00003; Leibson CL, 2008, MED CARE, V46, P127, DOI 10.1097/MLR.0b013e3181589b92; McCarthy EP, 2000, MED CARE, V38, P868, DOI 10.1097/00005650-200008000-00010; MCGLYNN EA, 2003, MED CARE S, V41, P1; Nguyen N, 2008, AM SURGEON, V74, P1012; Nolan T, 2006, JAMA-J AM MED ASSOC, V295, P1168, DOI 10.1001/jama.295.10.1168; Olsen MA, 2008, J AM COLL SURGEONS, V207, P326, DOI 10.1016/j.jamcollsurg.2008.04.021; PASTOR C, 2009, ANN M AM SOC COL REC; Premier inc, PREM PERSP DAT; *QMIS, QUAL NET; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; STRAUBE B, 2005, HLTH AFF MILLWOOD; *US DEP HHS, HOSP COMP QUAL TOOL; US Department of Health and Human Services, 2003, OCR PRIV BRIEF SUMM; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	35	391	394	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2010	303	24					2479	2485		10.1001/jama.2010.841	http://dx.doi.org/10.1001/jama.2010.841			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	613VM	20571014	Bronze			2022-12-01	WOS:000279010900025
J	Ameres, SL; Horwich, MD; Hung, JH; Xu, J; Ghildiyal, M; Weng, ZP; Zamore, PD				Ameres, Stefan L.; Horwich, Michael D.; Hung, Jui-Hung; Xu, Jia; Ghildiyal, Megha; Weng, Zhiping; Zamore, Phillip D.			Target RNA-Directed Trimming and Tailing of Small Silencing RNAs	SCIENCE			English	Article							PIWI-INTERACTING RNAS; DISTINCT MECHANISMS; ENDOGENOUS SIRNAS; STRUCTURAL BASIS; MESSENGER-RNA; RECOGNITION; ARGONAUTE2; MICRORNAS; 2'-O-METHYLATION; URIDYLATION	In Drosophila, microRNAs (miRNAs) typically guide Argonaute1 to repress messenger RNA (mRNA), whereas small interfering RNAs (siRNAs) guide Argonaute2 to destroy viral and transposon RNA. Unlike siRNAs, miRNAs rarely form extensive numbers of base pairs to the mRNAs they regulate. We find that extensive complementarity between a target RNA and an Argonaute1-bound miRNA triggers miRNA tailing and 3'-to-5' trimming. In flies, Argonaute2-bound small RNAs-but not those bound to Argonaute1-bear a 2'-O-methyl group at their 3' ends. This modification blocks target-directed small RNA remodeling: In flies lacking Hen1, the enzyme that adds the 2'-O-methyl group, Argonaute2-associated siRNAs are tailed and trimmed. Target complementarity also affects small RNA stability in human cells. These results provide an explanation for the partial complementarity between animal miRNAs and their targets.	[Ameres, Stefan L.; Horwich, Michael D.; Ghildiyal, Megha; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Ameres, Stefan L.; Horwich, Michael D.; Ghildiyal, Megha; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Hung, Jui-Hung; Xu, Jia] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Boston University; University of Massachusetts System; University of Massachusetts Worcester	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA.	phillip.zamore@umassmed.edu	Ghildiyal, Megha/F-7980-2014; Hung, Jui-Hung/G-2673-2012; Ameres, Stefan/G-3775-2010; Zamore, Phillip D/A-8941-2013; Xu, Jia/F-7750-2012; Ameres, Stefan L./B-4046-2012	Hung, Jui-Hung/0000-0003-2208-9213; Ameres, Stefan L./0000-0002-8248-3098; Xu, Jia/0000-0003-3921-018X; Zamore, Phillip/0000-0002-4505-9618	National Institute on Aging NRSA [F30AG030283]; EMBO [ALTF 522-2008]; Austrian Science Fund (FWF) [J2832-B09]; NIH [GM62862, GM65236]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065236, R01GM062862, R37GM062862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG030283] Funding Source: NIH RePORTER	National Institute on Aging NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EMBO(European Molecular Biology Organization (EMBO)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Ma and A. Boucher for help with fly husbandry, G. Farley for technical assistance, E. Pfister for cloning of miR-16 and miR-21 reporter constructs, and members of the Zamore lab for advice, suggestions, and critical comments on the manuscript. Sequence data are available through the NCBI Short Read Archive (www.ncbi.nlm.nih.gov/sites/sra) as GSM278704 (ago2414), SRA010045 (hen1<SUP>f00810</SUP> National Institute on Aging NRSA grant F30AG030283 (M. D. H.), and HeLa cell data), and GSE18806 (Oregon R). Supported by EMBO long-term fellowship ALTF 522-2008, Austrian Science Fund (FWF) Erwin Schrodinger-Auslandsstipendium J2832-B09 (S. L. A.), and NIH grants GM62862 and GM65236 (P.D.Z.). P.D.Z. is a member of the scientific advisory board of Regulus Therapeutics.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brodersen P, 2009, NAT REV MOL CELL BIO, V10, P141, DOI 10.1038/nrm2619; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Ghildiyal M, 2010, RNA, V16, P43, DOI 10.1261/rna.1972910; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Iwasaki S, 2009, MOL CELL, V34, P58, DOI 10.1016/j.molcel.2009.02.010; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kurth HM, 2009, RNA, V15, P675, DOI 10.1261/rna.1455509; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Ohara T, 2007, NAT STRUCT MOL BIOL, V14, P349, DOI 10.1038/nsmb1220; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P581, DOI 10.1038/nsmb.1438; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Okamura K, 2009, MOL CELL, V36, P431, DOI 10.1016/j.molcel.2009.09.027; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; PELISSON A, 1951, J VIROL, V81, P2007; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Sempere LF, 2002, DEV BIOL, V244, P170, DOI 10.1006/dbio.2002.0594; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; van Wolfswinkel JC, 2009, CELL, V139, P135, DOI 10.1016/j.cell.2009.09.012; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130	42	391	420	2	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 18	2010	328	5985					1534	1539		10.1126/science.1187058	http://dx.doi.org/10.1126/science.1187058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611XW	20558712	Green Accepted			2022-12-01	WOS:000278859200040
J	Bonetta, L				Bonetta, Laura			Whole-Genome Sequencing Breaks the Cost Barrier	CELL			English	Editorial Material																			0	37	38	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 11	2010	141	6					917	919		10.1016/j.cell.2010.05.034	http://dx.doi.org/10.1016/j.cell.2010.05.034			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550926	Bronze			2022-12-01	WOS:000278618800005
J	Newman, RD				Newman, Robert D.			Malaria control beyond 2010	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED-TRIAL; MICROSCOPY; RESISTANCE; MANAGEMENT; CHILDREN		WHO, CH-1211 Geneva 27, Switzerland	World Health Organization	Newman, RD (corresponding author), WHO, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	newmanr@who.int						Amin AA, 2007, J CLIN PHARM THER, V32, P429, DOI 10.1111/j.1365-2710.2007.00847.x; Ansah EK, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c930; Bisoffi Z, 2009, TROP MED INT HEALTH, V14, P491, DOI 10.1111/j.1365-3156.2009.02246.x; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Mita T, 2009, PARASITOL INT, V58, P201, DOI 10.1016/j.parint.2009.04.004; Newton PN, 2006, LANCET INFECT DIS, V6, P602, DOI 10.1016/S1473-3099(06)70581-3; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; Roll Back Malaria, 2010, MAL FUND RES UT 1 DE; Roll Back Malaria Partnership, 2008, GLOB MAL ACT PLAN; *WHO, WORLD MAL REP 2009; World Health Organization, 2008, MAL RAP DIAGN TEST P; World Health Organization (WHO), 2010, GUID TREATM MAL; Zurovac D, 2006, TROP MED INT HEALTH, V11, P432, DOI 10.1111/j.1365-3156.2006.01587.x	15	6	7	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 11	2010	340								c2714	10.1136/bmj.c2714	http://dx.doi.org/10.1136/bmj.c2714			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611MH	20543011				2022-12-01	WOS:000278818900002
J	Tian, Y; Li, ZP; Hu, WQ; Ren, HY; Tian, E; Zhao, Y; Lu, Q; Huang, XX; Yang, PG; Li, X; Wang, XC; Kovacs, AL; Yu, L; Zhang, H				Tian, Ye; Li, Zhipeng; Hu, Wanqiu; Ren, Haiyan; Tian, E.; Zhao, Yu; Lu, Qun; Huang, Xinxin; Yang, Peiguo; Li, Xin; Wang, Xiaochen; Kovacs, Attila L.; Yu, Li; Zhang, Hong			C. elegans Screen Identifies Autophagy Genes Specific to Multicellular Organisms	CELL			English	Article							PANCREATITIS; VACUOLES	The molecular understanding of autophagy has originated almost exclusively from yeast genetic studies. Little is known about essential autophagy components specific to higher eukaryotes. Here we perform genetic screens in C. elegans and identify four metazoan-specific autophagy genes, named epg-2, -3, -4, and -5. Genetic analysis reveals that epg-2, -3, -4, and -5 define discrete genetic steps of the autophagy pathway. epg-2 encodes a coiled-coil protein that functions in specific autophagic cargo recognition. Mammalian homologs of EPG-3/VMP1, EPG-4/EI24, and EPG-5/mEPG5 are essential for starvation-induced autophagy. VMP1 regulates autophagosome formation by controlling the duration of omegasomes. EI24 and mEPG5 are required for formation of degradative autolysosomes. This study establishes C. elegans as a multicellular genetic model to delineate the autophagy pathway and provides mechanistic insights into the metazoan-specific autophagic process.	[Hu, Wanqiu; Yu, Li] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci, Beijing 100084, Peoples R China; [Tian, Ye; Li, Zhipeng; Ren, Haiyan; Tian, E.; Zhao, Yu; Lu, Qun; Huang, Xinxin; Yang, Peiguo; Li, Xin; Wang, Xiaochen; Zhang, Hong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Tian, Ye] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Kovacs, Attila L.] Eotvos Lorand Univ, Dept Anat Cell & Dev Biol, H-1117 Budapest, Hungary	Tsinghua University; National Institute of Biological Sciences, Beijing; Beijing Normal University; Eotvos Lorand University	Yu, L (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci, Beijing 100084, Peoples R China.	liyulab@mail.tsinghua.edu.cn; zhanghong@nibs.ac.cn	ren, haiyan/A-8907-2015; Lu, Qun/O-2978-2018	Zhang, Hong/0000-0002-3342-5377; Li, Zhipeng/0000-0001-8806-9667; Huang, Xinxin/0000-0002-4298-4859; Tian, Ye/0000-0002-7675-9270; ren, haiyan/0000-0001-9995-3255; YANG, PEIGUO/0000-0002-2334-5664	National High Technology Projects 863 [2008AA022306]; Hungarian Scientific Research Funds [OTKA K75843]	National High Technology Projects 863(National High Technology Research and Development Program of China); Hungarian Scientific Research Funds(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	We thank Dr Xiaodong Wang for comments on the manuscript; Edvard Burghardt, Mariann Sarody, Fan Wu, Tao Sun, and Hui Zhang for technical assistance; Dr. Shohei Mitani for epg-5(tm3425); Dr. Gang Zhi and the NIBS antibody facility for preparing antibodies; and Dr. Isabel Hanson for editing services. This work was supported by the National High Technology Projects 863 (2008AA022306) (H.Z.) and Hungarian Scientific Research Funds OTKA K75843 (A.L.K.).	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Dusetti NJ, 2002, BIOCHEM BIOPH RES CO, V290, P641, DOI 10.1006/bbrc.2001.6244; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Gu ZM, 2000, MOL CELL BIOL, V20, P233, DOI 10.1128/MCB.20.1.233-241.2000; Hayashi-Nishino M, 2009, NAT CELL BIOL, V11, P1433, DOI 10.1038/ncb1991; Kovacs AL, 2010, FEBS LETT, V584, P1335, DOI 10.1016/j.febslet.2010.02.002; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39; Melendez A, 2008, DEVELOPMENT, V135, P2347, DOI 10.1242/dev.016105; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Ropolo A, 2007, J BIOL CHEM, V282, P37124, DOI 10.1074/jbc.M706956200; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Sigmond T, 2008, METHOD ENZYMOL, V451, P467, DOI 10.1016/S0076-6879(08)03228-X; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Vazquez CL, 2009, METHOD ENZYMOL, V452, P85, DOI 10.1016/S0076-6879(08)03606-9; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yla-Anttila P, 2009, AUTOPHAGY, V5, P1180; YU L, 2010, NATURE IN PRESS, DOI DOI 10.1038/NATURE09076; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022	24	300	318	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					1042	1055		10.1016/j.cell.2010.04.034	http://dx.doi.org/10.1016/j.cell.2010.04.034			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550938	Bronze			2022-12-01	WOS:000278618800018
J	Hirsch, IB; Brownlee, M				Hirsch, Irl B.; Brownlee, Michael			Beyond Hemoglobin A(1c)-Need for Additional Markers of Risk for Diabetic Microvascular Complications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GLUCOSE VARIABILITY; INTENSIVE TREATMENT; PROGRESSION; MELLITUS		[Hirsch, Irl B.] Univ Washington, Med Ctr Roosevelt, Div Metab Endocrinol & Nutr, Sch Med, Seattle, WA 98105 USA; [Hirsch, Irl B.] Univ Washington, Diabet Care Ctr, Seattle, WA 98105 USA; [Brownlee, Michael] Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10467 USA; [Brownlee, Michael] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Brownlee, Michael] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Hirsch, IB (corresponding author), Univ Washington, Med Ctr Roosevelt, Div Metab Endocrinol & Nutr, Sch Med, 4225 Roosevelt Way NE,Ste 101, Seattle, WA 98105 USA.	ihirsch@uw.edu						Brasacchio D, 2009, DIABETES, V58, P1229, DOI 10.2337/db08-1666; Brownlee M, 2006, JAMA-J AM MED ASSOC, V295, P1707, DOI 10.1001/jama.295.14.1707; Cohen RA, 1999, AM J MED, V107, P45, DOI 10.1016/S0002-9343(99)00165-5; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; Kilpatrick ES, 2006, DIABETES CARE, V29, P1486, DOI 10.2337/dc06-0293; Kovatchev BP, 2006, DIABETES CARE, V29, P2433, DOI 10.2337/dc06-1085; Lachin JM, 2008, DIABETES, V57, P995, DOI 10.2337/db07-1618; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017; Villeneuve LM, 2008, P NATL ACAD SCI USA, V105, P9047, DOI 10.1073/pnas.0803623105	10	116	121	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2010	303	22					2291	2292		10.1001/jama.2010.785	http://dx.doi.org/10.1001/jama.2010.785			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	607IY	20530784				2022-12-01	WOS:000278496800030
J	Boal, AK; Cotruvo, JA; Stubbe, J; Rosenzweig, AC				Boal, Amie K.; Cotruvo, Joseph A., Jr.; Stubbe, JoAnne; Rosenzweig, Amy C.			Structural Basis for Activation of Class Ib Ribonucleotide Reductase	SCIENCE			English	Article							SOLUBLE METHANE MONOOXYGENASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; RADICAL COFACTOR; ACTIVE FORM; FLAVODOXIN; MANGANESE; SUBUNIT; PROTEIN; IRON	The class Ib ribonucleotide reductase of Escherichia coli can initiate reduction of nucleotides to deoxynucleotides with either a Mn-2(III)-tyrosyl radical (Y center dot) or a Fe-2(III)-Y center dot cofactor in the NrdF subunit. Whereas Fe-2(III)-Y center dot can self-assemble from Fe-2(II)-NrdF and O-2, activation of Mn-2(II)-NrdF requires a reduced flavoprotein, NrdI, proposed to form the oxidant for cofactor assembly by reduction of O-2. The crystal structures reported here of E. coli Mn-2(II)-NrdF and Fe-2(II)-NrdF reveal different coordination environments, suggesting distinct initial binding sites for the oxidants during cofactor activation. In the structures of Mn-2(II)-NrdF in complex with reduced and oxidized NrdI, a continuous channel connects the NrdI flavin cofactor to the NrdF Mn-2(II) active site. Crystallographic detection of a putative peroxide in this channel supports the proposed mechanism of Mn-2(III)-Y center dot cofactor assembly.	[Cotruvo, Joseph A., Jr.; Stubbe, JoAnne] MIT, Dept Chem, Cambridge, MA 02139 USA; [Boal, Amie K.; Rosenzweig, Amy C.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Boal, Amie K.; Rosenzweig, Amy C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Stubbe, JoAnne] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Northwestern University; Northwestern University; Massachusetts Institute of Technology (MIT)	Stubbe, J (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	stubbe@mit.edu; amyr@northwestern.edu	Cotruvo, Joseph/N-5127-2019; Johnson, Michael D. L./B-4352-2012; Cotruvo, Joseph A/C-5700-2019	Cotruvo, Joseph A/0000-0003-4243-8257	NIH [GM58518, GM81393]; American Cancer Society [PF-10-148-01-DMC]; National Defense Science and Engineering Graduate fellowship; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058518, R01GM081393] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); National Defense Science and Engineering Graduate fellowship; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM58518 (A. C. R.) and GM81393 (J.S.), American Cancer Society grant PF-10-148-01-DMC (A. K. B.), and a National Defense Science and Engineering Graduate fellowship to J.A.C. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Use of the Life Sciences Collaborative Access Team (LS-CAT) Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (grant 085P1000817). Some data were collected at General Medicine and Cancer Institutes Collaborative Access Team (GM/CA-CAT), which has been funded in whole or in part with federal funds from the National Cancer Institute (grant Y1-CO-1020) and the National Institute of General Medical Science (grant Y1-GM-1104). We thank Z. Wawrzak for assistance with data processing and S. Lippard for helpful discussions. Coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 3N37 (Mn<INF>2</INF><SUP>II</SUP>-NrdF), 3N38 (Fe<INF>2</INF><SUP>II</SUP>-NrdF), 3N39 (NrdI<INF>ox</INF>-NrdF), 3N3A (NrdI<INF>hq</INF>-NrdF), and 3N3B (NrdI<INF>hq</INF>-NrdF<INF>perox</INF>).	ATKIN CL, 1973, J BIOL CHEM, V248, P7464; ATTA M, 1992, J BIOL CHEM, V267, P20682; Barynin VV, 2001, STRUCTURE, V9, P725, DOI 10.1016/S0969-2126(01)00628-1; Cotruvo JA, 2008, P NATL ACAD SCI USA, V105, P14383, DOI 10.1073/pnas.0807348105; Cotruvo JA, 2010, BIOCHEMISTRY-US, V49, P1297, DOI 10.1021/bi902106n; Cox N, 2010, J AM CHEM SOC, V132, P11197, DOI 10.1021/ja1036995; DIXON M, 1971, BIOCHIM BIOPHYS ACTA, V226, P241, DOI 10.1016/0005-2728(71)90092-2; Do LH, 2010, J AM CHEM SOC, V132, P1273, DOI 10.1021/ja909718f; Drennan CL, 1999, J MOL BIOL, V294, P711, DOI 10.1006/jmbi.1999.3151; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; Eriksson M, 1998, BIOCHEMISTRY-US, V37, P13359, DOI 10.1021/bi981380s; Gon S, 2006, ANTIOXID REDOX SIGN, V8, P735, DOI 10.1089/ars.2006.8.735; Hogbom M, 2002, BIOCHEMISTRY-US, V41, P1381, DOI 10.1021/bi011429l; Huque Y, 2000, J BIOL CHEM, V275, P25365, DOI 10.1074/jbc.M002751200; JORDAN A, 1994, P NATL ACAD SCI USA, V91, P12892, DOI 10.1073/pnas.91.26.12892; LUDWIG ML, 1992, CHEM BIOCH FLAVOENZY, V3, P427; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Monje-Casas F, 2001, J BIOL CHEM, V276, P18031, DOI 10.1074/jbc.M011728200; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Roca I, 2008, J BACTERIOL, V190, P4849, DOI 10.1128/JB.00185-08; Rohr AK, 2010, ANGEW CHEM INT EDIT, V49, P2324, DOI 10.1002/anie.200907143; Sazinsky MH, 2006, ACCOUNTS CHEM RES, V39, P558, DOI 10.1021/ar030204v; Sazinsky MH, 2005, J AM CHEM SOC, V127, P5814, DOI 10.1021/ja044099b; Uppsten M, 2004, FEBS LETT, V569, P117, DOI 10.1016/j.febslet.2004.05.059; Uppsten M, 2006, J MOL BIOL, V359, P365, DOI 10.1016/j.jmb.2006.03.035; Voegtli WC, 2003, J AM CHEM SOC, V125, P15822, DOI 10.1021/ja0370387; WILLING A, 1988, EUR J BIOCHEM, V170, P603, DOI 10.1111/j.1432-1033.1988.tb13740.x; Wu CH, 2007, BIOCHEMISTRY-US, V46, P11577, DOI 10.1021/bi7012454; ZHOU ZM, 1995, BIOCHEMISTRY-US, V34, P3183, DOI 10.1021/bi00010a007	30	105	105	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2010	329	5998					1526	1530		10.1126/science.1190187	http://dx.doi.org/10.1126/science.1190187			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650RK	20688982	Green Accepted			2022-12-01	WOS:000281869000043
J	Perocchi, F; Gohil, VM; Girgis, HS; Bao, XR; McCombs, JE; Palmer, AE; Mootha, VK				Perocchi, Fabiana; Gohil, Vishal M.; Girgis, Hany S.; Bao, X. Robert; McCombs, Janet E.; Palmer, Amy E.; Mootha, Vamsi K.			MICU1 encodes a mitochondrial EF hand protein required for Ca2+ uptake	NATURE			English	Article							RAT KIDNEY MITOCHONDRIA; CALCIUM-UPTAKE; YEAST MITOCHONDRIA; INNER MEMBRANE; UNIPORTER; TRANSPORT; CELL; PHOSPHORYLATION; GLYCOPROTEIN; OSCILLATIONS	Mitochondrial calcium uptake has a central role in cell physiology by stimulating ATP production, shaping cytosolic calcium transients and regulating cell death. The biophysical properties of mitochondrial calcium uptake have been studied in detail, but the underlying proteins remain elusive. Here we use an integrative strategy to predict human genes involved in mitochondrial calcium entry based on clues from comparative physiology, evolutionary genomics and organelle proteomics. RNA interference against 13 top candidates highlighted one gene, CBARA1, that we call hereafter mitochondrial calcium uptake 1 (MICU1). Silencing MICU1 does not disrupt mitochondrial respiration or membrane potential but abolishes mitochondrial calcium entry in intact and permeabilized cells, and attenuates the metabolic coupling between cytosolic calcium transients and activation of matrix dehydrogenases. MICU1 is associated with the mitochondrial inner membrane and has two canonical EF hands that are essential for its activity, indicating a role in calcium sensing. MICU1 represents the founding member of a set of proteins required for high-capacity mitochondrial calcium uptake. Its discovery may lead to the complete molecular characterization of mitochondrial calcium uptake pathways, and offers genetic strategies for understanding their contribution to normal physiology and disease.	[Perocchi, Fabiana; Gohil, Vishal M.; Girgis, Hany S.; Bao, X. Robert; Mootha, Vamsi K.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Perocchi, Fabiana; Gohil, Vishal M.; Girgis, Hany S.; Bao, X. Robert; Mootha, Vamsi K.] Broad Inst, Cambridge, MA 02142 USA; [Perocchi, Fabiana; Gohil, Vishal M.; Girgis, Hany S.; Bao, X. Robert; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [McCombs, Janet E.; Palmer, Amy E.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of Colorado System; University of Colorado Boulder	Mootha, VK (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	vamsi@hms.harvard.edu		perocchi, fabiana/0000-0002-1102-6500; Gohil, Vishal/0000-0002-9920-2563; McCombs, Janet/0000-0002-3514-8019; Bao, Xiaoyan/0000-0001-7931-2944	National Institutes of Health [GM084027, TR2 GM08759, GM0077465, DK080261]; HHMI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077465, R01GM084027, T32GM008759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Z. Grabarek, S. Silver and D. Root for advice; S. Calvo and A. Wolf for assistance with bioinformatics; P. Federico for technical assistance; and members of the Mootha Laboratory for valuable feedback. This work was supported by grants from the National Institutes of Health (GM084027) to A.E.P, TR2 GM08759 to J.E.M. and GM0077465, DK080261 awarded to V.K.M., and by an HHMI Early Career Physician Scientist Award to V.K.M.	Aichberger KJ, 2005, J IMMUNOL, V175, P1286, DOI 10.4049/jimmunol.175.2.1286; Balaban RS, 2009, BBA-BIOENERGETICS, V1787, P1334, DOI 10.1016/j.bbabio.2009.05.011; BALCAVAG.WX, 1973, BIOCHIM BIOPHYS ACTA, V305, P41, DOI 10.1016/0005-2728(73)90229-6; Bernardi P., 2007, V45, P481; BRAGADIN M, 1979, BIOCHEMISTRY-US, V18, P5972, DOI 10.1021/bi00593a033; Brini M, 1999, MICROSC RES TECHNIQ, V46, P380, DOI 10.1002/(SICI)1097-0029(19990915)46:6<380::AID-JEMT6>3.0.CO;2-Y; CARAFOLI E, 1971, BIOCHEM J, V122, P681, DOI 10.1042/bj1220681; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; DENTON R M, 1980, Biochemical Society Transactions, V8, P266; DOCAMPO R, 1989, J BIOL CHEM, V264, P108; FAVARON M, 1985, FEBS LETT, V183, P260, DOI 10.1016/0014-5793(85)80789-4; Filippin L, 2003, J BIOL CHEM, V278, P39224, DOI 10.1074/jbc.M302301200; Forner F, 2009, CELL METAB, V10, P324, DOI 10.1016/j.cmet.2009.08.014; Gaspers LD, 2008, METHODS, V46, P224, DOI 10.1016/j.ymeth.2008.09.012; Glitsch MD, 2002, EMBO J, V21, P6744, DOI 10.1093/emboj/cdf675; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; GUNTER KK, 1994, J BIOENERG BIOMEMBR, V26, P471, DOI 10.1007/BF00762732; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; IGBAVBOA U, 1988, J BIOL CHEM, V263, P1405; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Jouaville LS, 1999, P NATL ACAD SCI USA, V96, P13807, DOI 10.1073/pnas.96.24.13807; JOUAVILLE LS, 1995, NATURE, V377, P438, DOI 10.1038/377438a0; Kaftan EJ, 2000, J BIOL CHEM, V275, P25465, DOI 10.1074/jbc.M000903200; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Lawrie AM, 1996, J BIOL CHEM, V271, P10753, DOI 10.1074/jbc.271.18.10753; McDonald T, 2006, MOL CELL PROTEOMICS, V5, P2392, DOI 10.1074/mcp.T500036-MCP200; MIRONOVA GD, 1982, J BIOENERG BIOMEMBR, V14, P213, DOI 10.1007/BF00751016; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Mootha VK, 2001, EMBO J, V20, P661, DOI 10.1093/emboj/20.4.661; Moreau B, 2006, CURR BIOL, V16, P1672, DOI 10.1016/j.cub.2006.06.059; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; PANFILI E, 1976, NATURE, V264, P185, DOI 10.1038/264185a0; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Spat A, 2008, CELL CALCIUM, V44, P51, DOI 10.1016/j.ceca.2007.11.015; SPARAGNA GC, 1995, J BIOL CHEM, V270, P27510, DOI 10.1074/jbc.270.46.27510; Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423, DOI 10.1152/ajpcell.2000.278.2.C423; URIBE S, 1992, CELL CALCIUM, V13, P211, DOI 10.1016/0143-4160(92)90009-H; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670; VERCESI AE, 1992, BIOCHEM J, V284, P463, DOI 10.1042/bj2840463; Zazueta C, 1998, J BIOENERG BIOMEMBR, V30, P489, DOI 10.1023/A:1020546331217; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	48	613	630	0	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2010	467	7313					291	U67		10.1038/nature09358	http://dx.doi.org/10.1038/nature09358			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	650CF	20693986	Green Accepted			2022-12-01	WOS:000281824900031
J	Calo, E; Quintero-Estades, JA; Danielian, PS; Nedelcu, S; Berman, SD; Lees, JA				Calo, Eliezer; Quintero-Estades, Jose A.; Danielian, Paul S.; Nedelcu, Simona; Berman, Seth D.; Lees, Jacqueline A.			Rb regulates fate choice and lineage commitment in vivo	NATURE			English	Article							ADIPOCYTE DIFFERENTIATION; OSTEOBLAST DIFFERENTIATION; RETINOBLASTOMA GENE; TUMOR-SUPPRESSOR; OSTEOSARCOMA; TRANSCRIPTION; INACTIVATION; EXPRESSION; WHITE; P53	Mutation of the retinoblastoma gene (RB1) tumour suppressor occurs in one-third of all human tumours and is particularly associated with retinoblastoma and osteosarcoma(1). Numerous functions have been ascribed to the product of the human RB1 gene, the retinoblastoma protein (pRb). The best known is pRb's ability to promote cell-cycle exit through inhibition of the E2F transcription factors and the transcriptional repression of genes encoding cell-cycle regulators(1). In addition, pRb has been shown in vitro to regulate several transcription factors that are master differentiation inducers(2). Depending on the differentiation factor and cellular context, pRb can either suppress or promote their transcriptional activity. For example, pRb binds to Runx2 and potentiates its ability to promote osteogenic differentiation in vitro(3). In contrast, pRb acts with E2F to suppress peroxisome proliferator-activated receptor gamma subunit (PPAR-gamma), the master activator of adipogenesis(4,5). Because osteoblasts and adipocytes can both arise from mesenchymal stem cells, these observations suggest that pRb might play a role in the choice between these two fates. However, so far, there is no evidence for this in vivo. Here we use mouse models to address this hypothesis in mesenchymal tissue development and tumorigenesis. Our data show that Rb status plays a key role in establishing fate choice between bone and brown adipose tissue in vivo.	[Calo, Eliezer; Quintero-Estades, Jose A.; Danielian, Paul S.; Nedelcu, Simona; Berman, Seth D.; Lees, Jacqueline A.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Lees, JA (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jalees@mit.edu		Danielian, Paul/0000-0003-2651-0386	National Cancer Institute/National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA121921, P01CA042063] Funding Source: NIH RePORTER	National Cancer Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Jacks, C. Tabin and A. McMahon for providing key mutant mouse strains, K. Lane for pCW22, M. Hemann for the Rb shRNA, the University of Iowa Gene Transfer Vector Core for the adenoviral Cre and GFP vectors, and G. Karsenty for p6OSE2-Luc and control p4Luc. We also thank members of the Lees laboratory, S. Mukherjee and M. Hemann for input during this study. This work was supported by an National Cancer Institute/National Institutes of Health grant to J.A.L., who is a Ludwig Scholar at MIT.	Barski Artem, 2008, V455, P177, DOI 10.1007/978-1-59745-104-8_14; Berman SD, 2008, MOL CANCER RES, V6, P1440, DOI 10.1158/1541-7786.MCR-08-0176; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Clark JCM, 2008, J CANCER RES CLIN, V134, P281, DOI 10.1007/s00432-007-0330-x; Dali-Youcef N, 2007, P NATL ACAD SCI USA, V104, P10703, DOI 10.1073/pnas.0611568104; Fajas L, 2002, DEV CELL, V3, P903, DOI 10.1016/S1534-5807(02)00360-X; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; Korenjak M, 2005, CURR OPIN GENET DEV, V15, P520, DOI 10.1016/j.gde.2005.07.001; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417	20	231	243	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2010	466	7310					1110	U126		10.1038/nature09264	http://dx.doi.org/10.1038/nature09264			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20686481	Green Accepted, Green Submitted			2022-12-01	WOS:000281203600041
J	Zhou, TQ; Georgiev, I; Wu, XL; Yang, ZY; Dai, KF; Finzi, A; Kwon, YD; Scheid, JF; Shi, W; Xu, L; Yang, YP; Zhu, JA; Nussenzweig, MC; Sodroski, J; Shapiro, L; Nabel, GJ; Mascola, JR; Kwong, PD				Zhou, Tongqing; Georgiev, Ivelin; Wu, Xueling; Yang, Zhi-Yong; Dai, Kaifan; Finzi, Andres; Kwon, Young Do; Scheid, Johannes F.; Shi, Wei; Xu, Ling; Yang, Yongping; Zhu, Jiang; Nussenzweig, Michel C.; Sodroski, Joseph; Shapiro, Lawrence; Nabel, Gary J.; Mascola, John R.; Kwong, Peter D.			Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01	SCIENCE			English	Article							GP120 ENVELOPE GLYCOPROTEIN; RECEPTOR; SITE; EPITOPE; SURFACE; INDIVIDUALS; ATTACHMENT; MATURATION; HYPOTHESIS; VACCINES	During HIV-1 infection, antibodies are generated against the region of the viral gp120 envelope glycoprotein that binds CD4, the primary receptor for HIV-1. Among these antibodies, VRC01 achieves broad neutralization of diverse viral strains. We determined the crystal structure of VRC01 in complex with a human immunodeficiency virus HIV-1 gp120 core. VRC01 partially mimics CD4 interaction with gp120. A shift from the CD4-defined orientation, however, focuses VRC01 onto the vulnerable site of initial CD4 attachment, allowing it to overcome the glycan and conformational masking that diminishes the neutralization potency of most CD4-binding-site antibodies. To achieve this recognition, VRC01 contacts gp120 mainly through immunoglobulin V-gene regions substantially altered from their genomic precursors. Partial receptor mimicry and extensive affinity maturation thus facilitate neutralization of HIV-1 by natural human antibodies.	[Zhou, Tongqing; Georgiev, Ivelin; Wu, Xueling; Yang, Zhi-Yong; Dai, Kaifan; Kwon, Young Do; Shi, Wei; Xu, Ling; Yang, Yongping; Zhu, Jiang; Shapiro, Lawrence; Nabel, Gary J.; Mascola, John R.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Finzi, Andres; Sodroski, Joseph] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS,Dept Pathol,Div AIDS, Boston, MA 02115 USA; [Scheid, Johannes F.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Scheid, Johannes F.; Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Sodroski, Joseph] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Shapiro, Lawrence] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Harvard University; Harvard T.H. Chan School of Public Health; Columbia University	Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.	pdkwong@nih.gov	Zhou, Tongqing/A-6880-2010; Nussenzweig, Michel/AAE-7292-2019; Mascola, John/AAI-7193-2021; Do Kwon, Young/A-6957-2010; Shapiro, Lawrence/AAE-7172-2019	Zhou, Tongqing/0000-0002-3935-4637; Do Kwon, Young/0000-0002-1188-7458; Finzi, Andres/0000-0002-4992-5288	NIH; International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005022, ZIAAI005095, P30AI060354] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	T.Z., I.G., Z.Y., J.S., L.S., G.J.N., J.R.M., and P.D.K. designed the research; T.Z., I.G., X.W., Z.Y., K.D.A.F., W.S., L.X., Y.Y., and J.Z. performed the research; X.W., Y.K., J.F.S., M.C.N., and J.R.M. contributed new reagents or reference data; T.Z., I.G., X.W., J.S., L.S., G.J.N., J.R.M., and P.D.K. analyzed the data; and T.Z., I.G., J.S., L.S., G.J.N., J.R.M., and P.D.K. wrote the paper, on which all authors commented. We thank I.A. Wilson and members of the Structural Biology Section and Structural Bioinformatics Core, Vaccine Research Center, for discussions and comments on the manuscript; the staff of sector 22 for assistance with data collection; and J. Stuckey for assistance with figures. Support for this work was provided by the Intramural Research Program of NIH and by grants from NIH and from the International AIDS Vaccine Initiative's Neutralizing Antibody Consortium. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract W-31-109-Eng-38. Coordinates and structure factors for the VRC01-gp120 complex have been deposited with the PDB under accession code 3NGB.	Anderson JP, 2000, J VIROL, V74, P10752, DOI 10.1128/JVI.74.22.10752-10765.2000; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; MADDON PJ, 1985, CELL, V42, P93, DOI 10.1016/S0092-8674(85)80105-7; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Rits-Volloch S, 2006, EMBO J, V25, P5026, DOI 10.1038/sj.emboj.7601358; ROSSMANN MG, 1989, J BIOL CHEM, V264, P14587; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Smith TJ, 1996, NATURE, V383, P350, DOI 10.1038/383350a0; WEISS RA, 1985, NATURE, V316, P69, DOI 10.1038/316069a0; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wu XL, 2009, J VIROL, V83, P10892, DOI 10.1128/JVI.01142-09; Xiang SH, 2002, J VIROL, V76, P9888, DOI 10.1128/JVI.76.19.9888-9899.2002; Xiao XD, 2009, VIRUSES-BASEL, V1, P802, DOI 10.3390/v1030802; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	38	857	922	0	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					811	817		10.1126/science.1192819	http://dx.doi.org/10.1126/science.1192819			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20616231	Green Published, Green Accepted			2022-12-01	WOS:000280809900043
J	Kallen, AJ; Mu, Y; Bulens, S; Reingold, A; Petit, S; Gershman, K; Ray, SM; Harrison, LH; Lynfield, R; Dumyati, G; Townes, JM; Schaffner, W; Patel, PR; Fridkin, SK				Kallen, Alexander J.; Mu, Yi; Bulens, Sandra; Reingold, Arthur; Petit, Susan; Gershman, Ken; Ray, Susan M.; Harrison, Lee H.; Lynfield, Ruth; Dumyati, Ghinwa; Townes, John M.; Schaffner, William; Patel, Priti R.; Fridkin, Scott K.		ABCs MRSA Investigators Emerging I	Health Care-Associated Invasive MRSA Infections, 2005-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; BLOOD-STREAM INFECTIONS; SURVEILLANCE CULTURES; DISEASE; IMPACT; COLONIZATION; EMERGENCE; ADMISSION	Context Methicillin-resistant Staphylococcus aureus (MRSA) is a pathogen of public health importance; MRSA prevention programs that may affect MRSA transmission and infection are increasingly common in health care settings. Whether there have been changes in MRSA infection incidence as these programs become established is unknown; however, recent data have shown that rates of MRSA bloodstream infections (BSIs) in intensive care units are decreasing. Objective To describe changes in rates of invasive health care associated MRSA infections from 2005 through 2008 among residents of 9 US metropolitan areas. Design, Setting, and Participants Active, population-based surveillance for invasive MRSA in 9 metropolitan areas covering a population of approximately 15 million persons. All reports of laboratory-identified episodes of invasive (from a normally sterile body site) MRSA infections from 2005 through 2008 were evaluated and classified based on the setting of the positive culture and the presence or absence of health care exposures. Health care associated infections (ie, hospital-onset and health care associated community-onset), which made up 82% of the total infections, were included in this analysis. Main Outcome Measures Change in incidence of invasive health care associated MRSA infections and health care associated MRSA BSIs using population of the catchment area as the denominator. Results From 2005 through 2008, there were 21 503 episodes of invasive MRSA infection; 17 508 were health care associated. Of these, 15 458 were MRSA BSIs. The incidence rate of hospital-onset invasive MRSA infections was 1.02 per 10 000 population in 2005 and decreased 9.4% per year (95% confidence interval [Cl], 14.7% to 3.8%; P=.005), and the incidence of health care associated community-onset infections was 2.20 per 10 000 population in 2005 and decreased 5.7% per year (95% Cl, 9.7% to 1.6%; P=.01). The decrease was most prominent for the subset of infections with BSIs (hospital-onset: -11.2%; 95% Cl -15.9% to -6.3%; health care associated community-onset: -6.6%; 95% Cl -9.5% to -3.7%). Conclusion Over the 4-year period from 2005 through 2008 in 9 diverse metropolitan areas, rates of invasive health care associated MRSA infections decreased among patients with health care associated infections that began in the community and also decreased among those with hospital-onset invasive disease. JAMA. 2010;304(6):641-648	[Kallen, Alexander J.; Mu, Yi; Bulens, Sandra; Patel, Priti R.; Fridkin, Scott K.] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Atlanta, GA USA; [Bulens, Sandra] Atlanta Res & Educ Fdn, Decatur, GA USA; [Reingold, Arthur] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Petit, Susan] Connecticut Dept Publ Hlth & Addict Serv, Hartford, CT 06106 USA; [Gershman, Ken] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Ray, Susan M.] Emory Univ, Sch Med, Atlanta, GA USA; [Harrison, Lee H.] Maryland Emerging Infect Program, Baltimore, MD USA; [Harrison, Lee H.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Lynfield, Ruth] Minnesota Dept Hlth, St Paul, MN USA; [Dumyati, Ghinwa] Univ Rochester, Rochester, NY USA; [Townes, John M.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Schaffner, William] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	Centers for Disease Control & Prevention - USA; University of California System; University of California Berkeley; Colorado Department of Public Health & Environment; Emory University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Minnesota Department of Health (MHD); University of Rochester; Oregon Health & Science University; Vanderbilt University	Kallen, AJ (corresponding author), 1600 Clifton Rd NE,MS A-35, Atlanta, GA 30333 USA.	AKallen@cdc.gov		Shutt, Kathleen/0000-0003-3376-6152; Ray, Susan/0000-0002-6327-088X				[Anonymous], 2005, MMWR MORB MORTAL WKL; Burton DC, 2009, JAMA-J AM MED ASSOC, V301, P727, DOI 10.1001/jama.2009.153; Calfee DP, 2008, INFECT CONT HOSP EP, V29, pS62, DOI 10.1086/591061; Carrillo-Marquez MA, 2009, PEDIATR INFECT DIS J, V28, P1076, DOI 10.1097/INF.0b013e3181adbcfe; Centers for Disease Control and Prevention, ACT BACT COR SURV RE; Chaberny IF, 2008, J ANTIMICROB CHEMOTH, V62, P1422, DOI 10.1093/jac/dkn373; Cohen AL, 2008, INFECT CONT HOSP EP, V29, P901, DOI 10.1086/591741; Collins A., 2007, Morbidity and Mortality Weekly Report, V56, P197; DeFrances Carol J, 2007, Vital Health Stat 13, P1; DeFrances CJ, 2008, 5 NAT CTR HLTH STAT; Enayet I, 2006, CLIN INFECT DIS, V42, pE57, DOI 10.1086/501125; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Hidron AI, 2008, INFECT CONT HOSP EP, V29, P996, DOI 10.1086/591861; Huang SS, 2006, CLIN INFECT DIS, V43, P971, DOI 10.1086/507636; Kallen AJ, 2009, ANN EMERG MED, V53, P358, DOI 10.1016/j.annemergmed.2008.04.027; King MD, 2006, ANN INTERN MED, V144, P309, DOI 10.7326/0003-4819-144-5-200603070-00005; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Liebowitz Lynne D, 2009, Int J Antimicrob Agents, V34 Suppl 3, pS11, DOI 10.1016/S0924-8579(09)70551-5; Limbago B, 2009, J CLIN MICROBIOL, V47, P1344, DOI 10.1128/JCM.02264-08; Liu C, 2008, CLIN INFECT DIS, V46, P1637, DOI 10.1086/587893; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Muder RR, 2008, INFECT CONT HOSP EP, V29, P702, DOI 10.1086/589981; Pearson A, 2009, J ANTIMICROB CHEMOTH, V64, P11, DOI 10.1093/jac/dkp260; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Ridenour G, 2007, INFECT CONT HOSP EP, V28, P1155, DOI 10.1086/520102; Robicsek A, 2008, ANN INTERN MED, V148, P409, DOI 10.7326/0003-4819-148-6-200803180-00003; Robicsek A, 2009, INFECT CONT HOSP EP, V30, P623, DOI 10.1086/597550; Seybold U, 2006, CLIN INFECT DIS, V42, P647, DOI 10.1086/499815; Siegel JD, 2006, HEALTHCARE INFECT CO; U.S. Department of Health and Human Services Office of the Secretary Office of the Assistant Secretary for Health, HHS ACT PLAN PREV HE	31	323	332	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2010	304	6					641	648		10.1001/jama.2010.1115	http://dx.doi.org/10.1001/jama.2010.1115			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637PA	20699455	Bronze			2022-12-01	WOS:000280829200019
J	Sacco, T; Sacchetti, B				Sacco, Tiziana; Sacchetti, Benedetto			Role of Secondary Sensory Cortices in Emotional Memory Storage and Retrieval in Rats	SCIENCE			English	Article							FEAR-POTENTIATED STARTLE; VISUAL CONDITIONED-STIMULUS; ANTERIOR CINGULATE CORTEX; BASOLATERAL AMYGDALA; PERIRHINAL CORTEX; TEMPORAL CORTEX; AUDITORY-CORTEX; INVOLVEMENT; CONSOLIDATION; THALAMUS	Visual, acoustic, and olfactory stimuli associated with a highly charged emotional situation take on the affective qualities of that situation. Where the emotional meaning of a given sensory experience is stored is a matter of debate. We found that excitotoxic lesions of auditory, visual, or olfactory secondary sensory cortices impaired remote, but not recent, fear memories in rats. Amnesia was modality-specific and not due to an interference with sensory or emotional processes. In these sites, memory persistence was dependent on ongoing protein kinase M zeta activity and was associated with an increased activity of layers II-IV, thus suggesting a synaptic strengthening of corticocortical connections. Lesions of the same areas left intact the memory of sensory stimuli not associated with any emotional charge. We propose that secondary sensory cortices support memory storage and retrieval of sensory stimuli that have acquired a behavioral salience with the experience.	[Sacco, Tiziana; Sacchetti, Benedetto] Univ Turin, Dept Neurosci, I-10125 Turin, Italy; [Sacchetti, Benedetto] Natl Inst Neurosci, I-10125 Turin, Italy	University of Turin	Sacchetti, B (corresponding author), Univ Turin, Dept Neurosci, Corso Raffaello 30, I-10125 Turin, Italy.	benedetto.sacchetti@unito.it	Sacchetti, Benedetto/AFK-4141-2022; Sacchetti, Benedetto/AAG-2916-2022	Sacchetti, Benedetto/0000-0002-8695-8310	Italian Ministry of University	Italian Ministry of University(Ministry of Education, Universities and Research (MIUR))	We thank J. L. McGaugh for critical comments on the manuscript and L. Milano, A. Renna, D. Germano, V. Pastrone, D. Tonello, and G. Benvenuti for technical assistance. Supported by grants from the Italian Ministry of University.	BARTH DS, 1995, BRAIN RES, V678, P177, DOI 10.1016/0006-8993(95)00182-P; Boatman JA, 2006, EUR J NEUROSCI, V24, P894, DOI 10.1111/j.1460-9568.2006.04965.x; Calu DJ, 2007, CEREB CORTEX, V17, P1342, DOI 10.1093/cercor/bhl045; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; Chavez CM, 2009, NEUROBIOL LEARN MEM, V91, P382, DOI 10.1016/j.nlm.2008.10.010; COLEMAN J, 1980, BRAIN RES, V194, P205, DOI 10.1016/0006-8993(80)91329-3; DIAMOND DM, 1984, BEHAV NEUROSCI, V98, P189, DOI 10.1037/0735-7044.98.2.189; FALLS WA, 1993, BEHAV NEURAL BIOL, V60, P259, DOI 10.1016/0163-1047(93)90504-B; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; GONZALEZLIMA F, 1989, BRAIN RES, V489, P67, DOI 10.1016/0006-8993(89)90009-7; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; JARRELL TW, 1987, BRAIN RES, V412, P285, DOI 10.1016/0006-8993(87)91135-8; Kolb B.E., 1990, CEREBRAL CORTEX RAT; Ledoux J E, 1989, J Cogn Neurosci, V1, P238, DOI 10.1162/jocn.1989.1.3.238; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee YL, 1996, BEHAV NEUROSCI, V110, P836, DOI 10.1037/0735-7044.110.4.836; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Malin EL, 2006, P NATL ACAD SCI USA, V103, P1959, DOI 10.1073/pnas.0510890103; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd ed; Poremba A, 1998, EUR J NEUROSCI, V10, P3035, DOI 10.1046/j.1460-9568.1998.00304.x; ROMANSKI LM, 1992, NEUROSCI LETT, V142, P228, DOI 10.1016/0304-3940(92)90379-L; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; ROSEN JB, 1992, J NEUROSCI, V12, P4624; Sacchetti B, 1999, J NEUROSCI, V19, P9570; Sacchetti B, 2004, NEURON, V42, P973, DOI 10.1016/j.neuron.2004.05.012; Sacchetti B, 2002, P NATL ACAD SCI USA, V99, P8406, DOI 10.1073/pnas.112660399; Sacchetti B, 2007, EUR J NEUROSCI, V25, P2875, DOI 10.1111/j.1460-9568.2007.05508.x; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Shi CJ, 2001, J NEUROSCI, V21, P9844, DOI 10.1523/JNEUROSCI.21-24-09844.2001; Villa AEP, 1999, P NATL ACAD SCI USA, V96, P1106, DOI 10.1073/pnas.96.3.1106; Wan H, 2001, EUR J NEUROSCI, V14, P118, DOI 10.1046/j.0953-816x.2001.01625.x; Weinberger NM, 2004, NAT REV NEUROSCI, V5, P279, DOI 10.1038/nrn1366; Wilson DA, 2008, J NEUROPHYSIOL, V100, P2, DOI 10.1152/jn.90479.2008; ZHU XO, 1995, NEUROSCIENCE, V69, P821, DOI 10.1016/0306-4522(95)00320-I; Zilles K, 1985, CORTEX RAT	39	189	189	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					649	656		10.1126/science.1183165	http://dx.doi.org/10.1126/science.1183165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689011	Green Submitted			2022-12-01	WOS:000280602700030
J	Cooper, S; Khatib, F; Treuille, A; Barbero, J; Lee, J; Beenen, M; Leaver-Fay, A; Baker, D; Popovic, Z; Players, F				Cooper, Seth; Khatib, Firas; Treuille, Adrien; Barbero, Janos; Lee, Jeehyung; Beenen, Michael; Leaver-Fay, Andrew; Baker, David; Popovic, Zoran; Players, Foldit			Predicting protein structures with a multiplayer online game	NATURE			English	Article								People exert large amounts of problem-solving effort playing computer games. Simple image-and text-recognition tasks have been successfully 'crowd-sourced' through games(1-3), but it is not clear if more complex scientific problems can be solved with human-directed computing. Protein structure prediction is one such problem: locating the biologically relevant native conformation of a protein is a formidable computational challenge given the very large size of the search space. Here we describe Foldit, a multiplayer online game that engages non-scientists in solving hard prediction problems. Foldit players interact with protein structures using direct manipulation tools and user-friendly versions of algorithms from the Rosetta structure prediction methodology(4), while they compete and collaborate to optimize the computed energy. We show that top-ranked Foldit players excel at solving challenging structure refinement problems in which substantial backbone rearrangements are necessary to achieve the burial of hydrophobic residues. Players working collaboratively develop a rich assortment of new strategies and algorithms; unlike computational approaches, they explore not only the conformational space but also the space of possible search strategies. The integration of human visual problem-solving and strategy development capabilities with traditional computational algorithms through interactive multiplayer games is a powerful new approach to solving computationally-limited scientific problems.	[Cooper, Seth; Treuille, Adrien; Barbero, Janos; Beenen, Michael; Popovic, Zoran] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Khatib, Firas; Leaver-Fay, Andrew; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Treuille, Adrien; Lee, Jeehyung] Carnegie Mellon Univ, Sch Comp Sci, Pittsburgh, PA 15213 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Carnegie Mellon University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Popovic, Z (corresponding author), Univ Washington, Dept Comp Sci & Engn, Box 352350, Seattle, WA 98195 USA.	dabaker@u.washington.edu; zoran@cs.washington.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Barbero, Janos/0000-0002-8256-7734; Newman, Gregory/0000-0003-0503-5782	NSF [IIS0811902, 0906026]; DARPA [N00173-08-1-G025]; Howard Hughes Medical Institute; Microsoft; NVIDIA Fellowship; Div Of Biological Infrastructure [0906026] Funding Source: National Science Foundation; Div Of Information & Intelligent Systems [0953985] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Microsoft(Microsoft); NVIDIA Fellowship; Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank D. Salesin, K. Tuite, J. Snyder, D. Suskin, P. Krahenbuhl, A. C. Snyder, H. Lu, L. S. Tan, A. Chia, M. Yao, E. Butler, C. Carrico, P. Bradley, I. Davis, D. Kim, R. Das, W. Sheffler, J. Thompson, O. Lange, R. Vernon, B. Correia, D. Anderson, Y. Zhao, S. Herin and B. Bethurum for their help. We would like to thank N. Koga, R. Koga and A. Deacon and the JCSG for providing us with protein structures before their public release. We would also like to acknowledge all of the Foldit players who have made this work possible. Usernames of players whose solutions were used in figures can be found in Supplementary Table 4. This work was supported by NSF grants IIS0811902 and 0906026, DARPA grant N00173-08-1-G025, the DARPA PDP program, the Howard Hughes Medical Institute (D. B.), Microsoft, and an NVIDIA Fellowship. This material is based upon work supported by the National Science Foundation under a grant awarded in 2009.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Rosato A, 2009, NAT METHODS, V6, P625, DOI 10.1038/nmeth0909-625; von Ahn L., 2004, P SIGCHI C HUM FACT, DOI [10.1145/985692.985733, DOI 10.1145/985692.985733]; Von Ahn Luis, 2006, P SIGCHI C HUM FACT, P55, DOI DOI 10.1145/1124772.1124782; Westphal AJ, 2010, AIP CONF PROC, V1221, P131, DOI 10.1063/1.3399239; Yee N, 2006, CYBERPSYCHOL BEHAV, V9, P772, DOI 10.1089/cpb.2006.9.772	11	699	714	6	238	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2010	466	7307					756	760		10.1038/nature09304	http://dx.doi.org/10.1038/nature09304			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20686574	Green Accepted			2022-12-01	WOS:000280562500039
J	Buckholtz, JW; Treadway, MT; Cowan, RL; Woodward, ND; Li, R; Ansari, MS; Baldwin, RM; Schwartzman, AN; Shelby, ES; Smith, CE; Kessler, RM; Zald, DH				Buckholtz, Joshua W.; Treadway, Michael T.; Cowan, Ronald L.; Woodward, Neil D.; Li, Rui; Ansari, M. Sib; Baldwin, Ronald M.; Schwartzman, Ashley N.; Shelby, Evan S.; Smith, Clarence E.; Kessler, Robert M.; Zald, David H.			Dopaminergic Network Differences in Human Impulsivity	SCIENCE			English	Article							COCAINE		[Buckholtz, Joshua W.; Treadway, Michael T.; Schwartzman, Ashley N.; Shelby, Evan S.; Zald, David H.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Buckholtz, Joshua W.] Vanderbilt Univ, Vanderbilt Brain Inst, Grad Program Neurosci, Nashville, TN 37240 USA; [Cowan, Ronald L.; Woodward, Neil D.; Smith, Clarence E.; Zald, David H.] Vanderbilt Univ, Dept Psychiat, Nashville, TN 37240 USA; [Cowan, Ronald L.; Woodward, Neil D.] Vanderbilt Univ, Psychiat Neuroimaging Program, Nashville, TN 37240 USA; [Li, Rui; Ansari, M. Sib; Baldwin, Ronald M.; Kessler, Robert M.] Vanderbilt Univ, Dept Radiol, Nashville, TN 37240 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Buckholtz, JW (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	joshua.buckholtz@vanderbilt.edu	Buckholtz, Joshua/E-7299-2010; Woodward, Neil D/N-3365-2017; Treadway, Michael/O-9056-2017; Zald, David H/A-1448-2011; Woodward, Neil/V-3735-2019	Buckholtz, Joshua/0000-0002-9418-8686; 	National Institute on Drug Abuse [R01DA019670-04]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019670] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was funded by the National Institute on Drug Abuse (R01DA019670-04).	Barratt ES, 1999, PSYCHIAT RES, V86, P163, DOI 10.1016/S0165-1781(99)00024-4; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Lambert NM, 2006, ADDICTION, V101, P713, DOI 10.1111/j.1360-0443.2006.01408.x; Malloy-Diniz L, 2007, J INT NEUROPSYCH SOC, V13, P693, DOI 10.1017/S1355617707070889; SANTIAGO M, 1991, EUR J PHARMACOL, V204, P79, DOI 10.1016/0014-2999(91)90838-H; Verdejo-Garcia A, 2008, NEUROSCI BIOBEHAV R, V32, P777, DOI 10.1016/j.neubiorev.2007.11.003; Zilberman ML, 2003, BMC PSYCHIATRY, V3, DOI 10.1186/1471-244X-3-1	8	420	428	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					532	532		10.1126/science.1185778	http://dx.doi.org/10.1126/science.1185778			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	633EX	20671181	Green Accepted			2022-12-01	WOS:000280483500026
J	Kravitz, AV; Freeze, BS; Parker, PRL; Kay, K; Thwin, MT; Deisseroth, K; Kreitzer, AC				Kravitz, Alexxai V.; Freeze, Benjamin S.; Parker, Philip R. L.; Kay, Kenneth; Thwin, Myo T.; Deisseroth, Karl; Kreitzer, Anatol C.			Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry	NATURE			English	Article							SUBTHALAMIC NUCLEUS; MOVEMENT-DISORDERS; IN-VIVO; NEURONS; INTERNEURONS; LESIONS; MODELS; MICE	Neural circuits of the basal ganglia are critical for motor planning and action selection(1-3). Two parallel basal ganglia pathways have been described(4), and have been proposed to exert opposing influences on motor function(5-7). According to this classical model, activation of the 'direct' pathway facilitates movement and activation of the 'indirect' pathway inhibits movement. However, more recent anatomical and functional evidence has called into question the validity of this hypothesis(8-10). Because this model has never been empirically tested, the specific function of these circuits in behaving animals remains unknown. Here we report direct activation of basal ganglia circuitry in vivo, using optogenetic control(11-14) of direct-and indirect-pathway medium spiny projection neurons (MSNs), achieved through Cre-dependent viral expression of channelrhodopsin-2 in the striatum of bacterial artificial chromosome transgenic mice expressing Cre recombinase under control of regulatory elements for the dopamine D1 or D2 receptor. Bilateral excitation of indirect-pathway MSNs elicited a parkinsonian state, distinguished by increased freezing, bradykinesia and decreased locomotor initiations. In contrast, activation of direct-pathway MSNs reduced freezing and increased locomotion. In a mouse model of Parkinson's disease, direct-pathway activation completely rescued deficits in freezing, bradykinesia and locomotor initiation. Taken together, our findings establish a critical role for basal ganglia circuitry in the bidirectional regulation of motor behaviour and indicate that modulation of direct-pathway circuitry may represent an effective therapeutic strategy for ameliorating parkinsonian motor deficits.	[Kravitz, Alexxai V.; Freeze, Benjamin S.; Parker, Philip R. L.; Kay, Kenneth; Thwin, Myo T.; Kreitzer, Anatol C.] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Parker, Philip R. L.; Kreitzer, Anatol C.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA; [Freeze, Benjamin S.; Kreitzer, Anatol C.] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA; [Freeze, Benjamin S.; Kay, Kenneth; Kreitzer, Anatol C.] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94143 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Stanford University	Kreitzer, AC (corresponding author), Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	akreitzer@gladstone.ucsf.edu	Core, Vector/CAF-4832-2022	Kravitz, Alexxai/0000-0001-5983-0218; Parker, Philip R. L./0000-0002-6224-9747	W.M. Keck Foundation; Pew Biomedical Scholars Program; McKnight Foundation; NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064984] Funding Source: NIH RePORTER	W.M. Keck Foundation(W.M. Keck Foundation); Pew Biomedical Scholars Program; McKnight Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Marzullo and NeuroNexus Technologies for their assistance with the custom probe design, the Nikon Imaging Center at UCSF for assistance with image acquisition, R. Javier and A. Gittis for assistance with slice electrophysiology experiments, and L. Shoenfeld for assistance with genotyping and histology. A. C. K and co-workers are funded by the W.M. Keck Foundation, the Pew Biomedical Scholars Program, the McKnight Foundation and the NIH.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; BERGMAN H, 1994, J NEUROPHYSIOL, V72, P507, DOI 10.1152/jn.1994.72.2.507; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Gatev P, 2006, MOVEMENT DISORD, V21, P1566, DOI 10.1002/mds.21033; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; KAWAGUCHI Y, 1990, J NEUROSCI, V10, P3421; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kreitzer AC, 2009, ANNU REV NEUROSCI, V32, P127, DOI 10.1146/annurev.neuro.051508.135422; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Ouimet CC, 1998, BRAIN RES, V808, P8, DOI 10.1016/S0006-8993(98)00724-0; Schwarting RKW, 1996, PROG NEUROBIOL, V49, P215, DOI 10.1016/S0301-0082(96)00015-9; Smith Y, 1998, NEUROSCIENCE, V86, P353; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Surmeier DJ, 2005, CURR OPIN NEUROBIOL, V15, P312, DOI 10.1016/j.conb.2005.05.007; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	27	1151	1195	7	313	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2010	466	7306					622	U7		10.1038/nature09159	http://dx.doi.org/10.1038/nature09159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20613723	Bronze, Green Accepted			2022-12-01	WOS:000280412100053
J	Maxmen, A				Maxmen, Amy			Fighting the monster	NATURE			English	Editorial Material							TUBERCULOSIS THERAPY; ANTIRETROVIRAL DRUGS											Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Garcia-Vidal C, 2010, NEW ENGL J MED, V362, P2137; Kadhiravan T, 2010, NEW ENGL J MED, V362, P2138; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Wilson D, 2010, NEW ENGL J MED, V362, P2137, DOI 10.1056/NEJMc1003767	7	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S18	S19		10.1038/nature09243	http://dx.doi.org/10.1038/nature09243			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631699	Bronze			2022-12-01	WOS:000279867100032
J	Tay, S; Hughey, JJ; Lee, TK; Lipniacki, T; Quake, SR; Covert, MW				Tay, Savas; Hughey, Jacob J.; Lee, Timothy K.; Lipniacki, Tomasz; Quake, Stephen R.; Covert, Markus W.			Single-cell NF-kappa B dynamics reveal digital activation and analogue information processing	NATURE			English	Article							VARIABILITY; STABILITY; RESPONSES	Cells operate in dynamic environments using extraordinary communication capabilities that emerge from the interactions of genetic circuitry. The mammalian immune response is a striking example of the coordination of different cell types(1). Cell-to-cell communication is primarily mediated by signalling molecules that form spatiotemporal concentration gradients, requiring cells to respond to a wide range of signal intensities(2). Here we use high-throughput microfluidic cell culture(3) and fluorescence microscopy, quantitative gene expression analysis and mathematical modelling to investigate how single mammalian cells respond to different concentrations of the signalling molecule tumour-necrosis factor (TNF)-alpha, and relay information to the gene expression programs by means of the transcription factor nuclear factor (NF)-kappa B. We measured NF-kappa B activity in thousands of live cells under TNF-alpha doses covering four orders of magnitude. We find, in contrast to population-level studies with bulk assays(2), that the activation is heterogeneous and is a digital process at the single-cell level with fewer cells responding at lower doses. Cells also encode a subtle set of analogue parameters to modulate the outcome; these parameters include NF-kappa B peak intensity, response time and number of oscillations. We developed a stochastic mathematical model that reproduces both the digital and analogue dynamics as well as most gene expression profiles at all measured conditions, constituting a broadly applicable model for TNF-alpha-induced NF-kappa B signalling in various types of cells. These results highlight the value of high-throughput quantitative measurements with single-cell resolution in understanding how biological systems operate.	[Tay, Savas; Hughey, Jacob J.; Lee, Timothy K.; Quake, Stephen R.; Covert, Markus W.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Tay, Savas; Quake, Stephen R.] Howard Hughes Med Inst, Stanford, CA 94305 USA; [Lipniacki, Tomasz] Inst Fundamental Technol Res, PL-02106 Warsaw, Poland	Stanford University; Howard Hughes Medical Institute; Polish Academy of Sciences; Institute of Fundamental Technological Research of the Polish Academy of Sciences	Covert, MW (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	tlipnia@ippt.gov.pl; quake@stanford.edu; mcovert@stanford.edu	Lipniacki, Tomasz/AAC-6744-2019	Lipniacki, Tomasz/0000-0002-3488-2561; Covert, Markus/0000-0002-5993-8912; Hughey, Jacob/0000-0002-1558-6089	NIH; NCI [K99CA125994]; Foundation for Polish Science [TEAM 2009-3/6]; NSF/NIH [R01-GM086885]; Stanford Graduate Fellowship; Stanford Bio-X Graduate Fellowship; NATIONAL CANCER INSTITUTE [R00CA125994, K99CA125994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086885] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); NSF/NIH(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Graduate Fellowship(Stanford University); Stanford Bio-X Graduate Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Leyrat and R. Gomez-Sjoberg for development of the automated cell culture system, assistance with the software, and for contributions to experimental design and preliminary data. This research was supported in part by an NIH Director's Pioneer Award (to S.R.Q.), an NCI Pathway to Independence Award (K99CA125994) (to M.W.C.), the Foundation for Polish Science (TEAM 2009-3/6) and NSF/NIH grant no. R01-GM086885 (to T.L.), a Stanford Graduate Fellowship (to T.K.L.), and a Stanford Bio-X Graduate Fellowship (to J.J.H.).	Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; Bhat S, 2009, ANAL BIOANAL CHEM, V394, P457, DOI 10.1007/s00216-009-2729-5; CHEN YM, 2004, J PHARMACOL EXP THER, V103; Cheong R, 2006, J BIOL CHEM, V281, P2945, DOI 10.1074/jbc.M510085200; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Lipniacki T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-376; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; Toepke MW, 2006, LAB CHIP, V6, P1484, DOI 10.1039/b612140c; WILSON JW, 1999, APOPTOSIS GENES	28	574	583	4	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2010	466	7303					267	U149		10.1038/nature09145	http://dx.doi.org/10.1038/nature09145			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20581820	Green Accepted			2022-12-01	WOS:000279580800043
J	May, RM				May, Robert M.			Tropical Arthropod Species, More or Less?	SCIENCE			English	Editorial Material									Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	May, RM (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	robert.may@zoo.ox.ac.uk						ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; MAY RM, 1990, PHILOS T R SOC B, V330, P293, DOI 10.1098/rstb.1990.0200; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; *UK HL SCI TECHN S, 2007, 5 UK HOUS LORDS SCI	5	74	80	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					41	42		10.1126/science.1191058	http://dx.doi.org/10.1126/science.1191058			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595603				2022-12-01	WOS:000279402700022
J	Iskow, RC; McCabe, MT; Mills, RE; Torene, S; Pittard, WS; Neuwald, AF; Van Meir, EG; Vertino, PM; Devine, SE				Iskow, Rebecca C.; McCabe, Michael T.; Mills, Ryan E.; Torene, Spencer; Pittard, W. Stephen; Neuwald, Andrew F.; Van Meir, Erwin G.; Vertino, Paula M.; Devine, Scott E.			Natural Mutagenesis of Human Genomes by Endogenous Retrotransposons	CELL			English	Article							TRANSPOSABLE ELEMENTS; L1 RETROTRANSPOSITION; STRUCTURAL VARIATION; INSERTION; SEQUENCE; HYPOMETHYLATION; FREQUENCY; TUMORS; GENE	Two abundant classes of mobile elements, namely Alu and L1 elements, continue to generate new retrotransposon insertions in human genomes. Estimates suggest that these elements have generated millions of new germline insertions in individual human genomes worldwide. Unfortunately, current technologies are not capable of detecting most of these young insertions, and the true extent of germline mutagenesis by endogenous human retrotransposons has been difficult to examine. Here, we describe technologies for detecting these young retrotransposon insertions and demonstrate that such insertions indeed are abundant in human populations. We also found that new somatic L1 insertions occur at high frequencies in human lung cancer genomes. Genome-wide analysis suggests that altered DNA methylation may be responsible for the high levels of L1 mobilization observed in these tumors. Our data indicate that transposon-mediated mutagenesis is extensive in human genomes and is likely to have a major impact on human biology and diseases.	[Iskow, Rebecca C.; Vertino, Paula M.; Devine, Scott E.] Emory Univ, Genet & Mol Biol Grad Program, Atlanta, GA 30322 USA; [Iskow, Rebecca C.; Mills, Ryan E.; Torene, Spencer; Devine, Scott E.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [McCabe, Michael T.; Vertino, Paula M.] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA; [Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [McCabe, Michael T.; Van Meir, Erwin G.; Vertino, Paula M.; Devine, Scott E.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Neuwald, Andrew F.; Devine, Scott E.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 20201 USA; [Neuwald, Andrew F.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 20201 USA; [Devine, Scott E.] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 20201 USA; [Devine, Scott E.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 20201 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Devine, SE (corresponding author), Emory Univ, Genet & Mol Biol Grad Program, Atlanta, GA 30322 USA.	sdevine@som.umaryland.edu	Mills, Ryan E/F-4225-2010	Mills, Ryan E/0000-0003-3425-6998; Van Meir, Erwin G./0000-0003-2444-7707	American Cancer Society [PF-07-130-01-MGO]; SUN Microsystems; National Institute for General Medical Sciences, National Insitutes of Health (NIH) [R01GM078541]; National Cancer Institute, NIH [R01CA086335, R01CA116804, 1R01CA132065, 5P01CA116676]; National Human Genome Research Institute, NIH [F32HG004207, R01HG002898]; NATIONAL CANCER INSTITUTE [R01CA132065, P01CA116676, R01CA116804, R01CA086335] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG004207, R01HG002898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078541, T32GM008490] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); SUN Microsystems; National Institute for General Medical Sciences, National Insitutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Kristie Jones and Luke Tallon for help with 454 Titanium sequencing. We also thank Shari Corin, Julienne Mullaney, Michael Zwick, Ichiro Matsumura, and Xiaodong Cheng for helpful advice and Mark Mazaitis for help with artwork. This work was funded by grants from the American Cancer Society (PF-07-130-01-MGO to M. T. M.), SUN Microsystems (to W. S. P. and S. E. D.), the National Institute for General Medical Sciences, National Insitutes of Health (NIH) (R01GM078541 to A.F.N.), the National Cancer Institute, NIH (R01CA086335 and R01CA116804 to E. G. V. M.; 1R01CA132065 and 5P01CA116676 to P. M. V.), and the National Human Genome Research Institute, NIH (F32HG004207 to R. E. M. and R01HG002898 to S. E. D.).	Badge RM, 2003, AM J HUM GENET, V72, P823, DOI 10.1086/373939; BATZER MA, 2002, NAT REV GENET, V35, P501; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Bennettt EA, 2004, GENETICS, V168, P933, DOI 10.1534/genetics.104.031757; Bestor TH, 1998, NOVART FDN SYMP, V214, P228; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Boissinot S, 2001, MOL BIOL EVOL, V18, P926, DOI 10.1093/oxfordjournals.molbev.a003893; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Cordaux R, 2006, GENE, V373, P134, DOI 10.1016/j.gene.2006.01.019; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Daskalos A, 2009, INT J CANCER, V124, P81, DOI 10.1002/ijc.23849; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Hamady M, 2008, NAT METHODS, V5, P235, DOI [10.1038/nmeth.1184, 10.1038/NMETH.1184]; Howard G, 2008, ONCOGENE, V27, P404, DOI 10.1038/sj.onc.1210631; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kazazian HH, 1999, NAT GENET, V22, P130, DOI 10.1038/9638; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KIMURA M, 1971, NATURE, V229, P467, DOI 10.1038/229467a0; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li XM, 2001, HUM MUTAT, V17, P511, DOI 10.1002/humu.1134; Liu J, 1997, GENE CHROMOSOME CANC, V18, P232, DOI 10.1002/(SICI)1098-2264(199703)18:3<232::AID-GCC10>3.0.CO;2-K; MIKI Y, 1992, CANCER RES, V52, P643; Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; MORSE B, 1988, NATURE, V333, P87, DOI 10.1038/333087a0; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Myers JS, 2002, AM J HUM GENET, V71, P312, DOI 10.1086/341718; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Ovchinnikov I, 2001, GENOME RES, V11, P2050, DOI 10.1101/gr.194701; PEARSON M, 1985, ANNU REV MED, V36, P471; Sheen FM, 2000, GENOME RES, V10, P1496, DOI 10.1101/gr.149400; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; TAYLOR J, 2007, CURRENT PROTOCOLS BI; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang JX, 2006, HUM MUTAT, V27, P323, DOI 10.1002/humu.20307; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Xing JC, 2009, GENOME RES, V19, P1516, DOI 10.1101/gr.091827.109	44	398	423	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1253	U268		10.1016/j.cell.2010.05.020	http://dx.doi.org/10.1016/j.cell.2010.05.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20603005	Green Accepted, Bronze			2022-12-01	WOS:000279148100021
J	Yu, L; McPhee, CK; Zheng, LX; Mardones, GA; Rong, YG; Peng, JY; Mi, N; Zhao, Y; Liu, ZH; Wan, FY; Hailey, DW; Oorschot, V; Klumperman, J; Baehrecke, EH; Lenardo, MJ				Yu, Li; McPhee, Christina K.; Zheng, Lixin; Mardones, Gonzalo A.; Rong, Yueguang; Peng, Junya; Mi, Na; Zhao, Ying; Liu, Zhihua; Wan, Fengyi; Hailey, Dale W.; Oorschot, Viola; Klumperman, Judith; Baehrecke, Eric H.; Lenardo, Michael J.			Termination of autophagy and reformation of lysosomes regulated by mTOR	NATURE			English	Article							CELL-DEATH; MATURATION; SURVIVAL; PROGRAM; TOR	Autophagy is an evolutionarily conserved process by which cytoplasmic proteins and organelles are catabolized(1,2). During starvation, the protein TOR (target of rapamycin), a nutrient-responsive kinase, is inhibited, and this induces autophagy. In autophagy, double-membrane autophagosomes envelop and sequester intracellular components and then fuse with lysosomes to form autolysosomes, which degrade their contents to regenerate nutrients. Current models of autophagy terminate with the degradation of the autophagosome cargo in autolysosomes(3-5), but the regulation of autophagy in response to nutrients and the subsequent fate of the autolysosome are poorly understood. Here we show that mTOR signalling in rat kidney cells is inhibited during initiation of autophagy, but reactivated by prolonged starvation. Reactivation of mTOR is autophagy-dependent and requires the degradation of autolysosomal products. Increased mTOR activity attenuates autophagy and generates proto-lysosomal tubules and vesicles that extrude from autolysosomes and ultimately mature into functional lysosomes, thereby restoring the full complement of lysosomes in the cell-a process we identify in multiple animal species. Thus, an evolutionarily conserved cycle in autophagy governs nutrient sensing and lysosome homeostasis during starvation.	[Yu, Li; Zheng, Lixin; Liu, Zhihua; Wan, Fengyi; Lenardo, Michael J.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Yu, Li; Rong, Yueguang; Peng, Junya; Mi, Na] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Yu, Li; Rong, Yueguang; Peng, Junya; Mi, Na] State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [McPhee, Christina K.; Baehrecke, Eric H.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [McPhee, Christina K.] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA; [Mardones, Gonzalo A.; Hailey, Dale W.] NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Mardones, Gonzalo A.] Univ Austral Chile, Dept Physiol, Valdivia 5099200, Chile; [Zhao, Ying] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China; [Oorschot, Viola; Klumperman, Judith] Univ Med Ctr Utrecht, Dept Cell Biol, NL-3584 CX Utrecht, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Tsinghua University; University of Massachusetts System; University of Massachusetts Worcester; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Universidad Austral de Chile; Peking University; Utrecht University; Utrecht University Medical Center	Lenardo, MJ (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	lenardo@nih.gov		Mi, Na/0000-0003-3090-197X; RONG, YUEGUANG/0000-0001-6661-9664; Kary, Christina/0000-0002-2586-4185	Division of Intramural Research of the NIAID, NIH, Department of Health and Human Services; NIH [GM079431]; 973 program [2010CB833704]; NSF [20091300700]; Tsinghua University [20091081391]; Netherlands Organisation for Scientific Research (NWO) [918.56.611]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079431] Funding Source: NIH RePORTER	Division of Intramural Research of the NIAID, NIH, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 973 program(National Basic Research Program of China); NSF(National Science Foundation (NSF)); Tsinghua University; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the National Institute of Allergy and Infectious Diseases (NIAID) imaging core facility and Olympus China for technical support; O. Schwartz, J. Kabat, L. Koo, M. Czapiga (Bio-imaging facility (BIF), NIAID, NIH) and Q. Dong (Olympus China) for assistance with confocal microscopy and imaging processing; K. Nagashima and M. J. de la Cruz (NCI) for TEM analyses: J. Lippincott-Schwartz, H Bernstein, and J. Bonifacino for helpful discussions; D. Yamamoto, G. Davis and H. Kramer for constructs and fly strains; and M. v. Peski and R. Scriwanek for assistance with the preparation of the EM figures. This research was supported by the Division of Intramural Research of the NIAID, NIH, Department of Health and Human Services and NIH Grant GM079431 to E. B., 973 program 2010CB833704, NSF grant 20091300700, and Tsinghua University grant 20091081391 to Y.L. J. K. is the recipient of VICI grant 918.56.611 of the Netherlands Organisation for Scientific Research (NWO).	Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Massey AC, 2008, AUTOPHAGY, V4, P442, DOI 10.4161/auto.5654; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima Noboru, 2008, V445, P119, DOI 10.1007/978-1-59745-157-4_7; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yu L, 2004, CELL CYCLE, V3, P1124; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2008, AUTOPHAGY, V4, P567, DOI 10.4161/auto.5902	17	1033	1091	6	192	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 17	2010	465	7300					942	U11		10.1038/nature09076	http://dx.doi.org/10.1038/nature09076			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20526321	Green Accepted			2022-12-01	WOS:000278804500041
J	Chow, JC; Ciaudo, C; Fazzari, MJ; Mise, N; Servant, N; Glass, JL; Attreed, M; Avner, P; Wutz, A; Barillot, E; Greally, JM; Voinnet, O; Heard, E				Chow, Jennifer C.; Ciaudo, Constance; Fazzari, Melissa J.; Mise, Nathan; Servant, Nicolas; Glass, Jacob L.; Attreed, Matthew; Avner, Philip; Wutz, Anton; Barillot, Emmanuel; Greally, John M.; Voinnet, Olivier; Heard, Edith			LINE-1 Activity in Facultative Heterochromatin Formation during X Chromosome Inactivation	CELL			English	Article							LYON REPEAT HYPOTHESIS; SMALL INTERFERING RNAS; XIST RNA; RETROTRANSPOSON SUBFAMILY; L1 RETROTRANSPOSITION; DOSAGE COMPENSATION; GENE-EXPRESSION; MOUSE; ELEMENTS; CELLS	During X chromosome inactivation (XCI), Xist RNA coats and silences one of the two X chromosomes in female cells. Little is known about how XCI spreads across the chromosome, although LINE-1 elements have been proposed to play a role. Here we show that LINEs participate in creating a silent nuclear compartment into which genes become recruited. A subset of young LINE-1 elements, however, is expressed during XCI, rather than being silenced. We demonstrate that such LINE expression requires the specific heterochromatic state induced by Xist. These LINEs often lie within escape-prone regions of the X chromosome, but close to genes that are subject to XCI, and are associated with putative endo-siRNAs. LINEs may thus facilitate XCI at different levels, with silent LINEs participating in assembly of a heterochromatic nuclear compartment induced by Xist, and active LINEs participating in local propagation of XCI into regions that would otherwise be prone to escape.	[Chow, Jennifer C.; Ciaudo, Constance; Servant, Nicolas; Barillot, Emmanuel; Heard, Edith] Inst Curie, F-75248 Paris, France; [Chow, Jennifer C.; Ciaudo, Constance; Heard, Edith] Univ Strasbourg, CNRS UMR3215, F-67084 Strasbourg, France; [Chow, Jennifer C.; Ciaudo, Constance; Heard, Edith] Univ Strasbourg, INSERM U934, F-67084 Strasbourg, France; [Ciaudo, Constance; Voinnet, Olivier] Univ Strasbourg, Inst Biol Mol Plantes, CNRS UPR2357, F-67084 Strasbourg, France; [Fazzari, Melissa J.; Glass, Jacob L.; Attreed, Matthew; Greally, John M.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Fazzari, Melissa J.; Glass, Jacob L.; Attreed, Matthew; Greally, John M.] Albert Einstein Coll Med, Ctr Epigenom, Bronx, NY 10461 USA; [Mise, Nathan; Avner, Philip] Inst Pasteur, URA1968, F-75015 Paris, France; [Mise, Nathan] Jichi Med Univ, Dept Pharmacol, Mibu, Tochigi 3290431, Japan; [Servant, Nicolas; Barillot, Emmanuel] Mines ParisTech, F-77300 Fontainebleau, France; [Servant, Nicolas; Barillot, Emmanuel] INSERM U900, F-77300 Fontainebleau, France; [Wutz, Anton] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QN, England	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Jichi Medical University; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Cambridge	Heard, E (corresponding author), Inst Curie, F-75248 Paris, France.	edith.heard@curie.fr	Heard, Edith/D-7197-2017; 名丹, 三瀬/AAD-1036-2021; Greally, John/AAF-9540-2019; Ciaudo, Constance/A-2014-2012	Heard, Edith/0000-0001-8052-7117; Greally, John/0000-0001-6069-7960; Ciaudo, Constance/0000-0002-0857-4506; Voinnet, Olivier/0000-0001-6982-9544; Servant, Nicolas/0000-0003-1678-7410; BARILLOT, Emmanuel/0000-0003-2724-2002; Fazzari, Melissa/0000-0002-5674-3589	ANR; FRM; European Union [LSHG-CT-2005-018883]; Canceropole IdF; ERC [ERC-210890]; Prix Liliane Bettencourt for Life Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding Source: NIH RePORTER; Medical Research Council [G0800784, G0800784B, G0300723B] Funding Source: researchfish; MRC [G0800784] Funding Source: UKRI	ANR(French National Research Agency (ANR)); FRM(Fondation pour la Recherche Medicale); European Union(European Commission); Canceropole IdF(Region Ile-de-France); ERC(European Research Council (ERC)European Commission); Prix Liliane Bettencourt for Life Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank members of the Heard laboratory and Vincent Colot for critical reading of the manuscript; John Goodier and Deborah Bourc'his for advice and mouse LINE-1 plasmid constructs; and Valerie Cognat (IBMP) for expert bioinformatics analyses. This work was supported by grants from the ANR ("RNA ES"; to both E. H. and O.V.); FRM (Equipe FRM to E. H. and FRM fellowship to J.C.); HEROIC, an Integrated Project funded by the European Union under the 6th Framework Programme (LSHG-CT-2005-018883); and Canceropole IdF (GET project) to E. H; O.V.'s laboratory was further supported by an ERC Young Investigator Award (Grant ERC-210890 "Frontiers of RNAi") and Prix Liliane Bettencourt for Life Sciences.	Abrusan G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000172; Agrelo R, 2009, DEV CELL, V16, P507, DOI 10.1016/j.devcel.2009.03.006; Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Belancio VP, 2008, GENOME RES, V18, P343, DOI 10.1101/gr.5558208; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; BUZIN CH, 1994, DEVELOPMENT, V120, P3529; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Carrel L, 2006, PLOS GENET, V2, P1477, DOI 10.1371/journal.pgen.0020151; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chaumeil Julie, 2008, V463, P297, DOI 10.1007/978-1-59745-406-3_18; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Chow J, 2009, CURR OPIN CELL BIOL, V21, P359, DOI 10.1016/j.ceb.2009.04.012; Ciaudo C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000620; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Clemson CM, 1998, J CELL BIOL, V142, P13, DOI 10.1083/jcb.142.1.13; DeBerardinis RJ, 1999, GENOMICS, V56, P317, DOI 10.1006/geno.1998.5729; Filippova GN, 2005, DEV CELL, V8, P31, DOI 10.1016/j.devcel.2004.10.018; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; Goodier JL, 2001, GENOME RES, V11, P1677, DOI 10.1101/gr.198301; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Halic M, 2010, CELL, V140, P504, DOI 10.1016/j.cell.2010.01.019; Hansen RS, 2003, HUM MOL GENET, V12, P2559, DOI 10.1093/hmg/ddg268; Heitz E, 1928, JAHRB WISS BOT, V69, P762; Horman SR, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/32713; Huntley D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-501; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Li N, 2008, P NATL ACAD SCI USA, V105, P17055, DOI 10.1073/pnas.0807765105; Lin H, 2007, PLOS BIOL, V5, P2809, DOI 10.1371/journal.pbio.0050326; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Martienssen RA, 2005, TRENDS GENET, V21, P450, DOI 10.1016/j.tig.2005.06.005; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Naas TP, 1998, EMBO J, V17, P590, DOI 10.1093/emboj/17.2.590; Okamoto I, 2005, NATURE, V438, P369, DOI 10.1038/nature04155; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Popova BC, 2006, P NATL ACAD SCI USA, V103, P7706, DOI 10.1073/pnas.0602021103; Saze H, 2007, EMBO J, V26, P3641, DOI 10.1038/sj.emboj.7601788; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Wang Z, 2006, PLOS COMPUT BIOL, V2, P979, DOI 10.1371/journal.pcbi.0020113; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Yang F, 2010, GENOME RES, V20, P614, DOI 10.1101/gr.103200.109; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141; Yasuhara JC, 2006, TRENDS GENET, V22, P330, DOI 10.1016/j.tig.2006.04.008	55	227	239	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					956	969		10.1016/j.cell.2010.04.042	http://dx.doi.org/10.1016/j.cell.2010.04.042			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550932	Bronze			2022-12-01	WOS:000278618800011
J	Harvey, J; Warwick, I				Harvey, Julie; Warwick, Ian			A Patient's Journey Endometriosis	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Warwick, Ian] Lisburn Hlth Ctr, Lisburn BT28 1LU, England			julesharvey@yahoo.co.uk							0	11	11	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 10	2010	340								c2661	10.1136/bmj.c2661	http://dx.doi.org/10.1136/bmj.c2661			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611MF	20538637				2022-12-01	WOS:000278818700006
J	Abraham, T				Abraham, Thomas			Personal View The price of poor pandemic communication	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Hong Kong, Journalism & Media Studies Ctr, Publ Hlth Commun Programme, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Abraham, T (corresponding author), Univ Hong Kong, Journalism & Media Studies Ctr, Publ Hlth Commun Programme, Hong Kong, Hong Kong, Peoples R China.	thomas@hku.hk						[Anonymous], 2006, Wkly Epidemiol Rec, V81, P249	1	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 9	2010	340								c2952	10.1136/bmj.c2952	http://dx.doi.org/10.1136/bmj.c2952			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611MD	20534678	Green Submitted			2022-12-01	WOS:000278818500021
J	Cohen, D; Carter, P				Cohen, Deborah; Carter, Philip			WHO and the pandemic flu "conspiracies"	BRITISH MEDICAL JOURNAL			English	Editorial Material							NEURAMINIDASE INHIBITORS; INFLUENZA; OSELTAMIVIR; INFECTION; PREVENTION		[Carter, Philip] Bur Investigat Journalism, London, England			dcohen@bmj.com						Cohen D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5387; Cooper NJ, 2003, BRIT MED J, V326, P1235, DOI 10.1136/bmj.326.7401.1235; Doshi P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3471; *EUR SCI WORK GROU, REV POL PLAN 2006 20; Fendrick AM, 2003, ARCH INTERN MED, V163, P487, DOI 10.1001/archinte.163.4.487; Herlocher ML, 2004, J INFECT DIS, V190, P1627, DOI 10.1086/424572; Herlocher ML, 2003, J INFECT DIS, V188, P1355, DOI 10.1086/379049; *HOLM REP, TAM LAUNCH MED CAMP; *INF DIS SOC AM, CONGR 2009 SOC AW RE; *INT FED PHARM MAN, 2008, WHO INFL VIR SURV SY; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Monto AS, 2004, CLIN INFECT DIS, V39, P459, DOI 10.1086/422646; Monto AS, 2002, J INFECT DIS, V186, P1582, DOI 10.1086/345722; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; OSTERHAUS A, PROPHYLACTIC ROLE; *US FDA, FDA APPR DRUGS INFL; World Health Organization, 2003, GUID WHO GUID	19	84	88	0	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 3	2010	340								c2912	10.1136/bmj.c2912	http://dx.doi.org/10.1136/bmj.c2912			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608BM	20525679				2022-12-01	WOS:000278556500017
J	Tong, C; Li, P; Wu, NL; Yan, YZ; Ying, QL				Tong, Chang; Li, Ping; Wu, Nancy L.; Yan, Youzhen; Ying, Qi-Long			Production of p53 gene knockout rats by homologous recombination in embryonic stem cells	NATURE			English	Article							MUTAGENESIS; MICE; GENERATION; SELECTION	The use of homologous recombination to modify genes in embryonic stem (ES) cells provides a powerful means to elucidate gene function and create disease models(1). Application of this technology to engineer genes in rats has not previously been possible because of the absence of germline-competent ES cells in this species. We have recently established authentic rat ES cells(2,3). Here we report the generation of gene knockout rats using the ES-cell-based gene targeting technology. We designed a targeting vector to disrupt the tumour suppressor gene p53 (also known as Tp53) in rat ES cells by means of homologous recombination. p53 gene-targeted rat ES cells can be routinely generated. Furthermore, the p53 gene-targeted mutation in the rat ES-cell genome can transmit through the germ line via ES-cell rat chimaeras to create p53 gene knockout rats. The rat is the most widely used animal model in biological research(4-7). The establishment of gene targeting technology in rat ES cells, in combination with advances in genomics and the vast amount of research data on physiology and pharmacology in this species, now provide a powerful new platform for the study of human disease.	[Tong, Chang; Li, Ping; Ying, Qi-Long] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA; [Wu, Nancy L.; Yan, Youzhen] Univ So Calif, Keck Sch Med, Norris Canc Ctr Transgen, Knockout Core Facil, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Ying, QL (corresponding author), Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA.	qying@usc.edu			NIH/NCRR [1R01 RR025881]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR025881] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD010926] Funding Source: NIH RePORTER	NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a NIH/NCRR grant to Q.-L.Y. (1R01 RR025881). We thank members of the Ying laboratory and the USC Stem Cell Core for technical assistance; G. Chester for ordering rats; R. Montano and colleagues for rat husbandry; T. Saunders, E. Bryda and M. Pera for critical reading of the manuscript; E. Kho for financial support. We are also grateful to M. Pera and R. Maxson for their support and encouragement.	Adams DJ, 2008, PHYSIOL GENOMICS, V34, P225, DOI 10.1152/physiolgenomics.90242.2008; Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Behringer R., 2003, MANIPULATING MOUSE E; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Cozzi Jean, 2009, Methods Mol Biol, V561, P73, DOI 10.1007/978-1-60327-019-9_5; Feil R, 2007, Handb Exp Pharmacol, P3; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; GILL TJ, 1989, SCIENCE, V245, P269, DOI 10.1126/science.2665079; Hughes ED, 2007, MAMM GENOME, V18, P549, DOI 10.1007/s00335-007-9054-0; Izsvak Z, 2010, NAT METHODS, V7, P443, DOI [10.1038/NMETH.1461, 10.1038/nmeth.1461]; Jacob HJ, 1999, GENOME RES, V9, P1013, DOI 10.1101/gr.9.11.1013; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Kitada K, 2007, NAT METHODS, V4, P131, DOI 10.1038/nmeth1002; Kuhn Ralf, 2002, Methods Mol Biol, V180, P175; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Liu X, 1997, DEV DYNAM, V209, P85; Lu BS, 2007, MAMM GENOME, V18, P338, DOI 10.1007/s00335-007-9025-5; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; MCCARRICK JW, 1993, TRANSGENIC RES, V2, P183, DOI 10.1007/BF01977348; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Sambrook JF., 2001, MOL CLONING LAB MANU; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zan YH, 2003, NAT BIOTECHNOL, V21, P645, DOI 10.1038/nbt830	29	208	284	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2010	467	7312					211	U98		10.1038/nature09368	http://dx.doi.org/10.1038/nature09368			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	647KB	20703227	Green Accepted			2022-12-01	WOS:000281616300035
J	Livingston, G; Leavey, G; Manela, M; Livingston, D; Rait, G; Sampson, E; Bavishi, S; Shahriyarmolki, K; Cooper, C				Livingston, Gill; Leavey, Gerard; Manela, Monica; Livingston, Deborah; Rait, Greta; Sampson, Elizabeth; Bavishi, Shilpa; Shahriyarmolki, Khodayar; Cooper, Claudia			Making decisions for people with dementia who lack capacity: qualitative study of family carers in UK	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CAREGIVERS; MEMBER	Objective To identify common difficult decisions made by family carers on behalf of people with dementia, and facilitators of and barriers to such decisions, in order to produce information for family carers about overcoming barriers. Design Qualitative study to delineate decision areas through focus groups and complexity of decision making in individual interviews. Setting Community settings in London. Participants 43 family carers of people with dementia in focus groups and 46 carers who had already made such decisions in individual interviews. Results Family carers identified five core problematic areas of decision making: accessing dementia related health and social services; care homes; legal-financial matters; non-dementia related health care; and making plans for the person with dementia if the carer became too ill to care for them. They highlighted the difficulties in making proxy decisions, especially against active resistance, and their altered role of patient manager while still a family member. Families devised strategies to gain agreement in order to ensure that the person with dementia retained dignity. Conclusions The following strategies helped with implementation of decisions: introducing change slowly; organising legal changes for the carer as well as the patient; involving a professional to persuade the patient to accept services; and emphasising that services optimised, not impeded, independence. To access services, carers made patients' general practice appointments, accompanied them to the surgery, pointed out symptoms, gained permission to receive confidential information, asked for referral to specialist services, and used professionals' authority to gain patients' agreement. End of life decisions were particularly difficult. They were helped by knowledge of the person with dementia's previous views, clear prognostic information, and family support. Information sheets to help carers to overcome barriers to proxy decision making have been developed; their impact in practice has yet to be evaluated.	[Livingston, Gill; Manela, Monica; Livingston, Deborah; Sampson, Elizabeth; Bavishi, Shilpa; Shahriyarmolki, Khodayar; Cooper, Claudia] UCL, Dept Mental Hlth Sci, London W1W 7FJ, England; [Leavey, Gerard] NIAMH, Belfast BT7 1HE, Antrim, North Ireland; [Leavey, Gerard] Univ Ulster, Belfast BT7 1HE, Antrim, North Ireland; [Rait, Greta] MRC Gen Practice Res Framework, London NW1 2ND, England	University of London; University College London; Ulster University	Livingston, G (corresponding author), UCL, Dept Mental Hlth Sci, London W1W 7FJ, England.	g.livingston@ucl.ac.uk	Leavey, Gerard/AAU-2912-2020; Livingston, G/C-7081-2008; Cooper, Claudia A/C-1556-2008; Sampson, Elizabeth L/B-8647-2009	Leavey, Gerard/0000-0001-8411-8919; Cooper, Claudia A/0000-0002-2777-7616; Sampson, Elizabeth L/0000-0001-8929-7362; Rait, Greta/0000-0002-7216-7294; Livingston, Gill/0000-0001-6741-5516	BUPA Foundation; Medical Research Council [MC_U122797163] Funding Source: researchfish; MRC [MC_U122797163] Funding Source: UKRI	BUPA Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by BUPA Foundation, which had no role in the study design; the collection, analysis, and interpretation of data; or the writing of the article and the decision to submit it for publication. All the researchers are independent of the funders.	*ALZH RES FOR, 2008, AD RES PART INF CONS; [Anonymous], 2009, DEM ETH ISS; Butcher HK, 2001, RES NURS HEALTH, V24, P470, DOI 10.1002/nur.10005; Coffey A., 1996, MAKING SENSE QUALITA; Davies S, 2003, AGEING SOC, V23, P429, DOI 10.1017/S0144686X03001259; Department of Health, 2005, MENT CAP ACT 2005; Department of Health, 2009, LIVING WELL DEMENTIA; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Hansen L, 2004, J NURS SCHOLARSHIP, V36, P233, DOI 10.1111/j.1547-5069.2004.04043.x; Hirschman KB, 2006, AM J GERIAT PSYCHIAT, V14, P659, DOI 10.1097/01.JGP.0000203179.94036.69; Mezey M, 1996, J AM GERIATR SOC, V44, P144, DOI 10.1111/j.1532-5415.1996.tb02430.x; Miles M., 2019, QUALITATIVE DATA ANA, V4th; Potkins D, 2000, INT J GERIATR PSYCH, V15, P1005, DOI 10.1002/1099-1166(200011)15:11<1005::AID-GPS223>3.0.CO;2-0; Selwood A, 2007, J AFFECT DISORDERS, V101, P75, DOI 10.1016/j.jad.2006.10.025; Shah A, 2009, INT PSYCHOGERIATR, V21, P922, DOI 10.1017/S1041610209990391; Smith JA, 1996, PSYCHOL HEALTH, V11, P261, DOI 10.1080/08870449608400256; Wackerbarth S, 2002, GERONTOLOGIST, V42, P340; Wald C, 2003, INT J GERIATR PSYCH, V18, P313, DOI 10.1002/gps.828	18	145	146	0	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 18	2010	341								c4184	10.1136/bmj.c4184	http://dx.doi.org/10.1136/bmj.c4184			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	642KT	20719843	Green Published, hybrid, Green Submitted			2022-12-01	WOS:000281213100007
J	Javitt, G				Javitt, Gail			Assign regulation appropriate to the level of risk	NATURE			English	Editorial Material							GENOMIC PROFILES		[Javitt, Gail] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21218 USA	Johns Hopkins University	Javitt, G (corresponding author), Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21218 USA.	gjavitt1@jhu.edu						Janssens ACJW, 2008, AM J HUM GENET, V82, P593, DOI 10.1016/j.ajhg.2007.12.020; Javitt Gail H, 2004, Oklahoma Law Rev, V57, P251; Lachance CR, 2010, GENET MED, V12, P304, DOI 10.1097/GIM.0b013e3181dbd8b2; Mihaescu R, 2009, GENET MED, V11, P588, DOI 10.1097/GIM.0b013e3181b13a4f; Offit K, 2008, JAMA-J AM MED ASSOC, V299, P1353, DOI 10.1001/jama.299.11.1353	5	22	22	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2010	466	7308					817	818		10.1038/466817a	http://dx.doi.org/10.1038/466817a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	636TT	20703288				2022-12-01	WOS:000280766100017
J	Li, J; Liu, ZY; Tan, C; Guo, XM; Wang, LJ; Sancar, A; Zhong, DP				Li, Jiang; Liu, Zheyun; Tan, Chuang; Guo, Xunmin; Wang, Lijuan; Sancar, Aziz; Zhong, Dongping			Dynamics and mechanism of repair of ultraviolet-induced (6-4) photoproduct by photolyase	NATURE			English	Article							DNA PHOTOLYASE; ELECTRON-TRANSFER; CRYSTAL-STRUCTURE; COFACTOR; ENZYME; CRYPTOCHROME; HISTIDINES; BINDING	One of the detrimental effects of ultraviolet radiation on DNA is the formation of the (6-4) photoproduct, 6-4PP, between two adjacent pyrimidine rings(1). This lesion interferes with replication and transcription, and may result in mutation and cell death(2). In many organisms, a flavoenzyme called photolyase uses blue light energy to repair the 6-4PP (ref. 3). The molecular mechanism of the repair reaction is poorly understood. Here, we use ultrafast spectroscopy to show that the key step in the repair photocycle is a cyclic proton transfer between the enzyme and the substrate. By femtosecond synchronization of the enzymatic dynamics with the repair function, we followed the function evolution and observed direct electron transfer from the excited flavin cofactor to the 6-4PP in 225 picoseconds, but surprisingly fast back electron transfer in 50 picoseconds without repair. We found that the catalytic proton transfer between a histidine residue in the active site and the 6-4PP, induced by the initial photoinduced electron transfer from the excited flavin cofactor to 6-4PP, occurs in 425 picoseconds and leads to 6-4PP repair in tens of nanoseconds. These key dynamics define the repair photocycle and explain the underlying molecular mechanism of the enzyme's modest efficiency.	[Li, Jiang; Liu, Zheyun; Tan, Chuang; Guo, Xunmin; Wang, Lijuan; Zhong, Dongping] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Li, Jiang; Liu, Zheyun; Tan, Chuang; Guo, Xunmin; Wang, Lijuan; Zhong, Dongping] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; [Li, Jiang; Liu, Zheyun; Tan, Chuang; Guo, Xunmin; Wang, Lijuan; Zhong, Dongping] Ohio State Univ, Dept Biochem, Program Biophys, Columbus, OH 43210 USA; [Li, Jiang; Liu, Zheyun; Tan, Chuang; Guo, Xunmin; Wang, Lijuan; Zhong, Dongping] Ohio State Univ, Chem Phys Program, Columbus, OH 43210 USA; [Li, Jiang; Liu, Zheyun; Tan, Chuang; Guo, Xunmin; Wang, Lijuan; Zhong, Dongping] Ohio State Univ, Program Biochem, Columbus, OH 43210 USA; [Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Zhong, DP (corresponding author), Ohio State Univ, Dept Phys, 191 W Woodruff Ave, Columbus, OH 43210 USA.	dongping@mps.ohio-state.edu	Liu, Zheyun/N-4054-2013; Zhong, Dongping/I-2444-2013; Guo, Xunmin/E-7908-2013	Zhong, Dongping/0000-0001-9381-8992; 	National Institutes of Health [GM074813]; Packard fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002779] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074813] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard fellowship(The David & Lucile Packard Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank T. Todo and T. Kitagawa for the generous gift of Arabidopsis thaliana (6-4) photolyase plasmid; C. Forsyth for discussions; and Y.-T. Kao and C.-W. Chang for help during the experiments. This work is supported in part by the National Institutes of Health (research grant GM074813) and the Packard fellowship.	Borg OA, 2007, J PHYS CHEM A, V111, P2351, DOI 10.1021/jp0676383; Chang CW, 2010, P NATL ACAD SCI USA, V107, P2914, DOI 10.1073/pnas.1000001107; Domratcheva T, 2009, J AM CHEM SOC, V131, P17793, DOI 10.1021/ja904550d; Glas AF, 2009, CHEM-EUR J, V15, P10387, DOI 10.1002/chem.200901004; Hitomi K, 2001, J BIOL CHEM, V276, P10103, DOI 10.1074/jbc.M008828200; Hitomi K, 1997, J BIOL CHEM, V272, P32591, DOI 10.1074/jbc.272.51.32591; Hitomi K, 2009, P NATL ACAD SCI USA, V106, P6962, DOI 10.1073/pnas.0809180106; Joseph A, 2000, J AM CHEM SOC, V122, P11219, DOI 10.1021/ja002541u; Kao YT, 2008, J AM CHEM SOC, V130, P7695, DOI 10.1021/ja801152h; Kao YT, 2007, CELL BIOCHEM BIOPHYS, V48, P32, DOI 10.1007/s12013-007-0034-5; Kao YT, 2005, P NATL ACAD SCI USA, V102, P16128, DOI 10.1073/pnas.0506586102; LECLERC JE, 1991, P NATL ACAD SCI USA, V88, P9685, DOI 10.1073/pnas.88.21.9685; Li J, 2006, J PHYS CHEM B, V110, P16724, DOI 10.1021/jp062998b; Marcus RA, 2006, PHILOS T R SOC B, V361, P1445, DOI 10.1098/rstb.2006.1873; Maul MJ, 2008, ANGEW CHEM INT EDIT, V47, P10076, DOI 10.1002/anie.200804268; MITCHELL DL, 1988, PHOTOCHEM PHOTOBIOL, V48, P51; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Saxena C, 2004, J PHYS CHEM B, V108, P18026, DOI 10.1021/jp048376c; Schleicher E, 2007, J BIOL CHEM, V282, P4738, DOI 10.1074/jbc.M604734200; TAYLOR JS, 1994, ACCOUNTS CHEM RES, V27, P76, DOI 10.1021/ar00039a003; TODO T, 1993, NATURE, V361, P371, DOI 10.1038/361371a0; Wang HY, 2007, SCIENCE, V316, P747, DOI 10.1126/science.1140030; Yamamoto J, 2009, ORG BIOMOL CHEM, V7, P161, DOI 10.1039/b815458a; Yamamoto J, 2009, BIOCHEMISTRY-US, V48, P9306, DOI 10.1021/bi900956p; Zhao XD, 1997, J BIOL CHEM, V272, P32580, DOI 10.1074/jbc.272.51.32580; Zhong DP, 2007, CURR OPIN CHEM BIOL, V11, P174, DOI 10.1016/j.cbpa.2007.02.034	26	161	161	4	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2010	466	7308					887	U124		10.1038/nature09192	http://dx.doi.org/10.1038/nature09192			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20657578	Green Submitted, Green Accepted			2022-12-01	WOS:000280766100041
J	Ritchie, K; Carriere, I; Ritchie, CW; Berr, C; Artero, S; Ancelin, ML				Ritchie, K.; Carriere, I.; Ritchie, C. W.; Berr, C.; Artero, S.; Ancelin, M-L			Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors	BRITISH MEDICAL JOURNAL			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; BLOOD-PRESSURE; ELDERLY-PEOPLE; HEAD-INJURY; OLDEST-OLD; METAANALYSIS; POPULATION; CONSUMPTION; ALCOHOL	Objective To estimate the percentage reduction in incidence of dementia that would be obtained if specific risk factors were eliminated. Design Prospective seven year cohort study. Setting General population, Montpellier, France. Participants 1433 people aged over 65 with a mean baseline age of 72.5 (SD 5.1) years. Main outcome measures Diagnosis of mild cognitive impairment or dementia established by a standardised neurological examination. Results Cox models were constructed to derive hazard ratios and determine confounding and interaction effects for potentially modifiable risk factors for dementia. Mean percentage population attributable fractions were calculated with 95% confidence intervals derived from bootstrapping for seven year incidence of mild cognitive impairment or dementia. The final model retained crystallised intelligence (population attributable fraction 18.11%, 95% confidence interval 10.91% to 25.42%), depression (10.31%, 3.66% to 17.17%), fruit and vegetable consumption (6.46%, 0.15% to 13.06%), diabetes (4.88%, 1.87% to 7.98%), and apolipoprotein E epsilon 4 allele (7.11%, 2.44% to 11.98%). Conclusions Increasing crystallised intelligence and fruit and vegetable consumption and eliminating depression and diabetes are likely to have the biggest impact on reducing the incidence of dementia, outweighing even the effect of removing the principal known genetic risk factor. Although causal relations cannot be concluded with certainty, the study suggests priorities that may inform public health programmes.	[Ritchie, K.; Carriere, I.; Berr, C.; Artero, S.; Ancelin, M-L] Colombiere Hosp, INSERM, Nervous Syst Pathol Epidemiol & Clin Res U888, F-34093 Montpellier 5, France; [Ritchie, K.; Carriere, I.; Berr, C.; Artero, S.; Ancelin, M-L] Univ Montpellier 1, F-34000 Montpellier, France; [Ritchie, K.; Ritchie, C. W.] Univ London Imperial Coll Sci Technol & Med, St Marys Hosp, Fac Med, London SW7 2AZ, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Imperial College London	Ritchie, K (corresponding author), Colombiere Hosp, INSERM, Nervous Syst Pathol Epidemiol & Clin Res U888, F-34093 Montpellier 5, France.	karen.ritchie@inserm.fr	Artero, Sylvaine/AAE-6059-2020; berr, Claudine/D-5238-2014; Ancelin, Marie-Laure/L-1198-2019; Carrière, Isabelle/W-8728-2019; Ritchie, Karen/G-3571-2013; Ancelin, Marie-Laure/F-3079-2013	berr, Claudine/0000-0001-5254-7655; Ancelin, Marie-Laure/0000-0002-1149-4320; Ritchie, Karen/0000-0002-0688-8982; Ancelin, Marie-Laure/0000-0002-1149-4320; Carriere, Isabelle/0000-0002-3617-0752; Artero, Sylvaine/0000-0002-1671-226X	Novartis; National Research Agency [07 LVIE004]	Novartis(Novartis); National Research Agency(French National Research Agency (ANR))	The Esprit Study was funded by an unconditional grant from Novartis and from the National Research Agency (ANR Project 07 LVIE004). Funding from Novartis was used to purchase equipment and pay for secretarial assistance. ANR funding provided salaries for the interviewers and the costs of clinical and biological examinations. Neither body was involved in the statistical analyses or preparation of the manuscript.	Akbaraly TN, 2009, NEUROLOGY, V73, P854, DOI 10.1212/WNL.0b013e3181b7849b; Ancelin ML, 2006, BMJ-BRIT MED J, V332, P455, DOI 10.1136/bmj.38740.439664.DE; Ancelin ML, 2005, CURR PHARM DESIGN, V11, P4229, DOI 10.2174/138161205774913228; Anstey KJ, 2009, AM J GERIAT PSYCHIAT, V17, P542, DOI 10.1097/JGP.0b013e3181a2fd07; Artero S, 2006, DEMENT GERIATR COGN, V22, P465, DOI 10.1159/000096287; Ashford JW, 2004, J MOL NEUROSCI, V23, P157, DOI 10.1385/JMN:23:3:157; Baranov D, 2009, ANESTH ANALG, V108, P1627, DOI 10.1213/ane.0b013e318199dc72; Blair J. R., 1989, CLIN NEUROPSYCHOL, V3, P129, DOI DOI 10.1080/13854048908403285; Carriere I, 2009, ARCH INTERN MED, V169, P1317, DOI 10.1001/archinternmed.2009.229; Duron E, 2008, VASC HEALTH RISK MAN, V4, P363; Eriksson UK, 2008, DEMENT GERIATR COGN, V25, P148, DOI 10.1159/000112729; Etminan M, 2003, BMJ-BRIT MED J, V327, P128, DOI 10.1136/bmj.327.7407.128; Farooki A, 2009, NEUROLOGY, V72, P1030; FERRI C, 2005, LANCET, V17, P2112; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; GAMMANPILA UP, 2007, BMC GERIATR, V6, P7; Gao S, 1998, ARCH GEN PSYCHIAT, V55, P809, DOI 10.1001/archpsyc.55.9.809; Gharibzadeh S, 2007, MED HYPOTHESES, V68, P718, DOI 10.1016/j.mehy.2006.08.019; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hall CB, 2009, NEUROLOGY, V73, P356, DOI 10.1212/WNL.0b013e3181b04ae3; Harwood DG, 2010, INT J GERIATR PSYCH, V25, P511, DOI 10.1002/gps.2372; Helzner EP, 2009, ARCH NEUROL-CHICAGO, V66, P343, DOI 10.1001/archneur.66.3.343; Hendrie HC, 2001, JAMA-J AM MED ASSOC, V285, P739, DOI 10.1001/jama.285.6.739; Itzhaki RE, 2004, NEUROBIOL AGING, V25, P619, DOI 10.1016/j.neurobiolaging.2003.12.021; Jorm AF, 2001, AUST NZ J PSYCHIAT, V35, P776, DOI 10.1046/j.1440-1614.2001.00967.x; Lautenschlager NT, 1996, NEUROLOGY, V46, P641, DOI 10.1212/WNL.46.3.641; LECRUBIER Y, 1997, EUROPEAN PSYCHIAT, V12, P232; LEE Y, 2009, INT PSYCHOGERIATR, V9, P1; LIN C, 2010, BRIT MED J, V340, pB5465; Luchsinger JA, 2004, J AM GERIATR SOC, V52, P540, DOI 10.1111/j.1532-5415.2004.52159.x; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; Middleton LE, 2009, ARCH NEUROL-CHICAGO, V66, P1210, DOI 10.1001/archneurol.2009.201; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1; Peila R, 2001, STROKE, V32, P2882, DOI 10.1161/hs1201.100392; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Razay G, 2009, DEMENT GERIATR COGN, V28, P70, DOI 10.1159/000230877; RITCHIE K, 1995, LANCET, V346, P931, DOI 10.1016/S0140-6736(95)91556-7; Ritchie K, 1999, AGE AGEING, V28, P385, DOI 10.1093/ageing/28.4.385; Ritchie K, 2010, J ALZHEIMERS DIS, V20, pS161, DOI 10.3233/JAD-2010-1387; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Ryan J, 2009, NEUROLOGY, V73, P1729, DOI 10.1212/WNL.0b013e3181c34b0c; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; Seripa D, 2009, AGEING RES REV, V8, P214, DOI 10.1016/j.arr.2008.12.003; Steenland K, 2006, EPIDEMIOLOGY, V17, P512, DOI 10.1097/01.ede.0000229155.05644.43; STERN Y, 1992, ANN NEUROL, V32, P371, DOI 10.1002/ana.410320311; Stewart R, 2002, J AM GERIATR SOC, V50, P1227, DOI 10.1046/j.1532-5415.2002.50309.x; Stewart R, 2007, ARCH NEUROL-CHICAGO, V64, P103, DOI 10.1001/archneur.64.1.103; VANDUIJN CM, 1991, BRIT MED J, V302, P1491, DOI 10.1136/bmj.302.6791.1491; WHITE L, 2006, ALZ DIS ASSOC DIS, V20, P79	52	141	147	1	31	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 5	2010	341								c3885	10.1136/bmj.c3885	http://dx.doi.org/10.1136/bmj.c3885			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636WK	20688841	Green Published, hybrid, Green Submitted			2022-12-01	WOS:000280774200004
J	Beyrer, C; Malinowska-Sempruch, K; Kamarulzaman, A; Strathdee, SA				Beyrer, Chris; Malinowska-Sempruch, Kasia; Kamarulzaman, Adeeba; Strathdee, Steffanie A.			12 myths about HIV/AIDS and people who use drugs	LANCET			English	Editorial Material							INJECTION; EFFICACY		[Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA; [Malinowska-Sempruch, Kasia] Open Soc Inst, Drug Policy Program, Warsaw, Poland; [Kamarulzaman, Adeeba] Univ Malaya, Dept Med, Kuala Lumpur, Malaysia; [Strathdee, Steffanie A.] Univ Calif San Diego, Dept Epidemiol, San Diego, CA 92103 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universiti Malaya; University of California System; University of California San Diego	Beyrer, C (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Publ Hlth & Human Rights, Baltimore, MD 21205 USA.	cbeyrer@jhsph.edu	Strathdee, Steffanie A/B-9042-2009; KAMARULZAMAN, ADEEBA/B-5216-2010	Strathdee, Steffanie/0000-0002-7724-691X				Brady JE, 2008, J URBAN HEALTH, V85, P323, DOI 10.1007/s11524-007-9248-5; Fisher DG, 2003, JAIDS-J ACQ IMM DEF, V33, P199, DOI 10.1097/00126334-200306010-00014; Grigoryan A., 2009, Morbidity and Mortality Weekly Report, V58, P1291; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Institute of Medicine, 2006, PREV HIV INF INJ DRU; Kerr T., 2007, PUBLIC HLTH HUMAN RI, P11; Malta M, 2010, AIDS BEHAV, V14, P731, DOI 10.1007/s10461-008-9489-7; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; Mattick RP, 2009, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD002209; Mauer M., 2007, UNEVEN JUSTICE STATE; Mausbach BT, 2007, ANN BEHAV MED, V34, P263, DOI 10.1007/BF02874551; Mausbach BT, 2007, DRUG ALCOHOL DEPEN, V87, P249, DOI 10.1016/j.drugalcdep.2006.08.026; *OFF NAT DRUG CONT, MIN DRUGS FACTS FIG; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Stoltz JA, 2007, J PUBLIC HEALTH, V29, P35, DOI 10.1093/pubmed/fdl090; Strathdee SA, 2001, ARCH INTERN MED, V161, P1281, DOI 10.1001/archinte.161.10.1281; VLAHOV D, 2009, CLIN INFECT DIS, V104, P796; Wood E, 2008, JAMA-J AM MED ASSOC, V300, P550, DOI 10.1001/jama.300.5.550	18	19	20	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2010	376	9737					208	211		10.1016/S0140-6736(10)61005-7	http://dx.doi.org/10.1016/S0140-6736(10)61005-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632VM	20650524				2022-12-01	WOS:000280457200005
J	Erba, E; Bottini, C; Weissert, HJ; Keller, CE				Erba, Elisabetta; Bottini, Cinzia; Weissert, Helmut J.; Keller, Christina E.			Calcareous Nannoplankton Response to Surface-Water Acidification Around Oceanic Anoxic Event 1a	SCIENCE			English	Article							PLANKTON EVOLUTION; CALCIFICATION; NANNOFOSSILS; CARBON; STRATIGRAPHY; EXTINCTION; GREENHOUSE; SEDIMENTS; PULSE; EARTH	Ocean acidification induced by atmospheric CO2 may be a major threat to marine ecosystems, particularly to calcareous nannoplankton. We show that, during the Aptian (similar to 120 million years ago) Oceanic Anoxic Event 1a, which resulted from a massive addition of volcanic CO2, the morphological features of calcareous nannofossils traced the biological response to acidified surface waters. We observe the demise of heavily calcified nannoconids and reduced calcite paleofluxes at the beginning of a pre-anoxia calcification crisis. Ephemeral coccolith dwarfism and malformation represent species-specific adjustments to survive lower pH, whereas later, abundance peaks indicate intermittent alkalinity recovery. Deepwater acidification occurred with a delay of 25,000 to 30,000 years. After the dissolution climax, nannoplankton and carbonate recovery developed over similar to 160,000 years under persisting global dysoxia-anoxia.	[Erba, Elisabetta; Bottini, Cinzia] Univ Milan, Dipartimento Sci Terra Ardito Desio, I-20133 Milan, Italy; [Weissert, Helmut J.; Keller, Christina E.] ETH Zentrum, Dept Earth Sci, CH-8092 Zurich, Switzerland	University of Milan; Swiss Federal Institutes of Technology Domain; ETH Zurich	Erba, E (corresponding author), Univ Milan, Dipartimento Sci Terra Ardito Desio, Via Mangiagalli 34, I-20133 Milan, Italy.	elisabetta.erba@unimi.it	bottini, cinzia/T-1478-2017	bottini, cinzia/0000-0003-1287-5579; Allam, Sherif/0000-0002-5555-7928	MIUR (Italian Ministry of University and Research) [2007-2007W9B2WE 001]; Swiss Science Foundation [200021-113687]; ETH Zurich	MIUR (Italian Ministry of University and Research)(Ministry of Education, Universities and Research (MIUR)); Swiss Science Foundation(Swiss National Science Foundation (SNSF)); ETH Zurich(ETH Zurich)	E.E. and C.B. were funded through MIUR (Italian Ministry of University and Research), Research Programs of National Interest (PRIN) grant 2007-2007W9B2WE 001. H.J.W. and C. E. K. were funded by the Swiss Science Foundation (project 200021-113687) and by ETH Zurich. E. E. and C. B. investigated calcareous nannofossil assemblages, H.J.W. and C. E. K. analyzed C and O isotopes. All authors contributed to the synthesis and paleoceanographic model. Samples from DSDP site 463 were supplied by the Integrated Ocean Drilling Program.	Ando A, 2008, PALAEOGEOGR PALAEOCL, V260, P463, DOI 10.1016/j.palaeo.2007.12.007; Ramos JBE, 2010, BIOGEOSCIENCES, V7, P177, DOI 10.5194/bg-7-177-2010; Bernoulli D, 2009, SEDIMENTOLOGY, V56, P149, DOI 10.1111/j.1365-3091.2008.01017.x; Bown P, 2009, MAR MICROPALEONTOL, V71, P60, DOI 10.1016/j.marmicro.2009.01.005; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Dickens GR, 1997, GEOLOGY, V25, P259, DOI 10.1130/0091-7613(1997)025<0259:ABOGIT>2.3.CO;2; Erba E, 2004, MAR MICROPALEONTOL, V52, P85, DOI 10.1016/j.marmicro.2004.04.007; Erba E, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000884; ERBA E, 1994, PALEOCEANOGRAPHY, V9, P483, DOI 10.1029/94PA00258; Erba E, 1999, J FORAMIN RES, V29, P371; Gibbs SJ, 2006, SCIENCE, V314, P1770, DOI 10.1126/science.1133902; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Jenkyns HC, 2003, PHILOS T R SOC A, V361, P1885, DOI 10.1098/rsta.2003.1240; Jiang SJ, 2010, NAT GEOSCI, V3, P280, DOI 10.1038/NGEO775; Kump LR, 2009, OCEANOGRAPHY, V22, P94, DOI 10.5670/oceanog.2009.100; LARSON RL, 1991, GEOLOGY, V19, P547, DOI 10.1130/0091-7613(1991)019<0547:LPOEEF>2.3.CO;2; Larson RL, 1999, PALEOCEANOGRAPHY, V14, P663, DOI 10.1029/1999PA900040; Leckie RM, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000623; Malinverno A, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001769; Mehay S, 2009, GEOLOGY, V37, P819, DOI 10.1130/G30100A.1; Menegatti AP, 1998, PALEOCEANOGRAPHY, V13, P530, DOI 10.1029/98PA01793; Millan MI, 2009, EARTH PLANET SC LETT, V287, P392, DOI 10.1016/j.epsl.2009.08.023; Raffi I, 2008, MAR MICROPALEONTOL, V69, P119, DOI 10.1016/j.marmicro.2008.07.002; Ridgwell A, 2009, BIOGEOSCIENCES, V6, P2611, DOI 10.5194/bg-6-2611-2009; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Tejada MLG, 2009, GEOLOGY, V37, P855, DOI 10.1130/G25763A.1; Weissert H, 2004, J GEOL SOC LONDON, V161, P695, DOI 10.1144/0016-764903-087; Zachos JC, 2005, SCIENCE, V308, P1611, DOI 10.1126/science.1109004	29	171	176	3	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2010	329	5990					428	432		10.1126/science.1188886	http://dx.doi.org/10.1126/science.1188886			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20651148				2022-12-01	WOS:000280196500034
J	Liu, W; Tanasa, B; Tyurina, OV; Zhou, TY; Gassmann, R; Liu, WT; Ohgi, KA; Benner, C; Garcia-Bassets, I; Aggarwal, AK; Desai, A; Dorrestein, PC; Glass, CK; Rosenfeld, MG				Liu, Wen; Tanasa, Bogdan; Tyurina, Oksana V.; Zhou, Tian Yuan; Gassmann, Reto; Liu, Wei Ting; Ohgi, Kenneth A.; Benner, Chris; Garcia-Bassets, Ivan; Aggarwal, Aneel K.; Desai, Arshad; Dorrestein, Pieter C.; Glass, Christopher K.; Rosenfeld, Michael G.			PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression	NATURE			English	Article							S-PHASE; CHROMOSOME STRUCTURE; MENTAL-RETARDATION; HEAT REPEATS; METHYLATION; IDENTIFICATION; STABILITY; BINDING; PROTEIN; GENOME	While reversible histone modifications are linked to an ever-expanding range of biological functions(1-5), the demethylases for histone H4 lysine 20 and their potential regulatory roles remain unknown. Here we report that the PHD and Jumonji C (JmjC) domain-containing protein, PHF8, while using multiple substrates, including H3K9me1/2 and H3K27me2, also functions as an H4K20me1 demethylase. PHF8 is recruited to promoters by its PHD domain based on interaction with H3K4me2/3 and controls G1-S transition in conjunction with E2F1, HCF-1 (also known as HCFC1) and SET1A (also known as SETD1A), at least in part, by removing the repressive H4K20me1 mark from a subset of E2F1-regulated gene promoters. Phosphorylation-dependent PHF8 dismissal from chromatin in prophase is apparently required for the accumulation of H4K20me1 during early mitosis, which might represent a component of the condensin II loading process. Accordingly, the HEAT repeat clusters in two non-structuralmaintenance of chromosomes (SMC) condensin II subunits, N-CAPD3 and N-CAPG2 (also known as NCAPD3 and NCAPG2, respectively), are capable of recognizing H4K20me1, and ChIP-Seq analysis demonstrates a significant overlap of condensin II and H4K20me1 sites in mitotic HeLa cells. Thus, the identification and characterization of an H4K20me1 demethylase, PHF8, has revealed an intimate link between this enzyme and two distinct events in cell cycle progression.	[Liu, Wen; Tanasa, Bogdan; Tyurina, Oksana V.; Zhou, Tian Yuan; Ohgi, Kenneth A.; Garcia-Bassets, Ivan; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Liu, Wen] Univ Calif San Diego, Grad Program Biol, La Jolla, CA 92093 USA; [Tanasa, Bogdan] Scripps Res Inst, Kellogg Sch Sci & Technol, La Jolla, CA 92037 USA; [Gassmann, Reto; Desai, Arshad] Univ Calif San Diego, Dept Cellular & Mol Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Liu, Wei Ting; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Aggarwal, Aneel K.] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu	Dorrestein, Pieter/D-5012-2012; Glass, Christopher/AAI-3933-2021; Dorrestein, Pieter/ABF-2930-2020; Gassmann, Reto/M-6488-2013; Garcia-Bassets, Ivan/F-5075-2010	Glass, Christopher/0000-0003-4344-3592; Gassmann, Reto/0000-0002-0360-2977; Benner, Christopher/0000-0002-4618-0719; Garcia-Bassets, Ivan/0000-0002-6941-9585; Liu, Wen/0000-0003-3434-4162	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA097134, R01 CA097134-09] Funding Source: Medline; NHLBI NIH HHS [R01 HL065445] Funding Source: Medline; NIDDK NIH HHS [R01 DK018477, R01 DK039949-18, R01 DK018477-35, R37 DK039949, R01 DK039949] Funding Source: Medline; NINDS NIH HHS [R01 NS034934, R01 NS034934-21] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA097134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039949, R01DK039949, R01DK018477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Belmont AS, 2006, CURR OPIN CELL BIOL, V18, P632, DOI 10.1016/j.ceb.2006.09.007; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Fortschegger K, 2010, MOL CELL BIOL, V30, P3286, DOI 10.1128/MCB.01520-09; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Haering CH, 2009, CHROMOSOME RES, V17, P127, DOI 10.1007/s10577-008-9008-8; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Houston SI, 2008, J BIOL CHEM, V283, P19478, DOI 10.1074/jbc.M710579200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hudson DF, 2009, CHROMOSOME RES, V17, P131, DOI 10.1007/s10577-008-9009-7; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Loenarz C, 2010, HUM MOL GENET, V19, P217, DOI 10.1093/hmg/ddp480; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Neuwald AF, 2000, GENOME RES, V10, P1445, DOI 10.1101/gr.147400; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sasik R, 2004, J MOL ENDOCRINOL, V33, P1, DOI 10.1677/jme.0.0330001; Schwender H, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-144; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tanner S, 2005, ANAL CHEM, V77, P4626, DOI 10.1021/ac050102d; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Wolf F, 2007, CELL CYCLE, V6, P1408; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yeong FM, 2003, CURR BIOL, V13, P2058, DOI 10.1016/j.cub.2003.10.032; Yin Y, 2008, CELL CYCLE, V7, P1423, DOI 10.4161/cc.7.10.5867; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	42	289	300	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					508	U14		10.1038/nature09272	http://dx.doi.org/10.1038/nature09272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20622854	Green Accepted, Green Published			2022-12-01	WOS:000280141200040
J	ten Hacken, NHT; van der Molen, T				ten Hacken, Nick H. T.; van der Molen, Thys			Easily Missed? Bronchiectasis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[ten Hacken, Nick H. T.; van der Molen, Thys] Univ Groningen, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands	University of Groningen	ten Hacken, NHT (corresponding author), Univ Groningen, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands.	n.h.t.ten.hacken@long.umcg.nl						BARKER AF, 2008, CLIN MANIFESTATIONS; Chang AB, 2002, MED J AUSTRALIA, V177, P200, DOI 10.5694/j.1326-5377.2002.tb04733.x; Evans DJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001392.pub2; GUDBJERG CE, 1955, ACTA RADIOL, V43, P209, DOI 10.3109/00016925509172763; JONES AP, 2000, COCHRANE DB SYST REV; Keistinen T, 1997, EUR RESPIR J, V10, P2784, DOI 10.1183/09031936.97.10122784; King PT, 2009, COPD, V6, P130, DOI 10.1080/15412550902766934; Li AM, 2005, EUR RESPIR J, V26, P8, DOI 10.1183/09031936.05.00127704; NICOTRA MB, 1995, CHEST, V108, P955, DOI 10.1378/chest.108.4.955; Parr DG, 2007, AM J RESP CRIT CARE, V176, P1215, DOI 10.1164/rccm.200703-489OC; Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120; Onen ZP, 2007, RESP MED, V101, P1390, DOI 10.1016/j.rmed.2007.02.002; Rosen MJ, 2006, CHEST, V129, p122S, DOI 10.1378/chest.129.1_suppl.122S; Smith IE, 1996, BRIT J RADIOL, V69, P589, DOI 10.1259/0007-1285-69-823-589; TENHACKEN N, 2008, CLIN EVID; vanderBruggenBogaarts BAHA, 1996, CHEST, V109, P608, DOI 10.1378/chest.109.3.608; Weycker D., 2005, Clinical Pulmonary Medicine, V12, P205, DOI 10.1097/01.cpm.0000171422.98696.ed	17	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2010	341								c2766	10.1136/bmj.c2766	http://dx.doi.org/10.1136/bmj.c2766			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628XC	20630967				2022-12-01	WOS:000280156700002
J	Bayon, R; Jenkins, M				Bayon, Ricardo; Jenkins, Michael			The business of biodiversity	NATURE			English	Editorial Material									[Bayon, Ricardo] EKO Asset Management Partners, New York, NY 10019 USA; [Jenkins, Michael] Forest Trends, Washington, DC 20007 USA		Bayon, R (corresponding author), EKO Asset Management Partners, 1350 Ave Amer,29th Floor, New York, NY 10019 USA.	rbayon@ekoamp.com; mjenkins@Forest-trends.org						BAYON R, 2008, WORLD 2008 INNOVATIO, P123; *BUS BIOD OFFS PRO, 2009, BBOP PIL PROJ CAS ST; Hamilton K., 2010, BUILDING BRIDGES STA; Madsen B, 2010, STATE BIODIVERSITY M; PERROTMAITRE D, 2010, MOUNTAIN FORUM B; Stanton T., 2010, STATE WATERSHED PAYM	6	42	43	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					184	185		10.1038/466184a	http://dx.doi.org/10.1038/466184a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	621LR	20613823				2022-12-01	WOS:000279580800018
J	Hapfelmeier, S; Lawson, MAE; Slack, E; Kirundi, JK; Stoel, M; Heikenwalder, M; Cahenzli, J; Velykoredko, Y; Balmer, ML; Endt, K; Geuking, MB; Curtiss, R; McCoy, KD; Macpherson, AJ				Hapfelmeier, Siegfried; Lawson, Melissa A. E.; Slack, Emma; Kirundi, Jorum K.; Stoel, Maaike; Heikenwalder, Mathias; Cahenzli, Julia; Velykoredko, Yuliya; Balmer, Maria L.; Endt, Kathrin; Geuking, Markus B.; Curtiss, Roy, III; McCoy, Kathy D.; Macpherson, Andrew J.			Reversible Microbial Colonization of Germ-Free Mice Reveals the Dynamics of IgA Immune Responses	SCIENCE			English	Article							PLASMA-CELLS; COMMENSAL BACTERIA; T-CELLS; MEMORY; MAINTENANCE; GUT	The lower intestine of adult mammals is densely colonized with nonpathogenic (commensal) microbes. Gut bacteria induce protective immune responses, which ensure host-microbial mutualism. The continuous presence of commensal intestinal bacteria has made it difficult to study mucosal immune dynamics. Here, we report a reversible germ-free colonization system in mice that is independent of diet or antibiotic manipulation. A slow (more than 14 days) onset of a long-lived (half-life over 16 weeks), highly specific anticommensal immunoglobulin A (IgA) response in germ-free mice was observed. Ongoing commensal exposure in colonized mice rapidly abrogated this response. Sequential doses lacked a classical prime-boost effect seen in systemic vaccination, but specific IgA induction occurred as a stepwise response to current bacterial exposure, such that the antibody repertoire matched the existing commensal content.	[Hapfelmeier, Siegfried; Slack, Emma; Kirundi, Jorum K.; Balmer, Maria L.; Macpherson, Andrew J.] Univ Bern, Univ Klin Viszerale Chirurg & Med UVCM, DKF Maurice Muller Labs, MEM, CH-3013 Bern, Switzerland; [Hapfelmeier, Siegfried; Lawson, Melissa A. E.; Slack, Emma; Kirundi, Jorum K.; Stoel, Maaike; Cahenzli, Julia; Velykoredko, Yuliya; Geuking, Markus B.; McCoy, Kathy D.; Macpherson, Andrew J.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON L8N 3Z5, Canada; [Heikenwalder, Mathias] Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland; [Endt, Kathrin] Fed Inst Technol, Inst Microbiol, CH-8093 Zurich, Switzerland; [Curtiss, Roy, III] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA	University of Bern; University Hospital of Bern; McMaster University; University of Zurich; University Zurich Hospital; Arizona State University; Arizona State University-Tempe	Hapfelmeier, S (corresponding author), Univ Bern, Univ Klin Viszerale Chirurg & Med UVCM, DKF Maurice Muller Labs, MEM, CH-3013 Bern, Switzerland.	hapfelmeier@gmail.com; andrew.macpherson@insel.ch	Balmer, Maria L/A-8546-2013; McCoy, Kathy/ABD-5814-2021; Hapfelmeier, Siegfried/B-6005-2011; Balmer, Maria Luisa/AAB-8993-2021; Slack, Emma/AAD-5837-2019; Lawson, Melissa/K-5848-2014; Heikenwalder, Mathias/AAA-2269-2020; Slack, Emma/B-1612-2016	Hapfelmeier, Siegfried/0000-0002-6913-7932; Balmer, Maria Luisa/0000-0003-0356-6352; Slack, Emma/0000-0002-2473-1145; Slack, Emma/0000-0002-2473-1145; Kirundi, Jorum/0000-0001-9617-0634; Lawson, Melissa/0000-0001-9882-8663	Swiss National Science Foundation [310030_124732]; Canadian Institutes of Health Research; Crohn's and Colitis Foundation of Canada; Genome Canada; Farncombe Foundation; Canadian Association of Gastroenterology; Canada Research Chairs program; Oncosuisse Foundation [OCS 02113-08-2007]; German Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060557] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Crohn's and Colitis Foundation of Canada; Genome Canada(Genome Canada); Farncombe Foundation; Canadian Association of Gastroenterology; Canada Research Chairs program(Canada Research Chairs); Oncosuisse Foundation; German Science Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Zhang, H. Roberts, J. Notarangelo, S. Armstrong, S. Competente, M. Provenza, J. Bodewes, and R. McArthur for their technical support and B. Stecher, W.-D. Hardt, A. J. Muller, N. A. Bos, C. Mueller, R. M. Zinkernagel, A. G. Rolink, A. Lanzavecchia, and C. Reis e Sousa for their helpful comments and editing the manuscript. Grant support: Swiss National Science Foundation (310030_124732), Canadian Institutes of Health Research, Crohn's and Colitis Foundation of Canada, Genome Canada, Farncombe Foundation, Canadian Association of Gastroenterology. This research was also supported with funding from the Canada Research Chairs program to K. D. M. and A. J. M. M. H. is a fellow of the Prof. Dr. Max Cloetta foundation and was supported by grants of the Oncosuisse Foundation (OCS 02113-08-2007). S. H. was supported in part by a German Science Foundation fellowship, and the clean mouse facility Bern was supported by the Genaxen Foundation. The authors have no conflicts of interests to declare.	BENTLEY AT, 1988, J BACTERIOL, V170, P1063, DOI 10.1128/jb.170.3.1063-1068.1988; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; FECSIK AI, 1964, J EXP MED, V120, P1041, DOI 10.1084/jem.120.6.1041; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; MATTIOLI CA, 1973, J EXP MED, V138, P452, DOI 10.1084/jem.138.2.452; NAKAYAMA K, 1988, BIO-TECHNOL, V6, P693, DOI 10.1038/nbt0688-693; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; SHROFF KE, 1995, INFECT IMMUN, V63, P3904, DOI 10.1128/IAI.63.10.3904-3913.1995; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Tough DF, 2003, TRENDS IMMUNOL, V24, P404, DOI 10.1016/S1471-4906(03)00169-8; Zinkernagel RM, 2006, IMMUNOL REV, V211, P310, DOI 10.1111/j.0105-2896.2006.00402.x	16	484	525	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1705	1709		10.1126/science.1188454	http://dx.doi.org/10.1126/science.1188454			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576892	Green Accepted			2022-12-01	WOS:000279107400047
J	Martello, G; Rosato, A; Ferrari, F; Manfrin, A; Cordenonsi, M; Dupont, S; Enzo, E; Guzzardo, V; Rondina, M; Spruce, T; Parenti, AR; Daidone, MG; Bicciato, S; Piccolo, S				Martello, Graziano; Rosato, Antonio; Ferrari, Francesco; Manfrin, Andrea; Cordenonsi, Michelangelo; Dupont, Sirio; Enzo, Elena; Guzzardo, Vincenza; Rondina, Maria; Spruce, Thomas; Parenti, Anna R.; Daidone, Maria Grazia; Bicciato, Silvio; Piccolo, Stefano			A MicroRNA Targeting Dicer for Metastasis Control	CELL			English	Article							EXPRESSION; DEFINITION; SIGNATURE; INVASION; SUBTYPES; GENES; FILES; ZEB1; RNAS	Although specific microRNAs (miRNAs) can be upregulated in cancer, global miRNA downregulation is a common trait of human malignancies. The mechanisms of this phenomenon and the advantages it affords remain poorly understood. Here we identify a microRNA family, miR-103/107, that attenuates miRNA biosynthesis by targeting Dicer, a key component of the miRNA processing machinery. In human breast cancer, high levels of miR-103/107 are associated with metastasis and poor outcome. Functionally, miR-103/107 confer migratory capacities in vitro and empower metastatic dissemination of otherwise nonaggressive cells in vivo. Inhibition of miR-103/107 opposes migration and metastasis of malignant cells. At the cellular level, a key event fostered by miR-103/107 is induction of epithelial-to-mesenchymal transition (EMT), attained by downregulating miR-200 levels. These findings suggest a new pathway by which Dicer inhibition drifts epithelial cancer toward a less-differentiated, mesenchymal fate to foster metastasis.	[Martello, Graziano; Manfrin, Andrea; Cordenonsi, Michelangelo; Dupont, Sirio; Enzo, Elena; Piccolo, Stefano] Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, I-35126 Padua, Italy; [Rosato, Antonio; Rondina, Maria] Univ Padua, Dept Oncol & Surg Sci, I-35126 Padua, Italy; [Rosato, Antonio] Ist Oncol Veneto, I-35126 Padua, Italy; [Ferrari, Francesco; Bicciato, Silvio] Univ Modena & Reggio Emilia, Dept Biomed Sci, Ctr Genome Res, I-41100 Modena, Italy; [Guzzardo, Vincenza; Parenti, Anna R.] Univ Padua, Sect Pathol, Dept Med Diagnost Sci & Special Therapies, I-35126 Padua, Italy; [Spruce, Thomas] Univ London Imperial Coll Sci Technol & Med, MRC, Mol Embryol Grp, Ctr Clin Sci, London W12 0NN, England; [Daidone, Maria Grazia] Natl Canc Inst, Dept Expt Oncol, I-20133 Milan, Italy	University of Padua; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; IRCCS Istituto Oncologico Veneto (IOV); Universita di Modena e Reggio Emilia; University of Padua; Imperial College London; Fondazione IRCCS Istituto Nazionale Tumori Milan	Piccolo, S (corresponding author), Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, Viale Colombo 3, I-35126 Padua, Italy.	piccolo@bio.unipd.it	Rosato, Antonio/E-8626-2010; Dupont, Sirio/AAP-8133-2021; Spruce, Thomas/K-7520-2017; Manfrin, Andrea/AAC-1066-2020; Martello, Graziano/AAM-3325-2021; Cordenonsi, Michelangelo/K-7692-2016; Ferrari, Francesco/H-5007-2012; Bicciato, Silvio/C-9825-2009; Daidone, Maria Grazia/E-9232-2017; BICCIATO, Silvio/J-4466-2019	Rosato, Antonio/0000-0002-5263-8386; Spruce, Thomas/0000-0001-7389-9254; Manfrin, Andrea/0000-0002-1519-6582; Cordenonsi, Michelangelo/0000-0002-8253-5724; Ferrari, Francesco/0000-0002-9811-3753; Bicciato, Silvio/0000-0002-1944-7078; Daidone, Maria Grazia/0000-0002-4786-1321; BICCIATO, Silvio/0000-0002-1944-7078; PICCOLO, STEFANO/0000-0002-2037-0004; Enzo, Elena/0000-0001-9768-6368; Martello, Graziano/0000-0001-5520-085X; Dupont, Sirio/0000-0002-6869-1966	Cariparo Foundation; Carimodena Foundation; AIRC; University of Padua; IIT (Italian Institute of Technology); Telethon; ISSN "Giovani Ricercatori"	Cariparo Foundation(Fondazione Cariparo); Carimodena Foundation; AIRC(Fondazione AIRC per la ricerca sul cancro); University of Padua; IIT (Italian Institute of Technology)(Istituto Italiano di Tecnologia - IIT); Telethon(Fondazione Telethon); ISSN "Giovani Ricercatori"	This work is supported by Cariparo Foundation Excellence-grant and Carimodena Foundation international grants to S. B., and AIRC, University of Padua Strategic-grant, Cariparo Foundation Excellence-grant, IIT (Italian Institute of Technology), and Telethon grants to S. P., and ISSN "Giovani Ricercatori" to G. M. We thank T. Rodriguez, O. Wessely, and D. Volpin for comments on the manuscript; the anonymous reviewers for thoughtful directions; and S. Bobisse and R. Venerando for help with cytofluorimeter. We are grateful to colleagues for gifts of reagents: L. Naldini (lentiviral vectors), T. Jacks (mouse shDicer plasmid), P. Provost (Dicer cDNA), W. Filipowicz (Dicer antibody), R. Agami (miR-Vec), F. Miller (4T1 cells), G. Hannon (Dicer null cells), and R. Weinberg (SUM149 cells).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bicciato S, 2009, NUCLEIC ACIDS RES, V37, P5057, DOI 10.1093/nar/gkp520; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Ferrari F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-446; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Loi S, 2007, CRIT REV ONCOL HEMAT, V61, P187, DOI 10.1016/j.critrevonc.2006.09.005; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Zhang Y, 2009, CANCER RES, V69, P3795, DOI 10.1158/0008-5472.CAN-08-4596	46	527	555	1	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1195	U176		10.1016/j.cell.2010.05.017	http://dx.doi.org/10.1016/j.cell.2010.05.017			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20603000	Bronze			2022-12-01	WOS:000279148100016
J	Alvarez, SE; Harikumar, KB; Hait, NC; Allegood, J; Strub, GM; Kim, EY; Maceyka, M; Jiang, HL; Luo, C; Kordula, T; Milstien, S; Spiegel, S				Alvarez, Sergio E.; Harikumar, Kuzhuvelil B.; Hait, Nitai C.; Allegood, Jeremy; Strub, Graham M.; Kim, Eugene Y.; Maceyka, Michael; Jiang, Hualiang; Luo, Cheng; Kordula, Tomasz; Milstien, Sheldon; Spiegel, Sarah			Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2	NATURE			English	Article							SPHINGOSINE 1-PHOSPHATE; TNF-ALPHA; ACTIVATION; KINASE; RIP1; IKK; UBIQUITYLATION; BINDING; CELLS; P38	Tumour-necrosis factor (TNF) receptor-associated factor 2 (TRAF2) is a key component in NF-kappa B signalling triggered by TNF-alpha(1,2). Genetic evidence indicates that TRAF2 is necessary for the polyubiquitination of receptor interacting protein 1 (RIP1)(3) that then serves as a platform for recruitment and stimulation of I kappa B kinase, leading to activation of the transcription factor NF-kappa B. Although TRAF2 is a RING domain ubiquitin ligase, direct evidence that TRAF2 catalyses the ubiquitination of RIP1 is lacking. TRAF2 binds to sphingosine kinase 1 (SphK1)(4), one of the isoenzymes that generates the pro-survival lipid mediator sphingosine-1-phosphate (S1P) inside cells. Here we show that SphK1 and the production of S1P is necessary for lysine-63-linked polyubiquitination of RIP1, phosphorylation of I kappa B kinase and I kappa B alpha, and I kappa B alpha degradation, leading to NF-kappa B activation. These responses were mediated by intracellular S1P independently of its cell surface G-protein-coupled receptors. S1P specifically binds to TRAF2 at the amino-terminal RING domain and stimulates its E3 ligase activity. S1P, but not dihydro-S1P, markedly increased recombinant TRAF2-catalysed lysine-63-linked, but not lysine-48-linked, polyubiquitination of RIP1 in vitro in the presence of the ubiquitin conjugating enzymes (E2) UbcH13 or UbcH5a. Our data show that TRAF2 is a novel intracellular target of S1P, and that S1P is the missing cofactor for TRAF2 E3 ubiquitin ligase activity, indicating a new paradigm for the regulation of lysine-63-linked polyubiquitination. These results also highlight the key role of SphK1 and its product S1P in TNF-alpha signalling and the canonical NF-kappa B activation pathway important in inflammatory, antiapoptotic and immune processes.	[Alvarez, Sergio E.; Harikumar, Kuzhuvelil B.; Hait, Nitai C.; Allegood, Jeremy; Strub, Graham M.; Kim, Eugene Y.; Maceyka, Michael; Kordula, Tomasz; Milstien, Sheldon; Spiegel, Sarah] Virginia Commonwealth Univ, Dept Biochem & Mol Biophys, Sch Med, Richmond, VA 23298 USA; [Alvarez, Sergio E.; Harikumar, Kuzhuvelil B.; Hait, Nitai C.; Allegood, Jeremy; Strub, Graham M.; Kim, Eugene Y.; Maceyka, Michael; Kordula, Tomasz; Milstien, Sheldon; Spiegel, Sarah] Virginia Commonwealth Univ, Massey Canc Ctr, Sch Med, Richmond, VA 23298 USA; [Jiang, Hualiang; Luo, Cheng] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China	Virginia Commonwealth University; Virginia Commonwealth University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biophys, Sch Med, 1101 E Marshall St, Richmond, VA 23298 USA.	sspiegel@vcu.edu	Harikumar, Kuzhuvelil/AAC-2407-2020; Maceyka, Michael/B-9277-2008	Harikumar, Kuzhuvelil/0000-0002-1763-4179; 	National Institute of Health [R37GM043880, R01CA61774, R01AI50094, U19AI077435]; Ministry of Scientific and Technology of China [2009CB918502]; NATIONAL CANCER INSTITUTE [R01CA061774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077435, R01AI050094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043880] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Scientific and Technology of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Z. J. Chen, B. Darnay and M. Karin for HA-ubiquitin and TRAF constructs, and R. Proia for the Sphk1<SUP>-/-</SUP> mice. This work was supported by grants from the National Institute of Health (R37GM043880, R01CA61774, R01AI50094, U19AI077435 to S.S.) and in part by the Ministry of Scientific and Technology of China (2009CB918502 to C.L.).	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Giussani P, 2006, MOL CELL BIOL, V26, P5055, DOI 10.1128/MCB.02107-05; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Ki SH, 2007, J BIOL CHEM, V282, P1938, DOI 10.1074/jbc.M606080200; Kimura T, 2006, J BIOL CHEM, V281, P37457, DOI 10.1074/jbc.M605823200; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Li S, 2009, MOL CELL, V33, P30, DOI 10.1016/j.molcel.2008.11.023; Maceyka M, 2008, MOL CELL BIOL, V28, P5687, DOI 10.1128/MCB.00465-08; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Paugh BS, 2008, FASEB J, V22, P455, DOI 10.1096/fj.07-8276com; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Theiss AL, 2009, MOL BIOL CELL, V20, P4412, DOI 10.1091/mbc.E09-05-0361; VAN BJ, 1998, J CELL BIOL, V142, P229; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Wang HP, 2008, P NATL ACAD SCI USA, V105, P20197, DOI 10.1073/pnas.0810461105; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Yin Q, 2009, BIOCHEMISTRY-US, V48, P10558, DOI 10.1021/bi901462e; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200	30	548	583	7	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					1084	U149		10.1038/nature09128	http://dx.doi.org/10.1038/nature09128			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577214	Green Accepted			2022-12-01	WOS:000279056900054
J	Petherick, A				Petherick, Anna			Chagas disease in the Chaco	NATURE			English	Editorial Material							TRIATOMA-INFESTANS											Ceballos LA, 2009, J MED ENTOMOL, V46, P1195, DOI 10.1603/033.046.0530; Cecere MC, 2006, EMERG INFECT DIS, V12, P1096; Cohen JE, 2001, SCIENCE, V293, P694, DOI 10.1126/science.1060638; Gurtler RE, 2007, P NATL ACAD SCI USA, V104, P16194, DOI 10.1073/pnas.0700863104; Vazquez-Prokopec GM, 2006, MED VET ENTOMOL, V20, P273, DOI 10.1111/j.1365-2915.2006.00637.x	5	4	4	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					S18	S20		10.1038/nature09226	http://dx.doi.org/10.1038/nature09226			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20571550	Bronze			2022-12-01	WOS:000279056900030
J	Shen, B; Makley, DM; Johnston, JN				Shen, Bo; Makley, Dawn M.; Johnston, Jeffrey N.			Umpolung reactivity in amide and peptide synthesis	NATURE			English	Article							NITROALDOL HENRY REACTION; CHIRAL PROTON CATALYSIS; STAUDINGER LIGATION; ENANTIOSELECTIVE SYNTHESIS; OXIDATIVE AMIDATION; ACID-DERIVATIVES; BOND FORMATION; BRONSTED ACID; CATHEPSIN-K; ALDEHYDES	The amide bond is one of nature's most common functional and structural elements, as the backbones of all natural peptides and proteins are composed of amide bonds. Amides are also present in many therapeutic small molecules. The construction of amide bonds using available methods relies principally on dehydrative approaches, although oxidative and radical-based methods are representative alternatives. In nearly every example, carbon and nitrogen bear electrophilic and nucleophilic character, respectively, during the carbon-nitrogen bond-forming step. Here we show that activation of amines and nitroalkanes with an electrophilic iodine source can lead directly to amide products. Preliminary observations support a mechanism in which the polarities of the two reactants are reversed (German, umpolung) during carbon-nitrogen bond formation relative to traditional approaches. The use of nitroalkanes as acyl anion equivalents provides a conceptually innovative approach to amide and peptide synthesis, and one that might ultimately provide for efficient peptide synthesis that is fully reliant on enantioselective methods.	[Shen, Bo; Makley, Dawn M.; Johnston, Jeffrey N.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Dept Chem, Nashville, TN 37235 USA	Vanderbilt University	Johnston, JN (corresponding author), Vanderbilt Univ, Vanderbilt Inst Chem Biol, Dept Chem, Nashville, TN 37235 USA.	jeffrey.n.johnston@vanderbilt.edu	Johnston, Jeff/AAW-1271-2021; Shen, Bo/D-6294-2011	Johnston, Jeff/0000-0002-0885-636X; 	Vanderbilt Institute of Chemical Biology; NIH [GM084333, T32 GM065086]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063557, T32GM065086, R01GM084333, R56GM063557] Funding Source: NIH RePORTER	Vanderbilt Institute of Chemical Biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Vanderbilt Institute of Chemical Biology, and in part (catalyst preparation and development) by the NIH (GM084333 and Chemistry-Biology Interface training grant T32 GM065086 in support of D.M.M.).	Ballini R, 2004, TETRAHEDRON, V60, P1017, DOI 10.1016/j.tet.2003.11.016; Bode JW, 2006, CURR OPIN DRUG DISC, V9, P765; Bode JW, 2006, ANGEW CHEM INT EDIT, V45, P1248, DOI 10.1002/anie.200503991; Cassidy MP, 2006, ANGEW CHEM INT EDIT, V45, P3154, DOI 10.1002/anie.200503805; Chan WK, 2006, J AM CHEM SOC, V128, P14796, DOI 10.1021/ja064479s; Cho SH, 2005, J AM CHEM SOC, V127, P16046, DOI 10.1021/ja056399e; Davis TA, 2010, J AM CHEM SOC, V132, P2880, DOI 10.1021/ja908814h; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; ERDIK E, 1989, CHEM REV, V89, P1947, DOI 10.1021/cr00098a014; Gao J, 2008, J ORG CHEM, V73, P2955, DOI 10.1021/jo800075t; Gauthier JY, 2008, BIOORG MED CHEM LETT, V18, P923, DOI 10.1016/j.bmcl.2007.12.047; Grayson EJ, 2005, ORG LETT, V7, P2361, DOI 10.1021/ol050624f; GROBEL BT, 1977, SYNTHESIS-STUTTGART, P357; Gunanathan C, 2007, SCIENCE, V317, P790, DOI 10.1126/science.1145295; Katoh T, 2008, TETRAHEDRON LETT, V49, P598, DOI 10.1016/j.tetlet.2007.11.162; Kohn M, 2004, ANGEW CHEM INT EDIT, V43, P3106, DOI 10.1002/anie.200401744; KOVACIC P, 1970, CHEM REV, V70, P639, DOI 10.1021/cr60268a002; Li XC, 2008, J AM CHEM SOC, V130, P5446, DOI 10.1021/ja800612r; Marques-Lopez E, 2009, EUR J ORG CHEM, V2009, P2401, DOI 10.1002/ejoc.200801097; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MERRIFIELD RB, 1964, J AM CHEM SOC, V86, P304, DOI 10.1021/ja01056a056; Nilsson BL, 2000, ORG LETT, V2, P1939, DOI 10.1021/ol0060174; Nordstrom LU, 2008, J AM CHEM SOC, V130, P17672, DOI 10.1021/ja808129p; Nugent BM, 2004, J AM CHEM SOC, V126, P3418, DOI 10.1021/ja031906i; Ono, 2001, NITRO GROUP ORGANIC; Palmer JT, 2005, J MED CHEM, V48, P7520, DOI 10.1021/jm058198r; Palomo C, 2004, ANGEW CHEM INT EDIT, V43, P5442, DOI 10.1002/anie.200460506; Palomo C, 2007, EUR J ORG CHEM, V2007, P2561, DOI 10.1002/ejoc.200700021; Pinnick H., 1990, ORG REACT, V38, P655, DOI [10.1002/0471264180.or038.03, DOI 10.1002/0471264180.0R038.03]; Saxon E, 2002, J AM CHEM SOC, V124, P14893, DOI 10.1021/ja027748x; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Saxon E, 2000, ORG LETT, V2, P2141, DOI 10.1021/ol006054v; SEEBACH D, 1975, J ORG CHEM, V40, P231, DOI 10.1021/jo00890a018; SEEBACH D, 1979, ANGEW CHEM INT EDIT, V18, P239, DOI 10.1002/anie.197902393; Shen B, 2008, ORG LETT, V10, P4397, DOI 10.1021/ol801797h; Singh A, 2008, J AM CHEM SOC, V130, P5866, DOI 10.1021/ja8011808; Singh A, 2007, J AM CHEM SOC, V129, P3466, DOI 10.1021/ja068073r; Stenmark HG, 2000, J ORG CHEM, V65, P3875, DOI 10.1021/jo000055j; Valeur E, 2009, CHEM SOC REV, V38, P606, DOI 10.1039/b701677h; Westermann B, 2003, ANGEW CHEM INT EDIT, V42, P151, DOI 10.1002/anie.200390071; WILLIAMS RM, 1992, CHEM REV, V92, P889, DOI 10.1021/cr00013a007; Wilt JC, 2008, CHEM COMMUN, P4177, DOI 10.1039/b808393b; Wong FT, 2008, ORG LETT, V10, P2333, DOI 10.1021/ol8004276; Yoo WJ, 2006, J AM CHEM SOC, V128, P13064, DOI 10.1021/ja064315b; Zhong YL, 2005, TETRAHEDRON LETT, V46, P1099, DOI 10.1016/j.tetlet.2004.12.088	45	238	239	5	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					1027	U82		10.1038/nature09125	http://dx.doi.org/10.1038/nature09125			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	614KI	20577205	Green Accepted			2022-12-01	WOS:000279056900042
J	Ahmad, M; McCallum, IJD; Mercer-Jones, M				Ahmad, Mukhtar; McCallum, Iain J. D.; Mercer-Jones, Mark			Management of faecal incontinence in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ANAL-SPHINCTER; PREVALENCE		[Ahmad, Mukhtar; Mercer-Jones, Mark] Queen Elizabeth Hosp, Gateshead NE9 6SX, England; [McCallum, Iain J. D.] N Tyneside Gen Hosp, N Shields NE29 8NH, England		Mercer-Jones, M (corresponding author), Queen Elizabeth Hosp, Gateshead NE9 6SX, England.	mark.mercer-jones@ghnt.nhs.uk						Altomare DF, 2008, DIS COLON RECTUM, V51, P432, DOI 10.1007/s10350-007-9170-7; Bartlett L, 2009, BRIT J SURG, V96, P1468, DOI 10.1002/bjs.6745; BROWN SR, 2007, COCHRANE DB SYST REV, V2, P1757, DOI DOI 10.1002/14651858.CD00157.PUB2; Chapman AE, 2002, BRIT J SURG, V89, P138, DOI 10.1046/j.0007-1323.2001.02018.x; CHEETHAM MJ, 2002, COCHRANE DB SYST REV, V3; Chelvanayagam S, 2000, Nurs Times, V96, P15; Christensen P, 2009, DIS COLON RECTUM, V52, P286, DOI 10.1007/DCR.0b013e3181979341; Collings Sarah, 2004, Br J Community Nurs, V9, P520; Collinson R, 2010, COLORECTAL DIS, V12, P97, DOI 10.1111/j.1463-1318.2009.02049.x; Collinson R, 2009, COLORECTAL DIS, V11, P77, DOI 10.1111/j.1463-1318.2008.01539.x; DEUTEKOM M, 2005, COCHRANE DB SYST REV, V3; Fader M, 2008, HEALTH TECHNOL ASSES, V12, P1; Fader M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007408; Fynes M, 1999, LANCET, V354, P983, DOI 10.1016/S0140-6736(98)11205-9; Guise JM, 2007, OBSTET GYNECOL, V109, P281, DOI 10.1097/01.AOG.0000254164.67182.78; HINDS JP, 1990, GASTROENTEROLOGY, V98, P1538, DOI 10.1016/0016-5085(90)91087-M; KAMM MA, 1994, LANCET, V344, P730, DOI 10.1016/S0140-6736(94)92213-6; Lauti M, 2008, COLORECTAL DIS, V10, P553, DOI 10.1111/j.1463-1318.2007.01439.x; Macmillan AK, 2004, DIS COLON RECTUM, V47, P1341, DOI 10.1007/s10350-004-0593-0; Maeda Y, 2010, COCHRANE DB SYST REV, V5; Mowatt G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004464.pub2; *NAT I HLTH CLIN E, 2007, CG49 NAT I HLTH CLIN; Norton C, 2001, ALIMENT PHARM THER, V15, P1147, DOI 10.1046/j.1365-2036.2001.01039.x; NORTON CC, 2009, COCHRANE DB SYST REV, V1; O'Brien PE, 2004, DIS COLON RECTUM, V47, P1852, DOI 10.1007/s10350-004-0717-6; Oom DMJ, 2009, DIS COLON RECTUM, V52, P1681, DOI 10.1007/DCR.0b013e3181b13862; Perry S, 2002, GUT, V50, P480, DOI 10.1136/gut.50.4.480; Rockwood TH, 1999, DIS COLON RECTUM, V42, P1525, DOI 10.1007/BF02236199; Thekkinkattil DK, 2009, BRIT J SURG, V96, P680, DOI 10.1002/bjs.6597; Vaizey CJ, 1997, LANCET, V349, P612, DOI 10.1016/S0140-6736(96)09188-X; WORSOE J, 2007, DIS COLON RECTUM, V50, P1023	31	5	5	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 15	2010	340								c2964	10.1136/bmj.c2964	http://dx.doi.org/10.1136/bmj.c2964			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614JA	20551123				2022-12-01	WOS:000279051800006
J	Ziemer, DC; Kolm, P; Weintraub, WS; Vaccarino, V; Rhee, MK; Twombly, JG; Narayan, V; Koch, DD; Phillips, LS				Ziemer, David C.; Kolm, Paul; Weintraub, William S.; Vaccarino, Viola; Rhee, Mary K.; Twombly, Jennifer G.; Narayan, Venkat; Koch, David D.; Phillips, Lawrence S.			Glucose-Independent, Black-White Differences in Hemoglobin A(1c) Levels	ANNALS OF INTERNAL MEDICINE			English	Article							MEAN BLOOD-GLUCOSE; HEALTH-CARE ACCESS; GLYCEMIC CONTROL; GLYCATED HEMOGLOBIN; ETHNIC DISPARITIES; MICROVASCULAR COMPLICATIONS; DIABETIC-RETINOPATHY; BIOLOGICAL VARIATION; RACIAL DISPARITIES; HBA(1C) LEVELS	Background: A previous study of participants with prediabetes found that hemoglobin A(1c) (HbA(1c)) levels differed between black and white participants with no differences in glucose concentration. Objective: To determine whether black-white differences in HbA(1c) level are present in other populations and across the full spectrum of glycemia. Design: Cross-sectional, retrospective. Setting: Outpatient. Participants: 1581 non-Hispanic black and white participants between 18 and 87 years of age without known diabetes in the SIGT (Screening for Impaired Glucose Tolerance) study and 1967 non-Hispanic black and white participants older than 40 years without known diabetes in the NHANES III (Third National Health and Nutrition Examination Survey). Measurements: HbA(1c) levels, anthropometry, and plasma glucose levels during oral glucose tolerance testing. Results: Hemoglobin A(1c) levels were higher in black than in white participants with normal glucose tolerance (0.13 percentage point [P < 0.001] in the SIGT sample and 0.21 percentage point [P < 0.001] in the NHANES III sample), prediabetes (0.26 percentage point [P < 0.001] and 0.30 percentage point [P < 0.001], respectively), or diabetes (0.47 percentage point [P < 0.020] and 0.47 percentage point [P < 0.013], respectively) after adjustment for plasma glucose levels and other characteristics known to correlate with HbA(1c) levels. Limitation: The mechanism for the differences is unknown. Conclusion: Black persons have higher HbA(1c) levels than white persons across the full spectrum of glycemia, and the differences increase as glucose intolerance worsens. These findings could limit the use of HbA(1c) to screen for glucose intolerance, indicate the risk for complications, measure quality of care, and evaluate disparities in health.	[Ziemer, David C.] Emory Univ, Sch Med, Div Endocrinol, Atlanta, GA 30303 USA; Med Ctr, US Dept Vet Affairs, Atlanta, GA USA; Christiana Care Hlth Syst, Newark, DE USA	Emory University; US Department of Veterans Affairs; Christiana Care Health System	Ziemer, DC (corresponding author), Emory Univ, Sch Med, Div Endocrinol, 49 Jesse Hill Jr Dr SE, Atlanta, GA 30303 USA.		, Viola/AAW-5600-2020		National Institutes of Health and National Center for Research Resources [DK07298, DK062668, RR017643, DK066204, RR00039]; U.S. Department of Veterans Affairs Health Services Research and Development Service [SHP 08-144, IIR 07-138]; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR017643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK062668, R18DK066204] Funding Source: NIH RePORTER	National Institutes of Health and National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. Department of Veterans Affairs Health Services Research and Development Service(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	By the National Institutes of Health and National Center for Research Resources (awards DK07298, DK062668, RR017643, DK066204, and RR00039) and U.S. Department of Veterans Affairs Health Services Research and Development Service (awards SHP 08-144 and IIR 07-138).	Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; BOFILL C, 1994, METABOLISM, V43, P614, DOI 10.1016/0026-0495(94)90204-6; BUNN HF, 1976, J CLIN INVEST, V57, P1652, DOI 10.1172/JCI108436; *CDCP, 2006, NHANES 3 LAB DAT FIL; Chou AF, 2007, WOMEN HEALTH ISS, V17, P150, DOI 10.1016/j.whi.2007.03.003; Coban E, 2004, ACTA HAEMATOL-BASEL, V112, P126, DOI 10.1159/000079722; Cohen RM, 2008, DIABETES CARE, V31, P151, DOI 10.2337/dc07-1465; DAVIE SJ, 1992, DIABETES, V41, P167, DOI 10.2337/diabetes.41.2.167; de Rekeneire N, 2003, DIABETES CARE, V26, P1986, DOI 10.2337/diacare.26.7.1986; Delamater AM, 1999, DIABETES CARE, V22, P700, DOI 10.2337/diacare.22.5.700; Dyck PJ, 2006, DIABETES CARE, V29, P2282, DOI 10.2337/dc06-0525; EBERHARDT MS, 1994, J CLIN EPIDEMIOL, V47, P1181, DOI 10.1016/0895-4356(94)90105-8; Eldeirawi K, 2003, AM J EPIDEMIOL, V157, P624, DOI 10.1093/aje/kwg023; Gallegos-Macias Angela R, 2003, Pediatr Diabetes, V4, P19, DOI 10.1034/j.1399-5448.2003.00020.x; GOLDSTEIN DE, 1987, CLIN CHEM, V33, P2267; Gould BJ, 1997, CLIN CHIM ACTA, V260, P49, DOI 10.1016/S0009-8981(96)06508-4; Harris MI, 1998, DIABETES CARE, V21, P1230, DOI 10.2337/diacare.21.8.1230; Harris MI, 2001, DIABETES CARE, V24, P454, DOI 10.2337/diacare.24.3.454; Hashimoto K, 2008, DIABETES CARE, V31, P1945, DOI 10.2337/dc08-0352; Heisler M, 2007, ARCH INTERN MED, V167, P1853, DOI 10.1001/archinte.167.17.1853; Hempe JM, 2002, J DIABETES COMPLICAT, V16, P313, DOI 10.1016/S1056-8727(01)00227-6; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Herman WH, 2009, J CLIN ENDOCR METAB, V94, P1689, DOI 10.1210/jc.2008-1940; Hozumi M, 1998, J NUTR SCI VITAMINOL, V44, P1, DOI 10.3177/jnsv.44.1; Khera PK, 2008, DIABETES, V57, P2445, DOI 10.2337/db07-1820; Kilpatrick ES, 2008, DIABETOLOGIA, V51, P365, DOI 10.1007/s00125-007-0883-x; Kilpatrick ES, 1998, DIABETES CARE, V21, P261, DOI 10.2337/diacare.21.2.261; Kirk JK, 2005, ANN PHARMACOTHER, V39, P1489, DOI 10.1345/aph.1E685; Kirk JK, 2006, DIABETES CARE, V29, P2130, DOI 10.2337/dc05-1973; Lachin JM, 2008, DIABETES, V57, P995, DOI 10.2337/db07-1618; Maney M, 2007, DIABETES CARE, V30, P245, DOI 10.2337/dc06-0771; Fernandez-Real JM, 2009, J CLIN ENDOCR METAB, V94, P982, DOI 10.1210/jc.2008-1211; MARTINA WV, 1993, CLIN CHEM, V39, P2259; McCarter RJ, 2006, DIABETES CARE, V29, P352, DOI 10.2337/diacare.29.02.06.dc05-1594; MODAN M, 1988, DIABETES CARE, V11, P422, DOI 10.2337/diacare.11.5.422; Nathan DM, 2007, DIABETOLOGIA, V50, P2239, DOI 10.1007/s00125-007-0803-0; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; NATHAN DM, 1983, CLIN CHEM, V29, P466; Quandt SA, 2005, ETHNIC DIS, V15, P656; Rhee MK, 2008, DIABETES EDUCATOR, V34, P655, DOI 10.1177/0145721708320903; Rhee MK, 2005, J HEALTH CARE POOR U, V16, P734; Roberts WL, 2002, CLIN CHEM, V48, P383; Saudek CD, 2008, J CLIN ENDOCR METAB, V93, P2447, DOI 10.1210/jc.2007-2174; SCHNEIDER RG, 1976, BLOOD, V48, P629; SIMON M, 1980, DIABETES, V29, P467, DOI 10.2337/diabetes.29.6.467; Snieder H, 2001, DIABETES, V50, P2858, DOI 10.2337/diabetes.50.12.2858; STEVENS VJ, 1981, J CLIN INVEST, V67, P361, DOI 10.1172/JCI110043; Tarim O, 1999, PEDIATR INT, V41, P357; Wang X, 2004, J ENDOCRINOL INVEST, V27, P733, DOI 10.1007/BF03347514; Weykamp CW, 1999, CLIN CHEM, V45, P438; Ziemer DC, 2008, J GEN INTERN MED, V23, P528, DOI 10.1007/s11606-008-0524-1	51	247	249	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	2010	152	12					770	+		10.7326/0003-4819-152-12-201006150-00004	http://dx.doi.org/10.7326/0003-4819-152-12-201006150-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611OP	20547905				2022-12-01	WOS:000278827700002
J	Takeuchi, H; Inokuchi, K; Aoki, M; Suto, F; Tsuboi, A; Matsuda, I; Suzuki, M; Aiba, A; Serizawa, S; Yoshihara, Y; Fujisawa, H; Sakano, H				Takeuchi, Haruki; Inokuchi, Kasumi; Aoki, Mari; Suto, Fumikazu; Tsuboi, Akio; Matsuda, Ikuo; Suzuki, Misao; Aiba, Atsu; Serizawa, Shou; Yoshihara, Yoshihiro; Fujisawa, Hajime; Sakano, Hitoshi			Sequential Arrival and Graded Secretion of Sema3F by Olfactory Neuron Axons Specify Map Topography at the Bulb	CELL			English	Article							ODORANT RECEPTOR GENES; CELL-ADHESION MOLECULE; SENSORY NEURONS; ZONAL SEGREGATION; SEMAPHORIN 3F; MOUSE; EXPRESSION; GLOMERULI; SYSTEM; NEUROPILIN-2	In the mouse olfactory system, the anatomical locations of olfactory sensory neurons (OSNs) roughly correlate with their axonal projection sites along the dorsal-ventral (D-V) axis of the olfactory bulb (OB). Here we report that an axon guidance receptor, Neuropilin-2 (Nrp2), and its repulsive ligand, Sema-phorin-3F (Sema3F), are expressed by OSNs in a complementary manner that is important for establishing olfactory map topography. Sema3F is secreted by early-arriving axons of OSNs and is deposited at the anterodorsal OB to repel Nrp2-positive axons that arrive later. Sequential arrival of OSN axons as well as the graded and complementary expression of Nrp2 and Sema3F by OSNs help to form the topographic order along the D-V axis.	[Takeuchi, Haruki; Inokuchi, Kasumi; Aoki, Mari; Serizawa, Shou; Sakano, Hitoshi] Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Tokyo 1130032, Japan; [Suto, Fumikazu] Natl Inst Genet, Div Dev Genet, Mishima, Shizuoka 4118540, Japan; [Suto, Fumikazu] Tohoku Univ, Div Dev Neurosci, Grad Sch Med, Sendai, Miyagi 9808575, Japan; [Tsuboi, Akio] Nara Med Univ, Lab Mol Biol Neural Syst, Nara 6348521, Japan; [Matsuda, Ikuo; Aiba, Atsu] Kobe Univ, Grad Sch Med, Div Mol Genet, Kobe, Hyogo 6500017, Japan; [Suzuki, Misao] Kumamoto Univ, Ctr Anim Resources & Dev, Kumamoto 8620976, Japan; [Yoshihara, Yoshihiro] RIKEN, Brain Sci Inst, Lab Neurobiol Synapse, Wako, Saitama 3510198, Japan; [Fujisawa, Hajime] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Nagoya, Aichi 4648602, Japan	University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Tohoku University; Nara Medical University; Kobe University; Kumamoto University; RIKEN; Nagoya University	Sakano, H (corresponding author), Univ Tokyo, Dept Biophys & Biochem, Grad Sch Sci, Tokyo 1130032, Japan.	sakano@mail.ecc.u-tokyo.ac.jp	Tsuboi, Akio/R-6793-2019; Yoshihara, Yoshihiro/N-6481-2015	Tsuboi, Akio/0000-0002-4790-4512; Yoshihara, Yoshihiro/0000-0002-0319-7166; Takeuchi, Haruki/0000-0003-4911-4060; Aiba, Atsu/0000-0002-8192-0778; Aoki, Mari/0000-0002-2598-9850	Mitsubishi Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan; Global COE Program, Biosignaling, at the University of Tokyo	Mitsubishi Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program, Biosignaling, at the University of Tokyo(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We are grateful to M. Hori and S. Takashima for Nrp2 knockin mice, Y. Hiromi for anti-PlxnA3 antibodies, and members of our laboratory for their valuable comments. This work was supported by the Mitsubishi Foundation and by the Specially Promoted Research Grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan. H.T. was a pre-doctoral fellow of the Japan Society for the Promotion of Science and is supported by the Global COE Program, Biosignaling, at the University of Tokyo. This paper is dedicated to the late Shou Serizawa, who was a brilliant young scientist with a lot of potential.	ASTIC L, 1987, BRAIN RES, V424, P144, DOI 10.1016/0006-8993(87)91204-2; Bailey MS, 1999, J COMP NEUROL, V415, P423; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chen Y, 2006, CELL, V127, P881, DOI 10.1016/j.cell.2006.11.017; Chesler AT, 2007, P NATL ACAD SCI USA, V104, P1039, DOI 10.1073/pnas.0609215104; Cho JH, 2007, J NEUROSCI, V27, P9094, DOI 10.1523/JNEUROSCI.2217-07.2007; Cloutier JF, 2002, NEURON, V33, P877, DOI 10.1016/S0896-6273(02)00635-9; Cloutier JF, 2004, J NEUROSCI, V24, P9087, DOI 10.1523/JNEUROSCI.2786-04.2004; Dal Col JA, 2007, DEVELOPMENT, V134, P2481, DOI 10.1242/dev.006346; De Wit J, 2005, MOL CELL NEUROSCI, V29, P40, DOI 10.1016/j.mcn.2004.12.009; Duggan CD, 2008, J NEUROSCI, V28, P5229, DOI 10.1523/JNEUROSCI.1134-08.2008; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Hirata T, 2006, DEVELOPMENT, V133, P1433, DOI 10.1242/dev.02329; Imai T, 2008, CURR OPIN NEUROBIOL, V18, P251, DOI 10.1016/j.conb.2008.07.009; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Imai T, 2009, SCIENCE, V325, P585, DOI 10.1126/science.1173596; Ishii T, 2001, GENES CELLS, V6, P71, DOI 10.1046/j.1365-2443.2001.00398.x; Kaneko-Goto T, 2008, NEURON, V57, P834, DOI 10.1016/j.neuron.2008.01.023; Lemke G, 2005, ANNU REV CELL DEV BI, V21, P551, DOI 10.1146/annurev.cellbio.20.022403.093702; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Nguyen-Ba-Charvet KT, 2008, J NEUROSCI, V28, P4244, DOI 10.1523/JNEUROSCI.5671-07.2008; Nishizumi H, 2007, P NATL ACAD SCI USA, V104, P20067, DOI 10.1073/pnas.0706544105; Norlin EM, 2001, MOL CELL NEUROSCI, V18, P283, DOI 10.1006/mcne.2001.1019; Petersen CCH, 2007, NEURON, V56, P339, DOI 10.1016/j.neuron.2007.09.017; Prince JEA, 2009, J NEUROSCI, V29, P14211, DOI 10.1523/JNEUROSCI.3948-09.2009; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Royal SJ, 1999, J NEUROSCI, V19, P9856; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Sahay A, 2003, J NEUROSCI, V23, P6671; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; St John JA, 2003, J COMP NEUROL, V464, P131, DOI 10.1002/cne.10777; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Takashima S, 2002, P NATL ACAD SCI USA, V99, P3657, DOI 10.1073/pnas.022017899; Treloar HB, 2003, J COMP NEUROL, V458, P389, DOI 10.1002/cne.10590; Treloar HB, 2002, J NEUROSCI, V22, P2469, DOI 10.1523/JNEUROSCI.22-07-02469.2002; Tsuboi A, 2006, EUR J NEUROSCI, V23, P1436, DOI 10.1111/j.1460-9568.2006.04675.x; Tsuboi A, 1999, J NEUROSCI, V19, P8409; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Walz A, 2002, J NEUROSCI, V22, P4025, DOI 10.1523/JNEUROSCI.22-10-04025.2002; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; Yoshihara S, 2005, DEVELOPMENT, V132, P751, DOI 10.1242/dev.01619; Yoshihara Y, 1997, J NEUROSCI, V17, P5830	53	102	102	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					1056	1067		10.1016/j.cell.2010.04.041	http://dx.doi.org/10.1016/j.cell.2010.04.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550939	Bronze			2022-12-01	WOS:000278618800019
J	Kim, AM; Tingen, CM; Woodruff, TK				Kim, Alison M.; Tingen, Candace M.; Woodruff, Teresa K.			Sex bias in trials and treatment must end	NATURE			English	Editorial Material							BLOOD INSTITUTE; CLINICAL-TRIALS; NATIONAL HEART; WOMEN; LUNG; GUIDELINES; ENROLLMENT; ADHERENCE; HEALTH		[Kim, Alison M.; Tingen, Candace M.; Woodruff, Teresa K.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Woodruff, Teresa K.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University	Kim, AM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA.	tkw@northwestern.edu	Kim, Alison/D-6969-2014	Kim, Alison/0000-0001-5845-1865; Tingen, Candace/0000-0003-3503-019X; Woodruff, Teresa/0000-0002-1197-3399				Anderson GD, 2005, J WOMENS HEALTH, V14, P19, DOI 10.1089/jwh.2005.14.19; Bristol-Gould S, 2010, WOMENS HEALTH, V6, P183, DOI 10.2217/WHE.10.10; Day SC, 1996, AM J MED, V100, P375, DOI 10.1016/S0002-9343(97)89510-1; Geller SE, 2006, J WOMENS HEALTH, V15, P1123, DOI 10.1089/jwh.2006.15.1123; Harris DJ, 2000, NEW ENGL J MED, V343, P475, DOI 10.1056/NEJM200008173430706; Henrich JB, 2006, ACAD MED, V81, P476, DOI 10.1097/01.ACM.0000222268.60211.fc; Holden C, 2008, SCIENCE, V322, P219, DOI 10.1126/science.322.5899.219; Kim ESH, 2008, J AM COLL CARDIOL, V52, P672, DOI 10.1016/j.jacc.2008.05.025; Lewis V, 2010, INT J CARDIOL, V139, P204, DOI 10.1016/j.ijcard.2008.08.024; Mosca L, 2005, CIRCULATION, V111, P499, DOI 10.1161/01.CIR.0000154568.43333.82; Mostertz W, 2010, JAMA-J AM MED ASSOC, V303, P535, DOI 10.1001/jama.2010.80; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506; Zopf Y, 2008, EUR J CLIN PHARMACOL, V64, P999, DOI 10.1007/s00228-008-0494-6	13	153	154	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 10	2010	465	7299					688	689		10.1038/465688a	http://dx.doi.org/10.1038/465688a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	608AM	20535184				2022-12-01	WOS:000278551800018
J	Kahn, JM; Benson, NM; Appleby, D; Carson, SS; Iwashyna, TJ				Kahn, Jeremy M.; Benson, Nicole M.; Appleby, Dina; Carson, Shannon S.; Iwashyna, Theodore J.			Long-term Acute Care Hospital Utilization After Critical Illness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MECHANICAL VENTILATION; RACIAL VARIATION; UNITED-STATES; SEVERE SEPSIS; OUTCOMES; MEDICARE; MORTALITY; PATIENT; COSTS; EPIDEMIOLOGY	Context Long-term acute care hospitals have emerged as a novel approach for the care of patients recovering from severe acute illness, but the extent and increases in their activity at the national level are unknown. Objective To examine temporal trends in long-term acute care hospital utilization after an episode of critical illness among fee-for-service Medicare beneficiaries aged 65 years or older. Design, Setting, and Patients Retrospective cohort study using the Medicare Provider Analysis and Review files from 1997 to 2006. We included all Medicare hospitalizations involving admission to an intensive care unit of an acute care, nonfederal hospital within the continental United States. Main Outcome Measures Overall long-term acute care utilization, associated costs, and survival following transfer. Results The number of long-term acute care hospitals in the United States increased at a mean rate of 8.8% per year, from 192 in 1997 to 408 in 2006. During that time, the annual number of long-term acute care admissions after critical illness increased from 13 732 to 40 353, with annual costs increasing from $484 million to $1.325 billion. The age-standardized population incidence of long-term acute care utilization after critical illness increased from 38.1 per 100 000 in 1997 to 99.7 per 100 000 in 2006, with greater use among male individuals and black individuals in all periods. Over time, transferred patients had higher numbers of comorbidities (5.0 in 19972000 vs 5.8 in 2004-2006, P<.001) and were more likely to receive mechanical ventilation at the long-term acute care hospital (16.4% in 1997-2000 vs 29.8% in 20042006, P<.001). One-year mortality after long-term acute care hospital admission was high throughout the study period: 50.7% in 1997-2000 and 52.2% in 2004-2006. Conclusions Long-term acute care hospital utilization after critical illness is common and increasing. Survival among Medicare beneficiaries transferred to long-term acute care after critical illness is poor. JAMA. 2010; 303(22): 2253-2259	[Kahn, Jeremy M.] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Div Pulm Allergy & Crit Care, Philadelphia, PA 19104 USA; [Kahn, Jeremy M.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Carson, Shannon S.] Univ N Carolina, Sch Med, Div Pulm & Crit Care, Chapel Hill, NC USA; [Iwashyna, Theodore J.] Univ Michigan, Sch Med, Div Pulm & Crit Care, Ann Arbor, MI USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Michigan System; University of Michigan	Kahn, JM (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Div Pulm Allergy & Crit Care, Blockley Hall 723,423 Guardian Dr, Philadelphia, PA 19104 USA.	jmkahn@mail.med.upenn.edu		Benson, Nicole/0000-0001-5361-4311; Kahn, Jeremy/0000-0001-9688-5576; Iwashyna, Theodore/0000-0002-4226-9310	National Institutes of Health (NIH) [R01HL096651, K08HL091249]; Pennsylvania Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL091249, R01HL096651] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by grant R01HL096651 from the National Institutes of Health (NIH) (Dr Kahn). Dr Iwashyna is supported by NIH grant K08HL091249. This project was also funded, in part, under a grant from the Pennsylvania Department of Health, which specifically disclaims responsibility for any analyses, interpretations, or conclusions.	Aiken LH, 2002, JAMA-J AM MED ASSOC, V357, P1987, DOI [DOI 10.1001/JAMA.288.16.1987, 10.1001/jama.288.16.1987]; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; [Anonymous], CLIN CLASS SOFTW ICD; Barnato AE, 2008, AM J RESP CRIT CARE, V177, P279, DOI 10.1164/rccm.200703-480OC; Barnato AE, 2007, J GEN INTERN MED, V22, P338, DOI 10.1007/s11606-006-0088-x; BLUSTEIN J, 1994, AM J PUBLIC HEALTH, V84, P1018, DOI 10.2105/AJPH.84.6.1018; Carson SS, 2008, CRIT CARE MED, V36, P2061, DOI 10.1097/CCM.0b013e31817b8925; Carson SS, 2007, CHEST, V131, P2, DOI 10.1378/chest.06-2513; Carson SS, 1999, AM J RESP CRIT CARE, V159, P1568, DOI 10.1164/ajrccm.159.5.9809002; Carson SS, 2002, CRIT CARE CLIN, V18, P461, DOI 10.1016/S0749-0704(02)00015-5; Combes A, 2003, CRIT CARE MED, V31, P1373, DOI 10.1097/01.CCM.0000065188.87029.C3; Cox CE, 2009, CRIT CARE MED, V37, P2888, DOI 10.1097/CCM.0b013e3181ab86ed; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Engoren M, 2004, CHEST, V125, P220, DOI 10.1378/chest.125.1.220; Halpern NA, 2010, CRIT CARE MED, V38, P65, DOI 10.1097/CCM.0b013e3181b090d0; Horwitz JR, 2009, J HEALTH ECON, V28, P924, DOI 10.1016/j.jhealeco.2009.06.008; Horwitz LI, 2008, ARCH INTERN MED, V168, P1755, DOI 10.1001/archinte.168.16.1755; HSIA DC, 1992, JAMA-J AM MED ASSOC, V268, P896, DOI 10.1001/jama.268.7.896; Iglehart JK, 2005, NEW ENGL J MED, V352, P78, DOI 10.1056/NEJMhpr043631; Iwashyna TJ, 2009, MED CARE, V47, P787, DOI 10.1097/MLR.0b013e318197b1f5; Kahn JM, 2007, CURR OPIN CRIT CARE, V13, P514, DOI 10.1097/MCC.0b013e3282efb7c9; Kahn JM, 2006, NEW ENGL J MED, V355, P41, DOI 10.1056/NEJMsa053993; Kahn JM, 2010, INTENS CARE MED, V36, P8, DOI 10.1007/s00134-009-1672-4; LAUDERDALE DS, 1993, EPIDEMIOL REV, V15, P319, DOI 10.1093/oxfordjournals.epirev.a036123; Liu K, 2001, HEALTH CARE FINANC R, V23, P1; MacIntyre NR, 2005, CHEST, V128, P3937, DOI 10.1378/chest.128.6.3937; Medicare Payment Advisory Commission, 2004, REP C NEW APPR MED; Medicare Payment Advisory Commission, 2010, REP C MED PAYM POL; Pilcher DV, 2005, THORAX, V60, P187, DOI 10.1136/thx.2004.026500; Quan H, 2004, MED CARE, V42, P801, DOI 10.1097/01.mlr.0000132391.59713.0d; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Riley GF, 2009, MED CARE, V47, pS51, DOI 10.1097/MLR.0b013e31819c95aa; Scales DC, 2006, J CLIN EPIDEMIOL, V59, P802, DOI 10.1016/j.jclinepi.2005.11.015; Scheinhorn DJ, 2007, CHEST, V131, P85, DOI 10.1378/chest.06-1081; Scheinhorn DJ, 2007, CHEST, V131, P76, DOI 10.1378/chest.06-1079; Schonhofer B, 2002, INTENS CARE MED, V28, P908, DOI 10.1007/s00134-002-1287-5; Seneff MG, 2000, CRIT CARE MED, V28, P342, DOI 10.1097/00003246-200002000-00009; Shepardson LB, 1999, J GEN INTERN MED, V14, P15, DOI 10.1046/j.1525-1497.1999.00275.x; Taira DA, 2003, AM HEART J, V145, P452, DOI 10.1067/mhj.2003.3; Thygeson M, 2008, HEALTH AFFAIR, V27, P1283, DOI 10.1377/hlthaff.27.5.1283; Wunsch H, 2010, JAMA-J AM MED ASSOC, V303, P849, DOI 10.1001/jama.2010.216	41	205	210	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 9	2010	303	22					2253	2259		10.1001/jama.2010.761	http://dx.doi.org/10.1001/jama.2010.761			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	607IY	20530778	Green Submitted, Bronze, Green Accepted			2022-12-01	WOS:000278496800023
J	Cheng, MH				Cheng, Margaret Harris			Asia-Pacific faces diabetes challenge	LANCET			English	News Item																		2010, N ENGL J MED, V362, P1090	1	33	35	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2010	375	9733					2207	2210		10.1016/S0140-6736(10)61014-8	http://dx.doi.org/10.1016/S0140-6736(10)61014-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622HS	20626091				2022-12-01	WOS:000279652900012
J	Jacob, Y; Stroud, H; LeBlanc, C; Feng, SH; Zhuo, LT; Caro, E; Hassel, C; Gutierrez, C; Michaels, SD; Jacobsen, SE				Jacob, Yannick; Stroud, Hume; LeBlanc, Chantal; Feng, Suhua; Zhuo, Luting; Caro, Elena; Hassel, Christiane; Gutierrez, Crisanto; Michaels, Scott D.; Jacobsen, Steven E.			Regulation of heterochromatic DNA replication by histone H3 lysine 27 methyltransferases	NATURE			English	Article							ARABIDOPSIS-THALIANA; GENE REPRESSION; METHYLATION; SET; PROTEIN; REREPLICATION; MAINTENANCE; GENOME; PCNA; FORK	Multiple pathways prevent DNA replication from occurring more than once per cell cycle(1). These pathways block re-replication by strictly controlling the activity of pre-replication complexes, which assemble at specific sites in the genome called origins. Here we show that mutations in the homologous histone 3 lysine 27 (H3K27) monomethyltransferases, ARABIDOPSIS TRITHORAX-RELATED PROTEIN5 (ATXR5) and ATXR6, lead to re-replication of specific genomic locations. Most of these locations correspond to transposons and other repetitive and silent elements of the Arabidopsis genome. These sites also correspond to high levels of H3K27 monomethylation, and mutation of the catalytic SET domain is sufficient to cause the re-replication defect. Mutation of ATXR5 and ATXR6 also causes upregulation of transposon expression and has pleiotropic effects on plant development. These results uncover a novel pathway that prevents over-replication of heterochromatin in Arabidopsis.	[Jacob, Yannick; LeBlanc, Chantal; Zhuo, Luting; Hassel, Christiane; Michaels, Scott D.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Stroud, Hume; Caro, Elena; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Gutierrez, Crisanto] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	Indiana University System; Indiana University Bloomington; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Michaels, SD (corresponding author), Indiana Univ, Dept Biol, 915 E 3rd St, Bloomington, IN 47405 USA.	michaels@indiana.edu; jacobsen@ucla.edu	Gutierrez, Crisanto/ABH-8782-2020; Michaels, Scott/D-5458-2009; Caro, Elena/A-8097-2011; Caro, Elena/G-6352-2012; Caro, Elena/D-2611-2014	Caro, Elena/0000-0002-1034-1621; Michaels, Scott/0000-0001-5248-3487; Gutierrez, Crisanto/0000-0001-8905-8222	Le Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT); National Institutes of Health [GM075060]; Indiana METACyt Initiative of Indiana University; Lilly Endowment, Inc.; Spanish Ministry of Science and Innovation [BFU2009-9783, CSD2007-57B]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075060] Funding Source: NIH RePORTER	Le Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)(FQRNT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana METACyt Initiative of Indiana University; Lilly Endowment, Inc.; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Lambert and D. Galbraith for assistance with flow cytometry; Y. Bernatavichute for assistance with ChIP experiments; and M. Pellegrini and S. Cokus for advice on data analyses. Y.J. was supported by a fellowship from Le Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT). S. F. is a Howard Hughes Medical Institute Fellow of the Life Science Research Foundation. Research in the Michaels' laboratory was supported by grants from the National Institutes of Health (GM075060), the Indiana METACyt Initiative of Indiana University, and the Lilly Endowment, Inc. C. G. was supported by grants from the Spanish Ministry of Science and Innovation (BFU2009-9783 and CSD2007-57B). S.E.J. is an investigator of the Howard Hughes Medical Institute.	Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Caro Elena, 2008, SEB Exp Biol Ser, V59, P167; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Davidson IF, 2006, MOL CELL, V24, P433, DOI 10.1016/j.molcel.2006.09.010; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fransz P, 2006, CHROMOSOME RES, V14, P71, DOI 10.1007/s10577-005-1022-5; Fuchs J, 2006, TRENDS PLANT SCI, V11, P199, DOI 10.1016/j.tplants.2006.02.008; GALBRAITH DW, 1991, PLANT PHYSIOL, V96, P985, DOI 10.1104/pp.96.3.985; Gomez M, 2008, CELL CYCLE, V7, P1313, DOI 10.4161/cc.7.10.5881; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Joshi P, 2008, J BIOL CHEM, V283, P27757, DOI 10.1074/jbc.M804442200; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Mathieu O, 2005, EMBO J, V24, P2783, DOI 10.1038/sj.emboj.7600743; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Musselman CA, 2009, MOL INTERV, V9, P314, DOI 10.1124/mi.9.6.7; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108; Raynaud C, 2006, PLANT J, V47, P395, DOI 10.1111/j.1365-313X.2006.02799.x; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Zhang L, 2009, NEURAL REGEN RES, V4, P10	29	126	132	0	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2010	466	7309					987	U117		10.1038/nature09290	http://dx.doi.org/10.1038/nature09290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20631708	Green Accepted			2022-12-01	WOS:000281030300037
J	Jaffer, AK; Campo, RE; Gaski, G; Reyes, M; Gebhard, R; Ginzburg, E; Kolber, MA; Macdonald, J; Falcone, S; Green, BA; Barreras-Pagan, L; O'Neill, WW				Jaffer, Amir K.; Campo, Rafael E.; Gaski, Greg; Reyes, Mario; Gebhard, Ralf; Ginzburg, Enrique; Kolber, Michael A.; Macdonald, John; Falcone, Steven; Green, Barth A.; Barreras-Pagan, Lazara; O'Neill, William W.			An Academic Center's Delivery of Care After the Haitian Earthquake	ANNALS OF INTERNAL MEDICINE			English	Article								The Miller School of Medicine of the University of Miami and Project Medishare, an affiliated not-for-profit organization, provided a large-scale relief effort in Haiti after the earthquake of 12 January 2010. Their experience demonstrates that academic medical centers in proximity to natural disasters can help deliver effective medical care through a coordinated process involving mobilization of their own resources, establishment of focused management teams at home and on the ground with formal organizational oversight, and partnership with governmental and nongovernmental relief agencies. Proximity to the disaster area allows for prompt arrival of medical personnel and equipment. The recruitment and organized deployment of large numbers of local and national volunteers are indispensable parts of this effort. Multidisciplinary teams on short rotations can form the core of the medical response.	[O'Neill, William W.] Univ Miami Hlth Syst, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Miami Childrens Hosp, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Miami	O'Neill, WW (corresponding author), Univ Miami Hlth Syst, 1600 NW 10th Ave,RMSB 1122A, Miami, FL 33136 USA.	WONeill@med.miami.edu						Ginzburg E, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp1002026; Mulvey JM, 2008, INJURY, V39, P554, DOI 10.1016/j.injury.2007.07.025; Yang C, 2009, INJURY, V40, P488, DOI 10.1016/j.injury.2009.01.102	3	16	16	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 17	2010	153	4					262	265		10.7326/0003-4819-153-4-201008170-00266	http://dx.doi.org/10.7326/0003-4819-153-4-201008170-00266			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639KF	20643974				2022-12-01	WOS:000280973000007
J	Genovese, G; Friedman, DJ; Ross, MD; Lecordier, L; Uzureau, P; Freedman, BI; Bowden, DW; Langefeld, CD; Oleksyk, TK; Knob, ALU; Bernhardy, AJ; Hicks, PJ; Nelson, GW; Vanhollebeke, B; Winkler, CA; Kopp, JB; Pays, E; Pollak, MR				Genovese, Giulio; Friedman, David J.; Ross, Michael D.; Lecordier, Laurence; Uzureau, Pierrick; Freedman, Barry I.; Bowden, Donald W.; Langefeld, Carl D.; Oleksyk, Taras K.; Knob, Andrea L. Uscinski; Bernhardy, Andrea J.; Hicks, Pamela J.; Nelson, George W.; Vanhollebeke, Benoit; Winkler, Cheryl A.; Kopp, Jeffrey B.; Pays, Etienne; Pollak, Martin R.			Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans	SCIENCE			English	Article							STAGE RENAL-DISEASE; 9 GENE MYH9; POSITIVE SELECTION; NATURAL-SELECTION; HUMAN SERUM; POLYMORPHISMS; RHODESIENSE; GENOME	African Americans have higher rates of kidney disease than European Americans. Here, we show that, in African Americans, focal segmental glomerulosclerosis (FSGS) and hypertension-attributed end-stage kidney disease (H-ESKD) are associated with two independent sequence variants in the APOL1 gene on chromosome 22 {FSGS odds ratio = 10.5 [95% confidence interval (CI) 6.0 to 18.4]; H-ESKD odds ratio = 7.3 (95% CI 5.6 to 9.5)}. The two APOL1 variants are common in African chromosomes but absent from European chromosomes, and both reside within haplotypes that harbor signatures of positive selection. ApoL1 (apolipoprotein L-1) is a serum factor that lyses trypanosomes. In vitro assays revealed that only the kidney disease-associated ApoL1 variants lysed Trypanosoma brucei rhodesiense. We speculate that evolution of a critical survival factor in Africa may have contributed to the high rates of renal disease in African Americans.	[Genovese, Giulio; Friedman, David J.; Bernhardy, Andrea J.; Pollak, Martin R.] Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA; [Genovese, Giulio; Friedman, David J.; Bernhardy, Andrea J.; Pollak, Martin R.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Genovese, Giulio] Dartmouth Coll, Dept Math, Hanover, NH 03755 USA; [Friedman, David J.] Beth Israel Deaconess Med Ctr, Dept Med, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Ross, Michael D.; Knob, Andrea L. Uscinski] Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02215 USA; [Lecordier, Laurence; Uzureau, Pierrick; Vanhollebeke, Benoit; Pays, Etienne] Univ Libre Bruxelles, Inst Biol & Med Mol, Mol Parasitol Lab, B-6041 Gosselies, Belgium; [Freedman, Barry I.] Wake Forest Univ, Sch Med, Nephrol Sect, Dept Internal Med, Winston Salem, NC 27157 USA; [Bowden, Donald W.; Hicks, Pamela J.] Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Bowden, Donald W.; Hicks, Pamela J.] Wake Forest Univ, Sch Med, Ctr Diabet Res, Winston Salem, NC 27157 USA; [Bowden, Donald W.; Langefeld, Carl D.; Hicks, Pamela J.] Wake Forest Univ, Sch Med, Ctr Human Genom, Winston Salem, NC 27157 USA; [Langefeld, Carl D.] Wake Forest Univ, Sch Med, Ctr Publ Hlth Genom, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Langefeld, Carl D.] Wake Forest Univ, Sch Med, Div Publ Hlth Sci, Winston Salem, NC 27157 USA; [Oleksyk, Taras K.] Univ Puerto Rico, Dept Biol, Mayaguez, PR 00681 USA; [Nelson, George W.; Kopp, Jeffrey B.] NIDDKD, Kidney Dis Sect, NIH, Bethesda, MD 20892 USA; [Winkler, Cheryl A.] NCI, Lab Genom Divers, SAIC Frederick Inc, Frederick, MD 21702 USA; [Pollak, Martin R.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Dartmouth College; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Universite Libre de Bruxelles; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; University of Puerto Rico; University of Puerto Rico Mayaguez; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Pollak, MR (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA.	epays@ulb.ac.be; mpollak@bidmc.harvard.edu	Rinaldi2, Carlos/D-4479-2011; Kopp, Jeffrey B/O-2681-2015; Taras, Oleksyk/J-8805-2013	Kopp, Jeffrey B/0000-0001-9052-186X; Taras, Oleksyk/0000-0002-8148-3918; Friedman, David/0000-0002-0301-9298; Vanhollebeke, Benoit/0000-0002-0353-365X; Genovese, Giulio/0000-0003-3066-5575	Walloon Region; Fonds National de la Recherche Scientifique; Belgian Science Policy; NIH [R01 DK54931, K08-DK076868, R01 DK066358, R01 DK053591, R01 HL56266, R01 DK 070941, R01 DK 084149]; National Institute of Diabetes, Digestive, and Kidney Disease [Z01 DK043308]; NCI, Center for Cancer Research [ZIA BC 010022]; NephCure Foundation; NCI, NIH [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIABC010297, ZIABC010022] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066358, K08DK076868, R01DK070941, R01DK054931, Z01DK043308, R01DK053591, R01DK084149, ZIADK043308] Funding Source: NIH RePORTER	Walloon Region; Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Belgian Science Policy(Belgian Federal Science Policy Office); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes, Digestive, and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NephCure Foundation; NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Broad Institute Medical and Population Genetics Program for helpful advice and review of the manuscript. We thank the study participants for their participation and J. Robinson for the help provided accessing the 1000 Genomes project data. We thank X. C. Zhou [National Cancer Institute (NCI)] and E. Binns-Roemer (NCI), P. Poelvoorde [Universite Libre de Bruxelles (ULB)], P. Tebabi (ULB) and A. Pays (ULB) for excellent technical assistance. We thank the investigators in the BWH and NIH FSGS genetic studies: W. Briggs, R. Dart, S. Korbet, M. Mokrzycki, P. Kimmel, T. Ahuja, J. Berns, E. Simon, M. Smith, H. Trachtman, M. Michel, J. R. Schelling, G. Appel, and A. Katz. The work at the University of Brussels was supported by the "CIBLES" program of the Walloon Region, the Fonds National de la Recherche Scientifique, and the Interuniversity Attraction Poles program of the Belgian Science Policy. This work was also supported by grants from the NIH (R01 DK54931 to M.R.P; K08-DK076868 to D.J.F.; R01 DK066358 and R01 DK053591 to D. W. B.; and R01 HL56266, R01 DK 070941, and R01 DK 084149 to B.I.F.), the National Institute of Diabetes, Digestive, and Kidney Disease Intramural research program (Z01 DK043308 to J.B.K.), the Intramural Research Program of NCI, Center for Cancer Research (Project ZIA BC 010022; C.A.W. and G.W.N.), and the NephCure Foundation (to M.R.P). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The publisher or recipient acknowledges right of the U.S. Government to retain a nonexclusive, royalty-free license in and to any copyright covering the article. This project has been funded in part with federal funds from the NCI, NIH, under contract HHSN261200800001E. All participants gave informed consent for genetic studies, and research was conducted under protocols approved by the appropriate institutional review boards. J.B.K., G.W.N., C.A.W., and the NCI have a patent application pending for chromosome 22 polymorphisms and haplotypes for genetic screening and clinical applications. M.R.P., G.G., the Brigham and Women's Hospital, and Beth Israel Deaconess Medical Center have been added as coinventors to an amendment to this application naming the specific ApoL1 SNPs described in this manuscript. E.P., L.L., P.U., and ULB have applied for a patent related to the use of plasma from ESKD patients to treat human sleeping sickness by plasma transfer.	Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; BYRNE C, 1994, AM J KIDNEY DIS, V23, P16, DOI 10.1016/S0272-6386(12)80806-7; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman BI, 2009, NEPHROL DIAL TRANSPL, V24, P3366, DOI 10.1093/ndt/gfp316; Freedman BI, 2009, KIDNEY INT, V75, P736, DOI 10.1038/ki.2008.701; Gibson W, 2002, TRENDS PARASITOL, V18, P486, DOI 10.1016/S1471-4922(02)02390-5; GIBSON W C, 1986, Parasitology Today, V2, P255, DOI 10.1016/0169-4758(86)90011-6; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kimura R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000286; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Lecordier L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000685; Nelson GW, 2010, HUM MOL GENET, V19, P1805, DOI 10.1093/hmg/ddq039; Oleksyk TK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011474; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Satko SG, 2005, KIDNEY INT, V67, pS46, DOI 10.1111/j.1523-1755.2005.09411.x; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; Xong HV, 1998, CELL, V95, P839, DOI 10.1016/S0092-8674(00)81706-7	23	1293	1334	2	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					841	845		10.1126/science.1193032	http://dx.doi.org/10.1126/science.1193032			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20647424	Green Accepted			2022-12-01	WOS:000280809900051
J	Juliano, C; Wessel, G				Juliano, Celina; Wessel, Gary			Versatile Germline Genes	SCIENCE			English	Editorial Material							SOMATIC STEM-CELLS; SMALL MICROMERE LINEAGE; SEA-URCHIN; EXPRESSION; NANOS; POSTERIOR; EMBRYO; ORIGIN; HYDRA		[Juliano, Celina] Yale Univ, Dept Cell Biol, Stem Cell Ctr, New Haven, CT 06520 USA; [Wessel, Gary] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA	Yale University; Brown University	Juliano, C (corresponding author), Yale Univ, Dept Cell Biol, Stem Cell Ctr, New Haven, CT 06520 USA.	gary_wessel@brown.edu			NICHD NIH HHS [R01 HD028152-17, R01 HD028152] Funding Source: Medline; NIGMS NIH HHS [T32 GM007601] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD028152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007601] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ewen-Campen B, 2010, MOL REPROD DEV, V77, P3, DOI 10.1002/mrd.21091; Funayama N, 2010, DEV GROWTH DIFFER, V52, P1, DOI 10.1111/j.1440-169X.2009.01162.x; Juliano CE, 2006, DEV BIOL, V300, P406, DOI 10.1016/j.ydbio.2006.07.035; Juliano CE, 2010, DEV BIOL, V337, P220, DOI 10.1016/j.ydbio.2009.10.030; Mochizuki K, 2000, DEV GENES EVOL, V210, P591, DOI 10.1007/s004270000105; Mochizuki K, 2001, DEV GENES EVOL, V211, P299, DOI 10.1007/s004270100156; Rabinowitz JS, 2008, CURR BIOL, V18, P331, DOI 10.1016/j.cub.2008.01.055; Rebscher N, 2007, DEV BIOL, V306, P599, DOI 10.1016/j.ydbio.2007.03.521; Saffman EE, 1999, CELL MOL LIFE SCI, V55, P1141, DOI 10.1007/s000180050363; Shibata N, 2010, DEV GROWTH DIFFER, V52, P27, DOI 10.1111/j.1440-169X.2009.01155.x; Swartz SZ, 2008, DEV GENES EVOL, V218, P107, DOI 10.1007/s00427-008-0203-6; TANAKA S, 1990, DEV GROWTH DIFFER, V32, P145; Voronina E, 2008, DEV BIOL, V314, P276, DOI 10.1016/j.ydbio.2007.11.039	13	70	70	2	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					640	641		10.1126/science.1194037	http://dx.doi.org/10.1126/science.1194037			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20689009	Green Accepted			2022-12-01	WOS:000280602700027
J	Lieber, MR; Wilson, TE				Lieber, Michael R.; Wilson, Thomas E.			SnapShot: Nonhomologous DNA End Joining (NHEJ)	CELL			English	Editorial Material							REPAIR		[Lieber, Michael R.] Univ So Calif, Los Angeles, CA 90089 USA; [Wilson, Thomas E.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Southern California; University of Michigan System; University of Michigan	Lieber, MR (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.			Lieber, Michael/0000-0001-8809-0909; Lieber, Michael/0000-0003-3700-6345	NATIONAL CANCER INSTITUTE [R01CA102563, R37CA051105, R01CA100504] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA100504, R01 CA102563, R37 CA051105] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Downs JA, 2004, NAT REV MOL CELL BIO, V5, P367, DOI 10.1038/nrm1367; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009	5	41	43	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 6	2010	142	3					496	U174	496.e1	10.1016/j.cell.2010.07.035	http://dx.doi.org/10.1016/j.cell.2010.07.035			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	634TS	20691907	Bronze			2022-12-01	WOS:000280609100026
J	Ramnarayan, P; Thiru, K; Parslow, RC; Harrison, DA; Draper, ES; Rowan, KM				Ramnarayan, Padmanabhan; Thiru, Krish; Parslow, Roger C.; Harrison, David A.; Draper, Elizabeth S.; Rowan, Kathy M.			Effect of specialist retrieval teams on outcomes in children admitted to paediatric intensive care units in England and Wales: a retrospective cohort study	LANCET			English	Article							CRITICALLY-ILL; HOSPITAL VOLUME; HEALTH-CARE; MORTALITY; REDUCTION; TRANSPORT; IMPLEMENTATION; ADMISSION; DELIVERY; SURGERY	Background Intensive care services for children have undergone substantial centralisation in the UK. Along with the establishment of regional paediatric intensive care units (PICUs), specialist retrieval teams were set up to transport critically ill children from other hospitals. We studied the outcome of children transferred from local hospitals to PICUs. Methods We analysed data that were gathered for a cohort of children (<= 16 years) admitted consecutively to 29 PICUs in England and Wales during 4 years (Jan 1, 2005, to Dec 31, 2008). We compared unplanned admissions from wards within the same hospital as the PICU and from other hospitals; interhospital transfers by non-specialist and specialist retrieval teams; and patients transferred to their nearest PICU and those who were not. Primary outcome measures were mortality rate in PICU and length of stay in P ICU. We analysed data by use of logistic regression analysis. Findings There were 57997 admissions to PICUs during the study. Nearly half of unplanned admissions (17 649 [53%] of 33 492) were from other hospitals. Although children admitted from other hospitals were younger (median 10 months [IQR 1-55] vs 18 months [3-85]), sicker at admission (median predicted risk of mortality 6% [4-10] vs 4% [2-7]), stayed longer in PICUs (75 h [33-153] vs 43 h [18-116]), and had higher crude mortality rates (1384 [8%] of 17 649 vs 996 [6%] of 15843; odds ratio 1.27, 95% CI 1.16-1.38), the risk-adjusted mortality rate in PICUs was lower than among children admitted from within the same hospital (0.65, 0.53-0.80). In a multivariable analysis, use of a specialist retrieval team for transfer was associated with improved survival (0 58, 0.39-0.87). Interpretation These findings support the policy of combining centralisation of intensive care services for children with transfer by specialist retrieval teams.	[Ramnarayan, Padmanabhan] Great Ormond St Hosp Sick Children, Childrens Acute Transport Serv, London, England; [Thiru, Krish] City Univ London, Sch Informat, Ctr Hlth Informat, London EC1V 0HB, England; [Parslow, Roger C.] Leeds Inst Genet Hlth & Therapeut, Ctr Biostat & Epidemiol, Paediat Epidemiol Grp, Leeds, W Yorkshire, England; [Harrison, David A.; Draper, Elizabeth S.] Intens Care Natl Audit & Res Ctr, London, England; [Draper, Elizabeth S.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; City University London; University of Leeds; Intensive Care National Audit & Research Centre; University of Leicester	Ramnarayan, P (corresponding author), Great Ormond St Hosp NHS Trust, Childrens Acute Transport Serv, 44-B Bedford Row, London WC1R 4LL, England.		Harrison, David A/O-4355-2018; Draper, Elizabeth/S-6874-2019; Draper, Elizabeth S/I-6304-2018; Parslow, Roger/AAV-1477-2020; Ramnarayan, Padmanabhan/AAI-6783-2020	Harrison, David A/0000-0002-9002-9098; Draper, Elizabeth/0000-0001-9340-8176; Draper, Elizabeth S/0000-0001-9340-8176; Ramnarayan, Padmanabhan/0000-0003-0784-8154; Rowan, Kathryn/0000-0001-8217-5602; Parslow, Roger/0000-0002-3945-5294	National Clinical Audit and Patient Outcomes Programme through Healthcare Quality Improvement Partnership; Health Commission Wales Specialised Services	National Clinical Audit and Patient Outcomes Programme through Healthcare Quality Improvement Partnership; Health Commission Wales Specialised Services	PICANet is funded by the National Clinical Audit and Patient Outcomes Programme through Healthcare Quality Improvement Partnership, Health Commission Wales Specialised Services. National Health Service (NHS) Lothian and National Service Division NHS Scotland. the Royal Belfast Hospital for Sick Children, and the Pan Thames PICU Commissioning Consortium We thank all the staff in participating hospitals who gathered data for PICANet A full list of participating PICUs and steering group and clinical advisory group membership is available on the latest PICANet Annual Report We thank Steve Harris for commenting on an early draft of this report and contributing to discussions about the sensitivity analyses, and Philip McShane for extracting the study data from the PICANet database	Bazzani LG, 2007, CIRCULATION, V115, P2652, DOI 10.1161/CIRCULATIONAHA.106.678904; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Bellingan G, 2000, INTENS CARE MED, V26, P740; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Booy R, 2001, ARCH DIS CHILD, V85, P386, DOI 10.1136/adc.85.5.386; BRITTO J, 1995, BRIT MED J, V311, P836, DOI 10.1136/bmj.311.7009.836; Chan PS, 2008, JAMA-J AM MED ASSOC, V300, P2506, DOI 10.1001/jama.2008.715; CHAN PS, ARCH INTERN MED, V170, P18; Combes A, 2005, CRIT CARE MED, V33, P705, DOI 10.1097/01.CCM.0000158518.32730.C5; Department of Health, 1997, PAED INT CAR FRAM FU; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; ESCARCE JJ, 1990, JAMA-J AM MED ASSOC, V264, P2389, DOI 10.1001/jama.264.18.2389; FIELD D, 1991, ARCH DIS CHILD-FETAL, V66, P408, DOI 10.1136/adc.66.4_Spec_No.408; Gregory CJ, 2008, PEDIATRICS, V121, pE906, DOI 10.1542/peds.2007-2089; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Hanson CC, 2009, QUAL SAF HEALTH CARE, V18, P500, DOI 10.1136/qshc.2007.026054; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Maybloom B, 1997, LANCET, V350, P65, DOI 10.1016/S0140-6736(97)26027-7; McDonnell A, 2007, J CRIT CARE, V22, P212, DOI 10.1016/j.jcrc.2007.02.002; Odetola FO, 2008, PEDIATR CRIT CARE ME, V9, P20, DOI 10.1097/01.PCC.0000298642.11872.29; Orr RA, 2009, PEDIATRICS, V124, P40, DOI 10.1542/peds.2008-0515; Pearson G, 1997, LANCET, V349, P1213, DOI 10.1016/S0140-6736(96)12396-5; *PICA NET, 2006, NAT REP PAED INT CAR; Rosenberg AL, 2003, ANN INTERN MED, V138, P882, DOI 10.7326/0003-4819-138-11-200306030-00009; Shann F, 1997, INTENS CARE MED, V23, P201, DOI 10.1007/s001340050317; Stevenson A, 2005, EMERG MED J, V22, P795, DOI 10.1136/emj.2004.017822; Tibballs J, 2005, ARCH DIS CHILD, V90, P1148, DOI 10.1136/adc.2004.069401; *U YORK, 1996, EFF HLTH CAR HOSP VO; Vos GD, 2004, INTENS CARE MED, V30, P302, DOI 10.1007/s00134-003-2066-7	29	96	99	1	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2010	376	9742					698	704		10.1016/S0140-6736(10)61113-0	http://dx.doi.org/10.1016/S0140-6736(10)61113-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646YW	20708255				2022-12-01	WOS:000281582900029
J	Cai, WJ; Chen, LQ; Chen, BS; Gao, ZY; Lee, SH; Chen, JF; Pierrot, D; Sullivan, K; Wang, YC; Hu, XP; Huang, WJ; Zhang, YH; Xu, SQ; Murata, A; Grebmeier, JM; Jones, EP; Zhang, HS				Cai, Wei-Jun; Chen, Liqi; Chen, Baoshan; Gao, Zhongyong; Lee, Sang H.; Chen, Jianfang; Pierrot, Denis; Sullivan, Kevin; Wang, Yongchen; Hu, Xinping; Huang, Wei-Jen; Zhang, Yuanhui; Xu, Suqing; Murata, Akihiko; Grebmeier, Jacqueline M.; Jones, E. Peter; Zhang, Haisheng			Decrease in the CO2 Uptake Capacity in an Ice-Free Arctic Ocean Basin	SCIENCE			English	Article							SPATIAL VARIABILITY; CARBON-DIOXIDE; ACIDIFICATION; SHELF; PHYTOPLANKTON	It has been predicted that the Arctic Ocean will sequester much greater amounts of carbon dioxide (CO2) from the atmosphere as a result of sea ice melt and increasing primary productivity. However, this prediction was made on the basis of observations from either highly productive ocean margins or ice-covered basins before the recent major ice retreat. We report here a high-resolution survey of sea-surface CO2 concentration across the Canada Basin, showing a great increase relative to earlier observations. Rapid CO2 invasion from the atmosphere and low biological CO2 drawdown are the main causes for the higher CO2, which also acts as a barrier to further CO2 invasion. Contrary to the current view, we predict that the Arctic Ocean basin will not become a large atmospheric CO2 sink under ice-free conditions.	[Cai, Wei-Jun; Chen, Baoshan; Wang, Yongchen; Hu, Xinping; Huang, Wei-Jen] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; [Chen, Liqi; Gao, Zhongyong; Zhang, Yuanhui; Xu, Suqing] SOA, Inst Oceanog 3, Key Lab Global Change & Marine Atmospher Chem, Xiamen 361005, Peoples R China; [Lee, Sang H.] Korea Polar Res Inst, Inchon 406840, South Korea; [Chen, Jianfang; Zhang, Haisheng] SOA, Inst Oceanog 2, Lab Marine Ecosyst & Biogeochem, Hangzhou 310012, Zhejiang, Peoples R China; [Pierrot, Denis; Sullivan, Kevin] NOAA, Atlantic Oceanog & Meteorol Lab, Ocean Chem Div, Miami, FL 33149 USA; [Pierrot, Denis; Sullivan, Kevin] Univ Miami, Cooperat Inst Marine & Atmospher Sci, Miami, FL 33149 USA; [Murata, Akihiko] Japan Agcy Marine Earth Sci & Technol, Res Inst Global Change, Yokosuka, Kanagawa 2370061, Japan; [Grebmeier, Jacqueline M.] Univ Maryland, Ctr Environm Sci, Chesapeake Biol Lab, Solomons, MD 20688 USA; [Jones, E. Peter] Bedford Inst Oceanog, Ocean Sci Div, Dept Fisheries & Oceans, Dartmouth, NS B2Y 4A2, Canada	University System of Georgia; University of Georgia; State Oceanic Administration; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI); State Oceanic Administration; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); University of Miami; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University System of Maryland; University of Maryland Center for Environmental Science; Bedford Institute of Oceanography; Fisheries & Oceans Canada	Cai, WJ (corresponding author), Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA.	wcai@uga.edu	Pierrot, Denis/AAH-7687-2020; Grebmeier, Jacqueline/L-9805-2013; Pierrot, Denis/A-7459-2014; Cai, Wei-Jun/C-1361-2013; Hu, Xinping/F-6282-2011	Grebmeier, Jacqueline/0000-0001-7624-3568; Pierrot, Denis/0000-0002-0374-3825; Cai, Wei-Jun/0000-0003-3606-8325; Hu, Xinping/0000-0002-0613-6545; Huang, Wei-Jen/0000-0002-1713-2515	Ministry of Science and Technology of China [2009DFA22920]; Natural Science Foundation of China [40531007]; U.S. National Oceanic and Atmospheric Administration [NA05OAR4311161, NA09OAR4310078]; NSF [ARC-0909330]; Korean Arctic Research project [PM09020]; Chinese Arctic and Antarctic Administration; Polar Research Institute of China; Division Of Polar Programs [0909330] Funding Source: National Science Foundation	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); NSF(National Science Foundation (NSF)); Korean Arctic Research project; Chinese Arctic and Antarctic Administration; Polar Research Institute of China; Division Of Polar Programs(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank R. Wanninkhof, P. Yager, and N. Bates for discussions; J. Zhao for the salinity and temperature data; and H. Li and S. Gao for sample collection. Funding for the CHINARE CO<INF>2</INF> survey and subsequent synthesis was provided by the Ministry of Science and Technology of China (2009DFA22920), the Natural Science Foundation of China (40531007), and the U.S. National Oceanic and Atmospheric Administration (NA05OAR4311161 and NA09OAR4310078) and NSF (ARC-0909330). The measurements for primary production of phytoplankton were funded by a Korean Arctic Research project (PM09020). We also thank the Chinese Arctic and Antarctic Administration and the Polar Research Institute of China for their support. We are grateful to the captain and crew of icebreaker Xuelong.	Anderson LG, 1998, GLOBAL BIOGEOCHEM CY, V12, P455, DOI 10.1029/98GB01372; Arrigo KR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035028; Bates NR, 2009, BIOGEOSCIENCES, V6, P2433, DOI 10.5194/bg-6-2433-2009; Bates NR, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003083; Carmack E, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017526; Codispoti LA, 2009, DEEP-SEA RES PT II, V56, P1144, DOI 10.1016/j.dsr2.2008.10.013; Comiso JC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031972; Fransson A, 2009, CONT SHELF RES, V29, P1317, DOI 10.1016/j.csr.2009.03.008; Gosselin M, 1997, DEEP-SEA RES PT II, V44, P1623, DOI 10.1016/S0967-0645(97)00054-4; Gradinger R, 2009, DEEP-SEA RES PT II, V56, P1201, DOI 10.1016/j.dsr2.2008.10.016; GREBMEIER JM, 2010, EOS, V91, P161, DOI DOI 10.1029/2010EO180001; Guo LD, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002593; Hansell DA, 2004, SCIENCE, V304, P858, DOI 10.1126/science.1096175; Kaltin S, 2005, MAR CHEM, V94, P67, DOI 10.1016/j.marchem.2004.07.010; Li WKW, 2009, SCIENCE, V326, P539, DOI 10.1126/science.1179798; Chen LQ, 2007, DEEP-SEA RES PT II, V54, P2619, DOI 10.1016/j.dsr2.2007.08.010; Montes-Hugo M, 2009, SCIENCE, V323, P1470, DOI 10.1126/science.1164533; Murata A, 2003, CONT SHELF RES, V23, P753, DOI 10.1016/S0278-4343(03)00046-3; Pabi S, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004578; Rysgaard S, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003572; Solomon S., 2007, ADV CLIM CHANG RES; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Wang MY, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037820; Yager PL, 1999, LIMNOL OCEANOGR, V44, P1882, DOI 10.4319/lo.1999.44.8.1882; Yamamoto-Kawai M, 2009, SCIENCE, V326, P1098, DOI 10.1126/science.1174190	25	168	199	6	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2010	329	5991					556	559		10.1126/science.1189338	http://dx.doi.org/10.1126/science.1189338			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20651119				2022-12-01	WOS:000280483500034
J	Yan, JS; Aldrich, RW				Yan, Jiusheng; Aldrich, Richard W.			LRRC26 auxiliary protein allows BK channel activation at resting voltage without calcium	NATURE			English	Article							LEUCINE-RICH REPEAT; POTASSIUM CHANNELS; BETA-SUBUNITS; CLONING; SENSOR; CELLS; EXPRESSION; HKCNMB3; FAMILY; CANCER	Large-conductance, voltage-and calcium-activated potassium (BK, or K(Ca)1.1) channels are ubiquitously expressed in electrically excitable and non-excitable cells(1,2), either as alpha-subunit (BK alpha) tetramers or together with tissue specific auxiliary beta-subunits (beta 1-beta 4)(3-5). Activation of BK channels typically requires coincident membrane depolarization and elevation in free cytosolic Ca2+ concentration ([Ca2+](i))(6,7), which are not physiological conditions for most non-excitable cells. Here we present evidence that in non-excitable LNCaP prostate cancer cells, BK channels can be activated at negative voltages without rises in [Ca2+](i) through their complex with an auxiliary protein, leucine-rich repeat (LRR)-containing protein 26 (LRRC26). LRRC26 modulates the gating of a BK channel by enhancing the allosteric coupling between voltage-sensor activation and the channel's closed-open transition. This finding reveals a novel auxiliary protein of a voltage- gated ion channel that gives an unprecedentedly large negative shift (similar to-140 mV) in voltage dependence and provides a molecular basis for activation of BK channels at physiological voltages and calcium levels in non-excitable cells.	[Yan, Jiusheng; Aldrich, Richard W.] Univ Texas Austin, Ctr Learning & Memory, Neurobiol Sect, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Aldrich, RW (corresponding author), Univ Texas Austin, Ctr Learning & Memory, Neurobiol Sect, Austin, TX 78712 USA.	raldrich@mail.utexas.edu			American Heart Association	American Heart Association(American Heart Association)	We are grateful to I. Pastan and X. F. Liu for the generous gift of LRRC26 antibody and plasmids. We thank J. Trimmer for discussion and W. Li, L. Scott, J. Greeson, X. Chen and H. Liu for reading the manuscript. We thank A. Hall, H. Cha and U. Bagaria for research assistance. Mass spectrometry was performed at the UC Davis Proteomics Facility. J. Y. acknowledges postdoctoral fellowship support from the American Heart Association.	Bao L, 2005, J GEN PHYSIOL, V126, P393, DOI 10.1085/jgp.200509346; BARRETT JN, 1982, J PHYSIOL-LONDON, V331, P211, DOI 10.1113/jphysiol.1982.sp014370; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Bloch M, 2007, ONCOGENE, V26, P2525, DOI 10.1038/sj.onc.1210036; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Cambien B, 2008, INT J CANCER, V123, P365, DOI 10.1002/ijc.23511; Egland KA, 2006, P NATL ACAD SCI USA, V103, P5929, DOI 10.1073/pnas.0601296103; Fodor AA, 2009, ANNU REV PHYSIOL, V71, P19, DOI 10.1146/annurev.physiol.010908.163124; Gessner G, 2005, J MEMBRANE BIOL, V208, P229, DOI 10.1007/s00232-005-0830-z; Horrigan FT, 2008, J GEN PHYSIOL, V131, P13, DOI 10.1085/jgp.200709877; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Kim HM, 2007, J BIOL CHEM, V282, P6726, DOI 10.1074/jbc.M608471200; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KOLB HA, 1990, REV PHYSIOL BIOCH P, V115, P51; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Ma ZM, 2006, J GEN PHYSIOL, V127, P309, DOI 10.1085/jgp.200509421; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Tang XD, 2004, NAT STRUCT MOL BIOL, V11, P171, DOI 10.1038/nsmb725; Thurm H, 2005, J PHYSIOL-LONDON, V569, P137, DOI 10.1113/jphysiol.2005.094680; Uebele VN, 2000, J BIOL CHEM, V275, P23211, DOI 10.1074/jbc.M910187199; Wang B, 2006, J GEN PHYSIOL, V127, P449, DOI 10.1085/jgp.200509436; Weaver AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/jnr.20240; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yan JS, 2008, MOL CELL PROTEOMICS, V7, P2188, DOI 10.1074/mcp.M800063-MCP200; Yang HH, 2008, NAT STRUCT MOL BIOL, V15, P1152, DOI 10.1038/nsmb.1507	28	164	168	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					513	U15		10.1038/nature09162	http://dx.doi.org/10.1038/nature09162			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20613726				2022-12-01	WOS:000280141200041
J	Scurlock, D				Scurlock, Donna			Vaccine, Please	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												dscurlockmd@comcast.net						*KEN MOD HIV TRANS, 2009, KEN HIV PREV RESP MO; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 21	2010	304	3					250	251		10.1001/jama.2010.751	http://dx.doi.org/10.1001/jama.2010.751			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628HV	20639552				2022-12-01	WOS:000280107500001
J	Pallares-Sanmartin, A; Leiro-Fernandez, V; Cebreiro, TL; Botana-Rial, M; Fernandez-Villar, A				Pallares-Sanmartin, Abel; Leiro-Fernandez, Virginia; Lourido Cebreiro, Tamara; Botana-Rial, Maribel; Fernandez-Villar, Alberto			Validity and Reliability of the Schamroth Sign for the Diagnosis of Clubbing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Pallares-Sanmartin, Abel; Leiro-Fernandez, Virginia; Lourido Cebreiro, Tamara; Botana-Rial, Maribel; Fernandez-Villar, Alberto] Complexo Hosp Univ Vigo, Pulmonol Serv, Vigo, Spain	Complexo Hospitalario Universitario de Vigo	Pallares-Sanmartin, A (corresponding author), Complexo Hosp Univ Vigo, Pulmonol Serv, Vigo, Spain.	alberto.fernandez.villar@sergas.es	Fernandez, Virginia Leiro/B-9679-2018	Fernandez, Virginia Leiro/0000-0001-9613-430X; Lourido Cebreiro, Tamara/0000-0002-0391-898X; FERNANDEZ-VILLAR, ALBERTO/0000-0001-7407-5249				[Anonymous], 2007, EVIDENCE BASED PHYS; LAMPE RM, 1983, CLIN PEDIATR, V22, P125, DOI 10.1177/000992288302200207; Martinez-Lavin M, 2007, SEMIN ARTHRITIS RHEU, V36, P380, DOI 10.1016/j.semarthrit.2006.11.004; Maslovsky I, 2005, AM J MED, V118, P1350, DOI 10.1016/j.amjmed.2005.09.036; Myers KA, 2001, JAMA-J AM MED ASSOC, V286, P341, DOI 10.1001/jama.286.3.341; SCHAMROTH L, 1976, S AFR MED J, V50, P297	6	9	9	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2010	304	2					159	161		10.1001/jama.2010.935	http://dx.doi.org/10.1001/jama.2010.935			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624IN	20628128				2022-12-01	WOS:000279811000020
J	Boiko, AD; Razorenova, OV; van de Rijn, M; Swetter, SM; Johnson, DL; Ly, DP; Butler, PD; Yang, GP; Joshua, B; Kaplan, MJ; Longaker, MT; Weissman, IL				Boiko, Alexander D.; Razorenova, Olga V.; van de Rijn, Matt; Swetter, Susan M.; Johnson, Denise L.; Ly, Daphne P.; Butler, Paris D.; Yang, George P.; Joshua, Benzion; Kaplan, Michael J.; Longaker, Michael T.; Weissman, Irving L.			Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271	NATURE			English	Article							CANCER STEM-CELLS; PROSPECTIVE IDENTIFICATION; PROGENITORS	The question of whether tumorigenic cancer stem cells exist in human melanomas has arisen in the last few years(1). Here we show that in melanomas, tumour stem cells (MTSCs, for melanoma tumour stem cells) can be isolated prospectively as a highly enriched CD271(+) MTSC population using a process that maximizes viable cell transplantation(1,2). The tumours sampled in this study were taken from a broad spectrum of sites and stages. High-viability cells isolated by fluorescence-activated cell sorting and re-suspended in a matrigel vehicle were implanted into T-, B- and natural-killer-deficient Rag2(-/-) gamma c(-/-) mice. The CD271(+) subset of cells was the tumour-initiating population in 90% (nine out of ten) of melanomas tested. Transplantation of isolated CD271(+) melanoma cells into engrafted human skin or bone in Rag2(-/-) gamma c(-/-) mice resulted in melanoma; however, melanoma did not develop after transplantation of isolated CD271(-) cells. We also show that in mice, tumours derived from transplanted human CD271(-) melanoma cells were capable of metastatsis in vivo. CD271(+) melanoma cells lacked expression of TYR, MART1 and MAGE in 86%, 69% and 68% of melanoma patients, respectively, which helps to explain why T-cell therapies directed at these antigens usually result in only temporary tumour shrinkage.	[Boiko, Alexander D.; Longaker, Michael T.; Weissman, Irving L.] Stanford Univ, Sch Med, Stanford Canc Ctr, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94304 USA; [Razorenova, Olga V.] Stanford Univ, Med Ctr, Stanford Canc Ctr, Dept Radiat Oncol, Stanford, CA 94305 USA; [van de Rijn, Matt; Weissman, Irving L.] Stanford Univ, Med Ctr, Stanford Canc Ctr, Dept Pathol, Stanford, CA 94305 USA; [Swetter, Susan M.] Stanford Univ, Med Ctr, Stanford Canc Ctr, Dept Dermatol,Pigmented Les & Melanoma Program, Stanford, CA 94305 USA; [Swetter, Susan M.; Yang, George P.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Johnson, Denise L.; Ly, Daphne P.; Butler, Paris D.; Yang, George P.; Longaker, Michael T.] Stanford Univ, Med Ctr, Stanford Canc Ctr, Dept Surg, Stanford, CA 94305 USA; [Ly, Daphne P.; Butler, Paris D.; Yang, George P.; Longaker, Michael T.] Stanford Univ, Sch Med, Dept Surg, Hagey Lab Pediat Regenerat Med,Div Plast & Recons, Stanford, CA 94305 USA; [Joshua, Benzion; Kaplan, Michael J.] Stanford Univ, Med Ctr, Stanford Canc Ctr, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA	Stanford Cancer Institute; Stanford University; Stanford Cancer Institute; Stanford University; Stanford Cancer Institute; Stanford University; Stanford Cancer Institute; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford Cancer Institute; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University	Boiko, AD (corresponding author), Stanford Univ, Sch Med, Stanford Canc Ctr, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94304 USA.	aboiko@stanford.edu; irv@stanford.edu	Ferris, Laura/I-7689-2012; Razorenova, Olga V/A-6400-2014	Joshua, Ben-Zion/0000-0002-2010-892X; van de Rijn, Matt/0000-0002-1909-9739; Rinner, Beate/0000-0002-6340-4905	American Cancer Society; NIH [F32 CA126252, 1RC2 DE02077-01]; Virginia & D.K. Ludwig Fund for Cancer Research; NIH/NCRR [UL1 RR025744]; Oak Foundation; Ellenburg Faculty Scholar Endowment; NATIONAL CANCER INSTITUTE [F32CA126252] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia & D.K. Ludwig Fund for Cancer Research; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Oak Foundation; Ellenburg Faculty Scholar Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank J. Bueno and S. Hicks for obtaining patient consent and specimens; K. Montgomery for immunohistochemistry analyses; D. Kim for NSG bone-grafted mice; K. Chan, L. Ailles and C. Park for advice and help in FACS and tumour transplantation assays; L. Cohen for MAGE antibodies; L. Jerabek, T. Storm and A. Mosley for laboratory and mouse management; P. Lovelace for FACS management; A. Olson for help with microscopy; all members of the Weissman Laboratory for experimental suggestions; and M. Clarke and members of his laboratory for critical discussions and reading. This research was initially supported in part by the American Cancer Society fellowship and in part by NIH F32 CA126252 NRSA fellowship to A. D. B.; the Virginia & D.K. Ludwig Fund for Cancer Research to I. L. W.; NIH/NCRR CTSA grant UL1 RR025744 to Stanford Spectrum M.v.d.R.; The Oak Foundation and NIH 1RC2 DE02077-01 to M. T. L.; the Oak Foundation and Ellenburg Faculty Scholar Endowment to G.P.Y.	Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; BAROFFIO A, 1988, P NATL ACAD SCI USA, V85, P5325, DOI 10.1073/pnas.85.14.5325; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; CHESA PG, 1988, J HISTOCHEM CYTOCHEM, V36, P383, DOI 10.1177/36.4.2831267; Cormier JN, 1997, CANCER J, V3, P37; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Eaves CJ, 2008, NATURE, V456, P581, DOI 10.1038/456581a; HERIN M, 1987, INT J CANCER, V39, P390, DOI 10.1002/ijc.2910390320; Iwamoto S, 1996, J AM ACAD DERMATOL, V35, P725, DOI 10.1016/S0190-9622(96)90728-8; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; La Porta C, 2009, STEM CELL REV REP, V5, P61, DOI 10.1007/s12015-008-9048-7; MARCHETTI D, 1993, INT J CANCER, V55, P692, DOI 10.1002/ijc.2910550430; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Passegue E, 2009, NAT MED, V15, P612, DOI [10.1038/nm0109-23, 10.1038/nm0609-612]; Pietra G, 2009, INT IMMUNOL, V21, P793, DOI 10.1093/intimm/dxp047; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rosenberg SA, 1996, J NATL CANCER I, V88, P1635, DOI 10.1093/jnci/88.22.1635; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Scheibenbogen C, 2000, J IMMUNOTHER, V23, P275, DOI 10.1097/00002371-200003000-00012; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Singh SK, 2003, CANCER RES, V63, P5821; Truzzi F, 2008, J INVEST DERMATOL, V128, P2031, DOI 10.1038/jid.2008.21; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Weissman I, 2005, JAMA-J AM MED ASSOC, V294, P1359, DOI 10.1001/jama.294.11.1359	30	535	554	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					133	U155		10.1038/nature09161	http://dx.doi.org/10.1038/nature09161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596026	Green Submitted, Green Accepted			2022-12-01	WOS:000279343800049
J	Llopis, PM; Jackson, AF; Sliusarenko, O; Surovtsev, I; Heinritz, J; Emonet, T; Jacobs-Wagner, C				Llopis, Paula Montero; Jackson, Audrey F.; Sliusarenko, Oleksii; Surovtsev, Ivan; Heinritz, Jennifer; Emonet, Thierry; Jacobs-Wagner, Christine			Spatial organization of the flow of genetic information in bacteria	NATURE			English	Article							CELL-CYCLE PROGRESSION; MESSENGER-RNA DECAY; ESCHERICHIA-COLI; CAULOBACTER-CRESCENTUS; TRANSCRIPTION; TRANSLATION; EXPRESSION; DNA; VISUALIZATION; LOCALIZATION	Eukaryotic cells spatially organize mRNA processes such as translation and mRNA decay. Much less is clear in bacterial cells where the spatial distribution of mature mRNA remains ambiguous. Using a sensitive method based on quantitative fluorescence in situ hybridization, we show here that in Caulobacter crescentus and Escherichia coli, chromosomally expressed mRNAs largely display limited dispersion from their site of transcription during their lifetime. We estimate apparent diffusion coefficients at least two orders of magnitude lower than expected for freely diffusing mRNA, and provide evidence in C. crescentus that this mRNA localization restricts ribosomal mobility. Furthermore, C. crescentus RNase E appears associated with the DNA independently of its mRNA substrates. Collectively, our findings show that bacteria can spatially organize translation and, potentially, mRNA decay by using the chromosome layout as a template. This chromosome-centric organization has important implications for cellular physiology and for our understanding of gene expression in bacteria.	[Llopis, Paula Montero; Jackson, Audrey F.; Sliusarenko, Oleksii; Emonet, Thierry; Jacobs-Wagner, Christine] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Sliusarenko, Oleksii; Surovtsev, Ivan; Heinritz, Jennifer; Jacobs-Wagner, Christine] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Emonet, Thierry] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Jacobs-Wagner, Christine] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Jacobs-Wagner, C (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	christine.jacobs-wagner@yale.edu	Emonet, Thierry/AAI-3740-2020; Llopis, Paula Montero/AAG-2853-2019	Jacobs-Wagner, Christine/0000-0003-0980-5334	Howard Hughes Medical Institute; National Institutes of Health [GM065835]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065835] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Angelastro, N. Ausmees, T. Cox, I. Golding, H. Lam, D. S. Peabody, D Leach, D. J. Sherratt and P. Viollier for strains and constructs, M. Cabeen for editorial help, and S. R. Kushner, J. Belasco, K. C. Huang, the Lambda lunch group at NIH, and the Jacobs-Wagner laboratory for valuable discussions. This work was funded in part by a Howard Hughes Medical Institute Predoctoral Fellowship (to A. F. J.), the National Institutes of Health (GM065835 to C.J.-W.) and the Howard Hughes Medical Institute.	Avedissian M, 1996, MOL MICROBIOL, V19, P79, DOI 10.1046/j.1365-2958.1996.347879.x; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Briegel A, 2006, MOL MICROBIOL, V62, P5, DOI 10.1111/j.1365-2958.2006.05355.x; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; Deana A, 2005, GENE DEV, V19, P2526, DOI 10.1101/gad.1348805; Derman AI, 2008, MOL MICROBIOL, V67, P935, DOI 10.1111/j.1365-2958.2007.06066.x; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; ELY B, 1991, METHOD ENZYMOL, V204, P372; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; Fang G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-4; FORCHHAMMER J, 1971, J MOL BIOL, V55, P563, DOI 10.1016/0022-2836(71)90337-8; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Golding I, 2004, P NATL ACAD SCI USA, V101, P11310, DOI 10.1073/pnas.0404443101; Guet CC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn329; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Khemici V, 2008, MOL MICROBIOL, V70, P799, DOI 10.1111/j.1365-2958.2008.06454.x; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lewis PJ, 2000, EMBO J, V19, P710, DOI 10.1093/emboj/19.4.710; LIM F, 1994, NUCLEIC ACIDS RES, V22, P3748, DOI 10.1093/nar/22.18.3748; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Mangan EK, 1999, J BACTERIOL, V181, P6160, DOI 10.1128/JB.181.19.6160-6170.1999; Mascarenhas J, 2001, EMBO REP, V2, P685, DOI 10.1093/embo-reports/kve160; MILLER OL, 1970, SCIENCE, V169, P392, DOI 10.1126/science.169.3943.392; Neidhardt F.C., 1996, ESCHERICHIA COLI SAL, P13; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Pilhofer M, 2009, SYST APPL MICROBIOL, V32, P186, DOI 10.1016/j.syapm.2008.12.007; Taghbalout A, 2007, P NATL ACAD SCI USA, V104, P1667, DOI 10.1073/pnas.0610491104; Tamames J, 2001, GENOME BIOL, V2; Valencia-Burton M, 2007, NAT METHODS, V4, P421, DOI 10.1038/NMETH1023; Valencia-Burton M, 2009, P NATL ACAD SCI USA, V106, P16399, DOI 10.1073/pnas.0907495106; Viollier PH, 2004, CURR OPIN MICROBIOL, V7, P572, DOI 10.1016/j.mib.2004.10.005; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; VOGEL U, 1994, J BACTERIOL, V176, P2807, DOI 10.1128/JB.176.10.2807-2813.1994; Ward D, 1997, MOL MICROBIOL, V26, P897, DOI 10.1046/j.1365-2958.1997.6242005.x; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2; YARCHUK O, 1992, J MOL BIOL, V226, P581, DOI 10.1016/0022-2836(92)90617-S	38	274	278	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					77	U90		10.1038/nature09152	http://dx.doi.org/10.1038/nature09152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20562858	Green Accepted			2022-12-01	WOS:000279343800037
J	Sozzani, R; Cui, H; Moreno-Risueno, MA; Busch, W; Van Norman, JM; Vernoux, T; Brady, SM; Dewitte, W; Murray, JAH; Benfey, PN				Sozzani, R.; Cui, H.; Moreno-Risueno, M. A.; Busch, W.; Van Norman, J. M.; Vernoux, T.; Brady, S. M.; Dewitte, W.; Murray, J. A. H.; Benfey, P. N.			Spatiotemporal regulation of cell-cycle genes by SHORTROOT links patterning and growth	NATURE			English	Article							ARABIDOPSIS ROOT; EXPRESSION; SCARECROW; PROGRESSION; ENDODERMIS; MECHANISM; MOVEMENT; DIVISION; PATHWAY; SHR	The development of multicellular organisms relies on the coordinated control of cell divisions leading to proper patterning and growth(1-3). The molecular mechanisms underlying pattern formation, particularly the regulation of formative cell divisions, remain poorly understood. In Arabidopsis, formative divisions generating the root ground tissue are controlled by SHORTROOT (SHR) and SCARECROW (SCR)(4-6). Here we show, using cell-type-specific transcriptional effects of SHR and SCR combined with data from chromatin immunoprecipitation-based microarray experiments, that SHR regulates the spatiotemporal activation of specific genes involved in cell division. Coincident with the onset of a specific formative division, SHR and SCR directly activate a D-type cyclin; furthermore, altering the expression of this cyclin resulted in formative division defects. Our results indicate that proper pattern formation is achieved through transcriptional regulation of specific cell-cycle genes in a cell-type-and developmental-stage-specific context. Taken together, we provide evidence for a direct link between developmental regulators, specific components of the cell-cycle machinery and organ patterning.	[Sozzani, R.; Cui, H.; Moreno-Risueno, M. A.; Busch, W.; Van Norman, J. M.; Vernoux, T.; Brady, S. M.; Benfey, P. N.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Sozzani, R.; Cui, H.; Moreno-Risueno, M. A.; Busch, W.; Van Norman, J. M.; Vernoux, T.; Brady, S. M.; Benfey, P. N.] Duke Univ, IGSP Ctr Syst Biol, Durham, NC 27708 USA; [Dewitte, W.; Murray, J. A. H.] Cardiff Sch Biosci, Cardiff CF10 3AX, Wales	Duke University; Duke University; Cardiff University	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	philip.benfey@duke.edu	MORENO-RISUENO, MIGUEL ANGEL/J-8832-2016; Murray, James AH/D-3399-2009; Brady, Siobhan/AAY-1729-2021; Vernoux, Teva/J-1695-2019; Cui, Hongchang/ABD-3278-2021; Dewitte, Walter/B-4560-2011; Busch, Wolfgang/B-8593-2008	MORENO-RISUENO, MIGUEL ANGEL/0000-0002-9794-1450; Murray, James AH/0000-0002-2282-3839; Vernoux, Teva/0000-0002-8257-4088; Cui, Hongchang/0000-0002-9870-748X; Busch, Wolfgang/0000-0003-2042-7290; Dewitte, Walter/0000-0002-0606-1686; Sozzani, Rosangela/0000-0003-3316-2367; Brady, Siobhan/0000-0001-9424-8055	Ministerio de Ciencia y Innovacion (Spain); Biotechnology and Biological Sciences Research Council [BB/E022383]; European Research Area in Plant Genomics network on Plant Stem Cells [BB/E024858]; NIH [RO1-GM043778, P50-GM081883]; NSF [AT2010 0618304]; Biotechnology and Biological Sciences Research Council [BB/E024858/1, BB/E022383/1, BB/E022383/2] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043778, P50GM081883] Funding Source: NIH RePORTER; BBSRC [BB/E022383/2, BB/E024858/1, BB/E022383/1] Funding Source: UKRI	Ministerio de Ciencia y Innovacion (Spain); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Area in Plant Genomics network on Plant Stem Cells; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank D. Orlando and R. Twigg for generating the list of probes for the ChIP-array; J. Nieuwland, S. Maughan and C. Collins for construction of the CYCD6; 1 reporter line and assistance in isolation of the cycd6; 1 mutant; L. Sanz, F. Patell and S. Scofield for isolation of the cycd2; 1 and cycd5; 1 mutants; J. Dinneny, M. Noor and members of the Benfey laboratory for their comments on the manuscript. Funding to M.A.M.-R. is provided by the Ministerio de Ciencia y Innovacion (Spain). W. D. and J.A.H.M. were funded by a Biotechnology and Biological Sciences Research Council grant (BB/E022383) and the European Research Area in Plant Genomics network on Plant Stem Cells (BB/E024858). This work was funded by grants to P.N.B. from the NIH (RO1-GM043778 and P50-GM081883) and from the NSF (AT2010 0618304).	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Andersen SU, 2008, PLANT CELL, V20, P88, DOI 10.1105/tpc.107.054676; BENFEY PN, 1993, DEVELOPMENT, V119, P57; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Blilou I, 2002, GENE DEV, V16, P2566, DOI 10.1101/gad.237302; Bougourd S, 2000, PLANT J, V24, P543, DOI 10.1046/j.1365-313x.2000.00892.x; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Busch W, 2010, DEV CELL, V18, P849, DOI 10.1016/j.devcel.2010.03.012; Casamitjana-Martinez E, 2003, CURR BIOL, V13, P1435, DOI 10.1016/S0960-9822(03)00533-5; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; De Smet I, 2008, SCIENCE, V322, P594, DOI 10.1126/science.1160158; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Ebel C, 2004, NATURE, V429, P776, DOI 10.1038/nature02637; FOE VE, 1989, DEVELOPMENT, V107, P1; Fukaki H, 1998, PLANT J, V14, P425, DOI 10.1046/j.1365-313X.1998.00137.x; Gallagher KL, 2009, PLANT J, V57, P785, DOI 10.1111/j.1365-313X.2008.03735.x; Gallagher KL, 2004, CURR BIOL, V14, P1847, DOI 10.1016/j.cub.2004.09.081; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Haseloff J, 1999, METHOD CELL BIOL, V58, P139; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Herranz H, 2008, CELL CYCLE, V7, P3335, DOI 10.4161/cc.7.21.6996; Levesque MP, 2006, PLOS BIOL, V4, P739, DOI 10.1371/journal.pbio.0040143; Lewis J, 2008, SCIENCE, V322, P399, DOI 10.1126/science.1166154; Menges M, 2005, PLANT J, V41, P546, DOI 10.1111/j.1365-313X.2004.02319.x; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Orlando DA, 2009, METHODS MOL BIOL, V553, P57, DOI 10.1007/978-1-60327-563-7_4; Paquette AJ, 2005, PLANT PHYSIOL, V138, P636, DOI 10.1104/pp.104.058362; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Schiefelbein J, 2003, CURR OPIN PLANT BIOL, V6, P74, DOI 10.1016/S136952660200002X; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Weigmann K, 1997, DEVELOPMENT, V124, P3555; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593	38	280	289	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					128	U149		10.1038/nature09143	http://dx.doi.org/10.1038/nature09143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596025	Green Accepted			2022-12-01	WOS:000279343800048
J	Hanotte, O; Dessie, T; Kemp, S				Hanotte, Olivier; Dessie, Tadelle; Kemp, Steve			Time to Tap Africa's Livestock Genomes	SCIENCE			English	Editorial Material							LANDSCAPE GENOMICS; SELECTION		[Hanotte, Olivier] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England; [Dessie, Tadelle] ILRI, Addis Ababa, Ethiopia; [Kemp, Steve] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Kemp, Steve] ILRI, Nairobi, Kenya	University of Nottingham; CGIAR; International Livestock Research Institute (ILRI); University of Liverpool; CGIAR; International Livestock Research Institute (ILRI)	Hanotte, O (corresponding author), Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England.	olivier.hanotte@nottingham.ac.uk	Hanotte, Olivier/B-4669-2013	Hanotte, Olivier/0000-0002-2877-4767				Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; KEMP S, DAGRIS 2007 DOMESTIC; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-35; Pariset L, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-7	7	36	38	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1640	1641		10.1126/science.1186254	http://dx.doi.org/10.1126/science.1186254			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576875				2022-12-01	WOS:000279107400025
J	Eaves, CJ; Humphries, RK				Eaves, Connie J.; Humphries, R. Keith			Acute Myeloid Leukemia and the Wnt Pathway	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STEM-CELLS; LEUKEMOGENESIS; HEMATOPOIESIS; CATENIN		[Eaves, Connie J.; Humphries, R. Keith] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency	Eaves, CJ (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.			Eaves, Connie/0000-0002-3452-1926; Humphries, Richard/0000-0003-0540-7005				Argiropoulos B, 2007, GENE DEV, V21, P2845, DOI 10.1101/gad.1619407; Chen JJ, 2010, NAT REV CANCER, V10, P23, DOI 10.1038/nrc2765; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624	5	41	47	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 17	2010	362	24					2326	2327		10.1056/NEJMcibr1003522	http://dx.doi.org/10.1056/NEJMcibr1003522			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	611LJ	20554989				2022-12-01	WOS:000278816300015
J	Papai, G; Tripathi, MK; Ruhlmann, C; Layer, JH; Weil, PA; Schultz, P				Papai, Gabor; Tripathi, Manish K.; Ruhlmann, Christine; Layer, Justin H.; Weil, P. Anthony; Schultz, Patrick			TFIIA and the transactivator Rap1 cooperate to commit TFIID for transcription initiation	NATURE			English	Article							YEAST TFIIA/TBP/DNA COMPLEX; DNA-BINDING; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; PROMOTER; ACTIVATION; PROTEIN; TAFS; DISTINCT	Transcription of eukaryotic messenger RNA (mRNA) encoding genes by RNA polymerase II (Pol II) is triggered by the binding of transactivating proteins to enhancer DNA, which stimulates the recruitment of general transcription factors (TFIIA, B, D, E, F, H) and Pol II on the cis-linked promoter, leading to pre-initiation complex formation and transcription(1). In TFIID-dependent activation pathways, this general transcription factor containing TATA-box-binding protein is first recruited on the promoter through interaction with activators(1-3) and cooperates with TFIIA to form a committed pre-initiation complex(4). However, neither the mechanisms by which activation signals are communicated between these factors nor the structural organization of the activated pre-initiation complex are known. Here we used cryo-electron microscopy to determine the architecture of nucleoprotein complexes composed of TFIID, TFIIA, the transcriptional activator Rap1 and yeast enhancer-promoter DNA. These structures revealed the mode of binding of Rap1 and TFIIA to TFIID, as well as a reorganization of TFIIA induced by its interaction with Rap1. We propose that this change in position increases the exposure of TATA-box-binding protein within TFIID, consequently enhancing its ability to interact with the promoter. A large Rap1-dependent DNA loop forms between the activator-binding site and the proximal promoter region. This loop is topologically locked by a TFIIA-Rap1 protein bridge that folds over the DNA. These results highlight the role of TFIIA in transcriptional activation, define a molecular mechanism for enhancer-promoter communication and provide structural insights into the pathways of intramolecular communication that convey transcription activation signals through the TFIID complex.	[Papai, Gabor; Ruhlmann, Christine; Schultz, Patrick] IGBMC, Dept Struct Biol & Genom, F-67404 Illkirch Graffenstaden, France; [Papai, Gabor; Ruhlmann, Christine; Schultz, Patrick] CNRS, UMR7104, F-67400 Illkirch Graffenstaden, France; [Papai, Gabor; Ruhlmann, Christine; Schultz, Patrick] INSERM, U964, F-67400 Illkirch Graffenstaden, France; [Papai, Gabor; Ruhlmann, Christine; Schultz, Patrick] Univ Strasbourg, F-67000 Strasbourg, France; [Tripathi, Manish K.; Layer, Justin H.; Weil, P. Anthony] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Vanderbilt University	Schultz, P (corresponding author), IGBMC, Dept Struct Biol & Genom, 1 Rue Laurent Fries,BP10142, F-67404 Illkirch Graffenstaden, France.	tony.weil@vanderbilt.edu; patrick.schultz@igbmc.fr		schultz, patrick/0000-0002-7310-6186; Papai, Gabor/0000-0002-2779-8679	Institut National de la Sante et de la Recherche Medicale; Centre National pour la Recherche Scientifique; Association pour la Recherche sur le Cancer; Fondation pour la Recherche Medicale; Agence Nationale pour le Recherche; EU [QLG2-CT-00988]; National Institutes of Health [GM52461]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM052461, R01GM052461] Funding Source: NIH RePORTER	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National pour la Recherche Scientifique; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale pour le Recherche(French National Research Agency (ANR)); EU(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Institut National de la Sante et de la Recherche Medicale, the Centre National pour la Recherche Scientifique, the Association pour la Recherche sur le Cancer, the Fondation pour la Recherche Medicale, the Agence Nationale pour le Recherche and the European SPINE program (G. P., C. R. and P. S., EU contract number QLG2-CT-00988), and the National Institutes of Health (M. K. T., J.H.L. and P. A. W., National Institutes of Health grant number GM52461).	Bleichenbacher M, 2003, J MOL BIOL, V332, P783, DOI 10.1016/S0022-2836(03)00887-8; Burley SK, 1996, ANNU REV BIOCHEM, V65, P769, DOI 10.1146/annurev.bi.65.070196.004005; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; Elmlund H, 2009, STRUCTURE, V17, P1442, DOI 10.1016/j.str.2009.09.007; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Garbett KA, 2007, MOL CELL BIOL, V27, P297, DOI 10.1128/MCB.01558-06; Geiger JH, 1996, SCIENCE, V272, P830, DOI 10.1126/science.272.5263.830; Grob P, 2006, STRUCTURE, V14, P511, DOI 10.1016/j.str.2005.11.020; Heymann JB, 2001, J STRUCT BIOL, V133, P156, DOI 10.1006/jsbi.2001.4339; JACQ X, 1994, CELL, V79, P107, DOI 10.1016/0092-8674(94)90404-9; Kokubo T, 1998, MOL CELL BIOL, V18, P1003, DOI 10.1128/MCB.18.2.1003; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Layer JH, 2010, J BIOL CHEM, V285, P15489, DOI 10.1074/jbc.M110.104810; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; LIEBERMAN PM, 1994, GENE DEV, V8, P995, DOI 10.1101/gad.8.9.995; Lieberman PM, 1997, MOL CELL BIOL, V17, P6624, DOI 10.1128/MCB.17.11.6624; Liu WL, 2009, GENE DEV, V23, P1510, DOI 10.1101/gad.1790709; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; Morse RH, 2000, TRENDS GENET, V16, P51, DOI 10.1016/S0168-9525(99)01936-8; Oelgeschlager T, 1996, NATURE, V382, P735, DOI 10.1038/382735a0; Ozer J, 1996, J BIOL CHEM, V271, P11182, DOI 10.1074/jbc.271.19.11182; Papai G, 2009, STRUCTURE, V17, P363, DOI 10.1016/j.str.2009.01.006; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RATHJEN J, 1990, NUCLEIC ACIDS RES, V18, P3219, DOI 10.1093/nar/18.11.3219; Sanders SL, 2000, J BIOL CHEM, V275, P13895, DOI 10.1074/jbc.275.18.13895; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; SHYKIND BM, 1995, GENE DEV, V9, P1354, DOI 10.1101/gad.9.11.1354; Simonetti A, 2008, NATURE, V455, P416, DOI 10.1038/nature07192; SUSSEL L, 1991, P NATL ACAD SCI USA, V88, P7749, DOI 10.1073/pnas.88.17.7749; Tan S, 1996, NATURE, V381, P127, DOI 10.1038/381127a0; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Verrijzer CP, 1996, TRENDS BIOCHEM SCI, V21, P338, DOI 10.1016/0968-0004(96)10044-X; WANG WD, 1992, GENE DEV, V6, P1716, DOI 10.1101/gad.6.9.1716	38	49	49	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 17	2010	465	7300					956	U14		10.1038/nature09080	http://dx.doi.org/10.1038/nature09080			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	611HN	20559389	Green Accepted			2022-12-01	WOS:000278804500044
J	Donnell, D; Baeten, JM; Kiarie, J; Thomas, KK; Stevens, W; Cohen, CR; McIntyre, J; Lingappa, JR; Celum, C				Donnell, Deborah; Baeten, Jared M.; Kiarie, James; Thomas, Katherine K.; Stevens, Wendy; Cohen, Craig R.; McIntyre, James; Lingappa, Jairam R.; Celum, Connie		Partners Prevention HSV HIV Transm	Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis	LANCET			English	Article							CD4 CELL COUNT; VIRAL LOAD; SEXUAL-BEHAVIOR; INFECTION; DISEASE; RISK; RNA	Background High plasma HIV-1 RNA concentrations are associated with increased risk of HIV-1 transmission. Initiation of antiretroviral therapy (ART) reduces plasma HIV-1 concentrations. We aimed to assess the effect of ART use by patients infected with HIV-1 on risk of transmission to their uninfected partners. Methods Participants in our prospective cohort analysis were from a randomised placebo-controlled trial that enrolled heterosexual African adults who were seropositive for both HIV-1 and herpes simplex virus type 2, and their HIV-1 seronegative partners. At enrolment, HIV-1 infected participants had CD4 counts of 250 cells per mu L or greater and did not meet national guidelines for ART initiation; during 24 months of follow-up, CD4 counts were measured every 6 months and ART was initiated in accordance with national guidelines. Uninfected partners were tested for HIV-1 every 3 months. The primary outcome was genetically-linked HIV-1 transmission within the study partnership. We assessed rates of HIV-1 transmission by ART status of infected participants. Findings 3381 couples were eligible for analysis. 349 (10%) participants with HIV-1 initiated ART during the study, at a median CD4 cell count of 198 (IQR 161-265) cells per mu L. Only one of 103 genetically-linked HIV-1 transmissions was from an infected participant who had started ART, corresponding to transmission rates of 0.37 (95% CI 0.09-2.04) per 100 person-years in those who had initiated treatment and 2.24 (1.84-2.72) per 100 person-years in those who had not-a 92% reduction (adjusted incidence rate ratio 0.08,95% CI 0.00-0.57, p=0.004). In participants not on ART, the highest HIV-1 transmission rate (8.79 per 100 person-years) was from those with CD4 cell counts lower than 200 cells per pL. In couples in whom the untreated HIV-1 infected partner had a CD4 cell count greater than 200 cells per pL, 66 (70%) of 94 transmissions occurred when plasma HIV-1 concentrations exceeded 50 000 copies per mL. Interpretation Low CD4 cell counts and high plasma HIV-1 concentrations might guide use of ART to achieve an HIV-1 prevention benefit. Provision of ART to HIV-1 infected patients could be an effective strategy to achieve population-level reductions in HIV-1 transmission.	[Donnell, Deborah] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98109 USA; [Donnell, Deborah] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98109 USA; [Donnell, Deborah; Baeten, Jared M.; Kiarie, James; Thomas, Katherine K.; Lingappa, Jairam R.; Celum, Connie] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Baeten, Jared M.; Lingappa, Jairam R.; Celum, Connie] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Baeten, Jared M.; Celum, Connie] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Lingappa, Jairam R.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Kiarie, James] Univ Nairobi, Dept Obstet & Gynaecol, Nairobi, Kenya; [Stevens, Wendy] Univ Witwatersrand, Dept Mol Med & Haematol, Natl Hlth Lab Serv, Johannesburg, South Africa; [McIntyre, James] Anova Hlth Inst, Johannesburg, South Africa; [Cohen, Craig R.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nairobi; National Health Laboratory Service; University of Witwatersrand; University of California System; University of California San Francisco	Donnell, D (corresponding author), Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, 1100 Fairview Ave N, Seattle, WA 98109 USA.	deborah@fhcrc.org	McIntyre, James/V-7115-2019; Lingappa, Jairam/N-7760-2017	Kapiga, Saidi/0000-0003-1753-4060; Thomas, Katherine K/0000-0002-7024-468X; kiarie, james/0000-0003-4180-7858; Donnell, Deborah/0000-0002-0587-7480	Bill & Melinda Gates Foundation; US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, U01AI038858, R01AI083034, P01AI057005] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding Bill & Melinda Gates Foundation; US National Institutes of Health.	[Anonymous], [No title captured]; [Anonymous], 2008, SCHWEIZ ARZTEZTG; [Anonymous], 2009, RAP ADV ANT THER HIV; ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bateganya M, 2005, AIDS PATIENT CARE ST, V19, P760, DOI 10.1089/apc.2005.19.760; Bunnell R, 2006, AIDS, V20, P85, DOI 10.1097/01.aids.0000196566.40702.28; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; Chaisson RE, 2000, JAMA-J AM MED ASSOC, V284, P3128, DOI 10.1001/jama.284.24.3128; Cohen MS, 2010, CLIN INFECT DIS, V50, pS85, DOI 10.1086/651478; Eisele TP, 2009, AIDS BEHAV, V13, P1097, DOI 10.1007/s10461-008-9473-2; Graham SM, 2007, AIDS, V21, P501, DOI 10.1097/QAD.0b013e32801424bd; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gupta P, 1997, J VIROL, V71, P6271, DOI 10.1128/JVI.71.8.6271-6275.1997; Kaida A, 2008, AIDS CARE, V20, P21, DOI 10.1080/09540120701426540; Lingappa JR, 2010, LANCET, V375, P824, DOI 10.1016/S0140-6736(09)62038-9; Luchters S, 2008, AIDS PATIENT CARE ST, V22, P587, DOI 10.1089/apc.2007.0247; Marcelin AG, 2008, AIDS, V22, P1677, DOI 10.1097/QAD.0b013e32830abdc8; Modjarrad K, 2008, AIDS, V22, P2179, DOI 10.1097/QAD.0b013e328312c756; Mofenson LM, 1999, JAMA-J AM MED ASSOC, V282, P577, DOI 10.1001/jama.282.6.577; Munderi P, 2010, CURR OPIN HIV AIDS, V5, P6, DOI 10.1097/COH.0b013e32833384d3; Phillips AN, 2001, JAMA-J AM MED ASSOC, V286, P2560, DOI 10.1001/jama.286.20.2560; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Stevens WS, 2010, J INFECT DIS, V201, pS16, DOI 10.1086/650392; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; WHO, 2009, UN ACC SCAL PRIOR HI; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; Wood E, 2007, LANCET, V370, P8, DOI 10.1016/S0140-6736(07)61025-3	28	687	715	2	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 12	2010	375	9731					2092	2098		10.1016/S0140-6736(10)60705-2	http://dx.doi.org/10.1016/S0140-6736(10)60705-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614OK	20537376	Green Accepted			2022-12-01	WOS:000279069300021
J	Shanbhag, NM; Rafalska-Metcalf, IU; Balane-Bolivar, C; Janicki, SM; Greenberg, RA				Shanbhag, Niraj M.; Rafalska-Metcalf, Ilona U.; Balane-Bolivar, Carlo; Janicki, Susan M.; Greenberg, Roger A.			ATM-Dependent Chromatin Changes Silence Transcription In cis to DNA Double-Strand Breaks	CELL			English	Article							RNA-POLYMERASE-II; ATAXIA-TELANGIECTASIA; GENE-EXPRESSION; DAMAGE RESPONSE; REPAIR; UBIQUITINATION; PHOSPHORYLATION; IDENTIFICATION; UBIQUITYLATION; CHECKPOINT	DNA double-strand breaks (DSBs) initiate extensive local and global alterations in chromatin structure, many of which depend on the ATM kinase. Histone H2A ubiquitylation (uH2A) on chromatin surrounding DSBs is one example, thought to be important for recruitment of repair proteins. uH2A is also implicated in transcriptional repression; an intriguing yet untested hypothesis is that this function is conserved in the context of DSBs. Using a novel reporter that allows for visualization of repair protein recruitment and local transcription in single cells, we describe an ATM-dependent transcriptional silencing program in cis to DSBs. ATM prevents RNA polymerase II elongation-dependent chromatin decondensation at regions distal to DSBs. Silencing is partially dependent on E3 ubiquitin ligases RNF8 and RNF168, whereas reversal of silencing relies on the uH2A deubiquitylating enzyme USP16. These findings give insight into the role of posttranslational modifications in mediating crosstalk between diverse processes occurring on chromatin.	[Shanbhag, Niraj M.; Balane-Bolivar, Carlo; Greenberg, Roger A.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA; [Greenberg, Roger A.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Pathol, Philadelphia, PA 19104 USA; [Rafalska-Metcalf, Ilona U.; Janicki, Susan M.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; The Wistar Institute	Greenberg, RA (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, 421 Curie Blvd, Philadelphia, PA 19104 USA.	rogergr@mail.med.upenn.edu			NCI [1R01CA138835-01, 1K08CA106597-01, 3K08CA106597-04S1]; ACS; Sidney Kimmel Foundation; Abramson Family Cancer Research Institute; Penn Genome Frontiers Institute;  [1-T32-CA-115299-01A2]; NATIONAL CANCER INSTITUTE [K08CA106597, T32CA115299, R01CA138835] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ACS(American Cancer Society); Sidney Kimmel Foundation; Abramson Family Cancer Research Institute; Penn Genome Frontiers Institute; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Genentech for providing linkage-specific antibodies; E. Brown, B. Johnson, G. Blobel, M. Lampson, and members of the Greenberg lab for critical discussion. R.A.G. gratefully acknowledges funding from the following: 1R01CA138835-01 from the NCI, an ACS Research Scholar Grant, K08 awards 1K08CA106597-01 and 3K08CA106597-04S1 from the NCI, the Sidney Kimmel Foundation Scholar Award, and funds from the Abramson Family Cancer Research Institute and from the Penn Genome Frontiers Institute. N.M.S. was supported by training grant 1-T32-CA-115299-01A2.	Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bredemeyer AL, 2008, NATURE, V456, P819, DOI 10.1038/nature07392; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Darzacq X, 2009, ANNU REV BIOPHYS, V38, P173, DOI 10.1146/annurev.biophys.050708.133728; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Green CM, 2002, EMBO REP, V3, P28, DOI 10.1093/embo-reports/kvf005; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; KASTAN MB, 1982, CELL, V30, P509, DOI 10.1016/0092-8674(82)90248-3; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Kruhlak M, 2007, NATURE, V447, P730, DOI 10.1038/nature05842; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mathas S, 2009, P NATL ACAD SCI USA, V106, P5831, DOI 10.1073/pnas.0900912106; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; O'Hagan HM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000155; OBRIEN T, 1994, NATURE, V370, P75, DOI 10.1038/370075a0; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shao G, 2009, P NATL ACAD SCI USA, V106, P3166, DOI 10.1073/pnas.0807485106; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; WAUGH DS, 1993, P NATL ACAD SCI USA, V90, P9596, DOI 10.1073/pnas.90.20.9596; Zhang Y, 2003, GENE DEV, V17, P2733, DOI 10.1101/gad.1156403; Ziv Y, 2006, NAT CELL BIOL, V8, P870, DOI 10.1038/ncb1446	46	498	508	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					970	981		10.1016/j.cell.2010.04.038	http://dx.doi.org/10.1016/j.cell.2010.04.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20550933	Bronze, Green Accepted			2022-12-01	WOS:000278618800012
J	Bonneux, L; Van Damme, W				Bonneux, Luc; Van Damme, Wim			Personal View Preventing iatrogenic pandemics of panic. Do it in a NICE way	BRITISH MEDICAL JOURNAL			English	Editorial Material							INFLUENZA; EPIDEMICS; VIRUS		[Bonneux, Luc] Netherlands Interdisciplinary Demog Inst, The Hague, Netherlands; [Van Damme, Wim] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	Royal Netherlands Academy of Arts & Sciences; Netherlands Interdisciplinary Demographic Institute (NIDI-KNAW); Institute of Tropical Medicine (ITM)	Bonneux, L (corresponding author), Netherlands Interdisciplinary Demog Inst, The Hague, Netherlands.	bonneux@nidi.nl	Van Damme, Wim/F-7404-2011	Van Damme, Wim/0000-0002-6344-3007				Bishop JF, 2009, NEW ENGL J MED, V361, P2591, DOI 10.1056/NEJMp0910445; Bonneux L, 2006, BMJ-BRIT MED J, V332, P786, DOI 10.1136/bmj.332.7544.786; Burch J, 2009, LANCET INFECT DIS, V9, P537, DOI 10.1016/S1473-3099(09)70199-9; Daniels N, 2000, BMJ-BRIT MED J, V321, P1300, DOI 10.1136/bmj.321.7272.1300; Institute of Medicine, 2009, CONFL INT MED RES ED; Kickbusch I, 2008, HEALTH PROMOT INT, V23, P1, DOI 10.1093/heapro/dan006; Morens DM, 2009, NEW ENGL J MED, V361, P225, DOI 10.1056/NEJMp0904819; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Van Damme W, 2000, TROP MED INT HEALTH, V5, P511; Watson R, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c641	10	6	7	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 9	2010	340								c3065	10.1136/bmj.c3065	http://dx.doi.org/10.1136/bmj.c3065			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611MD	20534667				2022-12-01	WOS:000278818500019
J	Peters, J; Dieppa-Perea, LM; Melendez, LM; Quirk, GJ				Peters, Jamie; Dieppa-Perea, Laura M.; Melendez, Loyda M.; Quirk, Gregory J.			Induction of Fear Extinction with Hippocampal-Infralimbic BDNF	SCIENCE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; LONG-TERM POTENTIATION; NEUROTROPHIC FACTOR; SYNAPTIC PLASTICITY; MEMORY; CONSOLIDATION; AMYGDALA; NEURONS; MECHANISMS; EXPRESSION	The extinction of conditioned fear memories requires plasticity in the infralimbic medial prefrontal cortex (IL mPFC), but little is known about the molecular mechanisms involved. Brain-derived neurotrophic factor (BDNF) is a key mediator of synaptic plasticity in multiple brain areas. In rats subjected to auditory fear conditioning, BDNF infused into the IL mPFC reduced conditioned fear for up to 48 hours, even in the absence of extinction training, which suggests that BDNF substituted for extinction. Similar to extinction, BDNF-induced reduction in fear required N-methyl-D-aspartate receptors and did not erase the original fear memory. Rats failing to learn extinction showed reduced BDNF in hippocampal inputs to the IL mPFC, and augmenting BDNF in this pathway prevented extinction failure. Hence, boosting BDNF activity in hippocampal-infralimbic circuits may ameliorate disorders of learned fear.	[Peters, Jamie; Dieppa-Perea, Laura M.; Quirk, Gregory J.] Univ Puerto Rico, Sch Med, Dept Psychiat, San Juan, PR 00936 USA; [Peters, Jamie; Dieppa-Perea, Laura M.; Quirk, Gregory J.] Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00936 USA; [Melendez, Loyda M.] Univ Puerto Rico, Sch Med, Dept Microbiol, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Quirk, GJ (corresponding author), Univ Puerto Rico, Sch Med, Dept Psychiat, San Juan, PR 00936 USA.	gjquirk@yahoo.com	Peters, Jamie/B-4288-2013		NIH [MH058883, MH081975, NS043011, MH083516, MH085383, RR003051]; University of Puerto Rico; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH058883, F32MH085383, R01MH081975, R01MH083516, R01MH058883, R37MH058883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS043011] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Puerto Rico; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We thank V. Garcia, D. Merced, N. Padilla, C. Rodriguez, J. Rodriguez-Romaguera, D. Sierra-Mercado, and A. Torrado for technical assistance and D. Pare and J. F. McGinty for helpful comments. Supported by NIH grants MH058883, MH081975, NS043011, MH083516, MH085383, and RR003051 and by the University of Puerto Rico.	Black IB, 1999, J NEUROBIOL, V41, P108, DOI 10.1002/(SICI)1097-4695(199910)41:1<108::AID-NEU14>3.0.CO;2-U; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Bredy TW, 2007, LEARN MEMORY, V14, P268, DOI 10.1101/lm.500907; Burgos-Robles A, 2007, NEURON, V53, P871, DOI 10.1016/j.neuron.2007.02.021; Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663; Chhatwal JP, 2006, NAT NEUROSCI, V9, P870, DOI 10.1038/nn1718; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; FALLS WA, 1992, J NEUROSCI, V12, P854; Garcia R, 2008, NEUROBIOL LEARN MEM, V89, P560, DOI 10.1016/j.nlm.2007.10.005; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Herry C, 2002, J NEUROSCI, V22, P577, DOI 10.1523/JNEUROSCI.22-02-00577.2002; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Kalisch R, 2006, J NEUROSCI, V26, P9503, DOI 10.1523/JNEUROSCI.2021-06.2006; Levine ES, 1998, P NATL ACAD SCI USA, V95, P10235, DOI 10.1073/pnas.95.17.10235; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; McGinty JF, 2010, BRAIN RES, V1314, P183, DOI 10.1016/j.brainres.2009.08.078; Messaoudi E, 2002, J NEUROSCI, V22, P7453; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rasmusson AM, 2002, NEUROPSYCHOPHARMACOL, V27, P133, DOI 10.1016/S0893-133X(02)00286-5; Santini E, 2001, J NEUROSCI, V21, P9009, DOI 10.1523/JNEUROSCI.21-22-09009.2001; Santini E, 2008, J NEUROSCI, V28, P4028, DOI 10.1523/JNEUROSCI.2623-07.2008; Soliman F, 2010, SCIENCE, V327, P863, DOI 10.1126/science.1181886; Sotres-Bayon F, 2006, BIOL PSYCHIAT, V60, P329, DOI 10.1016/j.biopsych.2005.10.012; Sotres-Bayon F, 2009, CEREB CORTEX, V19, P474, DOI 10.1093/cercor/bhn099	27	345	359	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 4	2010	328	5983					1288	1290		10.1126/science.1186909	http://dx.doi.org/10.1126/science.1186909			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	605AC	20522777	Green Accepted			2022-12-01	WOS:000278318600038
J	Wang, FW; Dai, J; Daum, JR; Niedzialkowska, E; Banerjee, B; Stukenberg, PT; Gorbsky, GJ; Higgins, JMG				Wang, Fangwei; Dai, Jun; Daum, John R.; Niedzialkowska, Ewa; Banerjee, Budhaditya; Stukenberg, P. Todd; Gorbsky, Gary J.; Higgins, Jonathan M. G.			Histone H3 Thr-3 Phosphorylation by Haspin Positions Aurora B at Centromeres in Mitosis	SCIENCE			English	Article							CHROMOSOMAL PASSENGER COMPLEX; HELA-CELLS; SURVIVIN; SPINDLE; KINASE; MCAK; ALIGNMENT; BOREALIN; KINETOCHORES; SMAC/DIABLO	Aurora B is a component of the chromosomal passenger complex (CPC) required for correct spindle-kinetochore attachments during chromosome segregation and for cytokinesis. The chromatin factors that recruit the CPC to centromeres are unknown, however. Here we show that phosphorylation of histone H3 threonine 3 (H3T3ph) by Haspin is necessary for CPC accumulation at centromeres and that the CPC subunit Survivin binds directly to H3T3ph. A nonbinding Survivin-D70A/D71A mutant does not support centromeric CPC concentration, and both Haspin depletion and Survivin-D70A/D71A mutation diminish centromere localization of the kinesin MCAK and the mitotic checkpoint response to taxol. Survivin-D70A/D71A mutation and microinjection of H3T3ph-specific antibody both compromise centromeric Aurora B functions but do not prevent cytokinesis. Therefore, H3T3ph generated by Haspin positions the CPC at centromeres to regulate selected targets of Aurora B during mitosis.	[Wang, Fangwei; Dai, Jun; Higgins, Jonathan M. G.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Daum, John R.; Gorbsky, Gary J.] Oklahoma Med Res Fdn, Cell Cycle & Canc Biol Res Program, Oklahoma City, OK 73104 USA; [Niedzialkowska, Ewa; Banerjee, Budhaditya; Stukenberg, P. Todd] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Oklahoma Medical Research Foundation; University of Virginia	Higgins, JMG (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Smith Bldg,1 Jimmy Fund Way, Boston, MA 02115 USA.	jhiggins@rics.bwh.harvard.edu	Dai, Jun/J-9718-2015	Wang, Fangwei/0000-0001-5617-282X; Gorbsky, Gary/0000-0003-3076-4725; Higgins, Jonathan/0000-0001-6622-8268; Stukenberg, Todd/0000-0002-6788-2111; Niedzialkowska, Ewa/0000-0002-0348-3154	American Cancer Society [RSG-05-13401-GMC]; National Institutes of Health [R01-GM074210, R01-GM050412, R01-GM063045]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050412, R01GM063045, R01GM074210] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. C. Earnshaw, H. Funabiki, M. A. Lampson, S. M. A. Lens, J. P. Noel, S. S. Taylor, L. Wordeman, and Y. Zheng for cDNAs and antibodies; C. Crafter of AstraZeneca for ZM447439; and H. Funabiki and A. Kelly for sharing unpublished results. J. D. and J. M. G. H. have patents pending on Haspin inhibitors. This work was funded by grants from the American Cancer Society (RSG-05-13401-GMC to J. M. G. H) and the National Institutes of Health (R01-GM074210 to J. M. G. H., R01-GM050412 to G. J. G., and R01-GM063045 to P.T.S.).	Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Cao LH, 2006, BIOCHEM BIOPH RES CO, V346, P400, DOI 10.1016/j.bbrc.2006.05.131; Carvalho A, 2003, J CELL SCI, V116, P2987, DOI 10.1242/jcs.00612; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Gassmann R, 2004, J CELL BIOL, V166, P179, DOI 10.1083/jcb.200404001; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Huang HM, 2007, J CELL BIOL, V177, P413, DOI 10.1083/jcb.200701122; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lens SMA, 2006, MOL BIOL CELL, V17, P1897, DOI 10.1091/mbc.E05-08-0727; Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307; Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Ohi R, 2004, MOL BIOL CELL, V15, P2895, DOI 10.1091/mbc.E04-02-0082; Rosasco-Nitcher SE, 2008, SCIENCE, V319, P469, DOI 10.1126/science.1148980; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Song ZY, 2003, J BIOL CHEM, V278, P23130, DOI 10.1074/jbc.M300957200; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; Sun CH, 2005, BIOCHEMISTRY-US, V44, P11, DOI 10.1021/bi0485171; Vader G, 2006, EMBO REP, V7, P85, DOI 10.1038/sj.embor.7400562; Vermaak D, 2009, ANNU REV GENET, V43, P467, DOI 10.1146/annurev-genet-102108-134802; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Welburn JPI, 2010, MOL CELL, V38, P383, DOI 10.1016/j.molcel.2010.02.034; Yue ZJ, 2008, J CELL BIOL, V183, P279, DOI 10.1083/jcb.200806118; Zeitlin SG, 2001, J CELL BIOL, V155, P1147, DOI 10.1083/jcb.200108125	30	328	339	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2010	330	6001					231	235		10.1126/science.1189435	http://dx.doi.org/10.1126/science.1189435			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660LP	20705812	Green Accepted			2022-12-01	WOS:000282644600045
J	Mariappan, M; Li, XZ; Stefanovic, S; Sharma, A; Mateja, A; Keenan, RJ; Hegde, RS				Mariappan, Malaiyalam; Li, Xingzhe; Stefanovic, Sandra; Sharma, Ajay; Mateja, Agnieszka; Keenan, Robert J.; Hegde, Ramanujan S.			A ribosome-associating factor chaperones tail-anchored membrane proteins	NATURE			English	Article							ENDOPLASMIC-RETICULUM; ER MEMBRANE; INSERTION; GET3; COMPLEX; RECOGNITION; BINDING; IDENTIFICATION; TRANSLATION; TERMINATION	Hundreds of proteins are inserted post-translationally into the endoplasmic reticulum (ER) membrane by a single carboxyterminal transmembrane domain (TMD)(1). During targeting through the cytosol, the hydrophobic TMD of these tail-anchored (TA) proteins requires constant chaperoning to prevent aggregation or inappropriate interactions. A central component of this targeting system is TRC40, a conserved cytosolic factor that recognizes the TMD of TA proteins and delivers them to the ER for insertion(2-4). The mechanism that permits TRC40 to find and capture its TA protein cargos effectively in a highly crowded cytosol is unknown. Here we identify a conserved three-protein complex composed of Bat3, TRC35 and Ubl4A that facilitates TA protein capture by TRC40. This Bat3 complex is recruited to ribosomes synthesizing membrane proteins, interacts with the TMDs of newly released TA proteins, and transfers them to TRC40 for targeting. Depletion of the Bat3 complex allows non-TRC40 factors to compete for TA proteins, explaining their mislocalization in the analogous yeast deletion strains(5-7). Thus, the Bat3 complex acts as a TMD-selective chaperone that effectively channels TA proteins to the TRC40 insertion pathway.	[Mariappan, Malaiyalam; Li, Xingzhe; Stefanovic, Sandra; Sharma, Ajay; Hegde, Ramanujan S.] NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA; [Li, Xingzhe] Peking Univ, Sch Basic Med Sci, Beijing 100191, Peoples R China; [Mateja, Agnieszka; Keenan, Robert J.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Peking University; University of Chicago	Hegde, RS (corresponding author), NICHHD, Cell Biol & Metab Program, NIH, Bethesda, MD 20892 USA.	hegder@mail.nih.gov	mariappan, malaiyalam/K-9024-2012	Keenan, Robert/0000-0003-1466-0889; Hegde, Ramanujan/0000-0001-8338-852X	National Institutes of Health; Edward Mallinckrodt Jr Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt Jr Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank S. Appathurai and M. Downing for technical assistance, Hegde lab members for advice, and J. Weissman and W. Clemons for useful discussions and sharing results before publication. This work was supported by the Intramural Research Program of the National Institutes of Health (R.S.H.) and Edward Mallinckrodt Jr Foundation (R.J.K.).	Berndt U, 2009, P NATL ACAD SCI USA, V106, P1398, DOI 10.1073/pnas.0808584106; Bozkurt G, 2010, FEBS LETT, V584, P1509, DOI 10.1016/j.febslet.2010.02.070; Bozkurt G, 2009, P NATL ACAD SCI USA, V106, P21131, DOI 10.1073/pnas.0910223106; Cao JH, 1996, MOL CELL BIOL, V16, P603; Chang YW, 2010, J BIOL CHEM, V285, P9962, DOI 10.1074/jbc.M109.087098; Chartron JW, 2010, P NATL ACAD SCI USA, V107, P12127, DOI 10.1073/pnas.1006036107; Copic A, 2009, GENETICS, V182, P757, DOI 10.1534/genetics.109.101105; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Desmots F, 2005, MOL CELL BIOL, V25, P10329, DOI 10.1128/MCB.25.23.10329-10337.2005; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Gautschi M, 2001, P NATL ACAD SCI USA, V98, P3762, DOI 10.1073/pnas.071057198; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; HIGH S, 1991, J CELL BIOL, V113, P35, DOI 10.1083/jcb.113.1.35; HOBDEN AN, 1978, BIOCHEM J, V170, P57, DOI 10.1042/bj1700057; Hu JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008061; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; LODISH HF, 1972, J BIOL CHEM, V247, P3622; Mateja A, 2009, NATURE, V461, P361, DOI 10.1038/nature08319; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Suloway CJM, 2009, P NATL ACAD SCI USA, V106, P14849, DOI 10.1073/pnas.0907522106; WANG S, 1995, J CELL BIOL, V130, P519, DOI 10.1083/jcb.130.3.519; WOLIN SL, 1989, J CELL BIOL, V109, P2617, DOI 10.1083/jcb.109.6.2617; Yamagata A, 2010, GENES CELLS, V15, P29, DOI 10.1111/j.1365-2443.2009.01362.x	30	196	201	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2010	466	7310					1120	U138		10.1038/nature09296	http://dx.doi.org/10.1038/nature09296			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20676083	Green Accepted			2022-12-01	WOS:000281203600043
J	Okiyoneda, T; Barriere, H; Bagdany, M; Rabeh, WM; Du, K; Hohfeld, J; Young, JC; Lukacs, GL				Okiyoneda, Tsukasa; Barriere, Herve; Bagdany, Miklos; Rabeh, Wael M.; Du, Kai; Hoehfeld, Joerg; Young, Jason C.; Lukacs, Gergely L.			Peripheral Protein Quality Control Removes Unfolded CFTR from the Plasma Membrane	SCIENCE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; E3 UBIQUITIN LIGASE; RETICULUM-ASSOCIATED DEGRADATION; CYSTIC-FIBROSIS; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; CHIP; HSC70; CELLS; CFTR-DELTA-F508	Therapeutic efforts to restore biosynthetic processing of the cystic fibrosis transmembrane conductance regulator lacking the F508 residue (Delta F508CFTR) are hampered by ubiquitin-dependent lysosomal degradation of nonnative, rescued Delta F508CFTR from the plasma membrane. Here, functional small interfering RNA screens revealed the contribution of chaperones, cochaperones, and ubiquitin-conjugating and -ligating enzymes to the elimination of unfolded CFTR from the cell surface, as part of a peripheral protein quality-control system. Ubiquitination of nonnative CFTR was required for efficient internalization and lysosomal degradation. This peripheral protein quality-control mechanism probably participates in the preservation of cellular homeostasis by degrading damaged plasma membrane proteins that have escaped from the endoplasmic reticulum quality control or are generated by environmental stresses in situ.	[Okiyoneda, Tsukasa; Barriere, Herve; Bagdany, Miklos; Rabeh, Wael M.; Du, Kai; Lukacs, Gergely L.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Okiyoneda, Tsukasa; Barriere, Herve; Bagdany, Miklos; Rabeh, Wael M.; Du, Kai; Young, Jason C.; Lukacs, Gergely L.] McGill Univ, GRASP, Montreal, PQ H3G 1Y6, Canada; [Hoehfeld, Joerg] Univ Bonn, Inst Cell Biol, D-53121 Bonn, Germany; [Young, Jason C.] McGill Univ, Dept Chem, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; University of Bonn; McGill University	Lukacs, GL (corresponding author), McGill Univ, Dept Physiol, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	gergely.lukacs@mcgill.ca	Rabeh, Wael/AAO-4647-2020	Rabeh, Wael/0000-0001-6071-8581; Lukacs, Gergely/0000-0003-0900-0675; Okiyoneda, Tsukasa/0000-0002-5175-2224	Canadian Cystic Fibrosis Foundation; Groupe de Recherche Axe sur la Structure des Proteines (GRASP); Deutsche Forschungsgemeinschaft; Canadian Institute of Health Resources; NIH; Cystic Fibrosis Foundation Therapeutics; Canadian Foundation for Innovation	Canadian Cystic Fibrosis Foundation; Groupe de Recherche Axe sur la Structure des Proteines (GRASP); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Canadian Institute of Health Resources; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); Canadian Foundation for Innovation(Canada Foundation for Innovation)	We thank J. Tavares and C. M. Mulvihill for CHIP purification and generating CFTR-His10 cells, respectively; H. Stenmark for Hrs antibody; and H. Lewis, C. Lima, and K. Iwai for NBD1-3S, SUMO, Ulp1, and UbcH5 plasmids, respectively. Lamp1, Lamp2, and CD63 antibodies were developed by J. August and J. Hildreth (University of Iowa). T.O. and W.M.R. were supported by a Canadian Cystic Fibrosis Foundation and a Groupe de Recherche Axe sur la Structure des Proteines (GRASP) postdoctoral fellowship, respectively. This work was supported by grants to J. H. from Deutsche Forschungsgemeinschaft, J.C.Y. and G.L.L. from the Canadian Institute of Health Resources, NIH, Cystic Fibrosis Foundation Therapeutics, the Canadian Cystic Fibrosis Foundation, and the Canadian Foundation for Innovation. J.C.Y. and G.L.L. are holders of Canada Research Chairs.	Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Arndt V, 2007, CELL MOL LIFE SCI, V64, P2525, DOI 10.1007/s00018-007-7188-6; Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Bomberger JM, 2009, J BIOL CHEM, V284, P18778, DOI 10.1074/jbc.M109.001685; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Dupre S, 2004, BBA-MOL CELL RES, V1695, P89, DOI 10.1016/j.bbamcr.2004.09.024; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Grove DE, 2009, MOL BIOL CELL, V20, P4059, DOI 10.1091/mbc.E08-09-0929; Harada K, 2006, J BIOL CHEM, V281, P12841, DOI 10.1074/jbc.M512975200; Hayashi H, 2009, MOL PHARMACOL, V75, P143, DOI 10.1124/mol.108.049288; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Okiyoneda T, 2004, MOL BIOL CELL, V15, P563, DOI 10.1091/mbc.E03-06-0379; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Tzankov S, 2008, J BIOL CHEM, V283, P27100, DOI 10.1074/jbc.M803923200; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	38	321	322	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					805	810		10.1126/science.1191542	http://dx.doi.org/10.1126/science.1191542			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20595578	Green Accepted			2022-12-01	WOS:000280809900042
J	Ephgrave, KS				Ephgrave, Kimberly S.			Maintenance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												kimberly-ephgrave@uiowa.edu							0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2010	304	6					615	616		10.1001/jama.2010.1118	http://dx.doi.org/10.1001/jama.2010.1118			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637PA	20699446				2022-12-01	WOS:000280829200001
J	Shannon, K; Csete, J				Shannon, Kate; Csete, Joanne			Violence, Condom Negotiation, and HIV/STI Risk Among Sex Workers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HIV; INTERVENTIONS; PREVENTION; POLICY		[Shannon, Kate] Univ British Columbia, BC Ctr Excellence HIV AIDS, Dept Med, Div Aids, Vancouver, BC V6Z 1Y6, Canada; [Shannon, Kate] Univ British Columbia, Fac Med, Vancouver, BC V6Z 1Y6, Canada; [Csete, Joanne] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of British Columbia; Columbia University	Shannon, K (corresponding author), Univ British Columbia, BC Ctr Excellence HIV AIDS, Dept Med, Div Aids, 608-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	kshannon@cfenet.ubc.ca						Blankenship KM, 2002, J LAW MED ETHICS, V30, P548, DOI 10.1111/j.1748-720X.2002.tb00425.x; Cohen J, 2004, SCIENCE, V304, P506, DOI 10.1126/science.304.5670.506; Decker MR, 2010, SEX TRANSM INFECT, V86, P236, DOI 10.1136/sti.2009.037846; Kerrigan D, 2006, AM J PUBLIC HEALTH, V96, P120, DOI 10.2105/AJPH.2004.042200; *OP SOC I, SEX WORK ACT NETW AR; Rekart ML, 2005, LANCET, V366, P2123, DOI 10.1016/S0140-6736(05)67732-X; Rhodes T., 2008, BMJ-BRIT MED J, V337/7669, P560; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Shannon K, 2009, AM J PUBLIC HEALTH, V99, P659, DOI 10.2105/AJPH.2007.129858; Shannon Kate, 2009, BRIT MED J, V339, P442	10	170	172	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2010	304	5					573	574		10.1001/jama.2010.1090	http://dx.doi.org/10.1001/jama.2010.1090			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	633SQ	20682941				2022-12-01	WOS:000280525700029
J	Taylor, DR				Taylor, Daniel R.			The Haircut	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												daniel.taylor@drexelmed.edu	taylor, daniel/GYU-3348-2022					Canada G., 1995, FIST STICK KNIFE GUN; FERRICK TA, 2007, PHILADELPHIA INQ 072; Hurt H, 2001, ARCH PEDIAT ADOL MED, V155, P1351, DOI 10.1001/archpedi.155.12.1351; PRESTON SH, 2006, WASHINGTON POST 0826	4	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2010	304	5					504	505		10.1001/jama.2010.1085	http://dx.doi.org/10.1001/jama.2010.1085			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633SQ	20682924				2022-12-01	WOS:000280525700001
J	Song, H; Hu, JX; Chen, W; Elliott, G; Andre, P; Gao, B; Yang, YZ				Song, Hai; Hu, Jianxin; Chen, Wen; Elliott, Gene; Andre, Philipp; Gao, Bo; Yang, Yingzi			Planar cell polarity breaks bilateral symmetry by controlling ciliary positioning	NATURE			English	Article							LEFT-RIGHT ASYMMETRY; NODAL EXPRESSION; GENE-EXPRESSION; SITUS-INVERSUS; LEFTWARD FLOW; PATHWAYS; MOUSE; ESTABLISHMENT; POLARIZATION; REGULATOR	Defining the three body axes is a central event of vertebrate morphogenesis. Establishment of left-right (L-R) asymmetry in development follows the determination of dorsal-ventral and anterior-posterior (A-P) body axes 1,2, although the molecular mechanism underlying precise L-R symmetry breaking in reference to the other two axes is still poorly understood. Here, by removing both Vangl1 and Vangl2, the two mouse homologues of a Drosophila core planar cell polarity (PCP) gene Van Gogh (Vang), we reveal a previously unrecognized function of PCP in the initial breaking of lateral symmetry. The leftward nodal flow across the posterior notochord (PNC) has been identified as the earliest event in the de novo formation of L-R asymmetry(3,4). We show that PCP is essential in interpreting the A-P patterning information and linking it to L-R asymmetry. In the absence of Vangl1 and Vangl2, cilia are positioned randomly around the centre of the PNC cells and nodal flow is turbulent, which results in disrupted L-R asymmetry. PCP in mouse, unlike what has been implicated in other vertebrate species, is not required for ciliogenesis, cilium motility, Sonic hedgehog (Shh) signalling or apical docking of basal bodies in ciliated tracheal epithelial cells. Our data suggest that PCP acts earlier than the unidirectional nodal flow during bilateral symmetry breaking in vertebrates and provide insight into the functional mechanism of PCP in organizing the vertebrate tissues in development.	[Song, Hai; Hu, Jianxin; Chen, Wen; Andre, Philipp; Gao, Bo; Yang, Yingzi] NHGRI, Dev Genet Sect, Genet Dis Res Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Yang, YZ (corresponding author), NHGRI, Dev Genet Sect, Genet Dis Res Branch, Bethesda, MD 20892 USA.	yingzi@mail.nih.gov		Gao, Bo/0000-0002-8684-5199	National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200349, ZIAHG000187, ZIAHG200342] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank members of the Yang laboratory for stimulating discussion; M. Kuehn, A. Kumar and J. Regard for critical reading of the manuscript; J. Fekecs and D. Leja for preparing the graphics; D. Wu for teaching us to dissect the mouse cochlea; and M. Kelley for the anti-Vangl2 antibodies. This study is supported by the intramural research programme of National Human Genome Research Institute.	Axelrod Jeffrey D, 2002, ScientificWorldJournal, V2, P434; Blum M, 2007, DIFFERENTIATION, V75, P133, DOI 10.1111/j.1432-0436.2006.00124.x; Borovina A, 2010, NAT CELL BIOL, V12, P407, DOI 10.1038/ncb2042; BROWN NA, 1990, DEVELOPMENT, V109, P1; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Gros J, 2009, SCIENCE, V324, P941, DOI 10.1126/science.1172478; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hashimoto M, 2010, NAT CELL BIOL, V12, P170, DOI 10.1038/ncb2020; Hayashi S, 2003, GENESIS, V37, P51, DOI 10.1002/gene.10225; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; Kishimoto N, 2008, DEV CELL, V14, P954, DOI 10.1016/j.devcel.2008.03.010; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; Lee JD, 2008, DEV DYNAM, V237, P3464, DOI 10.1002/dvdy.21598; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; Maisonneuve C, 2009, DEVELOPMENT, V136, P3019, DOI 10.1242/dev.038174; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Nakamura T, 2006, DEV CELL, V11, P495, DOI 10.1016/j.devcel.2006.08.002; Nonaka S, 2005, PLOS BIOL, V3, P1467, DOI 10.1371/journal.pbio.0030268; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; POOLE CA, 1985, CELL MOTIL CYTOSKEL, V5, P175, DOI 10.1002/cm.970050302; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Tabin CJ, 2006, CELL, V127, P27, DOI 10.1016/j.cell.2006.09.018; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Wilhelmi H, 1921, ARCH ENTWICKLUNG ORG, V48, P517, DOI 10.1007/BF02554577; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7	32	211	213	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2010	466	7304					378	U130		10.1038/nature09129	http://dx.doi.org/10.1038/nature09129			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20562861	Green Accepted			2022-12-01	WOS:000279867100051
J	Guenther, MG; Young, RA				Guenther, Matthew G.; Young, Richard A.			Repressive Transcription	SCIENCE			English	Editorial Material							GENE-EXPRESSION; NONCODING RNAS; CHROMATIN; POLYCOMB; PROTEINS; CELLS		[Guenther, Matthew G.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Guenther, MG (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	NHGRI NIH HHS [R01 HG002668, R01 HG002668-07] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Buratowski S, 2008, SCIENCE, V322, P1804, DOI 10.1126/science.1168805; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; TSAI MC, 2010, SCIENCE         0708, DOI DOI 10.1126/SCIENCE.1192002; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	17	39	40	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					150	151		10.1126/science.1193995	http://dx.doi.org/10.1126/science.1193995			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616255	Green Accepted, Green Submitted			2022-12-01	WOS:000279635200022
J	Beck, CR; Collier, P; Macfarlane, C; Malig, M; Kidd, JM; Eichler, EE; Badge, RM; Moran, JV				Beck, Christine R.; Collier, Pamela; Macfarlane, Catriona; Malig, Maika; Kidd, Jeffrey M.; Eichler, Evan E.; Badge, Richard M.; Moran, John V.			LINE-1 Retrotransposition Activity in Human Genomes	CELL			English	Article							HIGH-FREQUENCY RETROTRANSPOSITION; MULTIPLE SEQUENCE ALIGNMENT; HUMAN L1 RETROTRANSPOSITION; CULTURED HUMAN-CELLS; STRUCTURAL VARIATION; TRANSCRIPTION INITIATION; MAMMALIAN-CELLS; ELEMENTS; ENDONUCLEASE; DIVERSITY	Highly active (i.e., "hot") long interspersed element-1 (LINE-1 or L1) sequences comprise the bulk of retrotransposition activity in the human genome; however, the abundance of hot L1s in the human population remains largely unexplored. Here, we used a fosmid-based, paired-end DNA sequencing strategy to identify 68 full-length L1s that are differentially present among individuals but are absent from the human genome reference sequence. The majority of these L1s were highly active in a cultured cell retrotransposition assay. Genotyping 26 elements revealed that two L1s are only found in Africa and that two more are absent from the H952 subset of the Human Genome Diversity Panel. Therefore, these results suggest that hot L1s are more abundant in the human population than previously appreciated, and that ongoing L1 retrotransposition continues to be a major source of interindividual genetic variation.	[Beck, Christine R.; Moran, John V.] Univ Michigan, Dept Human Genet, Sch Med, Ann Arbor, MI 48109 USA; [Moran, John V.] Univ Michigan, Dept Internal Med, Sch Med, Ann Arbor, MI 48109 USA; [Moran, John V.] Univ Michigan, Howard Hughes Med Inst, Sch Med, Ann Arbor, MI 48109 USA; [Collier, Pamela; Macfarlane, Catriona; Badge, Richard M.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Malig, Maika; Kidd, Jeffrey M.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Leicester; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Beck, CR (corresponding author), Univ Michigan, Dept Human Genet, Sch Med, Ann Arbor, MI 48109 USA.	cregina@umich.edu; moranj@umich.edu		Badge, Richard/0000-0003-3201-336X; Kidd, Jeffrey/0000-0002-9631-1465; macfarlane, catriona/0000-0002-4733-5356	NIH [T32GM7544, T32000040, GM066695, GM060518]; National Science Foundation; Wellcome Trust [075163/Z/04/Z]; University of Michigan Cancer Center [5P30CA46592];  [HG004120]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000040, P01HG004120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544, R01GM060518, R01GM066695, R01GM082970] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Michigan Cancer Center(University of Michigan System); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Professor Sir Alec Jeffreys FRS for access to CEPH and Zimbabwean DNA samples and Professor Mark Jobling for access to HGDP DNA samples. We thank Dr. Elizabeth Marchani for advice on maximum likelihood age estimates and Dr. Jose Luis Garcia-Perez for plasmid JJ105/L1.3. We thank Dr. Garcia-Perez and members of the Moran lab for helpful comments. C. R. B. was supported in part by NIH training grants T32GM7544 and T32000040. J.M.K. was supported by a National Science Foundation Graduate Research Fellowship. Work in the laboratory of E. E. E. was supported by grant HG004120. P. C. and C. M. were supported by a Wellcome Trust Project Grant (075163/Z/04/Z) to R. M. B. and Professor Sir Alec Jeffreys FRS. J.V.M. is supported by NIH grants GM066695 and GM060518. The University of Michigan Cancer Center Support Grant (5P30CA46592) helped defray sequencing costs incurred in this study. J.V.M. and E. E. E. are Investigators of the Howard Hughes Medical Institute. E. E. E. is a member of the SAB for Pacific Biosciences.	Alisch RS, 2006, GENE DEV, V20, P210, DOI 10.1101/gad.1380406; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Athanikar JN, 2004, NUCLEIC ACIDS RES, V32, P3846, DOI 10.1093/nar/gkh698; Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Badge RM, 2003, AM J HUM GENET, V72, P823, DOI 10.1086/373939; Bennett EA, 2008, GENOME RES, V18, P1875, DOI 10.1101/gr.081737.108; Bennettt EA, 2004, GENETICS, V168, P933, DOI 10.1534/genetics.104.031757; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Boeke JD, 2003, GENOME RES, V13, P1975, DOI 10.1101/gr.1392003; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Boissinot S, 2004, GENOME RES, V14, P1221, DOI 10.1101/gr.2326704; Boissinot SP, 2001, MOL BIOL EVOL, V18, P2186, DOI 10.1093/oxfordjournals.molbev.a003765; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Brouha B, 2002, AM J HUM GENET, V71, P327, DOI 10.1086/341722; Cann HM, 2002, SCIENCE, V296, P261; Carroll ML, 2001, J MOL BIOL, V311, P17, DOI 10.1006/jmbi.2001.4847; Cordaux R, 2004, TRENDS GENET, V20, P464, DOI 10.1016/j.tig.2004.07.012; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cost GJ, 1998, BIOCHEMISTRY-US, V37, P18081, DOI 10.1021/bi981858s; DEININGER PL, 1992, TRENDS GENET, V8, P307, DOI 10.1016/0168-9525(92)90262-3; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; DOMBROSKI BA, 1993, P NATL ACAD SCI USA, V90, P6513, DOI 10.1073/pnas.90.14.6513; Donahue William F, 2007, Curr Protoc Hum Genet, VChapter 5, DOI 10.1002/0471142905.hg0520s54; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feisenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; FREEMAN JD, 1994, BIOTECHNIQUES, V17, P46; Frikke-Schmidt R, 2010, ATHEROSCLEROSIS, V208, P305, DOI 10.1016/j.atherosclerosis.2009.06.005; Garcia-Perez JL, 2007, GENOME RES, V17, P602, DOI 10.1101/gr.5870107; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; GRIMALDI G, 1983, NUCLEIC ACIDS RES, V11, P321, DOI 10.1093/nar/11.2.321; Han KD, 2005, GENOME RES, V15, P655, DOI 10.1101/gr.3492605; HOLMES SE, 1994, NAT GENET, V7, P143, DOI 10.1038/ng0694-143; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kimberland ML, 1999, HUM MOL GENET, V8, P1557, DOI 10.1093/hmg/8.8.1557; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lavie L, 2004, GENOME RES, V14, P2253, DOI 10.1101/gr.2745804; Lutz SM, 2003, AM J HUM GENET, V73, P1431, DOI 10.1086/379744; Marchani EE, 2009, GENOMICS, V94, P78, DOI 10.1016/j.ygeno.2009.04.002; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Morrish TA, 2007, NATURE, V446, P208, DOI 10.1038/nature05560; Myers JS, 2002, AM J HUM GENET, V71, P312, DOI 10.1086/341718; Ovchinnikov I, 2001, GENOME RES, V11, P2050, DOI 10.1101/gr.194701; Penzkofer T, 2005, NUCLEIC ACIDS RES, V33, pD498, DOI 10.1093/nar/gki044; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Sambrook J., 1989, MOL CLONING LAB MANU; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Seleme MDC, 2006, P NATL ACAD SCI USA, V103, P6611, DOI 10.1073/pnas.0601324103; Sheen FM, 2000, GENOME RES, V10, P1496, DOI 10.1101/gr.149400; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Tarraga J, 2007, NUCLEIC ACIDS RES, V35, pW38, DOI 10.1093/nar/gkm224; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang JX, 2006, HUM MUTAT, V27, P323, DOI 10.1002/humu.20307; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wei W, 2000, ANAL BIOCHEM, V284, P435, DOI 10.1006/abio.2000.4675; Weichenrieder O, 2004, STRUCTURE, V12, P975, DOI 10.1016/j.str.2004.04.011; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Xing JC, 2009, GENOME RES, V19, P1516, DOI 10.1101/gr.091827.109	77	378	385	1	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 25	2010	141	7					1159	U110		10.1016/j.cell.2010.05.021	http://dx.doi.org/10.1016/j.cell.2010.05.021			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20602998	Green Accepted, Bronze			2022-12-01	WOS:000279148100013
J	Einfeld, SL; Brown, R				Einfeld, Stewart L.; Brown, Rebecca			Down Syndrome-New Prospects for an Ancient Disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DOWN-SYNDROME; CHROMOSOME-21; RESCUE		[Einfeld, Stewart L.] Univ Sydney, Fac Hlth Sci, Camperdown, NSW 2050, Australia; [Einfeld, Stewart L.; Brown, Rebecca] Univ Sydney, Brain & Mind Res Inst, Camperdown, NSW 2050, Australia	University of Sydney; University of Sydney	Einfeld, SL (corresponding author), Univ Sydney, Fac Hlth Sci, BMRI Level 3,94 Mallett St, Camperdown, NSW 2050, Australia.	stewart.einfeld@sydney.edu.au						Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Costa ACS, 2008, NEUROPSYCHOPHARMACOL, V33, P1624, DOI 10.1038/sj.npp.1301535; Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114; Down John Langdon, 1866, CLIN LECT REPORTS LO, V3, P259; Guedj F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004606; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; Rachidi M, 2008, EUR J PAEDIATR NEURO, V12, P168, DOI 10.1016/j.ejpn.2007.08.010; Richard F, 1998, CHROMOSOME RES, V6, P263, DOI 10.1023/A:1009262622325; Shin M, 2009, PEDIATRICS, V124, P1565, DOI 10.1542/peds.2009-0745; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310	10	5	5	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2010	303	24					2525	2526		10.1001/jama.2010.842	http://dx.doi.org/10.1001/jama.2010.842			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	613VM	20571021				2022-12-01	WOS:000279010900033
J	Engemise, S; Gordon, C; Konje, JC				Engemise, Samuel; Gordon, Cerys; Konje, Justin C.			Easily Missed Endometriosis	BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSIS; WOMEN; ACCURACY		[Engemise, Samuel; Konje, Justin C.] Univ Hosp Leicester NHS Trust, Dept Canc Studies & Mol Med, Reprod Sci Sect, Leicester LE2 7LX, Leics, England; [Engemise, Samuel; Konje, Justin C.] Univ Leicester, Leicester LE2 7LX, Leics, England; [Gordon, Cerys] S Wigston Hlth Ctr, Wigston LE18 4SE, England	University Hospitals of Leicester NHS Trust; University of Leicester; University of Leicester	Konje, JC (corresponding author), Univ Hosp Leicester NHS Trust, Dept Canc Studies & Mol Med, Reprod Sci Sect, Leicester LE2 7LX, Leics, England.	jck4@le.ac.uk						Ballard KD, 2008, BJOG-INT J OBSTET GY, V115, P1382, DOI 10.1111/j.1471-0528.2008.01878.x; Barnard A., 2001, PAIN OBSTET GYNAECOL, P145; CARTER JE, 1994, J AM ASSOC GYN LAP, V2, P43, DOI 10.1016/S1074-3804(05)80830-8; Cramer DW, 2002, ANN NY ACAD SCI, V955, P11, DOI 10.1111/j.1749-6632.2002.tb02761.x; *EUR NETW END, INTR; Kennedy S, 2005, HUM REPROD, V20, P2698, DOI 10.1093/humrep/dei135; Laufer M R, 1997, J Pediatr Adolesc Gynecol, V10, P199; Lockhat FB, 2005, HUM REPROD, V20, P789, DOI 10.1093/humrep/deh650; Louden Sally F., 1995, Journal of Obstetrics and Gynaecology (Abingdon), V15, P307, DOI 10.3109/01443619509030929; MEURSSZOJDA MM, 2009, COLORECTAL DIS  1013; Moore J, 2002, ULTRASOUND OBST GYN, V20, P630, DOI 10.1046/j.1469-0705.2002.00862.x; *NHS EV, WOM HLTH ANN EV UPD; Rosa-e-Silva JC, 2008, CLIMACTERIC, V11, P525, DOI 10.1080/13697130802490256; *ROYAL COLL OBST G, 2007, INV MAN END; Winkel CA, 2003, OBSTET GYNECOL, V102, P397, DOI 10.1016/S0029-7844(03)00474-5; Wykes CB, 2004, BJOG-INT J OBSTET GY, V111, P1204, DOI 10.1111/j.1471-0528.2004.00433.x	16	14	15	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 23	2010	340								c2168	10.1136/bmj.c2168	http://dx.doi.org/10.1136/bmj.c2168			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618IP	20573761				2022-12-01	WOS:000279346400001
J	Bartsch, T; Schonfeld, R; Muller, FJ; Alfke, K; Leplow, B; Aldenhoff, J; Deuschl, G; Koch, JM				Bartsch, T.; Schoenfeld, R.; Mueller, F. J.; Alfke, K.; Leplow, B.; Aldenhoff, J.; Deuschl, G.; Koch, J. M.			Focal Lesions of Human Hippocampal CA1 Neurons in Transient Global Amnesia Impair Place Memory	SCIENCE			English	Article							SPATIAL MEMORY; RECOGNITION MEMORY; DAMAGE; RATS; REPRESENTATIONS; CLASSIFICATION; NAVIGATION; DEFICITS; SYSTEM; SECTOR	A critical role in place learning has been attributed to place cells within the cornu ammonis 1 (CA1) sector of the hippocampus in rodents. The role of CA1 cells in the human hippocampus with regard to place learning remains elusive. Using a virtual Morris water maze, we investigated patients with acute transient global amnesia (TGA), a rare self-limiting dysfunction of the hippocampal system. Fourteen individuals with selective and focal lesions in the CA1 sector of the hippocampus showed a profound impairment in place learning. The size of the lesions and the duration of the TGA correlated with the deficit in the performance.	[Bartsch, T.; Deuschl, G.] Univ Kiel, Dept Neurol, Univ Hosp Schleswig Holstein, D-2300 Kiel, Germany; [Schoenfeld, R.; Leplow, B.] Univ Halle Wittenberg, Inst Psychol, Halle, Germany; [Mueller, F. J.; Aldenhoff, J.; Koch, J. M.] Univ Kiel, Dept Psychiat, Univ Hosp Schleswig Holstein, D-2300 Kiel, Germany; [Alfke, K.] Univ Kiel, Inst Neuroradiol, Univ Hosp Schleswig Holstein, D-2300 Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; Martin Luther University Halle Wittenberg; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Bartsch, T (corresponding author), Univ Kiel, Dept Neurol, Univ Hosp Schleswig Holstein, D-2300 Kiel, Germany.	t.bartsch@neurologie.uni-kiel.de	Aldenhoff, Josef/E-9469-2010; Müller, Franz-Josef/E-3336-2010; Bartsch, Thorsten/F-9950-2010; Bartsch, Thorsten/AAR-5564-2021; Deuschl, Gunther/A-7986-2010	Müller, Franz-Josef/0000-0001-9478-8430; Bartsch, Thorsten/0000-0001-8387-5731; Bartsch, Thorsten/0000-0001-8387-5731; Deuschl, Gunther/0000-0002-4176-9196	Deutsche Forschungsgemeinschaft [SFB 654, KO 2067/1-2]; Faculty of Medicine, University of Kiel, Germany; Else Kroner-Fresenius-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Faculty of Medicine, University of Kiel, Germany; Else Kroner-Fresenius-Stiftung	We thank O. Jansen for helpful input and support and R. Rosentrager for technical assistance. This study has been supported by the Deutsche Forschungsgemeinschaft [to T.B., grant SFB 654 (TP A14); to J.M.K., grant KO 2067/1-2]; the Faculty of Medicine, University of Kiel, Germany (to T. B. and F.J.M.); and the Else Kroner-Fresenius-Stiftung (to F.J.M.). K.A. is currently affiliated with the Institute of Radiology and Neuroradiology, HELIOS Kliniken, Schwerin, Germany.	Abrahams S, 1997, NEUROPSYCHOLOGIA, V35, P11, DOI 10.1016/S0028-3932(96)00051-6; AUER RN, 1989, J NEUROSCI, V9, P1641; BACHEVALIER J, 1989, NEUROPSYCHOLOGIA, V27, P83, DOI 10.1016/0028-3932(89)90092-4; Bartsch T, 2008, NEUROLOGY, V70, P1030, DOI 10.1212/01.wnl.0000306633.06027.33; Bartsch T, 2006, BRAIN, V129, P2874, DOI 10.1093/brain/awl248; Bartsch T, 2007, ANN NEUROL, V62, P475, DOI 10.1002/ana.21189; Bartsch T, 2010, LANCET NEUROL, V9, P205, DOI 10.1016/S1474-4422(09)70344-8; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cianfoni A, 2005, ARCH NEUROL-CHICAGO, V62, P1468, DOI 10.1001/archneur.62.9.1468; Clark RE, 2000, J NEUROSCI, V20, P8853; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Epstein RA, 2008, TRENDS COGN SCI, V12, P388, DOI 10.1016/j.tics.2008.07.004; Griffin AL, 2007, J NEUROSCI, V27, P2416, DOI 10.1523/JNEUROSCI.4083-06.2007; Hartley T, 2003, NEURON, V37, P877, DOI 10.1016/S0896-6273(03)00095-3; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P834, DOI 10.1136/jnnp.53.10.834; Lavenex PB, 2006, J NEUROSCI, V26, P4546, DOI 10.1523/JNEUROSCI.5412-05.2006; Lee HY, 2007, NEURORADIOLOGY, V49, P481, DOI 10.1007/s00234-007-0213-5; Maguire EA, 1997, PHILOS T R SOC B, V352, P1475, DOI 10.1098/rstb.1997.0134; McNaughton BL, 1996, J EXP BIOL, V199, P173; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MOSER E, 1993, J NEUROSCI, V13, P3916; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Schoenfeld R, 2010, BEHAV BRAIN RES, V208, P169, DOI 10.1016/j.bbr.2009.11.022; Sedlaczek O, 2004, NEUROLOGY, V62, P2165, DOI 10.1212/01.WNL.0000130504.88404.C9; Spiers HJ, 2001, NEUROCASE, V7, P357, DOI 10.1076/neur.7.5.357.16245; Weon YC, 2008, AM J NEURORADIOL, V29, P1324, DOI 10.3174/ajnr.A1105; WHISHAW IQ, 1994, BRAIN RES BULL, V34, P283, DOI 10.1016/0361-9230(94)90065-5; Wolbers T, 2005, J NEUROSCI, V25, P3333, DOI 10.1523/JNEUROSCI.4705-04.2005; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950	33	118	122	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 11	2010	328	5984					1412	1415		10.1126/science.1188160	http://dx.doi.org/10.1126/science.1188160			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	608PO	20538952				2022-12-01	WOS:000278598400043
